<SEC-DOCUMENT>0001140361-25-035263.txt : 20250917
<SEC-HEADER>0001140361-25-035263.hdr.sgml : 20250917
<ACCEPTANCE-DATETIME>20250917164551
ACCESSION NUMBER:		0001140361-25-035263
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		53
FILED AS OF DATE:		20250917
DATE AS OF CHANGE:		20250917

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CoreWeave, Inc.
		CENTRAL INDEX KEY:			0001769628
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				823060021
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-289742
		FILM NUMBER:		251320635

	BUSINESS ADDRESS:	
		STREET 1:		290 W. MT. PLEASANT AVENUE, SUITE 4100
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039
		BUSINESS PHONE:		(973) 270-9737

	MAIL ADDRESS:	
		STREET 1:		290 W. MT. PLEASANT AVENUE, SUITE 4100
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atlantic Crypto Corp
		DATE OF NAME CHANGE:	20190304
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>ny20053122x2_s4a.htm
<DESCRIPTION>S-4/A
<TEXT>
<html><head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head><body style="color: #000000;" bgcolor="#ffffff">
<!--Begin Page 1-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 540pt;"><a name="ny20053122x2_s4a_100-regcov_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25pt; text-align: center;">As filed with the U.S. Securities and Exchange Commission on September 17, 2025 </div> <div class="BRDSX_regno" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 1pt; text-align: right;">Registration No. 333-289742 </div> </div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div><div class="BRDSX_block-main" style="width: 540pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13pt; font-weight: bold; margin-top: 8.75pt; text-align: center;">UNITED STATES <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 13pt; font-weight: bold; margin-top: 0pt; text-align: center;">SECURITIES AND EXCHANGE COMMISSION <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 12pt;"><font style="font-size: 12pt;">Washington, D.C. 20549 </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 6pt; text-align: center;">Amendment No. 1<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">to<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">FORM S-4 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;">REGISTRATION STATEMENT <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">UNDER</font><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 12pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-style: italic;">THE SECURITIES ACT OF 1933</font><font style="font-weight: normal;"> </font></div> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 18pt; font-weight: bold; margin-top: 8pt; text-align: center;">COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 9pt;"><font style="font-size: 9pt;">(Exact Name of Registrant as Specified in Its Charter) </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 172pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Delaware<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(State or Other Jurisdiction of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Incorporation or Organization)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">7372<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Primary Standard Industrial<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Classification Code Number)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">82-3060021 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(I. R. S. Employer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Identification Number)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 3pt; text-align: center;">290 W Mt. Pleasant Ave., Suite 4100 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Livingston, NJ 07039 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(973) 270-9737 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)<font style="font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 5pt; text-align: center;">Michael Intrator <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 0pt; text-align: center;">Chief Executive Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 0pt; text-align: center;">290 W Mt. Pleasant Ave., Suite 4100 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 0pt; text-align: center;">Livingston, NJ 07039 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.1pt; font-weight: bold; margin-top: 0pt; text-align: center;">(973) 270-9737 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-weight: bold; margin-top: 0pt; text-align: center; font-size: 8.9pt;"><font style="font-size: 8.9pt;">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</font><font style="font-size: 8.9pt; font-weight: normal;"> </font></div><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 96pt; border-bottom: 1pt solid #000000; margin-bottom: 2pt; margin-left: auto; margin-right: auto; margin-top: 4.75pt;"> </div></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-style: italic; font-weight: bold; margin-top: 5pt; text-align: center;">Copies to:</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 172pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Michael Gilson, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Michael Kaplan, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Tierney O&#8217;Rourke, Esq.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Hillary A. Coleman, Esq.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Davis Polk &amp; Wardwell LLP<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">900 Middlefield Road, Suite 200<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redwood City, California 94063<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(650) 752-2000</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Kristen McVeety<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">General Counsel<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Nisha Antony<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deputy General Counsel<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave, Inc.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">290 W Mt. Pleasant Ave., Suite 4100<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Livingston, NJ 07039<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(973) 270-9737</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 172pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">David A. Katz, Esq. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Karessa L. Cain, Esq.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">Wachtell, Lipton, Rosen &amp; Katz<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">51 West 52nd Street<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">New York, New York 10019<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9pt; font-weight: bold; margin-top: 0pt; text-align: center;">(212) 403-1000</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3pt; width: 172pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Approximate date of commencement of proposed sale to the public: <font style="font-weight: normal;">From time to time after this Registration Statement becomes effective and upon completion of the merger of Miami Merger Sub I, Inc., a wholly owned subsidiary of CoreWeave, Inc., with and into Core Scientific, Inc. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the securities being registered on this form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, check the following box. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If this form is a post-effective amendment filed pursuant to Rule&#160;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Securities Exchange Act of 1934. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: -2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: -2pt; width: 540pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 240pt; padding-bottom: 0.53pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;&#8195;Large accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.2pt;">&#x2610;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.2pt;">&#x2610; </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.19pt; padding-bottom: 0.53pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;&#8195;Non-accelerated filer</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.19pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#x2612;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 0.19pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Smaller reporting company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.49pt; padding-bottom: 0.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.2pt;">&#x2610; </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.19pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.19pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 0.19pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Emerging growth company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.49pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 1pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;<font style="font-size: 9.2pt;">&#x2610;</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.05pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.05pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Securities Exchange Act Rule&#160;13e-4(i) (Cross-Border Issuer Tender Offer) <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Securities Exchange Act Rule&#160;14d-l(d) (Cross-Border Third-Party Tender Offer) <font style="font-size: 1pt;">&#8201;</font>&#x2610; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8.9pt; font-weight: bold; margin-top: 3pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the U.S. Securities and Exchange Commission acting pursuant to said Section&#160;8(a), may determine.<font style="font-weight: normal;"> </font></div></div><div class="BRDSX_block-frill" style="width: 540pt; margin-top: 12pt; margin-left: 0pt;"><div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 1pt solid #000000; margin-top: 1pt; margin-bottom: 1pt; margin-left: auto; margin-right: auto;"> </div><div class="BRDSX_rule-full" style="height: 0pt; width: 100%; border-bottom: 2pt solid #000000; margin-bottom: 1pt; margin-left: auto; margin-right: auto; margin-top: 4pt;"> </div></div></div></div>
<!--End Page 1-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 2-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20053122x2_s4a_101-letter_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"> <div class="BRDSX_h1" style="color: #FC0014; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><div style="font-family: Arial, Helvetica, sans-serif; text-align: left; margin-bottom: 12pt;">Information contained herein is subject to completion or amendment. A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. The attached proxy statement/prospectus shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.</div>PRELIMINARY&#8212;SUBJECT TO COMPLETION&#8212;DATED SEPTEMBER 17, 2025<font style="color: #000000;"> </font></div> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 25.25pt; text-align: center;"><img style="height: 53px; width: 310px;" src="logo_corescientific.jpg"><br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">TRANSACTION PROPOSED&#8212;YOUR VOTE IS VERY IMPORTANT </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-align: left;">Dear Stockholders of Core Scientific, Inc.: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You are cordially invited to attend a special meeting (including any adjournments or postponements thereof, which we refer to as the &#8220;Special Meeting&#8221;) of stockholders of Core Scientific, Inc., a Delaware corporation (&#8220;Core&#160;Scientific&#8221;), to be held virtually via live webcast on [&#8195;] beginning at [&#8195;], Eastern Time (unless the Special Meeting is adjourned or postponed). Core Scientific stockholders will be able to virtually attend and vote at the Special Meeting by visiting www.virtualshareholdermeeting.com/CORZ2025SM, which we refer to as the &#8220;Special Meeting website.&#8221; For purposes of attendance at the Special Meeting, all references in the enclosed proxy statement/prospectus to &#8220;present&#8221; or &#8220;presence&#8221; will mean virtually present at the Special Meeting, and to &#8220;attend&#8221; or &#8220;attendance&#8221; will mean to attend or be in attendance at the Special Meeting through virtual means. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the Special Meeting, you will be asked to consider and vote on (a)&#160;a proposal to adopt the Agreement and Plan of Merger, dated as of July&#160;7, 2025 (as it may be amended from time to time, the &#8220;Merger Agreement&#8221;), by and among Core Scientific, CoreWeave, Inc., a Delaware corporation (&#8220;CoreWeave&#8221;) and Miami Merger Sub&#160;I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave (&#8220;Merger Sub&#8221;) pursuant to which and subject to the terms and conditions set forth therein, Merger Sub will merge with and into Core Scientific (the &#8220;Merger&#8221;), with Core Scientific continuing as the surviving company in the Merger and as a wholly owned subsidiary of Parent (the &#8220;Merger Agreement Proposal&#8221;) and (b)&#160;a proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger Agreement and the transactions contemplated by the Merger Agreement (the &#8220;Advisory Compensation Proposal&#8221;). </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the terms and conditions set forth in the Merger Agreement, at the effective time, by virtue of the Merger, each share of Core Scientific common stock, par value $0.00001 per share (&#8220;Core Scientific common stock&#8221;) (other than each share of Core Scientific common stock held in treasury or held or owned by Core Scientific, CoreWeave or Merger Sub immediately prior to the effective time (collectively, the &#8220;excluded shares&#8221;)), outstanding immediately prior to the effective time will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of Class&#160;A common stock of CoreWeave, par value $0.000005 per share (&#8220;CoreWeave common stock&#8221;) (such number of shares, the &#8220;exchange ratio,&#8221; and such consideration, the &#8220;Share Consideration&#8221;). No fractional shares of CoreWeave common stock will be delivered to any holder of shares of Core Scientific common stock upon completion of the Merger. Instead, all fractional shares of CoreWeave common stock that a holder of shares of Core Scientific common stock would otherwise be entitled to receive as a result of the Merger will be aggregated and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from the sale of such fractional share by the exchange agent in the Merger (&#8220;the exchange agent&#8221;) for the account of such holder, without interest and subject to any applicable withholding taxes (together with the Share Consideration, the &#8220;Merger Consideration&#8221;), in accordance with the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s board of directors (the &#8220;Core Scientific board&#8221;) has unanimously approved the Merger Agreement and recommends that Core Scientific&#8217;s stockholders vote in favor of adopting the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on CoreWeave&#8217;s closing stock price on [&#8195;], 2025, the most recent practicable date for which such information was available, the Merger Consideration represented approximately $[&#8195;] in implied value per share of Core Scientific common stock, which represents a premium of approximately [&#8195;]% over the closing price of the Core Scientific common stock on June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions. The value of the Merger Consideration to be received in exchange for each share of Core Scientific common stock will fluctuate with the market value of CoreWeave common stock until the Merger is complete. Core Scientific common stock is listed on The Nasdaq Global Select Market (the &#8220;Nasdaq&#8221;) under the symbol &#8220;CORZ&#8221;. CoreWeave common stock is listed on the Nasdaq under the symbol &#8220;CRWV&#8221;. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave cannot complete the Merger without adoption of the Merger Agreement by the affirmative vote of holders of a majority of the outstanding shares of Core Scientific common stock as of the Core Scientific record date and entitled to vote thereon. The failure by a Core Scientific stockholder to submit a vote and any abstention by a Core Scientific stockholder from voting will </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: justify;">have the same effect as a vote &#8220;AGAINST&#8221; the proposal to adopt the Merger Agreement. If you hold your<br></div></div></div></div>
<!--End Page 2-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 3-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 456pt;"><a name="ny20053122x2_s4a_101-letter_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 456pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">shares in &#8220;street name,&#8221; the failure to instruct your broker, bank or other nominee on how to vote your shares will have the same effect as a vote &#8220;AGAINST&#8221; the proposal to adopt the Merger Agreement.<font style="font-weight: normal;"> Core Scientific is holding the Special Meeting to vote on the proposal necessary to complete the Merger. Information about the Special Meeting, the Merger, the Merger Agreement and the other business to be considered by stockholders at the Special Meeting is contained in this proxy statement/prospectus. The Core Scientific board has fixed the close of business on [&#8195;], 2025 as the record date for the determination of Core Scientific stockholders entitled to notice of, and to vote at, the Special Meeting. We urge you to read this proxy statement/prospectus and the annexes and documents incorporated by reference carefully. </font>You should also carefully consider the risks that are described in the &#8220;Risk Factors&#8221; section beginning on page <a href="#tRF">28</a>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board has unanimously (i)&#160;determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, are fair to and in the best interests of Core Scientific and its stockholders, (ii)&#160;approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii)&#160;directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. The Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the proposal to adopt the Merger Agreement and &#8220;FOR&#8221; the proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger.<font style="font-weight: normal;"> </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Your vote is very important regardless of the number of shares of Core Scientific common stock that you own.<font style="font-weight: normal;"> </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Two Seas Capital LP, Two Seas Capital GP LLC and Sina Toussi (collectively, &#8220;Two Seas&#8221;), have filed a definitive proxy statement in connection with the Special Meeting. We recommend that Core Scientific stockholders disregard any proxy card sent to them by or on behalf of any person other than Core Scientific, including any gold proxy card and solicitation materials that may be sent by or on behalf of Two&#160;Seas, which is soliciting proxies to vote against the Merger Agreement Proposal and Advisory Compensation Proposal. If you have submitted such a proxy card (including a gold proxy card), we ask that you subsequently recast your vote as instructed on the WHITE proxy card mailed to you by Core Scientific, which will revoke any earlier dated proxy card that you submitted. Only the last validly executed proxy that you submit will be counted and such proxy will be counted only if it has been received 11:59 p.m., Eastern Time on [&#8195;]<font style="font-weight: normal;">.</font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Whether or not you plan to attend the Special Meeting virtually, please submit your proxy as soon as possible by following the instructions on the accompanying proxy card to make sure that your shares are represented at the meeting. If your shares are held in the name of a broker, bank or other nominee, please follow the instructions on the voting instruction form furnished by the broker, bank or other nominee. You must provide voting instructions by filling out the voting instruction form in order for your shares to be voted.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Special Meeting will be held in a virtual meeting format only. You will not be able to attend the Special Meeting physically in person. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">Very truly yours, </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Adam Sullivan <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific, Inc. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of the Merger or the other transactions described in this proxy statement/prospectus or the securities to be issued in connection with the Merger or determined if this proxy statement/prospectus is accurate or complete. Any representation to the contrary is a criminal offense.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus is dated [&#8195;], 2025, and is first being mailed to stockholders of Core Scientific on or about [&#8195;], 2025. </div></div></div></div>
<!--End Page 3-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 4-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_102-notice_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;"><img style="height: 53px; width: 310px;" src="logo_corescientific.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 20pt; text-align: center;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 11pt; font-weight: bold; margin-top: 0pt; text-align: center;">TO BE HELD [&#8195;] </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;">To our Stockholders<font style="font-style: italic;">:</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You are hereby notified that a Special Meeting of Stockholders of Core Scientific, Inc., a Delaware corporation (&#8220;Core Scientific&#8221;), will be held virtually at www.virtualshareholdermeeting.com/CORZ2025SM at [&#8195;], Eastern Time on [&#8195;] (unless the Special Meeting is adjourned or postponed) for the following purposes: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">a.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to vote on a proposal to adopt the Agreement and Plan of Merger, dated July&#160;7, 2025, as it may be amended from time to time, by and among CoreWeave, Inc., a Delaware corporation (&#8220;CoreWeave&#8221;), Miami Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of CoreWeave (&#8220;Merger Sub&#8221;), and Core Scientific (the &#8220;Merger Agreement&#8221;), which provides, among other things, that subject to the satisfaction or waiver of the conditions set forth therein, at the effective time, Merger Sub will merge with and into Core Scientific, with Core Scientific surviving as a wholly owned subsidiary of CoreWeave (the &#8220;Merger&#8221;), which is further described in the section titled &#8220;The Merger Agreement&#8221; beginning on page&#160;<a href="#tTMAT">218</a>, and a copy of which is attached as Annex&#160;A to the proxy statement/prospectus of which this notice forms a part (the &#8220;Merger Agreement Proposal&#8221;); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">b.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">to hold a non-binding advisory vote to approve the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger (the &#8220;Advisory Compensation Proposal&#8221;). </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific will transact no other business at the Special Meeting except such business as may properly be brought before the Special Meeting or any adjournment or postponement thereof by or at the direction of the Core Scientific board of directors (the &#8220;Core Scientific board&#8221;). Please refer to the proxy statement/prospectus of which this notice forms a part for further information with respect to the business to be transacted at the Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Only stockholders of record as of [&#8195;], 2025 are entitled to notice of, and to vote at, the Special Meeting. The Special Meeting will be a virtual only meeting conducted exclusively via live webcast at www.virtualshareholdermeeting.com/CORZ2025SM starting at [&#8195;], Eastern Time (with log-in beginning at [&#8195;], Eastern Time) on [&#8195;]. You will be able to attend the Special Meeting and vote your shares electronically during the meeting by going to www.virtualshareholdermeeting.com/CORZ2025SM and entering the 16-digit control number included on the proxy card or voting instruction form that you received. Because the Special Meeting is completely virtual and being conducted via live webcast, stockholders will not be able to attend the meeting in person. Participating stockholders who log on to the meeting using his, her or its unique 16-digit control number will also be able to examine the stockholder list during the Special Meeting by following the instructions provided on the meeting website. A list of stockholders of record will be available for inspection at our corporate headquarters located at 701 Brickell Ave, Suite 2500, Miami, FL 33131 during ordinary business hours during the 10-day period before the Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stockholders attending the Special Meeting will be in a listen-only mode and will not be able to speak during the webcast. If you encounter any difficulties while accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available on the virtual meeting registration page 15 minutes prior to the start of the meeting. Please give yourself sufficient time to log in and ensure you can hear the streaming audio before the meeting starts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Completion of the Merger is conditioned on adoption of the Merger Agreement by the Core Scientific stockholders, which requires the affirmative vote of holders of a majority of the issued and outstanding shares of Core Scientific common stock entitled to vote thereon. Completion of the Merger is not conditioned on approval of the Advisory Compensation Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board has unanimously (i)&#160;determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, are fair to and in the best interests of Core Scientific and its stockholders, (ii)&#160;approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants </div></div></div></div>
<!--End Page 4-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 5-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_102-notice_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii) directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. The Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and &#8220;FOR&#8221; the Advisory Compensation Proposal.<font style="font-weight: normal;"> </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Two Seas Capital LP, Two Seas Capital GP LLC and Sina Toussi (collectively, &#8220;Two Seas&#8221;), have filed a definitive proxy statement in connection with the Special Meeting. We recommend that Core Scientific stockholders disregard any proxy card sent to them by or on behalf of any person other than Core Scientific, including any gold proxy card and solicitation materials that may be sent by or on behalf of Two Seas, which is soliciting proxies to vote against the Merger Agreement Proposal and Advisory Compensation Proposal. If you have submitted such a proxy card (including a gold proxy card), we ask that you subsequently recast your vote as instructed on the WHITE proxy card mailed to you by Core Scientific, which will revoke any earlier dated proxy card that you submitted. Only the last validly executed proxy that you submit will be counted and such proxy will be counted only if it has been received 11:59 p.m., Eastern Time on [&#8195;]<font style="font-weight: normal;">. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Your vote is very important regardless of the number of shares of Core Scientific common stock that you own. The Merger cannot be completed without adoption of the Merger Agreement by the affirmative vote of holders of a majority of the outstanding shares of Core Scientific common stock as of the Core Scientific record date and entitled to vote thereon. The failure by a Core Scientific stockholder to submit a vote and any abstention by a Core Scientific stockholder from voting will have the same effect as a vote &#8220;AGAINST&#8221; the Merger Agreement Proposal. If you hold your shares in &#8220;street name,&#8221; the failure to instruct your broker, bank or other nominee on how to vote your shares will have the same effect as a vote &#8220;AGAINST&#8221; the Merger Agreement Proposal.<font style="font-weight: normal;"> </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If you plan to attend the Special Meeting virtually, please follow the instructions as outlined in this proxy statement/prospectus. Whether or not you expect to attend the Special Meeting virtually, we urge you to submit your vote in advance of the meeting. If your shares are held in the name of a broker, bank or other nominee, please vote by following the instructions on the voting instruction form furnished by the broker, bank or other nominee. If you hold your shares in your own name, submit a proxy to vote your shares as promptly as possible by (i)&#160;visiting the internet site listed on the accompanying proxy card, (ii)&#160;calling the toll-free number listed on the proxy card or (iii)&#160;submitting your proxy card by mail by using the self-addressed, stamped envelope provided.<font style="font-weight: normal;"> Submitting a proxy will not prevent you from voting virtually at the meeting, but it will help to secure a quorum and avoid added solicitation costs. Any eligible holder of Core Scientific common stock may vote virtually at the Special Meeting, thereby revoking any previous proxy. In addition, a proxy may also be revoked in writing before the Special Meeting in the manner described in the proxy statement/prospectus of which this notice is a part. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The proxy statement/prospectus of which this notice is a part provides a detailed description of the Merger and the Merger Agreement and the other matters to be considered at the Special Meeting. We urge you to carefully read this proxy statement/prospectus, including any documents incorporated by reference herein, and the annexes in their entirety. <font style="font-weight: bold;">In particular, we urge you to carefully read the section entitled &#8220;Risk Factors&#8221; beginning on page <a href="#tRF">28</a>.</font> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If you have any questions concerning the Merger or this proxy statement/prospectus, would like additional copies or need help voting your shares of Core Scientific common stock, please contact Core Scientific&#8217;s proxy solicitor: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">MacKenzie Partners, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">7 Penn Plaza </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">New York, New York 10001 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Call toll free: (800) 322-2885 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Email: proxy@mackenziepartners.com </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14pt; margin-left: 0pt; text-align: left;">By order of the Board of Directors of Core Scientific, </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 38pt; margin-left: 0pt; text-align: left;">Todd M. DuChene<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="font-weight: normal;">Chief Legal and Administrative Officer and Secretary </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="font-weight: normal;">[&#8195;], 2025 </font></div></div></div></div>
<!--End Page 5-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 6-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_103-additional_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">ADDITIONAL INFORMATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The accompanying proxy statement/prospectus incorporates by reference important business and financial information about Core Scientific from documents that are not included in or delivered with the accompanying proxy statement/prospectus. You can obtain the documents incorporated by reference into the accompanying proxy statement/prospectus (other than certain exhibits or schedules to these documents), without charge, by requesting them in writing or by telephone from Core Scientific at the following address and telephone number, or through the United States Securities and Exchange Commission (the &#8220;SEC&#8221;) website at www.sec.gov: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">Core Scientific, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">838 Walker Road, Suite 21-2105 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Dover, Delaware 19904 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Attention: Investor Relations </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">(512) 402-5233 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">ir@corescientific.com </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, if you have any questions concerning the Merger Agreement or the Merger or the other transactions contemplated by the Merger Agreement, or the accompanying proxy statement/prospectus, or if you would like additional copies of this proxy statement/prospectus or documents incorporated by reference herein, or if you need help voting your shares of Core Scientific common stock, please contact Core Scientific&#8217;s proxy solicitor: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">MacKenzie Partners, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">7 Penn Plaza </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">New York, New York 10001 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Call toll free: (800) 322-2885 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Email: proxy@mackenziepartners.com </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; text-align: center;">If you would like to request documents, please do so no later than five business days<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">before the date of the Special Meeting (which date is [&#8195;]).<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of the accompanying proxy statement/prospectus for further information. The contents of the websites of Core Scientific and CoreWeave are not being incorporated into this proxy statement/prospectus. The information about how you can obtain certain documents that are being incorporated by reference into the accompanying proxy statement/prospectus at these websites is being provided only for your convenience. </div></div></div></div>
<!--End Page 6-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 7-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_104-about_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">ABOUT THIS PROXY STATEMENT/PROSPECTUS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus, which forms part of a registration statement on Form&#160;S-4 filed with the SEC by CoreWeave, constitutes a prospectus of CoreWeave under Section&#160;5 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the shares of CoreWeave common stock and CoreWeave warrants (including shares of common stock underlying such warrants) to be issued to Core Scientific stockholders and warrant holders in the Merger in accordance with the Merger Agreement. This proxy statement/prospectus also constitutes a proxy statement of Core Scientific under Section&#160;14(a) the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). This proxy statement/prospectus also constitutes a notice of meeting with respect to the Core Scientific Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except where the context otherwise indicates, information provided in, or incorporated by reference into, this document regarding Core Scientific has been provided by Core Scientific and information provided in this document regarding CoreWeave and Merger Sub has been provided by CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No one has been authorized to provide you with information that is different from that provided in, or incorporated by reference into, this proxy statement/prospectus. This proxy statement/prospectus is dated [&#8195;], 2025 and you should assume that the information in this document is accurate only as of such date. You should assume that the information incorporated by reference into this document is accurate as of the date of such incorporated document. Neither the mailing of this proxy statement/prospectus to holders of Core Scientific common stock nor the issuance by CoreWeave of shares of CoreWeave common stock and CoreWeave warrants in connection with the Merger will create any implication to the contrary. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus does not constitute an offer to sell, or a solicitation of an offer to buy, any securities, or the solicitation of a proxy, in any jurisdiction to or from any person to whom it is unlawful to make any such offer or solicitation in such jurisdiction.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All currency amounts referenced in this proxy statement/prospectus are in U.S. dollars. In this proxy statement/prospectus, except as otherwise indicated or the context otherwise requires, references to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;closing&#8221; refers to the closing of the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;closing date&#8221; refers to the date on which the closing occurs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific 2029 Convertible Notes&#8221; refers to Core Scientific&#8217;s 3.00% Convertible Senior Notes due 2029 issued under the Core Scientific 2029 Notes Indenture; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific 2029 Notes Indenture&#8221; refers to the Indenture, dated August&#160;19, 2024, between Core Scientific and U.S. Bank Trust Company, National Association, as Trustee, as amended, restated, supplemented or otherwise modified from time to time, governing the terms of the Core Scientific 2029 Convertible Notes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific 2031 Convertible Notes&#8221; refers to Core Scientific&#8217;s 0.00% Convertible Senior Notes due 2031 issued under the Core Scientific 2031 Notes Indenture; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific 2031 Notes Indenture&#8221; refers to the Indenture, dated December&#160;5, 2024, between Core Scientific and U.S. Bank Trust Company, National Association, as Trustee, as amended, restated, supplemented or otherwise modified from time to time, governing the terms of the Core Scientific 2031 Convertible Notes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Core Scientific&#8221; refers to Core Scientific, Inc., a Delaware corporation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Core Scientific board&#8221; refers to the board of directors of Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Core Scientific bylaws&#8221; refers to the Third Amended and Restated Bylaws of Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific certificate of incorporation&#8221; refers to the Fourth Amended and Restated Certificate of Incorporation of Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific common stock&#8221; refers to the common stock, par value $0.00001 par value per share, of Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific Convertible Notes&#8221; refers to the Core Scientific 2029 Convertible Notes and the Core Scientific 2031 Convertible Notes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific CVR Agreement&#8221; refers to the Contingent Value Rights Agreement, dated as of January&#160;23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A.; </div></td></tr></table></div></div></div>
<!--End Page 7-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 8-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_104-about_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific warrant holders&#8221; refers to the holders of Tranche 1 Warrants and Tranche 2 Warrants of Core Scientific, in each case as of immediately prior to the effective time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Core Scientific Warrant Agreement&#8221; or &#8220;Warrant Agreement&#8221; refers to the Warrant Agreement, dated as of January&#160;23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A.; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;Core Scientific warrants&#8221; refers to the Tranche 1 Warrants and the Tranche 2 Warrants; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;CoreWeave&#8221; refers to CoreWeave, Inc., a Delaware corporation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;CoreWeave board&#8221; refers to the board of directors of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave bylaws&#8221; or &#8220;amended and restated bylaws&#8221; refers to the Amended and Restated Bylaws of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave certificate of incorporation&#8221; or &#8220;amended and restated certificate of incorporation&#8221; refers to the Amended and Restated Certificate of Incorporation of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave common stock&#8221; or &#8220;Class&#160;A common stock&#8221; refers to the Class&#160;A common stock, par value $0.000005 par value per share, of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave Class&#160;B common stock&#8221; or &#8220;Class&#160;B common stock&#8221; refers to the Class&#160;B common stock, par value $0.000005 par value per share, of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave Class&#160;C common stock&#8221; or &#8220;Class&#160;C common stock&#8221; refers to the Class&#160;C common stock, par value $0.000005 par value per share, of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave warrants&#8221; refers to the warrants to purchase CoreWeave common stock registered pursuant to this registration statement on Form&#160;S-4; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;CVRs&#8221; refers to the CVRs as set forth in the Core Scientific CVR Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;DGCL&#8221; refers to the Delaware General Corporation Law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;effective time&#8221; refers to the effective time of the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Merger&#8221; refers to the merger of Merger Sub with and into Core Scientific, with Core Scientific surviving as a wholly owned subsidiary of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Merger Agreement&#8221; refers to the Agreement and Plan of Merger, dated as of July&#160;7, 2025, by and among CoreWeave, Merger Sub and Core Scientific (as it may be amended from time to time); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Merger Sub&#8221; refers to Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;New Tranche 1 Warrants&#8221; refers to the New Tranche 1 Warrants as set forth in the Core Scientific Warrant Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;New Tranche 2 Warrants&#8221; refers to the New Tranche 2 Warrants as set forth in the Core Scientific Warrant Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">&#8220;SEC&#8221; refers to the U.S. Securities and Exchange Commission; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Surviving Corporation&#8221; refers to Core Scientific after Merger Sub merges with and into Core Scientific, with Core Scientific surviving the Merger as a wholly owned subsidiary of CoreWeave and as the surviving entity of the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Tranche 1 Warrants&#8221; refers to the Tranche 1 Warrants as set forth in the Core Scientific Warrant Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Tranche 2 Warrants&#8221; refers to the Tranche 2 Warrants as set forth in the Core Scientific Warrant Agreement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;transactions&#8221; refers to each of the transactions contemplated by the Merger Agreement, including the Merger. </div></td></tr></table></div></div></div>
<!--End Page 8-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 9-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_105-toc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">TABLE OF CONTENTS </div> <a name="TOC"><!--Anchor--></a><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 30pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 432pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;">Page</div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tQA">QUESTIONS AND ANSWERS<font style="padding-left: 3.97pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tQA"><font style="padding-left: 14.44pt;">1</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSUM">SUMMARY<font style="padding-left: 3.39pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSUM"><font style="padding-left: 9.44pt;">14</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSTC">The Companies<font style="padding-left: 0.63pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSTC"><font style="padding-left: 9.44pt;">14</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSTM">The Merger<font style="padding-left: 1.37pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSTM"><font style="padding-left: 9.44pt;">14</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tTCS">The Core Scientific Special Meeting<font style="padding-left: 0.11pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tTCS"><font style="padding-left: 9.44pt;">15</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tWCS">What Core Scientific Stockholders Will Receive in the Merger<font style="padding-left: 2.59pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tWCS"><font style="padding-left: 9.44pt;">16</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tNDA">No Dissenters&#8217; or Appraisal Rights<font style="padding-left: 1.96pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tNDA"><font style="padding-left: 9.44pt;">16</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tTOC">Treatment of Core Scientific Equity Awards<font style="padding-left: 4.72pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tTOC"><font style="padding-left: 9.44pt;">16</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tROT">Recommendation of the Core Scientific Board of Directors<font style="padding-left: 2.38pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tROT"><font style="padding-left: 9.44pt;">17</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tOC1">Opinions of Core Scientific&#8217;s Financial Advisors<font style="padding-left: 0.67pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tOC1"><font style="padding-left: 9.44pt;">18</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tOS">Ownership of Shares of CoreWeave Common Stock After the Merger<font style="padding-left: 3.93pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tOS"><font style="padding-left: 9.44pt;">18</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tIC">Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger<font style="padding-left: 1.13pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tIC"><font style="padding-left: 9.44pt;">19</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;"><a href="#tLS">Listing of Shares of CoreWeave Common Stock, New Tranche 1 Warrants and New Tranche 2 Warrants and Delisting and Deregistration of Core Scientific Common Stock, Tranche 1 Warrants and Tranche 2 Warrants<font style="padding-left: 2.17pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tLS"><font style="padding-left: 9.44pt;">19</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCM">Completion of the Merger is Subject to Certain Conditions<font style="padding-left: 3.09pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCM"><font style="padding-left: 9.44pt;">19</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tTM">The Merger May Not Be Completed Without All Required Regulatory Approvals<font style="padding-left: 1.47pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tTM"><font style="padding-left: 9.44pt;">20</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tNS">No Solicitation by Core Scientific<font style="padding-left: 0.1pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tNS"><font style="padding-left: 9.44pt;">21</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tTMA">Termination of the Merger Agreement<font style="padding-left: 3.77pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tTMA"><font style="padding-left: 9.44pt;">23</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSPP">Specific Performance; Remedies<font style="padding-left: 1.78pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSPP"><font style="padding-left: 9.44pt;">24</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tUSF">Material U.S. Federal Income Tax Consequences of the Merger<font style="padding-left: 4.57pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tUSF"><font style="padding-left: 9.44pt;">24</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tAT">Accounting Treatment<font style="padding-left: 3.95pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tAT"><font style="padding-left: 9.44pt;">25</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRCS">Rights of Core Scientific Stockholders Will Change as a Result of the Merger<font style="padding-left: 4.28pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tRCS"><font style="padding-left: 9.44pt;">25</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tLRTM">Litigation Relating to the Merger<font style="padding-left: 3.61pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tLRTM"><font style="padding-left: 9.44pt;">25</font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSRF">Risk Factors<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSRF"><font style="padding-left: 9.44pt;">25</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRF">RISK FACTORS<font style="padding-left: 4.32pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tRF"><font style="padding-left: 9.44pt;">28</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFLS">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS<font style="padding-left: 4.51pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tFLS"><font style="padding-left: 9.44pt;">89</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCPS">COMPARATIVE PER SHARE MARKET PRICE AND DIVIDEND INFORMATION<font style="padding-left: 0.7pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCPS"><font style="padding-left: 9.44pt;">91</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tMP">Market Prices<font style="padding-left: 2.86pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tMP"><font style="padding-left: 9.44pt;">91</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tDI">Dividends<font style="padding-left: 3.4pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tDI"><font style="padding-left: 9.44pt;">91</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tHO">Holders<font style="padding-left: 2.85pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tHO"><font style="padding-left: 9.44pt;">91</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTC">THE COMPANIES<font style="padding-left: 4.88pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tTC"><font style="padding-left: 9.44pt;">92</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCW">CoreWeave, Inc.<font style="padding-left: 2pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCW"><font style="padding-left: 9.44pt;">92</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCS">Core Scientific, Inc.<font style="padding-left: 2.31pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCS"><font style="padding-left: 9.44pt;">92</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tMMS">Miami Merger Sub I, Inc.<font style="padding-left: 3.62pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tMMS"><font style="padding-left: 9.44pt;">92</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tINFO">INFORMATION ABOUT COREWEAVE, INC.&#8217;S BUSINESS<font style="padding-left: 3.82pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tINFO"><font style="padding-left: 9.44pt;">93</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tCIM">COREWEAVE, INC. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS<font style="padding-left: 3.25pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCIM"><font style="padding-left: 4.44pt;">123</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tDAM">DIRECTORS AND MANAGEMENT OF COREWEAVE, INC.<font style="padding-left: 2.89pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tDAM"><font style="padding-left: 4.44pt;">150</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCIE">COREWEAVE, INC. EXECUTIVE COMPENSATION<font style="padding-left: 2.52pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tCIE"><font style="padding-left: 4.44pt;">159</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tSSM">THE CORE SCIENTIFIC SPECIAL MEETING<font style="padding-left: 1.03pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tSSM"><font style="padding-left: 4.44pt;">169</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tGEN">General<font style="padding-left: 2.85pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tGEN"><font style="padding-left: 4.44pt;">169</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tDTP">Date, Time and Place of the Special Meeting<font style="padding-left: 4.83pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tDTP"><font style="padding-left: 4.44pt;">169</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tPSM">Purposes of the Special Meeting<font style="padding-left: 1.78pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tPSM"><font style="padding-left: 4.44pt;">169</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRECO">Recommendation of the Core Scientific Board<font style="padding-left: 4.57pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tRECO"><font style="padding-left: 4.44pt;">169</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tVD">Voting by Directors and Executive Officers<font style="padding-left: 2.16pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tVD"><font style="padding-left: 4.44pt;">170</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tASM">Attendance at the Special Meeting<font style="padding-left: 3.45pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tASM"><font style="padding-left: 4.44pt;">170</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRD">Record Date<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tRD"><font style="padding-left: 4.44pt;">170</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tOSV">Outstanding Shares and Voting Rights of Core Scientific Stockholders<font style="padding-left: 2.17pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.28pt; text-align: left;"><a href="#tOSV"><font style="padding-left: 4.44pt;">170</font> </a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">i<br></div></div></div>
<!--End Page 9-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 10-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_105-toc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 30pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 432pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSL">Stockholder List<font style="padding-left: 2.29pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tSL">170 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tQAB">Quorum; Abstentions and Broker Non-Votes<font style="padding-left: 3.07pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tQAB">170 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tADJ">Adjournment<font style="padding-left: 1.18pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tADJ">170 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tVR">Vote Required<font style="padding-left: 1.37pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tVR">171 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tHV">How to Vote<font style="padding-left: 2.66pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tHV">171 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRH">Record Holders<font style="padding-left: 0.64pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tRH">172 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tBO">Beneficial Owners<font style="padding-left: 3.98pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tBO">172 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tPR">Proxies and Revocation<font style="padding-left: 2.86pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tPR">173 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tIET">Inspector of Elections; Tabulation of Votes<font style="padding-left: 4.69pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tIET">173 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSOP">Solicitation of Proxies<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tSOP">173 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tOMS">Other Matters<font style="padding-left: 2.86pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tOMS">173 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tHPS">Householding of Proxy Statement/Prospectus<font style="padding-left: 0.11pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tHPS">173 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tQAI">Questions and Additional Information<font style="padding-left: 0.09pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tQAI">174 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTHE">THE MERGER<font style="padding-left: 0.07pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tTHE">175 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tGENE">General<font style="padding-left: 2.85pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tGENE">175 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tTP">The Parties<font style="padding-left: 3.41pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tTP">175 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCWI">CoreWeave, Inc.<font style="padding-left: 2pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCWI">175 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCSI">Core Scientific, Inc.<font style="padding-left: 2.31pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCSI">175 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tMMSI">Miami Merger Sub I, Inc.<font style="padding-left: 3.62pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tMMSI">176 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tBOT">Background of the Merger<font style="padding-left: 0.84pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tBOT">176 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCRB">Certain Relationships between CoreWeave and Core Scientific<font style="padding-left: 3.74pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCRB">184 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRFT">Recommendation of the Core Scientific Board of Directors and Reasons for the Merger<font style="padding-left: 4.84pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tRFT">184 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCWR">CoreWeave&#8217;s Reasons for the Merger<font style="padding-left: 1.67pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCWR">191 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tCUP">Certain Unaudited Prospective Financial Information<font style="padding-left: 3.46pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCUP">191 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tOOC">Opinions of Core Scientific&#8217;s Financial Advisors<font style="padding-left: 0.67pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tOOC">197 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tFOT">Financing of the Merger<font style="padding-left: 4.72pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tFOT">212 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tRAR">Regulatory Approvals Required for the Merger<font style="padding-left: 2.53pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tRAR">212 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tNDO">No Dissenters&#8217; or Appraisal Rights<font style="padding-left: 1.96pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tNDO">214 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tUSFI">U.S. Federal Income Tax Consequences of the Merger<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tUSFI">214 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tACC">Accounting Treatment<font style="padding-left: 3.95pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tACC">215 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tPFS">Procedures for Surrendering Core Scientific Stock Certificates<font style="padding-left: 4.61pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tPFS">215 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;"><a href="#tLOS">Listing of Shares of CoreWeave Common Stock, New Tranche 1 Warrants and New Tranche 2 Warrants and Delisting and Deregistration of Shares of Core Scientific Common Stock, Tranche 1 Warrants and Tranche 2 Warrants<font style="padding-left: 2.99pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tLOS">216 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tLR2">Litigation Relating to the Merger<font style="padding-left: 3.61pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tLR2">216</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSD">Subsequent Developments <font style="padding-left: 3.98pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tSD">216</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tTMAT">THE MERGER AGREEMENT<font style="padding-left: 0.63pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tTMAT">218 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tMUS">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER<font style="padding-left: 3.71pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tMUS">249 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tIOC">INTERESTS OF CORE SCIENTIFIC&#8217;S DIRECTORS AND EXECUTIVE OFFICERS IN THE MERGER<font style="padding-left: 2.84pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tIOC">252 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPROP1">PROPOSAL I&#8212;ADOPTION OF THE MERGER AGREEMENT<font style="padding-left: 2.89pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tPROP1">256 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tPROP2">PROPOSAL II&#8212;NON-BINDING ADVISORY VOTE ON TRANSACTION-RELATED COMPENSATION FOR CERTAIN CORE SCIENTIFIC EXECUTIVE OFFICERS<font style="padding-left: 2.64pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tPROP2">257 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tUPF">UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION<font style="padding-left: 4.99pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tUPF">258 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tNOT">NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION<font style="padding-left: 0.63pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tNOT">264</a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCF">COREWEAVE&#8217;S CONSOLIDATED FINANCIAL STATEMENTS<font style="padding-left: 1.47pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCCF">276 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tDOC">DESCRIPTION OF COREWEAVE CAPITAL STOCK, NEW TRANCHE 1 WARRANTS AND NEW TRANCHE 2 WARRANTS<font style="padding-left: 0.82pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tDOC">277 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCRA">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS OF COREWEAVE<font style="padding-left: 1.57pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCRA">289 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCOS">COMPARISON OF STOCKHOLDER RIGHTS<font style="padding-left: 2.87pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;"><a href="#tCOS">293 </a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">ii<br></div></div></div>
<!--End Page 10-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 11-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_105-toc_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 30pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 432pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tBOO">BENEFICIAL OWNERSHIP OF SECURITIES<font style="padding-left: 4.18pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tBOO"><font style="padding-left: 0.55pt;">309</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSOW">Security Ownership of Certain Beneficial Owners and Management of CoreWeave<font style="padding-left: 1.01pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tSOW"><font style="padding-left: 0.55pt;">309</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><a href="#tSOS">Security Ownership of Certain Beneficial Owners and Management of Core Scientific<font style="padding-left: 1.32pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tSOS"><font style="padding-left: 0.55pt;">313</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXP">EXPERTS<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tEXP"><font style="padding-left: 0.55pt;">315</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tLM">LEGAL MATTERS<font style="padding-left: 3.22pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tLM"><font style="padding-left: 0.55pt;">315</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tFCS">FUTURE CORE SCIENTIFIC STOCKHOLDER PROPOSALS<font style="padding-left: 1.95pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tFCS"><font style="padding-left: 0.55pt;">315</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tHHO">HOUSEHOLDING OF PROXY MATERIALS<font style="padding-left: 3.26pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tHHO"><font style="padding-left: 0.55pt;">316</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tWYC">WHERE YOU CAN FIND MORE INFORMATION<font style="padding-left: 3.84pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tWYC"><font style="padding-left: 0.55pt;">317</font> </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXA">Annex&#160;A <font style="padding-left: 0.06pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tANNEXA">A-1 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXB">Annex&#160;B <font style="padding-left: 4.51pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tANNEXB"><font style="padding-left: 0.55pt;">B-1 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXC">Annex&#160;C <font style="padding-left: 4.51pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tANNEXC"><font style="padding-left: 0.55pt;">C-1 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXD">Annex&#160;D <font style="padding-left: 3.96pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tANNEXD">D-1 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXE">Annex&#160;E <font style="padding-left: 0.07pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tANNEXE"><font style="padding-left: 1.11pt;">E-1 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tPART2">PART II INFORMATION NOT REQUIRED IN THE PROSPECTUS<font style="padding-left: 3.87pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.22pt; text-align: left;"><a href="#tPART2"><font style="padding-left: 0.56pt;">II-1</font></a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">iii<br></div></div></div>
<!--End Page 11-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 12-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tQA"><!--Anchor--></a>QUESTIONS AND ANSWERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following are some questions that you, as a stockholder of Core Scientific, may have regarding the Merger and other matters being considered at the special meeting of Core Scientific stockholders (the &#8220;Special Meeting&#8221;) and brief answers to those questions. To better understand these matters, and for a description of the legal terms governing the Merger, Core Scientific urges you to carefully read the remainder of this proxy statement/prospectus because the information in this section does not provide all the information that might be important to you with respect to the Merger and the other matters being considered at the Special Meeting. Additional important information is also contained in the annexes to this proxy statement/prospectus and the documents incorporated by reference in this proxy statement/prospectus. See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus.<font style="font-style: normal;"> </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Why am I receiving this document? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">CoreWeave, Merger Sub and Core Scientific have entered into the Merger Agreement, providing for the merger of Merger Sub with and into Core Scientific, with Core Scientific surviving the Merger as a wholly owned subsidiary of CoreWeave. In order to complete the Merger, Core Scientific stockholders must approve Merger Agreement Proposal and all other conditions to the Merger must be satisfied or (to the extent permitted by applicable law) waived. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Core Scientific will hold the Special Meeting to obtain approval of the Merger Agreement Proposal and approvals with respect to certain other related matters. This proxy statement/prospectus, which you should read carefully, contains important information about the Merger and other matters being considered at the Special Meeting. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">This document is being delivered to you as both a proxy statement of Core Scientific and a prospectus of CoreWeave in connection with the Merger. It is the proxy statement by which the Core Scientific board is soliciting proxies from Core Scientific stockholders to vote at the Special Meeting, or at any adjournment or postponement of the Special Meeting, on the approval of the Merger Agreement Proposal and the approval of the Advisory Compensation Proposal, each as described more fully herein. In addition, this document is the prospectus by which CoreWeave will issue shares of CoreWeave common stock and CoreWeave warrants to Core Scientific stockholders and warrant holders in the Merger in accordance with the Merger Agreement. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Your vote is important regardless of the number of shares of Core Scientific common stock that you own. We encourage you to vote as soon as possible. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What is the purpose of the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">At the Special Meeting, holders of Core Scientific common stock as of the Core Scientific record date will act upon all the matters outlined in the Notice of Special Meeting of Stockholders. These include: </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">a proposal to adopt the Merger Agreement (the &#8220;Merger Agreement Proposal&#8221;); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger (the &#8220;Advisory Compensation Proposal&#8221;).</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What is a proxy and how does it work? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The Core Scientific board is asking for your proxy. A &#8220;proxy&#8221; is your legal designation of another person to vote the stock you own in the manner you direct. If you designate someone as your proxy in a written document, that document is also called a proxy or a proxy card. By giving your proxy to the persons named as proxy holders in the proxy card accompanying this proxy statement/prospectus, you authorize them to vote your shares of Core Scientific common stock at the Special Meeting in the manner you direct. You may cast votes &#8220;</font><font style="font-style: italic;">FOR</font><font style="font-weight: normal;">,&#8221; &#8220;</font><font style="font-style: italic;">AGAINST</font><font style="font-weight: normal;">&#8221; or &#8220;</font><font style="font-style: italic;">ABSTAIN</font><font style="font-weight: normal;">&#8221; with respect to both, either or neither of the matters the Core Scientific board is submitting to a vote of holders of Core Scientific common stock at the Special Meeting. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">If you complete and submit your proxy in one of the manners described below, but do not specify how to vote, the proxy holders will vote your shares &#8220;<font style="font-style: italic; font-weight: bold;">FOR</font>&#8221; each of the proposals described below. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">1<br></div></div></div>
<!--End Page 12-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 13-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who is soliciting my vote? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The Core Scientific board is soliciting your proxy. Core Scientific will pay for the proxy solicitation costs related to the Special Meeting. In addition to sending and making available these materials, some of Core Scientific&#8217;s directors, officers and other employees may solicit proxies by contacting Core Scientific stockholders by telephone, by mail, by e-mail or online. Core Scientific stockholders may also be solicited by, among others, news releases issued by Core Scientific and/or CoreWeave, postings on Core Scientific&#8217;s or CoreWeave&#8217;s websites and social media accounts and advertisements in periodicals. None of Core Scientific&#8217;s directors, officers or employees will receive any extra compensation for their solicitation services. Core Scientific has also retained MacKenzie Partners, Inc. as its proxy solicitor to assist in the solicitation of proxies. For these proxy solicitation services, MacKenzie Partners, Inc. will receive a fee not to exceed $175,000, plus reasonable out-of-pocket expenses and fees for any additional services. Core Scientific may also reimburse banks, brokers, and other nominees for their expenses in sending proxy solicitation materials to the beneficial owners of shares of Core Scientific common stock and obtaining their proxies. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What will Core Scientific stockholders receive for their shares of Core Scientific common stock in the Merger? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">At the effective time, by virtue of the Merger, each share of Core Scientific common stock (other than each share of Core Scientific common stock held in treasury or held or owned by Core Scientific, CoreWeave or Merger Sub immediately prior to the effective time) outstanding immediately prior to the effective time will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of CoreWeave common stock. No fractional shares of CoreWeave common stock will be delivered to any holder of shares of Core Scientific common stock upon completion of the Merger. Instead, all fractional shares of CoreWeave common stock that a holder of shares of Core Scientific common stock would otherwise be entitled to receive as a result of the Merger will be aggregated and, if a fractional share results from such aggregation, such holder will be entitled to receive the cash proceeds from the sale of such fractional share by the exchange agent for the account of such holder, without interest and subject to any applicable withholding taxes, in accordance with the Merger Agreement. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Although the number of shares of CoreWeave common stock that Core Scientific stockholders will receive in the Merger is fixed, the market value of the Merger Consideration will fluctuate with the market price of CoreWeave common stock and will not be known at the time that holders of Core Scientific common stock vote to adopt the Merger Agreement.<font style="font-weight: normal;"> Based on the closing price of CoreWeave common stock on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on July&#160;3, 2025, the last trading day prior to the announcement of the Merger Agreement, the 0.1235 exchange ratio represented approximately $20.40 in implied value for each share of Core Scientific common stock. Based on CoreWeave&#8217;s closing price on [&#8195;], 2025 of $[&#8195;], the 0.1235&#160;exchange ratio represented approximately $[&#8195;] in implied value for each share of Core Scientific common stock. </font>The market price of CoreWeave common stock when Core Scientific stockholders receive those shares after the Merger is completed could be greater than, less than or the same as the market price of shares of CoreWeave common stock on the date of this proxy statement/prospectus or at the time of the Special Meeting.<font style="font-weight: normal;"> </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How will the Merger affect Core Scientific equity awards?</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;"><font style="font-weight: normal;">At or immediately prior to the effective time: </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each award of restricted stock units of Core Scientific (each a &#8220;Core Scientific RSU Award&#8221;) that is outstanding as of immediately prior to the effective time and held by certain specified individuals, including Adam Sullivan, Jim Nygaard and Todd M. DuChene (each, a &#8220;Specified Individual&#8221;) or a non-employee member of the Core Scientific board will fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x)&#160;the total number of shares of Core Scientific common stock underlying such Core Scientific RSU Award as of immediately prior to the effective time, multiplied by (y)&#160;the exchange ratio; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">all other Core Scientific RSU Awards (other than Core Scientific PSU Awards) that are outstanding immediately prior to the effective time (each, an &#8220;Unvested Core Scientific RSU Award&#8221;) will each be canceled and converted into a restricted stock unit award with respect to a number of shares of CoreWeave </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">2<br></div></div></div>
<!--End Page 13-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 14-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">common stock equal to the product (rounded up to the nearest whole number of shares) of (x)&#160;the total number of shares of Core Scientific common stock underlying such Unvested Core Scientific RSU Award as of immediately prior to the effective time, multiplied by (y)&#160;the exchange ratio (each a &#8220;CoreWeave Rollover RSU Award&#8221;), and each such CoreWeave Rollover RSU Award will otherwise continue to be subject to the same terms and conditions (including vesting schedule and treatment on termination of employment) as were applicable to the corresponding Unvested Core Scientific RSU Award prior to the effective time; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each Core Scientific RSU Award that vests or is earned subject to the achievement of performance conditions and that is outstanding immediately prior to the effective time (each a &#8220;Core Scientific PSU&#160;Award&#8221;) and held by a Specified Individual will fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x)&#160;the total number of shares of Core Scientific common stock underlying such Core Scientific PSU Award as of immediately prior to the effective time (which number will be determined by deeming the applicable performance level to equal 300%), multiplied by (y)&#160;the exchange ratio; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">all other Core Scientific PSU Awards that are outstanding immediately prior to the effective time will each be cancelled and converted into a time-based restricted stock unit award with respect to a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying a Core Scientific PSU Award as of immediately prior to the effective time assuming a performance level of 300% multiplied by (y) the exchange ratio (each a &#8220;CoreWeave Rollover PSU Award&#8221;), and each such CoreWeave Rollover PSU Award will otherwise continue to be subject to the same terms and conditions (including service-based vesting and forfeiture conditions) as were applicable to the corresponding Core Scientific PSU Award immediately prior to the effective time (other than the applicable performance conditions); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each option to purchase shares of Core Scientific common stock (each a &#8220;Core Scientific Option&#8221;) that is outstanding and unexercised as of immediately prior to the effective time that has a per share exercise price that is less than (x)&#160;the exchange ratio multiplied by (y) the average of the volume weighted average trading prices of CoreWeave common stock on each of the five consecutive trading days ending on (and including) the last trading day prior to the date of the effective time (the &#8220;Per Core Scientific Share Price&#8221;) (each an &#8220;In the Money Option&#8221;) will be cancelled and converted into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to (x) the quotient obtained by dividing (a)&#160;the product obtained by multiplying (A)&#160;the excess, if any, of the Per Core Scientific Share Price over the exercise price per share of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (B)&#160;the number of shares of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (b)&#160;the Per Core Scientific Share Price multiplied by (y)&#160;the exchange ratio; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each Core Scientific Option that is not an In the Money Option and that is outstanding and unexercised as of immediately prior to the effective time will be cancelled at the effective time with no consideration payable in respect of such Core Scientific Option. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What will Core Scientific warrant holders receive for their Tranche 1 Warrants and Tranche 2 Warrants in the Merger? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">At the effective time, each (i)&#160;Tranche 1 Warrant will be automatically redeemed in exchange for the right to receive a New Tranche 1 Warrant exercisable for a number of shares of CoreWeave common stock (subject to cashless exercise as described below) equal to (a)&#160;the number of Warrant Shares (as defined in the Core Scientific Warrant Agreement) underlying such Tranche 1 Warrant, multiplied by (b)&#160;the exchange ratio, with such New&#160;Tranche 1 Warrant having an exercise price equal to (x) the Tranche 1 Exercise Price (as defined in the Core Scientific Warrant Agreement) in effect immediately prior to the effective time divided by (y)&#160;the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants and (ii)&#160;Tranche 2 Warrant will be converted into a non-penny Converted Tranche 2 Warrant (as defined in the Core Scientific Warrant Agreement) with an exercise price of $7.50 per Warrant Share (subject to adjustment on the terms set forth in the Core Scientific Warrant Agreement), which Converted Tranche 2 Warrant will be automatically redeemed in exchange for the right to receive a New Tranche 2 Warrant exercisable for a number </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">3<br></div></div></div>
<!--End Page 14-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 15-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">of shares of CoreWeave common stock (subject to cashless exercise as described below) equal to (a)&#160;the number of Warrant Shares underlying the Converted Tranche 2 Warrant, multiplied by (b) the exchange ratio, with such New Tranche 2 Warrant having an exercise price equal to (x)&#160;$7.50 per Warrant Share divided by (y)&#160;the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants. Both the New Tranche 1 Warrants and New Tranche 2 Warrants will be exercisable only on a cashless basis, pursuant to which the holder will be entitled to receive a number of shares of CoreWeave common stock equal to the total number of shares of CoreWeave common stock underlying the warrants being exercised multiplied by a fraction equal to (x) the current market price (as of the business day immediately preceding the date on which the exercise notice was delivered) of one share of CoreWeave common stock, minus the applicable exercise price, divided by (y) such current market price. </div> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">As of September 9, 2025, Core Scientific had 97,432,201 outstanding Tranche 1 Warrants exercisable for 97,432,201 shares of Core Scientific common stock at $6.81 per share and 12,118,829 outstanding Tranche 2&#160;Warrants exercisable for 12,118,829 shares of Core Scientific common stock at $0.01 per share. Based on the number of Core Scientific warrants outstanding as of September 9, 2025, and assuming no events occur requiring any adjustment to the number of shares underlying each Tranche 1 Warrant or Tranche 2 Warrant or the exercise price therefor prior to the Merger, the New Tranche 1 Warrants will be exercisable for up to 12,032,877 shares of CoreWeave Class A common stock at an exercise price of $55.141700 per share, and the New Tranche 2 Warrants will be exercisable for up to 1,496,676 shares of CoreWeave Class A common stock at an exercise price of $60.728745 per share, in each case, prior to giving effect to any effective reduction in share issuance that the cashless exercise mechanism described above may have. </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How will the Merger affect the Core Scientific 2029 Convertible Notes and 2031 Convertible Notes? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Holders of the Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes may convert their Core Scientific 2029&#160;Convertible Notes and Core Scientific 2031 Convertible Notes, as applicable, only under the following circumstances: (i)&#160;during the calendar quarter commencing after any quarter in which the last reported sale price of Core Scientific common stock for at least 20 of the last 30 consecutive trading days of such quarter exceeds 130% of the conversion price; (ii)&#160;during the five consecutive business days following any 10 consecutive trading day period when the trading price of the relevant notes is less than 98% of the product of the last reported sales price of Core Scientific common stock and the conversion rate on each such trading day; (iii)&#160;upon the occurrence of specified corporate events, including in connection with most mergers or changes of control (including the Merger) or significant distributions made on Core Scientific common stock; (iv)&#160;upon notice of redemption by Core Scientific; and (v)&#160;on or after June&#160;1, 2029 or March&#160;17, 2031, respectively, until the close of business of the scheduled trading day immediately before the applicable maturity date. Whether or not the Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes are otherwise then convertible, the consummation of the Merger will permit holders to convert their convertible notes as described in clause&#160;(iii) of the preceding sentence for a period of time set forth in the Core Scientific 2029 Notes Indenture and the Core Scientific 2031 Notes Indenture, as applicable. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Prior to the effective time, Core Scientific will enter into one or more supplemental indentures, with CoreWeave added as a full and unconditional guarantor, to the Core Scientific 2029 Notes Indenture and Core Scientific 2031 Notes Indenture, pursuant to which the right of the holders of then-outstanding Core Scientific 2029&#160;Convertible Notes and Core Scientific 2031&#160;Convertible Notes to convert their convertible notes into shares of Core Scientific common stock, cash or a combination thereof (at Core Scientific&#8217;s election) will be converted into a right to convert their convertible notes into a number of shares of CoreWeave common stock, cash or a combination thereof (at Core Scientific&#8217;s election), as determined, after giving effect to the exchange ratio, in accordance with and as required by the terms of the Core&#160;Scientific 2029 Notes Indenture and Core Scientific 2031 Notes Indenture, as applicable. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Because the consideration to Core Scientific stockholders for the Merger will consist solely of CoreWeave common stock (together with cash proceeds in lieu of any fractional shares), the Merger will not give rise to a &#8220;fundamental change&#8221; or a &#8220;make-whole fundamental change&#8221; under the terms of the Core Scientific 2029&#160;Notes Indenture and Core Scientific 2031 Notes Indenture. As a result, holders of the Core Scientific 2029&#160;Convertible Notes and Core Scientific 2031 Convertible Notes will not be entitled to exercise their right to require Core Scientific to repurchase their convertible notes on account of a fundamental change or to receive an increased &#8220;make-whole&#8221; conversion rate for a conversion of their convertible notes in connection with the Merger. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">4<br></div></div></div>
<!--End Page 15-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 16-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">If I am a holder of Core Scientific common stock, how will I receive the Merger Consideration to which I am entitled? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The conversion of Core Scientific common stock into the right to receive the Merger Consideration will occur automatically upon the completion of the Merger. Promptly following the effective time, the exchange agent will mail to the record holders of any certificate formerly representing any share of Core Scientific common stock: (i) a letter of transmittal in customary form containing such provisions as CoreWeave and Core Scientific may reasonably specify (including a provision that delivery of certificates will be effected, and risk of loss and title to shares of Core Scientific common stock will pass, only upon delivery of such certificates to the exchange agent) and (ii) instructions for use in effecting the surrender of certificates in exchange for the Merger Consideration. Upon surrender of a certificate to the exchange agent for exchange, together with a duly executed letter of transmittal and such other documents as may be reasonably required by the exchange agent or CoreWeave, the holder of such certificate will be entitled to receive (A)&#160;a certificate or evidence of shares in book-entry form representing the number of whole shares of CoreWeave common stock that such holder has the right to receive pursuant to the Merger Agreement and (B)&#160;cash in lieu of any fractional shares of CoreWeave common stock pursuant to the Merger Agreement. Any such certificate so surrendered will immediately be cancelled. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">With respect to book-entry shares held through the Depository Trust Company (&#8220;DTC&#8221;), the exchange agent will transmit to DTC or its nominees as soon as practicable after the effective time, but in any event within five&#160;business days thereafter, upon surrender of shares held of record by DTC or its nominees in accordance with DTC&#8217;s customary surrender procedures, the Share Consideration and cash in lieu of fractional shares otherwise payable to such holder of uncertificated shares. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">With respect to book-entry shares not held through DTC (each, a &#8220;Non-DTC Book-Entry Share&#8221;), the exchange agent will pay and deliver to each holder of record of any Non-DTC Book-Entry Share, as promptly as reasonably practicable after the effective time, but in any event within five business days thereafter, the applicable Share Consideration and a check in the amount (after giving effect to any required tax withholdings) of any cash in lieu of fractional shares of CoreWeave common stock otherwise payable to such holder of book-entry shares, and each Non-DTC Book-Entry Share will be promptly cancelled by the exchange agent. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who will own CoreWeave common stock immediately following the transactions? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">CoreWeave and Core Scientific estimate that, as of immediately following completion of the Merger, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]% of the outstanding shares of CoreWeave common stock (or, on a fully diluted basis, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]% of the shares of CoreWeave common stock). </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How important is my vote? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Your vote &#8220;</font><font style="font-style: italic;">FOR</font><font style="font-weight: normal;">&#8221; each proposal presented at the Special Meeting is very important regardless of the number of shares of Core Scientific common stock that you own, and you are encouraged to submit a proxy or proxies as soon as possible. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What vote is required to approve each proposal at the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Approval of the Merger Agreement Proposal requires the affirmative vote of holders of a majority of the issued and outstanding shares of Core Scientific common stock as of the Core Scientific record date and entitled to vote thereon. The required vote on the Merger Agreement Proposal is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure of any Core Scientific stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from voting by a Core Scientific stockholder will have the same effect as a vote &#8220;</font>AGAINST<font style="font-weight: normal;">&#8221; the Merger Agreement Proposal. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Approval of the Advisory Compensation Proposal requires the affirmative vote of the holders of a majority of the votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker non-votes), where a quorum is present. The required vote on the Advisory Compensation Proposal is based on the number </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">5<br></div></div></div>
<!--End Page 16-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 17-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">of shares actually voted&#8212;not the number of outstanding shares of Core Scientific common stock entitled to be voted thereon. Abstentions from voting by a Core Scientific stockholder attending the Special Meeting or a failure to attend the Special Meeting virtually or by proxy will have no effect on the outcome of the vote on the Advisory Compensation Proposal. Brokers do not have discretion to vote on this proposal without your instruction. If you do not instruct your broker how to vote on this proposal, those shares will not be counted as present or represented by proxy at the Special Meeting and, as a result, will have no effect on the outcome of the vote on the Advisory Compensation Proposal. While the Core Scientific board intends to consider the vote resulting from the Advisory Compensation Proposal, the vote is advisory only and therefore not binding on Core Scientific, and, if the proposed Merger Agreement is adopted by Core Scientific stockholders and the Merger is consummated, the compensation that is the subject of the Advisory Compensation Proposal, including amounts Core Scientific is contractually obligated to pay, will be payable even if the Advisory Compensation Proposal is not approved. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">See the section titled &#8220;The Core Scientific Special Meeting&#8212;Vote Required&#8221; beginning on page <a href="#tVR">171</a> of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How does the Core Scientific board recommend that I vote? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">At a meeting held on July&#160;7, 2025, the Core Scientific board unanimously (i)&#160;determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, were fair to and in the best interests of Core Scientific and its stockholders, (ii)&#160;approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii)&#160;directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Accordingly, the Core Scientific board unanimously recommends that holders of Core Scientific common stock vote &#8220;<font style="font-style: italic; font-weight: bold;">FOR</font>&#8221; the Merger Agreement Proposal and &#8220;<font style="font-style: italic; font-weight: bold;">FOR</font>&#8221; the Advisory Compensation Proposal. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Why am I being asked to consider and vote on the Advisory Compensation Proposal? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Under SEC rules, Core Scientific is required to seek a non-binding, advisory vote with respect to the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger. See the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8221; beginning on page <a href="#tIOC">252</a> of this proxy statement/prospectus. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Are there any Core Scientific stockholders who have already committed to voting in favor of the Merger Agreement Proposal at the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">At the close of business on [&#8195;] Core Scientific&#8217;s directors and executive officers had the right to vote approximately [&#8195;] shares of the then-outstanding Core Scientific common stock, collectively representing approximately [&#8195;]% of the Core Scientific common stock outstanding and entitled to vote on that date. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Will the CoreWeave common stock, New Tranche 1 Warrants and New Tranche 2 Warrants issued at the time of completion of the Merger be traded on an exchange? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">It is a condition to the consummation of the Merger that the shares of CoreWeave common stock to be issued to Core Scientific stockholders in connection with the Merger be approved for listing on the Nasdaq, subject to official notice of issuance. CoreWeave will use its reasonable best efforts to cause the New&#160;Tranche 1 Warrants and New Tranche 2 Warrants to be issued to Core Scientific warrant holders in connection with the Merger to be listed on the Nasdaq, subject to official notice of issuance, as promptly as practicable after the date of the Merger Agreement, and in any event prior to the effective time. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How will CoreWeave stockholders be affected by the Merger? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Upon completion of the Merger, each CoreWeave stockholder will hold the same number of shares of CoreWeave stock that such stockholder held immediately prior to completion of the Merger. As a result of the Merger, CoreWeave stockholders will own shares in a larger consolidated company with more assets. However, </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">6<br></div></div></div>
<!--End Page 17-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 18-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">because CoreWeave will be issuing additional shares of CoreWeave common stock to Core Scientific stockholders in exchange for their shares of Core Scientific common stock in connection with the Merger, each outstanding share of CoreWeave common stock, as of immediately prior to the Merger, will represent a smaller percentage of the aggregate number of shares of CoreWeave common stock outstanding after the Merger. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What are the material U.S. federal income tax consequences of the Merger to U.S. holders of shares of Core Scientific common stock? </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Core Scientific and CoreWeave intend for the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) for U.S. federal income tax purposes. Assuming the Merger so qualifies, U.S. holders (as defined in the section titled &#8220;Material U.S.&#160;Federal Income Tax Consequences of the Merger&#8221;) of shares of Core Scientific common stock generally will not recognize any gain or loss for U.S. federal income tax purposes upon receipt of CoreWeave common stock in exchange for Core Scientific common stock in the Merger, other than gain or loss, if any, with respect to any cash received in lieu of a fractional share of CoreWeave common stock. </font></div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">In connection with the effectiveness of the registration statement of which this proxy statement/prospectus is a part, each of Wachtell, Lipton, Rosen &amp; Katz, counsel to Core Scientific, and Davis Polk &amp; Wardwell LLP, counsel to CoreWeave, will deliver a legal opinion to the effect that the Merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. An opinion that the Merger &#8220;should&#8221; qualify as a reorganization within the meaning of Section 368(a) of the Code expresses a level of comfort that is stronger than &#8220;more likely than not&#8221; but less than &#8220;will.&#8221; Counsel is unable to provide a higher degree of certainty because there is no administrative or judicial authority that directly addresses facts similar to those of this transaction, including with respect to the federal income tax treatment of the Tranche 2 Warrants. Nonetheless, counsel believes that its opinion is justified based on the existing authorities.</div> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">The material U.S. federal income tax consequences of the Merger to U.S. holders are discussed in more detail in the section titled &#8220;Material U.S. Federal Income Tax Consequences of the Merger.&#8221; The discussion of the material U.S. federal income tax consequences contained in this proxy statement/prospectus is intended to provide only a general discussion and is not a complete analysis or description of all potential U.S. federal income tax consequences of the Merger. Such consequences may vary with, or be dependent on, individual circumstances. In addition, it does not address the effects of any foreign, state or local tax laws or any U.S.&#160;federal tax laws other than U.S. federal income tax laws. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Tax matters are complicated and the tax consequences of the Merger will depend on the facts of your own situation. You are urged to consult your own tax advisor as to the specific tax consequences of the Merger to you in your particular circumstances.<font style="font-weight: normal;"> </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">When do CoreWeave and Core Scientific expect to complete the Merger? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">CoreWeave and Core Scientific currently expect to complete the Merger in the fourth quarter of 2025, subject to timing of satisfaction of closing conditions to the Merger. However, neither CoreWeave nor Core Scientific can predict the actual date on which the Merger will be completed, nor can the parties provide any assurance that the Merger will be completed. See the section titled &#8220;Risk Factors,&#8221; &#8220;The Merger&#8212;Regulatory Approvals Required for the Merger&#8221; and &#8220;The Merger Agreement&#8212;Conditions to the Consummation of the Merger&#8221; beginning on pages <a href="#tRF">28</a>, <a href="#tRAR">212</a> and <a href="#tCCM1">223</a>, respectively, of this proxy statement/prospectus. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Is the completion of the Merger subject to any conditions? </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Yes. CoreWeave, Merger Sub and Core Scientific are not required to complete the Merger unless certain conditions are satisfied or waived (to the extent permitted by applicable law). These conditions include, among others, the affirmative vote of the holders of a majority of the issued and outstanding shares of Core Scientific common stock entitled to vote at the Special Meeting adopting the Merger Agreement and the expiration or termination of any applicable waiting period (or any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the Merger) applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;HSR Act&#8221;) (see the section titled &#8220;The Merger Agreement&#8212;Regulatory Approvals&#8221; beginning on page <a href="#tRA1">239</a> of this proxy statement/prospectus). For a more complete summary of the conditions that must be </font></div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">7<br></div></div></div>
<!--End Page 18-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 19-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">satisfied (or, to the extent permitted by applicable law, waived) prior to completion of the Merger, see the sections titled &#8220;The Merger Agreement&#8212;Conditions to the Consummation of the Merger&#8221; and &#8220;The Merger&#8212;Regulatory Approvals Required for the Merger&#8221; beginning on pages <a href="#tCCM1">223</a> and <a href="#tRAR">212</a>, respectively, of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if the Merger is not completed? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">In the event that the Merger Agreement is not adopted by Core Scientific&#8217;s stockholders at the Special Meeting or the Merger is not completed for any other reason, Core Scientific&#8217;s stockholders will not receive any consideration for shares of Core Scientific common stock they own. Instead, Core Scientific will remain an independent public company, Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will each continue to be listed and traded on Nasdaq and registered under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Core Scientific will continue to file periodic reports with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on account of Core Scientific common stock. If the Merger is not completed for any reason, including as a result of Core Scientific stockholders failing to approve the Merger Agreement Proposal, the ongoing businesses of Core Scientific may be adversely affected, and the anticipated benefits of having completed the Merger will not be realized. See the section titled &#8220;Risk Factors&#8212;Failure to complete the Merger could negatively impact the stock price and the future business and financial results of Core Scientific and CoreWeave&#8221; beginning on page <a href="#tFTC1">35</a> of this proxy statement/prospectus. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Under specified circumstances, Core Scientific may be required to pay a termination fee upon termination of the Merger Agreement, in the section titled &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement&#8221; beginning on page <a href="#tTOT1">245</a> of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">When and where is the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The Special Meeting will be a virtual only meeting conducted exclusively via live webcast at&#160;www.virtualshareholdermeeting.com/CORZ2025SM starting at [&#8195;], Eastern Time (with log-in beginning at&#160;[&#8195;], Eastern Time) on [&#8195;]. You will be able to attend the Special Meeting and vote your shares electronically during the meeting by going to www.virtualshareholdermeeting.com/CORZ2025SM and entering the 16-digit control number included on the proxy card or voting instruction form that you received. Because the Special Meeting is completely virtual and being conducted via live webcast, stockholders will not be able to attend the meeting in person. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who can vote at, and what is the record date of, the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">All Core Scientific stockholders who hold shares of Core Scientific common stock of record at the close of business on [&#8195;], 2025, the record date for the Special Meeting (the &#8220;Core Scientific record date&#8221;), are entitled to receive notice of, and to vote, at the Special Meeting or any adjournments or postponements thereof. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How many votes may I cast? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Each issued and outstanding share of Core Scientific common stock entitles its holder of record to one vote on each matter to be considered at the Special Meeting. The Core Scientific stockholders of record on the Core Scientific record date are the only Core Scientific stockholders that are entitled to receive notice of, and to vote at, the Special Meeting or any adjournments or postponements thereof. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What constitutes a quorum at the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">In order for business to be conducted at the Special Meeting, a quorum must be present. A quorum at the Special Meeting requires the presence of the holders of a majority of the voting power of the outstanding shares of Core Scientific common stock entitled to vote, present in person, by remote communication or by proxy at the Special Meeting. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">For purposes of determining whether there is a quorum, all shares that are present will count towards the quorum, which will include proxies received but marked as abstentions and will exclude broker non-votes. Broker non-votes occur when a beneficial owner holding shares in &#8220;street name&#8221; does not instruct the broker, bank or other nominee that is the record owner of such stockholder&#8217;s shares on how to vote those shares on a particular proposal. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">8<br></div></div></div>
<!--End Page 19-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 20-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What do I need to do now? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">After you have carefully read and considered the information contained in or incorporated by reference into this proxy statement/prospectus, please submit your proxy via the internet or by telephone in accordance with the instructions set forth on the enclosed proxy card or voting instruction form you received, or complete, sign, date and return the enclosed proxy card or voting instruction form in the self-addressed, stamped envelope provided as soon as possible so that your shares will be represented and voted at the Special Meeting. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Additional information on voting procedures can be found under the section titled &#8220;The Core Scientific Special Meeting&#8221; beginning on page <a href="#tSSM">169</a> of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How will my proxy be voted? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">If you submit your proxy via the internet, by telephone or by completing, signing, dating and returning the enclosed proxy card or voting instruction form, your proxy will be voted in accordance with your instructions. If you sign your proxy card and return it without indicating how you would like to vote your shares, your proxy card will be voted in accordance with the recommendation of the Core Scientific board. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Additional information on voting procedures can be found under the section titled &#8220;The Core Scientific Special Meeting&#8221; beginning on page <a href="#tSSM">169</a> of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who will count the votes? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The votes at the Special Meeting will be counted by an individual designated by the Core Scientific board to serve as inspector of election. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How do I vote my shares if I am a stockholder of record? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Core Scientific stockholders of record at the close of business on [&#8195;] may vote in one of the following ways: </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Internet</font>: Core Scientific stockholders of record may submit their proxy over the internet at www.proxyvote.com. Internet voting is available 24 hours a day and will be accessible until 11:59&#160;p.m., Eastern Time, on [&#8195;]. Stockholders will be given an opportunity to confirm that their voting instructions have been properly recorded. Core Scientific stockholders who submit a proxy this way need not send in their proxy card by mail. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Telephone</font>: Core Scientific stockholders of record may submit their proxy by calling 1-800-690-6903. Telephone voting is available 24 hours a day and will be accessible until 11:59&#160;p.m., Eastern Time, on [&#8195;]. Easy-to-follow voice prompts will guide stockholders through the voting and allow them to confirm that their instructions have been properly recorded. Core Scientific stockholders who submit a proxy this way need not send in their proxy card by mail. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Mail</font>: Core Scientific stockholders of record may submit their proxy by properly completing, signing, dating and mailing their proxy card or voting instruction form in the self-addressed, stamped envelope (if&#160;mailed in the United States) included with this proxy statement/prospectus. Core Scientific stockholders who vote this way should mail the proxy card early enough so that it is received prior to the closing of the polls at the Special Meeting. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Online During the Virtual Meeting</font>: Core Scientific stockholders of record may attend the virtual Special Meeting by entering his, her or its unique 16-digit control number and vote online; attendance at the virtual Special Meeting will not, however, in and of itself constitute a vote or a revocation of a prior proxy. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">If you are a beneficial holder of Core Scientific common stock, you are invited to attend the Special Meeting; however, because you are not a stockholder of record, you may not vote your shares at the Special Meeting unless you receive a voting instruction form with a 16-digit control number from your bank, broker or other nominee that is the stockholder of record with respect to your shares of Core Scientific common stock. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How can I vote during the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">All stockholders of record may vote online during the Special Meeting. Street name holders may vote online during the Special Meeting if they have a voting instruction form with a 16-digit control number, as described below. You may cast your vote electronically during the Special Meeting using the 16-digit control number </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">9<br></div></div></div>
<!--End Page 20-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 21-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">found on your proxy card or voting instruction form. If you do not have a control number, please contact your broker, bank or other nominee as soon as possible so that you can be provided with a control number.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: justify;">Whether you plan to attend the Special Meeting or not, we encourage you to vote by proxy as soon as possible. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who do I contact if I am encountering difficulties attending the Special Meeting online? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">If you encounter any difficulties while accessing the virtual meeting during the check-in or meeting time, a technical assistance phone number will be made available on the virtual meeting registration page 15 minutes prior to the start of the meeting. Please give yourself sufficient time to log-in and ensure you can hear the streaming audio before the meeting starts. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What should I do if I receive more than one set of voting materials for the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">You may receive more than one set of voting materials for the Special Meeting, including multiple copies of this proxy statement/prospectus and multiple proxy cards or voting instruction forms. For example, if you hold your shares of Core Scientific common stock in more than one brokerage account, you will receive a separate voting instruction form for each brokerage account in which you hold shares. If you are a holder of record of Core Scientific common stock and your shares are registered in more than one name, you will receive more than one&#160;proxy card. Please submit each separate proxy or voting instruction form that you receive by following the instructions set forth&#160;in each separate proxy or voting instruction form. If you fail to submit each separate proxy or voting instruction form that you receive, not all of your shares will be voted. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What&#8217;s the difference between holding shares as a stockholder of record and holding shares as a beneficial owner? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">If your shares of Core Scientific common stock are registered directly in your name with Core Scientific&#8217;s transfer agent, Computershare Trust Company, N.A., you are considered, with respect to those shares, to be the stockholder of record. If you are a stockholder of record, then this proxy statement/prospectus and your proxy card have been sent directly to you by Core Scientific. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">If your shares of Core Scientific common stock are held through a bank, broker or other nominee, you are considered the beneficial owner of shares of Core Scientific common stock held in &#8220;street name.&#8221; In that case, this proxy statement/prospectus has been forwarded to you by your bank, broker or other nominee who is considered, with respect to those shares, to be the stockholder of record. As the beneficial owner, you have the right to direct your bank, broker or other nominee how to vote your shares by following their instructions for voting, and you are also invited to attend the Special Meeting. But, because you are not the stockholder of record, you may not vote your shares at the Special Meeting unless you receive a voting instruction form with a 16-digit control number from your bank, broker or other nominee. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">If my shares are held in &#8220;street name&#8221; by my broker, bank or other nominee, will my broker, bank or other nominee automatically vote my shares for me? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">No. If your shares are held in the name of a broker, bank or other nominee, you will receive separate instructions from your broker, bank or other nominee describing how to vote your shares. The availability of the Internet or telephonic voting will depend on your broker&#8217;s, bank&#8217;s or other nominee&#8217;s voting process. Please check with your broker, bank or other nominee and follow the voting procedures provided by your broker, bank or other nominee on your voting instruction form. </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">You should instruct your broker, bank or other nominee how to vote your shares. Under the rules applicable to broker-dealers, your broker, bank or other nominee has discretionary authority to vote on proposals that are considered routine but does not have discretionary authority to vote your shares on proposals that are considered non-routine, and each of the proposals to be voted on at the Special Meeting is considered non-routine. As a result, no broker will be permitted to vote your shares at the Special Meeting without receiving instructions from you. A&#160;so-called &#8220;broker non-vote&#8221; results when banks, brokers and other nominees return a valid proxy but do not vote on a particular proposal because they do not have discretionary authority to vote on the matter and have not received specific voting instructions from the beneficial owner of such shares. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">10<br></div></div></div>
<!--End Page 21-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 22-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">Therefore, if you are a Core Scientific stockholder whose shares of common stock are held in street name and you do not instruct your broker, bank or other nominee on how to vote your shares: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">your broker, bank or other nominee may not vote your shares on the Merger Agreement Proposal, which will have the same effect as a vote &#8220;<font style="font-style: italic; font-weight: bold;">AGAINST</font>&#8221; such proposal; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">your broker, bank or other nominee will not be permitted to vote your shares on the Advisory Compensation Proposal, which will have no effect on the vote count for such proposal. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">A quorum at the Special Meeting requires the presence of the holders of a majority of the voting power of the outstanding shares of Core Scientific common stock entitled to vote, present in person, by remote communication or by proxy at the Special Meeting. For purposes of determining whether there is a quorum, all shares that are present will count towards the quorum, which will include proxies received but marked as abstentions and will exclude broker non-votes. </div> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Additional information on voting procedures can be found under the section titled &#8220;The Core Scientific Special Meeting&#8221; beginning on page <a href="#tSSM">169</a> of this proxy statement/prospectus. </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">I am a Core Scientific stockholder and I received a proxy card from someone other than Core Scientific. Should I sign and mail it?</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A<font style="font-weight: normal;">:</font><br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">It is recommended that you disregard any proxy card sent to you by or on behalf of any other person other than Core Scientific, including any gold proxy card and solicitation materials that may be sent to you by or on behalf of Two Seas, which is soliciting proxies to vote against the Merger Agreement Proposal and the Advisory Compensation Proposal. If you have submitted such a proxy card (including a gold proxy card), it is recommended that you subsequently recast your vote as instructed on the WHITE proxy card mailed to you by Core Scientific, which will revoke any earlier dated proxy card that you submitted. Only the last validly executed proxy that you submit will be counted and such proxy will be counted only if it has been received 11:59&#160;p.m., Eastern Time on [ ]. If you have any questions or need assistance, please contact MacKenzie Partners, Inc. toll free at (800) 322-2885 or by e-mail at proxy@mackenziepartners.com.</font></div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What do I do if I am a Core Scientific stockholder and I want to revoke my proxy? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Core Scientific stockholders of record may revoke their proxies at any time before their shares of Core Scientific common stock are voted at the Special Meeting in any of the following ways: </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delivering written notice of revocation of the proxy to Core Scientific&#8217;s corporate secretary at Core Scientific&#8217;s principal executive offices at 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, by no&#160;later than 11:59&#160;p.m., Eastern Time on [&#8195;]; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delivering another proxy with a later date to Core Scientific&#8217;s corporate secretary at Core Scientific&#8217;s principal executive offices at 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, by no later than 11:59&#160;p.m., Eastern Time on [&#8195;] (in which case only the later-dated proxy is counted and the earlier proxy is revoked); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">submitting another proxy again via the internet or by telephone at a later date, by no later than 11:59 p.m., Eastern Time on [&#8195;] (in which case only the later-dated proxy is counted and the earlier proxy is revoked); or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">attending the Special Meeting virtually, using his, her or its unique 16-digit control number and voting their shares online during the meeting; attendance at the virtual Special Meeting will not, in and of itself, revoke a valid proxy that was previously delivered unless you give written notice of revocation to the Core Scientific corporate secretary before the proxy is exercised or unless you vote your shares online during the Special Meeting. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">If a Core Scientific stockholder holds shares through a bank, broker or other nominee, such stockholder may change or revoke his, her or its voting instructions before the Special Meeting by providing instructions again through the means specified on his, her or its voting instruction form (with most having the option to do so by internet, telephone or mail), which must be received before 11:59&#160;p.m., Eastern Time on [&#8195;]. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">Additional information can be found under the section titled &#8220;The Core Scientific Special Meeting&#8221; beginning on page <a href="#tSSM">169</a> of this proxy statement/prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">11<br></div></div></div>
<!--End Page 22-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 23-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if I sell or otherwise transfer my shares of Core Scientific common stock before the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">The Core Scientific record date is prior to the date of the Special Meeting. If you sell or otherwise transfer your shares of Core Scientific common stock after the Core Scientific record date but before the Special Meeting, unless special arrangements (such as provision of a proxy) are made between you and the person to whom you transfer your shares of Core Scientific common stock, you will retain your right to vote such shares at the Special Meeting but will otherwise transfer ownership of and the economic interest in your shares of Core Scientific common stock. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">What happens if I sell or otherwise transfer my shares of Core Scientific common stock before the completion of the Merger? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Only holders of shares of Core Scientific common stock at the effective time will become entitled to receive the Merger Consideration. If you sell your shares of Core Scientific common stock prior to the completion of the Merger, you will not be entitled to receive the Merger Consideration by virtue of the Merger. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Do any of the officers or directors of Core Scientific have interests in the Merger that may differ from or be in addition to my interests as a Core Scientific stockholder? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">In considering the recommendation of the Core Scientific board that Core Scientific stockholders vote to approve the Merger Agreement Proposal and to approve the Advisory Compensation Proposal, Core Scientific stockholders should be aware that certain of Core Scientific&#8217;s directors and executive officers have interests in the Merger that are different from, or in addition to, the interests of Core Scientific stockholders generally. These interests may include, among others: </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the treatment of outstanding equity awards described in the section entitled &#8220;The Merger Agreement&#8212;Treatment of Core Scientific Equity Awards&#8221; beginning on page <a href="#tTOCS">220</a> of this proxy statement/prospectus; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">severance payments and benefits to certain Core Scientific executive officers under their individual letter agreements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">agreements with certain Core Scientific executive officers providing for excise tax reimbursements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">payment of annual cash incentive bonuses for fiscal year 2025 if such bonuses have not been paid prior to the effective time; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">continued indemnification and directors&#8217; and officers&#8217; liability insurance. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">The Core Scientific board was aware of and considered these potential interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement and in recommending the approval of the Merger Agreement Proposal and Advisory Compensation Proposal. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-align: justify;">For more information and quantification of these interests, see the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8221; beginning on page <a href="#tIOC">252</a> of this proxy statement/prospectus. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Where can I find voting results of the Special Meeting? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Core Scientific intends to publish the final results in a Current Report on Form&#160;8-K that will be filed with the SEC following the Special Meeting. All reports that Core Scientific and CoreWeave file with the SEC are publicly available when filed. See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Do Core Scientific stockholders have dissenters&#8217; or appraisal rights? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">Core Scientific stockholders are not entitled to dissenters&#8217; or appraisal rights in connection with the Merger. See the section titled &#8220;The Merger&#8212;No Dissenters&#8217; or Appraisal Rights&#8221; beginning on page <a href="#tNDO">214</a> of this proxy statement/prospectus. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">How can I find more information about CoreWeave and Core Scientific? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">You can find more information about CoreWeave and Core Scientific from various sources described in the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">12<br></div></div></div>
<!--End Page 23-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 24-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_106-qa_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Q:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Who can answer any questions I may have about the Special Meeting, the Merger or the transactions contemplated by the Merger Agreement? </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">A:<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: justify;"><font style="font-weight: normal;">If you have any questions about the Special Meeting, the Merger or the other transactions contemplated by the Merger Agreement or how to submit your proxy, or if you need additional copies of this proxy statement/prospectus or documents incorporated by reference herein, the enclosed proxy card or voting instructions, you should contact Core Scientific or Core Scientific&#8217;s proxy solicitor: </font></div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">Core Scientific, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">838 Walker Road, Suite 21-2105 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Dover, Delaware 19904 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Attention: Investor Relations <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(512) 402-5233 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">ir@corescientific.com<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">or<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">MacKenzie Partners, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">7 Penn Plaza <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">New York, New York 10001 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Call toll free: (800) 322-2885 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Email: proxy@mackenziepartners.com</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">13<br></div></div></div>
<!--End Page 24-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 25-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSUM"><!--Anchor--></a>SUMMARY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary highlights selected information from this proxy statement/prospectus. It may not contain all of the information that is important to you. You are urged to read carefully the entire proxy statement/prospectus, including the attached annexes, and the other documents incorporated by reference into, this proxy statement/prospectus in order to fully understand the Merger Agreement and the Merger. See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. Each item in this summary refers to the page of this proxy statement/prospectus on which that subject is discussed in more detail. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tSTC"><!--Anchor--></a>THE COMPANIES (See Page <a href="#tTC">92</a>) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Inc., which is referred to in this proxy statement/prospectus as CoreWeave, was originally formed as a Delaware limited liability company in 2017 and then converted to a Delaware corporation in 2018. CoreWeave, the AI Hyperscaler&#8482;, delivers a cloud platform of cutting-edge software powering the next wave of AI. CoreWeave's technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal trading market for CoreWeave common stock (NASDAQ: CRWV) is the Nasdaq Stock Market LLC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal executive offices of CoreWeave are located at 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ and its telephone number is (973) 270-9737 and its website is www.coreweave.com. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Core Scientific, Inc. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific, Inc., which is referred to in this proxy statement/prospectus as Core Scientific, is a leader in digital infrastructure for high-density colocation services and digital asset mining of bitcoin. Core Scientific operates dedicated, purpose-built facilities for digital asset mining and is a premier provider of digital infrastructure, software solutions and services to its third-party customers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants are traded on the Nasdaq under the symbol &#8220;CORZ,&#8221; &#8220;CORZW&#8221; and &#8220;CORZZ,&#8221; respectively. Following the Merger, Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will be delisted from the Nasdaq. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s principal executive offices are located at 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, and our telephone number is (512) 402-5233. Its corporate website address is www.corescientific.com. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additional information about Core Scientific and its subsidiaries are included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Miami Merger Sub I, Inc. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Miami Merger Sub I, Inc., which is referred to in this proxy statement/prospectus as Merger Sub, is a Delaware corporation and a wholly owned subsidiary of CoreWeave. Merger Sub was formed solely for the purpose of completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental to its formation and activities undertaken in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Merger Sub was formed in the State of Delaware on July&#160;2, 2025. The principal executive offices of Merger Sub are located at 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ and its telephone number is (973) 270-9737. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;"><a name="tSTM"><!--Anchor--></a>THE MERGER (See Page <a href="#tTHE">175</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Merger Sub and Core Scientific have entered into the Merger Agreement. Subject to the terms and conditions of the Merger Agreement and in accordance with applicable law, in the Merger, Merger Sub will be merged with and into Core Scientific, with Core Scientific continuing as the Surviving Corporation. Following completion of the Merger, Core Scientific will be a wholly owned subsidiary of CoreWeave. In connection with the Merger, Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will be delisted from the Nasdaq and deregistered under the Exchange Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A copy of the Merger Agreement is attached as Annex&#160;A to this proxy statement/prospectus. <font style="font-weight: bold;">You should read the Merger Agreement carefully because it is the legal document that governs the Merger</font>. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">14<br></div></div></div>
<!--End Page 25-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 26-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tTCS"><!--Anchor--></a>THE CORE SCIENTIFIC SPECIAL MEETING (See Page <a href="#tSSM">169</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Date, Time and Location<font style="font-style: normal; font-weight: normal;">. The Special Meeting will be a virtual meeting conducted exclusively via live webcast starting at [&#8195;], Eastern Time (with log-in beginning at [&#8195;], Eastern Time) on [&#8195;]. Core Scientific stockholders will be able to attend the Special Meeting online and vote shares electronically at the meeting by going to www.virtualshareholdermeeting.com/CORZ2025SM and entering the 16-digit control number included on the proxy card or voting instruction form you received. Because the Special Meeting is completely virtual and being conducted via live webcast, stockholders will not be able to attend the meeting in person. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Purposes of the Special Meeting<font style="font-style: normal; font-weight: normal;">. The Special Meeting is being held to consider and vote upon the following proposals: </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 1&#8212;the Merger Agreement Proposal</font>: to adopt the Merger Agreement, a copy of which is attached as Annex&#160;A to this proxy statement/prospectus and the material provisions of which are summarized in the section titled &#8220;The Merger Agreement&#8221; beginning on page <a href="#tTMAT">218</a> of this proxy statement/prospectus, pursuant to which, among other things, Merger Sub will merge with and into Core Scientific and each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave common stock. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 2&#8212;the Advisory Compensation Proposal</font>: to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger, the estimated value of which is disclosed in the table in the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page <a href="#tQOPP">254</a> of this proxy statement/prospectus. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific Record Date; Stockholders Entitled to Vote<font style="font-style: normal; font-weight: normal;">. The record date for the determination of Core Scientific stockholders entitled to notice of, and to vote at, the Special Meeting is the close of business on [&#8195;], 2025. Only Core Scientific stockholders who held Core Scientific common stock of record on the Core Scientific record date are entitled to vote at the Special Meeting or any adjournments or postponements of the Special Meeting. Each issued and outstanding share of Core Scientific common stock as of the Core Scientific record date entitles its holder of record to one vote on each matter to be considered at the Special Meeting. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Quorum<font style="font-style: normal; font-weight: normal;">. In order for business to be conducted at the Special Meeting, a quorum must be present. A quorum at the Special Meeting requires the presence, virtually or by proxy, of the holders of a majority of the voting power of the outstanding shares of Core Scientific common stock entitled to vote at the Special Meeting. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of determining whether there is a quorum, all shares that are present will count towards the quorum, which will include proxies received but marked as abstentions and will exclude broker non-votes. Broker non-votes occur when a beneficial owner holding shares in &#8220;street name&#8221; does not instruct the broker, bank or other nominee that is the record owner of such stockholder&#8217;s shares on how to vote those shares on a particular proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Required Vote; Treatment of Abstentions and Failure to Vote<font style="font-style: normal; font-weight: normal;">. The votes required for each proposal are as follows: </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 1&#8212;the Merger Agreement Proposal. </font>The affirmative vote of holders of a majority of the issued and outstanding shares of Core Scientific common stock on the Core Scientific record date and entitled to vote thereon is required to approve the Merger Agreement Proposal. The required vote on Proposal 1 is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure of any Core Scientific stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from voting by a Core Scientific stockholder will have the same effect as a vote &#8220;<font style="font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. Because the Merger Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger Agreement Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any Core Scientific shares held of record by them. As a result, a broker non-vote will have the same effect as a vote &#8220;<font style="font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 2&#8212;the Advisory Compensation Proposal. </font>The affirmative vote of the holders of a majority of the votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker non-votes), where a quorum is present, is required to approve the Advisory Compensation Proposal. The required vote on the Advisory Compensation Proposal is based on the number of shares actually voted&#8212;not the number </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">15<br></div></div></div>
<!--End Page 26-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 27-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">of outstanding shares of Core Scientific common stock entitled to be voted thereon. Abstentions from voting by a Core Scientific stockholder attending the Special Meeting or a failure to attend the Special Meeting virtually or by proxy will have no effect on the outcome of the vote on the Advisory Compensation Proposal. Brokers do not have discretion to vote on this proposal without your instruction. If you do not instruct your broker how to vote on this proposal, those shares will not be counted as present or represented by proxy at the Special Meeting and, as a result, will have no effect on the outcome of the vote on the Advisory Compensation Proposal. While the Core Scientific board intends to consider the vote resulting from the Advisory Compensation Proposal, the vote is advisory only and therefore not binding on Core Scientific, and, if the proposed Merger Agreement is adopted by Core Scientific stockholders and the Merger is consummated, the compensation that is the subject of the Advisory Compensation Proposal, including amounts Core Scientific is contractually obligated to pay, will be payable even if the Advisory Compensation Proposal is not approved. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Share Ownership; Voting by Core Scientific&#8217;s Directors and Executive Officers.<font style="font-style: normal; font-weight: normal;"> At the close of business on [&#8195;], Core Scientific&#8217;s directors and executive officers had the right to vote approximately [&#8195;] shares of the then-outstanding Core Scientific common stock, collectively representing approximately [&#8195;]% of the Core Scientific common stock outstanding and entitled to vote on that date. </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tWCS"><!--Anchor--></a>WHAT CORE SCIENTIFIC STOCKHOLDERS WILL RECEIVE IN THE MERGER (See Page <a href="#tMC1">219</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the terms and conditions set forth in the Merger Agreement, at the effective time, by virtue of the Merger, each share of Core Scientific common stock (other than each share of Core Scientific common stock held in treasury or held or owned by Core Scientific, CoreWeave or Merger Sub immediately prior to the effective time), outstanding immediately prior to the effective time will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of CoreWeave common stock, and cash proceeds from the sale of any fractional shares as described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No fractional shares of CoreWeave common stock will be delivered to any holder of shares of Core Scientific common stock upon completion of the Merger. Instead, all fractional shares of CoreWeave common stock that a holder of shares of Core Scientific common stock would otherwise be entitled to receive as a result of the Merger will be aggregated and, if a fractional share results from such aggregation, such holder will be entitled to receive proceeds from the sale of such fractional share by the exchange agent. No interest will be paid or accrued on cash proceeds from the sale of fractional shares of CoreWeave common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The exchange ratio of 0.1235 shares of CoreWeave common stock for each share of Core Scientific common stock is fixed, which means that it will not change between now and the date of the Merger, regardless of whether the market price of shares of either CoreWeave common stock or Core Scientific common stock changes. Based on the closing price of a share of CoreWeave common stock on the Nasdaq of $165.20 on July&#160;3, 2025, the last trading day prior to the public announcement of the Merger, the Merger Consideration represented approximately $20.40 in implied value for each share of Core Scientific common stock. Based on the closing price of a share of CoreWeave common stock on Nasdaq of $[&#8195;] on [&#8195;], 2025, the most recent practicable trading day prior to the date of this proxy statement/prospectus, the Merger Consideration represented approximately $[&#8195;] in implied value for each share of Core Scientific common stock. <font style="font-weight: bold;">Because CoreWeave will issue a fixed number of shares of CoreWeave common stock in exchange for each share of Core Scientific common stock, the value of the Merger Consideration that Core Scientific stockholders will receive in the Merger will depend on the market price of CoreWeave common stock at the time the Merger is completed. The market price of CoreWeave common stock when Core Scientific stockholders receive those shares after the Merger is completed could be greater than, less than or the same as the market price of shares of CoreWeave common stock on the date of this proxy statement/prospectus or at the time of the Special Meeting</font>. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tNDA"><!--Anchor--></a>NO DISSENTERS&#8217; OR APPRAISAL RIGHTS (See Page <a href="#tNDO">214</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Core Scientific stockholders are not entitled to dissenters&#8217; or appraisal rights in connection with the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tTOC"><!--Anchor--></a>TREATMENT OF CORE SCIENTIFIC EQUITY AWARDS (See Page <a href="#tTOCS">220</a>) </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Core Scientific RSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific RSU Award that is outstanding immediately prior to the effective time and held by the Specified Individuals or by a non-employee member of the Core Scientific board, will fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">16<br></div></div></div>
<!--End Page 27-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 28-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Core Scientific RSU Award as of immediately prior to the effective time, <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Unvested Core Scientific RSU Award that is outstanding immediately prior to the effective time will be cancelled and converted into a restricted stock unit award with respect to a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Unvested Core Scientific RSU Award as of immediately prior to the effective time, <font style="font-style: italic;">multiplied by</font> (y)&#160;the exchange ratio (i.e., a CoreWeave Rollover RSU Award), and each such CoreWeave Rollover RSU Award will otherwise continue to be subject to the same terms and conditions (including vesting schedule and treatment on termination of employment) as were applicable to the corresponding Unvested Core Scientific RSU Award prior to the effective time. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Core Scientific PSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific PSU Award that is outstanding immediately prior to the effective time, and held by the Specified Individuals, will vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Core Scientific PSU Award as of immediately prior to the effective time (which number will be determined by deeming the applicable performance level to equal 300%), <font style="font-style: italic;">multiplied b</font>y (y) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, all other Core Scientific PSU Awards that are outstanding immediately prior to the effective time will be cancelled and each will be converted into a time-based restricted stock unit award with respect to a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying a Core Scientific PSU Award as of immediately prior to the effective time assuming a performance level of 300% <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio (i.e., a CoreWeave Rollover PSU Award), and each such CoreWeave Rollover PSU Award will otherwise continue to be subject to the same terms and conditions (including service-based vesting and forfeiture conditions) as were applicable to the corresponding Core Scientific PSU Award immediately prior to the effective time (other than the applicable performance conditions). </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Core Scientific Options </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each In the Money Option will be cancelled and converted into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to (x) the quotient obtained by <font style="font-style: italic;">dividing</font> (a) the product obtained by <font style="font-style: italic;">multiplying</font> (A) the excess, if any, of the Per Core Scientific Share Price over the exercise price per share of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (B) the number of shares of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (b) the Per Core Scientific Share Price <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific Option that is not an In the Money Option and that is outstanding and unexercised as of immediately prior to the effective time will be cancelled at the effective time with no consideration payable in respect of such Core Scientific Option. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tROT"><!--Anchor--></a>RECOMMENDATION OF THE CORE SCIENTIFIC BOARD OF DIRECTORS (See Page&#160;<a href="#tRFT">184</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and &#8220;FOR&#8221; the Advisory Compensation Proposal.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the course of reaching its decision for Core Scientific to enter into the Merger Agreement and effect the Merger, the Core Scientific board considered a number of factors in its deliberations. For a more complete discussion of these factors, see the section titled &#8220;The Merger&#8212;Recommendation of the Core Scientific Board of Directors and Reasons for the Merger&#8221; beginning on page <a href="#tRFT">184</a> of this proxy statement/prospectus. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">17<br></div></div></div>
<!--End Page 28-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 29-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tOC1"><!--Anchor--></a>OPINIONS OF CORE SCIENTIFIC&#8217;S FINANCIAL ADVISORS (See Page <a href="#tOOC">197</a> and <a href="#tANNEXB">Annex B</a> and <a href="#tANNEXC">Annex C</a>) </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Opinion of Moelis &amp; Company LLC </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the meeting of the Core Scientific board on July&#160;7, 2025, Moelis &amp; Company LLC (&#8220;Moelis&#8221;) rendered its oral opinion, which was subsequently confirmed in its written opinion, dated July&#160;7, 2025, to the Core Scientific board that, as of the date thereof and based upon and subject to the assumptions made, procedures followed, matters considered and other limitations set forth in the opinion, the exchange ratio in the Merger was fair, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The full text of Moelis&#8217; written opinion dated July&#160;7, 2025, which sets forth the assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, is attached as Annex&#160;B to this proxy statement/prospectus and is incorporated herein by reference. You are encouraged to read the opinion carefully in its entirety. Moelis&#8217; opinion was provided for the use and benefit of the Core Scientific board (solely in its capacity as such) in its evaluation of the Merger. Moelis&#8217; opinion is limited solely to the fairness from a financial point of view of the exchange ratio in the Merger to the holders of Core Scientific common stock (other than the excluded shares), and does not address Core Scientific&#8217;s underlying business decision to effect the Merger or the relative merits of the Merger as compared to any alternative business strategies or transactions that might be available to Core Scientific. Moelis&#8217; opinion does not constitute a recommendation as to how any holder of securities of Core Scientific should vote or act with respect to the Merger or any other matter. Moelis&#8217; opinion was approved by a Moelis fairness opinion committee.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a summary of Moelis&#8217; opinion and the methodology that Moelis used to render its opinion, see the section titled &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of Moelis &amp; Company LLC&#8221; beginning on page&#160;<a href="#tOOC">197</a> and the full text of the written opinion of Moelis attached as Annex&#160;B to this proxy statement/prospectus. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Opinion of PJT Partners </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At a meeting of the Core Scientific board on July&#160;7, 2025, PJT Partners LP (&#8220;PJT Partners&#8221;) rendered its oral opinion, which was subsequently confirmed in its written opinion dated July&#160;7, 2025, to the Core Scientific board that, as of the date thereof and based upon and subject to the assumptions made, procedures followed, matters considered, and qualifications and limitations set forth in its written opinion, the exchange ratio in the Merger was fair to the holders of Core Scientific common stock (other than the excluded shares) from a financial point of view. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The full text of PJT Partners&#8217; written opinion delivered to the Core Scientific board, dated July&#160;7, 2025, is attached as Annex&#160;C and incorporated into this proxy statement/prospectus by reference in its entirety. PJT Partners&#8217; written opinion has been provided by PJT Partners at the request of the Core Scientific board and is subject to, among other things, the assumptions made, procedures followed, matters considered, and qualifications and limitations on the review undertaken by PJT Partners in connection with the opinion (which are stated therein). You are encouraged to read the opinion carefully in its entirety. PJT Partners provided its opinion to the Core Scientific board, in its capacity as such, in connection with and for purposes of its evaluation of the Merger only and PJT Partners&#8217; opinion does not constitute a recommendation as to any action the Core Scientific board should take with respect to the Merger or how any holder of Core Scientific common stock should vote or act with respect to the Merger or any other matter. The summary of the PJT Partners opinion contained in this proxy statement/prospectus is qualified in its entirety by reference to the full text of PJT Partners&#8217; written opinion. PJT Partners&#8217; opinion was approved by a PJT Partners fairness opinion committee.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a summary of PJT Partners&#8217; opinion and the methodology that PJT Partners used to render its opinion, see the section titled &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of PJT Partners&#8221; beginning on page <a href="#tOPJT">206</a> and the full text of the written opinion of PJT Partners attached as Annex&#160;C to this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tOS"><!--Anchor--></a>OWNERSHIP OF SHARES OF COREWEAVE COMMON STOCK AFTER THE MERGER </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on, among other things, the number of shares of Core Scientific common stock and the Core Scientific equity awards outstanding as of the close of business on [&#8195;], CoreWeave estimates that it will issue approximately [&#8195;] shares of CoreWeave common stock at closing pursuant to the Merger Agreement, provided that if additional </div> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">18<br></div></div></div>
<!--End Page 29-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 30-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Core Scientific equity awards are granted to certain Core Scientific employees as permitted under the Merger Agreement, if additional Tranche 1 Warrants and Tranche 2 Warrants are exercised for Core Scientific common stock prior to closing pursuant to the Core Scientific Warrant Agreement or if additional Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes are converted to Core Scientific common stock during the convertibility period pursuant to the Core Scientific 2029 Notes Indenture and Core Scientific 2031 Notes Indenture, as applicable, CoreWeave may be required to issue additional shares of CoreWeave common stock for issuance (see the section titled &#8220;The Merger Agreement&#8212;Treatment of Core Scientific Equity Awards&#8221;, &#8220;The Merger Agreement&#8212;Treatment of Warrants&#8221; and &#8220;The Merger Agreement&#8212;Treatment of Convertible Notes&#8221;). The actual number of shares of CoreWeave common stock to be issued will be determined at completion of the Merger based on the exchange ratio and the number of shares of Core Scientific common stock and the Core Scientific equity awards outstanding at that time, and CoreWeave will also reserve for issuance the maximum number of shares of CoreWeave common stock underlying the New Tranche 1 Warrants and New Tranche 2 Warrants and shares of CoreWeave common stock issuable upon conversion of the Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based upon the estimated number of shares of CoreWeave common stock that are expected to be outstanding immediately prior to the consummation of the Merger, we estimate that, as of immediately following completion of the Merger, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]% of the outstanding shares of CoreWeave common stock (or, on a fully diluted basis, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]% of the shares of CoreWeave common stock). </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tIC"><!--Anchor--></a>INTERESTS OF CORE SCIENTIFIC&#8217;S DIRECTORS AND EXECUTIVE OFFICERS IN THE MERGER (See Page <a href="#tIOC">252</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain directors and executive officers of Core Scientific have interests in the Merger that are different from, or in addition to, those of Core Scientific stockholders generally. These interests include, among others, the treatment of outstanding equity awards pursuant to the Merger Agreement; potential severance payments and benefits under individual letter agreements with certain Core Scientific executive officers; agreements with certain Core Scientific executive officers providing for excise tax reimbursements; payment of annual cash incentive bonuses for fiscal year 2025 if such bonuses have not been paid prior to the effective time; and continued indemnification and directors&#8217; and officers&#8217; liability insurance. The Core Scientific board was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending the approval of the Merger Agreement Proposal and Advisory Compensation Proposal. See the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8221; beginning on page <a href="#tIOC">252</a> of this proxy statement/prospectus for a more detailed description of these interests. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tLS"><!--Anchor--></a>LISTING OF SHARES OF COREWEAVE COMMON STOCK, NEW TRANCHE 1 WARRANTS AND NEW TRANCHE 2 WARRANTS AND DELISTING AND DEREGISTRATION OF CORE SCIENTIFIC COMMON STOCK, TRANCHE&#160;1 WARRANTS AND TRANCHE&#160;2 WARRANTS (See Page <a href="#tLOS">216</a>)</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave will use its reasonable best efforts to cause the shares of CoreWeave common stock, New Tranche&#160;1 Warrants and New Tranche 2 Warrants to be issued in connection with the Merger to be listed on the Nasdaq, where shares of CoreWeave common stock are currently traded. If the Merger is completed, shares of Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will no longer be listed on the Nasdaq and will be deregistered under the Exchange Act. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tCM"><!--Anchor--></a>COMPLETION OF THE MERGER IS SUBJECT TO CERTAIN CONDITIONS (See Page <a href="#tCCM1">223</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As more fully described in this proxy statement/prospectus and in the Merger Agreement, the obligation of each of CoreWeave, Core Scientific and Merger Sub to complete the Merger is subject to the satisfaction (or, to the extent permitted by applicable law, waiver) of a number of conditions.</div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">19<br></div></div></div>
<!--End Page 30-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 31-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Mutual Conditions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The obligations of CoreWeave and Core Scientific to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver (to the extent permitted by applicable law) by CoreWeave and Core Scientific of the following conditions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">receipt of the affirmative vote of the holders of a majority of the issued and outstanding shares of Core Scientific common stock entitled to vote thereon in favor of the adoption of this Merger Agreement, in accordance with applicable law and Core Scientific&#8217;s certificate of incorporation and bylaws (the &#8220;Core Scientific Stockholder Approval&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">this registration statement on Form&#160;S-4 becoming effective under the Securities Act, no SEC stop order suspending the effectiveness of this registration statement having been issued by the SEC and remaining in effect and no proceedings for such purpose pending before the SEC; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the expiration or termination of the waiting period (and any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the transactions contemplated by the Merger Agreement) applicable to the transactions contemplated by the Merger Agreement under the HSR Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the absence of any order enacted, promulgated, issued or entered by any governmental body enjoining, restraining, preventing or prohibiting the consummation of the Merger and the absence of any law in effect or enacted or promulgated prohibiting or making illegal the consummation of the Merger; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the approval for listing on Nasdaq, subject to official notice of issuance, of the CoreWeave common stock issuable to the Core Scientific stockholders in the Merger. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Additional Conditions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave&#8217;s and Merger Sub&#8217;s, on the one hand, and Core Scientific&#8217;s, on the other hand, obligations to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver (to the extent permitted by applicable law) of the following conditions as of the closing date: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">accuracy of the representations and warranties made in the Merger Agreement by, in the case of Core Weave and Merger Sub&#8217;s obligations to complete the Merger, Core Scientific and, in the case of Core Scientific&#8217;s obligation to complete the Merger, CoreWeave and Merger Sub, in each case, as of the date of completion of the Merger, subject to certain materiality thresholds; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">performance in all material respects by, in the case of CoreWeave and Merger Sub&#8217;s obligations to complete the Merger, Core Scientific and, in the case of Core Scientific&#8217;s obligation to complete the Merger, CoreWeave and Merger Sub, of the obligations required to be performed by it or them at or prior to the effective time of the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the absence since the date of the Merger Agreement of a material adverse effect on, in the case of CoreWeave and Merger Sub&#8217;s obligations to complete the Merger, Core Scientific and, in the case of Core Scientific&#8217;s obligation to complete the Merger, CoreWeave (see the section titled &#8220;The Merger Agreement&#8212;Definition of &#8216;Material Adverse Effect&#8217;&#8221; beginning on page <a href="#tDEFMAE">226</a> of this proxy statement/prospectus for the definition of material adverse effect); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">receipt of a certificate signed by a duly authorized officer of, in the case of CoreWeave and Merger Sub&#8217;s obligations to complete the Merger, Core Scientific and, in the case of Core Scientific&#8217;s obligation to complete the Merger, CoreWeave, as to the satisfaction of the conditions described in the preceding three bullets. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tTM"><!--Anchor--></a>THE MERGER MAY NOT BE COMPLETED WITHOUT ALL REQUIRED REGULATORY APPROVALS (See Page <a href="#tRA1">239</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Completion of the Merger is conditioned upon the expiration or termination of the waiting period (and any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the transactions contemplated by the Merger Agreement) applicable to the transactions contemplated by the Merger Agreement under the HSR Act. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">20<br></div></div></div>
<!--End Page 31-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 32-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The parties&#8217; HSR notifications were filed with the Federal Trade Commission (the &#8220;FTC&#8221;) and the Antitrust Division of the Department of Justice (the &#8220;DOJ&#8221;) on July&#160;25, 2025. The 30-day waiting period following the parties&#8217; filings expired on August&#160;25, 2025. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the HSR Act, certain transactions, including the Merger, may not be completed unless certain waiting period requirements have expired or been terminated. The HSR Act provides that each party must file its respective HSR notifications with the FTC and the DOJ. A transaction notifiable under the HSR Act may not be completed until the expiration of a 30-day waiting period following the parties&#8217; filings of their respective HSR notifications or the early termination of that waiting period. If the DOJ or FTC issues a request for additional information and documentary material (a &#8220;Second Request&#8221;) prior to the expiration of this initial 30-day waiting period, the transaction cannot close until the parties substantially comply with the Second Request and observe a second waiting period, which is 30 days by statute, but that can be extended through agreement or terminated earlier. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave have agreed in the Merger Agreement to (i) use reasonable best efforts to file, as soon as reasonably practicable after the date of the Merger Agreement, all filings, notifications, or other documents required to be filed with or as requested by any governmental body pursuant to any antitrust law with respect to the Merger and any other transactions contemplated by the Merger Agreement and (ii) cooperate with the other party in determining whether, and promptly preparing and making, any other filings or notifications or other consents required to be made with, or obtained from, any other governmental bodies in connection with the Merger and any other transactions contemplated by the Merger Agreement. Further, subject to the terms and conditions set forth in the Merger Agreement, CoreWeave and Core Scientific agreed to use their respective reasonable best efforts to take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable law to consummate and make effective the Merger and any other transactions contemplated by the Merger Agreement as soon as reasonably practicable. In furtherance of the foregoing, solely for the purpose of this section of the Merger Agreement, CoreWeave&#8217;s reasonable best efforts will be deemed to include, among other things, the divestiture, licensing or disposition or certain other remedial actions with respect to the business, product lines or assets of Core Scientific, CoreWeave or any of their respective subsidiaries, unless such actions would be material to the business, financial condition or results of operations of CoreWeave and Core Scientific, taken as a whole, but measured relative to the size and scale of Core Scientific and its subsidiaries. Further, neither CoreWeave nor Core Scientific may acquire any assets or businesses (or portions thereof) that compete with Core Scientific if such acquisition(s) would reasonably be expected to prevent or materially delay the closing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These requirements and the regulatory approvals required for completion of the Merger are described in more detail under the section titled &#8220;The Merger Agreement&#8212;Regulatory Approvals&#8221; beginning on page <a href="#tRA1">239</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tNS"><!--Anchor--></a>NO SOLICITATION BY CORE SCIENTIFIC (See Page <a href="#tNS1">238</a>)</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As more fully described in this proxy statement/prospectus and in the Merger Agreement, and subject to the exceptions described below, from the date of the Merger Agreement and continuing until the earlier of the effective time and the date, if any, on which the Merger Agreement is terminated in accordance with its terms, Core Scientific has agreed that it will not, and will cause its subsidiaries and its and their directors and officers not to, and will use its reasonable best efforts to cause its and their respective representatives not to, directly or indirectly: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">initiate, seek or solicit, or knowingly encourage or facilitate (including by way of furnishing non-public information) or knowingly cooperate with or take any other action that would reasonably be expected to promote, directly or indirectly, any inquiries or the making or submission of any proposal by a third party that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal (as defined under the section titled &#8220;The Merger Agreement&#8212;No Solicitation&#8221; beginning on page <a href="#tNS1">238</a> of this proxy statement/prospectus); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">participate, engage in or continue discussions (except to notify a person that makes an inquiry or offer with respect to an Acquisition Proposal of the existence of the provisions of the Merger Agreement described by this paragraph or to clarify whether any such inquiry, offer or proposal constitutes an Acquisition Proposal) or negotiations with, or disclose any non-public information or data relating to, Core Scientific or any of its subsidiaries or afford access to the properties, books or records of Core Scientific, or any of its subsidiaries to, or otherwise knowingly assist, facilitate or encourage any effort by, any third party, in each case, that has made or could reasonably be expected to make an Acquisition Proposal; </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">21<br></div></div></div>
<!--End Page 32-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 33-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">enter into any agreement, including any letter of intent, term sheet, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement (other than certain confidentiality agreements permitted under the Merger Agreement), with respect to an Acquisition Proposal; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">otherwise resolve or agree to do any of the items in the three bullet points above. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has agreed that it will not release or permit the release of any person from, or waive or permit the waiver of, any standstill or similar agreement with respect to any class of equity securities of Core Scientific or any of its subsidiaries, and will enforce or cause to be enforced each such agreement in accordance with its terms; provided, however, that Core Scientific may waive or fail to enforce any provision of such standstill or similar agreement of any person if the Core Scientific board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under applicable law.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has agreed to, and to cause its subsidiaries to, use reasonable best efforts to cause its and their respective representatives to, immediately cause to be terminated any solicitation, encouragement, discussion or negotiation with or involving any person (other than CoreWeave and its affiliates) conducted prior to the execution of the Merger Agreement by Core Scientific or any of its subsidiaries, or any of its or their respective representatives, with respect to an Acquisition Proposal. Core Scientific has agreed to immediately discontinue access by any person (other than CoreWeave and its affiliates and representatives) to any data room (virtual or otherwise) established by Core Scientific for the purpose of soliciting, intentionally encouraging or negotiating an Acquisition Proposal. Within five business days from the date of the Merger Agreement, Core Scientific has agreed to request the return or destruction of all confidential, non-public information provided to third parties that had entered into confidentiality agreements with Core Scientific or any of its subsidiaries since June&#160;30, 2024 relating to an Acquisition Proposal (substituting 50% for the 20% threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for the purpose of this sentence), to the extent provided for by the terms of any confidentiality agreements entered into in connection with the furnishing of such confidential information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding the foregoing restrictions, from the date of the Merger Agreement until obtaining the Core Scientific Stockholder Approval, Core Scientific and the Core Scientific board may take the actions described in the bullet points following the first paragraph of this section titled &#8220;&#8212;No Solicitation by Core Scientific,&#8221; with respect to a third party if, (x) Core Scientific receives a written Acquisition Proposal from a third party (and such Acquisition Proposal was not initiated, sought, solicited or knowingly encouraged or facilitated in non-de minimis breach of the terms described in this section) and (y) the Core Scientific board determines in good faith after consultation with its financial advisors and outside legal counsel that such proposal is or could reasonably be expected to lead to, a Superior Proposal (as defined under the section titled &#8220;The Merger Agreement&#8212;No Solicitation&#8221; beginning on page&#160;<a href="#tNS1">238</a> of this proxy statement/prospectus); provided, that Core Scientific may deliver non-public information to such third party pursuant to this sentence only pursuant to confidentiality agreements permitted under the Merger Agreement; provided, further, that all such information (to the extent that such information has not been previously provided or made available to CoreWeave) is provided or made available to CoreWeave, as the case may be, prior to or substantially concurrently with the time it is provided or made available to such third party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and the Core Scientific board are permitted to: (i) take and disclose to their stockholders a position with respect to an Acquisition Proposal pursuant to Rules 14d-9, 14e-2(a) or Item&#160;1012(a) of Regulation&#160;M-A promulgated under the Exchange Act or (ii) make any disclosure if the Core Scientific board has determined in good faith after consultation with its outside legal counsel and financial advisors that the failure to do so would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; provided, that this exception will not permit the Core Scientific board to make an Adverse Recommendation Change (as defined under the section titled &#8220;The Merger Agreement&#8212;Obligation to Recommend the Adoption of the Merger Agreement&#8221; beginning on page <a href="#tOTR1">236</a> of this proxy statement/prospectus), except to the extent permitted by the Merger Agreement as described in the section titled &#8220;Merger Agreement&#8212;Obligation to Recommend the Adoption of the Merger Agreement&#8221; beginning on page <a href="#tOTR1">236</a> of this proxy statement/prospectus. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">22<br></div></div></div>
<!--End Page 33-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 34-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tTMA"><!--Anchor--></a>TERMINATION OF THE MERGER AGREEMENT (See Page <a href="#tTOT1">245</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Merger Agreement may be terminated and the Merger may be abandoned:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to the effective time, by the mutual written consent of CoreWeave and Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by CoreWeave: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">at any time prior to the effective time, if any of Core Scientific&#8217;s covenants, representations or warranties contained in the Merger Agreement are or have become untrue, such that any of the closing conditions for CoreWeave relating to the accuracy of Core Scientific&#8217;s representations and warranties or compliance by Core Scientific with its covenants and agreements would not be satisfied, and such breach (A) is incapable of being cured by Core Scientific by or before the End Date or (B) is not cured within 30 days of receipt by Core Scientific of written notice from CoreWeave of such breach; provided, however, that CoreWeave will not have the right to terminate the Merger Agreement as described in this bullet point if any of CoreWeave or Merger Sub is then in breach of any representation, warranty, covenant or obligation under the Merger Agreement that would result in the failure to be satisfied of any of the closing conditions for Core Scientific relating to the accuracy of CoreWeave&#8217;s or Merger Sub&#8217;s representations and warranties or compliance by CoreWeave or Merger Sub with their covenants and agreements under the Merger Agreement; or </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">at any time prior to obtaining the Core Scientific Stockholder Approval, if the Core Scientific board or any committee thereof makes an Adverse Recommendation Change. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Core Scientific: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">at any time prior to the effective time, if any of CoreWeave&#8217;s or Merger Sub&#8217;s covenants, representations or warranties contained in the Merger Agreement are or have become untrue, such that any of the closing conditions for Core Scientific relating to the accuracy of CoreWeave&#8217;s or Merger Sub&#8217;s representations and warranties or compliance by CoreWeave or Merger Sub with its covenants and agreements would not be satisfied, and such breach (A) is incapable of being cured by CoreWeave or Merger Sub, as the case may be, by or before the End Date (as defined below), or (B) is not cured within 30 days of receipt by CoreWeave of written notice from Core Scientific of such breach; provided, however, that Core Scientific will not have the right to terminate the Merger Agreement as described in this bullet point if Core Scientific is then in breach of any representation, warranty, covenant or obligation under the Merger Agreement that would result in the failure to be satisfied of any of the closing conditions for CoreWeave relating to the accuracy of Core Scientific&#8217;s representations and warranties or compliance by Core Scientific with its covenants and agreements under the Merger Agreement; or </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">at any time prior to obtaining the Core Scientific Stockholder Approval (and subject to Core Scientific&#8217;s obligation to pay CoreWeave the Termination Fee (as defined under the section titled &#8220;The Merger Agreement&#8212;Termination Fee&#8221; beginning on page <a href="#tTE1">246</a> of this proxy statement/prospectus)), upon written notice to CoreWeave, in order to enter into a definitive agreement with a third party providing for a Superior Proposal, if in connection with such Superior Proposal, Core Scientific has complied in all material respects with its requirements as described in the sections titled &#8220;Merger Agreement&#8212;Obligation to Recommend the Adoption of the Merger Agreement&#8221; and &#8220;Merger Agreement&#8212;No Solicitation&#8221; beginning on pages <a href="#tOTR1">236</a> and <a href="#tNS1">238</a> respectively, of this proxy statement/prospectus. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by either CoreWeave or Core Scientific at any time prior to the effective time, if: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">(A) any order has become final and non-appealable, or (B) there is a law, in each case of (A) and (B) having the effect of permanently enjoining or restricting the consummation of the Merger or making the Merger illegal or otherwise prohibited; provided, however, that the right to terminate the Merger Agreement as described in this bullet point will not be available to any party material failure to comply with any provision of the Merger Agreement has been the primary cause of such order or law; </font></div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">23<br></div></div></div>
<!--End Page 34-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 35-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">the closing has not been consummated by 5:00 p.m., New York time on April&#160;7, 2026 (the &#8220;End Date&#8221;); provided, that the right to terminate the Merger Agreement as described in this bullet point will not be available to any party whose material failure to comply with any provision of the Merger Agreement has been the primary cause of the failure of the Merger to occur on or before the End Date; or </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">the Core Scientific Stockholder Approval has not been obtained at the Special Meeting, including any adjournment or postponement thereof; provided, that the right to terminate the Merger Agreement as described in this bullet point will not be available to Core Scientific if its material failure to comply with any provision of the Merger Agreement has been the primary cause of the failure to obtain the Core Scientific Stockholder Approval on or before such date. </font></div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of the valid termination of the Merger Agreement by either CoreWeave or Core Scientific, the Merger Agreement will be of no further force or effect. Certain provisions in the Merger Agreement relating to confidentiality, the Termination Fee, applicable law, third-party beneficiaries, reimbursement of expenses, termination, specific performance and certain other miscellaneous provisions will survive the termination of the Merger Agreement and will remain in full force and effect, and no such termination will relieve any person of any liability for fraud or an intentional breach of the Merger Agreement. Nothing will limit or prevent CoreWeave or Core Scientific from exercising any rights or remedies it may have related to specific performance in lieu of exercising any right it may have to terminate the Merger Agreement; provided that if the Merger Agreement is terminated, no party will have any rights or remedies for specific performance other than in respect of the provisions that are identified as surviving termination. No termination of the Merger Agreement will affect the obligations of the parties contained in the confidentiality agreement entered by Core Scientific and CoreWeave in connection with the transaction, all of which will survive the termination of the Merger Agreement in accordance with their terms. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><a name="tSPP"><!--Anchor--></a>SPECIFIC PERFORMANCE; REMEDIES (See Page <a href="#tSPR1">247</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the Merger Agreement, each of CoreWeave and Core Scientific is entitled to an injunction or injunctions to prevent breaches or threatened breaches of the Merger Agreement or to enforce specifically the terms and provisions of the Merger Agreement, in addition to any other remedy to which that party may be entitled at law or in equity (including damages in the event of the other party&#8217;s fraud or intentional and material breach of the Merger Agreement), without the necessity of proving the inadequacy of money damages as a remedy or posting any bond or other undertaking. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><a name="tUSF"><!--Anchor--></a>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER (See Page <a href="#tMUS">249</a>)</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave intend for the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code for U.S. federal income tax purposes. Assuming the Merger so qualifies, U.S. holders (as defined in the section titled &#8220;Material U.S. Federal Income Tax Consequences of the Merger&#8221;) of shares of Core Scientific common stock generally will not recognize any gain or loss for U.S. federal income tax purposes upon receipt of CoreWeave common stock in exchange for Core Scientific common stock in the Merger, other than gain or loss, if any, with respect to any cash received in lieu of a fractional share of CoreWeave common stock.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the effectiveness of the registration statement of which this proxy statement/prospectus is a part, each of Wachtell, Lipton, Rosen &amp; Katz, counsel to Core Scientific, and Davis Polk &amp; Wardwell LLP, counsel to CoreWeave, will deliver a legal opinion to the effect that the Merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. An opinion that the Merger &#8220;should&#8221; qualify as a reorganization within the meaning of Section 368(a) of the Code expresses a level of comfort that is stronger than &#8220;more likely than not&#8221; but less than &#8220;will.&#8221; Counsel is unable to provide a higher degree of certainty because there is no administrative or judicial authority that directly addresses facts similar to those of this transaction, including with respect to the federal income tax treatment of the Tranche 2 Warrants. Nonetheless, counsel believes that its opinion is justified based on the existing authorities. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The material U.S. federal income tax consequences of the Merger to U.S. holders are discussed in more detail in the section titled &#8220;Material U.S. Federal Income Tax Consequences of the Merger.&#8221; The discussion of the material U.S. federal income tax consequences contained in this proxy statement/prospectus is intended to provide only a general discussion and is not a complete analysis or description of all potential U.S. federal income tax consequences of the Merger. Such consequences may vary with, or be dependent on, individual circumstances. In addition, it does not address the effects of any foreign, state or local tax laws or any U.S. federal tax laws other than U.S. federal income tax laws. </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">24<br></div></div></div>
<!--End Page 35-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 36-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">TAX MATTERS ARE COMPLICATED AND THE TAX CONSEQUENCES OF THE MERGER WILL DEPEND ON THE FACTS OF YOUR OWN SITUATION. YOU ARE URGED TO CONSULT YOUR OWN TAX ADVISOR AS TO THE SPECIFIC TAX CONSEQUENCES OF THE MERGER TO YOU IN YOUR PARTICULAR CIRCUMSTANCES.<font style="font-weight: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tAT"><!--Anchor--></a>ACCOUNTING TREATMENT (See Page <a href="#tACC">215</a>) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger will be accounted for as a business combination using the acquisition method of accounting pursuant to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) 805, Business Combinations (&#8220;ASC&#160;805&#8221;), whereby CoreWeave is considered the accounting acquirer. CoreWeave will record the identifiable tangible and intangible assets acquired and liabilities assumed of Core Scientific at their respective fair values as of the closing date of the Merger. Any excess of the consideration transferred over the fair value of Core Scientific&#8217;s net assets will be allocated to goodwill. The consideration transferred will be based on the closing date fair value of consideration paid by CoreWeave, primarily CoreWeave common stock to be issued to Core Scientific stockholders and the effective settlement of pre-existing relationships, in connection with the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tRCS"><!--Anchor--></a>RIGHTS OF CORE SCIENTIFIC STOCKHOLDERS WILL CHANGE AS A RESULT OF THE MERGER (See Page <a href="#tCOS">293</a>) </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders, whose rights are currently governed by the Core Scientific certificate of incorporation, Core Scientific bylaws and Delaware law, will, upon completion of the Merger, become stockholders of CoreWeave and their rights will be governed by the CoreWeave certificate of incorporation, CoreWeave bylaws and Delaware law. As a result, Core Scientific stockholders will have different rights once they become CoreWeave stockholders due to differences between the governing documents of Core Scientific and CoreWeave. These differences are described in detail in &#8220;Comparison of Stockholder Rights&#8221; beginning on page <a href="#tCOS">293</a> of this proxy statement/prospectus. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tLRTM"><!--Anchor--></a>LITIGATION RELATING TO THE MERGER (See Page <a href="#tLR2">216</a>)</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of the date hereof, there are no pending lawsuits challenging the Merger. Since the public announcement of the Merger, Core Scientific has received letters from purported Core Scientific stockholders who contend that the registration statement on Form S-4 of which this proxy statement/prospectus forms a part fails to disclose certain allegedly material information and demands that Core Scientific make supplemental disclosures.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While Core Scientific believes that the contentions made in the letters described above are without merit, each of these matters is at a preliminary stage. It is possible that complaints and additional, similar letters may be received by Core Scientific regarding the Merger. Absent new or different allegations that are material or constitute a disclosure obligation under the U.S. federal securities laws, Core Scientific will not necessarily disclose such additional letters. Litigation is inherently uncertain, and there can be no assurance regarding the likelihood that Core Scientific&#8217;s defense of any potential lawsuits related to the Merger that may be filed in the future will be successful, nor can Core Scientific predict the amount of time and expense that will be required to resolve any potential lawsuits.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For additional information, see the section titled &#8220;The Merger&#8212;Litigation Relating to the Merger.&#8221; </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tSRF"><!--Anchor--></a>RISK FACTORS (See Page <a href="#tRF">28</a>)</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You should also carefully consider the risks that are described in the section titled &#8220;Risk Factors&#8221; beginning on page <a href="#tRF">28</a> of this proxy statement/prospectus, which include, but are not limited to, the following: </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17.5pt; margin-left: 20pt; text-align: left;">Risks Relating to the Merger </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Because the consideration to be received by Core Scientific stockholders in connection with the Merger will include a fixed number of shares of CoreWeave common stock, and the market price of such shares has fluctuated and will continue to fluctuate, Core Scientific stockholders cannot be sure of the value of the consideration they will receive in the Merger. Furthermore, under Delaware law, Core Scientific stockholders are not entitled to an appraisal of the fair value of their shares in connection with the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s and Core Scientific&#8217;s business relationships may be subject to disruption due to uncertainty associated with the Merger. </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">25<br></div></div></div>
<!--End Page 36-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 37-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Third parties may terminate or alter existing contracts or relationships with Core Scientific or CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">While the Merger Agreement is in effect, Core Scientific and CoreWeave are subject to restrictions on their respective business activities, including, among other things, restrictions on their respective ability to issue equity securities and engage in certain kinds of transactions, which could prevent each of Core Scientific and CoreWeave from pursuing strategic business opportunities, taking actions with respect to their respective businesses that they may consider advantageous and responding effectively and/or timely to competitive pressures and industry developments, and may as a result materially adversely affect each of their businesses, results of operations and financial conditions. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The Merger Agreement limits Core Scientific&#8217;s ability to pursue alternatives to the Merger and may discourage other companies from trying to acquire Core Scientific for greater consideration than what CoreWeave has agreed to pay pursuant to the Merger Agreement. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Completion of the Merger is subject to certain conditions and if these conditions are not satisfied, waived or fulfilled in a timely manner, the Merger may be delayed or not completed within the anticipated timeframe or at all. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">After completion of the Merger, CoreWeave may fail to realize the anticipated benefits of the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The historical financials of CoreWeave as provided in this proxy statement/prospectus may not be an indication of the future financial condition or results of operations of CoreWeave following the consummation of the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The unaudited pro forma condensed combined financial information included in this proxy statement/prospectus is preliminary and the actual financial condition and results of operations of the combined company after the Merger may differ materially. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The financial forecasts are based on various assumptions that may not be realized. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The opinions of Core Scientific&#8217;s financial advisors will not reflect changes in circumstances between the signing of the Merger Agreement and the completion of the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Certain of Core Scientific&#8217;s executive officers and directors have interests in the Merger that may be different from, or in addition to, your interests as a stockholder of Core Scientific or as a stockholder of CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Failure to complete the Merger could negatively impact the stock price and the future business and financial results of Core Scientific and CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">After the Merger, Core Scientific stockholders, as a group, will have a significantly lower ownership and voting interest in CoreWeave than they currently have in Core Scientific and will exercise less influence over management, in particular because the class of high-vote common stock of CoreWeave has the effect of concentrating voting power with CoreWeave&#8217;s co-founders. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Potential litigation against CoreWeave and Core Scientific could result in substantial costs, an injunction preventing the completion of the Merger and/or a judgment resulting in the payment of damages. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The expected dilution caused by the issuance of shares of CoreWeave common stock in connection with the Merger may adversely affect the market price of CoreWeave common stock. </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 20pt; text-align: left;">Risks Relating to CoreWeave </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s recent growth may not be indicative of its future growth, and if it does not effectively manage its future growth, CoreWeave&#8217;s business, operating results, financial condition, and prospects may be adversely affected. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave has a limited number of suppliers for significant components of the equipment it uses to build and operate its platform and provide its solutions and services. Any disruption in the availability of these components could delay CoreWeave&#8217;s ability to expand or increase the capacity of its infrastructure or replace defective equipment. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s business would be harmed if it were not able to access sufficient power or by increased costs to procure power, prolonged power outages, shortages, or capacity constraints. </div></td></tr></table></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">26<br></div></div></div>
<!--End Page 37-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 38-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 492pt;"><a name="ny20053122x2_s4a_107-summary_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_border-box" style="border-top: 1pt solid #000000; border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000; margin-bottom: 12pt; padding-top: 12pt; padding-bottom: 12pt; width: 492pt; margin-left: 0pt;"><div class="BRDSX_page-content" style="margin-left: 12pt;"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">If CoreWeave&#8217;s data center providers fail to meet the requirements of its business, or if the data center facilities experience damage, interruption, or a security breach, CoreWeave&#8217;s ability to provide access to its infrastructure and maintain the performance of its network could be negatively impacted. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">A substantial portion of CoreWeave&#8217;s revenue is driven by a limited number of its customers, and the loss of, or a significant reduction in, spend from one or a few of its top customers would adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">If CoreWeave fails to efficiently enhance its platform and develop and sell new solutions and services and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, and changing customer needs, requirements, or preferences, CoreWeave&#8217;s platform may become less competitive. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The broader adoption, use, and commercialization of artificial intelligence (&#8220;AI&#8221;) technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by CoreWeave&#8217;s customers to continue to use its CoreWeave Cloud Platform to support AI use cases in their systems, or CoreWeave&#8217;s ability to keep up with evolving AI technology requirements and regulatory frameworks, could have a material adverse effect on CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s operations require substantial capital expenditures, and it will require additional capital to fund its business and support its growth, and any inability to generate or obtain such capital on acceptable terms, if at all, or to lower our total cost of capital, may adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s substantial indebtedness could materially adversely affect its financial condition, its ability to raise additional capital to fund its operations, its ability to operate its business, its ability to react to changes in the economy or its industry, its ability to meet its obligations under its outstanding indebtedness and could divert its cash flow from operations for debt payments, and it may still incur substantially more indebtedness in the future. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The multi-class structure of CoreWeave&#8217;s common stock has the effect of concentrating voting power with its Co-Founders (as defined below), which will limit your ability to influence the outcome of important transactions, including a change in control. </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Risks Relating to Core Scientific </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus for a listing of documents incorporated by reference into this proxy </div></td></tr></table><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 40pt; text-align: left;">statement/prospectus containing applicable risks to the businesses of Core Scientific.  </div></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 12pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">27<br></div></div></div>
<!--End Page 38-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 39-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRF"><!--Anchor--></a>RISK FACTORS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the other information contained in, or incorporated by reference into, this proxy statement/prospectus, including the matters addressed in &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; beginning on page <a href="#tFLS">89</a> of this proxy statement/prospectus, the following risk factors should be considered carefully in determining whether to vote for the adoption of the Merger Agreement. You should also read and consider the risk factors associated with each of the businesses of CoreWeave and Core Scientific because these risk factors may affect the operations and financial results of the combined company. The risk factors for Core Scientific may be found under Part&#160;II, Item&#160;1A of Core Scientific&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended June&#160;30, 2025, filed with the SEC on August&#160;8, 2025; Part&#160;II, Item&#160;1A of Core Scientific&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended March&#160;31, 2025, filed with the SEC on May&#160;7, 2025; Part&#160;I, Item&#160;1A of Core Scientific&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, filed with the SEC on&#160;February&#160;27, 2025; and Core Scientific&#8217;s subsequent filings with the SEC, in each case, which are incorporated by reference into this proxy statement/prospectus. For information on where you can obtain copies of this information, see the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Risks relating to the Merger </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;"><a name="tRECEIVE"><!--Anchor--></a>Because the consideration to be received by Core Scientific stockholders in connection with the Merger will include a fixed number of shares of CoreWeave common stock, and the market price of such shares has fluctuated and will continue to fluctuate, Core Scientific stockholders cannot be sure of the value of the consideration they will receive in the Merger. Furthermore, under Delaware law, Core Scientific stockholders are not entitled to an appraisal of the fair value of their shares in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the Merger Agreement, at the effective time of the Merger, each share of Core Scientific common stock (other than each share of Core Scientific common stock held in treasury or held or owned by Core Scientific, CoreWeave or Merger Sub immediately prior to the effective time of the Merger) issued and outstanding immediately prior to the effective time of the Merger will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of CoreWeave common stock. The market value of the consideration Core Scientific&#8217;s stockholders will receive in the Merger will therefore fluctuate with the market price of CoreWeave common stock. The implied value of the Merger Consideration has fluctuated since the date of the announcement of the Merger Agreement and will continue to fluctuate until the date the Merger is completed, which could occur a considerable amount of time after the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the completion of the Merger, the market price of CoreWeave common stock, along with short selling activity in both CoreWeave common stock and Core Scientific common stock, has and is expected to continue to impact the market price of the Core Scientific common stock. The value of the Merger Consideration has fluctuated since the date of the announcement of the Merger Agreement and will continue to fluctuate from the date of this proxy&#160;statement/prospectus to the date of the Special Meeting and the date the Merger is completed and thereafter. The closing price per share of Core Scientific common stock as of June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions, was $12.30, and the closing price per share has fluctuated as high as $[&#8195;] and as low as $[&#8195;] between June&#160;25, 2025 and [&#8195;], 2025, the most recent practicable trading day prior to the date of this proxy statement/prospectus. The closing price per share of CoreWeave common stock as of June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions, was $159.50, and the closing price per share has fluctuated as high as $[&#8195;] and as low as $[&#8195;]&#160;between June&#160;25, 2025 and [&#8195;], 2025, the most recent practicable trading day prior to the date of this proxy statement/prospectus. Accordingly, at the time of the Special Meeting, Core Scientific stockholders will not know or be able to determine the market value of the Merger Consideration they would receive upon completion of the Merger. Stock price changes may result from a variety of factors, including, among others, interest rates, general market, industry, economic and geopolitical conditions, including the impact of continued inflation and associated changes in monetary policy, short-selling activity, the expiration of the initial public offering lock-up period applicable to CoreWeave securities, changes in and speculation regarding CoreWeave&#8217;s and Core Scientific&#8217;s respective businesses, operations and prospects, market assessments of the likelihood that the Merger will be completed, the timing of the Merger and regulatory considerations. Many of these factors are beyond CoreWeave&#8217;s and Core Scientific&#8217;s control. You are urged to obtain current market quotations for each of CoreWeave&#8217;s and Core Scientific&#8217;s common stock traded on the Nasdaq (trading symbols &#8220;CRWV&#8221; and &#8220;CORZ&#8221;, respectively). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, under Delaware law, the holders of Core Scientific common stock are not entitled to an appraisal of the fair value of their shares in connection with the Merger. Appraisal rights are statutory rights that enable stockholders to dissent from certain extraordinary transactions, such as certain mergers, and to demand that the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">28<br></div></div></div>
<!--End Page 39-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 40-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">corporation pay the fair value for their shares as determined by a court in a judicial proceeding instead of receiving the consideration offered to stockholders in connection with the applicable transaction. Under Delaware law, appraisal rights are not available for the shares of any class or series if the shares of the class or series are listed on a national securities exchange or held of record by more than 2,000 holders on the record date, unless the stockholders receive in exchange for their shares anything other than shares of stock of the surviving or resulting corporation or of any other corporation that is publicly listed or held by more than 2,000 holders of record, cash proceeds from the sale of fractional shares or fractional depositary receipts or any combination of the foregoing. Shares of Core Scientific common stock are listed on the Nasdaq, and Core Scientific&#8217;s stockholders will receive CoreWeave common stock pursuant to the Merger Agreement and cash proceeds from the sale of fractional shares. Approval for the listing of the shares of CoreWeave common stock on the Nasdaq is a condition to completion of the Merger. See the section titled &#8220;The Merger&#8212;No Dissenters&#8217; or Appraisal Rights&#8221; beginning on page <a href="#tNDO">214</a> of this proxy statement/prospectus. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The market price of CoreWeave common stock after the Merger may be affected by factors different from those affecting the market price of Core Scientific common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon completion of the Merger, holders of shares of Core Scientific common stock will become holders of shares of CoreWeave common stock. The businesses of CoreWeave differ from those of Core Scientific in important respects, and, accordingly, the results of operations of CoreWeave after the Merger, as well as the market price of CoreWeave common stock, may be affected by factors different from those currently affecting the results of operations of Core Scientific. For further information on the respective businesses of CoreWeave and Core Scientific and certain factors to consider in connection with those businesses, see the section titled &#8220;Risk Factors&#8212;Risks relating to CoreWeave&#8221; beginning on page <a href="#tRRCW">39</a> of this proxy statement/prospectus and the documents incorporated by reference into this proxy statement/prospectus and referred to in the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the market price of CoreWeave common stock may fluctuate significantly following completion of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, general fluctuations in stock markets could have a material adverse effect on the market for, or liquidity of, the CoreWeave common stock, regardless of CoreWeave&#8217;s actual operating performance. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Core Scientific may have difficulty attracting, motivating and retaining employees in light of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Uncertainty about the effect of the Merger on Core Scientific employees may impair Core Scientific&#8217;s ability to attract, retain and motivate personnel prior to and following the Merger. Employee retention may be particularly challenging during the pendency of the Merger, as employees of Core Scientific may experience uncertainty about their future roles with the combined business. If employees of Core Scientific depart, the integration of the companies may be more difficult and the combined business following the Merger may be harmed. Furthermore, CoreWeave may have to incur significant costs in identifying, hiring and retaining replacements for departing employees and may lose significant expertise and talent relating to the businesses of CoreWeave or Core Scientific, and CoreWeave&#8217;s ability to realize the anticipated benefits of the Merger may be adversely affected. In addition, there could otherwise be disruptions to or distractions for the workforce and management associated with integrating employees into CoreWeave. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s and Core Scientific&#8217;s business relationships may be subject to disruption due to uncertainty associated with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Parties with which CoreWeave or Core Scientific does business may experience uncertainty associated with the Merger, including with respect to current or future business relationships with CoreWeave, Core Scientific or the combined business. CoreWeave&#8217;s and Core Scientific&#8217;s business relationships may be subject to disruption as parties with which CoreWeave or Core Scientific does business may attempt to negotiate changes in existing business relationships or consider entering into business relationships with parties other than CoreWeave, Core Scientific or the combined business. These disruptions could have an adverse effect on the businesses, financial condition, results of operations or prospects of the combined business, including an adverse effect on CoreWeave&#8217;s ability to realize the anticipated benefits of the Merger. The risk, and adverse effect, of such disruptions could be exacerbated by a delay in completion of the Merger or termination of the Merger Agreement. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Third parties may terminate or alter existing contracts or relationships with Core Scientific or CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of Core Scientific and CoreWeave has contracts with business partners which may require Core Scientific or CoreWeave, as applicable, to obtain consent from these other parties in connection with the Merger. If these </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">29<br></div></div></div>
<!--End Page 40-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 41-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">consents cannot be obtained, the counterparties to these contracts and other third parties with which Core Scientific and/or CoreWeave currently have relationships may have the ability to terminate, reduce the scope of or otherwise adversely alter their relationships with either or both parties in anticipation of the Merger, or with the combined company following the transaction. The pursuit of such rights may result in Core Scientific, CoreWeave or the combined company suffering a loss of potential future revenue or incurring liabilities in connection with a breach of such agreements and may lose rights that are material to its business. Any such disruptions could limit the combined company&#8217;s ability to achieve the anticipated benefits of the Merger. The adverse effect of such disruptions could also be exacerbated by a delay in the completion of the Merger or the termination of the Merger Agreement. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">While the Merger Agreement is in effect, Core Scientific and CoreWeave are subject to restrictions on their respective business activities, including, among other things, restrictions on their respective ability to issue equity securities and engage in certain kinds of transactions, which could prevent each of Core Scientific and CoreWeave from pursuing strategic business opportunities, taking actions with respect to their respective businesses that they may consider advantageous and responding effectively and/or timely to competitive pressures and industry developments, and may as a result materially adversely affect each of their businesses, results of operations and financial conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While the Merger Agreement is in effect, Core Scientific and CoreWeave are subject to restrictions on their respective business activities, including, among other things, restrictions on their respective ability to issue equity securities and engage in certain kinds of transactions, and must generally operate their respective businesses in the ordinary course, subject to certain exceptions. These restrictions could prevent each of Core Scientific and CoreWeave from pursuing attractive business opportunities that may arise prior to the consummation of the Merger and may impact each of their financial conditions, results of operations and cash flows. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These restrictions could be in place for an extended period of time if the consummation of the Merger is delayed, which may delay or prevent each of CoreWeave and Core Scientific from undertaking business opportunities that, absent the Merger Agreement, they might have pursued, or from effectively responding to competitive pressures or industry developments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Whether or not the Merger is completed, the pending transaction may disrupt their respective current plans and operations, which could have an adverse effect on their respective businesses and financial results. For these and other reasons, the pendency of the Merger could adversely affect each of their businesses and financial results. See the section titled &#8220;The Merger Agreement&#8212;Conduct of Business Pending the Merger&#8221; beginning on page <a href="#tCBPM">229</a> of this proxy statement/prospectus. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The Merger Agreement limits Core Scientific&#8217;s ability to pursue alternatives to the Merger and may discourage other companies from trying to acquire Core Scientific for greater consideration than what CoreWeave has agreed to pay pursuant to the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement contains provisions that make it more difficult for Core Scientific to sell its business to a party other than CoreWeave. These provisions include a general prohibition on Core Scientific soliciting any Acquisition Proposal or offer for a competing transaction. Further, subject to certain exceptions, the Core Scientific board will not withdraw or modify in a manner adverse to CoreWeave the recommendation of the Core Scientific board in favor of the adoption of the Merger Agreement, and CoreWeave generally has a right to match any competing Acquisition Proposals that may be made. Notwithstanding the foregoing, at any time prior to the adoption of the Merger Agreement by Core Scientific stockholders, the Core Scientific board is permitted to withdraw or modify in a manner adverse to CoreWeave the recommendation of the Core Scientific board in favor of the adoption of the Merger Agreement in certain circumstances if it determines in good faith that the failure to take such action would reasonably likely be inconsistent with its fiduciary duties to Core Scientific stockholders under applicable law. The Merger Agreement does not require that Core Scientific submit the adoption of the Merger Agreement to a vote of Core Scientific stockholders if the Core Scientific board terminates the Merger Agreement in order to enter into an alternative acquisition agreement with respect to a competing transaction in accordance with the terms of the Merger Agreement. In certain circumstances, upon termination of the Merger Agreement, Core Scientific will be required to pay a termination fee of $270&#160;million to CoreWeave, including if Core Scientific terminates the Merger Agreement prior to obtaining Core Scientific Stockholder Approval in order to enter into an alternative acquisition agreement with respect to a competing transaction in accordance with the terms of the Merger Agreement. See the sections titled &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement&#8221; and &#8220;The Merger Agreement&#8212;Exclusive Remedy&#8221; beginning on pages <a href="#tTOT1">245</a> and <a href="#tEX">247</a>, respectively, of this proxy statement/prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">30<br></div></div></div>
<!--End Page 41-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 42-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While both Core Scientific and CoreWeave believe these provisions and agreements are reasonable and customary and are not preclusive of other offers, the restrictions, including the added expense of the $270&#160;million termination fee that may become payable by Core Scientific to CoreWeave in certain circumstances, might discourage a third party that has an interest in acquiring all or a significant part of Core Scientific from considering or proposing that acquisition, even if that party were prepared to pay consideration with a higher per-share value than the consideration payable in the Merger pursuant to the Merger Agreement. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;"><a name="tCM01"><!--Anchor--></a>Completion of the Merger is subject to certain conditions and if these conditions are not satisfied, waived or fulfilled in a timely manner, the Merger may be delayed or not completed within the anticipated timeframe or at all. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The obligation of each of CoreWeave and Core Scientific to complete the Merger is subject to the satisfaction or waiver (to the extent permitted by applicable law) of a number of conditions, including, among others: (i) the affirmative vote of the holders of a majority of the issued and outstanding shares of Core Scientific common stock entitled to vote at the Special Meeting adopting the Merger Agreement, (ii) the expiration or termination of any waiting period (and any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the Merger) applicable to the Merger under the HSR Act, (iii) the absence of any order enacted, promulgated, issued or entered by any governmental body enjoining, restraining, preventing or prohibiting the consummation of the Merger and any law in effect or enacted or promulgated prohibiting or making illegal the consummation of the Merger, (iv) the registration statement of which this proxy statement/prospectus is a part being declared effective and no stop order suspending the effectiveness of such registration statement having been issued by the SEC and remaining in effect and no proceedings for such purpose pending before the SEC, (v) the absence since the date of the Merger Agreement of a material adverse effect on, in the case of CoreWeave&#8217;s obligation to complete the Merger, Core Scientific (see the section titled &#8220;The Merger Agreement&#8212;Definition of &#8216;Material Adverse Effect&#8217;&#8221; beginning on page <a href="#tDEFMAE">226</a>, of this proxy statement/prospectus for the definition of material adverse effect) and (vi) the absence since the date of the Merger Agreement of a material adverse effect on, in the case of Core Scientific&#8217;s obligations to complete the Merger, CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a more complete summary of the conditions that must be satisfied or waived prior to completion of the Merger, see the section titled &#8220;The Merger Agreement&#8212;Conditions to the Consummation of the Merger&#8221; beginning on page <a href="#tCCM1">223</a> of this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of the conditions to consummation of the Merger are not within either Core Scientific&#8217;s or CoreWeave&#8217;s control, and neither company can predict when, or if, these conditions will be satisfied. If any of these conditions are not satisfied or waived prior to April&#160;7, 2026, it is possible that the Merger Agreement may be terminated. Although Core Scientific and CoreWeave have agreed in the Merger Agreement to use reasonable best efforts, subject to certain limitations, to complete the Merger as promptly as practicable, these and other conditions to the completion of the Merger may fail to be satisfied. In addition, satisfying the conditions to and completion of the Merger may take longer, and could cost more, than Core Scientific and CoreWeave expect. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, the requirements for obtaining the required clearances and approvals could delay the completion of the Merger for a significant period of time or prevent the Merger from occurring at all. A delay in completing the Merger could cause CoreWeave and Core Scientific to realize some or all of the benefits later than they otherwise expect to realize them if the Merger is successfully completed within the anticipated time frame, which could result in additional transaction costs to both CoreWeave and Core Scientific or in other negative effects associated with uncertainty about the completion of the Merger. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On September 4, 2025, Two Seas filed a preliminary proxy statement with the SEC to solicit votes of Core Scientific stockholders in opposition to the Core Scientific board&#8217;s recommendations on the Merger Agreement Proposal and the Advisory Compensation Proposal presented in this proxy statement/prospectus. The proxy contest will cause Core Scientific to incur additional solicitation and other costs, and may impair Core Scientific&#8217;s ability to obtain the votes required to approve the Merger Agreement Proposal and Advisory Compensation Proposal.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There can be no assurance that the conditions to the closing of the Merger will be satisfied, waived or fulfilled in a timely fashion or that the Merger will be completed. See the section titled &#8220;Risk Factors&#8212;Failure to complete the Merger could negatively impact the stock price and the future business and financial results of Core Scientific and CoreWeave&#8221; beginning on page <a href="#tFTC1">35</a> of this proxy statement/prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">31<br></div></div></div>
<!--End Page 42-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 43-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">The Merger Agreement may be terminated in accordance with its terms and the Merger may not be consummated. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement contains certain termination rights for each of Core Scientific and CoreWeave, including, among others: (i) if any order has become final and non-appealable or there is any law, in each case having the effect of permanently enjoining the consummation of the Merger or making the Merger illegal or otherwise prohibited; (ii) if the consummation of the Merger does not occur on or before April&#160;7, 2026, (iii) if the affirmative vote of the holders of a majority of the issued and outstanding shares of Core Scientific common stock entitled to vote was not obtained at the Special Meeting adopting the Merger Agreement and (iv) subject to certain conditions, if Core Scientific wishes to terminate the Merger Agreement to enter into a definitive agreement with respect to a superior proposal. Upon the termination of the Merger Agreement under specified circumstances, including, among others, the termination by Core Scientific in the event of a change of recommendation by the Core Scientific board or by Core Scientific in order to enter into a definitive agreement with respect to a superior proposal, Core Scientific would be required to pay CoreWeave a termination fee of $270&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">See the section titled &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement&#8221; beginning on page&#160;<a href="#tTOT1">245</a> of this proxy statement/prospectus and the section titled &#8220;The Merger Agreement&#8212;Termination Fee&#8221; beginning on&#160;page <a href="#tTE1">246</a> for a more complete discussion of the circumstances under which the Merger Agreement could be terminated and when a termination fee may be payable by Core Scientific. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Core Scientific may waive one or more of the closing conditions without re-soliciting stockholder approval. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific may determine to waive, in whole or part, one or more of the conditions to closing prior to Core Scientific being obligated to consummate the Merger. Any determination whether to waive any conditions to closing, or to re-solicit stockholder approval to amend or supplement this proxy statement/prospectus as a result of such a waiver, will be made by Core Scientific at the time of such waiver based on the facts and circumstances as they exist at that time. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">After completion of the Merger, CoreWeave may fail to realize the anticipated benefits of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific believe that there are significant benefits and synergies that may be realized through combining the infrastructure offerings of CoreWeave and Core Scientific. However, the efforts to realize these benefits and synergies will be a complex process and may disrupt CoreWeave&#8217;s and Core Scientific&#8217;s respective existing operations if not implemented in a timely and efficient manner. The full benefits of the Merger, including the anticipated cost savings and operations or growth opportunities, may not be realized as expected or may not be achieved within the anticipated time frame, or at all. Failure to achieve the anticipated benefits of the Merger could adversely affect CoreWeave&#8217;s and Core Scientific&#8217;s respective businesses, operating results or financial conditions, cause dilution to their respective earnings per share, decrease or delay any accretive effect of the Merger, adversely affect the price of their respective common stock (including the Merger Consideration) and cause the combined business to not perform as expected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific have operated and, until completion of the Merger, will continue to operate, independently, and there can be no assurances that their businesses can be integrated successfully. It is possible that the integration process could result in the loss of key Core Scientific expertise, the disruption of either company&#8217;s or both companies&#8217; ongoing businesses or in unexpected integration issues, higher than expected integration costs and an overall post-completion integration process that takes longer than originally anticipated. Specifically, the following issues, among others, must be addressed in integrating the operations of CoreWeave and Core Scientific to realize the anticipated benefits of the Merger so the combined business performs as expected: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">integrating the companies&#8217; physical assets, facilities and technologies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">integrating and achieving anticipated synergies of the combined business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">succeeding in applying CoreWeave&#8217;s technologies to Core Scientific&#8217;s assets; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">harmonizing the companies&#8217; operating practices, employee development and compensation programs, internal controls and other policies, procedures and processes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">maintaining existing agreements with commercial counterparties and avoiding delays in entering into new agreements with prospective commercial counterparties; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifying and eliminating redundant and underperforming assets; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">32<br></div></div></div>
<!--End Page 43-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 44-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">combining certain of the companies&#8217; operations, financial, reporting and corporate functions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">addressing possible differences in business backgrounds, corporate cultures and management philosophies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">consolidating the companies&#8217; administrative and information technology infrastructure; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">managing the movement of certain businesses and positions to different locations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">coordinating geographically dispersed organizations; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">effecting potential actions that may be required in connection with obtaining regulatory approvals. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, at times, the attention of certain members of either company&#8217;s or both companies&#8217; business or management and resources may be focused on completion of the Merger and the integration of the businesses of the two companies and diverted from day-to-day business operations, which may disrupt each company&#8217;s ongoing business and the business of the combined company. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The historical financials of CoreWeave as provided in this proxy statement/prospectus may not be an indication of the future financial condition or results of operations of CoreWeave following the consummation of the Merger. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The historical financials of CoreWeave as provided in this proxy statement/prospectus may not be indicative of CoreWeave&#8217;s future financial condition or results of operations following the consummation of the Merger. In particular, the historical financials of CoreWeave do not reflect any anticipated synergies, operating efficiencies or cost savings that may result from the Merger or any integration costs that may be incurred. Additionally, CoreWeave may potentially repurpose or divest a portion of Core Scientific&#8217;s digital asset mining self-mining and digital asset hosted mining businesses, which accounted for approximately $486.3&#160;million or approximately 95% of Core Scientific&#8217;s revenue for the fiscal year ended December&#160;31, 2024 and approximately $68.0 million or approximately 86.5% of Core Scientific&#8217;s revenue for the three months ended June 30, 2025, over the medium-term horizon. As a result, revenues from these businesses as shown in the historical financials of Core Scientific incorporated by reference in this proxy statement/prospectus may not be reflected in CoreWeave&#8217;s financial results in future periods as such. Additionally, CoreWeave currently accounts for 100% of Core Scientific&#8217;s HPC hosting revenue, with Core Scientific providing approximately 500 MW of digital infrastructure to host CoreWeave&#8217;s HPC operations as of October&#160;2024. Upon consummation of the Merger, revenue generated by Core Scientific by providing HPC hosting services to CoreWeave will cease. </div> <div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The unaudited pro forma condensed combined financial information included in this proxy statement/prospectus is preliminary and the actual financial condition and results of operations of the combined company after the Merger may differ materially. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information in this proxy statement/prospectus is presented for illustrative purposes only and is not necessarily indicative of what the combined company&#8217;s actual financial condition or results of operations would have been had the Merger been completed on the date indicated. The unaudited pro forma condensed combined financial information reflects adjustments, which are based upon preliminary estimates, to record the Core Scientific identifiable assets acquired and liabilities assumed at fair value and the resulting goodwill recognized. The fair value estimates reflected in this proxy statement/prospectus are preliminary, and final amounts will be based upon the actual consideration and the fair value of the assets and liabilities of Core Scientific as of the date of the completion of the Merger. Accordingly, the final acquisition accounting adjustments may differ materially from the pro forma adjustments reflected in this proxy statement/prospectus. For more information, see the section entitled &#8220;Unaudited Pro Forma Condensed Combined Financial Information.&#8221; </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">The financial forecasts are based on various assumptions that may not be realized. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial estimates set forth in the forecasts included under the section &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8221; were based on assumptions of, and information available to, Core Scientific&#8217;s management, when prepared, and these estimates and assumptions are subject to uncertainties, many of which are beyond Core Scientific&#8217;s control and may not be realized. Many factors mentioned in this proxy statement/prospectus, including the risks outlined in this &#8220;Risk Factors&#8221; section and the events or circumstances described under the section titled &#8220;Cautionary Statement Regarding Forward-Looking Statements,&#8221; will be important in determining the combined company&#8217;s future results. As a result of these contingencies, actual future results may vary materially from </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">33<br></div></div></div>
<!--End Page 44-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 45-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Core Scientific&#8217;s estimates. In view of these uncertainties, the inclusion of financial estimates in this proxy statement/prospectus is not and should not be viewed as a representation that the forecasted results will necessarily reflect actual future results. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s financial estimates were not prepared with a view toward public disclosure, and such financial estimates were not prepared with a view toward compliance with published guidelines of any regulatory or professional body. Further, any forward-looking statement speaks only as of the date on which it is made, and Core&#160;Scientific does not undertake any obligation, other than as required by applicable law, to update the financial estimates herein to reflect events or circumstances after the date those financial estimates were prepared or to reflect the occurrence of anticipated or unanticipated events or circumstances. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial estimates of Core Scientific included in this proxy statement/prospectus have been prepared by, and are the responsibility of, Core Scientific. Moreover, neither Marcum LLP (&#8220;Marcum&#8221;), Core Scientific&#8217;s independent accountant, Deloitte &amp; Touche LLP (&#8220;Deloitte&#8221;), CoreWeave&#8217;s independent registered public accountant, nor any other independent accountants, have compiled, examined or performed any procedures with respect to Core&#160;Scientific&#8217;s unaudited prospective financial information contained herein, nor have they expressed any opinion or any other form of assurance on such information or achievability thereof, and, accordingly, such independent accountants assume no responsibility for, and disclaim any association with, Core Scientific&#8217;s prospective financial information. The reports of such independent accountants incorporated by reference herein relate exclusively to the historical financial information of the entities named in those reports and do not cover any other information in this proxy statement/prospectus and should not be read to do so. See the section titled &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8221; beginning on page <a href="#tCUP">191</a> for more information. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">The opinions of Core Scientific&#8217;s financial advisors will not reflect changes in circumstances between the signing of the Merger Agreement and the completion of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board has received the separate opinions from each of its financial advisors in connection with the signing of the Merger Agreement, each to the effect that, and as of the date of such opinion and based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations set&#160;forth therein, the exchange ratio in the Merger Agreement is fair from a financial point of view to the holders of shares of Core Scientific common stock (other than the excluded shares). Changes in the operations and prospects of CoreWeave or Core Scientific, general market and economic conditions and other factors that may be beyond the control of CoreWeave or Core Scientific, and on which Core Scientific&#8217;s financial advisors&#8217; opinions were based, may significantly alter the value of CoreWeave or Core Scientific or the prices of the shares of CoreWeave common stock or Core Scientific common stock by the time the Merger is completed. The opinions do not speak as of the time the Merger will be completed or as of any date other than the date of each such opinion. Because Core Scientific does not currently anticipate asking its financial advisors to provide updated fairness opinions, the opinions will not address the fairness of the Merger Consideration from a financial point of view at the time that Core Scientific stockholders vote on the Merger Agreement Proposal or at the time the Merger is completed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a description of each of the opinions that Core Scientific received from its financial advisors, see the section entitled &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8221; beginning on page <a href="#tOOC">197</a>. A copy of each of the opinions of Moelis &amp; Company LLC and PJT Partners LP, Core Scientific&#8217;s financial advisors, is attached as Annex&#160;B and Annex&#160;C, respectively, to this proxy statement/prospectus. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">Completion of the Merger may trigger change in control or other provisions in certain agreements to which Core Scientific is a party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific is a party to certain agreements that give the counterparty certain rights following a &#8220;change in control,&#8221; including in some cases the right to terminate such agreements. Under some such agreements, the Merger may constitute a change in control and therefore the counterparty may exercise certain rights under the agreement upon the closing of the Merger. Any such counterparty may request modifications of its respective agreements as a condition to granting a waiver or consent under its agreement. There is no assurance that such counterparties will not exercise their rights under the agreements, including termination rights where available, and/or requires payment of substantial financial penalties. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">34<br></div></div></div>
<!--End Page 45-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 46-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Certain of Core Scientific&#8217;s executive officers and directors have interests in the Merger that may be different from, or in addition to, your interests as a stockholder of Core Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In considering the recommendation of the Core Scientific board to vote for the adoption of the Merger Agreement, Core Scientific stockholders should be aware that certain of the directors and executive officers of Core Scientific have interests in the Merger that are different from, or in addition to, the interests of Core Scientific stockholders generally, including the treatment of outstanding equity awards pursuant to the Merger Agreement, potential severance payments and benefits under individual letter agreements with certain Core Scientific executive officers; agreements with certain Core Scientific executive officers providing for excise tax reimbursements; payment of annual cash incentive bonuses for fiscal year 2025 if such bonuses have not been paid prior to the effective time; and continued indemnification and directors&#8217; and officers&#8217; liability insurance. The Core Scientific board was aware of these interests and considered them, among other matters, in evaluating and negotiating the Merger Agreement and approving the Merger, and in recommending the approval of the Merger Agreement Proposal and Advisory Compensation Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For more information, see the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8221; beginning on page <a href="#tIOC">252</a> of this proxy statement/prospectus. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;"><a name="tFTC1"><!--Anchor--></a>Failure to complete the Merger could negatively impact the stock price and the future business and financial results of Core Scientific and CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger is not completed for any reason, including as a result of Core Scientific stockholders failing to adopt the Merger Agreement or any other condition not being satisfied or waived, the ongoing businesses of Core&#160;Scientific and/or CoreWeave may be adversely affected, and, without realizing any of the benefits of having completed the Merger, CoreWeave and Core Scientific would be subject to a number of risks, including the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific and CoreWeave may experience negative reactions from the financial markets, including negative impacts on their respective stock prices; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific and CoreWeave may experience negative reactions from their respective customers, vendors, joint venture and other business partners, regulators and employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific and CoreWeave will be required to pay certain costs relating to the Merger, such as legal, accounting, financial advisor and printing fees, whether or not the Merger is completed; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Merger Agreement places certain restrictions on the conduct of Core Scientific&#8217;s and CoreWeave&#8217;s businesses prior to completion of the Merger, and such restrictions, the waiver of which is subject to the written consent of the other party (such consent not to be unreasonably withheld, conditioned or delayed), and subject to certain exceptions and qualifications, may prevent Core Scientific and CoreWeave from taking certain other specified actions or otherwise pursuing business opportunities during the pendency of the Merger that Core Scientific or CoreWeave would have made, taken or pursued if these restrictions were not in place (see the section titled &#8220;The Merger Agreement&#8212;Conduct of Business Pending the Merger&#8221; beginning on page <a href="#tCBPM">229</a> of this proxy statement/prospectus for a description of the restrictive covenants applicable to Core Scientific and CoreWeave); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">matters relating to the Merger (including integration planning) will require substantial commitments of time and resources by Core Scientific and CoreWeave management, which would otherwise have been devoted to day-to-day operations and other opportunities that may have been beneficial to Core Scientific or CoreWeave as an independent company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">in the event of a termination of the Merger Agreement under certain circumstances specified in the Merger Agreement, Core Scientific may be required to pay a termination fee of $270&#160;million to CoreWeave; to the extent that a termination fee is not promptly paid by Core Scientific when due, Core Scientific will be required to pay CoreWeave interest on such fee at the annual rate equal to the prime rate, as published in The Wall Street Journal in effect on the date such payment was required to be made, through the date such payment was actually received; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific and CoreWeave may face litigation related to any failure to complete the Merger or related to any enforcement proceeding commenced against Core Scientific or CoreWeave preventing the performance of their respective obligations pursuant to the Merger Agreement. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">35<br></div></div></div>
<!--End Page 46-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 47-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There can be no assurance that the risks described above will not materialize. If the Merger is not completed, these risks may materialize and may materially and adversely affect Core Scientific&#8217;s and CoreWeave&#8217;s businesses, financial condition, financial results, ratings, stock prices and/or, in the case of Core Scientific, warrant prices. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The shares of CoreWeave common stock to be received by Core Scientific stockholders upon completion of the Merger will have different rights from shares of Core Scientific common stock. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon completion of the Merger, Core Scientific stockholders will no longer be stockholders of Core Scientific, but will instead become stockholders of CoreWeave, and their rights as stockholders will be governed by CoreWeave&#8217;s certificate of incorporation and bylaws. The terms of CoreWeave&#8217;s certificate of incorporation and bylaws may be materially different than the terms of the Core Scientific certificate of incorporation and bylaws, which currently govern the rights of Core Scientific stockholders. See the section titled &#8220;Comparison of Stockholder Rights&#8221; beginning on page <a href="#tCOS">293</a> of this proxy statement/prospectus for a discussion of the different rights associated with CoreWeave common shares. </div> <div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If the Merger does not qualify as a &#8220;reorganization&#8221; under Section 368(a) of the Code, stockholders of Core Scientific common stock may be required to recognize gain or loss for U.S. federal income tax purposes upon the exchange of Core Scientific common stock for CoreWeave common stock in the Merger.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave intend for the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code for U.S. federal income tax purposes. The completion of the Merger is not conditioned on the Merger qualifying for the intended tax treatment or upon the receipt of an opinion of counsel to that effect, and neither Core Scientific nor CoreWeave will request a ruling from the IRS regarding the U.S. federal income tax consequences of the Merger. However, in connection with the effectiveness of the registration statement of which this proxy statement/prospectus is a part, each of Wachtell, Lipton, Rosen &amp; Katz, counsel to Core Scientific, and Davis Polk &amp; Wardwell LLP, counsel to CoreWeave, will deliver a legal opinion to the effect that the Merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. An opinion that the Merger &#8220;should&#8221; qualify as a reorganization within the meaning of Section 368(a) of the Code expresses a level of comfort that is stronger than &#8220;more likely than not&#8221; but less than &#8220;will.&#8221; Counsel is unable to provide a higher degree of certainty because there is no administrative or judicial authority that directly addresses facts similar to those of this transaction, including with respect to the federal income tax treatment of the Tranche 2 Warrants. Nonetheless, counsel believes that its opinion is justified based on the existing authorities. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These opinions will be based upon and rely on, among other things, various facts, assumptions, representations and warranties and covenants, including those contained in the Merger Agreement and in the officer&#8217;s certificates provided by CoreWeave (on behalf of itself and Merger Sub) and Core Scientific. If any of these facts, assumptions, representations and warranties and covenants underlying the tax opinions described above is or becomes incorrect, incomplete, inaccurate or is waived or violated, the validity of, and the conclusions reached in, such tax opinions may be affected or jeopardized. In addition, the opinions will be subject to certain qualifications and limitations as set forth therein. Moreover, an opinion of counsel represents such counsel&#8217;s judgment and is not binding on the IRS or any court and the IRS or a court may disagree with the conclusions reached by an opinion of counsel. Notwithstanding the receipt by CoreWeave and Core Scientific of the opinions of counsel, there can be no assurance that the IRS would not assert that the Merger fails to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code or that a court would not sustain such position. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger does not qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, a Core Scientific stockholder that is a U.S. holder (as defined in the section titled &#8220;Material U.S. Federal Income Tax Consequences of the Merger&#8221;) generally would recognize gain or loss for U.S. federal income tax purposes upon the exchange of Core Scientific common stock for CoreWeave common stock in the Merger. For more information on the material U.S. federal income tax consequences of the Merger, see the section titled &#8220;Material U.S. Federal Income Tax Consequences of the Merger.&#8221;</div> <div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">After the Merger, Core Scientific stockholders, as a group, will have a significantly lower ownership and voting interest in CoreWeave than they currently have in Core Scientific and will exercise less influence over management, in particular because the class of high-vote common stock of CoreWeave has the effect of concentrating voting power with CoreWeave&#8217;s co-founders. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on, among other things, the number of shares of Core Scientific common stock and the Core Scientific equity awards outstanding as of the close of business on [&#8195;], CoreWeave estimates that it will issue approximately [&#8195;] shares of CoreWeave common stock at closing pursuant to the Merger Agreement, provided that if additional </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">36<br></div></div></div>
<!--End Page 47-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 48-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Core Scientific equity awards are granted to certain Core Scientific employees as permitted under the Merger Agreement, if additional Tranche 1 Warrants and Tranche 2 Warrants are exercised for Core Scientific common stock prior to closing pursuant to the Core Scientific Warrant Agreement or if additional Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes are converted to Core Scientific common stock during the convertibility period pursuant to the Core Scientific 2029 Notes Indenture and Core Scientific 2031 Notes Indenture, as applicable, CoreWeave may be required to issue additional shares of CoreWeave common stock for issuance (see the sections titled &#8220;The Merger Agreement&#8212;Treatment of Core Scientific Equity Awards&#8221;, &#8220;The Merger Agreement&#8212;Treatment of Warrants&#8221; and &#8220;The Merger Agreement&#8212;Treatment of Convertible Notes&#8221;). The actual number of shares of CoreWeave common stock to be issued will be determined at completion of the Merger based on the exchange ratio and the number of shares of Core Scientific common stock and the Core Scientific equity awards outstanding at that time, and CoreWeave will also reserve for issuance the maximum number of shares of CoreWeave common stock underlying the New Tranche 1 Warrants and New Tranche 2 Warrants and shares of CoreWeave common stock issuable upon conversion of the Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes. CoreWeave has a significantly larger market capitalization than Core&#160;Scientific. Based on the number of shares of Core Scientific common stock outstanding as of [&#8195;], 2025, and the number of shares of CoreWeave common stock outstanding as of [&#8195;], 2025, CoreWeave and Core Scientific estimate that, as of immediately following completion of the Merger, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core&#160;Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]%, of the outstanding shares of CoreWeave common stock (or, on a fully diluted basis, holders of CoreWeave common stock as of immediately prior to the Merger will hold approximately [&#8195;]% and holders of Core Scientific common stock as of immediately prior to the Merger will hold approximately [&#8195;]% of the shares of CoreWeave common stock). Consequently, former Core Scientific stockholders, as a group, will have materially less influence over the management and policies of CoreWeave than they currently have over the management and policies of Core&#160;Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, CoreWeave&#8217;s Class&#160;B common stock has ten votes per share, CoreWeave&#8217;s Class&#160;A common stock has one vote per share and CoreWeave&#8217;s Class&#160;C common stock has no votes per share. As of June&#160;30, 2025, Michael&#160;Intrator, CoreWeave&#8217;s Chief Executive Officer, President, and Chairman of CoreWeave&#8217;s board of directors, Brian Venturo, CoreWeave&#8217;s Chief Strategy Officer, and Brannin McBee, CoreWeave&#8217;s Chief Development Officer (together, the &#8220;CoreWeave Co-Founders&#8221;) collectively held all of the issued and outstanding shares of CoreWeave&#8217;s Class&#160;B common stock. Because of the ten-to-one voting ratio between CoreWeave&#8217;s Class&#160;B common stock and Class&#160;A common stock, the CoreWeave Co-Founders collectively continue to control a significant percentage of the combined voting power of CoreWeave&#8217;s common stock, which voting power may increase over time upon the exercise or settlement and exchange of equity awards held by the CoreWeave Co-Founders pursuant to their equity exchange rights which provide each Co-Founder with the right (but not obligation) to require CoreWeave to exchange, for shares of CoreWeave Class&#160;B common stock, any shares of CoreWeave Class&#160;A common stock received by him upon the exercise or settlement of equity awards for shares of CoreWeave Class&#160;A common stock granted prior to September&#160;2024. Therefore, the CoreWeave Co-Founders, individually or together, will be able to significantly influence matters submitted to CoreWeave stockholders for approval, including the election of directors, amendments of CoreWeave&#8217;s organizational documents and any merger, consolidation, sale of all or substantially all of CoreWeave&#8217;s assets, or other major corporate transactions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, future issuances of CoreWeave Class&#160;C common stock may further concentrate the voting power of CoreWeave Co-Founders by prolonging the duration of their control and/or by giving them an opportunity to achieve liquidity without diminishing their voting power. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The interests of the CoreWeave Co-Founders, individually or together, may not coincide with the interests of the other holders of capital stock of CoreWeave, including Core Scientific stockholders who receive CoreWeave Class&#160;A common stock in the Merger. This concentration of ownership may harm the value of CoreWeave Class&#160;A common stock Core Scientific&#8217;s stockholders receive in the Merger by, among other things delaying, deferring or preventing a change in control of CoreWeave or impeding a merger, consolidation, takeover or other business combination involving CoreWeave. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">37<br></div></div></div>
<!--End Page 48-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 49-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Potential litigation against CoreWeave and Core Scientific could result in substantial costs, an injunction preventing the completion of the Merger and/or a judgment resulting in the payment of damages. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Securities class action lawsuits and derivative lawsuits are often brought against public companies that have entered into merger agreements. Even if such lawsuits are unsuccessful, defending against them can result in substantial costs. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stockholders of Core Scientific may file lawsuits against CoreWeave, Core Scientific and/or the directors and officers of either company in connection with the Merger. Since the public announcement of the Merger, Core Scientific has received letters from purported Core Scientific stockholders who contend that the registration statement on Form S-4 of which this proxy statement/prospectus forms a part fails to disclose certain allegedly material information. For additional information, see the section titled &#8220;The Merger&#8212;Litigation Relating to the Merger.&#8221; Potential lawsuits could prevent or delay the completion of the Merger and result in significant costs to Core Scientific and/or CoreWeave, including any costs associated with the indemnification of directors and officers. There can be no assurance that any of the defendants will be successful in the outcome of any potential lawsuits. </div> <div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave and Core Scientific may incur significant acquisition-related costs in connection with the Merger, which may be in excess of those anticipated by CoreWeave and Core Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific expect to incur a number of non-recurring costs associated with the Merger, combining the operations of the two companies and working to achieve desired synergies. The significant, non-recurring costs associated with the Merger include, among others, fees and expenses of financial, legal, accounting and other advisors and representatives, certain employment-related costs relating to employees of Core&#160;Scientific (which are described in the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8221; beginning on page <a href="#tIOC">252</a> of this proxy statement/prospectus), filing fees due in connection with filings required under the HSR Act and filing fees and printing and mailing costs for this proxy statement/prospectus. Some of these costs have already been incurred or may be incurred regardless of whether the Merger is completed, including a portion of the fees and expenses of financial advisors and other advisors and representatives and filing fees for this proxy statement/prospectus. CoreWeave also will incur transaction fees and costs related to formulating and implementing integration plans with respect to the two companies, including facilities and systems consolidation costs. CoreWeave and Core Scientific continue to assess the magnitude of these costs, and additional unanticipated costs may be incurred in the Merger and the integration of the two companies&#8217; businesses. Any substantial unanticipated costs could have an adverse effect on CoreWeave&#8217;s and Core Scientific&#8217; financial positions, results of operations and cash flows following the completion of the Merger. Moreover, the expected benefits of the Merger may not outweigh these costs in the near term, or at all. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The expected dilution caused by the issuance of shares of CoreWeave common stock in connection with the Merger may adversely affect the market price of CoreWeave common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The expected dilution caused by the issuance of the new shares of CoreWeave common stock to Core Scientific stockholders in connection with the payment of the Merger Consideration upon the closing of the Merger, either alone or in combination with any negative impact on the market price of CoreWeave common stock following the release of CoreWeave&#8217;s initial public offering lock-up restrictions, may result in fluctuations in the market price of CoreWeave common stock, including a stock price decrease. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The issuance of the New Tranche 1 Warrants and New Tranche 2 Warrants will increase the number of shares of CoreWeave common stock eligible for future resale in the public market and result in dilution to CoreWeave stockholders. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of September 9, 2025, Core Scientific had 97,432,201 outstanding Tranche 1 Warrants exercisable for&#160;97,432,201 shares of Core Scientific common stock at $6.81 per share and 12,118,829 outstanding Tranche&#160;2&#160;Warrants exercisable for 12,118,829 shares of Core Scientific common stock at $0.01 per share. Based on the number of Core Scientific warrants outstanding as of September 9, 2025, and assuming no events occur requiring any adjustment to the number of shares underlying each Tranche 1 Warrant or Tranche 2 Warrant or the exercise price therefor prior to the Merger, the New Tranche 1 Warrants will be exercisable for up to 12,032,877 shares of CoreWeave Class A common stock at an exercise price of $55.141700 per share, and the New Tranche 2 Warrants will be exercisable for up to 1,496,676 shares of CoreWeave Class A common stock at an exercise price of $60.728745 per share, in each case, prior to giving effect to any effective reduction in share issuance that the cashless exercise mechanism described below may have. </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">38<br></div></div></div>
<!--End Page 49-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 50-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At or immediately prior to the effective time, each (i) Tranche 1 Warrant will become the right to receive a New&#160;Tranche 1 Warrant exercisable for a number of shares of CoreWeave common stock (subject to cashless exercise as described below) equal to (a) the number of Warrant Shares (as defined in the Core Scientific Warrant Agreement) underlying such Tranche 1 Warrant, multiplied by (b) the exchange ratio, with such New Tranche 1 Warrant having an exercise price equal to the Tranche 1 Exercise Price (as defined in the Core Scientific Warrant Agreement) in effect immediately prior to the effective time divided by the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants and (ii) Tranche 2 Warrant shall become the right to receive a Converted Tranche 2 Warrant (as defined in the Core Scientific Warrant Agreement), which Converted Tranche 2 Warrant will be exercisable for a number of Warrant Shares with an exercise price of $7.50 per Warrant Share (subject to adjustment as set forth in the Core Scientific Warrant Agreement and otherwise on the same terms as the Tranche&#160;2&#160;Warrants), which will be converted into a New Tranche 2 Warrant exercisable for a number of shares of CoreWeave common stock (subject to cashless exercise as described below) equal to (a) the number of Warrant Shares underlying the Converted Tranche 2 Warrant, multiplied by (b) the exchange ratio, with such New Tranche&#160;2&#160;Warrant having an exercise price equal to $7.50 per Warrant Share divided by the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants. Both the New Tranche 1 Warrants and New Tranche 2 Warrants will be exercisable only on a cashless basis, pursuant to which the holder will be entitled to receive a number of shares of CoreWeave common stock equal to the total number of shares of CoreWeave common stock underlying the warrants being exercised multiplied by a fraction equal to (x) the current market price (as of the business day immediately preceding the date on which the exercise notice was delivered) of one share of CoreWeave common stock, minus the applicable exercise price, divided by (y) such current market price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent the trading price of CoreWeave common stock exceeds the applicable exercise price for the New Tranche 1 Warrants and New Tranche 2 Warrants, the shares of CoreWeave common stock issued upon exercise of any of the New Tranche 1 Warrants and New Tranche 2 Warrants will result in dilution to the existing holders of CoreWeave common stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of the CoreWeave common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tRRCW"><!--Anchor--></a>Risks relating to CoreWeave </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Risks Related to CoreWeave&#8217;s Business and Industry </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s recent growth may not be indicative of its future growth, and if it does not effectively manage its future growth, its business, operating results, financial condition, and prospects may be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave was founded in September&#160;2017 and launched its CoreWeave Cloud Platform in 2020 and has experienced significant growth in a short period of time. CoreWeave&#8217;s revenue was $1,213&#160;million and $395&#160;million for the three months ended June&#160;30, 2025 and 2024, respectively, and $2,194&#160;million and $584&#160;million for the six&#160;months ended June&#160;30, 2025 and 2024, respectively. Investors should not rely on the revenue growth of any prior quarterly or annual period as an indication of CoreWeave&#8217;s future performance. Even if CoreWeave&#8217;s revenue continues to increase, its revenue growth rate is expected to decline in the future as a result of a variety of factors, including the maturation of its business. Overall growth of CoreWeave&#8217;s revenue will depend on a number of factors, including but not limited to its ability to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">operate its cloud infrastructure, including due to supply chain limitations and data center or power availability; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compete with other companies in its industry, including those with greater financial, technical, marketing, sales, and other resources; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continue to develop new solutions and services and new functionality for its platform and successfully further optimize its existing infrastructure, solutions, and services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">retain existing customers and increase sales to existing customers, as well as attract new customers and grow its customer base; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">successfully expand its business domestically and internationally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">generate sufficient cash flow from operations and raise additional capital, including through indebtedness, to support continued investments in its platform to maintain its technological leadership and the security of its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">strategically expand its direct sales force and leverage its existing sales capacity; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">39<br></div></div></div>
<!--End Page 50-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 51-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">introduce and sell its solutions and services to new markets and verticals; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">recruit, hire, train, and manage additional qualified personnel for its research and development activities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">maintain its existing, and enter into new, more cost-efficient, financing structures; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">successfully identify and acquire or invest in businesses, products, or technologies that it believes could complement or expand its platform. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the factors discussed above, CoreWeave&#8217;s revenue growth may also be impacted by industry-specific factors, particularly the continued development of AI (including advancements in AI technology that may lead to further compute efficiencies), the broader adoption, use, and commercialization of AI and any impacts of the developing AI regulatory environment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As many of these factors are beyond CoreWeave&#8217;s control, it is difficult for it to accurately forecast its future operating results. If the assumptions that CoreWeave uses to plan its business are incorrect or change in reaction to changes in its market, it may be unable to maintain consistent revenue or revenue growth, the value of its stock could be volatile, and it may be difficult to achieve and, if achieved, maintain profitability. In addition, changes in the macroeconomic environment, including actual or perceived global banking and finance related issues, domestic and foreign regulatory uncertainty, changes in trade policies (including the imposition of tariffs, trade controls and other trade barriers), labor shortages, supply chain disruptions, volatile interest rates and inflation, spending environments, geopolitical instability, warfare and uncertainty, including the effects of the conflicts in the Middle East and Ukraine and tensions between China and Taiwan, weak economic conditions in certain regions, or a reduction in AI spending regardless of macroeconomic conditions may impact CoreWeave&#8217;s growth. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, as CoreWeave has grown, its number of customers has also increased, and it has increasingly managed more complex deployments of its infrastructure in more complex computing environments. The rapid growth and expansion of CoreWeave&#8217;s business places a significant strain on its management, operational, engineering, and financial resources. To manage any future growth effectively, CoreWeave must continue to improve and expand its infrastructure, including information technology (&#8220;IT&#8221;) and financial infrastructure, its operating and administrative systems and controls, and its ability to manage headcount, capital, and processes in an efficient manner. If CoreWeave does not manage future growth effectively, its business, operating results, financial condition, and prospects would be harmed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If CoreWeave continues to experience rapid growth, it may not be able to successfully implement or scale improvements to its systems, processes, and controls in an efficient, timely, or cost-effective manner. As CoreWeave grows, its existing systems, processes, and controls may not prevent or detect all errors, omissions, or fraud. Any future growth will continue to add complexity to CoreWeave&#8217;s organization and require effective coordination throughout its organization. Failure to manage any future growth effectively could result in increased costs, cause difficulty or delays in deploying CoreWeave&#8217;s platform to new and existing customers, reduce demand for its platform, and cause difficulties in introducing new solutions and services or other operational difficulties, and any of these difficulties would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave has a limited number of suppliers for significant components of the equipment it uses to build and operate its platform and provide its solutions and services. Any disruption in the availability of these components could delay CoreWeave&#8217;s ability to expand or increase the capacity of its infrastructure or replace defective equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave does not manufacture the components it uses to build the technology infrastructure underlying its platform. CoreWeave has a limited number of suppliers that it uses to procure and configure significant components of the technology infrastructure that it uses to operate its platform and provide its solutions and services to its customers. For example, as a result of CoreWeave&#8217;s obligations in its current customer contracts, all of the GPUs used in its infrastructure today are NVIDIA GPUs. Additionally, for the year ended December&#160;31, 2024, three suppliers accounted for 46%, 16%, and 14% of total purchases, and for the year ended December&#160;31, 2023, three suppliers accounted for 57%, 22%, and 11% of total purchases. Utilizing a limited number of suppliers of the components for CoreWeave&#8217;s technology infrastructure exposes it to risks, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">asymmetry between component availability and contractual performance obligations, including where specified components are required; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shifts in market-leading technologies away from those offered by its current suppliers that could impact its ability to offer its customers the solutions and services that they are seeking; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">40<br></div></div></div>
<!--End Page 51-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 52-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reduced control over production costs and constraints based on the then current availability, terms, and pricing of these components, including any delays in its supply chain (such as the recent delays associated with NVIDIA&#8217;s Blackwell GPUs); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">limited ability to control aspects of the quality, performance, quantity, and cost of its infrastructure or of its components; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the potential for binding price or purchase commitments with its suppliers at higher than market rates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reliance on its suppliers to keep up with technological advancements at the same pace as its business and customer demands, including their ability to continue to deliver next generation components that are substantially better than the prior generation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">consolidation among suppliers in its industry, which may harm its ability to negotiate and obtain favorable terms from its suppliers and the third-party suppliers that its suppliers rely on; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">labor and political unrest at facilities it does not operate or own; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">geopolitical disputes disrupting its or any of its suppliers&#8217; supply chains; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">business, legal compliance, litigation, and financial concerns affecting its suppliers or their ability to manufacture and ship components in the quantities, quality, and manner CoreWeave requires; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">impacts on its supply chain from adverse public health developments, including outbreaks of contagious diseases or pandemics; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">disruptions due to floods, earthquakes, storms, and other natural disasters, particularly in countries with limited infrastructure and disaster recovery resources, or regional conflicts. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s technology infrastructure components suppliers fulfill its supply requirements on the basis of individual purchase orders, which it often places on a just-in-time basis. CoreWeave currently has no long-term contracts or arrangements with its suppliers that guarantee capacity or the continuation of any particular payment terms. Accordingly, CoreWeave&#8217;s suppliers are not obligated to continue to fulfill its supply requirements, and the prices it is charged for its products and, if applicable, services could be increased on short notice. Further, because CoreWeave often submits purchase orders to its suppliers on a just-in-time basis, any delay from its suppliers may result in its inability to provide its infrastructure and platform to its customers on a timely basis and fulfill its contractual requirements under its customer contracts. Additionally, CoreWeave&#8217;s current customers have contractually specified its use of NVIDIA GPUs. If CoreWeave is required to change suppliers, its ability to meet its obligations to its customers, including scheduled compute access, could be adversely affected and its solutions may not be as performant, which could cause the loss of sales from existing or potential customers, delayed revenue, or an increase in its costs, which could adversely affect its margins. Any production or shipping interruptions for any reason, such as a natural disaster, epidemics, pandemics, capacity shortages, quality problems, or strike or other labor disruption at one of CoreWeave&#8217;s supplier locations or at shipping ports or locations, could adversely affect sales of its solution and services offerings. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave is continually working to expand and enhance its infrastructure features, technology, and network and other technologies to accommodate substantial increases in the computing power required by more compute-intensive workloads on its platform, the amount of data it hosts, and its overall number of total customers. CoreWeave may be unable to project accurately the rate or timing of these increases or to allocate resources successfully to address such increases and may underestimate the data center capacity needed to address such increases. CoreWeave&#8217;s limited number of suppliers, in turn, may not be able to quickly respond to its needs, which would have a negative impact on customer experience and contractual performance. In the future, CoreWeave may be required to allocate additional resources, including spending substantial amounts, to build, purchase, or lease or license data centers and equipment and upgrade its technology and network infrastructure in order to handle increased customer usage, and its suppliers may not be able to satisfy such requirements. In addition, CoreWeave&#8217;s network or its suppliers&#8217; networks might be unable to achieve or maintain data transmission capacity high enough to effectively deliver its services. CoreWeave may also face constraints on its ability to deliver its platform, solutions, and services if there is limited power supply. CoreWeave&#8217;s failure, or its suppliers&#8217; failure, to achieve or maintain high data transmission capacity and sufficient electrical services would impact its ability to meet customer needs and could significantly reduce consumer demand for its services. Such reduced demand and resulting loss of compute, cost </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">41<br></div></div></div>
<!--End Page 52-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 53-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">increases, or failure to upgrade its equipment or adapt to new technologies would harm its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, CoreWeave&#8217;s suppliers themselves rely on a complex network of third-party suppliers for semiconductor manufacturing, hardware components, and other critical inputs, which introduces additional risks to its supply chain. For example, NVIDIA relies on suppliers such as Taiwan Semiconductor Manufacturing Company for semiconductor fabrication and other manufacturers for compute and networking components. Any disruption in the operations of these upstream suppliers, whether due to equipment failures, geopolitical factors such as the potential for military conflict between China and Taiwan, or supply chain constraints, could affect CoreWeave&#8217;s suppliers&#8217; ability to supply the significant components of the equipment it uses to operate its platform and provide its solutions and services to its customers, which would, in turn, affect the availability of its solutions and services, as well as lead times. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, to the extent any of CoreWeave&#8217;s suppliers&#8217; businesses are impacted by business, legal compliance, litigation, and financial concerns, including regulatory scrutiny and export controls, its business, operating results, financial condition, and prospects may be adversely affected. For example, increasing use of tariffs, economic sanctions and export controls has impacted and may in the future impact the availability and cost of GPUs and other components of CoreWeave&#8217;s platform. The current U.S. presidential administration has discussed imposing broad-based tariffs on imported goods, which, if implemented on components of CoreWeave&#8217;s infrastructure and other products it uses, could increase its costs. Further, the former U.S. presidential administration had recently released new export controls targeting semiconductor manufacturing equipment and other items related to advanced integrated circuits. It is possible that these and additional restrictions could impede the supply chain in this industry. Additional export restrictions imposed on components of CoreWeave&#8217;s technologies by the U.S. government may also provoke responses from foreign governments that negatively impact its supply chain, increase the costs for affected imported goods, or limit its ability to obtain additional hardware components, which would also substantially reduce its ability to provide or develop its platform, solutions, and services. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of a supplier unavailability, component shortage, or supply interruption, CoreWeave may not be able to secure alternate sources in a timely manner. Securing alternate sources of supply for these components or services may be time-consuming, difficult, and costly and CoreWeave may not be able to source these components or services on terms that are acceptable to it, or at all, which may undermine its ability to fill its orders in a timely manner. Any interruption or delay in the supply of any of these components or services, or the inability to obtain these components or services from alternate sources at acceptable prices and within a reasonable amount of time, would harm CoreWeave&#8217;s ability to meet the demand of its customers, which in turn would have an adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s business would be harmed if it were not able to access sufficient power or by increased costs to procure power, prolonged power outages, shortages, or capacity constraints. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave depends on being able to secure power, which powers its data center facilities, in a cost-effective manner. CoreWeave&#8217;s inability to secure sufficient power or any power outages, shortages, supply chain issues, capacity constraints, or significant increases in the cost of securing power could have an adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave relies on third parties, third-party infrastructure, governments, and global suppliers to provide a sufficient amount of power to maintain its leased or licensed data center facilities and meet the needs of its current and future customers. CoreWeave has in the past experienced, and it may in the future experience, insufficient power to service a customer&#8217;s project. Any limitation on the delivered energy supply would limit CoreWeave&#8217;s ability to operate its platform. These limitations would have a negative impact on a given data center or limit CoreWeave&#8217;s ability to grow its business which could negatively affect its business, operating results, financial condition, and prospects. Limitations on generation, transmission, and distribution may also limit its ability to obtain sufficient power capacity for potential expansion sites in new or existing markets. Power providers, other participants in the power market, and those entities that regulate it may impose onerous operating conditions to any approval or provision of power or CoreWeave may experience significant delays and substantial increased costs to provide the level of electrical service required by its current or future leased or licensed data centers, or any data centers it may choose to construct in the future. CoreWeave&#8217;s ability to find appropriate sites for expansion, including existing sites to lease or license, will also be limited by access to power. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">42<br></div></div></div>
<!--End Page 53-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 54-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s data center facilities are affected by problems accessing electricity sources, such as planned or unplanned power outages and limitations on transmission or distribution of power. Unplanned power outages, including, but not limited to those relating to large storms, earthquakes, fires, tsunamis, cyberattacks, physical attacks on utility infrastructure, war, and any failures of electrical power grids more generally, and planned power outages by public utilities, such as Pacific Gas and Electric Company&#8217;s practice of planned outages in California to minimize fire risks, could harm CoreWeave&#8217;s customers and its business. Further, CoreWeave&#8217;s data center facilities are located in leased buildings where, depending upon the lease requirements and number of tenants involved, it may or may not control some or all of the infrastructure, including generators and fuel tanks. As a result, in the event of a power outage, CoreWeave could be dependent upon the landlord, as well as the utility company, to restore the power. Even if CoreWeave attempts to limit its exposure to system downtime by using backup generators, which are in turn supported by onsite fuel storage and through contracts with fuel suppliers, these measures may not always prevent downtime or solve for long-term or large-scale outages. Any outage or supply disruption could adversely affect CoreWeave&#8217;s customer experience, as well as its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The global energy market is currently experiencing inflation and volatility pressures. Various macroeconomic and geopolitical factors are contributing to the instability and global power shortage, including the war in Ukraine, severe weather events, governmental regulations, government relations, and inflation. CoreWeave expects the cost for power to continue to be volatile and unpredictable and subject to inflationary pressures, which could materially affect its financial forecasting, business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">If CoreWeave&#8217;s data center providers fail to meet the requirements of its business, or if the data center facilities experience damage, interruption, or a security breach, its ability to provide access to its infrastructure and maintain the performance of its network could be negatively impacted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave leases space in or otherwise license use of third-party data centers located in the United States, Europe and United Kingdom. CoreWeave&#8217;s business is reliant on these data center facilities. Given that CoreWeave leases or licenses use of this data center space, it does not control the operation of these third-party facilities. Consequently, CoreWeave could be subject to service disruptions as well as failures to provide adequate support for reasons that are outside of its direct control. CoreWeave&#8217;s data center facilities and network infrastructure are vulnerable to damage or interruption from a variety of sources including earthquakes, floods, fires, power loss, system failures, computer and other cybersecurity vulnerabilities, physical or electronic break-ins, human error, malfeasance or interference, including by employees, former employees, or contractors, as well terrorist acts and other catastrophic events. CoreWeave and the data center facilities it leases space in or license use of have experienced, and may in the future experience, disruptions, outages, and other performance problems due to a variety of factors, including availability or sufficiency of power, infrastructure changes, and capacity constraints, occasionally due to an overwhelming number of customers accessing its infrastructure simultaneously. CoreWeave&#8217;s third-party data centers and network infrastructure may also be subject to cybersecurity attacks, including supply chain attacks, due to the actions of outside parties or human error, malfeasance, insider threats, system errors or vulnerabilities, insufficient cybersecurity controls, a combination of these, or otherwise, which may cause service outages and otherwise impact its ability to provide its solutions and services. While CoreWeave reviews the security measures of its third-party data centers, it cannot ensure that these measures will be sufficient to prevent a cybersecurity attack or to protect the continued operation of its platform in the event of a cybersecurity attack, and any impact to its solutions and services may also impact its business, operating results, financial condition, and prospects. Data center facilities housing CoreWeave&#8217;s network infrastructure may also be subject to local administrative actions, changes to legal or permitting requirements, labor disputes, litigation to stop, limit, or delay operations, and other legal challenges, including local government agencies seeking to gain access to customer accounts for law enforcement or other reasons. In addition, while CoreWeave has entered into various agreements for the lease of data center space, equipment, maintenance, and other services, those third parties could fail to deliver on their contractual obligations under those agreements, including agreements to provide it with certain data, equipment, and utilities information required to run its business. Furthermore, CoreWeave may require the data centers it leases to have certain highly specific attributes in order to effectively run its business. For example, CoreWeave&#8217;s state-of-the art data centers may also require networking equipment, high-speed interconnects, enhanced access to power, and liquid cooling infrastructure. In some cases, these third-party data centers are required to undergo extensive retrofitting and improvement efforts, including to incorporate novel developments in CoreWeave&#8217;s industry, which are time consuming, expensive, and less efficient than if it were to lease from spaces already designed for its operations, and which may not ultimately be successful in meeting all of its requirements. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">43<br></div></div></div>
<!--End Page 54-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 55-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If third parties fail to successfully deliver on such performance requirements, CoreWeave&#8217;s ability to maintain the performance of its network would be negatively impacted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other factors, many of which are beyond CoreWeave&#8217;s control, that can affect the delivery, performance, and availability of its platform include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the development, maintenance, and functioning of the infrastructure of the internet as a whole; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the performance and availability of third-party telecommunications services with the necessary speed, data capacity, and security for providing reliable internet access and services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the success or failure of its redundancy systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the success or failure of its disaster recovery and business continuity plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">decisions by the owners and operators of the data center facilities where its infrastructure is installed or by global telecommunications service provider partners who provide it with network bandwidth to terminate its contracts, discontinue services to it, shut down operations or facilities, increase prices, change service levels, limit bandwidth, declare bankruptcy, breach their contracts with it, or prioritize the traffic of other parties; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to enter into data center agreements and leases according to its business needs and on terms and with counterparties acceptable to it; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changing sentiment by government regulators relating to data center development, including in response to public concerns regarding environmental impact and development, which may result in restrictive government regulation or otherwise impact the future construction of additional data centers. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, many of the leases CoreWeave has entered into for third-party data centers have multi-year terms and fixed capacity. If CoreWeave does not accurately anticipate the data center capacity required by its customers, including if they use less or more of its infrastructure than expected, it would incur additional costs due to leasing more capacity than is used and paid for by its customers or, alternatively, in seeking additional data center capacity to fulfill unexpected demand on terms that may not be economically reasonable or acceptable to it, if it are able to lease additional capacity at all. CoreWeave may also need to seek additional data center capacity in the event any leases with third parties are terminated or not renewed, which it may be unable to do on reasonable terms or at all. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The occurrence of any of these factors, or CoreWeave&#8217;s inability to efficiently and cost-effectively fix such errors or other problems that may be identified, could damage its reputation, negatively impact its relationship with its customers, or otherwise materially harm its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the future, CoreWeave may develop its own data centers, rather than relying on third parties and, because of its limited experience in this area, it could experience unforeseen difficulties. For example, any potential expansion of CoreWeave&#8217;s data center infrastructure would be complex, and unanticipated delays in the completion of those projects or availability of components may lead to increased project costs, operational inefficiencies, or interruptions in the delivery or degradation of the quality of its platform. In addition, there may be issues related to this infrastructure that are not identified during the testing phases of design and implementation, which may only become evident after CoreWeave has started to fully utilize the underlying equipment, that could further degrade its platform or increase its costs. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">A substantial portion of CoreWeave&#8217;s revenue is driven by a limited number of its customers, and the loss of, or a significant reduction in, spend from one or a few of its top customers would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A substantial portion of CoreWeave&#8217;s revenue is driven by a limited number of customers. CoreWeave recognized an aggregate of approximately 79% of its revenue from its top two customers for the three months ended June&#160;30, 2024. CoreWeave recognized an aggregate of approximately 71% and 59% of its revenue for the three&#160;months ended June&#160;30, 2025 and 2024, from its largest customer, Microsoft. None of CoreWeave&#8217;s other customers represented 10% or more of its revenue for the six months ended June&#160;30, 2025. Any negative changes in demand from Microsoft, in Microsoft&#8217;s ability or willingness to perform under its contracts with CoreWeave, in laws or regulations applicable to Microsoft or the regions in which it operates, or in its broader strategic relationship with Microsoft would adversely affect its business, operating results, financial condition, and prospects. During the three months ended March&#160;31, 2025, CoreWeave entered into a master services agreement with OpenAI&#160;OpCo&#160;LLC (&#8220;OpenAI&#8221;) and, as a result, it expects OpenAI to be a significant customer in future periods. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">44<br></div></div></div>
<!--End Page 55-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 56-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave anticipates that it will continue to derive a significant portion of its revenue from a limited number of customers for the foreseeable future, and in some cases, the portion of its revenue attributable to certain customers may increase in the future. The composition of CoreWeave&#8217;s customer base, including its top customers, may fluctuate from period to period given that its customer composition has evolved and is expected to continue to evolve significantly as its business continues to evolve and scale and as the use cases for AI continue to develop. However, CoreWeave may not be able to maintain or increase revenue from its top customers for a variety of reasons, including the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">customers may develop their own infrastructure that may compete with its services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">some of its customers may redesign their systems to require fewer of its services with limited notice to it and may choose not to renew or increase their purchases of its platform, solutions, and services; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its customers may have pre-existing or concurrent relationships with, or may be, current or potential competitors that may affect such customers&#8217; decisions to purchase its platform, solutions, and services. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Customer relationships often require CoreWeave to continually improve its platform, which may involve significant technological and design challenges, and its customers may place considerable pressure on it to meet tight development and capacity availability schedules. Accordingly, CoreWeave may have to devote a substantial amount of its resources to its strategic relationships, which could detract from or delay its completion of other important development projects. Delays in making capacity or AI infrastructure available and performing to contractual specifications could impair CoreWeave&#8217;s relationships with its customers and negatively impact forecasted sales of the services under development. Moreover, it is possible that CoreWeave&#8217;s customers may develop their own infrastructure that may compete with its services or adopt a competitor&#8217;s infrastructure for services that they currently buy from it. If that happens, CoreWeave&#8217;s revenue would be adversely impacted and its business, operating results, financial condition, and prospects would be materially and adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If CoreWeave fails to efficiently enhance its platform and develop and sell new solutions and services and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, and changing customer needs, requirements, or preferences, its platform may become less competitive. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The market in which CoreWeave competes is relatively new and subject to rapid technological change, evolving industry standards and regulatory changes, as well as changing customer needs, requirements, and preferences. The success of CoreWeave&#8217;s business will depend, in part, on its ability to, predict, adapt, and respond effectively to these changes on a timely basis. If CoreWeave is unable to develop and sell new solutions and services that satisfy and are adopted by new and existing customers and provide enhancements, new features, and capabilities to its infrastructure that keep pace with rapid technological and industry change, its business, operating results, financial condition, and prospects could be adversely affected. Further, prospective or existing customers may influence CoreWeave&#8217;s product roadmap by requiring features optimal for their particular use case. If CoreWeave is unable to adapt to meet customers&#8217; requirements, they may use competitive offerings or internal solutions that eliminate reliance on third-party providers, and its business, operating results, financial condition, and prospects could be adversely affected. Moreover, prioritizing development of such features may require significant engineering resources and may not be compatible with the requirements of other customers, which could impact overall adoption of CoreWeave&#8217;s platform. If new technologies emerge that limit or eliminate reliance on AI cloud platform providers like CoreWeave, or that enable its competitors to deliver competitive services at lower prices, more efficiently, more conveniently, or more securely, such technologies could adversely impact its ability to compete. If CoreWeave&#8217;s solutions do not allow it or its customers to comply with the latest regulatory requirements, sales of its platform, solutions, and services to existing customers may decrease and new customers will be less likely to adopt its platform. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s future growth is dependent upon its ability to continue to meet the needs of new customers and the expanding needs of its existing customers as their use of its platform, solutions, and services grows. As sales of its platform grow, CoreWeave will need to devote additional resources to expanding, improving, and maintaining its infrastructure and integrating with third-party applications. In addition, CoreWeave will need to appropriately scale its internal business systems and its services organization, including customer support, to serve its growing customer base, and to improve its IT and financial infrastructure, operating and administrative systems, and its ability to effectively manage headcount, capital and processes, including by reducing costs and inefficiencies. Any failure of, or delay in, these efforts could result in impaired system performance and reduced customer satisfaction, which would negatively impact CoreWeave&#8217;s revenue growth and its reputation. CoreWeave may not be successful in developing or implementing these technologies. In addition, it takes a significant amount of time to plan, develop, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">45<br></div></div></div>
<!--End Page 56-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 57-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">and test improvements to CoreWeave&#8217;s technologies and infrastructure, and it may not be able to accurately forecast demand or predict the results it will realize from such improvements. In some circumstances, CoreWeave may also determine to scale its technology through the acquisition of complementary businesses and technologies rather than through internal development, which may divert management&#8217;s time and resources. To the extent that CoreWeave does not effectively scale its operations to meet the needs of its growing customer base and to maintain performance as its customers expand their use of its services, CoreWeave will not be able to grow as quickly as it anticipates, its customers may reduce or terminate use of its platform and it will be unable to compete as effectively and its business, operating results, financial condition, and prospects will be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave continually works to upgrade and enhance its platform, solutions, and services in response to customer demand and to keep up with technological changes. Part&#160;of this process entails cycling out outdated components of CoreWeave&#8217;s infrastructure and replacing them with the latest technology available. This requires CoreWeave to make certain estimates with respect to the useful life of the components of its infrastructure and to maximize the value of the components of its infrastructure, including its GPUs, to the fullest extent possible. CoreWeave cannot guarantee that its estimates will be accurate or that its attempts at maximizing value will be successful. Any changes to the significant assumptions underlying CoreWeave&#8217;s estimates or to the estimates of its components&#8217; useful lives, or any inability to redeploy components of its existing infrastructure to extend past their contracted life could significantly affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s platform must also integrate with a variety of network, hardware, storage, and software technologies, and it needs to continuously modify and enhance the capabilities of its platform to adapt to changes and innovation in these technologies. If CoreWeave&#8217;s customers widely adopt new technologies, it may need to redesign parts of its platform to work with those new technologies. These development efforts may require significant engineering, marketing, and sales resources, all of which would affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. Any failure of CoreWeave&#8217;s infrastructure&#8217;s capabilities to operate effectively with future technologies and software platforms could reduce the demand for its platform. If CoreWeave is unable to respond to these changes in a cost-effective manner, its platform may become less marketable and less competitive or obsolete, and its business may be harmed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave must also continue to effectively manage its capital expenditures by maintaining and expanding its data center capacity, servers and equipment, grow in geographies where it currently have limited or no presence, and ensure that the performance, features, and reliability of its services and its customer service remain competitive in a rapidly changing technological environment. If CoreWeave fails to manage its growth, the quality of its platform may suffer, which could negatively affect its brand and reputation and harm its ability to retain and attract customers and employees. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The broader adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by CoreWeave&#8217;s customers to continue to use its CoreWeave Cloud Platform to support AI use cases in their systems, or its ability to keep up with evolving AI technology requirements and regulatory frameworks, could have a material adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of its growth strategy, CoreWeave seeks to attract and acquire customers requiring high-performance computing, such as AI, machine learning, and automated decision-making technologies, including proprietary AI&#160;algorithms and models (collectively, &#8220;AI Technologies&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">AI has been developing at a rapid pace, and continues to evolve and change. As demand continues for AI&#160;services, AI providers, including CoreWeave&#8217;s customers, have sought increased compute capacity to enable advancements in their AI models and service the demands of end users. CoreWeave cannot predict whether additional computing power will continue to be required to develop larger, more powerful AI models, or if the practical limits of AI technology will plateau in the future regardless of available compute capacity. Further, there have been recent advancements in AI technology, including open-source AI models, that may lead to compute and other efficiencies that may impact the demand for AI services, including CoreWeave&#8217;s platform, solutions, and services, which may adversely impact its revenue and profitability. In the event that existing scaling laws do not continue to apply as they have in the past, demand by CoreWeave&#8217;s customers for compute resources, including its solutions and services, may not continue to increase over time, or may decrease if overall demand for AI is impacted by a lack of further technological development. If CoreWeave is unable to keep up with the changing AI landscape or in developing services to meet its customers&#8217; evolving AI needs, or if the AI landscape does not develop to the extent it or its customers expect, its business, operating results, financial condition, and prospects may be adversely impacted. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">46<br></div></div></div>
<!--End Page 57-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 58-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, CoreWeave may incur significant costs and experience significant delays in developing new solutions and services or enhancing its current platform to adapt to the changing AI landscape, and may not achieve a return on investment or capitalize on the opportunities presented by demand for AI solutions. Moreover, while AI&#160;adoption is likely to continue and may accelerate, the long-term trajectory of this technological trend is uncertain. Further, market acceptance, understanding, and valuation of solutions and services that incorporate AI Technologies are uncertain and the perceived value of AI Technologies used and/or provided by its customers could be inaccurate. If AI is not broadly adopted by enterprises to the extent CoreWeave expects, or if new use cases do not arise, then its opportunity may be smaller than it expects. Further, if the consumer perception and perceived value of AI&#160;Technologies is inaccurate this could have a material adverse effect on CoreWeave&#8217;s customers, which in turn could have a material adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Concerns relating to the responsible use by CoreWeave&#8217;s customers of new and evolving technologies, such as AI, which are supported by its platform, may result in collateral reputational harm to it. AI may pose emerging ethical issues and if CoreWeave&#8217;s platform enables customer solutions that draw controversy due to their perceived or actual impact on society, it may experience brand or reputational harm, competitive harm, or legal liability. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, the rapid pace of innovation in the field of AI has led to developing and evolving regulatory frameworks globally, which are expected to become increasingly complex as AI continues to evolve. Regulators and lawmakers around the world have started proposing and adopting, or are currently considering, regulations and guidance specifically on the use of AI. Regulations related to AI Technologies have been introduced in the United&#160;States at the federal level and are also enacted and advancing at the state level. Additional regulations may impact CoreWeave&#8217;s customers&#8217; ability to develop, use and commercialize AI Technologies, which would impact demand for its platform, solutions, and services and may affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">AI and related industries, including cloud services, are under increasing scrutiny from regulators due to their concerns about market concentration, anti-competitive practices, and the pace of partnerships and acquisitions involving generative AI startups. As the industry continues to grow, transactions and business conduct will likely continue to draw scrutiny from regulators. CoreWeave&#8217;s customers may become subject to further AI regulations, including any restrictions on the total consumption of compute technology, which could cause a delay or impediment to the commercialization of AI technology and could lead to a decrease in demand for its customers&#8217; AI infrastructure, and may adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s operations require substantial capital expenditures, and it will require additional capital to fund its business and support its growth, and any inability to generate or obtain such capital on acceptable terms, if at all, or to lower its total cost of capital, may adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave requires substantial capital expenditures to support its growth and respond to business challenges. CoreWeave has made significant financial investments in its business, and it intends to continue to make such investments in the future, including expenditures to procure components for, maintain, upgrade, and enhance its platform, including costs related to obtaining third-party chips and leasing and maintaining, enhancing, and expanding its data centers. While CoreWeave has historically been able to fund capital expenditures from cash generated from operations, equity and debt financings, and borrowings under its term loan facilities, factors outside of its control, including those described in this &#8220;Risk Factors&#8221; section, and particularly those under the section titled &#8220;&#8212;Risks Related to CoreWeave&#8217;s Indebtedness,&#8221; could materially reduce the cash available from operations, impede its ability to raise additional capital, or significantly increase its capital expenditure requirements, which may result in its inability to fund the necessary level of capital expenditures to maintain and expand its operations. This could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additional financing may not be available on terms favorable to CoreWeave, if at all. If adequate financing is not available on acceptable terms, CoreWeave may be unable to invest in future growth opportunities, which could harm its business, operating results, financial condition, and prospects. If CoreWeave raises additional funds through equity or convertible debt issuances, its existing stockholders may suffer significant dilution and these securities could have rights, preferences, and privileges that are superior to those of holders of its Class&#160;A common stock. If CoreWeave obtains additional funds through debt financing, it may not be able to obtain such financing on terms favorable to it. Further, the current global macroeconomic environment could make it more difficult to raise additional capital on favorable terms, if at all. Such terms may involve restrictive covenants making it difficult to engage in capital raising activities and pursue business opportunities, including potential acquisitions. The trading </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">47<br></div></div></div>
<!--End Page 58-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 59-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">prices of recently-public companies have been highly volatile as a result of multiple factors including, the conflicts in the Middle East and Ukraine and tensions between China and Taiwan, inflation, interest rate volatility, domestic and foreign regulatory uncertainty, changes in trade policies, including the imposition of tariffs, trade controls and other trade barriers, actual or perceived instability in the banking system, and market downturns, which may reduce its ability to access capital on favorable terms or at all. In addition, a recession, depression, or other sustained adverse market event could adversely affect CoreWeave&#8217;s business and the value of its Class&#160;A common stock. If CoreWeave is unable to obtain adequate financing or financing on terms satisfactory to it when it requires, its ability to continue to support its business growth and to respond to business challenges could be significantly impaired and its business may be adversely affected, requiring it to delay, reduce, or eliminate some or all of its operations. Even if CoreWeave is able to raise such capital, it cannot guarantee that it will deploy it in such a fashion that allows it to achieve better operating results or grow its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, in order to fund investments in CoreWeave&#8217;s infrastructure, it has pioneered and scaled innovative financing structures that have enabled it to grow its business through timely and flexible access to capital. While CoreWeave expects its cost of capital to continue declining as it benefits from economies of scale and access new forms of financing, including asset-backed securitizations and rated parent-level debt, its ability to lower its cost of capital depends upon a number of factors, many of which are beyond its control, including broader macroeconomic conditions. If CoreWeave is unable to continue lowering its cost of capital, its ability to effectively compete, especially with larger competitors that have greater financial and other resources, as well as its operating results, financial condition, and business, may be adversely impacted. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s operating results may fluctuate significantly, which could make its future results difficult to predict and could cause its operating results to fall below expectations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s operating results have varied significantly from period to period in the past, and it expects that its operating results will continue to vary significantly in the future such that period-to-period comparisons of its operating results may not be meaningful. In addition, in future periods, CoreWeave may experience fluctuations in remaining performance obligations (&#8220;RPO&#8221;), given the nature of its committed contract business, the size of those contracts, and period-to-period variation in new business signed and revenue recognized from existing contracts. This could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. Accordingly, CoreWeave&#8217;s financial results in any one quarter should not be relied upon as indicative of future performance. Fluctuations in quarterly results may negatively impact the trading price of CoreWeave&#8217;s Class&#160;A common stock. CoreWeave&#8217;s quarterly financial results may fluctuate as a result of a number of factors, many of which are outside of its control and may be difficult to predict, including, without limitation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the amount and timing of operating costs and capital expenditures related to the expansion of its business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any power outages, shortages, supply chain issues, capacity constraints, or significant increases in the cost of securing power; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">general global macroeconomic and political conditions, both domestically and in its foreign markets that could impact some or all regions where it operates, including global economic slowdowns, domestic and foreign regulatory uncertainty, changes in trade policies, including the imposition of tariffs, trade controls and other trade barriers, actual or perceived global banking and finance related issues, increased risk of inflation, potential uncertainty with respect to the federal debt ceiling and budget and potential government shutdowns related thereto, interest rate volatility, supply chain disruptions, labor shortages, increases in energy costs and potential global recession; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the impact of natural or man-made global events on its business, including wars and other armed conflict, such as the conflicts in the Middle East and Ukraine and tensions between China and Taiwan; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in its legal or regulatory environment, including developments in regulations relating to AI and machine learning; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to attract new and retain existing customers, increase sales of its platform, or sell additional solutions and services to existing customers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the budgeting cycles, seasonal buying patterns, and purchasing practices of customers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing and length of its sales cycles; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in customer requirements or market needs; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">48<br></div></div></div>
<!--End Page 59-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 60-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in the growth rate of the cloud infrastructure market generally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the timing and success of new solution and service introductions by it or its competitors or any other competitive developments, including consolidation among its customers or competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any disruption in its strategic relationships; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to successfully expand its business domestically and internationally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">equity or debt financings and the capital markets environment, including interest rate changes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to reduce its cost of capital over time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">decisions by organizations to purchase specialized AI cloud infrastructure from larger, more established vendors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to successfully and timely deliver its solutions and services to customers under its committed contracts, including due to data center lead times; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to successfully and timely deploy launches of additional data centers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the timing and success of the integration of new infrastructure, including new GPU generations, into its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in its pricing policies or those of its competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">insolvency or credit difficulties confronting its customers, including bankruptcy or liquidation, due to individual, macroeconomic, and regulatory factors, including those specifically impacting early-stage AI&#160;ventures, affecting their ability to purchase or pay for its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">significant security breaches of, technical difficulties with, or interruptions to, the use of its platform or other cybersecurity incidents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">extraordinary expenses such as litigation or other dispute-related settlement payments or outcomes, taxes, regulatory fines or penalties; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the timing of revenue recognition and revenue deferrals; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future accounting pronouncements or changes in its accounting policies or practices; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">negative media coverage or publicity; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increases or decreases in its expenses caused by fluctuations in foreign currency exchange rates. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any of the above factors, individually or in the aggregate, could result in significant fluctuations in its financial condition, cash flows, and other operating results from period to period. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">CoreWeave faces intense competition and could lose market share to its competitors, which would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The market for AI cloud infrastructure and software is intensely competitive and is rapidly evolving, characterized by changes in technology, customer requirements, industry standards, regulatory developments, and frequent introductions of new or improved solutions and services. Key competitors that offer general purpose cloud computing as part of a broader, diversified product portfolio include Amazon (AWS), Google (Google Cloud Platform), IBM, Microsoft (Azure), and Oracle, a number of which are also its current customers. CoreWeave also competes with smaller cloud service providers focused on AI, including Crusoe and Lambda. CoreWeave expects to continue to face intense competition from current competitors, including as its competitors complete strategic acquisitions or form cooperative relationships and/or customer requirements evolve, as well as from new entrants into the market. If CoreWeave is unable to anticipate or react to these challenges, its competitive position could weaken, and it would experience a decline in revenue or reduced revenue growth, and loss of market share that could adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s ability to compete effectively depends upon numerous factors, many of which are beyond its control, including, but not limited to: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in customer or market needs, requirements, and preferences and its ability to fulfill those needs, requirements, and preferences; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">49<br></div></div></div>
<!--End Page 60-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 61-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to expand and augment its platform, including through infrastructure and new technologies, or increase sales of its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any power outages, shortages, supply chain issues, capacity constraints, or significant increases in the cost of securing power; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to attract, train, retain, and motivate talented employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to retain existing customers and increase sales to existing customers, as well as attract and retain new customers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the budgeting cycles, seasonal buying patterns, and purchasing practices of its customers, including any slowdown in technology spending due to U.S. and general global macroeconomic conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">price competition; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">stagnation in the adoption rate or changes in the growth rate of AI and AI cloud infrastructure sectors, including due to emerging AI technologies, which may lead to further compute efficiencies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the timing and success of new solution and service introductions by it or its competitors, including new competing technologies that may displace cloud infrastructure, or any other change in the competitive landscape of its industry, including consolidation among its competitors or customers and strategic partnerships entered into by and between its competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in its mix of solution and services sold, including changes in the average contracted usage of its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to successfully and continuously expand its business domestically and internationally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to secure necessary funding; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">deferral of orders from customers in anticipation of new or enhanced solutions and services announced by it or its competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">significant security breaches or, technical difficulties with, or interruptions to the use of its platform, including data security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the timing and costs related to the development or acquisition of technologies or businesses or entry into strategic partnerships; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to execute, complete, or efficiently integrate any acquisitions that it may undertake; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">increased expenses, unforeseen liabilities, or write-downs and any impact on its operating results from any acquisitions it consummates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to increase the size and productivity of its sales teams; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">decisions by potential customers to purchase cloud infrastructure and associated services from larger, more established technology companies; insolvency or credit difficulties confronting its customers, which could increase due to U.S. and global macroeconomic issues and which would adversely affect its customers&#8217; ability to purchase or pay for its platform in a timely manner or at all; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the cost and potential outcomes of litigation, regulatory investigations or actions, or other proceedings, which could have a material adverse effect on its business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future accounting pronouncements or changes in its accounting policies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increases or decreases in its expenses caused by fluctuations in foreign currency exchange rates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to comply with applicable domestic and international regulations and laws and to obtain the necessary licenses to conduct its business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">general global macroeconomic and political conditions, both domestically and in its foreign markets that could impact some or all regions where it operates, including global economic slowdowns, domestic and foreign regulatory uncertainty, changes in trade policies, including the imposition of tariffs. trade controls </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">50<br></div></div></div>
<!--End Page 61-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 62-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">and other trade barriers, actual or perceived global banking and finance related issues, increased risk of inflation, potential uncertainty with respect to the federal debt ceiling and budget and potential government shutdowns related thereto, interest rate volatility, supply chain disruptions, labor shortages, and potential global recession; and </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the impact of natural or man-made global events on its business, including outbreaks of contagious diseases or pandemics and wars and other armed conflicts, such as the conflicts in the Middle East and Ukraine and the tensions between China and Taiwan. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of its competitors have greater financial, technical, marketing, sales, and other resources, greater name recognition, longer operating histories, and a larger base of customers than CoreWeave does. CoreWeave&#8217;s competitors may be able to devote greater resources to the development, promotion, and sale of their solutions and services than it can, and they may offer lower pricing than it does or bundle certain competing solutions and services at lower prices. CoreWeave&#8217;s competitors may also have greater resources for research and development of new technologies, customer support, and to pursue acquisitions, and they have other financial, technical, or other resource advantages. CoreWeave&#8217;s larger competitors have substantially broader and more diverse solution and service offerings and more mature distribution and go-to-market strategies, which allows them to leverage their existing customer relationships and any distributor relationships to gain business in a manner that discourages potential customers from purchasing its platform. Further, CoreWeave&#8217;s current and future competitors may include its customers and suppliers, if any of these customers or suppliers were to cease purchasing services from it or supplying it with components as a result, its business, operating results, financial condition, and prospects could be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Conditions in its market could change rapidly and significantly as a result of technological advancements, including but not limited to increased advancements and proliferation in the use of AI and machine learning, partnerships between or acquisitions by its competitors, or continuing market consolidation, including consolidation of potential or existing customers with its competitors. Some of CoreWeave&#8217;s competitors have recently made or could make acquisitions of businesses or have established cooperative relationships that may allow them to offer more directly competitive and comprehensive solutions and services than were previously offered and adapt more quickly to new technologies and customer needs. These competitive pressures in CoreWeave&#8217;s market or its failure to compete effectively may result in price reductions, fewer orders, reduced revenue and operating margin, increased net losses, and loss of market share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Even if there is significant demand for specialized AI cloud infrastructure like CoreWeave&#8217;s, if its competitors include functionality that is, or is perceived to be, equivalent to or better than its in legacy solutions and services that are already generally accepted as necessary components of an organization&#8217;s operational architecture, it may have difficulty increasing the market penetration of its platform. Furthermore, even if the functionality offered by other cloud infrastructure providers is different and more limited than the functionality of CoreWeave&#8217;s platform, organizations may elect to accept such limited functionality in lieu of purchasing its solutions and services. If CoreWeave is unable to compete successfully, or if competing successfully requires it to take aggressive action with respect to pricing or other actions, its business, operating results, financial condition, and prospects would be adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">A network or data security incident against CoreWeave, or its third-party providers, whether actual, alleged, or perceived, could harm its reputation, create liability and regulatory exposure, and adversely impact its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Companies are subject to an increasing number, and wide variety, of attacks on their networks on an ongoing basis. Traditional computer &#8220;hackers,&#8221; malicious code (such as viruses and worms), phishing attempts, ransomware, account takeover, business email compromise, employee fraud or bad actors, theft or misuse, denial of service attacks, misconfigurations, bugs, or other vulnerabilities in commercial software that is integrated into CoreWeave&#8217;s (or its suppliers&#8217; or service providers&#8217;) IT systems, and sophisticated nation-state sponsored actors engage in cyber intrusions and attacks that create risks for its infrastructure and the data, including personal information, which it hosts and transmits. State-supported and geopolitical-related cyberattacks may rise in connection with regional geopolitical conflicts such as the conflicts in the Middle East and Ukraine and tensions between China and Taiwan. Moreover, the ongoing war in Ukraine and associated activities in Russia as well as in the Middle East, have increased the risk of cyberattacks on various types of infrastructure and operations. Additionally, bad actors are beginning to utilize AI-based tools to execute attacks, creating unprecedented cybersecurity challenges. CoreWeave may be a valuable target for cyberattacks given the critical data which it hosts and transmits. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">51<br></div></div></div>
<!--End Page 62-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 63-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although CoreWeave has implemented security measures designed to prevent such attacks, including a review of its third-party providers&#8217; measures, it cannot guarantee that such measures will operate effectively to protect its and its third-party providers&#8217; infrastructure, systems, networks, and physical facilities from breach due to the actions of outside parties or human error, malfeasance, insider threats, system errors or vulnerabilities, insufficient cybersecurity controls, a combination of the foregoing, or otherwise, and as a result, an unauthorized party may obtain access to its, its third-party providers&#8217; or its customers&#8217; systems, networks, or data. The techniques used to obtain unauthorized access to systems or sabotage systems, or disable or degrade services, change frequently and are often unrecognizable until launched against a target, and therefore CoreWeave may be unable to anticipate these techniques and implement adequate preventative measures. CoreWeave&#8217;s servers may be vulnerable to computer viruses or physical or electronic break-ins that its security measures may not detect. Protecting its own assets has become more expensive and these costs may increase as the threat landscape increases, including as a result of use by bad actors of AI. CoreWeave may face difficulties or delays in identifying or otherwise responding to any attacks or actual or potential security breaches or threats. These risks are exacerbated by developments in generative AI. A&#160;breach in CoreWeave&#8217;s or its third-party providers&#8217; data security or an attack against its platform could and have impacted its infrastructure and systems, creating system disruptions or slowdowns and providing access to malicious parties to information hosted and transmitted by its infrastructure, resulting in data, including the data of its customers, being publicly disclosed, misused, altered, lost, or stolen, which could subject it to liability and reputational harm and adversely affect its financial condition. While to date no incidents have had a material impact on CoreWeave&#8217;s operations or financial results, it cannot guarantee that material incidents will not occur in the future. If compromised, CoreWeave&#8217;s own systems could be used to facilitate or magnify an attack. Further, the increase in remote work by companies and individuals in recent years has generally increased the attack surface available to bad actors for exploitation, and as such, the risk of a cybersecurity incident potentially occurring has increased. Finally, CoreWeave has acquired and expect to continue to acquire companies with cybersecurity vulnerabilities or unsophisticated security measures, which exposes it to significant cybersecurity, operational and financial risks. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any actual, alleged, or perceived security breach in CoreWeave&#8217;s third-party providers&#8217; or partners&#8217; systems or networks, or any other actual, alleged or perceived data security breach that it or its third-party providers or partners suffer, could result in damage to its reputation, negative publicity, loss of customers and sales, loss of competitive advantages over its competitors, increased costs to remedy any problems and otherwise respond to any incident, regulatory investigations and enforcement actions, fines and penalties, costly litigation (including class actions), and other liability. CoreWeave would also be exposed to a risk of loss or litigation and potential liability under laws, regulations, and contracts that protect the privacy and security of personal information. For a description of the privacy and security laws, regulations and other industry requirements to which its business is subject, see the risk factor below &#8220;&#8212;CoreWeave is subject to laws, regulations, and industry requirements related to data privacy, data protection and information security, and user protection across different markets where CoreWeave conducts its business and such laws, regulations, and industry requirements are constantly evolving and changing. Any actual or perceived failure to comply with such laws, regulations, and industry requirements, or its privacy policies, could harm CoreWeave&#8217;s business.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Due to concerns about data security and integrity, a growing number of legislative and regulatory bodies have adopted breach notification and other requirements in the event that information subject to such laws is accessed by unauthorized persons and additional regulations regarding security of such data are possible. CoreWeave may need to notify governmental authorities and affected individuals with respect to such incidents. For example, laws in the European Union, the United Kingdom, and the United States may require businesses to provide notice to individuals whose personal information has been disclosed as a result of a data security breach. Complying with such numerous and complex regulations in the event of a data security breach can be expensive and difficult, and failure to comply with these regulations could subject CoreWeave to regulatory scrutiny and additional liability. In addition, certain of CoreWeave&#8217;s customer agreements, as well as privacy laws, may require it to promptly report security incidents involving its systems or those of its third-party partners that compromise the security, confidentiality, or integrity of certain processed customer data. Regardless of CoreWeave&#8217;s contractual protections, these mandatory disclosures could be costly, result in litigation, harm its reputation, erode customer trust, and require significant resources to mitigate issues stemming from actual or perceived security breaches. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although CoreWeave maintains cybersecurity insurance, there can be no guarantee that any or all costs or losses incurred will be partially or fully recouped from such insurance or that applicable insurance in the future will be available on economically reasonable terms or at all. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">52<br></div></div></div>
<!--End Page 63-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 64-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may also incur significant financial and operational costs to investigate, remediate, eliminate, and put in place additional tools and devices designed to prevent actual or perceived security breaches and other security incidents, as well as costs to comply with any notification obligations resulting from any security incidents. Any of these negative outcomes could adversely affect the market perception of infrastructure and customer and investor confidence in CoreWeave company, and would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, from time to time, government entities (including law enforcement bodies) may in the future seek CoreWeave&#8217;s assistance with obtaining access to its customers&#8217; data. Although CoreWeave strives to protect the privacy of its customers, it may be required from time to time to provide access to customer data to government entities. In light of CoreWeave&#8217;s privacy commitments, although it may legally challenge law enforcement requests to provide access to its systems or other customer content, it may nevertheless face complaints that it has provided information improperly to law enforcement or in response to non-meritorious third-party complaints. CoreWeave may experience adverse political, business, and reputational consequences, to the extent that it do not provide assistance to or comply with requests from government entities in the manner requested or challenge those requests publicly or in court or provide, or are perceived as providing, assistance to government entities that exceeds its legal obligations. Any such disclosure could significantly and adversely impact CoreWeave&#8217;s business and reputation. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">CoreWeave has a history of generating net losses as a result of the substantial investments it has made to grow its business and develop its platform, anticipate increases in its operating expenses in the future, and may not achieve or, if achieved, sustain profitability. If CoreWeave cannot achieve and, if achieved, sustain profitability, its business, operating results, financial condition, and prospects will be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave incurred net losses of $291&#160;million and $323&#160;million for the three months ended June&#160;30, 2025 and 2024, respectively, and $605&#160;million and $452&#160;million for the six months ended June&#160;30, 2025 and 2024, respectively, and it may not achieve or, if achieved, sustain profitability in the future. As of June&#160;30, 2025, CoreWeave had an accumulated deficit of $2.1&#160;billion. While CoreWeave has historically experienced significant growth in revenue over the last two years, it cannot predict whether it will maintain this level of growth or when it will achieve profitability. CoreWeave also expect its operating expenses to increase in the future, including its general and administrative expenses as a result of increased costs associated with operating as a public company and as it continues to invest for its future growth, including expanding its research and development function to drive further development of its platform, continuing to invest in the technology infrastructure underlying its platform and data center expansion, expanding its sales and marketing activities, developing the functionality to expand into adjacent markets, and reaching customers in new geographic locations and new verticals, which will negatively affect its operating results if its total revenue does not increase. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s operating efficiencies may decrease as it scales, and its revenue growth may slow as it grows. CoreWeave&#8217;s revenue could also decline for a number of other reasons, including reduced demand for its offerings, increased competition, a decrease in the growth or reduction in size of its overall market, or if it cannot capitalize on growth opportunities, including acquisitions and through new and enhanced solutions and services. Furthermore, to the extent CoreWeave&#8217;s anticipated cash payback period is longer than it expects, or if it fails to maintain or increase its revenue to offset increases in its operating expenses or manage its costs as it invests in its business, including if it does not maintain or improve its operating efficiencies, it may not achieve or sustain profitability, and if it cannot achieve and sustain profitability, its business, operating results, financial condition, and prospects will be adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">CoreWeave makes substantial investments in its technology and infrastructure and unsuccessful investments could materially adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The industry in which CoreWeave competes is characterized by rapid technological change, changes in customer requirements, frequent new product and service introductions and enhancements, short product cycles, and evolving industry standards. In order to remain competitive, CoreWeave has made, and expect to continue to make, significant investments in its technology and infrastructure. If CoreWeave fails to further develop its platform or develop new and enhanced solutions, services, and technologies, if it focuses on technologies that do not become widely adopted, or if new competitive technologies or industry standards that it does not support become widely accepted, demand for its solutions and services may be reduced. Increased investments in technology and infrastructure or unsuccessful improvement efforts could cause CoreWeave&#8217;s cost structure to fall out of alignment with demand for its solutions and services, which would have a negative impact on its business, operating results, financial condition, and prospects. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">53<br></div></div></div>
<!--End Page 64-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 65-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s platform is complex and performance problems or defects associated with its platform may adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It may become increasingly difficult to maintain and improve CoreWeave&#8217;s platform performance, especially during peak demand spikes and as its customer base grows and its platform becomes more complex. If CoreWeave&#8217;s platform is unavailable or if its customers are unable to access its platform within a reasonable amount of time or at all, it could experience a loss of customers, lost or delayed market acceptance of its platform, delays in payment to it by customers or issuance of credits to impacted customers, injury to its reputation and brand, warranty and legal claims against it, significant cost of remedying these problems, and the diversion of its resources. For example, in the past, CoreWeave has experienced, and it may in the future experience, insufficient power to service a customer&#8217;s project and have been required to provide service credits to that customer due to resulting performance issues. In addition, to the extent that it does not effectively address capacity constraints, upgrade its systems as needed, and continually develop its technology and network architecture to accommodate actual and anticipated changes in technology, its business, operating results, financial condition, and prospects, as well as its reputation, may be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, the hardware and software technology underlying CoreWeave&#8217;s platform is inherently complex and may contain material defects or errors, particularly when new solutions and services are first introduced or when new features or capabilities are released. CoreWeave has from time to time found defects or errors in its platform, and new defects or errors may be detected in the future by it or its customers. CoreWeave cannot ensure that its platform, including any new solutions and services that it releases, will not contain defects. Any real or perceived errors, failures, vulnerabilities, or bugs in CoreWeave&#8217;s platform could result in negative publicity or lead to data security, access, retention, or other performance issues, all of which could harm its business. CoreWeave also relies on third-party suppliers for the most significant components of the equipment it uses to operate its infrastructure. These third-party suppliers may also experience defects or errors in the products that CoreWeave utilizes in its platform, which would impact its platform and may result in performance problems or service interruptions. The costs incurred in correcting any such defects or errors, including those in third-party components, may be substantial and could harm CoreWeave&#8217;s business. Moreover, the harm to CoreWeave&#8217;s reputation and legal liability related to such defects or errors may be substantial and could similarly harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, most of CoreWeave&#8217;s customer agreements and terms of service contain service level commitments. If CoreWeave is unable to meet the stated service level commitments due to performance problems or defects, it may be contractually obligated to provide the affected customers with service credits or refunds, which could significantly affect its revenue in the periods in which any issues occur and the credits or refunds are applied. As a result of degradation of service and interruptions to its platform, CoreWeave has provided, and may continue to provide, service credits and/or refunds to certain of its affected customers with whom it had service level commitments. CoreWeave could also face customer terminations with refunds of prepaid amounts, which could significantly affect both its current and future revenues. Any service level failures could harm CoreWeave&#8217;s business. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Any failure of CoreWeave&#8217;s IT systems or those of one or more of its IT service providers, business partners, vendors, suppliers, or other third-party service providers, or any other failure by such third parties to provide services to it may negatively impact its relationships with customers and harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s business depends on various IT systems and outsourced IT services. CoreWeave relies on third-party IT service providers, business partners, vendors, and suppliers to provide critical IT systems, corporate infrastructure, and other services and are, by necessity, dependent on them to adequately address cybersecurity threats to, and other vulnerabilities, defects, or deficiencies of or in their own systems. This includes infrastructure such as electronic communications, finance, marketing, and recruiting platforms and services such as IT network development and network monitoring, and third-party data center hosting of its systems for CoreWeave&#8217;s internal and customer use. CoreWeave does not own or control the operation of the third-party facilities or equipment used to provide such services. CoreWeave&#8217;s third-party vendors and service providers have no obligation to renew their agreements with it on commercially reasonable terms or at all. If CoreWeave is unable to renew these agreements on commercially reasonable terms, including with respect to service levels and cost, or at all, it may be required to transition to a new provider, and it may incur significant costs and possible service interruption in connection with doing so. In addition, such service providers could decide to close their facilities or change or suspend their service offerings without adequate notice to it. Moreover, any financial difficulties, such as bankruptcy, faced by such vendors, the nature and extent of which are difficult to predict, may harm CoreWeave&#8217;s business. Since CoreWeave cannot easily switch vendors without making other business trade-offs, any disruption with respect to its current providers would impact its operations and its business may be harmed. Furthermore, CoreWeave&#8217;s disaster recovery </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">54<br></div></div></div>
<!--End Page 65-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 66-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">systems and those of such third parties may not function as intended or may fail to adequately protect its business information in the event of a significant business interruption, Any termination, failure, or other disruption of any of such systems or services of CoreWeave&#8217;s third-party IT providers, business partners, vendors, and suppliers could lead to operating inefficiencies or disruptions, which could harm its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave has a limited operating history at its current scale, which makes it difficult to evaluate its current business and prospects and increases the risks associated with investment in its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has a relatively short history operating its business at its current scale and have grown rapidly during that time. CoreWeave was founded in September&#160;2017 and launched its CoreWeave Cloud Platform in 2020. Moreover, prior to 2022, CoreWeave had limited revenue, most of which was derived from its crypto mining offerings, which it has discontinued. CoreWeave&#8217;s limited operating history, including its limited history of selling its cloud infrastructure offering, the dynamic and rapidly evolving market in which it sells its platform, and the concentration of its revenue from a limited number of customers, as well as numerous other factors beyond its control, may make it difficult to evaluate its current business, prospects and other trends. CoreWeave has encountered, and will continue to encounter, risks and uncertainties frequently experienced by growing companies in rapidly changing industries and sectors, such as the risks and uncertainties described herein. Any predictions about CoreWeave&#8217;s future revenue and expenses may not be as accurate as they would be if it had a longer operating history or operated in a more predictable or established market. If CoreWeave&#8217;s assumptions regarding these risks and uncertainties are incorrect or change due to fluctuations in its markets, any material reduction in AI or machine learning spending, changes in demand for specialized AI cloud infrastructure, or otherwise, or if it does not address these risks successfully, its operating and financial results could differ materially from its expectations and its business, operating results, financial condition, and prospects would be adversely affected. CoreWeave cannot ensure that it will be successful in addressing these and other challenges it may face in the future. The risks associated with having a limited operating history may be exacerbated by current macroeconomic and geopolitical conditions discussed herein. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave has a limited history selling access to its platform under its current business model and are continuing to scale its operations and evolve its go-to-market strategy, which may make it difficult to evaluate its business and prospects and increase the risks associated with an investment in its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has a limited history selling access to its AI infrastructure and proprietary managed software and application services through its CoreWeave Cloud Platform under its current business model and it is continuing to scale its operations and evolve its go-to-market strategy. CoreWeave currently sells access to its platform either through committed contracts, which are take-or-pay, or on-demand, which are pay-as-you-go. For the three months ended June&#160;30, 2025 and 2024, committed contracts accounted for over 98% and 96% of our revenue, respectively. For the six months ended June&#160;30, 2025 and 2024, committed contracts accounted for over 98% and 95% of its revenue, respectively. There is no guarantee that in the future customers will continue to be willing to enter into, and that the industry will continue to support, a take-or-pay model, and any move towards a pay-as-you-go model will impact CoreWeave&#8217;s ability to forecast its expected cash flows and operating results, impact its margins, and affect its business, operating results, financial condition, and prospects. Moreover, CoreWeave&#8217;s committed contracts typically include a prepayment from its customers prior to them receiving any of its services. As of December&#160;31, 2023, and 2024, the weighted-average prepayment across all its active contracts was 15% to 25% of the total contract value (&#8220;TCV&#8221;). The level of prepayments CoreWeave receives from customers may fluctuate over time as it continues to scale its operations and evolve its go-to-market strategy, customer base, and the use cases for its platform. Moreover, any changes in the timing or level of customer payments, including prepayments, would impact its cash flows. Furthermore, scaling CoreWeave&#8217;s operations and evolving its go-to-market strategy may take more time and require more effort to implement than anticipated and may have results that are difficult to predict which could result in decreased revenue from its customers. CoreWeave&#8217;s business and pricing models have not been fully proven, and it has only a limited operating history with its current business and pricing models to evaluate its business and prospects, which subjects it to a number of uncertainties, including its ability to plan for and model future growth. Moreover, its historical revenue growth should not be considered indicative of its future performance. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If CoreWeave is unable to attract new customers, retain existing customers, and/or expand sales of its platform, solutions, and services to such customers, it may not achieve the growth it expects, which would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to grow CoreWeave&#8217;s business, it must continue to attract new customers in a cost-effective manner and enable these customers to realize the benefits associated with its platform. CoreWeave may experience difficulties demonstrating to customers the value of its platform and any new solutions and services that it offers. As CoreWeave </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">55<br></div></div></div>
<!--End Page 66-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 67-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">develops and introduces new solutions and services and add new and upgraded components of its platform (such as next-generation NVIDIA GPUs), it faces the risk that customers may not value or be willing to adopt these newer offerings, and may forgo adopting one or more newer generations of its existing offerings. Regardless of the improved features or superior performance of the newer offerings, customers may be unwilling to adopt CoreWeave&#8217;s platform due to design or pricing constraints, among other reasons. Even if customers choose to adopt its platform or new solutions and services that CoreWeave develops, they may be slow to do so. Because of the extensive time and resources that CoreWeave invests in research and development, if it is unable to sell new solutions and services, its revenue may decline and its business, operating results, financial condition, and prospects could be negatively affected. Historically, CoreWeave has used an internal sales team that is focused on responding to inbound inquiries, outbound prospecting targeting specific customers, expanding sales of its platform to existing customers, and expanding its revenue in specific markets to drive revenue growth. If its sales team is not successful at growing its customer base, its future growth will be impacted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave must persuade potential customers that its platform offers significant advantages over those of its competitors. As CoreWeave&#8217;s market matures, its solutions and services evolve, and competitors introduce lower cost and/or differentiated solutions or services that are perceived to compete with its platform, its ability to maintain or expand sales of its platform, solutions, and services could be impaired. Even if CoreWeave does attract new customers, the cost of new customer acquisition, implementation of its platform, and ongoing customer support may prove higher than anticipated, thereby adversely impacting its profitability. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other factors, many of which are out of CoreWeave&#8217;s control, may now or in the future impact its ability to retain existing customers, attract new customers, and expand sales of its platform, solutions, and services to such customers in a cost-effective manner, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">potential customers&#8217; commitments to existing solutions or services or greater familiarity or comfort with other solutions or services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to secure sufficient power for its platform and solutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">decreased spending on specialized AI cloud infrastructure or AI or machine learning development generally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">deteriorating general economic and geopolitical conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">future governmental regulation, which could adversely impact growth of the AI sector; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">negative media, industry, or financial analyst commentary regarding its platform, AI, and the identities and activities of some of its customers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its ability to expand, retain, and motivate its sales, customer success, cloud operations, and marketing personnel; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to obtain or maintain industry security certifications for its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the perceived risk, commencement, or outcome of litigation; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increased expenses associated with being a public company. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Some of CoreWeave&#8217;s customer contracts are on-demand and based on its terms of service, which do not require its customers to commit to a specific contractual period, and which permit the customer to terminate their contracts or decrease usage of its services with limited notice. Any service terminations could cause its operating results to fluctuate from quarter to quarter. CoreWeave&#8217;s customer retention may decline or fluctuate as a result of a number of factors, including its customers&#8217; satisfaction with the security, performance, and reliability of its platform, its prices and usage plans, its customers&#8217; AI development and use and related budgetary restrictions, the perception that competitive solutions and services provide better or less expensive options, negative public perception of it or its customers, and deteriorating general economic conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s future financial performance also depends in part on its ability to expand sales of its platform, solutions, and services to its existing customers. In order to expand CoreWeave&#8217;s commercial relationship with its customers, existing customers must decide that the increased cost associated with additional purchases of its platform, solutions, and services is justified by the additional functionality. CoreWeave&#8217;s customers&#8217; decision whether to increase their purchase is driven by a number of factors, including customer satisfaction with the security, performance, and reliability of its platform, the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">56<br></div></div></div>
<!--End Page 67-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 68-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">functionality of any new solutions and services CoreWeave may offer, general economic conditions, and customer reaction to its pricing model. If its efforts to expand its relationship with its existing customers are not successful, its business, operating results, financial condition, and prospects may materially suffer. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: justify;">If CoreWeave is unable to successfully build, expand, and deploy its sales organization in a timely manner, or at all, or to successfully hire, retain, train, and motivate its sales personnel, its growth and long-term success could be adversely impacted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has grown, and may continue to grow, its direct sales force and its sales efforts have historically depended on the significant direct involvement of its senior management team, including Michael Intrator, its Chief&#160;Executive Officer, President, and Chairman of its board of directors. The successful execution of CoreWeave&#8217;s strategy to increase its sales to existing customers, identify new potential customers, expand its customer base, and enter new U.S. and non-U.S. markets will depend, among other things, on its ability to successfully build and expand its sales organization and operations. CoreWeave has and plan to continue to dedicate significant resources to sales and marketing programs and to expand its sales and marketing capabilities to target additional potential customers and achieve broader market adoption of its platform, but there is no guarantee that it will be successful in attracting and maintaining additional customers. Moreover, identifying, recruiting, training, and managing sales personnel requires significant time, expense, and attention, including from CoreWeave&#8217;s senior management and other key personnel, which could adversely impact its business, operating results, financial condition, and prospects in the short and long term. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to successfully scale its current top-down sales model and as AI use cases expand, CoreWeave may need to increase the size of its direct sales force, both in the United States and outside of the United States, while preserving the cultural and mission-oriented elements of its company. If CoreWeave does not hire a sufficient number of qualified sales personnel, its future revenue growth and business could be adversely impacted. It may take a significant period of time before CoreWeave&#8217;s sales personnel are fully trained and productive, particularly in light of its current sales model, and there is no guarantee it will be successful in adequately training and effectively deploying its sales personnel. In addition, CoreWeave has invested, and may need to continue investing, significant revenues in its sales operations to enable its sales organization to run effectively and efficiently, including supporting sales strategy planning, sales process optimization, data analytics and reporting, and administering incentive compensation arrangements. Furthermore, hiring personnel in new countries requires additional setup and upfront costs that it may not recover if those personnel fail to achieve full productivity in a timely manner. CoreWeave&#8217;s business would be adversely affected if its efforts to build, expand, train, and manage its sales organization are not successful. CoreWeave periodically makes adjustments to its sales organization in response to market opportunities, competitive threats, management changes, product introductions or enhancements, acquisitions, sales performance, increases in sales headcount, cost levels, and other internal and external considerations. Any future sales organization changes may result in a temporary reduction of productivity, which could negatively affect its rate of growth. In addition, any significant change to the way CoreWeave structures and implement the compensation of its sales organization may be disruptive or may not be effective and may affect its revenue growth. If CoreWeave it unable to attract, hire, develop, retain, and motivate qualified sales personnel, if its new sales personnel are unable to achieve sufficient sales productivity levels in a reasonable period of time or at all, if its marketing programs are not effective or if it is unable to effectively build, expand, and manage its sales organization and operations, its sales and revenue may grow more slowly than expected or materially decline, and its business, operating results, financing condition, and prospects may be significantly harmed. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: justify;">If CoreWeave does not or cannot maintain the compatibility of its platform with its customers&#8217; existing technology, including third-party technologies that its customers use in their businesses, its business may be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The functionality and popularity of CoreWeave&#8217;s platform depend, in part, on its ability to integrate its platform with its customers&#8217; existing technology, including other third-party technologies that its customers use in their businesses. CoreWeave&#8217;s customers, or the third parties whose solutions and services its customers utilize, may change the features of their technologies, restrict its access to their technologies, or alter the terms governing use of their technologies in a manner that makes its platform incompatible with their technologies, and which would adversely impact its ability to service its customers. Such changes could functionally limit or prevent CoreWeave&#8217;s ability to use these third-party technologies in conjunction with its platform, which would negatively affect the adoption of its platform and harm its business. If CoreWeave fails to integrate its platform with its customers&#8217; technologies and with third-party technologies that its customers use, CoreWeave able to offer the functionality that its customers want or need, which could adversely impact its business. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">57<br></div></div></div>
<!--End Page 68-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 69-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If CoreWeave is not able to maintain and enhance its brand, its business, operating results, financial condition, and prospects may be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave believes that maintaining and enhancing its brand and its reputation is critical to continued market acceptance of its platform, its relationship with its existing customers and its ability to attract new customers. The successful promotion of CoreWeave&#8217;s brand will depend on a number of factors, including its ability to continue to provide reliable solutions and services that continue to meet the needs of its customers at competitive prices, its ability to successfully differentiate its platform from those of competitors, and the effectiveness of its marketing efforts. Further, industry standards continue to evolve and there is no consensus around performance benchmarks applied to CoreWeave and its competitors, which may impact its ability to promote its platform and its brand. Although CoreWeave believes it is important for its growth, its brand promotion activities may not be successful or yield increased revenue, and even if they do, any increased revenue may not offset the expenses it incurs in building its brand. If CoreWeave fails to successfully promote and maintain its brand, its business, operating results, financial condition, and prospects may be harmed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, independent industry and research firms often evaluate its offerings and provide reviews of its platform, as well as the solutions and services of its competitors, and perception of its platform in the marketplace may be significantly influenced by these reviews. If these reviews are negative, or less positive as compared to those of its competitors&#8217; solutions and services, its brand may be adversely affected. CoreWeave&#8217;s offerings may experience capacity and operational issues for a number of reasons that may or may not be related to the efficacy of its offerings in real world environments. To the extent potential customers, industry analysts, or research firms believe that the occurrence of capacity or computing issues is a flaw or indicates that CoreWeave&#8217;s platform does not provide significant value, it may lose such potential customer opportunities, and its reputation, business, operating results, financial condition, and prospects may be harmed. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">As CoreWeave expands its customer base, it may become further subject to counterparty credit risk, which would adversely impact its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although CoreWeave currently generates the majority of its revenue from large, established customers in the AI&#160;industry, it intends to increase the number of its enterprise customers over time, including customers in their early stages and/or private companies that may have increased risk of insolvency, bankruptcy, or other issues impacting their creditworthiness. For example, in March&#160;2025, CoreWeave entered into a master services agreement with OpenAI, a private company, pursuant to which OpenAI has committed to pay it up to approximately $11.9&#160;billion through October&#160;2030. CoreWeave&#8217;s business is, and may in the future be, subject to the risks of non-payment and non-performance by these customers, which risk is heightened given that a substantial portion of its revenue is currently, and is expected for the foreseeable future to be, driven by a limited number of customers. CoreWeave manages its exposure to credit risk through receipt of prepayments under its committed contracts, credit analysis and monitoring procedures, and may use letters of credit, prepayments, and guarantees. However, these procedures and policies cannot fully eliminate customer credit risk, and to the extent CoreWeave&#8217;s policies and procedures prove to be inadequate, it could negatively affect its business, operating results, financial condition, and prospects. In addition, some of CoreWeave&#8217;s customers may be highly leveraged and subject to its own operating and regulatory risks and, even if its credit review and analysis mechanisms work properly, it may experience risks of non-payment and non-performance in its dealings with such parties. In such event, CoreWeave may remain responsible for expenditures for components, infrastructure, and data center leases and build-outs, as well as related financing that it has undertaken for which it may not receive corresponding revenue. CoreWeave does not currently maintain credit insurance to insure against customer credit risk. If CoreWeave&#8217;s customers fail to fulfill their contractual obligations, it may have an adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s long-term success depends, in part, on its ability to expand the sale of its platform to customers located outside of the United States and its current, and any further, expansion of its international operations exposes it to risks that could have a material adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave generates a small portion of its revenue outside of the United States, and conducts its business activities in various foreign countries, where it has limited experience, where the challenges of conducting its business can be significantly different from those it has faced in more developed markets and where business practices may create internal control risks including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">slower than anticipated demand for AI and machine learning solutions offered by existing and potential customers outside the United States and slower than anticipated adoption of specialized AI cloud-based infrastructures by international businesses; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">58<br></div></div></div>
<!--End Page 69-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 70-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fluctuations in foreign currency exchange rates, which could add volatility to its operating results; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">limitations within its debt agreements that may restrict its ability to make investments in its foreign subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">new, or changes in, regulatory requirements, including with respect to AI; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">tariffs, export and import restrictions, restrictions on foreign investments, sanctions, and other trade barriers or protection measures; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">exposure to numerous, increasing, stringent (particularly in the European Union), and potentially inconsistent laws and regulations relating to privacy, data protection, and information security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">costs of localizing its platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">lack of acceptance of localized solutions and services; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the need to make significant investments in people, solutions, and infrastructure, typically well in advance of revenue generation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">challenges inherent in efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits, and compliance programs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">difficulties in maintaining its corporate culture with a dispersed and distant workforce; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">treatment of revenue from international sources, evolving domestic and international tax environments, and other potential tax issues, including with respect to its corporate operating structure and intercompany arrangements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">different or weaker protection of its intellectual property, including increased risk of theft of its proprietary technology and other intellectual property; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">economic weakness or currency-related disparities or crises; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compliance with multiple, conflicting, ambiguous or evolving governmental laws and regulations, including employment, tax, data privacy, anti-corruption, import/export, antitrust, data transfer, storage and protection, and industry-specific laws and regulations, including regulations related to AI; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">generally longer payment cycles and greater difficulty in collecting accounts receivable; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its ability to adapt to sales practices and customer requirements in different cultures; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the lack of reference customers and other marketing assets in regional markets that are new or developing for it, as well as other adaptations in its market generation efforts that it may be slow to identify and implement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">dependence on certain third parties, including third-party data center facility providers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">natural disasters, acts of war, terrorism, or pandemics, including the armed conflicts in the Middle East and Ukraine and tensions between China and Taiwan; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actual or perceived instability in the global banking system; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cybersecurity incidents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">corporate espionage; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.5pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">political instability and security risks in the countries where it is doing business and changes in the public perception of governments in the countries where it operates or plans to operate. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">59<br></div></div></div>
<!--End Page 70-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 71-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s sales cycles can be long and unpredictable, and its sales efforts require considerable time and expense. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s go-to-market approach currently focuses on a top-down sales model to drive demand and pipeline from the large AI labs and AI enterprises. Sales to such customers involve longer and more unpredictable sales cycles. Customers often view the purchase of CoreWeave&#8217;s platform as a significant strategic decision and, as a result, frequently require considerable time to evaluate, test, and qualify its platform prior to entering into or expanding a relationship with it. Large enterprises in particular, often undertake a significant evaluation process that further lengthens CoreWeave&#8217;s sales cycle. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s direct sales team develops relationships with its customers, and works on account penetration, account coordination, sales, and overall market development. CoreWeave spends substantial time and resources on its sales efforts without any assurance that its efforts will produce a sale. Cloud infrastructure capacity purchases are frequently subject to budget constraints, multiple approvals, and unanticipated administrative, processing, and other delays. As a result, it is difficult to predict whether and when a sale will be completed. The failure of CoreWeave&#8217;s efforts to secure sales after investing resources in a lengthy sales process would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 11.5pt; margin-left: 0pt; text-align: justify;">The sales prices of CoreWeave&#8217;s offerings may decrease, which may reduce its margins and adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has limited experience with respect to determining the optimal prices for its platform. As the market for cloud infrastructure and AI and machine learning solutions mature, or as new competitors introduce new infrastructure solutions or services that are similar to or compete with CoreWeave&#8217;s, it may be unable to effectively optimize its prices through increases or decreases or attract new customers at its offered prices or based on the same pricing model as it has used historically. Further, competition continues to increase in the market segments in which CoreWeave participates, and it expects competition to further increase in the future, thereby leading to increased pricing pressures. Larger competitors with more diverse offerings may reduce the price of any offerings that compete with CoreWeave&#8217;s or may bundle them with other solutions and services. This could lead customers to demand greater price concessions or additional functionality at the same price levels. As a result, in the future CoreWeave may be required to reduce its prices or provide more features and services without corresponding increases in price, which would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Existing and future acquisitions, strategic investments, partnerships, or alliances could be difficult to identify and integrate, divert the attention of key management personnel, disrupt CoreWeave&#8217;s business, dilute stockholder value, and adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of CoreWeave&#8217;s business strategy, it has in the past and expects to continue to make investments in and/or acquire complementary companies, services, products, technologies, or talent. For example, in July&#160;2025, we announced we had entered into the Merger Agreement with respect to the Merger. CoreWeave has also invested, including in the form of providing computing services, in certain privately held companies, and it may not realize a return on these investments. All of its acquisitions and venture investments are subject to a risk of partial or total loss of investment capital. CoreWeave&#8217;s ability as an organization to acquire and integrate other companies, services, or technologies in a successful manner is not guaranteed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the future, CoreWeave may not be able to find suitable acquisition candidates, and it may not be able to complete such acquisitions on favorable terms, if at all. CoreWeave&#8217;s due diligence efforts may fail to identify all of the challenges, problems, liabilities, or other shortcomings involved in an acquisition. Further, current and future changes to the U.S. and foreign regulatory approval process and requirements related to acquisitions may cause approvals to take longer than anticipated, not be forthcoming or contain burdensome conditions, which may prevent the transaction or jeopardize, delay or reduce the anticipated benefits of the transaction, and impede the execution of CoreWeave&#8217;s business strategy. If CoreWeave does complete acquisitions, it may not ultimately strengthen its competitive position or ability to achieve its business objectives, and any acquisitions it announces or completes could be viewed negatively by its customers or investors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, if CoreWeave is unsuccessful at integrating existing and future acquisitions, or the technologies and personnel associated with such acquisitions, into its company, the business, operating results, financing condition, and prospects of the combined company could be adversely affected. For example, in May&#160;2025, CoreWeave acquired Weights &amp; Biases, Inc. (&#8220;Weights &amp; Biases&#8221;), an AI developer platform. There can be no assurance that </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">60<br></div></div></div>
<!--End Page 71-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 72-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave will be successful in its efforts to integrate Weights &amp; Biases, its employees, and its products and services, into CoreWeave&#8217;s platform. Any integration process may require significant time and resources, and CoreWeave may not be able to manage the process successfully. CoreWeave may not successfully evaluate or utilize the acquired technology or personnel, or accurately forecast the financial impact of an acquisition transaction, causing unanticipated write-offs or accounting (including goodwill) charges. Additionally, integrations could take longer than expected, or if CoreWeave moves too quickly in trying to integrate an acquisition, strategic investment, partnership, or other alliance, it may fail to achieve the desired efficiencies. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has, and may in the future have, to pay cash, incur debt, issue equity securities or provide computing services, to pay for any such acquisition, each of which could adversely affect its financial condition and the market price of its Class&#160;A common stock. The sale of equity or issuance of debt to finance any such acquisitions could result in dilution to CoreWeave&#8217;s stockholders, which, depending on the size of the acquisition, may be significant. The incurrence of indebtedness would result in increased fixed obligations and could also include covenants or other restrictions that would impede CoreWeave&#8217;s ability to manage its operations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, CoreWeave&#8217;s ability to make acquisitions and finance acquisitions through the sale of equity or issuance of debt is limited by certain restrictions contained in its debt agreements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Additional risks CoreWeave may face in connection with acquisitions include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">diversion of management&#8217;s time and focus from operating its business to addressing acquisition integration challenges; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the inability to coordinate research and development and sales and marketing functions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the inability to integrate solution and service offerings; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">retention of key employees from the acquired company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in relationships with strategic partners or the loss of any key customers or partners as a result of acquisitions or strategic positioning resulting from the acquisition; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cultural challenges associated with integrating employees from the acquired company into its organization; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">integration of the acquired company&#8217;s accounting, customer relationship management, management information, human resources, and other administrative systems; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the need to implement or improve controls, procedures, and policies at a business that prior to the acquisition may have lacked sufficiently effective controls, procedures, and policies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">unexpected security risks or higher than expected costs to improve the security posture of the acquired company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">higher than expected costs to bring the acquired company&#8217;s IT infrastructure up to its standards; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">additional legal, regulatory, or compliance requirements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">financial reporting, revenue recognition, or other financial or control deficiencies of the acquired company that it does not adequately address and that cause its reported results to be incorrect; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">liability for activities of the acquired company before the acquisition, including intellectual property infringement claims, violations of laws, commercial disputes, tax liabilities, and other known and unknown liabilities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">failing to achieve the expected benefits of the acquisition or investment; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">litigation or other claims in connection with the acquired company, including claims from or against terminated employees, customers, current and former stockholders, or other third parties. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s failure to address these risks or other problems encountered in connection with acquisitions and investments could cause it to fail to realize the anticipated benefits of these acquisitions or investments, cause it to incur unanticipated liabilities, and harm its business generally. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For additional risks relating to the Merger, see the section titled &#8220;&#8212;Risks relating to the Merger.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">61<br></div></div></div>
<!--End Page 72-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 73-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which it competes achieve the forecasted growth, its business could fail to grow at similar rates, if at all. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The estimates of market opportunity and forecasts of market growth may prove to be inaccurate. Market opportunity estimates and growth forecasts, including those CoreWeave has generated itself, are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate, including the risks described herein. Even if the markets in which CoreWeave competes achieve the forecasted growth, its business could fail to grow at similar rates, if at all. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, if AI is not broadly adopted by enterprises to the extent CoreWeave expects, or if new use cases do not arise, then its opportunity may be smaller than it expects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The variables that go into the calculation of CoreWeave&#8217;s market opportunity are subject to change over time, and there is no guarantee that any particular number or percentage of addressable customers covered by its market opportunity estimates will purchase its platform at all or generate any particular level of revenue for it. Any expansion in the markets in which CoreWeave operates depends on a number of factors, including the cost, performance, and perceived value associated with its platform and those of its competitors. Even if the markets in which CoreWeave competes meet the size estimates and growth forecast, its business could fail to grow at similar rates, if at all. CoreWeave&#8217;s growth is subject to many factors, including its success in implementing its business strategy, which is subject to many risks and uncertainties. Accordingly, CoreWeave&#8217;s forecasts for market growth should not be taken as indicative of its future growth. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave has in the past, and may in the future, enter into collaborations or strategic alliances with third parties. If CoreWeave is unsuccessful in establishing or maintaining strategic relationships with these third parties or if these third parties fail to deliver certain operational services, its business, operating results, financial condition, and prospects could be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has in the past, and may in the future, enter into collaborations or strategic alliances with third parties in connection with the development, operation, and enhancements to its platform and the provision of its solutions and services. Identifying strategic relationships with third parties, and negotiating and documenting relationships with them, may be time-consuming and complex and may distract management. Moreover, CoreWeave may be delayed, or may not be successful, in achieving the objectives that it anticipates as a result of such strategic relationships. In evaluating counterparties in connection with collaborations or strategic alliances, CoreWeave considers a wide range of economic, legal, and regulatory criteria depending on the nature of such relationship, including the counterparties&#8217; reputation, operating results, and financial condition, operational ability to satisfy its and its customers&#8217; needs in a timely manner, efficiency and reliability of systems, certifications costs to it or to its customers, and licensure and compliance status. Despite this evaluation, third parties may still not meet CoreWeave&#8217;s or its customers&#8217; needs which may adversely affect its ability to deliver solutions and services to customers and may adversely impact its business, operating results, financial condition, and prospects. Counterparties to any strategic relationship may have economic or business interests or goals that are, or that may become, inconsistent with CoreWeave&#8217;s business interests or goals, and may subject it to additional risks to the extent such third party becomes the subject of negative publicity, faces its own litigation or regulatory challenges, or faces other adverse circumstances. Conflicts may arise with CoreWeave&#8217;s strategic partners, such as the interpretation of significant terms under any agreement, which may result in litigation or arbitration which would increase its expenses and divert the attention of its management. If CoreWeave is unsuccessful in establishing or maintaining strategic relationships with third parties, its ability to compete or to grow its revenue could be impaired and its business, operating results, financial condition, and prospects could be adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">The anticipated benefits of potential joint ventures may not be fully realized or take longer to realize than expected. In addition, CoreWeave&#8217;s joint venture investments could expose it to risks and liabilities in connection with the formation of the new joint ventures, the operation of such joint ventures without sole decision-making authority, and its reliance on joint venture partners who may have economic and business interests that are inconsistent with its business interests. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may enter into joint ventures in the future, including to develop and operate data centers. Certain sites that are intended to be utilized in joint ventures require investment for development. For example, in June&#160;2025, CoreWeave entered into a joint venture with a third-party infrastructure developer, to support the acquisition and development of a multi-phase data center campus in Kenilworth, New Jersey. The success of these joint ventures will </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">62<br></div></div></div>
<!--End Page 73-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 74-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">also depend, in part, on the successful development of the data center sites, and CoreWeave may not realize all of the anticipated benefits. Such development may be more difficult, time-consuming, or costly than expected and could result in increased costs, decreases in the amount of expected revenues, and diversion of management&#8217;s time and energy, which could materially impact CoreWeave&#8217;s business, operating results, financial condition, and prospects. Additionally, if it is determined these sites are no longer desirable for the joint ventures, CoreWeave would need to adapt such sites for other purposes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The success of any joint ventures will depend, in part, on the successful relationship between CoreWeave&#8217;s and its joint venture partners. A failure to successfully partner, or a failure to realize CoreWeave&#8217;s expectations for the joint ventures, including any contemplated exit strategy from a joint venture, could materially impact its business, operating results, financial condition, and prospects. These joint ventures could also be negatively impacted by inflation, supply chain issues, an inability to obtain financing on favorable terms or at all, an inability to fill the data center sites with customers as planned, and development and construction delays. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, in the future, CoreWeave may co-invest with other third parties through partnerships, joint ventures, or other entities in the future. These joint ventures could result in CoreWeave&#8217;s acquisition of non-controlling interests in, or shared responsibility for, managing the affairs of a property or portfolio of properties, partnership, joint venture, or other entity. CoreWeave may be subject to additional risks, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it may not have the right to exercise sole decision-making authority regarding the properties, partnership, joint venture, or other entity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if its partners become bankrupt or fail to fund their share of required capital contributions, it may choose to or be required to contribute such capital; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its partners may have economic, tax, or other business interests or goals which are inconsistent with its business interests or goals, and may be in a position to take actions contrary to its interests or objectives; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its joint venture partners may take actions that are not within its control, which could require it to dispose of the joint venture asset or purchase the partner&#8217;s interests or assets at an above-market price; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its joint venture partners may take actions unrelated to its business agreement but which reflect poorly on it because of its joint venture relationship; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">disputes between it and its partners may result in litigation or arbitration that would increase its expenses and prevent its management from focusing their time and effort on its day-to-day business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it may in certain circumstances be liable for the actions of its third-party partners or guarantee all or a portion of the joint venture&#8217;s liabilities, which may require it to pay an amount greater than its investment in the joint venture; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it may need to change the structure of an established joint venture or create new complex structures to meet its business needs or the needs of its partners which could prove challenging; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a joint venture partner&#8217;s decision to exit the joint venture may not be at an opportune time for it or in its business interests. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of these factors may result in returns on these investments being less than CoreWeave expects or in losses, and business, operating results, financial condition, and prospects may be adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Future acquisitions could include real property and subject CoreWeave to the general risks associated with the ownership of real property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave currently leases all of its data centers and office locations. However, CoreWeave could in the future make acquisitions that include real property, which would most likely be one or more data centers. As a result of any such acquisition, CoreWeave would directly own real property and become subject to the general risks associated with the ownership of real property, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in governmental laws and regulations, including the Americans with Disabilities Act and zoning ordinances, and the related costs of compliance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">increased upfront costs of purchasing real property; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the ongoing need for repair, maintenance and capital improvements; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">63<br></div></div></div>
<!--End Page 74-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 75-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg37"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">natural disasters, including earthquakes and floods, and acts of war or terrorism; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">general liability, property and casualty losses, some of which may be uninsured; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">liabilities for clean-up of undisclosed environmental contamination; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">liabilities incurred in the ordinary course of business. </div></td></tr></table><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If negative publicity arises with respect to CoreWeave, its employees, its third-party suppliers, service providers, or its partners, its business, operating results, financial condition, and prospects could be adversely affected, regardless of whether the negative publicity is true. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Negative publicity about CoreWeave or its platform, solutions, or services, even if inaccurate or untrue, could adversely affect its reputation and the confidence in its platform, solutions, or services, which could harm its business, operating results, financial condition, and prospects. Harm to CoreWeave&#8217;s reputation can also arise from many other sources, including employee misconduct, which it has experienced in the past, and misconduct by its partners, consultants, suppliers, and outsourced service providers. Additionally, negative publicity with respect to CoreWeave&#8217;s partners or service providers could also affect its business, operating results, financial condition, and prospects to the extent that it relies on these partners or if its customers or prospective customers associate its company with these partners. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s ability to maintain customer satisfaction depends in part on the quality of its customer support and cloud operations services. CoreWeave&#8217;s failure to maintain high-quality customer support and cloud operations services could have an adverse effect on its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave believes that the successful use of its platform requires a high level of support and engagement for many of its customers. In order to deliver appropriate customer support and engagement, CoreWeave must successfully assist its customers in deploying and continuing to use its platform, resolve performance issues, address interoperability challenges with the customers&#8217; existing IT infrastructure, and respond to security threats and cyber-attacks and performance and reliability problems that may arise from time to time. Increased demand for customer support and cloud operations services, without corresponding increases in revenue, could increase CoreWeave&#8217;s costs and adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, there can be no assurance that CoreWeave will be able to hire sufficient support personnel as and when needed, particularly if its sales exceed its internal forecasts. CoreWeave expects to increase the number of its customers, and that growth may put additional pressure on its customer support and cloud operations services teams. CoreWeave&#8217;s customer support and cloud operations services teams may need additional personnel to respond to customer demand. CoreWeave may be unable to respond quickly enough to accommodate short-term increases in customer demand for services. To the extent that CoreWeave is unsuccessful in hiring, training, and retaining adequate support resources, its ability to provide high-quality and timely support to its customers will be negatively impacted, and its customers&#8217; satisfaction and their purchase of its infrastructure could be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, as CoreWeave continues to grow its operations and expand outside of the United States, it needs to be able to provide efficient services that meet its customers&#8217; needs globally at scale, and its customer support and cloud operations services teams may face additional challenges, including those associated with operating the platforms and delivering support, training, and documentation in languages other than English and providing services across expanded time-zones. If CoreWeave is unable to provide efficient customer support services globally at scale, its ability to grow its operations may be harmed, and it may need to hire additional services personnel which could increase its expenses, and negatively impact its business, financial condition, operating results, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Risks Related to CoreWeave&#8217;s People </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave relies on its management team and other key employees and will need additional personnel to grow its business, and the loss of one or more key employees or its inability to attract and retain qualified personnel, including members of its board of directors, could harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s future success is dependent, in part, on its ability to hire, integrate, train, manage, retain, and motivate the members of its management team and other key employees throughout its organization as well as members of its board of directors. The loss of key personnel, particularly Michael Intrator, its Chief Executive Officer, President, and Chairman of its board of directors, Brian Venturo, its Chief Strategy Officer, and Brannin McBee, its Chief Development Officer (collectively, its &#8220;Co-Founders&#8221;), as well as certain of its key marketing, sales, finance, support, network development, people team, or technology personnel, could disrupt its operations and have an adverse effect on its ability to grow its business. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">64<br></div></div></div>
<!--End Page 75-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 76-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg38"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Competition for highly skilled personnel is intense, especially in the New York City, San Francisco Bay, and Seattle areas where CoreWeave has a substantial presence and need for highly skilled personnel, and it may not be successful in hiring or retaining qualified personnel to fulfill its current or future needs. More generally, the technology industry, and the cloud infrastructure industry more specifically, is also subject to substantial and continuous competition for engineers with high levels of experience in designing, developing, and managing infrastructure and related services. Moreover, the industry in which it operates generally experiences high employee attrition. CoreWeave has, from time to time, experienced, and it expects to continue to experience, difficulty in hiring and retaining highly skilled employees with appropriate qualifications. For example, in recent years, recruiting, hiring, and retaining employees with expertise in the AI computing industry has become increasingly difficult as the demand for AI computing infrastructure has increased as a result of the increase in AI and machine learning development, deployment, and demand. CoreWeave may be required to provide more training to its personnel than it currently anticipates. Further, labor is subject to external factors that are beyond its control, including its industry&#8217;s highly competitive market for skilled workers and leaders, cost inflation, overall macroeconomics, and workforce participation rates. Should CoreWeave&#8217;s competitors recruit its employees, its level of expertise and ability to execute its business plan would be negatively impacted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, many of CoreWeave&#8217;s key personnel are, or will soon be, vested in a substantial number of shares of its common stock, restricted stock units (&#8220;RSUs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), or stock options. Employees may be more likely to terminate their employment with CoreWeave if the shares they own or the shares underlying their vested RSUs, RSAs, or options have significantly appreciated in value relative to the original purchase prices of the shares, exercise price of the options, or grant date values of the RSUs, or RSAs, or, conversely, if the exercise price of the options that they hold are significantly above the trading price of its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, many of the companies with which CoreWeave competes for experienced personnel have greater resources than it has. CoreWeave&#8217;s competitors also may be successful in recruiting and hiring members of its management team, sales team, or other key employees, and it may be difficult for it to find suitable replacements on a timely basis, on competitive terms, or at all. CoreWeave has in the past, and may in the future, be subject to allegations that employees it hires have been improperly solicited, or that they have divulged proprietary or other confidential information or that their former employers own such employees&#8217; inventions or other work product, or that they have been hired in violation of non-compete provisions or non-solicitation provisions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, job candidates and existing employees often consider the value of the equity awards and other compensation they receive in connection with their employment. If the perceived value of CoreWeave&#8217;s compensatory package declines or is subject to significant value fluctuations, it may adversely affect its ability to attract and retain highly skilled employees. CoreWeave may also change the composition of its compensation package to employees, including the amount or ratio of cash and equity compensation. Any increases to the amount of cash compensation will increase its cash expenditures, which may impact its business, operating results, financial condition, and prospects. Further, CoreWeave&#8217;s competitors may be successful in recruiting and hiring members of its management team or other key employees as well as directors, and it may be difficult for it to find suitable replacements on a timely basis, on competitive terms, or at all. In recent years, the increased availability of hybrid or remote working arrangements has expanded the pool of companies that can compete for its employees and employment candidates. CoreWeave has entered into offer letters with certain of its key employees, however these agreements are on an &#8220;at-will&#8221; basis, meaning they are able to terminate their employment with it at any time and it does not have employment agreements with all of its key employees. If CoreWeave fails to attract new personnel or fails to retain and motivate its current personnel, its business and future growth prospects would be severely harmed. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">CoreWeave believes that its corporate culture has contributed to its success, and if it cannot maintain this culture as it grows, it could lose the innovation, creativity, and teamwork fostered by its culture, and its business may be harmed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave believes that its corporate culture has been, and will continue to be, a key contributor to its success. If CoreWeave does not continue to maintain its corporate culture, which includes its focus on its customers, as it grows and evolves, including as it continues to grow in headcount, it could harm its ability to foster the drive, innovation, inclusion, creativity, and teamwork that it believes is important to support its growth. As CoreWeave implements more complex organizational structures, it may find it increasingly difficult to maintain the beneficial aspects of its corporate culture, which could negatively impact its future success. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">65<br></div></div></div>
<!--End Page 76-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 77-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg39"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risks Related to CoreWeave&#8217;s Intellectual Property </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Failure to obtain, maintain, protect, or enforce CoreWeave&#8217;s intellectual property and proprietary rights could enable others to copy or use aspects of its platform without compensating it, which could harm its brand, business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave relies on a combination of trademark, copyright, trade secret, patent, unfair competition, and other related laws in the United States and internationally, as well as confidentiality agreements and contractual provisions with its customers, third-party manufacturing partners, joint venture partners, employees, and consultants to protect its technology and intellectual property rights. Despite CoreWeave&#8217;s efforts to protect its proprietary rights, unauthorized parties may attempt to copy aspects of its platform or obtain and use information that it regards as proprietary. In particular, CoreWeave is unable to predict or assure that: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">its intellectual property rights will not lapse or be invalidated, circumvented, challenged, or, in the case of third-party intellectual property rights licensed to it, be licensed to others; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">its intellectual property rights will provide competitive advantages to it; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">rights previously granted by third parties to intellectual property licensed or assigned to it, including portfolio cross-licenses, will not hamper its ability to assert its intellectual property rights or hinder the settlement of currently pending or future disputes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any of its pending or future trademark or patent applications will be issued or have the coverage originally sought; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it will be able to enforce its intellectual property rights in certain jurisdictions where competition is intense or where legal protection may be weak; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">it has sufficient intellectual property rights to protect its solutions and services or its business. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave customarily enters into confidentiality or license agreements with its employees, consultants, vendors, and customers, and makes significant efforts to limit access to and distribution of its proprietary information. However, such agreements may not be enforceable in full or in part in all jurisdictions and any breach could negatively affect CoreWeave&#8217;s business and its remedy for such breach may be limited. The contractual provisions that CoreWeave enters into may not prevent unauthorized use or disclosure of its proprietary technology or intellectual property rights and may not provide an adequate remedy in the event of unauthorized use or disclosure of its proprietary technology or intellectual property rights. Lastly, the measures CoreWeave employs to limit the access and distribution of its proprietary information may not prevent unauthorized use or disclosure of its proprietary technology or intellectual property. As such, CoreWeave cannot guarantee that the steps taken by it will prevent infringement, violation, or misappropriation of its technology. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave pursues the registration of its trademarks, service marks, patents, and domain names in the United&#160;States and in certain foreign jurisdictions. These processes are expensive and may not be successful in all jurisdictions or for every such application, and CoreWeave may not pursue such protections in all jurisdictions that may be relevant, for all its goods or services or in every class of goods and services in which it operates. As such, policing unauthorized use of its technology or platform is difficult. Additionally, CoreWeave may not be able to obtain, maintain, protect, exploit, defend, or enforce its intellectual property rights in every foreign jurisdiction in which it operates. For example, effective trade secret protection may not be available in every country in which CoreWeave&#8217;s platform is available or where it has employees or independent contractors. The loss of trade secret protection could make it easier for third parties to compete with CoreWeave&#8217;s platform by copying functionality. Any changes in, or unexpected interpretations of, the trade secret and employment laws in any country in which CoreWeave operates may compromise its ability to enforce its trade secret and intellectual property rights. In addition, CoreWeave believes that the protection of its trademark rights is an important factor in product recognition, protecting its brand and maintaining goodwill and if it does not adequately protect its rights in trademarks from infringement, any goodwill that it has developed in those trademarks could be lost or impaired, which could harm its brand and its business. The legal systems of certain countries do not favor the enforcement of trademarks trade secrets, and other intellectual property and proprietary protection, which could make it difficult for it to stop the infringement, misappropriation, dilution, or other violation of its intellectual property or marketing of competing platforms, solutions, or services in violation of its intellectual property rights generally. Any changes in, or unexpected interpretations of, intellectual property laws may compromise its ability to enforce its intellectual property rights. If CoreWeave fails to maintain, protect and enhance its intellectual property rights, its business, operating results, financial condition, and prospects may be harmed. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">66<br></div></div></div>
<!--End Page 77-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 78-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg40"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, defending CoreWeave&#8217;s intellectual property rights through litigation might entail significant expense. Such litigation could result in substantial costs and diversion of resources and could negatively affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. If CoreWeave is unable to protect its proprietary rights, it could find itself at a competitive disadvantage to others who need not incur the additional expense, time, and effort required to create its platform and other innovative offerings that have enabled it to be successful to date. Moreover, CoreWeave may need to expend additional resources to defend its intellectual property rights in foreign countries, and its inability to do so could impair its business or adversely affect its international expansion. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Third parties may claim that CoreWeave&#8217;s platform infringes, misappropriates, or otherwise violates their intellectual property rights, and such claims could be time-consuming or costly to defend or settle, result in the loss of significant rights, or harm its relationships with its customers or reputation in the industry. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Third parties have claimed and may, in the future, claim, that CoreWeave&#8217;s current or future offerings infringe their intellectual property rights, and such claims may result in legal claims against it, its third-party partners, and its customers. These claims may be time consuming, costly to defend or settle, damage CoreWeave&#8217;s brand and reputation, harm its customer relationships, and create liability for it. Contractually, CoreWeave is expected to indemnify its partners and customers for these types of claims. CoreWeave expects the number of such claims (whether warranted or not) to increase, particularly as a public company with an increased profile and visibility, as the level of competition in its market grows, as the functionality of its offerings overlaps with that of other cloud infrastructure companies, and as the volume of issued hardware and software patents and patent applications continues to increase. CoreWeave generally agrees in its customer and partner contracts to indemnify customers for certain expenses or liabilities they incur as a result of third-party intellectual property infringement claims associated with its platform. To the extent that any claim arises as a result of third-party technology CoreWeave has licensed for use in its platform, it may be unable to recover from the appropriate third party any expenses or other liabilities that it incurs. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Companies in the cloud infrastructure and technology industries, including some of CoreWeave&#8217;s current and potential competitors, may own large numbers of patents, copyrights, trademarks, and trade secrets and frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. In addition, many of these companies have the capability to dedicate substantially greater resources to enforce their intellectual property rights and to defend claims that may be brought against them. Furthermore, patent holding companies, non-practicing entities, and other adverse patent owners that are not deterred by CoreWeave&#8217;s existing intellectual property protections have sought and may, in the future, seek to assert patent claims against it. From time to time, third parties, including certain of these leading companies, have invited CoreWeave to license their patents and may, in the future, assert patent, copyright, trademark, or other intellectual property rights against it, its third-party partners, or its customers. CoreWeave may in the future receive notices that claim it has misappropriated, misused, or infringed other parties&#8217; intellectual property rights, and, to the extent it gains greater market visibility, it faces a higher risk of being the subject of intellectual property infringement claims. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There may be third-party intellectual property rights that cover significant aspects of CoreWeave&#8217;s technologies or business methods and assets. In the event that CoreWeave engages software engineers or other personnel who were previously engaged by competitors or other third parties, it may be subject to claims that those personnel inadvertently or deliberately incorporate proprietary technology of third parties into its platform or have improperly used or disclosed trade secrets or other proprietary information. CoreWeave may also in the future be subject to claims by its third-party manufacturing partners, employees, or contractors asserting an ownership right in its intellectual property as a result of the work they performed on its behalf. In addition, CoreWeave may lose valuable intellectual property rights or personnel. A loss of key personnel or CoreWeave&#8217;s work product could hamper or prevent its ability to develop, market, and support potential offerings and platform enhancements, which could severely harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any intellectual property claims, with or without merit, could be very time-consuming, could be expensive to settle or litigate, and could divert its management&#8217;s attention and other resources. These claims could also subject CoreWeave to significant liability for damages, potentially including treble damages if it is found to have willfully infringed patents or copyrights, and may require it to indemnify its customers for liabilities they incur as a result of such claims. These claims could also result in CoreWeave having to stop using technology found to be in violation of a third party&#8217;s rights. CoreWeave might be required to seek a license for the intellectual property, which may not be available on reasonable terms or at all. Even if a license were available, CoreWeave could be required to pay significant royalties, which would increase its operating expenses. Alternatively, CoreWeave could be required to </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">67<br></div></div></div>
<!--End Page 78-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 79-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg41"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">develop alternative non-infringing technology, which could require significant time, effort, and expense, and may affect the performance or features of its platform. If CoreWeave cannot license or develop alternative non-infringing substitutes for any infringing technology used in any aspect of its business, it would be forced to limit or stop sales of its platform and may be unable to compete effectively. Moreover, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of CoreWeave common stock. Any of these results would adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave licenses technology from third parties for the development of its solutions, and its inability to maintain those licenses could harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave currently incorporates, and will in the future incorporate, technology that it licenses from third parties, including software, into its offerings. If CoreWeave is unable to continue to use or license these technologies on reasonable terms, or if these technologies become unreliable, unavailable, or fail to operate properly, it may not be able to secure adequate alternatives in a timely manner or at all, and its ability to offer its solutions and remain competitive in its market would be harmed. Further, licensing technologies from third parties exposes CoreWeave to increased risk of being the subject of intellectual property infringement and vulnerabilities due to, among other things, its lower level of visibility into the development process with respect to such technology and the care taken to safeguard against risks. CoreWeave cannot be certain that its licensors do not or will not infringe on the intellectual property rights of third parties or that its licensors have or will have sufficient rights to the licensed intellectual property in all jurisdictions in which it may sell its platform. Some of CoreWeave&#8217;s agreements with its licensors may be terminated by them for convenience, or otherwise provide for a limited term. If CoreWeave is unable to continue to license technology because of intellectual property infringement claims brought by third parties against its licensors or against it, or if it is unable to continue its license agreements or enter into new licenses on commercially reasonable terms, its ability to develop and sell its platform containing or dependent on that technology would be limited, and its business, including its financial condition, cash flows, and operating results could be harmed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, if CoreWeave is unable to license technology from third parties, it may be forced to acquire or develop alternative technology, which it may be unable to do in a commercially feasible manner, or at all, and may require it to use alternative technology of lower quality or performance standards. This could limit or delay CoreWeave&#8217;s ability to offer new or competitive offerings and increase its costs. Third-party software CoreWeave relies on may be updated infrequently, unsupported, or subject to vulnerabilities that may not be resolved in a timely manner, any of which may expose its solutions to vulnerabilities. Any impairment of the technologies or of CoreWeave&#8217;s relationship with these third parties could harm its business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Some of CoreWeave&#8217;s technology incorporates &#8220;open-source&#8221; software, and failure to comply with the terms of the underlying open-source software licenses could adversely affect its business, results of operations, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave uses open-source software in its solutions and services and may continue to use open-source software in the future. Certain open-source licenses contain requirements that CoreWeave make available source code for modifications or derivative works it creates. If CoreWeave combines its proprietary software with open-source software in a certain manner, it could, under certain open-source licenses, be required to release the source code of its proprietary software to the public on unfavorable terms or at no cost. Any actual or claimed requirement to disclose CoreWeave&#8217;s proprietary source code or pay damages for breach of contract may allow its competitors to create similar products with lower development effort and time and, ultimately, could result in a loss of sales for it. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The use and distribution of open-source software may entail greater risks than the use of third-party commercial software, as open-source licensors generally do not provide support, warranties, indemnification or other contractual protections regarding infringement claims or the quality of the code, which they are not typically required to maintain and update, and they can change the license terms on which they offer the open-source software. Although CoreWeave believes that it has complied with its obligations under the applicable licenses for open-source software, it is possible that it may not be aware of all instances where open-source software has been incorporated into its proprietary software or used in connection with its solutions or its corresponding obligations under open-source. CoreWeave takes steps to monitor its use of open-source software in an effort both to comply with the terms of the applicable open-source licenses and to avoid subjecting its platform to conditions it does not intend, but there are </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">68<br></div></div></div>
<!--End Page 79-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 80-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg42"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">risks associated with use of open-source software that cannot be eliminated and could negatively affect its business. CoreWeave relies on multiple software programmers to design its proprietary software and, while it takes steps to vet software before it is incorporated into its proprietary software and monitor the software incorporated into its proprietary software, it cannot be certain that its programmers have not incorporated open-source software into its proprietary software that it intends to maintain as confidential or that they will not do so in the future. In addition, the wide availability of source code used in CoreWeave&#8217;s offerings could expose it to security vulnerabilities. Such use, under certain circumstances, could materially adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects, as well as its reputation, including if it is required to take remedial action that may divert resources away from its development efforts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On occasion, companies that use open-source software have faced claims challenging their use of open-source software or compliance with open-source license terms. There is evolving legal precedent for interpreting the terms of certain open-source licenses, including the determination of which works are subject to the terms of such licenses. The terms of many open-source licenses have not been interpreted by U.S. courts, and there is a risk that these licenses could be construed in ways that could impose unanticipated conditions or restrictions on CoreWeave&#8217;s ability to commercialize any offerings incorporating such software. Moreover, CoreWeave cannot ensure that its processes for controlling its use of open-source software in its platform will be effective. From time to time, CoreWeave may face claims from third parties asserting ownership of, or demanding release of, the open-source software or derivative works that it developed using such software (which could include its proprietary source code), or otherwise seeking to enforce the terms of the applicable open-source license. These claims, regardless of validity, could result in time consuming and costly litigation, divert management&#8217;s time and attention away from developing the business, expose it to customer indemnity claims, or force it to disclose source code. Litigation could be costly for it to defend, result in paying damages, entering into unfavorable licenses, have a negative effect on CoreWeave&#8217;s business, operating results. financial condition, and prospects, or cause delays by requiring it to devote additional research and development resources to change its solution. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Risks Related to Legal and Regulatory Matters of CoreWeave </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">CoreWeave is subject to laws and regulations, including governmental export and import controls, sanctions, and anti-corruption laws, that could impair its ability to compete in its markets and subject it to liability if it is not in full compliance with applicable laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is subject to laws and regulations, including governmental export and import controls, that could subject it to liability or impair its ability to compete in its markets. CoreWeave&#8217;s platform and related technology are subject to U.S. export controls, including the U.S. Department of Commerce&#8217;s Export Administration Regulations (also known as &#8220;EAR&#8221;), and it and its employees, representatives, contractors, agents, intermediaries, and other third parties are also subject to various economic and trade sanctions regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control and other U.S. government agencies. Changes to sanctions and export or import restrictions in the jurisdictions in which CoreWeave operates could further impact its ability to do business in certain parts of the world and to do business with certain persons and entities, which could adversely affect its business, operating results, financial condition, and prospects. In particular, CoreWeave is continuing to monitor recent and forthcoming developments in export controls with respect to the semiconductor industry and their impact on its sourcing of equipment for its computing infrastructure. In addition, CoreWeave is monitoring the January&#160;29, 2024 proposed rule from the U.S. Department of Commerce, Bureau of Industry and Security (&#8220;BIS&#8221;), which if implemented as proposed, would impose requirements on Infrastructure-as-a-Service providers and their foreign resellers to verify the identity and beneficial ownership of foreign person customers and to perform related reporting to BIS, as well as provide BIS authority to restrict certain Infrastructure-as-a-Service transactions with foreign persons. While CoreWeave has implemented certain procedures to facilitate compliance with applicable laws and regulations, it cannot ensure that these procedures are fully effective or that it, or third parties who it does not control, have complied with all laws or regulations in this regard. Failure by CoreWeave&#8217;s employees, representatives, contractors, partners, agents, intermediaries, or other third parties to comply with applicable laws and regulations also could have negative consequences to it, including reputational harm, government investigations, loss of export privileges and penalties. Changes in CoreWeave&#8217;s platform, and changes in or promulgation of new export and import regulations, may create delays in the introduction of its platform into international markets, prevent its customers with international operations from deploying its platform globally or, in some cases, prevent the export or import of its platform to certain countries, governments, or persons altogether. Any change in export or import regulations, economic sanctions, or related legislation, shift in the enforcement or scope of existing regulations, or change in the countries, governments, persons, or technologies targeted by such regulations, could result in decreased sales of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">69<br></div></div></div>
<!--End Page 80-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 81-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg43"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s platform, solutions, and services, or in its decreased ability to export or sell its platform, to existing or potential customers with international operations. Any decreased sales of CoreWeave&#8217;s platform, solutions, and services or limitation on its ability to export or sell its platform would adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is also subject to the United States Foreign Corrupt Practices Act of 1977, as amended (&#8220;FCPA&#8221;), the United Kingdom Bribery Act 2010 (the &#8220;Bribery Act&#8221;), and other anti-corruption, sanctions, anti-bribery, anti-money laundering, and similar laws in the United States and other countries in which it conducts activities. Anti-corruption and anti-bribery laws, which have been enforced aggressively and are interpreted broadly, prohibit companies and their employees, agents, intermediaries, and other third parties from promising, authorizing, making, or offering improper payments or other benefits to government officials and others in the public, and in certain cases, private sector. CoreWeave leverages third parties, including intermediaries and agents, to conduct its business in the United States and abroad, to sell its platform. CoreWeave and these third parties may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities and it may be held liable for the corrupt or other illegal activities of these third-party business partners and intermediaries, its employees, representatives, contractors, partners, agents, intermediaries, and other third parties, even if it does not explicitly authorize such activities. CoreWeave cannot ensure that its policies and procedures to address compliance with FCPA, the Bribery Act, and other anti-corruption, sanctions, anti-bribery, anti-money laundering, and similar laws, will be effective, or that all of its employees, representatives, contractors, partners, agents, intermediaries, or other third parties have not taken, or will not take actions, in violation of its policies and applicable law, for which it may be ultimately held responsible. As CoreWeave increases its international sales and business, its risks under these laws may increase. Noncompliance with these laws could subject it to investigations, severe criminal or civil sanctions, settlements, prosecution, loss of export privileges, suspension or debarment from U.S. government contracts, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, whistleblower complaints, adverse media coverage, and other consequences. Any investigations, actions, or sanctions could harm CoreWeave&#8217;s reputation, business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">CoreWeave is subject to laws, regulations, and industry requirements related to data privacy, data protection and information security, and user protection across different markets where it conducts its business and such laws, regulations, and industry requirements are constantly evolving and changing. Any actual or perceived failure to comply with such laws, regulations, and industry requirements, or its privacy policies, could harm CoreWeave&#8217;s business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Various local, state, federal, and international laws, directives, and regulations apply to CoreWeave&#8217;s collection, use, retention, protection, disclosure, transfer, and processing of personal information. These data protection and privacy laws and regulations are subject to uncertainty and continue to evolve in ways that could adversely impact CoreWeave&#8217;s business. These laws have a substantial impact on CoreWeave&#8217;s operations both in the United States and internationally and compliance with new and existing laws may result in significant costs due to implementation of new processes, which could ultimately hinder its ability to grow its business by extracting value from its data assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the United States, state and federal lawmakers and regulatory authorities have increased their attention on the collection and use of user data. For example, in California, the California Consumer Privacy Act of 2018 (as amended, the &#8220;CCPA&#8221;) requires companies that hit certain broad revenue or data processing related thresholds to, among other things, provide new disclosures to California users, and affords such users new privacy rights such as the ability to opt-out of certain processing of personal information and expanded rights to access and require deletion of their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is collected, used, and shared. The CCPA provides for civil penalties for violations, as well as a private right of action for security breaches that may increase security breach litigation. In addition, other states have enacted laws that contain obligations similar to the CCPA that have taken effect or will take effect in coming years and many others continue to propose similar laws, or are considering proposing similar laws. CoreWeave cannot fully predict the impact of recently proposed or enacted laws or regulations on its business or operations, but compliance may require it to modify its data processing practices and policies incurring costs and expense. Further, to the extent multiple state-level laws are introduced with inconsistent or conflicting standards, it may require costly and difficult efforts to achieve compliance with such laws. CoreWeave&#8217;s failure or perceived </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">70<br></div></div></div>
<!--End Page 81-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 82-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg44"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">failure to comply with state or federal privacy laws or regulations passed in the future could have a material adverse effect on its business, including how it uses personal information, its business, operating results, financial condition, and prospects and could expose it to regulatory investigations or possible fines. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, many foreign countries and governmental bodies, including the European Union, United Kingdom, Canada, and other jurisdictions in which CoreWeave operates or conducts its business, have laws and regulations concerning the collection, use, processing, storage, and deletion of personal data obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Such laws and regulations may require companies to implement new privacy and security policies, permit individuals to access, correct, and delete personal information stored or maintained by such companies, inform individuals of security breaches that affect their personal information, require that certain types of data be retained on local servers within these jurisdictions, and, in some cases, obtain individuals&#8217; affirmative opt-in consent to collect and use personal information for certain purposes. The increased focus on data sovereignty and data localization requirements around the world could also impact CoreWeave&#8217;s business model with respect to the storage, management, and transfer of data. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is subject to the European Union&#8217;s General Data Protection Regulation and the United Kingdom&#8217;s General Data Protection Regulation (collectively, the &#8220;GDPR&#8221;), which comprehensively regulate its use of personal data, including cross-border transfers of personal data out of the European Economic Area (&#8220;EEA&#8221;) and the U.K. The GDPR imposes stringent privacy and data protection requirements, and could increase the risk of non-compliance and the costs of providing CoreWeave&#8217;s services in a compliant manner. A breach of the GDPR could result in regulatory investigations, reputational damage, fines and sanctions, orders to cease or change CoreWeave&#8217;s processing of its data, enforcement notices, or assessment notices (for a compulsory audit). For example, if regulators assert that CoreWeave has failed to comply with the GDPR, it may be subject to fines. Since CoreWeave is subject to the supervision of relevant data protection authorities under multiple legal regimes (including separately in both the E.U.&#160;and the U.K.), it could be fined under those regimes independently in respect of the same breach. CoreWeave may also face civil claims including representative actions and other class action type litigation (where individuals have suffered harm), potentially amounting to significant compensation or damages liabilities, as well as associated costs, diversion of internal resources, and reputational harm. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The GDPR prohibits transfers of personal data from the EEA or U.K. to countries not formally deemed adequate by the European Commission or the U.K. Information Commission Office, respectively, including the United States, unless a particular compliance mechanism (and, if necessary, certain safeguards) is implemented. The mechanisms that CoreWeave and many other companies, including its customers, rely upon for European and U.K. data transfers (for example, Standard Contractual Clauses or the E.U.-U.S. Data Privacy Framework) are the subject of legal challenge, regulatory interpretation, and judicial decisions by the Court of Justice of the European Union. The suitability of Standard Contractual Clauses for data transfer in some scenarios has recently been the subject of legal challenge, and while the United States and the European Union reached agreement on the E.U.-U.S. Data Privacy Framework (and similar agreements were reached with respect to the U.K.), there are legal challenges to that data transfer mechanism as well. CoreWeave expects the legal complexity and uncertainty regarding international personal data transfers to continue, and as the regulatory guidance and enforcement landscape in relation to data transfers continues to develop, it could suffer additional costs, complaints, and/or regulatory investigations or fines; it may have to stop using certain tools and vendors and make other operational changes; it may have to implement alternative data transfer mechanisms under the GDPR and/or take additional compliance and operational measures; and/or it could otherwise affect the manner in which it provides its services, and could adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is also subject to evolving U.S., E.U., and U.K. privacy laws governing cookies, tracking technologies, and e-marketing. In the United States, plaintiffs are increasingly making use of existing laws such as the California Invasion of Privacy Act to litigate use of tracking technologies. In the European Union, regulators are increasingly focusing on compliance with requirements in the online behavioral advertising ecosystem. In the European Union, informed consent, including a prohibition on pre-checked consents and a requirement to ensure separate consents for each cookie, is required for the placement of a non-essential cookie or similar technologies on a user&#8217;s device and for direct electronic marketing. As regulators start to enforce the strict approach in recent guidance, this could lead to substantial costs, require significant systems changes, limit the effectiveness of CoreWeave&#8217;s marketing activities, divert the attention of its technology personnel, negatively impact its efforts to understand users, adversely affect its margins, increase costs, and subject it to additional liabilities. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">71<br></div></div></div>
<!--End Page 82-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 83-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg45"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There is a risk that as CoreWeave expands, it may assume liabilities for breaches experienced by the companies it acquires. Additionally, there are potentially inconsistent world-wide government regulations pertaining to data protection and privacy. Despite CoreWeave&#8217;s efforts to comply with applicable laws, regulations and other obligations relating to privacy, data protection, and information security, it is possible that its practices, offerings, or platform could fail, or be alleged to fail to meet applicable requirements. For instance, there are changes in the regulatory landscape relating to new and evolving technologies, such as generative AI. Changes to existing regulations, their interpretation or implementation, or new regulations could impede any potential use or development of AI Technologies, which could impair CoreWeave&#8217;s competitive position and result in an adverse effect on its business, operating results, financial condition, and prospects. CoreWeave&#8217;s failure, or the failure by its third-party providers or partners, to comply with applicable laws or regulations and to prevent unauthorized access to, or use or release of personal information, or the perception that any of the foregoing types of failure has occurred, even if unfounded, could subject it to audits, inquiries, whistleblower complaints, adverse media coverage, investigations, severe criminal, or civil sanctions, damage its reputation, or result in fines or proceedings by governmental agencies and private claims and litigation, any of which could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s business is subject to a wide range of laws and regulations, and its failure to comply with those laws and regulations could harm its business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s business is subject to regulation by various federal, state, local, and foreign governmental agencies, including agencies responsible for monitoring and enforcing employment and labor laws, workplace safety and environmental laws, including those related to energy usage and energy efficiency requirements, privacy and data protection laws, AI, financial services laws, anti-bribery laws, sanctions, national security, import and export controls, anti-boycott, federal securities laws, and tax laws and regulations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For example, government authorities have in the past sought to restrict data center development based on environmental considerations and have imposed moratoria on data center development, citing concerns about energy usage, requiring new data centers to meet energy efficiency requirements. CoreWeave may face higher costs from any laws requiring enhanced energy efficiency measures, changes to cooling systems, caps on energy usage, land use restrictions, limitations on back-up power sources, or other environmental requirements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In certain foreign jurisdictions, these regulatory requirements may be more stringent than those in the United&#160;States. These laws and regulations are subject to change over time and thus CoreWeave must continue to monitor and dedicate resources to ensure continued compliance. In particular, the global AI regulatory environment continues to evolve as regulators and lawmakers have started proposing and adopting, or are currently considering, regulations and guidance specifically on the use of AI. Non-compliance with applicable regulations or requirements could subject CoreWeave to investigations, sanctions, mandatory product recalls, enforcement actions, disgorgement of profits, fines, damages, civil and criminal penalties, or injunctions and jail time for responsible employees and managers. If any governmental sanctions are imposed, or if CoreWeave does not prevail in any possible civil or criminal litigation, its business, operating results, financial condition, and prospects could be materially adversely affected. In addition, responding to any action will likely result in a significant diversion of management&#8217;s attention and resources and an increase in professional fees. Enforcement actions and sanctions could harm CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">CoreWeave may become involved in litigation that may adversely affect it. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, CoreWeave may be subject to claims, suits, and other proceedings. Regardless of the outcome, legal proceedings can have an adverse impact on it because of legal costs and diversion of management attention and resources, and could cause it to incur significant expenses or liability, adversely affect its brand recognition, or require it to change its business practices. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change, and could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. It is possible that a resolution of one or more such proceedings could result in substantial damages, settlement costs, fines, and penalties that would adversely affect CoreWeave&#8217;s business, financial condition, operating results, or cash flows in a particular period. These proceedings could also result in reputational harm, sanctions, consent decrees, or orders requiring a change in CoreWeave&#8217;s business practices. Because of the potential risks, expenses, and uncertainties of litigation, CoreWeave may, from time to time, settle disputes, even where it has meritorious claims or defenses, by agreeing to settlement agreements. Because litigation is inherently unpredictable, CoreWeave cannot ensure that the results of any of these actions will not have a material adverse effect on its business, operating results, financial condition, and prospects. Any of these consequences could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">72<br></div></div></div>
<!--End Page 83-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 84-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg46"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Risks Related to Financial and Accounting Matters of CoreWeave </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">CoreWeave has identified material weaknesses in its internal control over financial reporting. If CoreWeave&#8217;s remediation of such material weaknesses is not effective, or if it experiences additional material weaknesses in the future or otherwise fails to develop and maintain effective internal control over financial reporting, its ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave are subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act of 2002 (the&#160;&#8220;Sarbanes-Oxley Act&#8221;), and the rules and regulations of the applicable listing standards of the Nasdaq. CoreWeave expects that the requirements of these rules and regulations will continue to increase its legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming, and costly, and place significant strain on its personnel, systems, and resources. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Sarbanes-Oxley Act requires, among other things, that CoreWeave maintain effective disclosure controls and procedures, and internal control, over financial reporting. CoreWeave is continuing to develop and refine its disclosure controls, internal control over financial reporting, and other procedures that are designed to ensure information required to be disclosed by it in its financial statements and in the reports that it will file with the SEC&#160;is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and information required to be disclosed in reports under the Exchange Act is accumulated and communicated to its principal executive and financial officers. In order to maintain and improve the effectiveness of CoreWeave&#8217;s internal controls and procedures, it has expended, and anticipates that it will continue to expend, significant resources, including accounting-related costs and significant management oversight. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is required to maintain internal control over financial reporting and to evaluate and determine the effectiveness of its internal control over financial reporting. Beginning with CoreWeave&#8217;s annual report on Form&#160;10-K for the year ending December&#160;31, 2026, it will be required to provide a management report on internal control over financial reporting, and it also expects its independent registered public accounting firm will be required to formally attest to the effectiveness of its internal control over financial reporting. Neither CoreWeave nor its independent registered public accounting firm were required to, and therefore did not, perform an evaluation of its internal control over financial reporting as of or for any period included in its financial statements, nor any period subsequent in accordance with the provisions of the Sarbanes-Oxley Act. However, while preparing the financial statements that are included in the Prospectus, CoreWeave identified material weaknesses in its internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in CoreWeave&#8217;s control over financial reporting such that there is a reasonable possibility that a material misstatement of its annual or interim financial statements will not be prevented or detected on a timely basis. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The material weaknesses identified pertained to the lack of effectively designed, implemented, and maintained IT general controls over applications that support CoreWeave&#8217;s financial reporting processes, insufficient segregation of duties across financially relevant functions, and lack of sufficient number of qualified personnel within its accounting, finance, and operations functions who possessed an appropriate level of expertise to provide reasonable assurance that transactions were being appropriately recorded and disclosed. CoreWeave has concluded that these material weaknesses existed because it did not have the necessary business processes, systems, personnel, and related internal controls. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, management had completed the following remedial actions to help address these material weaknesses: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">consulted with experts on technical accounting matters, internal controls, and in the preparation of its financial statements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">performed a risk assessment over the organization and IT systems used as part of financial reporting and business processes, including the various layers of technology; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">hired additional accounting, finance, and operations resources, including critical leadership roles with public company and internal control experience responsible for designing, implementing, and monitoring its internal controls, including the Chief Accounting Officer, Chief Operating Officer, and Chief&#160;Information Officer. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">73<br></div></div></div>
<!--End Page 84-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 85-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg47"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While management has made improvements to CoreWeave&#8217;s control environment and business processes to support and scale with its growing operations, the identified material weaknesses remain un-remediated. CoreWeave expects that its remediation efforts will continue to take place in 2025 and 2026, and include the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">designing, developing, and deploying an enhanced IT General Controls (&#8220;ITGC&#8221;) framework, including the implementation of a number of systems, processes and tools to enable the effectiveness and consistent execution of these controls; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continuing to implement ITGCs to manage access and program changes within its IT environment and to support the evaluation, monitoring, and ongoing effectiveness of key applications and key reports; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continuing to implement processes and controls to better manage and monitor its segregation of duties risks, including enhancing the usage of technology and tools for segregation of duties within CoreWeave&#8217;s systems, applications and tools; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continuing to expand its resources with the appropriate level of expertise within its accounting, finance, and operations functions; to implement, monitor, and maintain business processes and ITGCs. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may not be able to fully remediate these material weaknesses until these steps have been completed and the internal controls have been operating effectively for a sufficient period of time. This evaluation process, including testing the effectiveness of the remediation efforts, is expected to extend into 2026. Additionally, as stated above, CoreWeave has not performed an evaluation of its internal control over financial reporting; accordingly, it cannot ensure that it has identified all, or that it will not in the future have additional, material weaknesses. Further, to the extent CoreWeave acquires other businesses, the acquired company may not have a sufficiently robust system of internal controls and it may uncover new deficiencies. Material weaknesses may still exist when CoreWeave reports on the effectiveness of its internal control over financial reporting as required under Section&#160;404 of the Sarbanes-Oxley Act, beginning with its annual report on Form&#160;10-K for the year ending December&#160;31, 2026. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The process of designing and implementing internal control over financial reporting required to comply with the disclosure and attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act will be time consuming and costly. If during the evaluation and testing process CoreWeave identifies additional material weaknesses in its internal control over financial reporting or determine that existing material weaknesses have not been remediated, its management will be unable to assert that its internal control over financial reporting is effective. Even if CoreWeave&#8217;s management concludes that its internal control over financial reporting is effective, its independent registered public accounting firm may conclude that there are material weaknesses with respect to its internal control over financial reporting. If CoreWeave is unable to assert that its internal control over financial reporting is effective, or when required in the future, if its independent registered public accounting firm is unable to express an unqualified opinion as to the effectiveness of its internal control over financial reporting, investors may lose confidence in the accuracy and completeness of its financial reports, the market price of its stock could be adversely affected and it could become subject to litigation or investigations by the stock exchange on which its securities are listed, the SEC, or other regulatory authorities, which could require additional financial and management resources. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, as a public company, significant resources and management oversight are required. As a result, management&#8217;s attention may be diverted from other business concerns, which could harm CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">CoreWeave incurs significant costs and management resources as a result of operating as a public company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a public company, CoreWeave will incur significant legal, accounting, compliance, and other expenses that it did not incur as a private company. CoreWeave&#8217;s management and other personnel dedicate a substantial amount of time and incur significant expense in connection with compliance initiatives. As a public company, CoreWeave bears all of the internal and external costs of preparing and distributing periodic public reports in compliance with its obligations under the U.S. securities laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act, and the related rules and regulations implemented by the SEC have increased legal and financial compliance costs and will make some compliance activities more time-consuming. CoreWeave has invested, and will continue to invest, resources to comply with evolving laws, regulations, and standards, and this investment has resulted, and will continue to result, in increased general and administrative expenses and may divert management&#8217;s time and attention from its other business activities. If CoreWeave&#8217;s efforts to comply with new laws, regulations, and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">74<br></div></div></div>
<!--End Page 85-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 86-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg48"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against it, and its business may be harmed. In connection with CoreWeave&#8217;s IPO, it increased its directors&#8217; and officers&#8217; insurance coverage, which increased its insurance-related cost. In the future, it may be more expensive or more difficult for CoreWeave to obtain director and officer liability insurance, and it may be required to accept reduced coverage or incur substantially higher costs to obtain and maintain the same or similar coverage. These factors would also make it more difficult for CoreWeave to attract and retain qualified members of its board of directors, particularly to serve on its audit committee and compensation committee, and qualified executive officers. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave may be required to repurchase a significant number of its outstanding shares of Class&#160;A common stock for cash upon the exercise of certain holders&#8217; &#8220;put&#8221; rights, which would affect its financial condition and its ability to operate its business, as well as divert its cash flow from operations for such repurchases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">29,874,066 shares of CoreWeave&#8217;s Class&#160;A common stock were issued to holders of its Series&#160;C convertible preferred stock upon conversion thereof (the &#8220;Put Shares&#8221;) in connection with CoreWeave&#8217;s initial public offering in March&#160;2025 (the &#8220;IPO&#8221;) and are subject to a right to be &#8220;put&#8221; to it (the &#8220;Put Right&#8221;) on the first trading day immediately after March&#160;31, 2027, which is the second anniversary of the closing of its IPO (the &#8220;Public Sale Date&#8221;). Upon exercise of the Put Right, holders of the Put Shares would be entitled to receive from it an amount in cash equal to the original issue price per share of the Series&#160;C convertible preferred stock, which was $38.95 (the &#8220;Series&#160;C&#160;OIP&#8221;), representing an aggregate payment of $1.2&#160;billion. The Put Right will automatically terminate (on&#160;a share by share basis) on the date on which (i) such share is assigned, sold or transferred publicly or (ii) its Class&#160;A common stock has a 20 day volume-weighted average price in any consecutive 30 trading day period of at least&#160;175%&#160;of the Series&#160;C OIP at any point on or prior to the Public Sale Date during which Coatue Management, L.L.C. is not subject to a contractual lock-up agreement (clauses (i) and (ii) collectively, an &#8220;Exercise Termination Event&#8221;). If (i) there is a sale of CoreWeave prior to the Public Sale Date and (ii) there has not yet occurred an Exercise Termination Event, the Class&#160;A common stockholders still holding Put Shares shall be entitled in such sale transaction to receive the greater of (x) the consideration received per share the holders of its Class&#160;A common stock are entitled to receive in such sale transaction and (y) an amount in cash equal to the Series&#160;C OIP per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may not have enough available cash at the time it is required to repurchase the Put Shares, and it may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity or debt capital on terms that may be onerous or highly dilutive in order to make these repurchases. Further, any payments of cash used to repurchase the Put Shares will divert CoreWeave&#8217;s cash flow from its business operations and could impact its business initiatives. Any significant repurchase of the Put Shares would adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave could be subject to additional tax liabilities and United States federal and global income tax reform could adversely affect it. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is subject to U.S. federal, state, and local income taxes, sales, and other taxes in the United States and income taxes, withholding taxes, transaction taxes and other taxes in numerous foreign jurisdictions. Significant judgment is required in evaluating CoreWeave&#8217;s tax positions and its worldwide provision for income taxes. During the ordinary course of business, there are many activities and transactions for which the ultimate tax determination is uncertain. In addition, CoreWeave&#8217;s future income tax obligations could be adversely affected by changes in, or interpretations of, tax laws in the United States or in other jurisdictions in which it operates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For example, the United States tax law legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 significantly reformed the Internal Revenue Code of 1986, as amended (the &#8220;Internal Revenue Code&#8221;), reducing U.S.&#160;federal tax rates, making sweeping changes to rules governing international business operations, and imposing significant additional limitations on tax benefits, including the deductibility of interest and the use of net operating loss (&#8220;NOL&#8221;) carryforwards. Effective from CoreWeave&#8217;s taxable years beginning January&#160;1, 2022 through its taxable year beginning January&#160;1, 2024, the Tax Cuts and Jobs Act also required capitalization of research and certain software development expenses and amortization of such expenses over a period of five years if incurred in the United States and fifteen years if incurred outside the United States. On August&#160;16, 2022, President Biden signed the Inflation Reduction Act of 2022 (the &#8220;IRA&#8221;) into law. The IRA contains certain tax measures, including a corporate alternative minimum tax of 15% on some large corporations and an excise tax of 1% on certain corporate stock buy-backs taking place after December&#160;31, 2022. On July&#160;4, 2025, the legislation commonly referred to as the One&#160;Big Beautiful Bill Act (the &#8220;OBBBA&#8221;) was signed into law. The OBBBA amends key provisions of the tax code, including modifications to bonus </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">75<br></div></div></div>
<!--End Page 86-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 87-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg49"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">depreciation, domestic research cost expensing, and the business interest expense limitation. CoreWeave is still evaluating any changes required to its financial statements as a result of the OBBBA, which will be reflected on CoreWeave&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended September&#160;30, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the Organization for Economic Cooperation and Development (&#8220;OECD&#8221;) Inclusive Framework of 137 jurisdictions have joined a two-pillar plan to reform international taxation rules. The first pillar is focused on the allocation of taxing rights between countries for in-scope multinational enterprises that sell goods and services into countries with little or no local physical presence and is intended to apply to multinational enterprises with global&#160;turnover above &#8364;20&#160;billion. The second pillar is focused on developing a global minimum tax rate of at least&#160;15% applicable to in-scope multinational enterprises and is intended to apply to multinational enterprises with annual consolidated group revenue in excess of &#8364;750&#160;million. CoreWeave is still evaluating the impact of the OECD&#160;pillar one and pillar two rules as they continue to be refined by the OECD and implemented by various national governments. However, it is possible that the OECD pillar one and pillar two rules, as implemented by various national governments, could adversely affect CoreWeave&#8217;s effective tax rate or result in higher cash tax liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Due to the expanding scale of CoreWeave&#8217;s international business activities, these types of changes to the taxation of its activities could impact the tax treatment of its foreign earnings, increase its worldwide effective tax&#160;rate, increase the amount of taxes imposed on its business, and harm its financial position. Such changes may also apply retroactively to its historical operations and result in taxes greater than the amounts estimated and recorded in its financial statements. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">CoreWeave&#8217;s ability to use its net operating loss carryforwards and certain other tax attributes may be limited. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2024, CoreWeave had aggregate U.S. federal and state NOL carryforwards of $3.6&#160;billion and $61&#160;million, respectively, which may be available to offset future taxable income for U.S. income tax purposes. As of December&#160;31, 2024, CoreWeave had $3.6&#160;billion in federal NOL carryforwards, almost all of which can be carried forward indefinitely. As of December&#160;31, 2024, CoreWeave had state NOL carryforwards of $61&#160;million, of which $30&#160;million can be carried forward indefinitely. If the NOL carryforwards are not utilized, $31&#160;million will expire in varying amounts between the years 2032 and 2044. As of December&#160;31, 2024, CoreWeave had foreign NOL&#160;carryforwards of $5&#160;million that can be carried forward indefinitely. Realization of these net operating loss and research and development credit carryforwards depends on CoreWeave&#8217;s future taxable income, and there is a risk that certain of its existing carryforwards could expire unused and be unavailable to offset future income tax liabilities, which could adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, under Sections 382 and 383 of the Internal Revenue Code, if a corporation undergoes an &#8220;ownership&#160;change,&#8221; generally defined as a greater than 50% cumulative change (by value) in ownership by &#8220;5&#160;percent shareholders&#8221; over a rolling three-year period, the corporation&#8217;s ability to use its pre-change NOLs and other pre-change tax attributes, such as research and development credits, to offset its post-change income or taxes may be limited. CoreWeave has experienced, and may in the future experience, ownership changes as a result of shifts in its stock ownership. As a result, if CoreWeave earns net taxable income, its ability to use its pre-change U.S. NOL carryforwards and other tax attributes to offset U.S. federal taxable income may be subject to limitations, which could potentially result in increased future tax liability to it. In addition, CoreWeave may undergo additional ownership changes in the future, which could further limit its ability to use its NOLs and other pre-change tax attributes. Similar provisions of state tax law may also apply to limit CoreWeave&#8217;s use of accumulated state tax NOLs. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase CoreWeave&#8217;s state income tax liabilities. As a result of the foregoing, even if CoreWeave attains profitability, it may be unable to use all or a material portion of its net operating losses and other tax attributes, which could adversely affect its future cash flows. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave could be required to collect additional sales, use, value added, digital services, or other similar taxes or be subject to other liabilities with respect to past or future sales, that may increase the costs its customers would have to pay for its solutions and adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave does not collect sales and use, value added, or similar taxes in all jurisdictions in which it has sales because it has determined in consultation with its advisors that its sales in certain jurisdictions are not subject to such taxes. Sales and use, value added, and similar tax laws and rates vary greatly by jurisdiction and the application of such laws is subject to uncertainty. Jurisdictions in which it does not collect such taxes may assert that such taxes apply to its sales and seek to impose incremental or new sales, use, value added, digital services, or assert other tax </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">76<br></div></div></div>
<!--End Page 87-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 88-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg50"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">collection obligations on it, which could result in tax assessments, penalties, and interest, to it or its customers for past sales, and it may be required to collect such taxes in the future. If CoreWeave is unsuccessful in collecting such taxes from its customers, it could be held liable for such costs, which may adversely affect its operating results. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Further, an increasing number of U.S. states have considered or adopted laws that attempt to impose tax collection obligations on out-of-state companies. A successful assertion by one or more U.S. states requiring CoreWeave to collect taxes where it presently does not do so, or to collect more taxes in a jurisdiction in which it currently collects such taxes, could result in substantial liabilities, including taxes on past sales, as well as interest and penalties. Furthermore, certain jurisdictions, such as the U.K., France, and Canada, have enacted a digital services tax, which is generally a tax on gross revenue generated from users or customers located in those jurisdictions, and other jurisdictions are considering enacting similar laws. A successful assertion by a U.S. state or local government or a foreign jurisdiction that CoreWeave should have been or should be collecting additional sales, use, value added, digital services, or other similar taxes could, among other things, result in substantial tax payments, create significant administrative burdens for it, discourage potential customers from using its platform due to the incremental cost of any such sales or other related taxes, or otherwise harm its business. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s corporate structure and intercompany arrangements are subject to the tax laws of various jurisdictions, and it could be obligated to pay additional taxes, which would harm its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave is expanding its international operations and staff to support its business and growth in international markets. CoreWeave generally conducts its international operations through wholly-owned subsidiaries and is or may be required to report its taxable income in various jurisdictions worldwide based upon its business operations in those jurisdictions. CoreWeave&#8217;s corporate structure and associated transfer pricing policies contemplate future growth in international markets, and consider the functions, risks, and assets of the various entities involved in intercompany transactions. Furthermore, increases in tax rates, new or revised tax laws, and new interpretations of existing tax laws and policies by tax authorities and courts in various jurisdictions, could result in an increase in CoreWeave&#8217;s overall tax obligations which could adversely affect its business. CoreWeave&#8217;s intercompany relationships and intercompany transactions are subject to complex transfer pricing rules administered by tax authorities in various jurisdictions in which it operates with potentially divergent tax laws. The amount of taxes CoreWeave pays in different jurisdictions will depend on the application of the tax laws of the various jurisdictions, including the United States, to its intercompany transactions, international business activities, changes in tax rates, new or revised tax laws or interpretations of existing tax laws (which may have retroactive effect) and policies by tax authorities and courts in various jurisdictions, and its ability to operate its business in a manner consistent with its corporate structure and intercompany arrangements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It is not uncommon for tax authorities in different countries to have conflicting views, for instance, with respect to, among other things, the manner in which the arm&#8217;s length standard is applied for transfer pricing purposes, the transfer pricing and charges for intercompany services and other intercompany transactions, or with respect to the valuation of CoreWeave&#8217;s intellectual property and the manner in which its intellectual property is utilized within its group. If tax authorities in any of the jurisdictions in which CoreWeave conducts its international operations were to successfully challenge its transfer pricing, it could be required to reallocate part or all of its income to reflect transfer pricing adjustments, which could result in an increased tax liability for it. In such circumstances, if the country from where the income was reallocated did not agree to the reallocation, it could become subject to tax on the same income in both countries, resulting in double taxation. Furthermore, the relevant tax authorities may disagree with CoreWeave&#8217;s determinations as to the income and expenses attributable to specific jurisdictions. CoreWeave believes that its tax and financial accounting positions are reasonable and its tax reserves are adequate to cover any potential liability. CoreWeave also believes that its assumptions, judgments, and estimates are reasonable and that its transfer pricing for these intercompany transactions are on arm&#8217;s-length terms. However, the relevant tax authorities may disagree with CoreWeave&#8217;s tax positions, including any assumptions, judgments, or estimates used for these transfer pricing matters and intercompany transactions. If any of these tax authorities determine that CoreWeave&#8217;s transfer pricing for these intercompany transactions does not meet arm&#8217;s-length criteria, and were successful in challenging its positions, it could be required to pay additional taxes, interest, and penalties related thereto, which could be in excess of any reserves established therefor, and which could result in higher effective tax rates, reduced cash flows, and lower overall profitability of its operations. CoreWeave&#8217;s financial statements could fail to reflect adequate reserves to cover such a contingency. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">77<br></div></div></div>
<!--End Page 88-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 89-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg51"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may be audited in various jurisdictions, including in jurisdictions in which it is not currently filing, and such jurisdictions may assess new or additional taxes, sales taxes, and value added taxes against it. Although CoreWeave believes its tax estimates are reasonable, the final determination of any tax audits or litigation could be materially different from its historical tax provisions and accruals, which could have an adverse effect on its operating results or cash flows in the period or periods for which a determination is made. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">If CoreWeave&#8217;s estimates or judgments relating to its critical accounting policies prove to be incorrect or financial reporting standards or interpretations change, its operating results could be adversely affected. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in CoreWeave&#8217;s condensed consolidated financial statements and accompanying notes. CoreWeave bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, as discussed in the section titled &#8220;CoreWeave Inc. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Estimates.&#8221; The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities and equity, and the amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates used in preparing CoreWeave&#8217;s condensed consolidated financial statements include but are not limited to those related to the identification of performance obligations in revenue recognition, the valuation of stock-based awards, the valuation of derivatives and warrants, and accounting for leases, property and equipment, income taxes and variable interest entities. CoreWeave&#8217;s operating results may be adversely affected if its assumptions change or if actual circumstances differ from those in its assumptions, which could cause its operating results to fall below the expectations of industry or financial analysts and investors, resulting in a potential decline in the market price of its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, CoreWeave regularly monitors its compliance with applicable financial reporting standards and review new pronouncements and drafts thereof that are relevant to it. As a result of new standards, changes to existing standards, and changes in their interpretation, CoreWeave might be required to change its accounting policies, alter its operational policies, and implement new or enhance existing systems so that they reflect new or amended financial reporting standards, or it may be required to restate its published financial statements. For example, SEC proposals on climate-related disclosures may require CoreWeave to update its accounting or operational policies, processes, or systems to reflect new or amended financial reporting standards. Such changes to existing standards or changes in their interpretation may have an adverse effect on CoreWeave&#8217;s reputation, business, financial condition, and profit, or cause an adverse deviation from its revenue and operating profit target, which may adversely affect its financial results. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave is exposed to fluctuations in currency exchange rates, which could negatively affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s sales contracts are primarily denominated in U.S. dollars, and therefore a majority of its revenue is not subject to foreign currency risk. However, strengthening of the U.S. dollar increases the real cost of CoreWeave&#8217;s platform to its customers outside of the United States, which could lead to delays in the purchase of its platform and the lengthening of its sales cycle. If the U.S. dollar continues to strengthen, this could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. In addition, increased international sales in the future, including through continued international expansion, could result in foreign currency denominated sales, which would increase CoreWeave&#8217;s foreign currency risk. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s operating expenses incurred outside the United States and denominated in foreign currencies are increasing and are subject to fluctuations due to changes in foreign currency exchange rates. These expenses are denominated in foreign currencies and are subject to fluctuations due to changes in foreign currency exchange rates. CoreWeave does not currently hedge against the risks associated with currency fluctuations but may do so, or use other derivative instruments, in the future. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Risks Related to CoreWeave&#8217;s Indebtedness </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s substantial indebtedness could materially adversely affect its financial condition, its ability to raise additional capital to fund its operations, its ability to operate its business, its ability to react to changes in the economy or its industry, its ability to meet its obligations under its outstanding indebtedness and could divert its cash flow from operations for debt payments, and it may still incur substantially more indebtedness in the future. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has a substantial amount of debt, which requires significant interest and principal payments. As of June&#160;30, 2025, CoreWeave&#8217;s total indebtedness was $11.2&#160;billion and it had $3.7&#160;billion of undrawn availability under its Revolving Credit Facility and DDTL 2.0 Facility (each as defined below). In July&#160;2023, CoreWeave Compute Acquisition </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">78<br></div></div></div>
<!--End Page 89-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 90-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg52"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Co. II, LLC, CoreWeave&#8217;s direct, wholly owned subsidiary, entered into a delayed draw term loan facility (as amended, the &#8220;DDTL 1.0 Facility&#8221;) providing for up to $2.3&#160;billion in delayed draw term loans. In May&#160;2024, CoreWeave Compute Acquisition Co. IV, LLC, CoreWeave&#8217;s direct, wholly owned subsidiary, entered into a delayed draw term loan facility (as amended, the &#8220;DDTL 2.0 Facility&#8221;) providing for up to $7.6&#160;billion in delayed draw terms loans. In July&#160;2025, CoreWeave Compute Acquisition Co. V, LLC, CoreWeave&#8217;s direct, wholly owned subsidiary, and CoreWeave Compute Acquisition Co. VII, LLC, CoreWeave&#8217;s indirect subsidiary, entered into a delayed draw term loan facility (the &#8220;DDTL 3.0 Facility,&#8221; and, together with the DDTL 1.0 Facility and the DDTL 2.0 Facility, the &#8220;DDTL Facilities&#8221;) providing for up to $2.6&#160;billion in delayed draw term loans. All obligations under the DDTL Facilities are unconditionally guaranteed by CoreWeave. In May&#160;2025, CoreWeave amended its revolving credit facility to provide for a $1.5&#160;billion revolving credit facility (as amended, the &#8220;Revolving Credit Facility,&#8221; and, together with the DDTL Facilities, the &#8220;Credit Facilities&#8221;). As of June&#160;30, 2025, CoreWeave had entered into various agreements with original equipment manufacturers (&#8220;OEM&#8221;) and obtained financing for certain equipment with an aggregate notional balance of $2.2&#160;billion as of June&#160;30, 2025. In May&#160;2025, we issued $2.0&#160;billion in aggregate principal amount of the 2030 Notes (as defined herein). In July&#160;2025, CoreWeave issued $1.75&#160;billion in aggregate principal amount of the 2031 Notes (as defined herein). The Notes (as defined herein) are guaranteed on a senior unsecured basis by certain of CoreWeave&#8217;s wholly-owned subsidiaries and certain of its future direct and indirect wholly owned domestic restricted subsidiaries that guarantee the Revolving Credit Facility. In addition to CoreWeave&#8217;s substantial debt, it leases all of its data centers and certain equipment under lease agreements, some of which are accounted for as operating leases. As of June 30, 2025, CoreWeave recorded operating lease liabilities of $3.5&#160;billion, which represents its obligation to make lease payments under those lease arrangements. Subject to the limits contained in the credit agreements that govern its Credit Facilities and the indentures that govern the Notes, CoreWeave may be able to incur substantial additional debt from time to time to finance working capital, capital expenditures, investments or acquisitions, or for other purposes. If CoreWeave does so, the risks related to its high level of debt could increase. Specifically, CoreWeave&#8217;s high level of debt could have important consequences, including the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it may be difficult for CoreWeave to satisfy its obligations, including debt service requirements under its outstanding debt; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s ability to obtain additional financing for working capital, capital expenditures, debt service requirements, acquisitions, or other general corporate purposes may be impaired; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a substantial portion of cash flow from operations are required to be dedicated to the payment of principal and interest on CoreWeave&#8217;s indebtedness, therefore reducing its ability to use its cash flow to fund its operations, capital expenditures, future business opportunities, and other purposes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave could be more vulnerable to economic downturns and adverse industry conditions and its flexibility to plan for, or react to, changes in its business or industry is more limited; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s ability to capitalize on business opportunities and to react to competitive pressures, as compared to its competitors, may be compromised due to its high level of debt and the restrictive covenants in the credit agreements that govern its Credit Facilities and the indentures that govern the Notes; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CoreWeave&#8217;s ability to borrow additional funds or to refinance debt may be limited; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">it may cause potential or existing customers to not contract with CoreWeave due to concerns over its ability to meet its financial obligations under such contracts. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s ability to make scheduled payments on and to refinance its indebtedness depends on and is subject to its financial and operating performance, which in turn is affected by general and regional economic, financial, competitive, business and other factors, all of which are beyond its control, including the availability of financing in the international banking and capital markets. CoreWeave cannot ensure that its business will generate sufficient cash flow from operations or that future borrowings will be available to it in an amount sufficient to enable it to service its debt, to refinance its debt or to fund its other liquidity needs. For the six months ended June&#160;30, 2025, CoreWeave&#8217;s cash flows dedicated for debt service requirements totaled $1,996&#160;million, which includes principal payments of $1,575&#160;million and interest payments of $421&#160;million, inclusive of $59&#160;million related to capitalized interest. For the six months ended June&#160;30, 2025, CoreWeave&#8217;s net cash used in operating activities was $(190) million, which includes interest paid, net of capitalized amounts, of $362&#160;million. If CoreWeave&#8217;s cash flows and capital resources are insufficient to fund its debt service obligations, it could face substantial liquidity problems and could be forced to reduce or delay investments and capital expenditures or to dispose of material assets or operations, seek additional debt or equity capital or restructure or refinance its indebtedness. Further, any refinancing or restructuring of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">79<br></div></div></div>
<!--End Page 90-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 91-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg53"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s indebtedness could be at higher interest rates, may cause it to incur debt extinguishment costs, and may require it to comply with more onerous covenants that could further restrict its business operations. Moreover, in the event of a default, the holders of CoreWeave&#8217;s indebtedness could elect to declare such indebtedness be due and payable and/or elect to exercise other rights, such as the lenders under its Revolving Credit Facility terminating their commitments thereunder and ceasing to make further loans or the lenders under its DDTL Facilities instituting foreclosure proceedings against their collateral, any of which could materially adversely affect its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, financing through debt has historically been an important source of additional capital for CoreWeave, and it intends to continue to use debt as a source of financing in the future. As such, CoreWeave and its subsidiaries are able to incur additional debt and may be able to incur substantial additional debt in the future, subject to the restrictions contained in its debt instruments, some of which may be secured debt. CoreWeave&#8217;s existing debt agreements restrict its ability to incur additional indebtedness, including secured indebtedness, but if those restrictions are waived, or the Facilities or Notes mature or are repaid, it may not be subject to such restrictions under the terms of any subsequent indebtedness. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Furthermore, all of the debt under CoreWeave&#8217;s Credit Facilities bears interest at variable rates. If interest rates associated with CoreWeave&#8217;s floating rate debt (e.g., SOFR) increase, its debt service obligations on its Credit Facilities would increase even though the amount borrowed remained the same, and its net income and cash flows, including cash available for servicing its indebtedness, would correspondingly decrease. In addition, an increase in such interest rates could adversely affect CoreWeave&#8217;s future ability to obtain financing or materially increase the cost of any additional financing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave has issued letters of credit in favor of several of its third-party data center providers as a requirement to enter into leases for these facilities. These letters of credit are cash collateralized, these funds are reflected as restricted cash on CoreWeave&#8217;s condensed consolidated balance sheet, and it is limited in its ability to use these funds for its business operations. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Certain of CoreWeave&#8217;s debt agreements impose significant operating and financial restrictions on it and its subsidiaries, which may prevent it from capitalizing on business opportunities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The credit agreements that govern CoreWeave&#8217;s Credit Facilities, as well as the related parent guarantees, and the indentures that govern the Notes impose significant operating and financial restrictions on it. These restrictions will limit CoreWeave&#8217;s ability and/or the ability of its subsidiaries to, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">incur or guarantee additional debt or issue disqualified stock or preferred stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">pay dividends and make other distributions on, or redeem or repurchase, capital stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">make certain investments or acquisitions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">incur certain liens; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">enter into transactions with its affiliates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">merge or consolidate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">enter into agreements that restrict the ability of restricted subsidiaries to make dividends or other payments to the lenders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">prepay, redeem or repurchase any subordinated indebtedness or enter into amendments to certain subordinated indebtedness in a manner materially adverse to the lenders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">designate restricted subsidiaries as unrestricted subsidiaries; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">transfer or sell certain assets. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave is required to maintain specified financial covenant ratios and satisfy other financial condition tests under the credit agreements governing its Credit Facilities. As a result of these restrictions, CoreWeave is limited as to how it conducts its business, and it may be unable to raise additional debt or equity financing to compete effectively or to take advantage of new business opportunities. The terms of any future indebtedness CoreWeave may incur could include similar or more restrictive covenants. CoreWeave cannot ensure that it will be able to maintain compliance with these covenants in the future and, if it fails to do so, that it will be able to obtain waivers from the lenders and/or amend the covenants. CoreWeave&#8217;s failure to comply with the restrictive or financial </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">80<br></div></div></div>
<!--End Page 91-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 92-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg54"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">covenants described above as well as the terms of any future indebtedness could result in an event of default, which, if not cured or waived, could result in it being required to repay these borrowings before their due date. If CoreWeave is forced to refinance these borrowings on less favorable terms or is unable to refinance these borrowings, its business, operating results, financial condition, and prospects could be materially adversely affected. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Risks Related to Ownership of CoreWeave&#8217;s Class&#160;A Common Stock </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">The market price of CoreWeave&#8217;s Class&#160;A common stock may be volatile, and you could lose all or part of your investment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave cannot predict the prices at which its Class&#160;A common stock will continue to trade. The market price of CoreWeave&#8217;s Class&#160;A common stock depends on a number of factors, including those described in this &#8220;Risk&#160;Factors&#8221; section, many of which are beyond its control and may not be related to its operating performance. In addition, the limited public float of CoreWeave&#8217;s Class&#160;A common stock will tend to increase the volatility of the trading price of its Class&#160;A common stock. These fluctuations could cause you to lose all or part of your investment in CoreWeave&#8217;s Class&#160;A common stock. Factors that could cause fluctuations in the market price of CoreWeave&#8217;s Class&#160;A common stock include, but are not limited to, the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">actual or anticipated changes or fluctuations in CoreWeave&#8217;s operating results; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s incurrence of any additional indebtedness or any fluctuations in interest rates impacting its existing indebtedness; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the exercise by the former holders of CoreWeave&#8217;s Series&#160;C convertible preferred stock of the Put Right; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CoreWeave&#8217;s ability to produce timely and accurate financial statements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the financial projections CoreWeave may provide to the public, any changes in these projections, or its failure to meet these projections; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">announcements by CoreWeave or its competitors of new offerings or new or terminated significant contracts, commercial relationships, acquisitions, or capital commitments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">industry or financial analyst or investor reaction to CoreWeave&#8217;s press releases, other public announcements and filings with the SEC; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">rumors and market speculation involving CoreWeave or other companies in its industry; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">price and volume fluctuations in the overall stock market from time to time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the overall performance of the stock market or technology companies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the expiration of market standoff or contractual lock up agreements and sales of shares of CoreWeave&#8217;s Class&#160;A common stock by it or its stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">failure of industry or financial analysts to maintain coverage of CoreWeave, changes in financial estimates by any analysts who follow its company, or its failure to meet these estimates or the expectations of investors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">actual or anticipated developments in CoreWeave business or its competitors&#8217; businesses or the competitive landscape generally; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">litigation or other proceedings involving CoreWeave, its industry or both, or investigations by regulators into its operations or those of its competitors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">developments or disputes concerning CoreWeave&#8217;s intellectual property rights or its solutions, or third-party proprietary rights; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">new laws or regulations or new interpretations of existing laws or regulations applicable to CoreWeave&#8217;s business; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any major changes in CoreWeave&#8217;s management or its board of directors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the global political, economic, and macroeconomic climate, including but not limited to, actual or perceived instability in the banking industry, potential uncertainty with respect to the federal debt ceiling and budget </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">81<br></div></div></div>
<!--End Page 92-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 93-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg55"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">and potential government shutdowns related thereto, domestic and foreign regulatory uncertainty, changes in trade policies, including the imposition of tariffs, trade controls and other trade barriers, labor shortages, supply chain disruptions, potential recession, inflation, and rising interest rates; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other events or factors, including those resulting from war, armed conflict, including the conflicts in the Middle East and Ukraine and tensions between China and Taiwan, incidents of terrorism, or responses to these events; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">cybersecurity incidents. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies, particularly during the current period of global macroeconomic and geopolitical uncertainty. These economic, political, regulatory, and market conditions have and may continue to negatively impact the market price of CoreWeave&#8217;s Class&#160;A common stock, regardless of its actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market prices of a particular company&#8217;s securities, securities class action litigation has often been instituted against that company. Securities litigation, if instituted against CoreWeave, could result in substantial costs and divert its management&#8217;s attention and resources from its business. This could have an adverse effect on CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Sales of substantial amounts of CoreWeave&#8217;s Class&#160;A common stock in the public markets, or the perception that they might occur, could cause the market price of its Class&#160;A common stock to decline. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales of a substantial number of shares of CoreWeave&#8217;s Class&#160;A common stock into the public market, including shares of its Class&#160;A common stock held by its Co-Founders that have been converted from shares of its Class&#160;B common stock, and particularly sales by its directors, executive officers, and principal stockholders, or the perception that these sales might occur, could cause the market price of its Class&#160;A common stock to decline. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All of the shares of Class&#160;A common stock sold in the IPO are freely tradable without restrictions or further registration under the Securities Act, except that any shares held by CoreWeave&#8217;s affiliates, as defined in Rule&#160;144 under the Securities Act, would only be able to be sold in compliance with Rule&#160;144 and any applicable lock-up agreements described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, all of CoreWeave&#8217;s directors and executive officers, the selling stockholders, and certain other holders agreed, among other things, not to offer, sell or agree to sell, or otherwise dispose of interests in, directly or indirectly, any shares of CoreWeave&#8217;s common stock, subject to certain exceptions, without the prior written consent of Morgan Stanley &amp; Co. LLC, on behalf of the underwriters of the IPO, and Magnetar Financial LLC (the &#8220;Lock-Up Agreement&#8221;). Similarly, additional holders of CoreWeave&#8217;s Class&#160;A common stock were subject to market standoff provisions, pursuant to which such holders also agreed, among other things, not to offer, sell or agree to sell, or otherwise dispose of interests in, directly or indirectly, any shares of CoreWeave&#8217;s common stock following CoreWeave&#8217;s IPO, provided that such shares would be released from such restrictions to the extent such shares would be entitled to release under the Lock-Up Agreement. The Lock-Up Agreement expired on the close of trading on the second trading day after the date that CoreWeave publicly announced earnings for the three months ended June&#160;30, 2025. As a result, as of the close of trading on August&#160;14, 2025, such shares are freely tradable without restrictions or further registration under the Securities Act, subject to applicable vesting requirements and compliance with Rule&#160;144. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales of a substantial number of such shares, or the perception that such sales may occur, could cause CoreWeave&#8217;s market price to fall or make it more difficult for you to sell your Class&#160;A common stock at a time and price that you deem appropriate. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to CoreWeave&#8217;s third amended and restated investors&#8217; rights agreement, dated May&#160;16, 2024, certain holders of its Class&#160;A common stock can require it to file registration statements for the public resale of the Class&#160;A common stock held by them or to include such shares in registration statements that it may file for it or other stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave may also issue its shares of common stock or securities convertible into shares of its common stock from time to time in connection with a financing, acquisition, investment, or otherwise. Any further issuance could result in substantial dilution to CoreWeave&#8217;s existing stockholders and cause the market price of its Class&#160;A common stock to decline. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">82<br></div></div></div>
<!--End Page 93-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 94-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg56"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">The multi-class structure of CoreWeave&#8217;s common stock has the effect of concentrating voting power with its Co-Founders, which will limit your ability to influence the outcome of important transactions, including a change in control. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s Class&#160;B common stock has ten votes per share, its Class&#160;A common stock has one vote per share, and its Class&#160;C common stock has no votes per share. As of June&#160;30, 2025, CoreWeave&#8217;s Co-Founders collectively hold all of the issued and outstanding shares of its Class&#160;B common stock. Because of the ten-to-one voting ratio between CoreWeave&#8217;s Class&#160;B common stock and Class&#160;A common stock, its Co-Founders collectively continue to control a significant percentage of the combined voting power of its common stock, which voting power may increase over time upon the exercise or settlement and exchange of equity awards held by its Co-Founders pursuant to their equity exchange rights which provide each Co-Founder with the right (but not obligation) to require it to exchange, for shares of its Class&#160;B common stock, any shares of its Class&#160;A common stock received by him upon the exercise or settlement of equity awards for shares of its Class&#160;A common stock granted prior to September&#160;2024. Therefore, CoreWeave&#8217;s Co-Founders, individually or together, will be able to significantly influence matters submitted to its stockholders for approval, including the election of directors, amendments of its organizational documents and any merger, consolidation, sale of all or substantially all of its assets, or other major corporate transactions. CoreWeave&#8217;s Co-Founders, individually or together, may have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentrated control may have the effect of delaying, preventing, or deterring a change in control of CoreWeave, could deprive its stockholders of an opportunity to receive a premium for their capital stock as part of a sale of its company, and might ultimately affect the market price of its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Future transfers by the holders of Class&#160;B common stock will generally result in those shares converting into shares of Class&#160;A common stock, subject to limited exceptions, such as certain transfers effected for estate planning or charitable purposes. In addition, each share of Class&#160;B common stock will convert automatically into one share of Class&#160;A common stock upon the earlier of (i) a date that is fixed by CoreWeave&#8217;s board of directors that is no more than 61 days following the seventh anniversary of the IPO, or no later than May&#160;31, 2032, (ii) the date specified by the affirmative vote of two-thirds of the outstanding voting power of the Class&#160;B common stock, or (iii) no more than 61 days following the first date Mr.&#160;Intrator is no longer providing services that occupy substantially all of his working time and business efforts to CoreWeave as an officer, employee, or consultant, as determined by the board of directors (other than as a result of termination of Mr.&#160;Intrator&#8217;s employment without cause) (such conversion, the &#8220;Class&#160;B Automatic Conversion&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, future issuances of CoreWeave&#8217;s Class&#160;C common stock may further concentrate the voting power of its Co-Founders by prolonging the duration of their control and/or by giving them an opportunity to achieve liquidity without diminishing their voting power. See the section titled &#8220;&#8212;Any future issuance of CoreWeave&#8217;s Class&#160;C common stock may have the effect of further concentrating voting control in its Class&#160;B common stock, may discourage potential acquisitions of its business, and could have an adverse effect on the market price of its Class&#160;A common stock.&#8221; If CoreWeave is unable to effectively manage these risks, its business, operating results, financial condition, and prospects could be adversely affected. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: justify;">The multi-class structure of CoreWeave&#8217;s common stock may adversely affect the trading market for its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave cannot predict whether its multi-class structure will, over time, result in a lower or more volatile market price of its Class&#160;A common stock, adverse publicity, or other adverse consequences. Certain stock index providers exclude or limit the ability of companies with multi-class share structures from being added to certain of their indices. In addition, several stockholder advisory firms and large institutional investors oppose the use of multiple class structures. As a result, the multi-class structure of its common stock may make CoreWeave ineligible for inclusion in certain indices and may discourage such indices from selecting it for inclusion, notwithstanding its automatic termination provision, may cause stockholder advisory firms to publish negative commentary about its corporate governance practices or otherwise seek to cause it to change its capital structure, and may result in large institutional investors not purchasing shares of its Class&#160;A common stock. Given the sustained flow of investment funds into passive strategies that seek to track certain indices, any exclusion from certain stock indices could result in less demand for CoreWeave&#8217;s Class&#160;A common stock. Any actions or publications by stockholder advisory firms or institutional investors critical of CoreWeave&#8217;s corporate governance practices or capital structure could also adversely affect the value of its Class&#160;A common stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">83<br></div></div></div>
<!--End Page 94-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 95-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg57"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">If financial analysts issue inaccurate or unfavorable research regarding, or do not or cease to cover, CoreWeave&#8217;s Class&#160;A common stock, its stock price and trading volume could decline. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The trading market for CoreWeave&#8217;s Class&#160;A common stock is influenced by the research and reports that financial analysts publish about it, its business, its market and its competitors. CoreWeave does not control these analysts or the content and opinions included in their reports. As a new public company, the analysts who publish information about CoreWeave&#8217;s Class&#160;A common stock will have had relatively little experience with its business, which could affect their ability to accurately forecast its results and make it more likely that it fails to meet their estimates. If any of the analysts who cover CoreWeave issues an inaccurate or unfavorable opinion regarding its stock price, its stock price would likely decline. In addition, the stock prices of many companies in the technology industry have declined significantly after those companies have failed to meet, or significantly exceed, the financial guidance publicly announced by the companies or the expectations of analysts. If CoreWeave&#8217;s financial results fail to meet, or significantly exceed, its announced guidance, if any, or the expectations of analysts or public investors, analysts could downgrade its Class&#160;A common stock or publish unfavorable research about it. If one or more of these analysts cease coverage of CoreWeave&#8217;s Class&#160;A common stock or fail to publish reports on it regularly, its visibility in the financial markets could decrease, which in turn could cause its stock price or trading volume to decline. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave does not intend to pay dividends in the foreseeable future. As a result, your ability to achieve a return on your investment will depend on appreciation in the price of CoreWeave&#8217;s Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave currently intends to retain all available funds and any future earnings for use in the operation of its business and does not anticipate paying any dividends on its capital stock in the foreseeable future. Additionally, CoreWeave&#8217;s ability to pay dividends or make distributions is limited by certain restrictions contained in its Credit Facilities. Any future determination to declare dividends will be made at the discretion of CoreWeave&#8217;s board of directors and will depend on its financial condition, operating results, capital requirements, general business conditions, restrictions in its debt instruments and other factors that its board of directors may deem relevant. Accordingly, investors must rely on sales of their Class&#160;A common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Provisions in CoreWeave&#8217;s charter documents and under Delaware law could make an acquisition of its company, which may be beneficial to its stockholders, more difficult and may limit attempts by its stockholders to replace or remove its current management and members of its board of directors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provisions in CoreWeave&#8217;s amended and restated certificate of incorporation and amended and restated bylaws may have the effect of delaying or preventing a merger, acquisition or other change of control of its company that the stockholders may consider favorable. In addition, because CoreWeave&#8217;s board of directors is responsible for appointing the members of its management team, these provisions may frustrate or prevent any attempts by its stockholders to replace or remove its current management by making it more difficult for stockholders to replace members of its board of directors. Among other things, CoreWeave&#8217;s amended and restated certificate of incorporation and amended and restated bylaws include provisions that: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide that CoreWeave&#8217;s board of directors is classified into three classes of directors with staggered three-year terms; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">permit CoreWeave&#8217;s board of directors to establish the number of directors and fill any vacancies and newly created directorships; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">require supermajority voting to amend some provisions in CoreWeave&#8217;s amended and restated certificate of incorporation and amended and restated bylaws; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">authorize the issuance of &#8220;blank check&#8221; preferred stock that CoreWeave&#8217;s board of directors could use to implement a stockholder rights plan; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide that only the chairman of CoreWeave&#8217;s board of directors, its chief executive officer, its lead independent director or a majority of its board of directors will be authorized to call a special meeting of stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">eliminate the ability of CoreWeave&#8217;s stockholders to call special meetings of stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">do not provide for cumulative voting; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide that directors may only be removed &#8220;for cause&#8221; and only with the approval of two-thirds of CoreWeave&#8217;s stockholders; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">84<br></div></div></div>
<!--End Page 95-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 96-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg58"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide for a multi-class common stock structure in which holders of CoreWeave&#8217;s Class&#160;B common stock may have the ability to control the outcome of matters requiring stockholder approval, even if they own significantly less than a majority of the outstanding shares of its common stock, including the election of directors and other significant corporate transactions, such as a merger or other sale of its company or its assets; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">prohibit stockholder action by written consent, which requires all stockholder actions to be taken at a meeting of CoreWeave&#8217;s stockholders; provided that stockholder action by written consent of a majority of the voting power of all then-outstanding shares of its capital stock is permitted so long as the voting power of all then-outstanding shares of Class&#160;B common stock represents greater than a majority of the combined voting power of all then-outstanding shares of its capital stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">provide that CoreWeave&#8217;s board of directors is expressly authorized to make, alter, or repeal its amended and restated bylaws; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">establish advance notice requirements for nominations for election to CoreWeave&#8217;s board of directors or for proposing matters that can be acted upon by stockholders at annual stockholder meetings. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, Section&#160;203 of the General Corporation Law of the State of Delaware (&#8220;DGCL&#8221;), may discourage, delay, or prevent a change in control of CoreWeave. Section&#160;203 imposes certain restrictions on mergers, business combinations, and other transactions between CoreWeave and holders of 15% or more of its common stock. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s amended and restated bylaws contain exclusive forum provisions for certain claims, which may limit its stockholders&#8217; ability to obtain a favorable judicial forum for disputes with it or its directors, officers, or employees. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s amended and restated bylaws provide that the Court of Chancery of the State of Delaware, to the fullest extent permitted by law, will be the exclusive forum for any derivative action or proceeding brought on its behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against it arising pursuant to the DGCL, its amended and restated certificate of incorporation, or its amended and restated bylaws, or any action asserting a claim against it that is governed by the internal affairs doctrine or asserting an &#8220;internal corporate claim&#8221; as defined in the DGCL. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moreover, Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all claims brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. CoreWeave&#8217;s amended and restated bylaws provide that the federal district courts of the United States will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act (&#8220;Federal Forum Provision&#8221;). CoreWeave&#8217;s decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by CoreWeave&#8217;s stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. In addition, the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by CoreWeave&#8217;s stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s stockholders will not be deemed to have waived its compliance with the federal securities laws and the regulations promulgated thereunder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any person or entity purchasing or otherwise acquiring or holding any interest in any of CoreWeave&#8217;s securities shall be deemed to have notice of and consented to its exclusive forum provisions, including the Federal Forum Provision. These provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of their choosing for disputes with CoreWeave or its directors, officers, or employees, which may discourage lawsuits against it and its directors, officers, and employees. Alternatively, if a court were to find the choice of forum provision contained in CoreWeave&#8217;s amended and restated bylaws to be inapplicable or unenforceable in an action, it may incur additional costs associated with resolving such action in other jurisdictions, which could harm its business, operating results, financial condition, and prospects. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">85<br></div></div></div>
<!--End Page 96-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 97-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg59"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Any future issuance of CoreWeave&#8217;s Class&#160;C common stock may have the effect of further concentrating voting control in its Class&#160;B common stock, may discourage potential acquisitions of its business, and could have an adverse effect on the market price of its Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under CoreWeave&#8217;s amended and restated certificate of incorporation, it is authorized to issue up to 200,000,000&#160;shares of its Class&#160;C common stock. CoreWeave does not have current plans to issue any shares of its Class&#160;C common stock. However, any future issuance of CoreWeave&#8217;s Class&#160;C common stock may have the effect of further concentrating voting control in its Class&#160;B common stock, may discourage potential acquisitions of its business, and could have an adverse effect on the market price of its Class&#160;A common stock. Although CoreWeave has no current plans to issue any shares of its Class&#160;C common stock, it may in the future issue shares of its Class&#160;C common stock for a variety of corporate purposes, including financings, acquisitions, investments, and equity incentives to its employees, consultants, and directors. CoreWeave&#8217;s authorized but unissued shares of Class&#160;C common stock are available for issuance with the approval of its board of directors without stockholder approval, except as may be required by the listing rules of Nasdaq. Because CoreWeave&#8217;s Class&#160;C common stock carries no voting rights (except as otherwise required by law) and is not listed for trading on an exchange or registered for sale with the SEC, shares of its Class&#160;C common stock may be less liquid and less attractive to any future recipients of these shares than shares of its Class&#160;A common stock, although it may seek to list its Class&#160;C common stock for trading and register shares of its Class&#160;C common stock for sale in the future. Further, CoreWeave could issue shares of Class&#160;C common stock to its Co-Founders, and, in that event, they would be able to sell such shares of Class&#160;C common stock and achieve liquidity in their holdings without diminishing their voting power. In addition, because CoreWeave&#8217;s Class&#160;C common stock carries no voting rights (except as otherwise required by law), if it issues shares of its Class&#160;C common stock in the future, the holders of its Class&#160;B common stock may be able to hold significant voting control over most matters submitted to a vote of its stockholders for a longer period of time than would be the case if it issued its Class&#160;A common stock rather than its Class&#160;C common stock in such transactions. In addition, each share of CoreWeave&#8217;s Class&#160;C common stock will automatically convert into one share of its Class&#160;A common stock following both (i) the earliest of (a) the conversion or exchange of all then-outstanding shares of its Class&#160;B common stock into or for shares of its Class&#160;A common stock, (b) the Class&#160;B Automatic Conversion, and (c) the affirmative vote of the holders of a majority of the then-outstanding shares of Class&#160;B common stock and upon (ii)&#160;the date and time or occurrence of an event specified by the vote of the holders of a majority of the then-outstanding shares of Class&#160;A common stock. If CoreWeave issues shares of its Class&#160;C common stock in the future, such issuances would have a dilutive effect on the economic interests of its Class&#160;A and Class&#160;B common stock. Any such issuance of CoreWeave&#8217;s Class&#160;C common stock could also cause the market price of its Class&#160;A common stock to decline. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">General Risk Factors of CoreWeave </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Adverse global macroeconomic conditions, geopolitical risks, or reduced spending on AI and machine learning or on cloud infrastructure could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s business depends on the overall demand for and adoption of AI and machine learning and cloud infrastructure and on the economic health of its current and prospective customers. In addition, the purchase of CoreWeave&#8217;s platform is often discretionary and may involve a significant commitment of capital and other resources. Weak global and regional economic conditions, including United States and global macroeconomic issues, actual or perceived global banking and finance related issues, domestic and foreign regulatory uncertainty, changes in trade policies, including the imposition of tariffs, trade controls and other trade barriers, labor shortages, supply chain disruptions, rising interest rates and inflation, spending environments, geopolitical instability, warfare and uncertainty, including the effects of the conflicts in the Middle East and Ukraine, and tensions between China and Taiwan, weak economic conditions in certain regions or a reduction in business spending, including spending on developing AI and machine learning capabilities and on cloud infrastructure, regardless of macroeconomic conditions, could adversely affect CoreWeave&#8217;s business, operating results, financial condition, and prospects, including resulting in longer sales cycles, a negative impact on its ability to attract and retain new customers, increase sales of its platform, or sell additional solutions and services to its existing customers, lower prices for its solutions and services, and slower or declining growth. Deterioration in economic conditions in any of the countries in which CoreWeave does business could also cause slower or impaired collections on accounts receivable, which may adversely impact its business, operating results, financial condition, and prospects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Geopolitical risks, including those arising from trade tension and/or the imposition of trade tariffs, terrorist activity, or acts of civil or international hostility, are increasing. In particular, the imposition of tariffs, trade controls, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">86<br></div></div></div>
<!--End Page 97-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 98-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg60"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">border taxes, or other barriers to trade may directly or indirectly impact CoreWeave&#8217;s business, operating results, financial condition, prospects, and stock price. For example, the United States has recently announced tariffs, certain of which have been temporarily suspended, on imported goods from most countries and select countries have announced retaliatory tariffs in response, contributing to volatility in the markets. There can be no assurance that CoreWeave will be able to mitigate the impacts of the foregoing or any future changes in global trade dynamics on its business. Similarly, the potential for military conflict between China and Taiwan could have negative impacts on the global economy, including by affecting the supply of semiconductors from Taiwan, contributing to higher energy prices and creating uncertainty in the global capital markets. While CoreWeave does not currently have employees or direct operations in Taiwan, its suppliers rely heavily on semiconductors supplied by Taiwan which are an important component of its platform and any reduction in that supply could materially disrupt its operations. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">CoreWeave may be adversely affected by natural disasters, pandemics, and other catastrophic events, and by man-made problems such as war and regional geopolitical conflicts around the world, that could disrupt its business operations, and its business continuity and disaster recovery plans may not adequately protect it from a serious disaster. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Natural disasters or other catastrophic events may cause damage or disruption to CoreWeave&#8217;s operations, international commerce, and the global economy, and thus could have an adverse effect on it. CoreWeave&#8217;s business operations are also subject to interruption by fire, power shortages, flooding, and other events beyond its control. In&#160;addition, CoreWeave&#8217;s global operations expose it to risks associated with public health crises, such as pandemics and epidemics, which could harm its business and cause its operating results to suffer. Further, acts of war, armed conflict, terrorism and other geopolitical unrest, such as the conflicts in the Middle East and Ukraine and tensions between China and Taiwan, could cause disruptions in CoreWeave&#8217;s business or the businesses of its partners or the economy as a whole. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of a natural disaster, including a major earthquake, blizzard, or hurricane, or a catastrophic event such as a fire, power loss, cyberattack, or telecommunications failure, CoreWeave may be unable to continue its operations and may endure system interruptions, reputational harm, delays in development of its platform, lengthy interruptions in service, breaches of data security, and loss of critical data, all of which could have an adverse effect on its future operating results. Climate change could result in an increase in the frequency or severity of such natural disasters. Moreover, any of CoreWeave&#8217;s office locations or data centers may be vulnerable to the adverse effects of climate change. For example, certain of CoreWeave&#8217;s corporate offices and data centers are located in California, a state that frequently experiences earthquakes, wildfires, and resultant air quality impacts and power shutoffs associated with wildfire prevention, heatwaves, and droughts. These events can, in turn, have impacts on inflation risk, food security, water security, and on CoreWeave&#8217;s employees&#8217; health and well-being. Additionally, all the aforementioned risks will be further increased if CoreWeave does not implement an effective disaster recovery plan or its partners&#8217; disaster recovery plans prove to be inadequate. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: justify;">Investors&#8217; expectations of CoreWeave&#8217;s performance relating to environmental, social, and governance factors may impose additional costs and expose it to new risks. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There is an increasing focus from certain regulators, investors, employees, users, and other stakeholders concerning corporate responsibility, specifically related to environmental, social, and governance (&#8220;ESG&#8221;) matters both in the United States and internationally. Some investors may use these non-financial performance factors to guide their investment strategies and, in some cases, may choose not to invest in CoreWeave if they believe its policies and actions relating to corporate responsibility are inadequate. Further, there is particular focus on concerns relating to AI and its impact on the environment, including the power-intensive nature of the industry, high consumption of water, and reliance on critical minerals and rare elements, and CoreWeave is focused on sustainability goals and initiatives to mitigate the environmental impacts of its operations. CoreWeave may experience heightened scrutiny from its stakeholders and potential investors around these issues. CoreWeave may also face reputational damage in the event that it does not meet the ESG standards set by various constituencies or fail, or are perceived to fail, in its achievement of its sustainability goals, initiatives, or commitments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s sustainability initiatives, goals, or commitments could be difficult to achieve or costly to implement. Moreover, compliance with recently adopted and potential upcoming ESG requirements, including California legislation that requires various climate-related disclosures, the European Union&#8217;s Corporate Sustainability Reporting Directive and Corporate Sustainability Due Diligence Directive, and the United Kingdom&#8217;s Streamlined Energy and Carbon Reporting framework will require the dedication of significant time and resources. Additionally, if CoreWeave&#8217;s competitors&#8217; corporate social responsibility performance is perceived to be better than its, potential, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">87<br></div></div></div>
<!--End Page 98-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 99-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_108-risk_pg61"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">or current investors may elect to invest with its competitors instead. CoreWeave&#8217;s business may face increased scrutiny related to these activities and its related disclosures, including from the investment community, and its failure to achieve progress or manage the dynamic public sentiment and legal landscape in these areas on a timely basis, or at all, could adversely affect its reputation, business, and financial performance. </div><div class="BRDSX_frisk" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">CoreWeave could be subject to securities class action litigation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources, which could adversely affect CoreWeave&#8217;s business, operating results, or financial condition. Additionally, the dramatic increase in the cost of directors&#8217; and officers&#8217; liability insurance may cause it to opt for lower overall policy limits and coverage or to forgo insurance that it may otherwise rely on to cover significant defense costs, settlements, and damages awarded to plaintiffs, or incur substantially higher costs to maintain the same or similar coverage. These factors could make it more difficult for CoreWeave to attract and retain qualified executive officers and members of its board of directors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For litigation risk related to the Merger, see the section titled &#8220;&#8212;Risks Related to the Merger&#8212;Potential litigation against CoreWeave and Core Scientific could result in substantial costs, an injunction preventing the completion of the Merger and/or a judgment resulting in the payment of damages.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Risks relating to Core Scientific </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific is subject to the risks described in (i) Part&#160;I, Item&#160;1A, &#8220;Risk Factors&#8221; in Core Scientific&#8217;s Annual&#160;Report on Form&#160;10-K for the year ended December&#160;31, 2024 filed with the SEC on February&#160;27, 2025, (ii)&#160;Part&#160;II, Item&#160;1A of Core Scientific&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended June&#160;30, 2025, filed with the SEC on August&#160;8, 2025 and (iii) Core Scientific&#8217;s subsequent filings with the SEC, in each case, which are incorporated by reference into this proxy statement/prospectus. See the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">88<br></div></div></div>
<!--End Page 99-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 100-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_109-fls_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tFLS"><!--Anchor--></a>CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus, including the information included or incorporated by reference, contains &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including Section&#160;27A of the Securities Act, and Section&#160;21E of the Exchange Act. In this context, forward-looking statements often address future business and financial events, conditions, expectations, plans or ambitions, and often contain words such as &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;see,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;target,&#8221; similar expressions, and variations or negatives of these words, but not all forward-looking statements include such words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the Merger and the anticipated benefits thereof, projections, estimates and forecasts of revenue and other financial and performance metrics, projections of market opportunity and expectations, CoreWeave&#8217;s ability to scale and grow its business, the advantages and expected growth of CoreWeave and CoreWeave&#8217;s ability to source and retain talent. All such forward-looking statements are based upon current plans, estimates, expectations and ambitions that are subject to risks, uncertainties and assumptions, many of which are beyond the control of CoreWeave and Core Scientific, that could cause actual results to differ materially from those expressed in such forward-looking statements. Important risk factors that may cause such a difference include, but are not limited to: the completion of the Merger on anticipated terms, or at all, and timing of completion, including obtaining regulatory approvals that may be required on anticipated terms and Core Scientific Stockholder Approval for the Merger; uncertainty in the value of the consideration that Core Scientific stockholders would receive in the Merger, if completed, due to fluctuations in the market price of CoreWeave common stock; risk of fluctuations in the market price of CoreWeave common stock if a substantial number of shares of CoreWeave common stock become available for sale and are sold in a short period of time, including as a result of the expiration of market standoff or contractual lock-up agreements in connection with CoreWeave&#8217;s initial public offering, or the anticipation of such events; anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the combined company&#8217;s operations and other conditions to the completion of the Merger, including the possibility that any of the anticipated benefits of the Merger will not be realized or will not be realized within the expected time period; the ability of CoreWeave and Core Scientific to integrate their businesses successfully and to achieve anticipated synergies and value creation; potential litigation relating to the Merger that could be instituted against CoreWeave, Core Scientific or their respective directors and officers; the risk that disruptions from the Merger will harm CoreWeave&#8217;s or Core Scientific&#8217;s business, including current plans and operations and that management&#8217;s time and attention will be diverted on transaction-related issues; potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Merger; rating agency actions and CoreWeave&#8217;s and Core Scientific&#8217;s ability to access short- and long-term debt markets on a timely and affordable basis; legislative, regulatory and economic developments and actions targeting public companies in the artificial intelligence, power, data center and crypto mining industries and changes in local, national or international laws, regulations and policies affecting CoreWeave and Core Scientific; potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the Merger that could affect CoreWeave&#8217;s and/or the Core Scientific&#8217;s financial performance and operating results; certain restrictions during the pendency of the Merger that may impact Core Scientific&#8217;s ability to pursue certain business opportunities or strategic transactions or otherwise operate its business; acts of terrorism or outbreak of war, hostilities, civil unrest, attacks against CoreWeave or Core Scientific and other political or security disturbances; dilution caused by CoreWeave&#8217;s issuance of additional shares of its securities in connection with the Merger; the possibility that the transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; the impacts of pandemics or other public health crises, including the effects of government responses on people and economies; global or regional changes in the supply and demand for power and other market or economic conditions that impact demand and pricing; changes in technical or operating conditions, including unforeseen technical difficulties; development delays at CoreWeave and/or Core Scientific data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing sites; those risks described in Item&#160;1A of Core Scientific&#8217;s Quarterly Report on Form&#160;10-Q for the quarterly period ended March&#160;31, 2025, filed with the SEC on May&#160;7, 2025, Item&#160;1A of Core Scientific&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, filed with the SEC on February&#160;27, 2025 and subsequent reports on Forms&#160;10-Q and 8-K; and those risks that are described herein under the section titled &#8220;Risk Factors.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While the list of factors presented here and elsewhere in this proxy statement/prospectus is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">89<br></div></div></div>
<!--End Page 100-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 101-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_109-fls_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">You&#160;should not place undue reliance on any of these forward-looking statements as they are not guarantees of future performance or outcomes; actual performance and outcomes, including, without limitation, CoreWeave&#8217;s or Core Scientific&#8217;s actual results of operations, financial condition and liquidity, and the development of new markets or market segments in which CoreWeave or Core Scientific operate, may differ materially from those made in or suggested by the forward-looking statements contained in this communication. Neither CoreWeave nor Core Scientific assumes any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Neither future distribution of this communication nor the continued availability of this communication in archive form on CoreWeave&#8217;s or Core Scientific&#8217;s website should be deemed to constitute an update or re-affirmation of these statements as of any future date. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">90<br></div></div></div>
<!--End Page 101-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 102-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_110-market_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCPS"><!--Anchor--></a>COMPARATIVE PER SHARE MARKET PRICE AND DIVIDEND INFORMATION </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"><a name="tMP"><!--Anchor--></a>MARKET PRICES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth the closing price per share of CoreWeave common stock and Core Scientific common stock as reported on the Nasdaq on June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions, July&#160;3, 2025, the last trading day prior to the public announcement of the Merger on July&#160;7, 2025, and on [&#8194;], 2025, the most recent practicable trading day prior to the date of this proxy statement/prospectus for which this information was available. The table also shows the implied value of the Merger Consideration for each share of Core Scientific common stock as of the same dates. This implied value was calculated by multiplying the closing price of a share of CoreWeave common stock on the relevant date by the exchange ratio. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 53.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 53.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 63.69pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 7.61pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 7.61pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.69pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied Per Share <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value of Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consideration </div></td></tr><tr><td style="width: 252pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">June&#160;25, 2025<font style="padding-left: 2.01pt;"></font></div></td><td style="width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.41pt; text-align: left;">$159.50</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.91pt; text-align: left;">$12.30</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.69pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.1pt; text-align: left;">$19.70 </div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">July&#160;3, 2025<font style="padding-left: 3.68pt;"></font></div></td><td style="width: 7.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.41pt; text-align: left;">$165.20</div></td><td style="width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.91pt; text-align: left;">$18.00</div></td><td style="width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.69pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.1pt; text-align: left;">$20.40 </div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">[&#8195;], 2025<font style="padding-left: 2.01pt;"></font></div></td><td style="width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.41pt; text-align: left;">$<font style="padding-left: 10.84pt;">[&#8195;]</font></div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 12.91pt; text-align: left;">$<font style="padding-left: 5.84pt;">[&#8195;]</font></div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.69pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.1pt; text-align: left;">$<font style="padding-left: 5.84pt;">[&#8195;]</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 252pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 53.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 53.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 63.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The market prices of shares of CoreWeave common stock and Core Scientific common stock have fluctuated since the date of the announcement of the Merger Agreement and will continue to fluctuate from the date of this proxy statement/prospectus to the date of the Special Meeting and the date the Merger is completed. No assurance can be given concerning the market prices of shares of CoreWeave common stock and shares of Core Scientific common stock before completion of the Merger or shares of CoreWeave common stock after completion of the Merger. The exchange ratio is fixed in the Merger Agreement, but the market price of shares of CoreWeave common stock (and therefore the value of the Merger Consideration) when received by Core Scientific stockholders after the Merger is completed could be greater than, less than or the same as shown in the table above. Accordingly, Core Scientific stockholders are advised to obtain current market quotations for shares of CoreWeave common stock and shares of Core Scientific common stock in deciding whether to vote for adoption of the Merger Agreement. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tDI"><!--Anchor--></a>DIVIDENDS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On a quarterly basis, from the time the shares of the Series&#160;C redeemable convertible preferred stock were issued in May&#160;2024, until the completion of CoreWeave&#8217;s initial public offering on March&#160;31, 2025, CoreWeave paid holders of its Series&#160;C redeemable convertible preferred stock a cumulative dividend that accrued daily at a rate of 10% per annum on the accumulated stated value of such shares, equal to $38.95 per share (the accumulated stated value is the defined &#8220;original issue price&#8221;). After its initial public offering and the conversion of the Series&#160;C redeemable convertible preferred stock to redeemable Class&#160;A common stock, these dividend rights ceased, and there were no accrued and unpaid dividends as of March&#160;31, 2025. CoreWeave does not currently pay a dividend on shares of CoreWeave common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has never declared nor paid cash dividends on its capital stock. After the date of the Merger Agreement until the effective time, Core Scientific will not declare or establish a record date or pay any dividends on or make other distributions in respect of its capital stock or subsidiary securities without the prior written consent of CoreWeave, except for the declaration and payment of dividends or distributions by a wholly owned subsidiary of Core Scientific solely to its direct parent entity. For more information, see the section titled &#8220;The Merger Agreement&#8212;Conduct of Business Pending the Merger&#8221; beginning on page <a href="#tCBPM">229</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tHO"><!--Anchor--></a>HOLDERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of [&#8194;], there were [&#8194;] stockholders of record holding shares of CoreWeave common stock, [&#8194;] stockholders of record holding shares of CoreWeave Class&#160;B common stock, par value $0.000005 per share, and 0 stockholders of record holding shares of CoreWeave Class&#160;C common stock, par value $0.000005 per share. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">91<br></div></div></div>
<!--End Page 102-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 103-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_110-market_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTC"><!--Anchor--></a>THE COMPANIES </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"><a name="tCW"><!--Anchor--></a>COREWEAVE, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Inc., which is referred to in this proxy statement/prospectus as CoreWeave, was originally formed as a Delaware limited liability company in 2017 and then converted to a Delaware corporation in 2018. CoreWeave is headquartered in Livingston, New Jersey. CoreWeave, the AI Hyperscaler&#8482;, delivers a cloud platform of cutting-edge software powering the next wave of AI. CoreWeave&#8217;s technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal trading market for CoreWeave&#8217;s common stock (NASDAQ: CRWV) is the Nasdaq Stock Market LLC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal executive offices of CoreWeave are located at 290 W&#160;Mt. Pleasant Ave., Suite&#160;4100, Livingston, NJ and its telephone number is (973) 270-9737 and its website is www.coreweave.com. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tCS"><!--Anchor--></a>CORE SCIENTIFIC, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific, Inc., which is referred to in this proxy statement/prospectus as Core Scientific, is a leader in digital infrastructure for high-density colocation services and digital asset mining of bitcoin. Core Scientific operates dedicated, purpose-built facilities for digital asset mining and is a premier provider of digital infrastructure, software solutions and services to its third-party customers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants are traded on the Nasdaq under the symbol &#8220;CORZ,&#8221; &#8220;CORZW&#8221; and &#8220;CORZZ,&#8221; respectively. Following the Merger, Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will be delisted from the Nasdaq. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s principal executive offices are located at 838 Walker Road, Suite 21-2105, Dover, Delaware&#160;19904, and our telephone number is (512) 402-5233. Its corporate website address is www.corescientific.com. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additional information about Core Scientific and its subsidiaries are included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;Where You Can Find More Information&#8221; beginning on page&#160;<a href="#tWYC">317</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tMMS"><!--Anchor--></a>MIAMI MERGER SUB I, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Miami Merger Sub I, Inc., which is referred to in this proxy statement/prospectus as Merger Sub, is a Delaware corporation and a wholly owned subsidiary of CoreWeave. Merger Sub was formed solely for the purpose of completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental to its formation and activities undertaken in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Merger Sub was formed in the State of Delaware on July&#160;2, 2025. The principal executive offices of Merger Sub are located at 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ and its telephone number is (973) 270-9737. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">92<br></div></div></div>
<!--End Page 103-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 104-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; position: relative; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tINFO"><!--Anchor--></a>INFORMATION ABOUT COREWEAVE, INC.&#8217;S BUSINESS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Overview </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">CoreWeave powers the creation and delivery of the intelligence that drives innovation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are the AI Hyperscaler&#8482; driving the AI revolution.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup> Our CoreWeave Cloud Platform consists of our proprietary software and cloud services that deliver the software and software intelligence needed to manage complex AI infrastructure at scale. Our platform supports the development and use of ground-breaking models and the delivery of the next generation of AI applications that are changing the way we live and work across the globe&#8212;our platform is trusted by some of the world&#8217;s leading AI labs and AI enterprises, including Cohere, IBM, Meta, Microsoft, Mistral, NVIDIA, and OpenAI. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe AI is the next frontier for innovation in technology, driving productivity and efficiency gains and enabling new business models in nearly every industry and organization. According to IDC, AI will generate a cumulative global economic impact of $20&#160;trillion, or 3.5% of global GDP, by 2030. The generalized cloud infrastructure that drove the cloud revolution beginning in the 2000s was built to host websites, databases, and SaaS apps that have fundamentally different needs than the high performance requirements of AI. As workloads and technologies evolve, so too must the infrastructure and cloud software and services that power them. We believe we are at the start of a new cloud era that will drive the AI revolution. The opportunity for a purpose-built AI cloud platform, including the infrastructure and integrated software, is massive. Based on market research from Bloomberg Intelligence, total spending on AI inference/fine-tuning, AI workload monitoring, and training infrastructure, including AI servers, AI storage, training compute, cloud workloads, and networking, will reach approximately $399&#160;billion by 2028. For AI to reach its full potential, it needs a purpose-built AI cloud platform with infrastructure and managed cloud services that are delivered in an efficient, automated, and highly performant way. Enter CoreWeave, the AI Hyperscaler&#8482;. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We purpose-built our CoreWeave Cloud Platform to be the infrastructure and application platform for AI. Our platform manages the complexity of engineering, assembling, running, and monitoring state-of-the-art infrastructure at a massive scale to deliver high performance and efficiency to AI workloads. Through our proprietary software capabilities, we enable our customers to achieve substantially higher total system performance and more favorable uptime relative to other AI offerings within existing infrastructure cloud environments and unlock speed at scale. By delivering more compute cycles to AI workloads and thereby reducing the time required to train models, our capabilities can significantly accelerate the time to solution for customers in the ongoing hyper-competitive race to build the next bleeding-edge AI models. For example, in June&#160;2023, our NVIDIA H100 Tensor Core GPU training cluster completed the MLPerf benchmark test (which benchmarks how quickly a system can train a model from scratch) in eleven minutes&#8212;a record and 29 times faster than the next best competitor at the time of the benchmark test. Recently, we delivered the largest-ever MLPerf Training v5.0 submission on NVIDIA Blackwell, using 2,496&#160;NVIDIA Blackwell GPUs running on CoreWeave&#8217;s AI-optimized cloud platform. The submission was the largest NVIDIA GB200 NVL72 cluster ever benchmarked under MLPerf, 34 times larger than the only other submission from a cloud provider, achieved approximately 4.5 times faster training performance than the best submission from another organization&#8217;s GB200 cluster, and achieved 2 times faster training performance compared to other similar cluster sizes using prior generation hardware. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These efficiencies also extend from training to inference use cases, as our CoreWeave Cloud Platform significantly improves both run-time efficiency for inference workloads and enables overall higher AI application uptime. These performance gains help to ensure lower performance-adjusted costs and a superior end-user experience. The supercomputers we build to power our platform are optimized to support many types of AI workloads, and they are augmented by our suite of cloud services to deliver meaningful time and cost savings to customers through our orchestration, automation, and monitoring capabilities. </div></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 10pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;"><font style="position: relative; top: -3.25pt;">1</font><br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 8pt;"><font style="font-size: 8pt;">Based on our exclusive focus on AI cloud computing at the scale and with the capabilities of our platform, solutions, and services as compared to competing hyperscalers and our customer relationships with leading AI labs and AI enterprises, which position us to be among the first to experience and solve the challenges facing the AI cloud computing industry at scale. </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">93<br></div></div></div>
<!--End Page 104-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 105-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our multidisciplinary, customer-centric team has a proven ability to conceptualize, design, and implement solutions to solve the most complex engineering challenges in the pursuit of furthering AI. We hire individuals who help contribute to and maintain a culture centered around solving the most complex AI infrastructure scaling, performance, and reliability challenges. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Customers utilize our platform through a set of cloud services comprising Infrastructure Services, Managed Software Services, and Application Software Services, all augmented by our Mission Control and Observability software. Our comprehensive and integrated cloud services work together as a suite to deliver state-of-the-art compute, networking, and storage. These services enable the provisioning of infrastructure, the orchestration of workloads, and the proactive monitoring of our customers&#8217; training and inference environments to increase performance and minimize interruptions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CoreWeave Cloud Platform is hosted in our distributed network of active purpose-built data centers that are interconnected using low latency connections to major metropolitan areas, and incorporate state-of-the-art data center networking equipment, enhanced access to power and, where appropriate, the latest liquid cooling technologies. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2022, we had three data centers running more than 17,000 GPUs in total and supported by approximately 10 MW of active power, which grew to 10 data centers running more than 53,000 GPUs in total and supported by more than 70 MW of active power as of December&#160;31, 2023, grew further to 32 data centers running more than 250,000 GPUs in total and supported by more than 360 MW of active power as of December&#160;31, 2024, and grew further to 33 data centers supported by approximately 470 MW of active power as of June&#160;30, 2025. Our total contracted power extends to approximately 2.2 GW as of June&#160;30, 2025, which we expect to roll out over the coming years. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We benefit from robust collaborations with leading chipmakers, OEMs, and software providers to supply us with infrastructure components and other products. We have a proven track record of rapidly expanding our power capacity to support the growth of our data center footprint along with our collection of managed cloud services. We deploy a sophisticated financing strategy and have efficiently financed the development of additional compute capacity through the use of asset-backed debt, having raised total commitments of over $28.6&#160;billion in debt and equity to support the development of our platform. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our customers include some of the world&#8217;s leading AI labs and AI enterprises &#8212; the <font style="font-style: italic;">builders </font>and <font style="font-style: italic;">integrators </font>of AI &#8212; who depend on our platform for their core products and most promising innovations. We deliver significant benefits to our customers in terms of overall performance, time to market, and reduced cost of ownership, which results in our customers making large, long-term initial commitments and expanding those commitments with us over time. The vast majority of our revenue today is from multi-year committed contracts, whereby a customer purchases access to our platform over the contract term on a take-or-pay basis. We also sell access to our platform on an on-demand basis through a pay-as-you-go model. As of June&#160;30, 2025, we had $30.1&#160;billion of unsatisfied RPO. As of December&#160;31, 2024, we had $15.1&#160;billion of RPO reflecting an increase of 53%, from $9.9&#160;billion as of December&#160;31, 2023. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our ability to abstract away the complexity our customers would face in assembling, managing, and deploying this infrastructure themselves establishes us as a critical partner and leads to long-term, durable relationships that have the potential to expand over time. As evidence of this, three of our top five committed contract customers by TCV as of December&#160;31, 2024 signed agreements for additional capacity within 12 months of their respective initial purchase dates. These agreements, measured during each respective 12-month period from the initial date of signing, represented a cumulative increase of approximately $7.8&#160;billion in committed spend and a multiple of approximately 4x on initial contract value. Our deep relationships with customers are a competitive advantage, and our first-to-market track record with highly performant technology gives customers confidence in choosing CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Some of the most ambitious compute-intensive projects in the world are powered by our platform, and our business has grown rapidly since our inception. Our revenue was $584&#160;million and $2,194&#160;million for the six months ended June&#160;30, 2024 and 2025, representing period-over-period growth of 276%. Our revenue was $16&#160;million, $229&#160;million, and $1.9&#160;billion for the years ended December&#160;31, 2022, 2023, and 2024, respectively, representing year-over-year growth of 1,346% and 737%, respectively. During these periods, we continued to invest in growing our business to capitalize on our market opportunity. As a result, our net loss for the six months ended June&#160;30, 2024 and 2025 and the years ended December&#160;31, 2022, 2023, and 2024 was $452&#160;million, $605&#160;million, $31&#160;million, $594&#160;million, and $863&#160;million, respectively. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">94<br></div></div></div>
<!--End Page 105-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 106-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Industry Background </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Over the past five decades, technology has experienced multiple secular shifts that have revolutionized productivity. In the 1960s, mainframes introduced compute and storage technology to hundreds of thousands of organizations and helped to introduce new product capabilities such as high-volume transaction processing in banking. In the 1980s, the development of client-server architecture dramatically reduced the cost of compute, which enabled the personal computer (&#8220;PC&#8221;) revolution and resulted in widespread access to PCs and significant productivity gains. In the 1990s, the internet fundamentally changed the way people worked, interacted, shopped, and learned. In the 2000s and 2010s, mobile and cloud adoption unlocked new customer and developer experiences and led to a fundamental improvement in the flexibility of compute, creating millions of new digital products and experiences. AI represents the next major evolution of technology, and its impact is potentially greater than these transformational shifts of the past. AI is expected to support tens of billions of connected users, devices and applications. It is also expected to penetrate half of all U.S. households in three years, based on data demonstrating that the time to adoption by 50% of U.S. households of new technology has halved each cycle, measured in years. This expected penetration time is six times faster than PC adoption and two times faster than mobile adoption, and, since 2012, the amount of compute used in the largest AI training runs has been increasing exponentially, doubling every three to four months. It is akin to a new industrial revolution delivering significant productivity gains, enabling new products that are poised to radically reshape and transform industries, and helping organizations become far more efficient. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Demand and Supply Side Factors Enabling AI </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A combination of demand and supply side factors is enabling the massive and unprecedented growth of AI and powering the new industrial revolution. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Demand Side Factors </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI has advanced significantly. There is a proliferation of new use cases as AI models become more advanced and their capabilities extend beyond simple prediction and rules-based pattern recognition, to foundational model-based applications with human-like reasoning and judgment capabilities. AI is moving beyond generative AI, which is focused on content creation, to agentic AI that takes action to assist and advise across myriads of use cases. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI is significantly improving outcomes for businesses and individuals. AI is enabling a tectonic shift in productivity that is fundamentally changing the way we interact with technology on a daily basis and is driving material impacts such as faster drug discovery, personalized education, shorter software development cycles, better sales and customer support, and a multitude of other use cases. AI is also helping to narrow the skills gap that exists in specialized, yet highly in-demand occupations, including engineering, law, design, and medicine. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI is a strategic priority for organizations. AI has become a primary source of competitive differentiation. Management teams and boards are reshaping their technology budgets and rearchitecting their broader corporate strategies through the lens of AI as a strategic imperative. </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Supply Side Factors </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Foundational models are pervasive and effective. The explosion of commercially available foundational models, both proprietary and open-source, is democratizing access to AI and enabling more enterprises to develop AI products and services. Furthermore, continued investments in and the resulting effects of scaling have made these models more impactful and useful. Availability of performant and efficient cloud infrastructure is critical to run these models effectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The amount of data has grown rapidly. The vast amount of enterprise data and accessible public data is being further supplemented by the emergence and rapid growth of AI-generated synthetic data, creating a massive volume of data used to build and train AI models. Enormous amounts of compute and storage capacity will be required to process this data so that it can be deployed for AI use cases. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Infrastructure has evolved to enable AI workloads. New generations of infrastructure deliver significantly greater performance for AI workloads, with much greater speed and at dramatically lower cost, which in turn spurs more innovation as the infrastructure becomes more accessible. GPU performance, which powers AI model training and inference, has increased 7,000 times over the past two decades. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">95<br></div></div></div>
<!--End Page 106-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 107-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Infrastructure is the Key Enabler of AI </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To unlock the full potential of AI, continuous improvements in model architecture, access to data, and scalable, specialized, high-performance compute infrastructure are essential. We believe that specialized compute infrastructure is the key enabler that AI labs and AI enterprises need to train models, perform inference faster at scale, and accelerate their time to market. It has become generally accepted that there is a direct relationship between compute resources (FLOPs, training, and testing time) and model output quality. There has been a dramatic increase in the computational resources dedicated to training and hosting state-of-the-art AI models, with top models released by OpenAI, Google DeepMind, and Meta AI generally requiring exponentially greater quantities of compute compared to prior model generations to unlock performance gains. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This race towards more performant models and the resulting demand for increasingly significant amounts of compute resources should come as no surprise. According to various papers that analyze scaling laws such as &#8216;Scaling Laws for Neural Language Models,&#8217; as compute infrastructure scales, the performance of the foundational models also increases. This principle applies for both training and inference: it states that the more compute power available, the better both the models and applications built on top of them become. To achieve greater compute capabilities and succeed in AI, AI labs and AI enterprises require specialized compute platforms that run at superior performance and efficiency and maximize the utilization of the underlying infrastructure. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Delivering Performant AI Infrastructure is Immensely Challenging </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The highly specialized infrastructure that is required to unlock the potential of AI is immensely challenging to build and operate, especially at scale. Additionally, the software architectures utilized in generalized clouds for provisioning, orchestrating, and running AI workloads are neither purpose-built nor suitable for AI and cannot deliver the required efficiency and performance. The scale of the required infrastructure is staggering, with tens of thousands of GPUs, thousands of miles of high-speed networking cables, and hundreds of thousands of interconnects coming together to create &#8220;superclusters&#8221; for training and serving AI models, as well as hundreds of MW of power and petabytes of total storage. Depending on the configuration of the data center, a single 32,000-GPU cluster may require the deployment of approximately 600 miles of fiber cables and around 80,000 fiber connections. Acquiring the necessary high-performance components requires managing a complex global supply chain, and configuring and deploying those components in data centers requires deep operational experience. The data centers themselves need to be specifically designed for high-performance compute, which requires specialized heat management capabilities such as liquid cooling, with heat exchangers and subfloors to support high density racks and high power supply per rack. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Software is Critical to Unlocking the Performance and Efficiency of AI Infrastructure </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">AI supercomputers are some of the most complex computing machines to have ever been created, requiring purpose-built software to unlock performance and efficiency at massive scale. These supercomputers require software to test and validate each component and to provision the infrastructure so that compute-intensive workloads can run with minimal downtime. Moreover, AI supercomputers often require multiple specialized orchestration frameworks to schedule complex workloads, which frequently need to be paired with substantial engineering resources. Once operational, these AI workloads put enormous pressure on infrastructure, frequently leading to high rates of component failures that cause training and inference jobs to fail, and thus require constant monitoring to manage and reduce failures and downtime. While training foundational models, failure of a single system component adversely impacts the entire cluster, translating to either significantly reduced training performance or, more commonly, failure of the entire job. High failure rates result in a significant loss of efficiency and increased cost if not properly monitored and managed. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">AI Infrastructure Suffers from an MFU &#8220;Efficiency Gap&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Designing, provisioning, and maintaining the health of infrastructure is highly complex. Additionally, significant inefficiencies are associated with scheduling AI workloads on infrastructure at scale. Together, these complexities substantially increase the difficulty of maximizing the compute potential of infrastructure components, as measured by the MFU of the chips. MFU is a measure of the observed throughput compared to the theoretical system maximum if it operates at peak FLOPs. The complexity of managing AI infrastructure means that a majority of the compute capacity embedded in GPUs is lost to system inefficiencies, with empirical evidence suggesting observed levels of performance within the 35% to 45% range. Minimizing the efficiency gap between the approximately 35% and the theoretical 100% represents a significant opportunity for unlocking AI infrastructure performance potential and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">96<br></div></div></div>
<!--End Page 107-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 108-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">therefore the improvement in quality of AI overall. Moreover, the complexity of managing this high-performance infrastructure as it scales increases exponentially, making it increasingly challenging to extract high MFU and efficiency out of larger GPU clusters, which is what the market is currently demanding.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 285px; width: 380px;" src="ny20053122x2-efficiency.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">AI Requires a Purpose-Built Cloud </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The complexity and resource demands of AI workloads necessitate that they run in a cloud environment purpose-built for AI, with high-performance infrastructure as well as software and application services that alleviate the specific complexities and inefficiencies associated with running training and inference jobs. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Generalized clouds operated by hyperscalers were not built to serve the specific requirements of AI. These clouds were created over a decade ago and were designed for general purpose use cases such as search, e-commerce, generalized web-hosting, and databases, and relied on CPU-based web-scale compute, and thus are not optimal for the high compute intensity requirements of AI. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Organizations need access to a fundamentally different GPU-based compute infrastructure that is built from the ground-up for AI and proven to perform at the scale and efficiency required to deliver AI. Cloud platforms therefore need to be fundamentally reimagined and purpose-built to deliver the capacity, performance, storage, and scalability requirements of AI workloads and increase the MFU of the underlying infrastructure. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Requirements of the AI Cloud </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe the AI cloud requires a first-principles reimagining of how infrastructure is built, with the following requirements: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Superior infrastructure performance and efficiency. The AI cloud should be able to extract the maximum possible output from the underlying GPUs and other infrastructure components. To achieve this, it needs to deliver a combination of performance and resiliency to ensure maximum AI training and inference uptime. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Maximize performance. The AI cloud should run the latest and highest performance components and leverage an optimized technology stack that reduces latency and overhead to increase performance. Generalized clouds include virtualized compute, storage, and networking, and a host of managed services that are not required by AI workloads and typically consume additional resources, degrading performance. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Minimize downtime and failure rates. The AI cloud should be able to identify and rapidly solve performance issues and prevent failures before they occur. AI workloads push infrastructure to its limits, causing nodes to fail and inducing storage, memory, and network latencies, which interrupt training runs. This creates delays and increases the cost of compute. GPU offerings from generalized clouds do not have capabilities required for high-performance AI workloads due to their CPU-centric heritage. CPU-based clouds lack the remediation capabilities, such as predictive maintenance and proactive health monitoring, </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">97<br></div></div></div>
<!--End Page 108-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 109-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">needed to avoid the types of issues and outages experienced by GPU nodes, which are significantly more complex than CPU nodes. Traditional workload migrations that shift jobs away from impacted compute nodes in CPU-based clouds do not work for GPU-based infrastructure, which has far greater data and memory dependencies and job restart complexities. Moreover, due to their built-in layers of abstraction (e.g., virtualization), CPU-based clouds lack the complete node level visibility and the automation required to rapidly detect and remediate issues in GPU-based infrastructure. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Rapid access to the latest advancements in infrastructure. AI advancement is limited by the infrastructure that supports it. To continuously push the AI frontier, customers should be able to access the latest advancements in technology for each component of their AI infrastructure. Bleeding-edge AI training workloads today benefit from running on the latest GPUs, CPUs, and DPUs, from the most advanced storage, networking, and memory, and from high-density liquid-cooled data center racks to maximize performance and efficiency. Moreover, the latest advancements in infrastructure technology are not in and of themselves enough. Customers benefit from an integrated solution that enables seamless deployment, automation, orchestration and monitoring of their infrastructure and workloads. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Immediate &#8220;out-of-the-box&#8221; functionality. The AI cloud should deliver an autonomous, self-service approach with seamless deployment and automation, enabling developers and researchers to focus on delivering cutting-edge AI innovations. If not set up in the right way, due to the newness and the sheer scale of AI infrastructure deployments, GPU acceptance, provisioning, burn-in and testing issues can take months, which can significantly delay time to solution for the latest AI models and the products built on top of them. Moreover, when infrastructure is ready, it typically takes significant involvement from engineering resources to consume the infrastructure and deploy workloads due to a lack of provisioning automation. The AI cloud should be built to minimize delays and resource intensity and work out-of-the-box at scale. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Ability to run and dynamically balance all types of AI workloads. The AI cloud should incorporate dynamic workload scheduling and balancing between inference and training to optimize resource utilization and performance. At present, many AI developers use Slurm and Kubernetes as their orchestration and scheduling frameworks for training and inference compute, respectively, and are forced to run separate pools of capacity for each. This results in underutilization of their infrastructure, which results in a material reduction of efficiency and increase in cost. Customers should be able to host a wide variety of AI&#160;workloads such as training and inference on the same clusters concurrently and seamlessly. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Flexibility and customization with a specialized technology stack. Generalized cloud environments lack the flexibility to meet the specialized needs of AI applications, often forcing customers into rigid, predefined solutions. The AI cloud should be built to enable maximum composability, offering customers the freedom to tailor infrastructure and operational setup around their unique set of design requirements. Customers need a trusted partner with a track record of delivering performant and efficient AI cloud services at massive scale. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Lower performance-adjusted cost. The AI cloud should deliver superior value by prioritizing performance and efficiency to help ensure that customers get the maximum utilization out of their infrastructure investments. Generalized clouds that are not purpose-built for AI burden customers running AI workloads with lengthy setup times, higher failure rate, longer downtime, and manual engineering workflows. As a result, running AI workloads on them requires more time, effort, and compute, degrading cost relative to performance. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe the AI revolution requires a cloud that is performant, efficient, resilient, and purpose-built for AI. Today&#8217;s leading AI labs and AI enterprises demand high-performance and cost-efficient compute, storage, networking, and managed software services integrated into a cloud platform that enables them to bring their innovations to market faster by maximizing the utilization of their infrastructure and training and deploying models seamlessly and out-of-the box. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Our Solution </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CoreWeave Cloud Platform is an integrated solution that is purpose-built for running AI workloads such as model training and inference at maximum performance and efficiency. It includes Infrastructure Services, Managed Software Services, and Application Software Services, all of which are augmented by our Mission Control and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">98<br></div></div></div>
<!--End Page 109-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 110-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Observability software. Our proprietary software enables the provisioning of infrastructure, the orchestration of workloads, and the monitoring of our customers&#8217; training and inference environments to enable high availability and minimize downtime. Built on a microservices-based architecture, the components of our platform are fully fungible and composable. Customers can configure their use of our CoreWeave Cloud Platform to best fit their needs. For instance, they can choose to bring their own storage or managed software services or run our respective solutions, and choose the type and scale of deployment that best suits their workloads. This flexibility allows our customers to customize their use of our platform without compromising performance or efficiency. We have designed security as a fundamental component across our platform and technology stack. We leverage advanced security capabilities such as XDR and DLP, adhere to industry leading security standards such as SOC2 and ISO 27001, and employ our in-house information security teams to ensure that our customers operate in a secure environment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following is a summary of our Layered Architecture Stack. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 8.5pt; text-align: center;">CoreWeave&#8217;s Layered Architecture Stack<font style="font-style: normal; font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 323px; width: 336px;" src="ny20053122x2_tooling.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Infrastructure Services <font style="font-weight: normal;">provide our customers with access to advanced GPU and CPU compute, highly performant networking (supported by DPUs), and storage. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Managed Software Services <font style="font-weight: normal;">include CKS (a purpose-built-for-AI managed Kubernetes environment with a focus on efficiency, performance and ease of use), our flexible Virtual Private Cloud offering, and our Bare Metal service that runs Kubernetes directly on high-performance servers for maximum performance and efficiency. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Application Software Services<font style="font-weight: normal;"> build on top of our infrastructure and managed software services, integrating additional tools to further accelerate and improve training and inference for our customers. This includes SUNK, which allows customers to run Slurm-based workloads on top of Kubernetes and colocate jobs&#8212;including training and inference workloads&#8212;on a single cluster; CoreWeave Tensorizer, which significantly increases the efficiency of model checkpointing and enables high-speed model loading; and our inference optimization services. Following the completion of our acquisition of Weights &amp; Biases, we are augmenting our application services layer as an end-to-end, fully managed software platform, which will position us to accelerate development of our Application Software Services to target AI developers and enable them to develop, deploy and iterate AI faster. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our purpose-built technology stack is augmented by our lifecycle management and monitoring software, <font style="font-weight: bold;">Mission Control and Observability</font>, and our advanced cluster validation, proactive health checking capabilities, and observability capabilities. Our AI cloud runs in a distributed network of 33 active purpose-built <font style="font-weight: bold;">data centers</font>, which are specifically engineered to support high intensity AI workloads with features including enhanced power, liquid </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">99<br></div></div></div>
<!--End Page 110-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 111-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">cooling, and networking components, reinforcing the robustness of our entire technology stack. Our <font style="font-weight: bold;">Third-Party Tooling and Solutions</font> further enhance this flexibility by providing a composable architecture that allows customers to customize their solution by integrating additional third-party tools. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Key Benefits to Customers </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 20pt; text-align: left;">Through our CoreWeave Cloud Platform, we offer the following key benefits to customers: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Highly efficient infrastructure. Our CoreWeave Cloud Platform delivers more optimized MFU than the cloud infrastructure provided by generalized hyperscalers, thereby minimizing the efficiency gap between the observed GPU cluster performance and the theoretical maximum. Based on internal testing, our CoreWeave Cloud Platform offers up to approximately 20% improvement in system MFU over comparative benchmark MFU performance. This is achieved through the performance at scale of our CoreWeave Cloud Platform, including optimizations such as Tensorizer to accelerate modeling loading and checkpointing, our purpose-built infrastructure, and our rapid fault remediation and failure prevention capabilities. As a result, our customers either derive more performance out of their existing clusters or need less infrastructure to achieve the same level of performance. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Performance at scale. Our infrastructure is optimized to run AI workloads, delivering cutting-edge performance to AI model training and inference use cases. Our capabilities, such as Bare Metal GPU nodes, operate with highly performant system technologies, a scale-out network with one of the industry&#8217;s leading effective network speeds, storage services with data read speeds of up to 2GB per second per GPU, and software optimizations to efficiently utilize infrastructure performance. Our compute nodes spin up rapidly, our cloud enables seamless autoscaling to accommodate complex training runs, and our rapid model loading capabilities, facilitated by our Tensorizer solution, significantly reduce inference latency. Our CoreWeave Cloud Platform has broken performance records, including setting an MLPerf record that was 29 times faster than competitors in 2023. And recently, we delivered another best-performing submission with the largest-ever MLPerf Training v5.0 submission on NVIDIA Blackwell, using 2,496 NVIDIA Blackwell GPUs running on CoreWeave&#8217;s AI-optimized cloud platform. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Reliability and Resilience. Our Mission Control suite of capabilities help deliver and maintain vetted cloud infrastructure and provide observability into the health and performance of the entire solution. This helps ensure that our customers&#8217; clusters continue to operate at ideal performance, quickly recover from any hardware events, and ultimately get better value by using our cloud solution. Moreover, our automated GPU node validation capabilities ensure when nodes are remediated that they are immediately made available for use and do not remain idle. This allows our customers to focus more of their time and resources on building new products faster instead of managing AI infrastructure. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 296px; width: 372px;" src="ny20053122x2_mfu-gap.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8pt; text-align: center;">(1) Based on internal testing<font style="font-style: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">100<br></div></div></div>
<!--End Page 111-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 112-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Faster access to latest AI infrastructure advancements. Our customers benefit from faster access to the latest AI infrastructure advancements, including our access to the latest GPU technologies at scale. Our CoreWeave Cloud Platform enables customers to run their AI workloads on highly performant compute, networking, and storage infrastructure, optimized through our dedicated infrastructure management and workload orchestration software. We have a track record of being among the first to market with cutting-edge infrastructure technology. For instance, we were among the first to deliver NVIDIA H100, H200, GH200 clusters and the first to deliver GB200 clusters into production at scale and launch instances based on RTX Pro 6000. We now have one of the widest Blackwell portfolios available, including B200, and we were the first cloud provider with an initial deployment of NVIDIA GB300 NVL72-based systems. We are able to deploy the newest chips in our infrastructure and provide the compute capacity to customers in as little as two weeks from receipt from our OEM partners such as Dell and Super Micro. This allows our customers to take advantage of the latest innovations in AI infrastructure and performance to innovate, build new products, and serve customers faster. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Highly performant on day 1. Our full-featured managed software services make the consumption of infrastructure seamless. Automated provisioning and node validation remove the need for manual burn-in testing and ensure our highly-performant CoreWeave Cloud Platform is up and running for new customers and ready for consumption in a matter of hours from customer acceptance. Customers take receipt of the infrastructure and can immediately schedule and run training and inference jobs instead of investing significant time and resources in stress-testing compute nodes and verifying their health. CKS helps to ensure workloads of any type can be immediately scheduled on the infrastructure, while Mission Control automatically vets all the infrastructure to ensure on an ongoing basis that any faults are proactively detected and remediated. This shifts the burden of infrastructure management away from customers, significantly reducing costs and accelerating their time to solution. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Efficient GPU fleet utilization. Our CoreWeave Cloud Platform is architected to support all types of AI&#160;workloads, including training (consisting of pre-training and fine tuning), synthetic data generation, and inference, covering the full spectrum of customer requirements. Customers can orchestrate all these types of inference and training workloads across the same cluster simultaneously, enabled by our industry-leading Slurm integration, SUNK. Running different types of jobs on the same cluster at the same time increases the utilization of a customer&#8217;s AI infrastructure by allowing customers to seamlessly transition between Slurm based training jobs and containerized inference workloads on the same GPU cluster, negating the need to have two discrete clusters with lower efficiency. CKS, in conjunction with SUNK, enables this intelligent management of workload scheduling to prioritize serving inference demand spikes and better utilize GPU clusters across training and inference. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Flexible technology stack. We adapt to our customers&#8217; needs, enabling our customers to obtain the platform most ideal for their AI applications to run on. Our team is committed to moving quickly and solving problems for our customers that have never been addressed before as they develop and serve the next generation of foundational models. This partnership extends beyond support. Our flexibility is a key asset for our customers as we do not ask them to compromise, but rather empower them to integrate with our platform in the way that best suits their needs. Our microservices-based architecture tailored to AI enables this flexibility. For instance, customers can choose to bring their own storage instance, opt to run on Bare Metal, can elect for committed or on-demand deployment, and can generally configure their use of our CoreWeave Cloud Platform to best fit their requirements. This enables customers to obtain the platform most ideal for their AI applications to run on, providing them with exactly what they require without needing them to make tradeoffs or compromises that leads to reduced efficiency and increased costs. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Lower performance-adjusted cost. We deliver efficiency to our customers through fully optimized AI&#160;performance out-of-the-box, our rapid cluster remediation and failure prevention capabilities, and our differentiated ability to simultaneously and seamlessly run inference and training jobs on the same clusters. All this results in significantly improved infrastructure efficiency and higher MFU, which translates to lower costs relative to solutions provided by other cloud service providers for demanding AI workloads. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave Cloud Platform&#8217;s performance advantage, day-one utility and reliability, higher run-time efficiency, resiliency, and overall AI infrastructure uptime ensures customers can confidently build AI products and services, while benefiting from a lower total cost of ownership. It enables customers to deliver superior intelligence faster, and to expand their compute footprint in lockstep with the commercialization of their solutions. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">101<br></div></div></div>
<!--End Page 112-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 113-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Competitive Strengths </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our key competitive strengths, which we believe set us apart from the generalized cloud providers in the industry, include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We are purpose-built for AI. Our platform is fundamentally architected from the ground up to deliver cutting-edge performance for AI workloads. We have reimagined the traditional cloud architecture to deliver the infrastructure and technology stack required for AI, optimizing it to remove services such as the hypervisor layer and other unnecessary managed services that would otherwise cause performance leakage. It is built to efficiently run workloads on Bare Metal nodes, which makes our CoreWeave Cloud Platform more transparent given the wealth of GPU node-level metrics generated by our stack that most competing solutions are unable to retrieve. Our Managed Software Services, which include our orchestration solution, CKS, and our application services, are optimized for complex AI workloads. Our infrastructure is built on cutting-edge components, including the latest-generation GPUs, networking, and high-performance storage, all working cohesively to deliver unprecedented performance to our customers. Importantly, our data centers are also designed with our &#8220;no compromise&#8221; philosophy centered around AI, with our current builds incorporating liquid cooling where possible to maximize rack density and drive higher utilization of our data center footprint. These innovations are what enable us to help bridge the efficiency gap between the approximately 35% real-world infrastructure MFU and the 100% theoretical maximum. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We live at the bleeding-edge of technology. Our diverse, multi-disciplinary team is founded on a culture of saying yes to delivering our customers&#8217; needs. We are fearless in facing and overcoming complex engineering challenges, and we hire individuals who help contribute to and maintain a culture centered around this philosophy. We raise the standards of execution to meet the needs of our customers, which include some of the largest and most sophisticated organizations that themselves live on the bleeding-edge. We have demonstrated this in our ability to create some of the largest and most performant GPU clusters assembled to date, develop a rich suite of software and services that maximizes infrastructure utilization and efficiency, deliver against an accelerated data center build schedule, and consistently be among the first to market with cutting-edge infrastructure components. We were among the first to deliver NVIDIA H100, H200, GH200 clusters and the first to deliver GB200 clusters into production at scale and launch instances based on RTX Pro 6000. We now have one of the widest Blackwell portfolios available, including B200, and we were the first cloud provider with an initial deployment of NVIDIA GB300 NVL72-based systems. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We operate at scale. We benefit from a network of 33 active purpose-built data centers supported by approximately 470 MW of active power as of June&#160;30, 2025. There is a massive operational capability difference between operating clusters of thousands versus tens of thousands of GPUs. Our track record of operating at scale enables us to participate in this market in ways that others cannot. Our specialization in deploying AI infrastructure at massive scale enables us to serve some of the world&#8217;s leading providers of AI who require massive deployments in order to effectively train and serve the latest foundational models. Moreover, it enables us to benefit from clear economies of scale. It lends us critical brand recognition in the AI ecosystem that accelerates inbound demand for our solutions. It strengthens our supply chain relationships and enhances our access to the best engineering and product talent. And, importantly, it enables us to detect issues and derive insights from across our AI infrastructure sooner than our competitors. Over the long term, our platform delivers superior performance and value as a result. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We have a proven track record of securing power. Power is a key enabler of the AI revolution and an asset that we have managed to secure at scale. As of June&#160;30, 2025, we had approximately 470 MW of active power and approximately 2.2 GW of total contracted power. This provides us with a durable, multi-year runway in power capacity. We relentlessly and creatively explore additional opportunities to add power capacity, as demonstrated by our original agreements with Core Scientific for more than 500 MW of capacity as of December&#160;31, 2024. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We have demonstrated unique financing capabilities. We have designed our capital structure to enable the investments needed to maintain growth at the pace of AI innovation. We have pioneered GPU infrastructure-backed lending, and to date, we have raised over $28.6&#160;billion in debt and equity across 22&#160;financings. In May&#160;2024, we raised $7.6&#160;billion in committed GPU infrastructure-backed debt led by Blackstone and Magnetar, which represents one of the largest private debt financings in history and signals the confidence that debt investors have in funding our company to build and scale the next generation AI&#160;cloud. Since then, we have built on our momentum with a further $2.6&#160;billion GPU infrastructure-</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">102<br></div></div></div>
<!--End Page 113-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 114-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">backed debt facility (the &#8220;DDTL 3.0 Facility&#8221;), which was financed at SOFR +4%, a 9% decrease from our DDTL 2.0 Facility, and demonstrates our progress in reducing cost of capital and enhancing our credit profile. And we have also closed two private offerings of Notes for $2&#160;billion and $1.75&#160;billion respectively, with both offerings upsized from their initial offering size, highlighting investor demand and our ability build strong relationships with a diverse pool of investors, raise capital quickly and efficiently, and scale our capital sources at a decreasing cost of capital. This scale of funding has not been achieved by any established players or new entrants in the AI cloud space that we compete with today, demonstrating the confidence that investors have in our vision and execution capabilities. Our rapid growth and track record for creating high-performance compute clusters and financing them has enabled us to decrease our cost of capital over time. We intend to innovate the financing structures and strategies that we employ in order to access new forms of capital at the scale required to grow our business, while simultaneously driving down our overall cost of capital. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">We maintain robust ecosystem relationships. We benefit from strong, mutually beneficial relationships with our suppliers and customers that strengthen our solution and market position. Our relationship with NVIDIA strengthens our supply chain. We work with NVIDIA to deploy the latest GPU technologies at scale. In turn, we are a partner to NVIDIA in that our proprietary software and purpose-built infrastructure help to minimize the efficiency gap between the observed GPU cluster performance and the theoretical maximum GPU cluster performance, help to diversify their customer base, and help to get their technology in the hands of end customers faster. Our relationships with some of the world&#8217;s leading and most discerning AI labs and AI enterprises, including Microsoft, Meta, and OpenAI, further position us as a cornerstone of the evolving AI ecosystem and creates a flywheel that strengthens our engineering advantage through continuous learning and development.</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 227px; width: 492px;" src="ny20053122x2-flywheel.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These deep technical partnerships with our customers provide our engineers with exposure to unique technical challenges, enabling them to build an invaluable knowledge base regarding the complex requirements of running supercomputers efficiently to extract maximum performance, automate operations, and optimize total cost of management. This gives us the ability to deliver an AI cloud that can operate at the performance, scale and efficiency required by the world&#8217;s most complex workloads. Moreover, we serve some of the world&#8217;s leading AI labs and AI&#160;enterprises, which fosters a reinforcing cycle of continued innovation, as we are the first to experience and solve the challenges of the most compute intensive AI training and inference workloads. This data, which is only used internally to improve our services for our customers, is a critical input into our engineering process and strengthens our technological differentiation as we continue to push the boundaries of what is possible in computing. This &#8220;economy of AI leadership&#8221; ensures we can continuously improve our CoreWeave Cloud Platform over time in a positive feedback loop, by enabling us to learn from any issues or misconfigurations detected across our large infrastructure base and apply those learnings to all our clusters, which in turn positions us as a leading-edge provider of choice for new customers. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">103<br></div></div></div>
<!--End Page 114-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 115-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; position: relative; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Our Market Opportunity </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The impact of AI will be immense for organizations of all sizes across all sectors, which will realize significant productivity gains and time and cost-efficiencies by deploying AI technologies. IDC estimates that AI will add nearly $20&#160;trillion to global GDP by 2030. We believe businesses of all sizes will adopt AI products and services to enhance automation and improve decision making and will need to embed AI into their solutions to differentiate and remain competitive. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that CoreWeave will be one of the most sought-after platforms for the world&#8217;s AI workloads. Our solution enables AI products, services and models to train and run with significantly greater speed and efficiency. We have estimated our total addressable market opportunity by evaluating the size of the large and rapidly growing AI&#160;compute software and infrastructure market that we are pioneering. According to Bloomberg Intelligence, the market for AI inference/fine-tuning, AI workload monitoring, and training infrastructure, including AI servers, AI&#160;storage, training compute, cloud workloads, and networking, will increase by over $300&#160;billion from 2023 to 2028, growing at a CAGR of 38% from approximately $79&#160;billion in 2023 to approximately $399&#160;billion by 2028. This market opportunity is expected to include $330&#160;billion related to training infrastructure, which includes AI&#160;servers, AI storage, training compute, LLM licensing revenue, cloud workloads, and networking; $49&#160;billion related to inference infrastructure; and $20&#160;billion related to workload monitoring, all of which are supportable by CoreWeave. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The AI cloud infrastructure and software market is dynamic and will continue to evolve as new models are introduced and inference continues to scale. We believe we are ideally positioned to capture the opportunity as the market develops and continues to expand. At present, the AI compute market is centered on training the latest generations of models, which is being driven by a select few hyperscalers and AI labs which are advancing model quality and the standard of intelligence they output. While it is likely that inference will grow to account for an increasingly larger proportion of AI workloads, we expect that training and fine-tuning new generations of models on updated infrastructure will continue to be an important addressable market as new generations of hardware, networking, and storage are released. We believe that our best-of-breed software and infrastructure solution and our track record of being among the first to market with the latest infrastructure modalities makes us optimally suited to capture these bleeding-edge training workloads. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the near-term, we expect to see continued rapid growth in demanding inference workloads driven by an exponential increase in model size and complexity and complex reasoning skills, and we anticipate that these workloads will need to run on the latest generation of high-performance infrastructure. Over time, we expect there will be more widespread enterprise adoption of production workloads as enterprises train and serve their own models on high-performance cloud infrastructure leveraging proprietary data. These workloads will have a spectrum of complexity levels. Some of them will need to run on state-of-the-art infrastructure, while other, lower intensity workloads will run more efficiently on older generations of infrastructure. The acceleration of these lower intensity inference workloads will coincide with the growth of our geographically distributed compute base, which over time will consist of a broad range of cross-generation infrastructure as current generations roll off existing contracts and are superseded by new releases. We believe that the mix of hardware across generations that is optimized for different use cases in our compute base will ensure that we are optimally situated to capture all workload types, both inference and training. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Growth Strategies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Demand for AI training and inference continues to scale as models improve and AI drives enhancements to productivity and overall quality of life. Organizations are accessing AI either directly or through layers of abstraction, for instance through APIs that connect businesses to the leading foundational models in circulation today. We are committed to investing in our business to capitalize on the accelerating demand for AI compute and grow the adoption of our CoreWeave Cloud Platform, and are pursuing a number of strategies to enhance our ability to deliver the software and infrastructure to power the proliferation of intelligence across the world&#8217;s economy and society. Our principal growth strategies include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Extend our product leadership and innovation. We pioneered<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup> the AI Hyperscaler and are committed to innovating to extend our technology leadership. Our team operates at the bleeding-edge of technological advancement and continues to deliver new solutions and optimize our technology stack to deliver substantial performance and efficiency gains for AI workloads at scale. We have delivered and unlocked </div></td></tr></table></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div></div><div class="BRDSX_block-footnote" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 10pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;"><font style="position: relative; top: -3.25pt;">2</font><br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 8pt;"><font style="font-size: 8pt;">Based on the capabilities of our platform, solutions, and services as compared to competing hyperscalers, our track record of being among the first to deliver bleeding-edge infrastructure and technology, and our collaboration with leading data center providers and AI labs and AI enterprises to accelerate innovative technology and infrastructure in the AI cloud computing industry. </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">104<br></div></div></div>
<!--End Page 115-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 116-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">the performance of some of the largest GPU clusters assembled to date, and we continue to release additional updates to our cloud software services to further enhance the capabilities of our infrastructure, as demonstrated for example by our recent product releases including CKS, Mission Control, and SUNK all of which accelerate the ability of our customers to train and serve models. We plan to continue to prioritize investing in our product and engineering teams to develop our cloud software services. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Continue capturing additional workloads from existing customers. Our CoreWeave Cloud Platform serves some of the most powerful AI labs and AI enterprises that are building AI products today. Through some of these cornerstone customers, it addresses a massive volume of AI workloads directly from them or through their APIs. As these leading providers of AI continue to achieve product market fit with the latest foundational models, their training and inference workload volume will scale exponentially. Our dedicated focus on both AI labs and AI enterprises will enable us to achieve natural growth across this customer segment as AI continues to become ubiquitous, and as these customers realize the performance and efficiency benefits of our CoreWeave Cloud Platform. We have built dedicated teams of AI-experts across our engineering, product, sales and customer experience organization that understand customers&#8217; needs for rapidly evolving AI use cases. These teams work hand-in-hand with our customers to help them better understand our product capabilities and innovations to best position us to capture increasing spend as they expand. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Extend into broader enterprise customers across new industries and verticals. Our current and potential customers include the world&#8217;s premier AI labs and AI enterprises, for whom AI is a core component of their product strategy and overall business model, and who depend on our CoreWeave Cloud Platform to deliver the next generation of AI models and applications. As AI continues to become ubiquitous in daily life and as other verticals and industries, including regulated industries like banks, high-frequency trading, and pharmaceutical companies, begin to develop and build their own dedicated AI solutions, we plan to expand to serve those verticals and capitalize on the opportunity to provide our CoreWeave Cloud Platform to host their workloads. Although it is early, we have already started to see strong interest from such industries. We also anticipate that new industries and use cases will arise to take advantage of developing AI capabilities as AI models become more accessible and cheaper, presenting additional growth opportunities for our platform. We believe that our acquisition of Weights &amp; Biases will enable us to improve our CoreWeave Cloud Platform to address the needs of customers who are researching, building, and deploying AI models and applications. Following closing of the acquisition, we have integrated Weights &amp; Biases&#8217; capabilities as a new entry point for customers to access our CoreWeave Cloud platform and take advantage of the differentiated infrastructure and managed software services that we offer such as our Mission Control Integration and W&amp;B Inference, powered by the CoreWeave Cloud Platform. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Expand internationally. We are expanding our business to capitalize on growing demand for AI applications and solutions across the globe, driven by customers&#8217; desire to build their AI applications locally and minimize latency. In 2024, we established a presence in London, United Kingdom, Barcelona, Spain, and Falun, Sweden, with more than 40 MW of active power in these locations as of December&#160;31, 2024. In addition, we have contracted data center capacity in Canada, Sweden, Norway, and other countries in Europe with additional capacity in the pipeline. In addition, regulatory frameworks are expected to increasingly restrict data from flowing across borders, meaning that AI models may eventually need to be trained on regional data pools and served locally. Expanding our reach in key international markets enables us to serve that regional demand for AI&#160;compute. We are methodical around our international expansion and tailor it to where we see the most demand for AI compute. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Increase our vertical integration. We plan to continue to verticalize &#8220;up the stack&#8221; by innovating and adding to our software offerings to drive customer engagement and value (such as the acquisition of Weights &amp; Biases). At the same time, we may continue to verticalize &#8220;down the stack&#8221; by enhancing our data center capabilities to bolster our access to data center capacity, future-proof our solutions, and drive further operational efficiency (such as the acquisition of Core Scientific). We intend to achieve further vertical integration either organically or through targeted acquisitions. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">Verticalize &#8220;up the stack.&#8221; The strategic position of our solution as the control plane which drives the performance, efficiency and visibility into the underlying infrastructure enables us to build additional functionality and services on top of it, including dedicated layers of abstraction and automation to simplify the way customers interact with our infrastructure, as well as solutions for fine-tuning AI&#160;models and production environments for AI applications. This enables our customers to access </font></div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">105<br></div></div></div>
<!--End Page 116-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 117-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_ebl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 60pt; text-align: justify;">AI&#160;infrastructure more easily, scale as their need for AI workloads grows, and get their products to market faster. For example, we plan to further increase ease of use by abstracting complexity for our customers through our Global Inferencing solution which enables customers to automate the management of their inference deployments by plugging in APIs and avoiding the need to manage GPUs at a more granular level. We plan to also create tools to empower developers and machine learning engineers to seamlessly access and fine-tune foundational models to power AI applications on our platform achieving greater efficiency and productivity. Since the acquisition of Weights &amp; Biases, we believe we are better able to accelerate the expansion of our developer tools for both fine-tuning and training models, as well as building AI applications, and reinforces our ability to continue adding functionality &#8220;up the stack.&#8221; We are best positioned to add functionality &#8220;up the stack&#8221; given we control the underlying infrastructure, which is the most difficult layer of the technology stack to replicate given our investments into our infrastructure over time. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: justify; font-size: 10pt;"><font style="font-size: 10pt;">Verticalize &#8220;down the stack.&#8221; As data centers continue to evolve and take center stage as the next-generation supercomputers driving the AI revolution, our ability to further manage and customize our data center footprint will de-risk our future growth and expense. Currently, the majority of our data center portfolio is leased. We may make investments into data centers and increase the proportion of our data center footprint where we have direct ownership stakes. This will enable us to have more control and accountability over the delivery timeline of new builds, and allow us to exert more control over our data center costs. </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Maximize the economic life of our infrastructure. We seek to maximize the value of our fleet of GPUs to the fullest extent possible, and do this by monetizing the infrastructure underlying expired contracts through either another contract for the remainder of its economic life or through an on-demand consumption pool. We expect a large number of GPUs to become available for the on-demand distributed compute pool as our customers renew contracts with future generations of chips. These current generation chips will be well-suited to handle inference workloads and lower intensity training workloads after contracts expire, which will lead to cost optimal solutions for our customers. As the AI revolution continues and more widespread enterprise adoption of AI workloads occurs, there will be a breadth of workload complexity levels which will need to be matched to infrastructure with varying levels of performance and cost. Some of those workloads will be less computationally intensive and can be served by older generations of infrastructure. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Our Platform and Product Offerings </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CoreWeave Cloud Platform is an integrated solution that enables companies to run AI workloads with high performance and efficiency. It includes our Infrastructure Services, Managed Software Services, and Application Software Services, all bolstered by our Mission Control and Observability software. Our proprietary software underpins every component of the platform, allowing for highly secure provisioning of infrastructure, effective orchestration of workloads, and real-time monitoring of training and inference environments. Security is a fundamental component of our platform. We ensure our customers operate in a secure environment by implementing a zero trust model for data access and leveraging advanced security technologies, including XDR and DLP deployed across our endpoints. Additionally, we use single-sign-on and multi-factor authentication to ensure our CoreWeave Cloud Platform remains resilient against identity-based cyber threats. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; text-align: center;">CoreWeave Cloud Platform </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 181px; width: 467px;" src="ny20053122x2-architecture.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">106<br></div></div></div>
<!--End Page 117-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 118-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Infrastructure Services: Delivering bleeding-edge compute, networking, and storage infrastructure<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our platform is powered by our foundational Infrastructure Services, which utilize our proprietary software and a combination of high-performance GPUs, CPUs, DPUs, storage, and networking equipment, all calibrated to deliver the performance at scale required to power AI workloads. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Compute. Our compute is delivered through combinations of GPU and CPU nodes interconnected with state-of-the-art, high-performance networking technology such as NVIDIA InfiniBand and optimized through DPUs in a high throughput network topology that provides extensive scalability for AI workloads. GPU nodes are the primary engines for AI compute and are supported by the latest generation of CPUs, memory, PCI-Express data interconnects, NVMe SSDs, and DPUs. These components help to extract maximum performance out of GPUs and also offload non-core tasks. We continuously monitor the health and performance of GPU and CPU nodes to ensure improved resilience and rapid recovery. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">GPU Compute. We provide our customers with access to a vast portfolio of high-performance GPUs that are purpose-built for AI. This includes Blackwell chips, such as the NVIDIA GB200 that we were the first&#160; to market with at production scale, Hopper chips, and more. Our H100 architecture enabled us to break the MLPerf record in 2023, delivering training speeds 29 times faster than competitors at greater scale. And recently, we delivered another best-performing submission with the largest-ever MLPerf Training v5.0 submission on NVIDIA Blackwell, using 2,496 NVIDIA Blackwell GPUs running on CoreWeave&#8217;s AI-optimized cloud platform. We were among the first to deliver NVIDIA H100, H200, GH200 clusters and the first to deliver GB200 clusters into production at scale and launch instances based on RTX Pro 6000. We now have one of the widest Blackwell portfolios available, including B200, and we were the first cloud provider with an initial deployment of NVIDIA GB300 NVL72-based systems. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CPU Compute. We offer versatile CPU instances to support AI workloads. Our infrastructure utilizes some of the industry&#8217;s highest performing and latest CPUs instead of prior generation technology that can degrade GPU performance and utility. Our CPUs complement our GPUs by performing tasks, including data pre-processing, control plane functions, and workload orchestration, which frees GPUs to focus on compute intensive tasks. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">DPUs. DPUs optimize compute for AI workloads by offloading networking, security, and storage management tasks from GPUs and CPUs. They are a critical enabling component for increasing overall efficiency and performance. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Nimbus. Nimbus is our control and data-plane software running on our DPUs inside Bare Metal instances, performing the typical role of a hypervisor in enabling security, flexibility and performance. Nimbus-enabled DPUs remove the need for a virtualization layer and give customers the flexibility to run directly on our servers without a hypervisor, enabling greater compute performance. Nimbus also provides security through the isolation of customer models and data encryption, while enabling them to set up Virtual Private Cloud environments. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Networking. Our networking architecture is highly specialized and uniquely designed to meet the complex needs of AI use cases. It includes our high-performance InfiniBand based cluster networking, our data center network fabric which connects our GPU and CPU nodes to our control plane via DPUs for efficient offloading of certain processing tasks, our VPC networking framework, as well as our Direct Connect offering which provides enterprise-grade networking and supports multi-cloud deployments. The ultra-fast connection and superior throughput enabled by our networking architecture ensures faster training and inference times for our customers. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Cluster Networking is the result of our relationship with NVIDIA to design a networking architecture that is purpose-built for AI clusters. The NVIDIA InfiniBand network that we deploy is one of the largest in existence with up to 3,200Gbps of non-blocking GPU interconnect and provides industry-leading effective networking throughput to accelerate time to train and serve models. Our Blackwell deployments will further be supported by external NVLink Switches, a low latency, scalable, and energy-efficient protocol that allows GPUs to communicate with other GPUs and CPUs within the same and different systems more efficiently. These technologies enable us to offer our customers access to tens of thousands of GPUs connected in a single cluster, and the ability to create massive megaclusters. Our megacluster resilience is supported by Mission Control, which prevents and rapidly remediates any deficiencies that arise. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">107<br></div></div></div>
<!--End Page 118-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 119-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">VPC Networking creates isolated virtual networks to manage CoreWeave Cloud Platform resources, allows customers to securely connect compute, storage, and networking resources to their development and deployment platforms using the latest security best practices including encryption, isolation, and access control. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave Direct Connect plugs into our carrier grade networking backbone and enables embedded scale that supports our data centers. It is built to support multi-cloud needs, operates across the United States and Europe, and provides private, highly performant connections to transfer data with speed and security. It allows our customers to easily connect their CoreWeave clusters with resources available at other cloud providers or on-premises. Direct Connect boasts port speeds of up to 400Gbps, flexible options to connect through either dedicated ports or existing carriers, and budget-friendly costs with no data transfer or egress fees. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Storage. Our systems incorporate enterprise-grade, software-defined scale-out storage capabilities. Our highly performant, secure, and reliable storage capabilities are designed for the most complex and demanding AI workloads. They load data at rapid speeds, enabling large distributed AI workloads to be scaled up in seconds. These storage capabilities also allow customers to benefit from auto-provisioning of GPUs and store large volumes of model checkpoints and intermediate results so that teams can stay on track after interruptions to their training or inference jobs. Our purpose-built storage architecture enables our customers to achieve significantly faster load times. Our storage services, which include object storage and distributed file storage, leverage industry-best security practices, including encryption at rest and in transit, role-based identity access management, and authentication. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Object Storage. Given traditional object storage solutions are not designed for accelerated workloads, customers typically need to leverage a caching layer on top of object storage to run their GPU clusters at top performance. Our object storage solution is built from the ground-up specifically for AI. It eliminates the need for an intermediate cache based on a file storage system. It leverages our proprietary Local Object Transport Accelerator, which caches data locally onto GPU nodes to deliver the performance required to go straight from object storage to GPUs and is able to provide up to 66% price/performance than alternative solutions from traditional providers. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Distributed File Storage. We offer distributed file storage solutions that centralize asset storage and support parallel computation setups. For customers who require these features and prefer to utilize a distributed file storage system in addition to object storage, our Distributed File Storage system provides the flexibility to do so. Our platform also enables customers who run on-premise to integrate their own distributed file storage system into our platform, providing a truly flexible technology stack that is designed to support our customers&#8217; storage needs. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Dedicated Storage Clusters. Our microservices based architecture allows us to support our customers&#8217; choice of storage back-ends. We work with an ecosystem of storage cloud partners to provide flexibility and choice in order to get access to their preferred storage solutions that are well integrated with our CoreWeave Cloud Platform. </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">Managed Software and Application Software Services: Built for AI at<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Multiple Layers of the Cloud Technology Stack<font style="font-weight: normal;"> </font></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 253px; width: 594px;" src="ny20053122x2_appsoftware.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">108<br></div></div></div>
<!--End Page 119-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 120-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Managed Software Services: Fully managed deployment for the most efficient workloads </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Managed Software Services include CoreWeave Kubernetes Service, our AI workload orchestration and auto-scaling solution, our VPC product, and our Bare Metal service. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave Kubernetes Service. CKS is our AI-optimized, managed Kubernetes service that minimizes the burden of managing large GPU clusters. CKS is purpose-built for AI workloads and delivers fast performance, security, and flexibility in a fully managed Kubernetes solution. CKS has built-in guardrails and automated processes specialized for AI workloads that reduce the need for teams to spend countless hours managing complex Kubernetes clusters. CKS clusters leverage Bare Metal nodes without a hypervisor to maximize node performance, and our DPU-based architecture for complete isolation and acceleration with private-cluster VPCs. As such, CKS ensures that each node operates at peak performance within a secure, isolated environment. There are extensive customization options available to manage data, control access and policy, and handle authentication and other security controls, giving customers ultimate flexibility and authority over their specific data management practices. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Virtual Private Cloud. Our VPC solution allows customers to utilize an isolated, private section of our CoreWeave Cloud Platform where they can run their resources in a controlled network environment. It delivers a flexible experience backed by enhanced security, with both direct control and a high degree of customization. It enables hyper specific networking policies on a workload-by-workload basis, including terminating VPNs, managing routing, and access control. Our robust node isolation capabilities create both data and VPC segregation that deliver maximum security for our customer workloads. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Bare Metal. Our Bare Metal service is fast, reliable, and performant. The vast majority of AI workloads do not need virtualization. Instead, they need direct access to resources to run training, inference, and experimentation with maximum performance and low latency. We eliminate the need to have a hypervisor layer and enable our customers to run Kubernetes, or an orchestration platform of their choice, directly on Bare Metal instances. This allows us to combine the flexibility of cloud-like provisioning and the power and performance of dedicated hardware, unlocking higher performance, increasing reliability, freeing up compute resources, and allowing for in-depth insights on cluster health and performance through granular metrics. For customers who prefer a more managed experience, our Bare Metal service also enables customers to spin up Bare Metal nodes in CKS and offload certain basic functions such as storage and network drivers. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Application Software Services: Additional tools that accelerate and improve training and inferencing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Application Software Services allow companies to seamlessly integrate additional tools that accelerate and improve training and inference. Due to our microservices-based architecture, our platform is fully composable, with customers able to run their own orchestration solution or third-party applications seamlessly as part of our stack. As with all our other services, we follow security best practices at every step. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Slurm on Kubernetes Integration (SUNK). Slurm is an open-source workload manager popular among AI&#160;model developers and other users of high-performance compute. It is an industry leader for the orchestration of massive parallel scheduling jobs such as training LLMs. Kubernetes, on the other hand, is designed for containerized workloads in cloud-native environments making it particularly well suited for model serving. Customers previously had to either choose between Slurm or Kubernetes on a per cluster basis for their resource management needs, even though the two applications serve different use cases and excel in different environments. Often, this led to maintaining two distinct platforms and pools of compute. We have eliminated the need to choose between Slurm or Kubernetes by creating SUNK, a proprietary offering released in early 2024 that integrates Slurm with CKS and allows for Slurm jobs to run inside Kubernetes. This allows developers to leverage the resource management of both Slurm and Kubernetes and results in a seamless end-user experience. Different AI workloads can be co-located on the same cluster, including training, inference, and experimentation, unlocking greater workload fungibility. SUNK enhances the efficiency of compute by sharing resources between Slurm and Kubernetes and streamlining deployment of our system. Introducing Slurm into our stack has solved a major infrastructure pain point for our customers while reducing their total cost of ownership. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave Tensorizer. CoreWeave Tensorizer is our training and inference optimization solution that spins up models rapidly from storage directly into GPU memory from a variety of different endpoints. It serializes models into a single binary file and incorporates a caching layer to quickly flow models to the closest node to the client, thereby dramatically cutting down resource expenditure caused by long loading </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">109<br></div></div></div>
<!--End Page 120-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 121-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">times. When tested on a larger model size using a higher-performing GPU, the impact of Tensorizer on model load time becomes even more pronounced. In terms of relative performance, our Tensorizer had average model load times that were 1.7x and 1.4x faster than that of SafeTensors and HuggingFace respectively. Our Tensorizer solution also increases model training efficiency by enabling fast checkpoints and reducing restart times. Checkpointing ensures models are frequently saved and archived during the training process such that failures do not require full and time consuming restarts. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Weights &amp; Biases Models. Following the closing of our acquisition of Weights &amp; Biases, our platform now includes integrations to the Models product-line, which extends the capabilities we currently offer with SUNK and Tensorizer to include real-time tracking and visualization of training runs, customer packaging, and workflow optimization, and the ability to further optimize hyperparameters, track model lineage, and fine-tune both open-source and proprietary models. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Inference Optimization &amp; Services. Our platform is optimized for inference, delivering unparalleled flexibility, efficiency and access to the compute required to serve these workloads effectively. Through our planned inference optimization services, customers will be able to right-size their workloads with access to a varied GPU fleet customized to their specific performance and cost requirements, and can provision what they need when they need it to match the complexity of their workloads. Following the closing of the acquisition, we have implemented integrations with the Weights &amp; Biases&#8217; Weave product into our inference optimization services, such as &#8220;W&amp;B Inference, powered by CoreWeave,&#8221; supporting the real-time monitoring and debugging of LLMs and prompts, providing additional tools for rigorous evaluation of generative AI applications, and enabling monitoring and debugging agents and prompts. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Mission Control &amp; Observability: Delivering full visibility into and control over infrastructure and workloads </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">AI compute infrastructure brings together multiple cutting-edge technologies including the latest and most powerful compute resources, high bandwidth memory, high-speed chip-to-chip interconnects, and node-to-node connectivity. While these technologies deliver unprecedented performance, they come with the additional overhead and complexity of dealing with node and system failures. Our Mission Control &amp; Observability solution helps customers to manage their infrastructure and operations with a suite of services designed to ensure optimal setup and functionality of infrastructure components throughout their entire lifecycle, thereby preventing and rapidly remediating issues and enhancing performance. Mission Control consists of our FLCC and NLCC, and is complemented by our Observability solution. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Fleet LifeCycle Controller (FLCC). Our Fleet LifeCycle Controller automates node provisioning, testing, and monitoring to validate nodes and systems for Day 1 operations and beyond. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Node LifeCycle Controller (NLCC). Our Node LifeCycle Controller proactively assesses ongoing node health and performance to ensure problematic nodes are replaced with healthy ones before they cause failures. Both FLCC and NLCC are systems that are running on our back-end. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">110<br></div></div></div>
<!--End Page 121-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 122-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Observability. Our Observability solution provides access to a rich collection of node and system-level metrics to complement the capabilities of Mission Control that help prevent or quickly identify system faults and restore system-level performance. Faults can occur for various reasons, such as bad user configuration (memory allocation issues), misbehaving software updates, server component malfunctions, or issues in the high speed node-to-node network. Customers can collect and receive alerts on metrics across their fleet, using dashboards that visualize either the entire cluster or individual jobs, and identify root-cause issues in a matter of minutes, as well as early warning signs that enable them to replace or repair nodes that are close to failure. Our Observability solution gives customers deep insight into their infrastructure down to the temperature of individual GPUs. </div></td></tr></table><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; text-align: center;">CoreWeave Real-Time Dashboard</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; text-align: center;"><img style="height: 196px; width: 440px;" src="ny20053122x2-dashboard.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Deep Technical Partnerships </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our partnership strategy is to augment our capabilities by developing deep technical partnerships and relationships with companies that share our vision for empowering customers and accelerating the AI ecosystem. These partnerships are central to how we build our products and services: they enable us to unlock capabilities further up the stack and serve as layers of abstraction that extend our reach to a broader customer base who ultimately run on our infrastructure. Through our partnerships, we have been able to drive enhancements in AI Ops/inference (e.g., Run:ai), improve infrastructure capabilities (e.g., Datadog), and engineer new purpose-built data architectures (e.g., Vast Data and Pure Storage). Our partnership strategy further extends to our relationships and collaboration with suppliers like NVIDIA whose GPUs we bring to market in highly efficient and performant architecture for end customers, and to our data center providers such as Switch and Chirisa Technology Parks who we work with to integrate the most cutting-edge design and cooling standards customized for the performance requirements of AI workloads. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Customer Experience </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All of our solutions are complemented by our highly skilled and AI specialized Customer Experience teams, which provide deep insights and expertise in AI compute, networking, and storage. Our teams&#8217; deep AI expertise is fundamental to us gaining the trust of some of the world&#8217;s leading AI labs and AI enterprises, and so we have purposefully designed our Customer Experience organization in a way that seamlessly extends our expert capabilities to our customers. Our Customer Experience team is comprised of: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Fleet Ops and Cloud Ops: Teams that support our FLCC and NLCC solutions and function as operations centers supporting overall system resilience across our customers&#8217; infrastructure. Our Fleet Ops team monitors how fleets are operating, while our Cloud Ops team monitors customer-specific deployments. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Support specialists: Dedicated Support Operations Engineers and Customer Success Engineers who are tasked with setting-up deployments and working with customers to scale workloads as quickly and efficiently as possible. These teams help our customers achieve their goals with our product through proactive support and resources and focus on understanding and assisting customers post-sale to foster long-term relationships. Our team of engineering experts is available 24/7 to assist customers and provide the support needed to ensure optimal cluster performance. Support specialists also include our Documentation team, which creates and maintains the technical documentation to support our customer success, sales, and marketing teams. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">111<br></div></div></div>
<!--End Page 122-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 123-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Solutions architects: Experts who work with our engineering teams to ensure customer infrastructure runs at peak performance. Our solutions architects focus on helping customers understand and derive value from our platform, and cover both pre-sale and post-sale processes including proof-of-concept, implementation, switching to new architectures, and ongoing management/deployment. They ensure customers derive maximum value from their infrastructure and assist with any tuning work required to unlock the leading performance of our platform. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Across our entire platform, we are committed to delivering robust security solutions that maintain system integrity, availability, and data security. We continuously test our platform for security vulnerabilities using automated testing methods and have teams dedicated to penetration testing, enterprise vulnerability management, and application security. We also have a Security Operations team that monitors security events in real time 24 hours a day to provide continuous protection. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Our Data Center Footprint</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; text-align: center;"><img style="height: 225px; width: 569px;" src="ny20053122x2-map.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our platform is powered by some of the largest and most sophisticated data centers in the world, consisting of complex installations of the most cutting-edge GPU accelerators. These large clusters are designed and built with pioneering network architectures and a &#8220;no compromise&#8221; philosophy that centers around maximizing performance for AI workloads. The state-of-the-art hardware deployed in our data centers requires the most forward thinking physical infrastructure designs to deliver highly performant networking, power, and cooling characteristics. Each component of our data center technology stack is purposefully selected to contribute to, and compound, this performance advantage. The result is a geographically distributed and highly performant data center footprint underpinned by cutting-edge components, high-density design configurations, and robust security standards. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Cutting-edge data center technologies maximize rack density</font>. Our data centers are purposefully designed to maximize rack density and drive power per rack. They utilize advanced liquid cooling systems that enable the efficient use of space by removing the bulky chillers and airflow management equipment required in air cooling systems. The improved heat capacity of liquid cooling systems also allows us to stand up racks closer together, supporting higher power density while preventing performance degradation of our systems due to overheating. Liquid cooling systems, while highly efficient at supporting dense, power-intensive workloads, require a fundamental redesign of the data center in order to accommodate necessary piping, pumps, and heat exchangers. This often entails having a separate subfloor to contain routing and plumbing infrastructure while keeping the main floor more organized and compact to drive density. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">112<br></div></div></div>
<!--End Page 123-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 124-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">CoreWeave&#8217;s First NVIDIA GB200 NVL72 Cluster With Liquid Cooling</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 297px; width: 443px;" src="ny20053122x2_first-nvidia.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">These design requirements render traditional cloud service providers, who are tied to significant existing air-cooled data center footprints and buildout plans, incapable of maximizing their data center capacity without time intensive and costly retrofitting challenges. Liquid cooling systems and the greater power density and efficiency it unlocks, is not a nice-to-have feature but rather an essential component of any GPU-based infrastructure that is purpose-built for AI. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Broad Footprint. We have architected a distributed and interconnected portfolio of data centers that delivers a high density of compute close to major population centers, thereby minimizing latency for end users. Our portfolio covers cities spanning the United States and is rapidly expanding into new markets in Europe, delivering high-compute capacity to regions that are currently capacity constrained. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Massive Scale. Delivering highly performant and flexible infrastructure means building high capacity data centers that can quickly scale from tens to hundreds of megawatts in response to burst workloads, i.e., sudden surges in demand. We leverage dark fiber connectivity to deliver rapid and efficient inter-data-center connectivity and enable customer workloads to burst across regions. By connecting multiple active purpose-built data centers with high speed interconnects, we deliver the flexible compute required for large scale supercomputers optimized for AI workloads, and can scale this compute to match our customers&#8217; needs. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Embedded Security. We reinforce our infrastructure with industry leading security standards and certifications, including SOC 2 and ISO 27001, to ensure that customers are met with the most robust data security practices. Our security measures also extend to our physical security, where we employ rigorous standards around background checks, access control, security awareness training, and a zero-trust framework. This multi-layered approach ensures a secure, resilient operating environment at every level of our data centers. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Altogether, these design considerations have enabled us to deliver some of the most performant, efficient, and secure infrastructure deployments in the industry, at unprecedented scale. Our innovation also extends beyond the physical hardware and infrastructure powering our data centers to the supporting software and infrastructure services. This allows customers to run their AI jobs without the burden of managing the underlying infrastructure themselves. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had approximately 470 MW of active power and approximately 2.2 GW of total contracted power. This includes 33 cutting-edge data center facilities in the United States across 16 states, as well as facilities in three other countries. Importantly, our power capacity is available in large individual deployments that are capable of serving large infrastructure clusters, which is critical for our larger customers. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, we opened our European headquarters in London to help facilitate our expansion to Europe. Our initial expansion to Europe includes five sites in the United Kingdom, Spain, and Sweden. In June&#160;2024, we announced a $2.2&#160;billion investment to expand in Spain and Sweden and launch in Norway, which we expect will </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">113<br></div></div></div>
<!--End Page 124-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 125-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">more than double our MW of capacity by the end of 2025. In September 2025, CoreWeave also announced the next &#163;1.5 billion phase of its investment in AI data center capacity and operations in the United Kingdom, bringing the total announced investment in the country to &#163;2.5 billion. In June&#160;2025, we entered into a joint venture with a third-party infrastructure developer, to support the acquisition and development of a multi-phase data center campus in Kenilworth, New Jersey. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Our Culture and Values </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our mission is to power the creation and delivery of the intelligence that drives innovation. To succeed in this mission, we place great value on our team and emphasize the importance of a strong culture. Our diverse, multidisciplinary team is founded on a culture of saying yes and facing and overcoming complex engineering challenges. We have assembled leading engineering and go-to-market teams with what we believe is an unmatched knowledge base in accelerated computing at scale. These teams work synchronously to deliver our CoreWeave Cloud Platform and drive the maximum performance in AI workloads for our customers. To maintain this competitive advantage and continue to innovate, we remain focused on building an inclusive working environment in which our team members can push the boundaries of what is possible, and we empower our employees to grow and succeed with the right tools in a highly collaborative environment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have created and instilled a set of Core Values that our employees embrace and demonstrate each day. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our Core Values include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Be Curious at Your Core. We foster a mindset of continuous learning, understanding that curiosity drives innovation and is essential in staying ahead of our competition. Curiosity is a driving force that allows us to explore ideas and innovations that push boundaries, challenge the status quo, and better serve our customers. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Act Like an Owner. We take full responsibility for our work and our decisions to find the best solution to any challenge. We take initiative, hold ourselves accountable, and foster a culture where everyone feels empowered to contribute to our success. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Empower Employees. We trust each other to make decisions, communicate transparently, and are clear on our goals. We support each other with the tools, resources, and feedback necessary to succeed. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Deliver Best-in-Class&#160;Customer Experiences. We go above and beyond to understand our clients&#8217; needs and aim to exceed expectations at every step. Our commitment to excellence ensures we build lasting partnerships and set the standard for exceptional service. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Achieve More Together. Collaboration is at the heart of our success. Together, we unlock greater potential and solve challenges more effectively. We believe that by leveraging diverse perspectives, supporting each other, and working as one team, we can accomplish more than we could ever do alone. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We are also committed to diversity, inclusion and belonging: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Diversity. Ensuring diversity&#8212;in background, skill set, and perspective&#8212;which is business critical to continuing to innovate and bring new products into the market to effectively serve our customer base and new AI use cases. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Inclusion. Ensuring all employees have opportunities to learn, grow, develop, and perform the best work of their lives. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Belonging. Ensuring that all our employees feel they are a meaningful part of CoreWeave and they matter. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had 1,565 employees, with 1,401 in the United States and 164 in twelve other countries. We work to identify, attract, and retain employees who are aligned with and will help us progress with our mission, and we seek to provide competitive cash and equity compensation. We believe we have a good relationship with our employees and our strong culture differentiates us and is a key driver of business success. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Our Customers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We offer a solution used by organizations of all sizes that require sophisticated AI compute, from the largest of enterprises to small, well-funded start-ups. Our customers today are segmented into two key verticals: AI Natives and AI Enterprises. Companies within these verticals include the <font style="font-style: italic;">builders</font> of AI, the <font style="font-style: italic;">integrators</font> of AI, and those that have </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">114<br></div></div></div>
<!--End Page 125-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 126-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">business models whose success largely hinges on deploying AI capabilities in their core products and technology stack. Our differentiation lies in the specialized AI infrastructure that we deliver and make accessible to our customers on Day 1, which enables them to accelerate their time to market and achieve lower total costs of ownership. We shift the entire burden of managing infrastructure from our customers to our platform, allowing them to spend more time building models, serving models, or focusing on critical strategic priorities such as growing their customer base or developing their product roadmaps. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Our Customer Verticals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Our customers include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI Natives: Customers whose core competency and singular focus is AI. These companies serve as important layers of abstraction for the market and enable end customers across industries to unlock the power of AI by accessing the power of foundational models. This vertical includes: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI Labs: Research organizations building their own foundational models through proprietary datasets, and creating products to deliver those models to the market. While these labs have tended to focus more on building general-purpose models, industry-specific AI labs, such as the AI cluster at the Chan Zuckerberg Initiative Foundation supporting research in the life sciences, are expected to become a growing part of this segment. These AI labs deliver their general purpose models or custom versions of those models via APIs to businesses of all shapes and sizes in order to power a growing range of applications. Our AI Lab customers include, among others, Cohere, Mistral AI, and OpenAI. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI Ops / ML Ops: Organizations providing software or platform solutions &#8220;up the stack&#8221; from cloud infrastructure to make AI adoption easier for businesses with inference or training needs. These companies provide a range of solutions, including access to pre-trained model hubs and datasets, APIs to streamline model deployment, and dedicated tooling that helps optimize training and fine-tuning techniques. Companies within this space will be critical enablers of AI and its broader adoption as they will support customers who either lack the willingness, expertise, or financial means to build proprietary models through their own research teams and dedicated infrastructure. AI Ops / ML Ops customers include, among others, Replicate. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">AI Enterprises: Large companies whose business and product are not AI, but are being driven by AI. These include Fortune 500 companies and other large enterprises with business models that are increasingly AI-enabled through their own development efforts and/or that leverage AI directly to drive internal efficiency gains. We have seen initial traction in adopting our platform from big tech, financial institutions, and life sciences companies to date with customers such as Meta, IBM, Microsoft, and Jane Street. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the AI Natives and AI Enterprises who we sell to directly, there is a large segment of the market that uses our platform, solutions and services indirectly. This includes the tens of thousands of enterprises that have not yet built in-house AI models or systems, but who use solutions developed by AI Natives. As AI continues to find product market fit, we expect these enterprises to grow their indirect consumption of our platform through AI labs. Furthermore, as these enterprises increase their consumption and our product roadmap evolves and verticalizes up-the-stack, we expect that we will serve more of these enterprise customers directly through our dedicated solutions and partnerships. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Contracted customers had a weighted average contract term of approximately four years as of December&#160;31, 2024. Due to our focus on the leading organizations engaged in AI training and inference, we recognized an aggregate of approximately 41% and 73% of our revenue from our top three customers for the years ended December&#160;31, 2022 and 2023, respectively. We recognized an aggregate of approximately 77% of our revenue from our top two&#160;customers for the year ended December&#160;31, 2024 and 79% for the six months ended June&#160;30, 2025. None of our other customers represented 10% or more of our revenue for the year ended December&#160;31, 2024 and the six months ended June&#160;30, 2025. For the year ended December&#160;31, 2022, our largest customer accounted for 16% of our revenue. For the years ended December&#160;31, 2023 and 2024, our largest customer was Microsoft, which accounted for 35% and 62% of our revenue, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2023, we entered into a Master Services Agreement (the &#8220;Microsoft Master Services Agreement&#8221;) with Microsoft, pursuant to which we provide Microsoft with access to our infrastructure and platform services through fulfillment of reserved capacity orders submitted to us by Microsoft and as may be amended upon our and Microsoft&#8217;s mutual agreement. We have recognized revenue of $81&#160;million and $1.2&#160;billion for the years ended </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">115<br></div></div></div>
<!--End Page 126-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 127-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">December&#160;31, 2023 and 2024, respectively, pursuant to the Microsoft Master Services Agreement. The Microsoft Master Services Agreement will remain in place until either all outstanding orders under the Microsoft Master Services Agreement are expired or terminated, or the Microsoft Master Services Agreement is otherwise terminated in accordance with its terms. Either party may terminate the Microsoft Master Services Agreement for cause (i) upon 45 days&#8217; written notice to the other party of a breach or (ii) if the other party becomes subject to a bankruptcy petition or other insolvency proceeding, receivership, liquidation or assignment for the benefit of creditors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, we entered into a Master Services Agreement (the &#8220;OpenAI Master Services Agreement&#8221;) with OpenAI, pursuant to which we provide OpenAI access to cloud computing capacity through fulfillment of reserved capacity orders submitted to us by OpenAI and as may be amended upon our and OpenAI&#8217;s mutual agreement. As of March&#160;31, 2025, subject to any termination described below and satisfaction of delivery and availability of service requirements, OpenAI has committed to pay us up to approximately $11.9&#160;billion through October&#160;2030. The OpenAI Master Services Agreement will remain in place until either all outstanding orders under the OpenAI Master Services Agreement are expired or terminated, or the OpenAI Master Services Agreement is otherwise terminated in accordance with its terms. Either party may terminate the OpenAI Master Services Agreement (and any orders thereunder) for cause. Under the outstanding order under the OpenAI Master Services Agreement, we have established a special purpose vehicle that will hold the infrastructure, and we intend for the special purpose vehicle to incur indebtedness to finance the obligations under the OpenAI Master Services Agreement. Upon an event of default, OpenAI has a lien and security interest in the equity of the special purpose vehicle. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As part of the commercial agreement, we issued OpenAI 8,750,000 shares of Class&#160;A common stock in connection with the IPO in a concurrent private placement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our focus on committed contracts and revenue from some of the world&#8217;s leading providers of AI is deliberate in that these close relationships have allowed us to scale rapidly and provide us with unique insights into delivering highly performant and efficient AI compute at scale. In turn, we enable these customers to incorporate better AI into their products to drive faster time to market and broader adoption, thereby reinforcing their continued adoption of our platform. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Customer Case Studies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe the following case studies are examples of how some of our customers have selected, deployed and benefited from our platform, solutions and services. We have highlighted customers of varying size and types across different industries. Our customers experience different results depending on a number of factors, and these case studies are not necessarily representative of the results achieved by other customers of these types or otherwise. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; text-align: center;"><img style="height: 40px; width: 171px;" src="ny20053122x2_replicate.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Replicate </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Background: Replicate enables developers to easily run, fine-tune, and deploy both public and private machine learning models. Its cloud-based API allows for simple integration of AI capabilities without the need to manage the underlying infrastructure. Businesses rely on Replicate&#8217;s platform to integrate and scale inference workloads for generative AI applications &#8211; whether it be text, image, or video generation &#8211; across their end users. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Challenge: Many of the workloads that run on Replicate&#8217;s platform are for real-time applications where users expect near-instantaneous responses. The high variability nature of inference workloads meant that Replicate needed to be able to dynamically scale its platform in response to user demand. Other cloud solutions in the market did not offer the right set of capabilities and infrastructure to meet these needs &#8211; they lacked latest generation GPU-compute infrastructure, experienced bottlenecks that slowed down Replicate&#8217;s platform, and became cost prohibitive at scale for the level of performance required. To achieve its mission of making AI more accessible, Replicate needed a reliable, elastic, and highly performant solution that could accommodate burst workloads with minimal downtime, even as infrastructure was pushed to its maximum performance. Replicate also required a solution that provided lower performance-adjusted cost to support its pay-per-use pricing model in a cost-efficient way. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Solution &amp; Outcomes: </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">116<br></div></div></div>
<!--End Page 127-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 128-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Since 2022, Replicate has selected CoreWeave as its cloud provider to unlock access to high- performance compute for its inference needs, leveraging CoreWeave&#8217;s full-stack cloud platform delivered in a fully managed format. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Radically simplified infrastructure management enabled Replicate to focus more on innovating across its platform and building client engagement and less on operating highly complex infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s observability tools provided Replicate with valuable insights into billing and resource utilization. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Customer Quote: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave is our key cloud provider and has been instrumental in enabling our demanding inference workloads to scale seamlessly. CoreWeave has delivered high performance, resilience, and reliability that directly enables us to allow our customers to access and fine tune some of the best AI models on the market with minimal friction.&#8221; - Ben Firshman, CEO at Replicate</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 15.25pt; text-align: center;"><img style="height: 47px; width: 172px;" src="ny20053122x2_jane-street.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Jane Street </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Disclaimer: Jane Street is a customer and one of our investors. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Background: Jane Street is a global, technology-driven liquidity provider and trading firm. It leverages sophisticated quantitative analysis and a deep understanding of market mechanics to trade in even the most challenging situations. Its cutting-edge research has become increasingly dependent on GPU-powered compute. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Challenge: Jane Street required a flexible, full-stack solution that would meet its demands for scalability, efficiency, and security. Jane Street needed reliable access to state-of-the-art GPU infrastructure to train its next generation of trading models while maintaining the agility to adapt to rapidly evolving technology. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Solution &amp; Outcomes: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Since 2024, Jane Street has relied on CoreWeave to provide a full-stack compute solution purpose-built for the high performance and security requirements of Jane Street&#8217;s operations. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Jane Street benefited from the broad and flexible array of CoreWeave&#8217;s offerings, including direct connections, dedicated storage, upgrade options, and more, when designing, executing, and scaling its own proprietary models. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Through CoreWeave, Jane Street was able to obtain timely access to the latest cutting-edge infrastructure technologies, delivered in a fully managed fashion that enabled rapid deployment of workloads. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave provided Jane Street with scalability, enabling Jane Street to grow its training and inference workloads. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Jane Street achieved higher overall compute performance thanks to CoreWeave&#8217;s high-performance compute specialization. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Customer Quote: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;We decided on CoreWeave as our high-performance cloud provider after we saw how fast the CoreWeave team moved and got Hopper online first. We needed access to the latest cutting-edge hardware quickly, and we trusted CoreWeave to deliver it faster than any other provider. CoreWeave&#8217;s resilient, high-performance compute infrastructure is fundamental to allowing us to build quickly, as CoreWeave delivered a reliable cluster that could withstand our intense training requirements. CoreWeave&#8217;s deep technical capabilities and extensive scalability have been instrumental in pushing the boundaries of what&#8217;s possible in algorithmic trading.&#8221; - Craig Falls, Head of Quant Research, Jane Street </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">117<br></div></div></div>
<!--End Page 128-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 129-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; text-align: center;"><img style="height: 57px; width: 171px;" src="ny20053122x2_mistral.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Mistral AI </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Background: Mistral AI is a leading Paris-based AI lab that develops open-source AI models. Its most recent model, Mistral Large, is one of the world&#8217;s highest-performance LLMs available through an API, demonstrating remarkable performance across multiple critical benchmarks, including the Measuring Massive Multitask Language Understanding (MMLU), math and coding tasks, and complex reasoning challenges. From inception, Mistral&#8217;s mission has been focused on making frontier AI ubiquitous and providing high-quality, tailor-made solutions to builders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Challenge: To fulfill its mission and train bleeding-edge foundational models like Mistral Large, Mistral required a cloud computing platform for its training workloads that could provide access to rapid, flexible compute at a low performance-adjusted cost. Specifically, Mistral required a large high-performance GPU cluster that could scale to thousands of GPUs on a single InfiniBand fabric. Mistral also strongly desired to use Slurm to launch its jobs, due to its fluency with the scheduling system. In addition, Mistral could not afford to spend time on infrastructure management and needed a cloud solution that would offload the challenging operational aspects of managing bleeding-edge high-performance infrastructure. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Solution &amp; Outcomes: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Mistral selected CoreWeave in 2023 due to the strength of CoreWeave&#8217;s ML Perf benchmarks and CoreWeave&#8217;s track record of delivering InfiniBand-based networks for large GPU clusters that provided significant performance gains over clusters with ethernet-based networking. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The CoreWeave Cloud Platform provided immediate access to NVIDIA H100 Tensor Core GPU-based infrastructure, which enabled Mistral to increase the speed of its training runs and release Mistral-7B only a few months after founding. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s Mission Control lifecycle automation was instrumental in monitoring and maintaining infrastructure health while running massive training workloads at maximum performance. This automation offloaded the burden of managing infrastructure from Mistral&#8217;s small team, allowing the team to focus on its mission of building high-quality models, executing their AI roadmap efficiently, and ultimately getting their models to market faster. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave&#8217;s deep technical partnership with Mistral as a customer involved a Kubernetes-based continuous delivery model in a shared GitOps repository, which ultimately removed operational responsibilities from Mistral&#8217;s hands. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Over time, CoreWeave has become Mistral&#8217;s compute provider of choice due to its ability to deliver more performant deployments with the latest state-of-the-art NVIDIA architecture while lowering its cost per FLOP through its automation, monitoring, and infrastructure health management software. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Customer Quote: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;CoreWeave&#8217;s Mission Control has been transformative for our infrastructure, unlocking higher cluster performance and dramatically accelerating our time to market. CoreWeave&#8217;s intelligent lifecycle management and optimization tools and robust support solutions, have been critical in our journey to becoming an industry-leading AI model developer.&#8221; - Arthur Mensch, Chief Executive Officer and Co-Founder at Mistral </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Go-to-Market </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our go-to-market organization consists of Sales, Marketing, Partnerships, and Customer Experience. We operate as a lean team with a disciplined, long-term vision of the AI market trajectory, our ideal customers, and our growth levers, which allows us to maintain agility, operationalize our go-to-market strategy efficiently, and execute effectively. On that journey, we have developed significant brand awareness within an industry that has been historically dominated by trillion-dollar competitors, built an exceptional organic reputation in market among both customers and partners, and successfully executed on both bottoms-up and top-down sales models. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">118<br></div></div></div>
<!--End Page 129-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 130-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Since entering the specialized AI cloud market in the second half of 2020, our go-to-market strategy has been built upon a strong foundation of demand generation, solution selling, and a deep cultural commitment to delivering an exceptional customer experience. Our lean Sales team has afforded us the agility to adapt and direct our efforts towards the greatest business need for the long-run. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Initially, this meant focusing on a bottoms-up sales model that targeted engineering pain points through product-led growth. We focused on customer acquisition within our on-demand environment, supporting use cases across AI, Visual Effects, and Life Sciences companies that benefited from a managed solution that abstracted complexity and provided seamless, elastic consumption of compute resources. As our business continues to evolve, many of the PLG strategies we built to grow the business during this time continue to be critical to the growth and upsell strategies we deploy across our existing customer base moving forward. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Beginning in 2023, we transitioned our go-to-market motion to a direct named account strategy. This allowed us to transition from serving multiple high-growth start-ups delivering inference products built on top of open-source models, to securing billion-dollar contracts from some of the world&#8217;s leading and most important AI companies in the world. Our sales organization remains focused on this top-down sales model to drive demand and pipeline from the world&#8217;s most important AI Native and AI Enterprise businesses and is structured around a team of dedicated Account Managers, Account Executives, and Sales Development Representatives. We believe that, our acquisition of Weights &amp; Biases enables us to accelerate this build and deployment of our direct named account strategy, while also improving our PLG strategy to land customers with additional functionality that targets AI developers and AI and machine learning engineers. We expect to diversify our pricing model over time as we offer additional services built for AI developers, which we began to do following the closing of the acquisition of Weights &amp; Biases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Marketing organization is organized across three pillars: product marketing, demand-generation, and brand. Marketing is responsible for building and executing campaigns across the entirety of the customer journey, including brand awareness, demand generation, and customer and partner marketing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Customer Experience organization is the first line of support in the post-sale portion of the customer journey. Our dedicated teams enable us to better serve our customers and establish a high degree of trust by ensuring they derive maximum value from our CoreWeave Cloud Platform. Our Customer Experience teams function as an extension of our customers&#8217; engineering organizations, tackling challenges with the same level of urgency as their own teams and allowing them to leverage our deep AI infrastructure expertise to solve problems collaboratively. These close relationships give us unique insights into our customers&#8217; most pressing needs and enable us to support them not only with creative problem solving but also with proactive capacity planning as they seek to scale their AI workloads. This intimate knowledge of our customers&#8217; evolving needs allows us to anticipate and address future requirements in advance, and strategically positions us to continue expanding our business with them. Equally, these deep customer engagements add to our knowledge flywheel and increase our skill base in AI compute, allowing us to problem solve faster across all of our customers. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Sustainability </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">AI can drive numerous benefits. However, we recognize that there are also risks that need to be managed to ensure that our platform is built to maintain resiliency and assure its longevity. One of the challenges we will face is to ensure that we take appropriate steps to mitigate the environmental impacts of our operations. We are focused on the benefits our CoreWeave Cloud Platform can provide while managing the associated risks. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This strategy will be centered around: Climate Change Mitigation, Energy Efficiency Improvements, Responsible Resource Usage, Supplier Relationships, and ESG Oversight. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Climate Change Mitigation </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Energy Consumption &amp; Sustainable Infrastructure </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our fleet of 33 data centers necessarily uses a significant amount of power to enable our customers to train AI&#160;models, particularly large language, and deep learning models. This energy usage results in greenhouse gas (&#8220;GHG&#8221;) emissions, which impact the environment. Our goal is to minimize our environmental impact. For example, several of the existing data centers in the United States and Europe in which we are a tenant are powered by non-emitting sources of energy, and we are exploring other ways we can reduce our environmental impact. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are currently evaluating and measuring Scopes 1 and 2 GHG emissions from our facilities and data center operations and will soon begin to evaluate our emissions resulting from our supply chain (Scope 3). A large portion </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">119<br></div></div></div>
<!--End Page 130-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 131-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">of our GHG emissions are currently Scope 2 emissions, which result from purchased electricity for our data centers. The mix of our GHG emissions could shift over time as we grow and begin to control more of our data centers, potentially increasing our ability to contract larger amounts of non-emitting sources of energy. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As we continue to scale, we will seek to integrate GHG emissions management and other sustainability considerations into our lease negotiations for new data centers and the renewal of existing leases to reduce our data centers&#8217; environmental impacts. We will also seek to establish our operations in buildings that meet high levels of environmental standards. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Energy Efficiency Improvements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To improve operational and energy efficiency, we are using energy-efficient computing and are expanding our use of innovative cooling solutions. These actions are designed to optimize data center operations and performance and to reduce energy consumption required to train AI models. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are also investing in innovative cooling technologies that will allow us to manage the increased heat output stemming from our use of smaller and more dense servers and improve energy efficiency. We are also collecting the necessary data to improve our Power Use Effectiveness, which measures how efficiently data centers use energy. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Responsible Resource Usage </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 0pt; text-align: left;">Water Stewardship </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are committed to responsible water consumption that seeks to balance our Water Usage Effectiveness, which measures how efficiently data centers use water. We will also explore opportunities to participate in water replenishment programs. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 0pt; text-align: left;">Waste Management </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to managing scarce resources such as water, we intend to extend our responsible resource usage to waste management. For example, we intend to evaluate the potential for heat recovery systems to repurpose heat generated by our data centers, which can optimize power consumption and improve environmental performance. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Supplier Relationships </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We will also look for opportunities to utilize our relationships with suppliers to mitigate the environmental impacts of their operations, while improving our data centers&#8217; environmental performance. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">ESG Oversight </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We intend to appropriately integrate material ESG considerations into our strategic decisions, risk assessments and enterprise risk management, including identifying material ESG risks and incorporating them into a long-term risk management strategy. The risk management strategy will be implemented by internal sustainability staff with oversight by our board of directors. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Competition </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The end markets we target are highly competitive and are changing rapidly. As the technological landscape evolves, we anticipate continued competition from various industry participants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our primary competitors are larger, global enterprises that offer general purpose cloud computing as part of a broader, diversified product portfolio. Key companies in this category are Amazon (AWS), Google (Google Cloud Platform), IBM, Microsoft (Azure), and Oracle. While these businesses have greater resources than us across sales and marketing and research and development, and benefit from broad brand awareness, they are not purpose-built for the AI and accelerated compute use cases that we serve. As a result, some of these very competitors have become customers of, and partners to, CoreWeave in a number of cases, demonstrating our competitive differentiation and ability to deliver highly performant, purpose-built infrastructure that outperforms existing general purpose cloud solutions today. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to these large companies, we also compete with smaller cloud service providers, including Crusoe and Lambda. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">120<br></div></div></div>
<!--End Page 131-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 132-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">We believe we compete favorably based on the following factors: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our proven track record of delivering performance and reliability at scale; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our ability to service high-intensity AI workloads with greater efficiency; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our enhanced health monitoring and remediation capabilities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our automation and ease of use that shifts infrastructure management from our customers to our platform; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our speed to market with the latest generation of GPUs; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the scale of GPU clusters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our security; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our brand awareness and reputation within the AI community; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our customer experience, support, and service, with a focus on AI and accelerated computing use cases; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our customization that enables bespoke configurations for customers reliant on specific technology such as storage; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the price, total cost of ownership, and transparency; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our features, functionalities, and quality of user interface. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The pace of our organic growth demonstrates that we have become one of the technological leaders in accelerated AI computing. Our competitive differentiation is underpinned by our ability to service AI compute use cases more rapidly and flexibly than many competitors because of our access to some of the most performant hardware available and our proprietary software that is specially tailored for model training and inference. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Intellectual Property </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our intellectual property is an important aspect of our business and helps us to maintain our competitive position. To establish and protect our rights in our proprietary technology, we rely upon a combination of trade secret and trademark laws and contractual restrictions such as confidentiality agreements, licenses and intellectual property assignment agreements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We control access to our intellectual property and confidential information through internal and external controls. We maintain a policy requiring our employees, contractors, consultants and other third parties to enter into confidentiality and proprietary rights agreements to control access to and non-disclosure of our proprietary information. Intellectual property laws and our procedures and restrictions provide only limited protection, and any of our intellectual property rights may be challenged, invalidated, circumvented, infringed, misappropriated or violated. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Government Regulation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are subject to the laws and regulations of various jurisdictions and governmental agencies affecting our operations and the sale of our infrastructure and services in areas including, but not limited to: AI, AI, intellectual property; tax; import and export requirements; anti-corruption; economic and trade sanctions; national security and foreign investment; foreign exchange controls and cash repatriation restrictions; data privacy and security requirements (such as the CCPA); competition; advertising; employment; product regulations; environment, health and safety requirements; and consumer laws. To date, costs and accruals incurred to comply with these governmental regulations have not been material to our capital expenditures and results of operations. Although there is no assurance that existing or future governmental laws and regulations applicable to our operations and the sale of our infrastructure services will not have a material adverse effect on our capital expenditures, operating results, and competitive position, we do not currently anticipate material expenditures for government regulations. Nonetheless, we believe that global trade regulations could potentially have a material impact on our business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As a global company, the import and export of our infrastructure services and technology are subject to laws and regulations including international treaties, U.S. export controls and sanctions laws, customs regulations, and local trade rules around the world. The scope, nature, and severity of such controls varies widely across different countries and may change frequently over time. Such laws, rules, and regulations may delay the introduction of our </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">121<br></div></div></div>
<!--End Page 132-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 133-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_111-bus_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">infrastructure and services or impact our competitiveness through restricting our ability to do business in certain places or with certain entities and individuals. For example, the U.S. Department of Commerce continues to tighten export controls and add firms to the Entity List. These export restrictions, which would require that we obtain licenses from the U.S. Department of Commerce to allow us to export infrastructure services to such listed firms, could limit or prevent us from doing business with certain potential customers or potential suppliers. These restrictive governmental actions and any similar measures that may be imposed on U.S. companies by other governments could limit our ability to conduct business globally. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">See the risk factors titled &#8220;CoreWeave is subject to laws and regulations, including governmental export and import controls, sanctions, and anti-corruption laws, that could impair its ability to compete in its markets and subject it to liability if it is not in full compliance with applicable laws,&#8221; &#8220;CoreWeave is subject to laws, regulations, and industry requirements related to data privacy, data protection and information security, and user protection across different markets where CoreWeave conducts its business and such laws, regulations, and industry requirements are constantly evolving and changing. Any actual or perceived failure to comply with such laws, regulations, and industry requirements, or its privacy policies, could harm CoreWeave&#8217;s business,&#8221; and &#8220;CoreWeave&#8217;s business is subject to a wide range of laws and regulations, and its failure to comply with those laws and regulations could harm its business&#8221; for additional information regarding risks we face related to government regulation. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Facilities </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are headquartered in Livingston, New Jersey, where we occupy approximately 30,856 square feet of office space pursuant to a lease that is expected to expire in October&#160;2035, subject to the terms thereof. As of December&#160;31, 2024, we also lease office space in the United States in New York, New Jersey, the State of Washington, Pennsylvania and California, and internationally in the United Kingdom, with an aggregate of approximately 100,000 square feet of office space, and lease or license data centers in the United States in 16 states and internationally in the United Kingdom, Spain, and Sweden. For additional information regarding our data centers, see the section titled &#8220;&#8211;Our Platform and Product Offerings&#8211;Our Data Center Footprint&#8221; above. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that our current facilities are adequate to meet our current needs and that, should it be needed, suitable additional or alternative space will be available to accommodate our operations. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Legal Proceedings </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, we may be involved in various legal proceedings arising from the normal course of business activities. We are not presently a party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, results of operations, cash flows or financial condition. We may in the future receive claims from third parties asserting, among other things, infringement of their intellectual property rights. Defending such proceedings is costly and can impose a significant burden on management and employees, we may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be obtained. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">122<br></div></div></div>
<!--End Page 133-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 134-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCIM"><!--Anchor--></a>COREWEAVE, INC. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">FINANCIAL CONDITION AND RESULTS OF OPERATIONS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following discussion and analysis of financial condition and results of operations should be read together with CoreWeave&#8217;s consolidated financial statements and related notes, and other financial information, included elsewhere in this proxy statement/prospectus. In addition to CoreWeave&#8217;s historical results of operations and financial position, this discussion contains forward-looking statements that involve risks and uncertainties. CoreWeave&#8217;s actual results could differ materially from those discussed in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the section titled &#8220;Risk Factors&#8212;Risks relating to CoreWeave.&#8221; CoreWeave&#8217;s historical results are not necessarily indicative of the results to be expected for any period in the future, and results for any interim period should not be construed as an inference of what CoreWeave&#8217;s results would be for any full year or future period. Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Overview </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">CoreWeave powers the creation and delivery of the intelligence that drives innovation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CoreWeave Cloud Platform consists of our proprietary software and cloud services that deliver the software and software intelligence needed to manage complex AI infrastructure at scale. Our platform supports the development and use of ground-breaking models and the delivery of the next generation of AI applications that are changing the way we live and work across the globe&#8212;our platform is trusted by some of the world&#8217;s leading AI labs and AI enterprises. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Recent Developments </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Initial Public Offering </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, we completed our IPO, in which we issued and sold an aggregate of 36,590,000 shares of our Class&#160;A common stock at a public offering price of $40.00 per share. We received aggregate proceeds of $1.4&#160;billion after deducting the underwriting discounts and commissions and offering expenses payable by us. In connection with a commercial agreement with a strategic customer to provide AI infrastructure services, we also issued 8,750,000&#160;shares of Class&#160;A common stock on March&#160;31, 2025, with an aggregate value of $350&#160;million at the time of issuance based on a price per share equal to the IPO price. In April&#160;2025, the underwriters exercised a portion of their over-allotment option and purchased from us an additional 1,760,000 shares of Class&#160;A common stock at the IPO price, which resulted in net proceeds to us of $68&#160;million after deducting the underwriting discounts and commissions. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Business Combinations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May&#160;5, 2025, we acquired all of the outstanding equity interests of Weights &amp; Biases, Inc., an AI developer platform. The aggregate purchase consideration was $1.0&#160;billion in cash, stock, and fair value replacement of restricted stock units. Refer to Note&#160;4&#8212;Business Combination to our unaudited condensed consolidated financial statements included elsewhere in this proxy statement/prospectus for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;7, 2025, we entered into the Merger Agreement to acquire Core Scientific, a leading data center infrastructure provider, in an all-stock transaction (the &#8220;Core Scientific Acquisition&#8221;). The Core Scientific Acquisition is expected to help us verticalize our data center footprint to support revenue growth and improve operational profitability. The Core Scientific Acquisition is expected to close in the fourth quarter of 2025, subject to regulatory and Core Scientific stockholder approval and certain other closing conditions. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Key Factors Impacting Our Performance </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe the growth and success of our business depends on a number of key factors. These factors each present significant opportunities for our business, but also pose challenges that we must address in order to sustain our rapid growth and ensure the durability of our CoreWeave Cloud Platform. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Adoption of AI in Society </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The development and early adoption of AI models and the products built on top of them have contributed to our growth to date and our future success will depend in part on the continued adoption of AI. We believe AI is still in the early stages of its commercialization and that demand for model training and inference will continue to scale as </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">123<br></div></div></div>
<!--End Page 134-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 135-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">organizations embrace new use cases for AI and experience the productivity and efficiency gains associated with deploying AI products. The infrastructure that supports the use cases for AI is expected to continue improving as new generations of AI technologies are released and their performance continues to improve. Moreover, the volume of data on which models are trained is expected to continue to increase as more data is produced and becomes accessible to foundational models. As AI becomes more widespread, chip technology continues to improve, the amount of available data for training grows and companies continue to invest in infrastructure for AI, we believe that the adoption of AI will scale significantly. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Securing Sufficient Power Capacity </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe the data center installed base will need to scale significantly over the course of the coming years in terms of both space and power to keep pace with demand for AI products and high-performance compute. As of December&#160;31, 2022, we had three data centers running more than 17,000 GPUs in total and supported by approximately 10 MW of active power, which grew to 10 data centers running more than 53,000 GPUs in total and supported by more than 70 MW of active power as of December&#160;31, 2023, grew further to 32 data centers running more than 250,000 GPUs in total and supported by more than 360 MW of active power as of December&#160;31, 2024, and grew further to 33 data centers supported by approximately 470 MW of active power as of June&#160;30, 2025. Our total contracted power extends to approximately 2.2 GW as of June&#160;30, 2025, which we expect to roll out over the coming years. Importantly, our power capacity is available in large individual deployments that are capable of serving large infrastructure clusters, which is critical for our larger customers. We plan to continue to build out our access to power capacity and explore alternative energy solutions to support our growing capacity needs, including, but not limited to non-emitting sources of power. We believe that limited access to power will favor platforms like ours that are purpose-built to deliver maximum performance from a constrained pool of resources. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Maintaining a Robust Supply Chain to Service AI and High-Performance Compute Requirements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our future success depends in part on our access to the latest generation of high-performance chips and ancillary hardware, including GPUs, and other high-performance networking and storage equipment required to run our CoreWeave Cloud Platform. We have established close relationships with chipmakers and OEMs over time to secure our supply of hardware components and continue to strengthen these relationships through our demonstrated ability to deliver leading-edge compute at unparalleled scale and speed. Our future success also depends on our ability to access components such as chillers and HVAC systems for liquid cooling to maintain our data center infrastructure. We work actively with our suppliers on future capacity to ensure that our future resource needs are met while continuing to develop our relationships with leading component providers to incorporate the latest hardware innovations and assemble highly performant AI compute solutions for our customers. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Investing in Innovation and Technology Leadership </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our success is dependent on our ability to sustain innovation and technology leadership in order to maintain the competitive advantage of our solution and to bring the latest GPUs to market faster than our competition. We pioneered the AI Hyperscaler and have been able to nurture a unique technological differentiation across our CoreWeave Cloud Platform and a specialization in serving AI workloads. We have built a highly differentiated full stack solution for running AI training and inference workloads at maximum performance and efficiency, which we intend to continue to adapt and evolve with the support of our AI specific expertise. We plan to maintain our prioritization of investments in our engineering and product teams to continue to extend our technology leadership in AI infrastructure. Our engineering-led culture, coupled with our team&#8217;s embedded philosophy of embracing complex technical challenges, will be a critical factor to our future performance and in our ability to continue innovating. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our CoreWeave Cloud Platform is a critical part of the daily operations of the AI developers and providers of AI products and services that rely on our platform to train and inference their models. We remain committed to investing in and growing our business through continued technology leadership and expansion of our software suite to further optimize and enhance AI compute. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Driving More Workloads from Existing Customers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have strategically aligned with some of the world&#8217;s leading AI labs and AI enterprises that are building the next generation of foundational models and providing AI capabilities to organizations across the world. These AI leaders are the primary channel through which many non AI-native organizations access the benefits of AI today, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">124<br></div></div></div>
<!--End Page 135-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 136-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">given that they deliver AI-powered products and services that leverage our infrastructure to users without requiring them to build and run their own models. We are focused on continuing to capture AI cloud spend across these organizations as they train new models and build new AI capabilities for businesses and individuals, and focused on enabling them to maintain their innovation edge and accelerate the speed to market of their next generation of models. The significant benefits we deliver to these customers in terms of overall performance, efficiency, and reduced cost of ownership results in them making large initial commitments and expanding those commitments with us over time. As of June&#160;30, 2025, CoreWeave had $30.1&#160;billion of unsatisfied RPO. As of December&#160;31, 2024, we had $15.1&#160;billion RPO reflecting an increase of 53%, from $9.9&#160;billion as of December&#160;31, 2023. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Driving the continued retention and expansion of our customers will depend on our ability to handle the scale, performance, and efficiency required to accelerate their path to market and enable them to produce better AI products and services. Given the large initial commitments customers make for access to our CoreWeave Cloud Platform, we expect the growth of our RPO to be in steps, which may include periods of decline, versus a smooth linear trajectory. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Increasing Customer Adoption of our CoreWeave Cloud Platform </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect to see increasing adoption of AI globally as both existing industries innovate with AI and new industries arise. We anticipate that AI will expand beyond first movers to a broader set of enterprises that will utilize AI to drive internal efficiencies and implement AI into their products and services. These organizations are in their early stages of adopting the latest innovations in AI such as Generative AI, and are currently focused on running proof-of-concepts, adapting foundational models to optimize them for their specific use-cases and infusing them with their proprietary data for a broad range of vertical applications, from high frequency trading to drug discovery. As AI model capabilities grow and become more accessible and cheaper, we also expect to see the birth of new industries and use cases, which we may not be able to precisely anticipate today. Over time, as more non-AI-native organizations across a broader spectrum of industries run training and inference workloads on their own proprietary models, and as new industries with additional workload demands emerge, we believe we will be uniquely positioned to capture those workloads on our CoreWeave Cloud Platform. Our globally distributed and elastic infrastructure, which is optimized for performance and low latency, and our software stack, which makes it easy to deploy, manage, and monitor, are ideally suited to run and scale these workloads seamlessly. Successful acquisitions of new customers across these organizations will depend upon our ability to continue evolving our go-to-market organization and strategy, sufficient demand for AI compute, demand from end users of AI-enabled products and services, and overall pricing and competition. Our acquisition of Weights &amp; Biases positions us to accelerate our customer acquisition through broader exposure to the developer community and through the expansion of our application software services offering. The integration of Weights &amp; Biases&#8217; sales personnel and technology roadmap has increased our sales and marketing spend and technology and infrastructure spend respectively. Lastly, if AI is not broadly adopted by the enterprises to the extent we expect, or if new use cases do not arise, then our opportunity may be smaller than we expect. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Improving our Cost of Capital </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our business is driven by investments in infrastructure that is foundational to our platform. In order to fund these investments, we have pioneered and scaled innovative financing structures that have enabled us to grow our business at a rapid pace through timely and flexible access to capital. These include our use of DDTLs that are collateralized by contractual cash flows and infrastructure assets. These structures have allowed us to leverage the valuable infrastructure underpinning our contracts, the strong credit quality of many of our customers, and high visibility of our customer payments to drive down our cost of capital. We have also incorporated features such as investment grade tranches, as in the case of the DDTL 2.0 Facility, to further reduce our cost of capital. We have built on our momentum with a further $2.6&#160;billion GPU DDTL 3.0 Facility which was financed at SOFR +4%, a 9% decrease from our DDTL 2.0 Facility, and demonstrates our progress in reducing cost of capital and enhancing our credit profile. And we have also closed two private offerings of Notes for $2&#160;billion and $1.75&#160;billion respectively, with both offerings upsized from their initial offering size, highlighting investor demand and our ability to build strong relationships with a diverse pool of investors, raise capital quickly and efficiently, and scale our capital sources at a decreasing cost of capital. We expect to continue to incur indebtedness and that our cost of capital to continue declining as we benefit from economies of scale and access new forms of financing including asset backed securitizations and rated parent level debt. We expect this trajectory towards a lower cost of capital to enable us to accelerate growth at the pace of innovation and help drive continued investments in the most cutting-edge technology. However, our ability to lower our cost of capital depends upon a number of factors, many of which are beyond our </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">125<br></div></div></div>
<!--End Page 136-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 137-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">control, including broader macroeconomic conditions. If we are unable to continue lowering our cost of capital, our ability to effectively compete, especially with larger competitors that have greater financial and other resources, as well as our operating results, financial condition, and business, may be adversely impacted. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Components of Results of Operations </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We generate revenue by providing our customers with cloud computing services, including compute enabled by our software and infrastructure optimized for AI and high-performance computing. Our customers purchase our CoreWeave Cloud Platform services through either committed contracts or on an on-demand basis. Our revenue primarily comes from committed contracts. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Cost of Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue primarily consists of direct costs for data centers, including costs associated with our facilities, such as rent, utilities including power, personnel costs for employees involved in data center operations and customer success, including salaries, bonuses, benefits, stock-based compensation expense, and other related expenses and depreciation and amortization, including depreciation of power installation and distribution systems, and allocated overhead. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect our cost of revenue to increase in absolute dollar terms as we continue to grow our platform and expand our customer base. However, we anticipate that cost of revenue may fluctuate as a percentage of revenue in the future due to the timing of when data centers go live, and we achieve economies of scale and operational efficiencies. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">Technology and Infrastructure </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense consists of costs associated with our infrastructure, such as depreciation and amortization related to our servers, switches, networking equipment and internally developed software, personnel costs for employees associated with research and development of new and existing products and services or with maintaining our computing infrastructure, such as salaries, bonuses, benefits, stock-based compensation expense, travel expenses, and other related expenses, allocated overhead, and costs related to software subscriptions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect our technology and infrastructure expense to increase in absolute dollars as we continue to focus on growth and innovation. However, we anticipate technology and infrastructure expense may fluctuate as a percentage of revenue in the future due to the timing of when we achieve economies of scale and operational efficiencies, including through software innovation. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Sales and Marketing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense consists of personnel costs associated with selling and marketing our CoreWeave Cloud Platform, such as salaries, stock-based compensation expense, commissions, bonuses, travel expenses, and other related expenses, third-party professional services costs, allocated overhead, and advertising costs associated with marketing programs. We expect our sales and marketing expense to increase in absolute dollars as we grow our brand and expand our customer footprint. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">General and Administrative </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense consists of costs associated with corporate functions including our finance, legal, human resources, information technology (&#8220;IT&#8221;), and facilities. These costs include personnel costs, such as salaries, bonuses, benefits, stock-based compensation expense, and other related expenses, third-party professional services costs, such as legal, accounting, and audit services, corporate facilities, depreciation for equipment, furniture, and fixtures, and other costs necessary to operate our corporate functions, including expenses for non-income taxes, insurance, and office rental. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We expect to continue incurring additional expenses as a result of operating as a public company, including expenses to comply with the rules and regulations applicable to companies listed on a national securities exchange, expenses related to compliance and reporting obligations pursuant to the rules and regulations of the SEC, as well as higher expenses for general and director and officer insurance and professional services. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">126<br></div></div></div>
<!--End Page 137-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 138-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Gain (Loss) on Fair Value Adjustments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gain (loss) on fair value adjustments consists of gains and losses as a result of recording our derivative and warrant liabilities at fair value at the end of each reporting period, or prior to settlement of the associated instruments if settled during the reporting period. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Interest Expense, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest expense, net consists of interest associated with our finance leases and contractual interest, the amortization of debt discounts and issuance costs, and the accretion of redemption premiums associated with our debt obligations. Interest expense, net is reflected net of capitalized interest. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Other Income (Expense), Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other income (expense), net consists of investment income, foreign currency exchange gains (losses), gains (losses) on extinguishment of debt, interest income, gains (losses) on sale of investments and other non-operating gains and losses. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Provision for (benefit from) Income Taxes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The provision for (benefit from) income taxes consists primarily of income taxes in certain federal, state, local and foreign jurisdictions in which we conduct business. Foreign jurisdictions typically have different statutory tax rates from those in the United States. Accordingly, our effective tax rates may vary depending on the impact of the valuation allowance and nondeductible fair value adjustments to derivatives, as well as the relative proportion of foreign income to domestic income, generation of tax credits, changes in the valuation of our deferred tax assets and liabilities, and changes in tax laws. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Results of Operations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following tables set forth our consolidated statements of operations data for the periods indicated: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 152.54pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 152.54pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 1.08pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 152.54pt; padding-top: 1.08pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div></td></tr><tr><td style="width: 300pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 0.85pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$1,915,426</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">228,943</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">15,830</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.78pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">493,350</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">68,780</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">12,122</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.72pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">960,685</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">131,855</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">18,106</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.01pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">18,389</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">12,917</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">2,481</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.8pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.87pt;">118,644</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">29,842</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">6,001</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 1.57pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,59</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,068</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">243,394</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">38,710</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 4.2pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">324,358</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(14,451)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(22,880)</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Loss on fair value adjustments<font style="padding-left: 1.99pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(755,929)</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(533,952)</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(2,884)</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest expense, net<font style="padding-left: 3.93pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(360,824)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(28,404)</font> </div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(9,444)</font></div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income, net<font style="padding-left: 3.92pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">48,19</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">18,760</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">192</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 1.1pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(744,201)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(558,047)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.26pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(35,016)</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 2.02pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.87pt;">119,247 </font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">35,701</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(4,150)</font></div></td></tr><tr><td style="width: 300pt; padding-top: 0.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from continuing operations<font style="font-weight: normal; padding-left: 2.18pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 0.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(863,448</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,748</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 0.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(30,866</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from discontinued operations, net of tax<font style="font-weight: normal; padding-left: 0.82pt;"></font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 30pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;"> </font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 25.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(189</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 3.63pt;"></font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(863,448</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,748</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(31,055</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 4.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes stock-based compensation expense as follows: </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 1pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 118.82pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 118.82pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 1.08pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 118.82pt; padding-top: 1.08pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 3.53pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">1,307</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">694</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.51pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">133</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 1.47pt;"></font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">10,137</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt;">7,100</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">624</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 0.75pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">3,408</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt;">1,740</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">74</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 3.55pt;"></font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,635</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,620</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.01pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">659</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total stock-based compensation expense<font style="padding-left: 3.15pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$31,487</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$15,154</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,490</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">127<br></div></div></div>
<!--End Page 138-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 139-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.33pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.69pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.33pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.69pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 218.52pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div></td></tr><tr><td style="width: 240pt; padding-top: 2.51pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 0.85pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.51pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$1,212,788</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.51pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">395,371</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.51pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$2,194,420</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.51pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">584,055</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.78pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt;">312,667</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt;">108,838</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt;">575,061</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt;">168,058</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.72pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt;">669,913</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt;">182,886</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">1,231,315 </font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt;">275,767</font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.01pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt;">36,799</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.33pt;">4,172</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.5pt;">47,348</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 18.33pt;">8,222</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.8pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">174,200</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">21,754</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">348,957 </font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">37,440</font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 1.57pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,193,579</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">317,650</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,202,681</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">489,487</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 4.2pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt;">19,209</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt;">77,721</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 19.17pt;">(8,261) </font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt;">94,568</font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 0.9pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt;">(310,231)</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.5pt;">26,837</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(407,731)</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 3.93pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 9.17pt;">(266,966)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 10pt;">(66,766)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 9.17pt;">(530,801)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(107,422)</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense), net<font style="padding-left: 1.72pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,023</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,406</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">886 </font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">23,866</font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 1.1pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 9.17pt;">(242,734)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt;">(282,870)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 9.54pt;">(511,339) </font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(396,719)</font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 2.02pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">47,775</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">40,151</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">93,811</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">55,550</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 3.63pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(290,509</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(323,021</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(605,150</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(452,269</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes stock-based compensation as follows: </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 112.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 102.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 112.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 102.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 227.52pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 228pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;">$<font style="padding-left: 10pt;">2,701</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;">$<font style="padding-left: 7.5pt;">350</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">$<font style="padding-left: 10pt;">5,394 </font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">$<font style="padding-left: 12.5pt;">738</font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 3.47pt;"></font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 10pt;">47,683</font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 5pt;">2,080</font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 5pt;">102,282 </font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt;">4,437</font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 15pt;">8,494</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 12.5pt;">848</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10.37pt;">11,314 </font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt;">1,715</font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 0.55pt;"></font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">86,127</font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,382</font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">209,988</font></div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8,959</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 228pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="padding-left: 0.09pt;"></font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$145,005</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$7,660</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$328,978</font></div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$15,849</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 54.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 44.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We recognized no and $177&#160;million of stock-based compensation expense, net of no and $17&#160;million of capitalized costs primarily related to the development of internal-use software, during the three and six months ended June&#160;30, 2025, respectively, associated with vested RSUs as a result of the satisfaction of the liquidity-event performance-based vesting condition which was satisfied in connection with the IPO. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following tables set forth our consolidated statements of operations data expressed as a percentage of revenue for the periods indicated: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 106.31pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 106.31pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 1.85pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;">100%</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 3.33pt;">100%</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 3.33pt;">100% </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 3.53pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 5pt;">26</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt;">30</font> </div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt;">77</font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 1.47pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 5pt;">50</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt;">58</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 3.7pt;">114</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 0.75pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 10pt;">1</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 13.33pt;">6</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt;">16</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 3.55pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">13</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">38</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 2.57pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">83</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">106</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">245</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 0.2pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 5pt;">17</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 10pt;">(6)</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;">(145) </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 1.9pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 1.67pt;">(39)</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;">(233)</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 5pt;">(18)</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest expense, net<font style="padding-left: 4.93pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 1.67pt;">(19)</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 5pt;">(12)</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 5pt;">(60)</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other income, net<font style="padding-left: 4.92pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 2.1pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 1.67pt;">(39)</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;">(244)</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;">(221) </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 3.02pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.87pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(26</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 19.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 19.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">128<br></div></div></div>
<!--End Page 139-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 140-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 106.31pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 106.31pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from continuing operations<font style="font-weight: normal; padding-left: 3.18pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 2.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.71pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(45</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(259</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 2.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(195</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from discontinued operations, net of tax<font style="font-weight: normal; padding-left: 1.82pt;"></font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.71pt; text-align: left;"><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 4.63pt;"></font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.75pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.71pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(45</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(259</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.08pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.38pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(196</font><font style="padding-bottom: 0.5pt;">)%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 19.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 19.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 17.5pt;"> </div></div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4pt; margin-left: 0pt; text-align: left;">Note: Totals may not sum due to rounding. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 0.85pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;">100%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;">100%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;">100%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;">100% </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt;">26</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 5pt;">28</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">26</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">29</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 0.47pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt;">55</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 5pt;">46</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">56</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">47</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 4.75pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 10pt;">3</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 10pt;">1</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt;">2</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt;">1</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">14</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.38pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 1.57pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">98</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">80</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">100</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">84</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 4.2pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 10pt;">2</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 5pt;">20</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt;">16</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 0.9pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 1.67pt;">(78)</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt;">1</font> </div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt;">(70)</font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 3.93pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 1.67pt;">(22)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 1.67pt;">(17)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt;">(24)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt;">(18)</font> </div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense), net<font style="padding-left: 1.72pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 1.1pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 1.67pt;">(20)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 1.67pt;">(72)</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt;">(23)</font> </div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; padding-bottom: 0.5pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt;">(68)</font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 2.02pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">10</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 0.13pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">10</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 3.63pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.46pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(24</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.47pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(82</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(28</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.06pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(77</font><font style="padding-bottom: 0.5pt;">)%</font></div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 10.75pt;"> </div></div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4pt; margin-left: 0pt; text-align: left;">Note: Totals may not sum due to rounding. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Comparison of the Three and Six Months Ended June&#160;30, 2025 and 2024 </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 3pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 132.68pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 183.4pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 132.68pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 183.4pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 365.64pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands)</div></td></tr><tr><td style="width: 96pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,212,788</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$395,371</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$817,417</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">207%</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,194,420</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$584,055</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,610,365</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">276%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue for the three months ended June&#160;30, 2025 increased by $817&#160;million, or 207%, compared to the three&#160;months ended June&#160;30, 2024. Revenue for the six months ended June&#160;30, 2025 increased by $1,610&#160;million, or 276%, compared to the six months ended June&#160;30, 2024. This substantial growth was related to increased demand from both existing and new customer contracts and our ability to rapidly scale our operations, emphasizing the strength of our customer relationships and our ability to meet the evolving needs of the industry. Approximately 92% and 96% of the increase in revenue was attributable to expansion within our existing customer base and the remaining increase was attributable to new customers for the three and six months ended June&#160;30, 2025, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Cost of Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 3pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 172.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 172.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 352.38pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$312,667</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$108,838</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$203,829</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">187%</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$575,061</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$168,058</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$407,003</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">242% </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">26%</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">28%</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">26%</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">29%</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue for the three months ended June&#160;30, 2025 increased by $204&#160;million, or 187%, compared to the three months ended June&#160;30, 2024. This increase was primarily attributable to higher costs directly related to running our data centers to support the significant increase in customer demand, driven by the successful deployment of new and expanded data centers, which resulted in an increase in rent expense of approximately $113&#160;million, an increase </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">129<br></div></div></div>
<!--End Page 140-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 141-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">in data center utilities and power spend of approximately $54&#160;million. The increase is also attributable to an increase in depreciation and amortization related to power installation and distribution systems of approximately $15&#160;million, and an increase in personnel costs of approximately $12&#160;million, which includes headcount growth of employees directly associated with data centers and $2&#160;million related to stock-based compensation expense. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue for the six months ended June&#160;30, 2025 increased by $407&#160;million, or 242%, compared to the six months ended June&#160;30, 2024. This increase was primarily attributable to higher costs directly related to running our data centers to support the significant increase in customer demand, driven by the successful deployment of new and expanded data centers, which resulted in an increase in rent expense of approximately $234&#160;million, an increase in data center utilities and power spend of approximately $106&#160;million. The increase is also attributable to an increase in depreciation and amortization related to power installation and distribution systems of approximately $26&#160;million, and an increase in personnel costs of approximately $24&#160;million, which includes headcount growth of employees directly associated with data centers and $5&#160;million related to stock-based compensation expense. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Technology and Infrastructure </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 3pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 169.54pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 177.04pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 169.54pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 177.04pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 353.3pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 1.64pt;"></font></div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$669,913</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$182,886</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$487,027</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">266%</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,231,315</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$275,767</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$955,548</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">347% </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">55%</font></div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">46%</font></div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">56%</font></div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">47%</font></div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense for the three months ended June&#160;30, 2025 increased by $487&#160;million, or 266%, compared to the three months ended June&#160;30, 2024. This increase was primarily attributable to an increase in depreciation and amortization of approximately $379&#160;million, from $158&#160;million for the three months ended June&#160;30, 2024, to $537&#160;million for the three months ended June&#160;30, 2025. These increases in depreciation and amortization were related to investments in our platform and servers, switches, and other networking equipment fixed assets within our infrastructure, as well as an increase of approximately $76&#160;million of personnel costs, of which $46&#160;million related to stock-based compensation expense, and an increase of approximately $12&#160;million of equipment support and software expenses. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense for the six months ended June&#160;30, 2025 increased by $956&#160;million, or 347%, compared to the six months ended June&#160;30, 2024. This increase was primarily attributable to an increase in depreciation and amortization of approximately $731&#160;million, from $235&#160;million for the six months ended June&#160;30, 2024, to $966&#160;million for the six months ended June&#160;30, 2025. These increases in depreciation and amortization were related to investments in our platform and servers, switches, and other networking equipment fixed assets within our infrastructure, as well as an increase of approximately $159&#160;million of personnel costs, of which $98&#160;million related to stock-based compensation expense, and an increase of approximately $29&#160;million of equipment support and software expenses. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Sales and Marketing </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 3pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 167.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 167.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 167.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 167.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 347.38pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands)</div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$36,799</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$4,172</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$32,627</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">782%</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$47,348</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$8,222</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$39,126</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">476% </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">3%</font></div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">1%</font></div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">2%</font></div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">1%</font></div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense for the three months ended June&#160;30, 2025 increased by $33&#160;million, or 782%, compared to the three months ended June&#160;30, 2024. This increase was primarily attributable to an increase of $14&#160;million of advertising and sponsorship expenses and an increase of approximately $14&#160;million in personnel costs, of which $8&#160;million related to stock-based compensation expense. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense for the six months ended June&#160;30, 2025 increased by $39&#160;million, or 476%, compared to the six months ended June&#160;30, 2024. This increase was primarily attributable to an increase of approximately $18&#160;million in personnel costs, of which $10&#160;million related to stock-based compensation expense, and an increase of $16&#160;million of advertising and sponsorship expenses. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">130<br></div></div></div>
<!--End Page 141-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 142-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">General and Administrative </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 4pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 3pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 171.2pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 170.83pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 171.2pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 170.83pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 350.97pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">General and administrative<font style="padding-left: 3.29pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$174,200</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$21,754</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$152,446</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">701%</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$348,957</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$37,440</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$311,517</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">832% </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">14%</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">6%</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">16%</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">6%</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense for the three months ended June&#160;30, 2025 increased by $152&#160;million, or 701%, compared to the three months ended June&#160;30, 2024. This increase was primarily attributable to an increase of approximately $104&#160;million in personnel-related expenses, which includes headcount growth to support our expanding operations and $82&#160;million related to stock-based compensation expense. Professional services expenses also increased by approximately $52&#160;million, primarily from accounting, tax, legal, and advisory services necessary to support our growth and public company compliance activities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense for the six months ended June&#160;30, 2025 increased by $312&#160;million, or 832%, compared to the six months ended June&#160;30, 2024. This increase was primarily attributable to an increase of approximately $237&#160;million in personnel-related expenses, which includes headcount growth to support our expanding operations and $201&#160;million related to stock-based compensation expense. Professional services expenses also increased by approximately $79&#160;million, primarily from accounting, tax, legal, and advisory services necessary to support our growth and public company compliance activities. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Gain (Loss) on Fair Value Adjustments </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 161.63pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 178.13pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 161.63pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 178.13pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 349.9pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 2.73pt;"></font></div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.5pt; text-align: left;">$&#8212;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(310,231)</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$310,231</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.38pt; text-align: left;">NM</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$26,837</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(407,731)</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$434,568</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">NM</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4.5pt; margin-left: 0pt; text-align: left;">NM-Not meaningful </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gain (loss) on fair value adjustments for the three months ended June&#160;30, 2025 changed favorably by $310&#160;million compared to the three months ended June&#160;30, 2024. Gain (loss) on fair value adjustments for the six&#160;months ended June&#160;30, 2025 changed favorably by $435&#160;million compared to the six months ended June&#160;30, 2024. These changes was driven by a relative decrease in the period in the valuation of derivatives and warrants tied to our common stock and redeemable convertible preferred stock within the periods presented. On March&#160;21, 2025, we executed an amendment with the warrant holders to fix the exercise price, resulting in a final mark to market of the warrants and a reclassification of the final value of the warrants for common stock within additional paid-in capital, and therefore, there was no activity for the three months ended June&#160;30, 2025. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Interest Expense, Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 469.73pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172.37pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 177.37pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 172.37pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 177.37pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 355.74pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 1.93pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(266,966)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(66,766)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(200,200)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">300%</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(530,801)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(107,422)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(423,379)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">394%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest expense, net for the three months ended June&#160;30, 2025 increased by $200&#160;million, or 300%, compared to the three months ended June&#160;30, 2024. Interest expense, net for the six months ended June&#160;30, 2025 increased by $423&#160;million, or 394%, compared to the six months ended June&#160;30, 2024. These increases were attributable to increased borrowing levels and total debt obligations. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">131<br></div></div></div>
<!--End Page 142-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 143-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Other Income (Expense), Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 170.74pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 163.61pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 170.74pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 163.61pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.46pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 347.15pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Other income (expense), net<font style="padding-left: 3.28pt;"></font></div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$5,023</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$16,406</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.46pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(11,383)</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.78pt; text-align: left;">(69)%</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$886</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$23,866</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(22,980)</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.77pt; text-align: left;">(96)%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.46pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 20pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other income (expense), net for the three months ended June&#160;30, 2025 changed by $(11) million compared to the three months ended June&#160;30, 2024. This change was attributable to unfavorable foreign exchange losses of approximately $25&#160;million, partially offset by an increase of $11&#160;million from the gain on the sale of warrants received as a lease incentive, and an increase in interest and investment income of approximately $5&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other income (expense), net for the six months ended June&#160;30, 2025 changed by $(23) million compared to the six months ended June&#160;30, 2024. This change was attributable to unfavorable foreign exchange losses of approximately $45&#160;million partially offset by an increase in interest and investment income of approximately $13&#160;million, and an increase of $11&#160;million from the gain on the sale of warrants received as a lease incentive. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Provision for (benefit from) Income Taxes </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 165.62pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 170.25pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 165.62pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 170.25pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 347.95pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands)</div></td></tr><tr><td style="width: 108pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$47,775</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$40,151</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$7,624</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.43pt; text-align: left;">19%</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.13pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$93,811</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$55,550</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$38,261</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.43pt; text-align: left;">69% </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effective tax rate<font style="padding-left: 0.16pt;"></font></div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.17pt;">(20)%</font></div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(14)%</font></div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.13pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.8pt;">(18)%</font></div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.17pt;">(14)%</font></div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.04pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provision for (benefit from) income taxes for the three months ended June&#160;30, 2025 increased by $8&#160;million, or 19%, compared to the three months ended June&#160;30, 2024. Provision for (benefit from) income taxes for the six months ended June&#160;30, 2025 increased by $38&#160;million, or 69%, compared to the six months ended June&#160;30, 2024. We recorded income tax expense in all periods presented despite experiencing pre-tax losses in part due to nondeductible losses on fair value adjustments and projected limitations on our ability to realize certain tax benefits, which has resulted in us maintaining a full valuation allowance on our U.S. deferred tax assets. The increase in period-over-period income tax expense primarily resulted from an increase in pre-tax income excluding these nondeductible losses and the inability to record a net benefit from deferred tax assets generated in the period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our effective tax rate might fluctuate significantly in the future due to additional impacts from nondeductible items and future changes in the valuation allowance on net deferred tax assets. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Comparison of the Year Ended December&#160;31, 2024 and 2023 </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 194.08pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 194.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 194.08pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 1.51pt;"></font></div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$1,915,426</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$228,943</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$1,686,483</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">737%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue for the year ended December&#160;31, 2024 increased by $1.7&#160;billion, or 737%, compared to the year ended December&#160;31, 2023. This substantial growth was related to increased demand from both existing and new customer contracts and our ability to rapidly scale our operations, emphasizing the strength of our customer relationships and our ability to meet the evolving needs of the industry. Over 95% of the increase in revenue was attributable to expansion within our existing customer base and the remaining increase was attributable to new customers.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">132<br></div></div></div>
<!--End Page 143-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 144-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Cost of Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 189.08pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.08pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 1.53pt;"></font></div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$493,350</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$68,780</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$424,570</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">617% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">26%</font></div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">30%</font></div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue for the year ended December&#160;31, 2024 increased by $425&#160;million, or 617%, compared to the year ended December&#160;31, 2023. This increase was attributable to higher costs directly related to running our data centers to support the significant increase in customer demand, driven by the successful deployment of new data centers, which resulted in an increase in rent expense of approximately $290&#160;million, an increase in data center utilities and power spend of approximately $76&#160;million, an increase in personnel costs of approximately $22&#160;million, which includes headcount growth of employees directly associated with data centers, and an increase in depreciation and amortization related to power installation and distribution systems of approximately $18&#160;million. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Technology and Infrastructure </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 190.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 190.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 190.36pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 4.47pt;"></font></div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$960,685</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$131,855</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$828,830</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">629% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">50%</font></div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">58%</font></div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense for the year ended December&#160;31, 2024 increased by $829&#160;million, or 629%, compared to the year ended December&#160;31, 2023. This increase was attributable to an increase in depreciation and amortization of approximately $742&#160;million, from $101&#160;million for the year ended December&#160;31, 2023, to $843&#160;million for the year ended December&#160;31, 2024, resulting from investments in our platform and servers, switches, and other networking equipment fixed assets within our infrastructure, as well as an increase of approximately $56&#160;million of personnel costs and an increase of approximately $45&#160;million of equipment support and software expenses. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Sales and Marketing </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 185.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 3.75pt;"></font></div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$18,389</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$12,917</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$5,472</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.44pt; text-align: left;">42% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">1%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">6%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense for the year ended December&#160;31, 2024 increased by $5&#160;million, or 42%, compared to the year ended December&#160;31, 2023. This increase was attributable to an increase of approximately $3&#160;million in personnel costs to help our efforts in driving customer demand.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">General and Administrative </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 187.73pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.73pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.73pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 1.55pt;"></font></div></td><td style="width: 8.13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$118,644</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$29,842</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$88,802</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">298% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 32.13pt;">6%</font></div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">13%</font></div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense for the year ended December&#160;31, 2024 increased by $89&#160;million, or 298%, compared to the year ended December&#160;31, 2023. This increase was attributable to an increase of approximately $41&#160;million in personnel-related expenses, which includes headcount growth to support our expanding operations. Professional services expenses also increased by approximately $28&#160;million, primarily from accounting, tax, legal, and advisory services necessary to support our growth and public company preparation activities. Additional increases of approximately $10&#160;million were attributable to higher overhead costs, including facilities expenses and software costs.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">133<br></div></div></div>
<!--End Page 144-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 145-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Loss on Fair Value Adjustments </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 192.85pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 192.85pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 192.85pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss on fair value adjustments<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(755,929)</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(533,952)</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(221,977)</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.43pt; text-align: left;">42%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Loss on fair value adjustments for the year ended December&#160;31, 2024 increased by $222&#160;million, or 42%, compared to the year ended December&#160;31, 2023. This increase was driven by an increase in the valuation of derivatives and warrants tied to our common stock and redeemable convertible preferred stock within the periods presented.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Interest Expense, Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 191.57pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 191.57pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 191.57pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 2.93pt;"></font></div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(360,824)</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(28,404)</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$(332,420)</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;">1,170%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest expense, net for the year ended December&#160;31, 2024 increased by $332&#160;million, or 1,170%, compared to the year ended December&#160;31, 2023. This increase was attributable to higher borrowing levels under our Credit Facilities, resulting in an increase in interest expense, partially offset by capitalized interest associated with investments in our platform and data center infrastructure.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Other Income, Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 186.58pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.58pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.58pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income, net<font style="padding-left: 2.92pt;"></font></div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$48,194</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$18,760</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$29,434</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">157%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other income, net for the year ended December&#160;31, 2024 increased by $29&#160;million, or 157%, compared to the year ended December&#160;31, 2023. This increase was attributable to an increase in investment income of approximately $30 million and interest income of approximately $15&#160;million, partially offset by a loss on extinguishment of debt of approximately $11&#160;million.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Provision for Income Taxes </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 187.73pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.73pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.73pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Provision for income taxes<font style="padding-left: 1.54pt;"></font></div></td><td style="width: 8.13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$119,247</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$35,701</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$83,546</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">234% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effective tax rate<font style="padding-left: 1.16pt;"></font></div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 23.8pt;">(16)%</font></div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 24.17pt;">(6)%</font></div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provision for income taxes for the year ended December&#160;31, 2024 increased by $84&#160;million, or 234%, compared to the year ended December&#160;31, 2023. We recorded income tax expense in all periods presented despite experiencing pre-tax losses in part due to nondeductible losses on fair value adjustments and projected limitations on our ability to realize certain tax benefits, which has resulted in us maintaining a full valuation allowance on our U.S. deferred tax assets. The increase in year over year income tax expense primarily resulted from an increase in pre-tax income excluding these nondeductible losses and the inability to record a net benefit from deferred tax assets generated in the period.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our effective tax rate might fluctuate significantly in the future due to additional impacts from non-deductible items and future changes in the valuation allowance on net deferred tax assets.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">134<br></div></div></div>
<!--End Page 145-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 146-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Comparison of the Year Ended December&#160;31, 2023 and 2022 </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 189.01pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.01pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.01pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 1.51pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$228,943</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$15,830</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$213,113</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.18pt; text-align: left;">1,346%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue for the year ended December&#160;31, 2023 increased by $213&#160;million, or 1,346%, compared to the year ended December&#160;31, 2022. This substantial growth was related to increased demand from both new and existing customer contracts and our ability to rapidly scale our operations and meet the evolving needs of the industry. Approximately 88% of the increase in revenue was from sales to new customers and the remaining increase was attributable to sales to existing customers.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Cost of Revenue </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 186.58pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.58pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.58pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 1.53pt;"></font></div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$68,780</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$12,122</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$56,658</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">467% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">30%</font></div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">77%</font></div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.7pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue for the year ended December&#160;31, 2023 increased by $57&#160;million, or 467%, compared to the year ended December&#160;31, 2022. This increase was attributable to higher costs directly related to running our data centers to support the significant increase in customer demand, driven by the successful deployment of new data centers, which resulted in an increase in rent expense of approximately $48&#160;million and an increase in personnel costs of approximately $2&#160;million, which includes headcount growth of employees directly supporting data center operations.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Technology and Infrastructure </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 189.01pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.01pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 189.01pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 4.47pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$131,855</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$18,106</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$113,749</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">628% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">58%</font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.87pt;">114%</font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense for the year ended December&#160;31, 2023 increased by $114&#160;million, or 628%, compared to the year ended December&#160;31, 2022. This increase was attributable to an increase in depreciation and amortization of approximately $90&#160;million, from $11&#160;million for the year ended December&#160;31, 2022, to $101&#160;million for the year ended December&#160;31, 2023, driven by investments in our platform and servers, switches, and other networking equipment fixed assets within our infrastructure, as well as an increase of approximately $17&#160;million of personnel costs and an increase of approximately $4&#160;million of equipment support and software expenses. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Sales and Marketing </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 185.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 3.75pt;"></font></div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$12,917</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$2,481</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$10,436</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">421% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">6%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">16%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense for the year ended December&#160;31, 2023 increased by $10&#160;million, or 421%, compared to the year ended December&#160;31, 2022. This increase was attributable to an increase of approximately $7&#160;million in personnel costs to help our efforts in driving customer demand.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">135<br></div></div></div>
<!--End Page 146-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 147-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">General and Administrative </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 185.36pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 185.36pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 1.55pt;"></font></div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$29,842</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$6,001</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$23,841</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.94pt; text-align: left;">397% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Percentage of revenue<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">13%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">38%</font></div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense for the year ended December&#160;31, 2023 increased by $24&#160;million, or 397%, compared to the year ended December&#160;31, 2022. This increase was attributable to an increase of approximately $16&#160;million in personnel related expenses, which includes headcount growth to support our expanding operations. Professional services expenses also increased by approximately $3&#160;million, primarily from accounting, tax, legal, and advisory services necessary to support our growth.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Loss on Fair Value Adjustments </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 190.35pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 190.35pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 190.35pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss on fair value adjustments<font style="padding-left: 0.99pt;"></font></div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(533,952)</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(2,884)</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(531,068)</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.38pt; text-align: left;">NM</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4.5pt; margin-left: 0pt; text-align: left;">NM &#8211; Not meaningful. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Loss on fair value adjustments for the year ended December&#160;31, 2023 increased by $531&#160;million, compared to the year ended December&#160;31, 2022. This increase was driven by an increase in the valuation of derivatives and warrants tied to our common stock and redeemable convertible preferred stock within the periods presented.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Interest Expense, Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 187.85pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.85pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 187.85pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 2.93pt;"></font></div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(28,404)</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(9,444)</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(18,960)</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.93pt; text-align: left;">201%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest expense, net for the year ended December&#160;31, 2023 increased by $19&#160;million, or 201%, compared to the year ended December&#160;31, 2022. This increase was attributable to higher borrowing levels under our Credit Facilities, resulting in an increase in interest expense, partially offset by capitalized interest associated with investments in our platform and data center infrastructure. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Other Income, Net </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 183.44pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 183.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 183.44pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income, net<font style="padding-left: 2.92pt;"></font></div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$18,760</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$192</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$18,568</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.39pt; text-align: left;">NM</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 20pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 4.5pt; margin-left: 0pt; text-align: left;">NM &#8211; Not meaningful. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other income, net for the year ended December&#160;31, 2023 increased by $19&#160;million, compared to the year ended December&#160;31, 2022. This increase was attributable to an increase in investment income of approximately $21&#160;million. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">136<br></div></div></div>
<!--End Page 147-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 148-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Provision for (benefit from) Income Taxes </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 186.17pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Change</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Change </div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 186.17pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(dollars in thousands) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$35,701</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(4,150)</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$39,851</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.27pt; text-align: left;">(960)% </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effective tax rate<font style="padding-left: 1.16pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24.17pt;">(6)%</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">12%</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.88pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.88pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provision for (benefit from) income taxes for the year ended December&#160;31, 2023 changed by $40&#160;million, or 960%, compared to the year ended December&#160;31, 2022. We recorded income tax expense for the year ended December&#160;31, 2023 despite experiencing pre-tax losses in part due to nondeductible losses on fair value adjustments and projected limitations on our ability to realize certain tax benefits, which has resulted in us maintaining a full valuation allowance on our U.S. deferred tax assets. The increase in year over year income tax expense primarily resulted from an increase in pre-tax income excluding these nondeductible losses and, the inability to record a net benefit from deferred tax assets generated in the period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our effective tax rate might fluctuate significantly in the future due to additional impacts from non-deductible items and future changes in the valuation allowance on net deferred tax assets. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Liquidity and Capital Resources </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have generated significant losses from operations, as reflected in our accumulated deficit of $2.1 billion as of June&#160;30, 2025. Additionally, we have generated significant negative cash flows from investing activities as we continue to support the growth of our CoreWeave Cloud Platform. We anticipate making significant investments for the foreseeable future, including in our infrastructure and go-to-market capabilities, to maintain our leadership and position us to continue to capitalize on the AI revolution. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, we completed our IPO, in which we issued and sold 36,590,000 shares of our Class&#160;A common stock at a public offering price of $40.00 per share, which resulted in net proceeds of $1.4&#160;billion. In April&#160;2025, the underwriters exercised a portion of their over-allotment option and purchased from us an additional 1,760,000 shares of Class&#160;A common stock at the IPO price, which resulted in net proceeds to us of $68&#160;million after deducting the underwriting discounts and commissions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our non-cancellable commitments are disclosed in <font style="font-style: italic;">Note&#160;8. Leases</font>,<font style="font-style: italic;"> Note&#160;9. Commitments and Contingencies, </font>and<font style="font-style: italic;"> Note&#160;10. Debt</font> to our unaudited condensed consolidated financial statements for the three and six months ended June&#160;30, 2025 and 2024 and audited consolidated financial statements for the years ended December&#160;31, 2022, 2023 and 2024 included elsewhere in this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe our existing balance of cash and cash equivalents and short-term investments, in addition to amounts available for borrowing under our various debt agreements, will be sufficient to meet our obligations due or anticipated to be due within one year from the date of this proxy statement/prospectus, including operating expenses, working capital, and current commitments for capital expenditures. Our future capital requirements may depend on many factors, including those set forth in the section of this proxy statement/prospectus entitled &#8220;Risk Factors.&#8221; We anticipate that future investments may require significant debt and/or equity financing. The sale of additional equity would result in dilution to our stockholders. The incurrence of additional debt would result in debt service obligations, and the instruments governing such debt could provide for operational and/or financial covenants that further restrict our operations. There can be no assurances that we will be able to raise additional capital on favorable terms or at all. The inability to raise capital could adversely affect our ability to achieve our business objectives. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">137<br></div></div></div>
<!--End Page 148-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 149-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes our principal sources of liquidity: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 472.43pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 64.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30 </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023 </div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 166.43pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div></td></tr><tr><td style="width: 300pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.72pt; text-align: left;">$1,152,883</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,361,083</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">217,147</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Short-term investments<font style="padding-left: 3.08pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.72pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">2,368</font> </div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Availability under existing facilities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.88pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.72pt; text-align: left;"><font style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,685,113</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,406,181</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">925,076</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total liquidity<font style="font-weight: normal; padding-left: 1.2pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.43pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.72pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,837,996</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$5,767,264</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,144,591</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 64.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refers to secured commitments under the revolving credit facility and delayed draw term loan agreements. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Revolving Credit Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June&#160;21, 2024, we entered into a credit agreement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, the guarantors party thereto, and the lenders and issuing banks party thereto (as amended, the &#8220;Revolving Credit Facility&#8221;). The Revolving Credit Facility matures on June&#160;21, 2027. On October&#160;7, 2024, the credit agreement was amended to provide for a $650&#160;million senior revolving credit facility consisting of (i) a $500&#160;million secured facility and (ii) a $150&#160;million unsecured facility. On December&#160;2, 2024, the Revolving Credit Facility was further amended to provide for the $650&#160;million senior revolving credit facility to be fully secured. On May&#160;2, 2025, the Revolving Credit Facility Agreement was further amended to increase the commitments thereunder to $1.5&#160;billion, with a $350&#160;million letter of credit sub-facility. Our Revolving Credit Facility may be increased by the sum of $500&#160;million plus an unlimited amount that does not result in our total net leverage ratio exceeding 6.00x or our secured net leverage ratio exceeding 4.00x, pursuant to the exercise of an uncommitted accordion feature through which existing and new lenders may, at their option, agree to provide additional financing. The proceeds of our Revolving Credit Facility may be used for working capital and general corporate purposes (including the financing of acquisitions and investments). Our Revolving Credit Facility also includes a $350&#160;million letter of credit sub-facility. As of June&#160;30, 2025, we had drawn $450&#160;million, had $11&#160;million of issued outstanding letters of credit, and had $1.0&#160;billion of remaining capacity on the Revolving Credit Facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amounts borrowed under our Revolving Credit Facility are subject to an interest rate per annum equal to, at our option, either (a) for base rate loans, an applicable margin of 0.75% plus a base rate (subject to a 1.00% floor) determined by reference to the highest of (i) the prime rate, (ii) the greater of (a) the federal funds effective rate and (b) the overnight bank funding rate, in each case, plus 0.50%, and (iii) the one month term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 1.00% or (b) for term benchmark loans, an applicable margin of 1.75% plus the Term SOFR (subject to a 0.00% floor) for a one, three or six month interest period. We may voluntarily prepay outstanding loans under our Revolving Credit Facility at any time without premium or penalty, other than customary &#8220;breakage&#8221; costs. The unused portion of our Revolving Credit Facility accrues unused commitment fees at a rate per annum equal to 0.25%, and letters of credit issued under our Revolving Credit Facility accrue participation fees on the stated amount of the letters of credit at a rate per annum equal to 1.75%. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The obligations under our Revolving Credit Facility are required to be unconditionally guaranteed by our restricted subsidiaries, which generally includes our direct and indirect wholly-owned domestic subsidiaries which are not designated by us as unrestricted subsidiaries. All obligations under our Revolving Credit Facility, and the guarantees of those obligations, are secured, subject to certain exceptions, by substantially all of Parent&#8217;s assets and the assets of its subsidiary guarantors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Revolving Credit Facility contains customary affirmative and negative covenants, including, but not limited to, restrictions on our and our restricted subsidiaries&#8217; ability to incur indebtedness, create liens, consolidate or merge, sell assets, including capital stock of our restricted subsidiaries, pay dividends on our capital stock or redeem, repurchase or retire our capital stock, engage in transactions with affiliates, create restrictions on our ability to create certain liens, have our restricted subsidiaries pay dividends or other amounts to us or make certain guarantees and make investments, loans, advances and acquisitions, in each case subject to certain expectations set forth in the Revolving Credit Facility. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">138<br></div></div></div>
<!--End Page 149-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 150-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are also required to comply with certain financial covenants on the last day of each fiscal quarter, including maintaining a total net leverage ratio of 6.00x, subject to increases to 7.00x in certain cases, and a minimum contracted revenue of $1.0&#160;billion. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Revolving Credit Facility contains customary events of default, including payment defaults, failure to perform or observe covenants, cross-defaults with certain other indebtedness, a change of control, and certain bankruptcy events, among others. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Additional Secured Commitments </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facility 1.0 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;30, 2023, one of our subsidiaries entered into a delayed draw term loan with various lenders and U.S.&#160;Bank, N.A., as the administrative agent. The agreement provides for a delayed draw term loan facility of up to $2.3&#160;billion (as amended, the &#8220;DDTL 1.0 Facility&#8221;). All obligations under the DDTL 1.0 Facility are unconditionally guaranteed by us and secured, subject to certain exceptions, by substantially all of the subsidiary&#8217;s assets and a pledge of 100% of the equity interests in the subsidiary. Borrowings under the DDTL 1.0 Facility were used to finance a portion of the purchase consideration, fees, and expenses relating to the acquisition of computing equipment. The maturity date of our DDTL 1.0 Facility is March&#160;29, 2028. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May&#160;15, 2024, the interest rate was modified to Term SOFR plus 9.62% or the alternative base rate plus 8.62%. The principal amount of the loans is required to be repaid in quarterly installments, with the final balloon payment due on March&#160;29, 2028. We are also required to prepay outstanding loans under the facility, subject to certain exceptions, with (i) 100% of the net proceeds of any disposition of uncontracted GPU servers, (ii) 100% of the net proceeds of any indebtedness not permitted under our DDTL 1.0 Facility, and (iii) 100% of the net proceeds of certain asset sales and casualty events. The loans are prepayable at any time, from time to time, at our option, and are required to be prepaid upon the occurrence of an event of default or change of control of us, or with the proceeds of certain asset dispositions or incurrences of indebtedness. If the loans are prepaid prior to the fourth anniversary of the loan commitment termination date, in addition to principal and accrued interest, we are required to pay an applicable premium equal to (a) with respect to prepayments made prior to the third anniversary of the loan commitment termination date, an amount equal to the present value of future interest payments that would have accrued on the principal amount of the loans being prepaid through the third anniversary of the loan commitment termination date based on the interest rate in effect plus 1.00% of the principal amount of the loans being prepaid and (b) with respect to prepayments made between the third and fourth anniversary of the loan commitment termination date, an amount equal to 1.00% of the principal amount of the loans being prepaid. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025 and December&#160;31, 2024, we had $1.8&#160;billion and $2.0&#160;billion outstanding, respectively, under the DDTL 1.0 Facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amounts borrowed under our DDTL 1.0 Facility are subject to an interest rate per annum equal to, at our option, either (i) for base rate loans, an applicable margin of 8.6196% plus a base rate (subject to a 0.00% floor) determined by reference to the highest of (a) the prime rate, (b) the federal funds effective rate plus 0.50%, and (c) the one month Term SOFR plus 1.00% or (ii) for Term SOFR loans, an applicable margin of 9.6196% plus the Term SOFR (subject to a 0.00% floor) for a three month interest period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our guarantee agreement under the DDTL 1.0 Facility contains certain covenants that, among other things and subject to certain exceptions, restrict our ability to incur additional indebtedness, including capital leases, create liens, pay dividends on its capital stock or redeem, repurchase or retire its capital stock, consolidate or merge, make acquisitions, and take certain actions with respect to its material project contracts. The DDTL 1.0 Facility also contains a number of other covenants that, among other things and subject to certain exceptions, restrict the ability of the borrower incur additional indebtedness, including capital leases; create liens; make investments, loans, and advances; consolidate or merge, sell assets, or make acquisitions; pay dividends on its capital stock or redeem, repurchase, or retire its capital stock; engage in transactions with our affiliates; have any subsidiaries; create restrictions on its ability to create certain liens; and take certain actions with respect to its material project contracts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The credit agreement governing our DDTL 1.0 Facility contains customary events of default, including payment defaults, failure to perform or observe covenants, cross-defaults with certain other indebtedness, a change of control, and certain bankruptcy events, among others. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">139<br></div></div></div>
<!--End Page 150-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 151-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facility 2.0 </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May&#160;16, 2024, another of our subsidiaries entered into a second delayed draw term loan facility with various lenders and U.S. Bank, N.A. as the administrative agent. The agreement provides for a delayed draw term loan facility of up to $7.6&#160;billion assuming the relevant collateralization requirements are met (as amended, the &#8220;DDTL&#160;2.0 Facility&#8221;). Under the DDTL 2.0 Facility, as amended on June 6, 2025, additional loans may be drawn until September 29, 2025, with an option to extend the commitment period by three months subject to lender consent. The total loans available are limited to a percentage of the depreciated purchase price of GPU servers and related infrastructure for the contract that the loans are being used to finance, with such percentage based upon the credit rating of the applicable customer. All obligations under the DDTL 2.0 Facility are unconditionally guaranteed by us and secured, subject to certain exceptions, by substantially all of the subsidiary&#8217;s assets and a pledge of 100% of the equity interests in the subsidiary. Borrowings under the DDTL 2.0 Facility will be used to finance a portion of the purchase consideration, fees, and expenses relating to the acquisition of computing equipment. The maturity date of our DDTL 2.0 Facility is, with respect to each loan, the date that is five years after the date each such loan was funded. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest on outstanding borrowings on the DDTL 2.0 Facility accrued at a rate per annum equal to either, at our election, Term SOFR or the alternative base rate plus a spread based on the credit quality of the associated customer contracts. For specified investment-grade customers, the spread is equal to 6.00% for Term SOFR loans and 5.00% for base rate loans. For investment-grade customers, the spread is equal to 6.50% for Term SOFR loans and 5.50% for base rate loans. For non-investment-grade customer contracts, the spread is equal to 13.00% for Term SOFR loans and 12.00% for base rate loans. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal amount of the loans is required to be repaid in quarterly installments, beginning in January&#160;2026, with the final balloon payment due five years after the applicable loan was funded. We are also required to prepay outstanding loans under the facility, subject to certain exceptions, with (i) 100% of the net proceeds of any disposition of uncontracted GPU servers, (ii) 100% of the net proceeds of any indebtedness not permitted under our DDTL 2.0 Facility, and (iii) 100% of the net proceeds of certain asset sales and casualty events. The loans are prepayable at any time, from time to time, at our option, and are required to be prepaid upon the occurrence of an event of default or change of control of us, or with the proceeds of certain asset dispositions or incurrences of indebtedness. If the loans are prepaid prior to the 30-month anniversary of the loan commitment termination date, in addition to principal and accrued interest, we are required to pay an applicable premium equal to the present value of future interest payments that would have accrued on the principal amount of the loans being prepaid through the 30-month anniversary of the loan commitment termination date based on the interest rate in effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025 and December&#160;31, 2024, we had borrowed $5.0&#160;billion and $3.8&#160;billion, respectively, against the DDTL 2.0 Facility and $2.6&#160;billion and $3.8&#160;billion, respectively, remained available for borrowing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our guarantee agreement under the DDTL 2.0 Facility contains certain covenants that, among other things and subject to certain exceptions, restrict our ability to incur additional indebtedness, including capital leases, create liens, pay dividends on its capital stock or redeem, repurchase or retire its capital stock, consolidate or merge, make acquisitions, and take certain actions with respect to its material project contracts. The DDTL 2.0 Facility also contains a number of other covenants that, among other things and subject to certain exceptions, restrict the ability of the borrower incur additional indebtedness, including capital leases; create liens; make investments, loans, and advances; consolidate or merge, sell assets, or make acquisitions; pay dividends on its capital stock or redeem, repurchase, or retire its capital stock; engage in transactions with our affiliates; have any subsidiaries; create restrictions on its ability to create certain liens; and take certain actions with respect to its material project contracts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The borrower under the DDTL 2.0 Facility is also required to comply with certain financial covenants on the last day of each fiscal quarter, including (i) beginning January&#160;2026, maintaining a contract coverage ratio of 1.4x, (ii) a non-IG collateral ratio of 0.35x or less, (iii) a non-IG revenue ratio of 0.35x or less and (iv) a minimum liquidity ratio of 2.0% of the principal amount of the loans outstanding under the facility, stepping down 1.0% upon the occurrence of certain events. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facility 3.0 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;28, 2025, CoreWeave Compute Acquisition Co. V, LLC (&#8220;CCAC V&#8221;), a Delaware limited liability company and a direct subsidiary of CoreWeave, Inc., a Delaware Corporation (the &#8220;Parent&#8221;) and CoreWeave Compute Acquisition Co. VII, LLC (&#8220;CCAC VII&#8221; and together with CCAC V, the &#8220;DDTL 3.0 Borrowers&#8221;), a Delaware limited liability company and an indirect subsidiary of the Parent as borrowers, entered into a credit </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">140<br></div></div></div>
<!--End Page 151-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 152-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">agreement (the &#8220;DDTL 3.0 Credit Agreement&#8221;) with MUFG Bank, Ltd., as administrative agent, U.S. Bank Trust Company, National Association as collateral agent, U.S. Bank National Association, as depository bank, Morgan Stanley Asset Funding, Inc. and MUFG Bank, Ltd. as joint lead arrangers and joint bookrunners, Goldman Sachs Bank USA, as joint lead arranger, and the lenders party thereto, providing for a $2.6&#160;billion delayed draw term loan facility (the &#8220;DDTL 3.0 Facility&#8221;). The DDTL 3.0 Facility was entered into primarily to finance capital expenditures required to perform a customer contract, including the acquisition of GPU servers and related infrastructure. The DDTL 3.0 Facility provides for delayed draw term loans available in one or more draws until the commitment termination date on July 28, 2026. The maturity date of the DDTL 3.0 Facility is August&#160;21, 2030. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amounts borrowed under the DDTL 3.0 Facility are subject to an interest rate per annum equal to, at our option, either (a) for base rate loans, an applicable margin of 3.00% plus a base rate (subject to a 0.00% floor) determined by reference to the highest of (i) the prime rate, (ii) the federal funds effective rate plus 0.50%, and (iii) daily simple SOFR plus 1.00% or (b) for SOFR loans, 4.00% plus the daily compounded SOFR, as applicable (subject to a 0.00%&#160;floor).The DDTL 3.0 Facility provides for payment of, among others, undrawn fees in an amount equal to 0.50% per annum on the average daily undrawn portion of the DDTL 3.0 Facility, which undrawn fees are payable monthly in arrears. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The obligations of CCAC VII (but not CCAC V) under the DDTL 3.0 Facility are unconditionally guaranteed by us pursuant to a parent guarantee and pledge agreement, dated as of July 28, 2025, by and among us, CCAC VII HoldCo LLC, a Delaware limited liability company (&#8220;CCAC VII HoldCo&#8221;) and U.S. Bank Trust Company, National Association (the &#8220;Parent Guarantee and Pledge Agreement&#8221;). All obligations under the DDTL 3.0 Facility are secured by substantially all assets of CCAC VII and a pledge of 100% of the equity interests in CCAC VII held by CCAC VII HoldCo and certain infrastructure purchased with the proceeds of the of the delayed draw term loans and owned by or transferred to CCAC V.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DDTL 3.0 Borrowers are also required to comply with certain financial covenants on the last day of each calendar month, including (i) maintaining a contract realization ratio of 0.85:1.00, (ii) beginning April 2027, maintaining a debt service coverage ratio for the most recently ended three full fiscal month period of less than 1.40:1.00 and (iii) maintaining a minimum liquidity amount of (a) prior to September 1, 2025, $50 million, (b) on and after September 1, 2025 but prior to March 1, 2026, $100 million, (c) on and after March 1, 2026 but prior to April 1, 2026, $175 million, (d) on and after April 1, 2026 but prior to May 1, 2026, $125 million, (e) on and after May 1, 2026 but prior to August 1, 2027, $100 million, (f) on and after August 1, 2027 but prior to August 1, 2028, $75 million and (g) on any monthly date on and after August 1, 2028, $50 million.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DDTL 3.0 Facility contains a number of other customary negative covenants, and the DDTL 3.0 Credit Agreement contains customary events of default, including payment defaults, failure to perform or observe covenants, cross-defaults with certain other indebtedness, a change of control, and certain bankruptcy events. The DDTL 3.0 Credit Agreement also contains events of default related to certain adverse events with respect to certain material contracts. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">2024 Term Loan Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On December&#160;16, 2024, we entered into a credit agreement providing for a $1.0&#160;billion term loan facility (the &#8220;2024 Term Loan Facility&#8221;) consisting of (i) a $229&#160;million secured facility and (ii) a $771 million unsecured facility, with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent, the guarantors party thereto, and the lenders party thereto. On December&#160;16, 2024, we borrowed the full $1.0&#160;billion of loans available under the 2024&#160;Term Loan Facility. Our 2024 Term Loan Facility may be increased by $500&#160;million pursuant to the exercise of an uncommitted accordion feature. The proceeds of our 2024 Term Loan Facility may be used for working capital and general corporate purposes (including the financing of acquisitions and investments). In connection with the IPO, the maturity date of the 2024 Term Loan Facility was accelerated and became due on April&#160;14, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On April&#160;11, 2025, with a portion of the proceeds received from our IPO, we paid an aggregate principal amount of $1.0&#160;billion to repay in full all outstanding obligations under our 2024 Term Loan Facility. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Additional Unsecured Commitments </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;">2025 Term Loan Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On March&#160;7, 2025, we entered into the 2025 Term Loan Facility with Morgan Stanley Senior Funding, Inc., as administrative agent, the guarantors party thereto, and the lenders party thereto, providing for a $300&#160;million unsecured term loan facility. The obligations under our 2025 Term Loan Facility are unconditionally guaranteed by </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">141<br></div></div></div>
<!--End Page 152-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 153-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">our subsidiary guarantors as described in the 2025 Term Loan Credit Agreement. Amounts borrowed under the 2025 Term Loan Facility may only be borrowed in a single funding. All unfunded commitments of the lenders under the 2025 Term Loan Facility terminated in connection with the IPO. There were no borrowings under the 2025 Term Loan Facility and in connection with the IPO, the 2025 Term Loan Facility was terminated. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">2030 Senior Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May&#160;27, 2025, we issued $2,000&#160;million in aggregate principal amount of 9.250% Senior Notes due 2030 (the &#8220;2030 Senior Notes&#8221;). The 2030 Notes were issued pursuant to an indenture, dated as of May&#160;27, 2025 (the &#8220;2030&#160;Indenture&#8221;), by and among us, the guarantor party thereto and Wilmington Trust, National Association, as trustee. The 2030 Senior Notes are guaranteed on a senior unsecured basis by CoreWeave Cash Management LLC, our wholly-owned subsidiary and certain of our future direct and indirect wholly owned domestic restricted subsidiaries that guarantee our existing revolving credit facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2030 Senior Notes will mature on June&#160;1, 2030 and bear interest at a rate of 9.250% per annum, payable semi-annually in cash in arrears on June&#160;1 and December&#160;1 of each year, beginning on December&#160;1, 2025. Interest on the 2030 Senior Notes will accrue from May&#160;27, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may redeem all or a portion of the 2030 Senior Notes at any time prior to June&#160;1, 2027 at a redemption price equal to 100% of the aggregate principal amount thereof, plus a make-whole premium, together with accrued and unpaid interest, if any, to, but excluding, the redemption date. We may redeem all or a portion of the 2030 Senior Notes at any time on or after June&#160;1, 2027 at the redemption prices set forth in the 2030 Indenture. At any time prior to June&#160;1, 2027, up to 40% of the aggregate principal amount of the 2030 Senior Notes may be redeemed with the net cash proceeds from certain equity offerings, at the redemption price specified in the 2030 Indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the occurrence of specified kinds of change of control triggering events, holders of the 2030 Senior Notes will have the right to require us to repurchase the 2030 Senior Notes at a purchase price equal to 101% of the principal amount plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2030 Indenture limits, among other things, the ability of us and our restricted subsidiaries to (i) incur or guarantee additional indebtedness or issue disqualified stock or certain preferred stock; (ii) pay dividends on or make other distributions in respect of equity interests or make other restricted payments; (iii) create liens on certain assets to secure indebtedness; (iv) make certain investments; (v) sell certain assets; (vi) enter into certain transactions with our affiliates; (vii) merge or consolidate with other persons or sell or otherwise dispose of all or substantially all of our assets; and (viii) designate our restricted subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of important limitations and exceptions that are set forth in the 2030 Indenture. The 2030 Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods). </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">2031 Senior Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;25, 2025, we issued $1,750&#160;million in aggregate principal amount of 9.000% Senior Notes due 2031 (the &#8220;2031 Senior Notes&#8221; and, together with the 2030 Senior Notes, the &#8220;Notes&#8221;). The 2031 Senior Notes were issued pursuant to an indenture, dated as of July&#160;25, 2025 (the &#8220;2031 Indenture&#8221;), by and among us, the guarantors party thereto and Wilmington Trust, National Association, as trustee. The 2031 Senior Notes are guaranteed on a senior unsecured basis by certain of our wholly-owned subsidiaries and certain of our future direct and indirect wholly owned domestic restricted subsidiaries that guarantee our existing revolving credit facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2031 Senior Notes will mature on February&#160;1, 2031 and bear interest at a rate of 9.000% per annum, payable semi-annually in cash in arrears on February&#160;1 and August&#160;1 of each year, beginning on February&#160;1, 2026. Interest on the 2031 Senior Notes will accrue from July&#160;25, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may redeem all or a portion of the 2031 Senior Notes at any time prior to February&#160;1, 2028 at a redemption price equal to 100% of the aggregate principal amount thereof, plus a make-whole premium, together with accrued and unpaid interest, if any, to, but excluding, the redemption date. We may redeem all or a portion of the 2031 Senior Notes at any time on or after February&#160;1, 2028 at the redemption prices set forth in the 2031 Indenture. At any time prior to February&#160;1, 2028, up to 40% of the aggregate principal amount of the 2031 Senior Notes may be redeemed with the net cash proceeds from certain equity offerings, at the redemption price specified in the 2031 Indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the occurrence of specified kinds of change of control triggering events, holders of the 2031 Senior Notes will have the right to require us to repurchase the 2031 Senior Notes at a purchase price equal to 101% of the principal amount plus accrued and unpaid interest, if any, to, but excluding, the repurchase date. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">142<br></div></div></div>
<!--End Page 153-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 154-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2031 Indenture limits, among other things, the ability of us and our restricted subsidiaries to (i) incur or guarantee additional indebtedness or issue disqualified stock or certain preferred stock; (ii) pay dividends on or make other distributions in respect of equity interests or make other restricted payments; (iii) create liens on certain assets to secure indebtedness; (iv) make certain investments; (v) sell certain assets; (vi) enter into certain transactions with our affiliates; (vii) merge or consolidate with other persons or sell or otherwise dispose of all or substantially all of our assets; and (viii) designate our restricted subsidiaries as unrestricted subsidiaries. These covenants are subject to a number of important limitations and exceptions that are set forth in the 2031 Indenture. The 2031 Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods). </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Cash Flows </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 204pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 103.64pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 146.41pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 204pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 103.64pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 146.41pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div></td></tr><tr class="BRDSX_header"><td style="width: 204pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.48pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 3.48pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr class="BRDSX_header"><td style="width: 204pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="13" style="width: 257.03pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands)</div></td></tr><tr><td style="width: 204pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by operating activities<font style="padding-left: 3.23pt;"></font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">(190,083) </font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">1,921,214</font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">2,749,168</font></div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">1,832,650</font></div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">910</font></div></td></tr><tr><td style="width: 204pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash used in investing activities<font style="padding-left: 3.78pt;"></font></div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,875,213) </font></div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(4,021,175)</font></div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(8,658,058)</font></div></td><td style="width: 3.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(3,147,710)</font></div></td><td style="width: 3.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(79,183)</font></div></td></tr><tr><td style="width: 204pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net cash provided by financing activities<font style="padding-left: 3.23pt;"></font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">4,083,046</font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">2,859,784</font></div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">7,464,648</font></div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,787,751</font></div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">81,454</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 204pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.49pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Operating Activities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by (used in) operating activities was $(190) million for the six months ended June&#160;30, 2025 as compared to net cash provided by operating activities of $1.9&#160;billion for the six months ended June&#160;30, 2024. The decrease was driven by an increase in accounts receivable, decrease in accounts payable and accrued expenses, and fewer committed contracts from new customer contracts involving upfront payments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by operating activities was $2.7&#160;billion for the year ended December&#160;31, 2024 as compared to $1.8&#160;billion for the year ended December&#160;31, 2023. The increase was driven by cash received for upfront payments from our committed contracts from new and expanded customer contracts, as well as higher accounts payable and accrued expenses due to the growth of our business and timing of accrual payments. The increase was partially offset by higher cash payments and an increase in accounts receivable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by operating activities was $1.8&#160;billion for the year ended December&#160;31, 2023, as compared to $1&#160;million for the year ended December&#160;31, 2022. The increase was driven by cash received for upfront payments from our committed contracts due to the increased demand for both new and expanded customer contracts. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Investing Activities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash used in investing activities was $3.9&#160;billion for the six months ended June&#160;30, 2025, as compared to $4.0&#160;billion for the six months ended June&#160;30, 2024. The decrease was driven by relatively lower capital investments in our infrastructure, including our GPU fleet, networking equipment, servers, switches and other necessary equipment for infrastructure asset security compared to the six months ended June&#160;30, 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash used in investing activities was $8.7&#160;billion for the year ended December&#160;31, 2024, as compared to $3.1&#160;billion for the year ended December&#160;31, 2023. The increase was driven by increased capital investments in our infrastructure, including our GPU fleet, networking equipment, and software development. The increase was partially offset by sales and maturities of marketable securities and available-for-sale marketable securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash used in investing activities was $3.1&#160;billion for the year ended December&#160;31, 2023 as compared to $79&#160;million for the year ended December&#160;31, 2022. The increase was driven by increased capital investments in our infrastructure, including our GPU fleet, networking equipment, and software development. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Financing Activities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by financing activities was $4.1&#160;billion for the six months ended June&#160;30, 2025, as compared to $2.9&#160;billion for the six months ended June&#160;30, 2024. The increase was driven by the issuance of debt and proceeds from our initial public offering. The increase was partially offset by higher payments on long-term debt. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by financing activities was $7.5&#160;billion for the year ended December&#160;31, 2024, as compared to $1.8&#160;billion for the year ended December&#160;31, 2023. The increase was driven by borrowings under our delayed draw term loans, proceeds from the issuance of our Series&#160;C redeemable convertible preferred stock, and proceeds from the issuance of our 2024 Term Loan Facility. The increase was partially offset by the settlement of our 2022 Senior Secured Note&#160;and higher payments on debt. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">143<br></div></div></div>
<!--End Page 154-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 155-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Net cash provided by financing activities was $1.8&#160;billion for the year ended December&#160;31, 2023, as compared to $81&#160;million for the year ended December&#160;31, 2022. The increase was driven by borrowings under our DDTL 1.0 Facility and proceeds from the issuance of our Series&#160;B redeemable convertible preferred stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Off-Balance Sheet Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We did not have during the periods presented, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Critical Accounting Estimates </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Management&#8217;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements and the related notes thereto, which have been prepared in accordance with GAAP. In preparing the consolidated financial statements, we apply accounting policies and estimates that affect the reported amounts and related disclosures. Inherent in such policies are certain key assumptions and estimates made by management, which we believe best reflect our underlying business and economic conditions. Our estimates are based on historical experience and various other factors and assumptions that we believe are reasonable under the circumstances. We regularly re-evaluate our estimates used in the preparation of the consolidated financial statements based on our latest assessment of the current and projected business and economic environment. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and actual results could differ materially from the amounts reported based on these estimates. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Revenue Recognition </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We generate revenue from the delivery of cloud computing services. Revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these goods or services. We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers (&#8220;ASC 606&#8221;). We account for revenue by applying the following steps: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Identification of the contract, or contracts, with the customer. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Identification of the performance obligations in the contract. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Determination of the transaction price. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Allocation of the transaction price to the performance obligations in the contract. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Recognition of the revenue when, or as, a performance obligation is satisfied. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We allocate the total transaction price to each distinct performance obligation in an arrangement containing multiple performance obligations on a relative stand-alone selling price (&#8220;SSP&#8221;) basis. The SSP reflects the price we would charge for a specific service if it were sold separately in similar circumstances and to similar customers. If a contract contains a single performance obligation, no allocation is required. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue includes both committed contracts and on-demand access. Committed contracts generally consist of two stand-ready obligations to process transactions, store data, and run customers&#8217; programs over a specified period, one being the compute infrastructure services and the other being the related support services. As these are both delivered ratably and over the same term, they are accounted for as one combined performance obligation. As a result, revenue is recognized ratably over the contract period. On-demand access is provided to customers on a consumption basis and is billed monthly in arrears based on usage of compute, storage, and other services in the period. As these contracts include an unknown quantity of transactions at a fixed contractual rate per transaction executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of services during that month. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Income Taxes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Management makes estimates, assumptions, and judgments to determine our provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against deferred tax assets. We recognize a deferred tax asset when it is more likely than not that the asset will be realized. We regularly review our deferred tax </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">144<br></div></div></div>
<!--End Page 155-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 156-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">assets for recoverability and establish a valuation based upon historical losses, projected future taxable income and the expected timing of the reversals of existing temporary differences. To the extent we increase or decrease the allowance in a period, we recognize the change in the allowance within &#8220;Provision for (benefit from) income taxes&#8221; in the audited consolidated statements of operations. Unforeseen changes in tax rates and tax laws, as well as differences in the projected taxable income as compared to actual taxable income, may affect these estimates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that there is a reasonable possibility that sufficient positive evidence may become available in the near-term to allow us to reach a conclusion that a portion of the valuation allowance may no longer be needed. If, as a result of the above, all or a portion of the valuation allowance is released, we would recognize a decrease to income tax expense for the period during which such release is recorded. The timing and amount of the valuation allowance release, if any, are subject to change on the basis of the level of profitability, if any, that we are able to actually achieve. Estimates of future taxable income are based on assumptions that are consistent with our plans. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We calculate the current and deferred income tax provision based on estimates and assumptions that could differ from the actual results reflected in income tax returns filed in subsequent years and record adjustments based on filed tax returns when identified. The amount of income taxes paid is subject to examination by U.S. federal and state tax authorities. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">Common Stock Valuations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to our IPO, the fair value of common stock underlying our stock-based awards was historically determined by our board of directors, with input from management and contemporaneous third-party valuations. We believe that our board of directors had the relevant experience and expertise to determine the fair value of our common stock. Given the absence of a public trading market of our common stock, and in accordance with the American Institute of Certified Public Accountants Practice Aid,<font style="font-style: italic;"> Valuation of Privately-Held Company Equity Securities Issued as Compensation</font>, our board of directors exercised reasonable judgment and considered numerous objective and subjective factors to determine the best estimate of the fair value of our common stock at each grant date. These factors included: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">contemporaneous valuations of our common stock performed by independent third-party specialists; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the prices, rights, preferences, and privileges of our redeemable convertible preferred stock relative to those of our common stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the prices paid for common or convertible preferred stock sold to third-party investors by us and in secondary transactions for shares repurchased by us in arm&#8217;s-length transactions, including any tender offers; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the lack of marketability inherent in our common stock and involving securities in a private company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">our actual operating and financial performance and estimated trends and prospects for our future performance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">our stage of development; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the hiring of key personnel and the experience of our management; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the likelihood of achieving a liquidity event, such as an initial public offering, direct listing, or sale of our company, given prevailing market conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the market performance of comparable publicly traded companies; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. and global capital market conditions. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In valuing our common stock, the fair value of our business was determined using various valuation methods, including combinations of income and market approaches, with input from management. The income approach estimates value based on the expectation of future cash flows that we may generate. These future cash flows are discounted to their present values using a discount rate derived from an analysis of the cost of capital of comparable publicly traded companies in our industry or similar business operations as of each valuation date, adjusted to reflect the inherent risks in our cash flows. The market approach estimates value based on a comparison of the subject company to comparable public companies in a similar line of business and may also include backsolves, which infers our value from recent financing rounds or tender offers. From these comparable companies, a representative market value multiple is determined and then applied to the subject company&#8217;s financial forecasts to estimate its value. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">145<br></div></div></div>
<!--End Page 156-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 157-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For each valuation, the fair value of our business determined by the income and market approaches was then allocated to the common stock using either the option-pricing method (&#8220;OPM&#8221;), or a hybrid of the probability-weighted expected return method (&#8220;PWERM&#8221;) and OPM methods. The OPM is based on the Black-Scholes-Merton option pricing model, which identifies a range of possible future outcomes, each with an associated probability. This method is appropriate when the range of possible future outcomes is difficult to predict, resulting in highly speculative forecasts. PWERM involves a forward-looking analysis of potential future outcomes for the enterprise, including an IPO and other market-based outcomes. After determining and allocating the equity value to the various classes of securities, a discount for lack of marketability (&#8220;DLOM&#8221;) is applied to arrive at the fair value of our common stock. The DLOM reflects the theory that private company stockholders have limited opportunities to sell their stock, and any such sale would involve significant transaction costs, thereby reducing the overall fair market value. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, we also considered any secondary transactions involving our capital stock. In evaluating those transactions, we took into account the facts and circumstances of each transaction to determine the extent to which they represented a fair value exchange and assigned the transactions an appropriate weighting in the valuation of our common stock. Factors considered include the number of different buyers and sellers, transaction volume, timing relative to the valuation date, whether the transactions occurred between willing and unrelated parties, and whether the transactions involved investors with access to our financial information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The application of these approaches and methodologies involved the use of highly complex and subjective estimates, judgments, and assumptions, such as those regarding our expected future revenue, expenses, and cash flows; discount rates; market multiples; the selection of comparable public companies; and the probability and timing of possible future events. Changes in any or all of these estimates and assumptions, or the relationships between those assumptions, impact our valuations as of each valuation date and may have a significant impact on the valuation of our common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors determines the fair value of each share of underlying our Class&#160;A common stock based on the closing price of our Class&#160;A common stock on the date of grant. Future expense amounts for any particular period could be affected by changes in our assumptions or market conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We estimate the fair value of stock options granted to employees and directors using the Black-Scholes option-pricing model. The fair value of stock options that are expected to vest is recognized as stock-based compensation expense on a straight-line basis over the requisite service period. The fair value of RSUs is estimated based on the fair market value of our common stock on the date of grant. We grant RSUs that vest upon the satisfaction of both a service-based vesting condition and a performance-based vesting condition. The fair value of RSUs that are expected to vest is recognized as stock-based compensation expense over the requisite service period, using the accelerated attribution method, once the performance-based vesting condition becomes probable of being achieved. As of December&#160;31, 2024, no stock-based compensation expense had been recognized for RSUs because the performance-based vesting condition had not been probable of being satisfied. In connection with the IPO, we recognized $177&#160;million of stock-based compensation expense, net of $17&#160;million of capitalized costs primarily related to the development of internal-use software, associated with vested RSUs with a liquidity-event performance-based vesting condition which was satisfied in connection with the IPO and for which the service-based vesting condition had also been satisfied as of that date. Concurrently with the IPO, we issued shares of Class&#160;A common stock upon settlement of RSUs subject to such performance-based vesting conditions. To meet the related tax withholding requirements for the net settlement of the vested RSUs, we withheld 392,135 shares underlying such equity awards, resulting in the net issuance of 518,785 shares of Class&#160;A common stock. Based on the IPO price of $40.00 per share, our related tax withholding obligation was $16&#160;million and was paid during the three months ended March&#160;31, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, the total unrecognized stock-based compensation expense related to unvested stock options was $73&#160;million, which is expected to be recognized over a weighted-average period of two years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, unrecognized stock-based compensation expense related to unvested RSUs was $1.1&#160;million, which is expected to be recognized over a weighted-average period of three years. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">146<br></div></div></div>
<!--End Page 157-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 158-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Valuation of Derivatives and Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are involved in certain debt financing transactions that contain embedded derivatives and include the issuance of common stock warrants. We measured the fair value of the embedded derivatives on the date of issuance and recognized derivative liabilities. The derivative liabilities are remeasured to fair value each reporting period until settlement or extinguishment, with changes in the fair value recorded in loss on fair value adjustments in the consolidated statements of operations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We account for warrants issued in connection with debt financings as either equity-classified or liability-classified instruments based on an assessment of the warrant&#8217;s specific terms at the time of issuance for each warrant and as of each subsequent reporting period while the warrants are outstanding. For equity-classified warrants, the relative fair value of the warrants at issuance is recorded in additional paid-in capital in the consolidated balance sheets and no changes in fair value are recognized after the issuance date. For liability-classified warrants, the relative fair value of the warrants at issuance is included within other derivative and warrant liabilities in the consolidated balance sheets and warrants are measured at fair value each period with changes in fair value recorded in loss on fair value adjustment to warrants in the audited consolidated statements of operations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may continue to adjust the derivative liabilities and warrant liabilities for changes in fair value until the earlier of conversions, exercise, or expirations. The fair value measurement of derivative liabilities and warrant liabilities are measured using unobservable inputs that require a high level of judgment to determine fair value. We estimate the fair value of derivative liabilities and warrant liabilities using a binomial lattice approach that incorporates a Monte Carlo simulation that considers our future stock price. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Leases </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We determine if an arrangement meets the definition of a lease at the inception of the lease, with leases classified at commencement as either operating or finance leases. Operating leases are reported separately in our audited consolidated balance sheets. Finance leases are recognized within property and equipment, net, and as a finance liability separately presented in our audited consolidated balance sheets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Right-of-use (&#8220;ROU&#8221;) assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease during the lease term. ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred, and prepaid lease payments, excluding lease incentives received prior to lease commencement. Lease liabilities are measured based on the discounted present value of the remaining lease payments at commencement date. We utilize our incremental borrowing rate (&#8220;IBR&#8221;) to discount the present value of the remaining lease payments. The IBR is based on our estimated rate of interest for a collateralized borrowing with a similar term and payments as the lease. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of our leases include escalation clauses, renewal options and termination options that are factored into the determination of lease payments when reasonably certain that we would exercise that option. Certain future minimum lease payments due under the operating lease agreements contain rent-free periods or escalating rent payment provisions. Our finance leases generally include purchase options and declining minimum payments. Short-term leases with an initial term of 12 months or less are not recorded on the balance sheets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We account for lease components and non-lease components as a single lease component. Payments under our lease agreements are primarily fixed. However, certain lease agreements contain variable payments, which are expensed as incurred and not included in the ROU assets and lease liabilities. Variable lease payments are mainly composed of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Operating leases are expensed on a straight-line basis over the lease term. The expense for finance leases includes both interest and amortization expense components, with the interest component calculated based on the effective interest method over the lease term and the amortization component calculated based on the straight-line amortization of the ROU asset over the lease term. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Recent Accounting Pronouncements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">See the sections titled &#8220;Overview and Summary of Significant Accounting Policies&#8212;Recent Accounting Pronouncements Adopted&#8221; and &#8220;&#8212;Recent Accounting Pronouncements Not Yet Adopted&#8221; in Note&#160;1 to our audited consolidated financial statements and the section titled &#8220;Recent Accounting Pronouncements Not Yet Adopted&#8221; in <font style="font-style: italic;">Note&#160;1&#8212;Overview and Summary of Significant Accounting Policies </font>our unaudited condensed consolidated financial statements in each case included elsewhere in this proxy statement/prospectus for more information. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">147<br></div></div></div>
<!--End Page 158-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 159-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Internal Control Over Financial Reporting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither we nor our independent registered public accounting firm were required to, and therefore did not perform, an evaluation of our internal control over financial reporting as of or for any period included in our financial statements, nor any period subsequent in accordance with the provisions of the Sarbanes-Oxley Act. However, while preparing the financial statements that are included elsewhere in this proxy statement/prospectus, we identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The material weaknesses identified pertained to the lack of effectively designed, implemented, and maintained IT general controls over tools and applications that support our financial reporting processes; insufficient segregation of duties across financially relevant functions, and lack of sufficient number of qualified personnel within our accounting, finance, and operations functions who possessed an appropriate level of expertise to provide reasonable assurance that transactions were being appropriately recorded and disclosed. We have concluded that these material weaknesses existed because we did not have the necessary business processes, systems, personnel and related internal controls. The deficiencies identified did not result in a material misstatement to our financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">We have taken and will continue to take action to remediate these material weaknesses, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">engagement with external consultants with extensive Sarbanes-Oxley Act experience </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">implementation of IT general controls to manage access and program changes within our IT environment and to support the evaluation, monitoring, and ongoing effectiveness of key application controls and key reports; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">implementation of processes and controls to better identify and manage segregation of duties risks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">designing and implementing controls related to significant accounts and disclosures to achieve complete, accurate and timely financial accounting, reporting and disclosures, including controls over account reconciliations, segregation of duties and the preparation and review of journal entries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">continued hiring of additional accounting, finance and operations resources with appropriate and sufficient technical expertise and to better allow for segregation of conflicting duties; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">consulting with experts on technical accounting matters, internal controls, and in the preparation of our financial statements. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe we are making progress toward achieving effectiveness of our internal control over financial reporting. The actions that we are taking are subject to ongoing management review and audit committee oversight. We will not be able to conclude whether the steps we are taking will fully remediate the material weaknesses in our internal control over financial reporting until we have completed our remediation efforts and subsequently evaluated their design and effectiveness over a sufficient period of time, and management concludes, through testing, that these are operating effectively. We may also conclude that additional measures are required to remediate the material weaknesses in our internal control over financial reporting. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Quantitative and Qualitative Disclosures About Market Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are exposed to market risk in the ordinary course of our business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily the result of fluctuations in interest rates. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Interest Rate Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had cash, cash equivalents, and marketable securities of $1.2&#160;billion. In addition, we had $0.9&#160;billion of restricted cash, cash equivalents, and marketable securities consisting of bank deposits related to collateralized loan facilities and letters of credit. Our cash, cash equivalents, and marketable securities are held for working capital purposes. We do not enter into investments for trading or speculative purposes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our exposure to market risk for changes in interest rates relates primarily to our DDTL 1.0 Facility, DDTL 2.0 Facility, DDTL 3.0 Facility, 2024 Term Loan Facility, and Revolving Credit Facility (described above), which bear </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">148<br></div></div></div>
<!--End Page 159-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 160-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_112-mda_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">floating interest rates, and a rising interest rate environment may increase the amount of interest paid on these loans. For the three and six months ended June&#160;30, 2025, each 100-basis point increase or decrease in interest rates would have increased or decreased our interest expense related to these facilities by approximately $18&#160;million and $36&#160;million, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Foreign Currency Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We transact business globally in multiple currencies. Our international costs and expenses denominated in foreign currencies, expose us to the risk of fluctuations in foreign currency exchange rates against the U.S. dollar. We are exposed to foreign currency risks related to our operating expenses denominated in currencies other than the U.S. dollar, including the British pound, Euro and Swedish krona. Accordingly, changes in exchange rates may negatively affect our future revenue and other operating results as expressed in U.S. dollars. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have experienced and will continue to experience fluctuations in our net income (loss) as a result of transaction gains or losses related to remeasurement of our asset and liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. During the six months ended June&#160;30, 2025, we entered into foreign currency derivative contracts to mitigate certain of the foreign currency exchange risk of our assets and liabilities denominated in currencies other than the functional currency. These contracts reduce, but do not eliminate, the impact of foreign currency exchange rate movements on our assets and liabilities. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Inflation Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We do not believe that inflation has had a material effect on our business, financial condition or results of operations, other than its impact on the general economy, which includes labor costs. Nonetheless, if our costs, in particular personnel-related costs, continue to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">149<br></div></div></div>
<!--End Page 160-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 161-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDAM"><!--Anchor--></a>DIRECTORS AND MANAGEMENT OF COREWEAVE, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Executive Officers and Non-Employee Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table provides information regarding our executive officers and non-employee directors as of June&#160;30, 2025: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 120pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Age</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Position(s) </div></td></tr><tr><td style="width: 120pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Executive Officers:<br></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator<font style="padding-left: 1.42pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">56</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer, President, and Chairman of the Board of Directors </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brian Venturo<font style="padding-left: 0.47pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">40</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Strategy Officer and Director </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brannin McBee<font style="padding-left: 3.08pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">40</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Development Officer </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Nitin Agrawal<font style="padding-left: 4.74pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">46</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Financial Officer </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kristen McVeety<font style="padding-left: 3.64pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">54</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General Counsel and Corporate Secretary </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chen Goldberg<font style="padding-left: 0.47pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">45</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Senior Vice President of Engineering </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-Employee Directors:<br></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Karen Boone<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup><font style="padding-left: 1.14pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">51</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Jack Cogen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(3)</sup><font style="padding-left: 2.81pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">69</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Glenn Hutchins<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)(3)(4)</sup><font style="padding-left: 2.4pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">69</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director </div></td></tr><tr><td style="width: 120pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Margaret C. Whitman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(3)</sup><font style="padding-left: 0.68pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7pt; text-align: left;">69</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 312pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Member of the audit committee. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Member of the compensation committee. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Member of the nominating and corporate governance committee. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Lead independent director. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Executive Officers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Michael Intrator<font style="font-style: normal; font-weight: normal;"> is one of our co-founders and has served as Chairman of our board of directors and as our Chief Executive Officer and President since September&#160;2017. Previously, from January&#160;2013 to January&#160;2018, Mr.&#160;Intrator was a co-founder and the Chief Executive Officer of Hudson Ridge Asset Management LLC, a natural gas hedge fund. From September&#160;1998 to July&#160;2014, he served in roles of increasing responsibilities, including as a Principal Portfolio Manager, for the asset management and advisory firm Natsource Asset Management LLC, where he oversaw investments in global environmental markets and related energy products. Mr.&#160;Intrator earned a B.A. in Political Science from Binghamton University, and an M.P.A. from Columbia University&#8217;s School of International and Public Affairs. We believe Mr.&#160;Intrator is qualified to serve as a member of our board of directors due to the perspective and experience he brings as our co-founder, Chief Executive Officer, and President. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Brian Venturo<font style="font-style: normal; font-weight: normal;"> is one of our co-founders and has served as a member of our board of directors since April&#160;2019 and as our Chief Strategy Officer since March&#160;2024. From October&#160;2017 to March&#160;2024, Mr.&#160;Venturo served as our Chief Technology Officer. Previously, from January&#160;2013 to January&#160;2018, Mr.&#160;Venturo was a Partner at Hudson Ridge Asset Management LLC, a natural gas hedge fund. From May&#160;2007 to December&#160;2012, he served as Portfolio Manager&#8212;Energy and Emissions for the asset management and advisory firm Natsource Asset Management LLC, where he managed a proprietary trading portfolio of investments in global environmental markets and related energy products. Mr.&#160;Venturo earned a B.A. in Economics from Haverford College. We believe Mr.&#160;Venturo is qualified to serve as a member of our board of directors due to the perspective and experience he brings as our co-founder and Chief Strategy Officer. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Brannin McBee<font style="font-style: normal; font-weight: normal;"> is one of our co-founders and has served as our Chief Development Officer since March&#160;2024. From September&#160;2017 to March&#160;2024, Mr.&#160;McBee served as our Chief Strategy Officer. Previously, he worked as a Proprietary Trader at Active Power Investments, a company in the North American Natural Gas, Power and Agriculture markets from April&#160;2020 to January&#160;2021. From March&#160;2017 to August&#160;2018, Mr.&#160;McBee was Vice&#160;President at Fourth Floor Coastal LLC, an exploration and production company in the oil and gas industry. Prior to that, from January&#160;2013 to January&#160;2018, he was a proprietary trader at Windy Bay Power LLC, a&#160;commodity-focused hedge fund. Mr.&#160;McBee earned a B.S. in Finance from the University of Colorado Boulder. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">150<br></div></div></div>
<!--End Page 161-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 162-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Nitin Agrawal<font style="font-style: normal; font-weight: normal;"> has served as our Chief Financial Officer since March&#160;2024. Prior to joining us, from May&#160;2021 to March&#160;2024, he served as Vice President, Finance of Google Cloud, the cloud computing services business segment of Alphabet Inc. From August&#160;2019 to April&#160;2021, Mr.&#160;Agrawal served as Chief Financial Officer of Mapbox, Inc., a location technology company. Prior to that, from January&#160;2015 to July&#160;2019, he served as Finance Director of the Compute Services division of Amazon Web Services, Inc., a cloud computing company and subsidiary of Amazon.com, Inc. Mr.&#160;Agrawal holds a Bachelor of Technology, Engineering from the National Institute of Technology in Kurukshetra, India, and an M.B.A. in Finance from The Fuqua School of Business at Duke University. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Kristen McVeety <font style="font-style: normal; font-weight: normal;">has served as our General Counsel since March&#160;2022 and as our Corporate Secretary since December&#160;2024. Prior to joining us, from February&#160;2003 to March&#160;2022, Ms.&#160;McVeety was a founder and partner of Gabler &amp; McVeety LLP, a law firm. Prior to founding Gabler &amp; McVeety, Ms.&#160;McVeety was an Associate in the Corporate and M&amp;A practice groups at Dorsey &amp; Whitney LLP from March&#160;1999 to February&#160;2003. She earned a B.A. in International Relations and Business Management from Boston University and a J.D. from Brooklyn Law School. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Chen Goldberg <font style="font-style: normal; font-weight: normal;">has served as our Senior Vice President of Engineering since August&#160;2024. Prior to joining us, from February&#160;2016 to August&#160;2024, Ms.&#160;Goldberg held multiple roles at Google Cloud, the cloud computing services business segment of Alphabet Inc, with her last role as General Manager &amp; Vice President of Engineering, leading the Kubernetes and Serverless team and product portfolio. Earlier in her career, Ms.&#160;Goldberg served as Director of Engineering at HP. Ms.&#160;Goldberg holds a B.A. in Management and Computer Sciences and an M.B.A. from The Open University of Israel. </font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Non-Employee Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Karen Boone<font style="font-style: normal; font-weight: normal;"> has served as a member of our board of directors since January&#160;2025. Ms.&#160;Boone previously served as the Interim Co-Chief Executive Officer and Co-President of Peloton Interactive, Inc. (&#8220;Peloton&#8221;) from May&#160;2024 to January&#160;2025. Prior to her service at Peloton, Ms.&#160;Boone served as the President and Chief Financial and Administrative Officer of Restoration Hardware, Inc., a home furnishings company, from May&#160;2014 to August&#160;2018 and as Chief Financial Officer from June&#160;2012 to May&#160;2014. Prior to that, from 1996 to 2012, Ms.&#160;Boone held various roles at Deloitte &amp; Touche LLP, a public accounting firm, most recently as an Audit Partner. Ms.&#160;Boone currently serves on the board of directors of Peloton, Sonos, Inc., Rivian Automotive, Inc. and several private companies. Ms.&#160;Boone earned a B.S. in Business Economics from the University of California, Davis. We believe Ms.&#160;Boone is qualified to serve as a member of our board of directors due to her financial expertise and her experience as a public company executive officer and director. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Jack Cogen<font style="font-style: normal; font-weight: normal;"> has served as a member of our board of directors since September&#160;2017. Mr.&#160;Cogen is a private investor. From September&#160;1994 to December&#160;2014, Mr.&#160;Cogen was a founder and the Chief Executive Officer of Natsource Asset Management LLC, an asset management and advisory firm focused on global environmental markets and related energy products. Additionally, from January&#160;2008 to January&#160;2011, Mr.&#160;Cogen served as Chair of the International Emissions Trading Association (the &#8220;IETA&#8221;), a non-profit trade organization committed to promoting high-integrity markets for corporate carbon footprint reduction, and Mr.&#160;Cogen continues to support the IETA as a Fellow. Mr.&#160;Cogen also previously served as a non-employee director of Hudson Ridge Asset Management LLC, a natural gas hedge fund, from November&#160;2013 to June&#160;2018. Mr.&#160;Cogen earned a B.A. from Rutgers University, as well as an M.S. in Mathematics and an M.B.A. from New York University. We believe Mr.&#160;Cogen is qualified to serve as a member of our board of directors due to his experience with technology companies and as an investor in our industry. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Glenn Hutchins <font style="font-style: normal; font-weight: normal;">has served as a member of our board of directors since February&#160;2025. Mr.&#160;Hutchins currently serves as the Chairman of North Island, an investment firm, a role he has held since 2013, and as Chairman of North&#160;Island Ventures, an investment firm, since 2020. He was a co-founder of Silver Lake, a technology investment firm, which was founded in 1999, and of which Mr.&#160;Hutchins served as Co-Chief Executive Officer until 2011 and, prior to that, as Managing Director from 1999 to 2011. Prior to that, Mr.&#160;Hutchins was a Senior Managing Director at The Blackstone Group, a global investment firm, from 1994 to 1999. He has served as a director of AT&amp;T Inc., a telecommunications company, since June&#160;2014 and as Vice Chairman and Lead Independent Director of Banco&#160;Santander S.A., a financial services firm, since December&#160;2022. Previously, Mr.&#160;Hutchins served as a director of Virtu Financial, Inc., a financial services firm, from July&#160;2017 to August&#160;2021 and as a director at Nasdaq, Inc., a global financial services technology company, from April&#160;2005 to July&#160;2017. Mr.&#160;Hutchins has served as the Co-Chairman of the Brookings Institution since November&#160;2018 and was a director of the Federal Reserve Bank of </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">151<br></div></div></div>
<!--End Page 162-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 163-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">New York from 2011 to 2020. He holds an A.B. from Harvard College, an M.B.A. from Harvard Business School, and a J.D. from Harvard Law School. We believe Mr.&#160;Hutchins is qualified to serve as a member of our board of directors due to his extensive operational, business planning, and investment expertise within the technology industry. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Margaret C. Whitman<font style="font-style: normal; font-weight: normal;"> has served as a member of our board of directors since March&#160;2025. Ms.&#160;Whitman previously served as United States Ambassador to Kenya from July&#160;2022 to November&#160;2024. Prior to that, she was Chief Executive Officer of Quibi Holdings, LLC, a mobile media company, from March&#160;2018 to February&#160;2021. From June&#160;2017 to February&#160;2018, Ms.&#160;Whitman served as Chief Executive Officer of Hewlett Packard Enterprise Company (&#8220;HPE&#8221;), a multinational information technology enterprise, and as HPE&#8217;s President and Chief Executive Officer from November&#160;2015 to June&#160;2017. Before her role at HPE, she was President and Chief Executive Officer of Hewlett-Packard Company (now known as HP Inc.) from September&#160;2011 to July&#160;2015, as well as Chair of their board of directors from July&#160;2014 to November&#160;2015. Ms.&#160;Whitman also served as President and Chief Executive Officer of eBay Inc., an e-commerce company, from March&#160;1998 to November&#160;2008. Ms.&#160;Whitman has previously served on the boards of directors of The Procter &amp; Gamble Company, a multinational consumer goods company, from February&#160;2011 to July&#160;2022, General Motors Company, a multinational automotive manufacturing company, from March&#160;2021 to July&#160;2022, and Dropbox, Inc., a cloud storage company, from September&#160;2017 to May&#160;2020. Ms.&#160;Whitman holds an A.B. in Economics from Princeton University and an MBA from Harvard Business School. We believe Ms.&#160;Whitman is qualified to serve as a member of our board of directors due to her extensive leadership, strategy, risk management, and industry experience. </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Family Relationships </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">There are no family relationships among any of our executive officers or directors. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Code of Business Conduct and Ethics </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has adopted a code of business conduct and ethics that applies to all of our employees, officers, and directors, including our Chief Executive Officer, Chief Financial Officer, and other executive and senior financial officers. The full text of our code of business conduct and ethics will be posted on the investor relations page on our website. We intend to disclose any amendments to our code of business conduct and ethics, or waivers of its requirements, on our website or in filings under the Exchange Act. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Classified Board of Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors consists of six members and is divided into three classes of directors that will serve staggered three-year terms. At each annual meeting of stockholders, a class of directors will be elected for a three-year term to succeed the same class whose term is then expiring. As a result, only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Our directors are divided among the three classes as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Class&#160;I directors include Michael Intrator and Jack Cogen and their terms will expire at the 2026 annual meeting of stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Class&#160;II directors include Margaret C. Whitman and Glenn Hutchins and their terms will expire at the 2027 annual meeting of stockholders; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Class&#160;III directors include Brian Venturo and Karen Boone and their terms will expire at the 2028 annual meeting of stockholders. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each director&#8217;s term continues until the election and qualification of his or her successor, or his or her earlier death, resignation, or removal. Our amended and restated certificate of incorporation and amended and restated bylaws authorize only our board of directors to fill vacancies on our board of directors. Any increase or decrease in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. This classification of our board of directors may have the effect of delaying or preventing changes in control of our company. See the section titled &#8220;Description of CoreWeave Capital Stock, New&#160;Tranche 1 Warrants and New Tranche 2 Warrants &#8212;Anti-Takeover Provisions.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Director Independence </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the rules of Nasdaq, independent directors must comprise a majority of a listed company&#8217;s board of directors. In addition, the rules of Nasdaq require that, subject to specified exceptions, each member of a listed </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">152<br></div></div></div>
<!--End Page 163-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 164-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">company&#8217;s audit, compensation, and nominating and corporate governance committees be independent. Under the rules of Nasdaq, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of that company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, compensation committee members must not have a relationship with us that is material to the director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Audit committee members must also satisfy the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act. In order to be considered independent for purposes of Rule&#160;10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors or any other board committee: accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries; or be an affiliated person of the listed company or any of its subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has undertaken a review of the independence of each director and considered whether each director has a material relationship with us that could compromise his or her ability to exercise independent judgment in carrying out his or her responsibilities. As a result of this review, our board of directors determined that each director other than Michael Intrator and Brian Venturo is an &#8220;independent director&#8221; as defined under the applicable rules and regulations of the SEC and the listing requirements and rules of Nasdaq. In making these determinations, our board of directors reviewed and discussed information provided by the directors and by us with regard to each director&#8217;s business and personal activities and relationships as they may relate to us and our management, including the beneficial ownership of our common stock by each non-employee director and the transactions involving them described in the section titled &#8220;Certain Relationships and Related Party Transactions of CoreWeave Inc.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Lead Independent Director </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has adopted corporate governance guidelines that provide that one of our independent directors will serve as our lead independent director. Our board of directors has appointed Glenn Hutchins to serve as our lead independent director. As lead independent director, Mr.&#160;Hutchins provides leadership to our board of directors if circumstances arise in which the role of Chief Executive Officer and chairperson of our board of directors may be, or may be perceived to be, in conflict, and perform such additional duties as our board of directors may otherwise determine and delegate. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Director Nomination Letter </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, we entered into the Director Nomination Letter with the Magnetar DNL Parties, pursuant to which, until the earlier of the date on which (i) no shares of our Class&#160;B common stock are outstanding and (ii) the Magnetar DNL Parties and their affiliates collectively no longer beneficially own at least 4,976,240 shares of our capital stock, if a designee or affiliate of the Magnetar DNL Parties is not then a member of our board of directors, the Magnetar DNL Parties have the collective right to nominate one individual for consideration to serve as a member of our board of directors (the &#8220;Magnetar Nominee&#8221;). The rights provided in the Director Nomination Letter will terminate upon the earliest of (i)&#160;such time as the Magnetar DNL Parties and their affiliates no longer beneficially own at least 4,976,240 shares of our capital stock, (ii) such time no shares of our Class&#160;B common stock are outstanding or (iii)&#160;the consummation of a merger or consolidation of CoreWeave that is effected (a) for independent business reasons unrelated to extinguishing such rights; and (b)&#160;for purposes other than (x)&#160;the reincorporation of CoreWeave in a different state; or (y)&#160;the formation of a holding company that will be owned exclusively by CoreWeave&#8217;s stockholders and will hold all of the outstanding shares of capital stock of CoreWeave&#8217;s successor. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our nominating and governance committee may consider the Magnetar Nominee in its sole discretion in accordance with its charter and the listing requirements and rules of Nasdaq. If our nominating and governance committee approves of the Magnetar Nominee for service on our board of directors, we will have the obligation to support the nomination of the Magnetar Nominee and to cause our board of directors to include the Magnetar Nominee in the slate of nominees recommended to our stockholders for election. To the extent that (a)&#160;our nominating and governance committee does not approve of the Magnetar Nominee for service on our board of directors or (b)&#160;the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">153<br></div></div></div>
<!--End Page 164-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 165-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Magnetar Nominee ceases to serve as a director for any reason (other than the failure of our stockholders to elect the Magnetar Nominee as a director), the Magnetar DNL Parties will have the right to nominate another nominee in accordance with the terms of the Director Nomination Letter until such time as a Magnetar Nominee is elected to our board of directors. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Role of Board in Risk Oversight </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Risk assessment and oversight are an integral part of our governance and management processes. Our board of directors encourages management to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses strategic and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks we face. Throughout the year, senior management reviews these risks with our board of directors at regular board meetings as part of management presentations that focus on particular business functions, operations, or strategies, and presents the steps taken by management to mitigate or eliminate such risks. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors does not have a standing risk management committee. Our board of directors administers this oversight function directly and through various standing committees that address risks in their respective areas of oversight. While our board of directors is responsible for monitoring and assessing strategic risk exposure, our audit committee is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The audit committee also reviews any related person transactions. Our nominating and corporate governance committee monitors the effectiveness of our corporate governance guidelines. Our compensation committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Committees of the Board of Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors has an audit committee, a compensation committee, and a nominating and corporate governance committee, each of which, pursuant to its respective charter, has the composition and responsibilities described below. Copies of the charters for each committee are available on the investor relations portion of our website. Members serve on these committees until their resignation or until otherwise determined by our board of directors. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Audit Committee </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our audit committee is composed of Karen Boone, Jack Cogen, and Margaret C. Whitman. Ms.&#160;Boone is the chair of our audit committee. The members of our audit committee meet the independence requirements under Nasdaq and SEC rules. Each member of our audit committee is financially literate. In addition, our board of directors has determined that Ms.&#160;Boone is an &#8220;audit committee financial expert&#8221; as that term is defined in Item&#160;407(d)(5)(ii) of Regulation S-K promulgated under the Securities Act. This designation does not, however, impose on her any supplemental duties, obligations, or liabilities beyond those that are generally applicable to the other members of our audit committee and board of directors. Our audit committee&#8217;s principal functions are to assist our board of directors in its oversight of: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">selecting a firm to serve as our independent registered public accounting firm to audit our consolidated financial statements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ensuring the independence of the independent registered public accounting firm; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and that firm, our interim and year-end operating results; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">establishing procedures for employees to anonymously submit concerns about questionable accounting or audit matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">considering the adequacy of our internal controls; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewing related party transactions that are material or otherwise implicate disclosure requirements; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">approving, or as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">154<br></div></div></div>
<!--End Page 165-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 166-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Compensation Committee </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our compensation committee is composed of Karen Boone and Glenn Hutchins. Mr.&#160;Hutchins is the chair of our compensation committee. The members of our compensation committee meet the independence requirements under Nasdaq and SEC rules. Each member of this committee is also a &#8220;non-employee director&#8221; within the meaning of Rule&#160;16b-3 under the Exchange Act. Our compensation committee is responsible for, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">evaluating, recommending, approving and reviewing executive officer and director compensation arrangements, plans, policies and programs maintained by CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">administering CoreWeave&#8217;s cash- and equity-based compensation plans; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewing with management the CoreWeave&#8217;s organization and people activities. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Nominating and Corporate Governance Committee </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our nominating and corporate governance committee is composed of Jack Cogen, Glenn Hutchins, and Margaret C. Whitman. Ms.&#160;Whitman is the chair of our nominating and corporate governance committee. The members of our nominating and corporate governance committee meet the independence requirements under Nasdaq and SEC rules. Our nominating and corporate governance committee&#8217;s principal functions include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">identifying, considering, and recommending candidates for membership on our board of directors; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">developing and recommending our corporate governance guidelines and policies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">overseeing the evaluation of our board of directors and our committees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">advising our board of directors on corporate governance matters; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">advising on any related matters required by federal securities laws. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Compensation Committee Interlocks and Insider Participation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">None of the members of the compensation committee is currently, or has been at any time, one of our officers or employees. None of our executive officers has served as a member of the board of directors, or as a member of the compensation or similar committee, of any entity that has one or more executive officers who served on our board or compensation committee during the year ended December&#160;31, 2024. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Director Compensation </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">2024 Director Compensation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the year ended December&#160;31, 2024, no compensation was paid to our non-employee members of our board of directors, and as of December&#160;31, 2024, none of our non-employee directors held unvested equity awards. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">2025 Director Compensation </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;">Karen Boone </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In January&#160;2025, we granted Karen Boone two awards of RSUs: the first award for 17,560 RSUs in connection with the commencement of her service on our board of directors (the &#8220;First Boone Award&#8221;) and the second award for 1,060 RSUs in connection with the commencement of her service as chair of our audit committee (the &#8220;Second&#160;Boone Award,&#8221; and, together with the First Boone Award, the &#8220;Boone RSU Awards&#8221;), each under the 2019 Plan, which may vest and be settled for shares of our Class&#160;A common stock. Each of the Boone RSU Awards has a ten-year term and will vest based on the satisfaction of service-based and performance-based vesting conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The service-based vesting condition for the First Boone Award will be satisfied as to 1/12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over three years, with the first vesting date scheduled for April&#160;6, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Ms.&#160;Boone&#8217;s continued service with us. The service-based vesting condition for the Second Boone Award will be satisfied as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over one year, with the first vesting date scheduled for April&#160;6, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Ms.&#160;Boone&#8217;s continued service with us. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The performance-based vesting condition for the Boone RSU Awards was satisfied in connection with our IPO. Ms.&#160;Boone will also receive an annual cash fee of $25,000 in connection with her service on our board of directors, to be paid quarterly and in arrears and to be pro-rated for partial quarters served. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">155<br></div></div></div>
<!--End Page 166-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 167-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Glenn Hutchins </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, we granted Glenn Hutchins four awards of RSUs: the first award for 17,340 RSUs in connection with the commencement of his service on our board of directors (the &#8220;First Hutchins Award&#8221;), the second&#160;award for 1,040 RSUs in connection with the commencement of his service as our lead independent director (the &#8220;Second Hutchins Award&#8221;), the third award for 520 RSUs in connection with the commencement of his service as the chair of our compensation committee (the &#8220;Third Hutchins Award&#8221;), and the fourth award for 520 RSUs in connection with the commencement of his service as the interim chair of our nominating and corporate governance committee (the &#8220;Fourth Hutchins Award,&#8221; and, together with the First Hutchins Award, the Second Hutchins Award, and the Third Hutchins Award, the &#8220;Hutchins RSU Awards&#8221;), each under the 2019 Plan, which may vest and be settled for shares of our Class&#160;A common stock. Each of the Hutchins RSU Awards has a ten-year term and will vest based on the satisfaction of service-based and performance-based vesting conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The service-based vesting condition for the First Hutchins Award will be satisfied as to 1/12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over three years, with the first vesting date scheduled for May&#160;10, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Mr.&#160;Hutchins&#8217;s continued service with us. The service-based vesting condition for the Second Hutchins Award, Third Hutchins Award, and Fourth Hutchins Award will each be satisfied as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over one year, with the first vesting date scheduled for May&#160;10, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Mr.&#160;Hutchins&#8217;s continued service with us. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The performance-based vesting condition for the Hutchins RSU Awards was satisfied in connection with our IPO. Mr.&#160;Hutchins will also receive an annual cash fee of $25,000 in connection with his service on our board of directors, to be paid quarterly and in arrears and to be pro-rated for partial quarters served. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Margaret C. Whitman </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, we granted Margaret C. Whitman two awards of RSUs: the first award for 14,340 RSUs in connection with the commencement of her service on our board of directors (the &#8220;First Whitman Award&#8221;) and the second award for 420 RSUs in connection with the commencement of her service as the chair of our nominating and corporate governance committee (the &#8220;Second Whitman Award,&#8221; and, together with the First Whitman Award, the &#8220;Whitman RSU Awards&#8221;), each under the 2019 Plan, which may vest and be settled for shares of our Class&#160;A common stock. Each of the Whitman RSU Awards has a ten-year term and will vest based on the satisfaction of service-based and performance-based vesting conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The service-based vesting condition for the First Whitman Award will be satisfied as to 1/12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over three years, with the first vesting date scheduled for June&#160;14, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Ms.&#160;Whitman&#8217;s continued service with us. The service-based vesting condition for the Second Whitman Award will be satisfied as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award quarterly over one year, with the first vesting date scheduled for June&#160;14, 2025 and each subsequent vesting date occurring on the quarterly anniversary thereof, subject to Ms.&#160;Whitman&#8217;s continued service with us. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The performance-based vesting condition for the Whitman RSU Awards was satisfied in connection with our IPO. Ms.&#160;Whitman will also receive an annual cash fee of $25,000 in connection with her service on our board of directors, to be paid quarterly and in arrears and to be pro-rated for partial quarters served. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Jack Cogen </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, we granted Jack Cogen one award for 4,780 RSUs (the &#8220;Cogen RSU Award&#8221;) in connection with his service on our board of directors, which is equivalent to the annual award to be granted to non-employee directors pursuant to our non-employee director compensation policy, as described below. The Cogen RSU Award was granted under the 2019 Plan, has a ten-year term and will be settled for shares of our Class&#160;A common stock based on the satisfaction of service-based and performance-based vesting conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The service-based vesting condition for the Cogen RSU Award will be satisfied on the earlier of (i) the date of the next annual meeting of our stockholders and (ii) the first anniversary of the grant date, subject to Mr.&#160;Cogen&#8217;s continued service with us. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">156<br></div></div></div>
<!--End Page 167-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 168-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The performance-based vesting condition for the Cogen RSU Award was satisfied in connection with our IPO. Mr.&#160;Cogen will also receive the cash compensation pursuant to our non-employee director compensation policy, as described below. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Non-Employee Director Compensation Policy </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, our board of directors approved a non-employee director compensation policy, pursuant to which our non-employee directors are eligible to receive the fees and equity awards described below. As described above, Mr.&#160;Hutchins and Mses. Boone and Whitman received equity grants in 2025, prior to our IPO and in connection with their joining our board of directors. As a result, they will not be eligible to receive the fees and equity awards under our non-employee director compensation policy until the date of our next annual meeting of our stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Employee directors will receive no additional compensation for their service as members of our board of directors. Michael Intrator and Brian Venturo are each compensated as employees for their service as our Chief&#160;Executive Officer and President and Chief Strategy Officer, respectively, and neither receives additional compensation for their service as members of our board of directors. See the section titled &#8220;CoreWeave, Inc. Executive and Director Compensation&#8212;Summary Compensation Table&#8221; for information regarding each of Michael Intrator&#8217;s and Brian Venturo&#8217;s compensation as our employee. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Cash Compensation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under our non-employee director compensation policy, each non-employee director is entitled to receive the annual cash compensation set forth below, payable quarterly in arrears and prorated for partial quarters of service. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">General Board Service Fee:<font style="font-style: normal;"> $25,000. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Lead Independent Director Fee (in addition to the general service fee):<font style="font-style: normal;"> $60,000. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Committee Chair Service Fee <font style="font-style: normal;">(in addition to the general service fee): </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Audit committee chair: $30,000. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Compensation committee chair: $20,000. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Nominating and governance committee chair: $15,000. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our non-employee directors may elect, on an annual basis, to convert all of his or her earned cash fees into a number of RSUs granted under the 2025 Plan, which will be fully vested on the date of grant. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Equity Compensation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each non-employee director is entitled to receive certain equity awards as set forth below. All such equity awards will be granted under the 2025 Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Initial Grant.<font style="font-style: normal;"> Each non-employee director who joins our board of directors will be granted, upon the date of his or her initial election or appointment to be a non-employee director (or as soon as practicable thereafter), an initial award of a number of restricted stock units determined by dividing (i) $800,000 by (ii) by the average closing price of our Class&#160;A common stock for the 30 calendar day period ending on the last day prior to the date of grant, rounded down to the nearest whole share. The initial award will vest quarterly with respect to 1/12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total number of RSUs subject to the award, so long as the non-employee director provides continuous service to us through each vesting date. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Annual Grant.<font style="font-style: normal;"> On the date of each annual meeting of our stockholders, each non-employee director who is then-serving, and will continue to serve, on our board of directors will be granted an annual award of a number of RSUs determined by dividing (i) $275,000 by (ii) by the average closing price of our Class&#160;A common stock for the 30 calendar day period ending on the last day prior to the date of grant, rounded down to the nearest whole share. The annual award will fully vest on the earliest to occur of (i) the date of the next annual meeting of our stockholders and (ii) the first anniversary of the grant date, in each case subject to the non-employee director&#8217;s continuous service through such date. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">157<br></div></div></div>
<!--End Page 168-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 169-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_113-management_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each non-employee director&#8217;s then-outstanding equity awards granted under the non-employee director compensation policy will become fully vested upon a change in control (as defined in the 2025 Plan), subject to the non-employee director remaining in continuous service until immediately prior to the closing of the change in control. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Limitations on Liability and Indemnification Matters </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated certificate of incorporation contains provisions that will limit the liability of our directors and officers for monetary damages to the fullest extent permitted by the DGCL. Consequently, our directors and officers will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors or officers, except liability for: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any breach of the director&#8217;s or officer&#8217;s duty of loyalty to us or our stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&#160;174 of the DGCL; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any transaction from which the director or officer derived an improper personal benefit; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to officers, any action by or in the right of the corporation. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated certificate of incorporation and our amended and restated bylaws require us to indemnify our directors and officers to the maximum extent not prohibited by the DGCL and allow us to indemnify other employees and agents as set forth in the DGCL. Subject to certain limitations, our amended and restated bylaws also require us to advance expenses incurred by our directors and officers for the defense of any action for which indemnification is required or permitted, subject to very limited exceptions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have entered, and intend to continue to enter, into separate indemnification agreements with our directors, officers, and certain of our other employees. These agreements, among other things, require us to indemnify our directors, officers, and key employees for certain expenses, including attorneys&#8217; fees, judgments, fines, and settlement amounts actually and reasonably incurred by such director, officer, or key employee in any action or proceeding arising out of their service to us or any of our subsidiaries or any other company or enterprise to which the person provides services at our request. Subject to certain limitations, our indemnification agreements also require us to advance expenses incurred by our directors, officers, and key employees for the defense of any action for which indemnification is required or permitted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that these provisions in our amended and restated certificate of incorporation and indemnification agreements are necessary to attract and retain qualified persons such as directors, officers, and key employees. We also maintain directors&#8217; and officers&#8217; liability insurance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breaches of their fiduciary duties. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder&#8217;s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers as required by these indemnification provisions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, executive officers or persons controlling us, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">158<br></div></div></div>
<!--End Page 169-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 170-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCIE"><!--Anchor--></a>COREWEAVE, INC. EXECUTIVE COMPENSATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our named executive officers, consisting of our principal executive officer and the next two most highly compensated executive officers, as of December&#160;31, 2024, were: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Michael Intrator, Chief Executive Officer and President; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Brian Venturo, Chief Strategy Officer; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Brannin McBee, Chief Development Officer. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Summary Compensation Table </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents summary information regarding the total compensation for services rendered in all capacities that was awarded to, earned by, or paid to our named executive officers for the year ended December&#160;31, 2024. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 20pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 26.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.32pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 180pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name and Principal Position</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fiscal <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Salary<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Bonus <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.06pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">All Other<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Compensation <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($) </div></td></tr><tr><td style="width: 180pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator,<font style="padding-left: 4.32pt;"></font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">Chief Executive Officer</font><br></div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">750,000</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,000,000</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.06pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.03pt; text-align: left;">&#8212;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.32pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;">18,252<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,768,252 </div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brian Venturo,<font style="padding-left: 2.97pt;"></font> <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">Chief Strategy Officer</font><br></div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">750,000</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,000,000</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.06pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.03pt; text-align: left;">&#8212;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;"><font style="padding-left: 5pt;">8,865</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,758,865 </div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brannin McBee,<font style="padding-left: 0.58pt;"></font> <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;"><font style="font-style: italic;">Chief Development Officer</font><br></div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">400,000</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,000,000</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.06pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.03pt; text-align: left;">&#8212;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.32pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.92pt; text-align: left;"><font style="padding-left: 5pt;">6,154</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">2,406,154</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 180pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 20pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 26.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.32pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">The amounts presented represent discretionary bonuses paid for contributions to our performance. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Each named executive officer was granted an RSU award that was subject to a time-based component and performance-based component (which constitutes the performance condition). As of the applicable grant date, we had not recognized stock-based compensation expense for these awards because achievement of the performance-based vesting component, as the performance condition, was not deemed probable. As a result, no value is included in the table for these awards. Assuming achievement of the performance-based vesting component, the aggregate grant-date fair values of the RSU awards for each of Mr.&#160;Intrator, Mr.&#160;Venturo, and Mr.&#160;McBee would have been $83,230,875, computed in accordance with ASC Topic 718, and representing the highest level of performance condition achievement for these awards. For information regarding the assumptions used in determining the fair value of these awards, please refer to Note&#160;11 of the consolidated financial statements included elsewhere in this proxy statement/prospectus. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Amounts reported in this column for Mr.&#160;Intrator represent the following: $12,692 for company contributions to our 401(k) plan and $5,560&#160;for spousal travel expenses incurred by us. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amounts reported in this column for Mr.&#160;Venturo represent $8,865 for company contributions to our 401(k) plan. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Amounts reported in this column for Mr.&#160;McBee represent $6,154 for company contributions to our 401(k) plan. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">Narrative to Summary Compensation Table </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Base Salaries </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our named executive officers receive a base salary to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role, and responsibilities. Mr.&#160;Intrator&#8217;s annual base salary for 2024 was $750,000, Mr.&#160;Venturo&#8217;s annual base salary for 2024 was $750,000 and Mr.&#160;McBee&#8217;s annual base salary for 2024 was $400,000. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Annual Bonuses </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We offer our named executive officers the opportunity to earn discretionary cash bonuses based upon individual performance. As described above in the Summary Compensation Table in the column titled &#8220;Bonus,&#8221; each of our named executive officers received a discretionary cash bonus equal to $2,000,000 with respect to their service during 2024. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Equity Compensation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, we have granted equity awards in the form of stock options and restricted stock units to our named executive officers, which are subject to vesting based on each named executive officer&#8217;s continued service with us. Our stock options generally allow employees to purchase shares of our Class&#160;A common stock at an exercise </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">159<br></div></div></div>
<!--End Page 170-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 171-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">price equal to the fair market value of a share on the date of grant, as determined by the board of directors. Our stock options typically vest over a four-year period, with new hire grants vesting as to 25% of the underlying shares on the first anniversary of the date of grant and in equal monthly installments over the following three-year period, and refresh, promotion, or merit-based grants vesting in equal monthly installments over the four-year period following the date of grant, in each case, subject to the holder&#8217;s continued service with us. Our restricted stock unit grants generally vest based on the satisfaction of a time-based vesting component and a performance-based vesting component. The performance-based vesting component was satisfied in connection with our IPO. The time-based vesting component for newly hired employees is generally satisfied as to 25% of the restricted stock units on the first anniversary of the applicable vesting commencement date and in equal quarterly installments over the subsequent three years, and the time-based component for refresh, promotion, or merit-based grants is generally satisfied in equal quarterly installments over four years. From time to time, our board of directors may also construct alternate vesting schedules as it determines are appropriate to motivate particular employees. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of our named executive officers currently holds outstanding stock options to purchase shares of our Class&#160;A common stock that were granted under our 2019 Plan, as set forth in the &#8220;&#8212;Outstanding Equity Awards at Fiscal 2024 Year-End&#8221; below. The options we grant to employees are intended to qualify as &#8220;incentive stock options&#8221; to the extent permitted under the U.S. Internal Revenue Code of 1986, as amended. Pursuant to certain equity exchange right agreements entered into with Michael Intrator, Brian Venturo, and Brannin McBee, each of Mr.&#160;Intrator, Mr.&#160;Venturo, and Mr.&#160;McBee has been granted Equity Exchange Rights in connection with the shares of Class&#160;A common stock underlying their outstanding options to require us to exchange any shares of Class&#160;A common stock that the named executive officer acquires upon the exercise of such stock option awards for an equivalent number (or value) of shares of our Class&#160;B common stock. See the section titled &#8220;Certain Relationships and Related Party Transactions of CoreWeave Inc.&#8212;Other Transactions&#8212;Equity Exchange Right Agreements&#8221; for more information on the Equity Exchange Rights. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2024, our board of directors granted RSU awards in respect of 1,750,000 shares of our Class&#160;A common stock to each of Messrs. Intrator, Venturo, and McBee. The RSU awards vest upon satisfaction of both a service-based condition and a performance-based condition. The service-based condition is satisfied in 16 quarterly installments beginning on March&#160;31, 2025 through December&#160;31, 2028, subject to continued service with us as of each such date. The performance-based condition was satisfied in connection with our IPO. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, we adopted the 2025 Plan in order to facilitate the grant of cash and equity incentives to directors, employees (including our named executive officers), and consultants of our company and to enable our company to obtain and retain services of these individuals. Following the effective date of the 2025 Plan, we no longer make any further grants under our 2019 Plan, However, the 2019 Plan will continue to govern the terms and conditions of the outstanding awards granted under it. For additional information about the 2025 Plan, please see the section titled &#8220;Stock Plans&#8221; below. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Other Elements of Compensation </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Welfare and Other Benefits </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We provide health, dental, vision, life, and disability insurance benefits to our named executive officers, on the same terms and conditions as provided to all other eligible U.S. employees. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We also sponsor a broad-based 401(k) plan intended to provide eligible U.S. employees with an opportunity to defer eligible compensation up to certain annual limits. As a tax-qualified retirement plan, contributions (if any) made by us are deductible by us when made, and contributions and earnings on those amounts are generally not taxable to the employees until withdrawn or distributed from the 401(k) plan. Our named executive officers are eligible to participate in our employee benefit plans, including our 401(k) plan, on the same basis as our other employees. During the year ended December&#160;31, 2024, we made matching contributions of up to 1.7% of each of our named executive officer&#8217;s base salary. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">160<br></div></div></div>
<!--End Page 171-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 172-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Outstanding Equity Awards at Fiscal 2024 Year-End </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents, for each of our named executive officers, information regarding outstanding stock options to purchase shares of Class&#160;A common stock held as of December&#160;31, 2024. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.52pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 170.67pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 92.58pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 170.67pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Option Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 92.58pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Vesting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Commencement <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Grant <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td><td style="width: 6.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Securities <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Underlying <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unexercised <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options (#) <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercisable</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Securities <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Underlying <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unexercised <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options (#) <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unexercisable</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Option <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Option <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Expiration <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares or <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock That <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Have Not <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Vested (#)</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Market Value <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">of Shares or <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Units of Stock <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">That Have <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Not Vested ($) </div></td></tr><tr><td rowspan="5" style="width: 84pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator<font style="padding-left: 4.14pt;"></font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="font-style: italic;">Chief Executive Officer</font><br></div></td><td style="width: 2.6pt; background-color: #CCEEFF;" rowspan="5"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">2/26/2021</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">2/26/2021</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">500,000</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 20pt;">&#8212;&#8194;</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">0.38</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">2/25/2031</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 12.5pt; padding-top: 2.08pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/29/2022</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/29/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">250,000</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 6pt;">250,000</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">1.07</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;">12/28/2027</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 14pt;">1,120</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 14pt;">1,880</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.80</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">6/27/2028</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">708,320</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;">1,291,680</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.80</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">7/15/2028</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/31/2024</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/31/2024<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;">1,750,000</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td rowspan="5" style="width: 84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brian Venturo<font style="padding-left: 1.38pt;"></font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="font-style: italic;">Chief Strategy Officer</font><br></div></td><td style="width: 2.6pt;" rowspan="5"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">8/31/2020</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">8/31/2020</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;">2,400,000</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 24pt;">&#8212;</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">0.13</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">8/30/2030</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/29/2022</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/29/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">250,000</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 6pt;">250,000</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">1.07</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;">12/28/2027</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;"></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 14pt;">1,120</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 14pt;">1,880</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.80</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">6/27/2028</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">708,320</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;">1,291,680</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.80</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">7/15/2028</font></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;"></div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/31/2024</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/31/2024<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup></div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;">1,750,000</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td rowspan="4" style="width: 84pt; height: 11.25pt; padding-top: 1.33pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brannin McBee<font style="padding-left: 0.47pt;"></font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;"><font style="font-style: italic;">Chief Development &#8194;Officer</font><br></div></td><td style="width: 2.6pt; background-color: #CCEEFF;" rowspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/29/2022</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/29/2022<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">100,000</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 6pt;">100,000</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">1.07</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;">12/28/2027</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">6/28/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 14pt;">1,120</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 14pt;">1,880</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.54</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">6/27/2033</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4pt;">7/16/2023</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"><font style="padding-left: 6pt;">354,160</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"><font style="padding-left: 6pt;">645,840</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;">2.54</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"><font style="padding-left: 4pt;">7/15/2033</font></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; height: 11.25pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.52pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 9.53pt; text-align: left;">12/31/2024</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.45pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">12/31/2024<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.61pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 4.81pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.84pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.91pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.73pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.37pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0.22pt; text-align: left;"></div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.07pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 3.03pt; text-align: left;">1,750,000</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.31pt; padding-top: 1.33pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 24.65pt; text-align: left;"></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 55.52pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 36.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 6.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 41.61pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 47.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 28.73pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 36.89pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 38.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 2.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 49.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 10.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">All outstanding equity awards were granted under the 2019 Plan. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The fully vested option award vested as to 1/3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> of the total award on the first anniversary of the vesting commencement date and as to 1/36<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary thereafter, subject to Mr.&#160;Intrator&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary of the vesting commencement date, subject to Mr.&#160;Intrator&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on the first anniversary of the vesting commencement date and as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary thereafter, subject to Mr.&#160;Intrator&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. Mr.&#160;Intrator was a holder of greater than 10% of our shares of common stock at the time of grant so, pursuant to Section&#160;422 of the Code (as defined below), the exercise price of this incentive stock option award reflects 110% of the fair market value of our common stock at the time of grant. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary of the vesting commencement date, subject to Mr.&#160;Intrator&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. Mr.&#160;Intrator was a holder of greater than 10% of our shares of common stock at the time of grant so, pursuant to Section&#160;422 of the Code, the exercise price of this incentive stock option award reflects 110% of the fair market value of our common stock at the time of grant. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The RSUs vest based on the satisfaction of both a service-based vesting condition and a performance-based vesting condition. The service-based vesting condition and performance-based vesting condition were not satisfied as to any of the RSUs as of December&#160;31, 2024. The RSUs vest as to 1/16<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award and may be settled for shares of Class&#160;A common stock on each quarterly anniversary of the vesting commencement date, once the performance-based vesting condition has been satisfied and subject to Mr.&#160;Intrator&#8217;s continued service with us. The performance-based vesting condition was satisfied in connection with our IPO. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The fully vested option award vested as to 1/3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> of the total award on the first anniversary of the vesting commencement date and as to 1/36<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary thereafter, subject to Mr.&#160;Venturo&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary of the vesting commencement date, subject to Mr.&#160;Venturo&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on the first anniversary of the vesting commencement date and as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary thereafter, subject to Mr.&#160;Venturo&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. Mr.&#160;Venturo was a holder of greater than 10% of our shares of common stock at the time of grant so, pursuant to Section&#160;422 of the Code, the exercise price of this incentive stock option award reflects 110% of the fair market value of our common stock at the time of grant. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary of the vesting commencement date, subject to Mr.&#160;Venturo&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. The shares of Class&#160;A common stock issuable </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">161<br></div></div></div>
<!--End Page 172-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 173-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 5.25pt; margin-left: 20pt; text-align: justify;">upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. Mr.&#160;Venturo was a holder of greater than 10% of our shares of common stock at the time of grant so, pursuant to Section&#160;422 of the Code, the exercise price of this incentive stock option award reflects 110% of the fair market value of our common stock at the time of grant. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The RSUs vest based on the satisfaction of both a service-based vesting condition and a performance-based vesting condition. The service-based vesting condition and performance-based vesting condition were not satisfied as to any of the RSUs as of December&#160;31, 2024. The RSUs vest as to 1/16<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award and may be settled for shares of Class&#160;A common stock on each quarterly anniversary of the vesting commencement date, once the performance-based vesting condition has been satisfied and subject to Mr.&#160;Venturo&#8217;s continued service with us. The performance-based vesting condition was satisfied in connection with our IPO. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(12)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary of the vesting commencement date, subject to Mr.&#160;McBee&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(13)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The option award vests as to 1/4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on the first anniversary of the vesting commencement date and as to 1/48<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award on each monthly anniversary thereafter, subject to Mr.&#160;McBee&#8217;s continued service with us. The shares of Class&#160;A common stock issuable upon the exercise of this option award are exchangeable for shares of Class&#160;B common stock pursuant to the Equity Exchange Rights. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(14)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The RSUs vest based on the satisfaction of both a service-based vesting condition and a performance-based vesting condition. The service-based vesting condition and performance-based vesting condition were not satisfied as to any of the RSUs as of December&#160;31, 2024. The RSUs vest as to 1/16<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> of the total award and may be settled for shares of Class&#160;A common stock on each quarterly anniversary of the vesting commencement date, once the performance-based vesting condition has been satisfied and subject to Mr.&#160;McBee&#8217;s continued service with us. The performance-based vesting condition was satisfied in connection with our IPO. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Executive Compensation Arrangements </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Executive Offer Letters </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As our Co-Founders, our named executive officers did not enter into offer letters or any other formal arrangements or understandings with us regarding their employment. We currently do not have employment agreements or offer letters with any of our named executive officers. All of our named executive officers are employed on an at-will basis, with no fixed term of employment. Each of our named executive officers will receive benefits upon certain qualifying terminations as described in the section titled &#8220;&#8212;Change of Control and Severance Arrangements.&#8221; </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Executive Severance and Change in Control Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have adopted an executive severance and change in control plan, under which each of our named executive officers participates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The executive severance and change in control plan provides that, upon a termination by us of an executive without &#8220;cause&#8221; or by the executive due to &#8220;good reason&#8221; (each as defined in the executive severance and change in control plan), the executive will receive (i) a lump sum payment equal to 12 months of such executive&#8217;s base salary and (ii) continued payment of COBRA premiums for 12 months (or, if earlier, until the date that the executive is eligible for substantially equivalent coverage under a subsequent employer&#8217;s plan). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The executive severance and change in control plan also provides that, if such termination of employment occurs within three months prior to, or 12 months following, a &#8220;change in control&#8221; (as defined in the executive severance and change in control plan), the executive will receive (i) a lump sum payment equal to 12 months of base salary, (ii) continued payment of COBRA premiums for 12 months (or, if earlier, when the executive is eligible for substantially equivalent coverage under a subsequent employer&#8217;s plan), and (iii) full accelerated vesting of all outstanding and unvested equity award held by the executive, provided that any outstanding and unvested equity awards subject to performance conditions will instead be subject to the terms set forth in the applicable award agreements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If our named executive officers are entitled to any benefits other than the benefits under the executive severance and change in control plan, each of his benefits under the executive severance and change in control plan shall be provided only to the extent more favorable than the corresponding benefit under such other arrangement. All such severance payments and benefits under the executive severance and change in control plan will be subject to each executive&#8217;s execution of a general release of claims against us. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Stock Plans </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We believe that our ability to grant equity-based awards is a valuable compensation tool that enables us to attract, retain, and motivate our employees, consultants, and members of our board of directors by aligning their financial interests with those of our stockholders. The principal features of our equity incentive plans are summarized below. These summaries are qualified in their entirety by reference to the actual text of the plans, which are filed as exhibits to the registration statement of which this proxy statement/prospectus is a part. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">162<br></div></div></div>
<!--End Page 173-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 174-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">2019 Stock Option Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The purpose of the 2019 Plan, adopted in July&#160;2019, was to attract, retain, and motivate eligible employees, directors, and consultants whose contributions are important to the success of our business. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Termination<font style="font-style: normal;">. We terminated the 2019 Plan upon the effective date of our 2025 Plan (described below). No new awards have been granted, or will be granted, under the 2019 Plan following the effective date of our 2025 Plan. Any outstanding awards granted under the 2019 Plan will remain outstanding, subject to the terms of our 2019 Plan and applicable award agreements, until such awards are exercised or until they terminate or expire by their terms. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2024, options to purchase 7,213,820 shares had been exercised and options to purchase 47,218,580 shares remained outstanding, with a weighted-average exercise price of $1.75 per share. As of December&#160;31, 2024, 15,454,720 awards of RSUs were granted under the 2019 Plan. No shares of restricted stock and no stock appreciation rights (&#8220;SARs&#8221;) were granted under the 2019 Plan. Certain options granted under the 2019 Plan are early exercisable and may be exercised for unvested shares of our common stock subject to a repurchase right. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Administration<font style="font-style: normal;">. Our 2019 Plan is administered by our board of directors or a committee appointed by our board of directors, referred to herein as the &#8220;administrator.&#8221; Subject to the terms of the 2019 Plan, the administrator has the authority to, among other things, construe and interpret our 2019 Plan as well as to prescribe, amend and rescind rules and regulations relating to the 2019 Plan and awards granted thereunder. The administrator may modify awards subject to the terms of the 2019 Plan. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Eligibility<font style="font-style: normal;">. Pursuant to the 2019 Plan, we were permitted to grant incentive stock options (&#8220;ISOs&#8221;) only to our employees or the employees of our parent or subsidiaries, as applicable (including officers and directors who were also employees). We were permitted to grant non-statutory stock options (&#8220;NQSOs&#8221;), RSUs, SARs, and shares of restricted stock to our employees (including officers and directors who were also employees), non-employee directors, and consultants, or the employees, directors, and consultants of our parent and subsidiaries, as applicable. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stock Options<font style="font-style: normal;">. The 2019 Plan provided for the grant of both (i) ISOs, which are intended to qualify for tax treatment as set forth under Section&#160;422 of the Code and (ii) NQSOs to purchase shares of our Class&#160;A common stock, each at a stated exercise price. The exercise price of each option must be at least equal to the fair market value of our common stock on the date of grant (unless otherwise determined by the administrator). However, the exercise price of any ISO granted to an individual who owned more than ten percent of the total combined voting power of all classes of our capital stock at the time of grant was required be at least equal to 110% of the fair market value of our common stock on the date of grant. The administrator determined the vesting schedule applicable to each option. The maximum permitted term of options granted under our 2019 Plan is ten years from the date of grant, except that the maximum permitted term of ISOs granted to an individual who owned more than ten percent of the total combined voting power of all classes of our capital stock at the time of grant is five years from the date of grant. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted Stock Units<font style="font-style: normal;">. The 2019 Plan also allowed for the grant of restricted stock units (&#8220;RSUs&#8221;), with terms as generally determined by the administrator (in accordance with the 2019 Plan) and to be set forth in an award agreement. RSUs represent the right to receive shares of our Class&#160;A common stock at a specified date in the future, subject to forfeiture of that right because of termination of employment or failure to achieve certain performance conditions. Generally, the vesting of our RSUs granted under the 2019 Plan is upon satisfaction of both a performance-based vesting condition and a time-based vesting schedule on or before the expiration date of such RSUs. RSUs will be forfeited in case of a termination of employment or service before the satisfaction of both the performance-based vesting condition and the time-based vesting schedule or, otherwise, generally in case of non-satisfaction of either the performance-based vesting condition or the time-based vesting schedule. The performance-based vesting condition was satisfied in connection with our IPO. RSUs that remained unvested as of the date of the IPO due to the RSUs&#8217; time-based vesting schedule will continue to vest after the performance-based vesting condition for so long as the holder remains in continuous service status through each such time-based vesting date. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted Stock, Stock Appreciation Rights<font style="font-style: normal;">. In addition, the 2019 Plan allowed for the grant of restricted stock awards (&#8220;RSAs&#8221;) and SARs, with terms as generally determined by the administrator (in accordance with the 2019 Plan) and to be set forth in an award agreement. We did not grant any shares of restricted stock or any SARs under the 2019 Plan, provided that certain options granted under the 2019 Plan are early exercisable and are exercised for unvested shares of our common stock subject to a repurchase right. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">163<br></div></div></div>
<!--End Page 174-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 175-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Limited Transferability<font style="font-style: normal;">. Unless otherwise determined by the administrator, awards granted under the 2019 Plan generally may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will, the laws of descent and distribution and, with respect to NQSOs, by instrument to an inter vivos or testamentary trust in which the NQSOs are to be passed to beneficiaries upon the death of the trustor, or by gift to a qualified family member. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Change of Control<font style="font-style: normal;">. In the event that we are subject to an &#8220;acquisition&#8221; or &#8220;other combination&#8221; (as defined in the 2019 Plan and generally meaning, collectively, a merger, a sale or transfer of more than 50% of the voting power of all of our outstanding securities, or a sale of all or substantially all of the assets of ours), the 2019 Plan provides that awards will be subject to the agreement evidencing such acquisition or other combination, which agreement need not treat all awards in a similar manner. Such agreement may, without the participant&#8217;s consent, provide for the continuation of outstanding awards, the assumption or substitution of awards, the acceleration of vesting of awards, the settlement of awards (whether or not vested) in cash, securities, or other consideration, or the cancellation of such awards for no consideration. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Adjustments<font style="font-style: normal;">. In the event that the number of outstanding shares of our Class&#160;A common stock is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification, or other change in our capital structure affecting our shares without consideration, then in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the 2019 Plan (i) the exercise prices of and number of shares subject to outstanding options and SARs, and (ii) the purchase prices of and/or number of shares subject to other outstanding awards will (to the extent appropriate) be proportionately adjusted (subject to required action by the board or our stockholders). </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Exchange, repricing, and buyout of awards<font style="font-style: normal;">. The administrator may modify, extend, or renew awards or issue new awards in exchange for the surrender and cancellation of any or all outstanding awards, provided that any such action will require the consent of the respective participants to the extent that any such action would impair any of the participants&#8217; existing rights. The administrator may, without prior stockholder approval, reduce the exercise price of options or SARs or buy an award previously granted with payment in cash, shares or other consideration, in each case, subject to the terms of the 2019 Plan. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dissolution or Liquidation<font style="font-style: normal;">. Our board of directors may terminate any and all outstanding options, RSUs, or SARs upon a dissolution or liquidation of us.</font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">2025 Equity Incentive Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, our board of directors and our stockholders approved our 2025 Plan as a successor to our 2019 Plan, which became effective on the date immediately prior to the pricing of the IPO. The 2025 Plan authorizes the award of both ISOs, which are intended to qualify for tax treatment under Section&#160;422 of the Code, and NQSOs, as well for the award of RSAs, SARs, RSUs, and performance and stock bonus awards. Pursuant to the 2025 Plan, ISOs may be granted only to our employees. We may grant all other types of awards to our employees, directors, and consultants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Share Reserve.<font style="font-style: normal;"> We have initially reserved 50,000,000 shares of our Class&#160;A common stock, plus any reserved shares of our Class&#160;A common stock not issued or subject to outstanding grants under the 2019 Plan on the effective date of the 2025 Plan, for issuance as our Class&#160;A common stock pursuant to awards granted under our 2025 Plan. The number of shares reserved for issuance under our 2025 Plan will increase automatically on January&#160;1 of each of 2026 through 2035 by the number of shares equal to the lesser of (a) five percent of the aggregate number of outstanding shares of all classes of our common stock plus the total number of shares of our Class&#160;A common stock issuable upon conversion of preferred stock (if any), in each case as of the immediately preceding December&#160;31, or (b) such number of shares of our Class&#160;A common stock as may be determined by our board of directors or our compensation committee. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, the shares set forth below will again be available for issuance pursuant to awards granted under our 2025 Plan: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares subject to options or SARs granted under our 2025 Plan that cease to be subject to the option or SAR for any reason other than exercise of the option or SAR; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares subject to awards granted under our 2025 Plan that are subsequently forfeited or repurchased by us at the original issue price; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares subject to awards granted under our 2025 Plan that otherwise terminate without such shares being issued; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">164<br></div></div></div>
<!--End Page 175-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 176-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares subject to awards granted under our 2025 Plan that are surrendered, cancelled, or exchanged for cash or a different award (or combination thereof); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares issuable upon the exercise of options granted under our 2019 Plan that, after the effective date of the 2025 Plan, are forfeited; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares issued pursuant to awards granted under our 2019 Plan that are forfeited or repurchased by us at the original price after the effective date of the 2025 Plan; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">shares subject to awards under our 2019 Plan or our 2025 Plan that are used to pay the exercise price of an option or withheld to satisfy the tax withholding obligations related to any award. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Shares of our Class&#160;A common stock that were either reserved, but not issued under the 2019 Plan prior to the IPO, or issued under the 2019 Plan and later become available for grant under our 2025 Plan, either as set forth above, shall be issued under the 2025 Plan only as shares of our Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Administration. <font style="font-style: normal;">Our 2025 Plan is administered by our compensation committee or by our board of directors acting in place of our compensation committee. Subject to the terms and conditions of the 2025 Plan, the administrator has the authority, among other things, to select the persons to whom awards may be granted, construe and interpret our 2025 Plan as well as to determine the terms of such awards and prescribe, amend, and rescind the rules and regulations relating to the 2025 Plan or any award granted thereunder. The 2025 Plan provides that the administrator may delegate its authority, including the authority to grant awards, to one or more executive officers to the extent permitted by applicable law, provided that awards granted to non-employee directors may only be determined by our board of directors. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Options. <font style="font-style: normal;">The 2025 Plan provides for the grant of both ISOs intended to qualify under Section&#160;422 of the Code, and NQSOs to purchase shares of our Class&#160;A common stock at a stated exercise price. ISOs may only be granted to employees, including officers and directors who are also employees. The exercise price of stock options granted under the 2025 Plan must be at least equal to the fair market value of our Class&#160;A common stock on the date of grant. ISOs granted to an individual who holds, directly or by attribution, more than ten percent of the total combined voting power of all classes of our capital stock must have an exercise price of at least 110% the fair market value of our Class&#160;A common stock on the date of grant. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Options may vest based on service and/or achievement of performance conditions, as determined by the administrator. The administrator may provide for options to be exercised only as they vest or to be immediately exercisable, with any shares issued on exercise being subject to our right of repurchase that lapses as the shares vest. No more than 150,000,000 shares may be issued pursuant to ISOs. The maximum term of options granted under our 2025 Plan is ten years from the date of grant, except that the maximum permitted term of ISOs granted to an individual who holds, directly or by attribution, more than ten percent of the total combined voting power of all classes of our capital stock is five years from the date of grant. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted Stock Awards. <font style="font-style: normal;">An RSA is an offer by us to grant or sell shares of our Class&#160;A common stock subject to restrictions, which may lapse based on the satisfaction of service and/or achievement of performance conditions. The price, if any, of an RSA will be determined by the administrator. Holders of RSAs, unlike holders of options, will have the right to vote and any dividends or distributions paid with respect to such shares will be subject to the same vesting terms and other restrictions as the RSA and will be accrued and paid when the vesting terms on such shares lapse. Unless otherwise determined by the administrator, vesting will cease on the date the participant no longer provides services to us and unvested shares may be forfeited to or repurchased by us. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stock Appreciation Rights. <font style="font-style: normal;">An SAR provides for a payment, in cash or shares of our Class&#160;A common stock (up to a specified maximum of shares, if determined by the administrator), to the participant based upon the difference between the fair market value of our Class&#160;A common stock on the date of exercise and a predetermined exercise price, multiplied by the number of shares. SARs may vest based on service and/or achievement of performance conditions. No SAR may have a term that is longer than ten years from the date of grant. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Restricted Stock Units. <font style="font-style: normal;">An RSU represents the right to receive shares of our Class&#160;A common stock at a specified date in the future and may be subject to vesting based on service and/or achievement of performance conditions. RSUs may be settled in cash, shares of our Class&#160;A common stock, or a combination of both as soon as practicable following vesting or on a later date subject to the terms of the 2025 Plan and any applicable award agreement (which may provide for settlement only in shares). No RSU may have a term that is longer than ten years from the date of grant. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">165<br></div></div></div>
<!--End Page 176-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 177-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Performance Awards. <font style="font-style: normal;">A performance award granted pursuant to the 2025 Plan may be in the form of a cash bonus, or an award of performance shares or performance units denominated in shares of our Class&#160;A common stock that may be settled in cash, property, or by issuance of those shares, subject to the satisfaction or achievement of specified performance conditions. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stock Bonus Awards. <font style="font-style: normal;">A stock bonus award provides for payment in the form of cash, shares of our Class&#160;A common stock, or a combination thereof, based on the fair market value of shares subject to such award as determined by the administrator. The awards may be granted as consideration for services already rendered, or at the discretion of the administrator, may be subject to vesting restrictions based on continued service and/or performance conditions. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Dividend Equivalent Rights. <font style="font-style: normal;">Dividend equivalent rights may be granted at the discretion of the administrator and represent the right to receive the value of dividends, if any, paid by us in respect of the number of shares of our Class&#160;A common stock underlying an award. Dividend equivalent rights will be subject to the same vesting or performance conditions as the underlying award and will be paid only when the underlying award becomes vested or may be deemed to have been reinvested by us. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Change of Control. <font style="font-style: normal;">Our 2025 Plan provides that, in the event of a corporate transaction that constitutes a change of control of our company under the terms of the plan, outstanding awards will be subject to the agreement evidencing the change of control, which need not treat all outstanding awards in an identical manner, and may include one or more of the following: (1) the continuation of the outstanding awards, (2) the assumption of the outstanding awards by the surviving corporation or a parent or subsidiary of the surviving corporation, (3) the substitution by the surviving corporation or a parent or subsidiary of the surviving corporation of new options or substantially equivalent equity awards for the outstanding awards, (4) the full or partial acceleration of exercisability or vesting or lapse of our right to repurchase or other terms of forfeiture and accelerated expiration of the award, or (5) may be settled for their intrinsic value (whether or not then vested or exercisable) in cash, cash equivalents, or equity (including cash or equity subject to deferred vesting and delivery consistent with vesting restrictions applicable to such awards or the underlying shares) followed by the cancellation of such awards, provided however, that such awards may be cancelled without consideration if such awards have no value, as determined by our compensation committee, in its discretion, in each case without the participant&#8217;s consent. The successor corporation may also issue, as replacement of our outstanding shares held by a participant, substantially similar shares, or other property subject to repurchase restrictions no less favorable to the participant. In the event such successor corporation refuses to assume, substitute, or replace any award in accordance with the 2025 Plan, then notwithstanding any other provision in the 2025 Plan to the contrary, each such award shall become fully vested and, as applicable, exercisable and any rights of repurchase or forfeiture restrictions thereon will lapse, immediately prior to the consummation of the corporate transaction. Awards subject to performance-based vesting that are not assumed pursuant to the foregoing shall be deemed earned and vested at 100% of target level, unless otherwise indicated pursuant to the terms and conditions of the applicable award agreement. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If an award vests in lieu of assumption or substitution in connection with a corporate transaction as provided above, our board of directors or our compensation committee will notify the holder of such award in writing or electronically that such award will be exercisable for a period of time determined by our board of directors or our compensation committee, in its sole discretion, and such award will terminate upon the expiration of such period without consideration. Any determinations by our board of directors or our compensation committee need not treat all outstanding awards in an identical manner, and shall be final and binding on each applicable participant. Our board of directors shall have full power and authority to assign our right to repurchase, right to re-acquire, and/or forfeiture rights to such successor or acquiring corporation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The vesting of all awards granted to our non-employee directors under our 2025 Plan shall accelerate in full in the event of a corporate transaction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Adjustment. <font style="font-style: normal;">In the event of a change in the number or class of outstanding shares of our Class&#160;A common stock, without consideration, by reason of a stock dividend, extraordinary dividend, or distribution (whether in cash, shares, or other property, other than a regular cash dividend), recapitalization, stock split, reverse stock split, subdivision, combination, consolidation, reclassification, spin-off or similar change in our capital structure, proportional adjustments will be made to the number and class of shares reserved for issuance under our 2025 Plan; the exercise prices, number, and class of shares subject to outstanding options or SARs; the number and class of shares subject to other outstanding awards; and any applicable maximum award limits with respect to ISOs. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">166<br></div></div></div>
<!--End Page 177-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 178-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Exchange, Repricing, and Buyout of Awards. <font style="font-style: normal;">The administrator may, without prior stockholder approval, (1)&#160;reduce the exercise price of outstanding options or SARs without the consent of any participant (provided that written notice of the repricing is provided to such participants) and (2) pay cash or issue new awards in exchange for the surrender and cancellation of any, or all, outstanding awards, subject to the consent of any affected participant to the extent required by the terms of the 2025 Plan. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Director Compensation Limits. <font style="font-style: normal;">No non-employee director may receive awards under our 2025 Plan in consideration for such director&#8217;s service as a non-employee director with a grant date value that when combined with cash compensation received for such director&#8217;s service as a non-employee director, exceeds $1&#160;million in a calendar year or $1.5&#160;million in the calendar year of his or her initial service as a non-employee director with us. Awards granted, or cash compensation paid, to an individual while he or she was serving in the capacity as an employee or in consideration of services as a consultant will not count for purposes of this limitation. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Clawback; Transferability. <font style="font-style: normal;">All awards are subject to clawback or recoupment pursuant to any compensation clawback or recoupment policy adopted by our board of directors or required by law, to the extent set forth in such policy or applicable agreement. Except in limited circumstances, awards granted under our 2025 Plan may generally not be transferred in any manner other than by will or by the laws of descent and distribution. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sub-plans. <font style="font-style: normal;">Subject to the terms of the 2025 Plan, the plan administrator may establish a sub-plan under the 2025&#160;Plan and/or modify the terms of awards granted to participants outside of the United States to comply with any laws or regulations applicable to any such jurisdiction. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amendment; Termination. <font style="font-style: normal;">Our board of directors or compensation committee may amend our 2025 Plan at any time, subject to stockholder approval as may be required. Our 2025 Plan will terminate ten years from the date our board of directors adopts the plan, unless it is terminated earlier by our board of directors. No termination or amendment of the 2025 Plan may adversely affect any then-outstanding award without the consent of the affected participant, except as is necessary to comply with applicable laws or as otherwise provided by the terms of the 2025&#160;Plan. </font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">2025 Employee Stock Purchase Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, our board of directors and our stockholders approved our 2025 ESPP, which became effective on the date of the pricing of the IPO to enable eligible employees to purchase shares of our Class&#160;A common stock with accumulated payroll deductions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2025 ESPP includes two components: a &#8220;423 Component&#8221; and a &#8220;Non-423 Component.&#8221; We intend the 423 Component to qualify as options issued under an &#8220;employee stock purchase plan&#8221; as that term is defined in Section&#160;423(b) of the Code. Except as otherwise provided in the 2025 ESPP or determined by the board of directors or the compensation committee, the Non-423 Component (if any) will operate and be administered in the same manner as the 423 Component. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Share Reserve. <font style="font-style: normal;">We have initially reserved 10,000,000 shares of our Class&#160;A common stock for issuance and sale under our 2025 ESPP. The number of shares reserved for issuance and sale under our 2025 ESPP will increase automatically on January&#160;1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup> of each of 2026 through 2035 by the number of shares equal to the lesser of (a) the number of shares equal to 1% of the sum of the total number of outstanding shares of all classes of our common stock plus the total number of shares of our Class&#160;A common stock issuable upon conversion of preferred stock (if any), in each case outstanding as of the immediately preceding December&#160;31 and (b) such number of shares of our Class&#160;A common stock determined by our board of directors or compensation committee; provided, that our board of directors or our compensation committee may in its sole discretion reduce the amount of the increase in any particular calendar year. Subject to stock splits, recapitalizations, or similar events, no more than 100,000,000 shares of our Class&#160;A common stock may be issued over the term of our 2025 ESPP. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Administration. <font style="font-style: normal;">Our 2025 ESPP is administered by our compensation committee or by our board of directors acting in place of our compensation committee, subject to the terms and conditions of our 2025 ESPP. Among other things, the administrator has the authority to determine eligibility for participation in our 2025 ESPP (to the extent permitted by applicable law), designate separate offerings under the plan (and determine the length of such offerings), and construe, interpret, and apply the terms of the plan. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Eligibility. <font style="font-style: normal;">Employees eligible to participate in any offering pursuant to our 2025 ESPP generally include any employee that is employed by us or certain of our designated subsidiaries at the beginning of the offering period. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">167<br></div></div></div>
<!--End Page 178-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 179-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_114-executive_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">However, the administrator may exclude employees who have been employed for less than two years, are customarily employed for 20 hours or less per week, are customarily employed for five months or less in a calendar year, are certain highly compensated employees as determined in accordance with applicable tax laws or are certain employees who are citizens or residents of a foreign jurisdiction if such participation is prohibited under applicable local laws or would violate the requirements of Section&#160;423 of the Code (with respect to an offering under a 423 Component). In addition, any employee who owns (or is deemed to own because of attribution rules) 5% or more of the total combined voting power or value of all classes of our capital stock, or the capital stock of one of our qualifying subsidiaries, or who owns such amount because of participation in our 2025 ESPP, is not eligible to participate in our 2025 ESPP. The administrator may impose additional restrictions on eligibility from time to time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Offerings. <font style="font-style: normal;">Under our 2025 ESPP, eligible employees are offered the option to purchase shares of our Class&#160;A common stock at a discount over a series of offering periods through accumulated payroll deductions over the period. Each offering period may itself consist of one or more purchase periods. No offering period may be longer than 27&#160;months. The purchase price for shares purchased under our 2025 ESPP during any given purchase period is 85% of the lesser of the fair market value of our Class&#160;A common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable purchase period. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No participant may purchase more than 5,000 shares of our Class&#160;A common stock (or such greater or lesser number as our compensation committee may determine) during any one purchase period and may not subscribe for more than $25,000 in fair market value of shares of our Class&#160;A common stock (determined as of the date the offering period commences) in any calendar year in which the offering is in effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Adjustments Upon Recapitalization. <font style="font-style: normal;">If the number or class of outstanding shares of our Class&#160;A common stock is changed by stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination, reclassification or similar change in our capital structure without consideration, then the administrator will proportionately adjust the number or class of shares of our Class&#160;A common stock that are available under our 2025&#160;ESPP, the purchase price and number or class of shares any participant has elected to purchase as well as the maximum number of shares which may be purchased by participants. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Change of Control. <font style="font-style: normal;">If we experience a change of control transaction as determined under the terms of our 2025&#160;ESPP, any offering period then in effect will be assumed or an equivalent option substituted by the successor corporation or a parent or a subsidiary of the successor corporation. In the event that the successor corporation refuses to assume or substitute for the purchase right, any offering period then in effect will be shortened and terminated on a final purchase date established by the administrator. The final purchase date will occur on or prior to the effective date of the change of control transaction, and our 2025 ESPP will terminate on the closing of the change of control. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Transferability. <font style="font-style: normal;">Participants may generally not assign, transfer, pledge, or otherwise dispose of payroll deductions credited to their account or any rights regarding an election to purchase shares pursuant to our 2025 ESPP other than by will or the laws of descent or distribution. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amendment; Termination. <font style="font-style: normal;">The board of directors or compensation committee may amend, suspend, or terminate our 2025 ESPP at any time without stockholder consent, except as required by law. Unless earlier terminated, our 2025 ESPP terminates upon the earlier to occur of the issuance of all shares of our Class&#160;A common stock reserved for issuance under our 2025 ESPP, or the tenth anniversary of the effective date. </font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Compensation Recovery Policy </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, we adopted a Compensation Recovery Policy (the &#8220;Compensation Recovery Policy&#8221;). The Compensation Recovery Policy is in accordance with the final rules regarding recovery of erroneously awarded executive officer compensation in connection with an accounting restatement, as adopted by the SEC in October&#160;2022, and consistent with the corresponding Nasdaq listing standards (together, the &#8220;Clawback Rules&#8221;). Pursuant to the Compensation Recovery Policy, and subject to certain limited exceptions in the Clawback Rules, in the event we are required to restate our financial statements, we are required to recoup erroneously awarded incentive-based compensation (as described in the Clawback Rules, including both cash and equity compensation) paid to any current or former executive officer (as described in the Clawback Rules) during the three completed fiscal&#160;years immediately prior to the date the accounting restatement was required. The amount recoverable is the amount of any incentive-based compensation received by the executive officer based on the financial statements prior to the restatement that exceeds the amount that such executive officer would have received had the incentive-based compensation been determined based on the financial restatement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">168<br></div></div></div>
<!--End Page 179-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 180-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSSM"><!--Anchor--></a>THE CORE SCIENTIFIC SPECIAL MEETING </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;"><a name="tGEN"><!--Anchor--></a>General </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus is being provided to Core Scientific stockholders as part of a solicitation of proxies by the Core Scientific board for use at the Special Meeting and at any adjournments or postponements of such Special Meeting. This proxy statement/prospectus provides Core Scientific stockholders with important information about the Special Meeting and should be read carefully in its entirety. In addition, this proxy statement/prospectus constitutes a prospectus for CoreWeave in connection with the issuance by CoreWeave of shares of CoreWeave common stock and CoreWeave warrants pursuant to the Merger Agreement. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><a name="tDTP"><!--Anchor--></a>Date, Time and Place of the Special Meeting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Special Meeting will be a virtual meeting conducted exclusively via live webcast online at www.virtualshareholdermeeting.com/CORZ2025SM starting at [&#8195;], Eastern Time (with log-in beginning at [&#8195;], Eastern Time) on [&#8195;]. Core Scientific stockholders will be able to attend the Special Meeting online and vote shares electronically at the meeting by going to www.virtualshareholdermeeting.com/CORZ2025SM and entering the 16-digit control number included on the proxy card or voting instruction form the stockholder received. Because the Special Meeting is completely virtual and being conducted via live webcast, stockholders will not be able to attend the meeting in person. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><a name="tPSM"><!--Anchor--></a>Purposes of the Special Meeting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Special Meeting is being held to consider and vote upon the following proposals: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 1&#8212;the Merger Agreement Proposal</font>: to adopt the Merger Agreement, a copy of which is attached as Annex&#160;A to this proxy statement/prospectus and the material provisions of which are summarized in the section titled &#8220;The Merger Agreement&#8221; beginning on page&#160;<a href="#tTMAT">218</a> of this proxy statement/prospectus, pursuant to which, among other things, Merger Sub will merge with and into Core Scientific and each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave common stock. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 2&#8212;the Advisory Compensation Proposal</font>: to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers that is based on or otherwise related to the Merger, the estimated value of which is disclosed in the table in the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to Scientific&#8217;s Named Executive Officers&#8221; beginning on page&#160;<a href="#tQOPP">254</a> of this proxy statement/prospectus. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;"><a name="tRECO"><!--Anchor--></a>Recommendation of the Core Scientific Board </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At a meeting held on July&#160;7, 2025, the Core Scientific board unanimously (i) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, were fair to and in the best interests of Core Scientific and its stockholders, (ii) approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii) directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. <font style="font-weight: bold;">The Core Scientific board unanimously recommends that the Core Scientific stockholders vote:</font> </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic; font-weight: bold;">Proposal 1: &#8220;FOR&#8221; the Merger Agreement Proposal; and</font> </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;"><font style="font-style: italic; font-weight: bold;">Proposal 2: &#8220;FOR&#8221; the Advisory Compensation Proposal.</font> </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus contains important information regarding these proposals and factors that Core Scientific stockholders should consider when deciding how to cast their votes. Core Scientific stockholders are encouraged to read carefully this proxy statement/prospectus in its entirety, including the annexes to this proxy statement/prospectus and documents incorporated by reference into this proxy statement/prospectus, for more detailed information regarding the Merger Agreement and the Merger. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">169<br></div></div></div>
<!--End Page 180-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 181-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tVD"><!--Anchor--></a>Voting by Directors and Executive Officers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On [&#8195;], Core Scientific directors and executive officers, as a group, beneficially owned and were entitled to vote [&#8195;] shares of Core Scientific common stock, or approximately [&#8195;]% of the issued and outstanding shares of Core Scientific common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tASM"><!--Anchor--></a>Attendance at the Special Meeting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Only Core Scientific stockholders of record on the Core Scientific record date, beneficial owners of Core Scientific common stock on the Core Scientific record date and holders of valid proxies for the Special Meeting may attend the virtual Special Meeting. A participating stockholder who logs on to the meeting using his, her or its unique 16-digit control number will also be able to examine the stockholder list during the Special Meeting by following the instructions provided on the meeting website. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tRD"><!--Anchor--></a>Record Date </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board has fixed the close of business on [&#8195;] as the Core Scientific record date for the determination of the Core Scientific stockholders entitled to receive notice of, and to vote at, the Special Meeting. The Core Scientific stockholders of record on the Core Scientific record date are the only Core Scientific stockholders that are entitled to receive notice of, and to vote at, the Special Meeting or any adjournments or postponements of the Special Meeting. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tOSV"><!--Anchor--></a>Outstanding Shares and Voting Rights of Core Scientific Stockholders </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of the close of business on [&#8195;], there were [&#8195;] shares of Core Scientific common stock issued and outstanding. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tSL"><!--Anchor--></a>Stockholder List </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A complete list of registered Core Scientific stockholders entitled to vote at the Special Meeting will be available for inspection at Core Scientific&#8217;s principal executive offices at 701 Brickell Ave, Suite 2500, Miami, FL 33131, during ordinary business hours, for a period of no less than ten days before the Special Meeting and will be available during the virtual Special Meeting at www.virtualshareholdermeeting.com/CORZ2025SM. If a Core Scientific stockholder wants to inspect the stockholder list, such stockholder should call the Core Scientific corporate secretary at (512) 402-5233 to schedule an appointment or request access. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tQAB"><!--Anchor--></a>Quorum; Abstentions and Broker Non-Votes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order for business to be conducted at the Special Meeting, a quorum must be present. A quorum at the Special Meeting requires the presence, virtually or by proxy, of the holders of a majority of the voting power of the outstanding shares of Core Scientific common stock entitled to vote at the Special Meeting. An abstention occurs when a stockholder is present for purposes of a quorum by virtually attending the Special Meeting and either does not vote or submits a ballot marked &#8220;abstain&#8221;. An abstention also occurs when a stockholder does not attend the meeting virtually and instead submits a proxy with an &#8220;abstain&#8221; instruction. Abstentions will be counted for purposes of determining whether there is a quorum at the Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Brokers, banks and other nominees who hold shares of Core Scientific common stock in &#8220;street name&#8221; for their customers do not have discretionary authority to vote the shares with respect to matters considered to be &#8220;non-routine.&#8221; The Merger Agreement Proposal and the Advisory Compensation Proposal are both &#8220;non-routine&#8221; matters. Accordingly, if brokers, banks or other nominees do not receive specific voting instructions from the beneficial owner of shares held in street name, they may not vote such shares with respect to these proposals. Under such circumstances, a &#8220;broker non-vote&#8221; would arise. &#8220;Broker non-votes,&#8221; if any, will not be counted for purposes of determining whether there is a quorum at the Special Meeting. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;"><a name="tADJ"><!--Anchor--></a>Adjournment </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a quorum is not present or represented or if there are not sufficient votes for the approval of the Merger Agreement Proposal and the Advisory Compensation Proposal, Core Scientific expects that the Special Meeting will be adjourned by the chairperson of the Special Meeting to solicit additional proxies, subject to the limitations on such </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">170<br></div></div></div>
<!--End Page 181-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 182-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">actions set forth in the Merger Agreement. In addition, the holders of a majority in voting power of Core Scientific common stock entitled to vote at the Special Meeting who are present virtually or by proxy at the Special Meeting have the power to adjourn such meeting, whether or not a quorum is present. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No notice of the reconvened meeting is required to be given if the date, time and place (including the means of remote communication) are (i) announced at the Special Meeting, (ii) displayed during the time scheduled for the Special Meeting, on the same electronic network used to enable stockholder and proxyholders to participate in the meeting by means of remote communication or (iii) set forth in the notice of the Special Meeting given in accordance with Core Scientific&#8217;s bylaws, provided however, if the adjournment is for more than 30 days, the notice of the reconvened meeting must be given to each stockholder of record entitled to vote at the reconvened Special Meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Core Scientific board must fix as the record date for determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and will give notice of the adjourned meeting to each stockholder of record entitled to vote at such adjourned meeting as of the record date so fixed for notice of such adjourned meeting. At any reconvened Special Meeting at which a quorum is present, (i) any business may be transacted that may have been transacted at the Special Meeting had a quorum been present and (ii) all proxies will be voted in the same manner as the manner in which such proxies would have been voted at the original convening of the Special Meeting, except for any proxies that have been validly revoked or withdrawn prior to the subsequent meeting. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tVR"><!--Anchor--></a>Vote Required </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The votes required for each proposal are as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 1&#8212;the Merger Agreement Proposal. </font>The affirmative vote of holders of a majority of the issued and outstanding shares of Core Scientific common stock on the Core Scientific record date and entitled to vote thereon is required to adopt the Merger Agreement Proposal. The required vote on Proposal 1 is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure of any Core Scientific stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from voting by a Core Scientific stockholder will have the same effect as a vote &#8220;<font style="font-style: italic; font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. Because the Merger Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger Agreement Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any Core Scientific shares held of record by them. As a result, a broker non-vote will have the same effect as a vote &#8220;<font style="font-style: italic; font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Proposal 2&#8212;the Advisory Compensation Proposal. </font>The affirmative vote of the holders of a majority of the votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker non-votes), where a quorum is present, is required to approve the Advisory Compensation Proposal. The required vote on the Advisory Compensation Proposal is based on the number of shares actually voted&#8212;not the number of outstanding shares of Core Scientific common stock entitled to be voted thereon. Abstentions from voting by a Core Scientific stockholder attending the Special Meeting or a failure to attend the Special Meeting virtually or by proxy will have no effect on the outcome of the vote on the Advisory Compensation Proposal. Brokers do not have discretion to vote on this proposal without your instruction. If you do not instruct your broker how to vote on this proposal, those shares will not be counted as present or represented by proxy at the Special Meeting and, as a result, will have no effect on the outcome of the vote on the Advisory Compensation Proposal. While the Core Scientific board intends to consider the vote resulting from the Advisory Compensation Proposal, the vote is advisory only and therefore not binding on Core Scientific, and, if the proposed Merger Agreement is adopted by Core Scientific stockholders and the Merger is consummated, the compensation that is the subject of the Advisory Compensation Proposal, including amounts Core Scientific is contractually obligated to pay, will be payable even if the Advisory Compensation Proposal is not approved. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tHV"><!--Anchor--></a>How to Vote </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders of record and beneficial owners of Core Scientific common stock on the Core Scientific record date may vote their shares of Core Scientific common stock by submitting a proxy or may vote virtually online at the Special Meeting by following the instructions provided on the proxy card or voting instruction </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">171<br></div></div></div>
<!--End Page 182-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 183-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">form received. Core Scientific recommends that Core Scientific stockholders entitled to vote submit a proxy prior to the Special Meeting even if they plan to attend the virtual Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders are encouraged to submit a proxy promptly. Each valid proxy received in time will be voted at the Special Meeting according to the choice specified, if any. Executed but uninstructed proxies (<font style="font-style: italic;">i.e.</font>,&#160;proxies that are properly signed, dated and returned but are not marked to tell the proxies how to vote) will be voted in accordance with the recommendations of the Core Scientific board.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Two Seas has filed a preliminary proxy statement in connection with the Special Meeting. It is recommended that Core Scientific stockholders disregard any proxy card sent to them by or on behalf of any person other than Core Scientific, including the gold proxy card and solicitation materials sent by or on behalf of Two Seas, which is soliciting proxies to vote against the Merger Agreement Proposal and Advisory Compensation Proposal. If you have submitted such a proxy card (including a gold proxy card), it is recommended that you subsequently recast your vote as instructed on the WHITE proxy card mailed to you by Core Scientific, which will revoke any earlier dated proxy card that you submitted. Only the last validly executed proxy that you submit will be counted and such proxy will be counted only if it has been received 11:59 p.m., Eastern Time on [&#8195;]. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tRH"><!--Anchor--></a>Record Holders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Core Scientific stockholders of record may vote in one of the following ways: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Internet</font>: Core Scientific stockholders of record may submit their proxy over the internet at www.proxyvote.com. Internet voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time, on [&#8195;]. Stockholders will be given an opportunity to confirm that their voting instructions have been properly recorded. Core Scientific stockholders who submit a proxy this way need not send in their proxy card by mail. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Telephone</font>: Core Scientific stockholders of record may submit their proxy by calling 1-800-690-6903. Telephone voting is available 24 hours a day and will be accessible until 11:59 p.m., Eastern Time, on [&#8195;]. Easy-to-follow voice prompts will guide stockholders through the voting and allow them to confirm that their instructions have been properly recorded. Core Scientific stockholders who submit a proxy this way need not send in their proxy card by mail. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Mail</font>: Core Scientific stockholders of record may submit their proxy by properly completing, signing, dating and mailing their proxy card or voting instruction form in the self-addressed, stamped envelope (if mailed in the United States) included with this proxy statement/prospectus. Core Scientific stockholders who vote this way should mail the proxy card early enough so that it is received prior to the closing of the polls at the Special Meeting. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Online During the Virtual Meeting</font>: Core Scientific stockholders of record may attend the virtual Special Meeting by entering their unique 16-digit control number and vote online; attendance at the virtual Special Meeting alone will not, however, in and of itself constitute a vote or a revocation of a prior proxy. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tBO"><!--Anchor--></a>Beneficial Owners </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders who hold their shares of Core Scientific common stock beneficially in &#8220;street name&#8221; and wish to submit a proxy must provide instructions to the bank, broker or other nominee that holds their shares of record as to how to vote their shares with respect to the Merger Agreement Proposal and the Advisory Compensation Proposal. Most beneficial owners will have a choice of voting before the Special Meeting by proxy over the internet, by telephone or by using a voting instruction form. Each beneficial owner of Core Scientific common stock should refer to the voting instruction form received to see what options are available and how to use them. However, attendance at the virtual Special Meeting will not, in and of itself, constitute a vote or a revocation of a prior proxy. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Brokers, banks and other nominees who hold shares of Core Scientific common stock in &#8220;street name&#8221; for their customers do not have discretionary authority to vote the shares with respect to matters considered to be &#8220;non-routine.&#8221; The Merger Agreement Proposal and the Advisory Compensation Proposal are all &#8220;non-routine&#8221; matters. Accordingly, if brokers, banks or other nominees do not receive specific voting instructions from the beneficial owner of shares held in street name, they may not vote such shares with respect to these proposals. Under such circumstances, a &#8220;broker non-vote&#8221; would arise. &#8220;Broker non-votes,&#8221; if any, will not be counted for purposes </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">172<br></div></div></div>
<!--End Page 183-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 184-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">of determining whether there is a quorum at the Special Meeting, will have the same effect as a vote &#8220;<font style="font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal and, assuming a quorum is present, will have no effect on the Advisory Compensation Proposal. Thus, for shares of Core Scientific common stock held in &#8220;street name,&#8221; only shares of Core Scientific common stock affirmatively voted &#8220;<font style="font-weight: bold;">FOR</font>&#8221; the Merger Agreement Proposal or the Advisory Compensation Proposal will be counted as a vote in favor of such proposal. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tPR"><!--Anchor--></a>Proxies and Revocation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders of record may revoke their proxies at any time before their shares of Core Scientific common stock are voted at the Special Meeting in any of the following ways: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delivering written notice of revocation of the proxy to Core Scientific&#8217;s corporate secretary at Core Scientific&#8217;s principal executive offices at 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, by no later than 11:59 p.m., Eastern Time on [&#8195;]; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">delivering another proxy with a later date to Core Scientific&#8217;s corporate secretary at Core Scientific&#8217;s principal executive offices at 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, by no later than 11:59 p.m., Eastern Time on [&#8195;] (in which case only the later-dated proxy is counted and the earlier proxy is revoked); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">submitting another proxy again via the internet or by telephone at a later date, by no later than 11:59 p.m., Eastern Time on [&#8195;] (in which case only the later-dated proxy is counted and the earlier proxy is revoked); or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">attending the Special Meeting virtually, using the stockholder&#8217;s unique 16-digit control number and voting their shares online during the meeting; attendance at the virtual Special Meeting will not, in and of itself, revoke a valid proxy that was previously delivered unless the stockholder gives written notice of revocation to the Core Scientific corporate secretary before the proxy is exercised or unless the stockholder votes their shares online during the Special Meeting. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a Core Scientific stockholder holds shares through a bank, broker or other nominee, such stockholder may change or revoke his, her or its voting instructions before the Special Meeting by providing instructions again through the means specified on his, her or its voting instruction form (with most having the option to do so by internet, telephone or mail), which must be received before 11:59 p.m., Eastern Time on [&#8195;]. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tIET"><!--Anchor--></a>Inspector of Elections; Tabulation of Votes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Voting results will be tabulated and certified by an individual designated by the Core Scientific board to serve as inspector of election. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tSOP"><!--Anchor--></a>Solicitation of Proxies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific will pay for the proxy solicitation costs related to the Special Meeting. In addition to sending and making available these materials, some of Core Scientific&#8217;s directors, officers and other employees may solicit proxies by contacting Core Scientific stockholders by telephone, by mail, by e-mail or online. Core Scientific stockholders may also be solicited by, among others, news releases issued by Core Scientific and/or CoreWeave, postings on Core Scientific&#8217;s or CoreWeave&#8217;s websites and social media accounts and advertisements in periodicals. None of Core Scientific&#8217;s directors, officers or employees will receive any extra compensation for their solicitation services. Core Scientific has also retained MacKenzie Partners, Inc. as its proxy solicitor to assist in the solicitation of proxies. For these proxy solicitation services, MacKenzie Partners, Inc. will receive a fee not to exceed $175,000, plus reasonable out-of-pocket expenses and fees for any additional services. Core Scientific may also reimburse banks, brokers, and other nominees for their expenses in sending proxy solicitation materials to the beneficial owners of shares of Core Scientific common stock and obtaining their proxies. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tOMS"><!--Anchor--></a>Other Matters </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At this time, Core Scientific knows of no other matters to be submitted at the Special Meeting other than those listed in the notice. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;"><a name="tHPS"><!--Anchor--></a>Householding of Proxy Statement/Prospectus </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Special Meeting materials with respect to two or more stockholders sharing the same address by </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">173<br></div></div></div>
<!--End Page 184-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 185-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_115-meeting_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">delivering a single set of Special Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the Special Meeting, a number of brokers with accountholders who are Core Scientific stockholders will be &#8220;householding&#8221; Core Scientific&#8217;s Special Meeting materials. These brokers will deliver one copy of this proxy statement/prospectus to stockholders that share an address, unless contrary instructions have been received from the affected stockholders. Once a broker notifies stockholders that the broker will be &#8220;householding&#8221; communications, &#8220;householding&#8221; will continue until the affected stockholders are notified otherwise or revoke their consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Special Meeting materials, please notify your broker or Core Scientific, Inc. Direct your written request to 838 Walker Road, Suite 21-2105, Dover, Delaware 19904, Attn: Corporate Secretary, or call (512) 402-5233. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tQAI"><!--Anchor--></a>Questions and Additional Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders may contact Core Scientific&#8217;s proxy solicitor with any questions about the Merger Agreement Proposal or the Advisory Compensation Proposal or how to vote or to request additional copies of any materials at: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">MacKenzie Partners, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">7 Penn Plaza </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">New York, New York 10001 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Call toll free: (800) 322-2885 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Email: proxy@mackenziepartners.com </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders should not return their stock certificates or send documents representing Core Scientific common stock with the enclosed proxy card. If the Merger is completed, the exchange agent for the Merger will send to Core Scientific stockholders a letter of transmittal and related materials and instructions for exchanging shares of Core Scientific common stock.<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">174<br></div></div></div>
<!--End Page 185-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 186-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTHE"><!--Anchor--></a>THE MERGER </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tGENE"><!--Anchor--></a>GENERAL </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus is being provided to holders of Core Scientific common stock in connection with the solicitation of proxies to be voted at the Special Meeting and at any adjournments or postponements of the Special Meeting. At the Special Meeting, Core Scientific will ask Core Scientific stockholders to consider and vote on (i) the Merger Agreement Proposal and (ii) the Advisory Compensation Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement provides for, among other things, the merger of Merger Sub with and into Core Scientific, with Core Scientific continuing as the Surviving Corporation and a wholly owned subsidiary of CoreWeave. <font style="font-weight: bold;">The Merger will not be completed unless Core Scientific stockholders adopt the Merger Agreement. </font>A copy of the Merger Agreement is attached as Annex&#160;A to this proxy statement/prospectus. You are urged to read the Merger Agreement in its entirety because it is the legal document that governs the Merger. For additional information about the Merger, see the sections titled &#8220;The Merger Agreement&#8212;Structure of the Merger&#8221; and &#8220;The Merger Agreement&#8212;Merger Consideration&#8221; beginning on pages <a href="#tSOT1">218</a> and <a href="#tMC1">219</a>, respectively, of this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger is completed, each outstanding share of Core Scientific common stock (other than the excluded shares) will be entitled to the right to receive the Merger Consideration, subject to any applicable withholding taxes for cash proceeds from the sale of fractional shares, in each case without interest. <font style="font-weight: bold;">Although the number of shares of CoreWeave common stock that Core Scientific stockholders will receive in the Merger is fixed, the market value of the Merger Consideration will fluctuate with the market price of CoreWeave common stock and will not be known at the time that Core Scientific stockholders vote to adopt the Merger Agreement.</font> Based on the closing price of CoreWeave common stock on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) on July&#160;3, 2025, the last trading day prior to the public announcement of the Merger Agreement, the 0.1235 exchange ratio represented approximately $20.40 in implied value for each share of Core Scientific common stock. Based on CoreWeave&#8217;s closing price on [&#8195;], 2025 of $[&#8195;], the 0.1235 exchange ratio represented approximately $[&#8195;] in implied value for each share of Core Scientific common stock. <font style="font-weight: bold;">The market price of CoreWeave common stock when Core Scientific stockholders receive those shares after the Merger is completed could be greater than, less than or the same as the market price of shares of CoreWeave common stock on the date of this proxy statement/prospectus or at the time of the Special Meeting.</font> </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;"><a name="tTP"><!--Anchor--></a>THE PARTIES </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;"><a name="tCWI"><!--Anchor--></a>COREWEAVE, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Inc., which is referred to in this proxy statement/prospectus as CoreWeave, was originally formed as a Delaware limited liability company in 2017 and then converted to a Delaware corporation in 2018. CoreWeave, the AI Hyperscaler&#8482;, delivers a cloud platform of cutting-edge software powering the next wave of AI. CoreWeave's technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal trading market for CoreWeave common stock (NASDAQ: CRWV) is the Nasdaq Stock Market LLC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal executive offices of CoreWeave are located at 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ and its telephone number is (973) 270-9737 and its website is www.coreweave.com. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;"><a name="tCSI"><!--Anchor--></a>CORE SCIENTIFIC, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific, Inc., which is referred to in this proxy statement/prospectus as Core Scientific, is a leader in digital infrastructure for high-density colocation services and digital asset mining of bitcoin. Core Scientific operates dedicated, purpose-built facilities for digital asset mining and is a premier provider of digital infrastructure, software solutions and services to its third-party customers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants are traded on the Nasdaq under the symbol &#8220;CORZ,&#8221; &#8220;CORZW&#8221; and &#8220;CORZZ,&#8221; respectively. Following the Merger, Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will be delisted from the Nasdaq. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s principal executive offices are located at 838 Walker Road, Suite 21-2105, Dover, Delaware&#160;19904, and our telephone number is (512) 402-5233. Its corporate website address is www.corescientific.com. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">175<br></div></div></div>
<!--End Page 186-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 187-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additional information about Core Scientific and its subsidiaries are included in documents incorporated by reference into this proxy statement/prospectus. For a list of the documents that are incorporated by reference in this proxy statement/prospectus, see the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tMMSI"><!--Anchor--></a>MIAMI MERGER SUB I, INC. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Miami Merger Sub I, Inc., which is referred to in this proxy statement/prospectus as Merger Sub, is a Delaware corporation and a wholly owned subsidiary of CoreWeave. Merger Sub was formed solely for the purpose of completing the Merger. Merger Sub has not carried on any activities to date, except for activities incidental to its formation and activities undertaken in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Merger Sub was formed in the State of Delaware on July&#160;2, 2025. The principal executive offices of Merger Sub are located at 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ and its telephone number is (973)&#160;270-9737. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tBOT"><!--Anchor--></a>BACKGROUND OF THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The terms of the Merger Agreement are the result of arm&#8217;s-length negotiations between representatives of Core Scientific and CoreWeave. The following is a summary of the key events leading up to the signing of the Merger Agreement and the key meetings, negotiations, discussions and actions by and between Core Scientific and CoreWeave and their respective advisors that preceded the public announcement of the transaction; it does not purport to catalogue every conversation or interaction among representatives of Core Scientific, CoreWeave and other parties.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the ordinary course of business, the Core Scientific board and senior management regularly review and evaluate Core Scientific&#8217;s long-term strategic plans and goals, overall industry trends and Core Scientific&#8217;s operations, future growth opportunities, competitive position and risks in light of current business and economic conditions. As part of such ongoing reviews and evaluations, the Core Scientific board and Core Scientific senior management regularly discuss key drivers of stockholder value creation and positive stock price performance for Core Scientific. In addition, in connection with such ongoing reviews and evaluations, the Core Scientific board meets periodically in the ordinary course of business to receive updates from Core Scientific senior management to consider and evaluate potential opportunities for business combinations, acquisitions, divestitures, joint ventures and other financial and strategic alternatives for Core Scientific. Over the past several years, however, Core Scientific has not received any proposals for an acquisition of Core Scientific, other than the proposals received from CoreWeave that are described below.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave have had a commercial relationship since 2019, which initially consisted of Core Scientific hosting CoreWeave GPUs at its sites to facilitate digital asset mining.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Over the past several years, as part of Core Scientific&#8217;s and CoreWeave&#8217;s existing commercial relationship (as further discussed below), Adam Sullivan, Core Scientific&#8217;s Chief Executive Officer, and other representatives of Core Scientific, on the one hand, and Michael Intrator, CoreWeave&#8217;s Chief Executive Officer, and other representatives of CoreWeave, on the other hand, have had discussions from time to time to better understand each other&#8217;s respective businesses, and to explore various ways in which they could collaborate through commercial relationships in order to advance their shared business objectives.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Beginning in February 2024, Core Scientific entered into a series of long-term contracts with CoreWeave to deliver infrastructure to host CoreWeave&#8217;s high-performance computing (&#8220;HPC&#8221;) operations. On February 29, 2024, Core Scientific entered into a long-term contract with CoreWeave to deliver 16 MW of infrastructure at Core Scientific&#8217;s Austin, Texas facility.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the commencement of operations in the Austin, Texas facility, on June 3, 2024, Core Scientific entered into a series of long-term contracts with CoreWeave to deliver approximately 200 MW of additional infrastructure to host CoreWeave&#8217;s HPC operations, which required Core Scientific to modify multiple existing sites.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 3, 2024, Core Scientific received an unsolicited, nonbinding written proposal from CoreWeave to acquire all of the outstanding shares of Core Scientific on a fully diluted basis for a price of $5.75 per share in cash (the &#8220;2024 Proposal&#8221;). The 2024 Proposal noted CoreWeave&#8217;s interest in opportunities presented by a potential strategic transaction between the two companies, given their recent commercial engagement. The 2024 Proposal also indicated that CoreWeave would fund the proposed transaction with cash on its balance sheet and that the proposed </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">176<br></div> </div></div>
<!--End Page 187-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 188-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">transaction would not require a financing condition. CoreWeave also proposed a 21-day exclusivity period to complete due diligence and sign and announce a transaction.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 4, 2024, Bloomberg reported that CoreWeave had offered to acquire Core Scientific in an all-cash bid of $5.75 per share of Core Scientific common stock.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 6, 2024, the Core Scientific board met to discuss the 2024 Proposal, including in light of Core Scientific&#8217;s standalone plan and strategic transition focused on investing in and growing its HPC business. In particular, the Core Scientific board discussed the value of the long-term contracts that had been entered into between Core Scientific and CoreWeave several days prior, and the expected standalone value of the commercial relationship between Core Scientific and CoreWeave. Following discussion, the Core Scientific board determined that the 2024 Proposal significantly undervalued Core Scientific relative to the potential value that could be obtained from pursuing Core Scientific&#8217;s standalone plan and accordingly did not provide a basis for further discussion at that time.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the board meeting, on June 6, 2024, Core Scientific issued a press release in which it confirmed that it had received the 2024 Proposal and that, after carefully reviewing the 2024 Proposal, the Core Scientific board had determined that the 2024 Proposal significantly undervalued Core Scientific and was not in the best interests of Core Scientific and its stockholders.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 25, 2024, CoreWeave exercised an option to secure an additional 70 MW of infrastructure from Core Scientific, and on August 6, 2024, CoreWeave exercised an option to secure an additional 112 MW of infrastructure from Core Scientific. On October 22, 2024, Core Scientific announced that CoreWeave had exercised its final option for an additional 120 MW of infrastructure.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On February 21, 2025, the Core Scientific board held a regularly scheduled meeting, during which members of the Core Scientific board engaged in a discussion with Core Scientific senior management regarding Core Scientific&#8217;s commercial contracts with CoreWeave and potential risks related to those contracts, as well as potential risk mitigation strategies and other alternatives that might be available to Core Scientific. The discussion was not the result of any actual adverse occurrence or action on the part of CoreWeave, but rather a hypothetical discussion resulting from recent news reports regarding DeepSeek, an artificial intelligence company that had recently released an open-source large language model. The recent news reports indicated that DeepSeek used fewer GPUs to build and develop its large language model than other companies that had developed and were developing large language models. The Core Scientific board discussed the potential impact of the release of DeepSeek&#8217;s large language model on the demand for digital infrastructure offered by Core Scientific given speculation regarding the efficiency of DeepSeek&#8217;s technology. In particular, the Core Scientific board discussed the potential competitive pressures on CoreWeave and the potential adverse impacts on CoreWeave if there were to be a decrease in the demand for digital infrastructure, and its impact on Core Scientific as a commercial counterparty to CoreWeave. Notwithstanding these potential adverse impacts, in light of the challenges that Core Scientific was facing in acquiring customers other than CoreWeave for its colocation operations, as well as the importance of Core Scientific&#8217;s existing commercial relationship with CoreWeave, the Core Scientific board discussed plans to continue to deepen the relationship between Core Scientific and CoreWeave, while continuing to work to acquire additional customers for its colocation operations.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On February 26, 2025, Core Scientific entered into a new agreement with CoreWeave to deliver an additional 70 MW of infrastructure at Core Scientific&#8217;s Denton, Texas facility.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On March 28, 2025, CoreWeave completed its initial public offering and became a publicly traded company listed on Nasdaq.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May 1, 2025, the Core Scientific board held a regularly scheduled meeting. Mr. Intrator, at the invitation of the Core Scientific board, attended a portion of the meeting and spoke with the Core Scientific board regarding CoreWeave&#8217;s significant commercial relationship with Core Scientific, CoreWeave&#8217;s strategy and CoreWeave&#8217;s recent initial public offering in March 2025, as well as potential additional future business opportunities between CoreWeave and Core Scientific.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 5, 2025, Mr. Intrator contacted Mr. Sullivan by phone, and stated that CoreWeave would be submitting a non-binding proposal to acquire all of the outstanding shares of Core Scientific. Mr. Intrator told Mr. Sullivan that there was a highly compelling strategic rationale for the combination of Core Scientific and CoreWeave, which CoreWeave and Core Scientific stockholders would participate in through an all-stock transaction. Mr. Intrator </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">177<br></div> </div></div>
<!--End Page 188-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 189-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">requested that Core Scientific enter into a confidentiality agreement with CoreWeave that would facilitate the exchange of confidential information to assist CoreWeave and its advisors&#8217; understanding and review of Core Scientific. Mr. Sullivan told Mr. Intrator that he would discuss this request with the Core Scientific board.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 6, 2025, Core Scientific received an unsolicited, non-binding written proposal to acquire all of the outstanding shares of Core Scientific in a stock-for-stock transaction with a fixed exchange ratio of 0.092 shares of CoreWeave common stock for each share of Core Scientific common stock (the &#8220;June 6 Proposal&#8221;). The June 6 Proposal indicated that using the closing share prices of CoreWeave and Core Scientific common stock on June 4, 2025, this exchange ratio implied a value of $15.00 per share of Core Scientific common stock and a premium of 45% to the 1-month VWAP, which represented an increase of approximately 160% from the $5.75 per share that CoreWeave had offered in the June 2024 Proposal. CoreWeave also requested a 21-day exclusivity period to complete due diligence and sign and announce a transaction.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Also, on June 6, 2025, the Core Scientific board held a meeting to discuss and consider the June 6 Proposal. The Core Scientific board discussed Core Scientific&#8217;s prior history with CoreWeave, including the 2024 Proposal, as well as Core Scientific&#8217;s significant commercial relationship with CoreWeave and CoreWeave&#8217;s familiarity with Core Scientific&#8217;s business and assets, which would facilitate an efficient diligence review of Core Scientific. During this meeting, the Core Scientific board also discussed potential risks and benefits of continuing to pursue Core Scientific&#8217;s standalone plan, including the fact that attracting new customers for the colocation business would require significant upfront capital expenditures and management attention. It was noted that such capital expenditures would need to commence during the second half of 2025 and would likely require Core Scientific to secure financing to fund such expenditures, and there was no guarantee that additional financing could be obtained, or would be available on the timing needed or on acceptable terms. The Core Scientific board discussed the risk that, at the time it would need to secure such financing and make such capital expenditures, Core Scientific would not likely have contractual commitments from new customers to utilize the locations in respect of which such expenditures would be made. Following such discussions, the Core Scientific board determined to continue pursuing its standalone plan while evaluating a potential transaction with CoreWeave, noting that such evaluation should be made in a manner and on a timeline that would not distract or delay Core Scientific from executing on its standalone plan in the event that the Core Scientific board ultimately determined not to pursue a transaction. The Core Scientific board authorized management to retain legal and financial advisors to advise Core Scientific with respect to the June 6 Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the course of its deliberations with respect to the potential transaction with CoreWeave, the Core Scientific board discussed with its financial and legal advisors the risks involved in utilizing a fixed exchange ratio, and potential alternative transaction terms, including cash consideration, a floating exchange ratio, an exchange ratio collar or a termination right if the trading price of CoreWeave common stock were to decline. The Core Scientific board also discussed with its financial and legal advisors alternatives that might be available to Core Scientific other than pursuing Core Scientific&#8217;s standalone plan or a potential transaction with CoreWeave, including reaching out to other potential alternative counterparties that could be interested and able to pursue a strategic transaction with Core Scientific, noting that following the Bloomberg report regarding the June 2024 Proposal, no other potential acquirer had since approached Core Scientific regarding a potential transaction.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the meeting, Core Scientific management contacted representatives of Moelis &amp; Company LLC (&#8220;Moelis&#8221;), who had acted as Core Scientific&#8217;s financial advisor in connection with prior matters, including in relation to Core Scientific&#8217;s commercial relationship with CoreWeave, as well as representatives of Wachtell, Lipton, Rosen &amp; Katz (&#8220;Wachtell Lipton&#8221;), legal counsel to Core Scientific. Following consultation with representatives of Moelis and Wachtell Lipton, Core Scientific proceeded to negotiate a confidentiality agreement with CoreWeave, including a customary standstill provision. Additionally, Mr. Sullivan informed Mr. Intrator that while Core Scientific was willing to provide access to diligence information (subject to negotiation of a mutually acceptable confidentiality agreement), the June 6 Proposal was insufficient and accordingly such information was being provided for the purpose of facilitating an improved proposal from CoreWeave.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 10, 2025, representatives of Wachtell Lipton sent a draft mutual confidentiality agreement to representatives of Davis Polk &amp; Wardwell LLP (&#8220;Davis Polk&#8221;), legal counsel to CoreWeave. Between June 10, 2025 and June 13, 2025, Core Scientific and CoreWeave negotiated the terms of the mutual confidentiality agreement. On June 13, 2025, Core Scientific and CoreWeave entered into the mutual confidentiality agreement, which included a customary standstill restriction on CoreWeave, but did not contain any standstill or exclusivity obligation on Core Scientific.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">178<br></div></div></div>
<!--End Page 189-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 190-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the execution of the mutual confidentiality agreement, CoreWeave and Core Scientific exchanged due diligence request lists and made available certain nonpublic information.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Beginning on June 13, 2025, Core Scientific made available to CoreWeave, Davis Polk, Goldman Sachs &amp; Co. LLC (&#8220;Goldman Sachs&#8221;), financial advisor to CoreWeave, and CoreWeave&#8217;s other representatives certain due diligence information. Thereafter, from June 13, 2025 through July 7, 2025, members of CoreWeave management and its representatives engaged in business, financial and legal due diligence with respect to Core Scientific. During the same period, members of Core Scientific management and its representatives engaged in business, financial and legal due diligence with respect to CoreWeave. Additionally, during this time period CoreWeave made available to Core Scientific and its representatives certain information, including a third-party equity research analyst model that formed the basis for the CoreWeave Standalone Projections prepared by Core Scientific management, which are more fully described in the section titled &#8220;&#8212;Certain Unaudited Prospective Financial Information&#8221;. The parties and their respective legal and financial advisors held multiple due diligence meetings with members of the other party&#8217;s management across the functional areas of their respective businesses, and requested certain documentation and answers to business, financial and legal due diligence questions.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 17, 2025, the Core Scientific board held a meeting to discuss the potential transaction with CoreWeave, with representatives of Core Scientific&#8217;s senior management and representatives of Moelis and Wachtell Lipton participating. Mr. Sullivan provided an update on discussions regarding a potential transaction with CoreWeave, including the execution of the mutual confidentiality agreement and the commencement of due diligence. Following this update, representatives of Wachtell Lipton reviewed, and the Core Scientific board discussed, the directors&#8217; roles and duties in the transaction context, including the Core Scientific board&#8217;s fiduciary duties under Delaware law. Representatives of Moelis then provided an overview of market perspectives on CoreWeave and certain historical trading and market information on Core Scientific and CoreWeave, including the rapid appreciation in the trading price of CoreWeave&#8217;s common stock since its IPO earlier in 2025, and discussed the June 6 Proposal and potential responses by Core Scientific. Mr. Sullivan expressed his view that, based on his conversations with Mr. Intrator, CoreWeave was likely willing to improve upon the terms of the June 6 Proposal, and recommended that the Core Scientific board reject the June 6 Proposal and request that CoreWeave improve upon the terms of the June 6 Proposal. The Core Scientific board also considered potential benefits and risks relating to alternative transaction terms, including the possibility of proposing cash consideration, a floating exchange ratio, an exchange ratio collar or a termination right if the trading price of CoreWeave common stock were to decline, and discussed the fact that exchange ratio collars and termination rights triggered by a decline in the trading price of a buyer&#8217;s common stock are uncommon in public company mergers. The Core Scientific board and its advisors also discussed the risks and implications of a fixed exchange ratio, and considered the scenario in which the price of CoreWeave common stock were to decline following the announcement of a transaction and prior to the Core Scientific stockholders meeting to vote on approval of the transaction, and the impact that such a decline would have on Core Scientific stockholders when deciding whether or not to support the transaction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following discussion among the members of the Core Scientific board, it was the consensus of the Core Scientific board that the June 6 Proposal was insufficient and that CoreWeave needed to improve its offer and provide additional due diligence information to enable Core Scientific to evaluate CoreWeave&#8217;s proposal. Additionally, the Core Scientific board reviewed the proposed material terms of engagement of Moelis to advise Core Scientific on the potential transaction. In addition, it was noted that two of the Core Scientific board members had previously been employed by and otherwise may have interests in Moelis, and accordingly, the Core Scientific board authorized management to negotiate the engagement of PJT Partners LP (&#8220;PJT Partners&#8221;) as an additional, independent financial advisor to Core Scientific on the terms described to the Core Scientific board at its June 17, 2025 meeting. The Core Scientific board selected Moelis and PJT Partners as its financial advisors because each are internationally recognized investment banking firms that have substantial experience in strategic transactions such as that under consideration. The Core Scientific board also instructed Core Scientific management to present a long-range outlook and financial plan at a meeting of the Core Scientific board that would take place later that week, which long-range outlook and financial plan would be used by the Core Scientific board and its financial advisors to evaluate the June 6 Proposal.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 18, 2025, representatives of Davis Polk furnished an initial draft Merger Agreement to representatives of Wachtell Lipton.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 19, 2025, the Core Scientific board held a meeting with members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton. At the meeting, members of Core Scientific senior management presented to and discussed with the Core Scientific board Core Scientific&#8217;s long-range outlook and </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">179<br></div> </div></div>
<!--End Page 190-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 191-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">financial plan, including the Core Scientific Standalone Projections that had been prepared by management for discussion and review with the Core Scientific board as well as the assumptions and strategic initiatives underlying such plan. The Core Scientific Standalone Projections are more fully described in the section titled &#8220;&#8212; Certain Unaudited Prospective Financial Information.&#8221; In particular, the Core Scientific board discussed the fact that CoreWeave was the only customer of Core Scientific&#8217;s colocation business, and that the standalone plan assumed that Core Scientific would deploy significant capital in the short-term in order to attract additional colocation customers, but that, as of yet, such additional customers had yet to materialize and Core Scientific had not secured the funding that would be required for such significant capital expenditures. The Core Scientific board also discussed a number of risks involved in successfully executing Core Scientific&#8217;s strategic plan to transition from digital asset mining and provision of digital infrastructure and third-party hosting services for digital asset mining to provision of high-density colocation services to third parties for GPU-based HPC operations, including the amounts and timing of significant capital expenditures that would be required as well as the challenges and risks Core Scientific would face in securing new customers and in securing financing for the projected capital expenditures in the absence of such customers. The Core Scientific board approved the Core Scientific Standalone Projections and authorized Core Scientific management to share the Core Scientific Standalone Projections with CoreWeave.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Representatives of Moelis then reviewed with the Core Scientific board their preliminary financial analysis of Core Scientific based on the Core Scientific Standalone Projections, which valuation the Core Scientific board discussed in the context of a potential transaction with CoreWeave. During this review, representatives of Moelis and PJT Partners each expressed their respective views that CoreWeave was uniquely positioned to engage in a transaction with Core Scientific given their extensive commercial relationship and strategic fit, and that there were not likely to be any potential alternative counterparties that would be interested and able to pursue a strategic transaction with Core Scientific, and noted that following the media reports regarding the June 2024 Proposal, no other potential acquirer had since approached Core Scientific regarding a potential transaction (as more fully described in the section titled &#8220;Recommendation of the Core Scientific Board of Directors and Reasons for the Merger&#8221;). Based on the views of Moelis and PJT Partners, among other things, the Core Scientific board determined not to reach out to other potential counterparties.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board then discussed potential next steps with respect to CoreWeave and the June 6 Proposal, and whether continuing to engage with CoreWeave was the best alternative to enhance stockholder value, or whether it would be preferable to terminate the discussions and focus on executing Core Scientific&#8217;s previously announced strategic transition. The Core Scientific board also discussed the potential benefits and risks relating to the proposed transaction terms. In addition the Core Scientific board discussed proposing certain alternative transaction terms, including proposing cash consideration, the possibility of a floating exchange ratio, an exchange ratio collar or a termination right if the trading price of CoreWeave common stock were to decline. The Core Scientific board determined that if CoreWeave substantially improved the terms of the June 6 Proposal and the parties negotiated a mutually acceptable transaction with Core Scientific on an expeditious timeline, then such a transaction could afford Core Scientific&#8217;s stockholders a compelling opportunity as compared to pursuing Core Scientific&#8217;s standalone plan.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following this discussion, it was the consensus of the Core Scientific board that the June 6 Proposal should be rejected, and that Mr. Sullivan should inform Mr. Intrator that CoreWeave would need to improve the terms of the June 6 Proposal in order to reach a transaction with Core Scientific. The Core Scientific board also instructed management and its advisors to continue the due diligence process so that if CoreWeave improved its proposal such that the Core Scientific board determined that it should pursue a potential transaction, such transaction could be agreed to expeditiously.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Also at the meeting, Core Scientific management discussed the proposed terms of engagement for the retention of Moelis and PJT Partners as Core Scientific&#8217;s financial advisors, and following discussion, the Core Scientific board approved and authorized such engagements. Prior to the meeting, Moelis had provided a relationship disclosure letter (a draft of which had been reviewed by members of Core Scientific senior management and Wachtell Lipton) to the Core Scientific board providing certain information regarding its relationships with Core Scientific, CoreWeave, and certain significant stockholders of CoreWeave, and PJT Partners had provided a relationship disclosure letter (a draft of which had been reviewed by members of Core Scientific senior management and Wachtell Lipton) to the Core Scientific board providing certain information regarding its relationships with Core Scientific, CoreWeave, and certain significant stockholders of CoreWeave, each of which letters were discussed with the Core Scientific board at the meeting.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">180<br></div></div></div>
<!--End Page 191-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 192-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the June 19, 2025 meeting, consistent with the direction of the Core Scientific board, Mr. Sullivan contacted Mr. Intrator and informed him that the Core Scientific board had determined that the June 6 Proposal was insufficient and that CoreWeave needed to improve the value and terms of the June 6 Proposal in order for it to be acceptable to Core Scientific. Mr. Sullivan raised the possibility of alternative transaction terms, including, among other things, a fixed value (instead of fixed exchange) ratio with a collar or the potential for CoreWeave to include a portion of cash consideration in its proposal. Mr. Intrator conveyed to Mr. Sullivan that CoreWeave was unwilling to consider changing the consideration structure to a fixed value deal (with or without a collar) or include cash consideration in its proposal, as such terms would not be acceptable to the CoreWeave board.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 26, 2025, the Wall Street Journal reported that CoreWeave was in talks to acquire Core Scientific. No other potential acquirer made a proposal to Core Scientific regarding a potential acquisition of Core Scientific following this report. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Also on June 26, 2025, Mr. Intrator contacted Mr. Sullivan by phone to deliver a revised proposal pursuant to which CoreWeave would acquire all of the outstanding shares of Core Scientific in a stock-for-stock transaction with a fixed exchange ratio of 0.122 shares of CoreWeave common stock for each share of Core Scientific common stock (the &#8220;June 26 Proposal&#8221;). The June 26 Proposal represented an approximate 28.6% increase from CoreWeave&#8217;s prior offer on June 6 and, using the closing share price of CoreWeave common stock on June 26, 2025, represented a premium of 56.8% over the closing price of Core Scientific common stock on June 25, 2025, the last unaffected trading day prior to media reports of the transaction. Mr. Intrator reiterated to Mr. Sullivan that CoreWeave was not willing to entertain any change to the transaction structure to provide a floating, as opposed to fixed, exchange ratio, an exchange ratio collar or cash consideration in the proposal.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr. Sullivan discussed the terms of the June 26 Proposal and the negotiations to date with Mr. Intrator with the Chairman and each of the other members of the Core Scientific board, and, based on these separate discussions, it was the consensus of such board members that Core Scientific and CoreWeave should continue to engage in order to determine whether the parties could reach agreement on a transaction.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Also on June 26, 2025, representatives of Wachtell Lipton furnished an initial draft Merger Agreement to representatives of Davis Polk, which included a &#8220;go shop&#8221; provision pursuant to which Core Scientific would be permitted to solicit alternative proposals for a third party to acquire Core Scientific, and which did not propose the size of the termination fee payable in order for Core Scientific to accept a superior proposal. Between June 26, 2025 and July 7, 2025, Mr. Sullivan and Mr. Intrator, as well as Core Scientific&#8217;s and CoreWeave&#8217;s respective management teams and legal and financial advisors, engaged in extensive negotiations regarding the terms of the proposed transaction, including with respect to the parties&#8217; continued obligations under their existing commercial agreements, Core Scientific&#8217;s ability to engage with alternative proposals and whether or not it would be permitted to solicit such proposals pursuant to a &#8220;go shop&#8221; provision, the size of the termination fee payable by Core Scientific in certain circumstances, Core Scientific&#8217;s obligations with respect to the operation of its business during the period between the signing of the Merger Agreement and the consummation of the Merger, the scope of the restrictions applicable to actions taken by each of Core Scientific and CoreWeave during the period between the signing of the Merger Agreement and the consummation of the Merger, employee compensation and benefits and employee retention matters, the structure of the transaction, and antitrust obligations.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 27, 2025, the Core Scientific board held a meeting with members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton. At the meeting, Mr. Sullivan provided an update regarding the status of discussions and negotiations of a potential transaction with CoreWeave since the June 19, 2025 Core Scientific board meeting. Members of senior management and representatives of Moelis and PJT Partners then discussed with the Core Scientific board the CoreWeave Standalone Projections, which the Core Scientific board approved for use in Moelis&#8217; and PJT Partners&#8217; financial analyses. The CoreWeave Standalone Projections are more fully described in &#8220;&#8212;Certain Unaudited Prospective Financial Information.&#8221; Representatives of Moelis and PJT Partners reviewed and discussed with the Core Scientific board, among other matters, the financial aspects of the proposed transaction and their respective preliminary financial analyses of the 0.122 exchange ratio in the June 26 Proposal. Additionally, representatives of Wachtell Lipton summarized for the Core Scientific board the terms of the draft Merger Agreement that had been circulated to Davis Polk on June 26, 2025. The Core Scientific board also considered potential benefits and risks relating to proceeding with a transaction providing for a fixed exchange ratio, particularly given the possibility that the trading price of CoreWeave common stock could decline following the expiration of the IPO-related lock-up restrictions on CoreWeave&#8217;s pre-IPO stockholders, as compared to alternative transaction terms, such as a floating exchange ratio, an exchange ratio collar or a termination right if the trading price </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">181<br></div> </div></div>
<!--End Page 192-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 193-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">of CoreWeave common stock were to decline, and noted that CoreWeave had made it clear that it would not be willing to agree to a transaction that contained any such alternative terms. Following discussion among the Core Scientific board, members of senior management and Core Scientific&#8217;s legal and financial advisors, it was the consensus of the Core Scientific board that, while the 0.122 exchange ratio in the June 26 Proposal represented a significant improvement in terms as compared to the 0.092 exchange ratio contained in the June 6 Proposal, Core Scientific should seek an additional improvement from CoreWeave to the terms of the June 26 Proposal. The Core Scientific board also discussed the possibility of Mr. Sullivan making a counteroffer whereby CoreWeave would acquire all of the outstanding shares of Core Scientific at an exchange ratio of 0.14 shares of CoreWeave common stock for each share of Core Scientific common stock, and it was the consensus of the Core Scientific board that Mr. Sullivan was authorized to do so if Mr. Sullivan believed it could help maximize the exchange ratio.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the June 27, 2025 meeting, consistent with the direction of the Core Scientific board, Mr. Sullivan contacted Mr. Intrator and informed him that the Core Scientific board had determined that the June 26 Proposal was insufficient and that CoreWeave needed to further improve the value and terms of the June 26 Proposal in order for it to be acceptable to Core Scientific. During the course of a series of discussions on June 27, 2025, Mr. Sullivan also told Mr. Intrator that he believed that the Core Scientific board would likely proceed with a transaction in which CoreWeave would acquire all of the outstanding shares of Core Scientific at a significantly increased exchange ratio of 0.14 shares of CoreWeave common stock for each share of Core Scientific common stock, which would represent an approximate 16.1% increase over CoreWeave&#8217;s prior offer and, using the closing share price of CoreWeave common stock on June 25, 2025, represented a premium of 81.5% over the closing price of Core Scientific common stock on June 25, 2025, the last unaffected trading day prior to media reports of the transaction. During these discussions, it was also confirmed that an increase in the exchange ratio would not be accompanied by a floating exchange ratio, an exchange ratio collar or any or any similar constructs.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Later on June 27, 2025, Mr. Intrator called Mr. Sullivan to deliver a further revised proposal pursuant to which CoreWeave would acquire all of the outstanding shares of Core Scientific at a fixed exchange ratio of 0.1235 shares of CoreWeave common stock for each share of Core Scientific common stock (the &#8220;June 27 Proposal&#8221;), with no exchange ratio collar or other alternative transaction term previously raised by Mr. Sullivan. The June 27 Proposal represented an increase of approximately 34% over the exchange ratio offered in the June 6 Proposal, an increase of approximately 2.5% over CoreWeave&#8217;s June 26 Proposal and, using the closing share price of CoreWeave common stock on June 25, 2025, represented a premium of 60.1% over the closing price of Core Scientific common stock on June 25, 2025, the last unaffected trading day prior to media reports of the transaction. Mr. Intrator informed Mr. Sullivan that CoreWeave was only willing to proceed with the exchange ratio set forth in the June 27 Proposal if the transaction was structured as proposed by CoreWeave, namely a fixed exchange ratio, with no exchange ratio collar or other alternative transaction terms. Mr. Intrator further communicated to Mr. Sullivan that the June 27 Proposal was CoreWeave&#8217;s best and final offer.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Mr. Sullivan discussed the terms of the June 27 Proposal and the negotiations to date with Mr. Intrator with the Chairman and each of the other members of the Core Scientific board and, based on these separate discussions, it was the consensus of such board members that Core Scientific and CoreWeave should continue to engage in order to determine whether the parties could reach agreement on a transaction, substantially on terms set forth in the June 27 Proposal.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 28, 2025, representatives of Wachtell Lipton sent representatives of Davis Polk a draft of Core Scientific&#8217;s disclosure letter.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 29, 2025, representatives of Davis Polk sent representatives of Wachtell Lipton a revised draft of the Merger Agreement, which draft removed the &#8220;go-shop&#8221; provision, pursuant to which Core Scientific would be permitted to solicit alternative proposals for a third party to acquire Core Scientific, and proposed a termination fee payable by Core Scientific in the event Core Scientific accepted a superior proposal of 4% of the equity value of the transaction.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July 1, 2025, the Core Scientific board held a meeting with members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton. At the meeting, Mr. Sullivan provided an update regarding the status of discussions and negotiations of a potential transaction with CoreWeave since the June 27, 2025 Core Scientific board meeting. Representatives of Moelis and PJT Partners reviewed and discussed with the Core Scientific board, among other matters, the financial aspects of the proposed transaction and their respective preliminary financial analyses of the proposed 0.1235 exchange ratio in the June 27 Proposal. Members of senior </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">182<br></div> </div></div>
<!--End Page 193-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 194-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">management and Core Scientific&#8217;s financial and legal advisors also provided an update on the due diligence associated with the potential transaction. Following discussion, the Core Scientific board of directors directed Core Scientific management to seek alignment with CoreWeave on the other aspects of the potential transaction, including with respect to definitive documentation.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Thereafter, members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton continued to engage in discussions with CoreWeave&#8217;s senior management and CoreWeave&#8217;s financial and legal advisors. Among other things, representatives of Wachtell Lipton and Davis Polk continued to exchange multiple drafts of the Merger Agreement and negotiated a number of issues.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">On July 3, 2025, Davis Polk sent Wachtell Lipton a draft of CoreWeave&#8217;s disclosure letter.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July 6, 2025, the Core Scientific board held a meeting with members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton. At the meeting, Mr. Sullivan provided an update regarding the status of discussions and negotiations of a potential transaction with CoreWeave since the June 27, 2025 Core Scientific board meeting. Representatives of Wachtell Lipton then reviewed with the Core Scientific board their fiduciary duties under Delaware law in the context of their consideration of the potential transaction, as well as the principal terms of the draft Merger Agreement and other transaction documentation. Representatives of Moelis and PJT Partners reviewed and discussed with the Core Scientific board, among other matters, the financial aspects of the proposed transaction and their respective financial analyses of the 0.1235 exchange ratio. The Core Scientific board discussed the fact that Mr. Intrator had stated that the June 27 Proposal was CoreWeave&#8217;s best and final offer and was not willing to offer additional value or change the structure of the transaction to include cash consideration, a floating exchange ratio, an exchange ratio collar or a termination right for Core Scientific under certain circumstances. The Core Scientific board also discussed the fact that no other potential acquirors had contacted Core Scientific to express an interest in pursuing a potential acquisition of Core Scientific following the June 4, 2024 Bloomberg report regarding the June 2024 Proposal, or the June 26, 2025 Wall Street Journal report that Core Scientific and CoreWeave were in discussions regarding a potential transaction. Further, the Core Scientific board considered the alternative of continuing to pursue Core Scientific&#8217;s standalone plan and, after discussion of potential benefits and risks &#8211; including execution risks and uncertainties of Core Scientific being able to obtain the financing needed or secure additional contractual commitments &#8211; it concluded that the transaction with CoreWeave would be more advantageous to its stockholders than remaining independent and executing on its standalone plan. Among other things, the Core Scientific board considered the possibility of future appreciation in the value of CoreWeave common stock and future growth of the combined company&#8217;s business. Following these discussions, the Core Scientific board instructed Core Scientific management and its advisors to continue to negotiate the terms of the potential transaction, with a further update to be provided to the Core Scientific board the next morning.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Thereafter, Core Scientific&#8217;s and CoreWeave&#8217;s respective management teams, with the assistance of their respective legal advisors, worked to finalize the remaining open issues related to the Merger Agreement and related transaction documents throughout the evening and night of July 6, 2025.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On the morning of July 7, the Core Scientific board held a meeting with members of Core Scientific senior management and representatives of Moelis, PJT Partners and Wachtell Lipton. Mr. Sullivan updated the Core Scientific board on the final negotiations with CoreWeave, and representatives of Wachtell Lipton updated the Core Scientific board on the terms of the Merger Agreement. Representatives of Moelis and PJT Partners then discussed the financial aspects of the potential transaction and discussed the respective financial analyses they had reviewed with the Core Scientific board at the July 6, 2025 meeting.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the discussion, at the request of the Core Scientific board, representatives of Moelis then delivered to the Core Scientific board its oral opinion on July 7, 2025 (which was subsequently confirmed by delivery of a written opinion, dated July 7, 2025 and that is attached to this information statement as Annex B) that, as of the date of such opinion and based upon and subject to the assumptions made, procedures followed, matters considered and other limitations set forth in the opinion, the per share merger consideration of 0.1235 shares of CoreWeave common stock was fair, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares). At the request of the Core Scientific board, representatives of PJT Partners then rendered to the Core Scientific board its oral opinion on July 7, 2025 (which was subsequently confirmed by delivery of a written opinion, dated July 7, 2025 and that is attached to this information statement as Annex C) that, as of the date of such opinion and based upon and subject to the assumptions made, procedures followed, matters considered and other limitations set forth in the opinion, the per share merger consideration of 0.1235 shares of CoreWeave common stock was fair, </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">183<br></div> </div></div>
<!--End Page 194-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 195-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares). Members of Core Scientific management also reviewed with the Core Scientific board certain draft communications to be used by the parties to announce the proposed transaction.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following further discussion, during which the members of the Core Scientific board considered the matters reviewed and discussed at that meeting and prior meetings, including factors described under the section of this proxy statement/prospectus titled &#8220;&#8212;Recommendation of the Core Scientific Board of Directors and Reasons for the Merger,&#8221; the Core Scientific board unanimously (i) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, are fair to and in the best interests of Core Scientific and its stockholders, (ii) approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii) directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Following the Core Scientific board&#8217;s approval, on July 7, 2025, the parties executed the Merger Agreement.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Thereafter, prior to the opening of the financial markets in New York on July 7, 2025, Core Scientific and CoreWeave issued a joint press release announcing the transaction and CoreWeave held an investor call to discuss the transaction. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tCRB"><!--Anchor--></a>CERTAIN RELATIONSHIPS BETWEEN COREWEAVE AND CORE SCIENTIFIC </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave have had a commercial relationship since 2019, which initially consisted of Core Scientific hosting CoreWeave GPUs at its sites to facilitate digital asset mining. Additionally, between February&#160;2024 and February&#160;2025, Core Scientific entered into a series of long-term contracts with CoreWeave to deliver infrastructure to host CoreWeave&#8217;s HPC operations. On February&#160;29, 2024, Core Scientific entered into a long-term contract with CoreWeave to deliver 16 MW of infrastructure at Core Scientific&#8217;s Austin, Texas facility. Following the commencement of operations in the Austin, Texas facility, on June&#160;3, 2024, Core Scientific entered into a series of long-term contracts with CoreWeave to deliver approximately 200 MW of additional infrastructure to host CoreWeave&#8217;s HPC operations, which require Core Scientific to modify multiple existing sites. On June&#160;25, 2024, CoreWeave exercised an option to secure an additional 70 MW of infrastructure, and on August&#160;6, 2024, CoreWeave exercised an option to secure an additional 112 MW of infrastructure. On October&#160;22, 2024, Core Scientific announced that CoreWeave had exercised its final option for an additional 120 MW of infrastructure. Thereafter, on February&#160;26, 2025, Core Scientific entered into a new agreement with CoreWeave to deliver an additional 70 MW of infrastructure at Core Scientific&#8217;s Denton, Texas facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as described in this proxy statement/prospectus, there are and have been no past, present or proposed material contracts, arrangements, understandings, relationships, negotiations or transactions during the current fiscal year of Core Scientific and CoreWeave or the five immediately preceding fiscal years of Core Scientific and CoreWeave, between Core Scientific or its affiliates, on the one hand, and CoreWeave or its affiliates, on the other hand, concerning a merger, consolidation or acquisition, a tender offer for or other acquisition of securities, the election of directors, or the sale or other transfer of a material amount of assets. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tRFT"><!--Anchor--></a>RECOMMENDATION OF THE CORE SCIENTIFIC BOARD OF DIRECTORS AND REASONS FOR THE MERGER</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">With the assistance of its financial and legal advisors, the Core Scientific board evaluated the Merger Agreement and the transactions contemplated thereby, including the Merger, and after careful consideration, at a special meeting of the Core Scientific board held on July&#160;7, 2025, unanimously (i) determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, are fair to and in the best interests of Core Scientific and its stockholders, (ii) approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii) directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">184<br></div></div></div>
<!--End Page 195-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 196-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and &#8220;FOR&#8221; the Advisory Compensation Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus contains important information regarding these proposals and factors that Core Scientific stockholders should consider when deciding how to cast their votes. Core Scientific stockholders are encouraged to read the entire document carefully, including the annexes to and documents incorporated by reference into this proxy statement/prospectus, for more detailed information regarding the Merger Agreement and the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the course of evaluating the Merger Agreement and the transactions contemplated thereby, including the Merger, the Core Scientific board of directors consulted with Core Scientific&#8217;s management as well as Core Scientific&#8217;s legal and financial advisors, and it considered a number of factors that the Core Scientific board believed supported its decision to approve the Merger Agreement and to recommend its adoption by Core Scientific stockholders, including the following material factors (not necessarily in order of relative importance): </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Greater Stockholder Value and Return Potential<font style="font-style: normal;">. The attractive value and nature of the consideration to be received in the Merger by Core Scientific stockholders, including the following benefits: </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the stock-for-stock merger allows Core Scientific stockholders to participate in the value and opportunities of CoreWeave, including any potential appreciation of CoreWeave common stock and future growth, which the Core Scientific board viewed as an important opportunity for Core Scientific stockholders to enhance long-term returns; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">based on the exchange ratio, Core Scientific stockholders will own approximately 8.9% of the combined company on a fully diluted pro forma basis (based on the total number of outstanding shares of common stock of CoreWeave and Core Scientific as of July&#160;7, 2025), allowing Core Scientific stockholders to participate in the benefits of future growth and expected synergies resulting from the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">based on the closing price of CoreWeave common stock of $165.20 on July&#160;3, 2025, the last trading day prior to the announcement of the transaction, the Merger Consideration represented an implied value of $20.40 per share of Core Scientific common stock, which implied an approximately 65.9% premium to Core Scientific&#8217;s unaffected closing price of $12.30 on June&#160;25, 2025, which was the last trading day prior to the publication of the first of several news stories in June&#160;2025 speculating on the potential transaction; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">based on the five-day VWAP of CoreWeave common stock of $161.03 for the five trading days prior to July&#160;7, 2025, the Merger Consideration represented an implied value of $19.89 per share of Core Scientific common stock, which implies an approximately 61.71% premium to Core Scientific&#8217;s unaffected closing price of $12.30 on June&#160;25, 2025, which was the last trading day prior to the publication of the first of several news stories in June&#160;2025 speculating on the potential transaction. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Ownership Stake in the Combined Company<font style="font-style: normal;">. The receipt of CoreWeave common stock as Merger Consideration provides Core Scientific stockholders with the opportunity to have an ownership stake in the combined company, which is expected to provide a number of significant potential strategic opportunities and benefits to create additional value for Core Scientific stockholders, including through the following:</font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the potential to deliver an additional 1.5 GW of additional power to CoreWeave&#8217;s pipeline while combining Core Scientific&#8217;s leading data center development and operations team with CoreWeave&#8217;s engineering team, creating an integrated platform and providing the combined company with direct control over the design and architecture of next generation builds to better serve customers, combined expertise and experience to address complex infrastructure engineering challenges, more visibility and control to optimize delivery timelines and costs of cloud infrastructure and potential for future expansions and additional power procurement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cash savings realized by CoreWeave internalizing leasing obligations to Core Scientific, which is expected to lead to an improved credit profile for the combined company and, together with the combined company&#8217;s increased size and scale, is expected to create increased borrowing capacity, while reducing cost of capital and enhancing liquidity; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">greater financing flexibility for the combined company given the ability to pursue additional infrastructure financing strategies to finance committed capital expenditures, and greater ability to attract new and diverse sources of financing to replace traditional debt or equity financing;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">185<br></div></div></div>
<!--End Page 196-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 197-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the ability to leverage the larger scale and capability of the combined company to accelerate deployment of artificial intelligence and HPC workloads; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cost synergies in the form of corporate general and administrative cost savings and operational efficiency through streamlining business operations and eliminating lease overhead to create potential for incremental cash flow; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the combined workforce is expected to continue to increase efficiency and deliver stockholder value, and the Merger Agreement includes provisions intended to facilitate the retention of certain Core Scientific employees and enhance their ability to provide value for stockholders of the combined company. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Nasdaq Listing. <font style="font-style: normal;">CoreWeave common stock issued as part of the Merger Consideration and the New Tranche 1 and New Tranche 2 Warrants issued at closing will be listed for trading on the Nasdaq and continue to provide liquidity for holders of Core Scientific common stock or warrants desiring to liquidate their investment after the Merger. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Best Available Strategic Alternative<font style="font-style: normal;">. The Core Scientific board reviewed possible alternatives to the Merger over a period of time and consulted with Core Scientific&#8217;s financial advisors regarding possible alternatives, including continuing to operate Core Scientific as an independent company or seeking a business combination with another party. Core Scientific&#8217;s financial advisors had each expressed their respective views that there were not likely to be any potential alternative counterparties that would be interested and able to pursue a strategic transaction with Core Scientific, and the fact that no other potential acquirors contacted Core Scientific to express an interest in pursuing a potential acquisition of Core Scientific, including following the June 4, 2024 </font>Bloomberg<font style="font-style: normal;"> report regarding CoreWeave&#8217;s June 2024 Proposal and the June 26, 2025 </font>Wall Street Journal<font style="font-style: normal;"> report that Core Scientific and CoreWeave were in discussions regarding a potential transaction. After considering the alternatives, the Core Scientific board determined that the Merger is the best available option for Core Scientific and its stockholders. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Extensive Negotiations<font style="font-style: normal;">. The Core Scientific board considered the fact that the Merger Consideration and other transaction terms reflected extensive negotiations between Core Scientific and CoreWeave and their respective advisors, and the fact that CoreWeave had communicated that 0.1235 shares of CoreWeave common stock for each share of Core Scientific common stock represented CoreWeave&#8217;s best and final offer, which represented an increase of approximately 34% over the exchange ratio in CoreWeave&#8217;s June 6 Proposal. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific Stockholder Approval<font style="font-style: normal;">. The Core Scientific board considered the fact that the consummation of the Merger would be conditioned on the adoption of the Merger Agreement by Core Scientific stockholders, and considered the scenario in which the price of CoreWeave common stock were to decline following the announcement of a transaction and prior to the Core Scientific stockholders meeting to vote on approval of the transaction, and the impact such a decline would have on Core Scientific stockholders when deciding whether or not to support the transaction. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Risks Related to Core Scientific&#8217;s Standalone Business Plan. <font style="font-style: normal;">The Core Scientific board considered the risks and uncertainties of Core Scientific remaining an independent public company pursuing its standalone plan, which would involve significant near-term capital expenditures and execution risk to secure power, customers and financing for its Colocation Pipeline Business, including the following factors: </font></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Capital Access</font>: The risk that data center builds generally require substantial debt and equity capital, and that existing sources of such capital tend to provide more flexible financing terms to their existing data center partners given comfort surrounding proven execution. On the other hand, capital access tends to be more restricted for new developers with more stringent requirements of completion guarantees. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Location</font>: The risk that most potential customers are focused on inference-ready locations for data center capacity, including for AI training needs, which may make certain locations less desirable in an evolving market.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Power</font>: The need for guaranteed sources of power for data center locations to attract potential customers, and the risks that Core Scientific would not be able to secure sufficient capacity of power, or that such power would not be available until future years. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">New Customers</font>: The risk that Core Scientific may have difficulty attracting additional customers for its colocation operations, including because many customers tend to be substantially exclusive in their choice </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">186<br></div></div></div>
<!--End Page 197-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 198-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">of data center developer, and often require substantial lead time to become onboarded with such customers before commencing lease discussions. Further, many potential customers are focused on finding more data center capacity with existing landlords, given their focus on meeting design requirements and execution. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Supply and Demand Risk</font>: The risk that an evolving space with multiple new operators may lead to substantial data center overbuild, reducing both leasing potential and margins. Further improvements in technology may require lower data center power to drive higher computer processing potential, driving down demand in future years and potentially making obtaining new customers more challenging and uncertain. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Strategic Pivot</font>: The risk that Core Scientific may be unable to successfully complete its previously announced strategic transition from digital asset mining and provision of digital infrastructure and third-party hosting services for digital asset mining to provision of high-density colocation services to third parties for GPU-based HPC operations, such as artificial intelligence-related applications, including the risk of being unable to obtain additional customers, and risks related to continuing Core Scientific&#8217;s hosted bitcoin mining or self-mining operations. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Expiration of CoreWeave Contracts:</font> The risk that the Colocation Contracted Business would experience a significant drop in revenue once the existing contracts with CoreWeave expire at the end of their term in 2038 if CoreWeave fails to renew or exercise their right to extend such contracts. </div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Superior Proposals<font style="font-style: normal;">. The Core Scientific board has the ability, under certain circumstances and subject to certain conditions specified in the Merger Agreement, to consider and respond to an unsolicited bona fide written acquisition proposal (as hereinafter defined) with respect to Core Scientific and to engage in negotiations with a third party making any such acquisition proposal and to terminate the Merger Agreement in order to enter into a superior proposal (as hereinafter defined), subject to, among other things, certain notice requirements and payment of a termination fee of $270 million by Core Scientific to CoreWeave, as further described in &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement.&#8221; </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Change in Recommendation<font style="font-style: normal;">. Subject to compliance with the applicable provisions of the Merger Agreement, the Core Scientific board may, before approval of the Merger by Core Scientific stockholders, change its recommendation to Core Scientific stockholders in certain circumstances if the Core Scientific board determines in good faith that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties to Core Scientific stockholders under applicable law. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Termination Fee<font style="font-style: normal;">. The Core Scientific board considered the fact that in certain circumstances (including the termination by CoreWeave in the event of a change of recommendation by the Core Scientific board or by Core Scientific in order to enter into a definitive agreement with respect to a superior proposal) a termination fee of $270&#160;million (representing approximately 3% of the equity value of the transaction) will be payable by Core Scientific, and after consultation with its outside legal counsel and financial advisors, was viewed as reasonable under the circumstances and not likely to preclude or unduly discourage another party from making a competing acquisition proposal. </font></div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Familiarity with Businesses. <font style="font-style: normal;">The Core Scientific board considered its knowledge of the business, operations, financial condition, earnings and prospects of both Core Scientific and CoreWeave, taking into account the results of Core Scientific&#8217;s due diligence review of CoreWeave, as well as its knowledge of the current and prospective environment in which Core Scientific and CoreWeave operate, including economic and market conditions. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">High Likelihood of Consummation. <font style="font-style: normal;">The Core Scientific board determined it is highly likely that the Merger will be completed in a timely manner given the commitment of both parties to complete the transaction pursuant to their respective obligations under the Merger Agreement and the absence of any significant closing conditions under the Merger Agreement, other than the approval of the Merger by Core Scientific&#8217;s stockholders. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tOOCSF"><!--Anchor--></a>Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of Moelis &amp; Company LLC<font style="font-style: normal;">. The Core Scientific board considered the opinion of Moelis to the effect that, as of July&#160;7, 2025, and based upon and subject to the assumptions made, procedures followed, matters considered and other limitations set forth in Moelis&#8217; written opinion, the exchange ratio in the Merger was fair, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares), as well as the financial analyses prepared by Moelis, as reviewed and discussed with the Core Scientific board, as more fully described in the section titled &#8220;The Merger&#8212;Opinions of </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">187<br></div></div></div>
<!--End Page 198-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 199-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Core Scientific&#8217;s Financial Advisors&#8212;Opinion of Moelis &amp; Company LLC&#8221; beginning on page B-<a href="#tANNEXB">1</a> of this proxy statement/prospectus. The full text of the written opinion of Moelis is attached as Annex&#160;B to this proxy statement/prospectus and is incorporated herein by reference. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tOOCS"><!--Anchor--></a>Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of PJT Partners<font style="font-style: normal;">. The Core Scientific board considered the financial presentation of PJT Partners and its oral opinion rendered to the Core Scientific board on July&#160;7, 2025, subsequently confirmed in its written opinion dated July&#160;7, 2025, that, as of the date thereof and based upon and subject to, among other things, the assumptions made, procedures followed, matters considered, and qualifications and limitations on the review undertaken by PJT Partners in connection with the opinion (which are stated therein), the exchange ratio to be received by the holders of shares of Core Scientific common stock (other than the excluded shares) in the Merger was fair to such holders from a financial point of view, as more fully described in the section titled &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of PJT Partners LP&#8221; beginning on page C-<a href="#tANNEXC">1</a> of this proxy statement/prospectus. The full text of the written opinion of PJT Partners is attached as Annex&#160;C to this proxy statement/prospectus and is incorporated herein by reference. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interim Operating Covenants<font style="font-style: normal;">. The Core Scientific board reviewed and considered the restrictions imposed on Core Scientific&#8217;s business and operations during the pendency of the Merger and concluded that such restrictions are reasonable and not unduly burdensome. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Tax-Free Merger. <font style="font-style: normal;">The Core Scientific board considered that the Merger is intended to qualify as a tax-free reorganization for U.S. federal income tax purposes, and if the Merger so qualifies, then U.S. holders of Core Scientific common stock generally will not recognize any gain or loss for U.S. federal income tax purposes upon the receipt of the Merger Consideration (except with respect to any cash in lieu of fractional shares of CoreWeave common stock). </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Other Terms of the Merger Agreement<font style="font-style: normal;">. The Core Scientific board reviewed and considered the terms of the Merger Agreement, taken as a whole, including the parties&#8217; representations, warranties and covenants, and the circumstances under which the Merger Agreement may be terminated, and concluded that such terms are reasonable to Core Scientific and the Core Scientific stockholders. The Core Scientific board noted in particular that the completion of the Merger is not subject to any condition based upon CoreWeave stockholder approval, which enhances the likelihood that the Merger will be completed. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board also considered various risks and other potentially negative factors concerning the Merger Agreement and the Merger, including the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Fixed Exchange Ratio</font>. The Core Scientific board considered the risk that because the Merger Consideration is based on a fixed exchange ratio rather than a fixed value, Core Scientific stockholders will bear the risk of a decrease in the trading price of CoreWeave common stock during the pendency of the Merger and the Merger Agreement does not provide Core Scientific with a collar or a value-based termination right, which means that the market value of the Merger Consideration (though not the pro forma ownership interest of Core Scientific stockholders in CoreWeave common stock) could decrease prior to the effective time if the trading price of CoreWeave common stock decreases. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Different Strategic Alternatives</font>. The Core Scientific board considered the risk that a different strategic alternative potentially could be more beneficial to Core Scientific stockholders than the Merger, although no alternative acquisition proposals had been identified or had materialized. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Expiration of Lock-Up of CoreWeave Common Stock</font>. The Core Scientific board considered that holders representing substantially all of the pre-IPO CoreWeave common stock (and securities convertible into CoreWeave common stock) are subject to lock-up agreements or market standoff provisions that prohibit the sale or other disposition of such securities until the earlier of either (i) after the close of trading on the second trading day after CoreWeave publicly announces earnings for the second quarter of 2025 or (ii)&#160;September&#160;23, 2025. Accordingly, the Core Scientific board considered the possibility that Core Scientific stockholders will bear the risk of a decrease in the trading price of CoreWeave common stock following the expiration of the lock-up period.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">188<br></div></div></div>
<!--End Page 199-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 200-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Termination Fee</font>. The Core Scientific board considered the obligation to pay CoreWeave a termination fee of $270&#160;million, depending on, among other factors, whether a third party making a superior proposal (as hereinafter defined) meets certain criteria specified in the Merger Agreement, as further described in &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement&#8221; and &#8220;The Merger Agreement&#8212;No Solicitation.&#8221; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Interim Operating Covenants</font>. The Core Scientific board reviewed and considered the restrictions imposed on Core Scientific&#8217;s business and operations during the pendency of the Merger and, although it concluded that such restrictions are reasonable and not unduly burdensome, such restrictions may delay or prevent Core Scientific from undertaking business opportunities that may arise or other actions it could potentially otherwise take with respect to the operations of Core Scientific pending the consummation of the Merger, including actions which may be needed to obtain new customers for Core Scientific&#8217;s high-density colocation services business. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Risks Associated with the Pendency of the Merger</font>. The Core Scientific board reviewed and considered the risks and contingencies relating to the announcement and pendency of the Merger (including the likelihood of litigation or other opposition challenging the Merger and the other transactions contemplated by the Merger Agreement) and the risks and costs to Core Scientific if the Merger is not completed in a timely manner or if the Merger does not close at all, including potential employee attrition, the impact on Core Scientific&#8217;s relationships with customers, suppliers, service providers, consultants and employees or other important business counterparties and the effect termination of the Merger Agreement may have on the trading price of Core Scientific common stock and Core Scientific&#8217;s operating results. In addition, the Core Scientific board considered the possibility that the Merger may not be completed, or that completion may be delayed for reasons that are beyond the control of Core Scientific or CoreWeave, including the failure of Core Scientific stockholders to approve the Merger Agreement Proposal or the failure of Core Scientific or CoreWeave to satisfy other requirements that are conditions to closing the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Risks to Core Scientific&#8217;s Stock Price</font>. The Core Scientific board considered the risk that the failure to complete the Merger could negatively affect the price of Core Scientific common stock and/or the future business and financial results of Core Scientific. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Possible Failure to Integrate</font>. The Core Scientific board reviewed and considered the potential challenges and difficulties in integrating the operations of Core Scientific and CoreWeave and the risk that operational efficiencies between the two companies, or other anticipated benefits of the Merger, might not be realized or might take longer to realize than expected. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Opportunity to Receive Acquisition Proposals and to Terminate the Merger in Order to Accept a Superior Proposal</font>. The Core Scientific board considered the possibility that a third party may be willing to enter into a strategic combination with Core Scientific on terms more favorable than the Merger. In connection therewith, the Core Scientific board considered the terms of the Merger Agreement placing certain limitations on the ability of Core Scientific to initiate, seek or solicit, or knowingly encourage or facilitate any inquiries or the making of any proposal by a third party with respect to an acquisition proposal and to disclose any nonpublic information to, or engage in discussions or negotiations with, a third party interested in pursuing an alternative business combination transaction (unless such third party has made an unsolicited bona fide written acquisition proposal (as hereinafter defined) that constitutes or is reasonably likely to lead to a superior proposal (as hereinafter defined) and such third party enters into a confidentiality agreement with Core Scientific having provisions that are no less favorable to such party than those contained in the confidentiality agreement between Core Scientific and CoreWeave), as further described in &#8220;The Merger Agreement&#8212;No Solicitation.&#8221; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Risks Associated with Regulatory Approval</font>. The Core Scientific board considered that the Merger is conditioned on the absence of an injunction prohibiting the consummation of the Merger and the expiration or termination of the waiting period under the HSR Act. Core Scientific and CoreWeave have agreed to use their respective reasonable best efforts to take all actions necessary, proper or advisable to complete the Merger and the other transactions contemplated by the Merger Agreement as soon as reasonably practicable, including obtaining each regulatory approval necessary to complete the Merger or to avoid an action or proceeding by a governmental body seeking to prevent the consummation of the Merger under any antitrust law. In addition, CoreWeave has agreed to use reasonable best efforts to take all actions </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">189<br></div></div></div>
<!--End Page 200-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 201-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">necessary, proper, or advisable to obtain the required regulatory approvals, including undertaking divestitures, licensing, or conduct or other remedial actions; however, it is not required to take any such actions if they would be material to the businesses of Core Scientific and CoreWeave, relative to the size and value of Core Scientific. Further, neither Core Scientific nor CoreWeave may acquire any assets or businesses (or portions thereof) that compete with Core Scientific if such acquisition(s) would reasonably be expected to prevent or materially delay the closing of the Merger. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Merger Costs</font>. The Core Scientific board considered the significant costs associated with the completion of the Merger, including Core Scientific management&#8217;s time and energy and potential opportunity cost that will be incurred by the combined company as a result of the Merger, as well as the transaction expenses arising from the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Third-Party Consents</font>. The Core Scientific board considered the risk that Core Scientific and CoreWeave may be obligated to complete the Merger without having obtained appropriate consents, approvals or waivers from the counterparties under certain of Core Scientific&#8217;s contracts that require consent or approval to consummate the Merger, and the risk that such consummation could trigger the termination of, or default under, such contracts or the exercise of rights by the counterparties under such contracts. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Appraisal Rights</font>. The Core Scientific board considered the fact that there are no appraisal rights for Core Scientific stockholders in connection with the Merger under Delaware law. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Other Risks</font>. The Core Scientific board considered risks of the type and nature described under the sections titled &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; and &#8220;Risk Factors.&#8221; </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the factors described above, the Core Scientific board considered the fact that some of Core Scientific&#8217;s directors and executive officers have other interests in the Merger that are different from, or in addition to, the interests of Core Scientific stockholders generally, as discussed herein under &#8220;&#8212;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board believed that, overall, the potential benefits of the Merger to Core Scientific stockholders outweighed the potential risks and uncertainties of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This discussion of the information and factors considered by the Core Scientific board in reaching its conclusion and recommendations is not intended to be exhaustive and is not provided in any specific order or ranking, but does set forth the material factors considered by the Core Scientific board. In view of the wide variety of factors considered by the Core Scientific board in evaluating the Merger Agreement and the related transactions contemplated thereby, including the Merger, and the complexity of these matters, the Core Scientific board did not find it practicable to, and did not attempt to, quantify, rank or otherwise assign relative or specific weight or values to any of these factors. In addition, different members of the Core Scientific board may have given different weight to different factors. The Core Scientific board viewed its position and recommendation as being based on an overall review of the totality of the information available to it and overall considered these factors to be favorable to, and to support, its determination regarding the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">It should be noted that this explanation of the reasoning of the Core Scientific board and all other information presented in this section is forward-looking in nature and, therefore, should be read in light of the factors discussed in the section titled &#8220;Cautionary Statement Regarding Forward-Looking Statements.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the reasons set forth above, the Core Scientific board determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, are fair to and in the best interests of Core Scientific and its stockholders and unanimously approved the Merger Agreement and the transactions contemplated thereby, including the Merger. As required by the Merger Agreement, the Core Scientific board recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and &#8220;FOR&#8221; the Advisory Compensation Proposal. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">190<br></div></div></div>
<!--End Page 201-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 202-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tCWR"><!--Anchor--></a>COREWEAVE&#8217;S REASONS FOR THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave believes the Merger will create sustainable long-term value for its stockholders. Key strategic benefits to CoreWeave include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Transaction Synergies</font>. The Merger is expected to accelerate CoreWeave&#8217;s strategy to deploy artificial intelligence and high-performance computing workloads at scale. The integration of Core Scientific&#8217;s high-performance data center infrastructure with CoreWeave&#8217;s platform is expected to enhance CoreWeave&#8217;s performance and expertise to help its customers harness the full potential of artificial intelligence. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Operational Efficiency</font>. Integrating the ownership of Core Scientific&#8217;s high-performance data center infrastructure enables CoreWeave to enhance operating efficiency while de-risking future expansion, solidifying its growth trajectory. The Merger is expected to generate cost savings through streamlining business operations and eliminating lease overhead to be paid for existing contractual sites. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Financing Flexibility</font>. The Merger is expected to open access to diverse financing sources for CoreWeave, allowing it to pursue infrastructure financing strategies to finance committed capital expenditures at a more attractive cost of capital. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Power Ownership and Expanded Expertise</font>. As a result of the Merger, CoreWeave is expected to gain greater access to a critical power footprint and optionality for future power capacity. CoreWeave will have direct input over design and architecture of next generation builds and more visibility to improve delivery timelines and costs of cloud infrastructure. Core Scientific augments CoreWeave&#8217;s expertise in power procurement, construction and site management for infrastructure assets. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tCUP"><!--Anchor--></a>CERTAIN UNAUDITED PROSPECTIVE FINANCIAL INFORMATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While Core Scientific has from time to time provided limited financial guidance to investors, Core Scientific does not, as a matter of course, make public projections as to future revenues, earnings or other results given, among other reasons, the inherent difficulty of predicting financial performance for future periods and the uncertainty, unpredictability and subjectivity of underlying assumptions and estimates. However, in connection with the Merger, prior to the execution of the Merger Agreement, Core Scientific management prepared and provided to the Core Scientific board certain nonpublic, internal financial projections regarding Core Scientific&#8217;s future operations in connection with its evaluation of the Merger. Due to the differing nature of the three businesses, Core Scientific management prepared separate financial projections for each of (i) Core Scientific&#8217;s existing contractual colocation business with CoreWeave (the &#8220;Colocation Contracted Business&#8221;) for fiscal years ending December 31, 2025 through December 31, 2043 (the &#8220;Core Scientific Colocation Contracted Business Projections&#8221;), (ii) Core Scientific&#8217;s projected (non-contracted) colocation business that Core Scientific management projected to develop with other potential customers which would involve being able to execute new colocation contracts which were not in effect as of the date of the Core Scientific Standalone Projections (the &#8220;Colocation Pipeline Business&#8221;) for fiscal years ending December 31, 2025 through December 31, 2032 (the &#8220;Core Scientific Colocation Pipeline Business Projections&#8221;), and (iii) Core Scientific&#8217;s digital asset self-mining and hosting business (&#8220;BTC Self Mining &amp; Hosting Business&#8221;) for fiscal years ending December 31, 2025 through December 31, 2027 (the &#8220;Core Scientific BTC Self Mining &amp; Hosting Business Projections&#8221;). Additionally, for the purposes of PJT Partners&#8217; calculation of the terminal value of the Colocation Pipeline Business, Core Scientific management provided projected Adjusted Cash EBITDA for the Colocation Pipeline Business for the fiscal year ending December 31, 2033 (the &#8220;2033 Colocation Pipeline Business Projected Cash EBITDA Amount&#8221;). Core Scientific management also prepared projections of Core Scientific&#8217;s net operating loss cash tax savings for fiscal years ending December 31, 2025 through December 31, 2027 (the &#8220;Core Scientific NOL Projections&#8221;, and together with the Core Scientific Colocation Contracted Business Projections, the Core Scientific Colocation Pipeline Business Projections, the Core Scientific BTC Self Mining &amp; Hosting Business Projections and the 2033 Colocation Pipeline Business Projected Cash EBITDA Amount, the &#8220;Core Scientific Standalone Projections&#8221;). The Core Scientific board approved the Core Scientific Standalone Projections for use by Core Scientific&#8217;s financial advisors, Moelis and PJT Partners, in connection with their respective financial analyses and opinions.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, Core Scientific management prepared and provided to the Core Scientific board in connection with its evaluation of the Merger, and to Core Scientific&#8217;s financial advisors, Moelis and PJT Partners, and directed such advisors&#8217; use and reliance thereon in connection with their respective financial analyses and opinions, certain financial projections regarding CoreWeave&#8217;s future operations for fiscal years ending December 31, 2025 through </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">191<br></div></div></div>
<!--End Page 202-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 203-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">December 31, 2030 for purposes of evaluating CoreWeave and the Merger, as applicable. The CoreWeave Standalone Projections were approved by the Core Scientific board for use by Core Scientific&#8217;s financial advisors in connection with their respective financial analyses and opinions (the &#8220;CoreWeave Standalone Projections,&#8221; and together with the Core Scientific Standalone Projections, the &#8220;Core Scientific Management Projections&#8221;). CoreWeave did not make available financial projections or other forecasts, but did discuss CoreWeave&#8217;s business and prospects with Core Scientific and its representatives. With respect to the fiscal years ended December 31, 2025 through December 31, 2028, the CoreWeave Standalone Projections were based on a certain equity research analyst model that CoreWeave&#8217;s management provided to Core Scientific&#8217;s management during the due diligence process. CoreWeave management communicated to Core Scientific management that, solely for the purposes of Core Scientific&#8217;s analysis, this equity research model was a reasonable starting point but given the unpredictability, uncertainty and subjectivity of the underlying assumptions and estimates inherent in financial projections and forecasts, CoreWeave did not adopt nor endorse such model. CoreWeave management further discussed its business plan with Core Scientific management as part of the due diligence process, in which third-party advisors participated. The financial projections regarding CoreWeave&#8217;s future operations for fiscal years ended December 31, 2029 through December 31, 2030 included in the CoreWeave Standalone Projections were derived by Core Scientific&#8217;s management based on extrapolations of the 2028 financial information and taking into account certain information they received during the due diligence process.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific provided the Core Scientific Standalone Projections (other than Net Operating Loss Utilization Cash Tax Savings and Unlevered Free Cash Flow) to CoreWeave and Goldman Sachs, except that Core Scientific did not provide CoreWeave and Goldman Sachs with the portion of the Core Scientific Colocation Contracted Business Projections relating to the fiscal years ended December 31, 2033 through December 31, 2043. Core Scientific has included below a summary of the Core Scientific Management Projections for the purpose of providing stockholders access to certain nonpublic information that was furnished to Moelis, PJT Partners and CoreWeave in connection with the Merger, and such information may not be appropriate for other purposes, and is not included to influence your decision, if you are a Core Scientific stockholder, to vote for the Merger Proposal or the Advisory Compensation Proposal. The inclusion of this summary should not be regarded as an indication that Core Scientific management or anyone who received the Core Scientific Management Projections then considered, or now considers, them to be a reliable prediction of future events, and the Core Scientific Management Projections should not be relied upon as such. This information is not fact and readers of this proxy statement/prospectus are cautioned not to place undue reliance on the Core Scientific Management Projections.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific Management Projections were not prepared with a view toward public disclosure, nor were they prepared with a view toward compliance with published guidelines established by the American Institute of Certified Public Accountants for preparation and presentations of financial projections, but in the view of Core Scientific management, were prepared on a reasonable basis and reflect assumptions and estimates available at the time they were prepared. This unaudited prospective financial information requires significant estimates and assumptions that make it inherently less comparable to the similarly titled GAAP measures in Core Scientific&#8217;s and CoreWeave&#8217;s historical GAAP financial statements. The Core Scientific Management Projections included in this section of the proxy statement/prospectus have been prepared by, and are the sole responsibility of, Core Scientific management. Neither Marcum LLP (&#8220;Marcum&#8221;), Core Scientific&#8217;s independent registered public accounting firm, Deloitte, CoreWeave&#8217;s independent registered public accounting firm, nor any other independent accountant has examined, compiled or performed any procedures with respect to this unaudited prospective financial information and, accordingly, neither Marcum nor Deloitte expresses an opinion or any other form of assurance on such information or its achievability, and assumes no responsibility for and disclaims any association with respect thereto. The report of Marcum contained in the Annual Report on Form 10-K for the year ended December 31, 2024, which is incorporated by reference into this proxy statement/prospectus, relates to Core Scientific&#8217;s historical financial information. It does not extend to the unaudited prospective financial information and should not be read to do so. Furthermore, the unaudited prospective financial information does not take into account any circumstances or events occurring after the date it was prepared.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While presented with numeric specificity, the Core Scientific Management Projections were based on numerous variables and assumptions, including the following key assumptions:</div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the conversion of the BTC Self Mining &amp; Hosting Business in 2027 to Colocation Pipeline capacity; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">192<br></div></div></div>
<!--End Page 203-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 204-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">that executing on the Colocation Pipeline Business plan would require deployment of over $7 billion of capital expenditures over an eight-year period (over half of which would be spent in the first three years) to build out new colocation sites at the cost per MW assumed in the Core Scientific Standalone Projections; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific would successfully sign new colocation contracts with other potential customers on the timeline, at the duration/renewal rate, and at the revenue rates per MW assumed in the Core Scientific Standalone Projections; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the conversion of Core Scientific into a real estate investment trust (&#8220;REIT&#8221;) in 2028, as a result of which no corporate taxes would be payable for the fiscal years ending December 31, 2028 through December 31, 2043 for the Colocation Contracted Business and December 31, 2028 through December 31, 2032 for the Colocation Pipeline Business; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">with respect to the Colocation Contracted Business, CoreWeave would elect to utilize one five-year extension to the term of each of the colocation agreements between Core Scientific and CoreWeave.</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific Management Projections were based on numerous other variables and assumptions (including but not limited to assumptions related to the probability of obtaining new customers for Core Scientific&#8217;s colocation operations, the capital expenditures necessary to acquire such customers, the pricing and availability of electrical power, and other assumptions related to industry performance and general business, economic, market and financial conditions and additional matters specific to Core Scientific&#8217;s and CoreWeave&#8217;s businesses, as applicable) that are inherently subjective and uncertain and are beyond the control of Core Scientific&#8217;s and CoreWeave&#8217;s management. Important factors that may affect actual results and cause the Core Scientific Management Projections to not be achieved include, but are not limited to, risks and uncertainties relating to Core Scientific&#8217;s and CoreWeave&#8217;s businesses (including their ability to achieve strategic goals, objectives and targets over applicable periods), industry performance, general business, economic, competitive, regulatory and financial market conditions and other factors described in the sections titled &#8220;Cautionary Statement Regarding Forward-Looking Statements,&#8221; and &#8220;Risk Factors&#8221; and the risks described in the periodic public reports filed by Core Scientific and CoreWeave with the SEC, which reports can be found as described in the section titled &#8220;Where You Can Find More Information.&#8221; The Core Scientific Management Projections also reflect numerous variables, expectations and assumptions available at the time they were prepared as to certain business decisions that are subject to change. As a result, actual results may differ materially from those contained in the Core Scientific Management Projections. Accordingly, there can be no assurance that the projected results summarized below will be realized. Core Scientific stockholders are urged to review the most recent SEC filings of Core Scientific and CoreWeave for a description of Core Scientific&#8217;s and CoreWeave&#8217;s respective reported and anticipated results of operations and financial condition and capital resources, including in the sections titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Core Scientific&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 27, 2025 and subsequent quarterly reports on Form 10-Q, which are incorporated by reference into this proxy statement/prospectus, and in the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in CoreWeave&#8217;s Prospectus dated March 27, 2025, filed with the SEC on March 31, 2025 pursuant to Rule 424(b) under the Securities Act, relating to the Registration Statement on Form S-1, as amended, and subsequent quarterly reports on Form 10-Q.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The inclusion of a summary of the Core Scientific Management Projections in this proxy statement/prospectus should not be regarded as an indication that any of Core Scientific, CoreWeave or their respective officers, directors, affiliates, advisors or other representatives considered the Core Scientific Management Projections to necessarily be predictive of actual future events, and the Core Scientific Management Projections should not be relied upon as such nor should the information contained in the Core Scientific Management Projections be considered appropriate for other purposes. None of Core Scientific, CoreWeave or their respective officers, directors, affiliates, advisors or other representatives can give you any assurance that actual results will not differ materially from the Core Scientific Management Projections. Core Scientific undertakes no obligation to update or otherwise revise or reconcile the Core Scientific Management Projections to reflect circumstances existing after the date the Core Scientific Management Projections were generated or to reflect the occurrence of future events, even in the event that any or all of the assumptions underlying the Core Scientific Management Projections are shown to be in error. Since the projections cover multiple years, such information by its nature becomes less predictive with each successive year.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave may calculate certain non-GAAP financial metrics, including Adjusted EBIT, Adjusted EBITDA and Unlevered Free Cash Flow (each as defined below) using different methodologies. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">193<br></div></div></div>
<!--End Page 204-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 205-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Consequently, the financial metrics presented in Core Scientific&#8217;s unaudited prospective financial information disclosures and in the sections of this proxy statement/prospectus with respect to the opinions of the financial advisors to Core Scientific, as they relate to each of Core Scientific and CoreWeave, may not be directly comparable to one another.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has not made and makes no representation to any Core Scientific stockholder in the Merger Agreement or otherwise concerning the Core Scientific Management Projections or regarding Core Scientific&#8217;s or CoreWeave&#8217;s ultimate performance compared to the information contained in the Core Scientific Management Projections or that the projected results will be achieved. Core Scientific urges all stockholders to review Core Scientific&#8217;s and CoreWeave&#8217;s most recent SEC filings for a description of Core Scientific&#8217;s and CoreWeave&#8217;s respective reported financial results.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Core Scientific Standalone Projections</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth selected unaudited prospective financial information representing Core Scientific management&#8217;s evaluation of Core Scientific&#8217;s estimated standalone future financial performance that Core Scientific management prepared and provided to the Core Scientific board in connection with its evaluation of the Merger, and to Core Scientific&#8217;s financial advisors, Moelis and PJT Partners, and directed such advisors&#8217; use and reliance thereon in connection with their respective financial analyses and opinions. The Core Scientific Standalone Projections have not been updated or revised to reflect information or results after the date the Core Scientific Standalone Projections were prepared or as of the date of this proxy statement/prospectus. The Core Scientific Standalone Projections were provided to Moelis and PJT Partners. The Core Scientific Standalone Projections (other than Net Operating Loss Utilization Cash Tax Savings and Unlevered Free Cash Flow) were also provided to CoreWeave and Goldman Sachs, except that the portion of the Core Scientific Colocation Contracted Business Projections relating to the fiscal years ended December 31, 2033 through December 31, 2043 was not provided to CoreWeave or Goldman Sachs. A summary of the Core Scientific Standalone Projections is presented in the following table, with all figures rounded to the nearest million. Core Scientific management directed Moelis and PJT Partners to use and rely upon the Core Scientific Standalone Projections for purposes of Moelis&#8217; and PJT Partners&#8217; respective opinions and financial analyses and the Core Scientific Standalone Projections were approved for Moelis&#8217; and PJT Partners&#8217; use by the Core Scientific board.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">194<br></div></div></div>
<!--End Page 205-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 206-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_116-merger_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 30pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Colocation Contracted Business</div></div><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 457.04pt;" colspan="55"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 65pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="55" style="width: 457.04pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ending December 31, </div></td></tr><tr class="BRDSX_header"><td style="width: 65pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3Q<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup> </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2027E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2028E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2029E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2030E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2031E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2032E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2033E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2034E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2035E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2036E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2037E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2038E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2039E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2040E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2041E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2042E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2043E </div></td></tr><tr class="BRDSX_header"><td style="width: 65pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="55" style="width: 457.04pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in millions)</div></td></tr><tr><td style="width: 65pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Net Cash Revenue<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> <font style="padding-left: 3.95pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<font style="padding-left: 2.51pt;">48 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$338 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$419 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$577 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$775 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$804 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 0.3pt;">811 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$829 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$858 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$888 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$919 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$952 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$985 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: justify;">$1,019 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: justify;">$1,055 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.45pt; text-align: justify;">$1,092 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: justify;">$1,130 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$986 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 2.58pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$184 </div></td></tr><tr><td style="width: 65pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Adjusted Cash EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup> <font style="padding-left: 2.47pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$<font style="padding-left: 2.51pt;">12 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$231 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$293 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$446 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$639 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$663 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$682 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$703 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$728 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$752 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$778 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$804 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$832 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">860 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">889 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.45pt; text-align: left;">$<font style="padding-left: 5.69pt;">919 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">955 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$837 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$150 </div></td></tr><tr><td style="width: 65pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Capital Expenditures<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 3.02pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$(95<font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 5.18pt;">(9</font><font style="padding-left: 0.16pt;">)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 5.18pt;">(3</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 5.18pt;">(8</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.34pt;">(10</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$<font style="padding-left: 1.34pt;">(10</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.34pt;">(10</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.34pt;">(10</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.63pt;">(11</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.63pt;">(11</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.63pt;">(11</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$<font style="padding-left: 1.34pt;">(12</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.34pt;">(12</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 7.03pt;">(13</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 7.03pt;">(13</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.45pt; text-align: left;">$<font style="padding-left: 7.03pt;">(14</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 7.03pt;">(14</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$<font style="padding-left: 1.34pt;">(13</font><font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$<font style="padding-left: 5.18pt;">(3</font><font style="padding-left: 0.16pt;">) </font></div></td></tr><tr><td style="width: 65pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Unlevered Free Cash Flow<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup> <font style="padding-left: 2.15pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 7.4pt; text-align: left;">$(90<font style="padding-left: 0.16pt;">) </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$179 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$234 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$430 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$622 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$645 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$663 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$685 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$708 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$732 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$757 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$782 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$809 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">836 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">865 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.45pt; text-align: left;">$<font style="padding-left: 5.69pt;">894 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: -3.44pt; text-align: left;">$<font style="padding-left: 5.69pt;">929 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.12pt; text-align: left;">$818 </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.78pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 1.13pt; text-align: left;">$147</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 17.78pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div><div class="BRDSX_block-main" style="width: 468pt; margin-left: 30pt;"><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Net Cash Revenue, a non-GAAP financial measure, refers to total revenue including the impact of annual escalators less any pass-through costs, with revenue recognized when received. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Adjusted Cash EBITDA, a non-GAAP financial measure, refers to earnings before interest, taxes, depreciation and amortization adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses, with revenue recognized when received. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Capital Expenditures, a non-GAAP financial measure, refers to required capital needed by Core Scientific to build and deliver the contracted colocation sites to CoreWeave; the management assumption for the development capital expenditure for the Colocation Contracted Business was approximately $100 million for the 70 MW expansion at Core Scientific&#8217;s Denton facility, implying approximately $1.5 million/MW of capital expenditure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to cash flow from operations before interest payments, adjusted to include capital expenditures, changes in net working capital, and stock-based compensation. For the period from April 2025 through December 2025, Core Scientific management identified certain one-time, non-recurring cash financial and legal expenses that were added back to Adjusted Cash EBITDA and not deducted from the Unlevered Free Cash Flow. These cash expenses, if deducted from the Unlevered Free Cash Flow, would further burden the free cash flow of Core Scientific. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Reflects the nine-month period from April 2025 through December 2025. PJT Partners&#8217; analysis utilized a June 30, 2025 valuation date and thus only used data from the last two quarters of 2025, resulting in Unlevered Free Cash Flows of ($62); these Unlevered Free Cash Flows are also burdened by one-time expenses related to cash legal and financial fees of ($1).</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Colocation Pipeline Business </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 474pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 132pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 330pt;" colspan="22"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 132pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 330pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ending December 31, </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 132pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3Q<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup> </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2027E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2028E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2029E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2030E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2031E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2032E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup> </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 132pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="25" style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in millions) </div></td></tr><tr><td style="width: 132pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net Cash Revenue<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.68pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 13.33pt;">2</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 15.83pt;">35</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 10.83pt;">217</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 10.83pt;">553</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 3.33pt;">827</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 3.33pt;">939</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.25pt; text-align: left;">$1,032</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.43pt; text-align: left;">$1,117</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 132pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjusted Cash EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 1.34pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 5pt;">(53)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 12.5pt;">(50)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 15.83pt;">98</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$<font style="padding-left: 10.83pt;">384</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 3.33pt;">624</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 3.33pt;">719</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.25pt; text-align: left;">$<font style="padding-left: 7.5pt;">796</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.43pt; text-align: left;">$<font style="padding-left: 7.13pt;">866 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 132pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Capital Expenditures<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 0.78pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$(539)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(1,365)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(2,222)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(1,579)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$(618)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$(515)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.25pt; text-align: left;">$<font style="padding-left: 4.17pt;">(391)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.43pt; text-align: left;">$<font style="padding-left: 3.8pt;">(104)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 132pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unlevered Free Cash Flow<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 0.8pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$(626)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(1,455)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(2,162)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.59pt; text-align: left;">$(1,239)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 5pt;">(37)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.34pt; text-align: left;">$<font style="padding-left: 3.33pt;">159</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.25pt; text-align: left;">$<font style="padding-left: 7.5pt;">359</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.43pt; text-align: left;">$<font style="padding-left: 7.13pt;">714</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 132pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Net Cash Revenue, a non-GAAP financial measure, refers to total revenue including the impact of annual escalators less any pass-through costs, with revenue recognized when received. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Adjusted Cash EBITDA, a non-GAAP financial measure, refers to earnings before interest, taxes, depreciation and amortization adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses, with revenue recognized when received. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Capital Expenditures, a non-GAAP financial measure, refers to required capital needed by Core Scientific to build and deliver the Colocation Pipeline sites to new potential customers assuming signing of new colocation contracts in the future; the management assumption for the development capital expenditure for the Colocation Pipeline Business was approximately $7.1 billion for approximately 600 MWs, implying approximately $11.9 million/MW of capital expenditure given limited or low possibility for other potential customers to share the capital expenditure costs for these sites.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to cash flow from operations before interest payments, adjusted to include capital expenditures, changes in net working capital, and stock-based compensation. For the period from April 2025 through December 2025, Core Scientific management identified certain one-time, non-recurring cash financial and legal expenses that were added back to Adjusted Cash EBITDA and not deducted from the Unlevered Free Cash Flow. These cash expenses, if deducted from the Unlevered Free Cash Flow, would further burden the free cash flow of Core Scientific. PJT Partners&#8217; analysis utilized 2033E Adjusted Cash EBITDA of $899, which estimate was provided by Core Scientific management, in calculating terminal value. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Reflects the nine-month period from April 2025 through December 2025. PJT Partners&#8217; analysis utilized a June 30, 2025 valuation date and thus only used data from the last two quarters of 2025, resulting in Unlevered Free Cash Flows of ($561); these Unlevered Free Cash Flows are also burdened by one-time expenses related to cash legal and financial fees of ($3).</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">195<br></div></div></div>
<!--End Page 206-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 207-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">BTC Self Mining &amp; Hosting Business</div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 144pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 318pt;" colspan="22"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 318pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ending December 31, </div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3Q<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup> </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2027E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2028E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2029E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2030E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2031E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2032E </div></td></tr><tr class="BRDSX_header"><td style="width: 144pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 318pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in millions) </div></td></tr><tr><td style="width: 144pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 1.51pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$220</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$177</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.43pt; text-align: left;">$112</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212; </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjusted Cash EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.34pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">73</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">68</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.43pt; text-align: left;">$<font style="padding-left: 4.63pt;">46</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Capital Expenditures<font style="padding-left: 1.52pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">&#8203;&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">&#8203;&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.43pt; text-align: left;">$<font style="padding-left: 4.63pt;">&#8203;&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212; </div></td></tr><tr><td style="width: 144pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unlevered Free Cash Flow<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 2.8pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">59</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.25pt; text-align: left;">$<font style="padding-left: 5pt;">55</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.43pt; text-align: left;">$<font style="padding-left: 4.63pt;">35</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.75pt; text-align: left;">$&#8212;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Adjusted Cash EBITDA, a non-GAAP financial measure, refers to earnings before interest, taxes, depreciation and amortization adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to cash flow from operations before interest payments, adjusted to include capital expenditures, changes in net working capital, and stock-based compensation. For the period from April 2025 through December 2025, Core Scientific management identified certain one-time, non-recurring cash financial and legal expenses that were added back to Adjusted Cash EBITDA and not deducted from the Unlevered Free Cash Flow. These cash expenses, if deducted from the Unlevered Free Cash Flow, would further burden the free cash flow of Core Scientific. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Reflects the nine-month period from April 2025 through December 2025. PJT Partners&#8217; analysis utilized a June 30, 2025 valuation date and thus only used data from the last two quarters of 2025, resulting in Unlevered Free Cash Flows of ($39); these Unlevered Free Cash Flows are also burdened by one-time expenses related to cash legal and financial fees of ($1).</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">Core Scientific NOL Projections</div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 213pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 249.01pt;" colspan="22"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 213pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 249.01pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ending December 31, </div></td></tr><tr class="BRDSX_header"><td style="width: 213pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3Q<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2027E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2028E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2029E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2030E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2031E</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2032E</div></td></tr><tr class="BRDSX_header"><td style="width: 213pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="22" style="width: 249.01pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in millions)</div></td></tr><tr><td style="width: 213pt; padding-top: 2.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net Operating Loss Utilization Cash Tax Savings<font style="padding-left: 3.12pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.33pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.66pt; text-align: left;">$&#8212; </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$70 </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$26</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$&#8212; </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.53pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$&#8212; </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$&#8212; </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.27pt; text-align: left;">$&#8212; </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.52pt; padding-top: 2.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.26pt; text-align: left;">$&#8212;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 9.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Reflects the nine-month period from April 2025 through December 2025. PJT Partners&#8217; analysis utilized a June 30, 2025 valuation date and thus only used data from the last two quarters of 2025.</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">CoreWeave Standalone Projections </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific management prepared certain unaudited prospective financial information regarding CoreWeave based on a certain equity research analyst model that CoreWeave&#8217;s management provided to Core Scientific&#8217;s management (though CoreWeave neither adopted nor endorsed such model) and other information provided to Core Scientific by CoreWeave during Core Scientific&#8217;s due diligence process. The CoreWeave Standalone Projections have not been updated or revised to reflect information or results after the date the CoreWeave Standalone Projections were prepared or as of the date of this proxy statement/prospectus. The CoreWeave Standalone Projections were provided by Core Scientific management to Moelis and PJT Partners, and a summary is presented in the following table, with all figures rounded to the nearest million. Core Scientific management directed Moelis and PJT Partners to use and rely upon the CoreWeave Standalone Projections for purposes of Moelis&#8217; and PJT Partners&#8217; respective opinions and financial analyses and the CoreWeave Standalone Projections were approved for Moelis&#8217; and PJT Partners&#8217; use by the Core Scientific board.</div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 246pt;" colspan="16"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="16" style="width: 246pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ending December 31, </div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">3Q<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup> </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2026E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2027E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2028E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2029E </div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2030E </div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="16" style="width: 246pt; padding-top: 2.08pt; padding-bottom: 2.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in millions) </div></td></tr><tr><td style="width: 216pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">4,040</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">12,307 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">17,614 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">20,354 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">22,813</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.51pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">24,310 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjusted EBIT<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup> <font style="padding-left: 4.78pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">656 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">2,924 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">4,845 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">5,707 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">6,593 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">7,147 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjusted EBITDA<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 3.67pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">2,727 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">9,166 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">13,538 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">15,899 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">17,607 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 3.33pt;">18,806 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Capital Expenditures<font style="padding-left: 3.52pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(20,251)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(17,186) </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(15,492) </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(15,356) </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(15,636) </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(15,141) </div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unlevered Free Cash Flow<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 4.8pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$(14,728) </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: justify;">$<font style="padding-left: 0.37pt;">(11,746) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 5pt;">(7,532) </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">305 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 20.83pt;">52 </font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 8.33pt;">1,659 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net Operating Loss Utilization Cash Tax Savings <font style="padding-left: 2.79pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8203;&#8212; </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 20.83pt;">21 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">355 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">456 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">558 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 15.83pt;">500</font></div></td></tr></table> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 10.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Adjusted EBIT, a non-GAAP financial measure, refers to earnings before interest and taxes, adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">196<br></div></div></div>
<!--End Page 207-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 208-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.25pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Adjusted EBITDA, a non-GAAP financial measure, refers to earnings before interest, taxes, depreciation and amortization adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Unlevered Free Cash Flow, a non-GAAP financial measure, refers to cash flow from operations before interest payments, adjusted to include capital expenditures, changes in net working capital, and stock-based compensation. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Reflects the nine-month period from April 2025 through December 2025. PJT Partners&#8217; analysis utilized a June 30, 2025 valuation date and thus only used data from the last two quarters of 2025, resulting in Unlevered Free Cash Flows of ($9,489). </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"><a name="tOOC"><!--Anchor--></a>OPINIONS OF CORE SCIENTIFIC&#8217;S FINANCIAL ADVISORS </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Opinion of Moelis &amp; Company LLC </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the meeting of the Core Scientific board on July&#160;7, 2025, Moelis rendered its oral opinion, which was subsequently confirmed in its written opinion, dated July&#160;7, 2025, to the Core Scientific board that, as of the date thereof and based upon and subject to the assumptions made, procedures followed, matters considered and other limitations set forth in the opinion, the exchange ratio in the Merger was fair, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The summary of the written opinion of Moelis set forth below is qualified in its entirety by the full text of Moelis&#8217; written opinion dated July&#160;7, 2025, which sets forth the assumptions made, procedures followed, matters considered and limitations on the review undertaken in connection with the opinion, and which is attached as Annex&#160;B to this proxy statement/prospectus and is incorporated herein by reference. You are encouraged to read the opinion carefully in its entirety. Moelis&#8217; opinion was provided for the use and benefit of the Core Scientific board (solely in its capacity as such) in its evaluation of the Merger. Moelis&#8217; opinion is limited solely to the fairness from a financial point of view of the exchange ratio in the Merger to the holders of Core Scientific common stock (other than the excluded shares), and does not address Core Scientific&#8217;s underlying business decision to effect the Merger or the relative merits of the Merger as compared to any alternative business strategies or transactions that might be available to Core Scientific. Moelis&#8217; opinion does not constitute a recommendation as to how any holder of securities of Core Scientific should vote or act with respect to the Merger or any other matter.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In arriving at its opinion, Moelis, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain publicly available business and financial information, including publicly available research analysts&#8217; financial forecasts, relating to Core Scientific and CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain internal information relating to the business, earnings, cash flow, assets, liabilities and prospects of Core Scientific furnished to Moelis by Core Scientific, including financial forecasts provided to or discussed with us by the management of Core Scientific which are referred to in this proxy statement/prospectus as the &#8220;Core Scientific Standalone Projections&#8221; (see the section titled &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8212;Core Scientific Standalone Projections&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed (a) certain information relating to the business, earnings, cash flow, assets, liabilities and prospects of CoreWeave furnished to Moelis by or at the direction of the management of CoreWeave and (b) certain financial forecasts of CoreWeave that were provided to and discussed with Moelis by the management of Core Scientific, including a certain equity research analyst model that the management of CoreWeave provided to management of Core Scientific, which are referred to collectively in this proxy statement/prospectus as the &#8220;CoreWeave Standalone Projections&#8221; (see the section titled &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8212;CoreWeave Standalone Projections&#8221;) and, together with the Core Scientific Standalone Projections, are referred to in this proxy statement/prospectus as the &#8220;Core Scientific Management Projections&#8221;; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed information regarding the capitalization of Core Scientific furnished to Moelis by Core Scientific and the capitalization of CoreWeave furnished to Moelis by the management of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed information regarding the strategic and financial benefits (including potential synergies) to the combined company discussed with Core Scientific, </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">conducted discussions with members of the senior managements and representatives of Core Scientific and participated in discussions with members of senior management of CoreWeave concerning the information described above, as well as the businesses and prospects of Core Scientific and CoreWeave generally; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">197<br></div></div></div>
<!--End Page 208-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 209-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed the reported prices and trading activity for Core Scientific common stock and CoreWeave common stock, including the market liquidity and average daily trading volumes of CoreWeave common stock relative to Core Scientific&#8217;s market capitalization; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed publicly available financial and stock market data of certain other companies in lines of business that Moelis deemed relevant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewed the financial terms of certain other transactions as Moelis deemed appropriate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewed a draft, dated July&#160;7, 2025, of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">participated in certain discussions and negotiations among representatives of Core Scientific and CoreWeave and their advisors; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">conducted such other financial studies and analyses and took into account such other information as Moelis deemed appropriate. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with its analysis and opinion, Moelis relied on the information supplied to, discussed with or reviewed by it being complete and accurate in all material respects. Moelis did not independently verify any such information (or assume any responsibility for the independent verification of any such information). Moelis also relied on the representation of Core Scientific management that they were not aware of any facts or circumstances that would make any such information inaccurate or misleading. Moelis relied upon, without independent verification, the assessment of Core Scientific and its legal, tax, regulatory and accounting advisors with respect to legal, tax, regulatory and accounting matters. With respect to the Core Scientific Standalone Projections referred to above, Moelis assumed, at the direction of the Core Scientific board, that they were reasonably prepared on a basis reflecting the best then available estimates and judgments of the management of Core Scientific as to the future performance of Core Scientific. With respect to the CoreWeave Standalone Projections referred to above, Moelis assumed, at the direction of the Core Scientific board, they were a reasonable basis upon which to evaluate the future performance of CoreWeave, and Moelis used such forecasts in performing its analyses. In addition, Moelis relied on the assessments of the managements of Core Scientific and CoreWeave as to the existing technology, products and services of Core Scientific and CoreWeave and the validity of, and risks associated with, the future technology, products and services of Core Scientific and CoreWeave, and Moelis assumed that there would be no developments with respect to any of the foregoing that would affect Moelis&#8217; analyses or opinion. In addition, Moelis relied on the assessments of the management of Core Scientific as to CoreWeave&#8217;s ability to retain key employees of Core Scientific and to integrate the businesses of Core Scientific and CoreWeave. Moelis did not express any views as to the reasonableness of any financial forecasts or the assumptions on which they were based. In addition, Moelis did not make any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet, or otherwise) of Core Scientific or CoreWeave, nor was it furnished with any such evaluation or appraisal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis&#8217; opinion did not address Core Scientific&#8217;s underlying business decision to effect the Merger or the relative merits of the Merger as compared to any alternative business strategies or transactions that might be available to Core Scientific. Moelis&#8217; opinion did not address any legal, regulatory, tax or accounting matters. Moelis was not asked to, and Moelis did not, offer any opinion as to any terms of the Merger Agreement or any aspect or implication of the Merger, except for the fairness of the exchange ratio from a financial point of view to the holders of Core Scientific common stock (other than the excluded shares). Moelis&#8217; opinion relates to the relative values of Core Scientific and CoreWeave. Moelis expressed no opinion as to what the value of CoreWeave common stock actually will be when issued pursuant to the Merger or the prices at which Core Scientific common stock or CoreWeave common stock may trade at any time. Moelis did not express any opinion as to fair value, viability or the solvency of Core Scientific or CoreWeave following the closing of the Merger. In rendering its opinion, Moelis assumed that the final executed form of the Merger Agreement would not differ in any material respect from the draft that Moelis reviewed, that the Merger would be consummated in accordance with its terms without any waiver or modification that could be material to its analysis, that the representations and warranties of each party set forth in the Merger Agreement were accurate and correct, and that the parties to the Merger Agreement would comply with all the material terms of the Merger Agreement. Moelis assumed that all governmental, regulatory or other consents or approvals necessary for the completion of the Merger would be obtained, except to the extent that any failures to </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">198<br></div></div></div>
<!--End Page 209-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 210-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">obtain such consents or approvals would not be material to its analysis. In addition, representatives of Core Scientific advised Moelis, and Moelis assumed, that the Merger would qualify as a tax free reorganization for federal income tax purposes. Moelis was not requested by Core Scientific to solicit and did not solicit indications of interest in a possible transaction with Core Scientific from any party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis&#8217; opinion was necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Moelis as of, the date of its opinion, and Moelis assumed no responsibility to update its opinion for developments after the date of its opinion. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis&#8217; opinion is for the use and benefit of the Core Scientific board (solely in its capacity as such) in its evaluation of the Merger. The opinion does not constitute a recommendation as to how any holder of securities should vote or act with respect to the merger or any other matter. Moelis&#8217; opinion did not address the fairness of the Merger or any aspect or implication thereof to, or any other consideration of or relating to, the holders of any class of securities, creditors or other constituencies of Core Scientific, other than the fairness of the exchange ratio from a financial point of view to the holders of Core Scientific common stock (other than the excluded shares). In addition, Moelis did not express any opinion as to the fairness of the amount or nature of any compensation to be received by any officers, directors or employees of any parties to the Merger, or any class of such persons, relative to the exchange ratio or otherwise. Moelis&#8217; opinion was approved by a Moelis fairness opinion committee. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Summary of Financial Analyses </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of the material financial analyses presented by Moelis to the Core Scientific board at its meeting held on July&#160;7, 2025, in connection with delivery of its opinion. This summary describes the material analyses underlying Moelis&#8217; opinion but does not purport to be a complete description of the analyses performed by Moelis in connection with its opinion. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Some of the summaries of financial analyses below include information presented in tabular format. In order to fully understand Moelis&#8217; analyses, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the analyses. Considering the data described below without considering the full narrative description of the financial analyses, including the methodologies and assumptions underlying the analyses, could create a misleading or incomplete view of Moelis&#8217; analyses. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the purposes of Moelis&#8217; analyses: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;EBITDA&#8221; was generally calculated as the relevant company&#8217;s earnings before interest, taxes, depreciation and amortization. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Adjusted EBITDA&#8221; was generally calculated as the relevant company&#8217;s EBITDA, adjusted for company defined non-recurring and non-cash items, stock based compensation, one-time expenses, and, for Core Scientific capital expenditure crediting under Core Scientific&#8217;s existing contracts with CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">&#8220;Total Enterprise Value&#8221; (or &#8220;TEV&#8221;) was generally calculated as the market value of the relevant company&#8217;s fully diluted common equity based on its closing stock price on a specified date, plus (a)&#160;debt, including financing leases less (b) cash, cash equivalents, short-term investments, and Bitcoin based on its price on a specified date plus (c) the book value of preferred stock and non-controlling interests less (d)&#160;equity method/investments in unconsolidated subsidiaries, where applicable (in each of the foregoing cases as of the relevant company&#8217;s most recently reported quarter end and adjusted for subsequent events). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The implied per share consideration (based on the closing price of CoreWeave common stock of $165.20 on July&#160;3, 2025, the last trading day prior to the announcement of the transaction and the exchange ratio) was $20.40. </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Discounted Cash Flow Analysis &#8211; Core Scientific </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on Moelis&#8217; professional judgment and experience, Moelis performed its discounted cash flow (&#8220;DCF&#8221;) analyses on a sum-of-the parts basis. As such, Moelis performed separate analyses for Core Scientific&#8217;s Colocation Contracted Business, Colocation Pipeline Business, and BTC Self Mining &amp; Hosting Business and summed the results of such analyses to determine the implied per share value range for the Core Scientific common stock, as further discussed below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Colocation Contracted Business<font style="font-weight: normal;">. Utilizing the Core Scientific Standalone Projections, Moelis performed a DCF analysis of the Colocation Contracted Business to calculate the present value, as of March&#160;31, 2025, of </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">199<br></div></div></div>
<!--End Page 210-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 211-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">estimated future unlevered after-tax free cash flows projected to be generated by Core Scientific&#8217;s Colocation Contracted Business for the last three fiscal quarters of 2025 and the fiscal years ending December&#160;31, 2026 through December&#160;31, 2043 (in each case discounted using a mid-year discounting convention). Moelis assumed the conversion of the Colocation Contracted Business into a real estate investment trust (&#8220;REIT&#8221;) in 2028 per guidance from Core Scientific management, which resulted in no corporate taxes for the fiscal years ending December&#160;31, 2028 through December&#160;31, 2043. Projected cash flows reflect Core Scientific management&#8217;s expected life of contracts and no terminal value was ascribed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis utilized a range of discount rates of 8.50% to 13.00% based on an estimated range of the weighted average cost of capital (&#8220;WACC&#8221;) for the Colocation Contracted Business. The estimated WACC range was derived using the Capital Asset Pricing Model and a size premium. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The foregoing analysis indicated an implied enterprise value range for the Colocation Contracted Business of $3.618&#160;billion to $5.166&#160;billion. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Colocation Pipeline Business<font style="font-weight: normal;">. Utilizing the Core Scientific Standalone Projections, Moelis performed a DCF analysis of the Colocation Pipeline Business to calculate the present value, as of March&#160;31, 2025, of the estimated future unlevered after-tax free cash flows projected to be generated by Core Scientific&#8217;s Colocation Pipeline Business for the last three fiscal quarters of 2025 and the fiscal years ending December&#160;31, 2026 through December&#160;31, 2032 (in each case discounted using a mid-year discounting convention). Moelis assumed the conversion of the Colocation Pipeline Business into a REIT in 2028 per guidance from Core Scientific management, which resulted in no corporate taxes for the fiscal years ending December&#160;31, 2028 through December&#160;31, 2032. Moelis also calculated the present value, as of March&#160;31, 2025, of the estimated terminal value range for the Colocation Pipeline Business derived by applying a selected range of terminal multiples of 18.0x to 23.0x to the estimate of the Colocation Pipeline Business&#8217;s terminal year Adjusted EBITDA from the Core Scientific Standalone Projections. The range of terminal multiples used by Moelis was selected based on its professional judgment and experience and was informed by the multiple ranges identified in Moelis&#8217; selected publicly traded companies analysis for Core Scientific, as further described below, and adjusted upward after taking into account the anticipation of a more diversified set of customers and platform potential in the Colocation Pipeline Business as compared to such publicly traded companies. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis utilized a range of discount rates of 11.00% to 16.00% based on an estimated range of the WACC for the Colocation Pipeline Business. The estimated WACC range was derived using the Capital Asset Pricing Model and a size premium. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The foregoing analysis indicated an implied enterprise value range for the Colocation Pipeline Business of $1.253&#160;billion to $4.981&#160;billion. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">BTC Self Mining &amp; Hosting Business<font style="font-weight: normal;">. Utilizing the Core Scientific Standalone Projections, Moelis performed a DCF analysis of the BTC Self Mining &amp; Hosting Business to calculate the present value, as of March&#160;31, 2025, of the estimated future unlevered after-tax free cash flows projected to be generated by Core Scientific&#8217;s BTC Self Mining &amp; Hosting Business for the last three fiscal quarters of 2025 and the fiscal years ending December&#160;31, 2026 through December&#160;31, 2027 (in each case discounted using a mid-year discounting convention). Given the finite life of the operations of the BTC Self Mining &amp; Hosting Business, no terminal value was ascribed to the BTC Self Mining &amp; Hosting Business. Management assumed the conversion of BTC Self Mining &amp; Hosting Business capacity at the end of its life to Colocation Pipeline Business capacity. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis utilized a range of discount rates of 11.75% to 18.25% based on an estimated range of the WACC for the BTC Self Mining &amp; Hosting Business. The estimated WACC range was derived using the Capital Asset Pricing Model and a size premium. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The foregoing analysis indicated an implied enterprise value range for the BTC Self Mining &amp; Hosting Business of $124 to $131&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Tax Attributes / Net Operating Losses<font style="font-weight: normal;">. Value attributable to Core Scientific&#8217;s tax attributes (which were projected net operating losses) was calculated separately and added to the standalone equity value of Core Scientific. The projected net operating losses were based on guidance from Core Scientific management and discounted, using a mid-year discounting convention, at discount rates of 8.50% to 17.00% utilizing the estimated cost of equity for the Colocation Contracted business derived using the Capital Asset Pricing Model and a size premium described above. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">200<br></div></div></div>
<!--End Page 211-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 212-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Combined Colocation Contracted Business, Colocation Pipeline Business, BTC Self Mining &amp; Hosting Business and Tax Attributes / Net Operating Losses<font style="font-weight: normal;">. To determine the implied equity value of Core Scientific based on the foregoing analyses, Moelis added the foregoing enterprise value ranges and, from that total, (i)&#160;subtracted Core Scientific&#8217;s net debt and (ii) divided by the fully diluted shares outstanding, in each case as provided by Core Scientific management. This analysis indicated an implied per share value range for Core Scientific common stock of $12.09 to $22.94, compared to the implied per share consideration (based on the closing price of CoreWeave common stock of $165.20 on July&#160;3, 2025 and the exchange ratio) of $20.40. </font></div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13.5pt; margin-left: 20pt; text-align: left;">Discounted Cash Flow Analysis - CoreWeave </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Utilizing the CoreWeave Standalone Projections that were provided to and discussed with Moelis by the management of Core Scientific, namely a certain equity research analyst model that the management of CoreWeave provided to management of Core Scientific, Moelis performed a DCF analysis to calculate the present values as of March&#160;31, 2025 of (i) the estimated unlevered after-tax free cash flows of CoreWeave for the last three fiscal quarters of 2025 and the fiscal years ending December&#160;31, 2026 through December&#160;31, 2030 (in each case discounted using a mid-year discounting convention) and (ii) the estimated terminal value range for CoreWeave derived by applying a selected range of terminal multiples of 12.0x to 18.0x to an estimate of CoreWeave&#8217;s terminal year Adjusted EBITDA from the CoreWeave Standalone Projections. The range of terminal multiples used by Moelis was selected based on its professional judgement and experience and was informed by the multiple ranges identified in Moelis&#8217; selected publicly traded companies analysis for CoreWeave, as further described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis utilized a range of discount rates of 11.00% to 12.50% based on an estimated range of the WACC for CoreWeave. The estimated WACC range was derived using the Capital Asset Pricing Model and a size premium. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Value attributable to CoreWeave&#8217;s tax attributes (which were projected net operating losses) was calculated separately and added to the standalone equity value of CoreWeave. The projected net operating losses were based on CoreWeave and Core Scientific management guidance and discounted, using a mid-year discounting convention, at discount rates of 11.00% to 13.50% utilizing the estimated cost of equity for CoreWeave derived using the Capital Asset Pricing Model and a size premium described above. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DCF analysis indicated an implied per share value range for CoreWeave common stock of $149.19 to $281.55 per share, compared to the closing price of CoreWeave common stock on July&#160;3, 2025 of $165.20. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13.5pt; margin-left: 20pt; text-align: left;">DCF-Based Implied Exchange Ratio and Ownership Percentage Analysis </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the implied per share value ranges for Core Scientific common stock and CoreWeave common stock presented in the DCF analyses above and the implied range of equity values for Core Scientific and CoreWeave (based on the implied per share value ranges presented in the standalone DCF analyses above), Moelis calculated a range of implied exchange ratios and implied pro forma ownership percentages of the pre-transaction holders of Core Scientific common stock in the combined company after giving effect to the Merger (the &#8220;implied pro forma Core Scientific ownership percentage&#8221;), which are presented below: </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.27pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.27pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 62.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.27pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.27pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 120.26pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 11.27pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.27pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied Exchange <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ratio<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 11.27pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.27pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied <font style="font-style: italic;">Pro Forma</font><font style="font-weight: normal;"> </font>Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ownership Percentage<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">DCF Analysis<font style="font-weight: normal; padding-left: 3.43pt;"></font></div></td><td style="width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.66pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.043 - 0.154x</div></td><td style="width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3.1% - 11.6%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 62.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.27pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 120.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The high end of the range of the implied exchange ratios and the implied <font style="font-style: italic;">pro forma </font>Core Scientific ownership percentages represent the high end of the implied per share value range or implied equity value range of Core Scientific versus the low end of the implied per share value range or implied equity value range of CoreWeave, respectively. The low end of the range of the implied exchange ratios and the implied <font style="font-style: italic;">pro forma</font> Core Scientific ownership percentages represents the low end of the implied per share value range or implied equity value range of Core Scientific versus the high end of the implied per share value range or implied equity value range of CoreWeave, respectively. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis compared (i) the range of the implied exchange ratios above to the exchange ratio of 0.1235x in the Merger and (ii) the range of the implied <font style="font-style: italic;">pro forma</font> Core Scientific ownership percentages above to the <font style="font-style: italic;">pro forma</font> Core Scientific ownership percentage of approximately 8.9% (assuming an exchange ratio of 0.1235x in the Merger). </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13.5pt; margin-left: 20pt; text-align: left;">Selected Publicly Traded Companies Analysis&#8212;Core Scientific </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis reviewed financial and stock market information of the selected publicly traded companies noted below (the &#8220;Selected Companies&#8221;), which Moelis determined, based on its professional judgment and experience, to be generally relevant in certain respects to Core Scientific for purposes of this analysis. In determining the publicly </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">201<br></div></div></div>
<!--End Page 212-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 213-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">traded companies to use in this analysis, Moelis referenced publicly traded companies that operate data centers in North America that support cloud and enterprise demand end-markets. Moelis considered selected publicly traded companies on the basis of size and scale, geographic presence, capacity, customer concentration, regulatory risk, capital structure, and capital spend profile. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Selected Companies used by Moelis in this analysis are as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Equinix Inc. (&#8220;Equinix&#8221;) </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Digital Realty Trust, Inc. and Digital Realty Trust, L.P. (together, &#8220;Digital Realty&#8221;) </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Keppel DC REIT Management Pte. Ltd. (&#8220;Keppel DC REIT&#8221;) </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Digital Core REIT Management Pte. Ltd. (&#8220;Digital Core REIT&#8221;) </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis reviewed and analyzed, among other things, the TEV of each of the Selected Companies, as well as Core Scientific, as a multiple of estimated Adjusted EBITDA for each of the calendar years 2026 and 2027, in each case as of, and based on publicly available consensus research estimates as of, July&#160;3, 2025, and compared to Core Scientific data as of (i) June&#160;25, 2025 (the last unaffected trading day prior to the Wall Street Journal report that Core Scientific and CoreWeave were engaged in merger discussions) and (ii) July&#160;3, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Selected Companies and their implied TEV to estimated Adjusted EBITDA for each of the calendar years used by Moelis in this analysis are summarized in the following table: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 354pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.89pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 354pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Selected Companies</div></td><td style="width: 10.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">TEV/Adj. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">EBITDA &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CY2026E</div></td><td style="width: 10.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">TEV/Adj. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">EBITDA &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CY2027E </div></td></tr><tr><td style="width: 354pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Equinix<font style="font-weight: normal; padding-left: 2.61pt;"></font></div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">18.6x</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">17.1x </div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Digital Realty<font style="font-weight: normal; padding-left: 1.52pt;"></font></div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">20.2x</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">17.9x </div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Keppel DC REIT<font style="font-weight: normal; padding-left: 0.41pt;"></font></div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">20.7x</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">19.6x </div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Digital Core REIT<font style="font-weight: normal; padding-left: 0.6pt;"></font></div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">17.8x</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">16.0x </div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mean<font style="font-weight: normal; padding-left: 2.06pt;"></font></div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">19.3x</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">17.6x </div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Median<font style="font-weight: normal; padding-left: 3.73pt;"></font></div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">19.4x </div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">17.5x</div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific Consensus (as of July&#160;3, 2025)<font style="font-weight: normal; padding-left: 3.14pt;"></font></div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">19.8x </div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">12.5x</div></td></tr><tr><td style="width: 354pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific Consensus Unaffected (as of June&#160;25, 2025)<font style="font-weight: normal; padding-left: 0.95pt;"></font></div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">12.8x</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.89pt; padding-top: 1.01pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 5pt;">8.2x</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 354pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.89pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.89pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the foregoing analysis and its professional judgement and experience, Moelis selected a reference range for TEV/Adjusted EBITDA multiples for Core Scientific of 14.0x to 20.0x for 2026E and 12.0x to 18.0x for 2027E. In determining the selected reference ranges to apply to Core Scientific&#8217;s estimated financial metrics, Moelis noted that (i) the low-end of the selected reference ranges represented a premium to Core Scientific&#8217;s unaffected trading multiple and (ii) the high-end of the selected reference ranges was in-line with the trading multiples of the Selected Companies, which Moelis deemed appropriate given that, among other factors, Core Scientific currently has only one customer in its Colocation Contracted Business and no customers in its Colocation Pipeline Business, as compared to the Selected Companies which have more diversified customer bases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis then applied these multiples to Core Scientific&#8217;s 2026E Adjusted EBITDA and 2027E Adjusted EBITDA from the Core Scientific Standalone Projections. Moelis noted that Adjusted EBITDA for Core Scientific included an add back for capital expenditure crediting under Core Scientific&#8217;s existing contracts with CoreWeave. Therefore, for the purposes of calculating implied per share value ranges, Moelis deducted from Core Scientific&#8217;s TEV (calculated based on the selected multiple reference ranges) the present value (discounted utilizing the mid-point of the WACC range for the Colocation Contracted Business) of the aggregate amount of such capital expenditure crediting over the life of the contracts, including cost of capital expense due at the end of the contracts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This analysis indicated implied per share value ranges for Core Scientific common stock of $14.66 to $20.74&#160;per share (based on 2026E Adjusted EBITDA) and $18.85 to $27.73 (based on 2027E Adjusted EBITDA), compared to the implied per share consideration (based on the closing price of CoreWeave common stock of $165.20 on July&#160;3, 2025 and the exchange ratio) of $20.40. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Selected Publicly Traded Companies Analysis&#8212;CoreWeave </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis reviewed financial and stock market information of the selected publicly traded companies noted below (the &#8220;CoreWeave Selected Companies&#8221;), which Moelis determined, based on its professional judgment and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">202<br></div></div></div>
<!--End Page 213-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 214-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">experience, to be generally relevant in certain respects to CoreWeave for purposes of this analysis. In determining the publicly traded companies to use in this analysis, Moelis referenced publicly-traded companies that operate within the broader AI and cloud infrastructure ecosystems that support cloud and enterprise demand end-markets. Moelis considered selected publicly traded companies on the basis of size and scale, business model similarity (percentage of business that supports cloud), growth and margin, business maturity, technology-driven differentiation, diversification, customer base and end-markets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The CoreWeave Selected Companies used by Moelis in this analysis are as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Pureplay Cloud </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">Oracle Corporation (&#8220;Oracle&#8221;) </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">Nebius B.V. (&#8220;Nebius&#8221;) </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Diversified Cloud </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">Microsoft Corporation (&#8220;Microsoft&#8221;) </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">Amazon.com, Inc. (&#8220;Amazon&#8221;) </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">Google LLC (&#8220;Google&#8221;) </font></div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 6pt;">&#9675;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; text-align: left; font-size: 10pt;"><font style="font-size: 10pt;">International Business Machines Corporation (&#8220;IBM&#8221;) </font></div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis reviewed and analyzed, among other things, the TEV of each of the CoreWeave Selected Companies, as well as CoreWeave, as a multiple of estimated Adjusted EBITDA for each of the calendar years 2026 and 2027 and as a multiple of Adjusted EBIT for calendar year 2027, in each case as of, and based on publicly available consensus research estimates as of, July&#160;3, 2025, and compared to CoreWeave data as of (i) June&#160;25, 2025 (the last unaffected trading day prior to the Wall Street Journal report that Core Scientific and CoreWeave were engaged in merger discussions) and (ii) July&#160;3, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The CoreWeave Selected Companies and their implied TEV to estimated Adjusted EBITDA for each of the calendar years 2026 and 2027 and their implied TEV to estimated Adjusted EBIT for calendar year 2027 used by Moelis in this analysis are summarized in the following table: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="border-left: 1pt solid #000000; border-right: 1pt solid #000000; border-top: 1pt solid #000000; border-bottom: 1pt solid #000000; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 79.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 79.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 79.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 180pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">CoreWeave Selected <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">Companies</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">EBITDA &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CY2026E</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">EBITDA &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CY2027E</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">EBIT &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CY2027E </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt; border-bottom: 1pt solid #000000;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 48pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: middle; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><img style="height: 52px; width: 32px;" src="ny20053122x2_head1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">&#8201;</div></td><td style="width: 5.75pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Oracle<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">20.4x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">16.6x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21.6x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Nebius<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">38.2x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">13.6x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">[NM] </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt; border-bottom: 1pt solid #000000;" rowspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="4" style="width: 48pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: middle; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><img style="height: 63px; width: 32px;" src="ny20053122x2_head2.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 3.25pt; text-align: left;">&#8201;</div></td><td style="width: 5.75pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;" rowspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Microsoft<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">18.4x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">15.8x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">19.5x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amazon<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">12.4x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">10.4x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">20.7x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Google<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">11.1x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">9.8x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">13.6x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">IBM<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">16.2x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">15.1x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">21.2x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt; border-bottom: 1pt solid #000000;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 48pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: middle; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mean<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">19.5x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">13.5x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; height: 22.25pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">19.3x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Median<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">17.3x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">14.3x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">20.7x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: middle; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt; border-right: 1pt solid #000000; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consensus <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(as of July&#160;3, 2025)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; margin-top: 0pt; margin-left: 0pt; text-align: left; font-size: 1pt;"><font style="font-size: 1pt;">&#8195;</font></div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">12.0x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">8.2x</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">23.9x </div></td><td style="width: 6pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48pt; padding-top: 0.26pt; text-align: left; vertical-align: middle;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consensus <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(Unaffected as of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">June&#160;25, 2025)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">11.6x</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.67pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">8.0x</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 79.66pt; padding-top: 0.26pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">23.1x</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 79.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 79.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 79.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">203<br></div></div></div>
<!--End Page 214-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 215-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the foregoing analysis and its professional judgement and experience, Moelis selected a reference range for (i) TEV / Adjusted EBITDA multiples for CoreWeave of 12.0x to 18.0x for 2026E and 9.0x to 13.0x for 2027E and (ii) TEV / Adjusted EBIT multiples for CoreWeave of 20.0x to 24.0x for 2027E. Moelis then applied these multiples to CoreWeave&#8217;s 2026E and 2027E Adjusted EBITDA and 2027E Adjusted EBIT from the CoreWeave Standalone Projections. In determining the selected Adjusted EBITDA reference ranges to apply to CoreWeave&#8217;s estimated financial metrics, Moelis considered (i) the current trading multiples for Amazon, Oracle, Nebius, and the other CoreWeave Selected Companies, and (ii) CoreWeave&#8217;s substantial growth relative to the other CoreWeave Selected Companies. In determining the selected Adjusted EBIT reference ranges to apply to CoreWeave&#8217;s estimated financial metrics, Moelis considered (i) the current trading multiples of the Selected Publicly Traded Cloud Solutions Providers, and (ii) the higher expected growth and earlier-stage capital investment lifecycle (contributing to expected higher short-term capital expenditure costs) for CoreWeave relative to the Selected Publicly Traded Cloud Solutions Providers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This analysis indicated implied per share value ranges for CoreWeave common stock of $178.05 to $274.41&#160;per share (based on 2026E Adjusted EBITDA), $198.77 to $293.65 (based on 2027E Adjusted EBITDA), and $155.16 to $189.23 (based on 2027E Adjusted EBIT). Moelis compared such implied per share value ranges to the closing price of CoreWeave common stock on July&#160;3, 2025 of $165.20. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Selected Publicly Traded Companies-Based Implied Exchange Ratio and Ownership Percentage Analysis </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the implied per share value ranges for Core Scientific common stock and CoreWeave common stock presented in the selected publicly traded companies analyses above and the implied range of equity values for Core Scientific and CoreWeave (based on the implied per share value ranges presented in the selected publicly traded companies analyses above), Moelis calculated a range of implied exchange ratios and implied <font style="font-style: italic;">pro forma</font> Core Scientific ownership percentages, which are presented below: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 90.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 120.26pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 90.97pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied Exchange Ratio<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 10.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied <font style="font-style: italic;">Pro Forma </font>Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ownership Percentage<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 216pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. EBITDA &#8211; CY2026E<font style="font-weight: normal; padding-left: 2.69pt;"></font></div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 90.97pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.053 &#8722; 0.116x</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">4.0 &#8722; 8.5% </div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. EBITDA &#8211; CY2027E<font style="font-weight: normal; padding-left: 2.69pt;"></font></div></td><td style="width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 90.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.064 &#8211; 0.139x</div></td><td style="width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">4.8 &#8211; 10.7% </div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">TEV/Adj. EBITDA/EBIT &#8211; CY2027E<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="font-weight: normal; padding-left: 1.91pt;"></font></div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 90.97pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.100 &#8211; 0.179x</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120.26pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">7.3 &#8211; 13.3%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 90.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 120.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The high end of the range of the implied exchange ratios and the implied <font style="font-style: italic;">pro forma </font>Core Scientific ownership percentages represent the high end of the implied per share value range or implied equity value range of Core Scientific versus the low end of the implied per share value range or implied equity value range of CoreWeave, respectively. The low end of the range of the implied exchange ratios and the implied <font style="font-style: italic;">pro forma</font> Core Scientific ownership percentages represents the low end of the implied per share value range or implied equity value range of Core Scientific versus the high end of the implied per share value range or implied equity value range of CoreWeave, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Moelis&#8217; analysis utilized 2027E Adjusted EBITDA for Core Scientific and Adjusted EBIT for CoreWeave as valuation metrics; while not directly comparable, these represented the closest approximation given the Core Scientific selected publicly traded companies analysis does not utilize EBIT as a valuation metric. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis compared (i) the range of implied exchange ratios above to the exchange ratio of 0.1235x in the Merger and (ii) the range of the implied <font style="font-style: italic;">pro forma </font>Core Scientific ownership percentages above to the <font style="font-style: italic;">pro forma </font>Core Scientific ownership percentage of approximately 8.9% (assuming an exchange ratio of 0.1235x in the Merger). </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">Other Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis also noted for the Core Scientific board certain additional factors that were not considered part of Moelis&#8217; financial analysis with respect to its opinion but were referenced for informational purposes only, including, among other things: </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;">Selected Precedent Transactions Analysis </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis considered select precedent transactions in the data center sector, but determined not to rely on a selected precedent transactions analysis in its financial analysis of Core Scientific due to less favorable attributes in credit quality of customers, customer diversification, business mix and scale for Core Scientific relative to the companies involved in such transactions. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">204<br></div></div></div>
<!--End Page 215-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 216-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">52-Week High / Low; Stock Performance and Trading Volume </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis reviewed the historical trading performance of the Core Scientific common stock over a 52-week period ending July&#160;3, 2025, which ranged from a closing low of $6.39 per share to a high of $18.23 per share (which implied a range of enterprise values for Core Scientific of $2.457&#160;billion to $7.975&#160;billion). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis also reviewed the historical trading performance of the CoreWeave common stock since its initial public offering through the period ending July&#160;3, 2025, which ranged from a closing low of $35.42 per share to a high of $183.58 per share (which implied a range of enterprise values for CoreWeave of $28.444&#160;billion to $113.059&#160;billion). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis noted the significant share price increase in CoreWeave&#8217;s stock since its initial public offering and its 30-day average daily trading volume of approximately $3.7&#160;billion as of July&#160;3, 2025. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Miscellaneous </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This summary of the analyses is not a complete description of Moelis&#8217; opinion or the analyses underlying, and factors considered in connection with, Moelis&#8217; opinion. The preparation of a fairness opinion is a complex analytical process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying Moelis&#8217; opinion. In arriving at its fairness determination, Moelis considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis. Rather, Moelis made its fairness determination on the basis of its professional judgment and experience after considering the results of all of its analyses. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">No company used in the analyses described above is identical to Core Scientific or CoreWeave. In addition, such analyses do not purport to be appraisals, nor do they necessarily reflect the prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by such analyses. Because the analyses described above (including much of the information used therein) are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, neither Core Scientific nor Moelis or any other person assumes responsibility if future results are materially different from those forecast. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as described in this summary, Core Scientific and the Core Scientific board imposed no other instructions or limitations on Moelis with respect to the investigations made or procedures followed by Moelis in rendering its opinion. The exchange ratio was determined through arms&#8217; length negotiations between Core Scientific, on the one hand, and CoreWeave, on the other, and was approved by the Core Scientific board and the CoreWeave board. Moelis did not recommend any specific consideration to Core Scientific or the Core Scientific board, or that any specific amount or type of consideration constituted the only appropriate consideration for the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis acted as financial advisor to Core Scientific in connection with the Merger. Core Scientific agreed to pay Moelis certain fees for its services, including an opinion fee of $2&#160;million upon the substantial completion by Moelis of the work in connection with rendering its opinion (regardless of the conclusion reached in that opinion) and a transaction fee of 0.60% - 0.70% of the implied fully diluted enterprise value of Core Scientific (the &#8220;Transaction Value&#8221;) to be determined at the closing of the Merger, upon consummation of the Merger. Such transaction fee would have been approximately $40 million - $50 million based on a Transaction Value calculated according to the 30-day VWAP of CoreWeave common stock, as of August 15, 2025, but which ultimately could be greater or less than such amount, depending on the Transaction Value as of the closing of the Merger. In addition, Core Scientific has agreed to reimburse Moelis for certain of its reasonable and documented out-of-pocket expenses, including reasonable attorney&#8217;s fees, and to indemnify Moelis and related persons for certain liabilities, including liabilities under the federal securities laws, arising out of its engagement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Moelis&#8217; affiliates, employees, officers and partners may at any time own securities (long or short) of Core Scientific, CoreWeave, Magnetar Capital Partners LP, a significant stockholder of CoreWeave (&#8220;Magnetar Capital&#8221;) or their respective affiliates. In the two years prior to the date of its opinion, Moelis acted as financial advisor to Core Scientific in connection with an agreement with CoreWeave involving Core Scientific&#8217;s development of high-powered computing capabilities, for which Moelis received total fees of $4,250,000. In the two years prior to the date of its opinion, Moelis has not been engaged by (and has not received any fees from) CoreWeave or Magnetar Capital. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Yadin Rozov and Elizabeth Crain, who are members of the Core Scientific board, were formerly employees of Moelis. Mr.&#160;Rozov left Moelis in August&#160;2019 and Ms.&#160;Crain left Moelis in November&#160;2024. Ms.&#160;Crain owns equity units that are exchangeable into approximately 41,000 shares of Moelis common stock (which were worth </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">205<br></div></div></div>
<!--End Page 216-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 217-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">approximately $2.7 million at the closing price of a share of Moelis&#8217; common stock on July 3, 2025) starting on various dates in 2026-2029. Moelis also has an obligation to pay Mr.&#160;Rozov and Ms.&#160;Crain certain Tax Receivable Agreement (&#8220;TRA&#8221;) payments over the next several years arising from their prior sales of Moelis equity (and, in the case of Ms.&#160;Crain, certain future sales), which Moelis estimates have a present value (using an 10% discount rate), as of July&#160;3, 2025, of roughly $1.1&#160;million and $1.6&#160;million, respectively. The actual payments to Mr.&#160;Rozov and Ms.&#160;Crain under the TRA may vary very substantially from the estimates because the actual payments are based on, among other things, Moelis&#8217; future tax rates and Moelis&#8217; ability to generate sufficient taxable income in the future to use the tax benefit (and, in the case of Ms.&#160;Crain, Moelis&#8217; future stock price at the time of future sales). </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the future, Moelis and its affiliates may provide such investment banking or other services to Core Scientific, CoreWeave, Magnetar Capital or their respective affiliates and would expect to receive compensation for such services. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board selected Moelis as its financial advisor in connection with the Merger because Moelis has substantial experience in similar transactions and familiarity with Core Scientific. Moelis is regularly engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, strategic transactions, corporate restructurings, and valuations for corporate and other purposes. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tOPJT"><!--Anchor--></a>Opinion of PJT Partners </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At a meeting of the Core Scientific board on July&#160;7, 2025, PJT Partners rendered its oral opinion, which was subsequently confirmed in its written opinion dated July&#160;7, 2025, to the Core Scientific board that, as of the date thereof and based upon and subject to, the assumptions made, procedures followed, matters considered, and qualifications and limitations set forth in its written opinion, the exchange ratio in the Merger was fair to the holders of Core Scientific common stock (other than the excluded shares) from a financial point of view. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The full text of PJT Partners&#8217; written opinion delivered to the Core Scientific board, dated July&#160;7, 2025, is attached as Annex&#160;C and incorporated into this proxy statement/prospectus by reference in its entirety. PJT Partners&#8217; written opinion has been provided by PJT Partners at the request of the Core Scientific board and is subject to, among other things, the assumptions made, procedures followed, matters considered, and qualifications and limitations on the review undertaken by PJT Partners in connection with the opinion (which are stated therein). You are encouraged to read the opinion carefully in its entirety. PJT Partners provided its opinion to the Core Scientific board, in its capacity as such, in connection with and for purposes of its evaluation of the Merger only and PJT Partners&#8217; opinion does not constitute a recommendation as to any action the Core Scientific board should take with respect to the Merger or how any holder of Core Scientific common stock should vote or act with respect to the Merger or any other matter. The following is a summary of PJT Partners&#8217; opinion and the methodology that PJT Partners used to render its opinion. This summary of the PJT Partners opinion contained in this proxy statement/prospectus is qualified in its entirety by reference to the full text of PJT Partners&#8217; written opinion. The issuance of PJT Partners&#8217; opinion was approved by a fairness committee of PJT Partners in accordance with established procedures.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In arriving at its opinion, PJT Partners, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain publicly available information concerning the business, financial condition and operations of Core Scientific and CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain internal information concerning the business, financial condition and operations of Core Scientific prepared and furnished to PJT Partners by the management of Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain information concerning the business, financial condition and operations of CoreWeave furnished to PJT Partners by or at the direction of the management of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain internal financial analyses, estimates and forecasts relating to Core Scientific, including projections that were prepared by or at the direction of the management of Core Scientific and approved for PJT Partners&#8217; use by the Core Scientific board, which are referred to in this proxy statement/prospectus as the &#8220;Core Scientific Standalone Projections&#8221; (see the section titled &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8212;Core Scientific Standalone Projections&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain financial analyses, estimates and forecasts relating to CoreWeave that were provided to and discussed with PJT Partners by the management of Core Scientific, including a certain equity research analyst&#8217;s model that the management of CoreWeave provided to PJT Partners and management of Core </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">206<br></div></div></div>
<!--End Page 217-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 218-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">Scientific, and which were approved for PJT Partners&#8217; use by the Core Scientific board, which are referred to collectively in this proxy statement/prospectus as the &#8220;CoreWeave Standalone Projections&#8221; (see the section titled &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8212;CoreWeave Standalone Projections&#8221;) and, together with the Core Scientific Standalone Projections, are referred to in this proxy statement/prospectus as the &#8220;Core Scientific Management Projections&#8221;; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">held discussions with members of senior management of Core Scientific and participated in discussions with members of senior management of CoreWeave, in each case, concerning, among other things, their evaluation of the Merger and the Core Scientific&#8217;s and CoreWeave&#8217;s respective businesses, operating and regulatory environments, financial conditions, prospects and strategic objectives, and potential strategic and financial benefits to the combined company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed the historical market prices and trading activity for the Core Scientific common stock and the CoreWeave common stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compared certain publicly available financial and stock market data for Core Scientific and CoreWeave with similar information for certain other companies that PJT Partners deemed to be relevant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewed a draft, dated July&#160;7, 2025, of the Merger Agreement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">performed such other financial studies, analyses and investigations, and considered such other matters, as PJT Partners deemed necessary or appropriate for purposes of rendering its opinion. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In preparing its opinion, with the consent of the Core Scientific board, PJT Partners relied upon and assumed the accuracy and completeness of the foregoing information and all other information discussed with or reviewed by PJT Partners, without independent verification thereof. PJT Partners assumed, with the consent of the Core Scientific board, that the Core Scientific Management Projections and the assumptions underlying the Core Scientific Management Projections, and all other financial analyses, estimates and forecasts provided to PJT Partners by Core Scientific&#8217;s management, were reasonably prepared in accordance with industry practice and represented Core Scientific management&#8217;s best currently available estimates and judgments as to the business and operations and future financial performance of Core Scientific and CoreWeave, as applicable. PJT Partners assumed no responsibility for and expressed no opinion as to the Core Scientific Management Projections, the assumptions upon which they were based or any other financial analyses, estimates and forecasts provided to PJT Partners by Core Scientific&#8217;s management. PJT Partners also assumed that there were no material changes in the assets, financial condition, results of operations, business or prospects of Core Scientific or CoreWeave since the respective dates of the last financial statements made available to PJT Partners. PJT Partners relied, with the consent of the Core Scientific board, on Core Scientific&#8217;s management&#8217;s representations and/or projections regarding taxable income, standalone net operating loss utilization and other tax attributes of Core Scientific. PJT Partners further relied, with the consent of the Core Scientific board, upon the assurances of the management of Core Scientific that they were not aware of any facts that would make the information, representations and projections, as applicable, provided by them or CoreWeave&#8217;s management inaccurate, incomplete or misleading.&#8195;</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners was not asked to undertake, and did not undertake, an independent verification of any information provided to or reviewed by PJT Partners, nor was it furnished with any such verification and PJT Partners did not assume any responsibility or liability for the accuracy or completeness thereof. PJT Partners did not conduct a physical inspection of any of the properties or assets of Core Scientific or CoreWeave. PJT Partners did not make an independent evaluation or appraisal of the assets or the liabilities (contingent or otherwise) of Core Scientific or CoreWeave, nor was it furnished with any such evaluations or appraisals, nor did it evaluate the solvency of Core Scientific or CoreWeave under any applicable laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners also assumed, with the consent of the Core Scientific board, that the final executed form of the Merger Agreement would not differ in any material respects from the draft reviewed by PJT Partners on July&#160;7, 2025 and the consummation of the Merger would be effected in accordance with the terms and conditions of the Merger Agreement, without waiver, modification or amendment of any material term, condition or agreement, and that, in the course of obtaining the necessary regulatory or third party consents and approvals (contractual or otherwise) for the Merger, no delay, limitation, restriction or condition would be imposed that would have an adverse effect on Core Scientific or CoreWeave or the contemplated benefits of the Merger. PJT Partners also assumed that the representations and warranties made by Core Scientific, CoreWeave and Merger Sub in the Merger Agreement and any related agreements were and would be true and correct in all respects material to its analysis. At the direction </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">207<br></div></div></div>
<!--End Page 218-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 219-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">of the Core Scientific board, PJT Partners assumed that it was intended for the Merger to qualify for U.S. federal income tax purposes as a reorganization within the meaning of Section&#160;368(a) of the Code. PJT Partners did not express any opinion as to any tax or other consequences that might result from the Merger, nor did its opinion address any legal, tax, regulatory or accounting matters, as to which PJT Partners understood that Core Scientific obtained such advice as it deemed necessary from qualified professionals. PJT Partners is not a legal, tax or regulatory advisor and relied upon without independent verification the assessment of Core Scientific and its legal, tax and regulatory advisors with respect to such matters. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In arriving at its opinion, PJT Partners was not asked to solicit, and did not solicit, interest from any party with respect to any sale, acquisition, business combination or other extraordinary transaction involving Core Scientific or its assets. PJT Partners did not consider the relative merits of the Merger as compared to any other business plan or opportunity that might be available to Core Scientific or the effect of any other arrangement in which Core Scientific might engage, and PJT Partners&#8217; opinion did not address the underlying decision by Core Scientific to engage in the Merger. PJT Partners&#8217; opinion was limited to the fairness of the exchange ratio as of the date of the opinion, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares), and PJT Partners&#8217; opinion did not address any other aspect or implication of the Merger, the Merger Agreement, any ancillary agreement or any other agreement or understanding entered into in connection with the Merger or otherwise. PJT Partners further expressed no opinion or view as to the fairness of the Merger to the holders of any other class of securities, creditors or other constituencies of Core Scientific or as to the underlying decision by Core Scientific to engage in the Merger. PJT Partners also expressed no opinion as to the fairness of the amount or nature of the compensation to any of Core Scientific&#8217;s officers, directors or employees, or any class of such persons, relative to the Merger Consideration to be received by the holders of Core Scientific common stock (other than the excluded shares) or otherwise.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners&#8217; opinion was necessarily based upon economic, market, monetary, regulatory and other conditions as they existed and could be evaluated, and the information made available to PJT Partners, as of the date of the opinion. PJT Partners expressed no opinion as to the prices or trading ranges at which Core Scientific common stock or CoreWeave common stock would trade at any time, as to the potential effects of volatility in the credit, financial and stock markets on Core Scientific, CoreWeave, or the Merger or as to the impact of the Merger on the solvency or viability of Core Scientific or CoreWeave or the ability of Core Scientific or CoreWeave to pay its obligations when they come due. PJT Partners&#8217; opinion does not constitute a recommendation to any holder of Core Scientific common stock as to how any stockholder should vote or act with respect to the Merger or any other matter. PJT Partners assumed no responsibility for updating or revising its opinion based on circumstances or events occurring after the date of the opinion.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The issuance of PJT Partners&#8217; opinion was approved by a fairness committee of PJT Partners in accordance with established procedures. PJT Partners&#8217; advisory services and opinion were provided to the Core Scientific board, in its capacity as such, in connection with and for the purposes of its evaluation of the Merger only and the opinion does not constitute a recommendation as to any action the Core Scientific board should take with respect to the Merger or any aspect thereof. PJT Partners&#8217; opinion does not constitute a recommendation to any holder of Core Scientific common stock as to how any stockholder should vote or act with respect to the Merger or any other matter. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 0pt; text-align: left;">Summary of Financial Analyses </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with rendering its opinion, PJT Partners performed certain financial, comparative and other analyses as summarized below. In arriving at its opinion, PJT Partners did not ascribe a specific range of values to the shares of Core Scientific common stock but rather made its determination as to fairness, from a financial point of view, to the holders of Core Scientific common stock (other than the excluded shares) of the exchange ratio on the basis of various financial and comparative analyses. The preparation of a fairness opinion is a complex process and involves various determinations as to the most appropriate and relevant methods of financial and comparative analyses and the application of those methods to the particular circumstances. Therefore, a fairness opinion is not readily susceptible to summary description. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In arriving at its opinion, PJT Partners did not attribute any particular weight to any single analysis or factor considered by it but rather made qualitative judgments as to the significance and relevance of each analysis and factor relative to all other analyses and factors performed and considered by it and in the context of the circumstances of the Merger. Accordingly, PJT Partners believes that its analyses must be considered as a whole, as considering any portion of such analyses and factors, without considering all analyses and factors as a whole, could create a misleading or incomplete view of the process underlying its opinion. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">208<br></div></div></div>
<!--End Page 219-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 220-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of the material financial analyses used by PJT Partners in preparing its opinion to the Core Scientific board. Certain financial analyses summarized below include information presented in tabular format. In order to fully understand the financial analyses used by PJT Partners, the tables must be read together with the text of each summary, as the tables alone do not constitute a complete description of the financial analyses. In performing its analyses, PJT Partners made numerous assumptions with respect to industry performance, general business and economic conditions and other matters, many of which are beyond the control of Core Scientific and CoreWeave. None of Core Scientific, CoreWeave, PJT Partners, or any other person assumes responsibility if future results are materially different from those discussed. Any estimates contained in these analyses are not necessarily indicative of actual values or predictive of future results or values, which may be significantly more or less favorable than as set forth below. In addition, analyses relating to the value of the businesses do not purport to be appraisals or reflect the prices at which the businesses may actually be sold. The financial analyses summarized below were based on the Core Scientific Management Projections and other financial information prepared and furnished to PJT Partners by or on behalf of the management of Core Scientific or CoreWeave, as applicable, and used at the direction of the management of Core Scientific and approved for PJT Partners&#8217; use by the Core Scientific board. The following summary does not purport to be a complete description of the financial analyses performed by PJT Partners. The following quantitative information, to the extent that it is based on market data, is based on market data as it existed, for Core Scientific and CoreWeave, as of the closing trading price on July&#160;3, 2025 (which represented the last trading day for Core Scientific common stock and CoreWeave common stock prior to the date of PJT Partners&#8217; opinion), and is not necessarily indicative of current or future market conditions. Fully diluted share numbers for Core Scientific and CoreWeave used below were provided by, and used at the direction of, Core Scientific management. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Discounted Cash Flow Analysis&#8212;Core Scientific </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to estimate the present value of Core Scientific common stock, PJT Partners performed a sum-of-the-parts discounted cash flow analysis of Core Scientific. A discounted cash flow analysis is a traditional valuation methodology used to derive a valuation of an asset by calculating the &#8220;present value&#8221; of estimated future cash flows generated by the asset. &#8220;Present value&#8221; refers to the current value of future cash flows or amounts and is obtained by discounting those future cash flows or amounts by a discount rate that takes into account macroeconomic assumptions and estimates of risk, the opportunity cost of capital, expected returns and other appropriate factors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To calculate the estimated sum-of-the-parts present value of Core Scientific common stock using the discounted cash flow method, PJT Partners added (a) Core Scientific&#8217;s projected after-tax unlevered free cash flows for the period June&#160;30, 2025 through fiscal year end 2043E based on the Core Scientific Standalone Projections for the Colocation Contracted Business, which unlevered free cash flows were discounted to their present value using a range of selected discount rates, (b) Core Scientific&#8217;s projected after-tax unlevered free cash flows for the period June&#160;30, 2025 through fiscal year end 2032E based on the Core Scientific Standalone Projections for the Colocation Pipeline Business and ranges of &#8220;terminal values&#8221; of the Core Scientific Colocation Pipeline Business as of June&#160;30, 2025, which amounts were discounted to their present value using a range of selected discount rates, (c) Core Scientific&#8217;s projected after-tax unlevered free cash flows for the period June&#160;30, 2025 through fiscal year end 2027E based on the Core Scientific Standalone Projections for the BTC Self Mining &amp; Hosting Business, which unlevered free cash flows were discounted to their present value using a range of selected discount rates, and (d) Core Scientific&#8217;s projected tax benefits for the period June&#160;30, 2025 through fiscal year end 2028E based on the Core Scientific Standalone Projections, which unlevered free cash flows were discounted to their present value using a range of selected discount rates. The after-tax unlevered free cash flows were calculated by taking the tax-affected earnings before interest and tax expense, adding depreciation and amortization, subtracting capital expenditures and adjusting for changes in working capital and other cash flow items. The residual value of the Core Scientific Colocation Pipeline Business at the end of the projection period, or &#8220;terminal value,&#8221; was estimated by applying the exit multiple range of 18.0x to 22.0x to Core Scientific&#8217;s terminal year Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses, with revenue recognized when received) calculated on a forward-looking (NTM) basis, which Adjusted EBITDA amount was estimated by Core Scientific management to be $899&#160;million. The ranges of after-tax discount rates of 10.00% to 12.00% (for the Colocation Contracted Business), 14.75% to 16.75% (for the Colocation Pipeline Business), 19.00% to 21.00% (for the BTC Self Mining &amp; Hosting Business) and 10.00% to 12.00% (for the tax benefits, based on the Colocation Contracted Business weighted average cost of capital) were selected based on PJT Partners&#8217; analysis of the weighted average cost of capital for each of the BTC Self Mining &amp; Hosting Business, the Colocation Contracted Business and the Colocation Pipeline Business. PJT </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">209<br></div></div></div>
<!--End Page 220-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 221-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Partners then calculated a range of implied equity values per share of Core Scientific common stock by subtracting Core Scientific&#8217;s estimated net debt from the estimated enterprise value derived using the discounted cash flow method and dividing such amount by the fully diluted number of shares of Core Scientific common stock as of June&#160;30, 2025.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"> </sup>The following summarizes the results of these calculations: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 119.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific Standalone DCF Analysis</div></td><td style="width: 18.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 119.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied equity<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">values per share of Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">common stock </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific Standalone Projections<font style="padding-left: 2.33pt;"></font></div></td><td style="width: 18.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 119.5pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">$13.17 &#8211; $18.47</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 119.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Discounted Cash Flow Analysis&#8212;CoreWeave </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In order to estimate the present value of CoreWeave common stock, PJT Partners performed a discounted cash flow analysis of CoreWeave. A discounted cash flow analysis is a traditional valuation methodology used to derive a valuation of an asset by calculating the &#8220;present value&#8221; of estimated future cash flows generated by the asset. &#8220;Present value&#8221; refers to the current value of future cash flows or amounts and is obtained by discounting those future cash flows or amounts by a discount rate that takes into account macroeconomic assumptions and estimates of risk, the opportunity cost of capital, expected returns and other appropriate factors. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To calculate the estimated enterprise value of CoreWeave using the discounted cash flow method, PJT Partners added (a) CoreWeave&#8217;s projected after-tax unlevered free cash flows for the period June&#160;30, 2025 through fiscal year end 2029E based on the CoreWeave Standalone Projections and ranges of &#8220;terminal values&#8221; of CoreWeave as of June&#160;30, 2025, and discounted such amount to its present value using a range of selected discount rates, and (b)&#160;CoreWeave&#8217;s projected tax benefits for the period June&#160;30, 2025 through fiscal year end 2030E based on the CoreWeave Standalone Projections, which amounts were discounted to their present value using a range of selected discount rates. The after-tax unlevered free cash flows were calculated by taking the tax-affected earnings before interest and tax expense, adding depreciation and amortization, subtracting capital expenditures and adjusting for changes in working capital and other cash flow items. The residual value of CoreWeave at the end of the projection period, or &#8220;terminal value,&#8221; was estimated by applying the exit multiple range of 20.0x to 30.0x to CoreWeave&#8217;s terminal year Adjusted EBIT (earnings before interest and taxes, adjusted for company defined non-recurring and non-cash items, stock-based compensation, and one-time expenses) from the CoreWeave Standalone Projections. The range of after-tax discount rates of 10.00% to 12.00% was selected based on PJT Partners&#8217; analysis of the weighted average cost of capital of CoreWeave. PJT Partners then calculated a range of implied equity values per share of CoreWeave common stock by subtracting CoreWeave&#8217;s estimated net debt from the estimated enterprise value derived using the discounted cash flow method and dividing such amount by the fully diluted number of shares of CoreWeave common stock as of June&#160;30, 2025. The following summarizes the results of these calculations: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.02pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.02pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 107.96pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave Standalone DCF Analysis</div></td><td style="width: 12.02pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.02pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 107.96pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied equity<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">values per share of CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">common stock </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave Standalone Projections<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 12.02pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.02pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 107.96pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">$90.77 &#8211; $184.23</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.02pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.02pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 107.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; margin-left: 20pt; text-align: left;">Discounted Cash Flow Analysis&#8212;Implied Exchange Ratio </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on the range of implied equity values per share of Core Scientific common stock and the range of implied equity values per share for CoreWeave common stock that were calculated by PJT Partners in its discounted cash flow analyses, PJT Partners calculated a range of implied exchange ratios of CoreWeave common stock per each share of Core Scientific common stock. PJT Partners calculated the low end of the implied exchange ratio range by dividing the low value of Core Scientific implied equity values per share reference range by the high value of CoreWeave implied equity values per share reference range. PJT Partners calculated the high end of the implied exchange ratio range by dividing the high value of Core Scientific implied equity values per share reference range by the low value of the CoreWeave implied equity values per share reference range. The result of this analysis, as compared to the exchange ratio of 0.1235x provided in the Merger, is summarized below: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 83.98pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 18.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.01pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 83.98pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Implied Exchange Ratio </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">DCF Analysis<font style="font-weight: normal; padding-left: 1.43pt;"></font></div></td><td style="width: 18.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 83.98pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">0.0715 - 0.2035x</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 83.98pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">210<br></div></div></div>
<!--End Page 221-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 222-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg37"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Other Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners also observed the additional factors described below, which were not considered part of its financial analyses in connection with rendering its opinion, but were referenced solely for informational purposes: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">financial, operating and public trading data relating to selected publicly-traded data infrastructure companies which, in its professional judgement, PJT Partners deemed comparable to Core Scientific, and which PJT Partners reviewed and compared in order to assess how the public market values shares of similar publicly-traded companies and to provide a range of relative implied equity values per share of Core Scientific common stock on a standalone basis, in each case by reference to these comparable companies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">historical trading prices of Core Scientific common stock during the 52-week period ending June&#160;25, 2025, which indicated low and high closing prices of Core Scientific common stock during such period of $6.20 to $18.63, as compared to the implied offer price per share of Core Scientific common stock of $19.70 (based on the prices of Core Scientific common stock and CoreWeave common stock as of June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">publicly available Wall Street research analysts&#8217; share price targets in the next 12 months for Core Scientific common stock, which indicated a target share price range for Core Scientific common stock of $15.00 to $20.00, as compared to the implied offer price per share of Core Scientific common stock of $19.70 (based on the prices of Core Scientific common stock and CoreWeave common stock as of June&#160;25, 2025, the last trading day prior to media reports that Core Scientific and CoreWeave were in merger discussions). </div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 0pt; text-align: left;">General </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or of the summary set forth above, without considering the analyses as a whole, could create an incomplete view of the processes underlying PJT Partners&#8217; opinion. In arriving at its fairness determination, PJT Partners considered the results of all of its analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, PJT Partners made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all of its analyses. The terms of the Merger Agreement, including the exchange ratio, were determined through arms&#8217; length negotiations between Core Scientific, on the one hand, and CoreWeave, on the other, and the decision to enter into the Merger Agreement was solely that of Core Scientific and CoreWeave.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners prepared these analyses for purposes of providing its opinion to the Core Scientific board as to the fairness, from a financial point of view, as of the date of the written opinion of PJT Partners, of the exchange ratio to the holders of shares of Core Scientific common stock (other than the excluded shares). These analyses do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of the parties or their respective advisors, none of Core Scientific, CoreWeave, PJT Partners or any other person assumes responsibility if future results are materially different from those forecast. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners is an internationally recognized investment banking firm and, as part of its and its affiliates&#8217; investment banking activities, is regularly engaged in the valuation of businesses and their securities in connection with mergers and acquisitions, investments for passive and control purposes, negotiated underwritings, competitive bids, secondary distributions of listed and unlisted securities, private placements and valuations for estate, corporate and other purposes. As a leading global M&amp;A, capital raising, restructuring and liability management, and governance and shareholder practices advisor, PJT Partners and its affiliates undertake significant client coverage efforts and have advised and/or discussed potential strategic transactions with a number of participants in Core Scientific&#8217;s sector. Core Scientific selected PJT Partners to act as its financial advisor because of its qualifications, reputation and experience in the valuation of businesses and securities in connection with mergers and acquisitions generally and in the data infrastructure industry specifically. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">PJT Partners is acting as financial advisor to Core Scientific in connection with the Merger. As compensation for its services in connection with the Merger, PJT Partners is entitled to receive from Core Scientific an aggregate fee of $10&#160;million, $3&#160;million of which became payable upon the delivery of PJT Partners&#8217; opinion to the Core </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">211<br></div></div></div>
<!--End Page 222-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 223-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg38"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Scientific board and the remainder of which is contingent and payable upon the consummation of the Merger. Core Scientific has agreed to reimburse PJT Partners for reasonable and documented out-of-pocket expenses and to indemnify PJT Partners for certain liabilities arising out of the performance of such services (including the rendering of PJT Partners&#8217; opinion). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the ordinary course of PJT Partners and its affiliates&#8217; businesses, PJT Partners and its affiliates may provide investment banking and other financial services to Core Scientific, CoreWeave or their respective affiliates and may receive compensation for the rendering of these services. During the two years preceding the date of its opinion, PJT Partners and certain of PJT Partners&#8217; affiliates are advising or have advised (i) Core Scientific in connection with restructuring matters unrelated to the Merger for which PJT Partners has received fees from Core Scientific of approximately $13&#160;million and in respect of which PJT Partners and its affiliates do not expect to receive additional fees in the future and (ii) a creditor group in which a significant stockholder of CoreWeave was a member, in connection with a distressed situation unrelated to Core Scientific or the Merger for which PJT Partners received fees paid by the debtor. PJT Partners and its affiliates have not advised or received fees from CoreWeave during this period. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><a name="tFOT"><!--Anchor--></a>FINANCING OF THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Completion of the Merger is not subject to any financing condition. Core Scientific has agreed to provide cooperation in connection with the arrangement of debt financing undertaken to finance the transactions contemplated by the Merger Agreement (if any) as may be customary and reasonably requested by CoreWeave, including, subject to certain exceptions and limitations, (i) making available to CoreWeave, its advisors and its debt financing sources such financial and other pertinent information regarding Core Scientific and its business as may be reasonably requested by CoreWeave, its advisors and its debt financing sources, (ii) assisting with the preparation of customary lender and investor presentations and other similar documents and materials in connection with the debt financing and otherwise providing customary assistance in the marketing efforts of CoreWeave and its debt financing sources, (iii) to the extent Core Scientific or any of its subsidiaries is to become an obligor or guarantor with respect to such debt financing, delivering all documentation and other information regarding such obligor or guarantor as is reasonably requested in writing by CoreWeave, its advisors and its debt financing sources at least nine days prior to closing and is required by certain laws in connection with such debt financing and (iv) assisting with CoreWeave&#8217;s preparation, negotiation and execution of definitive financing documentation as may reasonably be requested and which are conditioned on the occurrence of the closing. See the section titled &#8220;The Merger Agreement&#8212;Other Agreements&#8221; beginning on page <a href="#tOA1">244</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;"><a name="tRAR"><!--Anchor--></a>REGULATORY APPROVALS REQUIRED FOR THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Completion of the Merger is conditioned upon the expiration or termination of any waiting period (and any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the Merger) applicable to the Merger, under the HSR Act. The process for obtaining the requisite regulatory approvals for the Merger is ongoing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although CoreWeave and Core Scientific currently believe they should be able to obtain all required regulatory approvals in a timely manner, the parties cannot be certain when or if they will obtain them or, if obtained, whether the approvals will contain terms, conditions or restrictions not currently contemplated that will be detrimental to CoreWeave after the completion of the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The approval of an application for regulatory approval means only that the regulatory criteria for approval have been satisfied or waived. It does not mean that the approving regulatory authority has determined that the consideration to be received by holders of Core Scientific common stock and/or the Merger is fair to Core Scientific stockholders. Regulatory approval does not constitute an endorsement or recommendation of the Merger by any regulatory authority. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">U.S. Antitrust Filing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the HSR Act, certain transactions, including the Merger, may not be completed unless certain waiting period requirements have expired or been terminated. The HSR Act provides that each party must file its respective HSR notifications with the FTC and the DOJ. A transaction notifiable under the HSR Act may not be completed until the expiration of a 30-day waiting period following the parties&#8217; filings of their respective HSR notifications or the early termination of that waiting period. If the DOJ or FTC issues a request for additional information and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">212<br></div></div></div>
<!--End Page 223-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 224-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg39"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">documentary material (a &#8220;Second Request&#8221;) prior to the expiration of this initial 30-day waiting period, the transaction cannot close until the parties substantially comply with the Second Request and observe a second waiting period, which is 30 days by statute, but that can be extended through agreement or terminated earlier. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The parties&#8217; HSR notifications were filed with the FTC and the DOJ on July&#160;25, 2025. The 30-day waiting period following the parties&#8217; filings expired on August&#160;25, 2025. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At any time before or after the expiration or termination of any applicable waiting period, or any extension thereof, under the HSR Act, or before or after the Merger is completed, the DOJ or the FTC may take action under the antitrust laws in opposition to the Merger, including seeking to enjoin completion of the Merger, to rescind the Merger or to conditionally permit completion of the Merger subject to regulatory concessions or conditions. In addition, U.S. state attorneys general could take action under the antitrust laws as they deem necessary or desirable in the public interest, including, without limitation, seeking to enjoin the completion of the Merger or permitting completion subject to regulatory concessions or conditions. Private parties may also seek to take legal action under the antitrust laws under some circumstances. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although neither CoreWeave nor Core Scientific believes that the Merger will violate the antitrust laws, there can be no assurance that a challenge to the Merger on antitrust grounds will not be made or, if such a challenge is made, that it would not be successful. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">SEC Clearance of Registration Statement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The completion of the Merger is conditioned on the registration statement of which this proxy statement/prospectus is a part being declared effective under the Securities Act and no stop order suspending the effectiveness of the registration statement having been issued by the SEC and remaining in effect and no proceedings for such purpose pending before the SEC. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">NASDAQ Listing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the Merger Agreement, the shares of CoreWeave common stock to be issued in the Merger must have been approved for listing on the NASDAQ, subject to official notice of issuance. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Other Governmental Approvals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific are not aware of any material governmental approvals or actions that are required for completion of the Merger other than those described above. If any such additional governmental approvals or actions are required, CoreWeave and Core Scientific will use their respective reasonable best efforts, subject to certain limitations as described in the Merger Agreement, to take all actions necessary, proper or advisable to complete the Merger and the other transactions contemplated by the Merger Agreement as soon as reasonably practicable, including obtaining each regulatory approval necessary to complete the Merger or to avoid an action or proceeding by a governmental body seeking to prevent the consummation of the Merger under any antitrust law. There can be no assurance, however, that any additional approvals or actions will be obtained. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Efforts to Obtain Regulatory Approvals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave have agreed in the Merger Agreement to (i) use reasonable best efforts to file, as soon as reasonably practicable after the date of the Merger Agreement, all filings, notifications, or other documents required to be filed with or as requested by any governmental body pursuant to any antitrust law with respect to the Merger and any other transactions contemplated by the Merger Agreement and (ii) cooperate with the other party in determining whether, and promptly preparing and making, any other filings or notifications or other consents required to be made with, or obtained from, any other governmental bodies in connection with the Merger and any other transactions contemplated by the Merger Agreement. Further, subject to the terms and conditions set forth in the Merger Agreement, CoreWeave and Core Scientific agreed to use their respective reasonable best efforts to take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable law to consummate and make effective the Merger and any other transactions contemplated by the Merger Agreement as soon as reasonably practicable. In furtherance of the foregoing, solely for the purpose of this section of the Merger Agreement, CoreWeave&#8217;s reasonable best efforts will be deemed to include, among other things, the divestiture, licensing or disposition or certain other remedial actions with respect to the businesses, product lines or assets of Core </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">213<br></div></div></div>
<!--End Page 224-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 225-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg40"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Scientific, CoreWeave or any of their respective subsidiaries, unless such actions would be material to the business, financial condition or results of operations of CoreWeave and Core Scientific, taken as a whole, but measured relative to the size and scale of Core Scientific and its subsidiaries. Further, neither CoreWeave nor Core Scientific may acquire any assets or businesses (or portions thereof) that compete with Core Scientific if such acquisition(s) would reasonably be expected to prevent or materially delay the closing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These requirements are described in more detail in the section titled &#8220;The Merger Agreement&#8212;Regulatory Approvals&#8221; beginning on page <a href="#tRA1">239</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">No Assurances of Obtaining Approvals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">There can be no assurances that any of the regulatory approvals described above will be obtained and, if obtained, there can be no assurance as to the timing of such approvals, the ability to obtain such approvals on satisfactory terms or the absence of any litigation challenging such approvals. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Timing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to certain conditions, either CoreWeave or Core Scientific may terminate the Merger Agreement if the Merger is not completed on or before the end date (April&#160;7, 2025). See the section titled &#8220;The Merger Agreement&#8212;Termination of the Merger Agreement&#8221; beginning on page <a href="#tTOT1">245</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"><a name="tNDO"><!--Anchor--></a>NO DISSENTERS&#8217; OR APPRAISAL RIGHTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Core Scientific stockholders are not entitled to dissenters&#8217; or appraisal rights in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Appraisal rights are statutory rights that enable stockholders to dissent from an extraordinary transaction, such as a merger, and to demand that the corporation pay the fair value for their shares as determined by a court in a judicial proceeding instead of receiving the consideration offered to stockholders in connection with the transaction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of shares of Core Scientific common stock will not have rights to an appraisal of the fair value of their shares. Under Delaware law, appraisal rights are not available for the shares of any class or series if the shares of the class or series are listed on a national securities exchange or held of record by more than 2,000 holders on the record date, unless the stockholders receive in exchange for their shares anything other than shares of stock of the surviving or resulting corporation or of any other corporation that is publicly listed or held by more than 2,000 holders of record, cash proceeds from the sale of fractional shares or fractional depositary receipts or any combination of the foregoing. Shares of Core Scientific common stock are listed on the Nasdaq as of the record date, and Core Scientific stockholders will receive CoreWeave common shares pursuant to the Merger Agreement and cash proceeds from the sale of fractional shares. Approval for the listing of the shares of CoreWeave common stock on the Nasdaq is a condition to completion of the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;"><a name="tUSFI"><!--Anchor--></a>U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave intend for the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code for U.S. federal income tax purposes. Assuming the Merger so qualifies, U.S.&#160;holders (as defined in the section titled &#8220;<font style="font-style: italic;">Material U.S. Federal Income Tax Consequences of the Merger</font>&#8221;) of shares of Core Scientific common stock generally will not recognize any gain or loss for U.S. federal income tax purposes upon receipt of CoreWeave common stock in exchange for Core Scientific common stock in the Merger, other than gain or loss, if any, with respect to any cash received in lieu of a fractional share of CoreWeave common stock. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the effectiveness of the registration statement of which this proxy statement/prospectus is a part, each of Wachtell, Lipton, Rosen &amp; Katz, counsel to Core Scientific, and Davis Polk &amp; Wardwell LLP, counsel to CoreWeave, will deliver a legal opinion to the effect that the Merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code. These opinions will be based upon and rely on, among other things, various facts, assumptions, representations and warranties and covenants, including those contained in the Merger Agreement and in the officer&#8217;s certificates provided by CoreWeave (on behalf of itself and Merger Sub) and Core Scientific. In addition, the opinions will be subject to certain qualifications and limitations as set forth therein.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">An opinion that the Merger &#8220;should&#8221; qualify as a reorganization within the meaning of Section 368(a) of the Code expresses a level of comfort that is stronger than &#8220;more likely than not&#8221; but less than &#8220;will.&#8221; Counsel is unable </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">214<br></div> </div></div>
<!--End Page 225-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 226-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg41"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">to provide a higher degree of certainty because there is no administrative or judicial authority that directly addresses facts similar to those of this transaction, including with respect to the federal income tax treatment of the Tranche 2 Warrants. Nonetheless, counsel believes that its opinion is justified based on the existing authorities. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The material U.S. federal income tax consequences of the Merger to U.S. holders are discussed in more detail in the section titled &#8220;<font style="font-style: italic;">Material U.S. Federal Income Tax Consequences of the Merger</font>.&#8221; The discussion of the material U.S. federal income tax consequences contained in this proxy statement/prospectus is intended to provide only a general discussion and is not a complete analysis or description of all potential U.S. federal income tax consequences of the Merger. Such consequences may vary with, or be dependent on, individual circumstances. In addition, it does not address the effects of any foreign, state or local tax laws or any U.S. federal tax laws other than U.S. federal income tax laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">TAX MATTERS ARE COMPLICATED AND THE TAX CONSEQUENCES OF THE MERGER WILL DEPEND ON THE FACTS OF YOUR OWN SITUATION. YOU ARE URGED TO CONSULT YOUR OWN TAX ADVISOR AS TO THE SPECIFIC TAX CONSEQUENCES OF THE MERGER TO YOU IN YOUR PARTICULAR CIRCUMSTANCES. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tACC"><!--Anchor--></a>ACCOUNTING TREATMENT </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger will be accounted for as a business combination using the acquisition method of accounting pursuant to the provisions of ASC 805, whereby CoreWeave is considered the accounting acquirer. CoreWeave will record the identifiable tangible and intangible assets acquired and liabilities assumed of Core Scientific at their respective fair values as of the closing date of the Merger. Any excess of the consideration transferred over the fair value of Core Scientific&#8217;s net assets will be allocated to goodwill. The consideration transferred will be based on the closing date fair value of consideration paid by CoreWeave, primarily CoreWeave common stock to be issued to Core Scientific stockholders and the effective settlement of pre-existing relationships, in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial condition and results of operations of CoreWeave after completion of the Merger will reflect Core Scientific&#8217;s balances and results after completion of the Merger but will not be restated retroactively to reflect the historical financial condition or results of operations of Core Scientific. The earnings of CoreWeave following the completion of the Merger will include the effect of changes in the carrying value of assets and liabilities. Goodwill and intangible assets with indefinite useful lives will not be amortized, but will be tested for impairment at least annually, and all assets (including goodwill) will be tested for impairment when certain indicators are present. If, in the future, CoreWeave determines that tangible or intangible assets (including goodwill) are impaired, CoreWeave would record an impairment charge at that time. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tPFS"><!--Anchor--></a>PROCEDURES FOR SURRENDERING CORE SCIENTIFIC STOCK CERTIFICATES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the closing, CoreWeave will select a reputable bank, transfer agent or trust company, reasonably acceptable to Core Scientific, to act as exchange agent in the Merger for the payment and delivery of the aggregate Merger Consideration pursuant to an exchange agent agreement reasonably acceptable to Core Scientific. At or prior to the effective time, CoreWeave will cause to be deposited with the exchange agent the number of shares of CoreWeave common stock to be issued as Merger Consideration pursuant to the Merger Agreement. Promptly following the effective time, CoreWeave will cause the exchange agent to mail to the record holders of certificates representing Core Scientific common stock (i) a letter of transmittal in customary form containing such provisions as CoreWeave and Core Scientific may reasonably specify (including a provision that delivery of certificates shall be effected, and risk of loss and title to shares of Core Scientific common stock shall pass, only upon delivery of such certificates to the exchange agent) and (ii) instructions for use in effecting the surrender of such certificates in exchange for the Merger Consideration. Upon surrender of such certificate to the exchange agent for exchange, together with a duly executed letter of transmittal, and such other documents as may be reasonably required by the exchange agent or CoreWeave, the holder of such certificate will be entitled to receive (A) a certificate or evidence of shares in book-entry form representing the number of whole shares of CoreWeave common stock that such holder has the right to receive pursuant to the Merger Agreement and (B) cash in lieu of any such fractional shares of CoreWeave common stock pursuant to the Merger Agreement. At the effective time, each certificate formerly representing any share of Core Scientific common stock and each uncertificated share of Core Scientific common stock will cease to be outstanding and will represent only the right to receive the Merger Consideration pursuant to the Merger Agreement. See the section titled &#8220;The Merger Agreement&#8212;Procedures for Surrendering Core Scientific Common Stock Certificates&#8221; beginning on page <a href="#tPOS1">219</a> of this proxy statement/prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">215<br></div></div></div>
<!--End Page 226-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 227-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg42"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;"><a name="tLOS"><!--Anchor--></a>LISTING OF SHARES OF COREWEAVE COMMON STOCK, NEW TRANCHE 1 WARRANTS AND NEW TRANCHE 2 WARRANTS AND DELISTING AND DEREGISTRATION OF SHARES OF CORE SCIENTIFIC COMMON STOCK, TRANCHE 1 WARRANTS AND TRANCHE 2 WARRANTS<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave will use its reasonable best efforts to cause the shares of CoreWeave common stock, New&#160;Tranche 1 Warrants and New Tranche 2 Warrants to be issued in connection with the Merger to be listed on the Nasdaq, where shares of CoreWeave common stock are currently traded. If the Merger is completed, shares of Core Scientific common stock, Tranche 1 Warrants and Tranche 2 Warrants will no longer be listed on the Nasdaq and will be deregistered under the Exchange Act.</div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tLR2"><!--Anchor--></a>LITIGATION RELATING TO THE MERGER</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of the date hereof, there are no pending lawsuits challenging the Merger. Since the public announcement of the Merger, Core Scientific has received letters from purported Core Scientific stockholders who contend that the registration statement on Form S-4 of which this proxy statement/prospectus forms a part fails to disclose certain allegedly material information and demands that Core Scientific make supplemental disclosures. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While Core Scientific believes that the contentions made in the letters described above are without merit, each of these matters is at a preliminary stage. It is possible that complaints and additional, similar letters may be received by Core Scientific regarding the Merger. Absent new or different allegations that are material or constitute a disclosure obligation under the U.S. federal securities laws, Core Scientific will not necessarily disclose such additional letters. Litigation is inherently uncertain, and there can be no assurance regarding the likelihood that Core Scientific&#8217;s defense of any potential lawsuits related to the Merger that may be filed in the future will be successful, nor can Core Scientific predict the amount of time and expense that will be required to resolve any potential lawsuits.</div> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tSD"><!--Anchor--></a>SUBSEQUENT DEVELOPMENTS</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On August 7, 2025, Two Seas issued a press release announcing its opposition to the Merger on the terms that had been announced by Core Scientific and CoreWeave on July 7, 2025, and released an open letter to the Core Scientific board explaining why it opposes the transaction. In its letter, Two Seas stated that it intends to vote against the Merger and that it plans to solicit other Core Scientific stockholders to do the same. On August 8, 2025, Two Seas filed a Schedule 13D stating that, as of August 7, 2025, Two Seas was the beneficial owner of 19,122,842 shares of Core Scientific common stock.</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On September 4, 2025, Two Seas filed a preliminary proxy statement (the &#8220;Two Seas Proxy Statement&#8221;) with the SEC in connection with Two Seas&#8217; solicitation of proxies to vote against the Merger Agreement Proposal and the Advisory Compensation Proposal at the Special Meeting. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board unanimously determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, are fair to and in the best interests of Core Scientific and its stockholders, for the reasons described under the section of this proxy statement/prospectus titled &#8220;&#8212;Recommendation of the Core Scientific Board of Directors and Reasons for the Merger,&#8221; including the following considerations:</div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the receipt of CoreWeave common stock as Merger Consideration provides Core Scientific stockholders with the opportunity to have an ownership stake in the combined company which is expected to provide a number of significant potential strategic opportunities and benefits to create additional value for Core Scientific stockholders, including through cost synergies in the form of corporate general and administrative cost savings and operational efficiency through streamlining business operations and eliminating lease overhead to create potential for incremental cash flow, leveraging the larger scale and capability of the combined company to accelerate deployment of artificial intelligence and HPC workloads, and obtaining greater financing flexibility given the ability of the combined company to pursue additional infrastructure financing strategies to finance committed capital expenditures, and greater ability to attract new and diverse sources of financing to replace traditional debt or equity financing;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the proposed transaction eliminates the risks and uncertainties to Core Scientific of remaining an independent public company pursuing its standalone plan, which would involve significant near-term capital expenditures and execution risk to secure power, customers and financing for its Colocation Pipeline Business; and</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">216<br></div> </div></div>
<!--End Page 227-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 228-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_116-merger_pg43"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Core Scientific board carefully considered strategic alternatives in consultation with its advisors, including considering whether to continue operating Core Scientific as an independent company or seek a business combination with another party. Core Scientific&#8217;s financial advisors had each expressed their respective views that there were not likely to be any potential alternative counterparties that would be interested and able to pursue a strategic transaction with Core Scientific, and the fact that no other potential acquirors contacted Core Scientific to express an interest in pursuing a potential acquisition of Core Scientific, including following the June 4, 2024 Bloomberg report regarding CoreWeave&#8217;s June 2024 Proposal and the June 26, 2025 Wall Street Journal report that Core Scientific and CoreWeave were in discussions regarding a potential transaction. After considering the alternatives and overseeing extensive negotiations between Core Scientific and CoreWeave and their respective advisors (resulting in multiple increased offers from CoreWeave, with the culmination of CoreWeave stating that the 0.1235 exchange ratio represented its best and final offer, which represented an increase of approximately 34% over the exchange ratio in CoreWeave&#8217;s June 6 Proposal), the Core Scientific board determined that the Merger is the best available option for Core Scientific and its stockholders. The Core Scientific Board also considered that, given the existence of a &#8216;fiduciary out&#8217; and a reasonable termination fee, the Merger Agreement would not likely preclude or unduly discourage any third party with the financial capability and strategic interest of acquiring Core Scientific from pursuing a potential superior proposal.</div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and &#8220;FOR&#8221; the Advisory Compensation Proposal.</div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">217<br></div></div></div>
<!--End Page 228-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 229-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tTMAT"><!--Anchor--></a>THE MERGER AGREEMENT </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of the material terms and conditions of the Merger Agreement. This summary may not contain all the information about the Merger Agreement that is important to you. This summary set forth below and elsewhere in this proxy statement/prospectus is qualified in its entirety by reference to the Merger Agreement attached as <u>Annex&#160;A</u> to, and incorporated by reference into, this proxy statement/prospectus. You are encouraged to read the Merger Agreement in its entirety because it is the legal document that governs the Merger.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Explanatory Note&#160;Regarding the Merger Agreement and the Summary of the Merger Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement and the summary of its terms and conditions in this proxy statement/prospectus have been included to provide information about the material terms and conditions of the Merger Agreement. This summary and the information in the Merger Agreement are not intended to provide any other public disclosure of factual information about Core Scientific, CoreWeave or any of their respective subsidiaries or affiliates. The representations, warranties, covenants, and agreements contained in the Merger Agreement are made by CoreWeave, Core Scientific and Merger Sub (as applicable) only for the purposes of the Merger Agreement and only as of specific dates, and are qualified and subject to certain limitations and exceptions agreed to by CoreWeave, Core Scientific and Merger Sub in connection with negotiating the terms of the Merger Agreement, including being qualified by reference to confidential disclosures. In particular, in your review of the representations and warranties contained in the Merger Agreement and described in this summary, it is important to bear in mind that the representations and warranties were made solely for the benefit of the parties to the Merger Agreement and were negotiated for the purpose of allocating contractual risk among the parties to the Merger Agreement rather than to establish matters as facts. The representations and warranties may also be subject to a contractual standard of materiality or material adverse effect different from those generally applicable to stockholders and reports and documents filed with the SEC, including being qualified by reference to confidential disclosures. Moreover, information concerning the subject matter of the representations and warranties, which do not purport to be accurate as of the date of this proxy statement/prospectus, may have changed since the date of the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the foregoing reasons, the representations, warranties, covenants, and agreements and any descriptions of those provisions should not be read alone or relied upon as characterizations of the actual state of facts or condition of CoreWeave, Core Scientific, Merger Sub or any of their respective subsidiaries or affiliates. Instead, such provisions or descriptions should be read only in conjunction with the other information provided elsewhere in this proxy statement/prospectus or incorporated by reference into this proxy statement/prospectus. Please see the section&#160;entitled &#8220;Where You Can Find More Information&#8221; for more information about Core Scientific. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;"><a name="tSOT1"><!--Anchor--></a>Structure of the Merger </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the terms and subject to the conditions of the Merger Agreement, at the effective time, Merger Sub will be merged with and into Core Scientific, the separate corporate existence of Merger Sub will cease, and Core Scientific will continue as the Surviving Corporation and as a wholly owned subsidiary of CoreWeave. The Surviving Corporation will continue to exist under the laws of the State of Delaware.</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Charter and Bylaws; Directors and Officers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time and by virtue of the Merger, Core Scientific&#8217;s certificate of incorporation will be amended and restated (other than Articles V through VIII of Core Scientific&#8217;s existing certificate of incorporation, which provisions will not be amended, repealed or otherwise modified by virtue of the Merger and which are included as Articles V through VIII in the amended and restated certificate of incorporation of the Surviving Corporation) to be in the form attached as Exhibit&#160;A to the Merger Agreement, until thereafter changed or amended as provided therein or by applicable law. The bylaws of the Surviving Corporation will, at the effective time and by virtue of the Merger, be amended to be the bylaws of Merger Sub, as in effect immediately prior to the effective time, except that all references therein to Merger Sub will be deemed to be references to the Surviving Corporation, until thereafter changed or amended as provided therein or by applicable law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From and after the effective time, the initial directors and officers of the Surviving Corporation will be the directors and officers of Merger Sub immediately prior to the effective time, each to hold office until their respective successors have been duly elected, designated or qualified, or until his or her earlier death, resignation or removal in accordance with the organizational documents of the Surviving Corporation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">218<br></div></div></div>
<!--End Page 229-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 230-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Consummation and Effectiveness of the Merger </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The closing of the Merger is required to take place as soon as practicable (and, in any event, within three business days) after satisfaction or (to the extent permitted by applicable law) waiver of the conditions to closing described in the section titled &#8220;The Merger Agreement&#8212;Conditions to the Consummation of the Merger&#8221; beginning on page <a href="#tCCM1">223</a> of this proxy statement/prospectus (other than those conditions that by their terms are to be satisfied at the closing, but subject to the satisfaction or (to the extent permitted by applicable law) waiver of such conditions), or such other date as may be mutually agreed upon in writing by Core Scientific, CoreWeave and Merger Sub. The Merger will become effective at the time the certificate of merger for the Merger is duly filed with the Secretary of State of the State of Delaware or at such later date or time as agreed by CoreWeave and Core Scientific in writing and specified in the certificate of merger in accordance with the DGCL. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;"><a name="tMC1"><!--Anchor--></a>Merger Consideration </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the terms and conditions set forth in the Merger Agreement, at the effective time, by virtue of the Merger: (i) each share of Core Scientific common stock held in treasury or held or owned by Core Scientific, CoreWeave or Merger Sub immediately prior to the effective time (i.e., the excluded shares) will be cancelled without consideration; and (ii) each share of Core Scientific common stock, other than any excluded shares, outstanding immediately prior to the effective time will be cancelled and converted into the right to receive 0.1235 fully paid and non-assessable shares of CoreWeave common stock. No fractional shares of CoreWeave common stock will be issued in connection with the Merger, and Core Scientific stockholders who would have been entitled to receive a fraction of a share of CoreWeave common stock will receive cash in lieu of fractional shares as described in the section titled &#8220;The Merger Agreement&#8212;No Fractional Shares&#8221; beginning on page <a href="#tNFSS">220</a> of this proxy statement/prospectus. If Core Scientific changes the number of shares of Core Scientific common stock or CoreWeave changes the number of shares of CoreWeave common stock issued and outstanding prior to the effective time as a result of a reclassification, stock split (including a reverse stock split), stock dividend or distribution with a record date prior to the effective time, recapitalization or exchange, or other similar transaction (but excluding any change that results from (i) the exercise of stock options or other equity-based instruments to purchase shares of Core Scientific or CoreWeave common stock, (ii) the settlement of any other equity-based instruments to acquire shares of Core Scientific or CoreWeave common stock, (iii) the grant of stock-based compensation to directors or employees of Core Weave or Core Scientific under their compensation plans or arrangements, (iv) the exercise of Core Scientific warrants or Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes, (v) the issuance of disputed claims reserve shares in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific and its Affiliated Debtors or (vi) any share repurchases or buybacks by Core Scientific and CoreWeave), the Merger Consideration will be adjusted to reflect such change; provided that no adjustment will be made in connection with the issuance of shares of CoreWeave common stock as consideration in a transaction where CoreWeave is the surviving corporation or in connection with any offering of shares of CoreWeave common stock where CoreWeave receives consideration in exchange for the shares of CoreWeave common stock so offered (other than a rights offering or other similar transaction). </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">Appraisal Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In accordance with Section&#160;262 of the DGCL, no appraisal rights will be available to Core Scientific stockholders in connection with the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;"><a name="tPOS1"><!--Anchor--></a>Procedures for Surrendering Core Scientific Common Stock Certificates </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the closing, CoreWeave is required to select a reputable bank, transfer agent or trust company, reasonably acceptable to Core Scientific, to act as exchange agent in the Merger for the payment and delivery of the aggregate Merger Consideration pursuant to an exchange agent agreement reasonably acceptable to Core Scientific. At or prior to the effective time, CoreWeave is required to cause to be deposited with the exchange agent, for the benefit of Core Scientific stockholders, for exchange in accordance with the Merger Agreement through the exchange agent the number of shares of CoreWeave common stock to be issued as Merger Consideration (to be represented by book-entry shares of CoreWeave common stock). Promptly following the effective time, CoreWeave is required to cause the exchange agent to mail to the record holders of certificates that represented shares of Core Scientific common stock: (i) a letter of transmittal in customary form and containing such provisions as CoreWeave and Core Scientific may reasonably specify (including a provision confirming that delivery of certificates will be effected, and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">219<br></div></div></div>
<!--End Page 230-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 231-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">risk of loss and title to shares of Core Scientific common stock will pass, only upon delivery of such certificates to the exchange agent); and (ii) instructions for use in effecting the surrender of certificates in exchange for the Merger Consideration. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon surrender of a certificate to the exchange agent for exchange, together with a duly executed letter of transmittal and such other documents as may be reasonably required by the exchange agent or CoreWeave, the holder of such certificate will be entitled to receive (A) a certificate or evidence of shares in book-entry form representing the number of whole shares of CoreWeave common stock that such holder has the right to receive pursuant to the Merger Agreement and (B) cash in lieu of any fractional shares of CoreWeave common stock otherwise payable to such holder of uncertificated shares. Until surrendered as contemplated by the procedures outlined in this paragraph, each certificate will be deemed, from and after the effective time, to represent only the right to receive the Merger Consideration specified in the Merger Agreement. In the event of a transfer of ownership of shares of Core Scientific common stock that is not registered in Core Scientific&#8217;s transfer records, any portion of the Merger Consideration may be issued or paid (including in cash in lieu of fractional shares) to a person other than the person in whose name such certificate so surrendered is registered if such certificate is properly endorsed or otherwise is in proper form for transfer, and the person requesting such issuances and/or payments will pay any transfer or other taxes required by reason of such issuance and/or payment of the Merger Consideration to a person other than the registered holder of such shares of Core Scientific common stock or establish to the satisfaction of CoreWeave that such taxes have been paid or are not applicable. If any certificate is lost, stolen or destroyed, CoreWeave may require the owner of such lost, stolen or destroyed certificate to provide an appropriate affidavit and to deliver a bond as indemnity against any claim that may be made against the exchange agent, CoreWeave or the Surviving Corporation with respect to such certificate. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">With respect to uncertificated shares of Core Scientific common stock held through DTC, CoreWeave and Core Scientific are required to cooperate to establish procedures with the exchange agent and DTC to ensure that the exchange agent will transmit to DTC or its nominees as soon as practicable after the effective time, but in any event within five business days thereafter, upon surrender of shares held of record by DTC or its nominees in accordance with DTC&#8217;s customary surrender procedures, the Share Consideration and cash in lieu of fractional shares otherwise payable to such holder of uncertificated shares. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">With respect to uncertificated shares of Core Scientific common stock not held through DTC, CoreWeave is required to instruct, and to use its commercially reasonable efforts to cause, the exchange agent to pay and deliver to each holder of record of any such stock, as promptly as reasonably practicable after the effective time, but in any event within five business days thereafter, the applicable Share Consideration and a check in the amount (after giving effect to any required tax withholdings as provided in the Merger Agreement) of any cash in lieu of fractional shares of CoreWeave common stock otherwise payable to such holder of uncertificated shares. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tNFSS"><!--Anchor--></a>No Fractional Shares </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cash will be paid in lieu of fractional shares as described in the following sentence. Each holder of shares of Core Scientific common stock (other than any excluded shares) that otherwise would have been entitled to receive a fraction of a share of CoreWeave common stock will instead receive a cash payment (without interest) in respect of such fractional share in an amount equal to the product of (i) the aggregate net cash proceeds (net of all commissions, transfer taxes and other out-of-pocket costs and expenses of the exchange agent incurred in connection with such sales) received by the exchange agent selling at then-prevailing prices on Nasdaq the number of shares of CoreWeave common stock that represents the aggregate of all fractional entitlements of all holders of Core Scientific common stock and (ii) a fraction, the numerator of which is such fractional part of a share of CoreWeave common stock, and the denominator is the number of shares of CoreWeave common stock that represents the aggregate of all fractional entitlements of all holders of Core Scientific common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tTOCS"><!--Anchor--></a>Treatment of Core Scientific Equity Awards </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Core Scientific RSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific RSU Award that is outstanding immediately prior to the effective time and held by a Specified Individual or by a non-employee member of the Core Scientific board, will fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">220<br></div></div></div>
<!--End Page 231-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 232-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Core Scientific RSU Award as of immediately prior to the effective time, <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, all other Unvested Core Scientific RSU Awards that are outstanding immediately prior to the effective time will be cancelled and each will be converted into a restricted stock unit award with respect to a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Unvested Core Scientific RSU Award as of immediately prior to the effective time, <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio (i.e., a CoreWeave Rollover RSU Award), and each such CoreWeave Rollover RSU Award will otherwise continue to be subject to the same terms and conditions (including vesting schedule and treatment on termination of employment) as were applicable to the corresponding Unvested Core Scientific RSU Award prior to the effective time. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Core Scientific PSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific PSU Award that is outstanding immediately prior to the effective time and held by a Specified Individual, will vest and be cancelled and converted automatically into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (x) the total number of shares of Core Scientific common stock underlying such Core Scientific PSU Award as of immediately prior to the effective time (which number will be determined by deeming the applicable performance level to equal 300%), <font style="font-style: italic;">multiplied</font> <font style="font-style: italic;">b</font>y (y) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, all other Core Scientific PSU Awards that are outstanding immediately prior to the effective time will be cancelled and each will be converted into a time-based restricted stock unit award with respect to a number of shares of CoreWeave common stock equal to the product of (x) the total number of shares of Core Scientific common stock underlying such Core Scientific PSU Award as of immediately prior to the effective time assuming a performance level of 300% <font style="font-style: italic;">multiplied</font> <font style="font-style: italic;">by</font> (y) the exchange ratio (i.e., a CoreWeave Rollover PSU Award), and each such CoreWeave Rollover PSU Award will otherwise continue to be subject to the same terms and conditions (including service-based vesting and forfeiture conditions) as were applicable to the corresponding Core Scientific PSU Award immediately prior to the effective time (other than the applicable performance conditions). </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Core Scientific Options </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each In the Money Option will be cancelled and converted into the right to receive (without interest and less applicable tax withholding) a number of fully paid and non-assessable shares of CoreWeave common stock equal to (x) the quotient obtained by <font style="font-style: italic;">dividing</font> (a) the product obtained by <font style="font-style: italic;">multiplying</font> (A) the excess, if any, of the Per Core Scientific Share Price over the exercise price per share of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (B) the number of shares of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (b) the Per Core Scientific Share Price <font style="font-style: italic;">multiplied</font> <font style="font-style: italic;">by</font> (y) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific Option that is not an In the Money Option and that is outstanding and unexercised as of immediately prior to the effective time will be cancelled at the effective time with no consideration payable in respect of such Core Scientific Option. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Treatment of Core Scientific Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific warrants will be treated in accordance with the terms of the Core Scientific Warrant Agreement. Prior to the effective time, CoreWeave and Core Scientific will make all necessary and appropriate provisions to provide for the assumption by CoreWeave of the performance of Core Scientific under the Core Scientific Warrant Agreement. At the effective time and by virtue of the Merger: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a holder of a Tranche 1 Warrant as of immediately prior to the effective time will be entitled, following the effective time, and subject to the terms and conditions of the Core Scientific Warrant Agreement, to receive a New Tranche 1 Warrant exercisable for a number of shares of CoreWeave common stock equal to (1) the Warrant Shares (as defined in the Core Scientific Warrant Agreement) underlying such Tranche 1 Warrant, <font style="font-style: italic;">multiplied by</font> (2) the exchange ratio, with such New Tranche 1 Warrant having an exercise price per Warrant </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">221<br></div></div></div>
<!--End Page 232-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 233-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">Share equal to the Tranche 1 Exercise Price (as defined in the Core Scientific Warrant Agreement) in effect immediately prior to the effective time <font style="font-style: italic;">divided by </font>the Exchange Ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants; and </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a holder of a Tranche 2 Warrant as of immediately prior to the effective time will be entitled, following the effective time, and subject to the terms and conditions of the Core Scientific Warrant Agreement, to receive a Converted Tranche 2 Warrant (as defined in the Core Scientific Warrant Agreement), which Converted Tranche 2 Warrant will be exercisable for a number of Warrant Shares with an exercise price of $7.50 per Warrant Share (subject to adjustment as set forth in the Core Scientific Warrant Agreement and otherwise on the same terms as the Tranche 2 Warrants), which will be converted into a New Tranche 2 Warrant exercisable for a number of shares of CoreWeave common stock equal to (a) the Warrant Shares underlying the Converted Tranche 2 Warrants, <font style="font-style: italic;">multiplied by</font> (b) the exchange ratio, with such New Tranche 2 Warrant having an exercise price per Warrant Share equal to $7.50 per Warrant Share <font style="font-style: italic;">divided by</font> the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Tranche 1 Warrant will be automatically redeemed in accordance with the terms of the Core Scientific Warrant Agreement and all of the terms, obligations covenants and conditions of each Tranche 1 Warrant will thereafter be of no further force or effect and will represent only the right to receive a New Tranche 1 Warrant in accordance with the Merger Agreement, on the terms and subject to the conditions set forth in the Core Scientific Warrant Agreement. At the effective time, each Tranche 2 Warrant will be automatically converted, and each Converted Tranche 2 Warrant will be automatically redeemed, in each case in accordance with the terms of the Warrant Agreement, and all of the terms, obligations, covenants and conditions of each Tranche 2 Warrant and Converted Tranche 2 Warrant will thereafter be of no further force or effect, and each Converted Tranche 2 Warrant will represent only the right to receive a New Tranche 2 Warrant in accordance with the Merger Agreement, on the terms and subject to the conditions set forth in the Core Scientific Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For a description of the terms of the New Tranche 1 Warrants and New Tranche 2 Warrants, see the section titled &#8220;Description of CoreWeave Capital Stock, New Tranche 1 Warrants and New Tranche 2 Warrants&#8221; beginning on page <a href="#tDOC">277</a> of this proxy statement/prospectus. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tTOCSC"><!--Anchor--></a>Treatment of Core Scientific Convertible Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the effective time, within the time periods required by the terms of each of the Core Scientific 2029 and 2031 Notes Indentures, Core Scientific will, and will cause its representatives to, use reasonable best efforts to take all actions required by such indenture to be performed by it at or prior to the effective time as a result of the consummation of the Merger, including the giving of any notices that may be required by Core Scientific and CoreWeave and the delivery to the trustee, of any documents or instruments required to be delivered at or prior to the effective time to such trustee, in each case by such indenture as a result of the consummation of the Merger; provided, that Core Scientific will, to the extent practicable, deliver a draft of any such notice or other document to CoreWeave at least three business days prior to delivering or entering into such notice or other document in accordance with the terms of the indentures. Prior to the effective time, Core Scientific agrees to cooperate with CoreWeave by using reasonable best efforts to execute and deliver at (and subject to the consummation of) the effective time one or more supplemental indentures and officer&#8217;s certificates (to the extent required by the trustee pursuant to each such indenture), in each case in form and substance reasonably acceptable to CoreWeave and the trustee under such indentures, pursuant to each such indenture and use reasonable best efforts to cause the trustee under such indentures to execute and deliver at the effective time any such supplemental indentures, in each case required by the terms of such indenture as a result of the consummation of the Merger; provided that counsel for Core Scientific will not be required to deliver any legal opinion under any indenture unless specifically required by the trustee thereunder after CoreWeave&#8217;s counsel will have offered to provide the same. Core Scientific has agreed that, unless CoreWeave provides its prior written consent to Core Scientific&#8217;s election of a different settlement method, Core Scientific will elect to settle any conversion of the Convertible Notes occurring prior to the effective time solely by delivering Core Scientific common stock (together with cash in lieu of any fractional share, as provided in the applicable indenture). </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Treatment of Core Scientific Contingent Value Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Core Scientific CVRs will be treated in accordance with the terms of the Core Scientific Contingent Value Rights Agreement. Prior to the effective time, CoreWeave and Core Scientific will make all necessary and appropriate provisions to provide for the assumption by CoreWeave of Core Scientific&#8217;s obligations, duties and covenants under </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">222<br></div></div></div>
<!--End Page 233-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 234-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">the Core Scientific Contingent Value Rights Agreement. Additionally, following the effective time, for the purposes of Section&#160;4.4 of the Core Scientific Contingent Value Rights Agreement, CoreWeave common shares will be deemed to be the Surviving Entity Equity Securities (as defined in the Core Scientific Contingent Value Rights Agreement) (after giving effect to the exchange ratio). </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Listing of Shares of CoreWeave Common Stock, New Tranche 1 Warrants and New Tranche 2 Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave will use its reasonable best efforts to cause the shares of CoreWeave common stock, New Tranche 1 Warrants and New Tranche 2 Warrants to be issued in connection with the Merger to be listed on Nasdaq, where shares of CoreWeave common stock are currently traded. Approval for listing on Nasdaq of the shares of CoreWeave common stock issuable to Core Scientific stockholders in the Merger, subject to official notice of issuance, is a condition to the obligation of CoreWeave, Core Scientific and Merger Sub to complete the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;"><a name="tCCM1"><!--Anchor--></a>Conditions to the Consummation of the Merger </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Mutual Conditions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The obligations of CoreWeave and Core Scientific to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver (to the extent permitted by applicable law) by CoreWeave and Core Scientific of the following conditions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">receipt of the Core Scientific Stockholder Approval; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">this registration statement on Form&#160;S-4 becoming effective under the Securities Act, no SEC stop order suspending the effectiveness of this registration statement having been issued by the SEC and remaining in effect and no proceedings for such purpose pending before the SEC; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the expiration or termination of the waiting period (and any extension thereof, including any commitment to, or agreement with, any governmental body to delay the consummation of, or not to consummate before a certain date, the transactions contemplated by the Merger Agreement) applicable to the transactions contemplated by the Merger Agreement under the HSR Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the absence of any order enacted, promulgated, issued or entered by any governmental body enjoining, restraining, preventing or prohibiting the consummation of the Merger and the absence of any law in effect or enacted or promulgated prohibiting or making illegal the consummation of the Merger; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the approval for listing on Nasdaq, subject to official notice of issuance, of the CoreWeave common stock issuable to the Core Scientific stockholders in the Merger. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18pt; margin-left: 0pt; text-align: left;">Additional Conditions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, CoreWeave&#8217;s and Merger Sub&#8217;s obligations to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver (to the extent permitted by applicable law) of the following conditions as of the closing date: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties Core Scientific made in the Merger Agreement regarding certain aspects of corporate organization and corporate power, authority and enforceability, certain aspects of Core Scientific&#8217;s capitalization, certain aspects of Core Scientific&#8217;s subsidiaries, non-violation, broker&#8217;s fees, rights agreements and fairness opinions being true and correct in all material respects, on and as of the closing, with the same force and effect as if made on and as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); provided that all &#8220;Core Scientific Material Adverse Effect&#8221; (with such term as described in the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Definition of &#8216;Material Adverse Effect&#8221;&#8217;), &#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties will be disregarded; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties Core Scientific made in the Merger Agreement regarding certain aspects of capitalization being true and correct in all respects (except for <font style="font-style: italic;">de minimis</font> inaccuracies relative to the total fully diluted equity capitalization of Core Scientific), on and as of the closing, with the same force and effect as if made on and as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); provided that all &#8220;Core Scientific Material Adverse Effect,&#8221; &#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties will be disregarded; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">223<br></div></div></div>
<!--End Page 234-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 235-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties Core Scientific made in the Merger Agreement regarding the absence of a Core Scientific Material Adverse Effect having occurred between March&#160;31, 2025 and the date of the Merger Agreement being true and correct in all respects as of the closing; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each of the other representations and warranties Core Scientific made in the Merger Agreement being true and correct as of the closing (without giving effect to any &#8220;material,&#8221; &#8220;materiality,&#8221; &#8220;Core Scientific Material Adverse Effect&#8221; or similar phrases (other than the word &#8220;material&#8221; in the definition of &#8220;material contract&#8221;)) as if made as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)), except where the failure of any such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Core Scientific Material Adverse Effect; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compliance by Core Scientific in all material respects with all of the covenants and agreements under the Merger Agreement required to be performed by Core Scientific at or prior to the closing; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the absence of a Core Scientific Material Adverse Effect (defined below) since the date of the Merger Agreement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the delivery by Core Scientific to CoreWeave of a certificate executed by a duly authorized officer of Core Scientific, dated as of the closing date, stating that the conditions in the six preceding bullet points have been satisfied. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, Core Scientific&#8217;s obligations to consummate the transactions contemplated by the Merger Agreement are subject to the satisfaction or waiver (to the extent permitted by applicable law) of the following conditions as of the closing date: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties CoreWeave and Merger Sub made in the Merger Agreement regarding certain aspects of corporate organization and corporate power, authority and enforceability, certain aspects of CoreWeave&#8217;s capitalization, certain aspects of CoreWeave&#8217;s subsidiaries, non-violation, and broker&#8217;s fees being true and correct in all material respects, on and as of the closing, with the same force and effect as if made on and as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); provided that all &#8220;CoreWeave Material Adverse Effect&#8221; (with such term as described under the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Definition of &#8216;Material Adverse Effect&#8221;&#8217;), &#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties will be disregarded; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties CoreWeave and Merger Sub made in the Merger Agreement regarding certain aspects of CoreWeave&#8217;s capitalization being true and correct in all respects (except for <font style="font-style: italic;">de minimis</font> inaccuracies relative to the total fully diluted equity capitalization of CoreWeave), on and as of the closing, with the same force and effect as if made on and as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); provided that all &#8220;CoreWeave Material Adverse Effect&#8221; (with such term as described under the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Definition of &#8216;Material Adverse Effect&#8221;&#8217;), &#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties will be disregarded; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">certain representations and warranties CoreWeave made in the Merger Agreement regarding the absence of a CoreWeave Material Adverse Effect having occurred between March&#160;31, 2025 and the date of the Merger Agreement being true and correct in all respects as of the closing; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each of the other representations and warranties CoreWeave made in the Merger Agreement being true and correct as of the closing (without giving effect to any &#8220;material,&#8221; &#8220;materiality,&#8221; &#8220;CoreWeave Material Adverse Effect&#8221; or similar phrases (other than the word &#8220;material&#8221; in the definition of &#8220;material contract&#8221;)) as if made as of the closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)), except where the failure of any such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a CoreWeave Material Adverse Effect; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compliance by each of CoreWeave and Merger Sub in all material respects with its respective covenants and agreements under the Merger Agreement required to be performed by it at or prior to the closing; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the absence of a CoreWeave Material Adverse Effect (defined below) since the date of the Merger Agreement; and </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">224<br></div></div></div>
<!--End Page 235-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 236-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the delivery by CoreWeave to Core Scientific of a certificate executed by a duly authorized officer of CoreWeave, dated as of the closing date, stating that the conditions in the six preceding bullet points have been satisfied. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Representations and Warranties </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement contains customary representations and warranties by Core Scientific, CoreWeave and Merger Sub. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The representations and warranties of Core Scientific in the Merger Agreement relate to, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">corporate organization and corporate power; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">authority relative to execution and delivery of the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement and enforceability; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">capitalization; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">organization and standing of subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">absence of any conflict with or violation or breach of organizational documents or laws or additional payments as a result of consummation of the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">required governmental and other regulatory filings and consents in connection with the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">SEC documents, financial statements, and financial reporting procedures; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">undisclosed liabilities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">absence of certain developments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">compliance with laws; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">affiliate transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">title to assets and real property; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">material contracts and commitments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">intellectual property; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">litigation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">insurance; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">employee benefit plans; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">environmental matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">employment and labor matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">material relationships; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">government contracts; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">utility regulatory matters; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">fiber networks; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">broker&#8217;s fees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">accuracy of disclosure; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">rights agreements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">opinion of financial advisors; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">non-reliance. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">225<br></div></div></div>
<!--End Page 236-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 237-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The representations and warranties of CoreWeave and Merger Sub in the Merger Agreement relate to, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">corporate organization and corporate power; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">authority relative to execution and delivery of the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement and enforceability; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">capitalization; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">organization and standing of subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">absence of any conflict with or violation or breach of organizational documents or laws or additional payments as a result of consummation of the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">required governmental and other regulatory filings and consents in connection with the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">SEC documents, financial statements, and financial reporting procedures; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">undisclosed liabilities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">absence of certain developments; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">compliance with laws; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">affiliate transactions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">litigation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">broker&#8217;s fees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">accuracy of disclosure; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">ownership of Core Scientific&#8217;s equity interests; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">purpose of Merger Sub; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">qualification of the Merger as a &#8220;reorganization&#8221; for U.S. federal income tax purposes; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">non-reliance. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The representations and warranties made by CoreWeave, Merger Sub and Core Scientific are subject to exceptions and qualifications (including exceptions based on materiality or a CoreWeave Material Adverse Effect or a Core Scientific Material Adverse Effect, as applicable). In addition, the representations and warranties are qualified by certain documents filed with or furnished to the SEC by CoreWeave or Core Scientific and the confidential disclosure letters delivered by Core Scientific to CoreWeave and Merger Sub and by CoreWeave to Core Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">None of the representations, warranties or agreements contained in the Merger Agreement or in any certificate, document or instrument delivered pursuant to the Merger Agreement will survive the effective time, except for covenants and agreements which contemplate performance, in whole or in part, after the effective time or otherwise expressly by their terms survive the effective time. For more information, see the section titled &#8220;&#8212;Explanatory Note&#160;Regarding the Merger Agreement and the Summary of the Merger Agreement&#8221; above. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tDEFMAE"><!--Anchor--></a>Definition of &#8220;Material Adverse Effect&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of the representations and warranties in the Merger Agreement are qualified by a &#8220;material adverse effect&#8221; standard with respect to the party making such representations and warranties. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">226<br></div></div></div>
<!--End Page 237-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 238-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;Core Scientific Material Adverse Effect&#8221; means, for the purposes of the Merger Agreement, any change, effect, event, circumstance, occurrence, state of facts or development that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, assets, results of operations or financial condition of Core Scientific and its subsidiaries, taken as a whole, other than any change, effect, event, circumstance, occurrence, state of facts or development to the extent related to or resulting from: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">general business or economic conditions affecting the industry in which Core Scientific and its subsidiaries operate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">acts of god, weather conditions or environmental events and natural disasters (including any earthquakes, floods, hurricanes, tropical storms, fires, or other natural disasters), health emergencies, pandemics or epidemics (or the escalation of any of the foregoing) and any governmental or industry responses thereto; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">political or geopolitical conditions (including tariffs and sanctions), the occurrence or the escalation or worsening of any military or terrorist actions or cyberterrorism (including cyberterrorism data breaches), civil or political unrest, acts of war, hostilities or sabotage; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in economic, financial or market conditions, including changes in the artificial intelligence, financial, banking, currency, bitcoin, bitcoin mining, cryptocurrency, electricity, energy, power or securities markets and changes in cryptocurrency prices, commodity prices and regulatory, legislative or political conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in the prices of commodities, bitcoin or other digital assets after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in GAAP after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in laws or orders after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in Core Scientific&#8217;s stock price or the trading volume of Core Scientific&#8217;s stock or any change in the credit rating of Core Scientific (provided that the underlying causes of any such change, to the extent not otherwise excluded from the definition of a Core Scientific Material Adverse Effect, may be taken into consideration when determining whether a Core Scientific Material Adverse Effect has occurred); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the failure of Core Scientific to meet internal or analysts&#8217; expectations, projections or results of operations (provided that the underlying causes of any such failure to meet expectations, projections or results of operations, to the extent not otherwise excluded from the definition of a Core Scientific Material Adverse Effect, may be taken into consideration when determining whether a Core Scientific Material Adverse Effect has occurred); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any material adverse effect on the business, assets, results of operations or financial condition of CoreWeave or its subsidiaries and any impact thereof on Core Scientific or its subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">breaches or threatened breaches by CoreWeave or any of its subsidiaries of any commercial contract with Core Scientific or any of its subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the execution or delivery of the Merger Agreement, the announcement of the Merger Agreement or the transactions contemplated by the Merger Agreement, the identity of the parties to the Merger Agreement or the taking of any action required by the Merger Agreement, including the impact of any of the foregoing on the relationships of Core Scientific or any of its subsidiaries with governmental bodies, customers, suppliers, power providers, utility companies, contractors, partners, officers, employees or other business relations (it being understood that this bullet will not apply to a breach of certain representations and warranties of Core Scientific relating to authority and enforceability, non-violation, consents, intellectual property and employee benefit plans or the accuracy of such representations and warranties for the purposes of determining whether certain conditions to closing have been satisfied); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">transaction litigation (provided that the underlying causes of any such litigation, to the extent not otherwise excluded from the definition of a Core Scientific Material Adverse Effect, may be taken into consideration when determining whether a Core Scientific Material Adverse Effect has occurred); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any action (1) expressly required by the Merger Agreement, (2) taken by Core Scientific or any of its subsidiaries with CoreWeave&#8217;s written consent, to the extent the consequences thereof are reasonably foreseeable, or taken at CoreWeave&#8217;s written request or (3) any failure by Core Scientific or any of its subsidiaries to take any action as a result of CoreWeave&#8217;s or any of CoreWeave&#8217;s subsidiaries&#8217; failure or delay in providing consent, to the extent such failure or delay in providing consent would reasonably be expected to have a materially adverse effect on Core Scientific or its subsidiaries; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">227<br></div></div></div>
<!--End Page 238-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 239-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">provided, however, that if any change, effect, event, circumstance, occurrence, state of facts or development described in any of the first seven bullet points above has or has had a disproportionate adverse effect on Core Scientific and its subsidiaries, taken as a whole, relative to other participants in the industries in which Core Scientific and its subsidiaries operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in determining whether a Core Scientific Material Adverse Effect has occurred. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;CoreWeave Material Adverse Effect&#8221; means, for the purposes of the Merger Agreement, any change, effect, event, circumstance, occurrence, state of facts or development that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, assets, results of operations or financial condition of CoreWeave and its subsidiaries, taken as a whole, other than any change, effect, event, circumstance, occurrence, state of facts or development to the extent related to or resulting from: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">general business or economic conditions affecting the industry in which CoreWeave and its subsidiaries operate; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">acts of god, weather conditions or environmental events and natural disasters (including any earthquakes, floods, hurricanes, tropical storms, fires, or other natural disasters), health emergencies, pandemics or epidemics (or the escalation of any of the foregoing) and any governmental or industry responses thereto; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">political or geopolitical conditions (including tariffs and sanctions), the occurrence or the escalation or worsening of any military or terrorist actions or cyberterrorism (including cyberterrorism data breaches), civil or political unrest, acts of war, hostilities or sabotage; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in economic, financial or market conditions, including changes in the artificial intelligence, financial, banking, currency, bitcoin, bitcoin mining, cryptocurrency, electricity, energy, power or securities markets and changes in cryptocurrency prices, commodity prices and regulatory, legislative or political conditions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in the prices of commodities, bitcoin or other digital assets after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in GAAP after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">changes in laws or orders after the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">changes in CoreWeave&#8217;s stock price or the trading volume of CoreWeave&#8217;s stock or any change in the credit rating of CoreWeave (provided that the underlying causes of any such change, to the extent not otherwise excluded from the definition of a CoreWeave Material Adverse Effect, may be taken into consideration when determining whether a CoreWeave Material Adverse Effect has occurred); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the failure of CoreWeave to meet internal or analysts&#8217; expectations, projections or results of operations (provided that the underlying causes of any such failure to meet expectations, projections or results of operations, to the extent not otherwise excluded from the definition of a CoreWeave Material Adverse Effect, may be taken into consideration when determining whether a CoreWeave Material Adverse Effect has occurred); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">breaches or threatened breaches by Core Scientific or any of its subsidiaries of any commercial contract with CoreWeave or any of its subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the execution or delivery of the Merger Agreement, the announcement of the Merger Agreement or the transactions contemplated by the Merger Agreement, the identity of the parties to the Merger Agreement or the taking of any action required by the Merger Agreement, including the impact of any of the foregoing on the relationships of CoreWeave or any of its subsidiaries with governmental bodies, customers, suppliers, power providers, utility companies, contractors, partners, officers, employees or other business relations (it being understood that this bullet will not apply to a breach of certain representations and warranties of CoreWeave relating to authority and enforceability, non-violation and consents or the accuracy of such representations and warranties for the purposes of determining whether certain conditions to closing have been satisfied)); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">transaction litigation (provided that the underlying causes of any such litigation, to the extent not otherwise excluded from the definition of a CoreWeave Material Adverse Effect, may be taken into consideration when determining whether a CoreWeave Material Adverse Effect has occurred); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any action expressly required by the Merger Agreement or any action taken by CoreWeave or any of the subsidiaries of CoreWeave at Core Scientific&#8217;s written request or with Core Scientific&#8217;s consent; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">228<br></div></div></div>
<!--End Page 239-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 240-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">provided, however, that if any change, effect, event, circumstance, occurrence, state of facts or development described in any of the first seven bullet points above has or has had a disproportionate adverse effect on CoreWeave and its subsidiaries, taken as a whole, relative to other participants in the industries in which CoreWeave and its subsidiaries operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in determining whether a CoreWeave Material Adverse Effect has occurred. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tCBPM"><!--Anchor--></a>Conduct of Business Pending the Merger </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of Core Scientific and CoreWeave has agreed to certain covenants in the Merger Agreement restricting the conduct of its and its respective subsidiaries&#8217; businesses between the date of the Merger Agreement and the effective time or, if applicable, the date on which the Merger Agreement is validly terminated. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, except as required or prohibited by applicable law, as expressly required or expressly permitted by the Merger Agreement, with the prior written consent of CoreWeave or subject to specified exceptions set forth in the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub, from the date of the Merger Agreement until the earlier of the effective time or the date the Merger Agreement is validly terminated (the &#8220;pre-closing period&#8221;), Core Scientific is required to, and must cause its subsidiaries to, use commercially reasonable efforts to carry on their businesses in the ordinary course of business in all material respects, preserve intact their current business organizations and relationships with customers, suppliers, distributors, lenders, landlords, tenants, utility companies, power providers, governmental bodies and others having business relationships that in each case are material to Core Scientific or its subsidiaries taken as a whole, comply with applicable law in all material respects, maintain in effect all necessary permits that are material to Core Scientific and its subsidiaries taken as a whole and maintain the material assets and material properties of Core Scientific in their current condition in all material respects, ordinary wear and tear excepted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Without limiting the generality of the preceding paragraph, during the pre-closing period and except as set forth in the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub, as required or prohibited by applicable law, as expressly required or expressly permitted by the Merger Agreement or with the prior written consent of CoreWeave, Core Scientific and its subsidiaries have agreed not to take the following actions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">enter into any new line of business outside the existing lines of business of Core Scientific and its subsidiaries as of the date of the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(1) declare, set aside, establish a record date for or pay any dividends on or make other distributions (whether in cash, stock or property) in respect of any Core Scientific common stock or other equity securities of Core Scientific or its subsidiaries or (2) directly or indirectly redeem, repurchase, buyback or otherwise acquire any shares of Core Scientific common stock, Core Scientific subsidiary equity securities, any Core Scientific Convertible Notes, any Core Scientific warrants or any Core Scientific RSU Awards or Core Scientific PSU Awards with respect thereto, except, in each case, (A) for the declaration and payment of dividends or distributions by a direct or indirect wholly owned subsidiary of Core Scientific solely to its direct parent entity, (B) any forfeitures or repurchases of unvested Core Scientific RSU Awards, Core Scientific PSU Awards or other shares of securities of Core Scientific or its subsidiaries issued pursuant to or granted as awards under Core Scientific equity plans in accordance with the terms thereof as in effect as of the date of the Merger Agreement, (C) to satisfy any applicable tax withholding in respect of the vesting or settlement of any Core Scientific RSU Awards or Core Scientific PSU Awards, or (D) for the issuance of shares of Core Scientific common stock (and payment of cash in lieu of issuing any fractional share) to settle (x) any conversion of any of the Core Scientific Convertible Notes in accordance with the terms of the corresponding Core Scientific Notes Indenture or (y) any exercise of the Core Scientific warrants, in each case, as outstanding on the date of the Merger Agreement and in accordance with their respective terms on the date of the Merger Agreement, (E) payments of regular scheduled interest upon the Core Scientific Convertible Notes solely to the extent required pursuant to the terms of the corresponding Core Scientific 2029 and 2031 Notes Indentures or any exercise of the Core Scientific warrants, in each case, outstanding on the date of the Merger Agreement and in accordance with their respective terms as in effect on the date of the Merger Agreement, or (F) as required by the Core Scientific CVR Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(x) issue, sell, pledge, dispose of or otherwise encumber, or authorize the issuance, sale, pledge, disposition or other encumbrance of, or make or exercise any option to purchase with respect to, (1) any shares of Core Scientific capital stock or any Core Scientific subsidiary equity securities, (2) any securities convertible </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">229<br></div></div></div>
<!--End Page 240-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 241-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">into or exchangeable or exercisable for any such shares or ownership interest, (3) any phantom equity or similar contractual rights or (4) any rights, warrants or options to acquire any such shares or securities exchangeable into such shares, except in each case: (A) for the issuance of shares of Core Scientific common stock (and payment of cash in lieu of issuing any fractional shares) to settle (x) any conversion of the Core Scientific Convertible Notes in accordance with the terms of the corresponding Core Scientific 2029 and 2031 Notes Indentures existing as of the date of the Merger Agreement, or (y) any exercise of the Core Scientific warrants, in each case, outstanding on the date of the Merger Agreement in accordance with their respective terms as in effect on the date of the Merger Agreement, (B) for issuances of Core Scientific common stock upon the vesting or settlement of Core Scientific RSU Awards or Core Scientific PSU Awards outstanding prior to the date of the Merger Agreement or issued after the date of the Merger Agreement in compliance with the Merger Agreement, in each case in accordance with their respective terms, (C) for transactions solely between or among any of Core Scientific and its wholly owned subsidiaries, and (D) for certain liens permitted by the terms of the Merger Agreement or (y) amend or otherwise change any term of any Core Scientific capital stock or any Core Scientific subsidiary equity securities (in each case, whether by merger, consolidation or otherwise); </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">except as required by the terms of a Core Scientific benefit plan as in effect as of the date of the Merger Agreement, (A) grant or increase (or promise to commit to grant or increase) the wages, salary, severance, equity or other compensation or benefits with respect to any of Core Scientific&#8217;s or any of its subsidiaries&#8217; officers, directors, or employees, (B) establish, adopt, enter into, materially amend or terminate any Core Scientific benefit plan, other than the amendment of any Core Scientific benefit plan that is a broad-based welfare benefit plan in the ordinary course of business and in a manner that does not enhance the benefits under such Core Scientific benefit plan or increase the costs to Core Scientific or any of its subsidiaries, (C) accelerate the vesting, funding or time of payment of any compensation or other benefit, (D) enter into any transaction bonus, retention, change-of-control or similar agreement or arrangement with any employee of Core Scientific or any of its subsidiaries or pay or award (or commit to pay or award) any amounts in respect of the foregoing, (E) grant, or promise or commit to grant, any equity or equity-aligned awards or any long-term incentive awards, or (F) waive or release any noncompetition, non-solicitation, nondisclosure, noninterference, non-disparagement or other restrictive covenant obligation of any current or former employee or other individual service provider; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) adopt, enter into or amend any collective bargaining agreement or other contract with any labor union, works council or other similar employee representative body applicable to Core Scientific or its subsidiaries, or (B) engage in any conduct that would result in an employment loss or layoff for a sufficient number of employees of Core Scientific or its subsidiaries which would constitute a &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; under the Worker Adjustment and Retraining Notification Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">hire, engage, promote or terminate (other than for cause) any employee, except for (A) the hiring or engagement of any individual to whom an offer of employment has been extended on or prior to the date of the Merger Agreement as listed the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub or (B) the hiring, engagement, promotion or termination of any employee below the title of Senior Manager and with a base salary less than $180,000 in the ordinary course of business consistent with past practice; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) other than as expressly required by the Merger Agreement in furtherance of the transactions contemplated by the Merger Agreement, amend, or propose to amend any organizational document of Core Scientific (including by merger, consolidation or otherwise), (B) adopt a stockholders&#8217; rights plan or similar plan or (C) other than the Merger Agreement, enter into any agreement with respect to the voting of Core Scientific capital stock or any Core Scientific subsidiary securities; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">effect a recapitalization, reclassification of shares, stock split, reverse stock split, combination, subdivision or similar transaction or authorize the issuance of any other securities in respect of, in lieu of, or in substitution for shares of Core Scientific capital stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) adopt a plan of complete or partial liquidation or dissolution, of Core Scientific or any of its &#8220;significant subsidiaries,&#8221; as defined in Rule&#160;1-02(w) of Regulation S-X or (B) enter into any merger, liquidation, dissolution, reorganization or restructuring of Core Scientific or any such &#8220;significant subsidiaries&#8221;; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">230<br></div></div></div>
<!--End Page 241-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 242-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other than capital expenditures made pursuant to certain contracts related to properties being developed by Core Scientific and CoreWeave, incur, make or authorize any capital expenditures or any obligations or liabilities in respect thereof, other than capital expenditures that are in the ordinary course and do not exceed $5,000,000 individually or $10,000,000 in the aggregate or are contemplated by the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">acquire or agree to acquire, by merging or consolidating with, by purchasing an equity interest in or a portion of the assets of any business or any corporation, partnership, association or other business organization or division thereof, or otherwise acquire or agree to acquire any material assets of any other person, except for (A) purchases in the ordinary course of business or (B) transactions (1) solely among Core Scientific and one or more of its wholly owned subsidiaries, (2) solely among Core Scientific&#8217;s wholly owned subsidiaries or (3) pursuant to existing contractual obligations disclosed to CoreWeave prior to the date of the Merger Agreement, but excluding certain contractual obligations set forth in the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) incur, assume, endorse, guarantee, or otherwise become liable for any indebtedness for borrowed money or any surety bonds or letters of credit obligations or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities (directly, contingently or otherwise) or enter into any &#8220;keep well&#8221; or other agreement to maintain any financial statement condition of another person (other than Core Scientific or any of its subsidiaries), (B) make any material loans or advances to any other person or (C) make any material capital contributions to, or investments in, any other person, except, in each case, for (1) among Core Scientific and its wholly owned subsidiaries or to or among any wholly owned subsidiaries of Core Scientific, (2) any surety bonds or letters of credit obligations incurred, assumed, endorsed, guaranteed or for which Core Scientific or any of its subsidiaries otherwise become liable in the ordinary course of business, (3) any advances or deposits for the future delivery of goods or services, including under co-location agreements, and (4) guarantees by Core Scientific or its subsidiaries of obligations of Core Scientific or any of its subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">sell, transfer, assign, mortgage, encumber, pledge, license, lease, sublease, abandon or otherwise withdraw or dispose of any properties or assets with a fair market value in excess of $3,000,000 in the aggregate except for, in each case, (A) certain liens permitted by the Merger Agreement, (B) sales of inventory and equipment, or of obsolete or worthless assets, in each case in the ordinary course of business and (C) any transaction (I) solely among Core Scientific and one or more of its wholly owned subsidiaries or (II) solely among Core Scientific&#8217;s wholly owned subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) other than non-exclusive licenses granted in the ordinary course of business, sell, lease, assign, transfer, convey, dispose of, grant any license or sublicense in, to or under, create or incur any lien (other than certain liens permitted by the Merger Agreement) on, any material intellectual property owned by Core Scientific and its subsidiaries or (B) allow any material registered intellectual property to lapse or go abandoned, other than at the end of its maximum statutory term; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">pay, discharge, settle, compromise or satisfy, or offer or propose to pay, discharge, settle, compromise or satisfy, (A) any action or threatened action that results in the payment of monetary damages in excess of $3,000,000 in the aggregate, or that imposes any material restrictions or limitations upon the assets, operations or business of Core Scientific or any of its subsidiaries (or CoreWeave after closing) or equitable or injunctive remedies or the admission of wrongdoing by Core Scientific or any of its subsidiaries (or CoreWeave, after the closing) or (B) any action or threatened action (excluding any action or threatened action relating to taxes, such action and threatened actions being subject to the seventeenth bullet point of this section) that relates to the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">change its fiscal year or change any of its financial accounting methods or practices or internal accounting controls or disclosure controls and procedures in any respect, except as required by GAAP, Regulation S-X of the Securities Act, or a governmental body or quasi-governmental authority (including the Financial Accounting Standards Board or any similar organization); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other than in the ordinary course of business, (A) make, change or revoke any material tax election with respect to Core Scientific or any of its subsidiaries, (B) adopt or make any material change to any material method of tax accounting, (C) enter into any closing agreement relating to or affecting any material tax liability or refund of material taxes with respect to Core Scientific or any of its subsidiaries, (D) change any </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">231<br></div></div></div>
<!--End Page 242-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 243-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">material tax accounting period, (E) consent to any extension or waiver of the limitations period applicable to any material tax claim or assessment (other than any such extensions or waivers automatically granted), or (F) settle or compromise any material tax liability or refund of material taxes with respect to Core Scientific or any of its subsidiaries for an amount materially in excess of amounts reserved therefor, in the case of each of clauses (A) through (F), if such action would result in a material increase in the tax liability of Core Scientific and its subsidiaries, taken as a whole; </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">amend or modify in any material respect, terminate or fail to renew (including failing to exercise a renewal or extension option under) or grant any material waiver or consent under, any material contract (or any contract that, if existing on the date of the Merger Agreement, would be a material contract), or enter into any contract that, if existing on the date of the Merger Agreement, would be a material contract, or otherwise knowingly waive, release or assign any material rights, claims or benefits of Core Scientific or any of its subsidiaries with respect to any material contract (excluding certain contracts related to properties being developed by Core Scientific and CoreWeave, which are subject to the twenty-fourth bullet point of this section, and Core Scientific&#8217;s leases, which are subject to the twenty-fifth bullet point of this section), in each case other than (a) in the ordinary course and in a manner that is not reasonably expected to be adverse to Core Scientific or its subsidiaries or, after giving effect to the transactions contemplated by the Merger Agreement, CoreWeave and its subsidiaries, (b) the expiration or renewal of any material contract with a third party in accordance with its terms, or (c) as expressly contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">take any action to exempt any person from any state takeover statute or similar statute or regulation that applies to Core Scientific with respect to an Acquisition Proposal, including the restrictions on &#8220;business combinations&#8221; set forth in Section&#160;203 of the DGCL, except for CoreWeave, Merger Sub, or any of their respective subsidiaries or affiliates or to the extent permitted pursuant to the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">voluntarily abandon, withdraw, terminate, suspend, abrogate, amend or modify any permit issued to or held by Core Scientific or any of its subsidiaries in a manner that would materially impair the operation of the business of Core Scientific or any of its subsidiaries, taken as a whole; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) fail to maintain any material property insurance currently in effect covering the real property owned by Core Scientific and its subsidiaries or (B) cancel, amend or modify any material license or permit held by Core Scientific with respect to the real property owned by Core Scientific and its subsidiaries, the real property leased by Core Scientific and its subsidiaries or any part thereof which would be binding after the effective time in a manner that would materially impair the operation or the use of such real property (as currently used in connection with Core Scientific&#8217;s business); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">initiate or consent to any material zoning reclassification of any real property owned or leased by Core Scientific and its subsidiaries or any material change to any approved site plan (in each case, that is material to such real property owned or leased by Core Scientific or plan, as applicable), special use permit or other land use entitlement affecting any material real property owned or leased by Core Scientific, in each case, in a manner that would materially inhibit Core Scientific&#8217;s ability to develop or use the real property owned or leased by Core Scientific and its subsidiaries for data center operations; </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">fail to maintain in full force and effect existing material insurance policies (or substantially similar replacements thereto) (excluding property insurance covering real property owned by Core Scientific and its subsidiaries, which is the subject of the twenty-first bullet point of this section); provided that in the event of a termination, cancellation or lapse of any material insurance policy, Core Scientific will use reasonable best efforts to promptly obtain replacement policies on substantially consistent terms and providing substantially comparable insurance coverage with respect to the material assets, operations and activities of Core Scientific and its subsidiaries as currently in effect as of the date of the Merger Agreement; </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) enter into or materially amend, modify, waive any material rights under or grant any material consents under certain material contracts relating to certain of Core Scientific&#8217;s properties, other than in the ordinary course of business; provided that Core Scientific and its subsidiaries will not enter into any new co-location agreements with respect to any such properties or (B) enter into or materially amend, modify, waive any material rights under or grant any material consents under any non de minimis contract with respect to a property that is being developed by Core Scientific and CoreWeave; </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">232<br></div></div></div>
<!--End Page 243-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 244-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">enter into or materially amend, renew or extend (or fail to exercise a renewal or extension option under), or materially modify a Core Scientific real property lease or terminate any Core Scientific real property lease (except any termination that will occur at the end of the maximum term of such real property lease), other than by extending such term through the payment of any extension fee in an amount up to $3,000,000; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">fail to take certain actions set forth in the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">authorize, agree or commit to take any of the actions described in the bullet points above. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, except as required or prohibited by applicable law, as expressly required or expressly permitted by the Merger Agreement, with the prior written consent of Core Scientific or subject to specified exceptions set forth in the confidential disclosure letter delivered by CoreWeave to Core Scientific, during the pre-closing period, CoreWeave and its subsidiaries are required to use commercially reasonable efforts to carry on their businesses in the ordinary course of business in all material respects, and preserve intact their current business organizations and their relationships with material customers, material suppliers, governmental bodies and others having business relationships that are material to CoreWeave or its subsidiaries, taken as a whole. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Without limiting the generality of the preceding paragraph, during the pre-closing period and except as set forth in the confidential disclosure letter delivered by CoreWeave to Core Scientific, as required or prohibited by applicable law, as expressly permitted or expressly required by the Merger Agreement or with the prior written consent of Core Scientific, CoreWeave and its subsidiaries have agreed not to take the following actions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">declare, set aside, establish a record date for or pay any dividends on or make other distributions (whether in cash, stock or property) in respect of any CoreWeave capital stock, except (A) for the declaration and payment of dividends or distributions by a direct or indirect subsidiary of CoreWeave solely to its parent, (B) any forfeitures or repurchases of CoreWeave equity awards granted under the CoreWeave equity plans, or (C) to satisfy any applicable tax withholding in respect of the exercise, vesting or settlement of any CoreWeave equity award; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">issue, sell or authorize the issuance or sale of, or make any option to purchase with respect to, (1) any shares of CoreWeave capital stock or any equity securities of CoreWeave&#8217;s subsidiaries, (2) any securities convertible into or exchangeable or exercisable for any such shares or ownership interest, (3) any phantom equity or similar contractual rights or (4) any rights, warrants or options to acquire any such shares or securities exchangeable or convertible into such shares, except in each case: (A) the grant of CoreWeave equity awards or any other equity compensation award pursuant to any stockholder-approved equity plan, (B) for issuances of CoreWeave common stock upon the vesting, exercise or settlement of CoreWeave equity awards (and dividend equivalents thereon, if applicable) outstanding prior to the date of the Merger Agreement or issued after the date of the Merger Agreement in compliance with the Merger Agreement, (C) any exercise of the CoreWeave warrants and in accordance with their respective terms on the date of the Merger Agreement, (D) transactions solely between or among CoreWeave and its wholly owned subsidiaries, (E) or certain liens permitted by the terms of the Merger Agreement, (F) the issuance by CoreWeave of not more than 12.5% of the total number of shares of CoreWeave common stock issued and outstanding as of the date of the Merger Agreement determined on a fully-diluted basis, (G) the sale or issuance of CoreWeave common stock in connection with one or more mergers; acquisitions of securities, businesses, property or other assets, products or technologies; joint ventures; commercial relationships or other strategic corporate transactions or alliances, whether structured as a merger, stock purchase, business combination or otherwise and (H) the sale of CoreWeave common stock upon the exercise of the equity greenshoe option granted to Magnetar Financial LLC pursuant to a certain notes purchase agreement entered into by CoreWeave in 2021; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">other than as expressly permitted or required by the Merger Agreement in furtherance of the transactions contemplated by the Merger Agreement, amend, or propose to amend any of CoreWeave&#8217;s organizational documents (including by merger, consolidation or otherwise) in a manner that would be adverse to Core Scientific or Core Scientific&#8217;s stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">effect a recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction or authorize the issuance of any other securities in respect of, in lieu of, or in substitution for shares of its capital stock; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">233<br></div></div></div>
<!--End Page 244-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 245-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">adopt a plan of complete or partial liquidation or dissolution of CoreWeave or any of its &#8220;significant subsidiaries,&#8221; as defined in Rule&#160;1-02(w) of Regulation S-X; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">authorize, agree or commit to take any of the actions described in the bullet points above. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Transition and Development Committee </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As promptly as practicable following the date of the Merger Agreement and to the extent permitted by applicable law, each of CoreWeave and Core Scientific will appoint an equal number (to be mutually agreed) of representatives to a committee (the &#8220;Transition and Development Committee&#8221;), each of whom will have suitable seniority and the requisite skills, knowledge, experience and authority to discuss, coordinate and make arrangements related to integration matters between CoreWeave, on one hand, and Core Scientific and its subsidiaries, on the other hand. The purpose of the Transition and Development Committee will be to plan and discuss (i) integration planning, (ii)&#160;contractual pipelines, (iii) status of electric power, (iv) equipment procurement, (v) status of outstanding option contracts, letters of intent, and validation of site suitability and power, (vi) requests for consent made by Core Scientific or CoreWeave, as applicable, to conduct their respective businesses during the pre-closing period, and (vii)&#160;any other issue or matters that may otherwise be referred to the Transition and Development Committee. The members of the Transition and Development Committee will also cooperate to oversee and plan for the development of the properties being developed by Core Scientific and CoreWeave in accordance in all material respects with contracts between the parties or their respective subsidiaries and between Core Scientific or its subsidiaries with third&#160;parties with respect to such matters. It is understood and agreed that any failure by Core Scientific to comply with certain of its obligations set forth under the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Conduct of Business Pending the Merger&#8221; or this section that is primarily caused by, or primarily results from, any breach of contractual obligations owed CoreWeave or its subsidiaries to Core Scientific or its subsidiaries or any unreasonable failure or delay of CoreWeave or its subsidiaries in providing any consent reasonably requested by Core Scientific with respect to the matters described under the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Conduct of Business Pending the Merger&#8221; will not be taken into account for purposes of determining the satisfaction of the condition to CoreWeave&#8217;s obligation to consummate the Merger related to compliance by Core Scientific in all material respects with all of the covenants and agreements under the Merger Agreement required to be performed by Core Scientific at or prior to the closing. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each member of the Transition and Development Committee will be subject to confidentiality and other restrictions necessary or appropriate to ensure compliance with antitrust laws and any other applicable laws, in each case, as reasonably agreed by the parties. The Transition and Development Committee will participate in weekly, or as reasonably agreed between CoreWeave and Core Scientific, integration and development planning meetings and in connection therewith, prior to each such meeting (x) Core Scientific will use commercially reasonable efforts to provide CoreWeave with updated information reasonably requested in advance by CoreWeave for integration and development planning, including historical operating reports (provided that Core Scientific will only be required to provide CoreWeave with reports that Core Scientific prepares in the ordinary course of business), and (y) CoreWeave will use commercially reasonable efforts to timely review and respond to any requests from Core Scientific for CoreWeave&#8217;s consent or cooperation in connection with the matters addressed by the Transition and Development Committee. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17.5pt; margin-left: 0pt; text-align: left;">Registration Statement; Proxy Statement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of CoreWeave and Core Scientific has agreed that the information provided by it or any of its subsidiaries for inclusion in this proxy statement/prospectus will not, at the time that the proxy statement or any amendment or supplement thereto is filed with the SEC or is first mailed to Core Scientific stockholders or when the registration statement becomes effective, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. CoreWeave will use its reasonable best efforts, and Core Scientific will reasonably cooperate with CoreWeave in such efforts, to have the registration statement declared effective under the Securities Act as promptly as practicable after such filing and to keep the registration statement effective as long as necessary to consummate the transactions contemplated by the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific will use its reasonable best efforts to mail the proxy statement to its stockholders as promptly as practicable after the registration statement of which this prospectus forms a part is declared effective under the Securities Act. CoreWeave will use reasonable best efforts to take any action required to be taken under any applicable state securities laws and other applicable laws in connection with the issuance of shares of CoreWeave </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">234<br></div></div></div>
<!--End Page 245-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 246-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">common stock, New Tranche 1 Warrants an New Tranche 2 Warrants, and each party will furnish all information concerning Core Scientific, CoreWeave and the holders of capital stock of Core Scientific and CoreWeave, as applicable, as may be reasonably requested by another party in connection with any such action and the preparation, filing and distribution of the registration statement and the proxy statement. No filing of, or amendment or supplement to, or material correspondence to the SEC or its staff with respect to the registration statement or the proxy statement may be made by Core Scientific, CoreWeave or any of their respective subsidiaries, without providing the other party a reasonable opportunity to review and comment thereon and such party will give reasonable consideration in good faith to any comments made by the other party and its representatives; provided that, with respect to documents filed by a party that are incorporated by reference in the registration statement or proxy statement, the right to review and comment will apply only with respect to the information relating to the other party or its business, financial condition or results of operations, or the combined entity resulting from the transactions contemplated by the Merger Agreement; and provided, further, that this right to review and comment will not apply with respect to information relating to an Adverse Recommendation Change. CoreWeave will advise Core Scientific, promptly after it receives notice thereof, of the time when the registration statement has become effective or any supplement or amendment has been filed, the issuance of any stop order, the suspension of the qualification of the New Tranche 1 Warrants and New Tranche 2 Warrants issuable in connection with the Merger Agreement or the shares of CoreWeave common stock issuable in connection with the Merger for offering or sale in any jurisdiction, or any request by the SEC for amendment of the registration statement or comments thereon and responses thereto or requests by the SEC for additional information. Core Scientific will advise CoreWeave, promptly after it receives notice thereof, of any request by the SEC for the amendment of the proxy statement or comments thereon and responses thereto or requests by the SEC for additional information. If at any time prior to the effective time any information relating to Core Scientific, CoreWeave, or any of their respective affiliates, officers or directors, is discovered by Core Scientific or CoreWeave which should be set forth in an amendment or supplement to either the registration statement or the proxy statement so that any of such documents would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the party which discovers such information will promptly notify the other parties and an appropriate amendment or supplement describing such information will be promptly filed with the SEC, after the other party has had a reasonable opportunity to review and comment thereon, and to the extent required by applicable law, disseminated to Core Scientific stockholders. </div> <div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">The Special Meeting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific is required to take all action necessary in accordance with applicable law and its organizational documents to duly give notice of, establish a record date for, convene and hold as soon as reasonably practicable, and in any event within 45 days of the Registration Statement being declared effective under the Securities Act and the first mailing of the definitive proxy statement/prospectus, the Special Meeting to obtain the Core Scientific Stockholder Approval. Subject to terms described in the section titled &#8220;&#8212;Obligations to Recommend the Adoption of the Merger Agreement&#8221;, Core Scientific is required, through the Core Scientific board, to recommend that its stockholders adopt the Merger Agreement and to use reasonable best efforts to solicit from its stockholders proxies in favor of the adoption of the Merger Agreement and to take all other action necessary or advisable to secure the vote or consent of Core Scientific stockholders required by Core Scientific&#8217;s organizational documents, the rules of Nasdaq or applicable law to obtain such approvals. Core Scientific may not submit at the Special Meeting any matter for approval of its stockholders other than those required for the Core Scientific Stockholder Approval (and other than matters of procedure and matters required by or advisable under applicable law to be voted on by stockholders in connection therewith). Once Core Scientific has established a record date for the Special Meeting, Core Scientific will not change such record date or establish a different record date for the Special Meeting without the prior written consent of CoreWeave (such consent not to be unreasonably withheld, conditioned or delayed), unless otherwise required by applicable law. Additionally, Core Scientific will, reasonably promptly following any written request by CoreWeave (but in any event not more than once in any ten business day period), run a broker search for a deemed record date of twenty (20) business days after the date of such search for the Special Meeting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific will schedule and hold the Special Meeting as promptly as practicable after the Registration Statement is declared effective under the Securities Act (no later than the 45<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the first mailing of the proxy statement/prospectus); provided, that Core Scientific may, after reasonable consultation with CoreWeave, postpone, recess or adjourn the Special Meeting, and, if applicable, set a new record date for such meeting, (A) if required by law, (B) in order to obtain the requisite number of affirmative votes in person or by proxy as of such later date, or (C) to allow reasonable additional time for the filing and mailing of any supplemental or amended disclosure which the Core Scientific </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">235<br></div></div></div>
<!--End Page 246-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 247-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">board has determined in good faith after consultation with outside legal counsel is reasonably likely to be required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by Core Scientific&#8217;s stockholders prior to the Special Meeting; provided, however, that the Special Meeting may not be postponed or adjourned to a date that is more than 15 business days after the date for which the Special Meeting was originally scheduled (excluding any adjournments or postponements required by applicable law), or such shorter number of days such that the Special Meeting is reconvened no more than three business days prior to April&#160;7, 2026, without the prior written consent of CoreWeave (such consent not to be unreasonably withheld, conditioned or delayed). Core Scientific agrees that, unless the Merger Agreement is terminated in accordance with its terms, its obligation to hold the Special Meeting will not be affected by the making of any Adverse Recommendation Change (provided that in such event Core Scientific will have no obligation to solicit proxies to obtain the Core Scientific Stockholder Approval). Core Scientific will provide updates to CoreWeave with respect to the proxy solicitation for the Special Meeting (including interim results) as reasonably requested by CoreWeave. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tOTR1"><!--Anchor--></a>Obligation to Recommend the Adoption of the Merger Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as described below, Core Scientific has agreed that neither the Core Scientific board nor any committee thereof will directly or indirectly: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">withhold, withdraw (or amend, qualify or modify in a manner adverse to CoreWeave or Merger Sub), or publicly propose to withdraw (or amend, qualify or modify in a manner adverse to CoreWeave or Merger Sub), the approval, recommendation or declaration of advisability by the Core Scientific board or any such committee of the Merger; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">recommend, adopt or approve, or propose publicly to recommend, adopt or approve any Acquisition Proposal or resolve to take such action; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">publicly make any recommendation in connection with a tender offer or exchange offer by a third party other than a recommendation against such offer or a temporary &#8220;stop, look and listen&#8221; communication by the Core Scientific board of the type contemplated by Rule&#160;14d-9(f) under the Exchange Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">fail to include the Core Scientific board&#8217;s recommendation that Core Scientific stockholders approve the Merger and adopt the Merger Agreement (the &#8220;Core Scientific Board Recommendation&#8221;) in this proxy statement/prospectus; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">fail to reaffirm or re-publish the Core Scientific Board Recommendation following the date any Acquisition Proposal or any material modification thereto is first publicly disclosed or announced within ten business days of being requested by CoreWeave to do so or, if earlier, not later than two business days prior to the Special Meeting (any action described in this bullet point and the three preceding bullet points being referred to as an &#8220;Adverse Recommendation Change&#8221;). Such ten business day period will be extended for an additional five business days following any material modification to any Acquisition Proposal occurring after the receipt of CoreWeave&#8217;s request. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A &#8220;stop, look and listen&#8221; disclosure pursuant to Rule&#160;14d-9(f) promulgated under the Exchange Act, in connection with a tender or exchange offer, will not constitute an Adverse Recommendation Change. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">However, prior to obtaining the Core Scientific Stockholder Approval, and subject to Core Scientific&#8217;s compliance in all material respects with its obligations to call a special meeting to adopt the Merger Agreement (which are described in the section titled &#8220;<font style="font-style: italic;">&#8212;</font>The Special Meeting&#8221;) and non-solicitation obligations under the Merger Agreement (which are described in the section &#8220;<font style="font-style: italic;">&#8212;</font>No Solicitation&#8221;), in response to an Acquisition Proposal that the Core Scientific board has determined, after consultation with its outside legal counsel and financial advisors, is a Superior Proposal that has not been withdrawn and did not result from a non-de minimis breach of Core Scientific&#8217;s non-solicitation obligations under the Merger Agreement (as described in the section &#8220;<font style="font-style: italic;">&#8212;</font>No Solicitation&#8221;), the Core Scientific board may make an Adverse Recommendation Change or terminate the Merger Agreement in order to enter into a definitive agreement with respect to the Superior Proposal. However, in such a situation, Core Scientific may not make an Adverse Recommendation Change or terminate the Merger Agreement in response to a Superior Proposal: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 4pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">until four business days after Core Scientific provides written notice to CoreWeave advising CoreWeave that the Core Scientific board has received a Superior Proposal, specifying the terms and conditions of the proposal, identifying the person or group making the proposal and including copies of all documents pertaining to the proposal (with any change to the financial or other terms of a proposal that was previously the subject of a notice requiring a new notice, with the notice period in such case being two business days); </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">236<br></div></div></div>
<!--End Page 247-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 248-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if during such notice period, Core Scientific has negotiated, and has caused its representatives to negotiate in good faith with CoreWeave (to the extent CoreWeave wishes to negotiate) and CoreWeave proposes any alternative transaction in writing (including any modifications to the terms of the Merger Agreement), unless the Core Scientific board determines in good faith, after good faith negotiations between Core Scientific and CoreWeave (if such negotiations are requested by CoreWeave) during such notice period (after consultation with Core Scientific&#8217;s outside legal counsel and financial advisors and taking into account all financial, legal and regulatory terms and conditions of such alternative transaction proposal and expected timing of consummation and the relative risks of non-consummation of the alternative transaction proposal and the Superior Proposal) that the Acquisition Proposal giving rise to such notice period continues to be a Superior Proposal (assuming such revisions proposed by CoreWeave were to be given effect); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">unless the Core Scientific board determines in good faith after consultation with its outside legal counsel and financial advisors that the failure to make an Adverse Recommendation Change would be inconsistent with its fiduciary obligations under applicable law. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, prior to obtaining the Core Scientific Stockholder Approval, the Core Scientific board may effect an Adverse Recommendation Change in response or relating to an &#8220;Intervening Event&#8221; (as defined below) if the Core Scientific board determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable law; provided that: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific must first notify CoreWeave in writing at least four business days before taking such action of its intention to take such action, which notice must include a reasonably detailed description of such Intervening Event (with any material change to the facts and circumstances relating to the Intervening Event that was previously the subject of a notice requiring a new notice, with the notice period in such case being two business days); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if requested by CoreWeave, Core Scientific must negotiate, and cause its representatives to negotiate, with CoreWeave and its representatives during such notice period regarding any proposal by CoreWeave to amend the terms of the Merger Agreement in response to such Intervening Event; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Core Scientific board may not effect an Adverse Recommendation Change involving or relating to an Intervening Event unless, after such notice period, the Core Scientific board determines in good faith, after consultation with its outside legal counsel and taking into account any written proposal by CoreWeave to amend the terms of the Merger Agreement during such notice period, that the failure to take such action would continue to be inconsistent with its fiduciary duties under applicable law. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The parties have agreed that, from the date of the Merger Agreement, in addition to complying with the non-solicitation obligations of Core Scientific set forth in the Merger Agreement, as promptly as practicable after receipt thereof, and in any event within 24 hours, Core Scientific will advise CoreWeave in writing of any Acquisition Proposal received from any third party and the identity of the third party or group making any such Acquisition Proposal and the material terms and conditions thereof. Core Scientific has also agreed that it will keep CoreWeave reasonably informed, on a reasonably current basis, of the status and details of any such Acquisition Proposal, and will promptly, and in any event within twenty-four (24) hours, provide to CoreWeave copies of all such information, correspondence and written materials sent or provided to Core Scientific or any of its subsidiaries that describes any terms or conditions of any Acquisition Proposal (as well as written summaries of any material oral communications in which such third party has proposed any such terms or conditions). Any material amendment to any Acquisition Proposal will be deemed to be a new Acquisition Proposal for purposes of Core Scientific&#8217;s compliance with this paragraph. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the purposes of the Merger Agreement, an &#8220;Acquisition Proposal&#8221; means any bona fide indication of interest, inquiry, proposal or offer, whether or not in writing, from any person (other than CoreWeave or any of its subsidiaries), relating to any transaction or series of related transactions (other than certain transactions identified in the confidential disclosure letter delivered by Core Scientific to CoreWeave and Merger Sub) involving the (a) direct or indirect acquisition or purchase of a business or assets that constitutes 20% or more of the consolidated net revenues, net income or the assets (based on the fair market value thereof) of Core Scientific and its subsidiaries, taken as a whole, (b) direct or indirect issuance, acquisition or purchase of 20% or more of any class of equity securities, capital stock or voting securities (or any equity securities convertible into or exchangeable or redeemable for any such equity securities, capital stock or voting securities) of Core Scientific or any of its subsidiaries whose </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">237<br></div></div></div>
<!--End Page 248-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 249-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">business or assets constitute 20% or more of the consolidated net revenues, net income or assets of Core Scientific and its subsidiaries, taken as a whole, (c) tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in any person (other than CoreWeave or any of its subsidiaries) or group beneficially owning 20% or more of any class of equity securities, capital stock or voting securities of Core Scientific (or any equity securities convertible into, or exchangeable or redeemable for, any such equity or voting securities), (d)&#160;merger, consolidation, amalgamation, restructuring, transfer of assets or other business combination, joint venture, liquidation, dissolution, sale of shares of capital stock, share exchange, recapitalization or other similar transaction involving Core Scientific or any of its subsidiaries that if consummated would result in any person (other than CoreWeave or any of its subsidiaries) acquiring businesses or assets that constitute 20% or more of the consolidated net revenues, net income or assets of Core Scientific and its subsidiaries, taken as a whole or (e) any combination of the foregoing of clauses (a) through (d). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, for the purposes of the Merger Agreement, an &#8220;Intervening Event&#8221; means any material event, change, effect, development or occurrence first occurring or arising after the date of the Merger Agreement and prior to the Core Scientific Stockholder Approval that (i) was not known or reasonably foreseeable, or the material consequences of which were not known or reasonably foreseeable, to the Core Scientific board as of or prior to the execution of the Merger Agreement and (ii) does not relate to (A) any Acquisition Proposal or any inquiry, offer, request or proposal that would reasonably be expected to lead to an Acquisition Proposal, (B) any change in the market price or trading volume of the Core Scientific common stock or CoreWeave common stock (provided, that the underlying cause of such change may be taken into account, to the extent otherwise permitted by this definition), (C) the fact, in and of itself, that Core Scientific or any of its subsidiaries has met or exceeded any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (provided, that the underlying cause thereof may be taken into account, to the extent otherwise permitted by this definition), (D) any action taken by the parties pursuant to the affirmative covenants set forth in the section of the Merger Agreement relating to the parties&#8217; regulatory efforts, or (E) any breach of the Merger Agreement by Core Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, for the purposes of the Merger Agreement, a &#8220;Superior Proposal&#8221; means a written Acquisition Proposal (except the references in the definition thereof to &#8220;20%&#8221; are replaced by &#8220;50%&#8221;) made by any person (other than CoreWeave or any of its subsidiaries) that the Core Scientific board has determined in good faith, after consultation with its financial advisors and outside legal counsel, and after taking into account the legal, financial, conditional, financing, timing and regulatory aspects of the proposal and the transactions contemplated by the Merger Agreement (accounting for any revisions to the terms of the transactions proposed by CoreWeave in response to such Acquisition Proposal as contemplated above), (i) is reasonably likely to be consummated in accordance with its proposed terms if accepted by Core Scientific and (ii) if consummated, would be more favorable, from a financial point of view, to the stockholders (in their capacity as such) of Core Scientific than the transactions contemplated by the Merger Agreement. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tNS1"><!--Anchor--></a>No Solicitation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the exceptions described in the previous section and below, from the date of the Merger Agreement and continuing until the earlier of the effective time and the date, if any, on which the Merger Agreement is terminated in accordance with its terms, Core Scientific has agreed that it will not, and will cause its subsidiaries and its and their directors and officers not to, and will use its reasonable best efforts to cause its and their respective representatives not to, directly or indirectly: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">initiate, seek or solicit, or knowingly encourage or facilitate (including by way of furnishing non-public information) or knowingly cooperate with or take any other action that would reasonably be expected to promote, directly or indirectly, any inquiries or the making or submission of any proposal by a third party that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">participate, engage in or continue discussions (except to notify a person that makes an inquiry or offer with respect to an Acquisition Proposal of the existence of the provisions of the Merger Agreement described by this paragraph or to clarify whether any such inquiry, offer or proposal constitutes an Acquisition Proposal) or negotiations with, or disclose any non-public information or data relating to, Core Scientific or any of its subsidiaries or afford access to the properties, books or records of Core Scientific, or any of its subsidiaries to, or otherwise knowingly assist, facilitate or encourage any effort by, any third party, in each case, that has made or could reasonably be expected to make, or in connection with, an Acquisition Proposal; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">238<br></div></div></div>
<!--End Page 249-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 250-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">enter into any agreement, including any letter of intent, term sheet, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement (other than certain confidentiality agreements permitted under the Merger Agreement), with respect to an Acquisition Proposal; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">otherwise resolve or agree to do any of the items in the three bullet points above. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has agreed that it will not release or permit the release of any person from, or waive or permit the waiver of, any standstill or similar agreement with respect to any class of equity securities of Core Scientific or any of its subsidiaries, and will enforce or cause to be enforced each such agreement in accordance with its terms; provided, however, that Core Scientific may waive or fail to enforce any provision of such standstill or similar agreement of any person if the Core Scientific board determines in good faith, after consultation with its financial advisors and outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under applicable law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has agreed to, and to cause its subsidiaries to, use reasonable best efforts to cause its and their respective representatives to, immediately cause to be terminated any solicitation, encouragement, discussion or negotiation with or involving any person (other than CoreWeave and its affiliates) conducted prior to the execution of the Merger Agreement by Core Scientific or any of its subsidiaries, or any of its or their respective representatives, with respect to an Acquisition Proposal. Core Scientific has agreed to immediately discontinue access by any person (other than CoreWeave and its affiliates and representatives) to any data room (virtual or otherwise) established by Core Scientific for the purpose of soliciting, intentionally encouraging or negotiating an Acquisition Proposal. Within five business days from the date of the Merger Agreement, Core Scientific has agreed to request the return or destruction of all confidential, non-public information provided to third parties that had entered into confidentiality agreements with Core Scientific or any of its subsidiaries since June&#160;30, 2024 relating to an Acquisition Proposal (substituting 50% for the 20% threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for the purpose of this sentence), to the extent provided for by the terms of any confidentiality agreements entered into in connection with the furnishing of such confidential information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding the foregoing restrictions, from the date of the Merger Agreement until obtaining the Core Scientific Stockholder Approval, Core Scientific and the Core Scientific board may take the actions described in the bullet points following the first paragraph of this section titled &#8220;&#8212;No Solicitation,&#8221; with respect to a third party if, (x) Core Scientific receives a written Acquisition Proposal from a third party (and Acquisition Proposal was not initiated, sought, solicited or knowingly encouraged or facilitated in non-de minimis breach of the terms described in this section) and (y) the Core Scientific board determines in good faith after consultation with its financial advisors and outside legal counsel that such proposal is or could reasonably be expected to lead to, a<font style="font-style: italic;"> </font>Superior Proposal; provided, that Core Scientific may deliver non-public information to such third party pursuant to this sentence only pursuant to confidentiality agreements permitted under the Merger Agreement; provided, further, that all such information (to the extent that such information has not been previously provided or made available to CoreWeave) is provided or made available to CoreWeave, as the case may be, prior to or substantially concurrently with the time it is provided or made available to such third party. Core Scientific and the Core Scientific board are permitted to: (i) take and disclose to their stockholders a position with respect to an Acquisition Proposal pursuant to Rules 14d-9, 14e-2(a) or Item&#160;1012(a) of Regulation M-A promulgated under the Exchange Act or (ii) make any disclosure if the Core Scientific board has determined in good faith after consultation with its outside legal counsel and financial advisors that the failure to do so would be reasonably likely to be inconsistent with its fiduciary obligations under applicable law; provided, that this exception will not permit the Core Scientific board to make an Adverse Recommendation Change, except to the extent permitted by the Merger Agreement as described in the section titled &#8220;<font style="font-style: italic;">&#8212;</font>Obligation to Recommend the Adoption of the Merger Agreement.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tRA1"><!--Anchor--></a>Regulatory Approvals </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave each filed with the FTC and the DOJ their respective HSR notifications relating to the Merger on July&#160;25, 2025. Core Scientific and CoreWeave have agreed to, and to cause their respective subsidiaries to, (i) use reasonable best efforts to file, as soon as reasonably practicable after the date of the Merger Agreement, all filings, notifications, or other documents required to be filed with or as requested by any governmental body pursuant to any antitrust law with respect to the Merger and any other transactions contemplated by the Merger Agreement, and (ii) cooperate with the other party in determining whether, and promptly preparing and making, any other filings or notifications or other consents required to be made with, or obtained from, any other governmental bodies in connection with the Merger and any other transactions contemplated by the Merger </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">239<br></div></div></div>
<!--End Page 250-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 251-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Agreement. Further, subject to the terms and conditions set forth in the Merger Agreement, CoreWeave and Core Scientific agreed to use their respective reasonable best efforts to (and to cause their respective subsidiaries to) take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable under applicable law to consummate and make effective the Merger and any other transactions contemplated by the Merger Agreement as soon as reasonably practicable, including: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">obtaining all necessary actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals and, expirations or terminations of waiting periods from governmental bodies and making all necessary registrations and filings and taking all steps as may be reasonably necessary to obtain any such consent, decision, declaration, approval, clearance or waiver, or expiration or termination of a waiting period by or from, or to avoid an action or proceeding seeking to, pursuant to any antitrust law, enjoin, restrain, prevent, prohibit or make illegal consummation of the Merger or any other transaction contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining all necessary consents, authorizations, approvals or waivers from third parties; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">defending any lawsuit or other legal proceeding, whether judicial or administrative, brought by any governmental body or third party challenging the Merger Agreement or seeking to enjoin, restrain, prevent, prohibit or make illegal consummation of the Merger or any other transaction contemplated by the Merger Agreement and contesting and seeking to have vacated, lifted, reversed or overturned any order that enjoins, restrains, prevents, prohibits or makes illegal consummation of the Merger or any other transaction contemplated by the Merger Agreement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">refraining from taking any action that would reasonably be expected to impede, interfere with, prevent or materially delay the consummation of the Merger, other than with respect to the matters set forth in the last paragraph of this section. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In furtherance of the foregoing, solely for the purpose of this section, CoreWeave&#8217;s reasonable best efforts will be deemed to include taking the following actions to the extent necessary, proper or advisable to obtain any regulatory approvals: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">committing to or effecting, by consent decree, hold separate order or otherwise, the sale, lease, license, divestiture or disposition of any assets, equity securities, rights, product lines, or businesses of Core Scientific, CoreWeave or any of their respective subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">terminating existing relationships, contractual rights or obligations of Core Scientific, CoreWeave or any of their respective subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">terminating any venture or other arrangement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">creating any relationship, contractual right or obligation of Core Scientific, CoreWeave or any of their respective subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">effectuating any other change or restructuring of Core Scientific, CoreWeave or any of their respective subsidiaries; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">otherwise taking or committing to take any actions with respect to the businesses, product lines or assets of Core Scientific, CoreWeave or any of their respective subsidiaries (and, in each case, enter into agreements or stipulate to the entry of an order or decree or file appropriate applications with any governmental body in connection with any of the foregoing); </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">(each of the foregoing six bullet points, a &#8220;Remedy Action&#8221;); provided, however, that, notwithstanding anything in the Merger Agreement to the contrary, CoreWeave and its subsidiaries will not be required to take or agree to take (and neither Core Scientific nor any of its subsidiaries will take, offer to take, or otherwise agree to without CoreWeave&#8217;s prior written consent) any Remedy Action that would reasonably be expected to, either individually or in the aggregate, be material to the business, financial condition or results of operations of CoreWeave, Core Scientific and their respective subsidiaries, taken as a whole; provided, however, that for this purpose, CoreWeave, Core Scientific and their respective subsidiaries, taken as a whole, will be deemed a consolidated group of entities of the size and scale of a hypothetical company that is 100% of the size of Core Scientific and its subsidiaries, taken as a whole, as of the date of the Merger Agreement. Notwithstanding the foregoing, at the written request of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">240<br></div></div></div>
<!--End Page 251-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 252-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">CoreWeave, Core Scientific will, and will cause its subsidiaries to, agree to take any Remedy Action so long as such action is conditioned upon the occurrence of the closing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to the terms of the Merger Agreement, applicable laws relating to the sharing of information and the terms and conditions of the confidentiality agreement entered into by CoreWeave and Core Scientific, dated as of June&#160;13, 2025, from the date of the Merger Agreement until the effective time, each party to the Merger Agreement has also agreed to (i) give each other party reasonable advance notice of all meetings (including by telephone or videoconference) with any governmental body relating to the transactions contemplated by the Merger Agreement, (ii) to the extent not prohibited by such governmental body, give the other party (or the other party&#8217;s outside legal counsel) an opportunity to attend and participate in such meeting and consult with the other party in advance of any such meeting with any government body, in respect of any filing, proceeding, investigation (including the settlement of any investigation), litigation or other inquiry regarding the Merger or any other transaction contemplated by the Merger Agreement, (iii) to the extent practicable, give the other party reasonable advance notice of material oral communications with any governmental body relating to the Merger or any other transaction contemplated by the Merger Agreement, (iv) if any governmental body initiates material oral communication relating to the Merger or any other transaction contemplated by the Merger Agreement or such party provides material oral communications to a governmental body, promptly notify the other party of the substance of such communication, (v) provide each other with a reasonable advance opportunity to review and comment upon and consider in good faith the views of the other in connection with all written communications (including any analyses, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any party hereto relating to proceedings under antitrust laws) with a governmental body relating to the Merger or any other transaction contemplated by the Merger Agreement and (vi) promptly provide each other with copies of all written communications to or from any governmental body relating to the Merger or any other transaction contemplated by the Merger Agreement. Neither party may commit to or agree with any governmental body to (i) stay, toll or extend any applicable waiting period under the HSR Act, (ii) pull and refile or resubmit notification and report forms pursuant to the HSR Act, as applicable to the Merger and any transaction contemplated by the Merger Agreement, (iii) not consummate the Merger or any other transaction contemplated by the Merger Agreement before an agreed to date, or (iv) any timing agreement, in each case of the foregoing clauses (i)-(iv), without the prior written consent of the other party (such consent not to be unreasonably withheld, conditioned or delayed). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each party will consult with the other party and consider in good faith the views of the other party with respect to the defense of the Merger Agreement and the transactions contemplated by the Merger Agreement before any governmental body and the scheduling of, and strategic planning for, any meetings with, and the conducting of negotiations with, any governmental body regarding (i) the expiration or termination of any applicable waiting period relating to the Merger or any other transaction contemplated by the Merger Agreement under the HSR Act or (ii)&#160;obtaining any consent, approval, waiver, clearance, authorization or permission from a governmental body (collectively, the &#8220;Strategic Direction&#8221;); provided, that, subject to the terms of the Merger Agreement, CoreWeave will have the right to make the final determination as to the appropriate course of action with respect to the Strategic Direction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, without limiting the foregoing, each party has agreed that it will not, and will cause its respective subsidiaries not to, effect or agree to acquire any assets, licenses, rights, product lines, operations, business or person that competes with Core Scientific to the extent that such acquisition would reasonably be expected to prevent or materially delay the satisfaction of the closing conditions regarding (i) receipt of any required regulatory approval and (ii) the absence of any order enacted, promulgated, issued or entered by any governmental body enjoining, restraining, preventing or prohibiting the consummation of the Merger and the absence of any law in effect or enacted or promulgated prohibiting or making illegal the consummation of the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;"><a name="tIOD"><!--Anchor--></a>Indemnification of Officers and Directors </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has agreed that all rights to indemnification, advancement of expenses and exculpation from liabilities for acts or omissions occurring at or prior to the effective time in favor of the present and former directors, executive officers, and employees of Core Scientific or any of its subsidiaries as provided in Core Scientific&#8217;s and its subsidiaries&#8217; organizational documents, and indemnification agreements of Core Scientific and its subsidiaries in existence as of the date of the Merger Agreement, all of which are on terms that are not more favorable to the indemnified party than the form filed as Exhibit&#160;10.6 to Core Scientific&#8217;s Annual Report on 10-K for the fiscal year ended December&#160;31, 2024, will survive the Merger and will continue in full force and effect in accordance with their terms. CoreWeave has agreed to cause the certificate of incorporation and bylaws of the Surviving Corporation and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">241<br></div></div></div>
<!--End Page 252-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 253-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">the organizational documents of Core Scientific&#8217;s subsidiaries to contain provisions no less favorable with respect to indemnification, advancement of expenses, and exculpation from liabilities of present and former directors, executive officers, and employees of Core Scientific or its subsidiaries than are currently provided in Core Scientific&#8217;s and its subsidiaries&#8217; organizational documents. CoreWeave has agreed that these provisions may not be amended, repealed or otherwise modified in any manner that would adversely affect the rights thereunder until six years from the effective time, and, in the event that any action is pending or asserted or made during such period, until the disposition of any such action, unless such amendment, modification or repeal is required by applicable law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From and after the effective time, CoreWeave and the Surviving Corporation are required to, jointly and severally, indemnify and hold harmless each person who is or was a (i) director or executive officer (for the purposes of this sentence, &#8220;executive officer&#8221; includes those who, while serving as a director or executive officer of Core Scientific, is or was serving at the request of Core Scientific as a director, officer, employee, or agent of another corporation, including service with respect to an employee benefit plan) or (ii) other employee of Core Scientific or any of its subsidiaries, against all obligations to pay any threatened, asserted, pending or completed judgment, damages, settlement, losses, liabilities, or fine or penalty, interest and reasonable expenses incurred in connection with any action, whether civil, criminal, administrative, arbitrative or investigative, and whether formal or informal, by reason of the fact that the indemnified party is or was an executive officer, director or employee of Core Scientific or its subsidiaries, or an executive officer, director or employee of another entity if such service was at the request of Core Scientific, whether asserted or claimed prior to, at, or after the effective time, to the fullest extent provided for under applicable law, Core Scientific&#8217;s organizational documents, the organizational documents of Core Scientific&#8217;s subsidiaries and indemnification agreements of Core Scientific and its subsidiaries in existence as of the date of the Merger Agreement, all of which are on terms that are not more favorable to the indemnified party than the form filed as Exhibit&#160;10.6 to Core Scientific&#8217;s Annual Report on 10-K for the fiscal year ended December&#160;31, 2024. From and after the effective time, CoreWeave will advance to such indemnified party the claim expenses incurred by the indemnified party in connection with any such claims prior to its final disposition, and such advancement will be made as soon as reasonably practicable, but in any event no later than 30 days, after the receipt by CoreWeave or the Surviving Corporation of a written statement or statements requesting such advances from time to time (which will include invoices received by such indemnified party in connection with such claim expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditure made that would cause the indemnified party to waive any privilege accorded by applicable law will not be included with the invoice); provided that any such advances will be unsecured and interest free and made without regard to the indemnified party&#8217;s ability to repay such advances; provided, further, any person to whom expenses are advanced provides an undertaking to repay such advances if it is ultimately determined that such person is not entitled to be indemnified by CoreWeave or the Surviving Corporation; provided, further, that CoreWeave or the Surviving Corporation will not be obligated to make any advancement to the extent advancement is prohibited by law, Core Scientific&#8217;s organizational documents, the organizational documents of Core Scientific&#8217;s subsidiaries or any indemnification agreement in existence as of the date of the Merger Agreement to which such person and Core Scientific or any of its subsidiaries is a party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific will, prior to the effective time, purchase a tail policy or policies under the current directors&#8217; and officers&#8217; liability insurance policies maintained at such time by Core Scientific, and if Core Scientific does not obtain such tail policy or policies prior to the effective time of the Merger, CoreWeave or the Surviving Corporation will use reasonable best efforts to obtain such policy or policies (provided that the total premium for such tail policy or policies will not be in excess of 300% of the last annual premium paid by Core Scientific prior to the effective time (the &#8220;maximum premium&#8221;). The tail policy or policies are required to (i) be effective for a period from the effective time through and including the date six years after the effective time with respect to claims arising from acts, errors or omissions that existed or occurred prior to or at the effective time and (ii) provide coverage and amounts that are at least as protective to such directors and officers as the coverage provided by such existing policies and must contain other terms and conditions that are no less favorable to the covered individuals as the terms and conditions in such existing policies; provided, that the total premium for such tail policy or policies may not be in excess of the maximum premium. If such tail policy or policies cannot be obtained or can be obtained only by paying aggregate premiums in excess of the maximum premium, CoreWeave, or the Surviving Corporation are only required to obtain as much coverage as can be obtained by paying a premium equal to the maximum premium. CoreWeave is required to cause such tail policy or policies (whether obtained by Core Scientific, CoreWeave or the Surviving Corporation) to be maintained in full force and effect for their full term, and cause all obligations thereunder to be honored by the Surviving Corporation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">242<br></div></div></div>
<!--End Page 253-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 254-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Employee Matters </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the period commencing at the effective time and ending on the date that is the first anniversary of the effective time, CoreWeave will, or will cause one of its subsidiaries to, provide each Core Scientific employee with: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">annual base salary or wages, as applicable, that are no less than the annual base salary or wages, as applicable, in effect for each such Core Scientific employee immediately prior to the effective time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">target cash incentive opportunities that are no less than the target cash incentive opportunities in effect for such Core Scientific employee immediately prior to the effective time; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">annual target long-term incentive opportunities that are no less than the target long-term incentive opportunities in effect for similarly situated CoreWeave employees (excluding any off-cycle awards or any awards granted in connection with new hires or promotion); and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">employee benefits and other compensation (excluding any equity, equity-based or other long-term incentive compensation, deferred compensation, perquisites, change-in-control, transaction, stay, retention or similar bonuses or payments, severance or termination benefits) to such Core Scientific employee that are substantially comparable in the aggregate to those provided to such employee by Core Scientific and its subsidiaries immediately prior to the effective time or those provided to similarly situated employees of CoreWeave. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, during the period commencing at the effective time and ending on the date that is the first&#160;anniversary of the effective time, CoreWeave will, and will cause one of its subsidiaries to, provide each Core Scientific employee with severance and termination benefits that are no less favorable than the severance policies as set forth in Core Scientific&#8217;s confidential disclosure letter. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">With respect to any compensation or employee benefit plans or programs of CoreWeave or its subsidiaries in which any Core Scientific employees become eligible to participate on or after the effective time, CoreWeave and its subsidiaries will (or will cause the Surviving Corporation to) use commercially reasonable efforts to (i) waive all pre-existing conditions, exclusions and waiting periods with respect to participation and coverage requirements, except to the extent such pre-existing conditions, exclusions or waiting periods would apply under the analogous Core Scientific employee benefit plan, (ii) provide each such employee and their eligible dependents with credit for any co-payments or coinsurance and deductibles paid under a Core Scientific benefit plan that provides health care benefits during such plan year in which such employee becomes eligible for the CoreWeave benefit plan, to the same extent that such credit was given under the analogous Core Scientific employee benefit plan with respect to such plan year, in satisfying any applicable deductible, co-payment, coinsurance or maximum out-of-pocket requirements under any employee benefit plan of CoreWeave that provides health care benefits, and (iii) recognize all service of such employees with Core Scientific and its subsidiaries for all purposes with respect to any eligible CoreWeave benefit plan to the same extent that such service was taken into account under the analogous Core Scientific benefit plan prior to the effective time, subject to customary exclusions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the closing, Core Scientific will use commercially reasonable efforts to take all actions necessary to cause the account balances of the current and former employees of Core Scientific under the 401(k) plan (the &#8220;PEO 401(k) Plan&#8221;) sponsored by the professional employer organization engaged by Core Scientific (the &#8220;PEO&#8221;) to be spun off into a separate standalone 401(k) plan sponsored by Core Scientific that is intended to qualify under Section&#160;401(a) of the Code (the &#8220;Core Scientific 401(k) Plan&#8221;) in compliance with applicable laws, including the relevant provisions of ERISA and the Code, and PEO 401(k) Plan documents. If such plan spin-off is able to be timely completed based on commercially reasonable efforts of Core Scientific, then not less than three business days prior to the anticipated closing date, Core Scientific will take (or cause to be taken) all actions necessary and appropriate to terminate the Core Scientific 401(k) Plan, with such termination of the Core Scientific 401(k) Plan to be effective no later than the day immediately preceding the closing date (but contingent upon the closing). If the Core Scientific 401(k) Plan is terminated as described in this paragraph, Core Scientific will deliver to CoreWeave, no later than the day immediately preceding the closing date, evidence that the Core Scientific 401(k) Plan has been validly terminated. Additionally, CoreWeave will take all commercially reasonable actions to make the Core Scientific employees eligible to participate, effective as of immediately after the effective time, in a 401(k) plan sponsored by CoreWeave or a subsidiary of CoreWeave (the &#8220;CoreWeave 401(k) Plan&#8221;). If the Core Scientific 401(k) Plan is terminated as described in this paragraph, CoreWeave will also take all commercially reasonable actions to allow Core Scientific employees to make rollover contributions to the CoreWeave 401(k) Plan of &#8220;eligible rollover distributions&#8221; within the meaning of Section&#160;401(a)(31) of the Code from the Core Scientific 401(k) Plan, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">243<br></div></div></div>
<!--End Page 254-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 255-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">in the form of cash (and/or notes evidencing loans), in an amount equal to the full account balance (including loans) distributed to such Core Scientific employee from the Core Scientific 401(k) Plan. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tOA1"><!--Anchor--></a>Other Agreements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement contains certain other covenants and agreements, including covenants and agreements relating to, among other things, and subject to certain exceptions and qualifications described in the Merger Agreement: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">confidentiality and reasonable access by CoreWeave and its representatives to personnel of and certain information about Core Scientific and its subsidiaries for purposes reasonably related to consummating the transactions contemplated by the Merger Agreement or preparing for post-Merger integration or restructuring and the development of mutually acceptable protocols to manage communications between the parties and their respective employees; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">consultation between Core Scientific and CoreWeave in connection with certain public announcements; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">requirement for CoreWeave and Core Scientific and their respective boards to, subject to the terms of the Merger Agreement, grant such approvals and take such actions to eliminate the effect of any takeover law on any of the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">requirement for the CoreWeave board to approve the issuance of the Merger Consideration with respect to any employees of Core Scientific who, as a result of their relationship with CoreWeave, are subject or will become subject to the reporting requirements of Section&#160;16 of the Exchange Act to the extent necessary for such issuance to be an exempt acquisition pursuant to SEC Rule&#160;16b-3; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">requirement for the Core Scientific board to, to the extent necessary, approve the disposition of equity securities of Core Scientific by specified individuals to cause the disposition to be an exempt disposition under Rule&#160;16b-3 of the Exchange Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cooperation between Core Scientific and CoreWeave in the defense of certain litigation relating to the Merger and the transactions contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the use of Core Scientific&#8217;s and CoreWeave&#8217;s respective reasonable best efforts to cause the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cooperation between Core Scientific and CoreWeave in causing the delisting by the Surviving Corporation of Core Scientific common stock, the Tranche 1 Warrants and the Tranche 2 Warrants from Nasdaq and the deregistration of Core Scientific common stock, the Tranche 1 Warrants and the Tranche 2 Warrants under the Exchange Act; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave causing Merger Sub to not engage in any activities except as provided in or contemplated by the Merger Agreement; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">cooperation between Core Scientific and CoreWeave with respect to CoreWeave obtaining, at CoreWeave&#8217;s sole cost and expense, such title insurance (including any non-imputation and other endorsements) that CoreWeave reasonably determines to obtain in respect of the real property owned by Core Scientific and its subsidiaries; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific using reasonable best efforts to provide CoreWeave certain schedules of Core Scientific equity awards; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">requirement for Core Scientific to provide certain cooperation in connection with the arrangement of a debt financing undertaken by CoreWeave to finance the transactions contemplated by the Merger Agreement as may be customary and reasonably requested by CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">obtaining third party consents; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">further assurances; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">providing the other party with notice of certain events; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">certain matters related to indebtedness of Core Scientific. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">244<br></div></div></div>
<!--End Page 255-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 256-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"><a name="tTOT1"><!--Anchor--></a>Termination of the Merger Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Merger Agreement may be terminated and the Merger may be abandoned: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to the effective time, by the mutual written consent of CoreWeave and Core Scientific; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by CoreWeave: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to the effective time, if any of Core Scientific&#8217;s covenants, representations or warranties contained in the Merger Agreement are or have become untrue, such that any of the closing conditions for CoreWeave relating to the accuracy of Core Scientific&#8217;s representations and warranties or compliance by Core Scientific with its covenants and agreements would not be satisfied, and such breach (A) is incapable of being cured by Core Scientific by or before the End Date or (B) is not cured within 30 days of receipt by Core Scientific of written notice from CoreWeave of such breach; provided, however, that CoreWeave will not have the right to terminate the Merger Agreement as described in this bullet point if any of CoreWeave or Merger Sub is then in breach of any representation, warranty, covenant or obligation under the Merger Agreement that would result in the failure to be satisfied of any of the closing conditions for Core Scientific relating to the accuracy of CoreWeave&#8217;s or Merger Sub&#8217;s representations and warranties or compliance by CoreWeave or Merger Sub with their covenants and agreements under the Merger Agreement; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to obtaining the Core Scientific Stockholder Approval, if the Core Scientific board or any committee thereof makes an Adverse Recommendation Change; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by Core Scientific: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to the effective time, if any of CoreWeave&#8217;s or Merger Sub&#8217;s covenants, representations or warranties contained in the Merger Agreement are or have become untrue, such that any of the closing conditions for Core Scientific relating to the accuracy of CoreWeave&#8217;s or Merger Sub&#8217;s representations and warranties or compliance by CoreWeave or Merger Sub with its covenants and agreements would not be satisfied, and such breach (A) is incapable of being cured by CoreWeave or Merger Sub, as the case may be, by or before the End Date, or (B) is not cured within 30 days of receipt by CoreWeave of written notice from Core Scientific of such breach; provided, however, that Core Scientific will not have the right to terminate the Merger Agreement as described in this bullet point if Core Scientific is then in breach of any representation, warranty, covenant or obligation under the Merger Agreement that would result in the failure to be satisfied of any of the closing conditions for CoreWeave relating to the accuracy of Core Scientific&#8217;s representations and warranties or compliance by Core Scientific with its covenants and agreements under the Merger Agreement; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at any time prior to obtaining the Core Scientific Stockholder Approval (and subject to Core Scientific&#8217;s obligation to pay CoreWeave the Termination Fee), upon written notice to CoreWeave, in order to enter into a definitive agreement with a third party providing for a Superior Proposal, if in connection with such Superior Proposal, Core Scientific has complied in all material respects with its requirements as described in the sections titled &#8220;<font style="font-style: italic;">&#8212;</font>Obligations to Recommend the Adoption of the Merger Agreement&#8221;<font style="font-style: italic;"> </font>and<font style="font-style: italic;"> </font>&#8220;<font style="font-style: italic;">&#8212;</font>No Solicitation&#8221;; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">by either CoreWeave or Core Scientific at any time prior to the effective time, if: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">(A) any order has become final and non-appealable, or (B) there is a law, in each case of (A) and (B) having the effect of permanently enjoining or restricting the consummation of the Merger or making the Merger illegal or otherwise prohibited; provided, however, that the right to terminate the Merger Agreement as described in this bullet point will not be available to any party whose material failure to comply with any provision of the Merger Agreement has been the primary cause of such order or law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the closing has not been consummated by the End Date; provided, that the right to terminate the Merger Agreement as described in this bullet point will not be available to any party whose material failure to comply with any provision of the Merger Agreement has been the primary cause of the failure of the Merger to occur on or before the End Date; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the Core Scientific Stockholder Approval has not been obtained at the Special Meeting, including any adjournment or postponement thereof; provided, that the right to terminate the Merger Agreement as </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">245<br></div></div></div>
<!--End Page 256-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 257-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_bl" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 60pt; text-align: justify;">described in this bullet point will not be available to Core Scientific if its material failure to comply with any provision of the Merger Agreement has been the primary cause of the failure to obtain the Core Scientific Stockholder Approval on or before such date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of the valid termination of the Merger Agreement by either CoreWeave or Core Scientific, the Merger Agreement will be of no further force or effect. Certain provisions in the Merger Agreement relating to confidentiality, the Termination Fee, applicable law, third-party beneficiaries, reimbursement of expenses, termination, specific performance and certain other miscellaneous provisions will survive the termination of the Merger Agreement and will remain in full force and effect, and no such termination will relieve any person of any liability for fraud or an intentional breach of the Merger Agreement. Nothing will limit or prevent CoreWeave or Core Scientific from exercising any rights or remedies it may have related to specific performance in lieu of exercising any right it may have to terminate the Merger Agreement; provided that if the Merger Agreement is terminated, no party will have any rights or remedies for specific performance other than in respect of the provisions that are identified as surviving termination. No termination of the Merger Agreement will affect the obligations of the parties contained in the confidentiality agreement entered by Core Scientific and CoreWeave in connection with the transaction, all of which will survive the termination of the Merger Agreement in accordance with their terms. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;"><a name="tTE1"><!--Anchor--></a>Termination Fee </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger Agreement is terminated under specified circumstances, Core Scientific may be required to pay CoreWeave a termination fee of $270,000,000 (the &#8220;Termination Fee&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement provides that Core Scientific will pay the Termination Fee to CoreWeave if the Merger Agreement is terminated by: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave, at any time prior to obtaining the Core Scientific Stockholder Approval, as a result of the Core Scientific board or any committee thereof making an Adverse Recommendation Change; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave due to Core Scientific&#8217;s intentional breach of any provision of the Merger Agreement and (A)&#160;after the date of the Merger Agreement and prior to such termination, any third party has publicly disclosed or otherwise communicated to the Core Scientific board an Acquisition Proposal and such Acquisition Proposal, if public, has not have been publicly withdrawn at least two business days prior to such termination, and (B) within 12 months of any termination described in this bullet point, (x) Core Scientific or any of its subsidiaries enters into a definitive agreement with respect to an Acquisition Proposal (substituting fifty percent (50%) for the twenty percent (20%) threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for all purposes under this bullet point) that is subsequently consummated or (y)&#160;Core Scientific or its subsidiaries consummates an Acquisition Proposal; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific, at any time prior to obtaining the Core Scientific Stockholder Approval, in order to enter into a definitive agreement with a third party providing for a Superior Proposal; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave or Core Scientific as a result of (i) the Merger not having been consummated by the End Date without the Core Scientific Stockholder Approval having been obtained or (ii) the Core Scientific Stockholder Approval not having been obtained at the Special Meeting and (A) after the date of the Merger Agreement and prior to such termination, any third party has publicly disclosed an Acquisition Proposal and such Acquisition Proposal has not have been publicly withdrawn at least two business days prior to (x) the date of such termination (in the case of termination as a result of the Merger not having been consummated by the End Date) or (y) the Special Meeting (in the case of a termination as a result of the Core Scientific Stockholder Approval not having been obtained at the Special Meeting), and (B) within 12&#160;months of any termination described in this bullet point, (x) Core Scientific or any of its subsidiaries enters into a definitive agreement with respect to an Acquisition Proposal (substituting fifty percent (50%) for the twenty percent (20%) threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for all purposes under this bullet point) that is subsequently consummated or (y) Core Scientific or its subsidiaries consummates an Acquisition Proposal. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the purposes of the Merger Agreement and the description thereof contained in this proxy statement/prospectus: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If Core Scientific fails promptly to pay CoreWeave the Termination Fee when due, and, in order to obtain such payment, CoreWeave commences a suit which results in a judgment against Core Scientific for such Termination Fee, Core Scientific will pay to CoreWeave its reasonable and documented out-of-pocket costs and expenses (including </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">246<br></div></div></div>
<!--End Page 257-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 258-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">such attorneys&#8217; fees) in connection with such suit, together with interest on the Termination Fee, from the date payment was required to be made until the date of such payment at the prime rate published in the Wall Street Journal in effect on the date such payment was required to be made. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tEX"><!--Anchor--></a>Exclusive Remedy </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to certain exceptions relating to fraud and intentional material breaches, in the event that the Merger Agreement is terminated and CoreWeave receives the Termination Fee, CoreWeave&#8217;s right to receive the one-time payment of the Termination Fee from Core Scientific is the sole and exclusive remedy available to CoreWeave or any of its former, current or future equityholders, directors, officers, affiliates, agents or representatives against Core Scientific or any of its former, current or future equityholders, directors, officers, affiliates, agents or representatives with respect to the Merger Agreement and the other transactions contemplated by the Merger Agreement. In the event of payment of the Termination Fee, (i) none of CoreWeave or any of its former, current or future equityholders, directors, officers, affiliates, agents or representatives may seek to recover any other money damages or seek any other remedy based on a claim in law or equity with respect to any loss suffered, directly or indirectly, as a result of the failure of the Merger to be consummated, the termination of the Merger Agreement, any liabilities or obligations arising under the Merger Agreement, or any claims or actions arising out of or relating to any breach, termination or failure of or under the Merger Agreement, and (ii) none of Core Scientific or any of its former, current or future equityholders, directors, officers, affiliates, agents or representatives will have any further liability relating to or arising out of the Merger Agreement or the transactions contemplated by the Merger Agreement other than in respect of the provisions that survive the Merger Agreement and the confidentiality agreement. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Expenses </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement provides that CoreWeave and Merger Sub, on the one hand, and Core Scientific, on the other hand, will each pay their own expenses in connection with the negotiation of the Merger Agreement, the performance of its obligations thereunder and the consummation of the transactions contemplated by the Merger Agreement (whether consummated or not). Notwithstanding the foregoing, CoreWeave will be responsible for all filing fees to any governmental body in order to obtain any necessary action or non-action, waiver, consent, clearance, decision, declaration, approval, or expiration or termination of a waiting period under the HSR Act. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;"><a name="tSPR1"><!--Anchor--></a>Specific Performance; Remedies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement generally provides that (i) Core Scientific will be entitled to an injunction or injunctions to prevent breaches or threatened breaches of the Merger Agreement by CoreWeave or Merger Sub and to enforce specifically the terms and provisions of the Merger Agreement against CoreWeave or Merger Sub in addition to any other remedy to which Core Scientific is entitled at law or in equity, including damages in the event of CoreWeave&#8217;s or Merger Sub&#8217;s fraud or intentional material breach of the Merger Agreement, without the necessity of proving the inadequacy of money damages as a remedy or posting any bond or other undertaking, and (ii) CoreWeave and Merger Sub will be entitled to an injunction or injunctions to prevent breaches or threatened breaches of the Merger Agreement by Core Scientific and to enforce specifically the terms and provisions of the Merger Agreement in addition to any other remedy to which CoreWeave or Merger Sub is entitled at law or in equity, including damages in the event of the Core Scientific&#8217;s fraud or intentional material breach of the Merger Agreement, without the necessity of proving the inadequacy of money damages as a remedy or posting any bond or other undertaking. The parties acknowledge and agree that time is of the essence and that the parties would suffer ongoing irreparable injury for so long as any provision of the Merger Agreement is not performed in accordance with its specific terms, including but not limited to as a result of any dispute over the parties&#8217; obligations to consummate the transactions contemplated by the Merger Agreement. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Governing Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Merger Agreement and any action arising out of or related to the Merger Agreement or the transactions contemplated by the Merger Agreement are governed by and are required to be construed in accordance with the laws of the State of Delaware without regard to laws that would call for the application of the substantive laws of any jurisdiction other than the State of Delaware. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Amendments; Waivers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the effective time, any provision of the Merger Agreement may be amended if such amendment or waiver is in writing and signed by CoreWeave, Core Scientific and Merger Sub. After the receipt of the Core </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">247<br></div></div></div>
<!--End Page 258-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 259-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_117-agreement_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Scientific Stockholder Approval, no amendment may be made if such amendment requires further approval of Core Scientific stockholders under applicable law or the rules of Nasdaq, without the approval of such stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At any time prior to the effective time, the parties may, to the extent permitted by applicable law, (i) extend the time for the performance of any of the obligations or acts of the other parties, (ii) waive any inaccuracies in the representations and warranties of the other parties set forth in the Merger Agreement or any document delivered pursuant thereto or (iii) waive compliance with any of the agreements or conditions of the other parties contained in the Merger Agreement. After the receipt of the Core Scientific Stockholder Approval no waiver may be made if such waiver requires further approval of Core Scientific stockholders under applicable law or the rules of Nasdaq without the approval of such stockholders. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">248<br></div></div></div>
<!--End Page 259-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 260-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tMUS"><!--Anchor--></a>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES OF THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following discussion addresses the material U.S. federal income tax consequences of the Merger to U.S.&#160;holders (as defined below) of shares of Core Scientific common stock that exchange their shares of Core Scientific common stock for shares of CoreWeave common stock in the Merger. The discussion is based on the provisions of the Code, U.S. Treasury regulations promulgated thereunder, administrative rulings and judicial decisions, all as currently in effect as of the date hereof and all of which are subject to change (possibly with retroactive effect) and differing interpretations. Any such change or differing interpretation could affect the accuracy of the statements and conclusions set forth in this proxy statement/prospectus. Tax considerations arising under foreign, state or local laws, or U.S. federal laws other than those pertaining to U.S. federal income tax (such as estate or gift tax laws), are not addressed in this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of this discussion, the term &#8220;U.S. holder&#8221; refers to a beneficial owner of Core Scientific common stock that is, for U.S. federal income tax purposes: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an individual citizen or resident of the United States; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States or any of its political subdivisions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">a trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more United States persons (as defined in the Code) have the authority to control all substantial decisions of the trust or (ii) such trust has made a valid election under applicable U.S.&#160;Treasury regulations to be treated as a U.S. person; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">an estate that is subject to U.S. federal income taxation on its income regardless of its source. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This discussion applies only to U.S. holders of Core Scientific common stock that hold their shares of Core Scientific common stock as a capital asset within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion is not a complete description of all of the tax consequences of the Merger and, in particular, does not address any consequences arising under the alternative minimum tax, unearned income Medicare contribution tax pursuant to the Health Care and Education Reconciliation Act of 2010 or the Foreign Account Tax Compliance Act of 2010 (including the U.S. Treasury regulations promulgated thereunder and intergovernmental agreements entered into pursuant thereto or in connection therewith). This discussion also does not address all aspects of U.S. federal taxation that may be relevant to a particular U.S. holder in light of its personal circumstances or to U.S. holders subject to special treatment under the U.S. federal income tax laws, including, for example: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">banks, thrifts, mutual funds, insurance companies or other financial institutions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">partnerships, S corporations, or other pass-through entities (or investors in partnerships, S corporations, or other pass-through entities); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">tax-exempt organizations or governmental organizations; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">dealers or brokers in stocks, securities, commodities, or currencies; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">traders in securities that elect to use a mark-to-market method of accounting; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">individual retirement or other deferred accounts; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons that hold shares of Core Scientific common stock as part of a straddle, hedge, appreciated financial position, constructive sale, conversion, integrated or other risk reduction transaction; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">regulated investment companies or real estate investment trusts; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. holders whose &#8220;functional currency&#8221; is not the U.S. dollar; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">U.S. expatriates; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">persons required to accelerate the recognition of any item of gross income as a result of such income being recognized on an &#8220;applicable financial statement&#8221;; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">holders who, directly, indirectly or constructively own (or at any time during the five-year period ending on the date of the Merger owned) 5% or more of Core Scientific common stock; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">249<br></div></div></div>
<!--End Page 260-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 261-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">holders who acquired their shares of Core Scientific common stock in exchange for claims arising out of the Core Scientific chapter 11 case; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">stockholders who acquired their shares of Core Scientific common stock through the exercise of employee stock options, as a restricted stock award or otherwise as compensation. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a partnership or other entity or arrangement treated as a partnership for U.S. federal income tax purposes holds shares of Core Scientific common stock, the tax treatment of a partner in the partnership will generally depend on the status of the partner and the activities of the partner and partnership. Partnerships holding shares of Core Scientific common stock and partners in such partnerships are urged to consult their tax advisors about the tax consequences of the merger to them. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This discussion is not tax advice and does not purport to be a complete analysis or discussion of all U.S.&#160;federal income tax considerations relating to the Merger. The actual tax consequences of the Merger to you may be complex and may depend on your specific situation and on factors not within CoreWeave&#8217;s or Core Scientific&#8217;s control. You are urged to consult with your own tax advisor as to the tax consequences of the Merger in your particular circumstances, including any federal, state, local or foreign and other tax laws and of changes in those laws.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific and CoreWeave intend for the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code for U.S. federal income tax purposes. The completion of the Merger is not conditioned on the Merger qualifying for the intended tax treatment or upon the receipt of an opinion of counsel to that effect, and neither Core Scientific nor CoreWeave will request a ruling from the IRS regarding the U.S. federal income tax consequences of the Merger. However, in connection with the effectiveness of the registration statement of which this proxy statement/prospectus is a part, each of Wachtell, Lipton, Rosen &amp; Katz, counsel to Core Scientific, and Davis Polk &amp; Wardwell LLP, counsel to CoreWeave, will deliver a legal opinion to the effect that the merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code. An opinion that the Merger &#8220;should&#8221; qualify as a reorganization within the meaning of Section&#160;368(a) of the Code expresses a level of comfort that is stronger than &#8220;more likely than not&#8221; but less than &#8220;will.&#8221; Counsel is unable to provide a higher degree of certainty because there is no administrative or judicial authority that directly addresses facts similar to those of this transaction, including with respect to the federal income tax treatment of the Tranche 2 Warrants. Nonetheless, counsel believes that its opinion is justified based on the existing authorities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These opinions will be based upon and rely on, among other things, various facts, assumptions, representations and warranties and covenants, including those contained in the merger agreement and in the officer&#8217;s certificates provided by CoreWeave (on behalf of itself and Merger Sub) and Core Scientific. If any of these facts, assumptions, representations and warranties and covenants underlying the tax opinions described above is or becomes incorrect, incomplete, inaccurate or is waived or violated, the validity of, and the conclusions reached in, such tax opinions may be affected or jeopardized. In addition, the opinions will be subject to certain qualifications and limitations as set forth therein. Moreover, an opinion of counsel represents such counsel&#8217;s judgment and is not binding on the IRS or any court and the IRS or a court may disagree with the conclusions reached by an opinion of counsel. Notwithstanding the receipt by CoreWeave and Core Scientific of the opinions of counsel, there can be no assurance that the IRS would not assert that the merger fails to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code or that a court would not sustain such position. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 14pt; margin-left: 0pt; text-align: left;">Tax Consequences if the Merger Qualifies as a &#8220;Reorganization&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Provided the Merger qualifies as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code, the material U.S. federal income tax consequences of the Merger to U.S. holders generally are as follows. U.S. holders of Core Scientific common stock who exchange their shares of Core Scientific common stock for shares of CoreWeave common stock generally will not recognize any gain or loss for U.S. federal income tax purposes, except with respect to cash, if any, received in lieu of fractional shares of CoreWeave common stock (taxed in the manner described below). Each U.S. holder&#8217;s aggregate tax basis in the shares of CoreWeave common stock received in the Merger (including any fractional share deemed received and sold for cash, as discussed below) will equal such U.S.&#160;holder&#8217;s aggregate adjusted tax basis in the shares of Core Scientific common stock exchanged in the Merger. The holding period of the shares of CoreWeave common stock received by a U.S. holder in the Merger (including any fractional share deemed received and sold for cash, as discussed below) will include such U.S. holder&#8217;s holding period for the shares of Core Scientific common stock exchanged in the Merger. If a U.S. holder holds different blocks of Core Scientific common stock (generally, Core Scientific common stock acquired on different dates or at </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">250<br></div></div></div>
<!--End Page 261-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 262-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">different prices), such U.S. holder should consult its tax advisor with respect to the determination of the tax bases and/or holding periods of the particular shares of CoreWeave common stock received in the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A U.S. holder of shares of Core Scientific common stock who receives cash in lieu of a fractional share of CoreWeave common stock generally will be treated as having received the fractional share of CoreWeave common stock pursuant to the Merger and then as having sold that fractional share for cash. As a result, a U.S. holder generally will recognize gain or loss equal to the difference, if any, between the amount of cash received and the tax basis in such fractional share (determined as described above). Any such gain or loss generally will be capital gain or loss, and will be long-term capital gain or loss if, as of the effective time, the holding period for the shares (including the holding period of the Core Scientific common stock surrendered therefor) is greater than one year. The deductibility of capital losses is subject to limitations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Payments of cash to U.S. holders in lieu of a fractional share of CoreWeave common stock in connection with the Merger generally will be subject to information reporting and may be subject to U.S. federal backup withholding (currently, at a rate of 24%). To prevent backup withholding, U.S. holders of Core Scientific common stock should (1) furnish the exchange agent for the Merger (or other payor) with a properly completed IRS Form W-9 (or an applicable substitute or successor form) certifying such U.S. holder&#8217;s correct taxpayer identification number and that such U.S. holder is not subject to backup withholding and otherwise comply with all the applicable backup withholding rules or (2) otherwise establish an applicable exemption from backup withholding. Backup withholding is not an additional tax. Any amounts withheld from payments to a U.S. holder of shares of Core Scientific common stock under the backup withholding rules may be refunded or credited against such U.S. holder&#8217;s U.S. federal income tax liability provided that such U.S. holder timely furnishes the required information to the IRS. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Tax Consequences if the Merger Fails to Qualify as a &#8220;Reorganization&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger does not qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, a U.S.&#160;holder of Core Scientific common stock generally would recognize gain or loss for U.S. federal income tax purposes on each share of Core Scientific common stock surrendered in the Merger in an amount equal to the difference between the fair market value, on the date of the Merger, of the CoreWeave common stock received in the Merger (including any cash received in lieu of a fractional shares of CoreWeave common stock) and such holder&#8217;s tax basis in the Core Scientific common stock surrendered in the Merger. Gain or loss must be calculated separately for each block of Core Scientific common stock exchanged by such U.S. holder if such blocks were acquired at different times or for different prices. Any gain or loss recognized generally would be capital gain or loss, and generally would be long-term capital gain or loss if the U.S. holder&#8217;s holding period in a particular block of Core Scientific common stock is more than one year at the effective time. Long-term capital gain of certain non-corporate taxpayers, including individuals, generally is taxed at reduced U.S. federal income tax rates. The deductibility of capital losses is subject to limitations. A U.S. holder&#8217;s tax basis in shares of CoreWeave common stock received in the Merger would be equal to the fair market value thereof on the date of the Merger, and such U.S. holder&#8217;s holding period in such shares would begin on the day following the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preceding discussion is intended only as an overview of the material U.S. federal income tax consequences of the Merger and is not tax advice. It is not a complete analysis or discussion of all potential tax considerations that may be important to you. Thus, you are strongly encouraged to consult your tax advisor as to the specific tax consequences resulting from the Merger, including tax return reporting requirements, the applicability and effect of federal, state, local and other tax laws and the effect of any proposed changes in the tax laws.<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">251<br></div></div></div>
<!--End Page 262-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 263-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tIOC"><!--Anchor--></a>INTERESTS OF CORE SCIENTIFIC&#8217;S DIRECTORS AND <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">EXECUTIVE OFFICERS IN THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In considering the recommendation of the Core Scientific board that Core Scientific stockholders vote &#8220;FOR&#8221; the Merger Agreement Proposal and the Advisory Compensation Proposal, Core Scientific stockholders should be aware that the directors and executive officers of Core Scientific have interests in the Merger that are different from, or in addition to, those of Core Scientific stockholders generally. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These interests are described below. The Core Scientific board was aware of and considered these interests, among other matters, in evaluating and negotiating the Merger Agreement and the Merger, in approving the Merger Agreement, and in recommending the approval of the Merger Agreement Proposal and Advisory Compensation Proposal. The Merger will be a &#8220;change of control&#8221; for purposes of the Core Scientific executive compensation plans and agreements described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For purposes of this disclosure, the named executive officers of Core Scientific are Adam Sullivan, President and Chief Executive Officer, James Nygaard, Executive Vice President and Chief Financial Officer and Todd M. DuChene, Executive Vice President and Chief Legal and Administrative Officer. Also for purposes of this disclosure, there are no executive officers of Core Scientific other than the named executive officers.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Certain Assumptions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as otherwise specifically noted, for purposes of quantifying the potential payments and benefits described in this section, the following assumptions were used: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The relevant price per share of Core Scientific common stock is $13.34, which is the average closing price per share of Core Scientific common stock as reported on the Nasdaq over the first five business days following the first public announcement of the transaction on July&#160;7, 2025.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The effective time as referenced in this section occurred on August&#160;14, 2025, which is the assumed date of the effective time solely for purposes of the disclosure in this section.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The employment of each of Core Scientific's named executive officers was terminated by CoreWeave without &#8220;cause&#8221; or due to the executive&#8217;s resignation for &#8220;good reason&#8221; (as such terms are defined in the relevant plans and agreements), in either case immediately following the effective time. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The amounts indicated below are estimates based on multiple assumptions (including the assumptions described above) that may or may not actually occur or be accurate on the relevant date, and do not reflect certain compensation actions that may occur before completion of the transaction. Accordingly, the actual amounts received may differ materially from the estimates set forth below. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Treatment of Core Scientific Equity Awards </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7pt; margin-left: 20pt; text-align: left;">Core Scientific RSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific RSU Award held by Core Scientific&#8217;s non-employee directors or held by a Specified Individual (including each of Core Scientific&#8217;s named executive officers) that is outstanding immediately prior to the effective time will fully vest and be cancelled and converted into the right to receive (without interest and less applicable Tax withholding) a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (a) the total number of shares of Core Scientific common stock underlying such Core Scientific RSU Award as of immediately prior to the effective time, multiplied by (b) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Unvested Core Scientific RSU Award that is outstanding immediately prior to the effective time will be cancelled and converted into a CoreWeave Rollover RSU Award, with the number of shares of CoreWeave common stock underlying such CoreWeave Rollover RSU Award determined by multiplying (a) the total number of shares of Core Scientific common stock underlying such Unvested Core Scientific RSU Award as of immediately prior to the effective time, by (b) the exchange ratio, with such product rounded up to the nearest whole number of shares. Each such CoreWeave Rollover RSU Award will otherwise continue to be subject to the same terms and conditions (including vesting schedule and treatment on termination of employment) as applied to the corresponding Unvested Core Scientific RSU Award prior to the effective time. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">252<br></div></div></div>
<!--End Page 263-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 264-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Core Scientific PSU Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific PSU Award held by a Specified Individual (including each of Core Scientific&#8217;s named executive officers) that is outstanding immediately prior to the effective time will fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable Tax withholding) a number of shares of CoreWeave common stock equal to the product (rounded up to the nearest whole number of shares) of (a) the total number of shares of Core Scientific common stock underlying the Core Scientific PSU Award as of immediately prior to the effective time (determined by deeming the applicable performance level to equal 300%) multiplied by (b) the exchange ratio. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Core Scientific PSU Award (other than each Core Scientific PSU Award described above) that is outstanding immediately prior to the effective time will be cancelled and converted into a CoreWeave Rollover PSU Award, with the number of shares underlying such CoreWeave Rollover PSU Award determined by multiplying (a) the total number of shares of Core Scientific common stock underlying such Core Scientific PSU Award as of immediately prior to the effective time (determined by deeming the performance level to equal 300%) by (b) the exchange ratio, with such product rounded up to the nearest whole number of shares. Each such CoreWeave Rollover PSU Award will otherwise continue to be subject to the same terms and conditions (including service-based vesting and forfeiture conditions) as applied to the corresponding Core Scientific PSU Award prior to the effective time (other than applicable performance conditions). </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Core Scientific Options </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each In the Money Core Scientific Option will be cancelled and converted into the right to receive a number of shares of CoreWeave common stock (without interest and less applicable Tax withholding) equal to (x) the quotient obtained by <font style="font-style: italic;">dividing</font> (a) the product obtained by <font style="font-style: italic;">multiplying</font> (A) the excess, if any, of the Per Core Scientific Share Price over the exercise price per share of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (B) the number of shares of Core Scientific common stock subject to such Core Scientific Option immediately prior to the effective time by (b) the Core Scientific Share Price <font style="font-style: italic;">multiplied by</font> (y) the exchange ratio. At the effective time, each Core Scientific Option that is not an In the Money Core Scientific Option and is outstanding and unexercised as of immediately prior to the effective time will be cancelled at the effective time with no consideration payable in respect of such Core Scientific Option. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For an estimate of the amounts that would be payable to each of Core Scientific&#8217;s named executive officers in respect of their unvested Core Scientific equity awards at the effective time of the Merger, see the section titled &#8220;&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page <a href="#tQOPP">254</a>. Based on the relevant assumptions described above under &#8220;&#8212;Certain Assumptions,&#8221; the estimated aggregate value of unvested Core Scientific RSU Awards held by all five non-employee directors of Core Scientific that would become vested and payable at the effective time is $8,515,576.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Core Scientific Letter Agreements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has entered into individual letter agreements (the &#8220;Letter Agreements&#8221;) providing for Merger-related severance payments with each of Core Scientific&#8217;s named executive officers. Each of the Letter Agreements provides that, contingent upon the occurrence of the effective time, the named executive officer will separate from employment with Core Scientific and its affiliates on the closing date of the Merger, which separation will be treated as a resignation by the executive for good reason. Subject to the named executive officer&#8217;s execution and nonrevocation of a release of claims in favor of Core Scientific, each named executive officer will receive a lump sum cash severance payment (the &#8220;Severance Payment&#8221;) equal to the sum of: (a) two times the sum of (i) the executive&#8217;s annual base salary at the rate in effect as of immediately prior to the effective time and (ii) the executive&#8217;s target annual cash incentive bonus as in effect immediately prior to the effective time, and (b) 24 times the monthly cost of continuation coverage under Core Scientific&#8217;s group health plan pursuant to the Consolidated Omnibus Budget Reconciliation Act for the level of coverage in effect for the named executive officer and his dependents as of immediately prior to the effective time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of the Letter Agreements provides that, from and after the effective time, the Severance Payment will supersede any other cash severance agreement or arrangement between the named executive officer and Core Scientific. The named executive officer will not be eligible to receive the Severance Payment if (a) his employment with Core Scientific terminates for any reason prior to the effective time, (b) the named executive officer engages in conduct constituting Cause (as defined in the Letter Agreement), or (c) the named executive officer does not timely execute, or if he revokes, the release of claims described above. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">253<br></div></div></div>
<!--End Page 264-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 265-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For an estimate of the amounts that would be payable to each of Core Scientific&#8217;s named executive officers at the effective time under the Letter Agreements, see the section titled &#8220;&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page <a href="#tQOPP">254</a>. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Indemnification and Insurance</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the effective time, Core Scientific will purchase a tail policy under the current directors' and officers' liability insurance policies maintained by Core Scientific, and if Core Scientific does not obtain such tail policy or policies prior to the effective time, CoreWeave or the Surviving Corporation will use reasonable best efforts to obtain such policy or policies (provided that the total premium for such tail policy or policies will not be in excess of the maximum premium), which will be effective for six years following the effective time with respect to claims arising from acts, errors or omissions that existed or occurred prior to or at the effective time and provide coverage and amounts that are at least as protective to such directors and officers as the coverage provided by such existing policies and must contain other terms and conditions that are no less favorable to the covered individuals as the terms and conditions in such existing policies; provided, that the total premium for such tail policy or policies may not be in excess of the maximum premium. If such tail policy or policies cannot be obtained, CoreWeave or the Surviving Corporation will obtain as much coverage as can be obtained by paying a premium equal to the maximum premium. CoreWeave will maintain such tail policy or policies (whether obtained by Core Scientific, CoreWeave or the Surviving Corporation) for their full term. For more information, see &#8220;The Merger Agreement&#8212;Indemnification of Officers and Directors&#8221; beginning on page&#160;<a href="#tIOD">241</a> of this proxy statement/prospectus.</div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">2025 Annual Cash Bonuses of Executive Officers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If annual cash incentive bonuses for fiscal year 2025 have not been paid prior to the effective time, Core Scientific may take action to cause 2025 annual bonuses to be paid to Core Scientific employees, including named executive officers, who are eligible for 2025 annual bonuses in accordance with the terms and conditions of Core Scientific&#8217;s annual bonus program, with the applicable performance goals deemed to be achieved at the greater of the target level and the actual level of achievement as of the latest practicable date prior to the effective time (as determined in good faith by the compensation committee consistent with past practice). For an estimate of the amounts that would be payable to each of Core Scientific&#8217;s named executive officers with respect to such 2025 annual bonuses, see the section titled &#8220;&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page <a href="#tQOPP">254</a>. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Excise Tax Reimbursement Agreements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has entered into agreements (the &#8220;Excise Tax Reimbursement Agreements&#8221;) with each of its named executive officers, as well as two individuals who are not named executive officers, providing for reimbursements for excise taxes incurred under Section 4999 of the Code in connection with the Merger, so that on an after-tax basis such individual would be in the same position as though such excise tax did not apply, subject to an aggregate reimbursement cap of $85,000,000 for the total reimbursements for all five eligible individuals (as well as any additional individuals who may become party to such an agreement prior to the effective time). Each individual subject to the Excise Tax Reimbursement Agreements will be subject to a one-year post-termination non-competition covenant under the terms of his or her Excise Tax Reimbursement Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For an estimate of the amounts that would be payable to each of Core Scientific&#8217;s named executive officers at the effective time under the Excise Tax Reimbursement Agreements, see the section titled &#8220;&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page <a href="#tQOPP">254</a>. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;"><a name="tQOPP"><!--Anchor--></a>Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The information set forth below is required by Item&#160;402(t) of Regulation S-K regarding compensation that is based on or otherwise relates to the Merger that the Core Scientific named executive officers could receive in connection with the Merger. Except as otherwise specifically noted, the disclosure below uses the relevant assumptions described above under &#8220;&#8212;Certain Assumptions.&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">254<br></div></div></div>
<!--End Page 265-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 266-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_118-material_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The amounts indicated below are estimates based on multiple assumptions (including the assumptions described above) that may or may not actually occur or be accurate on the relevant date, and do not reflect certain compensation actions that may occur before completion of the Merger. Accordingly, the actual amounts received by our named executive officers may differ materially from the estimates set forth below. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 27.55pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 54.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 192pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cash <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Awards <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.55pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Benefits <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.64pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Tax <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reimbursement <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($) </div></td></tr><tr><td style="width: 192pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adam Sullivan<font style="padding-left: 3.4pt;"></font></div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4,743,750</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">102,042,213</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.55pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;">25,651</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.64pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.82pt; text-align: left;">25,122,450</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">131,934,064 </div></td></tr><tr><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">James Nygaard<font style="padding-left: 2.31pt;"></font></div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3,000,000</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,934,424</font></div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.55pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;">34,951</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.82pt; text-align: left;"><font style="padding-left: 5pt;">1,990,858</font></div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">15,960,233 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Todd M. DuChene<font style="padding-left: 3.28pt;"></font></div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,625,000</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">32,924,217</font></div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.55pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.02pt; text-align: left;">64,768</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.64pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.82pt; text-align: left;"><font style="padding-left: 5pt;">8,145,422</font></div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">43,759,407</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 192pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.55pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 54.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic;">Cash. </font>These amounts include the salary- and bonus-related cash severance payable to each named executive officer in connection with his termination of employment at the effective time as provided for under the Letter Agreements. These severance payments are equal to two&#160;times the sum of (a) the named executive officer&#8217;s annual base salary at the rate in effect as of immediately prior to the Effective Time and (b) the named executive officer&#8217;s target annual cash incentive bonus as in effect immediately prior to the Effective Time. These severance payments are &#8220;double trigger&#8221; and are only payable upon the occurrence of both the effective time and the termination of employment of each named executive officer. The amounts in this column also include the 2025 annual bonus payments described above under the section titled &#8220;&#8212;2025 Annual Cash Bonuses of Executive Officers.&#8221; These bonus payments are &#8220;single trigger&#8221; and are payable upon the occurrence of the effective time. The estimated amount of each such payment is set forth in the table below:</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2x Salary <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2x Bonus <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025 Bonus <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adam Sullivan<font style="padding-left: 0.4pt;"></font></div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,650,000</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,062,500</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,031,250</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">4,743,750 </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">James Nygaard<font style="padding-left: 4.31pt;"></font></div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,200,000</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,200,000</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">600,000</font></div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3,000,000 </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Todd M. DuChene<font style="padding-left: 0.28pt;"></font></div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,050,000</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">1,050,000</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.5pt;">525,000</font></div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2,625,000</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic;">Equity Awards. </font>These amounts reflect the potential value that each named executive officer could receive in connection with the accelerated vesting of unvested Core Scientific RSU Awards and Core Scientific PSU Awards. The Core Scientific RSU Awards and Core Scientific PSU&#160;Awards held by Core Scientific&#8217;s named executive officers that are outstanding as of immediately prior to the effective time will fully vest at the effective time (and such vesting is therefore pursuant to a &#8220;single-trigger&#8221; arrangement), with the Core Scientific PSU Awards deemed earned based on a performance level of 300%. For further details regarding the treatment of Core Scientific RSU Awards and Core Scientific PSU Awards in connection with the Merger, see &#8220;<font style="font-style: italic;">&#8212;</font>Treatment of Core Scientific Equity Awards.&#8221; The estimated value of unvested Core Scientific RSU Awards and Core Scientific PSU Awards held by each named executive officer is set forth in the table below: </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 264pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 264pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">RSU Awards <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">PSU Awards <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($)</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">($) </div></td></tr><tr><td style="width: 264pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adam Sullivan<font style="padding-left: 0.4pt;"></font></div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.96pt; text-align: left;">42,355,384</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;">59,686,829</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">102,042,213 </div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">James Nygaard<font style="padding-left: 4.31pt;"></font></div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.96pt; text-align: left;">10,934,424</div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,934,424 </font></div></td></tr><tr><td style="width: 264pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Todd M. DuChene<font style="padding-left: 0.28pt;"></font></div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.96pt; text-align: left;"><font style="padding-left: 0.74pt;">15,111,275</font></div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;">17,812,942</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">32,924,217</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 264pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50.94pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50.94pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.69pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic;">Benefits</font>. These amounts reflect the cash payments for benefit continuation payable to each named executive officer in connection with his termination of employment at the effective time as provided for under the Letter Agreements, equal to 24 times the monthly cost of continuation coverage under Core Scientific&#8217;s group health plan pursuant to the Consolidated Omnibus Budget Reconciliation Act for the level of coverage in effect for the named executive officer and his dependents as of immediately prior to the Effective Time. These severance payments are &#8220;double trigger&#8221; and are only payable upon the occurrence of both the effective time and the termination of employment of the applicable named executive officer. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic;">Tax Reimbursements</font>. These amounts reflect the estimated reimbursement payments for the named executive officers under the Excise Tax Reimbursement Agreements. These estimates were calculated taking into account the impact of an assumed valuation of each executive&#8217;s one-year post-termination non-compete covenant under his Excise Tax Reimbursement Agreement. For further details regarding the Excise Tax Reimbursement Agreements, see &#8220;<font style="font-style: italic;">&#8212;Excise Tax Reimbursement Agreements</font>.&#8221; </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">255<br></div></div></div>
<!--End Page 266-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 267-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_119-prop1_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPROP1"><!--Anchor--></a>PROPOSAL I&#8212;ADOPTION OF THE MERGER AGREEMENT </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific is asking its stockholders to adopt the Merger Agreement, on the terms and subject to the conditions of the Merger Agreement. For a detailed discussion of the terms of the Merger Agreement, see the section&#160;titled &#8220;The Merger Agreement.&#8221; At a meeting held on July&#160;7, 2025, the Core Scientific board unanimously (i)&#160;determined that the Merger Agreement and the transactions contemplated by the Merger Agreement, including the Merger, on the terms and conditions set forth in the Merger Agreement, were fair to and in the best interests of Core Scientific and its stockholders, (ii) approved and deemed advisable the execution and delivery of the Merger Agreement, the performance by Core Scientific of its covenants and agreements contained in the Merger Agreement and the consummation of the transactions contemplated by the Merger Agreement, including the Merger and (iii)&#160;directed that the adoption of the Merger Agreement be submitted to a vote of Core Scientific stockholders and resolved to recommend that Core Scientific stockholders approve the Merger and adopt the Merger Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Approval of the Merger Agreement Proposal is a condition to the closing of the Merger. If the Merger Agreement Proposal is not approved, the Merger will not occur. For a detailed discussion of the terms and conditions of the Merger, see the section titled &#8220;The Merger Agreement&#8212;Conditions to the Consummation of the Merger.&#8221; </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Required Vote </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Approval of the Merger Agreement Proposal requires the affirmative vote of holders of a majority of the issued and outstanding shares of Core Scientific common stock on the Core Scientific record date and entitled to vote thereon. The required vote is based on the number of outstanding shares&#8212;not the number of shares actually voted. The failure of any Core Scientific stockholder to submit a vote (i.e., by not submitting a proxy and not voting at the Special Meeting) and any abstention from voting by a Core Scientific stockholder will have the same effect as a vote &#8220;<font style="font-style: italic; font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. Because the Merger Agreement Proposal is non-routine, brokers, banks and other nominees do not have discretionary authority to vote on the Merger Agreement Proposal, and will not be able to vote on the Merger Agreement Proposal absent instructions from the beneficial owner of any Core Scientific shares held of record by them. As a result, a broker non-vote will have the same effect as a vote &#8220;<font style="font-style: italic; font-weight: bold;">AGAINST</font>&#8221; the Merger Agreement Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">IF YOU ARE A CORE SCIENTIFIC STOCKHOLDER, THE CORE SCIENTIFIC BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE MERGER AGREEMENT PROPOSAL.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">256<br></div></div></div>
<!--End Page 267-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 268-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_120-prop2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPROP2"><!--Anchor--></a>PROPOSAL II&#8212;NON-BINDING ADVISORY VOTE ON <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">TRANSACTION-RELATED COMPENSATION FOR CERTAIN CORE SCIENTIFIC <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">EXECUTIVE OFFICERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section&#160;14A of the Exchange Act, which was enacted as part of the Dodd-Frank Act, requires that Core Scientific provide its stockholders with the opportunity to vote to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers in connection with the Merger, as disclosed in this proxy statement/prospectus, including the compensation table and the related narrative named executive officer compensation disclosures set forth in the section titled &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page&#160;<a href="#tQOPP">254</a> of this proxy statement/prospectus. This vote is commonly referred to as a &#8220;golden parachute say on pay&#8221; vote. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accordingly, the Core Scientific board unanimously recommends that Core Scientific stockholders vote &#8220;<font style="font-style: italic; font-weight: bold;">FOR</font>&#8221; the adoption of the following resolution, on a non-binding advisory basis, at the Special Meeting: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">&#8220;RESOLVED, that Core Scientific&#8217;s stockholders approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Core Scientific&#8217;s named executive officers in connection with the Merger, as disclosed pursuant to Item&#160;402(t) of Regulation S-K in &#8220;Interests of Core Scientific&#8217;s Directors and Executive Officers in the Merger&#8212;Quantification of Potential Payments and Benefits to Core Scientific&#8217;s Named Executive Officers&#8221; beginning on page&#160;<a href="#tQOPP">254</a> of this proxy statement/prospectus (which disclosure includes the compensation table and related narrative named executive officer compensation disclosures required pursuant to Item&#160;402(t) of Regulation S-K).&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific stockholders should note that the Advisory Compensation Proposal is merely an advisory vote, which will not be binding on Core Scientific, CoreWeave or their respective boards of directors. Further, the underlying plans and arrangements are contractual in nature and not, by their terms, subject to stockholder approval. Accordingly, regardless of the outcome of the advisory vote, if the Merger is consummated, the eligibility of the Core Scientific named executive officers for such payments and benefits will not be affected by the outcome of the advisory vote. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The affirmative vote of the holders of a majority of the votes cast on such matter, voting affirmatively or negatively (excluding abstentions and broker non-votes), where a quorum is present, is required to approve the Advisory Compensation Proposal. The required vote on the Advisory Compensation Proposal is based on the number of shares actually voted&#8212;not the number of outstanding shares of Core Scientific common stock entitled to be voted thereon. Abstentions from voting by a Core Scientific stockholder attending the Special Meeting or a failure to attend the Special Meeting virtually or by proxy will have no effect on the outcome of the vote on the Advisory Compensation Proposal. Brokers do not have discretion to vote on this proposal without your instruction. If you do not instruct your broker how to vote on this proposal, those shares will not be counted as present or represented by proxy at the Special Meeting and, as a result, will have no effect on the outcome of the vote on the Advisory Compensation Proposal.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">IF YOU ARE A CORE SCIENTIFIC STOCKHOLDER, THE CORE SCIENTIFIC BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#8220;FOR&#8221; THE ADVISORY COMPENSATION PROPOSAL.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">257<br></div></div></div>
<!--End Page 268-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 269-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tUPF"><!--Anchor--></a>UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information is prepared in accordance with Article&#160;11 of Regulation S-X of the Exchange Act and should be read in conjunction with the accompanying notes. The following unaudited pro forma condensed combined financial information combines the historical consolidated financial position and results of operations of CoreWeave and the historical consolidated financial position and results of operations of Core Scientific after giving effect to the Merger as further described in <font style="font-style: italic;">Note&#160;1. Description of the Transactions and Basis of Presentation </font>and the pro forma effects of certain assumptions and adjustments described in <font style="font-style: italic;">&#8220;Notes to the Unaudited Pro Forma Condensed Combined Financial Information&#8221; </font>below. The unaudited pro forma condensed combined financial information has been prepared to give effect to the following (collectively, the &#8220;Transactions&#8221;): </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Application of the acquisition method of accounting under the provisions of the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) 805, <font style="font-style: italic;">Business Combinations</font> (&#8220;ASC 805&#8221;) where the assets and liabilities of Core Scientific will be recorded by CoreWeave at their respective fair values as of the closing date of the Merger (&#8220;Closing Date&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Preliminary adjustments to conform the financial statement presentation of Core Scientific to that of CoreWeave; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The Financing Transactions, as described and defined below; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The settlement of pre-existing relationships; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Adjustments to reflect estimated acquisition-related costs of the Merger. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information and related notes are derived from, and should be read in conjunction with, the following historical financial statements and the accompanying notes, which are contained in, or incorporated by reference into, as applicable, this proxy statement/prospectus: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The historical audited consolidated financial statements of CoreWeave and the related notes included herein as of and for the year ended December&#160;31, 2024; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The historical audited consolidated financial statements of Core Scientific and the related notes included in Core Scientific&#8217;s Annual Report on Form&#160;10-K as of and for the year ended December&#160;31, 2024; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The historical unaudited condensed consolidated financial statements of CoreWeave and the related notes included herein as of and for the six months ended June&#160;30, 2025; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The historical unaudited condensed consolidated financial statements of Core Scientific and the related notes included in Core Scientific&#8217;s Quarterly Report on Form&#160;10-Q as of and for the six months ended June&#160;30, 2025. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information should also be read together with other financial data included elsewhere in, or incorporated by reference into, as applicable, this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined balance sheet as of June&#160;30, 2025, gives pro forma effect to the Transactions as if they had been consummated on June&#160;30, 2025. The unaudited pro forma condensed combined statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, give pro forma effect to the Transactions as if they had been consummated on January&#160;1, 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information has been prepared using the acquisition method of accounting pursuant to the provisions of ASC 805, whereby CoreWeave is considered the accounting acquirer. The consideration transferred will be allocated to the identifiable assets acquired and liabilities assumed based upon their estimated fair values as of the Closing Date, and any excess value of the consideration transferred over the acquired net assets will be recognized as goodwill. The assets and liabilities of Core Scientific have been measured based on various preliminary estimates using assumptions that CoreWeave believes are reasonable, based on information that is currently available. The unaudited pro forma condensed combined financial information is based on preliminary accounting conclusions subject to potential revision, and as a result, has been presented for illustrative purposes only and is not necessarily indicative of the financial position and results of operations that would have been achieved had the Transactions occurred on the dates indicated. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">258<br></div></div></div>
<!--End Page 269-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 270-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information appearing below is based on available preliminary information and certain assumptions that are believed to be reasonable as of the date of this proxy statement/prospectus and also does not consider any potential effects of changes in market conditions on revenues or expense efficiencies, among other factors. Future results may vary significantly from the results reflected because of various factors, including those discussed in the sections titled &#8220;Cautionary Statement Regarding Forward-Looking Statements,&#8221; &#8220;Risk Factors&#8221; and the consolidated audited and unaudited financial statements of CoreWeave and Core Scientific included, or incorporated by reference, as applicable, in this proxy statement/prospectus. In addition, as explained in more detail in the accompanying notes, the preliminary allocation of the pro forma purchase price reflected in the unaudited pro forma condensed combined financial information is subject to adjustment and may vary significantly from the actual purchase price allocation that will be recorded upon completion of the Merger. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">259<br></div></div></div>
<!--End Page 270-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 271-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_121-unaudited_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 30pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June&#160;30, 2025 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div></div><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528.77pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.98pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.98pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 85pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reclassification <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Financing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquisition <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Settlement of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pre-existing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Relationships <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Combined </div></td></tr><tr><td style="width: 85pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.34pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current assets<br></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,152,883</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 5.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">581,345</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 20.13pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$1,723,750</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">4(a)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 23.38pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 20.13pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,457,978 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Restricted cash and cash equivalents, current<font style="padding-left: 0.97pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">560,173</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">560,173 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Accounts receivable, net<font style="padding-left: 3.52pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">1,933,698</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 14.29pt;">1,910</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">2(a)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 11.69pt;">(1,378)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">6(a)</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">1,934,230 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Digital assets<font style="padding-left: 0.61pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 31.18pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 9.74pt;">172,772</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">172,772 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Prepaid expenses and other current <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">assets<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">299,229</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 6.49pt;">248,733</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">2(a)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 3.9pt;">(232,625)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">6(b)(i)</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">315,337 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Customer funding receivable and other current assets<font style="padding-left: 0.18pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 31.18pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 9.74pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">250,643</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 3.9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(250,643</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">2(a)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 31.18pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 85pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-weight: bold; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Total current assets<font style="font-weight: normal; padding-left: 4pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">3,945,983</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 3.9pt;">1,004,760</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 3.9pt;">1,723,750</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 3.9pt;">(234,003)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">6,440,490 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Restricted cash and cash equivalents, non-current<font style="padding-left: 0.97pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">340,527</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">340,527 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Property and equipment, net<font style="padding-left: 3.52pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 3.9pt;">16,631,510</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 9.74pt;">828,603</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 3.9pt;">1,099,000</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">4(b)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 4.18pt;">18,559,113 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 1.88pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">3,380,201</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 9.74pt;">108,584</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 13.64pt;">34,083</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">4(c)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 7.8pt;">(96,640)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">6(i)</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">3,426,228 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangible assets, net<font style="padding-left: 1.58pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">205,895</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 14.29pt;">1,326</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">2(b)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 13.64pt;">43,674</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">4(d)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">250,895 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Goodwill<font style="padding-left: 3.6pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt;">812,970</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 24.03pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 3.9pt;">4,786,482</font> </div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">4(e)</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 10.39pt;">77,752</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">6(f)</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 1.73pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.8pt;">5,677,204</font> </div></td></tr><tr><td style="width: 85pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 0.55pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.64pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">924,277</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="padding-left: 13.64pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">36,105</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="padding-left: 11.69pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,326</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">2(b)</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="padding-left: 27.28pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="padding-left: 3.9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(165,938</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic; margin-top: 0pt; text-align: center;">6(c)(j)(k)</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 1.44pt; padding-bottom: 2.98pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.93pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">793,118 </font></div></td></tr><tr><td style="width: 85pt; padding-top: 2.69pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets<font style="font-weight: normal; padding-left: 4.36pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$26,241,363</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.74pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,978,052</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 7.41pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 20.13pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; font-style: italic;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,723,750</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 1.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$5,963,239 </font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 4.3pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(418,829</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt;">&#160;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.98pt; padding-top: 2.69pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$35,487,575</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.45pt; width: 85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 38.98pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.45pt; width: 38.98pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.8pt; margin-top: 8.45pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">260<br></div></div></div>
<!--End Page 271-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 272-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_121-unaudited_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June 30, 2025 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 101pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 35pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 19.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17.87pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 35pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 101pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reclassification <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Financing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquisition <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Settlement of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pre-existing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Relationships <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Combined </div></td></tr><tr><td style="width: 101pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0.02pt; text-indent: -0.02pt; text-align: left;">Liabilities, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)<br></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current liabilities<br></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.5pt;">1,226,579</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;">$<font style="padding-left: 7.58pt;">215,055</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;">$<font style="padding-left: 23.33pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;">$<font style="padding-left: 21pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;">$<font style="padding-left: 21pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;">$<font style="padding-left: 3.5pt;">(84,957)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(i)(k)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 3.5pt;">1,356,677 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities<font style="padding-left: 2.16pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7.26pt;">1,411,237</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 11.08pt;">183,988</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(c)(d)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 12.25pt;">45,559</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(f)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 3.5pt;">(147,094)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(k)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">1,493,690 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued expenses<font style="padding-left: 2.95pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 11.08pt;">180,641</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 8.75pt;">(180,641)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(c)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, current<font style="padding-left: 1.74pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">3,627,664</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 18.08pt;">1,550</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(d)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">3,629,214 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue, current<font style="padding-left: 1pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt;">951,346</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 11.08pt;">150,127</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 3.5pt;">(149,078)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(d)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.25pt;">952,395 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt;">279,080</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 14.58pt;">10,438</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(d)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 7.26pt;">(11,754)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(i)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.25pt;">277,764 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.75pt;">60,396</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 23.33pt;">547</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(d)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.75pt;">60,943 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<font style="padding-left: 2.78pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">53</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 14.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,899</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 12.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(15,882</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(d)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 19.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,070 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current liabilities<font style="font-weight: normal; padding-left: 4.65pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">7,556,355</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 11.08pt;">562,722</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 12.25pt;">45,559</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 3.5pt;">(392,883)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">7,771,753 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Debt, non-current<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">7,423,837</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 5.83pt;">1,057,696</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(e)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 3.5pt;">1,723,750</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(a)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 12.25pt;">27,304</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(g)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.5pt;">10,232,587 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative and warrant liabilities<font style="padding-left: 0.18pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24.5pt;">698</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 5.83pt;">1,316,690</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(f)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 9.92pt;">(92,555)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(h)</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">1,224,833</font> </div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred revenue, non-current<font style="padding-left: 3.17pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">3,896,173</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">3,896,173 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">3,168,392</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 14.58pt;">92,229</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(g)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 7pt;">(92,658)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(i)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">3,167,963 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Convertible and other notes payable, net of current portion</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 5.83pt;">1,057,696</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 3.5pt;">(1,057,696)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(e)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Finance lease liabilities, non-current<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.51pt;">3,112</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 19.51pt;">3,112 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Deferred tax liabilities, non-current<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt;">245,659</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.25pt;">245,659 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Warrant liabilities<font style="padding-left: 3.49pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 5.83pt;">1,316,690</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 3.5pt;">(1,316,690)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(f)</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current liabilities<font style="padding-left: 4.95pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">126,331</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 11.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">105,6</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">20</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 12.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(92,229</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(g)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 7.26pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(11,040</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(e)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">128,68</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 4.39pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">22,420,557</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,042,728</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,723,750</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 9.92pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">19,692</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(496,581</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">26,</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">670,762 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Commitments and contingencies<br></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redeemable common stock<br></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Redeemable Class&#160;A common stock<font style="padding-left: 4.47pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,159</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,159 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; equity (deficit)<br></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Preferred stock<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Class A common stock<font style="padding-left: 3.54pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 31.5pt;">2</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(i)</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 31.5pt;">2 </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Common stock<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 30.33pt;">3</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 25.67pt;">(3)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(i)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Class B common stock<font style="padding-left: 3.15pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Class&#160;C common stock<font style="padding-left: 3.15pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 28pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28pt;">&#8212; </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Treasury stock, at cost<font style="padding-left: 4.78pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.42pt;">(33,524)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 13.42pt;">(33,524) </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital<font style="padding-left: 1.16pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt;">4,772,825</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 5.83pt;">3,026,645</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 3.5pt;">1,980,124</font> </div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(i)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt;">9,779,594</font> </div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated other comprehensive <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">income (loss)<font style="padding-left: 0.76pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.17pt;">(271)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.17pt;">(271) </font></div></td></tr><tr><td style="width: 101pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 1.72pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 4.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,081,385</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(4,091,324</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,002,810</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">4(i)</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 9.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">77,752</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">6(f)</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 4.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,092,147</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total stockholders&#8217; equity <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 30pt; text-align: left;">(deficit)<font style="font-weight: normal; padding-left: 0.93pt;"></font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,657,647</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,064,676</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,982,931</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="padding-left: 9.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">77,752</font></div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">7,653,654</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 101pt; padding-top: 2.87pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Total liabilities, redeemable common stock, and stockholders&#8217; equity (deficit)<font style="font-weight: normal; padding-left: 0.93pt;"></font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$26,241,363</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,978,052</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.41pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 23.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.43pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,723,750</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 3.29pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$5,963,239 </font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 5.92pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(418,829</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.87pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35pt; padding-top: 2.87pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$35,487,575</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.75pt; width: 101pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 35pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 19.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 3.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 17.87pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 35pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0.5pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">261<br></div></div></div>
<!--End Page 272-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 273-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_121-unaudited_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Six Months Ended June&#160;30, 2025 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 21.37pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 33.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reclassification <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Financing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquisition <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Settlement of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pre-existing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Relationships <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Combined</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes<font style="font-style: normal; font-weight: normal;"> </font></div></td></tr><tr><td style="width: 108pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 0.6pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;">$2,194,420</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;">$<font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;">$<font style="padding-left: 2.33pt;">158,153</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(h)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;">$<font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;">$<font style="padding-left: 14.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;">$(19,133)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">6(g)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 2.33pt;">2,333,440</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.37pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Digital asset self-mining revenue<font style="padding-left: 1.79pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 5.83pt;">129,603</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 3.5pt;">(129,603)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(h)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Digital asset hosted mining revenue from customers<font style="padding-left: 1.93pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 12.83pt;">9,417</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 10.5pt;">(9,417)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(h)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Colocation revenue<font style="padding-left: 1.05pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 9.33pt;">19,133</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 7pt;">(19,133)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(h)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 0.77pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 8.75pt;">575,061</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 5.83pt;">144,725</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(i)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">(j)(k)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 5.83pt;">10,962</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">(c)(d)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 3.5pt;">(19,133)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">6(h)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 11.34pt;">711,615</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of digital asset self-mining</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 5.83pt;">120,759</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 3.5pt;">(120,759)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(i)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Cost of digital asset hosted mining services<font style="padding-left: 1.54pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 12.83pt;">6,620</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 10.5pt;">(6,620)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(i)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of colocation services<font style="padding-left: 3.89pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 9.33pt;">17,536</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 7pt;">(17,536)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(i)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Change in fair value of digital assets<font style="padding-left: 4.92pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 7pt;">(19,109)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt;">(19,109)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Losses on exchange or disposal of property, plant and equipment<font style="padding-left: 1.7pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 12.83pt;">4,172</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 10.5pt;">(4,172)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(j)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 0.83pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 3.5pt;">1,231,315</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 9.33pt;">13,089</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(j)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">(k)(l)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 14.58pt;">248</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.83pt;">1,244,652</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 3.33pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 12.25pt;">47,348</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 12.83pt;">6,165</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(l)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 14.58pt;">389</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.58pt;">53,902</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 4.28pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 8.75pt;">348,957</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 9.33pt;">82,163</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(k)(l)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 9.33pt;">4,362</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 11.08pt;">435,482</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Selling, general and administrative<font style="padding-left: 1.2pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 9.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">97,055</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(97,055</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(l)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 0.6pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,202,681</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">227,033</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,961</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 3.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(19,133</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,4</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">26,542</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 3.95pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 13.42pt;">(8,261)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 7pt;">(68,880)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 3.5pt;">(15,961)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.25pt;">(93,102)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss on debt extinguishment<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 10.5pt;">(1,377)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 12.83pt;">1,377</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(m)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gain (loss) on fair value adjustments</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 12.25pt;">26,837</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 3.5pt;">(288,494)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(n)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.75pt;">(261,657)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 6.42pt;">(530,801)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 12.83pt;">3,372</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 7pt;">(14,648)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(o)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 3.5pt;">(157,562)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(a)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 9.33pt;">2,601</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(f)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.75pt;">(697,038)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Change in fair value of warrants and contingent value rights<font style="padding-left: 0.93pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 24.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 3.5pt;">(288,494)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 5.83pt;">288,494</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(n)</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 26.83pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense), net<font style="padding-left: 0.21pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 21pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">886</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 15.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(364</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 9.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">13,271</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">2(m)(o)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">13,793</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 3.08pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 6.68pt;">(511,339)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 3.5pt;">(355,743)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 21.58pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 3.5pt;">(157,562)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 3.5pt;">(13,360)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 3.5pt;">(1,038,004)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 3.93pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 12.51pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">93,811</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">363</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="padding-left: 21.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(33,088</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(g)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="padding-left: 7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,806</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; text-align: center;">5(g)</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.58pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">58,280</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.62pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 2.54pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.92pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(605,150</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(356,106</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 9.04pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 18.08pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(124,474</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 6.51pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(10,554</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.68pt; text-align: left;"><font style="padding-left: 18.08pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,096,284</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 4.3pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.92pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(633,872</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(67,002</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,125,006</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h) </div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 3.46pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.92pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(660,717</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(67,002</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,151,851</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h) </div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 1.31pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 13.42pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.73</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 10.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.21</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15.75pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.7</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">7</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h) </div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 0.48pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 13.42pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.79</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 10.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.21</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15.75pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.8</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">3</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h) </div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 4.3pt;"></font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 8.75pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">366,765</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">316,593</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 11.08pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">405,5</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">87</font></div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; padding-bottom: 4.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h) </div></td></tr><tr><td style="width: 108pt; padding-top: 3.87pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 3.46pt;"></font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.47pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 1.49pt; text-align: left;"><font style="padding-left: 8.75pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">368,607</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 7.99pt; text-align: left;"><font style="padding-left: 5.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">316,593</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 21.37pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic;">&#160;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 33.83pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 11.08pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">407,</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">429</font></div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.87pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">5(h)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.75pt; width: 108pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 34.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 44.57pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 46.65pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 21.37pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 38.09pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 38.09pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 40.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 33.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 2.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.75pt; width: 16.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; margin-top: 0.5pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">262<br></div></div></div>
<!--End Page 273-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 274-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_121-unaudited_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended December&#160;31, 2024 <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 20.41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 20.82pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reclassification <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Financing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquisition <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Settlement of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pre-existing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Relationships <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pro Forma <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-weight: bold; margin-top: 0pt; text-align: center;">Combined</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes<font style="font-style: normal; font-weight: normal;"> </font></div></td></tr><tr><td style="width: 96pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 1.64pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;">$1,915,426</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;">$<font style="padding-left: 25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;">$<font style="padding-left: 8.12pt;">510,672</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(p)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;">$<font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;">$<font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;">$(24,378)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">6(g)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 2.5pt;">2,401,720</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.35pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Digital asset self-mining revenue<font style="padding-left: 0.39pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 11.87pt;">408,740</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 9.38pt;">(408,740)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(p)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Digital asset hosted mining revenue from <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">customers<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 15.62pt;">77,554</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 13.13pt;">(77,554)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(p)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">HPC hosting revenue<font style="padding-left: 3.73pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 15.62pt;">24,378</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 13.13pt;">(24,378)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(p)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 0.4pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.38pt;">493,350</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 11.87pt;">387,631</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(q)(r)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">(s)(t)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 10pt;">47,007</font> </div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">(c)(d)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 3.75pt;">(24,378)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">6(h)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 11.87pt;">903,610</font> </div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: top; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Cost of digital asset self-mining<font style="padding-left: 2.87pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 11.87pt;">314,335</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 9.38pt;">(314,335)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(q)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Cost of digital asset hosted mining services<font style="padding-left: 1.22pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 15.62pt;">53,558</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 13.13pt;">(53,558)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(q)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Cost of HPC hosting services<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 15.62pt;">21,709</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 13.13pt;">(21,709)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(q)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Change in fair value of digital assets<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 19.37pt;">1,052</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 19.37pt;">1,052</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Change in fair value of energy derivatives<font style="padding-left: 3.45pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 19.37pt;">2,757</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 16.88pt;">(2,757)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(r)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Losses on exchange or disposal of property, plant and equipment<font style="padding-left: 1.64pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 19.37pt;">4,210</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 16.88pt;">(4,210)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(s)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 3.73pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.38pt;">960,685</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 15.62pt;">21,865</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(s)<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">(t)(u)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 13.75pt;">9,126</font> </div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 11.87pt;">991,676</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 2.06pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 13.13pt;">18,389</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 19.37pt;">9,969</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 10pt;">18,985 </font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.62pt;">47,343</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.65pt;">118,644</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 12.15pt;">110,448</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 16.88pt;">(1,097)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(t)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 6.25pt;">160,255 </font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(b)(e)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 11.87pt;">388,250</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 15.9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">11,830</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 13.4pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(11,830</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(u)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Total operating expenses<font style="padding-left: 2.06pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 3.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,591,068</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 11.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">529,868</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 6.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">235,373</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 3.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(24,378</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 6.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">331,931</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 1.65pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.38pt;">324,358</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 13.13pt;">(19,196)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 3.75pt;">(235,373)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.62pt;">69,789</font> </div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss on debt extinguishment<font style="padding-left: 0.81pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 22.5pt;">(487)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 25pt;">487</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(v)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 0.8pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 6.88pt;">(755,929)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 3.75pt;">(1,369,157)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(w)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.75pt;">(2,125,086)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<font style="padding-left: 1.45pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 6.88pt;">(360,824)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 13.13pt;">(37,070)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 16.88pt;">(7,026)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(x)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 3.75pt;">(351,537)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">5(a)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 13.75pt;">1,171</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(f)</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.38pt;">(755,286)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Change in fair value of warrants and contingent <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 7.5pt; text-align: left;">value rights<font style="padding-left: 0.8pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 3.75pt;">(1,369,157)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 6.25pt;">1,369,157</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(w)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Reorganization items, net<font style="padding-left: 1.15pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 26.25pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 12.42pt;">111,439</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 19.37pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.42pt;">111,439</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense), net<font style="padding-left: 2.29pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 13.13pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">48,194</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">325</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 19.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6,539</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">2(v)(x)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 23.12pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 23.12pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 6.25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">34,797</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">6(h)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.62pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">89,855</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 0.38pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 6.88pt;">(744,201)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 3.75pt;">(1,314,146)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 3.75pt;">(351,537)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 3.75pt;">(234,202)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 6.25pt;">34,797</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.75pt;">(2,609,289)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 1.75pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 4.14pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.65pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">119,247</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 25pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">859</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="padding-left: 28.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(73,823</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">5(g)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">49,182</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; text-align: center;">5(g)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">7,307</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.16pt; text-align: left;">5(g)</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 19.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,408</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 1.47pt; padding-bottom: 3pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 3.72pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.13pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(863,448</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,315,005</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 5.21pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 25pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.73pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(277,714</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 3.74pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(185,020</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 6.78pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">27,490</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(2,613,697</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 2.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td></tr><tr><td style="width: 96pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Net loss attributable to common stockholders, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-align: left;">basic and diluted<font style="font-weight: normal; padding-left: 0.8pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.13pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(937,765</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,122,420</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(2,688,014</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">5(h)<font style="font-style: normal;"> </font></div></td></tr><tr><td style="width: 96pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Net loss per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 4.13pt;"></font></div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 14.38pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(4.30</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 16.88pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(4.39</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 13.13pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(10.</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">47</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; padding-bottom: 4pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">5(h)<font style="font-style: normal;"> </font></div></td></tr><tr><td style="width: 96pt; padding-top: 3.72pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-indent: -7.5pt; text-align: left;">Weighted-average shares used in computing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; margin-left: 7.5pt; text-align: left;">net loss per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 4.13pt;"></font></div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.48pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.36pt; text-align: left;"><font style="padding-left: 9.38pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">217,854</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.57pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 4.17pt; text-align: left;"><font style="padding-left: 11.87pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">255,832</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.65pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.41pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.09pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.82pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.44pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic;">&#160;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.25pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 11.87pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">256,6</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">76</font></div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16.33pt; padding-top: 3.72pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-style: italic; margin-top: 0pt; margin-left: 3.17pt; text-align: left;">5(h)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.5pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 34.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 44.57pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 46.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 20.41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 38.09pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 20.82pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 40.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 36.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 2.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.5pt; width: 16.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">See the accompanying notes to the Unaudited Pro Forma Condensed Combined Financial Information.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">263<br></div></div></div>
<!--End Page 274-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 275-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a name="tNOT"><!--Anchor--></a>NOTES TO THE UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Note&#160;1. Description of the Transactions and Basis of Pro Forma Presentation </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Description of the Merger </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On July&#160;7, 2025, CoreWeave entered into the Merger Agreement with Core Scientific and Merger Sub, pursuant to which and subject to the terms and conditions therein, at the effective time, Merger Sub will merge with and into Core Scientific, with Core Scientific surviving as a wholly owned subsidiary of CoreWeave. As a result of the Merger, each issued and outstanding share of Core Scientific common stock, par value $0.00001 per share, will be converted into the right to receive 0.1235 newly issued, fully paid and non-assessable shares of CoreWeave Class&#160;A common stock, par value $0.000005 per share. Additionally, at the effective time, each (i) Tranche 1 Warrant will be automatically redeemed in exchange for the right to receive a New Tranche 1 Warrant exercisable for a number of shares of CoreWeave Class&#160;A common stock (subject to cashless exercise as described below) equal to (a) the number of Warrant Shares (as defined in the Core Scientific Warrant Agreement) underlying such Tranche 1 Warrant, multiplied by (b) the exchange ratio, with such New Tranche 1 Warrant having an exercise price equal to (x) the Tranche 1 Exercise Price (as defined in the Core Scientific Warrant Agreement) in effect immediately prior to the effective time divided by (y) the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants and (ii) Tranche 2 Warrant will be converted into a non-penny Converted Tranche 2 Warrant (as defined in the Core Scientific Warrant Agreement) having an exercise price of $7.50 per Warrant Share (subject to adjustment on the terms set forth in the Core Scientific Warrant Agreement), which Converted Tranche 2 Warrant will be automatically redeemed in exchange for the right to receive a New Tranche 2 Warrant exercisable for a number of shares of CoreWeave Class&#160;A common stock (subject to cashless exercise as described below) equal to (a) the number of Warrant Shares underlying the Converted Tranche 2 Warrant, multiplied by (b) the exchange ratio, with such New Tranche 2 Warrant having an exercise price equal to (x) $7.50 per Warrant Share divided by (y) the exchange ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants. As a result, assuming no events occur requiring any adjustment to the number of shares underlying each Tranche&#160;1 Warrant or Tranche&#160;2 Warrant or the exercise price therefor prior to the Merger, each New Tranche&#160;1 Warrant will cover 0.1235&#160;shares of CoreWeave Class A common stock at an exercise price of $55.141700 per share, and each New Tranche&#160;2 Warrant will cover 0.1235 shares of CoreWeave Class A common stock at an exercise price of $60.728745 per share. Both the New Tranche 1 Warrants and New Tranche 2 Warrants will be exercisable only on a cashless basis, pursuant to which the holder will be entitled to receive a number of shares of CoreWeave Class&#160;A common stock equal to the total number of shares of CoreWeave Class&#160;A common stock underlying the warrants being exercised multiplied by a fraction equal to (x) the current market price (as of the business day immediately preceding the date on which the exercise notice was delivered) of one share of CoreWeave Class&#160;A common stock, minus the applicable exercise price, divided by (y) such current market price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, Core Scientific had (i)&#160;outstanding Tranche 1 Warrants exercisable for up to 97.5&#160;million shares of common stock at an exercise price of $6.81 per share; and (ii)&#160;outstanding Tranche&#160;2 Warrants exercisable for up to 15.1&#160;million shares of common stock at an exercise price of $0.01&#160;per share. Based on the number of Core Scientific warrants outstanding as of June&#160;30, 2025, and assuming no events occur requiring any adjustment to the number of shares underlying each Tranche&#160;1 Warrant or Tranche 2 Warrant or the exercise price therefor prior to the Merger, the New Tranche&#160;1 Warrants will be exercisable for up to 12.0&#160;million shares of CoreWeave Class&#160;A common stock at an exercise price of $55.141700 per share, and the New Tranche&#160;2 Warrants will be exercisable for up to 1.9&#160;million shares of CoreWeave Class A common stock at an exercise price of $60.728745 per share, in each case, prior to giving effect to any effective reduction in share issuance that the cashless exercise mechanism described above may have. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Financing Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May&#160;27, 2025, CoreWeave issued $2.0&#160;billion in aggregate principal amount of 9.250% senior notes due on June&#160;1, 2030 (the &#8220;2030 Senior Notes&#8221;). Additionally, on July&#160;25, 2025, CoreWeave issued $1.8&#160;billion in aggregate principal amount of 9.000% senior notes due on February&#160;1, 2031 (the &#8220;2031 Senior Notes&#8221; and together with the &#8220;2030 Senior Notes&#8221; the &#8220;Financing Transactions&#8221;). CoreWeave intends to use the proceeds from the Financing Transactions to pay the fees, costs and expenses of the Financing Transactions, for general corporate purposes, and the repayment of outstanding indebtedness. The Financing Transactions are not directly related to the Merger, but are material events entered into by CoreWeave, and included within the unaudited pro forma condensed combined financial information in accordance with Regulation S-X 210.11-01(a)(8). </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">264<br></div></div></div>
<!--End Page 275-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 276-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Basis of Pro Forma Presentation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information has been prepared in accordance with Article&#160;11 of Regulation S-X. The unaudited pro forma condensed combined balance sheet as of June&#160;30, 2025 combines the historical unaudited condensed consolidated balance sheets of CoreWeave and Core Scientific, giving effect to the Transactions as if they had been consummated on June&#160;30, 2025. The unaudited pro forma condensed combined statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, combines the historical condensed consolidated statements of operations of CoreWeave and Core Scientific, giving effect to the Transactions as if they had been consummated on January&#160;1, 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial information and explanatory notes have been prepared to illustrate the effects of the Merger under the acquisition method of accounting whereby CoreWeave is considered the accounting acquirer. The unaudited pro forma condensed combined financial information is presented for informational purposes only and does not necessarily indicate the financial results of the combined company had the companies been combined at the beginning of the periods presented, nor does it necessarily indicate the results of operations in future periods or the future financial position of the combined company. The results of operations of the combined company will be reported prospectively after the Closing Date following completion of the Merger. Under the acquisition method of accounting, the assets and liabilities of Core Scientific, as of the Closing Date, will be recorded by CoreWeave at their estimated fair values and any excess of the consideration transferred over the fair value of Core Scientific&#8217;s net assets will be allocated to goodwill. The pro forma allocation of the consideration transferred reflected in the unaudited pro forma condensed combined financial information is subject to adjustment and may vary materially from the actual allocation that will be recorded at the time the Merger is completed since, among other reasons, certain information will not be available until after the Merger is completed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the contemplated Transactions, CoreWeave and Core Scientific had several pre-existing relationships, which primarily related to HPC colocation agreements. Under these agreements, Core Scientific provides space, power, cooling, facilities operations, security, and other services to CoreWeave to support workloads for machine learning and artificial intelligence. Significant agreements include: (i) a contract to provide CoreWeave with 16 MW of infrastructure at Core Scientific&#8217;s Austin, Texas facility (the &#8220;Austin Lease&#8221;); (ii) a series of agreements to provide 571 MW of infrastructure across multiple sites in the United States (collectively, the &#8220;CoreWeave Colocation Agreements&#8221;); and (iii) various other arrangements primarily related to construction payables incurred on CoreWeave&#8217;s behalf (&#8220;Other Agreements&#8221;). The Austin Lease commenced in March&#160;2024 and was accounted for as an operating lease by both CoreWeave and Core Scientific; related revenues and expenses for the six months ended June&#160;30, 2025 and year ended December 31, 2024 are eliminated as intercompany in the unaudited pro forma condensed combined statement of operations. Refer to the historical financial statements and related notes of CoreWeave and Core Scientific for additional information on the background of these pre-existing relationships. Upon the consummation of the Transactions, all historical pre-existing relationships between CoreWeave and Core Scientific are considered effectively settled for accounting purposes and the related transactions and balances will become intercompany transactions. As such, in accordance with the guidance in ASC 805, all intercompany transactions and balances have been eliminated in the unaudited pro forma condensed combined financial information. Refer to <font style="font-style: italic;">Note&#160;6. Pro Forma Adjustments to Settle Pre-Existing Relationships</font> for: (i) adjustments made to Core Scientific&#8217;s historical unaudited condensed consolidated balance sheet as of June&#160;30, 2025, to eliminate balances related to pre-existing relationships, (ii) the adjustments made to CoreWeave and Core Scientific&#8217;s historical condensed consolidated statements of operations for the six months ended June&#160;30, 2025 and the year ended December&#160;31, 2024, to reflect the elimination of intercompany transactions, and (iii) the overall impact of the settlement of pre-existing relationships. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The unaudited pro forma condensed combined financial data is presented for illustrative purposes only and does not reflect the costs of any integration activities or cost savings or synergies that may be achieved as a result of the Merger. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Note&#160;2. CoreWeave and Core Scientific Reclassification Adjustments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the preparation of the unaudited pro forma condensed combined financial information, CoreWeave performed a preliminary analysis of Core Scientific&#8217;s historical financial information to identify differences in accounting policies and financial statement presentation as compared to those of CoreWeave. With the information currently available, CoreWeave has determined that there are certain accounting policy differences, and accordingly certain reclassifications and adjustments have been made to conform Core Scientific&#8217;s historical financial statements to the accounting policies and presentation used by CoreWeave in the preparation of the unaudited pro forma condensed combined financial information. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">265<br></div></div></div>
<!--End Page 276-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 277-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Following the closing of the Merger, CoreWeave will conduct a more detailed review of Core Scientific&#8217;s accounting policies to determine if differences in accounting policies require further reclassification or adjustment to Core Scientific&#8217;s historical financial statements. As a result, CoreWeave may identify additional differences between the accounting policies of CoreWeave and Core Scientific that, when conformed, could have a material impact on the unaudited pro forma condensed combined financial information presented herein. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following accounting policy and reclassification adjustments were made to conform the presentation of Core Scientific&#8217;s historical unaudited condensed consolidated balance sheet as of June&#160;30, 2025 to CoreWeave&#8217;s presentation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from customer funding receivable and other current assets to accounts receivable, net and prepaid expenses and other current assets. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from other non-current assets to intangible assets, net. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from accrued expenses to accrued liabilities. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from other current liabilities to accrued liabilities, debt, current, operating lease liabilities, current, and finance lease liabilities, current. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from convertible and other notes payable, net of current portion to debt, non-current. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(f)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from warrant liabilities to derivative and warrant liabilities. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(g)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from other non-current liabilities to operating lease liabilities, non-current. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following accounting policy and reclassification adjustments were made to conform the presentation of Core Scientific&#8217;s historical unaudited condensed consolidated statement of operations for the six months ended June&#160;30, 2025 to CoreWeave&#8217;s presentation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(h)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from digital asset self-mining revenue, digital asset hosted mining revenue from customers, and colocation revenue to revenue. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from cost of digital asset self-mining, cost of digital asset hosted mining services, and cost of colocation services to cost of revenue. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(j)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from losses on exchange or disposal of property, plant and equipment to cost of revenue and technology and infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(k)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification of depreciation expense from cost of revenue and general and administrative to technology and infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(l)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from selling, general and administrative to technology and infrastructure, sales and marketing, and general and administrative. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(m)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from loss on debt extinguishment to other income (expense), net. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(n)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from change in fair value of warrants and contingent value rights to gain (loss) on fair value adjustments. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(o)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification of interest and investment income from interest expense, net to other income (expense), net. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following accounting policy and reclassification adjustments were made to conform the presentation of Core Scientific&#8217;s historical audited consolidated statement of operations for the year ended December&#160;31, 2024 to CoreWeave&#8217;s presentation: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(p)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from digital asset self-mining revenue, digital asset hosted mining revenue from customers, and HPC hosting revenue to revenue. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(q)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from cost of digital asset self-mining, cost of digital asset hosted mining services, and cost of HPC hosting services to cost of revenue. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(r)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an alignment of accounting policies that results in movement of the change in fair value related to energy derivatives from change in fair value of energy derivatives to cost of revenue. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">266<br></div></div></div>
<!--End Page 277-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 278-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(s)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from losses on exchange or disposal of property, plant and equipment to cost of revenue and technology and infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(t)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification of depreciation expense from cost of revenue and general and administrative to technology and infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(u)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from research and development to technology and infrastructure. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(v)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Represents a reclassification from loss on debt extinguishment to other income (expense), net. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(w)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification from change in fair value of warrants and contingent value rights to gain (loss) on fair value adjustments. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(x)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents a reclassification of interest income and investment income from interest expense, net to other income (expense), net. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Note&#160;3. Preliminary Purchase Price Allocation </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Preliminary Estimated Merger Consideration </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The total preliminary estimated merger consideration is calculated as follows (in thousands, except exchange ratio and price per share): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 408pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific common stock outstanding as of June&#160;30, 2025<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">303,146 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exchange ratio<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">0.1235 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Shares of CoreWeave Class&#160;A common stock to be issued to holders of Core Scientific common stock<font style="padding-left: 4.39pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">37,439 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Price per share of CoreWeave Class&#160;A common stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 2.09pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8203;</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">120.47 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Preliminary estimated fair value of CoreWeave Class&#160;A common stock to be issued to holders of Core Scientific common stock<font style="padding-left: 1.65pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$4,510,218 </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Preliminary estimated fair value of CoreWeave Class&#160;A common stock to be issued to holders of Core Scientific In the Money Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 1.81pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">412</font> </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Preliminary estimated fair value of replacement equity awards attributable to pre-combination services<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 4.55pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">106,372</font> </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Preliminary estimated fair value of assumed debt in excess of par value<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 2.45pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">389,767</font> </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Settlement of pre-existing relationships<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 1.81pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(42,955</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total preliminary estimated merger consideration<font style="padding-left: 4.79pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,963,814</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents the closing price per share of CoreWeave Class&#160;A common stock as of September 15, 2025. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents the preliminary estimated fair value of approximately 3,418 shares of CoreWeave Class&#160;A common stock to be issued to holders of Core Scientific In the Money Options in connection with the Merger. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents the estimated fair value of certain Core Scientific RSU Awards and Core Scientific PSU Awards granted to employees attributable to pre-combination services which are expected to be replaced by CoreWeave Rollover RSU Awards, CoreWeave Rollover PSU Awards and shares of CoreWeave Class&#160;A common stock in connection with the Merger. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents the preliminary estimated fair value of convertible debt assumed by CoreWeave in excess of par value related to the Core Scientific 2029 Convertible Notes and the Core Scientific 2031 Convertible Notes in connection with the Merger, assuming that the conversion features embedded within are not bifurcated and recognized as a derivative liability consistent with Core Scientific&#8217;s historical unaudited condensed consolidated balance sheet as of June&#160;30, 2025. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents amounts related to the effective settlement of pre-existing relationships between CoreWeave and Core Scientific as of June&#160;30, 2025. Refer to <font style="font-style: italic;">Note&#160;6. Pro Forma Adjustments to Settle Pre-Existing Relationships</font> for further details on the pre-existing relationships and the amounts that are being settled as of the effective time of the Merger. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The final merger consideration could significantly differ from the amounts presented in the unaudited pro forma condensed combined financial information due to movements in the price of CoreWeave&#8217;s Class&#160;A common stock up to the closing date of the Merger. A sensitivity analysis related to the fluctuation in the price of CoreWeave&#8217;s Class&#160;A common stock was performed to assess the impact of a hypothetical change of 30% on CoreWeave&#8217;s Class&#160;A common stock closing price on the preliminary estimated merger consideration. CoreWeave believes that a 30% fluctuation in the market price of Core Weave&#8217;s Class&#160;A common stock is reasonably possible based on historical volatility. An increase or decrease in the closing price of CoreWeave&#8217;s Class&#160;A common stock could potentially result in a change of goodwill as of the closing date. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">267<br></div></div></div>
<!--End Page 278-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 279-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table shows the total preliminary estimated merger consideration resulting from a change in CoreWeave&#8217;s Class&#160;A common stock price (in thousands, except price per share): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48.43pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price</div></td><td style="width: 6.76pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.43pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preliminary <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Consideration </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">30% increase<font style="padding-left: 3.09pt;"></font></div></td><td style="width: 6.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$156.61</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.43pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;">$6,349,005 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">30% decrease<font style="padding-left: 1.42pt;"></font></div></td><td style="width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">&#8203;84.33 </font></div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.43pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.72pt; text-align: left;">$3,575,308</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.43pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">Preliminary Purchase Price Allocation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preliminary estimated merger consideration as shown in the table above is allocated to the identifiable tangible and intangible assets acquired and liabilities assumed of Core Scientific based on their preliminary estimated fair values. The fair value assessments are preliminary and are based on available information and certain assumptions, which CoreWeave believes are reasonable. Accordingly, the preliminary purchase price allocation is subject to further adjustment as additional information becomes available and as additional analyses and final valuations are completed. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth a preliminary allocation of the total preliminary estimated merger consideration to the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed of Core Scientific using Core Scientific&#8217;s historical unaudited condensed consolidated balance sheet as of June&#160;30, 2025, adjusted for reclassifications and presentational alignment to that of CoreWeave&#8217;s historical financial information, and for the effective settlement of pre-existing relationships (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.97pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June&#160;30, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025 </div></td></tr><tr><td style="width: 384pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 3.77pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;">$<font style="padding-left: 7.5pt;">581,345 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable, net<font style="padding-left: 1.27pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 30pt;">532 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Digital assets<font style="padding-left: 2.08pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 12.5pt;">172,772 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 1.59pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 17.5pt;">18,061 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net<font style="padding-left: 0.7pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 5pt;">1,927,603 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Intangible assets, net<font style="padding-left: 1.26pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 17.5pt;">45,000 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 12.5pt;">142,667 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 2.11pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">28,959 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets, excluding goodwill<font style="font-weight: normal; padding-left: 0.51pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$2,916,939 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities<br></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 4.31pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;">$<font style="padding-left: 7.5pt;">215,055 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities<font style="padding-left: 2.09pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 12.5pt;">183,988 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, current<font style="padding-left: 2.91pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 22.5pt;">1,550 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue, current<font style="padding-left: 1.84pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 22.5pt;">1,049 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 17.5pt;">10,438 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 1.84pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 30pt;">547 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<font style="padding-left: 1.54pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 22.5pt;">1,017 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, non-current<font style="padding-left: 4.59pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 5pt;">1,085,000 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Derivative and warrant liabilities<font style="padding-left: 2.11pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 5pt;">1,224,135</font> </div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 0.18pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 17.5pt;">92,229 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current liabilities<font style="padding-left: 3.21pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,35</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 2.43pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$2,817,359 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net assets acquired (a)<font style="font-weight: normal; padding-left: 2.84pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8203;99,580 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Preliminary estimated merger consideration (b)<font style="font-weight: normal; padding-left: 4.72pt;"></font></div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$4,963,814 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Estimated goodwill (b) &#8211; (a)<font style="font-weight: normal; padding-left: 4.88pt;"></font></div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.97pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.49pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$4,864,234</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 17.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.97pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">268<br></div></div></div>
<!--End Page 279-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 280-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preliminary purchase price allocation does not include acquired deferred tax balances as the deferred tax asset is offset by a valuation allowance. This determination is preliminary and subject to change based upon the final determination of the fair value of identified assets and liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Preliminary goodwill is calculated as the excess of the total preliminary estimated merger consideration over the estimated fair value of the underlying net assets to be acquired. The goodwill arising from the Merger is primarily attributable to the expected operational synergies between CoreWeave and Core Scientific that allows CoreWeave to verticalize its data center footprint, thereby supporting sustained revenue growth and enhanced profitability. The final calculation of goodwill could differ materially from the preliminary amounts presented in these unaudited pro forma condensed combined financial statements due to several factors including, but not limited to, fluctuations in the price of CoreWeave&#8217;s Class&#160;A common stock and the changes in the estimated fair value of assets acquired and liabilities assumed. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Note&#160;4. Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Transaction Accounting Adjustments include the following adjustments related to the unaudited pro forma condensed combined balance sheet as of June&#160;30, 2025, as follows: </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 0pt; text-align: left;">Financing Transaction Accounting Adjustments </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents the issuance of the 2031 Senior Notes, which were initially issued in July&#160;2025, for an aggregate principal amount of $1.8&#160;billion, less $26&#160;million of debt discounts and issuance costs. The net proceeds from the 2031 Senior Notes will be used for general corporate purposes. The unaudited pro forma condensed combined balance sheet does not include a pro forma adjustment related to the issuance of the 2030 Senior Notes, as the 2030 Senior Notes are already reflected within CoreWeave&#8217;s historical condensed consolidated balance sheet as of June&#160;30, 2025. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Acquisition Transaction Accounting Adjustments </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $1.1&#160;billion to increase the carrying amounts of Core Scientific&#8217;s property and equipment from their recorded net book values to their preliminary estimated fair values. This adjustment relates to land and power purchase agreements. The power purchase agreements are considered to be a component of the related data centers and the estimated useful lives are similar to that of the related data centers. As land is not a depreciable asset, and power purchase agreements relate to data centers under construction and not depreciated until the associated data centers are placed in service, no additional depreciation expense is recorded in the unaudited pro forma condensed combined statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, related to this adjustment. The acquired property and equipment consist of the following with preliminary fair value estimates (in thousands): </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 58.86pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Useful Life</div></td><td style="width: 8.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preliminary <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Land and improvements<font style="padding-left: 0.64pt;"></font></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">20 years<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">44,481 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Building and improvements<font style="padding-left: 1.19pt;"></font></div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">10 to 39 years</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">206,963 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Mining and network equipment<font style="padding-left: 0.64pt;"></font></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">3 to 5 years</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">62,322 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Electrical equipment<font style="padding-left: 0.64pt;"></font></div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">15 years</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">54,996 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other property, plant and equipment<font style="padding-left: 1.03pt;"></font></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5 to 7 years</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">1,336 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Construction in progress<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 0.79pt;"></font></div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,557,505 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total fair value of Core Scientific&#8217;s property and equipment<font style="font-weight: normal; padding-left: 3.09pt;"></font></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">1,927,603 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Core Scientific&#8217;s historical property and equipment, net<font style="padding-left: 3.2pt;"></font></div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(828,603</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma adjustments to property and equipment, net<font style="font-weight: normal; padding-left: 4.12pt;"></font></div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 58.86pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,099,000</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 58.86pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Estimated useful life of improvements. Land is not depreciated. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Includes $1.1&#160;billion of power purchase agreements. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $34&#160;million, comprising a $40&#160;million increase to recognize the favorable terms of the leases, partially offset by a $6&#160;million decrease to remeasure acquired right-of-use assets and lease liabilities in accordance with ASC 842, with the right-of-use asset adjusted to equal the lease liability. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">269<br></div></div></div>
<!--End Page 280-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 281-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $44 million to record intangible assets acquired from Core Scientific at their estimated fair value of $45&#160;million in connection with the Merger, offset by the elimination of $1&#160;million in historical intangible asset book values. Intangible assets acquired from Core Scientific relate to developed technologies and have an estimated useful life of three years. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents the recognition of the preliminary goodwill associated with the Merger, net of adjustment to preliminary goodwill for settlement of pre-existing relationships. Goodwill represents the total preliminary estimated merger consideration in excess of the fair value of the underlying net assets. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(f)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $46&#160;million to record estimated acquisition-related costs expected to be incurred by CoreWeave as an increase to accrued liabilities and a corresponding increase to accumulated deficit. These costs are non-recurring and are not expected to have a continuing impact on the combined company&#8217;s operating results in future periods. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(g)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $27&#160;million to debt, non-current to reflect the removal of historical unamortized debt issuance costs associated with the borrowings of the 2031 Convertible Senior Notes and the 2029 Convertible Senior Notes. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(h)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $93 million to record the estimated fair value of the New Tranche 1 Warrants and New Tranche 2 Warrants to be issued to Core Scientific warrant holders in connection with the Merger. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The following table summarizes the transaction accounting adjustments impacting the equity balances of Core Scientific, as well as new equity issued as consideration for the Merger (in thousands): </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 52.86pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 52.86pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 52.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 192pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments to <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments to <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquisition-<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">related Costs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Transaction <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accounting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments </div></td></tr><tr><td style="width: 192pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Class&#160;A common stock<font style="padding-left: 0.63pt;"></font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.93pt; text-align: left;">$<font style="padding-left: 30pt;">&#8212;</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.26pt; text-align: left;">$<font style="padding-left: 33.33pt;">&#8212;</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.16pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8212;</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 30pt;">&#8212; </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Common stock<font style="padding-left: 2.84pt;"></font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.93pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.26pt; text-align: left;"><font style="padding-left: 40pt;">(3)</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.16pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 36.67pt;">(3) </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital<font style="padding-left: 0.09pt;"></font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.93pt; text-align: left;"><font style="padding-left: 5pt;">5,006,769</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.26pt; text-align: left;"><font style="padding-left: 5pt;">(3,026,645)</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.16pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,980,124</font> </div></td></tr><tr><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 2.31pt;"></font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.93pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(42,955</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.26pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,091,324</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.16pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(45,559</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,002,810</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 192pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma net adjustment to equity<font style="font-weight: normal; padding-left: 4.75pt;"></font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.93pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,963,814</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.26pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,064,676</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.16pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(45,559</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$5,982,931</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 192pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.86pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.86pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 13.25pt;"> </div></div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Adjustments to CoreWeave Equity: </font>Represents the total preliminary estimated merger consideration of $5.0 billion, consisting of (i)&#160;issuance of approximately 37&#160;million shares of CoreWeave Class&#160;A common stock with an estimated fair value of $4.5 billion, (ii)&#160;settlement of Core Scientific In the Money Options, (iii) conversion of Core Scientific RSU Awards and Core Scientific PSU Awards granted to employees attributable to pre-combination services that are being replaced by CoreWeave Rollover RSU Awards, CoreWeave Rollover PSU Awards and shares of CoreWeave class A common stock with an estimated fair value of $106 million, (iv)&#160;estimated fair value of $390&#160;million in convertible debt assumed in excess of par value related to the Core Scientific 2029 Convertible Notes and the Core Scientific 2031 Convertible Notes, and (v) settlement of pre-existing relationships between CoreWeave and Core Scientific of $(43) million. Refer to <font style="font-style: italic;">Note&#160;6. Pro Forma Adjustments to Settle Pre-Existing Relationships</font> for further details. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Adjustments to Core Scientific Equity: </font>Represents the elimination of Core Scientific&#8217;s historical equity balances as of June&#160;30, 2025. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;"><font style="font-style: italic; font-weight: bold;">Acquisition-related Costs: </font>Represents $46&#160;million of estimated acquisition-related costs expected to be incurred by CoreWeave in connection with the Merger. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">270<br></div></div></div>
<!--End Page 281-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 282-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Note&#160;5. Pro Forma Adjustments to the Unaudited Condensed Combined Statements of Operations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Transaction Accounting Adjustments include the following adjustments related to the unaudited pro forma condensed combined statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, as follows: </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 0pt; text-align: left;">Financing Transaction Accounting Adjustments </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment to record $158&#160;million and $352&#160;million of interest expense for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, respectively, associated with the borrowings of the 2031 Senior Notes and the 2030 Senior Notes. The incremental interest expense has been calculated as follows (in thousands): </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 64.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 65.82pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, 2025</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense on 2031 Senior Notes<font style="padding-left: 2.23pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.46pt; text-align: left;">$<font style="padding-left: 5pt;">80,402</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;">$160,584 </div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense on 2030 Senior Notes<font style="padding-left: 2.23pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.46pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">95,700</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">190,953</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Subtotal<font style="padding-left: 2.17pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.46pt; text-align: left;"><font style="padding-left: 5pt;">176,102</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 5pt;">351,537 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Historical interest expense on 2030 Senior Notes<font style="padding-left: 0.59pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.46pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(18,540</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma adjustment to interest expense, net<font style="font-weight: normal; padding-left: 1.24pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$157,562</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$351,537</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 64.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 65.82pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">Acquisition Transaction Accounting Adjustments </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents the adjustments of $5 million and $169 million to record incremental stock-based compensation expense for the six months ended June&#160;30, 2025, and the year ended December&#160;31, 2024, respectively, to reflect the post-combination portion of the Core Scientific equity awards which are expected to be replaced by CoreWeave equity awards. The value for the replacement awards is based on the CoreWeave Class&#160;A common stock price as of September 15, 2025. The breakdown of the adjustment is as follows (in thousands): </div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 64.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 65.82pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, 2025</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.46pt; text-align: left;">$<font style="padding-left: 7.5pt;">&#8203;305</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;">$<font style="padding-left: 5pt;">&#8203;25,818 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 3.47pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.46pt; text-align: left;"><font style="padding-left: 12.5pt;">248</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 15pt;">9,126 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.46pt; text-align: left;"><font style="padding-left: 12.5pt;">389</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 10pt;">18,985 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 0.55pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.46pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,362</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">114,696</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;"> </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pro forma adjustment to stock-based compensation expense<font style="font-weight: normal; padding-left: 0.23pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$5,304 </font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.16pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$168,625</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 64.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 65.82pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $4&#160;million and $7&#160;million to record amortization expense for favorable contractual lease terms when compared to the market for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $7&#160;million and $14&#160;million to reflect amortization expense for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, respectively, for the estimated fair value of acquired intangible assets on a straight-line basis over their estimated useful lives. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $46&#160;million to record estimated acquisition-related costs expected to be incurred by CoreWeave in connection with the Merger for the year ended December&#160;31, 2024. These costs are non-recurring and are not expected to have a continuing impact on the combined company&#8217;s operating results in future periods. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(f)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents an adjustment of $3&#160;million and $1&#160;million to eliminate Core Scientific&#8217;s historical amortization of deferred financing costs for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(g)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Represents the estimated income tax impact of adjustments to the unaudited pro forma condensed combined statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024. A federal statutory rate of 21% and 21% for the six months ended June&#160;30, 2025, and for the year ended </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">271<br></div></div></div>
<!--End Page 282-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 283-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: justify;">December&#160;31, 2024, respectively, has been assumed for the pro forma adjustments. The federal statutory rate is not necessarily indicative of the effective tax rate of the combined company. Further, as preliminary assessments are ongoing, no adjustments have been recorded related to tax deduction limitations for acquisition-related costs. </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(h)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The unaudited pro forma condensed combined basic and diluted earnings per share calculations are based on the weighted average basic and diluted shares of CoreWeave. The following table summarizes the computation of the unaudited pro forma basic and diluted loss per share (in thousands, except per share data): </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 64.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 65.82pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, 2025</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Numerator:<br></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Pro forma combined net loss<font style="padding-left: 2.21pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;">$(1,096,284)</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;">$(2,613,697) </div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Dividends and accretion on Series&#160;C redeemable convertible <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;">preferred stock<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(28,722</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(74,317</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net loss attributable to CoreWeave common stockholders, basic</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;">$(1,125,006)</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;">$(2,688,014) </div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Change in fair value of common stock warrants<font style="padding-left: 4.47pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(26,845</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Net loss attributable to CoreWeave common stockholders, diluted<font style="padding-left: 2.72pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;">$(1,151,851)</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;">$(2,688,014) </div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Denominator:<br></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Historical CoreWeave weighted-average shares used in computing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">net loss attributable to common stockholders, basic<font style="padding-left: 0.85pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 15.83pt;">366,765</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 15.83pt;">217,854 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Shares of CoreWeave common stock to be issued<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.75pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">38,8</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">22</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">38,8</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">22 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Pro forma weighted-average shares used in computing net loss <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">attributable to common stockholders, basic<font style="padding-left: 0.28pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 15.83pt;">405,587</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 15.83pt;">256,676 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Effect of dilutive securities:<br></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Common stock warrants<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,842</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Pro forma weighted-average shares used in computing net loss <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">attributable to common stockholders, diluted<font style="padding-left: 3.05pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">407,4</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">29</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">256,6</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">76 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net loss per share attributable to common stockholders, basic<font style="padding-left: 4.95pt;"></font></div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 22.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.7</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">7</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 17.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(10.</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">47</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 288pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Pro forma net loss per share attributable to common stockholders, diluted<font style="padding-left: 2.72pt;"></font></div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 64.44pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.05pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 22.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.8</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">3</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 65.82pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.75pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 17.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(10.</font><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">47</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 64.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 65.82pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">As the Transactions are being reflected as if they had been consummated at the beginning of the periods presented, the calculation of weighted average basic and diluted shares outstanding assumes the shares issuable in connection with the Merger have been outstanding for the entire periods presented. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">For the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, the dilutive effects of the combined company&#8217;s convertible notes, certain warrants, stock options, RSAs, RSUs, and PSUs were excluded from the calculation of pro forma net loss per share attributable to common stockholders, diluted because including them would have been anti-dilutive. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Note&#160;6. Pro Forma Adjustments to Settle Pre-Existing Relationships </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in <font style="font-style: italic;">Note&#160;1. Description of the Transactions and Basis of Presentation, </font>as of the date hereof and prior to the consummation of the contemplated Transactions, CoreWeave and Core Scientific have pre-existing relationships primarily related to HPC colocation agreements. Core Scientific&#8217;s historical financial statements include certain historical balances related to pre-existing relationships with CoreWeave. As all historical pre-existing relationships between CoreWeave and Core Scientific will be considered effectively settled and the related transactions and balances will become intercompany transactions, balances related to pre-existing relationships were identified and eliminated from the historical CoreWeave and Core Scientific financial statements. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">272<br></div></div></div>
<!--End Page 283-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 284-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments to Core Scientific&#8217;s Historical Condensed Consolidated Balance Sheet as of June&#160;30, 2025 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific&#8217;s historical balance sheet includes balances that will be effectively settled as a part of the Merger. These amounts were eliminated as they will not be part of the identified assets acquired or liabilities assumed by CoreWeave. Presented below are the adjustments made to Core Scientific&#8217;s balance sheet as of June&#160;30, 2025, as reclassified in <font style="font-style: italic;">Note&#160;2. CoreWeave and Core Scientific Reclassification Adjustments</font>, reflecting the elimination of pre-existing relationship balances (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 52.86pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 52.94pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Historical, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Reclassified</div></td><td style="width: 7.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjustments to <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Eliminate <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Balances from <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Pre-Existing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Relationships</div></td><td style="width: 7.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 7.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">as Adjusted </div></td></tr><tr><td style="width: 216pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 0.77pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;">$<font style="padding-left: 7.5pt;">581,345</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;">$<font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">$<font style="padding-left: 7.5pt;">581,345 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable, net<font style="padding-left: 3.27pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,910</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 15pt;">(1,378)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(a)</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 30pt;">532 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Digital assets<font style="padding-left: 4.08pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">172,772</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 12.5pt;">172,772 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 3.59pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">248,733</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 5pt;">(230,672)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(b)</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 17.5pt;">18,061 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net<font style="padding-left: 2.7pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">828,603</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 12.5pt;">828,603 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 3.02pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">108,584</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 12.5pt;">108,584 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Intangible assets, net<font style="padding-left: 3.26pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,326</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,326 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">34,779</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(5,820</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;"><font style="padding-left: 0.56pt;">6(c)</font></div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">28,959 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total assets, excluding goodwill<font style="font-weight: normal; padding-left: 2.51pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,978,052</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(237,870</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,740,182 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities<br></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 1.31pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;">$<font style="padding-left: 7.5pt;">215,055</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;">$<font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;">$<font style="padding-left: 7.5pt;">215,055</font> </div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities<font style="padding-left: 4.09pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">183,988</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 12.5pt;">183,988 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, current<font style="padding-left: 4.91pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,550</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,550 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue, current<font style="padding-left: 3.84pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 12.5pt;">150,127</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 5pt;">(149,078)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(d)</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,049 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 17.5pt;">10,438</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 17.5pt;">10,438 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 3.84pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 30pt;">547</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 30pt;">547 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<font style="padding-left: 3.54pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,017</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 22.5pt;">1,017 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, non-current<font style="padding-left: 1.59pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 5pt;">1,057,696</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 5pt;">1,057,696 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 17.5pt;">92,229</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 17.5pt;">92,229 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current liabilities<font style="padding-left: 0.21pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">13,39</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="padding-left: 10.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(11,040</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;"><font style="padding-left: 0.56pt;">6(e)</font></div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,35</font><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 4.43pt;"></font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,726,038</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(160,118</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,565,920 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net assets acquired<font style="font-weight: normal; padding-left: 4.83pt;"></font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50.94pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">252,014</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.86pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.02pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(77,752</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;"><font style="padding-left: 2.22pt;">6(f)</font></div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.94pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">174,262</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50.94pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.86pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.08pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.07pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.94pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents elimination of accounts receivable from CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents elimination of certain customer funding receivables from CoreWeave for construction related payables and accrued expenses incurred on CoreWeave&#8217;s behalf. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents elimination of lease receivable related to the Austin Lease. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents elimination of prepayments received from CoreWeave in connection with the CoreWeave Colocation Agreements. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents elimination of refundable security deposits received from CoreWeave. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(f)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Reflects net assets eliminated from pre-existing relationships with a corresponding impact to preliminary goodwill. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">273<br></div></div></div>
<!--End Page 284-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 285-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments to CoreWeave and Core Scientific&#8217;s Historical Condensed Consolidated Statements of Operations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Presented below are the adjustments to eliminate intercompany transactions on the historical condensed consolidated statements of operations for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, related to the pre-existing relationship balances between CoreWeave and Core Scientific (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 82.59pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 82.59pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 82.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Six Month <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ended June&#160;30, 2025</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 18.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 3.68pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 82.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">For the Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 18.66pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes<font style="font-style: normal; font-weight: normal;"> </font></div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Scientific</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Scientific </div></td><td style="width: 3.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 216pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.79pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8212;</font></div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(19,133)</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(g)</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.79pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8212;</font></div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(24,378)</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(g)<font style="font-style: normal;"> </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 3.53pt;"></font></div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.79pt; text-align: left;">$(19,133)</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8212;</font></div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(h)</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 39.4pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.79pt; text-align: left;">$(24,378)</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 20.83pt;">&#8212;</font></div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.67pt; text-align: left;">6(h)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 39.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 39.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(g)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents elimination of revenues recognized by Core Scientific for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, related to the Austin Lease. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(h)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents elimination of lease expense, included in cost of revenue, recognized by CoreWeave for the six months ended June&#160;30, 2025, and for the year ended December&#160;31, 2024, related to the Austin Lease. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Settlement of Pre-Existing Relationships Adjustments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, in accordance with ASC 805, CoreWeave would recognize a gain or loss, measured as the lower of the amount by which the contract is favorable or unfavorable from the perspective of CoreWeave or the amount of stated settlement provisions, offset by any previously recognized amounts on the balance sheet. The arrangements between CoreWeave and Core Scientific did not include any stated settlement provisions. Presented below is the net gain (loss) that would be recognized related to settlement of pre-existing relationships (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 63.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Estimated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Settlement</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.53pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave&#8217;s <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Previously <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Recognized Net <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Assets (Liabilities)</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net Gain <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Loss) </div></td></tr><tr><td style="width: 252pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Austin Lease<font style="padding-left: 1.19pt;"></font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 8.33pt;">28,977</font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.94pt; text-align: left;"><font style="padding-left: 1.66pt;">6(i)</font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.53pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;">$<font style="padding-left: 10pt;">(5,820)</font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$34,797 </div></td></tr><tr><td style="width: 252pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave Colocation Agreements<font style="padding-left: 4.79pt;"></font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">149,078</font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.94pt; text-align: left;"><font style="padding-left: 1.66pt;">6(j)</font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.53pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;"><font style="padding-left: 8.33pt;">149,078</font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 252pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other Agreements<font style="padding-left: 0.64pt;"></font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(221,010</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.94pt; text-align: left;">6(k)</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.53pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(221,010</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 2.64pt;"></font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(42,955</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 63.53pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.35pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(77,752</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$34,797</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 63.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.06pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave previously recognized amounts related to the pre-existing relationships with Core Scientific. Presented below are adjustments to eliminate the previously recognized amounts from the respective financial statement line items on CoreWeave&#8217;s historical balance sheet as of June&#160;30, 2025 (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.72pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 18.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Austin Lease</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Colocation <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-style: italic; font-weight: bold; margin-top: 0pt; text-align: center;">Notes</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total </div></td></tr><tr><td style="width: 168pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;">$<font style="padding-left: 10pt;">1,953</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.77pt; text-align: left;">6(i)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 10pt;">1,953 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">assets<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 10pt;">96,640</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.77pt; text-align: left;">6(i)</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">96,640 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">149,078</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.78pt; text-align: left;">6(j)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">11,040</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.95pt; text-align: left;">6(k)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">160,118 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total assets<font style="font-weight: normal; padding-left: 0.88pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">98,593</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$149,078</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 8.7pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">11,040</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">258,711 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts payable<font style="padding-left: 3.31pt;"></font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 32.5pt;">1</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.77pt; text-align: left;">6(i)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">84,956</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.95pt; text-align: left;">6(k)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">84,957 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued liabilities<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">147,094</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 2.95pt; text-align: left;">6(k)</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">147,094 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">current<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 10.37pt;">11,754</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.77pt; text-align: left;">6(i)</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.37pt;">11,754 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">non-current<font style="padding-left: 3.85pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">92,658</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 3.77pt; text-align: left;">6(i)</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;"><font style="border-bottom: 1pt solid #000000; padding-left: 12.77pt; margin-left: 2.95pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">92,658 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 1.43pt;"></font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$104,413</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 22.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">232,050</font></div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$336,463 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net assets (liabilities)<font style="font-weight: normal; padding-left: 3.88pt;"></font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.88pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.68pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 6.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(5,820</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.72pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.61pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$149,078</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(221,010</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 18.66pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">&#160;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(77,752</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 20pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The Austin Lease has no stated settlement terms and the contract is not cancelable. The estimated amount relates to preliminary valuations for which the contract is favorable from the perspective of CoreWeave based on market terms. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">274<br></div></div></div>
<!--End Page 285-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 286-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 0pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(j)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The CoreWeave Colocation Agreements have no stated settlement terms, and are not cancelable. The CoreWeave Colocation Agreements were assessed to be at-market based on preliminary valuation performed comparing the contract terms and market terms, and the estimated settlement amounts were determined to be materially consistent with previously recorded amounts. The preliminary valuation performed is based on available information and certain assumptions including market data as of the valuation date. Accordingly, the estimated settlement amount is subject to further adjustment as additional information becomes available and as additional analyses and final valuations are completed. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(k)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The Other Agreements between CoreWeave and Core Scientific include certain customer funding agreements whereby Core Scientific incurred certain construction-related payables and accrued expenses on CoreWeave&#8217;s behalf and refundable security deposits related to the Austin Lease. The agreements were assessed to be at-market and the estimated settlement amounts were determined to be materially consistent with the previously recorded amounts. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">275<br></div></div></div>
<!--End Page 286-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 287-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_121-unaudited_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><a name="tCCF"><!--Anchor--></a>COREWEAVE&#8217;S CONSOLIDATED FINANCIAL STATEMENTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave&#8217;s condensed consolidated financial statements as of June 30, 2025 and for the six months ended June&#160;30, 2025 and 2024 and CoreWeave&#8217;s consolidated financial statements as of and for the fiscal years ended December&#160;31, 2024, 2023 and 2022 are included as Annex&#160;D and Annex&#160;E, respectively, to this proxy statement/prospectus. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">276<br></div></div></div>
<!--End Page 287-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 288-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tDOC"><!--Anchor--></a>DESCRIPTION OF COREWEAVE CAPITAL STOCK,<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">NEW TRANCHE 1 WARRANTS AND NEW TRANCHE 2 WARRANTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following description summarizes the most important terms of CoreWeave&#8217;s capital stock and the New Tranche 1 Warrants and New Tranche 2 Warrants. Because it is only a summary, it does not contain all the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of incorporation, our amended and restated bylaws, and our Rights Agreement, which are included as exhibits to this proxy statement/prospectus, and to the applicable provisions of Delaware law. Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">General </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our authorized capital stock consists of (a) 3,400,000,000 shares of common stock, $0.000005 par value per share, of which (i) 3,000,000,000 shares are designated as Class&#160;A common stock, $0.000005 par value per share, (ii)&#160;200,000,000 shares are designated as Class&#160;B common stock, $0.000005 par value per share, and (iii)&#160;200,000,000&#160;shares are designated as Class&#160;C common stock, $0.000005 par value per share, and (b)&#160;100,000,000&#160;shares of undesignated preferred stock, $0.000005 par value per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June&#160;30, 2025, there were outstanding: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">369,948,755 shares of our Class&#160;A common stock, held by 633 stockholders of record; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">118,102,040 shares of our Class&#160;B common stock, held by 22 stockholders of record; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">no shares of our Class&#160;C common stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">no shares of preferred stock; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">31,596,164 shares of our Class&#160;A common stock issuable upon the exercise of stock options, with a weighted-average exercise price of $1.14 per share, of which 9,109,000 shares will be exchangeable for an equal number of shares of our Class&#160;B common stock at the election of our Co-Founders upon exercise; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">25,685,664 shares of our Class&#160;A common stock issuable upon the vesting and settlement of RSUs outstanding; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">12,144,668 shares of our Class&#160;A common stock issuable upon the exercise of warrants to purchase shares of our Class&#160;A common stock, of which 7,807,282 had an exercise price of $0.0005 per share and 4,337,386 had an exercise price equal to the Regular Warrants Exercise Price; and</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">1,460,477 shares of our Class A common stock issuable upon the vesting of unvested RSA. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have no current plans to issue any shares of our Class&#160;C common stock. Our board of directors is authorized, without stockholder approval except as required by the rules of Nasdaq, to issue additional shares of our capital stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have three series of authorized common stock: Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock. The rights of holders of shares of Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock are identical, except with respect to voting and conversion rights. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Dividend Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of shares of our Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not have current plans to pay any dividends on our capital stock in the foreseeable future. Additionally, our ability to pay dividends or make distributions is currently restricted by the terms of our Credit Facilities and may be further restricted by any further indebtedness we incur. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">277<br></div></div></div>
<!--End Page 288-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 289-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any future determination to declare dividends will be made at the discretion of our board of directors and will depend, among other things, on our financial condition, operating results, capital requirements, general business conditions, restrictions in our debt instruments, and other factors that our board of directors may deem relevant. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Voting Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of shares of our Class&#160;A common stock are entitled to one vote for each share of our Class&#160;A common stock held on all matters submitted to a vote of stockholders, holders of our Class&#160;B common stock are entitled to ten votes for each share of our Class&#160;B common stock held on all matters submitted to a vote of stockholders, and holders of our Class&#160;C common stock are entitled to no votes for each share of our Class&#160;C common stock held on all matters submitted to a vote of stockholders, except as otherwise required by law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of shares of our Class&#160;A common stock and Class&#160;B common stock vote together as a single class on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by Delaware law. Delaware law could require holders of our Class&#160;A common stock, Class&#160;B common stock, or Class&#160;C common stock to vote separately as a single class if we were to seek to amend our restated certificate of incorporation in a manner that alters or changes the powers, preferences, or special rights of a class of our capital stock in a manner that affected its holders adversely. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, our amended and restated certificate of incorporation provides that a separate vote of the holders of our Class&#160;B common stock is required in connection with any amendment to our amended and restated certificate of incorporation that would alter the rights of the Class&#160;B common stock, reclassify any shares of our Class&#160;A common stock into shares senior to the Class&#160;B common stock, or authorize the issuance of any shares of capital stock with voting rights greater than one vote per share (other than the Class&#160;B common stock). We have not provided for cumulative voting for the election of directors in our amended and restated certificate of incorporation. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">No Preemptive or Similar Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock are not entitled to preemptive rights and are not subject to redemption (except for the put-right described below under the section titled &#8220;&#8212;Series&#160;C Preferred Stock Put Right&#8221;) or sinking fund provisions. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Right to Receive Liquidation Distributions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon our liquidation, dissolution, or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Conversion </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Class&#160;B Common Stock<font style="font-style: normal;">. Each outstanding share of our Class&#160;B common stock held by a Co-Founder or certain permitted affiliates (collectively, the &#8220;Applicable Holders&#8221;) is convertible at any time at the option of the applicable Co-Founder into one share of our Class&#160;A common stock. In addition, each share of our Class&#160;B common stock held by an Applicable Holder will convert automatically into one share of our Class&#160;A common stock (i) upon any transfer, whether or not for value, except for certain permitted transfers described in our amended and restated certificate of incorporation, including transfers to spouses, trusts for which the stockholder or their spouse serves as trustee, and partnerships, corporations, and other entities exclusively owned by the Co-Founder or their spouse; (ii) upon the date fixed by the board of directors, which date will be no more than 61 days following the first date on which the applicable Co-Founder and his permitted affiliates hold less than 50% of the aggregate outstanding shares of our Class&#160;A common stock and Class&#160;B common stock (including shares underlying outstanding options or other convertible securities) held at the time of pricing of the IPO; (iii) upon the date fixed by the board of directors following the first date the applicable Co-Founder is no longer providing services that occupy substantially all of his working time and business efforts to us as an officer, employee, or consultant, as determined by the board of directors (other than as a result of termination of such Co-Founder&#8217;s employment without cause) (a &#8220;Service Termination&#8221;), which date will be no more than 61 days following such Service Termination; (iv) upon the date the applicable Co-Founder&#8217;s employment is terminated for cause; and (v) upon the date fixed by the board of directors after the death or disability of the applicable Co-Founder, which date will be no more than 61 days following such Service Termination. Once converted or transferred and converted into our Class&#160;A common stock, the Class&#160;B common stock will not be reissued. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">278<br></div></div></div>
<!--End Page 289-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 290-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All the outstanding shares of our Class&#160;B common stock will convert automatically into shares of our Class&#160;A common stock upon the earlier of (x) a date that is fixed by our board of directors that is no more than 61 days following the seventh anniversary of our IPO, (y) the date specified by the affirmative vote of two-thirds of the outstanding voting power of the Class&#160;B common stock, or (z) no more than 61 days following Michael Intrator&#8217;s Service Termination. Following such conversion, each share of Class&#160;A common stock will have one vote per share and the rights of the holders of all outstanding common stock will be identical. Once converted into our Class&#160;A common stock, the Class&#160;B common stock may not be reissued. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Class&#160;C Common Stock. <font style="font-style: normal;">All of the outstanding shares of our Class&#160;C common stock will automatically convert into shares of our Class&#160;A common stock following both (a) the earliest of (i) the conversion or exchange of all then-outstanding shares of our Class&#160;B common stock into or for shares of our Class&#160;A common stock, (ii) the Class&#160;B Automatic Conversion, and (iii) the affirmative vote of the holders of a majority of the then-outstanding shares of Class&#160;B common stock and upon (b) the date and time or occurrence of an event specified by the vote of the holders of a majority of the then-outstanding shares of Class&#160;A common stock. We have no current plans to issue any Class&#160;C common stock. </font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Class&#160;C Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our authorized but unissued shares of Class&#160;C common stock are available for issuance with the approval of our board of directors without stockholder approval, except as may be required by the rules of Nasdaq. We have no current plans to issue any shares of our Class&#160;C common stock. However, we may in the future issue shares of our Class&#160;C common stock for a variety of corporate purposes, including financings, acquisitions, investments, and equity incentives to our employees, consultants, and directors. Our Class&#160;C common stock provides us with the flexibility to do so without diluting the existing voting power of the outstanding shares of our Class&#160;A and Class&#160;B common stock. Because our Class&#160;C common stock carries no voting rights (except as otherwise required by law) and is not listed for trading on an exchange or registered for sale with the SEC, shares of our Class&#160;C common stock may be less liquid and less attractive to any future recipients of these shares than shares of our Class&#160;A common stock, although we may seek to list shares of our Class&#160;C common stock for trading and register shares of our Class&#160;C common stock for sale in the future. In addition, because our Class&#160;C common stock carries no voting rights (except as otherwise required by law), if we issue shares of our Class&#160;C common stock in the future, the holders of our Class&#160;B common stock may be able to hold significant voting control and determine the outcome of most matters submitted to a vote of our stockholders for a longer period of time than would be the case if we issued shares of our Class&#160;A common stock rather than shares of our Class&#160;C common stock in such transactions. In addition, if we issue shares of our Class&#160;C common stock in the future, such issuances would have a dilutive effect on the economic interests of our Class&#160;A and Class&#160;B common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">No shares of our convertible preferred stock are outstanding. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations, or restrictions, in each case without further vote or action by our stockholders. Our board of directors can also increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. The number of authorized shares of our preferred stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the vote of the holders of our capital stock entitled to vote thereon, without a separate vote of the holders of the preferred stock, irrespective of the provisions of Section&#160;242(b)(2) of the DGCL, unless a separate vote of the holders of one or more series is required pursuant to the terms of any applicable certificate of designation. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in our control and might adversely affect the market price of our Class&#160;A common stock and the voting and other rights of the holders of our Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock. We have no current plan to issue any shares of preferred stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">279<br></div></div></div>
<!--End Page 290-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 291-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Options </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had outstanding stock options to purchase an aggregate of 0 shares of our Class&#160;A common stock under our 2025 Plan and 44,105,000 shares of our Class&#160;A common stock under our 2019 Plan, with a weighted-average exercise price of $1.74 per share. Pursuant to the equity exchange agreement between us and each of its co-founders, each co-founder has the right to exchange any shares of Class&#160;A common stock received upon the exercise of certain option awards granted prior to September&#160;2024 and held by such co-founder into an equal number of shares of Class&#160;B common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">RSUs </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had outstanding RSUs that may be settled for an aggregate of 25,686,000 shares of our Class&#160;A common stock under our 2019 Plan and our 2025 Plan. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Warrants </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Existing CoreWeave Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, we had outstanding warrants to purchase 12,144,668 shares of our Class&#160;A common stock, of which 7,807,282 had an exercise price of $0.0005 per share and 4,337,386 had an exercise price equal to the Regular Warrants Exercise Price. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">New Warrants </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the effective time, each Tranche 1 Warrant and Tranche 2 Warrant issued by Core Scientific will be automatically redeemed, with the holder thereof entitled to receive a New Tranche 1 Warrant or a Converted Tranche&#160;2 Warrant that converts into a New Tranche 2 Warrant of CoreWeave, respectively, with substantially the same terms and conditions as applied to the Tranche 1 Warrants immediately prior to the effective time; however, (i)&#160;the New Tranche 1 Warrant will cover a number of shares of CoreWeave common stock equal to the product of the number of shares of Core Scientific common stock subject to the Tranche 1 Warrant and the exchange ratio and will have an exercise price per share equal to the amount obtained by dividing the per share exercise price of the Tranche 1 Warrant by the exchange ratio, and (ii) the New Tranche 2 Warrant will cover a number of shares of CoreWeave common stock equal to the product of the number of shares of Core Scientific common stock subject to the Converted Tranche 2 Warrant and the exchange ratio and will have an exercise price per share equal to the amount obtained by dividing $7.50 by the exchange ratio. As a result, assuming no events occur requiring any adjustment to the number of shares underlying each Tranche 1 Warrant or Tranche 2 Warrant or the exercise price therefor prior to the Merger, each New Tranche 1 Warrant will cover 0.1235 shares of CoreWeave common stock at an exercise price of $55.141700 per share, and each New Tranche 2 Warrant will cover 0.1235 shares of CoreWeave common stock at an exercise price of $60.728745 per share. Each New Tranche 1 Warrant and New Tranche 2 Warrant will be subject to cashless exercise only, as described below under &#8220;&#8212;Core Scientific Warrant Agreement.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, Core Scientific had (i) outstanding Tranche 1 Warrants exercisable for up to 97.5&#160;million&#160;shares of common stock at an exercise price of $6.81 per share; and (ii) outstanding Tranche 2 Warrants exercisable for up to 15.1&#160;million shares of common stock at an exercise price of $0.01 per share. Based on the number of Core Scientific warrants outstanding as of June&#160;30, 2025, and assuming no events occur requiring any adjustment to the number of shares underlying each Tranche 1 Warrant or Tranche 2 Warrant or the exercise price therefor prior to the Merger, the New Tranche 1 Warrants will be exercisable for up to 12.0 million shares of CoreWeave common stock at an exercise price of $55.141700 per share, and the New Tranche 2 Warrants will be exercisable for up to 1.9 million shares of CoreWeave common stock at an exercise price of $60.728745 per share, in each case, prior to giving effect to any effective reduction in share issuance that the cashless exercise mechanism described below may have. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;">Core Scientific Warrant Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On January&#160;23, 2024, after Core Scientific&#8217;s emergence from bankruptcy, Core Scientific entered into the Warrant Agreement providing for the issuance of 98,313,313 warrants, each exercisable for one share of Core Scientific common stock at an exercise price of $6.81 per share (i.e., the &#8220;Tranche 1 Warrants&#8221;) and (ii) an aggregate of 81,927,898 warrants, each exercisable for one share of Core Scientific common stock at an exercise price of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">280<br></div></div></div>
<!--End Page 291-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 292-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">$0.01&#160;per share (i.e., the &#8220;Tranche 2 Warrants&#8221; and, together with the Tranche 1 Warrants, the &#8220;Warrants&#8221;). Upon Core Scientific&#8217;s emergence from bankruptcy, holders of Core Scientific&#8217;s previous common stock received, for each share of Core Scientific&#8217;s previous stock held, 0.253244 Tranche 1 Warrants and 0.211037 Tranche 2 Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of Core Scientific common stock at an exercise price of $6.81 per share (the &#8220;Tranche 1 Exercise Price&#8221;). Each whole Tranche&#160;2&#160;Warrant entitles the registered holder to purchase one whole share of Core Scientific common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of Core Scientific common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days (the&#160;&#8220;Triggering Event&#8221;), which event occurred on July&#160;11, 2024. The Tranche 1 and Tranche 2 Exercise Prices are subject to adjustment for specific events as set forth in the Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Tranche 1 Warrants are exercisable at any time until 5:00 p.m., New York City time, on January&#160;23, 2027 (or, if such day is not a business day, the next subsequent business day), and the Tranche 2 Warrants are exercisable at any time until 5:00 p.m., New York City time, on January&#160;23, 2029 (or, if such day is not a business day, the next subsequent business day), each at 5:00 p.m., New York City time, or earlier upon the occurrence of certain events as set forth in the Warrant Agreement. The Warrant Agreement provides that the Warrant Agreement, with respect to the Tranche 1 Warrants or Tranche 2 Warrants, may be amended with the prior written consent of holders holding a majority of the shares then issuable upon exercise of the Tranche 1 Warrants or Tranche 2 Warrants then outstanding, as applicable; provided, however, that any amendment or supplement to the Warrant Agreement that would reasonably be expected to materially and adversely affect any right of a holder of Warrants shall require the written consent of such holder. In addition, the consent of each holder of Warrants affected shall be required for any amendment pursuant to which the applicable exercise price would be increased, the number of shares issuable upon exercise of Warrants would be decreased (other than pursuant to adjustments provided in the Warrant Agreement) or the applicable expiration date would be revised to an earlier date; provided, however, that Core Scientific and the warrant agent may amend the Warrant Agreement without the consent of holders of Warrants to (i) to cure any ambiguity; (ii) correct any defective provision; or (iii) make any other provisions with respect to matters or questions arising under the Warrant Agreement as long as the new provisions do not adversely affect (other than a de minimis adverse effect) the interest of holders of Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Warrants may be exercised upon prior written notice of such election, payment of the applicable exercise price (subject, in the case of the Tranche 2 Warrant, to a holder&#8217;s right to elect cashless exercise), together with any applicable taxes and governmental charges, and, with respect to Warrants held through the book-entry facilities of the Depository (as defined in the Warrant Agreement), book-entry transfer of such Warrants to the warrant agent on or prior to the settlement date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Tranche 2 Warrants may be exercised on a cashless basis, pursuant to which the holder shall be entitled to receive a number of shares of Core Scientific common stock equal to the total number of shares of Core Scientific common stock underlying the Tranche 2 Warrants being exercised multiplied by a fraction equal to (x) the current market price (as of the business day immediately preceding the date on which the exercise notice was delivered) of one share of Core Scientific common stock, minus the applicable exercise price, divided by (y) such current market price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding anything to the contrary in the preceding two paragraphs, both the New Tranche 1 Warrants and New Tranche 2 Warrants when issued will be exercisable only on a cashless basis, pursuant to which the holder will be entitled to receive a number of shares of CoreWeave common stock equal to the total number of shares of CoreWeave common stock underlying the warrants being exercised multiplied by a fraction equal to (x) the current market price (as of the business day immediately preceding the date on which the exercise notice was delivered) of one share of CoreWeave common stock, minus the applicable exercise price, divided by (y) such current market price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of Warrants do not have the rights or privileges of holders of Core Scientific common stock or any voting rights on account of such Warrants until they exercise their Warrants. Upon exercise of the Warrants, the holder thereof will be entitled to the same rights as holders of Core Scientific common stock with respect to the shares issuable upon such exercise. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the Warrant Agreement, if, upon exercise, a holder would be entitled to receive a fractional interest in a share, such fractional interest will be rounded to the next higher whole number of the number of shares of Core </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">281<br></div></div></div>
<!--End Page 292-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 293-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Scientific common stock to be issued to the holder. If more than one Tranche 1 Warrant or Tranche 2 Warrant is presented for exercise in full at the same time by the same holder, the number of full shares issuable upon the exercise thereof will be computed on the basis of the aggregate number of shares purchasable on exercise of the warrants so presented. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Effective January&#160;24, 2024, the Tranche 1 Warrants and Tranche 2 Warrants began trading on the Nasdaq Global Select Market under the symbols &#8220;CORZW&#8221; and &#8220;CORZZ,&#8221; respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the year ended December&#160;31, 2024, 0.6&#160;million Tranche 1 Warrants were exercised, which resulted in cash receipts of $4.4&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Tranche 2 Warrants became exercisable as of the close of trading on July&#160;11, 2024, when the daily volume weighted average trading price of Core Scientific common stock exceeded $8.72 per share for the 20<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> consecutive trading day pursuant to the Warrant Agreement. During the year ended December&#160;31, 2024, 60.9&#160;million Tranche 2 Warrants were exercised, which resulted in cash receipts of $0.6&#160;million. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Registration Rights </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Rights Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain holders of shares of our Class&#160;A common stock and Class&#160;B common stock or their permitted transferees are entitled to rights with respect to the registration of their shares under the Securities Act. These rights are provided under the terms of our Rights Agreement, which was entered into in connection with our convertible preferred stock financings prior to the IPO, and include demand registration rights, Form&#160;S-3 registration rights, and piggyback registration rights. In any registration made pursuant to our Rights Agreement, all fees, costs, and expenses of underwritten registrations will be borne by us and all selling expenses, including estimated underwriting discounts, selling commissions, stock transfer taxes, and fees and disbursements of counsel for any holder will be borne by the holders of the shares being registered, provided, however, that we will pay the reasonable fees and disbursements of one counsel to any selling holders not to exceed $50,000. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The registration rights terminate (i) four years following the completion of our IPO or (ii) with respect to any particular stockholder, at the time that such stockholder can sell all of its registrable securities (as defined in our Rights Agreement) without any restriction on volume or manner of sale in any three-month period pursuant to Rule&#160;144 of the Securities Act or any successor rule thereto. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;">Demand Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of 375,927,734 shares of our Class&#160;A common stock will be entitled to demand registration rights at any time after September&#160;23, 2025. Under the terms of our Rights Agreement, we will be required, upon the request of holders representing a majority of the then-outstanding shares that are entitled to registration rights under our Rights Agreement, to file a registration statement on Form&#160;S-1 to register, as soon as practicable and in any event within 60 days of the date of the request, all or a portion of these shares for public resale, if the aggregate price to the public of the shares offered is at least $10&#160;million, net of selling expenses. We are required to effect only two registrations pursuant to this provision of the Rights Agreement. We may postpone the filing of a registration statement no more than once during any 12-month period for a period of not more than 90 days if our board of directors determines in good faith that the filing would be materially detrimental to us. We are not required to effect a demand registration under certain additional circumstances specified in our Rights Agreement. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20pt; margin-left: 20pt; text-align: left;">Form&#160;S-3 Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of 375,927,734 shares of our Class&#160;A common stock are entitled to Form&#160;S-3 registration rights at any time when we are eligible to use Form&#160;S-3. The holders representing at least 20% of the then-outstanding shares having registration rights can request that we register all or part of their shares on Form&#160;S-3 if we are eligible to file a registration statement on Form&#160;S-3 and if the aggregate price to the public of the shares offered is at least $4&#160;million. The holders may only require us to effect at most two registration statements on Form&#160;S-3 in any 12-month period. We may postpone the filing of a registration statement on Form&#160;S-3 no more than once during any 12-month period for a period of not more than 90 days if our board of directors determines that the filing would be materially detrimental to us. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">282<br></div></div></div>
<!--End Page 293-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 294-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Piggyback Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we register any of our securities for public sale for cash, holders of 375,927,734 shares of our Class&#160;A common stock having registration rights will have the right to include their shares in the registration statement. However, this right does not apply to a registration relating to employee benefit plans, a registration relating to an SEC Rule&#160;145 transaction, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of our common stock, or a registration in which the only common stock being registered is common stock issuable upon conversion of debt securities that are also being registered. The underwriters of any underwritten offering will have the right to limit the number of shares registered by these holders if they determine that marketing factors require limitation, in which case the number of shares to be registered will be apportioned pro rata among these holders, according to the total amount of securities entitled to be included by each holder. However, the number of shares to be registered by these holders cannot be reduced (i) unless all other securities (other than securities to be sold by us) are first excluded from the offering or (ii)&#160;below&#160;30% of the total shares covered by the registration statement, other than in the IPO. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Magnetar Amended and Restated Registration Rights Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the Magnetar Registration Rights Agreement, the Magnetar RRA Parties will be entitled to rights with respect to the registration of the Magnetar Registrable Securities under the Securities Act. The registration rights will terminate five years following the completion of our IPO. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each of the Magnetar RRA Parties is subject to a lock-up agreement with the underwriters pursuant to which it has agreed, among other things, that without the prior written consent of Morgan Stanley, it will not make any demand for, or exercise any right with respect to, the registration of any shares of our Class&#160;A common stock or any security convertible into or exercisable or exchangeable for our Class&#160;A common stock during the Lock-up Period. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17pt; margin-left: 20pt; text-align: left;">Shelf Takedown Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At any time and from time to time after the effective date of any shelf registration statement, the Magnetar RRA Parties may request to sell in an underwritten offering that is registered pursuant to the shelf registration statement all or a portion of the Magnetar Registrable Securities having an aggregate offering price in excess of $15&#160;million, net of selling expenses, or otherwise constituting the total aggregate Magnetar Registrable Securities then held by the Magnetar RRA Parties. We are required to effect two such shelf takedowns. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 17pt; margin-left: 20pt; text-align: left;">Demand Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the Magnetar Registration Rights Agreement, as amended, if we receive a request from the Magnetar RRA Parties, we will be required to file a registration statement on Form&#160;S-1 or Form&#160;S-3, if available (the &#8220;Initial Shelf&#8221;), to register the resale of the Magnetar Registrable Securities no later than 45 days following such request, and to use our reasonable best efforts to have the Initial Shelf declared effective as soon as practicable after the filing thereof, but no later than 75 days following such request (or 90 days if the SEC notifies us of its intention to review the Initial Shelf). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For each monthly delay in the filing or effectiveness of the Initial Shelf, subject to certain exceptions as provided in the Magnetar Registration Rights Agreement, we will be required to pay to the Magnetar RRA Parties an amount in cash, as partial liquidated damages, equal to the product of 0.25% multiplied by the aggregate principal amounts of the 2025 Notes and the 2025 Convertible Notes; provided that such amount will be capped at 3.0% of such aggregate principal amount for any delay beyond one year. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If at any time after the date that is 180 days after the effective date of the Initial Shelf, we receive a request from the Magnetar RRA Parties that we file a Form&#160;S-1 registration statement with respect to Magnetar Registrable Securities (1) having an anticipated aggregate offering price in excess of $15&#160;million, net of selling expenses, or (2) constituting the total aggregate Magnetar Registrable Securities then held by all Magnetar RRA Parties, then we will, as soon as practicable, and in any event within 60 days after the date such request is given, file a Form&#160;S-1 registration statement under the Securities Act covering all Magnetar Registrable Securities that the initial requesting Magnetar RRA Parties requested to be registered and any additional Magnetar Registrable Securities or equivalent securities requested to be included in such registration statement by any other Magnetar RRA Parties, or other holders of our securities, as specified by notice given by the Magnetar RRA Parties or other holders to us within 20 days of the date the demand notice is given, and in each case, subject to applicable limitations provided in the Magnetar </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">283<br></div></div></div>
<!--End Page 294-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 295-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Registration Rights Agreement; provided that we may use a Form&#160;S-3 registration statement instead of a Form&#160;S-1 registration statement if we would qualify to use a Form&#160;S-3 registration statement within 60 days after the date on which the request from Magnetar RRA Parties is received. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition, if at any time when we are eligible to use a Form&#160;S-3 registration statement, we receive a request from the Magnetar RRA Parties holding Magnetar Registrable Securities that we file a Form&#160;S-3 registration statement with respect to outstanding Magnetar Registrable Securities having an anticipated aggregate offering price of at least $5&#160;million, net of selling expenses, then we will, as soon as practicable, and in any event within 45 days after the date such request is given, file a Form&#160;S-3 registration statement under the Securities Act covering all Magnetar Registrable Securities or equivalent securities requested to be included in such registration statement by the Magnetar RRA Parties or other holders of our securities, as specified by notice given by the Magnetar RRA Parties or other holders to us within 20 days of the date the demand notice is given, and in each case, subject to the applicable limitations provided in the Magnetar Registration Rights Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We may postpone the filing of a registration statement on Form&#160;S-1 or S-3, including the Initial Shelf, no more than once during any 12-month period for a period of not more than 60 days if our board of directors determines in good faith that the filing would be materially detrimental to us. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Piggyback Registration Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If we propose to register any of our securities under the Securities Act or consummate an underwritten offering pursuant to a previously filed registration statement (including pursuant to the Rights Agreement), subject to certain exceptions as described in the Magnetar Registration Rights Agreement, we will, at such time, promptly give each Magnetar RRA Party notice of such registration or underwritten offering. Upon the request of each Magnetar RRA Party given within 20 days after such notice is given by us, we will cause to be registered for resale all of the Magnetar Registrable Securities that each such Magnetar RRA Party has requested to be included in such registration and/or use our reasonable best efforts to include all of the Magnetar Registrable Securities that each such Magnetar RRA Party has requested to be included in such underwritten offering. The underwriters of any underwritten offering will have the right to limit the number of shares registered by these holders, including the Magnetar RRA Parties, if they determine that marketing factors require limitation, in which case the number of shares to be registered will be apportioned pro rata among the holders, according to the total amount of securities entitled to be included by each holder; provided, that the number of Magnetar Registrable Securities held by the Magnetar RRA Parties to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Series&#160;C Preferred Stock Put Right </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">29,874,066 Put Shares are subject to the Put Right on the first trading day immediately after March&#160;31, 2027, the second anniversary of the closing of our IPO. Upon exercise of the Put Right, holders of the Put Shares would be entitled to receive from us an amount in cash equal to the Series&#160;C OIP of $38.95, representing an aggregate payment of $1.2&#160;billion. There are no accrued and unpaid dividends with respect to the shares of Series&#160;C convertible preferred stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Put Right shall automatically terminate (on a share by share basis) on the date on which (i) such share is assigned, sold, or transferred publicly or (ii) our Class&#160;A common stock has a 20 day volume-weighted average price in any consecutive 30 trading day period of at least 175% of the Series&#160;C OIP at any point on or prior to the Public Sale Date during which Coatue Management, L.L.C. is not subject to a contractual lock-up agreement (clauses&#160;(i)&#160;and&#160;(ii) collectively, an &#8220;Exercise Termination Event&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Upon the exercise of a Put Right by a holder of Put Shares, (i) we will be deemed to issue an unsecured note senior in the right of payment to all our outstanding equity securities to such holder having a principal amount equal to the amount payable to such holder pursuant to such Put Right to satisfy its obligations (each, a &#8220;Note&#8221;), which Put Note&#160;shall be due and payable 15 days after the Public Sale Date (the &#8220;Note&#160;Payment Date&#8221;), and (ii) the applicable Put Shares shall be placed into an escrow account. The Put Note&#160;shall accrue interest on the principal amount thereof beginning on the date of issuance at a rate of 10% per annum (compounding quarterly), provided that the interest rate shall increase to 14% per annum if we fail to pay the principal amount on or before the Note&#160;Payment Date. In the event a Put Note&#160;is not fully satisfied on or prior to the Note&#160;Payment Date, the escrow agent or other party shall be instructed to liquidate the shares held in such escrow account commencing on the Note&#160;Payment Date and distribute the proceeds in respect thereof ratably to the unsatisfied exercising holders, which distributed proceeds shall be applied against the amounts owing in respect of the applicable Put Notes. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">284<br></div></div></div>
<!--End Page 295-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 296-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If (i) there is a sale of us prior to the Public Sale Date and (ii) there has not yet occurred an Exercise Termination Event, the holders of our Class&#160;A common stock still holding Put Shares shall be entitled in such sale transaction to receive the greater of (x) the consideration received per share the holders of our Class&#160;A common stock are entitled to receive in such sale transaction and (y) an amount in cash equal to the Series&#160;C OIP per share. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Anti-Takeover Provisions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The provisions of the DGCL, our amended and restated certificate of incorporation, and our amended and restated bylaws could have the effect of delaying, deferring, or discouraging another person from acquiring control of our company. These provisions, which are summarized below, are expected to discourage certain types of coercive takeover practices and inadequate takeover bids and encourage persons seeking to acquire control of our company to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 0pt; text-align: left;">Delaware Law </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are subject to the provisions of Section&#160;203 of the DGCL regulating corporate takeovers. In general, Section&#160;203 prohibits a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section&#160;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">before the stockholder became interested, our board of directors approved either the business combination or the transaction, which resulted in the stockholder becoming an interested stockholder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">upon consummation of the transaction, which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans in some instances, but not the outstanding voting stock owned by the interested stockholder; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">at or after the time the stockholder became interested, the business combination was approved by our board and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock, which is not owned by the interested stockholder. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Section&#160;203 defines a business combination to include: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any merger or consolidation involving the corporation and the interested stockholder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any sale, transfer, lease, pledge, or other disposition involving the interested stockholder of 10% or more of the assets of the corporation; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">subject to exceptions, any transaction that results in the issuance of transfer by the corporation of any stock of the corporation to the interested stockholder; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges, or other financial benefits provided by or through the corporation. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In general, Section&#160;203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">Amended and Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our amended and restated certificate of incorporation and our amended and restated bylaws include a number of provisions that may have the effect of deterring hostile takeovers, or delaying or preventing changes in control of our management team or changes in our board of directors or our governance or policy, including the following: </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">285<br></div></div></div>
<!--End Page 296-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 297-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Multi-Class&#160;Common Stock</font>. As described above in the section titled &#8220;&#8212;Common Stock&#8212;Voting Rights,&#8221; our amended and restated certificate of incorporation provides for a multi-class common stock structure pursuant to which holders of our Class&#160;B common stock may have significant influence over the outcome of matters submitted to our stockholders for approval, even if they own significantly less than a majority of the shares of our outstanding common stock, including the election of directors and significant corporate transactions, such as a merger or other sale of our company or its assets. Our Co-Founders have the ability to exercise significant influence over those matters. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Board of Directors Vacancies. </font>Our amended and restated certificate of incorporation and our amended and restated bylaws authorize generally only our board of directors to fill vacant directorships resulting from any cause or created by the expansion of our board of directors. In addition, the number of directors constituting our board of directors may be set only by resolution adopted by a majority vote of our entire board of directors. These provisions prevent a stockholder from increasing the size of our board of directors and gaining control of our board of directors by filling the resulting vacancies with its own nominees. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Classified Board.</font> Our amended and restated certificate of incorporation and amended and restated bylaws provide that our board of directors is classified into three classes of directors. The existence of a classified board of directors could delay a successful tender offeror from obtaining majority control of our board of directors, and the prospect of that delay might deter a potential offeror. For additional information, see the section titled &#8220;Management&#8212;Classified Board of Directors.&#8221; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Directors Removed Only for Cause.</font> Our amended and restated certificate of incorporation provides that stockholders may remove directors only for cause and only by the affirmative vote of the holders of at least two-thirds of the voting power of the then-outstanding capital stock. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Supermajority Requirements for Amendments of Our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws. Our amended and restated certificate of incorporation further provides that the affirmative vote of holders of at least two-thirds of the voting power of all of the then outstanding shares of capital stock is required to amend certain provisions of our amended and restated certificate of incorporation, including provisions relating to the classified board, the size of our board of directors, removal of directors, special meetings, and actions by written consent. The affirmative vote of holders of at least two-thirds of the voting power of all of the then outstanding shares of capital stock are required to amend or repeal our amended and restated bylaws, although our amended and restated bylaws may be amended by a simple majority vote of our board of directors. Additionally, in the case of any proposed adoption, amendment, or repeal of any provisions of the amended and restated bylaws that is approved by our board of directors and submitted to the stockholders for adoption, if two-thirds of our board of directors elects to submit such adoption, amendment, or repeal of any provisions of our amended and restated bylaws to our stockholders for adoption, then only the affirmative vote of a majority of the voting power of all of the then outstanding shares of capital stock shall be required to adopt, amend, or repeal any provision of our amended and restated bylaws. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Stockholder Action; Special Meetings of Stockholders.</font> Our amended and restated certificate of incorporation provides that our stockholders may not take action by written consent but may only take action at annual or special meetings of our stockholders; provided that stockholder action by written consent of a majority of the voting power of all then-outstanding shares of our capital stock is permitted so long as the voting power of all then-outstanding shares of Class&#160;B common stock represents greater than a majority of the combined voting power of all then-outstanding shares of our capital stock. As a result, holders of our capital stock, other than holders of a majority of then-outstanding shares of Class&#160;B common stock as previously described, would not be able to amend our amended and restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our amended and restated bylaws. Our amended and restated certificate of incorporation and our amended and restated bylaws provide that special meetings of our stockholders may be called only by a majority of our board of directors, the chairperson of our board of directors, our chief executive officer, or our lead independent director, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders to take any action, including the removal of directors. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">286<br></div></div></div>
<!--End Page 297-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 298-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Advance Notice Requirements for Stockholder Proposals and Director Nominations.</font> Our amended and restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our amended and restated bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice. These provisions may preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders. We expect that these provisions might also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of our company. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">No Cumulative Voting.</font> The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation and amended and restated bylaws do not provide for cumulative voting. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Issuance of Undesignated Preferred Stock.</font> Our board of directors has the authority, without further action by the stockholders, to issue up to 100,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock enables our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Choice of Forum.</font> In addition, our amended and restated bylaws provide that, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising pursuant to the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; any action asserting a claim against us is governed by the internal affairs doctrine or asserting an &#8220;internal corporate claim,&#8221; as defined by the DGCL; or any to interpret, apply, enforce, or determine the validity of the amended and restated certificate of incorporation or amended and restated bylaws. The enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find these types of provisions to be inapplicable or unenforceable. Our amended and restated bylaws also contain a Federal Forum Provision. While there can be no assurance that federal or state courts will follow the holding of the Supreme Court of the State of Delaware which recently found that such provisions are facially valid under Delaware law or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. As Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder, there is uncertainty as to whether a court would enforce such provision. Further, Section&#160;27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. In addition, the Federal Forum Provision applies, to the fullest extent permitted by law, to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court. Our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder. Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to our exclusive forum provisions, including the Federal Forum Provision. These provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of their choosing for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find the Federal Forum Provision in our amended and amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could harm our business. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">287<br></div></div></div>
<!--End Page 298-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 299-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_122-description_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Transfer Agent and Registrar </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The transfer agent and registrar for our Class&#160;A common stock and Class&#160;B common stock is Computershare Trust Company, N.A. The transfer agent&#8217;s address is 150 Royall Street, Canton, Massachusetts 02021. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Exchange Listing </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our Class&#160;A common stock is listed on the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) under the symbol &#8220;CRWV.&#8221; We intend to list the New Tranche 1 Warrants and the New Tranche 2 Warrants on Nasdaq under the symbols &#8220;CRWVW&#8221; and &#8220;CRWVZ&#8221; respectively. However, no assurance can be given that our listing applications for the New Tranche 1&#160;Warrants and/or the New Tranche 2 Warrants will be approved. </div> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">288<br></div></div></div>
<!--End Page 299-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 300-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_123-certain_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCRA"><!--Anchor--></a>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS OF COREWEAVE </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise specified or the context otherwise requires, all references to &#8220;CoreWeave,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;our company&#8221; in this Section&#160;refer to CoreWeave, Inc. and its subsidiaries.<font style="font-style: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the compensation arrangements discussed in the sections titled &#8220;Directors and Management of CoreWeave, Inc.&#8221; and &#8220;CoreWeave, Inc. Executive Compensation,&#8221; the following is a description of each transaction since January&#160;1, 2022 and each currently proposed transaction in which: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">we have been or are to be a participant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the amount involved exceeded or will exceed $120,000; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">any of our directors, executive officers, or holders of more than 5% of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Tender Offers </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">2024 Tender Offer </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2024, certain existing stockholders and new stockholders offered to purchase shares of our Class&#160;A common stock (including certain shares of our Class&#160;A common stock issued upon (i) exercise of vested options to purchase common stock; and/or (ii) conversion of shares of our convertible preferred stock and Class&#160;B common stock), Class&#160;B common stock, and convertible preferred stock, from certain of our securityholders for $47.00 per share in cash (the &#8220;2024 Tender Offer&#8221;). An aggregate of 13,851,240 shares of our Class&#160;A common stock, Class&#160;B common stock, and convertible preferred stock were tendered for an aggregate purchase price of $651&#160;million. Each share of our Class&#160;B common stock and convertible preferred stock sold in the 2024 Tender Offer was automatically converted into one share of Class&#160;A common stock immediately prior to each purchase. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We did not receive any consideration from the sale proceeds of the 2024 Tender Offer, except for amounts received upon the net exercise of employee stock options by certain of our employees who exercised vested options to sell the subsequently issued shares in the 2024 Tender Offer. The aggregate amount received by us in respect of these net exercises for shares sold in the 2024 Tender Offer was $1&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain funds affiliated with Glenn Hutchins, who joined as a member of our board of directors in February&#160;2025, participated in the 2024 Tender Offer as purchasers of our Class&#160;A common stock. Other than Mr.&#160;Hutchins, none of our directors or officers participated as purchasers in the 2024 Tender Offer. The following table summarizes the shares of Class&#160;A common stock purchased by our directors and officers: </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 53.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 71.97pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholder <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock </div></td><td style="width: 10.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.68pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 71.97pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Class A <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total Purchase Price</div></td></tr><tr><td style="width: 300pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Funds affiliated with Glenn Hutchins<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.76pt;"></font></div></td><td style="width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.31pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.4pt; text-align: left;">212,780</div></td><td style="width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 71.97pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.48pt; text-align: left;">$ 9,999,097</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 53.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 71.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of shares held by certain funds for which Glenn Hutchins, a member of our board of directors, serves as investment manager. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain of our directors and officers and their affiliates participated as sellers in the 2024 Tender Offer. The following table summarizes the shares of our Class&#160;A common stock, our Class&#160;B common stock, and our convertible preferred stock sold by our directors and officers and their affiliated parties in the 2024 Tender Offer. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">289<br></div></div></div>
<!--End Page 300-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 301-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_123-certain_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The amounts set forth in the column titled &#8220;Total Purchase Price&#8221; represent the gross sales proceeds realized by the seller, before any reduction for transaction costs, tax withholding, or amounts remitted to us in respect of the net exercise of employee stock options: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 324pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 41.32pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 61.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholder <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></div></td><td style="width: 10.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Class&#160;A <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total Purchase <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price </div></td></tr><tr><td style="width: 324pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Michael Intrator<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 1.92pt;"></font></div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;">1,063,980</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;">$<font style="padding-left: 5pt;">49,999,245 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Brian Venturo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 0.97pt;"></font></div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;">2,241,560</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;">$ 105,336,856 </div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Brannin McBee<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 3.58pt;"></font></div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;">2,075,080</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;">$<font style="padding-left: 5pt;">97,513,519 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kristen McVeety<font style="padding-left: 2.64pt;"></font></div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 7.5pt;">135,660</font></div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;">$<font style="padding-left: 10pt;">5,257,701 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Jack Cogen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 0.79pt;"></font></div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 0.37pt;">1,110,080</font></div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;">$<font style="padding-left: 5pt;">52,165,606</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 324pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 41.32pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 61.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares held by Michael Intrator, our Chief Executive Officer, President, and chairman of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares held by Brian Venturo, our Chief Strategy Officer and a member of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of shares held by Brannin McBee, our Chief Development Officer, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of shares held by Jack Cogen, a member of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">All shares of our Class&#160;B common stock and convertible preferred stock were converted into shares of our Class&#160;A common stock immediately prior to being sold in the 2024 Tender Offer. </div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 0pt; text-align: left;">2023 Tender Offer </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2023, certain existing stockholders and new stockholders offered to purchase shares of our Class&#160;A common stock (including certain shares of our Class&#160;A common stock issued upon (i) exercise of vested options to purchase common stock and (ii) conversion of shares of our convertible preferred stock) and convertible preferred stock from certain of our securityholders for $15.50 per share in cash (the &#8220;2023 Tender Offer&#8221;). An aggregate of 41,476,000 shares of our Class&#160;A common stock and convertible preferred stock were tendered for an aggregate purchase price of $643&#160;million. Each share of our convertible preferred stock sold in the 2023 Tender Offer was automatically converted into one share of Class&#160;A common stock immediately prior to each purchase. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Certain of our directors and officers and their affiliates participated as sellers in the 2023 Tender Offer. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes the shares of our Class&#160;A common stock sold by our directors and officers and their affiliated parties in the 2023 Tender Offer. The amounts set forth in the column titled &#8220;Total Purchase Price&#8221; represent the gross sales proceeds realized by the seller, before any reduction for transaction costs, tax withholding, or amounts remitted to us in respect of the net exercise of employee stock options: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 61.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Class&#160;A <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase Price </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Michael Intrator<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.92pt;"></font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.58pt; text-align: left;">7,098,620</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$ 109,978,920 </div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Brian Venturo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 3.97pt;"></font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.58pt; text-align: left;">4,622,520</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">71,616,703 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Brannin McBee<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 1.58pt;"></font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.58pt; text-align: left;">3,447,360</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">53,409,948 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kristen McVeety<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 1.9pt;"></font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.58pt; text-align: left;"><font style="padding-left: 12.5pt;">83,480</font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 10pt;">1,293,356 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Persons and entities affiliated with Jack Cogen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 3.79pt;"></font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 61.17pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.58pt; text-align: left;">8,002,260</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$ 123,979,015</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 61.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares held by Michael Intrator, our Chief Executive Officer and chairman of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares held by Brian Venturo, our Chief Strategy Officer and a member of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of shares held by Brannin McBee, our Chief Development Officer, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of 83,480 shares directly held of record and sold by Kristen McVeety, our General Counsel and Secretary. The total purchase price reported in the table above includes $45,664 Ms.&#160;McVeety paid to us in connection with her net exercise of employee stock options concurrent with her sale in the 2023 tender offer. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Consists of held by Jack Cogen, a member of our board of directors, and certain related persons and affiliates. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">All shares of our convertible preferred stock were converted into shares of our common stock immediately prior to being sold in the 2023 Tender Offer. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">290<br></div></div></div>
<!--End Page 301-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 302-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_123-certain_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">Convertible Preferred Stock Financings </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Series&#160;B-1 Convertible Preferred Stock Financing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In April&#160;2023, we issued an aggregate of 12,484,540 shares of our Series&#160;B-1 convertible preferred stock at a purchase price of $0.41 per share upon conversion of convertible notes previously issued to several accredited private investors for an aggregate principal amount of $4&#160;million and which bore a PIK interest rate of 7% per annum. Each outstanding share of our Series&#160;B-1 convertible preferred stock was convert automatically into shares of our Class&#160;A common stock immediately prior to the completion of the IPO. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes the shares of our Series&#160;B-1 convertible preferred stock acquired by certain of our directors and their affiliates: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 70.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 51.83pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder</div></td><td style="width: 8.53pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.05pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares of Series&#160;B-1 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Convertible<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td style="width: 8.53pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.83pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Purchase Price </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 4.68pt;"></font></div></td><td style="width: 8.53pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.05pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.03pt; text-align: left;">1,458,680</div></td><td style="width: 8.53pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.17pt; text-align: left;">$ 584,959 </div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Jack Cogen and affiliated entities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 4.33pt;"></font></div></td><td style="width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 70.05pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 15.03pt; text-align: left;">1,458,720</div></td><td style="width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.17pt; text-align: left;">$ 584,961</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 70.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.53pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 51.83pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares directly held of record by Michael Intrator. Mr.&#160;Intrator is our Chief Executive Officer, President, and Chairman of our board of directors. Mr.&#160;Intrator and certain of his affiliates beneficially own more than 5% of our outstanding capital stock. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of shares acquired by entities affiliated with Jack Cogen, a member of our board of directors. Additionally, Mr.&#160;Cogen and certain of his affiliates beneficially own more than 5% of our outstanding capital stock. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Other Transactions </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Equity Exchange Right Agreements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September&#160;2024, we entered into an Equity Exchange Right Agreement with each of our Co-Founders, Messrs. Intrator, Venturo, and McBee, pursuant to which each of our Co-Founders have a right (but not an obligation), to require us to exchange, for shares of our Class&#160;B common stock, any shares of our Class&#160;A common stock received by him upon the exercise or settlement of equity awards for shares of our Class&#160;A common stock (the &#8220;Equity Exchange Rights&#8221;). The Equity Exchange Rights only apply to equity awards granted to our Co-Founders prior to September&#160;2024. As of June&#160;30, 2025, there were 9,109,000 shares of our Class&#160;A common stock subject to outstanding stock options to purchase shares of our Class&#160;A common stock held by our Co-Founders and that may be exchanged, upon exercise, for an equivalent number of shares of our Class&#160;B common stock pursuant to the Equity Exchange Rights. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Equity Exchange Rights terminate (a) with respect to shares of our Class&#160;A common stock subject to equity awards that are held by our Co-Founders, on the date on which such shares are forfeited pursuant to the terms of the applicable equity award, and (b) with respect to shares of our Class&#160;A common stock issued upon the exercise or settlement of equity awards held by a Co-Founder, (i) when the Co-Founder sells, transfers, or otherwise disposes of such shares of our Class&#160;A common stock or (ii) upon the earlier of (i) a date that is fixed by our board of directors that is no more than 61 days following the seventh anniversary of the IPO, (ii) the date specified by the affirmative vote of two-thirds of the outstanding voting power of the Class&#160;B common stock, or (iii) no more than 61 days following Michael Intrator&#8217;s Service Termination (as defined herein). </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Employment Arrangement with an Immediate Family Member </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Michael McBee, the brother of Brannin McBee, our Chief Development Officer, has been employed by us in a non-executive role since November&#160;2024. For the year ended December&#160;31, 2024, Mr.&#160;Michael McBee&#8217;s annual base salary was $190,000, in addition to equity compensation. Mr.&#160;Michael McBee&#8217;s compensation was based on reference to external market practice of similar positions or internal pay equity when compared to the compensation paid to employees in similar positions who were not related to our Chief Development Officer. Mr.&#160;Michael McBee was also eligible for equity awards on the same general terms and conditions as applicable to employees in similar positions who were not related to our Chief Development Officer. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Registration Rights Agreements </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 0pt; text-align: left;">Investors&#8217; Rights Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are party to a Third Amended and Restated Investors&#8217; Rights Agreement between us and other parties, dated May&#160;16, 2024 (the &#8220;Rights Agreement&#8221;), which provides, among other things, that certain holders of our capital </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">291<br></div></div></div>
<!--End Page 302-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 303-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_123-certain_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">stock, including certain affiliates of Jack Cogen, a member of our board of directors, and Michael Intrator, our Chief Executive Officer, President, and Chairman of our board of directors, and Brian Venturo, our Chief Strategy Officer, have the right to demand that we file a registration statement or request that their shares of our capital stock be included on a registration statement that we are otherwise filing. See the section titled &#8220;Description of CoreWeave Capital Stock, New Tranche 1 Warrants and New Tranche 2 Warrants&#8212;Registration Rights&#8221; for more information regarding these registration rights. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Voting Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to our Voting Agreement, certain holders of our capital stock agreed to vote their shares on certain matters, including with respect to the election of members of our board of directors. Holders of our capital stock, including Jack Cogen, a member of our board of directors, and certain of his affiliates, and Michael Intrator, our Chief Executive Officer and President, and certain of his affiliates, Brian Venturo, our Chief Strategy Officer, and certain of his affiliates, and certain affiliates of Brannin McBee, our Chief Development Officer, were parties to our Voting Agreement. Our Voting Agreement was terminated upon the completion of the IPO. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Indemnification Agreements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have entered into, and intend to continue to enter into, separate indemnification agreements with each of our executive officers and directors. The indemnification agreements and our amended and restated bylaws require us to indemnify our directors to the fullest extent not prohibited by DGCL. Subject to very limited exceptions, our amended and restated bylaws also require us to advance expenses incurred by our directors and officers. For more information regarding these agreements, see the section titled &#8220;Directors and Management of CoreWeave, Inc.&#8212;Limitations on Liability and Indemnification Matters&#8221; for more information regarding these registration rights. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Directed Share Program </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At our request, the underwriters reserved for sale, at the initial public offering price, up to 1,875,000 shares of our Class&#160;A common stock, or 5% of the shares being offered pursuant to the IPO, to our current employees, including management, other service providers, and other individuals and entities as determined by certain of our authorized officers. The directed share program did not limit the ability of our directors, officers and their family members, or holders of more than 5% of our capital stock, to purchase more than $120,000 in value of our Class&#160;A common stock. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Policies and Procedures for Related Party Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our audit committee has the primary responsibility for reviewing and approving or disapproving &#8220;related party transactions,&#8221; which are transactions between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person has or will have a direct or indirect material interest. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our written policy regarding transactions between us and related persons provide that a related person is defined as a director, executive officer, nominee for director or 5% stockholder, in each case since the beginning of the most recently completed year, and any of their immediate family members. Our audit committee charter provides that our audit committee shall review and approve or disapprove any related party transactions. In approving or rejecting any such transactions, our audit committee considers the relevant facts and circumstances available and deemed relevant to our audit committee, including, but not limited to, the commercial reasonableness of the terms of the transaction and the materiality and character of the related person&#8217;s direct or indirect interest in the transaction. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">292<br></div></div></div>
<!--End Page 303-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 304-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCOS"><!--Anchor--></a>COMPARISON OF STOCKHOLDER RIGHTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the transactions contemplated by the Merger Agreement are completed, Core Scientific stockholders will receive shares of CoreWeave common stock in connection with the Merger and become stockholders of CoreWeave. The following is a summary of certain differences between (i) the current rights of Core Scientific stockholders under Delaware law, the Core Scientific certificate of incorporation and the Core Scientific bylaws and (ii) the current rights of CoreWeave stockholders under Delaware law, the CoreWeave certificate of incorporation and the CoreWeave bylaws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although it is impracticable to compare all of the aspects in which CoreWeave&#8217;s and Core Scientific&#8217;s governing instruments differ with respect to stockholder rights, the following discussion summarizes certain material differences between them. The following summary is not a complete statement of the rights of stockholders of the two companies or a complete description of the specific provisions referred to below. This summary is qualified in its entirety by reference to the DGCL and Core Scientific&#8217;s and CoreWeave&#8217;s governing documents (which we urge you to read carefully and in their entirety). Copies of the respective corporations&#8217; governing documents have been filed with the SEC. To find out where copies of these documents can be obtained, see the section titled &#8220;Where You Can Find More Information&#8221; beginning on page <a href="#tWYC">317</a> of this proxy statement/prospectus. In addition, the identification of some of the differences in the rights of CoreWeave and Core Scientific stockholders is not intended to indicate that other differences that are equally important do not exist. CoreWeave and Core Scientific urge you to carefully read this entire proxy statement/prospectus, the relevant provisions of the DGCL and the other documents to which CoreWeave and Core Scientific refer in this proxy statement/prospectus for a more complete understanding of the differences between the rights of a CoreWeave and Core Scientific stockholder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Between the date of the Merger Agreement and the effective time, Core Scientific has agreed not to amend its governing documents and CoreWeave has agreed not to amend its governing documents in a manner that would be adverse to Core Scientific or Core Scientific stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific are incorporated under the laws of the State of Delaware. Accordingly, the rights of CoreWeave and Core Scientific stockholders are governed by the DGCL and other applicable Delaware law. As a result of the Merger, Core Scientific stockholders will receive shares of CoreWeave common stock and will become CoreWeave stockholders. Thus, following the Merger, the rights of Core Scientific stockholders who become CoreWeave stockholders in connection with the Merger will be governed by the DGCL and other applicable Delaware law and will also then be governed by the CoreWeave certificate of incorporation and the CoreWeave bylaws. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">293<br></div></div></div>
<!--End Page 304-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 305-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">CERTAIN KEY FEATURES OF STOCKHOLDER RIGHTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 1pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.28pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.28pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.28pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 0.91pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Authorized Capital Stock</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.91pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">CoreWeave&#8217;s authorized capital stock consists of (i) 3,400,000,000 shares of Common Stock, $0.000005 par value per share (&#8220;Common Stock&#8221;), of which (a)&#160;3,000,000,000 shares are designated as CoreWeave common stock, (b)&#160;200,000,000&#160;shares are designated as Class&#160;B common stock, $0.000005 par value per share, and (c) 200,000,000 shares are designated as Class&#160;C common stock, $0.000005 par value per share, and (ii)&#160;100,000,000 shares of Preferred Stock, $0.000005 par value per share (&#8220;Preferred Stock&#8221;).<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the CoreWeave certificate of incorporation, the number of authorized shares of any class of stock may be increased or decreased by a vote of the holders of the stock of CoreWeave entitled to vote, voting as a single class. In addition, under the CoreWeave certificate of incorporation, the CoreWeave board is authorized, subject to any limitations prescribed by the DGCL, to (i) provide for the issuance of shares of Preferred Stock in one or more series and to establish from time to time the number of shares to be included in each such series, (ii)&#160;fix the designation, powers, preferences and relative, participating, optional or other special rights of the shares of each such series, (iii) increase or decrease the number of shares of any such series, (iv) designate, fix and determine any new series of Preferred Stock without approval of the holders of Common Stock or Preferred Stock and (v) determine the powers, preferences and rights, including voting powers, dividend rights, liquidation rights, redemption rights and conversion rights, senior to, junior to or pari passu with the rights of the Common Stock, any series of the Preferred Stock or any future class or series of CoreWeave&#8217;s capital stock.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">As of September 9, 2025, there were (i)&#160;380,162,985 shares of CoreWeave Class A common stock, (ii) 114,939,540 shares of CoreWeave Class B common stock, (iii)&#160;no shares of CoreWeave Class C common stock and (iv) no shares of CoreWeave Preferred Stock outstanding.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.91pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Core Scientific&#8217;s authorized capital stock consists of (i) 10,000,000,000 shares of Core Scientific common stock and (ii)&#160;2,000,000,000 shares of preferred stock, $0.00001 par value per share (&#8220;Core&#160;Scientific preferred stock&#8221;).<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the Core Scientific certificate of incorporation, the number of authorized shares of Core Scientific common stock and Core Scientific preferred stock may be increased or decreased (but not below the number of shares thereof then outstanding) from time to time by the affirmative vote of the holders of at least a majority of the voting power of Core Scientific&#8217;s then outstanding shares of stock entitled to vote thereon, voting together as a single class. In addition, under the Core Scientific certificate of incorporation, the Core Scientific board is authorized, to the fullest extent permitted by the DGCL, to provide for the issuance of shares of Core Scientific preferred stock in one or more series and to fix for each such series (i) the number of shares constituting such series and the designation of such series, (ii) the voting powers (if any), whether full or limited, of the shares of such series, (iii) the powers, preferences, and relative, participating, optional or other special rights of the shares of each such series, and (iv)&#160;the qualifications, limitations, and restrictions thereof, and to cause to be filed with the Secretary of State of the State of Delaware a certificate of designation with respect thereto.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">As of September 9, 2025, there were<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">(i) 306,543,223 shares of Core Scientific common stock and (ii) no shares of Core Scientific preferred stock outstanding.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">294<br></div></div></div>
<!--End Page 305-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 306-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Voting Rights</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Except as otherwise expressly provided by the CoreWeave certificate of incorporation or as required by law, the holders of shares of Common Stock will at all times vote together as a single class and not as separate series or classes on all matters submitted to a vote of the stockholders of CoreWeave but will not be entitled to vote on any amendments to the CoreWeave certificate of incorporation that relate solely to the terms of one or more outstanding class or series of Preferred Stock if the holders of such affected class or series are entitled to vote thereon. On all matters on which holders of Common Stock are entitled to vote, (x) each holder of CoreWeave common stock has the right to one (1) vote per share of CoreWeave common stock held of record by such holder, (y) each holder of Class&#160;B common stock has the right to ten (10) votes per share of Class&#160;B common stock held of record by such holder and (z)&#160;shares of Class&#160;C common stock have no voting rights, except as otherwise required by law.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Except as otherwise required by law or as otherwise provided in any certificate of designation for any series of Core Scientific preferred stock, the holders of Core Scientific common stock possess all voting power for the election of directors of the Core Scientific board and all other matters requiring stockholder action. Each outstanding share of Core Scientific common stock entitles the holder thereof to one vote on each matter properly submitted to the stockholders of Core Scientific for their vote. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cumulative Voting</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under Delaware law, stockholders of a Delaware corporation do not have the right to cumulate their votes in the election of directors unless that right is granted in the certificate of incorporation of the corporation. The CoreWeave certificate of incorporation prohibits cumulative voting.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under Delaware law, stockholders of a Delaware corporation do not have the right to cumulate their votes in the election of directors unless that right is granted in the certificate of incorporation of the corporation. The Core Scientific certificate of incorporation does not grant such right. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Quorum</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that the presence in person or by proxy at a meeting of the holders of a majority of the voting power of shares of stock issued and outstanding and entitled to vote at the meeting is a quorum.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that the presence in person, by remote communication, if applicable, or by proxy of the holders of a majority of the voting power of the outstanding shares of stock entitled to vote at the meeting is a quorum. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder Rights Plans</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">CoreWeave does not have a stockholder rights plan. While CoreWeave has no present intention to adopt a stockholder rights plan, the CoreWeave board, pursuant to its authority to issue preferred stock, could do so without stockholder approval at any future time. See the section titled &#8220;Description of CoreWeave Capital Stock, New Tranche 1 Warrants and New Tranche 2 Warrants&#8221; beginning on page <a href="#tDOC">277</a> of this proxy statement/prospectus.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Core Scientific does not have a stockholder rights plan. While Core Scientific has no present intention to adopt a stockholder rights plan, the Core Scientific board, pursuant to its authority to issue preferred stock, could do so without stockholder approval at any future time. </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">295<br></div></div></div>
<!--End Page 306-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 307-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Rights of Preferred Stock</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation provides that the CoreWeave board is authorized to determine the designation, powers (including voting powers), preferences and relative, participating, optional or other special rights (and the qualifications, limitations or restrictions thereof) of each series or class of Preferred Stock.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">As of the date of this proxy statement/prospectus, no shares of Preferred Stock were outstanding.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that the Core Scientific board is authorized to determine the number of shares, designation, powers (including voting powers), preferences, and relative, participating, optional or other special rights (and the qualifications, limitations or restrictions thereof) of each series of Core Scientific preferred stock.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">As of the date of this proxy statement/prospectus, no shares of Core Scientific preferred stock were outstanding. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Preemptive Rights</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under Delaware law, stockholders of corporations have no preemptive rights unless the certificate of incorporation provides otherwise.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation does not provide that stockholders have preemptive rights.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under Delaware law, stockholders of corporations have no preemptive rights unless the certificate of incorporation provides otherwise.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation does not provide that stockholders have preemptive rights. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Number of Directors</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The DGCL provides that the board of directors of a Delaware corporation must consist of one or more directors as fixed by the company&#8217;s certificate of incorporation or bylaws.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave board currently has six&#160;members. The CoreWeave certificate of incorporation and the CoreWeave bylaws provide that, subject to the special rights of the holders of any class or series of Preferred Stock to elect additional directors under specified circumstances, the total number of directors constituting the CoreWeave board will be fixed from time to time exclusively by resolution of the CoreWeave board.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The DGCL provides that the board of directors of a Delaware corporation must consist of one or more directors as fixed by the company&#8217;s certificate of incorporation or bylaws.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific board currently has seven members. The Core Scientific certificate of incorporation provides that, subject to the special rights of the holders of any series of Core Scientific preferred stock to elect additional directors under specified circumstances, the total number of directors constituting the Core Scientific board will be fixed exclusively by the Core Scientific board. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Election of Directors</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that directors will be elected by a plurality of the votes cast by the holders of the shares present in person or represented by proxy at the meeting and entitled to vote on the election of directors. Each director holds office until the earlier of (i) the date when such director&#8217;s successor has been duly elected and qualified or (ii) such director&#8217;s earlier death, resignation, disqualification or removal. Election of directors need not be by written ballot.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that directors will be elected by a plurality of the votes cast by the holders of shares present in person or represented by proxy at the meeting of stockholders and entitled to vote thereon. Each director holds office until the earlier of (i) the date when such director&#8217;s successor has been duly elected and qualified or (ii)&#160;such director&#8217;s earlier death, resignation or removal. </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">296<br></div></div></div>
<!--End Page 307-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 308-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Filling Vacancies on the Board of Directors</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the CoreWeave certificate of incorporation, any vacancy occurring on the CoreWeave board, however caused, and any newly created directorship resulting from any increase in the authorized number of directors, may be filled by the affirmative vote of a majority of the remaining directors then in office, even though less than a quorum, or by a sole remaining director, and may not be filled by the stockholders. Any director elected to fill a vacancy or newly created directorship will hold office for the remainder of the term of the class of director in which the vacancy or new directorship was created and will hold office until such director&#8217;s successor will have been duly elected and qualified, or until such director&#8217;s earlier death, resignation, disqualification or removal.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the Core Scientific certificate of incorporation, any vacancy on the Core Scientific board resulting from death, resignation, disqualification, removal or other causes and any newly created directorships resulting from any increase in the number of directors, may be filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Core Scientific board or by the sole remaining director, and not by the stockholders (unless the Core Scientific board determined by resolution that any such vacancy or newly created directorship be filled by the stockholders and except as otherwise provided by law). Any director elected to fill a vacancy or newly created directorship will hold office for a term expiring at the first annual meeting of stockholders held after such director&#8217;s election and will hold office until such director&#8217;s successor will have been duly elected and qualified, or until such director&#8217;s earlier death, resignation or removal. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Removal of Directors</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the CoreWeave certificate of incorporation, no director may be removed from the CoreWeave board except for cause and only by the affirmative vote of the holders of at least two-thirds (2/3) of the voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock entitled to vote generally in the election of directors, voting together as a single class. No decrease in the number of directors constituting the CoreWeave board will shorten the term of any director.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the Core Scientific certificate of incorporation, until the 2026 annual meeting of Core Scientific stockholders, no director may be removed from the Core Scientific board except for cause and only by the affirmative vote of the holders of at least a majority of the shares of capital stock of Core Scientific entitled to vote on the election of such directors, voting together as a single class. From and after the 2026 annual meeting of Core Scientific stockholders, any director of the Core Scientific board may be removed, with or without cause, only by the affirmative vote of the holders of at least a majority of the shares of capital stock of Core Scientific entitled to vote on the election of such directors, voting together as a single class. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Special Meetings of Directors</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that special meetings of the CoreWeave board may be called at the direction of the chairperson of the CoreWeave board, the chief executive officer, the lead independent director or a majority of the members of the CoreWeave board then in office. Any such meeting may be held on such date and at such time and place as such person or persons calling the meeting fixes.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that special meetings of the Core Scientific board may be called at the direction of the chairperson of the Core Scientific board, the chief executive officer or the Core Scientific board. Any such meeting may be held on such date and at such time and place as such person or persons calling the meeting fixes.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">297<br></div></div></div>
<!--End Page 308-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 309-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director Nominations by Stockholders</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, unless directors are elected by written consent in lieu of an annual meeting, an annual stockholder meeting will be held for the election of directors on a date and time designated by or in the manner provided in the bylaws. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that nominations of persons for election to the CoreWeave board and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to CoreWeave&#8217;s notice of meeting (or any supplement thereto), (B) by or at the direction of the CoreWeave board or any committee thereof, (C) by any stockholder of CoreWeave who (x) was a stockholder of record of CoreWeave both at the time the notice was provided and at the time of the annual meeting, (y) is entitled to vote at the meeting and (z) complies with the notice procedures and other requirements set forth in the CoreWeave bylaws, or (D) as may be provided in the certificate of designations for any series of Preferred Stock.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, unless directors are elected by written consent in lieu of an annual meeting, an annual stockholder meeting will be held for the election of directors on a date and time designated by or in the manner provided in the bylaws.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that nominations of persons for election to the Core Scientific board and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to Core Scientific&#8217;s notice of meeting (or any supplement thereto), (B) by or at the direction of the Core Scientific board or any committee thereof, (C) by any stockholder of Core Scientific who (x) was a stockholder of record of Core Scientific both at the time the stockholder provided the required notice under the Core Scientific bylaws and at the time of the annual meeting, (y) is entitled to vote at the meeting and (z) complies with the notice procedures and other requirements set forth in the Core Scientific bylaws. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder Proposals (Other than Director Nominations)</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, meetings of stockholders may be held at such place as may be designated by or in the manner provided in the certificate of incorporation or bylaws, or if not so designated, as determined by the board of directors.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that nominations of persons for election to the CoreWeave board and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to CoreWeave&#8217;s notice of meeting (or any supplement thereto), (B) by or at the direction of the CoreWeave board or any committee thereof, (C) by any stockholder of CoreWeave who (x) was a stockholder of record of CoreWeave both at the time the notice was provided and at the time of the annual meeting, (y) is entitled to vote at the meeting and (z) complies with the notice procedures and other requirements set forth&#160;in the CoreWeave bylaws, or (D) as may be provided in the certificate of designations for any series of Preferred Stock. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, meetings of stockholders may be held at such place as may be designated by or in the manner provided in the certificate of incorporation or bylaws, or if not so designated, as determined by the board of directors.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that nominations of persons for election to the Core Scientific board and the proposal of other business to be considered by the stockholders may be made at an annual meeting of stockholders only (A) pursuant to Core Scientific&#8217;s notice of meeting (or any supplement thereto), (B) by or at the direction of the Core Scientific board or any committee thereof, (C) by any stockholder of Core Scientific who (x) was a stockholder of record of Core Scientific both at the time the stockholder provided the required notice under the Core Scientific bylaws and at the time of the annual meeting, (y) is entitled to vote at the meeting and (z) complies with the notice procedures and other requirements set forth in the Core Scientific bylaws. </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">298<br></div></div></div>
<!--End Page 309-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 310-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder Action by Written Consent</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The DGCL provides that, unless otherwise provided in a corporation&#8217;s certificate of incorporation or bylaws, any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth the action so taken, are signed by the holders of issued and outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation provides that stockholders may not act by written consent in lieu of a meeting. Notwithstanding the foregoing, so long as the voting power of all of the then-outstanding shares of Class&#160;B common stock represents greater than a majority of the combined voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock, any action required or permitted to be taken at any meeting of the stockholders of CoreWeave may be taken without a meeting if holders of a majority of the voting power of all of the then-outstanding shares of capital stock of CoreWeave entitled to vote thereon, voting together as a single class, consent in writing or by electronic transmission.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The DGCL provides that, unless otherwise provided in a corporation&#8217;s certificate of incorporation or bylaws, any action required or permitted to be taken at any annual or special meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a consent or consents in writing, setting forth&#160;the action so taken, are signed by the holders of issued and outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that stockholders may not act by written consent in lieu of a meeting. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Incorporation Amendments</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, an amendment to a corporation&#8217;s charter generally requires the approval of the corporation&#8217;s board of directors and the holders of a majority of the outstanding stock entitled to vote thereon unless the charter requires a higher vote. In addition, if the proposed amendment would increase or decrease the aggregate number of authorized shares of a class of stock, increase or decrease the par value of the shares of such class or change the powers, preferences or special rights of the shares so as to affect them adversely, the holders of a majority of the outstanding shares of such class will be entitled to vote as a class upon the proposed amendment.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation provides that the affirmative vote of the holders of at least two-thirds (2/3) of the</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, an amendment to a corporation&#8217;s charter generally requires the approval of the corporation&#8217;s board of directors and the holders of a majority of the outstanding stock entitled to vote thereon unless the charter requires a higher vote. In addition, if the proposed amendment would increase or decrease the aggregate number of authorized shares of a class of stock, increase or decrease the par value of the shares of such class or change the powers, preferences or special rights of the shares so as to affect them adversely, the holders of a majority of the outstanding shares of such class will be entitled to vote as a class upon the proposed amendment.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that the affirmative vote of the holders of at least two-thirds of </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">299<br></div></div></div>
<!--End Page 310-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 311-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock entitled to vote, voting together as a single class, is required to amend or repeal, or adopt any provision (other than Section&#160;1.1 of Article&#160;IV regarding authorized shares); <font style="font-style: italic;">provided</font>, that, if two-thirds (2/3) of the CoreWeave board has approved such amendment, then only the affirmative vote of the holders of a majority of the voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock entitled to vote, voting together as a single class (in addition to any other vote required by law), is required to approve such amendment.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Prior to an automatic conversion of all shares of Class&#160;B common stock and Class&#160;C common stock into shares of CoreWeave common stock in accordance with the CoreWeave certificate of incorporation, and in addition to any other vote required pursuant to Article&#160;X of the CoreWeave certificate of incorporation, CoreWeave will not, without the prior affirmative vote of the holders of at least two-thirds (2/3) of the then-outstanding shares of Class&#160;B common stock, voting separately as a single class: (i)&#160;amend any provision of the CoreWeave certificate of incorporation relating to the voting, conversion or other rights, powers, preferences, privileges or restrictions of the Class&#160;B common stock; (ii) reclassify any outstanding shares of CoreWeave common stock or Class&#160;C common stock into shares having rights as to dividends or liquidation that are senior to the Class&#160;B common stock or the right to have more than one (1) vote for each share thereof; or (iii) authorize, or issue any shares of, any class or series of capital stock of CoreWeave (other than Class&#160;B common stock) having the right to more than one (1) vote for each share thereof.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The affirmative vote of the holders of CoreWeave common stock representing at least seventy-five percent (75%) of the voting power of all of the then-outstanding shares of CoreWeave common stock, voting separately as a single class, and the affirmative vote of the holders of Class&#160;B common stock representing at least seventy-</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">the voting power of all of the then outstanding shares of capital stock of Core Scientific entitled to vote generally in the election of directors, voting together as a single class, is required to alter, amend or repeal Articles V (board of directors; bylaw amendments and stockholder actions), VI&#160;(director and officer indemnification), VII (choice of forum) and VIII&#160;(amendments of the certificate of incorporation) of the Core Scientific certificate of incorporation.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">300<br></div></div></div>
<!--End Page 311-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 312-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">five percent (75%) of the voting power of all of the then-outstanding shares of Class&#160;B common stock, voting separately as a single class, will be required to amend any provision inconsistent with, Section&#160;3 of Article&#160;IV&#160;regarding common stock or Section&#160;2 of Article&#160;X regarding amendments of the CoreWeave certificate of incorporation.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Bylaw Amendments</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, the power to make, alter or repeal bylaws is conferred upon the stockholders. A corporation may, however, in its certificate of incorporation also confer upon the board of directors the power to make, alter or repeal its bylaws. The CoreWeave certificate of incorporation grants the CoreWeave board the power to adopt, amend and repeal the CoreWeave bylaws by a vote of a majority of the board. CoreWeave&#8217;s stockholders may also adopt, alter, amend or repeal the CoreWeave bylaws upon the affirmative vote of the holders of at least two-thirds (2/3) of the voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock entitled to vote thereon, voting together as a single class; <font style="font-style: italic;">provided</font>, that, in the case of any adoption, amendment or repeal of any provision of the CoreWeave bylaws that the CoreWeave board elects to submit to the stockholders for adoption and which is approved by at least two-thirds (2/3) of CoreWeave&#8217;s whole board, then, only the affirmative vote of the holders of a majority of the voting power of all of the then-outstanding shares of CoreWeave&#8217;s capital stock entitled to vote, voting together as a single class (in addition to any requirements of law), is required to adopt, amend or repeal any such provision of the CoreWeave bylaws.</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, the power to make, alter or repeal bylaws is conferred upon the stockholders. A corporation may, however, in its certificate of incorporation also confer upon the board of directors the power to make, alter or repeal its bylaws. The Core Scientific certificate of incorporation grants the Core Scientific board to adopt, amend or repeal the Core Scientific bylaws. Core Scientific&#8217;s stockholders may also adopt, amend or repeal the Core Scientific bylaws upon the affirmative vote of the holders of at least two-thirds of the voting power of all of the then-outstanding shares of the capital stock of Core Scientific entitled to vote generally in the election or directors, voting together as a single class.</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Special Meetings of Stockholders </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the CoreWeave certificate of incorporation, special meetings of CoreWeave&#8217;s stockholders may be called only by the chairperson of CoreWeave&#8217;s board, CoreWeave&#8217;s chief executive officer, the lead independent director or CoreWeave&#8217;s board acting pursuant to a resolution adopted by a majority of the whole board and may not be called by the stockholders or any other person or persons. The special meeting may be held either at a place, within or without the State of </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the Core Scientific bylaws, special meetings of Core Scientific&#8217;s stockholders may be called only by the chairperson of Core Scientific&#8217;s board, Core Scientific&#8217;s chief executive officer, the Core Scientific board pursuant to a resolution adopted by a majority of the total number of authorized directors, or Core Scientific stockholders of record who own, in the aggregate, at least 20% of the voting power of the outstanding shares of Core Scientific then entitled to vote on the matter or matters to be brought before </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">301<br></div></div></div>
<!--End Page 312-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 313-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware as the CoreWeave board in its sole discretion may fix, or solely by means of remote communication as the CoreWeave board in its sole discretion may determine. Business transacted at any special meeting of stockholders will be limited to matters relating to the purpose or purposes stated in the notice of the meeting. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">the proposed special meeting. The Core Scientific board (or its designee) will determine the date, time and play, if any, of such special meeting. No business may be transacted at such special meeting otherwise than specified in the notice of meeting. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Notice of Meetings of Stockholders </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that notice of all meetings of stockholders must be given in accordance with applicable law stating the date, time and place, if any, of the meeting, the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting, and the record date for determining the stockholders entitled to vote at the meeting (if such date is different from the record date for determining the stockholders entitled to notice of the meeting). In the case of a special meeting, such notice must also set forth the purpose or purposes for which the meeting is called. Notice of any meeting of stockholders must be given not less than ten (10), nor more than sixty (60), days before the date of the meeting to each stockholder of record entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of the meeting. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that notice of all meetings of stockholders must be given in accordance with applicable law stating the date, time and place, if any, of the meeting, the record date for determining stockholders entitled to vote at the meeting, if such record date is different from the record date for determining stockholders entitled to notice of the meeting, and the means of remote communications, if any, by which stockholders and proxyholders may be deemed to be present in person and vote at any such meeting, and in the case of special meetings, the purpose or purposes of the meeting. Notice of any meeting of stockholders must be given not less than ten (10), nor more than sixty (60), days before the date of the meeting to each stockholder entitled to vote at such meeting as of the record date for determining the stockholders entitled to notice of such meeting.</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Limitation of Personal Liability of Directors </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation provides that, to the fullest extent permitted by law, no director or officer of CoreWeave will be personally liable to CoreWeave or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable. If the DGCL is amended to authorize the further elimination or limitation of the liability of a director or officer, then the liability of a director or officer of CoreWeave will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that, to the fullest extent permitted by law, no director or officer of Core Scientific will be personally liable to Core Scientific or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, as applicable. If the DGCL is amended to authorize the further elimination or limitation of the liability of a director or officer, then the liability of a director or officer of Core Scientific will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Indemnification of Directors and Officers </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law provides that a corporation has the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding by reason of the fact the person is or was a director, officer, employee or agent of the </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law provides that a corporation has the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding by reason of the fact the person is or was a director, officer, employee or agent of the </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">302<br></div></div></div>
<!--End Page 313-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 314-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">corporation, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law permits expenses (including attorneys&#8217; fees) incurred by an officer or director of the corporation in defending any civil, criminal, administrative or investigative action, suit or proceeding to be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it is ultimately determined that such person is not entitled to be indemnified by the corporation as authorized under the DGCL.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, the indemnification and advancement of expenses provided by, or granted pursuant to &#167; 145, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and will inure to the benefit of heirs, executors and administrators of such a person.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Pursuant to the CoreWeave bylaws, CoreWeave&#8217;s current and former directors and officers will be indemnified and held harmless by CoreWeave to the fullest extent permitted by the DGCL against all expenses, costs, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes and penalties and amounts paid or to be paid in settlement) reasonably incurred or suffered by such indemnitee, <font style="font-style: italic;">provided</font> such indemnitee acted in good faith and in a manner that the indemnitee reasonably believed to be in or not opposed to the best interests of CoreWeave, and, with respect to any criminal proceeding, had no reasonable cause to believe the indemnitee&#8217;s conduct was unlawful. Such indemnification will continue as to an indemnitee who has ceased </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">corporation, against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person&#8217;s conduct was unlawful.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law permits expenses (including attorneys&#8217; fees) incurred by an officer or director of the corporation in defending any civil, criminal, administrative or investigative action, suit or proceeding to be paid by the corporation in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it is ultimately determined that such person is not entitled to be indemnified by the corporation as authorized under the DGCL.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Under the DGCL, the indemnification and advancement of expenses provided by, or granted pursuant to &#167; 145, unless otherwise provided when authorized or ratified, continue as to a person who has ceased to be a director, officer, employee or agent and will inure to the benefit of heirs, executors and administrators of such a person.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Pursuant to the Core Scientific bylaws, Core Scientific&#8217;s current and former directors and executive officers will be indemnified and held harmless to the fullest extent permitted by the DGCL&#160;against all expenses (including attorneys&#8217; fees), judgments, fines (including ERISA&#160;excise taxes or penalties) and amounts paid in settlement actually and reasonably incurred by such indemnitee, <font style="font-style: italic;">provided</font> such indemnitee acted in good faith and in a manner that the indemnitee reasonably believed to be in or not opposed to the best interests of Core Scientific, and, with respect to any criminal proceeding, had no reasonable cause to believe the indemnitee&#8217;s conduct was unlawful, <font style="font-style: italic;">provided further</font> that Core Scientific may modify the extent of such indemnification by </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">303<br></div></div></div>
<!--End Page 314-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 315-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">to be a director or officer of CoreWeave for such proceedings brought by reason of the fact that such person is or was a director or officer of CoreWeave. CoreWeave will indemnify such indemnitee seeking indemnity in connection with a proceeding initiated by such indemnitee only if such proceeding was authorized by the CoreWeave board or such indemnification is authorized by an agreement approved by the CoreWeave board. The CoreWeave bylaws permit CoreWeave to grant rights to indemnification and to advancement of expenses to any person who is or was a director, officer, employee or agent of CoreWeave. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">individual contracts with its directors and executive officers. Core Scientific is not obligated such indemnitee in connection with a proceeding initiated by such indemnitee unless (i) such indemnification is expressly required to be made by applicable law, (ii) such proceeding was authorized by the Core Scientific board, (iii) such indemnification is provided by Core Scientific, in its sole discretion, pursuant to the powers vested in Core Scientific under the DGCL or any other applicable law and (iv) such indemnification is required to be made under Section&#160;46(d) of the Core Scientific bylaws. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividends </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave certificate of incorporation provides that, subject to the preferential or other rights of any holders of Preferred Stock then outstanding, the holders of all series of Common Stock are treated equally, identically and ratably, on a per share basis, with respect to any dividends or distributions (other than authorized repurchases of outstanding Common Stock) as may be declared and paid from time to time by the CoreWeave board out of any assets of CoreWeave legally available, unless a disparate dividend is approved in advance by the affirmative vote of the holders of a majority of the then-outstanding shares of each series of Common Stock, voting as separate series; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that, notwithstanding the foregoing, in the event a dividend or distribution (other than authorized repurchases of outstanding Common Stock) is paid in the form of shares of a series of Common Stock (or securities convertible into or exchangeable or exercisable for such shares), the holders of a series of Common Stock, as such, will receive shares of such series of Common Stock (or rights to acquire such shares). </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific bylaws provide that the Core Scientific board may declare dividends upon the capital stock of Core Scientific, subject to the provisions of the Core Scientific certificate of incorporation and applicable law. Dividends may be paid in cash, in property, or in shares of Core Scientific&#8217;s capital stock, subject to the provisions of the Core Scientific certificate of incorporation and applicable law.</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; Rights of Dissent and Appraisal </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law provides that any stockholder of a corporation who holds shares of stock on the making of a demand pursuant to &#167; 262(d) of the DGCL with respect to such shares, who continuously holds such shares through the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, who has otherwise complied with &#167; 262(d) of the </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Delaware law provides that any stockholder of a corporation who holds shares of stock on the making of a demand pursuant to &#167; 262(d) of the DGCL with respect to such shares, who continuously holds such shares through the effective date of the merger, consolidation, conversion, transfer, domestication or continuance, who has otherwise complied with &#167; 262(d) of the </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">304<br></div></div></div>
<!--End Page 315-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 316-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">DGCL and who has neither voted in favor of the merger, consolidation, conversion, transfer, domestication or continuance nor consented thereto in writing pursuant to &#167; 228 of the DGCL will be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#8217;s shares of stock. Appraisal rights will be available under Delaware law for the shares of any class or series of stock of a constituent, converting, transferring, domesticating or continuing corporation in a merger, consolidation, conversion, transfer, domestication or continuance to be effected, subject to the limitations detailed in &#167; 262 of the DGCL. The DGCL further provides that any corporation may provide in its certificate of incorporation that appraisal rights will be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation, the sale of all or substantially all of the assets of the corporation or a conversion effected, or a transfer, domestication or continuance effected.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Neither the CoreWeave certificate of incorporation nor the CoreWeave bylaws address appraisal rights. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">DGCL and who has neither voted in favor of the merger, consolidation, conversion, transfer, domestication or continuance nor consented thereto in writing pursuant to &#167; 228 of the DGCL will be entitled to an appraisal by the Court of Chancery of the fair value of the stockholder&#8217;s shares of stock. Appraisal rights will be available under Delaware law for the shares of any class or series of stock of a constituent, converting, transferring, domesticating or continuing corporation in a merger, consolidation, conversion, transfer, domestication or continuance to be effected, subject to the limitations detailed in &#167; 262 of the DGCL. The DGCL further provides that any corporation may provide in its certificate of incorporation that appraisal rights will be available for the shares of any class or series of its stock as a result of an amendment to its certificate of incorporation, any merger or consolidation in which the corporation is a constituent corporation, the sale of all or substantially all of the assets of the corporation or a conversion effected, or a transfer, domestication or continuance effected.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Neither the Core Scientific certificate of incorporation nor the Core Scientific bylaws address appraisal rights.</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Anti-Takeover Provisions </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">CoreWeave has not opted out of &#167; 203 of the DGCL, which prohibits a defined set of transactions between a Delaware corporation, such as CoreWeave, and an &#8220;interested stockholder.&#8221; An interested stockholder is generally defined as a person who, together with any affiliates or associates of such person &#8220;owns&#8221; (as&#160;defined in &#167; 203 of the DGCL, which includes direct and indirect beneficial ownership) 15% or more of the outstanding voting stock of a Delaware corporation. This provision may prohibit the corporation from engaging in a business combination with an interested stockholder for a period of three years after the time the interested stockholder becomes an interested stockholder. The term &#8220;business combination&#8221; is broadly defined to include a broad array of transactions, including certain mergers, consolidations, sales or other dispositions of assets having an aggregate </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Core Scientific has not opted out of &#167; 203 of the DGCL, which prohibits a defined set of transactions between a Delaware corporation, such as Core Scientific, and an &#8220;interested stockholder.&#8221; An interested stockholder is generally defined as a person who, together with any affiliates or associates of such person &#8220;owns&#8221; (as&#160;defined in &#167; 203 of the DGCL, which includes direct and indirect beneficial ownership) 15% or more of the outstanding voting stock of a Delaware corporation. This provision may prohibit the corporation from engaging in a business combination with an interested stockholder for a period of three years after the time the interested stockholder becomes an interested stockholder. The term &#8220;business&#160;combination&#8221; is broadly defined to include a broad array of transactions, including certain mergers, consolidations, sales or other dispositions of assets having an </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">305<br></div></div></div>
<!--End Page 316-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 317-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">market value of 10% or more of the aggregate market value of the consolidated assets of the corporation or all of the outstanding stock of the corporation, and certain other transactions that would increase the interested stockholder&#8217;s proportionate share ownership in the corporation, result in the interested stockholder&#8217;s acquisition of stock of a direct or indirect majority-owned subsidiary of the corporation or the receipt of the interested stockholder of certain financial benefits. This prohibition is effective unless: (i) the business combination or the transaction that resulted in the stockholder becoming an interested stockholder is approved by the CoreWeave board prior to the time the interested stockholder becomes an interested stockholder; (ii) the interested stockholder acquired at least 85% of the voting stock of CoreWeave not owned by directors who are also officers or by qualified employee stock plans, in the transaction in which it becomes an interested stockholder; or (iii) the business combination is approved by a majority of the CoreWeave board and by the affirmative vote of 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">aggregate market value of 10% or more of the aggregate market value of the consolidated assets of the corporation or all of the outstanding stock of the corporation, and certain other transactions that would increase the interested stockholder&#8217;s proportionate share ownership in the corporation, result in the interested stockholder&#8217;s acquisition of stock of a direct or indirect majority-owned subsidiary of the corporation or the receipt of the interested stockholder of certain financial benefits. This prohibition is effective unless: (i) the business combination or the transaction that resulted in the stockholder becoming an interested stockholder is approved by the Core Scientific board prior to the time the interested stockholder becomes an interested stockholder; (ii) the interested stockholder acquired at least 85% of the voting stock of Core Scientific not owned by directors who are also officers or by qualified employee stock plans, in the transaction in which it becomes an interested stockholder; or (iii)&#160;the business combination is approved by a majority of the Core Scientific board and by the affirmative vote of 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder. </div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholder Vote on Fundamental or Extraordinary Corporate Transactions </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">In addition to any vote required pursuant to applicable law or the CoreWeave certificate of incorporation, the affirmative vote of the holders of a majority of the then-outstanding shares of each series of Common Stock, voting as separate series, is required to approve any merger, consolidation, conversion, transfer, domestication or continuance (whether or not CoreWeave is the surviving entity, a &#8220;Fundamental Change&#8221;) unless the holders of each series of Common Stock, as such, will be entitled to receive equal, identical and ratable per share distributions or payments, if any, in connection with such Fundamental Change; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that, notwithstanding the foregoing, in the case of a distribution or payment in the form of securities in connection with a Fundamental Change, any or all such series of Common Stock may (but is not required to) receive different or disproportionate distributions or payments in the form of securities of CoreWeave or another entity if the only difference among </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Neither the Core Scientific certificate of incorporation nor the Core Scientific bylaws contains voting requirements for approval of mergers, sales or other fundamental or extraordinary corporate transactions that differ from those related to ordinary course corporate actions. </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">306<br></div></div></div>
<!--End Page 317-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 318-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">the securities distributed or paid to each series of Common Stock will be the voting rights thereof, which will be substantially similar to the voting rights of the series of Common Stock in respect of which such securities are distributed or paid; and <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">further</font>, that in the event that the holders of a series of Common Stock are granted rights to elect to receive one of two or more alternative forms of consideration, the holders of each series of Common Stock will be deemed to have received equal, identical and ratable per share distributions or payments in connection with such Fundamental Change if holders of each series of Common Stock are granted substantially similar election rights. Notwithstanding the foregoing, (x)&#160;consideration to be distributed or paid to a holder of Common Stock in connection with any such Fundamental Change pursuant to any employment, consulting, severance or similar services arrangement or (y) a negotiated agreement between a holder of Common Stock and any counterparty (or an &#8220;affiliate&#8221; thereof (as defined pursuant to Rule&#160;405 promulgated under the Securities Act) to a Fundamental Change wherein such holder is contributing, selling, transferring or otherwise disposing of shares of CoreWeave&#8217;s capital stock to such counterparty (or an &#8220;affiliate&#8221; thereof)) as part of a &#8220;rollover&#8221; or similar transaction that is in connection with such Fundamental Change, in each case, will not be deemed to be consideration distributed or paid to the holder of shares of Common Stock for these purposes. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 84pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exclusive Forum </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The CoreWeave bylaws provide that unless CoreWeave consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if such court does not have jurisdiction, the federal district court for the District of Delaware) is the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of CoreWeave, (ii) any action asserting a claim for a breach of a fiduciary duty owed by any director, officer, other employee or agent stockholder of CoreWeave to CoreWeave or CoreWeave&#8217;s stockholders, (iii) any action asserting a claim against CoreWeave or any current or </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">The Core Scientific certificate of incorporation provides that unless Core Scientific consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware (or, if and only if, the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if, all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) and any appellate court therefrom shall be the sole and exclusive forum for the following claims or causes of action brought under Delaware statutory or common law: </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">307<br></div></div></div>
<!--End Page 318-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 319-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_124-comparison_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 84pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">CoreWeave Stockholder Rights</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Stockholder Rights </div></td></tr><tr><td style="width: 84pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">former director, officer, stockholder, employee or agent of CoreWeave arising pursuant to any provision of the DGCL, the CoreWeave certificate of incorporation or the CoreWeave bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, (iv) any action to interpret, apply, enforce or determine the validity of the CoreWeave certificate of incorporation or the CoreWeave bylaws, (v) any action asserting a claim against CoreWeave governed by the internal affairs doctrine, or (vi) any action asserting an &#8220;internal corporate claim&#8221; as that term is defined in &#167; 115 of the DGCL.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">In addition, unless CoreWeave consents in writing to the selection of an alternative forum, the federal district courts of the United States of America are the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 180pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">(i)&#160;any derivative claim or action brought on Core Scientific&#8217;s behalf; (ii) any claim or cause of action asserting a breach of fiduciary duty by any of Core Scientific&#8217;s current or former director, officer or other employee; (iii) any claim or cause of action asserting a claim against Core Scientific arising out of, or pursuant to, the DGCL, the certificate of incorporation or the bylaws; (iv) any claim or cause of action seeking to interpret, apply, enforce or determine the validity of the certificate of incorporation or the bylaws (including any right, obligation, or remedy thereunder); (v) any claim or cause of action as to which the DGCL confers jurisdiction to the Court of Chancery of the State of Delaware; or (vi)&#160;any claim or cause of action asserting a claim against Core Scientific or any of its directors, officers or other employees, that is governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;">In addition, the federal courts of the United&#160;States of America are the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 3.25pt; margin-left: 0pt; text-align: left;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">308<br></div></div></div>
<!--End Page 319-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 320-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_125-ownership_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tBOO"><!--Anchor--></a>BENEFICIAL OWNERSHIP OF SECURITIES </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; text-align: center;"><a name="tSOW"><!--Anchor--></a>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">MANAGEMENT OF COREWEAVE</div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table and accompanying footnotes set forth information regarding (i) the beneficial ownership of CoreWeave as of September 9, 2025, which is prior to the Merger and (ii) the expected beneficial ownership of CoreWeave as of immediately after the consummation of the Merger, with respect to: </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each of CoreWeave&#8217;s current named executive officers and directors at September 9, 2025, each of whom are expected to continue as an executive officer or director of CoreWeave immediately after the consummation of the Merger; </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">all executive officers and directors of CoreWeave as a group at September 9, 2025 and all executive officers and directors of CoreWeave as a group immediately after the consummation of the Merger;</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">each person known by CoreWeave to be the beneficial owner of more than 5% of the outstanding shares of CoreWeave Class&#160;A common stock or Class&#160;B common stock at September 9, 2025 and/or as of immediately after the consummation of the Merger. </div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The amounts and percentages of common stock beneficially owned are reported on the basis of regulations of the SEC governing the determination of beneficial ownership of securities. Under the rules of the SEC, a person is deemed to be a &#8220;beneficial owner&#8221; of a security if that person has or shares &#8220;voting power,&#8221; which includes the power to vote or to direct the voting of the security, or &#8220;investment power,&#8221; which includes the power to dispose of or to direct the disposition of the security. A person is also deemed to be a beneficial owner of any securities of which that person has a right to acquire beneficial ownership within 60 days. Under these rules, more than one person may be deemed a beneficial owner of the same securities and a person may be deemed to be a beneficial owner of securities as to which that person has no economic interest. Except as otherwise noted, the persons and entities listed in the table below have sole voting and investing power with respect to all of the shares of CoreWeave Class&#160;A common stock and/or Class&#160;B commons stock that they beneficially own or will own subject to community property laws where applicable. Unless otherwise indicated, the address of each beneficial owner in the table below is c/o&#160;CoreWeave, Inc., 290 W Mt. Pleasant Ave., Suite 4100, Livingston, NJ 07039. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the Merger, the beneficial ownership information included below has been determined based on 380,162,985 shares of CoreWeave Class&#160;A common stock, 114,939,540 shares of Class&#160;B common stock and no shares of Class&#160;C common stock issued and outstanding as of September 9, 2025. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">After the Merger, the beneficial ownership of CoreWeave Class&#160;A common stock and Class&#160;B common stock set forth in the table below has been determined assuming that there will be 419,744,217 shares of CoreWeave Class A common stock and 114,939,540 shares of Class&#160;B common stock outstanding after the Merger, based on the following assumptions: </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">380,162,985 shares of CoreWeave Class&#160;A common stock and 114,939,540 shares of CoreWeave Class&#160;B common stock outstanding at September 9, 2025 prior to the consummation of the Merger; </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">39,581,232 shares of CoreWeave Class&#160;A common stock issued to Core Scientific stockholders in connection with the consummation of the Merger (assuming the full issuance of 288,460 shares of Core Scientific common stock for disputed claims in connection with Core Scientific&#8217;s Plan of Reorganization but no issuance of Core Scientific common stock pursuant to outstanding CVRs for payments that are not yet payable, and will not become payable, until January&#160;23, 2026 and January&#160;23, 2027); </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">No exercise of the 97,432,201 Tranche 1 Warrants and 12,118,829 Tranche 2 Warrants outstanding as of September 9, 2025 in connection with the consummation of the Merger and no exercise of the 97,432,201 New Tranche 1 Warrants and 12,118,829 New Tranche 2 Warrants immediately after the consummation of the Merger; </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">No conversion of the Core Scientific 2029 Convertible Notes and Core Scientific 2031 Convertible Notes as of September 9, 2025 in connection with the consummation of the Merger and no conversion of such notes immediately after the consummation of the Merger; and </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">309<br></div></div></div>
<!--End Page 320-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 321-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 504pt;"><a name="ny20053122x2_s4a_125-ownership_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 18pt;"> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The directors and executive officers of Core Scientific and 5% or more beneficial owners of Core Scientific common stock as of September 9, 2025 continuing to beneficially own an equal number of Core Scientific common stock as of the date of the Merger, which will be exchanged for CoreWeave Class A common stock in an amount determined pursuant to the exchange ratio. </div></td></tr></table> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If, however, the Merger occurs after the third fiscal quarter of 2025 as is currently expected, a certain number of Core Scientific RSU Awards and Core Scientific PSU Awards held by certain directors and executive officers of Core Scientific may vest prior to the Merger, which would increase their respective individual beneficial ownership in the combined company following the Merger.</div> </div><div class="BRDSX_block-main" style="width: 504pt; margin-left: 0pt;"> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 504pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 73.44pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 77.44pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 28.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 73.44pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 77.44pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 29.61pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 92pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 73.44pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially Owned <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Before <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">the Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class&#160;A </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 77.44pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Owned Before <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">the Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class B </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Voting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">before <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Merger </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 73.44pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially Owned <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">After <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">the Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class&#160;A </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 77.44pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficially Owned <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">After <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">the Merger <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class B </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">%Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Voting <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">after the <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Merger </div></td></tr><tr class="BRDSX_header"><td style="width: 92pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Beneficial Owner </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 1.08pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">% </div></td></tr><tr><td style="width: 92pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Named Executive Officers and Directors:<br></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 1.08pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup> <font style="padding-left: 2.48pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">7,343,688</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.93%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">56,902,460</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">48.67%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">37.20%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">7,343,688</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.75%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">56,902,460</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">48.67%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">36.27%</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brannin McBee<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup> <font style="padding-left: 3.81pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">304,884</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">26,392,480</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">22.82%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">17.19%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">304,884</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">26,392,480</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">22.82%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">16.76%</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Brian Venturo<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup> <font style="padding-left: 4.73pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">879,720</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">38,212,300</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">32.16%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">24.42%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">879,720</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">38,212,300</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">32.16%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">23.82%</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Karen Boone<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup> <font style="padding-left: 2.26pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">15,680</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">15,680</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Jack Cogen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup> <font style="padding-left: 2.58pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">17,129,596</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">4.51%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.12%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">17,129,596</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">4.08%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.09%</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Glenn Hutchins<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup> <font style="padding-left: 4.25pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">399,400</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">399,400</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Margaret C. Whitman<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup> <font style="padding-left: 3.88pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">2,580</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">2,580</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">*</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">All executive officers and directors as a group (10&#160;persons)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup> <font style="padding-left: 1.92pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">27,786,896</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">7.28%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">121,507,240</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">100.00%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">77.83%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">27,786,896</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">6.59%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">121,507,240</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">100.00%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">75.95%</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Other 5% or Greater Stockholders:<br></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#160;</div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Funds or accounts managed or advised by Magnetar Financial LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup> <font style="padding-left: 1.8pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">105,282,503</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">26.81%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">6.83%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">105,282,503</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">24.36%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">6.66% </div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Entities affiliated with FMR LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup> <font style="padding-left: 4.9pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">25,016,051</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">6.58%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.64%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">25,016,051</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">5.96%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.59% </div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">NVIDIA Corporation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup> <font style="padding-left: 3.05pt;"></font></div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">24,182,460</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">6.36%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.58%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">24,182,460</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">5.76%</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.54% </div></td></tr><tr><td style="width: 92pt; padding-top: 0.33pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 8pt; text-indent: -8pt; text-align: left;">Entities affiliated with Jane Street Group LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup> <font style="padding-left: 4.82pt;"></font></div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">19,994,532</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">5.26%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.01pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.31%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">19,994,532</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24.66pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">4.76%</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.66pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">&#8212;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.61pt; padding-top: 0.33pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; text-align: right;">1.27%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.25pt; width: 92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 24.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 28.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 28.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 24.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 40pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 28.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 4.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.25pt; width: 29.61pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div><div class="BRDSX_block-main" style="width: 468pt; margin-left: 18pt;"><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-top: 3pt; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt;"> </div></div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1%</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">This table is based on information supplied by officers and directors and principal stockholders of CoreWeave and Schedules 13D and 13G and Forms 3 and 4 filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, CoreWeave believes that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 7,153,330 shares of CoreWeave Class A common stock directly held by Michael Intrator; (ii) 21,867,489 shares of CoreWeave Class B common stock directly held by Mr. Intrator; (iii) 1,980,900 shares of CoreWeave Class B common stock issuable upon the exercise of stock options directly held by Mr. Intrator which are exercisable within 60 days of September 9, 2025; (iv) 140,358 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025; (v) 365,200 shares of CoreWeave Class B common stock directly held by Mr. Intrator&#8217;s spouse; (vi) 50,000 shares of CoreWeave Class A common stock directly held by Omnadora Capital LLC (&#8220;Omnadora&#8221;); (vii) 25,549,280 shares of CoreWeave Class B common stock directly held by Omnadora; (viii) 266,031 shares of CoreWeave Class B common stock directly held by the PMI 2024 F&amp;F GRAT (&#8220;PMI&#8221;), (ix) 7,240 shares of CoreWeave Class B common stock directly held by the Silver Thimble Resulting Trust (&#8220;Silver Thimble&#8221;); (x) 4,576,000 shares of CoreWeave Class B common stock directly held by the Intrator Family GST-Exempt Trust (the &#8220;Intrator GST Trust&#8221;); and (xi) 2,290,320 shares of CoreWeave Class B common stock directly held by the Intrator Family Trust (together with the Intrator GST Trust, the &#8220;Intrator Family Trusts&#8221;). Mr. Intrator serves as the sole manager of Omnadora Management LLC, which is the manager of Omnadora, and therefore may be deemed to exercise voting and investment discretion over securities held by Omnadora. Mr. Intrator&#8217;s spouse is the trustee of PMI and co-trustee of the Intrator Family Trusts and may be deemed to exercise voting and investment discretion over securities held by them. Mr. Intrator serves as the sole manager of Copper Thimble LLC, which is the investment manager of Silver Thimble, and therefore may be deemed to exercise voting and investment discretion over securities held by Silver Thimble. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 121,965 shares of CoreWeave Class A common stock directly held by Brannin McBee; (ii) 10,642,260 shares of CoreWeave Class B common stock directly held by Mr. McBee; (iii) 705,900 shares of CoreWeave Class B common stock issuable upon the exercise of stock options directly held by Mr. McBee which are exercisable within 60 days of September 9, 2025; (iv) 121,119 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025; (v) 2,300,300 shares of CoreWeave Class B common stock directly held by Mr. McBee&#8217;s spouse; (vi) 5,166,020 shares of CoreWeave Class B common stock directly held by the Brannin J. McBee 2022 Irrevocable Trust (&#8220;McBee Trust&#8221;); (vii) 6,000,000 shares of CoreWeave Class B common stock directly held by the Canis Major 2025 GRAT (the &#8220;Canis Major GRAT&#8221;); (viii) 104,000 shares of CoreWeave Class B common stock directly held by the Canis Major 2025 Family Trust LLC (&#8220;Canis Major LLC&#8221;); (ix) 360,000 shares of CoreWeave </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 18pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">310<br></div> </div></div>
<!--End Page 321-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 322-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_125-ownership_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 5.25pt; margin-left: 20pt; text-align: justify;">Class B common stock directly held by the Canis Major 2024 Irrevocable Trust LLC (&#8220;Canis 2024 LLC&#8221;); (x) 1,000,000 shares of CoreWeave Class B common stock directly held by the Canis Minor 2025 GRAT (the &#8220;Canis Minor GRAT&#8221;); (xi) 114,000 shares of CoreWeave Class B common stock directly held by the Canis Minor 2025 Family Trust LLC (the &#8220;Canis Minor LLC&#8221;); (xii) 1,800 shares of CoreWeave Class A common stock directly held by Mr. McBee&#8217;s minor child; and (xiii) 60,000 shares of CoreWeave Class A common stock directly held by the Canis Major SM Trust (the &#8220;Canis SM Trust&#8221;). Mr. McBee&#8217;s spouse serves as trustee of the McBee Trust and the Canis Minor GRAT and may be deemed to exercise voting and investment discretion over securities held by each of them. Mr. McBee serves as trustee of the Canis Major GRAT, and as manager of each of Canis Major LLC, Canis Minor LLC, and Canis 2024 LLC, and, therefore, may be deemed to exercise voting and investment discretion over securities held by each of them. Mr. McBee may be deemed to have beneficial ownership with respect to the shares of CoreWeave Class A common stock directly held by the Canis SM Trust by virtue of his power to replace its professional trustee.</div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 240,331 shares of CoreWeave Class A common stock directly held by Brian Venturo; (ii) 14,593,347 shares of CoreWeave Class B common stock directly held by Mr. Venturo; (iii) 3,880,900 shares of CoreWeave Class B common stock issuable upon the exercise of stock options directly held by Mr. Venturo which are exercisable within 60 days of September 9, 2025; (iv) 126,771 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025; (v) 2,001,900 shares of CoreWeave Class B common stock directly held by Mr. Venturo&#8217;s spouse; (vi) 6,274,500 shares of CoreWeave Class B common stock directly held by West Clay Capital LLC (&#8220;West Clay&#8221;); (vii) 5,402,057 shares of CoreWeave Class B common stock directly held by the 2023 Venturo Family GRAT dated June 30, 2023 (&#8220;Venturo GRAT I&#8221;); (viii) 1,788,596 shares of CoreWeave Class B common stock directly held by the Venturo Family 2024 Friends and Family GRAT (&#8220;Venturo GRAT II&#8221;); (ix) 4,271,000 shares of CoreWeave Class B common stock directly held by the Venturo Family GST Exempt Trust dated June 30, 2023 (the &#8220;Venturo GST Trust&#8221;); (x) 22,500 shares of CoreWeave Class A common stock directly held by Mr. Venturo&#8217;s father-in-law, who is a member of his household; (xi) 245,059 shares of CoreWeave Class A common stock directly held by the YOLO ECV Trust; and (xii) 245,059 shares of CoreWeave Class A common stock directly held by the YOLO APV Trust. Mr. Venturo serves as managing member of West Clay and as trustee of Venturo GRAT I and Venturo GRAT II and may be deemed to exercise voting and investment discretion over securities held by each of them. Mr. Venturo&#8217;s spouse serves as trustee of the Venturo GST Trust and may be deemed to exercise voting and investment discretion over securities held by it. Mr. Venturo may be deemed have beneficial ownership with respect to the shares of CoreWeave Class A common stock directly held by the YOLO ECV Trust and the YOLO APV Trust, by virtue of his power to replace their independent trustee.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 3,440 shares of CoreWeave Class A common stock directly held by Karen Boone; (ii) 1,720 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025; and (iii) 10,520 shares of CoreWeave Class A common stock directly held by The Boone Family Trust, dated August 6, 2015 (the &#8220;Boone Trust&#8221;). Karen Boone and her spouse are co-trustees of the Boone Trust and as such may be deemed to exercise voting and investment discretion over securities held by it. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 261,140 shares of CoreWeave Class A common stock directly held by Jack Cogen; (ii) 136,560 shares of CoreWeave Class A common stock directly held by Mr. Cogen&#8217;s spouse; (iii) 1,200,000 shares of CoreWeave Class A common stock directly held by the Cogen Family Trust, dated December 17, 2012 (&#8220;Cogen 2012 Trust&#8221;); (iv) 19,200 shares of CoreWeave Class A common stock directly held by the Jack D. Cogen 2020 Family Trust (&#8220;Cogen 2020 Trust&#8221;); (v) 126,220 shares of CoreWeave Class A common stock directly held by the Cherry Tree 2024 GRAT; (vi) 10,329,676 shares of CoreWeave Class A common stock directly held by CW Holding 987 LLC; (vii) 654,200 shares of CoreWeave Class A common stock directly held by Birch Tree Trust LLC; (viii) 654,200 shares of CoreWeave Class A common stock directly held by Chestnut Tree Trust LLC; (ix) 654,200 shares of CoreWeave Class A common stock directly held by Maple Tree Trust LLC; (x) 654,200 shares of CoreWeave Class A common stock directly held by Willow Tree Trust LLC; (xi) 110,000 shares of CoreWeave Class A common stock directly held by Birch Br Trust LLC; (xii) 110,000 shares of CoreWeave Class A common stock directly held by Chestnut Br Trust LLC; (xiii) 110,000 shares of CoreWeave Class A common stock directly held by Maple Br Trust LLC; (xiv) 110,000 shares of CoreWeave Class A common stock directly held by Willow Br Trust LLC; and (xv) 2,000,000 shares of CoreWeave Class A common stock directly held by Pine Tree Trust LLC (together with Birch Tree Trust LLC, Chestnut Tree Trust LLC, Maple Tree Trust LLC, Willow Tree Trust LLC, Birch Br Trust LLC, Chestnut Br Trust LLC, Maple Br Trust LLC, and Willow Br Trust LLC, the &#8220;Tree LLCs&#8221;). Mr. Cogen&#8217;s spouse is co-trustee of the Cogen 2012 Trust and as such may be deemed to exercise shared voting and investment discretion over securities held by it. Mr. Cogen may be deemed have beneficial ownership with respect to the shares of our Class A common stock directly held by the Cogen 2020 Trust, by virtue of his power to replace its trustee. Mr. Cogen serves as trustee of the Cherry Tree 2024 GRAT and as manager of CW Holding 987 LLC and each of the Tree LLCs and may be deemed to exercise voting and investment discretion over securities held by each of them.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 3,920 shares of CoreWeave Class A common stock directly held by Glenn Hutchins; (ii) 10,640 shares of CoreWeave Class A common stock directly held by North Island Inferno Fund II LLC (&#8220;North Island Inferno&#8221;); and (iii) 384,840 shares of CoreWeave Class A common stock directly held by Tide Mill LLC (&#8220;Tide Mill&#8221;). Mr. Hutchins serves as investment manager for North Island Inferno and as such may be deemed to exercise shared voting and investment discretion over securities held by it. The managing member of Tide Mill is North Island Management, LLC (&#8220;NIM&#8221;). Mr. Hutchins serves as chairman of NIM and may be deemed to directly or indirectly exercise voting and investment discretion over the investments of Tide Mill. The business address of each of the aforementioned parties is: 330&#160;Madison Avenue, 33rd Floor, New York, NY 10017.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Consists of (i) 1,280 shares of CoreWeave Class A common stock directly held by Margaret C. Whitman; and (ii) 1,300 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The reported amounts represent the total of all securities beneficially owned by our directors and officers, consisting of (i) 26,096,801 shares of CoreWeave Class A common stock; (ii) 114,939,540 shares of CoreWeave Class B common stock; (iii) 1,176,487 shares of CoreWeave Class A common stock issuable upon the exercise of stock options which are exercisable within 60 days of September 9, 2025; (iv)&#160;6,567,700 shares of CoreWeave Class B common stock issuable upon the exercise of stock options which are exercisable within 60 days of September&#160;9, 2025; and (v) 513,608 shares of CoreWeave Class A common stock issuable upon the vesting and settlement of restricted stock units within 60 days of September 9, 2025.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a statement filed on Schedule 13G with the SEC on April 1, 2025 by Magnetar Financial LLC (&#8220;MFL&#8221;), Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman (collectively, with MFL, &#8220;Magnetar&#8221;), as well as a Form 4 filed by Magnetar on September 9, 2025, and Forms 3, as amended (collectively, the &#8220;Section 16 Reports&#8221;), filed with respect to transaction date March 27, 2025, by Magnetar, CW Opportunity LLC (&#8220;CW Opportunity&#8221;), and Magnetar Structured Credit Fund LP (&#8220;Magnetar SCF&#8221; and, together with Magnetar and CW Opportunity, the &#8220;Magnetar Entities&#8221;). Pursuant to the aforementioned disclosures, the securities reported as beneficially owned by the Magnetar Entities consist of (i) 7,140,206 shares of CoreWeave Class A common stock directly held by CW Opportunity 2 LP; (ii) 28,839,164 shares of CoreWeave Class A common stock directly held by CW Opportunity; (iii) 2,445,023 shares of CoreWeave Class A common stock and 1,335,913 shares of CoreWeave Class A common stock issuable upon the exercise of warrants </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"> <div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">311<br></div> </div></div>
<!--End Page 322-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 323-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_125-ownership_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_ftnote" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 5.25pt; margin-left: 20pt; text-align: justify;">directly held by Magnetar Alpha Star Fund LLC; (iv) 390,913 shares of CoreWeave Class A common stock directly held by Magnetar Capital Master Fund, Ltd; (v) 6,970,919 shares of CoreWeave Class A common stock and 1,457,361 shares of CoreWeave Class A common stock issuable upon the exercise of warrants directly held by Magnetar Constellation Master Fund Ltd; (vi) 8,901,058 shares of CoreWeave Class A common stock, 2,550,383 shares of CoreWeave Class A common stock issuable upon the exercise of warrants, and 119,625 shares of CoreWeave Class A common stock issuable upon the exercise of stock options directly held by Magnetar Lake Credit Fund LLC; (vii) 9,827,219 shares of CoreWeave Class A common stock, 242,891 shares of CoreWeave Class A common stock issuable upon the exercise of warrants, and 16,500 shares of CoreWeave Class A common stock issuable upon the exercise of stock options directly held by Magnetar Longhorn Fund LP; (viii) 1,941,236 shares of CoreWeave Class A common stock and 1,335,913 shares of CoreWeave Class A common stock issuable upon the exercise of warrants directly held by Magnetar SC Fund Ltd; (ix) 11,429,982 shares of CoreWeave Class A common stock, 728,678 shares of CoreWeave Class A common stock issuable upon the exercise of warrants, and 179,250 shares of CoreWeave Class A common stock issuable upon the exercise of stock options directly held by Magnetar SCF; (x) 4,932,036 shares of CoreWeave Class A common stock and 2,671,831 shares of CoreWeave Class A common stock issuable upon the exercise of warrants directly held by Magnetar Xing He Master Fund Ltd; (xi) 4,373,797 shares of CoreWeave Class A common stock, 1,700,255 shares of CoreWeave Class A common stock issuable upon the exercise of warrants, and 51,375 shares of CoreWeave Class A common stock issuable upon the exercise of stock options directly held by Purpose Alternative Credit Fund - F LLC; (xii) 1,153,675 shares of CoreWeave Class A common stock, 121,443 shares of CoreWeave Class A common stock issuable upon the exercise of warrants, and 8,250 shares of CoreWeave Class A common stock issuable upon the exercise of stock options directly held by Purpose Alternative Credit Fund - T LLC; and (xiii) 4,417,607 shares of CoreWeave Class A common stock directly held by Longhorn Special Opportunities Fund LP. Pursuant to the statement filed by Magnetar on Schedule 13G, Magnetar reported shared dispositive and voting power with respect to the securities collectively held by Magnetar and sole dispositive and voting power with respect to no securities. Pursuant to the Section 16 Reports, MFL, which is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940, as amended, serves as investment adviser to each of CW Opportunity, CW Opportunity 2 LP, Magnetar Capital Master Fund, Ltd, Magnetar Constellation Master Fund, Ltd, Magnetar Longhorn Fund LP, Magnetar SC Fund Ltd, Magnetar Xing He Master Fund Ltd, Purpose Alternative Credit Fund - F LLC, Purpose Alternative Credit Fund - T LLC, and Longhorn Special Opportunities Fund LP. MFL is the general partner of Magnetar SCF and the manager of Magnetar Alpha Star Fund LLC and Magnetar Lake Credit Fund LLC. In such capacities, MFL may be deemed to indirectly exercise investment and voting discretion over securities directly held by them. Magnetar Capital Partners LP is the sole member and parent holding company of MFL. Supernova Management LLC is the general partner of Magnetar Capital Partners LP. David J. Snyderman is the manager of Supernova Management LLC. As such, each of Magnetar Capital Partners LP, Supernova Management LLC, and Mr. Snyderman may be deemed to indirectly exercise investment and voting discretion over securities directly held by each of the securityholders listed in this footnote (10). The business address of each of the aforementioned parties is 1603 Orrington Avenue, 13th Floor, Evanston, IL 60201.</div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based solely on Amendment No. 1 to its statement filed with the SEC on August 6, 2025 on Schedule 13G by FMR LLC and Abigail P. Johnson (together, &#8220;FMR&#8221;), for themselves and on behalf of the following subsidiaries or affiliates of FMR: (i) FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Management &amp; Research Company LLC, and Strategic Advisers LLC, each as a beneficial owner in its capacity as a registered investment adviser, and (ii) Fidelity Institutional Asset Management Trust Company and Fidelity Management Trust Company, each as a beneficial owner in its capacity as a bank. Pursuant to the aforementioned statement, FMR LLC reported sole dispositive power over 25,016,050.65 shares of CoreWeave Class A common stock, sole voting power over 24,219,215.45 shares of CoreWeave Class A common stock, and shared dispositive or voting power over no securities. Ms. Johnson reported sole dispositive power over 25,016,050.65 shares of CoreWeave Class A common stock, and shared voting power and sole dispositive or voting power over no securities. Additionally, pursuant to the statement, members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#8217; voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#8217; voting agreement, members of the Johnson family may be deemed, under the Investment Advisers Act of 1940, as amended, to form a controlling group with respect to FMR LLC. The business address of each of the aforementioned parties is 245 Summer Street, Boston, Massachusetts 02210.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(12)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based solely on a statement filed with the SEC on May 15, 2025 on Schedule 13G by NVIDIA Corporation (&#8220;NVIDIA&#8221;). Pursuant to the statement, NVIDIA reported sole dispositive and voting power with respect to 24,182,460 shares of CoreWeave Class A common stock and shared dispositive or voting power with respect to no securities. The business address of NVIDIA is 2788 San Tomas Expressway, Santa Clara, California 95051.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(13)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based solely on a statement filed with the SEC on August 20, 2025 on Schedule 13G by Jane Street Group, LLC (&#8220;JS Group&#8221;), Jane Street Capital, LLC (&#8220;JS Capital&#8221;), Jane Street Options, LLC (&#8220;JS Options&#8221;), Jane Street Global Trading, LLC (&#8220;JS Trading&#8221;) and Jane Street Singapore Pte. Ltd (&#8220;JS Singapore&#8221;). Pursuant to the statement: (i) JS Group reported shared dispositive and voting power over 19,994,532 shares of CoreWeave Class A common stock and sole dispositive or voting power over no securities, (ii) JS Capital reported shared dispositive and voting power over 1,875,086 shares of CoreWeave Class A common stock and sole dispositive or voting power over no securities, (iii) JS Options reported shared dispositive and voting power over 11,049,400 shares of CoreWeave Class A common stock and sole dispositive or voting power over no securities, (iv) JS Trading reported shared dispositive and voting power over 5,693,017 shares of CoreWeave Class A common stock and sole dispositive or voting power over no securities, and (v) JS Singapore reported shared dispositive and voting power over 1,377,029 shares of CoreWeave Class A common stock and sole dispositive or voting power over no securities. The business address of JS Group, JS Capital, JS Options, and JS Trading is: 250 Vesey Street, 6th Floor, New York, NY 10281, and the business address of JS Singapore is: c/o Tricor Evatthouse Corporate Services (A division of Tricor Singapore Pte Ltd), 80 Robinson Road #02-00, Singapore 068898. </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">312<br></div></div></div>
<!--End Page 323-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 324-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_125-ownership_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSOS"><!--Anchor--></a>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">MANAGEMENT OF CORE&#160;SCIENTIFIC </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth certain information regarding the ownership of Core Scientific common stock as of September 11, 2025 by: (i) each director of Core Scientific; (ii) each named executive officer of Core Scientific; (iii)&#160;all current executive officers and directors of Core Scientific as a group; and (iv) all those known by Core Scientific to be beneficial owners of more than five percent of its common stock. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Core Scientific has determined beneficial ownership in accordance with the rules and regulations of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, Core Scientific believes, based on information furnished to Core Scientific, that the persons and entities named in the table below have sole voting and sole investment power with respect to all shares that they beneficially own, subject to applicable community property laws. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Applicable percentages are based on 306,833,449 shares of Core Scientific common stock outstanding on September 11, 2025 and does not include 97,432,201 Tranche 1 Warrants and 11,987,114 Tranche 2 Warrants outstanding on that date. In computing the number of shares beneficially owned by a person and the percentage ownership of such person, Core Scientific deemed to be outstanding all shares of Core Scientific common stock issuable upon the exercise of Tranche 1 Warrants and Tranche 2 Warrants held by such person and shares subject to any Core Scientific RSU Awards held by such person that would vest based on service-based vesting conditions within 60 days of September 11, 2025. Except as described above, Core Scientific did not deem such shares outstanding for the purpose of computing the percentage ownership of any other person. </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Unless otherwise noted below, the address of each stockholder below is c/o Core Scientific, Inc., 838 Walker Road, Suite 21-2105, Dover, Delaware 19904. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 116.44pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 116.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Beneficial Ownership of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Core Scientific Common Stock </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name of Beneficial Owner</div></td><td style="width: 7.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 7.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Percent of <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Directors and Named Executive Officers:<br></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adam Sullivan<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup><font style="padding-left: 3.66pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 5pt;">1,292,635</font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">* </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Todd M. DuChene<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup><font style="padding-left: 3.53pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 5pt;">1,439,132</font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">* </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Denise Sterling<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup><font style="padding-left: 2pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 12.5pt;">713,222</font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">*</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">James P. Nygaard, Jr.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup><font style="padding-left: 2.29pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 12.5pt;">335,002</font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">* </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Jeff Booth<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup><font style="padding-left: 2.17pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 17.5pt;">47,793</font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">* </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Jordan Levy<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup><font style="padding-left: 4.22pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 12.5pt;">158,993</font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">* </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Yadin Rozov<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup><font style="padding-left: 1.88pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 12.5pt;">107,793</font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">*</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Eric Weiss<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup><font style="padding-left: 1.31pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 17.5pt;">73,793</font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;"><font style="padding-left: 12.5pt;">*</font> </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">All current directors and executive officers as a group (7 individuals)<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;"><font style="padding-left: 5pt;">3,455,141</font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">1.1% </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">5% Stockholders<br></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">The Vanguard Group<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup><font style="padding-left: 0.11pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;">27,249,215</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">8.9% </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">BlackRock, Inc.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup><font style="padding-left: 0.75pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;">23,299,564</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">7.6% </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Two Seas Capital LP<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup><font style="padding-left: 4.51pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;">19,122,842</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">6.2%</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">G1 Execution Services, LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup><font style="padding-left: 2.99pt;"></font></div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;">18,336,176</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">6.0%</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Situational Awareness LP<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup><font style="padding-left: 1.95pt;"></font></div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.26pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.14pt; text-align: left;">17,682,918</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.64pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.58pt; text-align: left;">5.8%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.64pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Less than 1%</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">This table is based on information supplied by officers and directors and principal stockholders of Core Scientific and Schedules 13D and 13G and Forms 3 and 4 filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, Core Scientific believes that each of the stockholders named in the table has sole voting and investment power with respect to the shares indicated as beneficially owned.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents 1,118,531 shares of Core Scientific common stock owned by Mr. Sullivan and 114,364 Tranche 1 Warrants which are exercisable into shares of Core Scientific common stock at $6.81 per share and 59,740 shares of Core Scientific common stock issuable within 60 days of September 11, 2025.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents 881,090 shares of Core Scientific common stock owned by Mr.&#160;DuChene, 537,133 Tranche 1 Warrants which are exercisable into shares of Core Scientific common stock at $6.81 per share and 20,909 shares of Core Scientific common stock issuable within 60 days of September 11, 2025.</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">313<br></div></div></div>
<!--End Page 324-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 325-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_125-ownership_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 5.25pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents 461,446 shares of Core Scientific common stock owned by Ms. Sterling, 123,696 Tranche 1 Warrants which are exercisable into shares of Core Scientific common stock at $6.81 per share, 103,080 Tranche 2 Warrants which are exercisable into shares of Core Scientific common stock at $.01 per share and 25,000 shares of common stock issuable within 60 days of September 11, 2025.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Represents 201,645 shares of Core Scientific common stock owned by Mr. Nygaard and 133,357 Tranche 1 Warrants which are exercisable into shares of Core Scientific common stock at $6.81 per share.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(6)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 47,793 shares of Core Scientific common stock owned by Mr.&#160;Booth.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(7)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 158,993 shares of Core Scientific common stock owned by Mr. Levy.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(8)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 107,793 shares of Core Scientific common stock owned by Mr. Rozov.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(9)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Represents 73,793 shares of Core Scientific common stock owned by Mr. Weiss.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(10)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a Schedule 13G filed with the SEC by The Vanguard Group on July&#160;29, 2025. Of the shares of Core Scientific common stock beneficially owned, The Vanguard Group reported that it has sole dispositive power with respect to 26,589,700 shares, shared dispositive power with respect to 659,515 shares, sole voting power with respect to 0 shares, and shared voting power with respect to 306,408 shares. The Vanguard Group listed its principal place of business as 100 Vanguard Blvd., Malvern, PA 19355.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(11)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a Schedule 13G filed with the SEC by BlackRock, Inc. on July&#160;16, 2025. Of the shares of Core Scientific common stock beneficially owned, BlackRock, Inc. reported that it has sole dispositive power with respect to 23,299,564 shares, shared dispositive power with respect to 0 shares, sole voting power with respect to 22,773,781 shares, and shared voting power with respect to 0 shares. BlackRock, Inc. listed its principal place of business as 50 Hudson Yards, New York, New York 10001.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(12)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a Schedule 13D filed with the SEC by Two Seas Capital LP, Two Seas Capital GP LLC and Sina Toussi (together, &#8220;Two Seas&#8221;) on August&#160;8, 2025. Of the shares of Core Scientific common stock beneficially owned, Two Seas reported that it has sole dispositive power with respect to 19,122,842 shares, shared dispositive power with respect to 0 shares, sole voting power with respect to 19,122,842 shares, and shared voting power with respect to 0 shares. Two Seas listed its principal place of business as 32 Elm Place, 3<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">rd</sup> Floor, Rye, New York 10580.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(13)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a Schedule 13G filed with the SEC by G1 Execution Services, LLC, SIG Brokerage, LP, Susquehanna Investment Group and Susquehanna Securities, LLC on August 14, 2025. Of the shares of Core Scientific common stock beneficially owned, (i) G1 Execution Services, LLC reported that it has sole dispositive power with respect to 997 shares, shared dispositive power with respect to 18,336,176&#160;shares, sole voting power with respect to 997 shares, and shared voting power with respect to 18,336,176 shares; (ii)&#160;SIG&#160;Brokerage, LP reported that it has sole dispositive power with respect to 93,916 shares, shared dispositive power with respect to 18,336,176 shares, sole voting power with respect to 93,916 shares, and shared voting power with respect to 18,336,176 shares; (iii)&#160;Susquehanna Investment Group reported that it has sole dispositive power with respect to 1,492,600 shares, shared dispositive power with respect to 18,336,176 shares, sole voting power with respect to 1,492,600 shares, and shared voting power with respect to 18,336,176&#160;shares; and (iv) Susquehanna Securities, LLC reported that it has sole dispositive power with respect to 16,748,663 shares, shared dispositive power with respect to 18,336,176 shares, sole voting power with respect to 16,748,663 shares, and shared voting power with respect to 18,336,176 shares. G1 Execution Services, LLC listed its principal place of business as 175 W. Jackson Blvd., Suite 1700, Chicago, IL 60604. SIG Brokerage, LP, Susquehanna Investment Group and Susquehanna Securities, LLC each listed their principal place of business as 401 E. City Avenue, Suite 220, Bala Cynwyd, PA 19004.</div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(14)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Based on a Schedule 13D filed with the SEC by Situational Awareness LP, SAI AI GP LP, Situational Awareness LLC, Situational Awareness Partners LP, Leopold Aschenbrenner and Carl Shulman (together, &#8220;Situational Awareness&#8221;) on August 19, 2025. Of the shares of Core Scientific common stock beneficially owned, Situational Awareness reported that it has sole dispositive power with respect to 0 shares, shared dispositive power with respect to 17,682,918 shares, sole voting power with respect to 0 shares, and shared voting power with respect to 17,682,918 shares. Situational Awareness listed its principal place of business as 512 Second Street, Suite 400, San Francisco, CA 94107.</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; margin-left: 0pt; text-align: left;">Section&#160;16(a) Beneficial Ownership Reporting Compliance </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section&#160;16(a) of the Exchange Act requires Core Scientific&#8217;s directors, officers and beneficial owners of more than 10% of a registered class of Core Scientific&#8217;s equity securities to file initial reports of ownership and reports of changes in ownership with the SEC. Such persons are also required to furnish Core Scientific with copies of all Section&#160;16(a) reports they file. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based solely on Core Scientific&#8217;s review of the copies of such reports received by Core Scientific in the year ended December&#160;31, 2024, or written representations from certain reporting persons, Core Scientific believes that no director, officer or beneficial owner of more than 10% of the outstanding Core Scientific common stock failed to file on a timely basis the reports required under Section&#160;16(a) of the Exchange Act during the year ended December&#160;31, 2024, except for the Form&#160;4 for an Core Scientific RSU Award grant to Denise Sterling, Core Scientific&#8217;s former Executive Vice President, Chief Financial Officer in connection with her transition agreement entered into with Core Scientific which was filed fifteen business days late.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">314<br></div></div></div>
<!--End Page 325-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 326-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_126-expert_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tEXP"><!--Anchor--></a>EXPERTS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of CoreWeave, Inc. as of December&#160;31, 2024 and 2023, and for each of the two years in the period ended December&#160;31, 2024, included in this proxy statement/prospectus, have been audited by Deloitte&#160;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are included in reliance upon the report of such firm given their authority as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The financial statements of CoreWeave, Inc. for the year ended December&#160;31, 2022 included in this proxy statement/prospectus have been audited by RSM US LLP, an independent registered public accounting firm, as stated in their report. Such financial statements are included in reliance upon the report of such firm given their authority as experts in accounting and auditing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The consolidated financial statements of Core Scientific appearing in Core Scientific&#8217;s Annual Report (Form&#160;10-K) for the year ended December&#160;31, 2024, and the effectiveness of Core Scientific&#8217;s internal control over financial reporting as of December&#160;31, 2024 have been audited by Marcum LLP, independent registered public accounting firm, as set forth in its reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given on the authority of such firm as an expert in accounting and auditing. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; text-align: center;"><a name="tLM"><!--Anchor--></a>LEGAL MATTERS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The validity of the shares of CoreWeave common stock to be issued to Core Scientific stockholders pursuant to the Merger will be passed upon by Davis Polk &amp; Wardwell LLP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain U.S. federal income tax consequences relating to the transactions will be passed upon for CoreWeave by Davis Polk&#160;&amp; Wardwell LLP, counsel to CoreWeave, and for Core Scientific by Wachtell, Lipton, Rosen&#160;&amp; Katz, counsel to Core Scientific. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18pt; text-align: center;"><a name="tFCS"><!--Anchor--></a>FUTURE CORE SCIENTIFIC STOCKHOLDER PROPOSALS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger Agreement is approved by the requisite vote of Core Scientific&#8217;s stockholders and the Merger is completed, Core Scientific will become a wholly owned subsidiary of CoreWeave and, consequently, will not hold subsequent annual meetings of its stockholders. After the completion of the Merger, Core Scientific stockholders would be entitled to participate, as stockholders of CoreWeave following the Merger, in the annual meetings of the stockholders of CoreWeave. CoreWeave and Core Scientific currently expect to complete the Merger in the fourth quarter of 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the Merger Agreement is not adopted by the requisite vote of holders of Core Scientific common stock or if the Merger is otherwise not completed for any reason in 2025, Core Scientific intends to hold an annual meeting of its stockholders in 2026. Core Scientific&#8217;s proxy statement for the 2025 annual meeting of Core Scientific stockholders contained information regarding presentation of stockholder proposals under Rule&#160;14a-8 or other business or nominations at a 2026 annual meeting of Core Scientific stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Any Core Scientific stockholder who desires to submit a proposal for action at the 2026 annual meeting of Core Scientific stockholders and wishes to have the proposal (&#8220;Rule&#160;14a-8 Proposal&#8221;) included in Core Scientific&#8217;s proxy materials must follow the procedures set forth in Rule&#160;14a-8 under the Exchange Act and must submit the Rule&#160;14a-8 Proposal in writing to Core Scientific&#8217;s Corporate Secretary at its principal executive offices no later than November&#160;28, 2025, in addition to complying with certain rules and regulations promulgated by the SEC. Only those Rule&#160;14a-8 Proposals that are timely received by Core Scientific and proper for stockholder action (and otherwise proper) will be included in Core Scientific&#8217;s proxy materials. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Alternatively, in accordance with the advance notice provisions of the Core Scientific bylaws, stockholders seeking to present a stockholder proposal or nomination at the 2026 annual meeting of Core Scientific stockholders, without having it included in Core Scientific&#8217;s proxy materials, must timely submit notice of such proposal or nomination. To be timely, a stockholder&#8217;s notice must be received in writing by Core Scientific&#8217;s Corporate Secretary at its principal executive offices not later than the close of business on the 90<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day, nor earlier than the close of business on the 120<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day, before the first anniversary of the 2025 annual meeting of Core Scientific stockholders, unless the date of the 2026 annual meeting of Core Scientific stockholders is advanced by more than 30 days or delayed by more than 70 days from the anniversary of the 2025 annual meeting of Core Scientific stockholders. For the 2026 annual meeting of Core Scientific stockholders, this means that any such proposal or nomination must be </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">315<br></div></div></div>
<!--End Page 326-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 327-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_126-expert_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">submitted no earlier than January&#160;12, 2026 and no later than February&#160;11, 2026. If the date of the 2026 annual meeting of Core Scientific stockholders is advanced by more than 30 days or delayed by more than 70 days from the anniversary of the 2025 annual meeting of Core Scientific stockholders, the stockholder must submit any such proposal or nomination no earlier than the close of business on the 120<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day prior to the 2026 annual meeting of Core Scientific stockholders and not later than the close of business on the later of the 90<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day prior to the 2026 annual meeting of Core Scientific stockholders or the 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day following the day on which public announcement of the date of the 2026 annual meeting of Core Scientific stockholders is first made by Core Scientific. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to satisfying the deadlines in the advance notice provisions of the Core Scientific bylaws, to comply with the universal proxy rules, a Core Scientific stockholder who intends to solicit proxies in support of nominees submitted under these advance notice provisions must include in their notice the information required by Rule&#160;14a-19 under the Exchange Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notice of any proposals or nominations for the 2026 annual meeting of Core Scientific stockholders should be sent to Core Scientific&#8217;s Corporate Secretary at c/o Core Scientific, Inc., 838 Walker Road, Suite 21-2105, Dover, Delaware 19904. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tHHO"><!--Anchor--></a>HOUSEHOLDING OF PROXY MATERIALS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Special Meeting materials with respect to two or more stockholders sharing the same address by delivering a single set of Special Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the Special Meeting, a number of brokers with accountholders who are Core Scientific stockholders will be &#8220;householding&#8221; Core Scientific&#8217;s Special Meeting materials. These brokers will deliver one copy of this proxy statement/prospectus to stockholders that share an address, unless contrary instructions have been received from the affected stockholders. Once a broker notifies stockholders that the broker will be &#8220;householding&#8221; communications, &#8220;householding&#8221; will continue until the affected stockholders are notified otherwise or revoke their consent. If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Special Meeting materials, please notify your broker or Core Scientific, Inc. Direct your written request to 838&#160;Walker Road, Suite&#160;21-2105, Dover, Delaware 19904, Attn: Corporate Secretary, or call (512)&#160;402-5233. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">316<br></div></div></div>
<!--End Page 327-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 328-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_127-info_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tWYC"><!--Anchor--></a>WHERE YOU CAN FIND MORE INFORMATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave and Core Scientific file annual, quarterly and special reports, proxy statements and other information with the SEC. The SEC maintains a website that has reports, proxy and information statements and other information about CoreWeave and Core Scientific. The address of that site is https://www.sec.gov. The reports and other information filed by CoreWeave and Core Scientific with the SEC are also available at their respective websites, which are https://investors.coreweave.com/ and https://investors.corescientific.com/. Information on these websites is not part of this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has filed a registration statement on Form&#160;S-4 to register with the SEC the shares of CoreWeave common stock and CoreWeave warrants to be issued to Core Scientific stockholders in connection with the Merger. This proxy statement/prospectus is a part of that registration statement and constitutes a prospectus of CoreWeave in addition to being the proxy statement of Core Scientific for the Special Meeting. The registration statement, including the attached exhibits and schedules, contains additional relevant information about CoreWeave and CoreWeave common stock. The rules and regulations of the SEC allow Core Scientific to omit certain information included in the registration statement from this proxy statement/prospectus. You may obtain a free copy of the registration statement, this proxy statement/prospectus as well as any amendments, schedules and exhibits by written or oral request to the address set forth below: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8pt; text-align: center;">CoreWeave, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">290 W Mt. Pleasant Ave., Suite 4100</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Livingston, NJ</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Attention: Investor Relations</font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">(973) 270-9737 </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The SEC allows Core Scientific to &#8220;incorporate by reference&#8221; information into this proxy statement/prospectus. This means that important information can be disclosed to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this proxy statement/prospectus, except for any information superseded by information in this proxy statement/prospectus or in later filed documents incorporated by reference into this proxy statement/prospectus. This proxy statement/prospectus incorporates by reference the documents set forth below that Core Scientific has previously filed with the SEC and any additional documents that it may file with the SEC under Section&#160;13(a), 13(c), 14 or 15(d) of the Exchange Act after the initial filing of this registration statement and on or prior to effectiveness of this registration statement and after the effectiveness of this proxy statement/prospectus and until the date that the offering is terminated (other than, in each case, those documents, or the portions of those documents or exhibits thereto, deemed to be furnished and not filed in accordance with SEC rules). These documents contain important information about Core Scientific and its financial performance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus incorporates by reference the documents set forth below previously filed with the SEC: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025008302/core-20241231.htm ">February&#160;27, 2025</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific&#8217;s Quarterly Reports on Form&#160;10-Q for the quarters ended March&#160;31, 2025 and June&#160;30, 2025, which were filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025023242/core-20250331.htm ">May&#160;7, 2025</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025039284/core-20250630.htm ">August&#160;8, 2025</a>, respectively&#894; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific&#8217;s Current Reports on Form&#160;8-K filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025009570/core-20250302.htm">March&#160;4, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025012594/core-20250312.htm">March&#160;13, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025021837/core-20250428.htm">May&#160;2, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025025065/core-20250512.htm">May&#160;13, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025026294/core-20250513.htm">May&#160;16, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000162828025027960/core-20250523.htm">May&#160;27, 2025</a> and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000119312525156266/d945892d8k.htm">July&#160;7, 2025</a> (other than the portions of those documents not deemed to be filed). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Core Scientific&#8217;s Definitive Proxy Statement on Schedule 14A for Core Scientific&#8217;s 2025 annual stockholder meeting, filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1839341/000119312525065652/d925494ddef14a.htm">March&#160;28, 2025</a>. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The description of Core Scientific&#8217;s registered securities filed as <a href="https://www.sec.gov/Archives/edgar/data/1839341/000119312522088850/d268076dex413.htm">Exhibit&#160;4.11</a> to its Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, including any amendments or reports filed for the purpose of updating such information. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has supplied all information contained in this proxy statement/prospectus relating to CoreWeave, and Core Scientific has supplied all information contained or incorporated by reference in this proxy statement/prospectus relating to Core Scientific. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">317<br></div></div></div>
<!--End Page 328-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 329-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_127-info_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Documents incorporated by reference are available from Core Scientific without charge, excluding any exhibits to those documents, unless the exhibit is specifically incorporated by reference into this proxy statement/prospectus. you may obtain these documents incorporated by reference by requesting them in writing or by telephone from the following address and telephone number: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 8.5pt; text-align: center;">Core Scientific, Inc.<font style="font-weight: normal;"> </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">838 Walker Road, Suite 21-2105 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Dover, Delaware 19904 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">Attention: Investor Relations </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">(512) 402-5233 </font><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;"><font style="font-weight: normal;">ir@corescientific.com </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To obtain timely delivery of the documents, you must request them no later than five business days before the date of the Special Meeting. Therefore, if you would like to request documents from Core Scientific, please do so by [&#8195;], 2025 in order to receive them before the Special Meeting.<font style="font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Neither CoreWeave nor Core Scientific has authorized anyone to provide you with information that is different from what is contained in this proxy statement/prospectus. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If you are in a jurisdiction in which offers to exchange or sell, or solicitations of offers to exchange or purchase, the securities offered by this proxy statement/prospectus or solicitations of proxies are unlawful, or if you are a person to whom it is unlawful to direct these types of activities, then the offer presented in this proxy statement/prospectus does not extend to you. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This proxy statement/prospectus is dated [&#8195;], 2025. You should not assume that the information in it is accurate as of any date other than that date, and neither its mailing to Core Scientific stockholders nor the issuance of shares of CoreWeave common stock in the Merger will create any implication to the contrary. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">318<br></div></div></div>
<!--End Page 329-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 330-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;"><a name="tANNEXA"><!--Anchor--></a>Annex A</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 7.5pt; text-align: center;">AGREEMENT AND PLAN OF MERGER<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">by and among<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">COREWEAVE, INC.,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">MIAMI MERGER SUB I, INC.,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">and<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CORE SCIENTIFIC, INC.<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">dated as of July&#160;7, 2025<font style="font-weight: normal;"> </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-1<br></div></div></div>
<!--End Page 330-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 331-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><u>TABLE OF CONTENTS</u> </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 60pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 318pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page&#160;No.</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA1">Article&#160;I DEFINITIONS<font style="padding-left: 3.55pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA1"><font style="padding-left: 5pt;">A-5</font></a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS101">Section&#160;1.01.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS101">Certain Definitions<font style="padding-left: 2.75pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS101"><font style="padding-left: 5pt;">A-5</font></a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS102">Section&#160;1.02.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS102">Other Defined Terms<font style="padding-left: 4.2pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS102">A-16</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS103">Section&#160;1.03.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS103">Other Definitional Provisions<font style="padding-left: 0.54pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS103">A-18</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA2">Article&#160;II THE MERGER<font style="padding-left: 3.16pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA2">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS201">Section&#160;2.01.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS201">The Merger<font style="padding-left: 2.37pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS201">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS202">Section&#160;2.02.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS202">Closing<font style="padding-left: 4.39pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS202">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS203">Section&#160;2.03.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS203">Effective Time<font style="padding-left: 0.12pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS203">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS204">Section&#160;2.04.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS204">Effects of the Merger<font style="padding-left: 2.58pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS204">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS205">Section&#160;2.05.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS205">Certificate of Incorporation and Bylaws of the Surviving Corporation<font style="padding-left: 1.16pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS205">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS206">Section&#160;2.06.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS206">Directors and Officers of the Surviving Corporation<font style="padding-left: 2.99pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS206">A-19</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tANXAA3">Article&#160;III EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES AND BOOK-ENTRY SHARES<font style="padding-left: 2.79pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA3">A-20</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS301">Section&#160;3.01.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS301">Effect on Capital Stock in the Merger<font style="padding-left: 0.37pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS301">A-20</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS302">Section&#160;3.02.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS302">Treatment of Company Equity Awards<font style="padding-left: 2.92pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS302">A-20</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS303">Section&#160;3.03.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS303">Closing of the Company Transfer Books<font style="padding-left: 4.41pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS303">A-21</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS304">Section&#160;3.04.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS304">Exchange Fund; Exchange of Certificates; Cancellation of Book-Entry Positions<font style="padding-left: 3.84pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS304">A-21</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS305">Section&#160;3.05.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS305">No Fractional Shares; Certain Calculations; No Appraisal Rights<font style="padding-left: 1.14pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS305">A-23</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS306">Section&#160;3.06.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS306">Withholding<font style="padding-left: 0.34pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS306">A-23</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS307">Section&#160;3.07.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS307">Adjustments to Prevent Dilution<font style="padding-left: 3.31pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS307">A-23</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS308">Section&#160;3.08.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS308">Further Action<font style="padding-left: 1.07pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS308">A-24</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA4">Article&#160;IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY<font style="padding-left: 4.74pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA4">A-24</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS401">Section&#160;4.01.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS401">Organization and Corporate Power<font style="padding-left: 3.51pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS401">A-24</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS402">Section&#160;4.02.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS402">Authorization; Valid and Binding Agreement<font style="padding-left: 2.39pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS402">A-24</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS403">Section&#160;4.03.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS403">Company Capital Stock<font style="padding-left: 3.3pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS403">A-25</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS404">Section&#160;4.04.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS404">Subsidiaries<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS404">A-26</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS405">Section&#160;4.05.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS405">No Breach<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS405">A-27</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS406">Section&#160;4.06.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS406">Consents, etc.<font style="padding-left: 3.85pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS406">A-27</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS407">Section&#160;4.07.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS407">SEC Reports; Disclosure Controls and Procedures<font style="padding-left: 0.57pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS407">A-28</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS408">Section&#160;4.08.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS408">No Undisclosed Liabilities<font style="padding-left: 1.64pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS408">A-29</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS409">Section&#160;4.09.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS409">Absence of Certain Developments<font style="padding-left: 0.56pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS409">A-29</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS410">Section&#160;4.10.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS410">Compliance with Laws<font style="padding-left: 1.09pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS410">A-29</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS411">Section&#160;4.11.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS411">Transactions with Affiliates<font style="padding-left: 3.29pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS411">A-31</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS412">Section&#160;4.12.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS412">Title to Assets; Real Properties<font style="padding-left: 3.67pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS412">A-31</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS413">Section&#160;4.13.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS413">Tax Matters<font style="padding-left: 1.78pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS413">A-33</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS414">Section&#160;4.14.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS414">Contracts and Commitments<font style="padding-left: 4.41pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS414">A-34</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS415">Section&#160;4.15.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS415">Intellectual Property<font style="padding-left: 2.75pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS415">A-37</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS416">Section&#160;4.16.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS416">Litigation<font style="padding-left: 1.06pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS416">A-39</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS417">Section&#160;4.17.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS417">Insurance<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS417">A-39</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS418">Section&#160;4.18.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS418">Employee Benefit Plans<font style="padding-left: 2.2pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS418">A-39</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS419">Section&#160;4.19.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS419">Environmental Compliance and Conditions<font style="padding-left: 4.42pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS419">A-40</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS420">Section&#160;4.20.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS420">Employment and Labor Matters<font style="padding-left: 4.99pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS420">A-41</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS421">Section&#160;4.21.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS421">Material Relationships<font style="padding-left: 3.86pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS421">A-41</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS422">Section&#160;4.22.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS422">Government Contracts<font style="padding-left: 3.86pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS422">A-42</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS423">Section&#160;4.23.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS423">Regulatory Matters<font style="padding-left: 2.2pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS423">A-42</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 60pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 318pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-2<br></div></div></div>
<!--End Page 331-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 332-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 60pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 318pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page&#160;No.</div></td></tr><tr><td style="width: 36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS424">Section&#160;4.24.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS424">Fiber Network<font style="padding-left: 1.08pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS424">A-42</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS425">Section&#160;4.25.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS425">Brokerage<font style="padding-left: 3.85pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS425">A-42</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS426">Section&#160;4.26.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS426">Disclosure<font style="padding-left: 2.74pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS426">A-42</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS427">Section&#160;4.27.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS427">No Rights Agreement<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS427">A-43</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS428">Section&#160;4.28.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS428">Fairness Opinion<font style="padding-left: 1.08pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS428">A-43</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS429">Section&#160;4.29.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS429">NO OTHER REPRESENTATIONS AND WARRANTIES<font style="padding-left: 3.2pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS429">A-43</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS430">Section&#160;4.30.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS430">NON-RELIANCE<font style="padding-left: 1.08pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS430">A-43</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA5">Article&#160;V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB<font style="padding-left: 4.91pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA5">A-44</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS501">Section&#160;5.01.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS501">Organization and Corporate Power<font style="padding-left: 3.51pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS501">A-44</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS502">Section&#160;5.02.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS502">Authorization; Valid and Binding Agreement<font style="padding-left: 2.39pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS502">A-44</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS503">Section&#160;5.03.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS503">Parent Capital Stock<font style="padding-left: 1.64pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS503">A-45</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS504">Section&#160;5.04.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS504">Subsidiaries<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS504">A-45</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS505">Section&#160;5.05.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS505">No Breach<font style="padding-left: 1.63pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS505">A-46</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS506">Section&#160;5.06.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS506">Consents, etc.<font style="padding-left: 3.85pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS506">A-46</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS507">Section&#160;5.07.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS507">SEC Reports; Disclosure Controls and Procedures<font style="padding-left: 0.57pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS507">A-46</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS508">Section&#160;5.08.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS508">No Undisclosed Liabilities<font style="padding-left: 1.64pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS508">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS509">Section&#160;5.09.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS509">Absence of Certain Developments<font style="padding-left: 0.56pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS509">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS510">Section&#160;5.10.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS510">Compliance with Laws<font style="padding-left: 1.09pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS510">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS511">Section&#160;5.11.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS511">Transactions with Affiliates<font style="padding-left: 3.29pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS511">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS512">Section&#160;5.12.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS512">Litigation<font style="padding-left: 1.06pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS512">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS513">Section&#160;5.13.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS513">Brokerage<font style="padding-left: 3.85pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS513">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS514">Section&#160;5.14.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS514">Disclosure<font style="padding-left: 2.74pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS514">A-48</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS515">Section&#160;5.15.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS515">Ownership of Company Capital Stock<font style="padding-left: 4.43pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS515">A-49</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS516">Section&#160;5.16.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS516">Merger Sub<font style="padding-left: 2.37pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS516">A-49</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS517">Section&#160;5.17.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS517">Merger Qualification<font style="padding-left: 0.16pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS517">A-49</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS518">Section&#160;5.18.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS518">No Other Representations and Warranties<font style="padding-left: 1pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS518">A-49</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS519">Section&#160;5.19.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS519">NON-RELIANCE<font style="padding-left: 1.08pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS519">A-49</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA6">Article&#160;VI COVENANTS RELATING TO CONDUCT OF BUSINESS<font style="padding-left: 1.54pt;"></font> </a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA6">A-50</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS601">Section&#160;6.01.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS601">Covenants of the Company<font style="padding-left: 3.86pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS601">A-50</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS602">Section&#160;6.02.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS602">Covenants of Parent<font style="padding-left: 2.75pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS602">A-54</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS603">Section&#160;6.03.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS603">No Control of Other Party&#8217;s Business<font style="padding-left: 1.66pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS603">A-55</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA7">Article&#160;VII ADDITIONAL COVENANTS OF THE PARTIES<font style="padding-left: 4.17pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA7">A-55</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS701">Section&#160;7.01.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS701">Investigation<font style="padding-left: 3.29pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS701">A-55</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS702">Section&#160;7.02.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS702">Registration Statement; Proxy Statement<font style="padding-left: 4.99pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS702">A-57</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS703">Section&#160;7.03.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS703">Company Stockholders&#8217; Meeting<font style="padding-left: 1.83pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS703">A-58</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS704">Section&#160;7.04.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS704">Non-Solicitation by Company; Company Board Recommendation<font style="padding-left: 1.66pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS704">A-59</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS705">Section&#160;7.05.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS705">Regulatory Approvals; Additional Agreements; Performance of Merger Sub<font style="padding-left: 1.89pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS705">A-61</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS706">Section&#160;7.06.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS706">Employment and Labor Matters<font style="padding-left: 4.99pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS706">A-63</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS707">Section&#160;7.07.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS707">Indemnification of Officers and Directors<font style="padding-left: 0.76pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS707">A-64</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS708">Section&#160;7.08.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS708">Public Disclosure<font style="padding-left: 3.86pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS708">A-66</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS709">Section&#160;7.09.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS709">NASDAQ Listing<font style="padding-left: 2.19pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS709">A-66</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS710">Section&#160;7.10.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS710">Takeover Laws<font style="padding-left: 3.45pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS710">A-66</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS711">Section&#160;7.11.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS711">Section&#160;16 Matters<font style="padding-left: 3.31pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS711">A-66</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS712">Section&#160;7.12.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS712">Transaction Litigation<font style="padding-left: 0.87pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS712">A-66</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS713">Section&#160;7.13.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS713">Tax Matters<font style="padding-left: 1.78pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS713">A-67</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS714">Section&#160;7.14.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS714">Company Convertible Notes<font style="padding-left: 4.42pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS714">A-67</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS715">Section&#160;7.15.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS715">Company Warrants<font style="padding-left: 2.62pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS715">A-68</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 60pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 318pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-3<br></div></div></div>
<!--End Page 332-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 333-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 60pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 318pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page&#160;No.</div></td></tr><tr><td style="width: 36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS716">Section&#160;7.16.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS716">Contingent Value Rights<font style="padding-left: 0.7pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS716">A-68</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS717">Section&#160;7.17.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS717">Merger Sub Consent<font style="padding-left: 1.26pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS717">A-68</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS718">Section&#160;7.18.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS718">Stock Exchange Delisting; Deregistration<font style="padding-left: 1.67pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS718">A-68</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS719">Section&#160;7.19.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS719">Obligations of Merger Sub<font style="padding-left: 0.72pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS719">A-68</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS720">Section&#160;7.20.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS720">Title Insurance<font style="padding-left: 4.77pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS720">A-69</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS721">Section&#160;7.21.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS721">Updated Equity Awards Schedule<font style="padding-left: 3.68pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS721">A-69</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS722">Section&#160;7.22. </a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS722">Financing.<font style="padding-left: 3.01pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS722">A-69</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS723">Section&#160;7.23.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS723">Third Party Consents<font style="padding-left: 3.86pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS723">A-70</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS724">Section&#160;7.24.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS724">Further Assurances<font style="padding-left: 2.76pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS724">A-70</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS725">Section&#160;7.25.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS725">Notices of Certain Events<font style="padding-left: 4.99pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS725">A-71</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS726">Section&#160;7.26.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS726">Treatment of Company Indebtedness<font style="padding-left: 0.35pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS726">A-71</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA8">Article&#160;VIII CONDITIONS TO CLOSING</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA8">A-71</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS801">Section&#160;8.01.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS801">Conditions to All Parties&#8217; Obligations<font style="padding-left: 1.83pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS801">A-71</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS802">Section&#160;8.02.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS802">Conditions to Parent&#8217;s and Merger Sub&#8217;s Obligations<font style="padding-left: 4.07pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS802">A-72</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS803">Section&#160;8.03.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS803">Conditions to the Company&#8217;s Obligations<font style="padding-left: 1.08pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS803">A-72</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA9">Article&#160;IX TERMINATION</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA9">A-73</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS901">Section&#160;9.01.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS901">Termination<font style="padding-left: 1.76pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS901">A-73</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS902">Section&#160;9.02.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS902">Effect of Termination<font style="padding-left: 2.7pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS902">A-74</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS903">Section&#160;9.03.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS903">Termination Fees<font style="padding-left: 0.11pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS903">A-74</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAA10">Article&#160;X MISCELLANEOUS</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAA10">A-75</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1001">Section&#160;10.01.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1001">Expenses<font style="padding-left: 2.74pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1001">A-75</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1002">Section&#160;10.02.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1002">Amendment<font style="padding-left: 1.07pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1002">A-75</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1003">Section&#160;10.03.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1003">Waiver<font style="padding-left: 1.87pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1003">A-76</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1004">Section&#160;10.04.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1004">No Survival of Representations and Warranties<font style="padding-left: 3.23pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1004">A-76</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1005">Section&#160;10.05.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1005">Entire Agreement; Counterparts<font style="padding-left: 1.1pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1005">A-76</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1006">Section&#160;10.06.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1006">Applicable Law; Jurisdiction<font style="padding-left: 2.76pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1006">A-76</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1007">Section&#160;10.07.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1007">Waiver of Jury Trial<font style="padding-left: 2.43pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1007">A-77</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1008">Section&#160;10.08.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1008">Assignability<font style="padding-left: 2.18pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1008">A-77</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1009">Section&#160;10.09.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1009">No Third Party Beneficiaries<font style="padding-left: 2.4pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1009">A-77</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1010">Section&#160;10.10.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1010">Notices<font style="padding-left: 4.96pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1010">A-78</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1011">Section&#160;10.11.</a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1011">Severability<font style="padding-left: 2.18pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1011">A-78</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1012">Section&#160;10.12.</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANXAS1012">Specific Performance<font style="padding-left: 3.32pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tANXAS1012">A-79</a></div></td></tr><tr><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 60pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 318pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXHIBITA">Exhibit&#160;A &#8211; Form&#160;of Amended and Restated Certificate of Incorporation of the Surviving Corporation<font style="padding-left: 0.85pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tEXHIBITA">A-83</a></div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXHIBITB">Exhibit&#160;B &#8211; Form&#160;of Company Tax Opinion Representation Letter<font style="padding-left: 2.23pt;"></font></a></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tEXHIBITB"><font style="padding-left: 5pt;">A-0</font></a></div></td></tr><tr><td colspan="7" style="width: 426pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tEXHIBITC">Exhibit&#160;C &#8211; Form&#160;of Parent Tax Opinion Representation Letter<font style="padding-left: 0.57pt;"></font></a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.72pt; text-align: left;"><a href="#tEXHIBITC"><font style="padding-left: 5pt;">A-0</font></a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 426pt; background-color: #CCEEFF;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-4<br></div></div></div>
<!--End Page 333-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 334-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">AGREEMENT AND PLAN OF MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This AGREEMENT AND PLAN OF MERGER (this &#8220;<u>Agreement</u>&#8221;) is made and entered into as of July&#160;7, 2025, by and among CoreWeave, Inc. (&#8220;<u>Parent</u>&#8221;), a Delaware corporation, Miami Merger Sub I, Inc., a Delaware&#160;corporation and a wholly owned Subsidiary of Parent (&#8220;<u>Merger Sub</u>&#8221;), and Core Scientific, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;). Parent, Merger Sub and the Company are sometimes referred to herein individually as a &#8220;<u>Party</u>&#8221; and collectively as the &#8220;<u>Parties</u>&#8221;. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">RECITALS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">WHEREAS, the board of directors of Parent (the &#8220;<u>Parent Board</u>&#8221;) and the board of directors of the Company (the &#8220;<u>Company Board</u>&#8221;) each propose to effect a transaction pursuant to which Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned Subsidiary of Parent (the &#8220;<u>Merger</u>&#8221;) and pursuant to which each share of common stock of the Company, $0.00001 par value per share (the &#8220;<u>Company Common Stock</u>&#8221;), outstanding at the Effective Time will be converted into the right to receive a number of newly issued, fully paid and non-assessable shares of Class&#160;A common stock of Parent, $0.000005 par value per share (the &#8220;<u>Parent Class&#160;A </u><u>Common Stock</u>&#8221;), equal to the Exchange Ratio, as more fully provided in this Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">WHEREAS, the Company Board has unanimously (i) determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable, fair to and in the best interests of the Company and its stockholders (the &#8220;<u>Company Stockholders</u>&#8221;), (ii) approved and deemed advisable the execution and delivery of this Agreement, the performance by the Company of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger and (iii) directed that the adoption of this Agreement be submitted to a vote at a meeting of the Company Stockholders and resolved to recommend that the Company Stockholders approve the Merger and adopt this Agreement (the &#8220;<u>Company Board </u><u>Recommendation</u>&#8221;); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">WHEREAS, the Parent Board has unanimously (i) determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable and in the best interests of Parent and its stockholders (the &#8220;<u>Parent Stockholders</u>&#8221;) and (ii) approved and deemed advisable the execution and delivery of this Agreement, the performance by Parent of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger and the issuance of shares of Parent Class&#160;A Common Stock, the New Tranche 1 Warrants (as defined below) and the New Tranche 2 Warrants (as defined below), in each case in connection therewith; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">WHEREAS, the board of directors of Merger Sub (the &#8220;<u>Merger Sub Board</u>&#8221;) has (i) unanimously determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable and in the best interests of Merger Sub and its sole stockholder, (ii) unanimously approved and deemed advisable the execution and delivery of this Agreement, the performance by Merger Sub of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger, and (iii)&#160;recommended that Parent, as the sole stockholder of Merger Sub, adopt this Agreement and approve the Contemplated Transactions, including the Merger; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">WHEREAS, it is intended that the Merger qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code (as defined below) and the Treasury Regulations (as defined below), and that this Agreement will be a &#8220;plan of reorganization&#8221; within the meaning of Treasury Regulations Section&#160;1.368-2(g) and 1.368-3(a). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">NOW, THEREFORE, in consideration of the premises, representations and warranties and mutual covenants contained herein and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound, the Parties hereby agree as follows: </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;"><a name="tANXAA1"><!--Anchor--></a>ARTICLE&#160;I<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">DEFINITIONS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS101"><!--Anchor--></a>Section&#160;1.01.&#8195;<u>Certain Definitions</u>. For purposes of this Agreement: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Acceptable Confidentiality Agreement</u>&#8221; means any agreement with the Company that is either (a) in effect as of the execution and delivery of this Agreement or (b) executed, delivered and effective after the execution and delivery of this Agreement, in either case containing provisions that require any counterparty thereto (and any of its Affiliates and Representatives) that receive information of, or with respect to, the Company or any of its Subsidiaries </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-5<br></div></div></div>
<!--End Page 334-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 335-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">to keep such information confidential, subject to customary exceptions; <u>provided</u>, <u>however</u>, that, in each case, (i) the provisions contained therein are no less favorable in the aggregate to the Company and no less restrictive on the Company&#8217;s counterparty (and its Affiliates and representatives) than the terms of the Non-Disclosure Agreement (but, for the avoidance of doubt, such confidentiality agreement need not contain a &#8220;standstill&#8221; or similar obligation), and (ii) such agreement does not contain any provision that prohibits the Company from satisfying its obligations to provide disclosure to Parent pursuant to <u>Section&#160;7.04</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Acquisition Proposal</u>&#8221; means any bona fide indication of interest, inquiry, proposal or offer, whether or not in writing, from any Person (other than Parent or any of its Subsidiaries), relating to any transaction or series of related transactions (other than the transactions set forth on <u>Section&#160;1.01(a)</u> of the Company Disclosure Letter) involving the (a) direct or indirect acquisition or purchase of a business or assets that constitutes twenty percent (20%) or more of the consolidated net revenues, net income or the assets (based on the fair market value thereof) of the Company and its Subsidiaries, taken as a whole, (b) direct or indirect issuance, acquisition or purchase of twenty percent (20%) or more of any class of equity securities, capital stock or voting securities (or any equity securities convertible into or exchangeable or redeemable for any such equity securities, capital stock or voting securities) of the Company or any of its Subsidiaries whose business or assets constitute twenty percent (20%) or more of the consolidated net revenues, net income or assets of the Company and its Subsidiaries, taken as a whole, (c) tender offer (including a self-tender offer) or exchange offer that, if consummated, would result in any Person (other than Parent or any of its Subsidiaries) or group beneficially owning 20% or more of any class of equity securities, capital stock or voting securities of the Company (or any equity securities convertible into, or exchangeable or redeemable for, any such equity or voting securities), (c) merger, consolidation, amalgamation, restructuring, transfer of assets or other business combination, joint venture, liquidation, dissolution, sale of shares of capital stock, share exchange, recapitalization or other similar transaction involving the Company or any of its Subsidiaries that if consummated would result in any Person (other than Parent or any of its Subsidiaries) acquiring businesses or assets that constitute twenty percent (20%) or more of the consolidated net revenues, net income or assets of the Company and its Subsidiaries, taken as a whole or (d)&#160;any combination of the foregoing of clauses (a) through (c). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Action</u>&#8221; means any claim, controversy, charge, cause of action, complaint, demand, audit, dispute, examination, mediation, action, suit, arbitration, investigation, litigation, subpoena, enforcement action or other legal proceeding (including any civil, criminal, administrative, regulatory, appellate or other legal proceeding), whether at equity or at law, in contract, in tort or otherwise. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Affiliate</u>&#8221; of any particular Person means any other Person controlling, controlled by or under common control with such particular Person. For the purposes of this definition, &#8220;controlling,&#8221; &#8220;controlled&#8221; and &#8220;control&#8221; mean the possession, directly or indirectly, of the power to direct the management and policies of a Person whether through the ownership of voting securities, contract or otherwise. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Antitrust Laws</u>&#8221; mean the Sherman Antitrust Act of 1890, the Clayton Antitrust Act of 1914, the HSR Act, the Federal Trade Commission Act, state antitrust laws, and all other applicable Laws (including non-U.S. Laws), and rules and regulations promulgated thereunder, issued by a Governmental Body that are designed or intended to preserve or protect competition; prohibit and restrict agreements in restraint of trade or monopolization, attempted monopolization, restraints of trade and abuse of a dominant position; or prevent acquisitions, mergers or other business combinations and similar transactions, the effect of which may be to lessen or impede competition or to tend to create or strengthen a dominant position or to create a monopoly. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Business Day</u>&#8221; means any day that is not a Saturday, a Sunday or a day on which commercial banks are authorized or required by applicable law to close in New York, New York. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Code</u>&#8221; means the Internal Revenue Code of 1986, as amended. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company 2029 Convertible Notes</u>&#8221; means the Company&#8217;s 3.00% Convertible Senior Notes due 2029 issued under the Company 2029 Notes Indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company 2029 Notes Indenture</u>&#8221; means that certain Indenture, dated August&#160;19, 2024, between the Company and U.S. Bank Trust Company, National Association, as Trustee, as amended, restated, supplemented or otherwise modified from time to time, governing the terms of the Company 2029 Convertible Notes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company 2031 Convertible Notes</u>&#8221; means the Company&#8217;s 0.00% Convertible Senior Notes due 2031 issued under the Company 2031 Notes Indenture. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-6<br></div></div></div>
<!--End Page 335-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 336-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company 2031 Notes Indenture</u>&#8221; means that certain Indenture, dated December&#160;5, 2024, between the Company and U.S. Bank Trust Company, National Association, as Trustee, as amended, restated, supplemented or otherwise modified from time to time, governing the terms of the Company 2031 Convertible Notes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Company Balance Sheet Date</u>&#8221; means March&#160;31, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Company Capital Stock</u>&#8221; means the Company Common Stock and the Company Preferred Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Convertible Notes</u>&#8221; means, collectively, the Company 2029 Convertible Notes and the Company 2031 Convertible Notes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company CVR Agreement</u>&#8221; means that certain Contingent Value Rights Agreement, dated as of January&#160;23, 2024, by and between the Company and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Employee</u>&#8221; means each individual who is an employee of the Company or its Subsidiaries as of the relevant time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Equity Plans</u>&#8221; means the Company 2024 Stock Incentive Plan, the Company 2021 Equity Incentive Plan and the Company 2018 Omnibus Incentive Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Company ESPP</u>&#8221; means the Company&#8217;s 2021 Employee Stock Purchase Plan, as amended. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Fundamental Representations</u>&#8221; means the representations and warranties of the Company set forth in <u>Section&#160;4.01</u> (<font style="font-style: italic;">Organization and Corporate Power</font>) (solely with respect to the first, fourth and fifth sentences thereof); <u>Section&#160;4.02</u> (<font style="font-style: italic;">Authorization; Valid and Binding Agreement</font>); <u>Section&#160;4.03(c)</u> (other than the third and fourth&#160;sentences thereof) and <u>Section&#160;4.03(e)</u> (<font style="font-style: italic;">Capital Stock</font>); <u>Section&#160;4.04(b)</u> (<font style="font-style: italic;">Subsidiaries</font>); <u>Section&#160;4.05</u> (<font style="font-style: italic;">No&#160;Breach</font>) (solely with respect to clause (a) thereof); <u>Section&#160;4.25</u> (<font style="font-style: italic;">Brokerage</font>); <u>Section&#160;4.27</u> <font style="font-style: italic;">No Rights Agreement</font>); and <u>Section&#160;4.28</u> (<font style="font-style: italic;">Fairness Opinion</font>). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Fundamental Representations &#8211; De Minimis</u>&#8221; means the representations and warranties of the Company set forth in <u>Section&#160;4.03(a)</u>, <u>Section&#160;4.03(b)</u> and the third and fourth sentences of <u>Section&#160;4.03(c)</u> (<font style="font-style: italic;">Company Capital Stock</font>). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Material Adverse Effect</u>&#8221; means any change, effect, event, circumstance, occurrence, state of facts or development, that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, assets, results of operations or financial condition of the Company and its Subsidiaries, taken as a whole, other than any change, effect, event, circumstance, occurrence, state of facts or development to the extent related to or resulting from: (i) general business or economic conditions affecting the industry in which the Company and its Subsidiaries operate; (ii) acts of god, weather conditions or environmental events and natural disasters (including any earthquakes, floods, hurricanes, tropical storms, fires, or other natural disasters), health emergencies, pandemics or epidemics (or the escalation of any of the foregoing) and any governmental or industry responses thereto; (iii) political or geopolitical conditions (including tariffs and sanctions), the occurrence or the escalation or worsening of any military or terrorist actions or cyberterrorism (including cyberterrorism data breaches), civil or political unrest, acts of war, hostilities or sabotage; (iv) changes in general economic, financial or market conditions, including changes in the artificial intelligence, financial, banking, currency, bitcoin, bitcoin mining, cryptocurrency, electricity, energy, power or securities markets and changes in cryptocurrency prices, commodity prices and regulatory, legislative or political conditions; (v) changes in the prices of commodities, bitcoin or other digital assets after the date hereof; (vi) changes in GAAP after the date hereof; (vii) changes in Laws or Orders after the date hereof; (viii) changes in the Company&#8217;s stock price or the trading volume of the Company&#8217;s stock or any change in the credit rating of the Company (<u>provided, that</u>, the underlying causes of any such change, to the extent not otherwise excluded from the definition of a Company Material Adverse Effect, may be taken into consideration when determining whether a Company Material Adverse Effect has occurred); (ix) the failure of the Company to meet internal or analysts&#8217; expectations, projections or results of operations (<u>provided, that</u>, the underlying causes of such failure to meet expectations, projections or results of operations, to the extent not otherwise excluded from the definition of a Company Material Adverse Effect, may be taken into account in determining whether there has been a Company Material Adverse Effect); (x) any material adverse effect on the business, assets, results of operations or financial condition of Parent or its Subsidiaries and any impact thereof on the Company or its Subsidiaries; (xi) breaches or threatened breaches by Parent or any of its Subsidiaries of any commercial Contract with the Company or any of its Subsidiaries; (xii) the execution or delivery of this Agreement, the announcement of this Agreement or the Contemplated Transactions, the identity of the Parties or the taking of any action required by </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-7<br></div></div></div>
<!--End Page 336-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 337-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">this Agreement, including the impact of any of the foregoing on the relationships of the Company or any of its Subsidiaries with Governmental Bodies, customers, suppliers, power providers, utility companies, contractors, partners, officers, employees or other business relations (it being understood that this <u>clause (xii)</u> shall not apply to a breach of the representations and warranties set forth in <u>Sections 4.02</u>, <u>4.05</u>, <u>4.06</u>, <u>4.15(i)</u> or the first sentence of <u>4.18(e)</u> or the accuracy of such representations and warranties for the purposes of the closing condition set forth in <u>Section&#160;8.02(a)</u>); (xiii) Transaction Litigation (<u>provided, that</u>, the underlying causes of any such litigation, to the extent not otherwise excluded from the definition of a Company Material Adverse Effect, may be taken into consideration when determining whether a Company Material Adverse Effect has occurred) and (xiv) any action (1)&#160;expressly required by this Agreement, (2) taken by the Company or any of the Company Subsidiaries with Parent&#8217;s written consent, to the extent the consequences thereof are reasonably foreseeable, or taken at Parent&#8217;s written request or (3) any failure by the Company or any of the Company Subsidiaries to take any action as a result of Parent&#8217;s or any of Parent&#8217;s Subsidiaries&#8217; failure or delay in providing consent, to the extent such failure or delay in providing consent would reasonably be expected to have a materially adverse effect on the Company or its Subsidiaries; <u>provided</u>, <u>however</u>, that if any change, effect, event, circumstance, occurrence, state of facts or development described in any of <u>clauses (i)</u> through <u>(vii)</u> has or has had a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other participants in the industries in which the Company and its Subsidiaries operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in determining whether a Company Material Adverse Effect has occurred. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Option</u>&#8221; means an option to purchase shares of Company Common Stock granted pursuant to a Company Equity Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Owned Intellectual Property</u>&#8221; means any and all Intellectual Property that is owned or purported to be owned by the Company or any of its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Plan</u>&#8221; means a Plan that the Company or any of its Subsidiaries is a party to, sponsors, maintains, contributes to, or is obligated to contribute to, in each case, for the benefit of any current or former employee, officer, individual independent contractor or director of the Company or any of its Subsidiaries, or with respect to which the Company or any of its Subsidiaries has any Liability. For clarity, &#8220;Company Plans&#8221; includes &#8220;Company Equity Plans.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Company Preferred Stock</u>&#8221; means the preferred stock of the Company, par value $0.00001 per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company PSU Award</u>&#8221; means each Company RSU Award that vests or is earned subject to the achievement of performance conditions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company RSU Award</u>&#8221; means each award of restricted stock units representing the right to vest in and be issued shares of Company Common Stock granted pursuant to a Company Equity Plan, other than each Company PSU Award. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Secured Debt Documents</u>&#8221; means, collectively, that certain Amended and Restated Equipment Schedule No. 10, dated as of September&#160;18, 2023, by and among ACM ELF ST LLC, Core Scientific, Inc. and Core Scientific Operating Company and made in connection with the Master Equipment Lease Agreement #32109 dated as of June&#160;3, 2021, in each case, as amended, modified, refinanced or replaced from time to time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Company Warrant Agreement</u>&#8221; means that certain Warrant Agreement, dated as of January&#160;23, 2024 by and between the Company and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Company Warrants</u>&#8221; means the Tranche 1 Warrants and the Tranche 2 Warrants. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Consent</u>&#8221; means any approval, consent, ratification, permission, waiver or authorization (including any Permit). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Contemplated Transactions</u>&#8221; means each of the transactions contemplated by this Agreement, including the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Contract</u>&#8221; means any agreement, contract, subcontract, lease, binding understanding, obligation, promise, instrument, indenture, mortgage, note, option, warranty, purchase order, order form, license, sublicense, commitment or letter of intent, term sheet, indication of interest or similar document or undertaking of any nature, which, in each case, is legally binding upon a party or on any of its Affiliates, in each case excluding any Company Plan. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-8<br></div></div></div>
<!--End Page 337-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 338-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>CVRs</u>&#8221; shall have the meaning set forth in the Company CVR Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Data Center Customer Contract</u>&#8221; means the primary or base (i) license, lease, sublease or other Contract with any Person pursuant to which the Company or any of its Subsidiaries gives such Person a right to use or occupy space at any Company Real Property or (ii) master service agreement pursuant to which the Company or any of its Subsidiaries provides services to a Person related to such Person&#8217;s use or occupancy of space at any Company Real Property, in each case, other than any Contract to which Parent or any of its Subsidiaries or Affiliates is a party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Development Contracts</u>&#8221; means the development agreements, general contractor contracts, architect contracts, development management agreements, Electric Contracts engineering contracts and all other design, consulting, service or construction contracts, in each case related to the construction or development of a Development Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Digital Assets</u>&#8221; means any cryptographic tokens, cryptographic coins, cryptographic currencies or other cryptographic assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>DTC</u>&#8221; means The Depository Trust Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Electric Contract</u>&#8221; means each Contract between the Company or any of its Subsidiaries, on the one hand, and a utility company or electric power provider, on the other hand, that provides for or enables (i) construction, design or engineering of electric infrastructure (including any contributions in aid of construction); (ii) interconnection for purposes of receiving electric service; (iii) purchase of any long-lead electrical equipment; (iv) purchase of electric power or electric energy; or (v) initiation or completion of any studies necessary to determine feasibility of electric service or facilities necessary to provide electric service. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Environmental Laws</u>&#8221; means all Laws and Orders, concerning pollution or protection of the environment or natural resources, the handling, transportation, treatment, storage, distribution, labeling, Release, threatened Release, control or cleanup of any Hazardous Substances, and health and safety (as it relates to exposure to Hazardous Substances, noise, vibration, heat or odor) and all Permits issued or required to be issued thereunder (&#8220;<u>Environmental </u><u>Permits</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>ERISA Affiliate</u>&#8221; means, with respect to any entity, any other entity, trade or business (whether or not incorporated) which is, or has at any relevant time been, treated as a single employer under Section&#160;414 of the Code. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Exchange Ratio</u>&#8221; means 0.1235. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Excluded Information</u>&#8221; means any (1) description of all or any portion of any debt financing, including any &#8220;description of notes&#8221;, &#8220;plan of distribution&#8221; and information customarily provided by investment banks or their counsel or advisors in the preparation of an offering memorandum for private placements of non-convertible bonds pursuant to Rule&#160;144A under the Securities Act, (2) risk factors relating to, or any description of, all or any component of any debt financing, (3) historical financial statements or other information required by Rule&#160;3-03(e), 3 03(e), Rule,&#160;3-05, Rule&#160;3-09, Rule&#160;3-10, Rule&#160;3-16, Rule&#160;13-01 or Rule&#160;13-02 of Regulation S-X under the Securities Act; any compensation discussion and analysis or other information required by Item&#160;10, Item&#160;402 and Item&#160;601 of Regulation S-K under the Securities Act or XBRL exhibits; or any information regarding executive compensation or related persons related to SEC Release Nos. 33-8732A, 34-54302A and IC-27444A, (4) other information customarily excluded from an offering memorandum for private placements of non-convertible high-yield bonds pursuant to Rule&#160;144A under the Securities Act in a &#8220;Rule&#160;144A-for-life&#8221; offering, (5) consolidating financial statements, separate Subsidiary financial statements, related party disclosures, or any segment information, including any required by FASB Accounting Standards Codification Topic 280, (6) financial statements or other financial data (including selected financial data) for any period earlier than the year ended December&#160;31, 2023, (7) financial information that the Company does not maintain in the ordinary course of business, (8) information not reasonably available to the Company under its current reporting systems, (9) (x) pro forma financial information or pro forma financial statements or (y) projections or (10) any financial statements whatsoever other than those of the Company that have been publicly filed in its Form&#160;10-K for the fiscal years ended December&#160;31, 2023 and December&#160;31, 2024 and its Form&#160;10-Q for the fiscal quarters ended March&#160;31, 2024, June&#160;30, 2024, September&#160;30, 2024 and March&#160;31, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Ex-Im Laws</u>&#8221; means all applicable Laws relating to export, re-export, transfer, and import controls, including the U.S. Export Administration Regulations, the customs and import Laws administered by U.S. Customs and Border Protection, and the EU Dual Use Regulation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>FERC</u>&#8221; means the Federal Energy Regulatory Commission, and any successor thereto. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-9<br></div></div></div>
<!--End Page 338-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 339-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>FPA</u>&#8221; means the Federal Power Act and the implementing regulations of FERC thereunder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Fraud</u>&#8221; means actual and intentional fraud under the common law of Delaware (and shall exclude any claim based on equitable fraud, constructive knowledge, reckless or negligent misrepresentation or any similar theory). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>GAAP</u>&#8221; means United States generally accepted accounting principles. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Governmental Body</u>&#8221; means any federal, state, provincial, local, municipal, foreign or other governmental or quasi-governmental authority, including without limitation any arbitrator and applicable securities exchanges, or any department, minister, agency, commission, commissioner, board, subdivision, bureau, agency, instrumentality, court or other tribunal of any of the foregoing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Government Contract</u>&#8221; means any Contract for the sale of supplies or services currently in performance or that has not been closed that is between the Company or any of its Subsidiaries, on the one hand, and a Governmental Body, on the other hand, or entered into by the Company or any of its Subsidiaries as a subcontractor at any tier in connection with a Contract between another Person and a Governmental Body. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Hazardous Substance</u>&#8221; means petroleum, polychlorinated biphenyls, asbestos or asbestos-containing materials, radioactive materials, per- and polyfluoroalkyl substances, noise or any hazardous substance as defined in CERCLA or any waste, material or substance that is regulated, defined or designated as dangerous, hazardous, radioactive, explosive, toxic or a pollutant or contaminant under or pursuant to any Environmental Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>In the Money Option</u>&#8221; means each Company Option that is outstanding and unexercised as of immediately prior to the Effective Time that has a per share exercise price that is less than the Per Company Share Price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Indebtedness</u>&#8221; means, with respect to any Person, without duplication, all obligations or undertakings by such Person: (i) for borrowed money; (ii) evidenced by bonds, debentures, notes or similar instruments; (iii) pursuant to securitization or factoring programs or arrangements; (iv) pursuant to guarantees of any Indebtedness of any other Person (other than between or among such Person and its Subsidiaries); (v) net cash payment obligations of such Person under swaps, options, derivatives and other hedging Contracts or arrangements that will be payable upon termination thereof (assuming termination on the date of determination); (vi) in the form of capital lease obligations of such Person; (vii) in the form of reimbursement obligations of such Person under letters of credit to the extent such letters of credit have been drawn; and (viii) in the form of deferred purchase price of any assets or property, earnout, holdback or similar payments (other than trade payables incurred in the ordinary course of business). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Indentures</u>&#8221; means each of the Company 2029 Notes Indenture and the Company 2031 Notes Indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Intellectual Property</u>&#8221; means any and all intellectual property or similar proprietary rights throughout the world, including any and all of the following, and any and all rights in, arising out of, or associated therewith: (a)&#160;patents (including utility and design patents), patent applications (including divisionals, continuations, continuations in part, provisionals, and renewal applications), statutory invention registrations and similar or equivalent rights in inventions and designs, and renewals, reexaminations, substitutions, extensions or reissues thereof (&#8220;<u>Patents</u>&#8221;); (b) trademarks, service marks, trade dress, trade names, logos and other designations of origin (whether or not registered), the goodwill associated with the foregoing, registrations and applications to register the foregoing, and extensions, modifications and renewals thereof; (c) Internet domain names and social media identifiers, and any goodwill associated therewith; (d) copyrights, copyrightable writings and any other equivalent rights in works of authorship (whether or not registered), including rights in databases, data collections and Software, registrations and applications for registration of the foregoing, and renewals, reversions, restorations, derivative works or extensions of any of the foregoing, now or hereafter provided by applicable Law, regardless of the medium of fixation or means of expression; (e) trade secrets and industrial secret rights, rights in know-how, data, confidential or proprietary business or technical information, including formulae, concepts, methods, techniques, source code, documentation, inventions (whether or not patentable), procedures, processes (including manufacturing and production processes), algorithms, schematics, drawings, blueprints, manuals, specifications, prototypes, models, designs, customer lists and supplier lists, financial and marketing plans, and pricing and cost information, in each case, that derives independent economic value, whether actual or potential, from not being known to other persons, (collectively, &#8220;<u>Trade Secrets</u>&#8221;&#8220;)); (f) other similar or equivalent intellectual property and proprietary rights anywhere in the world; and (g) rights to sue or recover and retain damages and costs and attorneys&#8217; fees for past, present and future infringement, misappropriation or other violation of any of the foregoing. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-10<br></div></div></div>
<!--End Page 339-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 340-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Intervening Event</u>&#8221; means any material event, change, effect, development or occurrence first occurring or arising after the date of this Agreement and prior to the Company Stockholder Approval that (i) was not known or reasonably foreseeable, or the material consequences of which were not known or reasonably foreseeable, to the Company Board as of or prior to the execution of this Agreement and (ii) does not relate to (A) any Acquisition Proposal or any inquiry, offer, request or proposal that would reasonably be expected to lead to an Acquisition Proposal, (B) any change in the market price or trading volume of the Company Common Stock or Parent Common Stock (<u>provided</u>, that the underlying cause of such change may be taken into account, to the extent otherwise permitted by this definition), (C) the fact, in and of itself, that the Company or any of its Subsidiaries has met or exceeded any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (<u>provided</u>, that the underlying cause thereof may be taken into account, to the extent otherwise permitted by this definition), (D) any action taken by the Parties pursuant to the affirmative covenants set forth in <u>Section&#160;7.05</u>, or (E) any breach of this Agreement by the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>IT Assets</u>&#8221; means any and all computers, Software, servers, workstations, routers, hubs, switches, circuits, networks, data communications lines and other information technology equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Knowledge</u>&#8221; of the Company or Parent, as applicable, means, with respect to any matter in question, the actual knowledge of any of such Party&#8217;s executive officers listed on <u>Section&#160;1.1(b)</u> of the Company Disclosure Letter (such persons, the &#8220;<u>Company Knowledge Persons</u>&#8221;) or <u>Section&#160;1.01</u> of the Parent Disclosure Letter (such persons, the &#8220;<u>Parent Knowledge Persons</u>&#8221;), as applicable, in each case after reasonable inquiry of their direct reports. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Law</u>&#8221; means any foreign or U.S. federal, state or local law (including common law), treaty, statute, code, order, ordinance, Permit, rule, regulation, guidance document or other requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Body, and, for the sake of clarity, includes Environmental Laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Liability</u>&#8221; means, with respect to any Person, any liability or obligation of that Person of any kind, character or description, whether known or unknown, absolute or contingent, accrued or unaccrued, asserted or unasserted, disputed or undisputed, liquidated or unliquidated, secured or unsecured, joint or several, due or to become due, vested or unvested, executory, determined, determinable or otherwise, and whether or not the same is required to be accrued on the financial statements of that Person in accordance with GAAP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Liens</u>&#8221; means any lien, mortgage, security interest, pledge, encumbrance, deed of trust, security interest, claim, lease, sublease, charge, option, preemptive right, right of first refusal, subscription right, easement, servitude, proxy, voting trust or agreement, transfer restriction under any stockholder or similar agreement, encumbrance or restriction, in each case, other than transfer restrictions under applicable securities laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>New Tranche 1 Warrants</u>&#8221; shall have the meaning set forth in the Company Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>New Tranche 2 Warrants</u>&#8221; shall have the meaning set forth in the Company Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Order</u>&#8221; means any decision, award, writ, judgment, decree, ruling, verdict, injunction, assessment, penalty, or similar order made, issued or entered by, or settlement with, any Governmental Body. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Organizational Documents</u>&#8221; means, with respect to any Person (other than a natural Person), (a) the certificate or articles of incorporation, organization, amalgamation or continuation and any joint venture, limited liability company, operating or partnership agreement and other similar documents adopted or filed in connection with the creation, formation or organization of such Person and (b) all bylaws, limited liability agreement, voting agreement, shareholders agreement and similar documents, instruments or agreements relating to the organization or governance of such Person, in each case, as amended or supplemented. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Parent Capital Stock</u>&#8221; means the Parent Common Stock and the Parent Preferred Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Class&#160;A Common Stock</u>&#8221; means the shares of Class&#160;A common stock, par value $0.000005 per share, of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Class&#160;B Common Stock</u>&#8221; means the shares of Class&#160;B common stock, par value $0.000005 per share, of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Class&#160;C Common Stock</u>&#8221; means the shares of Class&#160;C common stock, par value $0.000005 per share, of Parent. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-11<br></div></div></div>
<!--End Page 340-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 341-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Common Stock</u>&#8221; means, collectively, the Parent Class&#160;A Common Stock, the Parent Class&#160;B Common Stock and the Parent Class&#160;C Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Developments Properties</u>&#8221; means the Company Real Property set forth on <u>Section&#160;1.01(c)</u> of the Company Disclosure Letter. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Equity Award</u>&#8221; means each Parent Option, Parent RSU Award or other equity award issued pursuant to a Parent Equity Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Equity Plans</u>&#8221; means each of Parent&#8217;s 2025 Equity Incentive Plan and 2019 Stock Option Plan, as amended. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Fundamental Representations</u>&#8221; means the representations and warranties of Parent set forth in <u>Section&#160;5.01</u> (<font style="font-style: italic;">Organization and Corporate Power</font>) (solely with respect to the first, fourth and fifth sentences thereof); <u>Section&#160;5.02</u> (<font style="font-style: italic;">Authorization; Valid and Binding Agreement</font>); <u>Section&#160;5.03(b)</u> (other than the third and fourth sentences thereof) (<font style="font-style: italic;">Parent Capital Stock</font>); the third sentence of <u>Section&#160;5.04(b)</u> (<font style="font-style: italic;">Subsidiaries</font>); and <u>Section&#160;5.05</u> (<font style="font-style: italic;">No Breach</font>) (solely with respect to clause (a) thereof); and <u>Section&#160;5.13</u> (<font style="font-style: italic;">Brokerage</font>). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Fundamental Representations &#8211; De Minimis</u>&#8221; means the representations and warranties of Parent set forth in <u>Section&#160;5.03(a)</u> and the third and fourth sentences of <u>Section&#160;5.03(b)</u> (<font style="font-style: italic;">Parent Capital Stock</font>). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Material Adverse Effect</u>&#8221; means any change, effect, event, circumstance, occurrence, state of facts or development, that, individually or in the aggregate, has had or would reasonably be expected to have a material adverse effect on the business, assets, results of operations or financial condition of Parent and its Subsidiaries, taken as a whole, other than any change, effect, event, circumstance, occurrence, state of facts or development to the extent related to or resulting from: (i) general business or economic conditions affecting the industry in which Parent and its Subsidiaries operate; (ii) acts of god, weather conditions or environmental events and natural disasters (including any earthquakes, floods, hurricanes, tropical storms, fires, or other natural disasters), health emergencies, pandemics or epidemics (or the escalation of any of the foregoing) and any governmental or industry responses thereto; (iii)&#160;political or geopolitical conditions (including tariffs and sanctions), the occurrence or the escalation or worsening of any military or terrorist actions or cyberterrorism (including cyberterrorism data breaches), civil or political unrest, acts of war, hostilities or sabotage; (iv) changes in general economic, financial or market conditions, including changes in the artificial intelligence, financial, banking, currency, bitcoin, bitcoin mining, cryptocurrency, electricity, energy, power or securities markets and changes in cryptocurrency prices, commodity prices and regulatory, legislative or political conditions; (v) changes in the prices of commodities, bitcoin or other digital assets after the date hereof; (vi) changes in GAAP after the date hereof; (vii) changes in Laws or Orders after the date hereof; (viii)&#160;changes in Parent&#8217;s stock price or the trading volume of Parent&#8217;s stock or any change in the credit rating of Parent (provided, that, the underlying causes of any such change, to the extent not otherwise excluded from the definition of a Parent Material Adverse Effect, may be taken into consideration when determining whether a Parent Material Adverse Effect has occurred); (ix) the failure of Parent to meet internal or analysts&#8217; expectations, projections or results of operations (<u>provided, that</u>, the underlying causes of such failure to meet expectations, projections or results of operations, to the extent not otherwise excluded from the definition of a Parent Material Adverse Effect, may be taken into account in determining whether there has been a Parent Material Adverse Effect); (x) breaches or threatened breaches by the Company or any of its Subsidiaries of any commercial Contract with Parent or any of its Subsidiaries; (xi) the execution or delivery of this Agreement, the announcement of this Agreement or the Contemplated Transactions, the identity of the Parties or the taking of any action required by this Agreement, including the impact of any of the foregoing on the relationships of Parent or any of its Subsidiaries with Governmental Bodies, customers, suppliers, power providers, utility companies, contractors, partners, officers, employees or other business relations (it being understood that this clause (xi) shall not apply to a breach of the representations and warranties set forth in <u>Sections 5.02</u>, <u>5.05, 5.06 </u>or the accuracy of such representations and warranties for the purposes of the closing condition set forth in <u>Section&#160;8.03(a)</u>); (xii) Transaction Litigation (<u>provided</u>, <u>that</u>, the underlying causes of any such litigation, to the extent not otherwise excluded from the definition of a Parent Material Adverse Effect, may be taken into consideration when determining whether a Parent Material Adverse Effect has occurred); and (xiii) any action expressly required by this Agreement or any action taken by Parent or any of the Subsidiaries of Parent at the Company&#8217;s written request or with the Company&#8217;s consent); <u>provided</u>, <u>however</u>, that if any change, effect, event, circumstance, occurrence, state of facts or development described in any of <u>clauses (i)</u> through <u>(vii)</u> has or has had a disproportionate adverse effect on Parent and its </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-12<br></div></div></div>
<!--End Page 341-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 342-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Subsidiaries, taken as a whole, relative to other participants in the industries in which Parent and its Subsidiaries operate, then the incremental disproportionate adverse effect (and only the incremental disproportionate adverse effect) may be taken into account in determining whether a Parent Material Adverse Effect has occurred. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent 2021 Note&#160;Purchase Agreement</u>&#8221; means the Note&#160;Purchase Agreement, dated as of October&#160;19, 2021, as amended, restated, supplemented or otherwise modified from time to time, among Parent, Magnetar Financial LLC and the lenders named on the Schedule of Lenders attached thereto. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent 2022 Note&#160;Purchase Agreement</u>&#8221; means the Note&#160;Purchase Agreement, dated as of October&#160;17, 2022, as amended, restated, supplemented or otherwise modified from time to time, among Parent and the lenders party thereto. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Option</u>&#8221; means each award granted pursuant to a Parent Equity Plan of an option to purchase shares of Parent Class&#160;A Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Parent Preferred Stock</u>&#8221; means the preferred stock of Parent, par value $0.000005 per share. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent RSU Award</u>&#8221; means each award of restricted stock units representing the right to vest in and be issued shares of Parent Class&#160;A Common Stock granted pursuant to a Parent Equity Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Parent Warrants</u>&#8221; means the warrants, as amended, restated, supplemented or otherwise modified from time to time, to purchase Parent Class&#160;A Common Stock issued pursuant to the Parent 2022 Note&#160;Purchase Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>PEO Plan</u>&#8221; means each Company Plan that is sponsored or maintained by a professional employer organization. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Per Company Share Price</u>&#8221; means (i) the Exchange Ratio multiplied by (ii) the average of the volume weighted average trading prices of Parent Class&#160;A Common Stock (as reported by Bloomberg L.P. or, if not reported therein, in another authoritative source mutually selected by the Parties) on each of the 5 consecutive trading days ending on (and including) the last trading day prior to the date of the Effective Time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Permits</u>&#8221; means all approvals, authorizations, certificates, clearances, consents, exemptions, franchises, grants, licenses, orders, permits, qualifications, registrations, waivers or other similar authorizations of all Governmental Bodies, including Environmental Permits. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Permitted Liens</u>&#8221; means (a) statutory Liens for Taxes or other governmental charges not yet due and payable or the amount or validity of which is being contested in good faith by appropriate proceedings and for which appropriate reserves are established in the financial statements in accordance with GAAP, (b) mechanics&#8217;, carriers&#8217;, workers&#8217;, repairers&#8217;, contractors&#8217;, subcontractors&#8217;, suppliers&#8217; and similar statutory Liens arising or incurred in the ordinary course of business in respect of the construction, maintenance, repair or operation of assets for amounts which are not delinquent (or which are being contested in good faith by appropriate proceedings), and which are not, individually or in the aggregate, significant, (c) solely with respect to real property, zoning, entitlement, building and other land use regulations or restrictions imposed by a Governmental Body having jurisdiction over the Company Real Property that do not materially impair the occupancy or use of such real property for the purposes for which it is currently used in connection with the Company&#8217;s business, (d) covenants, conditions, restrictions, easements and other similar matters of record affecting title to the Company Real Property that do not, individually or in the aggregate, materially impair the operation or use of such real property for the purposes for which it is currently used in connection with the Company&#8217;s business, (e) Liens arising under workers&#8217; compensation, unemployment insurance and social security, (f) Liens securing indebtedness or liabilities that are reflected in the Company SEC Documents, (g) Liens arising from non-exclusive licenses, covenants not to sue and similar non-exclusive rights granted with respect to Intellectual Property, (h) Liens, encumbrances or imperfections of title which do not secure indebtedness for borrowed money or the deferred purchase price of any assets (or any guarantee thereof) and which do not and would not reasonably be expected to, individually or in the aggregate, materially impair the use of the subject property as used by the Company and its Subsidiaries, (i) Liens affecting the fee interest of any Leased Real Property, (j) non-monetary Liens that do not, individually or in the aggregate, materially interfere with the present use, or materially detract from the value of, the property encumbered thereby, (k) Liens in favor of the Company or any of its Subsidiaries, (l) security deposits and cash collateral securing performance bonds, leases and letters of credit in the ordinary course of business, (m) Liens to be released at or prior to the Closing, (n) leases, subleases, licenses and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-13<br></div></div></div>
<!--End Page 342-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 343-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">occupancy agreements by the Company as landlord, sublandlord or licensor as set forth on <u>Section&#160;4.12(b)</u> of the Company Disclosure Letter and (o) Liens, existing as of the date hereof, details which have been made available to Parent, prior to the date hereof, securing obligations under the Company Secured Debt Documents. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Person</u>&#8221; means an individual, a partnership, a corporation, a limited liability company, an unlimited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, any other entity or any Governmental Body or any &#8220;group&#8221; within the meaning of Section&#160;13(d) of the Exchange Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Personal Information</u>&#8221; means all data relating to an identified or identifiable natural person (<font style="font-style: italic;">i.e.</font>, data that identifies an individual or, in combination with any other information or data, is capable of identifying a natural person) or information that constitutes &#8220;personal data&#8221;, &#8220;personal information&#8221; or &#8220;personally identifiable information&#8221;, or any similar term, as defined in any Privacy Laws applicable to the Company and its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Physical Network</u>&#8221; means the fibers and fiber miles owned or leased by the Company or its Subsidiaries with indefeasible rights of use and swaps. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Plan</u>&#8221; means any (i) &#8220;employee benefit plan&#8221; within the meaning of Section&#160;3(3) of ERISA (whether or not subject to ERISA) or (ii) and other plan, policy, program, arrangement or agreement providing for any compensation or benefits, in each case, whether written or unwritten, funded or unfunded, whether or not subject to ERISA and covering one or more Persons, including, without limitation, any stock purchase, stock option, restricted stock, other equity-based, phantom equity, severance, separation, retention, consulting, employment, change in control, bonus, incentive, deferred compensation, pension, retirement, supplemental retirement, health, dental, vision, disability, life insurance, death benefit, health, welfare, vacation, paid time off, leave of absence, employee assistance, legal services, tuition assistance, fringe benefit or other benefit plan, policy, program, arrangement, or agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Prior Sale Agreement</u>&#8221; means any purchase or sale Contract relating to any fee interest real property or leasehold interest in any material Real Property Lease conveyed, transferred, assigned or otherwise disposed of by the Company or any Subsidiary since January&#160;1, 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Privacy Laws</u>&#8221; means any and all applicable Laws relating to the protection or processing of Personal Information, data privacy, cybersecurity or the privacy of electronic communications in any relevant jurisdiction, including, to the extent applicable, the California Consumer Privacy Act of 2018, (as amended by the California&#160;Privacy Rights Act of 2020), the EU General Data Protection Regulation 2016/679 of April&#160;27, 2016 and the equivalent thereof under the laws of the United Kingdom. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<font style="font-weight: normal;"><u>PUHCA</u>&#8221; means the Public Utility Holding Company Act of 2005 and the implementing regulations of FERC thereunder. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Release</u>&#8221; means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, disposing or migration into or through the environment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Representative</u>&#8221; means the directors, officers, employees, accountants, consultants, legal counsel, financial advisors and agents and other representatives of a party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Sanctioned Country</u>&#8221; means any country or other territory subject to a comprehensive export, import, financial or investment embargo under any Sanctions Laws, which currently comprise Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, the so-called Donetsk People&#8217;s Republic, and the so-called Luhansk People&#8217;s Republic. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Sanctioned Person</u>&#8221; means any Person with whom dealings are restricted or prohibited under any Sanctions Laws, including the Sanctions Laws of the United States, the United Kingdom, the European Union or the United&#160;Nations, including (i) any Person identified in any list of Sanctioned Persons maintained by (A) the United&#160;States Department of Treasury, Office of Foreign Assets Control, the United States Department of Commerce, Bureau of Industry and Security or the United States Department of State, (B) His Majesty&#8217;s Treasury of the United&#160;Kingdom, (C) any committee of the United Nations Security Council, or (D) the European Union, (ii) any Person located, organized, or resident in, organized in, or a Governmental Authority or government instrumentality of, any Sanctioned Country and (iii) any Person directly or indirectly fifty percent (50%) or more owned or controlled by, or acting for the benefit or on behalf of, a Person described in the foregoing clauses (i) or (ii). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Sanctions Laws</u>&#8221; means all applicable Laws concerning economic sanctions, including embargoes, export restrictions, the ability to make or receive international payments, the freezing or blocking of assets of targeted </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-14<br></div></div></div>
<!--End Page 343-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 344-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Persons, the ability to engage in transactions with specified Persons or countries or the ability to take an ownership interest in assets of specified Persons or located in a specified country, including any applicable Laws threatening to impose economic sanctions on any person for engaging in proscribed behavior. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Software</u>&#8221; means any and all (a) computer programs, applications, systems and code, including software implementations of algorithms, models and methodologies, program interfaces, source code, object code, firmware, operating systems and specifications; (b) development and design tools, library functions and compilers; and (c)&#160;media, documentation and other works of authorship, including user manuals and training materials, solely to the extent embedded in or necessary to operate the forgoing or on which any of the foregoing is recorded. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>State Commission</u>&#8221; has the meaning set forth in 18 C.F.R. &#167; 1.101(k). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to any Person, any corporation, partnership, association, limited liability company, unlimited liability company or other business entity of which (a) if a corporation, a majority of the total voting power of shares of stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof, or (b) if a partnership, association, limited liability company, or other business entity, a majority of the partnership or other similar ownership interests thereof is at the time owned or controlled, directly or indirectly, by any Person or one or more Subsidiaries of that Person or a combination thereof. For purposes hereof, a Person or Persons shall be deemed to have a majority ownership interest in a partnership, association, limited liability company or other business entity if such Person or Persons are allocated a majority of partnership, association, limited liability company or other business entity gains or losses or otherwise control the managing director, managing member, general partner or other managing Person of such partnership, association, limited liability company or other business entity. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Superior Proposal</u>&#8221; means a written Acquisition Proposal (except the references in the definition thereof to &#8220;twenty percent (20%)&#8221; shall be replaced by &#8220;fifty percent (50%)&#8221;) made by any Person (other than Parent or any of its Subsidiaries) that the Company Board has determined in good faith, after consultation with its financial advisor and outside legal counsel, and after taking into account the legal, financial, conditional, financing, timing and regulatory aspects of the proposal and the Contemplated Transactions (accounting for any revisions to the terms of the Contemplated Transactions proposed by Parent in response to such Acquisition Proposal as contemplated by <u>Section&#160;7.04(b)</u>), (i) is reasonably likely to be consummated in accordance with its proposed terms if accepted by the Company and (ii) if consummated, would be more favorable, from a financial point of view, to the stockholders (in their capacity as such) of the Company than the Contemplated Transactions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Takeover Law</u>&#8221; means any &#8220;moratorium,&#8221; &#8220;control share acquisition,&#8221; &#8220;fair price,&#8221; &#8220;supermajority,&#8221; &#8220;affiliate transaction,&#8221; or &#8220;business combination&#8221; statute or regulation or other similar antitakeover Laws of any Governmental Body. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Tax</u>&#8221; or &#8220;<u>Taxes</u>&#8221; means any and all federal, state, local or non-U.S. income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding (including backup withholding), social security, unemployment, disability, real property, personal property, sales, use, transfer, registration, value-added, alternative or add-on minimum, estimated, or other tax of any kind, including any interest, penalty or addition thereto. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Tax Proceeding</u>&#8221; means any action, suit, proceeding, audit or claim in respect of any Tax or Tax Return. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Tax Return</u>&#8221; means any return, report, statement, information return or other document (including any amendments thereof and any attachments or schedules thereto) required to be filed with any Governmental Body with respect to Taxes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Tax Sharing Agreement</u>&#8221; means any agreement or arrangement binding the Company or any of its Subsidiaries that provides for the allocation, apportionment, sharing, indemnification or assignment of any Tax liability or benefit, or the transfer or assignment of income, revenues, receipts, or gains for the purpose of determining any Person&#8217;s Tax liability (other than Tax sharing or indemnification provisions contained in an agreement entered into in the ordinary course of business the primary subject matter of which does not relate to Taxes). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Taxing Authority</u>&#8221; means any Governmental Body responsible for the imposition or collection of any Tax. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Third Party</u>&#8221; means any Person, other than the Company, Parent or any of their respective Affiliates or Representatives acting in their capacity as such. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-15<br></div></div></div>
<!--End Page 344-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 345-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Tranche 1 Warrants</u>&#8221; shall have the meaning set forth in the Company Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Tranche 2 Warrants</u>&#8221; shall have the meaning set forth in the Company Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Transaction Litigation</u>&#8221; means any Action (including any class action or derivative litigation) asserted or commenced by, on behalf of or in the name of, against or otherwise involving the Company or Parent or any of their respective Subsidiaries, the Company Board or Parent Board, any committee thereof and/or any of the Company&#8217;s or Parent&#8217;s directors or officers, each as applicable, relating directly or indirectly to this Agreement, the Merger or any of the Contemplated Transactions or disclosures of a party relating to the Contemplated Transactions, including any such claim or legal proceeding based on allegations that the Company&#8217;s or Parent&#8217;s entry into this Agreement, as applicable, or the terms and conditions of this Agreement or any of the Contemplated Transactions constituted a breach of the fiduciary duties of any member of the Company Board or Parent Board or any officer of the Company or Parent, each as applicable, except for any Action solely among the Parties or their Affiliates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">&#8220;<u>Treasury Regulations</u>&#8221; means the U.S. Treasury regulations promulgated under the Code. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">&#8220;<u>Valid Right</u>&#8221; means a right of ownership, use or occupancy arising under fee title, a leasehold interest, an easement (including arising under a statute or other applicable Law), a Permit, a license, an indefeasible right to use, a colocation right, a co-occupancy right, a conduit right, a pole attachment right, a regeneration site right, an interconnection right or other similar right. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS102"><!--Anchor--></a>Section&#160;1.02.&#8195;<u>Other Defined Terms</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The below table lists the sections where the below terms are defined. </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Term</u> <u>Location</u> </div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adverse Recommendation Change</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.04(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Agreement</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Anti-Corruption Laws</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(f) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Book-Entry Share</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.03 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cancelled Shares</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.01(a)(i) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CERCLA</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.19(a)(iv) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.03 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Certificate of Merger</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.03 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Claim Expenses</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.07(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Closing</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Closing Date</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company 10-K</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.03(e) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Board</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Board Recommendation</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Common Stock</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Disclosure Letter</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Article&#160;IV </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Knowledge Persons</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Definition of Knowledge, 1.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Material Contract</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.14(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Organizational Documents</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Product</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Section&#160;4.15(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Real Property</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Real Property Lease</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Real Property Leases</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company SEC Documents</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.07(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Securities</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.03(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Software</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Section&#160;4.15(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Stockholder Approval</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Stockholders</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Stockholders&#8217; Meeting</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.03(a) </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-16<br></div></div></div>
<!--End Page 345-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 346-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Term</u> <u>Location</u> </div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Company Subsidiary Securities</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.04(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Confidentiality Agreement</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.01(e) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">D&amp;O Claim</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.07(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Davis Polk</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.13(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Debt Financing Sources</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.22(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Development Property</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">DGCL</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effective Time</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.03 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Electronic Delivery</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">10.05 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Eligible Shares</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.01(a)(ii) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">End Date</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">9.01(d)(ii) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Enforceability Exceptions</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">ERISA</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.18(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exchange Act</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.06 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exchange Agent</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.04(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exchange Fund</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.04(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">FCPA</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forum</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">10.06(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">HSR Act</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.06 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Indemnified Party</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.07(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intended Tax Treatment</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.13(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intentional Breach</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">9.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Joint Venture Entities</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.03(e) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leased Real Property</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Maximum Premium</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.07(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Measurement Date</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.03(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Merger</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Merger Consideration</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.01(a)(ii) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Merger Sub</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Merger Sub Consents</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Merger Sub I Board</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">NASDAQ</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New Plans</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.06(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-DTC Book-Entry Share</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3.04(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">OECD Convention</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Owned Real Property</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Balance Sheet Date</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.08 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Board</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Class&#160;A Common Stock</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Disclosure Letter</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Article&#160;V </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Knowledge Persons</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Definition of Knowledge, 1.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent SEC Documents</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.07(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Securities</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.03(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Stockholders</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Recitals </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Subsidiary Securities</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.04 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parties</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Party</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Preamble </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Patents</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Definition of Intellectual Property, 1.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-Closing Period</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">6.01(a) </div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-17<br></div></div></div>
<!--End Page 346-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 347-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Term</u> <u>Location</u> </div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Pre-Stabilized Property</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.12(e) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Privacy Requirements</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(f) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prohibited Payment</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property Material Contracts</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.14(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proxy Statement</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.02(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Registered IP</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.15(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Registration Statement</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.02(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sarbanes-Oxley</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(c) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">SEC</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.06 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Securities Act</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.06 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Security Breach</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.15(h) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Significant Subsidiary</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5.04 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Strategic Direction</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.05(e) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Surviving Corporation</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">2.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Surviving Provisions</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">9.02 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Termination Fee</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">9.03(b) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Trade Control Laws</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(h) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Trade Secrets</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">Definition of Intellectual Property, 1.01 </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">UK Bribery Act</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.10(g) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Wachtell</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">7.13(a) </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">WARN</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">4.20(c)</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS103"><!--Anchor--></a>Section&#160;1.03.&#8195;<u>Other Definitional Provisions</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;All references in this Agreement to &#8220;Exhibits&#8221;, &#8220;Annexes&#8221;, &#8220;disclosure letters&#8221;, &#8220;Articles&#8221;, &#8220;Sections&#8221;, &#8220;subsections&#8221; and other subdivisions refer to the corresponding Exhibits, Annexes, disclosure letters, Articles, Sections, subsections and other subdivisions of or to this Agreement unless expressly provided otherwise. Titles appearing at the beginning of any Articles, Sections, subsections or other subdivisions of this Agreement, or in any parenthetical headings following section references, are for convenience only, do not constitute any part of this Agreement, and will be disregarded in construing the language hereof. All references in this Agreement to &#8220;days&#8221; refer to &#8220;calendar days&#8221; unless otherwise specified. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Exhibits and disclosure letters to this Agreement are attached hereto and by this reference incorporated herein for all purposes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The words &#8220;this Agreement,&#8221; &#8220;herein,&#8221; &#8220;hereby,&#8221; &#8220;hereunder,&#8221; and &#8220;hereof,&#8221; and words of similar import, refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The words &#8220;this Article,&#8221; &#8220;this Section&#8221; and &#8220;this subsection,&#8221; and words of similar import, refer only to the Article, Section&#160;or subsection hereof in which such words occur. The words &#8220;either,&#8221; &#8220;or,&#8221; &#8220;neither,&#8221; &#8220;nor&#8221; and &#8220;any&#8221; are not exclusive. The word &#8220;including&#8221; (in its various forms) means including without limitation. References to &#8220;from&#8221; or &#8220;through&#8221; any date mean, unless otherwise specified, &#8220;from and including&#8221; or &#8220;through and including&#8221;, respectively. The word &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; shall mean the degree to which a subject or other theory extends and such phrase shall not mean &#8220;if&#8221;. All references to &#8220;$&#8221; and &#8220;dollars&#8221; shall be deemed to refer to U.S. currency unless otherwise specifically provided. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Pronouns in masculine, feminine or neuter genders shall be construed to state and include any other gender, and words, terms and titles (including terms defined herein) in the singular form shall be construed to include the plural and vice versa, unless the context otherwise requires. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;References to any &#8220;Law&#8221; shall be deemed to refer to such Law as amended from time to time and to any rules or regulations promulgated thereunder as of the referenced time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;This Agreement shall not be construed as if prepared by one of the Parties, but rather according to its fair meaning as a whole, as if all Parties had prepared it. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;Disclosure of any fact or item in the Company Disclosure Letter or Parent Disclosure Letter with respect to the correspondingly numbered representation, warranty or covenant of the Company or Parent, as </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-18<br></div></div></div>
<!--End Page 347-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 348-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">applicable, in this Agreement shall be deemed to have been disclosed with respect to any other representation or warranty of the Company or Parent, as applicable, in this Agreement in respect of which the applicability of such disclosure is reasonably apparent on its face. The specification of any dollar amount in the representations or warranties contained in this Agreement or the inclusion of any specific item in the Company Disclosure Letter or the Parent Disclosure Letter is not intended to imply that such amounts, or higher or lower amounts or the items so included or other items, are or are not material. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tANXAA2"><!--Anchor--></a>ARTICLE&#160;II<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">THE MERGER </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS201"><!--Anchor--></a>Section&#160;2.01.&#8195;<u>The Merger</u>. Upon the terms and subject to the conditions of this Agreement, in accordance with the Delaware General Corporation Law (the &#8220;<u>DGCL</u>&#8221;), at the Effective Time, Merger Sub shall be merged with and into the Company, the separate corporate existence of Merger Sub shall cease, and the Company shall continue as the surviving corporation in the Merger (the &#8220;<u>Surviving Corporation</u>&#8221;). The Surviving Corporation shall continue to exist under the laws of the State of Delaware, with all of its rights, privileges, immunities, powers and franchises, unaffected by the Merger except as set forth in this <u>Article&#160;II</u>. After the Merger, the Surviving Corporation shall be a wholly owned Subsidiary of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS202"><!--Anchor--></a>Section&#160;2.02.&#8195;<u>Closing</u>. The closing of the Merger (the &#8220;<u>Closing</u>&#8221;) shall take place as soon as practicable (and, in any event, within three (3) Business Days) after satisfaction or (to the extent permitted by applicable Law) waiver of the conditions set forth in <u>Article&#160;VIII</u> (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction or (to the extent permitted by applicable Law) waiver of such conditions) (the date on which the Closing actually occurs, the &#8220;<u>Closing Date</u>&#8221;), by electronic transmission of documents, or such other date or place as may be mutually agreed upon in writing by the Parties. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS203"><!--Anchor--></a>Section&#160;2.03.&#8195;<u>Effective Time</u>. Subject to the provisions of this Agreement, at the Closing, the Parties shall cause a certificate of merger (the &#8220;<u>Certificate of Merger</u>&#8221;) to be executed, acknowledged and filed with the Secretary of State of the State of Delaware in accordance with the relevant provisions of the DGCL and shall make all other filings and recordings required under the DGCL. The Merger shall become effective at such time as the Certificate of Merger has been duly filed with the Secretary of State of the State of Delaware or at such later date or time as may be agreed by Parent and the Company in writing and specified in the Certificate of Merger in accordance with the DGCL (the effective time of the Merger being referred to herein as the &#8220;<u>Effective Time</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS204"><!--Anchor--></a>Section&#160;2.04.&#8195;<u>Effects of the Merger</u>. The Merger shall have the effects set forth in this Agreement and in the applicable provisions of the DGCL. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS205"><!--Anchor--></a>Section&#160;2.05.&#8195;<u>Certificate of Incorporation and Bylaws of the Surviving Corporation</u>. At the Effective Time and by virtue of the Merger, the certificate of incorporation of the Surviving Corporation shall be amended and restated (other than Articles V through VIII of the existing certificate of incorporation of the Company, which provisions shall not be amended, repealed or otherwise modified by virtue of the Merger and which are included as Articles V through VIII in the amended and restated certificate of incorporation of the Surviving Corporation) to be in the form attached hereto as <u>Exhibit&#160;A</u>, until thereafter changed or amended as provided therein or by applicable Law and, in all cases, subject to <u>Section&#160;7.07</u>. The bylaws of the Surviving Corporation shall, at the Effective Time and by virtue of the Merger, be amended to be the bylaws of Merger Sub, as in effect immediately prior to the Effective Time, except that all references therein to Merger Sub shall be deemed to be references to the Surviving Corporation, until thereafter changed or amended as provided therein or by applicable Law and, in all cases, subject to <u>Section&#160;7.07</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS206"><!--Anchor--></a>Section&#160;2.06.&#8195;<u>Directors and Officers of the Surviving Corporation</u>. From and after the Effective Time, the initial directors and officers of the Surviving Corporation shall be the directors and executive officers of Merger Sub immediately prior to the Effective Time, each to hold office in accordance with the Organizational Documents of the Surviving Corporation until their respective successors shall have been duly elected, designated or qualified, or until their earlier death, resignation or removal in accordance with the Organizational Documents of the Surviving Corporation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-19<br></div></div></div>
<!--End Page 348-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 349-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tANXAA3"><!--Anchor--></a>ARTICLE&#160;III<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">EFFECT OF THE MERGER ON CAPITAL STOCK; EXCHANGE OF CERTIFICATES <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">AND BOOK-ENTRY SHARES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS301"><!--Anchor--></a>Section&#160;3.01.&#8195;&#8194;<u>Effect on Capital Stock in the Merger</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Effect on Company Capital Stock</u>. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder of shares of capital stock thereof: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;each share of Company Common Stock held in treasury or held or owned by the Company, Parent or Merger Sub immediately prior to the Effective Time (collectively, the &#8220;<u>Cancelled Shares</u>&#8221;) shall be cancelled and retired and shall cease to exist, and no consideration shall be delivered in exchange therefor; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;each share of Company Common Stock, other than any Cancelled Shares, outstanding immediately prior to the Effective Time (collectively, the &#8220;<u>Eligible Shares</u>&#8221;) shall be cancelled and converted into the right to receive a number of fully paid and non-assessable shares of Parent Class&#160;A Common Stock equal to the Exchange Ratio (such consideration, the &#8220;<u>Merger Consideration</u>&#8221;), subject to <u>Section&#160;3.05</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;<u>Effect on Merger Sub Capital Stock</u>. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder of shares of capital stock thereof, each share of common stock of Merger Sub outstanding immediately prior to the Effective Time shall be converted into and become one (1) validly issued, fully paid and non-assessable share of common stock, par&#160;value $0.0001 per share, of the Surviving Corporation, and shall constitute the only outstanding shares of capital stock of the Surviving Corporation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS302"><!--Anchor--></a>Section&#160;3.02.&#8195;<u>Treatment of Company Equity Awards</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Company RSU </u>Awards. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder thereof, each Company RSU Award outstanding immediately prior to the Effective Time shall: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;if held by a Specified Individual (as defined below) or a non-employee director of the Company, fully vest and be cancelled and converted automatically into the right to receive (without interest and less applicable Tax withholding) a number of fully paid and non-assessable shares of Parent Class&#160;A Common Stock equal to the product (rounded up to the nearest whole number of shares) of (A) the total number of shares of Company Common Stock underlying such Company RSU Award as of immediately prior to the Effective Time, <font style="font-style: italic;">multiplied</font> by (B) the Exchange Ratio, which shall be delivered as soon as reasonably practicable following the Closing Date and in no event later than five (5) business days following the Closing Date (or on such later date as is required to comply with Section&#160;409A of the Code); or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;if not covered by <u>Section&#160;3.02(a)(i)</u>, shall be canceled and converted into a restricted stock unit award with respect to a number of shares of Parent Class&#160;A Common Stock equal to the product (rounded up to the nearest whole number of shares) of (A) the total number of shares of Company Common Stock underlying such Company RSU Award as of immediately prior to the Effective Time, <font style="font-style: italic;">multiplied</font> by (Y) the Exchange Ratio (each a &#8220;<u>Parent Rollover RSU Award</u>&#8221;), and, except as otherwise expressly provided in this <u>Section&#160;3.02(a)(ii)</u>, the contractual obligations in respect of each Parent Rollover RSU Award shall be subject to the same terms and conditions (including, for the avoidance of doubt, vesting schedule and treatment on termination of employment) as were applicable to the corresponding Company RSU Award prior to the Effective Time. &#8220;<u>Specified Individual</u>&#8221; means each employee of the Company who enters into an agreement with the Company providing for the treatment described in <u>Section&#160;3.02(a)(i)</u> and <u>Section&#160;3.02(b)(i)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;<u>Company PSU Awards</u>. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Merger Sub, the Company or any holder thereof, each Company PSU Award outstanding immediately prior to the Effective Time shall: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;if held by a Specified Individual, vest and be cancelled and converted automatically into the right to receive (without interest and less applicable Tax withholding) a number of fully paid and non-assessable shares of Parent Class&#160;A Common Stock equal to the product (rounded up to the nearest whole number of </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-20<br></div></div></div>
<!--End Page 349-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 350-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">shares) of (A) the total number of shares of Company Common Stock underlying such Company PSU&#160;Award as of immediately prior to the Effective Time (which number shall be determined by deeming the applicable performance level to equal 300%), <font style="font-style: italic;">multiplied</font> by (y) the Exchange Ratio, which shall be delivered as soon as reasonably practicable following the Closing Date and in no event later than five&#160;(5)&#160;business days following the Closing Date (or on such later date as is required to comply with Section&#160;409A of the Code); or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;if not covered by <u>Section&#160;3.02(b)(i)</u>, be cancelled and converted into a time-based restricted stock unit award with respect to a number of shares of Parent Class&#160;A Common Stock equal to the product (rounded up to the nearest whole number of shares) of (A) the total number of shares of Company Common Stock underlying such Company PSU Award as of immediately prior to the Effective Time (which number shall be determined by deeming the applicable performance level to equal 300%) <font style="font-style: italic;">multiplied</font> by (B) the Exchange Ratio (each a &#8220;<u>Parent Rollover PSU Award</u>&#8221;), and, except as otherwise expressly provided in this <u>Section&#160;3.02(b)(ii)</u>, the contractual obligations in respect of each such Parent Rollover PSU Award shall be subject to the same terms and conditions (including, for the avoidance of doubt, treatment on termination of employment) as were applicable to the corresponding Company PSU Award immediately prior to the Effective Time (other than the applicable performance conditions). The service vesting date for each Parent Rollover PSU Award will be (x) if granted in respect of a Company PSU Award that was granted in 2024, December&#160;31, 2026 or (y) if granted in respect of a Company PSU Award that was granted in 2025, December&#160;31, 2027. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;<u>Company Options</u>. At the Effective Time, each In the Money Option shall, by virtue of the Merger and without further action on the part of the holder thereof, be cancelled and converted into the right to receive (without interest and less applicable Tax withholding) a number of fully paid and non-assessable shares of Parent Class&#160;A Common Stock equal to the In the Money Net Option Share Amount <font style="font-style: italic;">multiplied</font> by the Exchange Ratio. For purposes of this Agreement, &#8220;In the Money Net Option Share Amount&#8221; means, with respect to each In the Money Company Option, the quotient obtained by dividing (i) the product obtained by multiplying (A) the excess, if any, of the Per Company Share Price over the exercise price per share of Company Common Stock subject to such Company Option immediately prior to the Effective Time by (B) the number of shares of Company Common Stock subject to such Company Option immediately prior to the Effective Time by (ii) the Per Company Share Price. Each Company Option that is not an In the Money Option and is outstanding and unexercised as of immediately prior to the Effective Time shall be cancelled at the Effective Time with no consideration payable in respect thereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;<u>Resolutions</u>. Prior to the Effective Time, the Company Board (or an applicable committee thereof) shall adopt any resolutions authorizing the treatment of the equity awards as set forth in this <u>Section&#160;3.02</u>. As soon as practicable following the Effective Time, Parent shall either (i) file with the SEC a post-effective amendment to the Form&#160;S-4 or a registration statement on Form&#160;S-8 (or any successor or other appropriate form) with respect to the Parent Class&#160;A Common Stock underlying the converted Parent Rollover RSU Awards and converted Parent Rollover PSU Awards or (ii) assume the converted Parent Rollover RSU Awards and converted Parent Rollover PSU Awards under an existing Parent Equity Plan with respect to which a registration statement on Form&#160;S-8 (or any successor or other appropriate form) is currently effective. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS303"><!--Anchor--></a>Section&#160;3.03.&#8195;<u>Closing of the Company Transfer Books</u>. At the Effective Time, (a) (i) each certificate formerly representing any share of Company Common Stock (each, a &#8220;<u>Certificate</u>&#8221;) and (ii) each uncertificated share of Company Common Stock (each, a &#8220;<u>Book-Entry Share</u>&#8221;) shall cease to be outstanding and in either case shall represent only the right to receive the Merger Consideration as contemplated by <u>Section&#160;3.01(a)</u> and all holders of Certificates or Book-Entry Shares shall cease to have any rights as Company Stockholders; and (b) the stock transfer books of the Company shall be closed with respect to all shares of Company Common Stock outstanding immediately prior to the Effective Time. No further transfer of any such shares of Company Common Stock shall be made on such stock transfer books after the Effective Time. If after the Effective Time, a valid Certificate is presented to the Exchange Agent, to the Surviving Corporation or to Parent, such Certificate shall be cancelled and shall be exchanged as provided in this <u>Article&#160;III</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS304"><!--Anchor--></a>Section&#160;3.04.&#8195;<u>Exchange Fund; Exchange of Certificates; Cancellation of Book-Entry Positions</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Prior to the Closing, Parent shall select a reputable bank, transfer agent or trust company, reasonably acceptable to the Company, to act as exchange agent in the Merger (the &#8220;<u>Exchange Agent</u>&#8221;) for the payment </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-21<br></div></div></div>
<!--End Page 350-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 351-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">and delivery of the aggregate Merger Consideration pursuant to an exchange agent agreement reasonably acceptable to the Company. At or prior to the Effective Time, Parent shall cause to be deposited with the Exchange Agent, for the benefit of the Company Stockholders, for exchange in accordance with this <u>Article&#160;III</u> through the Exchange Agent, on behalf of itself, the number of shares of Parent Class&#160;A Common Stock to be issued as Merger Consideration pursuant to <u>Section&#160;3.01(a)</u> (to be represented by book-entry shares of Parent Class&#160;A Common Stock) (the shares of Parent Class&#160;A Common Stock deposited with the Exchange Agent pursuant to this <u>Section&#160;3.04(a)</u> and any cash deposited with the Exchange Agent (including as payment for fractional shares to which a Company Stockholder is entitled in accordance with <u>Section&#160;3.05(a)</u>) being referred to herein collectively as the &#8220;<u>Exchange Fund</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;With respect to Book-Entry Shares held through DTC, Parent and the Company shall cooperate to establish procedures with the Exchange Agent and DTC to ensure that the Exchange Agent will transmit to DTC or its nominees as soon as practicable after the Effective Time, but in any event within five (5) Business Days thereafter, upon surrender of shares held of record by DTC or its nominees in accordance with DTC&#8217;s customary surrender procedures, the Merger Consideration, and cash in lieu of fractional shares of Parent Class&#160;A Common Stock otherwise payable to such holder of Book-Entry Shares pursuant to <u>Section&#160;3.05(a)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;With respect to Book-Entry Shares not held through DTC (each, a &#8220;<u>Non-DTC Book-Entry Share</u>&#8221;), Parent shall instruct, and use its commercially reasonable efforts to cause, the Exchange Agent to pay and deliver to each holder of record of any Non-DTC Book-Entry Share, as promptly as reasonably practicable after the Effective Time, but in any event within five (5) Business Days thereafter, the applicable Merger Consideration and a check in the amount (after giving effect to any required Tax withholdings as provided in <u>Section&#160;3.06</u>) of any cash in lieu of fractional shares of Parent Class&#160;A Common Stock otherwise payable to such holder of Book-Entry Shares pursuant to <u>Section&#160;3.05(a)</u> and each Non-DTC Book-Entry Share shall be promptly cancelled by the Exchange Agent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Promptly following the Effective Time, Parent shall cause the Exchange Agent to mail to the record holders of Certificates (i) a letter of transmittal in customary form and containing such provisions as Parent and the Company may reasonably specify (including a provision confirming that delivery of Certificates shall be effected, and risk of loss and title to shares of Company Common Stock shall pass, only upon delivery of such Certificates to the Exchange Agent) and (ii) instructions for use in effecting the surrender of Certificates in exchange for the Merger Consideration, as provided in <u>Section&#160;3.01(a)</u>. Upon surrender of a Certificate to the Exchange Agent for exchange, together with a duly executed letter of transmittal and such other documents as may be reasonably required by the Exchange Agent or Parent, the holder of such Certificate shall be entitled to receive (A) a certificate or evidence of shares in book-entry form representing the number of whole shares of Parent Class&#160;A Common Stock that such holder has the right to receive pursuant to the provisions of <u>Section&#160;3.01(a)</u> and (B) cash in lieu of any fractional shares of Parent Class&#160;A Common Stock pursuant to <u>Section&#160;3.05(a)</u>. Any such Certificate so surrendered shall immediately be cancelled. Until surrendered as contemplated by this <u>Section&#160;3.04(d)</u>, each Certificate shall be deemed, from and after the Effective Time, to represent only the right to receive the Merger Consideration as contemplated by this <u>Article&#160;III</u>. In the event of a transfer of ownership of shares of Company Common Stock that is not registered in the transfer records of the Company, any portion of the Merger Consideration may be issued or paid (in cash in lieu of fractional shares pursuant to <u>Section&#160;3.05(a)</u>) to a Person other than the Person in whose name such Certificate so surrendered is registered if such Certificate is properly endorsed or otherwise is in proper form for transfer, and the Person requesting such issuances and/or payments pays any transfer or other Taxes required by reason of such issuance and/or payment of the Merger Consideration to a person other than the registered holder of such shares of Company Common Stock or establishes to the satisfaction of Parent that such Taxes have been paid or are not applicable. If any Certificate shall have been lost, stolen or destroyed, Parent may, in its discretion and as a condition precedent to the issuance and/or payment of the Merger Consideration, require the owner of such lost, stolen or destroyed Certificate to provide an appropriate affidavit and to deliver a bond (in such sum as Parent may reasonably direct) as indemnity against any claim that may be made against the Exchange Agent, Parent or the Surviving Corporation with respect to such Certificate. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Any portion of the Exchange Fund that remains undistributed as of the date that is twelve (12) months after the Closing Date shall be delivered to Parent upon its request, and any holders of Certificates who have not theretofore surrendered their Certificates to the Exchange Agent in accordance with <u>Section&#160;3.04(d)</u> or any holders of Certificates or Book-Entry Shares who have not cashed any check payable to them in respect of any </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-22<br></div></div></div>
<!--End Page 351-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 352-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">cash in lieu of fractional shares of Parent Class&#160;A Common Stock issuable to such holders pursuant to <u>Section&#160;3.05(a)</u> shall thereafter look only to Parent for satisfaction of their claims for Merger Consideration (including any cash in lieu of fractional shares of Parent Class&#160;A Common Stock), subject to applicable abandoned property law, escheat law or similar Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;None of Parent, Merger Sub or the Surviving Corporation or any of their respective Affiliates shall be liable to any current or former Company Stockholder or to any other Person with respect to any Merger Consideration, properly delivered to any public official in compliance with any applicable abandoned property law, escheat law or similar Law. If any Certificate shall not have been surrendered or any check payable in respect of any cash in lieu of fractional shares of Parent Class&#160;A Common Stock issuable to such holders pursuant to <u>Section&#160;3.05(a)</u> shall not have been cashed prior to five (5) years after the Closing Date (or immediately prior to such earlier date on which any portion of the Merger Consideration would otherwise escheat to or become the property of any Governmental Body), any portion of the Merger Consideration remaining in the Exchange Fund shall, to the extent permitted by applicable Law, become the property of Parent, free and clear of all claims or interest of any Person previously entitled thereto. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS305"><!--Anchor--></a>Section&#160;3.05.&#8195;<u>No Fractional Shares; Certain Calculations; No Appraisal Rights</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;No fractional shares of Parent Class&#160;A Common Stock shall be issued in connection with the Merger, no dividends or distributions of Parent shall relate to such fractional share interests, no certificates or book-entry positions for any such fractional shares shall be issued, and such fractional share interests shall not entitle the owner thereof to vote or to any rights as a Parent Stockholder. Notwithstanding any other provision of this Agreement, each holder of Eligible Shares exchanged pursuant to the Merger who would otherwise have been entitled to receive a fraction of a share of Parent Class&#160;A Common Stock (after aggregating all Company Shares represented by the Certificates and Book Entry Shares delivered by such holder) shall receive, in lieu thereof, cash (without interest) in an amount equal to the product of (i) the aggregate net cash proceeds as determined below and (ii) a fraction, the numerator of which is such fractional part of a share of Parent Class&#160;A Common Stock, and the denominator is the number of shares of Parent Class&#160;A Common Stock constituting a portion of the Exchange Fund as represents the aggregate of all fractional entitlements of all holders of Company Common Stock. As promptly as possible following the Effective Time, the Exchange Agent shall sell at then-prevailing prices on the NASDAQ such number of shares of Parent Class&#160;A Common Stock constituting a portion of the Exchange Fund as represents the aggregate of all fractional entitlements of all holders of Company Common Stock, with the cash proceeds (net of all commissions, transfer taxes and other out-of-pocket costs and expenses of the Exchange Agent incurred in connection with such sales) of such sales to be used by the Exchange Agent to fund the foregoing payments in lieu of fractional shares. The Parties acknowledge that payment of the cash consideration in lieu of issuing fractional shares of Parent Class&#160;A Common Stock pursuant to this <u>Article&#160;III</u> was not separately bargained-for consideration but merely represents mechanical rounding off for purposes of avoiding the expense and inconvenience to Parent that would otherwise be caused by the issuance of fractional shares of Parent Class&#160;A Common Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;All calculations performed pursuant to the terms of this Agreement shall be calculated to four decimal places (<font style="font-style: italic;">e.g.</font>, 0.0001), where applicable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;In accordance with Section&#160;262 of the DGCL, no appraisal rights shall be available to the Company Stockholders in connection with the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS306"><!--Anchor--></a>Section&#160;3.06.&#8195;<u>Withholding</u>. Each of the Company, Parent, Merger Sub, the Surviving Corporation and the Exchange Agent shall be entitled to deduct and withhold such amounts as are required under applicable Law to be deducted and withheld from the amounts payable (including shares of Parent Class&#160;A Common Stock deliverable) under this Agreement in accordance with applicable Law and shall pay the amount deducted or withheld to the appropriate Taxing Authority in accordance with applicable Law. The Company, Parent, Merger Sub, the Surviving Corporation and the Exchange Agent, as the case may be, shall cooperate in good faith to minimize any such deduction or withholding. To the extent such amounts are so deducted or withheld and paid over to the appropriate Taxing Authority, such deducted or withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction or withholding was made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS307"><!--Anchor--></a>Section&#160;3.07.&#8195;<u>Adjustments to Prevent Dilution</u>. Without limiting the other provisions of this Agreement, in the event that the Company changes the number of shares of Company Common Stock issued and outstanding prior to the Effective Time or Parent changes the number of shares of Parent Common Stock issued and outstanding prior to </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-23<br></div></div></div>
<!--End Page 352-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 353-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">the Effective Time, in either case, as a result of a reclassification, stock split (including a reverse stock split), stock dividend or distribution with a record date prior to the Effective Time, recapitalization or exchange, or other similar transaction, but excluding any change that results from (a) the exercise of stock options or other equity-based instruments to purchase shares of Company Common Stock or Parent Common Stock (as set forth in <u>Section&#160;4.03</u> and <u>Section&#160;5.03</u>, respectively), (b) the settlement of any other equity-based instruments to purchase or otherwise acquire shares of Company Common Stock or Parent Common Stock (as set forth in <u>Section&#160;4.03</u> and <u>Section&#160;5.03</u>), (c) the grant of stock-based compensation to directors or employees of Parent or (other than any such grants not made in accordance with the terms of this Agreement) the Company under Parent&#8217;s or the Company&#8217;s, as applicable, stock option or compensation plans or arrangements, (d)&#160;the exercise of Company Warrants or Company Convertible Notes, (e) the issuance of the Disputed Claims Reserve Shares in accordance with the terms of the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) (the &#8220;<u>Plan of </u><u>Reorganization</u>&#8221;) or (f) any share repurchases or buybacks by the Company or Parent, the consideration paid in accordance with this Agreement shall be equitably adjusted to reflect such change; <u>provided, that</u>, notwithstanding anything to the contrary in this <u>Section&#160;3.07</u>, no adjustment shall be made in connection with the issuance of shares of Parent Common Stock as consideration in a transaction where Parent is the surviving corporation or in connection with any offering of shares of Parent Common Stock where Parent receives consideration in exchange for the shares of Parent Common Stock so offered (other than a rights offering or other similar transaction); <u>provided</u>, that, that nothing in this <u>Section&#160;3.07</u> shall be construed to permit the Company or Parent to take any action with respect to its securities that is prohibited by the terms of this Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS308"><!--Anchor--></a>Section&#160;3.08.&#8195;<u>Further Action</u>. If, at any time after the Effective Time, any further action is determined by Parent or the Company to be necessary or desirable to carry out the purposes of this Agreement or to vest the Surviving Corporation with full right, title and possession of and to rights and property of Merger Sub and the Company, the officers and directors of Parent shall be further authorized to take such action. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; text-align: center;"><a name="tANXAA4"><!--Anchor--></a>ARTICLE&#160;IV<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as otherwise disclosed in (a) Company SEC Documents publicly filed with or furnished on or after January&#160;1, 2024 until two (2) Business Days prior to the date of this Agreement (excluding any disclosures in &#8220;risk&#160;factors&#8221; or otherwise relating to forward-looking statements to the extent that they are cautionary, predictive or forward-looking in nature (in each case, other than any description of historical facts or events included therein)); provided, that, this clause (a) shall not apply to the representations and warranties set forth in <u>Section&#160;4.01</u>, <u>Section&#160;4.02</u>, <u>Section&#160;4.03</u>, <u>Section&#160;4.04</u>, the first sentence of <u>Section&#160;4.09</u>, <u>Section&#160;4.27</u>, <u>Section&#160;4.28</u> and <u>Section&#160;4.29</u>, or (b) the confidential disclosure letter delivered by the Company to Parent and Merger Sub concurrently with this Agreement (the &#8220;<u>Company Disclosure Letter</u>&#8221;), the Company represents and warrants to Parent and Merger Sub as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS401"><!--Anchor--></a>Section&#160;4.01.&#8195;<u>Organization and Corporate Power</u>. The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, with full corporate power and authority to enter into this Agreement and perform its obligations hereunder. The Company and each of its Subsidiaries has all requisite corporate or other entity power and authority and all authorizations, licenses and Permits necessary to own, lease and operate its properties and to carry on its business as it is now being conducted, except where the failure to hold such authorizations, licenses and Permits would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole. The Company and each of its Subsidiaries is duly qualified or authorized to do business and is in good standing in every jurisdiction (to the extent such concept exists in such jurisdiction) in which its ownership or leasing of property or the conduct of business as now conducted requires it to qualify, except where the failure to be so qualified, authorized or in good standing would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. True and complete copies of the Certificate of Incorporation and the Bylaws of the Company (the &#8220;<u>Company Organizational Documents</u>&#8221;) have been heretofore made available to Parent and each is in full force and effect. The Company is not in breach of the Company Organizational Documents in any material respect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS402"><!--Anchor--></a>Section&#160;4.02.&#8195;<u>Authorization; Valid and Binding Agreement</u>. The Company has all requisite corporate power and authority to execute and deliver this Agreement, to perform its obligations hereunder and thereunder, and to consummate the Merger and the Contemplated Transactions, subject, in the case of the Merger, to the receipt of the affirmative vote of the holders of a majority of the issued and outstanding shares of Company Common Stock entitled to vote thereon in favor of the adoption of this Agreement, in accordance with applicable Law and the Company&#8217;s </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-24<br></div></div></div>
<!--End Page 353-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 354-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Organizational Documents (the &#8220;<u>Company Stockholder Approval</u>&#8221;). The Company Board has unanimously (i)&#160;determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable, fair to and in the best interests of, the Company and the Company Stockholders, (ii)&#160;approved and deemed advisable the execution and delivery of this Agreement, the performance by the Company of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger and (iii) directed that the adoption of this Agreement be submitted to a vote at a meeting of the Company Stockholders and resolved to recommend that the Company Stockholders adopt this Agreement. The execution, delivery and performance by the Company of this Agreement and the consummation by the Company of the transactions contemplated hereby, subject to obtaining the Company Stockholder Approval, are within the Company&#8217;s corporate powers and have been duly authorized by all necessary corporate action on the part of the Company. Such approvals, determinations, declarations, resolutions and directions are valid and have not been amended or withdrawn (except as permitted by and in accordance with <u>Section&#160;7.04(b)</u> or <u>7.04(c)</u>). Except for the Company Stockholder Approval, no other corporate proceeding or vote of the holders of any capital stock of the Company or any of its Subsidiaries, including pursuant to the Laws of the State of Delaware or the listing standards of the NASDAQ Global Select Market (&#8220;<u>NASDAQ</u>&#8221;), on the part of the Company or any of its Subsidiaries is necessary to authorize or adopt this Agreement, or to consummate the Merger and the Contemplated Transactions (except for the filing of the Certificate of Merger, the Registration Statement and Proxy Statement as required by applicable Law). The Company has duly executed and delivered this Agreement, and, assuming the due authorization, execution and delivery by Parent, Merger Sub and any other counterparty thereto, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights and remedies generally and by general principles of equity (collectively, the &#8220;<u>Enforceability Exceptions</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS403"><!--Anchor--></a>Section&#160;4.03.&#8195;<u>Company Capital Stock</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The authorized capital stock of the Company consists of 10,000,000,000 shares of Company Common Stock and 2,000,000,000 shares of Company Preferred Stock. As of the close of business on July&#160;2, 2025 (the &#8220;<u>Measurement Date</u>&#8221;), there were (i) 303,694,175 shares of Company Common Stock issued and outstanding, (ii) no shares of Company Preferred Stock issued and outstanding, (iii) no shares of Company Common Stock and no shares of Company Preferred Stock issued and held in the treasury of the Company, (iv)&#160;16,766,394&#160;shares of Company Common Stock underlying outstanding Company RSU Awards, (v)&#160;11,650,284 shares of Company Common Stock underlying outstanding Company PSU Awards (treating for this purpose the performance-based vesting conditions to which such Company PSU Award is subject as having been attained at &#8220;maximum&#8221; level), (vi) 344,076 shares of Company Common Stock underlying outstanding Company Options, (vii) 97,540,730 shares of Company Common Stock underlying Tranche 1 Warrants with an Exercise Price (as defined in the Company Warrant Agreement) of $6.81 per share and 14,754,345 shares of Company Common Stock underlying Tranche 2 Warrants with an Exercise Price (as defined in the Company Warrant Agreement) of $0.01 per share, (viii) 51,783,625 CVRs outstanding pursuant to the Company CVR Agreement and (ix) 288,460 shares of Company Common Stock held in reserve for disputed claims pursuant to the Plan of Reorganization. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;As of the close of business on the Measurement Date, (i) the Conversion Rate (as defined in the Company 2029 Notes Indenture) for the Company 2029 Convertible Notes was equal to 90.9256 shares of Company Common Stock per $1,000 of outstanding principal amount of Company 2029 Convertible Notes and (ii) the Conversion Rate (as defined in the Company 2031 Notes Indenture) for the Company 2031 Convertible Notes was equal to 44.4587 shares of Company Common Stock per $1,000 of outstanding principal amount of Company 2031 Convertible Notes. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;All of the outstanding shares of Company Common Stock have been duly authorized and validly issued and are fully paid, non-assessable and free of preemptive or similar rights. All of the issued and outstanding shares of Company Common Stock were issued in compliance with all applicable Laws concerning the issuance of securities. Except for the Company Convertible Notes, there are no outstanding bonds, debentures, notes or other Indebtedness of the Company having the right to vote (or convertible into, or exchangeable or exercisable for, securities having the right to vote) on any matters on which stockholders of the Company may vote. Except as specified in this <u>Section&#160;4.03</u> or as set forth on <u>Section&#160;4.03(c)</u> of the Company Disclosure Letter, the Company does not have any other equity securities or securities containing any equity features authorized, issued or outstanding, and there are no agreements, options, warrants or other rights or </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-25<br></div></div></div>
<!--End Page 354-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 355-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">arrangements existing or outstanding which provide for the sale or issuance of any of the foregoing by the Company. Except as specified in this <u>Section&#160;4.03</u> or as set forth on <u>Section&#160;4.03(c)</u> of the Company Disclosure Letter, there are no outstanding (i) shares of capital stock or other equity interests or voting securities or ownership interests of the Company, (ii) securities convertible or exchangeable, directly or indirectly, into capital stock or other equity interests or voting securities or ownership interests of the Company, (iii) options, warrants, purchase rights, subscription rights, preemptive rights, conversion rights, exchange rights, calls, puts, rights of first refusal, binding commitments or other Contracts that require the Company to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem capital stock or other equity interests or voting securities or ownerships interests of the Company, (iv) restricted shares, restricted stock units, stock appreciation rights, phantom stock, profit participation or similar securities of the Company or (v) bonds, debentures, notes or other Indebtedness for borrowed money of the Company having the right to vote on any matters on which Company Stockholders may vote (collectively, the &#8220;<u>Company Securities</u>&#8221;). Except as specified in this <u>Section&#160;4.03</u>, there are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any of the Company Securities. Neither the Company nor any of its Subsidiaries is a party to any voting agreement with respect to the voting, registration or transfer of any Company Securities. Since the Company Balance Sheet Date, neither the Company nor any of its Subsidiaries has declared, set aside or paid any dividends on, or made any other distributions (whether in cash or stock) in respect of, any capital stock or other equity interests or voting securities of such Person (other than cash dividends and distributions by a direct or indirect wholly owned Subsidiary of the Company to its parent entity). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;As of the close of business on the Measurement Date, there were 20,001,828 shares of Company Common Stock reserved for issuance pursuant to future grants under the Company Equity Plans. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(e)&#8195;&#8206;No Company Common Stock is owned by any Subsidiary of the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;Section&#160;4.03(f) of the Company Disclosure Letter sets forth, as of the date hereof, each joint venture, partnership or other similar arrangement or other entity in which the Company has an equity interest (other than a Subsidiary of the Company) (collectively, the &#8220;<u>Joint Venture Entities</u>&#8221; ), including for each Joint Venture Entity the name and jurisdiction of formation of such Joint Venture Entity. All of the equity or voting interests in a Joint Venture Entity that are owned, directly or indirectly, beneficially and of record, by the Company or its Subsidiaries, are owned by the Company or its Subsidiaries, as applicable, free and clear of all Liens, other than Liens to be released in connection with the Closing, and transfer restrictions other than transfer restrictions of general applicability as may be provided under the Securities Act or other applicable securities Laws (including any restriction on the right to vote, sell or otherwise dispose of such shares of capital stock or other equity or voting interests). Except as set forth on <u>Section&#160;4.03(f)</u> of the Company Disclosure Letter or the Company&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024 (&#8220;<u>Company 10-K</u>&#8221;), the Company does not directly or indirectly hold any equity interests of any Person. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;Section&#160;4.03(g) of the Company Disclosure Letter sets forth, for each equity award (including each Company RSU Award, Company PSU Award and Company Option), the holder, type of award, grant date, quantity granted, quantity vested, quantity unvested, quantity outstanding, and, if applicable, grant price. All of the Company RSU Awards, Company PSU Awards and Company Options were duly granted pursuant to the Company Equity Plans, and were properly accounted for in the Company's financial statements. There are no Company Securities that have not been issued but are subject to a binding promise to issue. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(h)&#8195;Other than the Company Convertible Notes and the Company Secured Debt Documents, as of the date hereof, the Company has no outstanding indebtedness for borrowed money. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS404"><!--Anchor--></a>Section&#160;4.04.&#8195;<u>Subsidiaries</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Section&#160;4.04</u> of the Company Disclosure Letter lists all of the Subsidiaries of the Company, and for each Subsidiary the jurisdiction of formation. Each of the Subsidiaries of the Company is a corporation or other entity duly organized, validly existing and in good standing (to the extent such concept exists in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, except where failure to be in good standing has, or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. None of the Subsidiaries of the Company is in violation of its organizational documents in any material respect. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-26<br></div></div></div>
<!--End Page 355-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 356-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;All of the outstanding shares of capital stock or equivalent equity interests of each of the Company&#8217;s Subsidiaries have been validly issued, are fully paid and nonassessable, and are not subject to any preemptive rights in favor of any Person other than the Company and are owned of record and beneficially, directly or indirectly, by the Company free and clear of all Liens (other than Permitted Liens). None of the Company&#8217;s Subsidiaries has any equity securities authorized, issued or outstanding, other than the shares of capital stock or equivalent equity interests of such Subsidiary held directly or indirectly by the Company, and there are no agreements, options, warrants or other rights or arrangements existing or outstanding which provide for the sale or issuance of any of the foregoing. There are no outstanding or authorized options or other rights to acquire from any of the Company&#8217;s Subsidiaries, or any obligations of any of the Company&#8217;s Subsidiaries to issue, any capital stock, voting securities, or securities convertible into or exchangeable for capital stock or voting securities of any of the Company&#8217;s Subsidiaries, or restricted shares, restricted stock units, stock appreciation rights, performance units, contingent value rights, &#8220;phantom&#8221; stock or similar securities (collectively, &#8220;<u>Company Subsidiary Securities</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;There are no outstanding obligations of the Company or its Subsidiaries to repurchase, redeem, or otherwise acquire any of the Company Subsidiary Securities, and there are no other options, calls, warrants, or other rights, relating to Company Subsidiary Securities. Except for the capital stock or other equity or voting interests of its Subsidiaries set forth on <u>Section&#160;4.04</u> of the Company Disclosure Letter and the Joint Venture Entities, the Company does not own, directly or indirectly, any capital stock or other equity or voting interests in any Person. The Company and its Subsidiaries have no obligation to acquire equity securities of, or make any capital contribution to or equity investment in, any other Person. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS405"><!--Anchor--></a>Section&#160;4.05.&#8195;<u>No Breach</u>. Except as set forth in <u>Section&#160;4.05</u> of the Company Disclosure Letter, the execution, delivery and performance of this Agreement by the Company and, subject to obtaining the Company Stockholder Approval, the consummation of the Contemplated Transactions, do not and will not (a) conflict with or violate the Company Organizational Documents, (b) assuming all consents, approvals, authorizations and other actions described in <u>Section&#160;4.06</u> have been obtained and all filings and obligations described in <u>Section&#160;4.06</u> have been made, conflict with or violate any Law or Order to which the Company, its Subsidiaries or any of its or their properties or assets is subject or (c) with or without the giving of notice or lapse of time or both, conflict with or result in any breach of, constitute a default under, result in a violation of, give rise to a right of termination, cancellation or acceleration under, give rise to any penalties, repayment obligations, special assessments or additional payments under, result in the creation of any Lien (other than any Permitted Lien) upon any assets of the Company or any of its Subsidiaries pursuant to, or require any consent, waiver, approval of any other Person pursuant to, the provisions of any Company Material Contract (other than any Company Material Contract to which Parent or any of Parent&#8217;s Subsidiaries is a party), Company Real Property Lease or any Permit that is material to the operations of the Company&#8217;s business, taken as a whole; except, in the case of each of clauses (b) and (c) of this <u>Section&#160;4.05</u>, for any conflicts, violations, consents, approvals, authorizations, breaches, defaults, terminations, cancellations, accelerations, penalties, repayment obligations, special assessments or additional payments, Liens or waivers which has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS406"><!--Anchor--></a>Section&#160;4.06.&#8195;<u>Consents, etc.</u> Except for (a) the applicable requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the &#8220;<u>HSR Act</u>&#8221;) and any other Antitrust Law, (b) applicable requirements of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;<u>SEC</u>&#8221;) promulgated thereunder (the &#8220;<u>Exchange Act</u>&#8221;), (c) the filing of the Registration Statement and the Proxy Statement under the Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder (the &#8220;<u>Securities Act</u>&#8221;), (d) any filings required under state or foreign securities Laws, including any &#8220;blue sky&#8221; Laws, (e) any filings required by NASDAQ, (f) the filing of the Certificate of Merger, and (g) any filings (A) the failure of which to make would not prevent or materially impair the Company&#8217;s ability to consummate the Merger prior to the End Date and (B) the absence of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries is required to submit any notice, report or other filing with any Governmental Body in connection with the execution, delivery or performance by it of this Agreement or the consummation of the Contemplated Transactions. Other than as stated above or as set forth on <u>Section&#160;4.06</u> of the Company Disclosure Letter, no consent, approval or authorization of any Governmental Body is required to be obtained by the Company or any of its Subsidiaries in connection with its execution, delivery and performance of this Agreement or the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-27<br></div></div></div>
<!--End Page 356-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 357-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">consummation of the Contemplated Transactions, except for those consents, approvals and authorizations the failure of which to obtain (A) would not prevent or materially impair the Company&#8217;s ability to consummate the Merger prior to the End Date or (B) would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS407"><!--Anchor--></a>Section&#160;4.07.&#8195;<u>SEC Reports; Disclosure Controls and Procedures</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The Company has timely filed or furnished all forms, reports and other documents with the SEC required to be filed or furnished by the Company since June&#160;30, 2022 (such reports or documents, together with any exhibits and schedules thereto and information incorporated therein, the &#8220;<u>Company SEC Documents</u>&#8221;). No Subsidiary of the Company is required to file or furnish, or files or furnishes, any form, report or other document with the SEC. As of their respective filing dates (or, if amended, supplemented or superseded by a filing at least two (2) Business Days prior to the date of this Agreement, then on the date of such most recent applicable amendment, supplement or superseding filing) (and as of the date of effectiveness, in the case of any Company SEC Document that is a registration statement or an amendment or supplement to a registration statement): (i)&#160;each of the Company SEC Documents complied in all material respects with the applicable requirements of the Securities Act, the Exchange Act, the NASDAQ and the Sarbanes-Oxley Act (as the case may be), and the rules and regulations promulgated thereunder, each as in effect on the date so filed or furnished, and (ii) none of the Company SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The financial statements (including related notes, if any) contained in the Company SEC Documents (i) complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto at such time; (ii) were prepared in accordance with GAAP, applied on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements or, in the case of unaudited statements, as permitted by Form&#160;10-Q of the SEC); and (iii) fairly present in all material respects the consolidated financial position of the Company and its consolidated Subsidiaries as of the respective dates thereof and the consolidated results of operations and cash flows of the Company and its consolidated Subsidiaries for the periods covered thereby (subject, in the case of unaudited statements, to the absence of footnote disclosure and to normal year-end audit adjustments (or with respect to pro forma financial information, subject to the qualifications stated therein)). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The Company has designed and maintains a system of internal control over financial reporting (as defined in Rules 13a&#8211;15(f) and 15d&#8211;15(f) of the Exchange Act) that provides reasonable assurances regarding the reliability of financial reporting. The Company maintains disclosure controls and procedures (as defined in Rules 13a&#8211;15(e) and 15d&#8211;15(e) of the Exchange Act) reasonably designed to provide reasonable assurance that all information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to the Company&#8217;s management as appropriate to allow timely decisions regarding required disclosure and to make certifications required pursuant to Sections 302 and 906 of the Sarbanes Oxley Act. The Company&#8217;s internal control over financial reporting is in compliance in all material respects with the applicable requirements of Section&#160;404 of the Sarbanes-Oxley Act. The Company has disclosed, based on its most recent evaluation of its disclosure controls and procedures and internal control over financial reporting prior to the date of this Agreement, to the Company&#8217;s auditors and the audit committee of the Company Board (A) any significant deficiencies and material weaknesses in the design or operation of its internal control over financial reporting that are reasonably likely to adversely affect in any material respect the Company&#8217;s ability to record, process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal control over financial reporting. Since June&#160;30, 2022, any material change in internal control over financial reporting required to be disclosed in any Company SEC Document has been so disclosed. As of the date of this Agreement, there have not been, since June&#160;30, 2022, any complaints or concerns made through the Company&#8217;s whistleblower hot line or equivalent system for receipt of employee concerns regarding alleged violations of law or questionable accounting or auditing matters that are material to the Company and its Subsidiaries, taken as a whole, that remain outstanding or unresolved. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-28<br></div></div></div>
<!--End Page 357-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 358-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;As of the date hereof, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to any Company SEC Documents and, to the Company&#8217;s Knowledge, none of the Company SEC Documents is the subject of ongoing SEC review. To the Company&#8217;s Knowledge, there are no SEC inquiries or investigations pending or threatened, in each case regarding any accounting practices of the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Neither the Company nor any of its Subsidiaries is a party to, and has no commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among the Company or any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any &#8220;off-balance-sheet arrangements&#8221; (as defined in Item&#160;303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material Liabilities of, the Company or any of its Subsidiaries in the Company&#8217;s published financial statements or other Company SEC Documents. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;There are no outstanding loans or other extensions of credit made by the Company or any of its Subsidiaries to any executive officer (as defined in Rule&#160;3b-7 under the 1934 Act) or director of the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;Since June&#160;30, 2022, each of the principal executive officer and principal financial officer of the Company (or each former principal executive officer and principal financial officer of the Company, as applicable) has made all certifications required by Rule&#160;13a-14 and 15d-14 under the 1934 Act and Sections 302 and 906 of the Sarbanes-Oxley Act and any related rules and regulations promulgated by the SEC and the NASDAQ, and the statements contained in any such certifications were complete and correct as of their respective dates. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(h)&#8195;Except as set forth in the Company SEC Documents, since January&#160;23, 2024, there has been no transaction, or series of similar transactions, agreements, arrangements or understandings, nor is there any proposed transaction as of the date of this Agreement, or series of similar transactions, agreements, arrangements or understandings to which the Company or any of its Subsidiaries was or is to be a party, that would be required to be disclosed under Item&#160;404 of Regulation S-K promulgated under the 1933 Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS408"><!--Anchor--></a>Section&#160;4.08.&#8195;<u>No Undisclosed Liabilities</u>. Except (a) as and to the extent disclosed and provided for or reserved against on the unaudited consolidated balance sheet of the Company as of the Company Balance Sheet Date (or disclosed in the notes to such balance sheet) that is included in the Company SEC Documents; (b) as incurred after the date thereof in the ordinary course of business (but excluding violations of law or regulation or breaches of Contracts or Permits or torts); (c) as incurred in connection with this Agreement or the Contemplated Transactions; or (d) as have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company, together with its Subsidiaries, does not have any Liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS409"><!--Anchor--></a>Section&#160;4.09.&#8195;<u>Absence of Certain Developments</u>. Since the Company Balance Sheet Date to the date of this Agreement, there has not been any Company Material Adverse Effect. Since the Company Balance Sheet Date to the date of this Agreement, none of the Company or any of its Subsidiaries has taken or omitted to take any action that, if taken or omitted during the period from the date of this Agreement through the Effective Time without Parent&#8217;s consent, would constitute a breach of <u>Section&#160;6.01(b)(ii)</u>, <u>Section&#160;6.01(b)(v)</u>, Section&#160;6.01(b)(vii), <u>Section&#160;6.01(b)(ix)</u>, <u>Section&#160;6.01(b)(xi)</u>, <u>Section&#160;6.01(b)(xiii)</u>, <u>Section&#160;6.01(b)(xv)</u>, <u>Section&#160;6.01(b)(xvi)</u> or <u>Section&#160;6.01(b)(xix)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS410"><!--Anchor--></a>Section&#160;4.10.&#8195;<u>Compliance with Laws</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The Company and each of its Subsidiaries, and to the Knowledge of the Company each Joint Venture Entity, are, and have been since June&#160;30, 2022, in compliance with all Laws applicable to them or any of the properties or other assets, businesses or operations of the Company and its Subsidiaries, except where any noncompliance would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since June&#160;30, 2022, (i) neither the Company nor any of its Subsidiaries has received any written notice from any Governmental Body that (A) alleges any violation or noncompliance of any applicable Law, and to the Company&#8217;s Knowledge, there is no such investigation or inquiry pending or (B)&#160;asserts any fine, assessment or cease and desist order, or the suspension, revocation or limitation or </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-29<br></div></div></div>
<!--End Page 358-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 359-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">restriction of any Permit issued to or held by the Company or any of its Subsidiaries and (ii) neither the Company nor any of its Subsidiaries has entered into any agreement or settlement with any Governmental Body with respect to its alleged noncompliance with, or violation of, any applicable Law. There is no Order outstanding against the Company or any of its Subsidiaries: (i) that is or would reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole; or (ii) that is outstanding as of the date hereof and that in any manner seeks to prevent, enjoin or materially delay the Merger. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and each of its Subsidiaries and, to the Knowledge of the Company, each of their respective officers and directors (in their capacities as such) is in compliance, and has since June&#160;30, 2022 complied with (i) the applicable provisions of the Sarbanes-Oxley Act of 2002 and the related rules and regulations promulgated under such act (&#8220;<u>Sarbanes-Oxley</u>&#8221;) or the Exchange Act and (ii) the applicable listing and corporate governance rules and regulations of NASDAQ. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) to the Knowledge of the Company, each Permit reasonably anticipated to be required for the future development, design, construction, ownership or operation of any projects, properties or assets in development by the Company and its Subsidiaries is reasonably expected to be obtained in due course and without material unanticipated cost or material adverse conditions prior to the time the same is required to be obtained under applicable Laws, (ii) the Company and each of its Subsidiaries is and since January&#160;23, 2024 has been in compliance with the terms and requirements of all Permits necessary to own, lease and operate its properties and to carry on its business as it is now being conducted, (iii) such Permits are in full force and effect and are not subject to any pending or threatened Action by any Governmental Body to suspend, cancel, modify, terminate or revoke any such Permit and (iv) since January&#160;23, 2024, there has occurred no violation by the Company or any of its Subsidiaries of, or default (with or without notice or lapse of time, or both) that would reasonably be expected to result in any suspension, cancellation, modification, termination or revocation of any such Permit. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Except as would not have a Company Material Adverse Effect, (i) the Company and its Subsidiaries are in compliance, and have at all times since June&#160;30, 2022 been in compliance, with all (A) Privacy Laws, including the EU General Data Protection Regulation 2016/679/EU of April&#160;27, 2016, as applicable, as well as all applicable (B) contractual requirements, its own policies and binding industry standards, in each case under this clause (B), relating to privacy, data protection, cybersecurity and/or the collection, transfer, use or other processing of Personal Information collected, used or held for use, or processed by, or otherwise in the possession or control of, the Company or any of its Subsidiaries (collectively with all Privacy Laws, &#8220;<u>Privacy </u><u>Requirements</u>&#8221;), (ii) no Actions, claims or investigations by any Governmental Body or any Person are pending or threatened in writing, against the Company or any of its Subsidiaries alleging a violation of any Privacy Requirement or any Person&#8217;s privacy, personal or confidentiality rights, and (iii) neither the Company nor any of its Subsidiaries have received any written notice, Order, complaint or other correspondence from any Governmental Body alleging a breach of, or non-compliance with, any Privacy Requirement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, neither the Company nor its Subsidiaries nor any of the Company Knowledge Persons (i) are aware of any fact which would reasonably be expected to result in a violation of FCPA or any other applicable anti-bribery or anti-corruption Law (collectively, the &#8220;<u>Anti-</u><u>Corruption Laws</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken as a whole, the Company, its Subsidiaries and, to the Knowledge of the Company, each of their respective directors, officers, or employees while acting on behalf of the Company or any of its Subsidiaries has, at all time since June&#160;30, 2022, been in compliance with Anti-Corruption Laws and has not, (i) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977 (the &#8220;<u>FCPA</u>&#8221;), (ii) violated or is in violation of any applicable Law enacted in any jurisdiction in connection with or arising under the OECD Convention Combating Bribery of Foreign Public Officials in International Business Transactions (the &#8220;<u>OECD Convention</u>&#8221;), (iii) violated or is in violation of any provision of the UK Bribery Act of 2010 (the &#8220;<u>UK Bribery Act</u>&#8221;), (iv) violated any Anti-Corruption Law in any other country or jurisdiction where the Company and or Subsidiaries operate, (v) made, offered to make, promised to make, or authorized the payment or giving of, directly or indirectly, any bribe, rebate, payoff, influence payment, kickback or other </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-30<br></div></div></div>
<!--End Page 359-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 360-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">unlawful payment or gift of money or anything of value prohibited under any applicable Law addressing matters comparable to those addressed by the FCPA, the UK Bribery Act, or the OECD Convention implementing legislation concerning such payments or gifts in any jurisdiction (any such payment, a &#8220;<u>Prohibited Payment</u>&#8221;), (vi) been subject to any investigation by any Governmental Body with regard to any Prohibited Payment or (vii))&#160;violated or is in violation of any other Laws regarding use of funds for political activity or commercial bribery. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(h)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, none of the Company nor any of its Subsidiaries, nor to the Knowledge of the Company, any of their respective officers, directors or employees acting on their behalf, is currently, or has since June&#160;30, 2022 been: (i) a Sanctioned Person, (ii) organized or ordinarily resident in a Sanctioned Country, (iii)&#160;engaging in any unlawful dealings or transactions with or for the benefit of any Sanctioned Person or in any Sanctioned Country, (iv) engaging in any export, reexport, transfer or provision of any goods, software, technology, data or service without, or exceeding the scope of any licenses or authorizations under all applicable Ex-Im Laws, or (v) otherwise in violation of applicable Sanctions Laws, Ex-Im Laws, or the anti-boycott laws administered by the U.S. Department of Commerce and the U.S. Department of Treasury&#8217;s Internal Revenue Service (collectively, &#8220;<u>Trade Control Laws</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(i)&#8195;Since June&#160;30, 2022 through the date of this Agreement, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, none of the Company nor any of its Subsidiaries has, in connection with or relating to the business of the Company or any of its Subsidiaries, received from any Governmental Body or any other Person any notice, inquiry, or internal or external allegation; made any voluntary or involuntary disclosure to a Governmental Body; or conducted any internal investigation or audit concerning any actual or potential violation or wrongdoing related to Anti-Corruption Laws or Trade Control Laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS411"><!--Anchor--></a>Section&#160;4.11.&#8195;<u>Transactions with Affiliates</u>. Since June&#160;30, 2022, there have been no transactions, or series of related transactions, agreements, arrangements or understandings in effect, nor are there any currently proposed transactions, or series of related transactions, agreements, arrangements or understandings, that would be required to be disclosed under Item&#160;404(a) of Regulation S-K that have not been otherwise disclosed in the Company SEC Documents filed prior to the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS412"><!--Anchor--></a>Section&#160;4.12.&#8195;<u>Title to Assets; Real Properties</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The Company and its Subsidiaries have good and valid title to, or hold pursuant to valid and enforceable leases or other comparable contract rights, all of the material machinery, equipment, tangible personal property and other material tangible assets necessary for the conduct of the business of the Company and its Subsidiaries, taken as a whole, in each case free and clear of any Liens (other than Permitted Liens), except where the failure to do so would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;<u>Section&#160;4.12(b)</u> of the Company Disclosure Letter contains a true, correct, current and complete list of all real property (by identity of owner and either street address or legal description available to the Company) owned by the Company or its Subsidiaries, which constitutes all the real property currently owned and used in the Company&#8217;s business (all such real property, together with all right, title and interest of the Company or any such Subsidiary in and to (A) all buildings, structures and other improvements and fixtures located on or under such real property and (B) all easements, rights and other appurtenances to such real property, are referred to herein individually and collectively as the &#8220;<u>Owned Real Property</u>). Except as would not reasonably be expected to have a Company Material Adverse Effect: (i) the Company or one of its Subsidiaries has good, valid and marketable fee simple title to the Owned Real Property free and clear of all Liens other than Permitted Liens and (ii) there are no existing, pending or, to the Knowledge of the Company, threatened, expropriation, condemnation, eminent domain or similar proceedings affecting any of the Owned Real Property other than Permitted Liens. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;<u>Section&#160;4.12(c)</u> of the Company Disclosure Letter contains a true, correct, current and complete list (and legal description available to the Company) of all real property occupied, licensed or leased by the Company or any of its Subsidiaries, which includes, without limitation, all occupied, licensed or leased real property currently used in, and necessary for, the conduct of the Company&#8217;s business (the &#8220;<u>Leased Real </u><u>Property</u>&#8221;, and together with Owned Real Property, collectively, the &#8220;<u>Company Real Property</u>&#8221;). The Company </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-31<br></div></div></div>
<!--End Page 360-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 361-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">has made available to Parent a true and complete copy, as of the date hereof, of all leases, licenses and occupancy agreements affecting Leased Real Property, including all amendments, extensions, renewals, guaranties, estoppels and subordination agreements with respect thereto (each, a &#8220;<u>Company Real Property Lease</u>&#8221; and collectively, the &#8220;<u>Company Real Property Leases</u>&#8221;). Except as would not reasonably be expected to have a Material Adverse Effect: (i) the Company and/or the applicable Subsidiary lessee has a valid leasehold interest in such Leased Real Property, free and clear of all Liens other than Permitted Liens, (ii) the Company Real Property Leases are legal, valid and binding obligations of the Company or a Subsidiary of the Company (as the case may be) and, to the Knowledge of the Company, each of the other parties thereto, and enforceable in accordance with its terms against the Company or its Subsidiaries (as the case may be), and in full force and effect, and the Company or one of its Subsidiaries holds a valid and existing leasehold interest in the Company Real Property under each such Company Real Property Lease, (iii) neither the Company nor any of its Subsidiaries, nor, to the Knowledge of the Company, any Third Party to the applicable Company Real Property Leases, is in breach or default under any such Company Real Property Lease, (iv) no event has occurred which, if not remedied, would result in a default, violation or breach by the Company or any of its Subsidiaries under the Company Real Property Leases, and, to the Knowledge of the Company, no event has occurred which, if not remedied, would result in a default, violation or breach by any Third Party under the Company Real Property Leases, (v) there are no existing, pending or, to the Knowledge of the Company, threatened expropriation, condemnation, eminent domain or similar proceedings, litigation, claims, actions, suits, proceedings, arbitrations, investigations or administrative actions affecting any of the Leased Real Property, (vi) to the Knowledge of the Company, the Company and its Subsidiaries have performed in all material respects all material obligations required to be performed by them under the Company Real Property Leases, (vii) except for Permitted Liens, there are no written or oral subleases, licenses, concessions or other contracts granting to any Person other than the Company or its applicable Subsidiary the right to use or occupy any Leased Real Property or any portion thereof and (viii) except for Permitted Liens, neither the Company nor any of its Subsidiaries has collaterally assigned or granted any other security interest in any Company Real Property Lease or any interest therein. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Except as would not have a Company Material Adverse Effect, with respect to each Development Property other than a Parent Development Property, the Company or a Subsidiary of the Company has obtained all material Permits which are necessary to permit the construction and development contemplated by the Development Contracts at the Company Real Properties in accordance with the Company&#8217;s plan as of the date of this Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since January&#160;1, 2025 there have been no power service interruptions at the Company Real Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;<u>Pre-Stabilized Properties. Section&#160;4.12(f)</u> of the Company Disclosure Letter sets forth, as of the date of this Agreement, a list of each material Company Real Property that is the site of a data hall that (i) has been in service for less than 24 months and (ii) is less than 85% occupied (each, a &#8220;<u>Pre-Stabilized Property</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;<u>Development Properties. Section&#160;4.12(g)</u> of the Company Disclosure Letter sets forth, as of the date of this Agreement, a list of each material Company Real Property that is, or is expected to be, the site of a facility for which activities have commenced or are expected to commence within the next 12 months to prepare the space for its intended use (each, a &#8220;<u>Development Property</u>&#8221;). With respect to each Development Property other than a Parent Development Property, the Company or a Subsidiary of the Company has obtained all material Permits which are necessary to permit the construction and development thereof in accordance with the Company&#8217;s plan as of the date of this Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(h)&#8195;<u>Condemnation; Eminent Domain Proceedings; Zoning.</u> As of the date hereof, there are no pending or, to the Knowledge of the Company, threatened condemnation, eminent domain or rezoning proceedings relating to any of the Company Real Properties that would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) the classification of each parcel of Company Real Property under applicable zoning Laws, ordinances and regulations permits the use and occupancy of such parcel and the operation of the business of the Company and its Subsidiaries, (ii) there are sufficient parking spaces, loading docks and other facilities at such parcel to comply with such zoning Laws, ordinances and regulations and (iii) the Company&#8217;s and its Subsidiaries&#8217; use or occupancy of the Company Real </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-32<br></div></div></div>
<!--End Page 361-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 362-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">Property or any portion thereof or the operation of the business of the Company and its Subsidiaries is not dependent on a &#8220;permitted nonconforming use&#8221; or &#8220;permitted non-conforming structure&#8221; or similar variance, exemption or approval from any Governmental Authority. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(i)&#8195;<u>Outstanding Claims or Violations. Section&#160;4.12(i)</u> of the Company Disclosure Letter lists each fee interest in real property or leasehold interest in any ground lease (or sublease) conveyed, transferred, assigned or otherwise disposed of by the Company or any Subsidiary (if a Subsidiary at the time of such conveyance, transfer, assignment or disposition) since June&#160;30, 2022. Other than as set forth in <u>Section&#160;4.12(i)</u> of the Company Disclosure Letter, to the Knowledge of the Company, as of the date hereof, none of the Company or any of its Subsidiaries has received any written notice of any outstanding claims under any Prior Sale Agreements which would reasonably be expected to result in liability to the Company or any Subsidiary, in an amount, in the aggregate, in excess of $5,000,000. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(j)&#8195;<u>Section&#160;4.12(j)</u> of the Company Disclosure Letter sets forth a true and complete list of all Digital Assets beneficially owned by the Company and its Subsidiaries as of the Measurement Date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(k)&#8195;<u>Electric Contracts</u>. Except as provided in <u>Section&#160;4.12(k)</u> of the Company Disclosure Letter, and except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;Either the Company or a Subsidiary holds all Electric Contracts necessary to conduct business in the ordinary course of business at each Owned Real Property and each Leased Real Property; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;Since January&#160;23, 2024, neither the Company nor any Subsidiary has been subject to (i) &#8220;claw back&#8221; or any other action by a party to an Electric Contract to rescind, terminate or cancel or otherwise remove access to any quantity of electric power (or the infrastructure necessary for its delivery) previously made available to the Company, any of its Subsidiaries, or its customer(s) at any Owned Real Property or Leased Real Property, or (ii) subject to any Action or informal claim that service under an Electric Contract will be materially reduced, cancelled or otherwise made unavailable to the Company, any of its Subsidiaries, or its customer(s) at any Owned Real Property or Leased Real Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(l)&#8195;Except as would not reasonably be expected to have a Company Material Adverse Effect, the Owned Real Property is in compliance with the terms and provisions of all covenants and easements affecting such Owned Real Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS413"><!--Anchor--></a>Section&#160;4.13.&#8195;<u>Tax Matters</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(a)&#8195;Except as would not have a Company Material Adverse Effect: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;(A) the Company and its Subsidiaries have timely filed or caused to be filed (taking into account any applicable extensions) all Tax Returns required to be filed by them; (B) such Tax Returns are true, complete and correct; (C) the Company and its Subsidiaries have paid (or have had paid on their behalf) all Taxes due and payable and required to be paid by them; and (D) as of the Company Balance Sheet Date, any Liability of the Company or any of its Subsidiaries for accrued Taxes not yet due and payable, or which are being contested in good faith through appropriate proceedings, has been provided for in the financial statements of the Company in accordance with applicable accounting practices and procedures; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;each of the Company and each of its Subsidiaries has properly and timely withheld or collected and timely paid, or is properly holding for timely payment, all material Taxes required to be withheld, collected and paid over by it under Applicable Law, and each of the Company and each of its Subsidiaries has complied in all material respects with all related information reporting, withholding and record retention requirements; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;no Tax deficiency or assessment has been assessed against the Company or any of its Subsidiaries that has not been resolved or paid in full; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;in the past five (5) years, no claim that has not been resolved has been made in writing by any Taxing Authority in a jurisdiction in which either the Company or any of its Subsidiaries does not file a Tax Return that the Company or such Subsidiary, as applicable, is subject to taxation by that jurisdiction or required to file a Tax Return in such jurisdiction; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-33<br></div></div></div>
<!--End Page 362-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 363-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(v)&#8195;there are no Liens for Taxes upon any of the assets of the Company or any of its Subsidiaries, except for Permitted Liens; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vi)&#8195;neither the Company nor any of its Subsidiaries has been a party to any &#8220;listed transaction&#8221; as defined in Treasury Regulations Section&#160;1.6011-4(b)(2); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vii)&#8195;(A) there are no Actions with any Taxing Authority with respect to Taxes or Tax Returns of the Company or any of its Subsidiaries that are currently being conducted, pending, or threatened in writing, and (B) there are no outstanding requests for rulings in respect of any Tax or Tax asset between the Company or any of its Subsidiaries and any Taxing Authority; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(viii)&#8195;neither the Company nor any of its Subsidiaries has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to an assessment or deficiency for any Taxes, which waiver or extension is currently in effect (other than pursuant to extensions of time obtained in the ordinary course of business or automatically granted extensions of time); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ix)&#8195;(A) neither the Company nor any of its Subsidiaries is a party to or bound by any Tax Sharing Agreement (other than any commercial agreement and any agreement that does not relate primarily to Taxes) and (B) neither the Company nor any of its Subsidiaries (I) is or has been a member of an affiliated group filing a combined, consolidated or unitary Tax Return (other than a group the common parent of which is or was the Company or any of its Subsidiaries or any group comprised solely of one or more of the Company and any of its present or former Subsidiaries) or (II) has Liability for the Taxes of any Person (other than the Company or its Subsidiaries) under Treasury Regulation Section&#160;1.1502-6 (or any similar provision of state, local or non-U.S. Law), as a transferee or as a successor, or by contract (other than any commercial arrangements that are not primarily related to Taxes); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(x)&#8195;neither the Company nor any of its Subsidiaries will be required to include any item of income in, or exclude any item of deduction from, taxable income for any taxable period ending after the Closing as a result of any closing agreement as described in Section&#160;7121 of the Code (or any corresponding provision of state, local or non-U.S. Law) (&#8220;<u>Closing Agreement</u>&#8221;) with a Taxing Authority executed by the Company or any of its Subsidiaries before the Closing; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xi)&#8195;neither the Company nor any of its Subsidiaries has been a &#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; within the meaning of Code section 355(a)(1)(A) (or any similar provision of state, local or non-U.S. Law) in any distribution that was purported or intended to qualify for tax-free treatment under Section&#160;355 of the Code (or any similar provision of state, local or non-U.S. Law) during the two (2)-year period ending on the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Neither the Company nor any of its Subsidiaries has taken or agreed to take any action, and, to the Knowledge of the Company, there are no facts, agreements, plans or other circumstances, in each case, that would reasonably be expected to prevent or impede the Merger from qualifying as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS414"><!--Anchor--></a>Section&#160;4.14.&#8195;<u>Contracts and Commitments</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;As of the date hereof and except as set forth in <u>Section&#160;4.14(a)</u> of the Company Disclosure Letter, neither the Company nor any of its Subsidiaries is a party to or bound by any: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;&#8220;material contract&#8221; (as such term is defined in Item&#160;601(b)(10) of Regulation S-K of the SEC) with respect to the Company or any of its Subsidiaries that was required to be, but has not been, filed with the SEC and listed in the Company&#8217;s 10-K, or any Company SEC Documents filed after the date of filing of such Form&#160;10-K until the date hereof; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;Contract (other than Development Contracts relating to the Parent Development Properties) that (individually or together with additional related Contracts with the same Person or its Affiliates) involves the payment or receipt of amounts by the Company or any of its Subsidiaries of more than $70,000,000 in the aggregate in the calendar year ended December&#160;31, 2024 or any subsequent calendar year that cannot be cancelled at any time by the Company or its applicable Subsidiary without penalty or further payment on no more than sixty (60) days&#8217; notice; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-34<br></div></div></div>
<!--End Page 363-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 364-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;Contract (A) relating to the disposition or acquisition (or option to acquire), directly or indirectly (by merger, sale of stock, sale of assets, or otherwise), by the Company or any of its Subsidiaries of any business, rights, equity interests or assets, other than the sale of inventory in the ordinary course of business, which contains any ongoing financial obligations, indemnification, &#8220;earn-out&#8221; or milestone payments or other contingent payment or any obligation to provide any guarantee thereunder that are still in effect that are reasonably likely to result in claims in excess of $2,000,000 after the date hereof or (B)&#160;that involves a purchase or sale price in excess of $2,500,000; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;Contract that is a partnership, strategic alliance, joint venture, limited liability company agreement or similar Contract relating to the formation, creation, operation, management or control of any joint ventures, partnerships, co-development, co-promotion, collaborations or similar arrangements; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(v)&#8195;Contract providing for material indemnification by the Company or any its Subsidiaries or requiring the Company or any of its Subsidiaries to provide a guarantee thereunder, other than indemnification obligations in commercial agreements in the ordinary course of business or indemnification agreements with current or former officers or directors of the Company; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vi)&#8195;Contract (A) prohibiting or materially limiting in any material respect the right of the Company or its Subsidiaries (1) to compete in any line of business or (2) to conduct business with any Person or in any geographical area, territory, (B) obligating the Company or its Subsidiaries to purchase or otherwise obtain any product or service exclusively from a single party or sell any product or service exclusively to a single party, (C) under which any Person has been granted the right to manufacture, sell, market or distribute any Product or service of the Company or its Subsidiaries on an exclusive basis to any Person or group of Persons or in any geographical area, territory or (D) containing any &#8220;most favored nation&#8221; or most favored customer provision, preferential right or rights of first or last offer, negotiation or refusal; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vii)&#8195;Contract that contains a put, call or similar right pursuant to which the Company or any of its Subsidiaries could be required to purchase or sell, as applicable, any material assets or any equity interests of any Person (excluding, in respect of the foregoing, the Company Convertible Notes and agreements solely between the Company and its wholly owned Subsidiaries); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 40pt; text-indent: 20pt; text-align: left;">(viii)&#8195;Contract required to be listed on <u>Section&#160;4.21(a)</u> of the Company Disclosure Letter&#894; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ix)&#8195;mortgages, indentures, guarantees, loans or credit agreements or other Contracts that evidence indebtedness for borrowed money of the Company or any Subsidiary thereof (whether secured or unsecured (but in each case, excluding ordinary course extensions of trade credit (such as funding of customer non-recurring charges))) having an aggregate principal (or committed amount) of $10,000,000 or more, other than intercompany Indebtedness to or among the Company and its Subsidiaries or among any of its Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(x)&#8195;Contract under which the Company or any of its Subsidiaries are expected to make annual capital expenditures in excess of $20,000,000 during the current or subsequent fiscal year; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xi)&#8195;Electric Contract pursuant to which the Company or any of its Subsidiaries have contracted for electric delivery capacity or energy supply (or both) of at least 20 megawatts per calendar year; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xii)&#8195;Settlement agreement, or agreement entered into in connection with a settlement agreement, corporate integrity agreement, consent decree, deferred prosecution agreement, or other similar type of agreement with or imposed by any Governmental Body, in each case that has existing or contingent performance or payment obligations; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xiii)&#8195;Contract of the Company or any of its Subsidiaries pursuant to which (A) the Company or any of its Subsidiaries licenses or obtains any right or covenant not to be sued with respect to any Intellectual Property from a Third Party that is material to the conduct of Company&#8217;s and its Subsidiaries&#8217; businesses (other than for off-the-shelf technology or Software that are generally available on non-discriminatory commercial terms), or (B) a Third Party licenses or obtains any right or covenant not to be sued with respect to any Intellectual Property from the Company or any of its Subsidiaries (other than non-exclusive licenses in the ordinary course of business, including to customers or vendors in connection with the sale or licensing of any products or services); </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-35<br></div></div></div>
<!--End Page 364-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 365-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xiv)&#8195;Contract of the Company or any of its Subsidiaries relating to the settlement of any Action that provides for any continuing material Liabilities on the part of the Company or any of its Subsidiaries, which will involve payments after the date hereof of consideration in excess of $2,500,000; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xv)&#8195;any Development Contract, in each case, that involves the receipt or payment by the Company or any of its Subsidiaries of amounts in excess of $50,000,000 in the aggregate in any fiscal year; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xvi)&#8195;any Data Center Customer Contract that involves the receipt or payment of amounts in excess of $10,000,000 in the aggregate in any fiscal year by the Company or any of its Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xvii)&#8195;Contract of the Company or any of its Subsidiaries that prohibits, materially limits or materially restricts the payment of dividends or distributions in respect of the capital stock of the Company or any of its Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xviii)&#8195;any Contract, subcontract, agreement, license, sublicense, lease, sublease, instrument, indenture, promissory note or other legally binding commitment or undertaking that creates or grants any Lien, other than Permitted Liens, on any Owned Real Property securing obligations in an amount exceeding, individually or in the aggregate, $1,000,000; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xix)&#8195;any Contract that relates to the acquisition of any real property or sale of Owned Real Property or the granting of any right of first offer, right of first refusal or other option to purchase or sell any interest in real property (&#8220;<u>Property Material Contracts)</u>; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xx)&#8195;that is required to be disclosed under Item&#160;404 of Regulation S-K promulgated under the 1933&#160;Act; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxi)&#8195;(A) with any beneficial owner (as defined in Rule&#160;13d-3 under the 1934 Act) of 5% or more of any class of securities of the Company or any of its Subsidiaries who has filed a Schedule 13D or Schedule 13G under the 1934 Act (or, to the Company&#8217;s Knowledge, is required to make such a filing) since January&#160;23, 2024, or (B) that is required to be disclosed under Item&#160;404 of Regulation S-K promulgated under the 1933 Act; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxii)&#8195;any (A) Company Space Lease and (B) Real Property Lease pursuant to which the Company or any of its Subsidiaries is a tenant as of the date of this Agreement, except for any Real Property Lease for which the aggregate annual rent payments do not exceed $1,000,000; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxiii)&#8195;except for any capital contribution requirements as set forth in the organizational documents of any Joint Venture Entity provided to Parent prior to the date hereof, requires the Company or any of its Subsidiaries to make any investment (in each case, in the form of a loan, capital contribution or similar transaction) in any non-wholly owned Subsidiary of the Company or other Person in excess of $1,000,000); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 40pt; text-indent: 20pt; text-align: left;">(xxiv)&#8195;relates to a forward equity sale or similar transaction; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxv)&#8195;containing any swap, cap, floor, collar, futures contract, forward contract, option and any other derivative financial instrument, contract or arrangement, based on any commodity, security, instrument, asset, rate or index of any kind or nature whatsoever; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxvi)&#8195;is between the Company or any of its Subsidiaries and a Governmental Body, or has been entered into by the Company or any of its Subsidiaries as a subcontractor at any tier in connection with a Contract between another Person and a Governmental Body; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxvii)&#8195;any commitment by the Company or any of its Subsidiaries to enter into any of the foregoing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each such Contract described in <u>clauses (i)</u> through <u>(xxviii)</u> of this <u>Section&#160;4.14(a)</u>, together with each Company Real Property Lease with annual rent in excess of $3,000,000 is referred to herein as a &#8220;<u>Company Material </u><u>Contract</u>.&#8221; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Parent has been given access to a true, correct and complete copy as of the date hereof of all Company Material Contracts in effect as of the date hereof, together with all material amendments thereto. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: (i) none of the Company or any of its Subsidiaries (A) is, or has received notice that any Third Party to any Company Material Contract is, in violation or breach of or default (with or without notice </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-36<br></div></div></div>
<!--End Page 365-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 366-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg37"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">or lapse of time or both) under any Company Material Contract, (ii) to the Company&#8217;s Knowledge, there has occurred no event giving to any Third Party any right of termination, amendment or cancellation of (with or without notice or lapse of time or both) any such Company Material Contract and (iii) each such Company Material Contract is in full force and effect and is a legal, valid and binding agreement of, and enforceable against, the Company or any of its Subsidiaries, and, to the Knowledge of the Company, each other party thereto, except as enforcement may be limited by the Enforceability Exceptions. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, as of the date hereof, no party to any Company Material Contract has given any notice of termination, cancellation or materially adverse (to the Company and its Subsidiaries) amendment of any Company Material Contract or that it intends to seek to terminate or cancel or amend the terms and conditions of any Company Material Contract in a manner that is materially adverse to the Company and its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS415"><!--Anchor--></a>Section&#160;4.15.&#8195;<u>Intellectual Property</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Section&#160;4.15(a)</u> of the Company Disclosure Letter sets forth a complete and correct list as of the date hereof of all registrations, issuances and applications for registration or issuance of Company Owned Intellectual Property (&#8220;<u>Registered IP&#8221;</u>). Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, as of the date hereof, all registration, maintenance and renewal fees applicable to the Registered IP have been paid with the relevant Governmental Body or other authorities in the applicable jurisdictions for the purposes of maintaining such items. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect (i) solely and exclusively own all right, title and interest in, to and under all Company Owned Intellectual Property, in each case, free and clear of all Liens (except for Permitted Liens) and (ii) owns or otherwise possesses valid, legally sufficient and enforceable rights to use, and immediately following the consummation of the Contemplated Transactions, will continue to own or possess valid, legally sufficient and enforceable rights to use, all Intellectual Property used in or held for use in, or otherwise necessary for, the conduct of the Company&#8217;s and its Subsidiaries&#8217; businesses as presently conducted. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and except as set forth on <u>Section&#160;4.15(b)</u> of the Company Disclosure Letter, (A) each item of Registered IP is subsisting, in full force and effect, and not invalid or unenforceable (other than applications for registration or issuance of Company Owned Intellectual Property) and (B) the Company Owned Intellectual Property is not subject to any outstanding Order adversely affecting the use thereof or rights thereto by the Company or its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries, nor the conduct of the Company&#8217;s and its Subsidiaries&#8217; businesses, nor the use of any Intellectual Property by the Company or any of its Subsidiaries, nor any of their products, services or Software that is sold, offered for sale, or otherwise provided by the Company or any of its Subsidiaries (each, a &#8220;<u>Company Product</u>&#8221;), misappropriates, infringes on, or otherwise violates the Intellectual Property of any Third Party, or since June&#160;30, 2022, has misappropriated, infringed on, or otherwise violated the Intellectual Property or any Third Party. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any of its Subsidiaries has since June&#160;30, 2022 received any written notice of any pending Action alleging that the Company or any of its Subsidiaries, the conduct of Company&#8217;s and its Subsidiaries&#8217; businesses, or any Company Product, infringes, misappropriates, or otherwise violates, or since June&#160;30, 2022, has infringed, misappropriated or otherwise violated any Intellectual Property of any Third Party (including an unsolicited offer to license third-party Intellectual Property). Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, as of the date hereof, there is no Action pending, or to the Knowledge of the Company, threatened in writing against the Company or its Subsidiaries or any of their respective Affiliates at Law or in equity by or before any Governmental Body (A) alleging that the Company or any of its Subsidiaries, the conduct of Company&#8217;s and its Subsidiaries&#8217; businesses, or any Company Product, infringes, misappropriates, or otherwise violates, or since June&#160;30, 2022, has infringed, misappropriated or otherwise violated, the Intellectual Property of any Third Party (B) alleging any of the Company Owned Intellectual Property is invalid or unenforceable or (C) challenging or seeking to deny or restrict, the rights of the Company or any of its Subsidiaries in any of the Company Owned Intellectual Property. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-37<br></div></div></div>
<!--End Page 366-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 367-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg38"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect and except as set forth on <u>Section&#160;4.15(d)</u> of the Company Disclosure Letter, to the Knowledge of the Company, no Person is misappropriating, infringing or violating, or since June&#160;30, 2022, has misappropriated, infringed or violated, any Company Owned Intellectual Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) each current and former employee, independent contractor and consultant of the Company or any of its Subsidiaries involved in the invention, creation, development or design of any Intellectual Property since June&#160;30, 2022 has assigned by operation of law. or has presently assigned by executing a valid and binding written agreement, to the Company or one of its Subsidiaries all right, title, and interest in and to all Intellectual Property invented, created, developed, conceived and/or reduced to practice during the term and scope of such employee&#8217;s employment or such independent contractor&#8217;s or consultant&#8217;s work for the Company or one of its Subsidiaries, and (ii) no current or former stockholder, officer, director, or employee of the Company or any of its Subsidiaries has since June&#160;30, 2022 claimed any right (whether or not currently exercisable), or interest in or to any Company Owned Intellectual Property. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and each of its Subsidiaries have taken commercially reasonable steps to maintain and protect the confidentiality of Trade Secrets, the value of which is contingent upon maintaining the confidentiality thereof, in each case, which are owned, licensed, used or held for use by the Company or any of its Subsidiaries. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no such Trade Secrets has been disclosed other than to employees, contractors, consultants, representatives and agents of the Company or any of its Subsidiaries under an enforceable obligation of confidentiality and, to the Knowledge of the Company, there has been no unauthorized disclosure of any such Trade Secrets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) since June&#160;30, 2022, none of the proprietary Software included in the Company Owned Intellectual Property (&#8220;<u>Company Software</u>&#8221; ) (A) to the Knowledge of the Company, contains any work, bomb, backdoor, clock, timer or other disabling device code, design or routine which can cause Software to be erased, inoperable or otherwise incapable of being used, either automatically or upon command, (B) has been distributed or incorporates any Software in a manner that requires, under the terms or conditions of any license to which such Company Software or Software incorporated therein is subject, that any such Company Software be (1) made available or distributed in source code form, (2) licensed for the purpose of making derivative works, (3) licensed under terms that allow reverse engineering, reverse assembly or disassembly of any kind, or (4) redistributable at no charge, or (C) is subject to any agreement with any Person under which the Company or any of its Subsidiaries has deposited, or could be required to deposit, into escrow the source code of such Company Software and no such source code has been released to any Person, or is entitled to be released to any Person, by any escrow agent and (ii) the consummation of the Contemplated Transactions will not trigger the release of any source code of any Company Software. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(h)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: (i) the IT Assets owned, leased or licensed by the Company and its Subsidiaries are sufficient for the current needs of the Company and each of its Subsidiaries to, and operate in all respects as reasonably required by the Company and each of its Subsidiaries in order for each of them to, operate its respective business as presently conducted; (ii) the Company and its Subsidiaries have implemented commercially reasonable physical, technical and organization measures consistent with industry standards and all Privacy Requirements designed to protect the confidentiality and security of the IT Assets owned by the Company and its Subsidiaries, or otherwise in their possession or control, and Personal Information and other information stored or contained therein or processed thereby against any unauthorized use, access, interruption, destruction, alteration, modification, disclosure, loss, exfiltration or corruption, or other security incident (each, a &#8220;<u>Security Breach</u>&#8221;); (iii) since June&#160;30, 2022, there has been no Security Breach of any of the IT Assets owned by, or, to the Knowledge of the Company, licensed or leased by, the Company and its Subsidiaries or of any Personal Information processed thereby or on behalf of the Company or any of its Subsidiaries or otherwise in the possession or control of the Company or any of its Subsidiaries; (iv) since June&#160;30, 2022, neither the Company nor any of its Subsidiaries has been required under applicable Law to notify Governmental Bodies, affected individuals or other Persons of any Security Breach; and (v) since June&#160;30, 2022, the Company and its </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-38<br></div></div></div>
<!--End Page 367-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 368-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg39"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">Subsidiaries have used commercially reasonable efforts to ensure that all service providers, data processors and other third parties that process any Personal Information on behalf of the Company or any of its Subsidiaries or who access any IT Assets in the Company&#8217;s or any of its Subsidiaries&#8217; possession or control comply with all Privacy Requirements and maintain the privacy, security, integrity and confidentiality of such Personal Information and IT Assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(i)&#8195;Neither the execution and delivery of this Agreement, nor the performance of this Agreement by the Company or any of its Subsidiaries, will result in the loss, forfeiture, termination, or impairment of, or give rise to a right of any Person to limit, terminate, or failure to consent to the continued use of, any rights of the Company or any of its Subsidiaries in any Company Owned Intellectual Property, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS416"><!--Anchor--></a>Section&#160;4.16.&#8195;<u>Litigation</u>. There are no, and since June&#160;30, 2022, there have not been, any Actions pending, or to the Knowledge of the Company, threatened against the Company or any of its Subsidiaries, or any director or officer of the Company or any of its Subsidiaries, at law or in equity, or before or by any Governmental Body, and the Company and its Subsidiaries are not subject to or in violation of any Order, except, in each case, that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Since June&#160;30, 2022, there has not been any internal investigation conducted by the Company or the Company Board (or any committee thereof) concerning any material allegations of fraud or malfeasance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS417"><!--Anchor--></a>Section&#160;4.17.&#8195;<u>Insurance</u>. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (a) all insurance policies are in such amounts and against such risks as the Company or such Subsidiary reasonably has determined to be prudent, taking into account the industries in which the Company and such Subsidiary operates, and as is sufficient to comply with applicable Law, (b) each insurance policy under which the Company or any of its Subsidiaries is an insured or otherwise the principal beneficiary of coverage is in full force and effect and all premiums due thereon have been paid in full and the Company and its Subsidiaries are in compliance with the terms and conditions of such insurance policy, and (c) no notice of cancellation or termination has been received with respect to any insurance policy from the insurance provider, and there is no existing default or event which, with the giving of notice or lapse of time or both, would constitute a default by any insured under such Company insurance policies. Schedule 4.17 of the Company Disclosure Letter sets forth all material insurance policies held by the Company and its Subsidiaries as of the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS418"><!--Anchor--></a>Section&#160;4.18.&#8195;<u>Employee Benefit Plans</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Section&#160;4.18(a)</u> of the Company Disclosure Letter sets forth a true, complete and correct list of all material Company Plans in effect on the date hereof. Each Company Plan that is intended to meet the requirements to be qualified under Section&#160;401(a) of the Code is the subject of a favorable determination letter or is covered by a favorable opinion letter from the Internal Revenue Service, and, to the Knowledge of the Company, there are no existing circumstances that would reasonably be expected to result in the disqualification of such Company Plan. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Company Plan has been established and maintained in accordance with the requirements of the Code, the Employee Retirement Income Security Act of 1974, as amended (&#8220;<u>ERISA</u>&#8221;), and other applicable Laws. Neither the Company nor any of its Subsidiaries has engaged in a transaction with respect to any Company Plan that could reasonably be expected to subject the Company or any of its Subsidiaries to a tax or penalty imposed by either Section&#160;4975 of the Code or Section&#160;502(i) of ERISA. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;With respect to each material Company Plan (in the case of a material PEO Plan, solely to the extent copies are reasonably available to the Company), the Company has made available to Parent true and complete copies of the following (as applicable) prior to the date hereof: (i) the Plan document, including all material amendments thereto or, with respect to any such unwritten Plan, a summary of all material terms thereof, (ii)&#160;the summary plan description along with all summaries of material modifications thereto, (iii) a copy of the most recent actuarial report for the Plan, (iv) a copy of all material filings and non-routine correspondence with any Governmental Body relating to a Company Plan received or sent within the last two (2) years, and (v) the most recent Internal Revenue Service determination or opinion letter. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;With respect to each Company Plan, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) all contributions required to be made by the Company or any of its Subsidiaries to, and premiums payable by the Company or any of its Subsidiaries in respect of, such Company Plan have been timely made or, to the extent not required to be made on or before </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-39<br></div></div></div>
<!--End Page 368-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 369-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg40"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">the date hereof, have been properly accrued on the Company&#8217;s financial statements in accordance with GAAP, and (ii) there are no Actions pending, or to the Knowledge of the Company, threatened, against any Company Plan (or in the case of a PEO Plan, in relation to the participation by the Company or any of its Subsidiaries in such Company Plan), other than routine claims for benefits. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;None of the Company, any of its Subsidiaries or any of their respective ERISA Affiliates has in the past six (6) years sponsored or contributed to (or been required to contribute to), or maintained an employee benefit plan that is or was within the past six (6) years, (i) subject to Title IV or Section&#160;302 of ERISA or Section&#160;412 of the Code, (ii) a &#8220;multiemployer plan&#8221; within the meaning of Sections 3(37) and 4001(a)(3) of ERISA, (iii) a &#8220;multiple employer plan&#8221; within the meaning of Section&#160;413(c) of the Code or (iv) a &#8220;multiple employer welfare arrangement&#8221; within the meaning of Section&#160;3(40) of ERISA. None of the Company Plans obligates the Company or any of its Subsidiaries to provide a current or former employee (or any spouse or dependent thereof) any life insurance or medical or health benefits after his or her termination of employment with the Company or any of its Subsidiaries, other than as required under Part&#160;6 of Subtitle B of Title I of ERISA, Section&#160;4980B of the Code or any other Law at the sole expense of the participant and coverage through the end of the month of termination of employment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Neither the execution or delivery of this Agreement, nor the consummation of the Contemplated Transactions, will, either individually or together with the occurrence of some other event (including, but not limited to, a termination of employment or service), (i) result in any payment or benefit (including severance, bonus or other similar payment) becoming due to any current or former officer, director, independent contractor (who is a natural person) or employee of the Company or any of its Subsidiaries, (ii) increase any benefits or compensation otherwise payable under any Company Plan to any current or former officer, director, independent contractor (who is a natural person) or employee of the Company or any of its Subsidiaries, (iii) result in the acceleration of the time of payment or vesting of any payments or benefits owed to any current or former officer, director, independent contractor (who is a natural person) or employee of the Company or any of its Subsidiaries under any Company Plan, (iv) require the Company or its Subsidiaries to set aside any assets to fund any compensation or benefits under any Company Plan, (v) limit the ability of the Company or any of its Subsidiaries to amend or terminate any Company Plan or (vi) result in any payment that would, individually or in combination with any other payment, constitute an &#8220;excess parachute payment&#8221; within the meaning of Section&#160;280G of the Code or in the imposition of an excise Tax under Section&#160;4999 of the Code. Neither the Company nor any of its Subsidiaries has any obligation to pay any gross-up, reimbursement or other payment in respect of any Tax imposed under Section&#160;4999 or Section&#160;409A of the Code. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS419"><!--Anchor--></a>Section&#160;4.19.&#8195;<u>Environmental Compliance and Conditions</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Except for matters that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;the Company and its Subsidiaries are, and since June&#160;30, 2022 have been, in compliance with all Environmental Laws; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;the Company or its Subsidiaries holds, and are and have been in compliance since June&#160;30, 2022 with, all authorizations, licenses and Permits required under Environmental Laws to operate its business as presently conducted; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;neither the Company nor its Subsidiaries has received any written claim, notice or complaint, or been subject to any Action from any Governmental Body or Third Party regarding any actual or alleged violation of Environmental Laws or any Liabilities or potential Liabilities investigation costs, cleanup costs, response costs, corrective action costs, personal injury, property damage, natural resources damages or attorney fees arising under any actual or alleged violation of Environmental Laws, and to the Knowledge of the Company, no such Action has been threatened; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;neither the Company nor any of its Subsidiaries has exposed any Person to, disposed or arranged for disposal of or released any Hazardous Substance, including at any Company Real Property, so as to give rise to Liability for investigation costs, cleanup costs, response costs, corrective action costs, personal injury, property damage, natural resources damages or attorney fees under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended (&#8220;<u>CERCLA</u>&#8221;), or any other Environmental Laws; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-40<br></div></div></div>
<!--End Page 369-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 370-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg41"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(v)&#8195;no Hazardous Substances are present or have been disposed of or released on, at, in or under (i)&#160;any real property currently or formerly owned, leased or operated by, or (ii) any property or facility to which any Hazardous Substance has been transported for disposal, recycling or treatment by or on behalf of, in each case, the Company or its Subsidiaries or to the Company&#8217;s Knowledge, any of their respective predecessors; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vi)&#8195;neither the Company nor any of its Subsidiaries has assumed or retained any Liabilities under any applicable Environmental Laws of any other Person, including in any acquisition or divestiture of any property or business; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vii)&#8195;to the Company&#8217;s Knowledge, there is no Liability of the Company or any of its Subsidiaries as a result of any Environmental Law or Hazardous Substances. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;To the Company&#8217;s Knowledge, the Company has made available to Parent all environmental, health and safety reports (including Phase I and Phase II) reports that relate to the Company or its Subsidiaries or to any property or facility owned or leased by the Company or its Subsidiaries, in each case that are in the Company&#8217;s possession. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS420"><!--Anchor--></a>Section&#160;4.20.&#8195;<u>Employment and Labor Matters</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Since June&#160;30, 2022, neither the Company nor any of its Subsidiaries is a party to, bound by, or subject to, any collective bargaining agreement or other similar agreement with a labor union, works council or other employee representative body and no employees of the Company or any of its Subsidiaries are represented by a labor union, works council or other similar employee representative body. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since June&#160;30, 2022, there has been no actual or threatened unfair labor practice charges, grievances, strikes, lockouts, work stoppages or other labor disputes against or affecting the Company or its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) there are no material Actions or any disputes (other than routine individual grievances) pending or to the Company&#8217;s Knowledge threatened (A) between the Company or any of its Subsidiaries and any of their respective officers, directors, or employees or (B) by or before any Governmental Body affecting the Company or any of its Subsidiaries concerning employment matters, and (ii) as of the date of this Agreement, to the Knowledge of the Company, no labor union, labor organization, works council or group of employees of the Company or its Subsidiaries has made a demand for recognition or certification. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company and its Subsidiaries are, and since June&#160;30, 2022 have been, in compliance in all material respects with all applicable Laws relating to labor and employment, including all such Laws relating to wages, hours, human rights, immigration, discrimination, pay equity, workers&#8217; compensation, safety and health, worker classification (including employee-independent contractor classification and the proper classification of employees as exempt employees and non-exempt employees), the Worker Adjustment and Retraining Notification Act (&#8220;<u>WARN</u>&#8221;) and any similar foreign, state, provincial or local &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Since June&#160;30, 2022, to the Knowledge of the Company, (i) there has been no material allegation of sexual or other discrimination, harassment or sexual misconduct made against any current or former officer, director or employee of the Company, (ii) neither the Company nor any of its Subsidiaries has entered into any material settlement agreement related to allegations of the foregoing conduct by any current or former officer, director or employee of the Company, and (iii) all material allegations of the foregoing conduct by any current or former officer, director or employee of the Company have been duly investigated in good faith or otherwise addressed in accordance with the applicable Company policy in effect at the time and applicable Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS421"><!--Anchor--></a>Section&#160;4.21.&#8195;<u>Material Relationships</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;<u>Section&#160;4.21(a</u>) of the Company Disclosure Letter sets forth a complete and accurate list of (i) the Company&#8217;s 10 largest customers (based on a consolidation of each customer with each of its Affiliates) for the fiscal year ended December&#160;31, 2024, as measured by aggregate monthly contractual rent (defined as cash rent including customer reimbursements for metered power) (the &#8220;<u>Top Customers</u>&#8221;), (ii) the Company&#8217;s 10 largest vendors, suppliers or services providers (based on a consolidation of each vendor, supplier or service provider </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-41<br></div></div></div>
<!--End Page 370-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 371-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg42"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">with each of its Affiliates) for the fiscal year ended December&#160;31, 2024, as measured by aggregate expenditures made by the Company and its Subsidiaries to each such vendor, supplier or servicer provider (the &#8220;<u>Top&#160;Suppliers</u>&#8221;) and (iii) the Company&#8217;s 15 largest electrical power suppliers for the fiscal year ended December&#160;31, 2024, in each case as measured by the aggregate amount of megawatts purchased (the &#8220;<u>Top&#160;Power Suppliers</u>&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Except as set forth on <u>Section&#160;4.21(b)</u> of the Company Disclosure Letter, since the Company Balance Sheet Date through the date hereof, no Top Customer, Top Supplier or Top Power Supplier of the Company and its Subsidiaries listed on <u>Section&#160;4.21(a</u>) of the Company Disclosure Letter has cancelled, rescinded, terminated, or notified the Company or its Subsidiaries in writing of any intention to cancel, rescind or terminate any Contract or business relationship with the Company or its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS422"><!--Anchor--></a>Section&#160;4.22.&#8195;<u>Government Contracts</u>. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, since June&#160;30, 2022, neither the Company nor any of its Subsidiaries has (a) breached or violated any Government Contract; (b) been excluded from bidding by a Governmental Body; (c) been audited or investigated by any Governmental Body with respect to any Government Contract; (d) conducted or initiated any internal investigation or made any disclosure with regard to any irregularity in connection with a Government Contract; (e) received any small business set aside contract or other order or contract requiring small business or other preferred bidder status; or (f) to the Knowledge of the Company, received any allegations of fraud, false claims or overpayments with respect to any of the Company&#8217;s or the its Subsidiaries&#8217; Government Contracts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS423"><!--Anchor--></a>Section&#160;4.23.&#8195;<u>Regulatory Matters</u>. None of the Company or any of its Subsidiaries is subject to any one or more of the following: (i) regulation as an &#8220;electric utility company&#8221;, a &#8220;public-utility company&#8221; or a &#8220;holding company&#8221; as defined under PUHCA, (ii) regulation as a &#8220;public utility&#8221; within the meaning of Section&#160;201(e) of the FPA or (iii) any Laws or regulations of any State Commission pertaining to rates, incurrence of Indebtedness or organizational matters. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS424"><!--Anchor--></a>Section&#160;4.24.&#8195;<u>Fiber Network</u>. Except for violations and defaults that would not have or reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The collocation facilities operated by the Company as commercial data centers and the Company&#8217;s Physical Network, taken as a whole, are, in all material respects, working, functional, fit for the purpose intended, have been maintained, subject to ordinary wear and tear, in good repair and working order condition and are without any material defects for purposes of operating the business as operated by the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Company has a Valid Right, or otherwise has the right, to use all equipment reasonably necessary to operate the Physical Network of the Company as currently operated by the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS425"><!--Anchor--></a>Section&#160;4.25.&#8195;<u>Brokerage</u>. Other than Moelis &amp; Company LLC and PJT Partners LP (each, a &#8220;<u>Financial </u><u>Advisor</u>&#8221;), no Person is entitled to any brokerage commissions, finders&#8217; fees or similar compensation in connection with the Contemplated Transactions based on any arrangement or agreement made by or on behalf of the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS426"><!--Anchor--></a>Section&#160;4.26.&#8195;<u>Disclosure</u>. None of the information supplied or to be supplied by or on behalf of the Company in writing for inclusion or incorporation by reference in (a) the Registration Statement will, at the time the Registration Statement is filed with the SEC and becomes effective under the Securities Act (or, with respect to any post-effective amendment or supplement, at the time such post-effective amendment or supplement becomes effective) or (b) the Proxy Statement and any amendments or supplements thereto, will, at the time the Proxy Statement is mailed to the Company Stockholders, or at the time of the Company Stockholders&#8217; Meeting, contain any untrue statement of a material fact, or omit to state any material fact required to be stated therein, necessary in order to make the statements therein, at that time and in light of the circumstances under which they are made, not false or misleading. The Proxy Statement will comply as to form in all material respects with the applicable provisions of the Exchange Act and the rules and regulations promulgated by the SEC thereunder. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to any information not supplied by or on behalf of the Company for inclusion or incorporation by reference in the foregoing documents. The representations and warranties contained in this <u>Section&#160;4.26</u> will not apply to statements or omissions included in the Registration Statement or Proxy Statement upon information furnished to the Company in writing by Parent specifically for use therein. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-42<br></div></div></div>
<!--End Page 371-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 372-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg43"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS427"><!--Anchor--></a>Section&#160;4.27.&#8195;<u>No Rights Agreement</u>. There is no stockholder rights plan, &#8220;poison pill,&#8221; anti-takeover plan or other similar device in effect to which the Company is a party or by which it is otherwise bound. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS428"><!--Anchor--></a>Section&#160;4.28.&#8195;<u>Fairness Opinion</u>. The Company Board has received the separate opinions of Moelis &amp; Company LLC and PJT Partners LP, each to the effect that, and as of the date of such opinion and based upon and subject to the assumptions made, procedures followed, matters considered and qualifications and limitations set forth therein, the Exchange Ratio is fair from a financial point of view to the holders of shares of Company Common Stock (other than the Cancelled Shares), and each such opinion has not been withdrawn, revoked or modified. A true and complete copy of such opinion shall be provided to Parent promptly after the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS429"><!--Anchor--></a>Section&#160;4.29.&#8195;<u>NO OTHER REPRESENTATIONS AND WARRANTIES</u>. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS <u>ARTICLE IV</u> (AS MODIFIED BY THE COMPANY DISCLOSURE LETTER) AND IN THE CERTIFICATE DELIVERED PURSUANT TO <u>SECTION&#160;8.03(D)</u>, NEITHER THE COMPANY NOR ANY PERSON ON BEHALF OF THE COMPANY MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND THE COMPANY HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE CONSUMMATION OF THE CONTEMPLATED TRANSACTIONS. IN PARTICULAR, WITHOUT LIMITING THE FOREGOING DISCLAIMER, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS <u>ARTICLE IV</u> (AS MODIFIED BY THE COMPANY DISCLOSURE LETTER) AND IN THE CERTIFICATE DELIVERED PURSUANT TO <u>SECTION&#160;8.03(D)</u>, NEITHER THE COMPANY NOR ANY OTHER PERSON MAKES OR HAS MADE ANY REPRESENTATION OR WARRANTY TO PARENT OR ANY OF ITS AFFILIATES OR REPRESENTATIVES WITH RESPECT TO (I) ANY FINANCIAL PROJECTION, FORECAST, ESTIMATE, BUDGET OR PROSPECT INFORMATION RELATING TO THE COMPANY OR ANY OF ITS SUBSIDIARIES OR THEIR RESPECTIVE BUSINESSES; OR (II) ANY ORAL OR WRITTEN INFORMATION PRESENTED TO PARENT OR ANY OF ITS AFFILIATES OR REPRESENTATIVES IN THE COURSE OF THEIR DUE DILIGENCE INVESTIGATION OF THE COMPANY, THE NEGOTIATION OF THIS AGREEMENT OR IN THE COURSE OF THE MERGER OR THE TRANSACTIONS CONTEMPLATED HEREBY. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS430"><!--Anchor--></a>Section&#160;4.30.&#8195;<u>NON-RELIANCE</u>. NEITHER THE COMPANY NOR ANY OF ITS SUBSIDIARIES IS RELYING, AND NEITHER THE COMPANY NOR ANY OF ITS SUBSIDIARIES HAS RELIED, ON ANY REPRESENTATIONS OR WARRANTIES WHATSOEVER BY OR ON BEHALF OF, PARENT, MERGER SUB OR ANY OF THEIR RESPECTIVE AFFILIATES REGARDING THE SUBJECT MATTER OF THIS AGREEMENT, EXPRESS OR IMPLIED, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES IN <u>ARTICLE IV</u> OR ANY CERTIFICATE DELIVERED PURSUANT TO <u>SECTION 8.03(D)</u>. SUCH REPRESENTATIONS AND WARRANTIES BY PARENT AND MERGER SUB CONSTITUTE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES OF EACH OF PARENT AND MERGER SUB IN CONNECTION WITH THE CONTEMPLATED TRANSACTIONS AND THE COMPANY UNDERSTANDS, ACKNOWLEDGES AND AGREES ON BEHALF OF ITSELF AND EACH OF ITS SUBSIDIARIES THAT ALL OTHER REPRESENTATIONS AND WARRANTIES OF ANY KIND OR NATURE WHETHER EXPRESS, IMPLIED OR STATUTORY ARE SPECIFICALLY DISCLAIMED BY EACH OF PARENT AND MERGER SUB. NEITHER PARENT NOR ANY OTHER PERSON WILL HAVE OR BE SUBJECT TO ANY LIABILITY OR INDEMNIFICATION OBLIGATION TO THE COMPANY OR ANY OTHER PERSON RESULTING FROM THE DISTRIBUTION TO THE COMPANY, OR THE COMPANY&#8217;S USE OF, ANY SUCH INFORMATION, INCLUDING ANY INFORMATION, DOCUMENTS, PROJECTIONS, FORECASTS OR OTHER MATERIAL MADE AVAILABLE TO THE COMPANY IN CERTAIN &#8220;DATA ROOMS&#8221; OR MANAGEMENT PRESENTATIONS IN EXPECTATION OF THE CONTEMPLATED TRANSACTIONS. IN CONNECTION WITH ITS DUE DILIGENCE INVESTIGATION OF PARENT, THE COMPANY HAS RECEIVED AND MAY CONTINUE TO RECEIVE AFTER THE DATE HEREOF FROM PARENT CERTAIN ESTIMATES, PROJECTIONS, FORECASTS AND OTHER FORWARD-LOOKING INFORMATION REGARDING PARENT AND ITS BUSINESSES AND OPERATIONS. THE COMPANY ACKNOWLEDGES THAT THERE ARE UNCERTAINTIES INHERENT IN ATTEMPTING TO MAKE SUCH ESTIMATES, PROJECTIONS, FORECASTS AND OTHER FORWARD-LOOKING STATEMENTS AND THAT THE COMPANY WILL HAVE NO CLAIM AGAINST PARENT AND MERGER SUB WITH RESPECT THERETO UNLESS ANY SUCH INFORMATION IS EXPRESSLY INCLUDED IN A REPRESENTATION OR WARRANTY CONTAINED IN THIS AGREEMENT OR CERTIFICATE DELIVERED PURSUANT TO <u>SECTION 8.03(D)</u>. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-43<br></div></div></div>
<!--End Page 372-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 373-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg44"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tANXAA5"><!--Anchor--></a>ARTICLE&#160;V<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as otherwise disclosed in (a) Parent SEC Documents filed with or furnished on or after March&#160;3, 2025 until two (2) Business Day prior to the date of this Agreement (excluding any disclosures in &#8220;risk factors&#8221; or otherwise relating to forward-looking statements to the extent that they are cautionary, predictive or forward-looking in nature (in each case, other than any description of historical facts or events included therein)); <u>provided</u>, <u>that</u>, this clause (a) shall not apply to the representations and warranties set forth in <u>Section&#160;5.01</u>, <u>Section&#160;5.02</u>, <u>Section&#160;5.03</u>, <u>Section&#160;5.04</u>, the first sentence of <u>Section&#160;5.09</u> and <u>Section&#160;5.18</u> or (b) the confidential disclosure letter delivered by Parent to the Company concurrently with this Agreement (the &#8220;<u>Parent Disclosure Letter</u>&#8221;), Parent and Merger Sub represent and warrant to the Company as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS501"><!--Anchor--></a>Section&#160;5.01.&#8195;<u>Organization and Corporate Power</u>. Parent is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, with full corporate power and authority to enter into this Agreement and perform its obligations hereunder. Parent and each of its Subsidiaries has all requisite corporate or other entity power and authority and all authorizations, licenses and Permits necessary to own, lease and operate its properties and to carry on its business as it is now being conducted, except where the failure to hold such authorizations, licenses and Permits would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Parent and each of its Subsidiaries is duly qualified or authorized to do business and is in good standing in every jurisdiction (to the extent such concept exists in such jurisdiction) in which its ownership or leasing of property or the conduct of business as now conducted requires it to qualify, except where the failure to be so qualified, authorized or in good standing would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. True and complete copies of the Certificate of Incorporation and the Bylaws of Parent have been heretofore made available to the Company and each is in full force and effect. Parent is not in breach of its Certificate of Incorporation or Bylaws in any material respects. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS502"><!--Anchor--></a>Section&#160;5.02.&#8195;<u>Authorization; Valid and Binding Agreement</u>. Each of Parent and Merger Sub has all requisite corporate power and authority to execute and deliver this Agreement, to perform their respective obligations hereunder, and to consummate the Merger and the Contemplated Transactions, subject, in the case of the Merger, to the receipt of board approval of Parent and board approval of Merger Sub (the &#8220;<u>Parent Board Approvals</u>&#8221;) and the written consent of Parent as the sole stockholder of Merger Sub to the adoption of this Agreement (the &#8220;<u>Merger Sub </u><u>Consent</u>&#8221;). The Parent Board has unanimously (a) determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable and in the best interests of, Parent and the Parent Stockholders and (b) approved and deemed advisable the execution and delivery of this Agreement, the performance by Parent of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger, and the issuance of shares of Parent Class&#160;A Common Stock, New Tranche 1 Warrants and New Tranche 2 Warrants in connection therewith, each on the terms and subject to the conditions set forth herein. The Merger Sub Board has (i) unanimously determined that this Agreement and the Contemplated Transactions on the terms and subject to the conditions set forth herein are advisable and in the best interests of Merger Sub and its sole stockholder, (ii) unanimously approved and deemed advisable the execution and delivery of this Agreement, the performance by Merger Sub of its covenants and agreements contained herein and the consummation of the Contemplated Transactions, including the Merger, and (iii) recommended that Parent, as the sole stockholder of Merger Sub, adopt this Agreement and approve the Contemplated Transactions, including the Merger. As of the date of this Agreement, such approvals, determinations, declarations, resolutions and directions are valid and have not been amended or withdrawn. Except for the Parent Board Approvals and the Merger Sub Consent, no other corporate proceeding, including pursuant to the laws of the State of Delaware or the listing standards of NASDAQ, on the part of Parent or Merger Sub is necessary to authorize or adopt this Agreement, or to consummate the Merger and the Contemplated Transactions (except for the filing of the Certificate of Merger, appropriate merger documents under the HSR Act, the Registration Statement and Proxy Statement as required by applicable Law). Parent is its own &#8220;ultimate parent entity&#8221; for purposes of the HSR Act (as that term is defined in 16&#160;C.F.R.&#160;&#167;801.1(a)(3)). Each of Parent and Merger Sub has duly executed and delivered this Agreement, and, assuming the due authorization, execution and delivery by the Company and any other counterparty thereto, this Agreement constitutes their legal, valid and binding obligation, enforceable against it in accordance with its terms except as enforcement may be limited by the Enforceability Exceptions. The shares of Parent Class&#160;A Common Stock issued pursuant to the Merger will be duly authorized, validly issued, fully paid and nonassessable and not subject to preemptive rights, and the New Tranche 1 Warrants and New Tranche 2 Warrants when issued in accordance with the terms hereof will be duly authorized and validly issued. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-44<br></div></div></div>
<!--End Page 373-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 374-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg45"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS503"><!--Anchor--></a>Section&#160;5.03.&#8195;<u>Parent Capital Stock</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;As of the date hereof, the authorized capital stock of Parent consists of (w) 3,000,000,000 shares of Parent Class&#160;A Common Stock, (x) 200,000,000 shares of Parent Class&#160;B Common Stock, (y)&#160;200,000,000&#160;shares of Parent Class&#160;C Common Stock and (z) 100,000,000 shares of Parent Preferred Stock. As of the Measurement Date, there were (i) 369,949,555 shares of Parent Class&#160;A Common Stock issued and outstanding, (ii) 118,102,040 shares of Parent Class&#160;B Common Stock issued and outstanding, (iii) no shares of Parent Class&#160;C Common Stock issued and outstanding, (iv) 6,588,000 shares of Parent Common Stock issued and held in the treasury of Parent, (v) no shares of Parent Preferred Stock issued and outstanding, (v)&#160;71,209,656&#160;shares of Parent Class&#160;A Common Stock subject to outstanding Parent Equity Awards, (vi)&#160;46,492,798 shares of Parent Class&#160;A Common Stock reserved for issuance under the Parent Equity Plans, (vii) 4,337,386 shares of Parent Class&#160;A Common Stock underlying Parent Warrants with an Exercise Price (as defined in the Parent Warrants issued pursuant to the Parent 2021 Note&#160;Purchase Agreement) of $1.55 per share, and 7,807,282 shares of Parent Class&#160;A Common Stock underlying Parent Warrants with an Exercise Price (as defined in the Parent Warrants issued pursuant to the Parent 2021 Note&#160;Purchase Agreement) of $0.0005 per share and (viii) 375,000 shares of Parent Class&#160;A Common Stock subject to purchase in connection with an equity greenshoe option granted to Magnetar Financial LLC pursuant to the Parent 2021 Note&#160;Purchase Agreement. As of the Measurement Date, 10,000,000 shares of Parent Common Stock were reserved for future purchase under the Parent employee stock purchase plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;All of the outstanding shares of Parent Capital Stock have been, and all shares that may be issued pursuant to any Parent Equity Plan will be, when issued in accordance with the respective terms thereof, duly authorized and validly issued and are fully paid, non-assessable and free of preemptive or similar rights. All of the issued and outstanding shares of Parent Capital Stock were issued in compliance with all applicable Laws concerning the issuance of securities. There are no outstanding bonds, debentures, notes or other Indebtedness of Parent having the right to vote (or convertible into, or exchangeable or exercisable for, securities having the right to vote) on any matters on which stockholders of the Parent may vote. Except as specified in this <u>Section&#160;5.03</u> or as set forth on <u>Section&#160;5.03(b)</u> of the Parent Disclosure Letter, Parent does not have any other equity securities or securities containing any equity features authorized, issued or outstanding, and there are no agreements, options, warrants or other rights or arrangements existing or outstanding which provide for the sale or issuance of any of the foregoing by Parent. Except as specified in this <u>Section&#160;5.03</u> or as set forth on <u>Section&#160;5.03(b)</u> of the Parent Disclosure Letter, there are no outstanding or promised (i) shares of capital stock or other equity interests or voting securities or ownership interests of Parent, (ii) securities convertible or exchangeable, directly or indirectly, into capital stock or other equity interests or voting securities or ownerships interests of Parent, (iii) options, warrants, purchase rights, subscription rights, preemptive rights, conversion rights, exchange rights, calls, puts, rights of first refusal, binding commitments or other Contracts that require Parent to issue, sell or otherwise cause to become outstanding or to acquire, repurchase or redeem capital stock or other equity interests or voting securities or ownership interests of Parent, (iv) restricted shares, restricted stock units, stock appreciation rights, phantom stock, profit participation or similar securities of Parent or (v)&#160;bonds, debentures, notes or other indebtedness for borrowed money of Parent having the right to vote on any matters on which Parent Stockholders may vote (collectively, the &#8220;<u>Parent Securities</u>&#8221;). As of the date hereof, there are no outstanding obligations of Parent or any of its Subsidiaries to repurchase, redeem or otherwise acquire any of the Parent Securities. Neither Parent nor any of its Subsidiaries is a party to any voting agreement with respect to the voting, registration or transfer of any Parent Securities. Since the Parent Balance Sheet Date to the date hereof, neither Parent nor any of its Subsidiaries has declared, set aside or paid any dividends on, or made any other distributions (whether in cash or stock) in respect of, any capital stock or other equity interests or voting securities of such Person (other than dividends and distributions by a direct or indirect wholly owned Subsidiary of Parent to its parent entity). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS504"><!--Anchor--></a>Section&#160;5.04.&#8195;<u>Subsidiaries</u>. Parent&#8217;s registration statement on Form&#160;S-1 filed with the SEC on March&#160;3, 2025 identifies, as of its filing date, all &#8220;significant subsidiaries&#8221; (as defined under Rule&#160;1-02(w) of Regulation S-X promulgated pursuant to the 1934 Act) (each, a &#8220;<u>Significant Subsidiary</u>&#8221;) of Parent and their respective jurisdictions of organization. Each Significant Subsidiary of Parent is a corporation or other entity duly organized, validly existing and in good standing (to the extent such concept exists in such jurisdiction) under the laws of the jurisdiction of its incorporation or organization, except where failure to be in good standing has, or would reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. All of the outstanding shares of capital stock or equivalent equity interests of each of Parent&#8217;s Significant Subsidiaries have been validly issued, are fully paid and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-45<br></div></div></div>
<!--End Page 374-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 375-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg46"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">nonassessable, and are owned of record and beneficially, directly or indirectly, by Parent free and clear of all Liens (other than Permitted Liens). None of Parent&#8217;s Significant Subsidiaries has any other equity securities authorized, issued or outstanding, and there are no agreements, options, warrants or other rights or arrangements existing or outstanding which provide for the sale or issuance of any of the foregoing. There are no outstanding or authorized options or other rights to acquire from any of Parent&#8217;s Significant Subsidiaries, or any obligations of any of Parent&#8217;s Significant Subsidiaries to issue, any capital stock, voting securities, or securities convertible into or exchangeable for capital stock or voting securities of any of Parent&#8217;s Subsidiaries (collectively, &#8220;<u>Parent Subsidiary Securities</u>&#8221;). There are no outstanding obligations of Parent or its Significant Subsidiaries to repurchase, redeem, or otherwise acquire any Parent Subsidiary Securities, and there are no other options, calls, warrants, or other rights, relating to Parent Subsidiary Securities to which Parent or its Significant Subsidiaries is a party. Except for the capital stock or other equity or voting interests of its Significant Subsidiaries, Parent does not own, directly or indirectly, any capital stock or other equity or voting interests in any Person. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS505"><!--Anchor--></a>Section&#160;5.05.&#8195;<u>No Breach</u>. Except as set forth in <u>Section&#160;5.05</u> of the Parent Disclosure Letter, the execution, delivery and performance of this Agreement by Parent and the consummation of the Contemplated Transactions do not and will not (a) conflict with or violate any of Parent&#8217;s Organizational Documents, (b) assuming all consents, approvals, authorizations and other actions described in <u>Section&#160;5.06</u> have been obtained and all filings and obligations described in <u>Section&#160;5.06</u> have been made, conflict with or violate any Law or Order to which Parent, its Subsidiaries or any of its or their properties or assets is subject or (c) with or without the giving of notice or lapse of time or both, conflict with or result in any breach of, constitute a default under, result in a violation of, give rise to a right of termination, cancellation or acceleration under, give rise to any penalties, repayment obligations, special assessments or additional payments under, result in loss of any benefit under, result in the creation of any Lien (other than any Permitted Lien) upon any assets of Parent or any of its Subsidiaries pursuant to or require any consent, waiver, approval of any other Person pursuant to, the provisions of any material contract of Parent; except, in the case of each of clauses (b) and (c) of this <u>Section&#160;5.05</u>, for any conflicts, violations, consents, approvals, authorizations, breaches, defaults, terminations, cancellations, accelerations, penalties, repayment obligations, special assessments or additional payments, Liens or waivers, which has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS506"><!--Anchor--></a>Section&#160;5.06.&#8195;<u>Consents, etc.</u> Except for (a) the applicable requirements of the HSR Act and any other Antitrust Law, (b) applicable requirements of the Exchange Act, (c) the filing of the Registration Statement, including the Proxy Statement under the Securities Act, (d) any filings required under state or foreign securities Laws, including any &#8220;blue sky&#8221; Laws, (e) any filings required by NASDAQ, (f) the filing of the Certificate of Merger and (g) any filings (A) the failure of which to make would not prevent or materially impair Parent&#8217;s ability to consummate the Merger prior to the End Date or (B) the absence of which has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, neither Parent nor any of its Subsidiaries is required to submit any notice, report or other filing with any Governmental Body in connection with the execution, delivery or performance by it of this Agreement or the consummation of the Contemplated Transactions. Other than as stated above or as set forth on <u>Section&#160;5.06</u> of the Parent Disclosure Letter, no consent, approval or authorization of any Governmental Body is required to be obtained by Parent or any of its Subsidiaries in connection with its execution, delivery and performance of this Agreement or the consummation of the Contemplated Transactions, except for those consents, approvals and authorizations the failure of which to obtain (A) would not prevent or materially impair Parent&#8217;s ability to consummate the Merger prior to the End Date or (B) has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS507"><!--Anchor--></a>Section&#160;5.07.&#8195;<u>SEC Reports; Disclosure Controls and Procedures</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Except as set forth on <u>Section&#160;5.07(a)</u> of the Parent Disclosure Letter, Parent has timely filed or furnished all forms, reports and other documents with the SEC required to be filed or furnished by Parent since March&#160;27, 2025 (such reports or documents, together with any exhibits and schedules thereto, and information incorporated herein, the &#8220;<u>Parent SEC Documents</u>&#8221;). No Subsidiary of Parent is required to file or furnish, or files or furnishes, any form, report or other document with the SEC. As of their respective filing dates (or, if amended, supplemented or superseded by a filing at least two (2) Business Days prior to the date of this Agreement, then on the date of such most recent applicable amendment, supplement or superseding filing) (and as of the date of effectiveness, in the case of any Parent SEC Documents that is a registration statement or an amendment or supplement to a registration statement): (i) each of the Parent SEC Documents complied in all material respects with the applicable requirements of the Securities Act, the Exchange Act, the NASDAQ and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-46<br></div></div></div>
<!--End Page 375-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 376-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg47"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">the Sarbanes-Oxley Act (as the case may be), and the rules and regulations promulgated thereunder, each as in effect on the date so filed or furnished, and (ii) none of the Parent SEC Documents contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The financial statements (including related notes, if any) contained in the Parent SEC Documents (i)&#160;complied as to form in all material respects with the published rules and regulations of the SEC applicable thereto at such time; (ii) were prepared in accordance with GAAP, applied on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial statements or, in the case of unaudited statements, as permitted by Form&#160;10-Q of the SEC); and (iii) fairly present in all material respects the consolidated financial position of Parent and its consolidated Subsidiaries as of the respective dates thereof and the consolidated results of operations and cash flows of Parent and its consolidated Subsidiaries for the periods covered thereby (subject, in the case of unaudited statements, to the absence of footnote disclosure and to normal year-end audit adjustments (or with respect to pro forma financial information, subject to the qualifications stated therein)). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Parent has designed and maintains a system of internal control over financial reporting (as defined in Rules 13a&#8211;15(f) and 15d&#8211;15(f) of the Exchange Act) that provides reasonable assurances regarding the reliability of financial reporting. Parent maintains disclosure controls and procedures (as defined in Rules&#160;13a&#8211;15(e) and 15d&#8211;15(e) of the Exchange Act) reasonably designed to provide reasonable assurance that all information required to be disclosed by Parent in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and is accumulated and communicated to Parent&#8217;s management as appropriate to allow timely decisions regarding required disclosure. Parent&#8217;s internal control over financial reporting is in compliance in all material respects with the applicable requirements of Section&#160;404 of the Sarbanes-Oxley Act. Parent has disclosed, based on its most recent evaluation of its disclosure controls and procedures and internal control over financial reporting prior to the date of this Agreement, to Parent&#8217;s auditors and the audit committee of the Parent Board (A) any significant deficiencies and material weaknesses in the design or operation of its internal control over financial reporting that are reasonably likely to adversely affect in any material respect Parent&#8217;s ability to record, process, summarize and report financial information and (B) any fraud, whether or not material, that involves management or other employees who have a significant role in Parent&#8217;s internal control over financial reporting. Since March&#160;27, 2025, any material change in internal control over financial reporting required to be disclosed in any Parent SEC Document has been so disclosed. As of the date of this Agreement, there have not been, since June&#160;30, 2022, any complaints or concerns made through Parent&#8217;s whistleblower hot line or equivalent system for receipt of employee concerns regarding alleged violations of law or questionable accounting or auditing matters that are material to Parent and its Subsidiaries, taken as a whole, that remain outstanding or unresolved. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;As of the date hereof, there are no outstanding or unresolved comments in comment letters received from the SEC staff with respect to any Parent SEC Documents and, to the Knowledge of Parent, none of the Parent SEC Documents is the subject of ongoing SEC review. To the Knowledge of Parent, there are no SEC inquiries or investigations pending or threatened, in each case regarding any accounting practices of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Neither Parent nor any of its Subsidiaries is a party to, and has no commitment to become a party to, any joint venture, off-balance sheet partnership or any similar Contract (including any Contract or arrangement relating to any transaction or relationship between or among Parent or any of its Subsidiaries, on the one hand, and any unconsolidated Affiliate, including any structured finance, special purpose or limited purpose entity or Person, on the other hand, or any &#8220;off-balance-sheet arrangements&#8221; (as defined in Item&#160;303(a) of Regulation S-K under the Exchange Act)), where the result, purpose or intended effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, Parent or any of its Subsidiaries in Parent&#8217;s published financial statements or other Parent SEC Documents. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;Since March&#160;3, 2025, each of the principal executive officer and principal financial officer of Parent (or each former principal executive officer and principal financial officer of Parent, as applicable) has made all certifications required by Rule&#160;13a-14 and 15d-14 under the 1934 Act and Sections 302 and 906 of the Sarbanes-Oxley Act and any related rules and regulations promulgated by the SEC and the NASDAQ, and the statements contained in any such certifications were complete and correct as of their respective dates. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-47<br></div></div></div>
<!--End Page 376-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 377-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg48"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(g)&#8195;There are no outstanding loans or other extensions of credit made by Parent or any of its Subsidiaries to any executive officer (as defined in Rule&#160;3b-7 under the 1934 Act) or director of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS508"><!--Anchor--></a>Section&#160;5.08.&#8195;<u>No Undisclosed Liabilities</u>. Except (a) as and to the extent disclosed and provided for or reserved against on the unaudited consolidated balance sheet of Parent of March&#160;31, 2025 (the &#8220;<u>Parent Balance Sheet Date</u>&#8221;) (or disclosed in the notes to such balance sheet) that is included in the Parent SEC Documents; (b) as incurred after the date thereof in the ordinary course of business (but excluding violations of law or regulation, breaches of Contracts or Permits or torts); (c) as incurred in connection with this Agreement or the Contemplated Transactions; or (d) as have not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, Parent, together with its Subsidiaries, does not have any Liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS509"><!--Anchor--></a>Section&#160;5.09.&#8195;<u>Absence of Certain Developments</u>. Since the Parent Balance Sheet Date to the date of this Agreement, there has not been any Parent Material Adverse Effect. Except as in connection with the Contemplated Transactions, since the Parent Balance Sheet Date to the date of this Agreement, none of Parent or any of its Subsidiaries has taken or omitted to take any action that, if taken or omitted during the period from the date of this Agreement through the Effective Time without the Company&#8217;s consent, would constitute a breach of <u>Section&#160;6.02(b)(i)</u>, <u>Section&#160;6.02(b)(ii)</u> or <u>Section&#160;6.02(b)(iv)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS510"><!--Anchor--></a>Section&#160;5.10.&#8195;<u>Compliance with Laws</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Parent and each of its Subsidiaries are and have been since June&#160;30, 2022, in compliance with all Laws, applicable to them or any of the properties or other assets or businesses or operations of Parent and its Subsidiaries, except where any noncompliance would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Except as would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, since June&#160;30, 2022, (i) neither Parent nor any of its Subsidiaries has received any written notice from any Governmental Body that (A) alleges any violation or noncompliance of any applicable Law, and to Parent&#8217;s Knowledge, there is no such investigation or inquiry pending or (B) asserts any fine, assessment or cease and desist order, or the suspension, revocation or limitation or restriction of any Permit issued to or held by Parent or any of its Subsidiaries and (ii) neither Parent nor any of its Subsidiaries has entered into any agreement or settlement with any Governmental Body with respect to its alleged noncompliance with, or violation of, any applicable Law. There is no Order outstanding against Parent or any of its Subsidiaries that is or would reasonably be expected to be, individually or in the aggregate, material to Parent and its Subsidiaries, taken as a whole. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS511"><!--Anchor--></a>Section&#160;5.11.&#8195;<u>Transactions with Affiliates</u>. Since June&#160;30, 2022 until the date hereof, there have been no transactions, or series of related transactions, agreements, arrangements or understandings in effect, nor are there any currently proposed transactions, or series of related transactions, agreements, arrangements or understandings, that would be required to be disclosed under Item&#160;404(a) of Regulation S-K that have not been otherwise disclosed in the Parent SEC Documents filed prior to the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS512"><!--Anchor--></a>Section&#160;5.12.&#8195;<u>Litigation</u>. There are no, and since June&#160;30, 2022, there have not been, any Actions pending, or to the Knowledge of Parent, threatened against Parent or any of its Subsidiaries, or any director or officer of Parent or any of its Subsidiaries, at law or in equity, or before or by any Governmental Body, and Parent and its Subsidiaries are not subject to or in violation of any Order, except, in each case, that would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Since June&#160;30, 2022, there has not been any internal investigation conducted by Parent or the Parent Board (or any committee thereof) concerning any material allegations of fraud or malfeasance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS513"><!--Anchor--></a>Section&#160;5.13.&#8195;<u>Brokerage</u>. Other than Goldman Sachs &amp; Co LLC, no Person is entitled to any brokerage commissions, finders&#8217; fees or similar compensation in connection with the Contemplated Transactions based on any arrangement or agreement made by or on behalf of Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS514"><!--Anchor--></a>Section&#160;5.14.&#8195;<u>Disclosure</u>. None of the information supplied or to be supplied by or on behalf of Parent in writing for inclusion or incorporation by reference in (a) the Registration Statement will, at the time the Registration Statement is filed with the SEC and becomes effective under the Securities Act (or, with respect to any post-effective amendment or supplement, at the time such post-effective amendment or supplement becomes effective) or (b) the Proxy Statement and any amendments or supplements thereto, will, at the time the Proxy Statement is mailed to the Company Stockholders, or at the time of the Company Stockholders&#8217; Meeting, contain any untrue statement of a </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-48<br></div></div></div>
<!--End Page 377-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 378-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg49"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">material fact or omit to state any material fact required to be stated therein, necessary in order to make the statements therein, at that time and in light of the circumstances under which they are made, not false or misleading. The Proxy Statement will comply as to form in all material respects with the applicable provisions of the Exchange Act and the rules and regulations promulgated by the SEC thereunder. Notwithstanding the foregoing, Parent makes no representation or warranty with respect to any information not supplied by or on behalf of Parent for inclusion or incorporation by reference in the foregoing documents. The representations and warranties contained in this <u>Section&#160;5.14</u> will not apply to statements or omissions included in the Registration Statement or Proxy Statement upon information furnished to Parent in writing by the Company specifically for use therein. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS515"><!--Anchor--></a>Section&#160;5.15.&#8195;<u>Ownership of Company Capital Stock</u>. Parent and its Subsidiaries do not beneficially own, and do not have any interest in, and, in the last three (3) years, have not beneficially owned or had any interest in any shares of Company Capital Stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS516"><!--Anchor--></a>Section&#160;5.16.&#8195;<u>Merger Sub</u>. Merger Sub was organized solely for the purpose of entering into this Agreement and consummating the Contemplated Transactions and has not engaged in any activities or business and have incurred no liabilities or obligations whatsoever, in each case other than those incident to its organization and the execution of this Agreement and the consummation of the Contemplated Transactions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS517"><!--Anchor--></a>Section&#160;5.17.&#8195;<u>Merger Qualification</u>. Neither Parent nor either Merger Sub has taken or agreed to take any action, and, to the Knowledge of Parent, there are no facts, agreements, plans or other circumstances, in each case, that would reasonably be expected to prevent or impede the Merger from qualifying as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS518"><!--Anchor--></a>Section&#160;5.18.&#8195;<u>NO OTHER REPRESENTATIONS AND WARRANTIES</u>. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS <u>ARTICLE V</u> (AS MODIFIED BY THE PARENT DISCLOSURE LETTER), AND IN THE CERTIFICATE DELIVERED PURSUANT TO <u>SECTION&#160;8.03(D)</u>, NEITHER PARENT NOR ANY PERSON ON BEHALF OF PARENT MAKES ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND PARENT HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE CONSUMMATION OF THE CONTEMPLATED TRANSACTIONS. IN PARTICULAR, WITHOUT LIMITING THE FOREGOING DISCLAIMER, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS ARTICLE V (AS MODIFIED BY THE PARENT DISCLOSURE LETTER) AND IN THE CERTIFICATE DELIVERED PURSUANT TO <u>SECTION 8.03(D)</u>, NEITHER PARENT, MERGER SUB NOR ANY OTHER PERSON MAKES OR HAS MADE ANY REPRESENTATION OR WARRANTY TO COMPANY OR ANY OF ITS AFFILIATES OR REPRESENTATIVES WITH RESPECT TO (I) ANY FINANCIAL PROJECTION, FORECAST, ESTIMATE, BUDGET OR PROSPECT INFORMATION RELATING TO PARENT OR ANY OF ITS SUBSIDIARIES OR THEIR RESPECTIVE BUSINESSES; OR (II) ANY ORAL OR WRITTEN INFORMATION PRESENTED TO COMPANY OR ANY OF ITS AFFILIATES OR REPRESENTATIVES IN THE COURSE OF ITS DUE DILIGENCE INVESTIGATION OF PARENT, THE NEGOTIATION OF THIS AGREEMENT OR IN THE COURSE OF THE MERGER OR THE TRANSACTIONS CONTEMPLATED HEREBY. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS519"><!--Anchor--></a>Section&#160;5.19.&#8195;<u>NON-RELIANCE</u>. NEITHER PARENT, MERGER SUB NOR ANY OF PARENT&#8217;S OTHER SUBSIDIARIES IS RELYING, AND NEITHER PARENT, MERGER SUB NOR ANY OF PARENT&#8217;S OTHER SUBSIDIARIES HAS RELIED, ON ANY REPRESENTATIONS OR WARRANTIES WHATSOEVER BY OR ON BEHALF OF, COMPANY OR ANY OF ITS AFFILIATES REGARDING THE SUBJECT MATTER OF THIS AGREEMENT, EXPRESS OR IMPLIED, EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES IN <u>ARTICLE IV</u> OR ANY CERTIFICATE DELIVERED PURSUANT TO <u>SECTION 8.02(D)</u>. SUCH REPRESENTATIONS AND WARRANTIES BY THE COMPANY CONSTITUTE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES OF THE COMPANY IN CONNECTION WITH THE CONTEMPLATED TRANSACTIONS AND EACH OF PARENT AND MERGER SUB UNDERSTANDS, ACKNOWLEDGES AND AGREES ON BEHALF OF ITSELF AND EACH OF ITS SUBSIDIARIES THAT ALL OTHER REPRESENTATIONS AND WARRANTIES OF ANY KIND OR NATURE WHETHER EXPRESS, IMPLIED OR STATUTORY ARE SPECIFICALLY DISCLAIMED BY THE COMPANY. NEITHER THE COMPANY NOR ANY OTHER PERSON WILL HAVE OR BE SUBJECT TO ANY LIABILITY OR INDEMNIFICATION OBLIGATION TO PARENT OR ANY OTHER PERSON RESULTING FROM THE DISTRIBUTION TO PARENT OR MERGER SUB, OR PARENT&#8217;S OR MERGER SUB&#8217;S USE OF, ANY SUCH INFORMATION, INCLUDING ANY INFORMATION, DOCUMENTS, PROJECTIONS, FORECASTS OR </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-49<br></div></div></div>
<!--End Page 378-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 379-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg50"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">OTHER MATERIAL MADE AVAILABLE TO PARENT OR MERGER SUB IN CERTAIN &#8220;DATA ROOMS&#8221; OR MANAGEMENT PRESENTATIONS IN EXPECTATION OF THE CONTEMPLATED TRANSACTIONS. IN CONNECTION WITH THEIR DUE DILIGENCE INVESTIGATION OF THE COMPANY, PARENT AND MERGER SUB HAVE RECEIVED AND MAY CONTINUE TO RECEIVE AFTER THE DATE HEREOF FROM THE COMPANY CERTAIN ESTIMATES, PROJECTIONS, FORECASTS AND OTHER FORWARD-LOOKING INFORMATION REGARDING THE COMPANY AND ITS BUSINESSES AND OPERATIONS. PARENT AND MERGER SUB ACKNOWLEDGE THAT THERE ARE UNCERTAINTIES INHERENT IN ATTEMPTING TO MAKE SUCH ESTIMATES, PROJECTIONS, FORECASTS AND OTHER FORWARD-LOOKING STATEMENTS AND THAT PARENT AND MERGER SUB WILL HAVE NO CLAIM AGAINST THE COMPANY WITH RESPECT THERETO UNLESS ANY SUCH INFORMATION IS EXPRESSLY INCLUDED IN A REPRESENTATION OR WARRANTY CONTAINED IN THIS AGREEMENT OR CERTIFICATE DELIVERED PURSUANT TO <u>SECTION 8.03(D)</u>. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;"><a name="tANXAA6"><!--Anchor--></a>ARTICLE&#160;VI<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">COVENANTS RELATING TO CONDUCT OF BUSINESS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS601"><!--Anchor--></a>Section&#160;6.01.&#8195;<u>Covenants of the Company</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Except (i) as required or prohibited by applicable Law, (ii) as expressly required or expressly permitted by this Agreement, (iii) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed), or (iv) as set forth in <u>Section&#160;6.01(a)</u> of the Company Disclosure Letter, from the date hereof until the earlier of the Effective Time or the date this Agreement is validly terminated in accordance with <u>Article&#160;IX</u> (the &#8220;<u>Pre-Closing Period</u>&#8221;), the Company shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to (A) carry on its business in the ordinary course of business in all material respects, (B) preserve intact its current business organizations and its relationships with customers, suppliers, distributors, lenders, landlords, tenants, utility companies, power providers, Governmental Bodies and others having business relationships that in each case are material to the Company or its Subsidiaries taken as a whole, (C) comply with applicable Law in all material respects, (D) maintain in effect all necessary Permits that are material to the Company and its Subsidiaries taken as a whole and (E) maintain the material assets and material properties of the Company in their current condition in all material respects, ordinary wear and tear excepted; <u>provided</u>, that (i) no action by the Company or any of its Subsidiaries to the extent expressly permitted by an exception to any of <u>Section&#160;6.01(b)</u> shall be a breach of this sentence unless such action would constitute a breach of another provision of this <u>Section&#160;6.01</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Without limiting the generality of <u>Section&#160;6.01(a)</u>, during the Pre-Closing Period and except (i) as set forth in <u>Section&#160;6.01(b)</u> of the Company Disclosure Letter, (ii) as required or prohibited by applicable Law, (iii)&#160;as expressly required or expressly permitted by this Agreement or (iv) with the prior written consent of Parent (not to be unreasonably withheld, conditioned or delayed), the Company shall not and shall cause its Subsidiaries, not to: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;enter into any new line of business outside the existing lines of business of the Company and its Subsidiaries as of the date of this Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;(1) declare, set aside, establish a record date for or pay any dividends on or make other distributions (whether in cash, stock or property) in respect of any Company Capital Stock or Company Subsidiary Securities or other equity securities of the Company or its Subsidiaries or (2) directly or indirectly redeem, repurchase, buyback or otherwise acquire any shares of Company Capital Stock, any Company Subsidiary Securities, any Company Convertible Notes, any Company Warrants or any Company RSU Awards or Company PSU Awards with respect thereto, except, in each case, (A) for the declaration and payment of dividends or distributions by a direct or indirect wholly owned Subsidiary of the Company solely to its direct parent entity, (B) any forfeitures or repurchases of unvested Company RSU Awards, Company PSU Awards or other shares of Company Capital Stock issued pursuant to or granted as awards under the Company Equity Plans in accordance with the terms thereof as in effect as of the date hereof, (C)&#160;to satisfy any applicable Tax withholding in respect of the vesting or settlement of any Company RSU Awards or Company PSU Awards, (D) for the issuance of shares of Company Common Stock (and payment of cash in lieu of issuing any fractional share) to settle (x) any conversion of any of the Company Convertible Notes in accordance with the terms of the corresponding Indenture or (y) any exercise of the Company Warrants, in each case, as outstanding on the date hereof and in accordance with their respective terms on the date hereof, (E) payments of regular scheduled interest upon the Company Convertible Notes </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-50<br></div></div></div>
<!--End Page 379-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 380-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg51"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">solely to the extent required pursuant to the terms of the corresponding Indenture or any exercise of the Company Warrants, in each case, outstanding on the date hereof and in accordance with their respective terms as in effect on the date hereof, or (F) as required by the Company CVR Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;(x) issue, sell, pledge, dispose of or otherwise encumber, or authorize the issuance, sale, pledge, disposition or other encumbrance of, or make or exercise any option to purchase with respect to, (1) any shares of Company Capital Stock or any Company Subsidiary Securities, (2) any securities convertible into or exchangeable or exercisable for any such shares or ownership interest, (3) any phantom equity or similar contractual rights or (4) any rights, warrants or options to acquire any such shares or securities exchangeable into such shares, except in each case: (A) for the issuance of shares of Company Common Stock (and payment of cash in lieu of issuing any fractional shares) to settle (x) any conversion of the Company Convertible Notes in accordance with the terms of the corresponding Indenture existing as of the date hereof, or (y) any exercise of the Company Warrants, in each case, outstanding on the date hereof in accordance with their respective terms as in effect on the date of this Agreement, (B) for issuances of Company Common Stock upon the vesting or settlement of Company RSU Awards or Company PSU&#160;Awards outstanding prior to the date hereof or issued after the date hereof in compliance with this Agreement, in each case in accordance with their respective terms, (C) for transactions solely between or among any of the Company and its wholly owned Subsidiaries, and (D) Permitted Liens or (y) amend or otherwise change any term of any Company Capital Stock or Company Subsidiary Security (in each case, whether by merger, consolidation or otherwise); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;except as required by the terms of a Company Plan as in effect as of the date hereof, (A) grant or increase (or promise to commit to grant or increase) the wages, salary, severance, equity or other compensation or benefits with respect to any of the Company&#8217;s or any of its Subsidiaries&#8217; officers, directors, or employees, (B) establish, adopt, enter into, materially amend or terminate any Company Plan, other than the amendment of any Company Plan that is a broad-based welfare benefit plan in the ordinary course of business and in a manner that does not enhance the benefits under such Company Plan or increase the costs to the Company or any of its Subsidiaries, (C) accelerate the vesting, funding or time of payment of any compensation or other benefit, (D) enter into any transaction bonus, retention, change-of-control or similar agreement or arrangement with any employee of the Company or any of its Subsidiaries or pay or award (or commit to pay or award) any amounts in respect of the foregoing, (E) grant, or promise or commit to grant, any equity or equity-aligned awards or any long-term incentive awards, (F) waive or release any noncompetition, non-solicitation, nondisclosure, noninterference, non-disparagement or other restrictive covenant obligation of any current or former employee or other individual service provider; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(v)&#8195;(A) adopt, enter into or amend any collective bargaining agreement or other Contract with any labor union, works council or other similar employee representative body applicable to the Company or its Subsidiaries or (B) engage in any conduct that would result in an employment loss or layoff for a sufficient number of employees of the Company or its Subsidiaries which would constitute a &#8220;plant closing&#8221; or &#8220;mass layoff&#8221; under WARN; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vi)&#8195;hire, engage, promote or terminate (other than for cause) any employee, except for (A) the hiring or engagement of any individual to whom an offer of employment has been extended on or prior to the date hereof as listed in <u>Section&#160;6.01(b)(vi)</u> of the Company Disclosure Letter or (B) the hiring, engagement, promotion or termination of any employee below the title of Senior Manager and with a base salary less than $180,000 in the ordinary course of business consistent with past practice; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vii)&#8195;(A) other than as expressly required by this Agreement in furtherance of the Contemplated Transactions, amend, or propose to amend any Company Organizational Document (including by merger, consolidation or otherwise); (B) adopt a stockholders&#8217; rights plan or similar plan or (C) other than this Agreement, enter into any agreement with respect to the voting of the Company Capital Stock or any Company Subsidiary Securities; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(viii)&#8195;effect a recapitalization, reclassification of shares, stock split, reverse stock split, combination, subdivision or similar transaction or authorize the issuance of any other securities in respect of, in lieu of, or in substitution for shares of Company Capital Stock; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-51<br></div></div></div>
<!--End Page 380-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 381-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg52"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ix)&#8195;(i) adopt a plan of complete or partial liquidation or dissolution, of the Company or any of its &#8220;significant subsidiaries,&#8221; as defined in Rule&#160;1-02(w) of Regulation S-X or (ii) enter into any merger, liquidation, dissolution, reorganization or restructuring of the Company or any such &#8220;significant subsidiaries&#8221;; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(x)&#8195;other than capital expenditures made pursuant to Development Contracts with respect to the Parent Development Properties, incur, make or authorize any capital expenditures or any obligations or liabilities in respect thereof, other than capital expenditures that are in the ordinary course and do not exceed $5,000,000 individually or $10,000,000 in the aggregate or are contemplated by Annex&#160;6.01(b)(x) to the Company Disclosure Letter; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xi)&#8195;acquire or agree to acquire, by merging or consolidating with, by purchasing an equity interest in or a portion of the assets of any business or any corporation, partnership, association or other business organization or division thereof, or otherwise acquire or agree to acquire any material assets of any other Person, except for (A) purchases in the ordinary course of business, (B) transactions (I) solely among the Company and one or more of its wholly owned Subsidiaries or (II) solely among the Company&#8217;s wholly owned Subsidiaries and (C) pursuant to existing contractual obligations disclosed to Parent prior to the date hereof but excluding the contractual obligations contemplated by Section&#160;6.01(b)(xxvi); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xii)&#8195;(A) incur, assume, endorse, guarantee, or otherwise become liable for any indebtedness for borrowed money or any surety bonds or letters of credit obligations or issue or sell any debt securities or calls, options, warrants or other rights to acquire any debt securities (directly, contingently or otherwise) or enter into any &#8220;keep well&#8221; or other agreement to maintain any financial statement condition of another Person (other than the Company or any of its Subsidiaries), (B) make any material loans or advances to any other Person, or (C) make any material capital contributions to, or investments in, any other Person, except, in each case, for (1) among the Company and its wholly owned Subsidiaries or to or among any wholly owned Subsidiaries of the Company, (2) any surety bonds or letters of credit obligations incurred, assumed, endorsed, guaranteed or for which the Company or any of its Subsidiaries otherwise become liable in the ordinary course of business, (3) any advances or deposits for the future delivery of goods or services, including under co-location agreements, and (4) guarantees by the Company or its Subsidiaries of obligations of the Company or any of its Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xiii)&#8195;sell, transfer, assign, mortgage, encumber, pledge, license, lease, sublease, abandon or otherwise withdraw or dispose of any properties or assets with a fair market value in excess of $3,000,000 in the aggregate except for, in each case, (x) Permitted Liens, (y) sales of inventory and equipment, or of obsolete or worthless assets, in each case in the ordinary course of business, and (z) any transaction (I)&#160;solely among the Company and one or more of its wholly owned Subsidiaries or (II) solely among the Company&#8217;s wholly owned Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xiv)&#8195;(A) other than non-exclusive licenses granted in the ordinary course of business, sell, lease, assign, transfer, convey, dispose of, grant any license or sublicense in, to or under, create or incur any Lien (other than Permitted Liens) on, any material Company Owned Intellectual Property or (B) allow any material Registered IP to lapse or go abandoned, other than at the end of its maximum statutory term; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xv)&#8195;pay, discharge, settle, compromise or satisfy, or offer or propose to pay, discharge, settle, compromise or satisfy, (A) any Action or threatened Action that results in the payment of monetary damages in excess of $3,000,000 in the aggregate, or that imposes any material restrictions or limitations upon the assets, operations or business of the Company or any of its Subsidiaries (or Parent after Closing) or equitable or injunctive remedies or the admission of wrongdoing by the Company or any of its Subsidiaries (or Parent, after the Closing) or (B) any Action or threatened Action (excluding any Action or threatened Action relating to Taxes, such Action and threatened Actions being subject to <u>Section&#160;6.01(b)(xvii)</u>) that relates to the transactions contemplated hereby; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xvi)&#8195;change its fiscal year or change any of its financial accounting methods or practices or internal accounting controls or disclosure controls and procedures in any respect, except as required by GAAP, Regulation S-X of the Exchange Act, or a Governmental Body or quasi-governmental authority (including the Financial Accounting Standards Board or any similar organization); </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-52<br></div></div></div>
<!--End Page 381-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 382-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg53"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xvii)&#8195;other than in the ordinary course of business, (A) make, change or revoke any material Tax election with respect to the Company or any of its Subsidiaries, (B) adopt or make any material change to any material method of Tax accounting, (C) enter into any Closing Agreement relating to or affecting any material Tax Liability or refund of material Taxes with respect to the Company or any of its Subsidiaries, (D) change any material Tax accounting period, (E) consent to any extension or waiver of the limitations period applicable to any material Tax claim or assessment (other than any such extensions or waivers automatically granted), or (F) settle or compromise any material Tax Liability or refund of material Taxes with respect to the Company or any of its Subsidiaries for an amount materially in excess of amounts reserved therefor, in the case of each of clauses (A) through (F), if such action would result in a material increase in the Tax liability of the Company and its Subsidiaries, taken as a whole (it being agreed and understood that none of clauses <u>(i)</u> through <u>(xvi)</u> nor clause <u>(xviii)</u> through (xxvii) of this <u>Section&#160;6.01(b)</u> shall apply to Tax compliance matters other than clause <u>(xxvii)</u> insofar as it relates to this clause (xvii); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xviii)&#8195;amend or modify in any material respect, terminate or fail to renew (including failing to exercise a renewal or extension option under) or grant any material waiver or consent under, any Company Material Contract (or any Contract that, if existing on the date hereof, would be a Company Material Contract), or enter into any Contract that, if existing on the date hereof, would be a Company Material Contract, or otherwise knowingly waive, release or assign any material rights, claims or benefits of the Company or any of its Subsidiaries with respect to any Company Material Contract (excluding any Development Contracts with respect to the Parent Development Properties, which shall be subject to <u>Section&#160;6.01(b)(xxiv)</u>, and Real Property Leases, which shall be subject to <u>Section&#160;6.01(b)(xxv)</u>), in each case other than (a) in the ordinary course and in a manner that is not reasonably expected to be adverse to the Company or its Subsidiaries or, after giving effect to the Contemplated Transactions, Parent and its Subsidiaries, (b) the expiration or renewal of any Company Material Contract with a Third Party in accordance with its terms, or (c) as expressly contemplated by this Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xix)&#8195;take any action to exempt any Person from any state takeover statute or similar statute or regulation that applies to the Company with respect to an Acquisition Proposal, including the restrictions on &#8220;business combinations&#8221; set forth in Section&#160;203 of the DGCL, except for Parent, Merger Sub, or any of their respective Subsidiaries or Affiliates or to the extent permitted pursuant to <u>Section&#160;7.04</u>; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xx)&#8195;voluntarily abandon, withdraw, terminate, suspend, abrogate, amend or modify any Permit issued to or held by the Company or any of its Subsidiaries in a manner that would materially impair the operation of the business of the Company or any of its Subsidiaries, taken as a whole; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxi)&#8195;(i) fail to maintain any material property insurance currently in effect covering the Owned Real Property or (ii) cancel, amend or modify any material license or Permit held by the Company with respect to the Owned Real Property, Company Real Property Leases or any part thereof which would be binding after the Effective Time in a manner that would materially impair the operation or the use of such real property (as currently used in connection with the Company&#8217;s business); </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxii)&#8195;initiate or consent to any material zoning reclassification of any Company Real Property or any material change to any approved site plan (in each case, that is material to such Company Real Property or plan, as applicable), special use permit or other land use entitlement affecting any material Company Real Property or Leased Real Property, in each case, in a manner that would materially inhibit the Company&#8217;s ability to develop or use the Company Real Property for data center operations; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxiii)&#8195;fail to maintain in full force and effect existing material insurance policies (or substantially similar replacements thereto) (excluding property insurance covering Owned Real Property, which is the subject of <u>Section&#160;6.01(b)(xxi)</u>); <u>provided</u> that in the event of a termination, cancellation or lapse of any material insurance policy, the Company shall use reasonable best efforts to promptly obtain replacement policies on substantially consistent terms and providing substantially comparable insurance coverage with respect to the material assets, operations and activities of the Company and its Subsidiaries as currently in effect as of the date hereof; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxiv)&#8195;(A) enter into or materially amend, modify, waive any material rights under or grant any material consents under any material Development Contract at any Development Property that is not a Parent Development Property, other than in the ordinary course of business; <u>provided</u> that the Company and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-53<br></div></div></div>
<!--End Page 382-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 383-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg54"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">its Subsidiaries shall not enter into any new co-location agreements with respect to any Development Property that is not a Parent Development Property or (B) enter into or materially amend, modify, waive any material rights under or grant any material consents under any non de minimis Development Contract with respect to a Parent Development Property; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxv)&#8195;enter into or materially amend, renew or extend (or fail to exercise a renewal or extension option under), or materially modify a Company Real Property Lease or terminate any Company Real Property Lease (except any termination that shall occur at the end of the maximum term of such Real Property Lease), other than by extending such term through the payment of any extension fee in an amount up to $3,000,000; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxvi)&#8195;fail to take any action contemplated to be taken by the Company on <u>Section&#160;6.01(b)(xxvi)</u> of the Company Disclosure Letter; or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(xxvii)&#8195;authorize, agree or commit to take any of the actions described in <u>Section&#160;6.01(b)(i)</u> through&#160;(xxvi). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS602"><!--Anchor--></a>Section&#160;6.02.&#8195;<u>Covenants of Parent</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Except (i) as set forth in <u>Section&#160;6.02(a)</u> of the Parent Disclosure Letter, (ii) as required or prohibited by applicable Law, (iii) as expressly permitted or expressly required by this Agreement or (iv) with the prior written consent of the Company (which consent shall not be unreasonably delayed, withheld or conditioned), during the Pre-Closing Period, Parent shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to (A) carry on its business in the ordinary course of business in all material respects and (B) preserve intact its current business organizations and its relationships with material customers, material suppliers, Governmental Bodies and others having business relationships that are material to Parent or its Subsidiaries taken as a whole, <u>provided</u>, that (i) no action by Parent or any of its Subsidiaries to the extent expressly permitted by an exception to any of <u>Section&#160;6.02(b)</u> shall be a breach of this sentence unless such action would constitute a breach of another provision of this <u>Section&#160;6.02</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Without limiting the generality of <u>Section&#160;6.02(a)</u>, during the Pre-Closing Period and except (i) as set forth in <u>Section&#160;6.02(b)</u> of the Parent Disclosure Letter, (ii) as required or prohibited by applicable Law, (iii) as expressly required or expressly permitted by this Agreement or (iv) with the prior written consent of the Company (which consent shall not be unreasonably delayed, withheld or conditioned), Parent shall not and shall cause its Subsidiaries not to: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;(1) declare, set aside, establish a record date for or pay any dividends on or make other distributions (whether in cash, stock or property) in respect of any Parent Capital Stock, except (A) for the declaration and payment of dividends or distributions by a direct or indirect Subsidiary of Parent solely to its parent, (B) any forfeitures or repurchases of Parent Equity Awards granted under the Parent Equity Plans, or (C) to satisfy any applicable Tax withholding in respect of the exercise, vesting or settlement of any Parent Equity Award; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;issue, sell or authorize the issuance or sale of, or make any option to purchase with respect to, (1) any shares of Parent Capital Stock or any equity securities of Parent&#8217;s subsidiaries, (2) any securities convertible into or exchangeable or exercisable for any such shares or ownership interest, (3) any phantom equity or similar contractual rights or (4) any rights, warrants or options to acquire any such shares or securities exchangeable into such shares, except in each case: (A) the grant of Parent Equity Awards or any other equity compensation award pursuant to any stockholder-approved equity plan, (B) for issuances of Parent Common Stock upon the vesting, exercise or settlement of Parent Equity Awards (and dividend equivalents thereon, if applicable) outstanding prior to the date hereof or issued after the date hereof in compliance with this Agreement, (C) any exercise of the Parent Warrants and in accordance with their respective terms on the date hereof, (D) transactions solely between or among Parent and its wholly owned Subsidiaries, (E) Permitted Liens, (F) the issuance by Parent of not more than 12.5% of the total number of shares of Parent Common Stock issued and outstanding as of the date of this Agreement determined on a fully-diluted basis, (G) the sale or issuance of Parent Common Stock in connection with one or more mergers; acquisitions of securities, businesses, property or other assets, products or technologies; joint </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-54<br></div></div></div>
<!--End Page 383-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 384-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg55"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">ventures; commercial relationships or other strategic corporate transactions or alliances, whether structured as a merger, stock purchase, business combination or otherwise and (I) the sale of Parent Class&#160;A Common Stock upon the exercise of the equity greenshoe option granted to Magnetar Financial LLC pursuant to the Parent 2021 Note&#160;Purchase Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;other than as expressly permitted or required by this Agreement in furtherance of the Contemplated Transactions, amend, or propose to amend any of Parent&#8217;s Organizational Documents (including by merger, consolidation or otherwise) in a manner that would be adverse to the Company or the Company&#8217;s stockholders; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;effect a recapitalization, reclassification of shares, stock split, reverse stock split or similar transaction or authorize the issuance of any other securities in respect of, in lieu of, or in substitution for shares of its capital stock; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(v)&#8195;adopt a plan of complete or partial liquidation or dissolution, of Parent or any of its &#8220;significant subsidiaries,&#8221; as defined in Rule&#160;1-02(w) of Regulation S-X; or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(vi)&#8195;authorize, agree or commit to take any of the actions described in <u>Section&#160;6.02(b)(i)</u> through <u>Section&#160;6.02(b)(iv)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS603"><!--Anchor--></a>Section&#160;6.03.&#8195;<u>No Control of Other Party&#8217;s Business</u>. Nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct Parent&#8217;s or any of its Subsidiaries&#8217; operations or give Parent, directly or indirectly, the right to control or direct the Company&#8217;s or any of its Subsidiaries&#8217; operations prior to the Effective Time. Prior to the Effective Time, each of the Company and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over its respective operations. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15pt; text-align: center;"><a name="tANXAA7"><!--Anchor--></a>ARTICLE&#160;VII<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">ADDITIONAL COVENANTS OF THE PARTIES </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS701"><!--Anchor--></a>Section&#160;7.01.&#8195;<u>Investigation</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Upon Parent&#8217;s reasonable advance notice to the Company, for purposes reasonably related to consummating the Contemplated Transactions, or preparing for post-Merger integration or restructuring and notwithstanding anything to the contrary in the Confidentiality Agreement, the Company and its Subsidiaries shall afford to Parent and its Representatives reasonable access during normal business hours during the Pre-Closing Period to the Company&#8217;s and its Subsidiaries&#8217; personnel and properties, Contracts, books and records and any report, schedule or other documents filed or received by it pursuant to the requirements of applicable Law and with such additional financial, operating and other data and information regarding the Company and its Subsidiaries, as Parent may reasonably request, <u>provided</u>, <u>however</u>, that such access shall be in a manner so as to not unreasonably interfere with the normal business operations of the Company or any of its Subsidiaries. Notwithstanding the foregoing, neither the Company nor its Subsidiaries shall be required to afford such access to Parent and its Representatives if, in the reasonable judgment of the Company, it would cause a loss of privilege to the Company or any of its Subsidiaries, or would constitute a violation of any applicable Law, would result in the disclosure of any valuations of the Company or Parent in connection with the Contemplated Transactions or portions of the minutes of the meetings of the Company Board or any committee thereof (including any presentations or other materials prepared by or for the Company Board or any committee thereof) where the Company Board or such committee, as applicable, discussed the Contemplated Transactions or any similar transaction between the Company and any other Person, would result in the disclosure of any information that is reasonably pertinent to a litigation where Parent or any of its Affiliates, on the one hand, and the Company or any of its Affiliates, on the other hand, are adverse parties or reasonably likely to become adverse parties or would result in the unauthorized disclosure of any Trade Secrets; <u>provided</u>, in each case, that the Company has used its reasonable best efforts to find an alternative way to provide the access or information contemplated by this <u>Section&#160;7.01(a)</u> to Parent and its Representatives, as applicable, that does not cause such loss, constitute such violation or breach or result in such disclosure or exposure. No access or information provided pursuant to this <u>Section&#160;7.01</u> shall limit or otherwise affect or be deemed to modify any representation or warranty made by the Company or the remedies available to Parent, Merger Sub or the Company hereunder. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Following the date of this Agreement, the Company and Parent shall use reasonable efforts to develop mutually acceptable protocols (including with respect to antitrust considerations) to manage communications </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-55<br></div></div></div>
<!--End Page 384-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 385-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg56"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">between the Parties and their respective employees. Disclosure of any information pursuant to this <u>Section&#160;7.01</u> or <u>Section&#160;7.05</u> shall be subject to any additional confidentiality or joint defense agreement the Parties may mutually determine to enter into. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(c)&#8195; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;As promptly as practicable following the date of this Agreement and to the extent permitted by applicable Law, each of Parent and the Company shall appoint an equal number (to be mutually agreed) of representatives to a committee (the &#8220;<u>Transition and Development Committee</u>&#8221;), each of whom shall have suitable seniority and the requisite skills, knowledge, experience and authority to discuss, coordinate and make arrangements related to integration matters between Parent, on one hand, and the Company and its Subsidiaries, on the other hand. The purpose of the Transition and Development Committee shall be to plan and discuss (i) integration planning, (ii) contractual pipelines, (iii) status of electric power, (iv)&#160;equipment procurement, (v) status of outstanding option contracts, letters of intent, and validation of site suitability and power, (vi) requests for consent made by the Company or Parent, as applicable, pursuant to <u>Section&#160;6.01</u> or <u>6.02</u>, as applicable, and (vii) any other issue or matters that may otherwise be referred to the Transition and Development Committee. The members of the Transition and Development Committee will also cooperate to oversee and plan for the development of the Parent Development Properties in accordance in all material respects with Contracts between the Parties or their respective Subsidiaries and between the Company or its Subsidiaries with Third Parties with respect to such matters. It is understood and agreed that any failure by the Company to comply with its obligations pursuant to <u>Section&#160;6.01(a)</u>, <u>Section&#160;6.01(b)</u> (solely in respect of <u>Section&#160;6.01(b)(xxi)</u>), <u>Section&#160;6.01(b)(xviii)</u> (solely with respect to Company Material Contracts to which Parent or any of its Subsidiaries is party), Section&#160;<u>6.01(b)(xxiii)</u> (solely with respect to any Company Real Property with respect to which Parent is a party to a Development Contract) and <u>Section&#160;6.01(b)(xxv)</u> (solely with respect to any Company Real Property Lease with respect to which Parent is a party) or this <u>Section&#160;7.01(c)</u> that is primarily caused by, or primarily results from, any breach of contractual obligations owed by Parent or its Subsidiaries to the Company or its Subsidiaries or any unreasonable failure or delay of Parent or its Subsidiaries in providing any consent reasonably requested by the Company pursuant to <u>Section&#160;6.01</u>, shall not be taken into account for purposes of determining the satisfaction of the conditions in <u>Section&#160;8.02(b)</u>; <u>provided that</u>, the Company shall not be deemed in breach of <u>Section&#160;6.01(a)</u>, including for the purposes of the closing condition in <u>Section&#160;8.02(b)</u>, as a result of the failure to take any action that the Company requested Parent&#8217;s consent to take pursuant to <u>Section&#160;6.01(b)</u> and Parent declined to consent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;Each member of the Transition and Development Committee shall be subject to confidentiality and other restrictions necessary or appropriate to ensure compliance with Antitrust Laws and any other applicable Laws, in each case, as reasonably agreed by the Parties. The Transition and Development Committee shall participate in weekly, or as reasonably agreed between Parent and the Company, integration and development planning meetings and in connection therewith, prior to each such meeting (x)&#160;the Company shall use commercially reasonable efforts to provide Parent with updated information reasonably requested in advance by Parent for integration and development planning, including historical operating reports (<u>provided</u> that the Company shall only be required to provide Parent with reports that the Company prepares in the ordinary course of business), and (y) Parent shall use commercially reasonable efforts to timely review and respond to any requests from the Company for Parent&#8217;s consent or cooperation in connection with the matters addressed by the Transition and Development Committee. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Prior to the Closing Date, nothing herein shall authorize any Party or its Representatives to undertake any environmental testing or sampling at any of the properties owned, operated or leased by the other Party or its Subsidiaries absent the prior consent of such other Party or its Subsidiaries. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;The Parties hereby agree that all information provided to them or their respective Representatives (as defined in the Confidentiality Agreement) (or, in the case of Parent, Debt Financing Sources) in connection with this Agreement and the consummation of the Contemplated Transactions, including the information provided pursuant to <u>Section&#160;7.01(a)</u>, shall be deemed to be Confidential Information, as such term is defined in, and shall be treated in accordance with, that certain confidentiality letter agreement between Parent and the Company dated as of June&#160;13, 2025 (as it may be amended, the &#8220;<u>Confidentiality Agreement</u>&#8221;). In furtherance of the foregoing, each of Parent and the Company agrees that it will not, and will cause its Representatives (as defined therein) (excluding Third Party Representatives (as defined therein), who it will only need to direct) not to, use </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-56<br></div></div></div>
<!--End Page 385-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 386-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg57"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">any information obtained pursuant to this <u>Section&#160;7.01</u> for any competitive or other prohibited purpose unrelated to the consummation of the Contemplated Transactions or the preparation for post-Closing integration, restructuring or financing transactions; <u>provided</u> that the Receiving Party (as defined therein) shall be responsible for any breach or violation of the terms of the Confidentiality Agreement applicable to its Representatives (as defined therein) by its Representatives (as defined therein) (in such capacity) (including any failure to comply with a direction required to be given under the Confidentiality Agreement). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS702"><!--Anchor--></a>Section&#160;7.02.&#8195;<u>Registration Statement; Proxy Statement</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;As soon as practicable after the execution of this Agreement, and in any event within 45 days after the date of this Agreement, (i) the Company shall prepare and cooperate with Parent with respect to a proxy statement (the &#8220;<u>Proxy Statement</u>&#8221;) in preliminary form, which shall contain the Company Board Recommendation (unless an Adverse Recommendation Change has occurred), and (ii) Parent shall prepare and file with the SEC (x) a registration statement on Form&#160;S-4, in which the Proxy Statement shall be included and (y) a prospectus relating to (i) the shares of Parent Class&#160;A Common Stock, (ii) the New Tranche 1 Warrants and (iii) the New Tranche 2 Warrants to be offered and sold pursuant to this Agreement and the Merger (such registration statement together with the amendments and supplements thereto, the &#8220;<u>Registration Statement</u>&#8221;). Each of Parent and the Company covenants and agrees that the information provided by it or any of its Subsidiaries for inclusion in the Proxy Statement (and the letter to stockholders, notice of meeting and form of proxy included therewith) will not, at the time that the Proxy Statement or any amendment or supplement thereto is filed with the SEC or is first mailed to the Company Stockholders or when the Registration Statement becomes effective, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. Parent shall use its reasonable best efforts, and the Company shall reasonably cooperate with Parent in such efforts, to have the Registration Statement declared effective under the Securities Act as promptly as practicable after such filing and to keep the Registration Statement effective as long as necessary to consummate the Contemplated Transactions, including the Merger. In furtherance thereof, Parent and the Company will work together in good faith, including with each Party&#8217;s Representatives (and including by providing reasonable access to relevant data, schedules and work papers), to prepare financial statements, financial information and such other information as required to be included in the Registration Statement, subject to <u>Section&#160;7.01(e)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Each of Parent and the Company shall reasonably cooperate with each other and provide, and require its Representatives to provide, the other party and its Representatives with all true, correct and complete information regarding the Company or any of its Affiliates or equityholders that is required by Law to be included in the Registration Statement or reasonably requested by the other Party to be included in the Registration Statement. Each of Parent and the Company will use reasonable best efforts to cause their respective independent accounting firms to deliver consent letters regarding the inclusion of their opinions with respect to the Company&#8217;s or Parent&#8217;s, as applicable, financial statements that are included in the Registration Statement, which such consent letter shall be customary in scope and substance for consent letters delivered by independent public accountants in connection with registration statements similar to the Registration Statement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The Company shall use its reasonable best efforts to mail the Proxy Statement to its stockholders as promptly as practicable after the Registration Statement is declared effective under the Securities Act. Parent shall use reasonable best efforts to take any action required to be taken under any applicable state securities Laws and other applicable Laws in connection with the issuance of (i) shares of Parent Class&#160;A Common Stock, (ii) New Tranche 1 Warrants and (iii) New Tranche 2 Warrants, in each case, pursuant to this Agreement, and each Party shall furnish all information concerning the Company, Parent and the holders of capital stock of the Company and Parent, as applicable, as may be reasonably requested by another Party in connection with any such action and the preparation, filing and distribution of the Registration Statement and the Proxy Statement. No filing of, or amendment or supplement to, or material correspondence to the SEC or its staff with respect to the Registration Statement or the Proxy Statement may be made by Parent, the Company or any of their respective Subsidiaries, without providing the other Party a reasonable opportunity to review and comment thereon and such Party shall give reasonable consideration in good faith to any comments made by the other Party and its Representatives; <u>provided</u> that, with respect to documents filed by a Party that are incorporated by reference in the Registration Statement or Proxy Statement, the foregoing right to review and comment shall apply only with respect to the information relating to the other Party or its business, financial condition or results </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-57<br></div></div></div>
<!--End Page 386-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 387-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg58"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">of operations, or the combined entity resulting from the Contemplated Transactions; and <u>provided</u>, <u>further</u>, that this right to review and comment shall not apply with respect to information relating to an Adverse Recommendation Change. Parent shall advise the Company, promptly after it receives notice thereof, of the time when the Registration Statement has become effective or any supplement or amendment has been filed, the issuance of any stop order, the suspension of the qualification of the New Tranche 1 Warrants and New&#160;Tranche&#160;2 Warrants issuable in connection with this Agreement or the shares of Parent Class&#160;A Common Stock issuable in connection with the Merger for offering or sale in any jurisdiction, or any request by the SEC for amendment of the Registration Statement or comments thereon and responses thereto or requests by the SEC for additional information. The Company shall advise Parent, promptly after it receives notice thereof, of any request by the SEC for the amendment of the Proxy Statement or comments thereon and responses thereto or requests by the SEC for additional information. If at any time prior to the Effective Time any information relating to the Company or Parent, or any of their respective Affiliates, officers or directors, is discovered by the Company or Parent which should be set forth in an amendment or supplement to either the Registration Statement or the Proxy Statement so that any of such documents would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party which discovers such information shall promptly notify the other Parties and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC, after the other Party has had a reasonable opportunity to review and comment thereon (subject to the rights to review and comment described in the second sentence of this <u>Section&#160;7.02(c)</u>), and, to the extent required by applicable Law, disseminated to the Company Stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS703"><!--Anchor--></a>Section&#160;7.03.&#8195;<u>Company Stockholders&#8217; Meeting</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;The Company will, reasonably promptly following any written request by Parent (but in any event not more than once in any ten Business Day period), run a broker search for a deemed record date of 20 Business Days after the date of such search for the Company Stockholders Meeting. The Company shall take all action necessary in accordance with applicable Law and the Company Organizational Documents to duly give notice of, establish a record date for, convene and hold as soon as reasonably practicable, and in any event within forty-five (45) days of the Registration Statement being declared effective under the Securities Act and the first&#160;mailing of the definitive Proxy Statement, a meeting of the Company Stockholders to obtain the Company Stockholder Approval (the &#8220;<u>Company Stockholders&#8217; Meeting</u>&#8221;). Subject to <u>Section&#160;7.04</u>, the Company will, through the Company Board, recommend that the Company Stockholders adopt this Agreement and will use reasonable best efforts to solicit from the Company Stockholders proxies in favor of the adoption of this Agreement and to take all other action necessary or advisable to secure the vote or consent of the Company Stockholders required by the Company Organizational Documents, the rules of NASDAQ or applicable Law to obtain such approvals. The Company shall not submit at the Company Stockholders&#8217; Meeting any matter for approval of the Company Stockholders other than those required for the Company Stockholder Approval (and other than matters of procedure and matters required by or advisable under applicable Law to be voted on by the Company Stockholders in connection therewith). Once the Company has established a record date for the Company Stockholders&#8217; Meeting, the Company will not change such record date or establish a different record date for the Company Stockholders Meeting without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed), unless otherwise required by Applicable Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Company shall schedule and hold the Company Stockholders&#8217; Meeting as promptly as practicable after the Registration Statement is declared effective under the Securities Act (no later than the 45th day following the first mailing of the Proxy Statement and Registration Statement); <u>provided</u>, that the Company may, after reasonable consultation with Parent, postpone, recess or adjourn the Company Stockholders&#8217; Meeting, and, if applicable, set a new record date for such meeting, (i) if required by Law, (ii) in order to obtain the requisite number of affirmative votes in person or by proxy as of such later date, or (iii) to allow reasonable additional time for the filing and mailing of any supplemental or amended disclosure which the Company Board has determined in good faith after consultation with outside legal counsel is reasonably likely to be required under applicable Law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company Stockholders prior to the Company Stockholders&#8217; Meeting; <u>provided</u>, <u>however</u>, that the Company Stockholders&#8217; Meeting shall not be postponed or adjourned to a date that is more than fifteen (15) Business Days after the date for which the Company Stockholders Meeting was originally scheduled (excluding any adjournments or postponements required by applicable Law), or such shorter number of days such that the Company Stockholders&#8217; Meeting is reconvened no more than three (3) Business Days prior to the End Date, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-58<br></div></div></div>
<!--End Page 387-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 388-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg59"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">without the prior written consent of Parent (such consent not to be unreasonably withheld, conditioned or delayed). The Company agrees that, unless this Agreement is terminated pursuant to <u>Section&#160;9.01</u>, its obligation to hold the Company Stockholders&#8217; Meeting shall not be affected by the making of any Adverse Recommendation Change (<u>provided</u> that in such event the Company shall have no obligation to solicit proxies to obtain the Company Stockholder Approval). The Company shall provide updates to Parent with respect to the proxy solicitation for the Company Stockholders&#8217; Meeting (including interim results) as reasonably requested by Parent. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS704"><!--Anchor--></a>Section&#160;7.04.&#8195;<u>Non-Solicitation by Company; Company Board Recommendation</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;From the date of this Agreement and continuing until the earlier of the Effective Time and the date, if any, on which this Agreement is terminated in accordance with <u>Section&#160;9.01</u>, the Company shall not, and shall cause its Subsidiaries and its and their directors and officers not to, and shall use its reasonable best efforts to cause its and their respective Representatives not to, directly or indirectly (i) initiate, seek or solicit, or knowingly encourage or facilitate (including by way of furnishing non-public information) or knowingly cooperate with or take any other action that would reasonably be expected to promote, directly or indirectly, any inquiries or the making or submission of any proposal by a Third Party that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal; (ii) participate, engage in or continue discussions (except to notify a Person that makes an inquiry or offer with respect to an Acquisition Proposal of the existence of the provisions of this <u>Section&#160;7.04</u> or to clarify whether any such inquiry, offer or proposal constitutes an Acquisition Proposal) or negotiations with, or disclose any non-public information or data relating to, the Company or any of its Subsidiaries or afford access to the properties, books or records of the Company or any of its Subsidiaries to, or otherwise knowingly assist, facilitate or encourage any effort by, any Third Party, in each case that has made or could reasonably be expected to make, or in connection with, an Acquisition Proposal; (iii) enter into any agreement, including any letter of intent, term sheet, memorandum of understanding, agreement in principle, merger agreement, acquisition agreement or other similar agreement (other than an Acceptable Confidentiality Agreement), with respect to an Acquisition Proposal or (iv) otherwise resolve or agree to do any of the foregoing. The Company shall not release or permit the release of any Person from, or waive or permit the waiver of, any standstill or similar agreement with respect to any class of equity securities of the Company or any of its Subsidiaries, and will enforce or cause to be enforced each such agreement in accordance with its terms; <u>provided</u>, <u>however</u>, that the Company may waive or fail to enforce any provision of such standstill or similar agreement of any Person if the Company Board determines in good faith, after consultation with its financial advisor and outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with its fiduciary duties under applicable Law. From the date of this Agreement, the Company shall, and shall cause its Subsidiaries to, and shall use reasonable best efforts to cause its and their respective Representatives to, immediately cause to be terminated any solicitation, encouragement, discussion or negotiation with or involving any Person (other than Parent and its Affiliates) conducted heretofore by the Company or any Subsidiary thereof or any of its or their respective Representatives, with respect to an Acquisition Proposal and, in connection therewith, the Company shall immediately discontinue access by any Person (other than Parent and its Affiliates and Representatives) to any data room (virtual or otherwise) established by the Company or its Representatives for the purpose of soliciting, intentionally encouraging or negotiating an Acquisition Proposal. Within five (5) Business Days from the date of this Agreement, the Company shall request the return or destruction of all confidential, non-public information provided to Third&#160;Parties that have entered into confidentiality agreements with the Company or any Subsidiary thereof since June&#160;30, 2024 relating to an Acquisition Proposal (substituting fifty percent (50%) for the twenty percent (20%) threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for the purpose of this sentence), to the extent provided for by the terms of any confidentiality agreements entered into in connection with the furnishing of such confidential information. Notwithstanding anything to the contrary in this <u>Section&#160;7.04(a)</u>, from the date of this Agreement until obtaining the Company Stockholder Approval, the Company and the Company Board may take any actions prohibited by <u>clauses (i)</u> through <u>(iv)</u> of this <u>Section&#160;7.04(a)</u> with respect to a Third Party if (x) the Company receives a written Acquisition Proposal from a Third Party (and such Acquisition Proposal was not initiated, sought, solicited or knowingly encouraged or facilitated in non-de minimis breach of <u>Section&#160;7.04</u>) and (y) the Company Board determines in good faith after consultation with its financial advisor and outside legal counsel that such proposal is or could reasonably be expected to lead to, a Superior Proposal; <u>provided</u>, that the Company may deliver non-public information to such Third Party pursuant to this sentence only pursuant to an Acceptable Confidentiality Agreement with respect to the Company; <u>provided</u>, <u>further</u>, that </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-59<br></div></div></div>
<!--End Page 388-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 389-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg60"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">all such information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, prior to or substantially concurrently with the time it is provided or made available to such Third Party. Nothing contained in this <u>Section&#160;7.04</u> shall prohibit the Company or the Company Board from (i) taking and disclosing to the Company Stockholders a position with respect to an Acquisition Proposal pursuant to Rules 14d-9 or 14e-2(a) or Item&#160;1012(a) of Regulation M-A promulgated under the Exchange Act or (ii) from making any disclosure if the Company Board has determined in good faith after consultation with its outside legal counsel and financial advisor that the failure to do so would be reasonably likely to be inconsistent with its fiduciary obligations under applicable Law; <u>provided</u>, that this sentence shall not permit the Company Board to make an Adverse Recommendation Change, except to the extent permitted by <u>Section&#160;7.04(b)</u> or <u>Section&#160;7.04(c)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Neither the Company Board nor any committee thereof may directly or indirectly (i) withhold, withdraw (or amend, qualify or modify in a manner adverse to Parent or Merger Sub), or publicly propose to withdraw (or amend, qualify or modify in a manner adverse to Parent or Merger Sub), the approval, recommendation or declaration of advisability by the Company Board or any such committee of the Merger; (ii)&#160;recommend, adopt or approve, or propose publicly to recommend, adopt or approve any Acquisition Proposal or resolve to take such action; (iii) publicly make any recommendation in connection with a tender offer or exchange offer by a Third Party other than a recommendation against such offer or a temporary &#8220;stop, look and listen&#8221; communication by the Company Board of the type contemplated by Rule&#160;14d-9(f) under the Exchange Act; (iv) fail to include the Company Board Recommendation in the Proxy Statement; or (v) fail to reaffirm or re-publish the Company Board Recommendation following the date any Acquisition Proposal or any material modification thereto is first publicly disclosed or announced within ten (10) Business Days of being requested by Parent to do so or, if earlier, not later than two (2) Business Days prior to the Company Stockholders&#8217; Meeting (any action described in this sentence being referred to as an &#8220;<u>Adverse Recommendation </u><u>Change</u>&#8221;); <u>provided</u>, that such ten (10) Business Day period shall be extended for an additional five (5) Business Days following any material modification to any Acquisition Proposal occurring after the receipt of Parent&#8217;s request. A &#8220;stop, look and listen&#8221; disclosure pursuant to Rule&#160;14d-9(f) promulgated under the Exchange Act in connection with a tender or exchange offer shall not constitute an Adverse Recommendation Change. Notwithstanding the foregoing, prior to obtaining the Company Stockholder Approval, and subject to the Company&#8217;s compliance in all material respects with the provisions of <u>Section&#160;7.03</u> and <u>Section&#160;7.04(a)</u>, <u>(b)</u> and <u>(d)</u>, in response to an Acquisition Proposal that the Company Board has determined, after consultation with its outside legal counsel and financial advisor, is a Superior Proposal that has not been withdrawn, and did not result from a non-de minimis breach of <u>Section&#160;7.04(a)</u>, the Company Board may make such an Adverse Recommendation Change or terminate this Agreement pursuant to <u>Section&#160;9.01(c)(ii)</u> and subject to <u>Section&#160;9.03(a)(iii)</u>; <u>provided</u>, <u>however</u>, that the Company may not make an Adverse Recommendation Change or terminate this Agreement pursuant to <u>Section&#160;9.01(c)(ii)</u> in response to a Superior Proposal (x) until four&#160;(4)&#160;Business Days after the Company provides written notice to Parent advising Parent that the Company Board has received a Superior Proposal, specifying the terms and conditions of such Superior Proposal, identifying the Person or group making such Superior Proposal and including copies of all documents pertaining to such Superior Proposal (it being understood and agreed that any change to the financial or other terms of a proposal that was previously the subject of a notice hereunder shall require a new notice as provided herein, but with respect to any such subsequent notices, references to a &#8220;four (4) Business Day period&#8221; shall be deemed references to a &#8220;two (2) Business Day period&#8221;); (y) if during such four (4) or two (2) Business Day period, the Company has negotiated, and has caused its Representatives to negotiate in good faith with Parent (to the extent Parent wishes to negotiate) and Parent proposes any alternative transaction in writing (including any modifications to the terms of this Agreement), unless the Company Board determines in good faith, after good faith negotiations between the Company and Parent (if such negotiations are requested by Parent) during such four (4) or two (2) Business Day period (after consultation with the Company&#8217;s outside legal counsel and financial advisor and taking into account all financial, legal and regulatory terms and conditions of such alternative transaction proposal and expected timing of consummation and the relative risks of non-consummation of the alternative transaction proposal and the Superior Proposal) that the Acquisition Proposal giving rise to the notice described in clause (x) continues to be a Superior Proposal (assuming such revisions proposed by Parent were to be given effect) and (z) unless the Company Board determines in good faith after consultation with its outside legal counsel and financial advisor that the failure to make an Adverse Recommendation Change would be inconsistent with its fiduciary obligations under applicable Law. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-60<br></div></div></div>
<!--End Page 389-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 390-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg61"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Notwithstanding <u>Section&#160;7.04(b)</u>, prior to obtaining the Company Stockholder Approval, the Company Board may effect an Adverse Recommendation Change in response or relating to an Intervening Event if the Company Board determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be inconsistent with its fiduciary duties under applicable Law; <u>provided</u>, that (i) the Company shall first notify Parent in writing at least four (4) Business Days before taking such action of its intention to take such action, which notice shall include a reasonably detailed description of such Intervening Event (it being understood and agreed that any material change to the facts and circumstances relating to such Intervening Event shall require a new notice as provided herein, but with respect to any such subsequent notices references to a &#8220;four (4) Business Day period&#8221; shall be deemed references to a &#8220;two (2) Business Day period&#8221;), (ii) if requested by Parent, the Company shall have negotiated, and caused its Representatives to negotiate, with Parent and its Representatives during such four (4) or two (2) Business Day period (as applicable) following such notice regarding any proposal by Parent to amend the terms of this Agreement in response to such Intervening Event, and (iii) the Company Board shall not effect any Adverse Recommendation Change involving or relating to an Intervening Event unless, after the four (4) or two (2) Business Day period (as applicable) described in the foregoing clause (ii), the Company Board determines in good faith, after consultation with its outside legal counsel and taking into account any written proposal by Parent to amend the terms of this Agreement during such four (4) or two (2) Business Day period (as applicable), that the failure to take such action would continue to be inconsistent with its fiduciary duties under applicable Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;The Parties agree that, from the date of this Agreement, in addition to the other obligations of the Company set forth in this <u>Section&#160;7.04(a)-(c)</u>, as promptly as practicable after receipt thereof, and in any event within twenty-four (24) hours, the Company shall advise Parent in writing of any Acquisition Proposal received from any Third Party and the identity of the Third Party or group making any such Acquisition Proposal and the material terms and conditions thereof. The Company agrees that it shall keep Parent reasonably informed, on a reasonably current basis, of the status and details of any such Acquisition Proposal, and shall promptly, and in any event within twenty-four (24) hours, provide to Parent copies of all such information, correspondence and written materials sent or provided to the Company or any of its Subsidiaries that describes any terms or conditions of any Acquisition Proposal (as well as written summaries of any material oral communications in which such Third Party has proposed any such terms or conditions). Any material amendment to any Acquisition Proposal will be deemed to be a new Acquisition Proposal for purposes of the Company&#8217;s compliance with this <u>Section&#160;7.04(d)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS705"><!--Anchor--></a>Section&#160;7.05.&#8195;<u>Regulatory Approvals; Additional Agreements; Performance of Merger Sub</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;As soon as reasonably practicable after the date of this Agreement and in any event within twenty&#160;(20)&#160;Business Days, the Company and Parent each shall file, or shall cause to be filed, all required Notification and Report Forms pursuant to the HSR Act relating to the Merger and any other Contemplated Transaction. The Company and Parent shall, and shall cause their respective Subsidiaries to, (i) use reasonable best efforts to file, as soon as reasonably practicable after the date hereof, all other filings, notifications, or other documents required to be filed with or as requested by any Governmental Body pursuant to any Antitrust Law with respect to the Merger and any other Contemplated Transaction, and (ii) cooperate with the other Party in determining whether, and promptly preparing and making, any other filings or notifications or other Consents required to be made with, or obtained from, any other Governmental Bodies in connection with the Merger and any other Contemplated Transaction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Subject to the terms and conditions set forth in this Agreement, each of the Parties shall use their respective reasonable best efforts to (and shall cause their respective Subsidiaries to) take, or cause to be taken, all actions, to file, or cause to be filed, all documents and to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things necessary, proper or advisable under applicable Laws to consummate and make effective the Merger and any other Contemplated Transaction as soon as reasonably practicable including (i) obtaining all necessary actions or nonactions, waivers, Consents, clearances, decisions, declarations, approvals and, expirations or terminations of waiting periods from Governmental Bodies and making all necessary registrations and filings and taking all steps as may be reasonably necessary to obtain any such Consent, decision, declaration, approval, clearance or waiver, or expiration or termination of a waiting period by or from, or to avoid an action or proceeding seeking to, pursuant to any Antitrust Law, enjoin, restrain, prevent, prohibit or make illegal consummation of the Merger or any other Contemplated Transaction Law (&#8220;<u>Regulatory Approvals</u>&#8221;); (ii) obtaining all necessary Consents, authorizations, approvals or waivers from </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-61<br></div></div></div>
<!--End Page 390-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 391-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg62"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">third&#160;parties; (iii) defending any lawsuit or other legal proceeding, whether judicial or administrative, brought by any Governmental Body or third party challenging this Agreement or seeking to enjoin, restrain, prevent, prohibit or make illegal consummation of the Merger or any other Contemplated Transaction and contesting and seeking to have vacated, lifted, reversed or overturned any Order that challenges, enjoins, restrains, prevents, prohibits or makes illegal consummation of the Merger or any other Contemplated Transaction; and (iv)&#160;refraining from taking any action that would reasonably be expected to impede, interfere with, prevent or materially delay the consummation of the Merger other than with respect to the subject matter of <u>Section&#160;7.05(f)</u>, which actions shall exclusively be governed by <u>Section&#160;7.05(f)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;In furtherance of the foregoing, solely for the purpose of this <u>Section&#160;7.05</u>, Parent&#8217;s reasonable best efforts shall be deemed to include taking the following actions to the extent necessary, proper or advisable to obtain any Regulatory Approvals: (i) commit to or effect, by consent decree, hold separate order or otherwise, the sale, lease, license, divestiture or disposition of any assets, equity securities, rights, product lines, or businesses of the Company, Parent or any of their respective Subsidiaries, (ii) terminate existing relationships, contractual rights or obligations of the Company, Parent or any of their respective Subsidiaries, (iii) terminate any venture or other arrangement, (iv) create any relationship, contractual right or obligation of the Company, Parent or any of their respective Subsidiaries, (v) effectuate any other change or restructuring of the Company, Parent or any of their respective Subsidiaries, or (vi) otherwise take or commit to take any actions with respect to the businesses, product lines or assets of the Company, Parent or any of their respective Subsidiaries (and, in each case, enter into agreements or stipulate to the entry of an order or decree or file appropriate applications with any Governmental Body in connection with any of the foregoing) (each of the foregoing clauses (i)-(vi) a &#8220;<u>Remedy Action</u>&#8221;); <u>provided</u>, <u>however</u>, that, notwithstanding anything in this Agreement to the contrary, Parent and its Subsidiaries shall not be required to take or agree to take (and neither the Company nor any of its Subsidiaries shall take, offer to take, or otherwise agree to without Parent&#8217;s prior written consent) any Remedy Action that would reasonably be expected to, either individually or in the aggregate, be material to the business, financial condition or results of operations of Parent, the Company and their respective Subsidiaries, taken as a whole; <u>provided</u>, <u>however</u>, that for this purpose, Parent, the Company and their respective Subsidiaries, taken as a whole, shall be deemed a consolidated group of entities of the size and scale of a hypothetical company that is 100% of the size of the Company and its Subsidiaries, taken as a whole, as of the date of this Agreement. Notwithstanding the foregoing, at the written request of Parent, the Company shall, and shall cause its Subsidiaries to, agree to take any Remedy Action so long as such action is conditioned upon the occurrence of the Closing. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Subject to and without limiting the generality of anything contained in this <u>Section&#160;7.05</u> and subject to applicable Laws relating to the sharing of information and the terms and conditions of the Confidentiality Agreement, during the Pre-Closing Period, each Party shall (i) give each other Party reasonable advance notice of all meetings (including by telephone or videoconference) with any Governmental Body relating to the Merger or any other Contemplated Transaction, (ii) to the extent not prohibited by such Governmental Body, give the other Party (or the other Party&#8217;s outside legal counsel) an opportunity to attend and participate in such meeting and consult with the other Party in advance of any such meeting with any Governmental Body, in respect of any filing, proceeding, investigation (including the settlement of any investigation), litigation or other inquiry regarding the Merger or any other Contemplated Transaction, (iii) to the extent practicable, give the other Party reasonable advance notice of material oral communications with any Governmental Body relating to the Merger or any other Contemplated Transaction, (iv) if any Governmental Body initiates material oral communication relating to the Merger or any other Contemplated Transaction or such Party provides material oral communication to a Governmental Body, promptly notify the other Party of the substance of such communication, (v) provide each other with a reasonable advance opportunity to review and comment upon and consider in good faith the views of the other in connection with all written communications (including any analyses, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any Party hereto relating to proceedings under the Antitrust Laws) with a Governmental Body relating to the Merger or any other Contemplated Transaction and (vi) promptly provide each other with copies of all written communications to or from any Governmental Body relating to the Merger or any other Contemplated Transaction. The Parties may, as they deem advisable and necessary, designate any competitively sensitive materials provided to the other under this <u>Section&#160;7.05</u> as &#8220;outside counsel only.&#8221; Such materials and the information contained therein shall be given only to outside legal counsel and previously-agreed outside economic consultants of the recipient and will not be disclosed by such outside legal counsel or outside </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-62<br></div></div></div>
<!--End Page 391-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 392-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg63"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">economic consultants to employees, officers or directors of the recipient without the advance written consent of the Party providing such materials. Neither Party shall commit to or agree with any Governmental Body to (i)&#160;stay, toll or extend any applicable waiting period under the HSR Act, (ii) pull and refile or resubmit the Notification and Report Forms pursuant to the HSR Act as applicable to the Merger and any other Contemplated Transaction, (iii) not consummate the Merger or any other Contemplated Transaction before an agreed to date, or (iv) any timing agreement, in each case of the foregoing clauses (i)-(iv), without the prior written consent of the other Party (such consent not to be unreasonably withheld, conditioned or delayed). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Each Party shall consult with the other Party and consider in good faith the views of the other Party with respect to the defense of this Agreement and the transactions contemplated hereby before any Governmental Body and the scheduling of, and strategic planning for, any meetings with, and the conducting of negotiations with, any Governmental Body regarding (i) the expiration or termination of any applicable waiting period relating to the Merger or any other Contemplated Transaction under the HSR Act or (ii) obtaining any consent, approval, waiver, clearance, authorization or permission from a Governmental Body (collectively, the &#8220;<u>Strategic Direction</u>&#8221;); <u>provided</u>, that, subject to the terms of <u>Section&#160;7.05(d)</u>, Parent shall have the right to make the final determination as to the appropriate course of action with respect to the Strategic Direction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(f)&#8195;In addition and without limiting the foregoing, each Party shall not, and shall cause their respective Subsidiaries not to, effect or agree to acquire any assets, licenses, rights, product lines, operations, business or Person that competes with the Company to the extent that such acquisition would reasonably be expected to prevent or materially delay the satisfaction of the conditions set forth in <u>Section&#160;8.01(c)</u> or <u>Section&#160;8.01(d)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS706"><!--Anchor--></a>Section&#160;7.06.&#8195;<u>Employment and Labor Matters</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;During the period commencing at the Effective Time and ending on the first anniversary thereof, Parent shall, or shall cause one of its Subsidiaries to, provide each Company Employee with the following: (i)&#160;annual base salary or wages, as applicable, that are no less than the annual base salary or wages, as applicable, in effect for each such Company Employee immediately prior to the Effective Time, (ii) target cash incentive opportunities that are no less than the target cash incentive opportunities in effect for such Company Employee immediately prior to the Effective Time, (iii) annual target long-term incentive opportunities that are no less than the target long-term incentive opportunities in effect for similarly situated Parent employees (excluding any off-cycle awards or any awards granted in connection with new hires or promotion), and (iv) employee benefits and other compensation (excluding any equity, equity-based or other long-term incentive compensation, deferred compensation, perquisites, change-in-control, transaction, stay, retention or similar bonuses or payments, severance or termination benefits) to such Company Employee that are substantially comparable in the aggregate to those provided to such employee by the Company and its Subsidiaries immediately prior to the Effective Time or those provided to similarly situated employees of Parent. During the period commencing at the Effective Time and ending on the first anniversary thereof, Parent shall, or shall cause one of its Subsidiaries to, provide each Company Employee with severance or termination benefits that are no less favorable than those set forth on <u>Section&#160;7.06</u> of the Company Disclosure Letter. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;With respect to any compensation or employee benefit plans or programs of Parent or its Subsidiaries in which any Company Employees become eligible to participate on or after the Effective Time (the &#8220;<u>New&#160;Plans</u>&#8221;), Parent and its Subsidiaries shall, or shall cause the Surviving Corporation to, use commercially reasonable efforts to (i) waive all pre-existing conditions, exclusions and waiting periods with respect to participation and coverage requirements applicable to such employees and their eligible dependents under any New Plans, except to the extent such pre-existing conditions, exclusions or waiting periods would apply under the analogous Company Plan, (ii) provide each such employee and their eligible dependents with credit for any co-payments or coinsurance and deductibles paid under a Company Plan that provides health care benefits during the first plan year in which such employee becomes eligible for the New Plan, to the same extent that such credit was given under the analogous Company Plan with respect to such plan year, in satisfying any applicable deductible, co-payment, coinsurance or maximum out-of-pocket requirements under any New Plan that provides health care benefits, and (iii) recognize all service of such employees with the Company and its Subsidiaries for all purposes with respect to any New Plan to the same extent that such service was taken into account under the analogous Company Plan prior to the Effective Time; <u>provided</u>, that the foregoing service recognition shall not apply (A) to the extent it would result in duplication of benefits for the same period of service, (B) for purposes of any defined benefit pension plan, or (C) for purposes of any benefit plan that is a frozen plan or provides grandfathered benefits. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-63<br></div></div></div>
<!--End Page 392-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 393-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg64"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Prior to the Closing Date, the Company will use commercially reasonable efforts to take all actions necessary to cause the account balances of the current and former employees of the Company under the 401(k)&#160;plan (the &#8220;<u>PEO 401(k) Plan</u>&#8221;) sponsored by the professional employer organization engaged by the Company (the &#8220;<u>PEO</u>&#8221;) to be spun off into a separate standalone 401(k) plan sponsored by the Company that is intended to qualify under Section&#160;401(a) of the Code (the &#8220;<u>Company 401(k) Plan</u>&#8221;) in compliance with applicable Laws, including the relevant provisions of ERISA and the Code, and PEO 401(k) Plan documents. If such plan spin-off is able to be timely completed based on commercially reasonable efforts of the Company, then not less than three (3) Business Days prior to the anticipated Closing Date, the Company shall take (or cause to be taken) all actions necessary and appropriate to terminate the Company 401(k) Plan, with such termination of the Company 401(k) Plan to be effective no later than the day immediately preceding the Closing Date (but contingent upon the Closing). If the Company 401(k) Plan is terminated as described in this <u>Section&#160;7.06(c)</u>, the Company shall deliver to Parent, no later than the day immediately preceding the Closing Date, evidence that the Company 401(k) Plan has been validly terminated. Parent shall take all commercially reasonable actions to make the Company Employees eligible to participate, effective as of immediately after the Effective Time, in a 401(k) plan sponsored by Parent or a Subsidiary thereof (the &#8220;Parent 401(k) Plan&#8221;). If the Company 401(k)&#160;Plan is terminated as described in this <u>Section&#160;7.06(c)</u>, Parent shall also take all commercially reasonable actions to allow Company Employees to make rollover contributions to the Parent 401(k) Plan of &#8220;eligible rollover distributions&#8221; within the meaning of Section&#160;401(a)(31) of the Code from the Company 401(k) Plan, in the form of cash (and/or notes evidencing loans), in an amount equal to the full account balance (including loans) distributed to such Company Employee from the Company 401(k) Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Nothing contained in this <u>Section&#160;7.06</u>, express or implied (i) shall be deemed to be an amendment to any particular Company Plan or other particular employee benefit plan, (ii) shall be construed to require Company, or any of its Subsidiaries to establish, amend, assume, maintain or modify any particular employee benefit plan (including any Plan), program, agreement or arrangement or prohibit Parent, the Company or any of their respective Subsidiaries from amending, modifying or terminating any particular employee benefit plan (including any Plan), program, agreement or arrangement, (iii) is intended to or shall confer upon any Person (including employees, retirees, or dependents or beneficiaries of employees or retirees of the Company or its Subsidiaries) any rights as a third-party beneficiary of this Agreement or (iv) shall preclude Parent, the Company or any of their Subsidiaries from terminating the employment of any employee at any time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS707"><!--Anchor--></a>Section&#160;7.07.&#8195;<u>Indemnification of Officers and Directors</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Parent agrees that all rights to indemnification, advancement of expenses and exculpation from liabilities for acts or omissions occurring at or prior to the Effective Time now existing in favor of the present and former directors, executive officers and employees of the Company or any of its Subsidiaries as provided in the Company Organizational Documents, similar organizational documents of the Company&#8217;s Subsidiaries and indemnification agreements of the Company and its Subsidiaries in existence as of the date hereof, all of which are on terms that are not more favorable to the indemnified party than the form filed as Exhibit&#160;10.6 to the Company&#8217;s Form&#160;10-K, shall survive the Merger and shall continue in full force and effect in accordance with their terms. In furtherance of the foregoing, Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation and the organizational documents of the Company&#8217;s Subsidiaries to contain provisions no less favorable with respect to indemnification, advancement of expenses, and exculpation from liabilities of present and former directors, executive officers, and employees of Company and/or its Subsidiaries than are currently provided in the Company Organizational Documents and the organizational documents of the Company&#8217;s Subsidiaries, which provisions may not be amended, repealed or otherwise modified in any manner that would adversely affect the rights thereunder of any such individuals until six (6) years from the Effective Time, and, in the event that any Action is pending or asserted or made during such period, until the disposition of any such Action, unless such amendment, modification or repeal is required by applicable Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;From and after the Effective Time, Parent and the Surviving Corporation shall jointly and severally indemnify and hold harmless each person who is or was a (i) director or executive officer (for the purposes of this provision, &#8220;executive officer&#8221; includes those who, while serving as a director or executive officer of the Company, is or was serving at the request of the Company as a director, officer, employee, or agent of another corporation, including service with respect to an employee benefit plan), or (ii) other employee of the Company or any of its Subsidiaries (each, together with such person&#8217;s heirs, successors, executors, administrators or personal or legal representatives, an &#8220;<u>Indemnified Party</u>&#8221;), against all obligations to pay any threatened, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-64<br></div></div></div>
<!--End Page 393-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 394-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg65"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">asserted, pending or completed judgment, damages, settlement, losses, liabilities, or fine or penalty, interest and reasonable expenses (including legal expenses and other reasonable expenses that may be incurred by any Indemnified Party in successfully enforcing the indemnity and other obligations provided in this <u>Section&#160;7.07</u>) incurred in connection with any Action (such amounts, the &#8220;<u>Claim Expenses</u>&#8221;, and such claims made against any Indemnified Party, a &#8220;<u>D&amp;O Claim</u>&#8221;), whether civil, criminal, administrative, arbitrative or investigative, and whether formal or informal, by reason of the fact that the Indemnified Party is or was an executive officer, director or employee of the Company or its Subsidiaries, or an executive officer, director or employee of another entity or Company Plan if such service was at the request of the Company, whether asserted or claimed prior to, at, or after the Effective Time, to the fullest extent provided for under applicable Law, the Company Organizational Documents, the organizational documents of the Company&#8217;s Subsidiaries and indemnification agreements of the Company and its Subsidiaries in existence as of the date hereof, all of which are on terms that are not more favorable to the indemnified party than the form filed as Exhibit&#160;10.6 to the Company&#8217;s Form&#160;10-K. From and after the Effective Time, Parent shall advance to such Indemnified Party the Claim Expenses incurred by the Indemnified Party in connection with any D&amp;O Claim prior to its final disposition, and such advancement shall be made as soon as reasonably practicable, but in any event no later than 30 days, after the receipt by the Parent or the Surviving Corporation of a written statement or statements requesting such advances from time to time (which shall include invoices received by such Indemnified Party in connection with such Claim Expenses but, in the case of invoices in connection with legal services, any references to legal work performed or to expenditure made that would cause the Indemnified Party to waive any privilege accorded by applicable Law shall not be included with the invoice); <u>provided</u> that any such advances shall be unsecured and interest free and made without regard to the Indemnified Party&#8217;s ability to repay such advances; <u>provided</u>, <u>further</u>, any person to whom expenses are advanced provides an undertaking to repay such advances if it is ultimately determined that such person is not entitled to be indemnified by Parent or the Surviving Corporation; <u>provided</u>, <u>further</u>, that Parent or the Surviving Corporation shall not be obligated to make any advancement to the extent advancement is prohibited by Law, the Company Organizational Documents, the organizational documents of the Company&#8217;s Subsidiaries or any indemnification agreement in existence as of the date hereof to which such person and the Company or any of its Subsidiaries is a party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The Company shall, prior to the Effective Time, purchase a tail policy or policies under the current directors&#8217; and officers&#8217; liability insurance policies maintained at such time by the Company, which tail policy or policies (i) will be effective for a period from the Effective Time through and including the date six (6) years after the Effective Time with respect to claims arising from acts, errors or omissions that existed or occurred prior to or at the Effective Time and (ii) will provide coverage and amounts that are at least as protective to such directors and officers as the coverage provided by such existing policies and contain other terms and conditions and contain other terms and conditions that are no less favorable to the covered individuals as the terms and conditions in such existing policies; <u>provided</u>, that the total premium for such tail policy or policies shall not be in excess of 300% of the last annual premium paid by the Company prior to the Effective Time (the &#8220;<u>Maximum </u><u>Premium</u>&#8221;). In the event the Company does not obtain such tail policy or policies prior to the Effective Time, Parent or the Surviving Corporation shall use reasonable best efforts to obtain such tail policy or policies, <u>provided</u> that the total premium for such tail policy or policies shall not be in excess of the Maximum Premium, and <u>provided</u>, <u>further</u>, that if such tail policy or policies cannot be obtained or can be obtained only by paying aggregate premiums in excess of the Maximum Premium, Parent and the Surviving Corporation shall only be required to obtain as much coverage as can be obtained by paying a premium equal to the Maximum Premium. Parent shall cause such tail policy or policies (whether obtained by the Company, Parent or the Surviving Corporation) to be maintained in full force and effect for their full term, and cause all obligations thereunder to be honored by the Surviving Corporation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;This <u>Section&#160;7.07</u> shall survive the consummation of the Merger and is intended to benefit, and is enforceable by, any Indemnified Party. The indemnification and advancement provided for in this <u>Section&#160;7.07</u> is not exclusive of any other rights to which the Indemnified Party is entitled whether pursuant to Law, Contract, or otherwise. If Parent, the Surviving Corporation or any of their respective successors or assigns (i) consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity resulting from such consolidation or merger or (ii) liquidates, dissolves or winds-up, or transfers all or majority of its properties and assets to any Person, then, and in each such case, Parent shall make proper provision such that the respective successors and assigns of Parent and the Surviving Corporation assume the applicable obligations set forth in this <u>Section&#160;7.07</u>.</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-65<br></div></div></div>
<!--End Page 394-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 395-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg66"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;Each of the Indemnified Parties or other Persons who are beneficiaries under the &#8220;tail&#8221; policy referred to in this <u>Section&#160;7.07</u> (and, after the death of any of the foregoing Persons, such Person&#8217;s heirs, successors, executors, administrators and representatives) are intended to be third-party beneficiaries of this <u>Section&#160;7.07</u>, with full rights of enforcement as if a party thereto. Nothing in this Agreement is intended to, shall be construed to or shall release, waive or impair any rights to directors&#8217; and officers&#8217; insurance claims under any policy that is or has been in existence with respect to the Company or any of its Subsidiaries for any of their respective directors, officers or other employees, it being understood and agreed that the indemnification provided for in this <u>Section&#160;7.07</u> is not prior to or in substitution for any such claims under such policies. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS708"><!--Anchor--></a>Section&#160;7.08.&#8195;<u>Public Disclosure</u>. The initial press release relating to this Agreement shall be a joint press release, and thereafter Parent and the Company shall consult with each other before issuing, and provide each other the reasonable opportunity to review and comment upon, any press release or other public statements with respect to the Merger or the Contemplated Transactions, and shall not issue any such press release or make any such public statement prior to such consultation, except as may be required by applicable Law or court process or any listing agreement with or rule of any national securities exchange or association; <u>provided</u>, <u>however</u>, that no Party shall issue a press release or otherwise make any public statement or disclosure concerning the other Party&#8217;s business, financial condition or results of operations without the consent of such other Party. The restrictions of this <u>Section&#160;7.08</u> do not apply to communications (i) in connection with and following an Adverse Recommendation Change in compliance with <u>Section&#160;7.04</u>; (ii) in connection with any dispute between the Parties regarding this Agreement, the Merger or the other Contemplated Transactions; and (iii) if the information contained therein substantially reiterates (or is consistent with) previous releases, public disclosures or public statements made by the Company and/or Parent in compliance with this <u>Section&#160;7.08</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS709"><!--Anchor--></a>Section&#160;7.09.&#8195;<u>NASDAQ Listing</u>. Parent shall, in accordance with the requirements of NASDAQ, file with NASDAQ a listing application covering (i) the shares of Parent Class&#160;A Common Stock, (ii) the New Tranche 1&#160;Warrants and (iii) the New Tranche 2 Warrants, in each case, to be issued pursuant to this Agreement, as promptly as reasonably practicable after the date of this Agreement. Parent shall use its reasonable best efforts to cause (i) the shares of Parent Class&#160;A Common Stock, (ii) the New Tranche 1 Warrants and (iii) the New Tranche 2 Warrants, in each case, to be issued pursuant to this Agreement to be listed on NASDAQ, subject to official notice of issuance, as promptly as practicable after the date of this Agreement, and in any event prior to the Effective Time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS710"><!--Anchor--></a>Section&#160;7.10.&#8195;<u>Takeover Laws</u>. If any Takeover Law may become, or may purport to be, applicable to the Contemplated Transactions, each of Parent and the Company and the members of its respective board of directors, to the extent permissible under applicable Law, shall grant such approvals and take such actions, in accordance with the terms of this Agreement, as are necessary so that the Contemplated Transactions may be consummated as promptly as practicable, and in any event prior to the End Date, on the terms and conditions contemplated hereby and otherwise, to the extent permissible under applicable Law, act to eliminate the effect of any Takeover Law on any of the Contemplated Transactions.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS711"><!--Anchor--></a>Section&#160;7.11.&#8195;<u>Section&#160;16 Matters</u>. Parent shall, prior to the Effective Time, cause the Parent Board to approve the issuance of the Merger Consideration with respect to any employees of the Company who, as a result of their relationship with Parent as of or following the Effective Time, are subject or will become subject to the reporting requirements of Section&#160;16 of the Exchange Act to the extent necessary for such issuance to be an exempt acquisition pursuant to SEC Rule&#160;16b-3. Prior to the Effective Time, the Company Board shall approve the disposition of Company equity securities (including derivative securities) in connection with the Merger by those directors and officers of the Company subject to the reporting requirements of Section&#160;16 of the Exchange Act to the extent necessary for such disposition to be an exempt disposition pursuant to SEC Rule&#160;16b-3. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS712"><!--Anchor--></a>Section&#160;7.12.&#8195;<u>Transaction Litigation</u>. Each of the Company and Parent shall as promptly as reasonably practicable notify the other Party (including by providing copies of all pleadings and any material correspondence with respect thereto) of any Transaction Litigation and shall keep the other Party reasonably informed with respect to the status thereof. Each of the Company and Parent shall provide the other Party with the opportunity to participate in the defense of any Transaction Litigation with respect to the first Party or the Contemplated Transactions. For purposes of this <u>Section&#160;7.12</u>, &#8220;participate&#8221; means that the Company or Parent, as applicable, shall keep the other Party reasonably apprised of the proposed strategy and other significant decisions with respect to any Transaction Litigation, and the other Party may offer comments or suggestions with respect to such Transaction Litigation which the first Party shall consider in good faith. Prior to the Effective Time, neither the Company nor Parent shall compromise, settle, come to an arrangement regarding or agree to comprise, settle or come to an arrangement </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-66<br></div></div></div>
<!--End Page 395-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 396-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg67"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">regarding any Transaction Litigation, without the prior written consent of the other Party, which, with respect to any such settlement that only requires payment of monetary amounts by the Company or Parent, as applicable, shall not be unreasonably withheld, conditioned or delayed. Notwithstanding anything to the contrary in this <u>Section&#160;7.12</u>, in the event of any conflict with any other covenant or agreement contained in <u>Section&#160;7.05</u> that expressly addresses the subject matter of this <u>Section&#160;7.12</u>, <u>Section&#160;7.05</u> shall govern and control. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS713"><!--Anchor--></a>Section&#160;7.13.&#8195;<u>Tax Matters</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;For U.S. federal income tax purposes, it is intended that the Merger qualifies as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code, and the regulations promulgated thereunder, and this Agreement is intended to constitute, and the Parties hereto hereby adopt this Agreement as, a &#8220;plan of reorganization&#8221; for purposes of Sections 354, 361 and 368 of the Code and within the meaning of Treasury Regulations Section&#160;1.368-2(g) (the &#8220;<u>Intended Tax Treatment</u>&#8221;). Each of Parent and the Company shall (and shall cause its Subsidiaries and Affiliates to) use reasonable best efforts to cause the Merger to qualify as a &#8220;reorganization&#8221; within the meaning of Section&#160;368(a) of the Code. The Parties shall (and shall cause their Subsidiaries and Affiliates to) (i) not take any action or intentionally fail to take any action, in either case, that could reasonably be expected to prevent or impede the Merger from qualifying for the Intended Tax Treatment and (ii) report the Merger for all Tax purposes consistent with the Intended Tax Treatment and shall not take any position on any Tax Return, in connection with any Tax Proceeding or otherwise inconsistent therewith unless so required by a Taxing Authority as a result of a &#8220;determination&#8221; within the meaning of Section&#160;1313(a) of the Code. Each of Parent and the Company will use its reasonable best efforts and will cooperate with one another to obtain any opinion(s) of counsel to be issued regarding the federal income tax treatment of the Merger, including in connection with the declaration of effectiveness of the Registration Statement by the SEC. In connection with the foregoing, the Company shall use its reasonable best efforts to deliver to Wachtell, Lipton, Rosen &amp; Katz (&#8220;<u>Wachtell</u>&#8221; ), counsel to the Company, and Davis Polk &amp; Wardwell LLP (&#8220;<u>Davis Polk</u>&#8221;), counsel to Parent, certificates (dated as of the necessary date and signed by an officer of the Company), substantially in the form of Exhibit&#160;A, containing representations of the Company, and Parent shall use its reasonable best efforts to deliver to Wachtell and Davis Polk certificates (dated as of the necessary date and signed by an officer of Parent), substantially in the form of Exhibit&#160;B, containing representations of Parent, in each case, in connection with any Tax opinion described in this <u>Section&#160;7.13(a)</u>. Parent and the Company shall also provide such other information as reasonably requested by Wachtell or Davis Polk for purposes of rendering any opinion described in this <u>Section&#160;7.13(a)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Parties agree that the tax year of the Company for U.S. federal income tax purposes will end at the close of the Closing Date and that the Company will join the U.S. federal consolidated tax return in which Parent is the common parent as of the opening of the next day. Parent shall post a duly completed IRS Form&#160;8937 on its website not later than forty-five (45) days after the Closing Date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS714"><!--Anchor--></a>Section&#160;7.14.&#8195;<u>Company Convertible Notes</u>. Prior to the Effective Time, within the time periods required by the terms of each Indenture, the Company shall, and shall cause its Representatives to, use reasonable best efforts to take all actions required by such Indenture to be performed by the Company at or prior to the Effective Time as a result of the consummation of the Merger, including the giving of any notices that may be required by the Company or Parent and the delivery to the trustee, of any documents or instruments required to be delivered at or prior to the Effective Time to such trustee, in each case by such Indenture as a result of the consummation of the Merger; provided, that the Company shall, to the extent practicable, deliver a draft of any such notice or other document to Parent at least three (3) Business Days prior to delivering or entering into such notice or other document in accordance with the terms of the Indentures. Without limiting the generality of the foregoing, prior to the Effective Time, the Company agrees to cooperate with Parent, at Parent&#8217;s written request, by using reasonable best efforts to (i) execute and deliver (or cause to be executed and delivered, as applicable) at (and subject to the consummation of) the Effective Time one or more supplemental indentures and officer&#8217;s certificates (to the extent required by the trustee pursuant to each such Indenture), in each case in form and substance reasonably acceptable to Parent and the trustee under the Indentures, pursuant to each such Indenture and (ii) use reasonable best efforts to cause the trustee under the Indentures to execute and deliver at the Effective Time any such supplemental indentures, in each case required by the terms of such Indenture as a result of the consummation of the Merger; <u>provided</u> that counsel for the Company shall not be required to deliver any legal opinion under any Indenture unless specifically required by the trustee thereunder after Parent&#8217;s counsel shall have offered to provide the same. The Company agrees that, unless Parent </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-67<br></div></div></div>
<!--End Page 396-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 397-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg68"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">provides its prior written consent to the Company&#8217;s election of a different settlement method, the Company shall elect to settle any conversion of the Convertible Notes occurring prior to the Effective Time solely by delivering Company Common Stock (together with cash in lieu of any fractional share, as provided in the applicable Indenture). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS715"><!--Anchor--></a>Section&#160;7.15.&#8195;<u>Company Warrants</u>. The Company Warrants shall be treated in accordance with the terms of the Company Warrant Agreement. Prior to the Effective Time, Parent and the Company shall make all necessary and appropriate provisions to provide for the assumption by Parent of the performance of the Company&#8217;s covenants under the Company Warrant Agreement. At the Effective Time and by virtue of the Merger, (i) a holder of a Tranche&#160;1 Warrant as of immediately prior to the Effective Time shall be entitled, following the Effective Time, and subject to the terms and conditions of the Company Warrant Agreement, to receive a New Tranche 1 Warrant exercisable for a number of shares of Parent Class&#160;A Common Stock equal to (1) the Warrant Shares (as defined in the Company Warrant Agreement) underlying such Tranche 1 Warrant, <font style="font-style: italic;">multiplied by</font> (2) the Exchange Ratio, with such New&#160;Tranche 1 Warrant having an exercise price per Warrant Share equal to the Tranche 1 Exercise Price (as defined in the Company Warrant Agreement) in effect immediately prior to the Effective Time <font style="font-style: italic;">divided by </font>the Exchange Ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants, <font style="font-style: italic;">mutatis mutandis</font> and (ii)&#160;a holder of a Tranche 2 Warrant as of immediately prior to the Effective Time shall be entitled, following the Effective Time, and subject to the terms and conditions of the Company Warrant Agreement, to receive a Converted Tranche&#160;2 Warrant (as defined in the Company Warrant Agreement), which Converted Tranche 2 Warrant shall be exercisable for a number of Warrant Shares with an exercise price of $7.50 per Warrant Share (subject to adjustment as set forth in the Company Warrant Agreement and otherwise on the same terms as the Tranche 2 Warrants), which shall be converted into a New Tranche 2 Warrant exercisable for a number of shares of Parent Class&#160;A Common Stock equal to (a) the Warrant Shares underlying the Converted Tranche 2 Warrants, <font style="font-style: italic;">multiplied by</font> (b) the Exchange Ratio, with such New Tranche 2 Warrant having an exercise price per Warrant Share equal to $7.50 per Warrant Share <font style="font-style: italic;">divided by</font> the Exchange Ratio, and otherwise having terms substantially the same as the terms of the Tranche 1 Warrants, <font style="font-style: italic;">mutatis mutandis</font>. At the Effective Time, each Tranche 1 Warrant shall be automatically redeemed in accordance with the terms of the Company Warrant Agreement and all of the terms, obligations covenants and conditions of each Tranche 1 Warrant shall thereafter be of no further force or effect and shall represent only the right to receive a New Tranche 1 Warrant in accordance with this <u>Section&#160;7.15</u>, on the terms and subject to the conditions set forth in the Warrant Agreement. At the Effective Time, each Tranche 2 Warrant shall be automatically converted, and each Converted Tranche 2 Warrant shall be automatically redeemed, in each case in accordance with the terms of the Warrant Agreement, and all of the terms, obligations, covenants and conditions of each Tranche 2 Warrant and Converted Tranche 2 Warrant shall thereafter be of no further force or effect, and each Converted Tranche 2 Warrant shall represent only the right to receive a New Tranche 2 Warrant in accordance with this <u>Section&#160;7.15</u>, on the terms and subject to the conditions set forth in the Company Warrant Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS716"><!--Anchor--></a>Section&#160;7.16.&#8195;<u>Contingent Value Rights Agreement</u>. The CVRs shall be treated in accordance with the terms of the Contingent Value Rights Agreement. Prior to the Effective Time, Parent and the Company shall make all necessary and appropriate provisions to provide for the assumption by Parent of the Company&#8217;s obligations, duties and covenants under the Contingent Value Rights Agreement. Additionally, following the Effective Time, for the purposes of Section&#160;4.4 of the Contingent Value Rights Agreement, Parent Class&#160;A Common Shares shall be deemed to be the Surviving Entity Equity Securities (as defined in the Contingent Value Rights Agreement) (after giving effect to the Exchange Ratio).</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS717"><!--Anchor--></a>Section&#160;7.17.&#8195;<u>Merger Sub Consent</u>. Immediately following the execution of this Agreement, Parent shall execute and deliver, in accordance with Section 228 of the DGCL and in its capacity as the sole stockholder of Merger Sub, a written consent adopting this Agreement and promptly deliver a copy of such consent to the Company. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS718"><!--Anchor--></a>Section&#160;7.18.&#8195;<u>Stock Exchange Delisting; Deregistration</u>. Prior to the Effective Time, the Company shall cooperate with Parent and use its reasonable best efforts to take, or cause to be taken, all actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its part under applicable Laws and rules and policies of NASDAQ to enable the delisting by the Surviving Corporation of the Company Common Stock, the Tranche 1 Warrants and the Tranche 2 Warrants from NASDAQ and the deregistration of the Company Common Stock, the Tranche 1 Warrants and the Tranche 2 Warrants under the Exchange Act as promptly as practicable after the Effective Time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS719"><!--Anchor--></a>Section&#160;7.19.&#8195;<u>Obligations of Merger Sub</u>. Parent shall take all action necessary to cause Merger Sub to duly perform, satisfy and discharge on a timely basis each of the covenants, obligations and liabilities of Merger Sub under this Agreement. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-68<br></div></div></div>
<!--End Page 397-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 398-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg69"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS720"><!--Anchor--></a>Section&#160;7.20.&#8195;<u>Title Insurance</u>. The Company and its Subsidiaries shall reasonably cooperate with Parent in connection with Parent&#8217;s obtaining, at Parent&#8217;s sole cost and expense, such title insurance (including any non-imputation and other endorsements) that Parent reasonably determines to obtain in respect of the Owned Real Property, including by executing and delivering such affidavits, estoppels, certificates or other documents or information as may be as may be reasonably requested by the title company issuing the same for the delivery of a final owner&#8217;s policy of title insurance with respect to such Owned Real Property in form and substance (including endorsements) reasonably acceptable to Parent; <u>provided</u> that the Company shall only be required to take or commit to take any such actions if the issuance of any such policy and the effectiveness of such affidavits, estoppels, certificates or other documents are subject to the consummation of the Merger; <u>provided</u>, <u>further</u>, that the Company&#8217;s failure of compliance with this <u>Section&#160;7.20</u> shall not be taken into account for purposes of determining the satisfaction of the condition referred to in <u>Section&#160;8.02(b)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS721"><!--Anchor--></a>Section&#160;7.21.&#8195;<u>Updated Equity Awards Schedule</u>. Upon Parent&#8217;s written request, the Company will use reasonable best efforts to provide Parent, within three days of such written request, a revised version of <u>Section&#160;4.03(a)</u> of the Company Disclosure Schedule, updated as of the most recent practicable date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS722"><!--Anchor--></a>Section&#160;7.22.&#8195;<u>Financing.</u> </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;Prior to the Closing (or earlier termination of this Agreement), the Company shall provide and shall use reasonable best efforts to cause its officers, directors, employees, accountants, consultants and legal counsel to provide such cooperation in connection with the arrangement of a debt financing undertaken to finance the transactions contemplated by this Agreement as may be customary and reasonably requested by Parent, including, but not limited to, (i) making available to Parent, its advisors and its sources for debt financing (&#8220;<u>Debt </u><u>Financing Sources&#8221;) such financial and other pertinent information regarding the Company and its business as </u><u>may be reasonably requested by Parent, its advisors or Debt Financing Sources, including such </u>information as is necessary to allow Parent to prepare pro forma financial statements; (ii) assisting with the preparation of customary lender and investor presentations, rating agency presentations, marketing materials and other similar documents and materials in connection with the debt financing and participating in a reasonable number of meetings, presentations, road shows, drafting sessions and due diligence sessions with providers or potential providers of the debt financing and ratings agencies, at reasonable and mutually agreed times and places (which may be virtual), and otherwise providing customary assistance in the marketing efforts of Parent and its Debt Financing Sources; (iii) to the extent that the Company or any of its Subsidiaries is to become an obligor or a guarantor with respect to such debt financing, delivering, at least three (3) Business Days prior to Closing, all documentation and other information regarding such obligor or guarantor as is reasonably requested in writing by Parent, its advisors and its financing sources at least nine (9) days prior to Closing and is required by applicable &#8220;know your customer&#8221; and anti-money laundering rules and regulations, including the USA&#160;PATRIOT Act and beneficial ownership regulations (including beneficial ownership certifications as under&#160;31&#160;C.F.R. &#167; 1010.230) in connection with such debt financing; (iv) assisting with Parent&#8217;s preparation, negotiation and execution of definitive financing documentation and the schedules and exhibits thereto (including loan agreements, guarantees, collateral agreements, hedging arrangements, customary officer&#8217;s certificates and corporate resolutions, as applicable) as may reasonably be requested and which are conditioned on the occurrence of the Closing; <u>provided</u>, <u>however</u>, that nothing in this <u>Section&#160;7.22</u> will require any such cooperation to the extent that it would (1) cause any representation or warranty in this Agreement to be breached by the Company or any of its Affiliates, (2) require the Company or any of its Subsidiaries or any of their respective officers, directors, employees, accountants, consultants or legal counsel to (A) pay any fees or reimburse any expenses or incur any other expense, liability or obligation in connection with such debt financing or otherwise incur any obligation under any agreement, certificate, document or instrument, (B) enter into, execute or deliver any certificate, agreement, arrangement, document or instrument or agree to any change or modification of any existing certificate, document, instrument or agreement, (C) require the Company or any of its Subsidiaries to give to any other Person any indemnities in connection with such debt financing, (D) pass resolutions or consents to approve or authorize the entry into any debt financing or any definitive agreement for such debt financing; or (E) provide access to or disclose information that the Company or any of its Subsidiaries determines would jeopardize any attorney-client privilege or other applicable privilege or protection of the Company or any of its Affiliates (<u>provided</u><font style="font-style: italic;">, </font><u>however</u><font style="font-style: italic;">,</font> that the Company shall use its commercially reasonable efforts to provide an alternative means of disclosing or providing such information to the maximum extent that does not result in a loss of such legal privilege and in the event that the Company does not provide access or information in reliance on this clause, the Company shall provide notice to Parent that information is being </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-69<br></div></div></div>
<!--End Page 398-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 399-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg70"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">withheld), (3) unreasonably interfere with the ongoing business operations of the Company or any of its Subsidiaries, (4) reasonably be expected to cause any director, officer, employee or stockholder of the Company or any of its Subsidiaries to incur any personal liability, (5) reasonably be expected to conflict with the organizational documents of the Company or any of its Affiliates or any applicable Laws, (6) reasonably be expected to result in a material violation or breach of, or a default (with or without notice, lapse of time, or both) under, any Contract to which the Company or any of its Subsidiaries is a party, (7) require the delivery of any opinion of counsel or (8) require the Company or any of its Subsidiaries to prepare or deliver or cause the preparation or delivery of (A) any financial statements or other financial information that are not reasonably available to it or are not prepared in the ordinary course of its financial reporting practice or (B) any Excluded Information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Company hereby consents to the use of the logos of the business of the Company in connection with the debt financing; <u>provided</u>, that such logos shall be used solely in a manner that is not intended or reasonably likely to harm, disparage or otherwise adversely affect the Company or its reputation or goodwill.</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Parent shall, promptly upon request by the Company, reimburse the Company and each of its Subsidiaries for all reasonable and documented out-of-pocket costs incurred by them or their respective officers, directors, employees, accountants, consultants and legal counsel in connection with such cooperation described in <u>Section&#160;7.22(a)</u> and shall reimburse, indemnify and hold harmless the Company and its Subsidiaries and their respective officers, directors, employees, accountants, consultants and legal counsel, from and against any and all losses suffered or incurred by them in connection with the debt financing, any action taken by them pursuant to this <u>Section&#160;7.22</u> or the provision or use of any information used in connection therewith. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;The Parties acknowledge and agree that the provisions contained in this <u>Section&#160;7.22</u> represent the sole obligation of the Company with respect to cooperation in connection with the arrangement of any financing to be obtained by Parent with respect to or in connection with the transactions contemplated by this Agreement, and no other provision of this Agreement (including the Exhibits and Schedules hereto) shall be deemed to expand or modify such obligations. In no event shall the receipt or availability of any funds or financing by Parent, any of its Affiliates or any other financing or other transactions be a condition to any of Parent&#8217;s obligations under this Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;All non-public or otherwise confidential information regarding the Company or any of its Affiliates obtained by Parent or its representative pursuant to this <u>Section&#160;7.22</u> shall be kept confidential in accordance with the Confidentiality Agreement; <u>provided that</u>, notwithstanding anything to the contrary herein or in the Confidentiality Agreement, such information may be disclosed to prospective lenders, underwriters, initial purchasers, dealer managers and agents during syndication and marketing of the applicable debt financing that enter into confidentiality arrangements customary for financing transactions of the same type as such debt financing (including customary &#8220;click-through&#8221; confidentiality undertakings). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notwithstanding anything to the contrary in this Agreement, the Company&#8217;s breach of any of the covenants required to be performed by it under this <u>Section&#160;7.22</u> shall not be considered in determining the satisfaction of the conditions set forth in <u>Section&#160;8.02</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS723"><!--Anchor--></a>Section&#160;7.23.&#8195;<u>Third Party Consents</u>. Without prejudice to <u>Section&#160;7.02</u> and <u>Section&#160;7.05</u>, during the Pre-Closing Period, subject to <u>Section&#160;7.02</u> and <u>Section&#160;7.05</u>, upon Parent&#8217;s written request, the Company shall use commercially reasonable efforts to seek the consents, approvals and waivers that are required in connection with the consummation of the Contemplated Transactions and that are requested in writing by Parent, including from the parties to the Contracts set forth on <u>Section&#160;7.23</u> of the Company Disclosure Letter and any other Contracts reasonably requested by Parent; <u>provided</u>, <u>that</u> in no event shall the Company be required to pay, prior to the Effective Time, any fee, penalty or other consideration or otherwise provide any value or other consideration to any Person or incur any liability for any such consents, approvals and waivers (except to the extent Parent agrees to pay any such amount to the applicable Third Party or, at the Company&#8217;s election, reimburse the Company any such amount). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS724"><!--Anchor--></a>Section&#160;7.24.&#8195;<u>Further Assurances</u>. At and after the Effective Time, the officers and directors of the Surviving Corporation shall be authorized to execute and deliver, in the name and on behalf of the Company, any deeds, bills of sale, assignments, assurances or other instruments and to take and do, in the name and on behalf of the Company, any other actions and things to vest, perfect or confirm of record or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets of the Company acquired or to be acquired by the Surviving Corporation as a result of, or in connection with, the Merger. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-70<br></div></div></div>
<!--End Page 399-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 400-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg71"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS725"><!--Anchor--></a>Section&#160;7.25.&#8195;<u>Notices of Certain Events</u><font style="font-style: italic;">. </font>Each of the Company and Parent shall use reasonable best efforts to promptly notify the other of: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;any notice or other communication from any Third Party alleging that the consent of such Third Party is or may be required in connection with the transactions contemplated by this Agreement; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;any notice or other communication from any Governmental Body (A) in connection with the Contemplated Transactions (other than such communications contemplated in <u>Section&#160;7.05</u>, which shall be governed by such section) or (B) in connection with any material violation or alleged material violation of applicable Law or any material Permit of the Company or its Subsidiaries; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;any Actions commenced or, to its Knowledge, threatened in writing against, the Company or any of its Subsidiaries or Parent and any of its Subsidiaries, as the case may be, that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to this Agreement or that challenge the consummation of Contemplated Transactions; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;any exercise by the Company or any of its Subsidiaries of any right of first offer, right of first refusal or other option to purchase or sell any interest in real property; </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;"><u>provided</u> that the delivery of any notice pursuant to this <u>&#8206;Section&#160;7.25</u> shall not limit or otherwise affect the remedies available hereunder to the Party receiving such notice; provided, further, that that (i) the Company&#8217;s failure of compliance with this <u>Section&#160;7.25</u> shall not be taken into account for purposes of determining the satisfaction of the condition referred to in <u>Section&#160;8.02(b)</u> and (ii) Parent&#8217;s failure of compliance with this <u>Section&#160;7.25</u> shall not be taken into account for purposes of determining the satisfaction of the condition referred to in <u>Section&#160;8.03(b)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS726"><!--Anchor--></a>Section&#160;7.26.&#8195;<u>Treatment of Company Indebtedness</u>. During the Pre-Closing Period, the Company will use commercially reasonable efforts to obtain from the lenders under the applicable debt instrument or the agent or trustee on behalf thereof customary lien release documentation, or other documentation evidencing release of all encumbrances, security interests and collateral securing indebtedness for borrowed money, or file UCC-3 termination statements or any other documents required to evidence the discharge of any existing Liens on the assets of the Company and its Subsidiaries, as reasonably requested by Parent, including under the instruments listed on <u>Section&#160;7.26</u> of the Company Disclosure Letter (each of which indebtedness for borrowed money the Company or its Subsidiaries has been repaid prior to the date hereof). Notwithstanding anything to the contrary in this Agreement, (a) no such documentation shall be required from the lenders under the applicable debt instrument or the agent or trustee on behalf thereof to the extent that any such Lien (or the indebtedness related thereto) was discharged or released by a final order of a court of competent jurisdiction and (b) the Company&#8217;s breach of any of the covenants required to be performed by it under this <u>Section&#160;7.26</u> shall not be considered in determining the satisfaction of the conditions set forth in <u>Section&#160;8.02</u>. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; text-align: center;"><a name="tANXAA8"><!--Anchor--></a>ARTICLE&#160;VIII<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDITIONS TO CLOSING </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS801"><!--Anchor--></a>Section&#160;8.01.&#8195;<u>Conditions to All Parties&#8217; Obligations</u>. The obligations of Parent, Merger Sub and the Company to consummate the Contemplated Transactions are subject to the satisfaction or waiver (to the extent permitted by applicable Law) by Parent and the Company of the following conditions: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(a)&#8195;The Company Stockholder Approval shall have been obtained; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Registration Statement shall have become effective under the Securities Act, and no stop order suspending the effectiveness of the Registration Statement shall have been issued by the SEC and remain in effect and no proceedings for such purpose shall be pending before the SEC; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The waiting period (and any extension thereof, including any commitment to, or agreement with, any Governmental Body to delay the consummation of, or not to consummate before a certain date, the Contemplated Transactions) applicable to the Contemplated Transactions under the HSR Act shall have expired or been terminated; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;There shall be no Order (whether temporary, preliminary or permanent) enacted, promulgated, issued or entered by any Governmental Body enjoining, restraining, preventing or prohibiting the consummation of the Merger and there shall be no Law in effect or enacted or promulgated prohibiting or making illegal the consummation of the Merger; and </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-71<br></div></div></div>
<!--End Page 400-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 401-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg72"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(e)&#8195;The shares of Parent Class&#160;A Common Stock constituting Merger Consideration issuable to the Company Stockholders pursuant to this Agreement shall have been approved for listing on the NASDAQ, subject to official notice of issuance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS802"><!--Anchor--></a>Section&#160;8.02.&#8195;<u>Conditions to Parent&#8217;s and Merger Sub&#8217;s Obligations</u>. The obligations of Parent and Merger Sub to consummate the Contemplated Transactions are subject to the satisfaction or waiver (to the extent permitted by applicable Law) by Parent and Merger Sub of the following conditions as of the Closing Date:</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195; (1) Each of the representations and warranties of the Company contained in Article&#160;IV (other than the Company Fundamental Representations, the Company Fundamental Representations &#8211; De Minimis and the first&#160;sentence of <u>Section&#160;4.09</u> (<font style="font-style: italic;">Absence of Certain Developments</font>)) shall be true and correct as of the Closing (without giving effect to any &#8220;material,&#8221; &#8220;materiality,&#8221; &#8220;Company Material Adverse Effect&#8221; or similar phrases, except that the word &#8220;material&#8221; in the definition of &#8220;Company Material Contract&#8221; shall not be disregarded) as if made as of such date (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)), except where the failure of any such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect and (2) (A) the Company Fundamental Representations shall be true and correct in all material respects on and as of the Closing, with the same force and effect as if made on and as of the Closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)), and (B) the Company Fundamental Representations &#8211; De Minimis shall be true and correct in all respects (except for de minimis inaccuracies relative to the total fully diluted equity capitalization of the Company), and on and as of the Closing, with the same force and effect as if made on and as of the Closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); <u>provided</u>, <u>that</u>, in the case of <u>clauses (2)(A)</u> and <u>(2)(B)</u>, all &#8220;Company Material Adverse Effect,&#8221; &#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties shall be disregarded and (3) the representations and warranties of the Company contained in the first&#160;sentence of <u>Section&#160;4.09</u> (<font style="font-style: italic;">Absence of Certain Developments</font>) shall be true and correct in all respects as of the Closing; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Company shall have complied in all material respects with all of the covenants and agreements under this Agreement that are required to be performed by it at or prior to the Closing; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Since the date of this Agreement, there shall not have been or occurred any Company Material Adverse Effect; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;The Company shall have delivered to Parent a certificate of the Company executed by a duly authorized officer thereof, dated as of the Closing Date, stating that the conditions in <u>Section&#160;8.02(a)</u>, <u>Section&#160;8.02(b)</u> and <u>Section&#160;8.02(c)</u> have been satisfied. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS803"><!--Anchor--></a>Section&#160;8.03.&#8195;<u>Conditions to the Company&#8217;s Obligations</u>. The obligations of the Company to consummate the Contemplated Transactions are subject to the satisfaction or waiver (to the extent permitted by applicable Law) by the Company of the following conditions as of the Closing Date: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;(1) Each of the representations and warranties of Parent and Merger Sub contained in Article&#160;V (other than the Parent Fundamental Representations, Parent Fundamental Representations &#8211; De Minimis and <u>Section&#160;5.08</u> (<font style="font-style: italic;">Absence of Certain Developments</font>)) shall be true and correct as of the Closing (without giving effect to any &#8220;material,&#8221; &#8220;materiality,&#8221; &#8220;Parent Material Adverse Effect&#8221; or similar phrases) as if made as of such date (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)), except where the failure of any such representations and warranties to be true and correct has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect, and (2) (A) the Parent Fundamental Representations shall be true and correct in all material respects on and as of the Closing, with the same force and effect as if made on and as of the Closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)) and (B) the Parent Fundamental Representations &#8211; De Minimis shall be true and correct in all respects (except for de minimis inaccuracies relative to the total fully diluted equity capitalization of Parent), on and as of the Closing, with the same force and effect as if made on and as of the Closing (except to the extent any such representation and warranty expressly relates to an earlier date (in which case as of such earlier date)); <u>provided</u>, <u>that</u>, in the case of <u>clauses (2)(A)</u> and <u>(2)(B)</u>, all &#8220;Parent Material Adverse Effect,&#8221; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-72<br></div></div></div>
<!--End Page 401-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 402-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg73"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-align: justify;">&#8220;material&#8221; and &#8220;materiality&#8221; qualifications contained in such representations and warranties shall be disregarded and (3) the representations and warranties of Parent contained in the first sentence of <u>Section&#160;5.09</u> (<font style="font-style: italic;">Absence of Certain Developments</font>) shall be true and correct in all respects as of the Closing; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;Each of Parent and Merger Sub shall have complied in all material respects with all of its respective covenants and agreements under this Agreement that are required to be performed by it at or prior to the Closing; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;Since the date of this Agreement, there shall not have been or occurred any Parent Material Adverse Effect; and </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(d)&#8195;Parent shall have delivered to the Company a certificate of Parent executed by a duly authorized officer thereof, dated as of the Closing Date, stating that the conditions in <u>Section&#160;8.03(a)</u>, <u>Section&#160;8.03(b)</u> and <u>Section&#160;8.03(c)</u> have been satisfied. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; text-align: center;"><a name="tANXAA9"><!--Anchor--></a>ARTICLE&#160;IX<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">TERMINATION </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS901"><!--Anchor--></a>Section&#160;9.01.&#8195;<u>Termination</u>. This Agreement may be terminated and the Merger may be abandoned: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(a)&#8195;at any time prior to the Effective Time, by the mutual written consent of Parent and the Company; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(b)&#8195;by Parent: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;at any time prior to the Effective Time, if any of the Company&#8217;s covenants, representations or warranties contained in this Agreement shall be or have become untrue, such that the conditions set forth in <u>Section&#160;8.02(a)</u> or <u>Section&#160;8.02(b)</u> would not be satisfied, and such breach (A) is incapable of being cured by the Company by or before the End Date or (B) is not cured within thirty (30) days of receipt by the Company of written notice from Parent of such breach; <u>provided</u>, <u>however</u>, that Parent shall not have the right to terminate this Agreement pursuant to this <u>Section&#160;9.01(b)(i)</u> if any of Parent or Merger Sub is then in breach of any representation, warranty, covenant or obligation hereunder that would result in the failure to be satisfied of the conditions set forth in <u>Section&#160;8.03(a)</u> or <u>Section&#160;8.03(b)</u>; or</div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;at any time prior to obtaining the Company Stockholder Approval, if the Company Board or any committee thereof makes an Adverse Recommendation Change. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(c)&#8195;by the Company: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;at any time prior to the Effective Time, if any of Parent&#8217;s or Merger Sub&#8217;s covenants, representations or warranties contained in this Agreement shall be or have become untrue, such that the conditions set forth in <u>Section&#160;8.03(a)</u> or <u>Section&#160;8.03(b)</u> would not be satisfied, and such breach (A) is incapable of being cured by Parent or Merger Sub, as the case may be, by or before the End Date, or (B)&#160;is not cured within thirty (30) days of receipt by Parent of written notice from the Company of such breach; <u>provided</u>, <u>however</u>, that the Company shall not have the right to terminate this Agreement pursuant to this <u>Section&#160;9.01(c)(i)</u> if the Company is then in breach of any representation, warranty, covenant or obligation hereunder that would result in the failure to be satisfied of the conditions set forth in <u>Section&#160;8.02(a)</u> or <u>Section&#160;8.02(b)</u>; or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;at any time prior to obtaining the Company Stockholder Approval (and subject to <u>Section&#160;9.03(a)</u>), upon written notice to Parent, in order to enter into a definitive agreement with a Third&#160;Party providing for a Superior Proposal if the Company has complied in all material respects with <u>Section&#160;7.04</u> with respect to such Superior Proposal; or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(d)&#8195;by either Parent or the Company at any time prior to the Effective time, if: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;(A) any Order has become final and non-appealable, or (B) there shall be a Law, in each case of (A) and (B), having the effect of permanently enjoining or restricting the consummation of the Merger or making the Merger illegal or otherwise prohibited; <u>provided</u>, <u>however</u>, that the right to terminate this Agreement under this <u>Section&#160;9.01(d)(i)</u> shall not be available to any Party whose material failure to comply with any provision of this Agreement has been the primary cause of such Order or Law; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-73<br></div></div></div>
<!--End Page 402-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 403-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg74"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;the Merger contemplated hereby has not been consummated by 5:00 p.m., New York time on April&#160;7, 2026 (the &#8220;<u>End Date</u>&#8221;); <u>provided</u>, that the right to terminate this Agreement under this <u>Section&#160;9.01(d)(ii)</u> shall not be available to any Party whose material failure to comply with any provision of this Agreement has been the primary cause of the failure of the Merger to occur on or before such date; or </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;the Company Stockholder Approval shall not have been obtained at the Company Stockholders&#8217; Meeting, including any adjournment or postponement thereof; <u>provided</u>, that the right to terminate this Agreement under this <u>Section&#160;9.01(d)(iii)</u> shall not be available to the Company if its material failure to comply with any provision of this Agreement has been the primary cause of the failure to obtain the Company Stockholder Approval on or before such date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS902"><!--Anchor--></a>Section&#160;9.02.&#8195;<u>Effect of Termination</u>. In the event of the valid termination of this Agreement by either Parent or the Company as provided in <u>Section&#160;9.01</u>, written notice thereof shall forthwith be given by the terminating Party to the other Party specifying the provision hereof pursuant to which such termination is made and this Agreement shall be of no further force or effect; <u>provided</u>, <u>however</u>, that (a) <u>Section&#160;7.01(e)</u>, <u>Section&#160;7.22(c)</u>, this <u>Section&#160;9.02</u>, <u>Section&#160;9.03 </u>and <u>Article&#160;X</u> (other than <u>Section&#160;10.12</u>, except to the extent that <u>Section&#160;10.12</u> relates to the specific performance of the provisions of this Agreement that survive termination) shall survive the termination of this Agreement and shall remain in full force and effect (collectively, the &#8220;<u>Surviving Provisions</u>&#8221;), and (b) no such termination will relieve any Person of any Liability for Fraud or a material breach of this Agreement that is a consequence of an act or omission intentionally undertaken by the breaching party with knowledge that such act or omission would result in a material breach of this Agreement (an &#8220;<u>Intentional Breach</u>&#8221;). No termination of this Agreement shall affect the obligations of the parties contained in the Confidentiality Agreement, all of which obligations shall survive the termination of this Agreement in accordance with their terms. Nothing shall limit or prevent Parent or the Company from exercising any rights or remedies it may have under <u>Section&#160;10.12</u> (<font style="font-style: italic;">Specific Performance</font>) in lieu of exercising any right it may have to terminate this Agreement pursuant to <u>Section&#160;9.01</u> (<font style="font-style: italic;">Termination</font>), <u>provided</u> that if this Agreement is terminated pursuant to <u>Section&#160;9.01</u>, no party shall have any rights or remedies under <u>Section&#160;10.12</u> (<font style="font-style: italic;">Specific Performance</font>) other than in respect of the Surviving Provisions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS903"><!--Anchor--></a>Section&#160;9.03.&#8195;<u>Termination Fees</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(a)&#8195;In the event that this Agreement is terminated: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(i)&#8195;by Parent pursuant to <u>Section&#160;9.01(b)(ii)</u> (<font style="font-style: italic;">Adverse Recommendation Change</font>), then the Company shall pay the Termination Fee to Parent in cash by wire transfer of immediately available funds within two&#160;(2) Business Days following such termination; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(ii)&#8195;by Parent pursuant to <u>Section&#160;9.01(b)(i)</u> (<font style="font-style: italic;">Breach of Covenants, Representations and Warranties</font>) based on an Intentional Breach by the Company of any provision of this Agreement, and <u>provided</u>, in the case of this <u>clause (ii)</u>, that (A) after the date hereof and prior to such termination, any Third Party shall have publicly disclosed or otherwise communicated to the Company Board an Acquisition Proposal and such Acquisition Proposal, if public, shall not have been publicly withdrawn at least two (2) Business Days prior to such termination, and (B) within twelve (12) months of any termination described in this <u>clause (ii)</u>, (x) the Company or any of its Subsidiaries enters into a definitive agreement with respect to an Acquisition Proposal (substituting fifty percent (50%) for the twenty percent (20%) threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for all purposes under this <u>Section&#160;9.03(a)</u>) that is subsequently consummated or (y) the Company or its Subsidiaries consummates an Acquisition Proposal, then the Company shall pay the Termination Fee to Parent in cash by wire transfer of immediately available funds prior to or concurrently with the consummation of such Acquisition Proposal; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iii)&#8195;by the Company pursuant to <u>Section&#160;9.01(c)(ii)</u> (<font style="font-style: italic;">Superior Proposal</font>), then the Company shall pay the Termination Fee to Parent in cash by wire transfer of immediately available funds concurrently with such termination and any purported termination pursuant to <u>Section&#160;9.01(c)(ii)</u> (<font style="font-style: italic;">Superior Proposal</font>) shall be of no force or effect until such payment is made; </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 40pt; text-indent: 20pt; text-align: justify;">(iv)&#8195;by Parent or the Company (as applicable) pursuant to <u>Section&#160;9.01(d)(ii)</u> (<font style="font-style: italic;">End Date</font>) without the Company Stockholder Approval having been obtained, or pursuant to <u>Section&#160;9.01(d)(iii)</u> (<font style="font-style: italic;">Company Stockholder Approval</font>), and <u>provided</u>, in the case of this <u>clause (iv)</u>, that (A) after the date hereof and prior to such termination, any Third Party shall have publicly disclosed an Acquisition Proposal and such Acquisition Proposal shall not have been publicly withdrawn at least two (2) Business Days prior to (x) the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-74<br></div></div></div>
<!--End Page 403-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 404-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg75"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 40pt; text-align: justify;">date of such termination (in the case of termination pursuant to <u>Section&#160;9.01(d)(ii)</u> (<font style="font-style: italic;">End Date</font>)) or (y) the Company Stockholders&#8217; Meeting (in the case of a termination pursuant to <u>Section&#160;9.01(d)(iii))</u>, and (B)&#160;within twelve (12) months of any termination described in this <u>clause (iv)</u>, (x) the Company or any of its Subsidiaries enters into a definitive agreement with respect to an Acquisition Proposal (substituting fifty&#160;percent (50%) for the twenty percent (20%) threshold set forth in the definition of &#8220;Acquisition Proposal&#8221; for all purposes under this <u>Section&#160;9.03(a)</u>) that is subsequently consummated or (y) the Company or its Subsidiaries consummates an Acquisition Proposal, then the Company shall pay the Termination Fee to Parent in cash by wire transfer of immediately available funds prior to or concurrently with the consummation of such Acquisition Proposal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subject to <u>clause (b)</u> of <u>Section&#160;9.02</u>, Parent&#8217;s right to receive the one-time payment of the Termination Fee from the Company as provided in this <u>Section&#160;9.03(a)</u> shall be the sole and exclusive remedy available to Parent or any of its former, current or future equityholders, directors, officers, Affiliates, agents or Representatives against the Company or any of its former, current or future equityholders, directors, officers, Affiliates, agents or Representatives with respect to this Agreement and the Contemplated Transactions in the event that this Agreement is terminated and Parent receives the Termination Fee in accordance with <u>Section&#160;9.03(a)</u>, and, upon such payment of the Termination Fee, (i) in no event may Parent or any of its former, current or future equityholders, directors, officers, Affiliates, agents or Representatives seek to recover any other money damages or seek any other remedy based on a claim in Law or equity with respect to any loss suffered, directly or indirectly, as a result of the failure of the Merger to be consummated, the termination of this Agreement, any Liabilities or obligations arising under this Agreement, or any claims or actions arising out of or relating to any breach, termination or failure of or under this Agreement, and (ii)&#160;none of the Company or any of its former, current or future equityholders, directors, officers, Affiliates, agents or Representatives shall have any further Liability relating to or arising out of this Agreement or the Contemplated Transactions other than in the case of clauses <u>(i)</u> and <u>(ii)</u> in respect of the Surviving Provisions and the Confidentiality Agreement. For the avoidance of doubt, Parent may seek specific performance to cause the Company to consummate the Contemplated Transactions in accordance with <u>Section&#160;10.12</u> or the payment of the Termination Fee pursuant to this <u>Section&#160;9.03(a)</u> (or both concurrently), but in no event shall Parent be entitled to both (x) equitable relief ordering the Company to consummate the Contemplated Transactions in accordance with <u>Section&#160;10.12</u> (as a result of which the Contemplated Transactions are consummated) and (y) the payment of the Termination Fee pursuant to this <u>Section&#160;9.03(a)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">(b)&#8195;As used in this Agreement, (i) &#8220;<u>Termination Fee</u>&#8221; shall mean (a) $270,000,000. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;The Parties acknowledge that the agreements contained in this <u>Section&#160;9.03</u> are an integral part of the Contemplated Transactions, and that, without these agreements, neither the Company nor Parent would enter into this Agreement. The Parties agree that the Termination Fee is liquidated damages and not a penalty, and the payment of the Termination Fee in the circumstances specified herein is supported by due and sufficient consideration. Accordingly and notwithstanding anything herein to the contrary, if the Company fails promptly to pay any amount due pursuant to this <u>Section&#160;9.03</u>, and, in order to obtain such payment, Parent commences a suit which results in a judgment against the Company for the payment set forth in this <u>Section&#160;9.03</u>, the Company shall pay to Parent its reasonable and documented out-of-pocket costs and expenses (including such attorneys&#8217; fees) in connection with such suit, together with interest on the Termination Fee, to be paid or reimbursed to Parent under this <u>Section&#160;9.03(c)</u> from the date payment was required to be made until the date of such payment at the prime rate published in the <font style="font-style: italic;">Wall Street Journal</font> in effect on the date such payment was required to be made. </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; text-align: center;"><a name="tANXAA10"><!--Anchor--></a>ARTICLE&#160;X<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">MISCELLANEOUS </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1001"><!--Anchor--></a>Section&#160;10.01.&#8195;<u>Expenses</u>. Except as otherwise expressly provided herein, Parent and Merger Sub, on the one hand, and the Company, on the other hand, shall each pay its own expenses (including attorneys&#8217; and accountants&#8217; fees and expenses) in connection with the negotiation of this Agreement, the performance of its obligations hereunder and the consummation of the Contemplated Transactions (whether consummated or not). Notwithstanding anything in this Agreement to the contrary, Parent shall be responsible for all filing fees to any Governmental Body in order to obtain any necessary action or non-action, waiver, Consent, clearance, decision, declaration, approval, or expiration or termination of a waiting period under the HSR Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1002"><!--Anchor--></a>Section&#160;10.02.&#8195;<u>Amendment</u>. At any time prior to the Effective Time, any provision of this Agreement may be amended (whether before or after any required approval by the Company Stockholders) if, and only if, such </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-75<br></div></div></div>
<!--End Page 404-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 405-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg76"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">amendment or waiver is in writing and signed by Parent, the Company and Merger Sub; <u>provided</u>, <u>however</u>, that after the receipt of the Company Stockholder Approval, no amendment shall be made which by applicable Laws or the rules of NASDAQ requires further approval of the Company Stockholders without the further approval of such stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS1003"><!--Anchor--></a>Section&#160;10.03.&#8195;<u>Waiver</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;At any time prior to the Effective Time, the Parties may, to the extent permitted by applicable Law, (i) extend the time for the performance of any of the obligations or acts of the other Parties, (ii) waive any inaccuracies in the representations and warranties of the other Parties set forth in this Agreement or any document delivered pursuant hereto or (iii) waive compliance with any of the agreements or conditions of the other Parties contained herein; <u>provided</u>, <u>however</u>, that after the receipt of the Company Stockholder Approval no waiver shall be made which by applicable Laws or the rules of NASDAQ requires further approval of the Company Stockholders without the further approval of such stockholders. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;No failure on the part of any Party to exercise any power, right, privilege or remedy under this Agreement, and no delay on the part of any Party in exercising any power, right, privilege or remedy under this Agreement, shall operate as a waiver of such power, right, privilege or remedy, and no single or partial exercise of any such power, right, privilege or remedy shall preclude any other or further exercise thereof or of any other power, right, privilege or remedy. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;No Party shall be deemed to have waived any claim arising out of this Agreement, or any power, right, privilege or remedy under this Agreement, unless the waiver of such claim, power, right, privilege or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party, and any such waiver shall not be applicable or have any effect except in the specific instance in which it is given. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1004"><!--Anchor--></a>Section&#160;10.04.&#8195;<u>No Survival of Representations and Warranties</u>. None of the representations, warranties or agreements contained in this Agreement or in any certificate, document or instrument delivered pursuant to this Agreement shall survive the Effective Time, except for covenants and agreements which contemplate performance, in whole or in part, after the Effective Time or otherwise expressly by their terms survive the Effective Time. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1005"><!--Anchor--></a>Section&#160;10.05.&#8195;<u>Entire Agreement; Counterparts</u>. This Agreement (and the exhibits, annexes and schedules hereto, the Company Disclosure Letter and the Parent Disclosure Letter) constitutes the entire agreement among the Parties and supersede all other prior agreements and understandings, both written and oral, among or between any of the Parties with respect to the subject matter hereof, it being understood that the Confidentiality Agreement shall continue in full force and effect until the Closing Date and shall survive any termination of this Agreement. This Agreement may be executed in several counterparts (including counterparts delivered by electronic transmission), each of which shall be deemed an original and all of which shall constitute one and the same instrument. Any such counterpart, to the extent delivered by fax or .pdf, .tif, .gif, .jpg or similar attachment to electronic mail or any electronic signature complying with the U.S. federal ESIGN Act of 2000 (e.g., www.docusign.com) (any such delivery, an &#8220;<u>Electronic Delivery</u>&#8221;), will be treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. This Agreement shall become effective when each party hereto shall have received a counterpart hereof signed (including by electronic signature) by all of the other Parties hereto. Until and unless each Party has received a counterpart hereof signed (including by electronic signature) by the other Party hereto, this Agreement shall have no effect and no Party shall have any right or obligation hereunder (whether by virtue of any other oral or written agreement or other communication). No Party may raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each Party forever waives any such defense, except to the extent such defense relates to lack of authenticity. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;"><a name="tANXAS1006"><!--Anchor--></a>Section&#160;10.06.&#8195;<u>Applicable Law; Jurisdiction</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(a)&#8195;This Agreement (and any Action arising out of or related hereto or the Contemplated Transactions or to the inducement of any Party to enter herein, whether for breach of contract, tortious conduct or otherwise and whether predicated on common law, statute or otherwise) shall be governed by and construed in accordance with the Laws of the State of Delaware without regard to the Laws of the State of Delaware or any other jurisdiction that would call for the application of the substantive Laws of any jurisdiction other than the State of Delaware. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-76<br></div></div></div>
<!--End Page 405-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 406-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg77"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(b)&#8195;The Parties agree that the appropriate, exclusive and convenient forum (the &#8220;<u>Forum</u>&#8221;) for any Actions among any of the Parties arising out of or related to this Agreement or the Contemplated Transactions shall be in the Delaware Court of Chancery, except where such court lacks subject matter jurisdiction. In such event, the Forum shall be in the federal district court sitting in Wilmington, Delaware, or, in the event such federal district court lacks subject matter jurisdiction, then in the superior court in the City of Wilmington, New Castle County, Delaware. The Parties irrevocably submit to the jurisdiction of such courts solely in respect of any disputes between them arising out of or related to this Agreement or the Contemplated Transactions. The Parties further agree that no Party shall bring suit with respect to any disputes arising out of or related to this Agreement or the Contemplated Transactions in any court or jurisdiction other than the above specified courts; <u>provided</u>, <u>however</u>, that the foregoing shall not limit the rights of any Party to obtain execution of a judgment in any other jurisdiction. The Parties further agree, to the extent permitted by Law, that a final and non-appealable judgment against any Party in any Action contemplated above shall be conclusive and may be enforced in any other jurisdiction within or outside the U.S. by suit on the judgment, a certified or exemplified copy of which shall be conclusive evidence of the fact and amount of such judgment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">(c)&#8195;To the extent that any Party has or hereafter may acquire any immunity from jurisdiction of any court or from any legal process (whether through service or notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) with respect to itself or its property, each such Party hereby irrevocably (i) waives such immunity in respect of its obligations with respect to this Agreement and (ii) submits to the personal jurisdiction of each court described in <u>Section&#160;10.06(b)</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1007"><!--Anchor--></a>Section&#160;10.07.&#8195;<u>Waiver of Jury Trial</u>. EACH OF THE PARTIES IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE CONTEMPLATED TRANSACTIONS. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B) EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER, (C) EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (D)&#160;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <u>SECTION 10.07</u>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1008"><!--Anchor--></a>Section&#160;10.08.&#8195;<u>Assignability</u>. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the Parties and their respective successors and permitted assigns; <u>provided</u>, <u>however</u>, that neither this Agreement nor any rights, interests or obligations hereunder may be assigned by any Party without the prior written consent of all other Parties, and any attempted assignment of this Agreement or any of such rights, interests or obligations without such consent shall be void and of no effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1009"><!--Anchor--></a>Section&#160;10.09.&#8195;<u>No Third Party Beneficiaries</u>. Except for, following the Effective Time, the right of the Indemnified Parties to enforce the provisions of <u>Section&#160;7.07</u> and the rights of the Company&#8217;s Affiliates and the Company&#8217;s and its Affiliates&#8217; respective officers, directors, employees, accountants, consultants and legal counsel to enforce the provisions of <u>Section&#160;7.22(c)</u>, each of whom is an express third-party beneficiary of such provisions, Parent, the Company and Merger Sub agree that (a) their respective representations, warranties and covenants set forth herein are solely for the benefit of the other Parties, in accordance with and subject to the terms of this Agreement, and (b) this Agreement is not intended to, and does not, confer upon any Person other than the Parties any rights or remedies hereunder, including the right to rely upon the representations and warranties set forth herein. Notwithstanding the preceding sentence, following the Effective Time, the provisions of <u>Article&#160;III</u> shall be enforceable by holders of Company Common Stock solely to the extent necessary to receive the Merger Consideration to which such holders are entitled thereunder, the provisions of <u>Section&#160;3.02</u> shall be enforceable by holders of Company Equity Awards to the extent necessary to receive the amounts to which such holders are entitled thereunder. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-77<br></div></div></div>
<!--End Page 406-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 407-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg78"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1010"><!--Anchor--></a>Section&#160;10.10.&#8195;<u>Notices</u>. All notices, demands and other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given and received (a) when personally delivered, (b) the day following the day (except if not a Business Day then the next Business Day) on which the same has been delivered prepaid to a reputable national overnight air courier service, or (c) when sent by electronic mail (without receipt of a delivery failure notice). Notices, demands and communications, in each case to the respective Parties, shall be sent to the applicable address set forth below, unless another address has been previously specified in writing: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 408pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 48pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Notices to Parent and Merger Sub</u>: </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc.</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">290 W Mount Pleasant Ave, Suite 4100 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Livingston, NJ 07039 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attention: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kristen McVeety </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Email: [&#8195;] </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">with copies (which shall not constitute notice) to: </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Davis Polk &amp; Wardwell LLP</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">450 Lexington Avenue </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New York, New York 10017 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">and </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Davis Polk &amp; Wardwell LLP </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">900 Middlefield Road, Suite 200 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redwood City, California 94063 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attention: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Gilson </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Kaplan</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tierney O&#8217;Rourke</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Email: [&#8195;] </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">and </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Kirkland &amp; Ellis LLP </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">609 Main Street </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Houston, Texas 77002 </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attention: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Douglas E. Bacon, P.C. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">David B. Feirstein, P.C. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Melissa D. Kalka, P.C. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Email: [&#8195;]</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><u>Notices to the Company</u>: </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific, Inc. </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">83 Walker Road, Suite 21-2105</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dover, Delaware 19904</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attention: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Todd M. DuChene </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Email: [&#8195;] </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">with a copy (which shall not constitute notice) to:</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Wachtell, Lipton, Rosen &amp; Katz </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">51 West 52nd Street</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">New York, New York 10019</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Attention: </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">David A. Katz </div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 360pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Karessa L. Cain</div></td></tr><tr><td style="width: 48pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 408pt; padding-top: 0.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Email: [&#8195;]</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 408pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1011"><!--Anchor--></a>Section&#160;10.11.&#8195;<u>Severability</u>. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law, such provision shall be ineffective only to the extent of such </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-78<br></div></div></div>
<!--End Page 407-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 408-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg79"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this Agreement, and the Parties shall amend or otherwise modify this Agreement to replace any prohibited or invalid provision with an effective and valid provision that gives effect to the intent of the Parties to the maximum extent permitted by applicable Law. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;"><a name="tANXAS1012"><!--Anchor--></a>Section&#160;10.12.&#8195;<u>Specific Performance</u>. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed by the Company, Parent, or Merger Sub in accordance with their specific terms or were otherwise breached by the Company, Parent or Merger Sub and that monetary damages, even if available, would not be an adequate remedy therefor. Except as set forth in <u>Section&#160;9.03</u>, it is accordingly agreed that (a) the Company shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement by Parent or Merger Sub and to enforce specifically the terms and provisions hereof against Parent or Merger Sub in any court having jurisdiction, this being in addition to any other remedy to which the Company is entitled at law or in equity, including damages in the event of Parent&#8217;s or Merger Sub&#8217;s Fraud or Intentional Breach of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy or posting any bond or other undertaking and (b) Parent and Merger Sub shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement by the Company and to enforce specifically the terms and provisions hereof against the Company in any court having jurisdiction, this being in addition to any other remedy to which Parent or Merger Sub is entitled at law or in equity, including damages in the event of the Company&#8217;s Fraud or Intentional Breach of this Agreement, without the necessity of proving the inadequacy of money damages as a remedy or posting any bond or other undertaking. The Parties further agree not to oppose the granting of an injunction, specific enforcement or other equitable relief on the basis that any other Party has an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or in equity. The Parties acknowledge that the agreements contained in this <u>Section&#160;10.12</u> are an integral part of the Contemplated Transactions and that, without these agreements, neither the Company nor Parent would enter into this Agreement. The Parties acknowledge and agree that time is of the essence and that the Parties would suffer ongoing irreparable injury for so long as any provision of this Agreement is not performed in accordance with its specific terms, including but not limited to as a result of any dispute over the Parties&#8217; obligations to consummate the Contemplated Transactions. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">[<font style="font-style: italic;">Signature page follows</font>]</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-79<br></div></div></div>
<!--End Page 408-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 409-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg80"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">IN WITNESS WHEREOF, the Parties have executed this Agreement on the day and year first above written. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CORE SCIENTIFIC, INC. </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Adam Sullivan </div></td></tr><tr><td style="width: 228pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adam Sullivan </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: left;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">[Signature Page to Merger Agreement]<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-80<br></div></div></div>
<!--End Page 409-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 410-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg81"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">IN WITNESS WHEREOF, the Parties have executed this Agreement on the day and year first above written. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">COREWEAVE, INC. </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Michael Intrator </div></td></tr><tr><td style="width: 228pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chief Executive Officer</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: left;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">[Signature Page to Merger Agreement]<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-81<br></div></div></div>
<!--End Page 410-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 411-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg82"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">IN WITNESS WHEREOF, the Parties have executed this Agreement on the day and year first above written. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">MIAMI MERGER SUB I, INC. </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Michael Intrator </div></td></tr><tr><td style="width: 228pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.76pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 24pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 192pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">President, Chief Executive Officer</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0.5pt; margin-left: 0pt; text-align: left;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">[Signature Page to Merger Agreement]<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-82<br></div></div></div>
<!--End Page 411-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 412-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_300-annexa_pg83"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tEXHIBITA"><!--Anchor--></a>EXHIBIT A <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">Form&#160;of Amended and Restated Certificate of the Surviving Corporation</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; text-align: center;">[<font style="font-style: italic;">See Attached</font>] </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">A-83<br></div></div></div>
<!--End Page 412-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 413-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_301-annexb_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;"><a name="tANNEXB"><!--Anchor--></a>Annex B</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.25pt; margin-left: 0pt; text-align: left;"><img style="height: 28px; width: 113px;" src="logo_moelis.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 20.5pt; text-align: right;">July 7, 2025</div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Board of Directors <br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific, Inc. <br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">838 Walker Road<br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Suite 21-2105<br></div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dover, DE 19904 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">Members of the Board: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You have requested our opinion as to the fairness, from a financial point of view, to the holders of common stock, par value $0.00001 per share (&#8220;<u>Company Common</u> <u>Stock</u>&#8221;), of Core Scientific, Inc. (the &#8220;<u>Company</u>&#8221;) of the Exchange Ratio (as defined below) pursuant to the Agreement and Plan of Merger (the &#8220;<u>Agreement</u>&#8221;) to be entered into by and among the Company, CoreWeave, Inc. (the &#8220;<u>Acquiror</u>&#8221;) and Miami Merger Sub I, Inc., a wholly owned subsidiary of the Acquiror (the &#8220;<u>Acquisition Sub</u>&#8221;). As more fully described in the Agreement, Acquisition Sub will be merged with and into the Company (the &#8220;<u>Transaction</u>&#8221;) with the Company surviving the Transaction and becoming a wholly-owned subsidiary of the Acquiror and each issued and outstanding share of Company Common Stock (other than any Cancelled Shares (as defined in the Agreement)) outstanding immediately prior to the Effective Time (as defined in the Agreement) will be converted into the right to receive 0.1235 (the &#8220;<u>Exchange Ratio</u>&#8221;) of a share of the Class&#160;A common stock, par value $0.000005 per share (&#8220;<u>Acquiror Common Stock</u>&#8221;), of the Acquiror. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In arriving at our opinion, we have, among other things: (i) reviewed certain publicly available business and financial information, including publicly available research analysts&#8217; financial forecasts, relating to the Company and the Acquiror; (ii) reviewed certain internal information relating to the business, earnings, cash flow, assets, liabilities and prospects of the Company furnished to us by the Company, including financial forecasts provided to or discussed with us by the management of the Company; (iii) reviewed (a) certain information relating to the business, earnings, cash flow, assets, liabilities and prospects of the Acquiror furnished to us by the Acquiror and (b) certain financial forecasts of the Acquiror that were provided to and discussed with us by the management of the Company, including a certain equity research analyst model that the management of the Acquirer commented on and discussed with us and management of the Company; (iv) reviewed information regarding the capitalization of the Company furnished to us by the Company and the Acquiror furnished to us by the Acquiror; (v) reviewed information regarding the strategic and financial benefits (including potential synergies) to the combined company discussed with the Company, (vi) conducted discussions with members of the senior managements and representatives of the Company and the Acquiror concerning the information described in clauses (i) through (v) of this paragraph, as well as the businesses and prospects of the Company and the Acquiror generally; (vii) reviewed the reported prices and trading activity for the Company Common Stock and Acquiror Common Stock, including the market liquidity and average daily trading volumes of the Acquiror Common Stock relative to the Company&#8217;s market capitalization; (viii) reviewed publicly available financial and stock market data of certain other companies in lines of business that we deemed relevant; (ix) reviewed the financial terms of certain other transactions as we deemed appropriate; (x) reviewed a draft, dated July&#160;7, 2025, of the Agreement; (xi) participated in certain discussions and negotiations among representatives of the Company and the Acquiror and their advisors; and (xii) conducted such other financial studies and analyses and took into account such other information as we deemed appropriate.</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">399 Park Avenue | 4th Floor | New York, NY 10022 </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.25pt; margin-left: 0pt; text-align: left;"><img style="height: 11px; width: 219px;" src="ny20053122x2_annexb1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;"> </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">B-1<br></div></div></div>
<!--End Page 413-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 414-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_301-annexb_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with our analysis and opinion, we have relied on the information supplied to, discussed with or reviewed by us being complete and accurate in all material respects. We have not independently verified any such information (or assumed any responsibility for the independent verification of any such information). We have also relied on the representation of the Company&#8217;s management that they are not aware of any facts or circumstances that would make any such information inaccurate or misleading. We have relied upon, without independent verification, the assessment of the Company and its legal, tax, regulatory and accounting advisors with respect to legal, tax, regulatory and accounting matters. With respect to the financial forecasts relating to the Company referred to above, we have assumed, at your direction, that they have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company as to the future performance of the Company. With respect to the financial forecasts relating to the Acquiror referred to above, we have assumed, at your direction, they are a reasonable basis upon which to evaluate the future performance of the Acquiror, and we have used such forecasts in performing our analyses. In addition, we have relied on the assessments of the managements of the Company and the Acquiror as to the existing technology, products and services of the Company and the Acquiror and the validity of, and risks associated with, the future technology, products and services of the Company and the Acquiror, and we have assumed that there will be no developments with respect to any of the foregoing that would affect our analyses or opinion. In addition we have relied on the assessments of the management of the Company as to the Acquiror&#8217;s ability to retain key employees of the Company and to integrate the businesses of the Company and the Acquiror. We express no views as to the reasonableness of any financial forecasts or the assumptions on which they are based. In addition, we have not made any independent evaluation or appraisal of any of the assets or liabilities (contingent, derivative, off-balance-sheet, or otherwise) of the Company or the Acquiror, nor have we been furnished with any such evaluation or appraisal. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our opinion does not address the Company&#8217;s underlying business decision to effect the Transaction or the relative merits of the Transaction as compared to any alternative business strategies or transactions that might be available to the Company. Our opinion does not address any legal, regulatory, tax or accounting matters. We have not been asked to, nor do we, offer any opinion as to any terms of the Agreement or any aspect or implication of the Transaction, except for the fairness of the Exchange Ratio from a financial point of view to the holders of Company Common Stock. Our opinion relates to the relative values of the Company and the Acquiror. We express no opinion as to what the value of Acquiror Common Stock actually will be when issued pursuant to the Transaction or the prices at which Company Common Stock or Acquiror Common Stock may trade at any time. We are not expressing any opinion as to fair value, viability or the solvency of the Company or the Acquiror following the closing of the Transaction. In rendering this opinion, we have assumed, that the final executed form of the Agreement will not differ in any material respect from the draft that we have reviewed, that the Transaction will be consummated in accordance with its terms without any waiver or modification that could be material to our analysis, that the representations and warranties of each party set forth in the Agreement are accurate and correct, and that the parties to the Agreement will comply with all the material terms of the Agreement. We have assumed that all governmental, regulatory or other consents or approvals necessary for the completion of the Transaction will be obtained, except to the extent that could not be material to our analysis. In addition, representatives of the Company have advised us, and we have assumed that the Transaction will qualify as a tax free reorganization for federal income tax purposes. We have not been authorized to solicit and have not solicited indications of interest in a possible transaction with the Company from any party. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof, and we assume no responsibility to update this opinion for developments after the date hereof. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have acted as your financial advisor in connection with the Transaction and will receive a fee for our services, the principal portion of which is contingent upon the consummation of the Transaction. We also became entitled to a fee upon having substantially completed our work in connection with the delivery of this opinion, regardless of the conclusion reached herein. Our affiliates, employees, officers and partners may at any time own securities (long or short) of the Company and the Acquiror. In the two years prior to the date hereof, we have provided investment banking and other services to the Company unrelated to the Transaction including acting as, among other things, financial advisor to the Company in connection with an agreement with Acquiror involving the Company&#8217;s development of high-powered computing capabilities, for which we received compensation for our services. In the two years prior to the date hereof, we have not provided investment banking or other services to the Acquiror. In the future we may provide investment banking and other services to the Company and/or the Acquiror for which we would expect to receive compensation for such services. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">B-2<br></div></div></div>
<!--End Page 414-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 415-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_301-annexb_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This opinion is for the use and benefit of the Board of Directors of the Company (solely in its capacity as such) in its evaluation of the Transaction. This opinion does not constitute a recommendation as to how any holder of securities should vote or act with respect to the Transaction or any other matter. This opinion does not address the fairness of the Transaction or any aspect or implication thereof to, or any other consideration of or relating to, the holders of any class of securities, creditors or other constituencies of the Company, other than the fairness of the Exchange Ratio from a financial point of view to the holders of Company Common Stock. In addition, we do not express any opinion as to the fairness of the amount or nature of any compensation to be received by any officers, directors or employees of any parties to the Transaction, or any class of such persons, relative to the Exchange Ratio or otherwise. This opinion was approved by a Moelis &amp; Company LLC fairness opinion committee. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based upon and subject to the foregoing, it is our opinion that, as the date hereof, the Exchange Ratio in the Transaction is fair from a financial point of view to the holders of Company Common Stock (other than the Cancelled Shares (as defined in the Agreement)). </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Very truly yours,</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ MOELIS &amp; COMPANY LLC</div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">MOELIS &amp; COMPANY LLC</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">B-3<br></div></div></div>
<!--End Page 415-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 416-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_302-annexc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;"><a name="tANNEXC"><!--Anchor--></a>Annex&#160;C</div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><img style="height: 17px; width: 123px;" src="ny20053122x2_annexc1.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">&#8201;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 228pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;"><img style="height: 53px; width: 72px;" src="ny20053122x2_annexc2.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-align: left;">July&#160;7, 2025 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Board of Directors <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Core Scientific, Inc. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">838 Walker Road <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Suite 21-2105 <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dover, Delaware 19904<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Members of the Board of Directors: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We understand that Core Scientific, Inc. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) proposes to enter into an Agreement and Plan of Merger (the &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), among the Company, CoreWeave, Inc. (&#8220;<font style="font-weight: bold;">Purchaser</font>&#8221;), and Miami Merger Sub I, Inc. (&#8220;<font style="font-weight: bold;">Merger Sub</font>&#8221;), a wholly owned subsidiary of Purchaser, pursuant to which Merger Sub will merge with and into the Company (the &#8220;<font style="font-weight: bold;">Merger</font>&#8221;) with the Company surviving the Merger and becoming a wholly-owned subsidiary of Purchaser, and each outstanding share of common stock, par value $0.00001 per share, of the Company (such shares, the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;) (excluding any Cancelled Shares (as defined in the Agreement)) will be converted into the right to receive 0.1235 shares of Class&#160;A common stock, par value $0.000005 per share, of Purchaser (such ratio, the &#8220;<font style="font-weight: bold;">Exchange Ratio</font>&#8221;, and such transaction, the &#8220;<font style="font-weight: bold;">Transaction</font>&#8221;). The terms and conditions of the Transaction are set forth in the Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">You have asked us for our opinion as to the fairness of the Exchange Ratio in the Transaction, from a financial point of view, to the holders of the Shares. In arriving at the opinion set forth below, we have, among other things: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain publicly available information concerning the business, financial condition and operations of the Company and Purchaser; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain internal information concerning the business, financial condition and operations of the Company prepared and furnished to us by the management of the Company; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain information concerning the business, financial condition and operations of Purchaser furnished to us by or at the direction of the management of Purchaser; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain internal financial analyses, estimates and forecasts relating to the Company, including projections that were prepared by or at the direction of the management of the Company and approved for our use by the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221; or &#8220;<font style="font-weight: bold;">you</font>&#8221;) (collectively, the &#8220;<font style="font-weight: bold;">Company Projections</font>&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(v)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed certain financial analyses, estimates and forecasts relating to Purchaser that were provided to and discussed with us by the management of the Company, including a certain equity research analyst&#8217;s model which Purchaser commented on and discussed with us and management of the Company, and which were approved for our use by the Board of Directors (collectively, the &#8220;<font style="font-weight: bold;">Purchaser Projections</font>&#8221; and, together with the Company Projections, the &#8220;<font style="font-weight: bold;">Projections</font>&#8221;); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(vi)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">held discussions with members of senior management of the Company and participated in discussions with members of senior management of Purchaser, in each case, concerning, among other things, their evaluation of the Transaction and the Company&#8217;s and Purchaser&#8217;s respective businesses, operating and regulatory environments, financial conditions, prospects and strategic objectives, and potential strategic and financial benefits to the combined company; </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 14.75pt; margin-left: 0pt; text-align: left;"><img style="height: 9px; width: 321px;" src="ny20053122x2_annexc3.jpg"><br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8201;</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">C-1<br></div></div></div>
<!--End Page 416-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 417-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_302-annexc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(vii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">reviewed the historical market prices and trading activity for the Shares and the common stock of Purchaser; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(viii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">compared certain publicly available financial and stock market data for the Company and Purchaser with similar information for certain other companies that we deemed to be relevant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ix)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">reviewed a draft, dated July 7, 2025, of the Agreement; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 30pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(x)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">performed such other financial studies, analyses and investigations, and considered such other matters, as we deemed necessary or appropriate for purposes of rendering this opinion. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In preparing this opinion, with your consent, we have relied upon and assumed the accuracy and completeness of the foregoing information and all other information discussed with or reviewed by us, without independent verification thereof. We have assumed, with your consent, that the Projections and the assumptions underlying the Projections, and all other financial analyses, estimates and forecasts provided to us by the Company&#8217;s management, have been reasonably prepared in accordance with industry practice and represent the Company management&#8217;s best currently available estimates and judgments as to the business and operations and future financial performance of the Company and Purchaser, as applicable. We assume no responsibility for and express no opinion as to the Projections, the assumptions upon which they are based or any other financial analyses, estimates and forecasts provided to us by the Company&#8217;s management. We have also assumed that there have been no material changes in the assets, financial condition, results of operations, business or prospects of the Company and Purchaser since the respective dates of the last financial statements made available to us. We have relied, with your consent, on the Company management&#8217;s representations and/or projections regarding taxable income, standalone net operating loss utilization and other tax attributes of the Company. We have further relied, with your consent, upon the assurances of the management of the Company that they are not aware of any facts that would make the information, representations and projections provided by them inaccurate, incomplete or misleading. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We have not been asked to undertake, and have not undertaken, an independent verification of any information provided to or reviewed by us, nor have we been furnished with any such verification and we do not assume any responsibility or liability for the accuracy or completeness thereof. We did not conduct a physical inspection of any of the properties or assets of the Company or Purchaser. We did not make an independent evaluation or appraisal of the assets or the liabilities (contingent or otherwise) of the Company or Purchaser, nor have we been furnished with any such evaluations or appraisals, nor have we evaluated the solvency of the Company or Purchaser under any applicable laws. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We also have assumed, with your consent, that the final executed form of the Agreement will not differ in any material respects from the draft reviewed by us and that the consummation of the Transaction will be effected in accordance with the terms and conditions of the Agreement, without waiver, modification or amendment of any material term, condition or agreement, and that, in the course of obtaining the necessary regulatory or third party consents and approvals (contractual or otherwise) for the Transaction, no delay, limitation, restriction or condition will be imposed that would have an adverse effect on the Company or Purchaser or the contemplated benefits of the Transaction. We have also assumed that the representations and warranties made by the Company and Purchaser in the Agreement are and will be true and correct in all respects material to our analysis. At your direction, we have assumed that it is intended for the Merger to qualify for U.S. federal income tax purposes as a reorganization within the meaning of Section&#160;368(a) of the Internal Revenue Code of 1986, as amended. We do not express any opinion as to any tax or other consequences that might result from the Transaction, nor does our opinion address any legal, tax, regulatory or accounting matters, as to which we understand that the Company obtained such advice as it deemed necessary from qualified professionals. We are not legal, tax or regulatory advisors and have relied upon without independent verification the assessment of the Company and its legal, tax and regulatory advisors with respect to such matters. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In arriving at our opinion, we were not asked to solicit, and did not solicit, interest from any party with respect to any sale, acquisition, business combination or other extraordinary transaction involving the Company or its assets. We have not considered the relative merits of the Transaction as compared to any other business plan or opportunity that might be available to the Company or the effect of any other arrangement in which the Company might engage and our opinion does not address the underlying decision by the Company to engage in the Transaction. Our opinion is limited to the fairness of the Exchange Ratio in the Transaction as of the date hereof, from a financial point of view, to the holders of the Shares (other than any Cancelled Shares (as defined in the Agreement)), and our opinion does not address any other aspect or implication of the Transaction, the Agreement, or any other agreement or understanding entered into in connection with the Transaction or otherwise. We further express no opinion or view </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">C-2<br></div></div></div>
<!--End Page 417-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 418-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_302-annexc_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">as to the fairness of the Transaction to the holders of any other class of securities, creditors or other constituencies of the Company or as to the underlying decision by the Company to engage in the Transaction. We also express no opinion as to the fairness of the amount or nature of the compensation to any of the Company&#8217;s officers, directors or employees, or any class of such persons, relative to the Merger Consideration (as defined in the Agreement) to be received by the holders of the Shares or otherwise. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Our opinion is necessarily based upon economic, market, monetary, regulatory and other conditions as they exist and can be evaluated, and the information made available to us, as of the date hereof. We assume no responsibility for updating or revising our opinion based on circumstances or events occurring after the date hereof. We express no opinion as to the prices or trading ranges at which the Shares or common stock of Purchaser will trade at any time, as to the potential effects of volatility in the credit, financial and stock markets on the Company, Purchaser or the Transaction or as to the impact of the Transaction on the solvency or viability of the Company or Purchaser or the ability of the Company or Purchaser to pay its obligations when they come due. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">This opinion has been approved by a fairness committee of PJT Partners LP in accordance with established procedures. This opinion is provided to the Board of Directors, in its capacity as such, in connection with and for the purposes of its evaluation of the Transaction only and is not a recommendation as to any action the Board of Directors should take with respect to the Transaction or any aspect thereof. This opinion does not constitute a recommendation to any holder of the Shares as to how any stockholder should vote or act with respect to the Transaction or any other matter. This opinion is not to be quoted, referenced, summarized, paraphrased or excerpted, in whole or in part, in any registration statement, prospectus or proxy or information statement, or in any other report, document, release or other written or oral communication prepared, issued or transmitted by the Board of Directors, including any committee thereof, or the Company, without our prior written approval. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">However, a copy of this opinion may be included, in its entirety, as an exhibit to any proxy statement, information statement, registration statement or Schedule 14D-9 the Company is required to file with the U.S. Securities and Exchange Commission and distribute to its stockholders in connection with the Transaction. Any summary of or reference to this opinion or the analysis performed by us in connection with the rendering of this opinion in such documents shall require our prior written approval. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">We are acting as financial advisor to the Company with respect to the Transaction and will receive a fee from the Company for our services, a portion of which is payable upon the rendering of this opinion and a significant portion of which is contingent upon the consummation of the Transaction. In addition, the Company has agreed to reimburse us for our reasonable and documented out-of-pocket expenses and to indemnify us for certain liabilities arising out of the performance of such services (including the rendering of this opinion). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the ordinary course of our and our affiliates&#8217; businesses, we and our affiliates may provide investment banking and other financial services to the Company, Purchaser or their respective affiliates and may receive compensation for the rendering of these services. During the two years preceding the date of this opinion, we and certain of our affiliates are advising or have advised (i) the Company in connection with restructuring matters unrelated to the Transaction for which we have received fees from the Company and (ii) a creditor group in which a significant shareholder of Purchaser was a member, in connection with a distressed situation unrelated to the Company or the Transaction for which we received fees paid by the debtor. We and our affiliates have not advised or received fees from Purchaser during this period. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; text-align: center;">&#10038; &#10038; &#10038; </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">C-3<br></div></div></div>
<!--End Page 418-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 419-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_302-annexc_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Based on and subject to the foregoing, we are of the opinion, as investment bankers, that, as of the date hereof, the Exchange Ratio in the Transaction is fair to the holders of the Shares (other than any Cancelled Shares (as defined in the Agreement)) from a financial point of view. </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 216pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Very truly yours,</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ PJT Partners LP</div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 240pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">PJT Partners LP</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">C-4<br></div></div></div>
<!--End Page 419-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 420-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;"><a name="tANNEXD"><!--Anchor--></a>Annex&#160;D </div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;">CoreWeave Condensed Consolidated Financial Statements (Unaudited) </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-1<br></div></div></div>
<!--End Page 420-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 421-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 20.18pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 432pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 432pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCBS">Condensed Consolidated Balance Sheets<font style="padding-left: 4pt;"></font></a></div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCBS"><font style="padding-left: 4.63pt;">D-3 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSO">Condensed Consolidated Statements of Operations<font style="padding-left: 2.9pt;"></font></a></div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSO"><font style="padding-left: 4.63pt;">D-5 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSL">Condensed Consolidated Statements of Comprehensive Loss<font style="padding-left: 1.8pt;"></font></a></div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSL"><font style="padding-left: 4.63pt;">D-6 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;"><a href="#tCCSR">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)<font style="padding-left: 0.57pt;"></font></a></div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSR"><font style="padding-left: 4.63pt;">D-7 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSF">Condensed Consolidated Statements of Cash Flows<font style="padding-left: 4.01pt;"></font></a></div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCCSF"><font style="padding-left: 4.63pt;">D-9 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tNOTES">Notes to Condensed Consolidated Financial Statements<font style="padding-left: 3.45pt;"></font></a></div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.18pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tNOTES">D-11</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 20.18pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-2<br></div></div></div>
<!--End Page 421-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 422-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCCBS"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDENSED CONSOLIDATED BALANCE SHEETS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current assets<br></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 0.77pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">1,152,883</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">1,361,083 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, current<font style="padding-left: 4.98pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">560,173</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">37,394 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable, net<font style="padding-left: 3.27pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">1,933,698</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">416,526 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 3.59pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">299,229</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">101,246 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current assets<font style="font-weight: normal; padding-left: 3.53pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,945,983</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">1,916,249 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<font style="padding-left: 1.65pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">340,527</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">637,356 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<font style="padding-left: 1.64pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">29,308 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment, net<font style="padding-left: 2.7pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">16,631,510</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.37pt;">11,914,774 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 3.02pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,380,201</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">2,589,547 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangible assets, net<font style="padding-left: 3.26pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">205,895</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">4,909 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Goodwill<font style="padding-left: 0.73pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">812,970</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">19,544 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 0.78pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">924,277</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">720,912 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets<font style="font-weight: normal; padding-left: 3.88pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$26,241,363</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$17,832,599 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.66pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Liabilities, Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)<br></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current liabilities<br></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 1.31pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">1,226,579</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 12.5pt;">868,259 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities<font style="padding-left: 4.09pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10.37pt;">1,411,237</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">355,821 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, current<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 1.59pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,627,664</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">2,468,425 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue, current<font style="padding-left: 3.84pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">951,346</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">768,927 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">279,080</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">213,104 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 3.84pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">60,396</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">57,801 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 0.22pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">53</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">230,244 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current liabilities<font style="font-weight: normal; padding-left: 4.07pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">7,556,355</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">4,962,581 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Debt, non-current<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 3.26pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">7,423,837</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">5,457,915 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative and warrant liabilities<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">698</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">200,089 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred revenue, non-current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,896,173</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,294,977 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,168,392</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">2,388,912 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance lease liabilities, non-current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.87pt;">3,112</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">34,120 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities, non-current<font style="padding-left: 4.4pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">245,659</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">149,232 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current liabilities<font style="padding-left: 0.21pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">126,331</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">36,260 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 4.43pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">22,420,557</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,524,086 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Commitments and contingencies (<font style="font-style: italic;">Note&#160;9</font>)<br></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redeemable convertible preferred stock and redeemable common stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><br></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Redeemable convertible preferred stock, $0.000005 par value per share, no and 206,169 shares authorized as of June&#160;30, 2025 and December&#160;31, 2024, respectively; no and 184,635 shares issued and outstanding as of June&#160;30, 2025 and December&#160;31, 2024, respectively<font style="padding-left: 3.01pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10.74pt;">1,722,111 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Redeemable Class&#160;A common stock, $0.000005 par value per share, 29,874&#160;and no shares issued and outstanding as of June&#160;30, 2025 and December&#160;31, 2024, respectively<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,159</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; equity (deficit)<br></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Preferred stock, $0.000005 par value per share, 100,000 and no shares authorized as of June&#160;30, 2025 and December&#160;31, 2024, respectively; no&#160;shares issued and outstanding as of June&#160;30, 2025 and December&#160;31, 2024<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212; </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-3<br></div></div></div>
<!--End Page 422-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 423-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Class&#160;A common stock, $0.000005 par value per share, 3,000,000 and 540,680&#160;shares authorized as of June&#160;30, 2025 and December&#160;31, 2024, respectively; 346,663 and 121,277 shares issued as of June&#160;30, 2025 and December&#160;31, 2024, respectively; and 340,075 and 114,689 shares outstanding as of June&#160;30, 2025 and December&#160;31, 2024, respectively<font style="padding-left: 2.22pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 45pt;">2</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 45pt;">1 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Class&#160;B common stock, $0.000005 par value per share, 200,000 and 150,000&#160;shares authorized as of June&#160;30, 2025 and December&#160;31, 2024, respectively; 118,102 and 118,198 shares issued and outstanding as of June&#160;30, 2025 and December&#160;31, 2024, respectively<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 45pt;">0</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 45pt;">0 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Class&#160;C common stock, $0.000005 par value per share, 200,000 and no&#160;shares authorized as of June&#160;30, 2025 and December&#160;31, 2024, respectively; no shares issued and outstanding as of June&#160;30, 2025 and December&#160;31, 2024<font style="padding-left: 1.96pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212;</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Treasury stock, at cost, 6,588 shares as of June&#160;30, 2025 and December&#160;31, 2024<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.17pt;">(33,524)</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.17pt;">(33,524) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Additional paid-in capital<font style="padding-left: 4.09pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">4,772,825</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">1,096,160 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated other comprehensive income (loss)<font style="padding-left: 4.14pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 31.67pt;">(271)</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 0.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 40pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accumulated deficit<font style="padding-left: 1.31pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,081,385</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 0.41pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,476,235</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total stockholders&#8217; equity (deficit)<font style="font-weight: normal; padding-left: 0.22pt;"></font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,657,647</font></div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; padding-bottom: 2.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(413,598</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.66pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Total liabilities, redeemable convertible preferred stock, redeemable common stock, and stockholders&#8217; equity (deficit)<font style="font-weight: normal; padding-left: 2.93pt;"></font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$26,241,363</font></div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.66pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$17,832,599</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 20.5pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refer to <font style="font-style: italic;">Note&#160;14&#8212;Related-Party Transactions</font> for further information on related party arrangements. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-4<br></div></div></div>
<!--End Page 423-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 424-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCCSO"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 106.33pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96.69pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 106.33pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 96.69pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 252pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 2.85pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$1,212,788</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">395,371</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$2,194,420</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">584,055 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 4.53pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt;">312,667</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt;">108,838</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt;">575,061</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt;">168,058 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 2.47pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt;">669,913</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt;">182,886</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">1,231,315</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt;">275,767 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 1.75pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt;">36,799</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.33pt;">4,172</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.5pt;">47,348</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 18.33pt;">8,222 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 4.55pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">174,200</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">21,754</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">348,957</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">37,440 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 3.57pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,193,579</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">317,650</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,202,681</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">489,487 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 1.2pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt;">19,209</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt;">77,721</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 19.17pt;">(8,261)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt;">94,568 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Gain (loss) on fair value adjustments<font style="padding-left: 2.9pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt;">(310,231)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.5pt;">26,837</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(407,731) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 2.61pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 9.17pt;">(266,966)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 10pt;">(66,766)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 9.17pt;">(530,801)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(107,422) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income (expense), net<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,023</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,406</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">886</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">23,866 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 3.1pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 9.17pt;">(242,734)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5pt;">(282,870)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 9.54pt;">(511,339)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 5pt;">(396,719) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 4.02pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">47,775</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">40,151</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 17.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">93,811</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">55,550 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 0.63pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(290,509</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(323,021</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(605,150</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(452,269</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 4.87pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(290,509</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(338,617</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(633,872</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(467,865</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 1.53pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(290,509</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(338,617</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(660,717</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(467,865</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 2.84pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.60</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.62</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.73</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.23</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 4.5pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.60</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.62</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.79</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.23</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss per&#160;share attributable to common stockholders, basic<font style="font-weight: normal; padding-left: 3pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">486,591</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,626</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">366,765</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,560 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss per&#160;share attributable to common stockholders, diluted<font style="font-weight: normal; padding-left: 4.5pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">486,591</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.83pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,626</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.18pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">368,607</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.01pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.1pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,560</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 43.01pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refer to<font style="font-style: italic;"> Note&#160;14&#8212;Related-Party Transactions</font> for further information on related party arrangements. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-5<br></div></div></div>
<!--End Page 424-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 425-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCCSL"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 252pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 106.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 96.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 106.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 96.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 252pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 252pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 0.63pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.54pt; text-align: left;">$(290,509)</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.55pt; text-align: left;">$(323,021)</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;">$(605,150)</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;">$(452,269) </div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other comprehensive income (loss):<br></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Unrealized gain (loss) on available-for-sale marketable securities, net<font style="padding-left: 3.69pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.54pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.55pt; text-align: left;"><font style="padding-left: 30.83pt;">27</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="padding-left: 30.83pt;">85 </font></div></td></tr><tr><td style="width: 252pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Change in fair value of derivatives, net<font style="padding-left: 3.74pt;"></font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.54pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(271</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.55pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(271</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 252pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total comprehensive loss<font style="font-weight: normal; padding-left: 1.74pt;"></font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.54pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(290,780</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.55pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(322,994</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(605,421</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.14pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(452,184</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 252pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-6<br></div></div></div>
<!--End Page 425-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 426-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_303-annexd_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 30pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCCSR"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK, REDEEMABLE COMMON STOCK, AND STOCKHOLDERS&#8217; EQUITY (DEFICIT) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div></div><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 67.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 60.17pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.71pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 27.73pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold;">&#160;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 67.7pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Convertible <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 60.17pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class&#160;A Common <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 55.71pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 27.73pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 32.79pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Paid-in <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Capital</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 47.85pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Comprehensive <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Loss</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 40.78pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 42.38pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders&#8217; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Deficit) </div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold;">&#160;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td><td style="width: 3.56pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, December&#160;31, 2024<font style="font-weight: normal; padding-left: 1.39pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 2.39pt;">184,635</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 2.92pt;">1,722,111</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 21.59pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">232,887</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;">$<font style="padding-left: 3.6pt;">1</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;">$(33,524)</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;">$1,096,160</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;">$<font style="padding-left: 5.99pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;">$(1,476,235)</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;">$<font style="padding-left: 3pt;">(413,598) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Series&#160;C redeemable convertible preferred stock accretion to redemption value<font style="padding-left: 1.23pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">29</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 22.8pt;">(29)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 22.8pt;">(29) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Cash dividend on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 3.05pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 10.2pt;">(28,693)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 10.2pt;">(28,693) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Reclassification of warrants from liability to equity classified<font style="padding-left: 4.82pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">172,808</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">172,808 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions and offering costs<font style="padding-left: 4.38pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">36,590</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 3.6pt;">1,391,515</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 3.6pt;">1,391,515 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Conversion of redeemable convertible preferred stock in connection with initial public offering<font style="padding-left: 3.95pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">(184,635)</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">(1,722,140)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;">29,874</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">1,163,159</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 0.26pt;">155,112</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 7.2pt;">1</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">558,981</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">558,982 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock for contract incentive<font style="padding-left: 0.04pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.2pt;">8,750</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">350,000</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">350,000 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock upon settlement of restricted stock units<font style="padding-left: 3.01pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.86pt;">911</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Tax withholdings on settlement of restricted stock units<font style="padding-left: 2.86pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.2pt;">(392)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 10.2pt;">(15,685)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 10.2pt;">(15,685) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.2pt;">1,675</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 16.2pt;">2,794</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 16.2pt;">2,794 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">202,670</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">202,670 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.22pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(314,641</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 6.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(314,641</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, March&#160;31, 2025<font style="font-weight: normal; padding-left: 1.77pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;">29,874</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">1,163,159</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">435,533</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 7.2pt;">2</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 3.6pt;">(33,524)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 3.6pt;">3,730,521</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 3.6pt;">(1,790,876)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 3.6pt;">1,906,123 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock upon underwriters' exercise of over-allotment option, net of underwriting discounts and commissions<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.2pt;">1,760</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 12.6pt;">67,669</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 12.6pt;">67,669 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock and restricted stock awards for business combination<font style="padding-left: 4.23pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">19,174</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">928,900</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">928,900 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of replacement restricted stock units for business combination<font style="padding-left: 4.23pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 16.2pt;">3,861</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 16.2pt;">3,861 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Tax withholdings on issuance of common stock and restricted stock awards for business combination<font style="padding-left: 1.01pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.2pt;">(472)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 10.2pt;">(24,332)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 10.2pt;">(24,332) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of common stock upon settlement of restricted stock units<font style="padding-left: 3.01pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.46pt;">1,811</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Tax withholdings on settlement of restricted stock units<font style="padding-left: 2.86pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10.2pt;">(904)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 10.2pt;">(92,541)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 10.2pt;">(92,541) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.2pt;">1,275</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 16.2pt;">1,744</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 16.2pt;">1,744 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 9pt;">157,003</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 9pt;">157,003 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Other comprehensive income (loss)<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 3.6pt;">(271)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 19.2pt;">(271) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.22pt;"></font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="padding-left: 12.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="padding-left: 9.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(290,509</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="padding-left: 6.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(290,509</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 2.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, June&#160;30, 2025<font style="font-weight: normal; padding-left: 2.64pt;"></font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.79pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.79pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 23.99pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 20.66pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.43pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">29,874</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,163,159</font></div></td><td style="width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">458,177</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.19pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.6pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">2</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.96pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(33,524</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.2pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,772,825</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.52pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(271</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.78pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(2,081,385</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 4.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,657,647</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.55pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 25.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 34.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 20.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 32.39pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.31pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 23.4pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 25.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 27.73pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 32.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 47.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 40.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.56pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 42.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-7<br></div></div></div>
<!--End Page 426-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 427-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 528pt;"><a name="ny20053122x2_s4a_303-annexd_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 528pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 528pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 63.61pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 57.8pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 56.41pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 27.73pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.85pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold;">&#160;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 63.61pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Convertible <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 57.8pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Class&#160;A Common <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 56.41pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 27.73pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 32.79pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Paid-in <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Capital</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 47.85pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Other <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Comprehensive <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Loss</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 40.77pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 42.38pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders&#8217; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Equity <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Deficit) </div></td></tr><tr class="BRDSX_header"><td style="width: 96pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold;">&#160;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.26pt; padding-bottom: 2.53pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td><td style="width: 3.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 96pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, December&#160;31, 2023<font style="font-weight: normal; padding-left: 1.39pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">154,678</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 5.4pt;">464,690</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;">$&#8212;</div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">203,520</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;">$<font style="padding-left: 3.6pt;">1</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;">$(32,054)</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;">$<font style="padding-left: 2.39pt;">48,397</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;">$(148)</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;">$<font style="padding-left: 5.4pt;">(612,787)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.26pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;">$<font style="padding-left: 5.4pt;">(596,591) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of Series&#160;B redeemable convertible preferred stock<font style="padding-left: 3.27pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.2pt;">4,483</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.6pt;">25,000</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Closing settlement of Series&#160;B tranche option<font style="padding-left: 0.03pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.6pt;">69,598</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.6pt;">215</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">45</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">45 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5.99pt;">10,181</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 14.99pt;">10,181 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Other comprehensive income (loss)<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">58</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">58 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.22pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(129,248</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(129,248</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, March&#160;31, 2024<font style="font-weight: normal; padding-left: 1.77pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">159,161</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9pt;">559,288</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">203,735</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 7.2pt;">1</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 3.6pt;">(32,054)</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 5.99pt;">58,623</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 7.2pt;">(90)</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 9pt;">(742,035)</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.76pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 9pt;">(715,555) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Issuance of Series&#160;C redeemable convertible preferred stock, net of issuance costs of $3.0&#160;million<font style="padding-left: 1.21pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">29,523</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 3.6pt;">1,147,476</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Series&#160;C redeemable convertible preferred stock accretion to redemption value<font style="padding-left: 1.23pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">14</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 16.2pt;">(14)</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 25.19pt;">(14) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Paid-in-kind dividend on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 3.27pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.6pt;">15,582</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 3.6pt;">(15,582)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 12.6pt;">(15,582) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.86pt;">411</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 14.99pt;">597</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 23.99pt;">597 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Repurchase of common stock for business combination<font style="padding-left: 3.45pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 4.8pt;">(2,105)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212; </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 3.82pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 9.59pt;">9,608</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 18.59pt;">9,608 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-indent: -7.2pt; text-align: left;">Other comprehensive income (loss)<font style="padding-left: 1.02pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;">&#8212;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt;">27</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 27.59pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 27.59pt;">27 </font></div></td></tr><tr><td style="width: 96pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.22pt;"></font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 25.19pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="padding-left: 3.6pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="padding-left: 18.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="padding-left: 9.59pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(323,021</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 1.51pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="padding-left: 9pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(323,021</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 96pt; padding-top: 2.76pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance, June&#160;30, 2024<font style="font-weight: normal; padding-left: 2.64pt;"></font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">188,684</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.39pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,722,360</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 22.73pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.77pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.25pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 8.23pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$&#8212;</font></div></td><td style="width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.4pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">202,041</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.19pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 7.2pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.6pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.73pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 0.97pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(32,054</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.79pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.5pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 2.39pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">53,232</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.85pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 15.53pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.6pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(63</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.77pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 2.99pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,065,056</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.38pt; padding-top: 2.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.2pt; margin-top: 0pt; margin-left: 3.8pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,043,940</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.55pt; width: 96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 23.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 32.39pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 22.73pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 27.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.66pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 23.4pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 25.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 27.73pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 32.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 47.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 40.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 42.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 30pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-8<br></div></div></div>
<!--End Page 427-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 428-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCCSF"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 114.34pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 114.34pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from operating activities:<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 0.18pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">(605,150)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">(452,269) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Adjustments to reconcile net loss to net cash provided by (used in) operating activities<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Depreciation and amortization<font style="padding-left: 0.21pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,002,978</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">243,970 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-cash lease expense<font style="padding-left: 1.33pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 16.2pt;">144,113</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">42,015 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Amortization of debt discounts and issuance costs and accretion of redemption premiums<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">66,727</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">15,605 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Loss (gain) on fair value adjustments<font style="padding-left: 0.79pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(26,837)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">407,731 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Stock-based compensation<font style="padding-left: 0.76pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">328,978</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">15,849 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred income taxes<font style="padding-left: 1.33pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">90,884</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">43,207 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-cash reconciling items<font style="padding-left: 3pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">40,132</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,848) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes in operating assets and liabilities, net of effect of business acquisition:<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable<font style="padding-left: 1.32pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,504,696)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(180,748) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 3.59pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(120,448)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">1,636 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable and accrued expenses<font style="padding-left: 4.69pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(289,173)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">697,848 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue<font style="padding-left: 2.99pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">742,892</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,524,487 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Lease liabilities<font style="padding-left: 4.64pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.87pt;">(110,451)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(20,708) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">49,968</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(413,561</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by (used in) operating activities<font style="font-weight: normal; padding-left: 4.32pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(190,083</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,921,214 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from investing activities:<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Purchase of property and equipment, including capitalized internal-use software<font style="padding-left: 4.08pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,860,351)</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(3,989,096) </div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sale of available-for-sale marketable securities<font style="padding-left: 2.69pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">840 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Maturities of marketable securities<font style="padding-left: 1.9pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">29,308</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">47,822 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of restricted marketable securities<font style="padding-left: 1.37pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(29,308) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of strategic investments<font style="padding-left: 2.45pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(50,000) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sale of warrants received as lease incentive<font style="padding-left: 4.72pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">100,645</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Business combination, net of cash acquired<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(45,706)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of notes receivable<font style="padding-left: 3.57pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(73,000)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other investing activities<font style="padding-left: 1.31pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(26,109</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,433</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by (used in) investing activities<font style="font-weight: normal; padding-left: 2.09pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(3,875,213</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(4,021,175</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from financing activities:<br></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of debt<font style="padding-left: 0.23pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">4,432,723</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">1,821,541 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Repayments of debt<font style="padding-left: 1.86pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,574,867)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(74,416) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Payment of debt issuance costs<font style="padding-left: 0.78pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(36,536)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,479) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of redeemable convertible preferred stock, net of issuance costs<font style="padding-left: 0.05pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,172,476 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Redeemable convertible preferred stock cash dividends paid<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(28,693)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from exercise of stock options<font style="padding-left: 4.69pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 25.83pt;">4,538</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 33.33pt;">642 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Proceeds from initial public offering, net of underwriting discounts and commissions<font style="padding-left: 1.29pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">1,422,619</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of common stock, net of underwriting discounts and commissions<font style="padding-left: 0.55pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt;">67,669</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Payment of tax withholdings on settlement of RSUs and RSAs<font style="padding-left: 0.24pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(132,558)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs paid<font style="padding-left: 3.74pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">(27,763)</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other financing activities<font style="padding-left: 0.21pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(44,086</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(56,980</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by (used in) financing activities<font style="font-weight: normal; padding-left: 0.42pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,083,046</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,859,784 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net increase in cash, cash equivalents, and restricted cash<font style="padding-left: 1.41pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 15.83pt;">17,750</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">759,823 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents, and restricted cash&#8212;beginning of period<font style="padding-left: 3.61pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,035,833</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">480,075 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents, and restricted cash&#8212;end of period<font style="padding-left: 4.16pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">2,053,583</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,239,898 </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-9<br></div></div></div>
<!--End Page 428-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 429-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 114.34pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 114.34pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.33pt; padding-bottom: 1.63pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Supplemental disclosures of cash flow information:<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash paid for interest, net of capitalized amounts<font style="padding-left: 1.64pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 7.5pt;">361,557</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 12.5pt;">24,862 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-cash investing and financing activities:<br></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Capitalized interest not yet paid<font style="padding-left: 2.99pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 12.5pt;">21,980</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 12.5pt;">36,052 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease right-of-use assets acquired through lease liability<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">968,630</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">887,179 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Accounts payable and accrued expenses related to property and equipment additions<font style="padding-left: 1.84pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 5pt;">2,132,972</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">146,867 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of common stock for contract incentive<font style="padding-left: 4.14pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">350,000</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Conversion of redeemable convertible preferred stock in connection with initial public offering<font style="padding-left: 3.14pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 5pt;">1,722,140</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Fair value of common stock issued as consideration for a business combination<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">928,900</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Fair value of equity awards assumed in a business combination<font style="padding-left: 3.61pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 22.5pt;">3,861</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Reclassification of warrant liabilities to equity<font style="padding-left: 4.13pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">172,808</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Settlement of Series&#160;B tranche liability<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">69,598 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Reclassification of customer deposit to debt<font style="padding-left: 4.13pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">230,244</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-cash investments<font style="padding-left: 4.09pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">71,947</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 22.5pt;">7,633 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Warrants received as lease incentive<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">89,956</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Reconciliation of cash, cash equivalents, and restricted cash to condensed consolidated balance sheets:<br></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 0.77pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$1,152,883</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$1,028,044 </div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, current<font style="padding-left: 4.98pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">560,173</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 0.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">79,725 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, non-current<font style="padding-left: 1.65pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">340,527</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.26pt; padding-bottom: 1.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">132,129 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total cash, cash equivalents, and restricted cash<font style="font-weight: normal; padding-left: 4.67pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,053,583</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,239,898</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these condensed consolidated financial statements.<br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-10<br></div></div></div>
<!--End Page 429-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 430-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tNOTES"><!--Anchor--></a>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(unaudited) </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">1. Overview and Summary of Significant Accounting Policies </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Organization and Description of Business </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Inc. (together with its subsidiaries, the &#8220;Company&#8221; or &#8220;CoreWeave&#8221;), was originally formed as a Delaware limited liability company in 2017 and then converted to a Delaware corporation in 2018. The Company is headquartered in Livingston, New Jersey. The Company is a modern cloud infrastructure technology company which offers the CoreWeave Cloud Platform that consists of proprietary software and cloud services that deliver the automation and efficiency needed to manage complex AI infrastructure at scale. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 20pt; text-align: left;">Initial Public Offering<font style="font-style: normal; font-weight: normal;"> </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company completed its initial public offering (&#8220;IPO&#8221;), in which the Company issued and sold 36,590,000 shares of its Class&#160;A common stock at a public offering price of $40.00 per share, which resulted in net proceeds of $1.4&#160;billion after deducting the underwriting discounts and commissions and before deducting offering costs of $31&#160;million. In April&#160;2025, the underwriters exercised a portion of their over-allotment option and purchased from the Company an additional 1,760,000 shares of Class&#160;A common stock at the IPO price, which resulted in net proceeds to the Company of $68&#160;million after deducting the underwriting discounts and commissions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, all outstanding shares of the Company's Series&#160;Seed, Series&#160;A, Series&#160;B, and Series&#160;B-1 redeemable convertible preferred stock automatically converted into 155,111,700 shares of Class&#160;A common stock, and all outstanding shares of the Company's Series&#160;C redeemable convertible preferred stock were automatically converted into 29,874,066 shares of redeemable Class&#160;A common stock. Refer to <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, the Company recognized $177&#160;million of stock-based compensation expense, net of $17&#160;million of capitalized costs, primarily related to the development of internal-use software, associated with vested restricted stock units (&#8220;RSUs&#8221;) with a liquidity-event performance-based vesting condition which was satisfied in connection with the IPO and for which the service-based vesting condition had also been satisfied as of that date. Concurrently with the IPO, the Company issued shares of its Class&#160;A common stock upon settlement of RSUs subject to such performance-based vesting conditions. To meet the related tax withholding requirements for the net settlement of the vested RSUs, the Company withheld 392,135 shares underlying such equity awards, resulting in the net issuance of 518,785 shares of Class&#160;A common stock. Based on the IPO price of $40.00 per share, the Company&#8217;s related tax withholding obligation was $16&#160;million and was paid during the three months ended March&#160;31, 2025. Refer to <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">At the closing of the IPO, the maturity date of the Company&#8217;s 2024 Term Loan Facility (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>), accelerated and became due in April&#160;2025, and the Company became subject to a requirement to fund $500&#160;million into designated escrow accounts in connection with its DDTL 2.0 Facility (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>). In April&#160;2025, the conditions requiring restriction of this amount were lifted and the $500&#160;million previously classified as restricted cash, current, in connection with the DDTL 2.0 Facility was no longer restricted. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Prior to the IPO, deferred offering costs, which consisted of accounting, legal and other fees directly related to the IPO, were capitalized as other non-current assets on the condensed consolidated balance sheets. In connection with the IPO, $31&#160;million of deferred offering costs were reclassified to stockholders&#8217; equity (deficit) as a reduction of the net proceeds received from the IPO. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">Basis of Presentation and Consolidation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and include the accounts of the Company and its wholly and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-11<br></div></div></div>
<!--End Page 430-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 431-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">These unaudited interim condensed consolidated financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. In management&#8217;s opinion, the unaudited interim condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and include all adjustments, which include only normal recurring adjustments, necessary to fairly state the Company&#8217;s financial position and results of operations. The interim results are not necessarily indicative of the operating results expected for the full year or any future period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company determines at inception of each arrangement whether an entity in which the Company has made an investment or in which the Company has other variable interests is considered a variable interest entity (&#8220;VIE&#8221;). Investments that are considered VIEs are evaluated to determine whether the Company is the primary beneficiary of the VIE, in which case it would be required to consolidate the entity. The Company evaluates whether it has (1) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. If the Company is not the primary beneficiary of the VIE, the investment or other variable interest is accounted for in accordance with applicable U.S. GAAP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In circumstances where an entity does not have the characteristics of a VIE, it would be considered a voting interest entity (&#8220;VOE&#8221;). The Company would consolidate a VOE when the Company has a majority equity interest and has control over significant operating, financial, and investing decisions of the entity. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Stock Split </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company effected a twenty-for-one stock split of its common stock and redeemable convertible preferred stock. All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Use of Estimates </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. Significant estimates include the fair value of financial assets and liabilities; useful lives assigned to property and equipment; the discount rates used for operating and finance leases; valuation of derivative and warrant liabilities; stock-based compensation, including the determination of the fair value of the Company&#8217;s common stock prior to the IPO; valuation of acquired intangible assets; the assessment of recoverability of intangible assets and their estimated useful lives; and accounting for income taxes, including the valuation allowance on deferred tax assets and the measurement of uncertain tax positions. Assumptions are reviewed regularly to ensure they remain relevant and reasonable, particularly in areas of high subjectivity. The Company bases its estimates on historical experience and assumptions that management considers reasonable. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">Significant Accounting Policies </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s significant accounting policies are discussed in &#8220;<font style="font-style: italic;">Note&#160;1&#8212;Overview and Summary of Significant</font> <font style="font-style: italic;">Accounting Policies</font>&#8221; of the audited consolidated financial statements for the fiscal year ended December 31, 2024, included in the Company&#8217;s final prospectus filed with the SEC pursuant to Rule&#160;424(b)(4) under the Securities Act of 1933, as amended, in connection with the IPO (the &#8220;Prospectus&#8221;). During the six months ended June&#160;30, 2025, the Company updated its derivative instruments and joint venture accounting policies as described below. Other than these updates, there have been no material changes to the Company&#8217;s accounting policies. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">Derivative Financial Instruments and Hedging </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company uses derivative financial instruments to manage risk associated with interest rate and foreign currency fluctuations. These instruments include interest rate swaps designated as cash flow hedges and foreign exchange forward contracts used as non-designated economic hedges. All derivative instruments are recognized on the condensed consolidated balance sheets at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 815, <font style="font-style: italic;">Derivatives and Hedging </font>(&#8220;ASC 815&#8221;). The Company's interest rate swaps and foreign currency forward contracts are classified within Level&#160;2 as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. The Company does </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-12<br></div></div></div>
<!--End Page 431-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 432-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">not enter into derivatives for trading or speculative purposes. However, certain debt and equity financing transactions are derivatives in their entirety or include embedded features that are bifurcated and accounted for as embedded derivatives. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information about derivatives associated with financing transactions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the Company enters into power purchase agreements (&#8220;PPAs&#8221;) to secure power capacity for existing, under construction, and planned data center builds. These agreements are specifically designed to support the Company in managing its energy needs as it encounters rapidly increasing energy demands. Agreements that do not meet the &#8216;normal purchase and normal sale&#8217; scope exception, contain a notional amount and are for delivery of electricity in markets where notional amounts are readily convertible to cash (or where contracts can be net-settled) are classified as derivative instruments. These derivative instruments are not designated for special hedge accounting under ASC 815, and therefore changes in the value of these contracts are recorded in earnings. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Generally, derivative assets and liabilities are classified as either current or non-current based on the timing of expected settlement. The non-current position is included in other non-current assets or derivative and warrant liabilities on the condensed consolidated balance sheets. Cash flows associated with derivatives that are not designated for special hedge accounting are classified as operating activities, while those cash flows from interest rate swaps that are designated cash flow hedges are classified as financing activities. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18pt; margin-left: 20pt; text-align: left;">Interest Rate Swaps </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company enters into interest rate swaps to hedge the variability of cash flows related to interest payments on variable-rate debt. These swaps are designated as cash flow hedges under ASC 815, and therefore the changes in the fair-value of these swaps is recorded in accumulated other comprehensive income (loss) and reclassified into earnings (interest expense, net) when the hedged interest payment is recognized. The Company assesses hedge effectiveness at inception, and on a quarterly basis thereafter, to ensure the hedging relationship is highly effective. As of June&#160;30, 2025, all interest rate swaps were deemed highly effective. Refer to <font style="font-style: italic;">Note&#160;3&#8212;Fair Value Measurements</font> for additional information. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Foreign Exchange Forward Contracts </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company uses forward contracts to mitigate foreign currency risk associated with foreign currency-denominated leasing liabilities. These contracts are not designated as accounting hedges under ASC 815 and therefore considered economic hedges. Changes in the fair-value of these forward contracts are recognized immediately in earnings within other income (expense), net. Refer to <font style="font-style: italic;">Note&#160;3&#8212;Fair Value Measurements</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Joint Ventures </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may, from time to time, enter into joint venture arrangements. The Company evaluates these investments in accordance with ASC 810, <font style="font-style: italic;">Consolidation, </font>to determine if it is the primary beneficiary under the VIE model or has a controlling interest under the VOE model and therefore requires consolidation. For those investments in which the Company is not the primary beneficiary, or does not have a controlling financial interest, but exercises significant influence, the equity method of accounting is applied under ASC 323, <font style="font-style: italic;">Investments-Equity Method and Joint Ventures</font>. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Research and Development </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Research and development costs were $80&#160;million and $12&#160;million for the three months ended June 30, 2025 and 2024, respectively, and $150&#160;million and $21&#160;million for the six months ended June 30, 2025 and 2024, respectively, and are included within technology and infrastructure expense in the condensed consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Segment Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;), the chief executive officer, reviews discrete financial information presented on a consolidated basis for purposes of regularly making operating decisions, allocation of resources, and assessing financial performance. The Company operates its business in one operating segment and, therefore, has one reportable segment. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-13<br></div></div></div>
<!--End Page 432-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 433-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The CODM uses consolidated net loss to measure segment profit or loss in order to identify underlying trends in the performance of the business for purposes of allocating resources and evaluating financial performance. The Company&#8217;s objective in making resource allocation decisions is to optimize the consolidated financial results. Significant segment expenses that the CODM reviews and utilizes to manage the Company&#8217;s operations are cost of revenue, technology and infrastructure, sales and marketing, and general and administrative expenses at the consolidated level, which are presented in the Company&#8217;s condensed consolidated statements of operations. Other segment items included in consolidated net loss include gain (loss) on fair value adjustments, interest expense, net, other income (expense), net, and provision for (benefit from) income taxes, which are presented in the Company&#8217;s condensed consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">Recent Accounting Pronouncements Not Yet Adopted </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09, <font style="font-style: italic;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</font>, which improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the effective tax rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for annual periods beginning after December 15, 2024. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In November&#160;2024, the FASB issued ASU No. 2024-03, <font style="font-style: italic;">Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</font>, which requires more detailed disclosures, on an annual and interim basis, about specified categories of expenses (including employee compensation, depreciation, and amortization) included in certain expense captions presented on the consolidated statements of operations. This guidance as further clarified through ASU No. 2025-01, <font style="font-style: italic;">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40)</font> will be effective for annual periods beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. Upon adoption, the guidance can be applied either prospectively or retrospectively. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2025, the FASB issued ASU No. 2025-03, <font style="font-style: italic;">Business Combinations (Topic 805) and Consolidation (Topic&#160;810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity</font>, which provides clarifying guidance on determining the accounting acquirer in certain transactions involving VIEs. The update aims to improve consistency and comparability in financial reporting. The guidance will be effective for annual periods beginning after December&#160;15, 2026, including interim periods within those annual periods. Early adoption is permitted. Upon adoption, the guidance will be applied prospectively. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2025, the FASB issued ASU No. 2025-04, <font style="font-style: italic;">Compensation&#8212;Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer</font>, to reduce diversity in practice and improve the decision usefulness and operability of the guidance for share-based consideration payable to a customer in conjunction with selling goods and services. The guidance will be effective for annual periods beginning after December&#160;15, 2026, including interim periods within those annual periods. Early adoption is permitted. Updates are to be applied on a retrospective, or modified retrospective basis. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20pt; margin-left: 0pt; text-align: left;">2. Revenue </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Disaggregation of Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company primarily generates its revenue through providing cloud computing services, which include both committed contracts and on-demand services. Revenue recognized related to customer commitments, including revenue from delivering capacity prior to commitment start dates, represented 98% and 96% of total revenue for the three months ended June 30, 2025 and 2024, respectively, and 98% and 95% of total revenue for the six months ended June 30, 2025 and 2024, respectively. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-14<br></div></div></div>
<!--End Page 433-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 434-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Significant Customers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following customers accounted for 10% or more of the Company&#8217;s revenue for the periods presented: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer A<font style="padding-left: 3.62pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.96pt; text-align: left;">71%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.97pt; text-align: left;">59%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;">72%</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;">51% </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer B<font style="padding-left: 3.62pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.96pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.97pt; text-align: left;">20%</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;">24% </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer C<font style="padding-left: 3.62pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.96pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.97pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;"><font style="padding-left: 10pt;">* </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer D<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.96pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 19.97pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.56pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Customer did not represent 10% or more of revenue. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The customer references of A through D may represent different customers than those reported in a previous period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Customer A, C, and D accounted for 39%, 25%, and 25% of accounts receivable, net, respectively, as of June&#160;30, 2025. Customer A accounted for 66% of accounts receivable, net as of December 31, 2024. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Strategic Customer Agreement </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into a commercial agreement (the &#8220;Commercial Agreement&#8221;) with OpenAI OpCo, LLC (&#8220;OpenAI&#8221;), pursuant to which the Company provides OpenAI access to cloud computing capacity through fulfillment of reserved capacity orders submitted to the Company by OpenAI. As of June 30, 2025, subject to the satisfaction of delivery and availability of service requirements, OpenAI has committed to pay the Company up to $11.9&#160;billion through October&#160;2030. In the event of the Company&#8217;s repeated failure to meet availability of service requirements, OpenAI has the right to terminate all or a portion of the committed amount. Under the outstanding order submitted pursuant to the Commercial Agreement, the Company has established a special purpose vehicle that will hold the infrastructure, and the Company intends for the special purpose vehicle to incur indebtedness to finance its obligations under the Commercial Agreement. Upon an event of default, OpenAI has a lien and security interest in the equity of the special purpose vehicle. As part of the Commercial Agreement, the Company issued 8,750,000 shares of its Class&#160;A common stock in connection with the IPO in March&#160;2025, having an aggregate value of $350&#160;million at the time of issuance based on a price per share equal to the IPO price. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company accounted for the $350&#160;million as a contra-revenue asset. As of June 30, 2025, the Company classified $41&#160;million as short-term included in prepaid expenses and other current assets on the condensed consolidated balance sheets and $309&#160;million as long-term included in other non-current assets on the condensed consolidated balance sheets. Revenue will be recognized net of the contra-revenue asset amount over time as the Company provides the related cloud computing services. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Contract Balances </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The timing of revenue recognition, billings and cash collections result in accounts receivable and deferred revenue. A receivable is recorded at the invoice amount, net of an allowance for credit losses, and is recognized in the period when the Company has the right to invoice its customers and when its right to consideration is unconditional. Payment terms and conditions vary by contract type, although terms generally include a requirement of payment within 60 days. On occasion, the Company has granted payment terms of up to 360 days. In instances where the timing of revenue recognition differs from the timing of payment, the Company has determined that its contracts generally do not include a significant financing component. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred revenue, including current and non-current balances as of June 30, 2025 and December 31, 2024, was $4.8&#160;billion and $4.1&#160;billion, respectively. For the six months ended June 30, 2025 and 2024, revenue recognized from deferred revenue at the beginning of the period was $603&#160;million and $128 million, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Remaining Performance Obligations (&#8220;RPO&#8221;) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the Company had $30.1&#160;billion of unsatisfied RPO, of which 50% is expected to be recognized over the initial 24 months ending June 30, 2027, 40% between months 25 and 48, and the remaining balance recognized between months 49 and 72. This includes amounts from the Commercial Agreement with OpenAI (as described above). </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-15<br></div></div></div>
<!--End Page 434-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 435-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">3. Fair Value Measurements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company measures certain financial assets and liabilities at fair value on a recurring basis in accordance with ASC 820, <font style="font-style: italic;">Fair Value Measurement</font>, which establishes a framework for measuring fair value and a fair value hierarchy based on the observability of inputs. This hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs when determining fair value as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 20pt; text-indent: 20pt; text-align: left;">Level 1&#8212;Observable inputs such as quoted prices in active markets for identical assets or liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity, which require management judgment or estimation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents information about the Company&#8217;s financial assets and liabilities that are measured at fair value on a recurring basis within the fair value hierarchy as of the end of each reporting period (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Hierarchy </div></td><td style="width: 7.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 7.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 300pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial assets:<br></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;1</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">55,508</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 10.37pt;">2,411 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, current<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;1</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">518,199</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">24,185 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;1</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">56,250 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Certificates of deposit<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;2</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">29,308 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Foreign exchange forward contracts not designated as accounting hedges<font style="padding-left: 4.73pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;2</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt;">2,279</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Power purchase agreements<font style="padding-left: 4.22pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;3</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,444</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,562 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total financial assets<font style="font-weight: normal; padding-left: 2.34pt;"></font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$579,430</font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">114,716</font></div></td></tr><tr><td style="width: 300pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial liabilities:<br></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative and warrant liabilities<br></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest rate swaps designated as accounting hedges<font style="padding-left: 0.38pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;2</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 17.5pt;">271</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Warrant liabilities<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;3</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">199,645 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Power purchase agreements<font style="padding-left: 4.22pt;"></font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.27pt; text-align: left;">Level&#160;3</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">427</font></div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">444 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total financial liabilities<font style="font-weight: normal; padding-left: 2.88pt;"></font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 17.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">698</font></div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$200,089</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company carries the 2030 Senior Notes (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>) at its amortized cost basis and presents the fair value for disclosure purposes only. As of June&#160;30, 2025, the fair value of the 2030 Senior Notes was $2.0&#160;billion. The fair value of the 2030 Senior Notes, which are classified as Level&#160;2 financial instruments, was determined based on the quoted prices of the 2030 Senior Notes in an over-the-counter market on the last trading day of the reporting period. Refer to <font style="font-style: italic;">Note&#160;10 &#8212; Debt</font> for additional information. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-16<br></div></div></div>
<!--End Page 435-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 436-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The notional amounts of the Company's outstanding interest rate swaps and foreign exchange forward contracts were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative instruments designated as accounting hedges<br></div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest rate swaps<font style="padding-left: 1.44pt;"></font></div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">50,000</font></div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$&#8212; </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative instruments not designated as accounting hedges<br></div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Foreign exchange forward contracts<font style="padding-left: 0.9pt;"></font></div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$107,748</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$&#8212;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Gain (loss) associated with interest rate swaps and foreign exchange forward contracts were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 78.06pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 14.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 78.06pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three and Six Months <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Ended June&#160;30, 2025 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest rate swaps designated as accounting hedges<br></div></td><td style="width: 14.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 14.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 78.06pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Loss recognized in other comprehensive income (loss), net<font style="padding-left: 1.21pt;"></font></div></td><td style="width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 78.06pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 25.28pt; text-align: left;">$<font style="padding-left: 4.17pt;">(271) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign exchange forward contracts not designated as accounting hedges<br></div></td><td style="width: 14.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 14.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 78.06pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Gain recognized in other income (expense), net<font style="padding-left: 2.87pt;"></font></div></td><td style="width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 78.06pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 25.28pt; text-align: left;">$2,279</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 14.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 78.06pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June&#160;30, 2025, the amount the Company expects to reclassify out of accumulated other comprehensive income (loss) into earnings within the next twelve months is not material. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s valuation of the warrant liabilities utilized the Black-Scholes option-pricing model that relied on the following significant inputs: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 35.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.62pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">March&#160;21,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 9.3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock price<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 9.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.62pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.31pt; text-align: left;">$41</div></td><td style="width: 9.3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$48 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 3.46pt;"></font></div></td><td style="width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.62pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.31pt; text-align: left;"><font style="padding-left: 5pt;">60%</font></div></td><td style="width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 5pt;">60% </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free rate<font style="padding-left: 4.98pt;"></font></div></td><td style="width: 9.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.62pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.31pt; text-align: left;"><font style="padding-left: 10pt;">4%</font></div></td><td style="width: 9.3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">4% </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 4.96pt;"></font></div></td><td style="width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.62pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10.31pt; text-align: left;"><font style="padding-left: 10pt;">0%</font></div></td><td style="width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">0%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)</font>, the warrant liabilities for the warrants for the Company's Class&#160;A common stock were remeasured immediately before modification when modified to equity classified warrants on March&#160;21, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power Purchase<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements &#8211;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Asset</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrant<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liabilities </div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power Purchase<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements &#8211;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liability </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at December&#160;31, 2024<font style="font-weight: normal; padding-left: 4.34pt;"></font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;">$2,562</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 3.33pt;">199,645</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.85pt; text-align: left;">$444 </div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adjustment to fair value <font style="padding-left: 2.21pt;"></font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 12.5pt;">882</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(26,837)</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.85pt; text-align: left;"><font style="padding-left: 6.67pt;">(17) </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Reclassification<font style="padding-left: 1.64pt;"></font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(172,808</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.85pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at June&#160;30, 2025<font style="font-weight: normal; padding-left: 1.91pt;"></font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$3,444</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 25.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.85pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$427</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Notes Receivable </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notes receivable are primarily related to the DCSP Financing Arrangements (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>) and are reported at their amortized costs basis. As of June 30, 2025 and December 31, 2024, the Company determined that the fair values of its notes receivable approximate the carrying values. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-17<br></div></div></div>
<!--End Page 436-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 437-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">4. Business Combination </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On May 5, 2025, the Company acquired all of the outstanding equity interests of Weights and Biases, Inc. (&#8220;Weights &amp; Biases&#8221;), an AI developer platform. The transaction is expected to extend the Company's application software services offering to include additional developer-focused capabilities for the training of models and development of AI applications. The aggregate purchase consideration was $1.0&#160;billion, which was comprised of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 396pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid by the Company<font style="padding-left: 1.86pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 12.5pt;">96,498 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of Class&#160;A common stock and restricted stock awards issued by the Company<font style="padding-left: 4.75pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">928,900 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of replacement restricted stock units <font style="padding-left: 2.48pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,861 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total purchase price<font style="font-weight: normal; padding-left: 4.63pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,029,259</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the acquisition, the Company entered into compensation arrangements for stock-based awards with a value totaling $123&#160;million. Of this amount, $33&#160;million was recognized in the total purchase price. $6&#160;million was recognized as compensation expense on the acquisition date and $5&#160;million was recorded as additional compensation expense during the three months ended June&#160;30, 2025. The remaining compensation expense of $79&#160;million will be recognized on a straight-line basis over the respective awards' remaining requisite service period. Certain stock-based awards are in the form of restricted stock awards (&#8220;RSAs&#8221;). The RSAs represent legally outstanding common shares that are subject to service-based vesting conditions and repurchase rights held by the Company, which lapse upon vesting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The acquisition-related costs were $29&#160;million, which was recorded in general and administrative expense in the condensed consolidated statements of operations during the three months ended June&#160;30, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The allocation of the purchase price is preliminary and subject to change as the Company finalizes its assessment of the fair values of the assets acquired and liabilities assumed during the measurement period following the acquisition date. The preliminary fair values of assets acquired and liabilities assumed on the acquisition date are summarized as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 396pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 0.77pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 12.5pt;">50,792 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts receivable, net<font style="padding-left: 3.27pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">13,418 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 3.59pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">2,205 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment, net<font style="padding-left: 2.7pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">858 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 3.02pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">1,080 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangible assets, net<font style="padding-left: 3.26pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">207,600 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Goodwill<font style="padding-left: 0.73pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">793,426 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 4.11pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">178 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total assets acquired<font style="font-weight: normal; padding-left: 2.96pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,069,557 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accounts payable<font style="padding-left: 1.31pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">885 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued liabilities<font style="padding-left: 4.09pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">7,036 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred revenue, current<font style="padding-left: 3.84pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">25,414 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">283 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other current liabilities<font style="padding-left: 3.54pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35pt;">31 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred revenue, non-current<font style="padding-left: 0.51pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">309 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30pt;">797 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities, non-current<font style="padding-left: 4.4pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,543 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total liabilities assumed<font style="font-weight: normal; padding-left: 4.44pt;"></font></div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">40,298 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total purchase price<font style="font-weight: normal; padding-left: 4.63pt;"></font></div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,029,259</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-18<br></div></div></div>
<!--End Page 437-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 438-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The acquired assets and assumed liabilities were recorded at their estimated fair values. The following table presents the amounts allocated to the intangible assets identified as of the date of acquisition and the estimated useful lives (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.65pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Useful Lives <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in years) </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer relationships<font style="padding-left: 2.19pt;"></font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 5pt;">36,100</font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">12 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Developed technology<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt;">161,800</font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5 - 7 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Trade name<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">9,700</font></div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">5 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total <font style="font-weight: normal; padding-left: 0.31pt;"></font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$207,600</font></div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.65pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The excess of the purchase price over the fair value of the net assets acquired was allocated to goodwill, none of which is expected to be deductible for tax purposes. Goodwill is primarily attributable to the assembled workforce as well as the anticipated synergies from the integration of Weights &amp; Biases&#8217; technology with the Company&#8217;s technology. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From the date of the acquisition, the financial results of Weights &amp; Biases are not material to the Company&#8217;s consolidated financial statements. Pro forma revenue and net income have not been presented because the historical results would not have been material to the condensed consolidated financial statements in any period presented. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">5. Property and Equipment, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment, net, consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology equipment<font style="padding-left: 2.88pt;"></font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$13,170,295</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">9,146,575 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">459,742</font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">139,508 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Data center equipment and leasehold improvements<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">830,875</font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">384,372 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture, fixtures, and other assets<font style="padding-left: 1.12pt;"></font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">12,949</font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">8,684 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Construction in progress<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10.74pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,111,256</font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,200,866 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total property and equipment<font style="font-weight: normal; padding-left: 4.41pt;"></font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5.37pt;">18,585,117</font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">12,880,005 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: accumulated depreciation and amortization<font style="font-style: normal; padding-left: 3.71pt;"></font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,953,607</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(965,231</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total property and equipment, net<font style="font-weight: normal; padding-left: 0.25pt;"></font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$16,631,510</font></div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">11,914,774</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Depreciation and amortization on property and equipment was $553&#160;million and $164&#160;million for the three&#160;months ended June 30, 2025 and 2024, respectively, and $996&#160;million and $243&#160;million for the six months ended June 30, 2025 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalized $17&#160;million and $6&#160;million of software development costs during the three months ended June 30, 2025 and 2024, respectively, and $43&#160;million and $12&#160;million during the six months ended June 30, 2025 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalizes interest associated with the construction of data centers and purchases of related technology equipment. There was $23&#160;million and $41&#160;million of interest capitalized during the three months ended June 30, 2025 and 2024, respectively, and $36&#160;million and $73&#160;million of interest capitalized during the six months ended June 30, 2025 and 2024, respectively. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">6. Goodwill and Intangible Assets </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Goodwill </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the changes to goodwill (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 420pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 420pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 420pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2025<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">19,544 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Addition<font style="padding-left: 1.95pt;"></font></div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">793,426 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at June&#160;30, 2025<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$812,970</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 420pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-19<br></div></div></div>
<!--End Page 438-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 439-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">There were no impairment charges recorded to goodwill for any of the periods presented. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Intangible Assets, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Intangible assets, net consisted of the following (dollars in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 108pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 196.69pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 144.76pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 196.69pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30, 2025</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 144.76pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr class="BRDSX_header"><td style="width: 108pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Useful Lives <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in years)</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross </div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortization </div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net </div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross </div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortization </div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net </div></td></tr><tr><td style="width: 108pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Acquired technologies<font style="padding-left: 4.42pt;"></font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.33pt; text-align: left;"><font style="padding-left: 5pt;">5</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;">$167,253</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.15pt; text-align: left;">$<font style="padding-left: 4.63pt;">(9,271)</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;">$157,982</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;">$5,453</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">$<font style="padding-left: 0.37pt;">(3,611)</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;">$1,842 </div></td></tr><tr><td style="width: 108pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.99pt;"></font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.33pt; text-align: left;">10</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">49,697</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.15pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,784</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">47,913</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,897</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(830</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,067 </font></div></td></tr><tr><td style="width: 108pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.65pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$216,950</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.15pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(11,055</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$205,895</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$9,350</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(4,441</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,909</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 108pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.65pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Included in Other are customer relationships and trade names. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amortization expenses for intangible assets were $6&#160;million and $1&#160;million for the three months ended June 30, 2025 and 2024, respectively, and $7&#160;million and $1&#160;million for the six months ended June 30, 2025 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the expected future amortization expense related to intangible assets was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 420pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 420pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 5.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 420pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Remaining portion of 2025<font style="padding-left: 1.41pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">18,940 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">36,264 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">36,250 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">36,082 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">36,069 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">42,290 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total expected future amortization expense<font style="font-weight: normal; padding-left: 0.34pt;"></font></div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$205,895</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 420pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.25pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12.5pt; margin-left: 0pt; text-align: left;">7. Condensed Consolidated Balance Sheets Components </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Prepaid Expenses and Other Current Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prepaid expenses and other current assets consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 0.37pt;">114,367</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 5pt;">67,393 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Strategic agreement contra-revenue asset<font style="padding-left: 3.92pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">41,136</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other current assets<font style="padding-left: 4.44pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">143,726</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">33,853 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total prepaid expenses and other current assets<font style="font-weight: normal; padding-left: 3.15pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$299,229</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$101,246</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 20pt; text-align: left;">Other Non-current Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other non-current assets consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Strategic agreement contra-revenue asset<font style="padding-left: 3.92pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$308,864</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">207,771</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">145,424 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Strategic investments<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.37pt;">117,220</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">102,220 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Equity method investment<font style="padding-left: 3.3pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">56,947</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-20<br></div></div></div>
<!--End Page 439-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 440-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Notes receivable<font style="padding-left: 2.76pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 5pt;">56,862</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$107,597 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Escrow funds<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">336,055 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">176,613</font></div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,616 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="font-weight: normal; padding-left: 2.58pt;"></font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$924,277</font></div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$720,912</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.84pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 25.75pt; margin-left: 20pt; text-align: left;">Accrued Liabilities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Accrued liabilities consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.63pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued purchases<font style="padding-left: 3.88pt;"></font></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.63pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 7.13pt;">905,707</font></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$105,733 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Accrued interest<font style="padding-left: 3.87pt;"></font></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.63pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">219,114</font></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">157,310 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other accrued liabilities<font style="padding-left: 2.77pt;"></font></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.63pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.13pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">286,416</font></div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">92,778 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total accrued liabilities<font style="font-weight: normal; padding-left: 4.22pt;"></font></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.63pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,411,237</font></div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$355,821</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 44.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">8. Leases </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company enters into leases as a lessee for data centers, office buildings, and technology equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Leases for offices generally have an initial term of three to ten years, often with multi-year renewal periods. Data center leases generally have an initial term from five to fifteen years, some of which include options to extend the leases for up to ten years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The components of lease cost related to operating leases for the periods presented were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.41pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.41pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease cost<font style="padding-left: 4.76pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.41pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">$180,450</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.41pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.47pt; text-align: left;">$65,781</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;">$335,502</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;">$100,757 </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Variable lease cost<font style="padding-left: 1.43pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.41pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">57,851</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.41pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.47pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">10,524</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">101,780</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">13,438 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total lease cost<font style="font-weight: normal; padding-left: 1.78pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 52.41pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$238,301</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.41pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.47pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$76,305</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$437,282</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">114,195</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 52.41pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.41pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Supplemental condensed consolidated cash flow and other information related to operating leases for the periods presented were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.1pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.1pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid for amounts included in the measurement of lease liabilities:<br></div></td><td style="width: 4.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating cash flows from operating leases<font style="padding-left: 4.81pt;"></font></div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.05pt; text-align: left;">$301,288</div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.05pt; text-align: left;">$79,428</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Information relating to the lease term and discount rate for operating leases were as follows: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 372pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 29.11pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 372pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.11pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.93pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 372pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted-average remaining lease term (in years):<br></div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.11pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 372pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating leases<font style="padding-left: 2.31pt;"></font></div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.56pt; text-align: left;"><font style="padding-left: 5pt;">9</font></div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.58pt; text-align: left;"><font style="padding-left: 5pt;">9 </font></div></td></tr><tr><td style="width: 372pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted-average discount rate:<br></div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 372pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating leases<font style="padding-left: 2.31pt;"></font></div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29.11pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.56pt; text-align: left;">12%</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.58pt; text-align: left;">12%</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 372pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 29.11pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.93pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-21<br></div></div></div>
<!--End Page 440-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 441-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The future lease payments included in the measurement of the Company&#8217;s operating lease liabilities as of June&#160;30, 2025, were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 59.38pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Future Payments </div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 6.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases </div></td></tr><tr><td style="width: 396pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Remaining portion of 2025<font style="padding-left: 2.41pt;"></font></div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;">$<font style="padding-left: 10.83pt;">336,597 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 15.83pt;">683,723 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 16.2pt;">700,911 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 15.83pt;">710,950 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 15.83pt;">647,554 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 1.86pt;"></font></div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,620,187 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total undiscounted lease payments<font style="padding-left: 1.47pt;"></font></div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 8.33pt;">5,699,922 </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: imputed interest<font style="font-style: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,252,450</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 396pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Present value of lease liabilities<font style="font-weight: normal; padding-left: 2.62pt;"></font></div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 59.38pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.52pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">3,447,472</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 59.38pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the Company executed additional lease agreements, primarily for data centers and office buildings, that had not yet commenced. The aggregate amount of estimated future undiscounted lease payments associated with such leases is $34.0&#160;billion. These leases will commence between 2025 and 2028 with estimated lease terms of four to 16 years. During the six months ended June 30, 2025, the Company modified certain agreements resulting in the termination of the related escrow agreements. As a result, $304&#160;million of the cash held in escrow, inclusive of interest, was returned to the Company with the remaining escrow balance applied toward future lease payments at that time. These escrow funds were previously included within other non-current assets on the condensed consolidated balance sheets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the Company had additional lease agreements for various data center locations with commencement dates subject to regulatory approvals and completion of landlord improvements. The Company may be required to make fixed lease payments of up to $0.9&#160;billion over the next 13 years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In April&#160;2025, the Company entered into a finance lease for data center infrastructure assets with the DCSP (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>). Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has entered into a lease agreement for various buildings located at a single site intended to be used as a data center. The agreement provides access to 133 MW of electrical power, which is expected to be delivered in phases in 2026. The Company will make contractual rent payments based on construction costs incurred by the lessor. The total contractual rent payments range from $3.8&#160;billion to $4.8&#160;billion over the 15 year term of this lease. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the Company has entered into lease agreements whereby the Company will pay a portion of the construction costs incurred by the lessor during the construction period and during the lease term, which are considered variable lease payments. These lease agreements provide access to 135 MW of electrical power, which is expected to be delivered in phases between 2025 and 2027. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company will assess lease classification upon lease commencement. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Unconsolidated Joint Venture </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2025, the Company entered into a joint venture (the &#8220;JV&#8221;) with a third-party infrastructure developer to support the acquisition and development of a multi-phase data center campus in Kenilworth, New Jersey. Upon formation, the third-party infrastructure developer obtained an 85% equity interest while the Company holds the remaining 15% equity interest in the JV. The Company contributed net assets worth $57&#160;million for its 15% equity interest. The JV will construct and develop the campus using a combination of additional debt and equity capital. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company accounts for its unconsolidated investment in the JV as an equity method investment included in other non-current assets on the condensed consolidated balance sheets. The carrying amount of the Company&#8217;s investment in the JV is $57&#160;million as of June&#160;30, 2025. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-22<br></div></div></div>
<!--End Page 441-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 442-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">9. Commitments and Contingencies </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Letters of Credit </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, the Company had outstanding Letters of Credit (&#8220;LOC&#8221;) associated with its lease agreements in the aggregate amount of $272&#160;million and $533&#160;million, respectively. As of June 30, 2025 and December 31, 2024, the Company had not drawn on any of these LOC and was in compliance with the terms and conditions set forth by the financial institution. These LOC renew annually and expire on various dates through 2041. The Company also has a LOC arrangement associated with its debt agreements. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Indemnifications </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company enters into indemnification provisions under certain agreements with other parties in the ordinary course of business. In its customer agreements, the Company has agreed to indemnify, defend, and hold harmless the indemnified party for third party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic customers, the Company has agreed to indemnify, defend, and hold harmless the indemnified party for noncompliance with certain additional representations and warranties made by the Company. In addition, the Company indemnifies its officers, directors, and certain key employees while they are serving in good faith in their respective capacities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While the Company has entered into various indemnification agreements, it has not incurred any material costs or claims under these agreements to date, and management does not expect any future claims to have a material adverse effect on the Company&#8217;s financial position or results of operations. It is not possible to determine the maximum potential amount under these indemnification provisions due to the Company&#8217;s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision. To date, there have been no claims under any indemnification provisions. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Litigation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, the Company may be subject to various proceedings, lawsuits, disputes, or claims in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that would, individually or taken together, have a material adverse effect on its business, financial position, results of operations, or cash flows. As of June 30, 2025 and December 31, 2024, the Company has not accrued any material potential loss. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 17pt; margin-left: 0pt; text-align: left;">10. Debt </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The total debt obligations are as follows (dollars in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 57.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 30.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 192pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Maturities </div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Effective<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Interest<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Rates </div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">June&#160;30,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 192pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">DDTL 1.0 Facility<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;2028</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 8.33pt;">15%</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 4.63pt;">1,782,500</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">2,012,500 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">DDTL 2.0 Facility<font style="padding-left: 3.5pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;2029</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 8.7pt;">11%</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.63pt;">4,953,967</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">3,843,819 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2030 Senior Notes<font style="padding-left: 3.41pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">June&#160;2030</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 8.33pt;">10%</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.63pt;">2,000,000</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024 Term Loan Facility<font style="padding-left: 2.63pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">April&#160;2025</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 8.33pt;">12%</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 39.63pt;">&#8212;</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,000,000 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revolving Credit Facility<font style="padding-left: 0.63pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">June&#160;2027</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 13.33pt;">7%</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.13pt;">450,000</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">OEM Financing Arrangements<font style="padding-left: 4.54pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;2026 &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;2028</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;">9-10%</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.63pt;">1,728,388</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,177,158 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Magnetar Loan<font style="padding-left: 2.3pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">January&#160;2029</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.94pt; text-align: left;"><font style="padding-left: 8.33pt;">12%</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.13pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">256,630</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total principal of debt<font style="padding-left: 3.01pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">11,171,485</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">8,033,477 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Less: Unamortized discount and issuance costs<font style="font-style: normal; padding-left: 4.51pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(119,984</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(107,137</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Total debt, net of unamortized discount and issuance costs<font style="font-weight: normal; padding-left: 0.08pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">11,051,501</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">7,926,340 </font></div></td></tr><tr><td style="width: 192pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Debt, current<font style="font-style: normal; padding-left: 0.74pt;"></font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.3pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(3,627,664</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,468,425</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 192pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total debt, non-current<font style="font-weight: normal; padding-left: 3.13pt;"></font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 57.76pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.2pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.63pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">7,423,837</font></div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">5,457,915</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 192pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 57.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.26pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-23<br></div></div></div>
<!--End Page 442-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 443-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the future principal payments for the Company&#8217;s total debt were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.63pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 17.18pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 384pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Remaining portion of 2025<font style="padding-left: 0.41pt;"></font></div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 12.13pt;">986,052 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 1.5pt;"></font></div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">4,218,457 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 1.5pt;"></font></div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">2,833,142 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 1.5pt;"></font></div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">1,010,054 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 1.5pt;"></font></div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 17.13pt;">123,780 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,000,000 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 4.64pt;"></font></div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.63pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$11,171,485</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 384pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 17.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The total interest expense for the Company&#8217;s debt obligations was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual interest expense<font style="padding-left: 2.55pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.21pt; text-align: left;">$250,312</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;">$100,237</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;">$483,084</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;">$164,859 </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Amortization of debt discounts and issuance costs and accretion of redemption premiums<font style="padding-left: 2pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.21pt; text-align: left;"><font style="padding-left: 10pt;">29,036</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 15pt;">7,547</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 10pt;">66,727</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 10pt;">15,605 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: capitalized interest<font style="font-style: normal; padding-left: 1.24pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.21pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(23,186</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(40,687</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(36,278</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(72,864</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 0.64pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.21pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$256,162</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.22pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">67,097</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$513,533</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.1pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.81pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$107,600</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.1pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the Company's weighted-average interest rate on short-term debt instruments, which was comprised of the Magnetar Loan, and certain of the OEM Financing Arrangements, was 12.3%. As of December 31, 2024, the Company's weighted-average interest rate on short-term debt instruments, which was comprised of the 2024 Term Loan Facility, was 9.6%. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loans </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2023, the Company entered into a Delayed Draw Term Loan 1.0 Facility (as amended, the &#8220;DDTL 1.0&#160;Facility&#8221;), which provided for a delayed draw term loan facility of up to $2.3&#160;billion. In May&#160;2024, the Company entered into a Delayed Draw Term Loan 2.0 Facility (as amended, the &#8220;DDTL 2.0 Facility&#8221;), which provides for another delayed draw term loan facility of up to $7.6&#160;billion. The principal amount of the DDTL 1.0 Facility is required to be repaid in quarterly installments, with the final balloon payment due on March&#160;28, 2028. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the DDTL 2.0 Facility, additional loans may be drawn until June&#160;2025, with an option to extend the commitment period by three months subject to lender consent. In June, 2025, the Company extended the commitment period to September, 2025. The principal amount of the DDTL 2.0 Facility is required to be repaid in quarterly installments, beginning in January&#160;2026, with the final balloon payment due five years after the applicable loan was funded. The total loans available are constrained by the purchase price of assets for which the loans are being used to finance with such percentage based upon the depreciable cost of graphics processing unit (&#8220;GPU&#8221;) servers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s DDTL 1.0 Facility and DDTL 2.0 Facility require the Company to maintain certain restricted cash balances. The Company is required to maintain restricted cash equal to 4.00% of the drawn balance on the DDTL 1.0 Facility, but in no event greater than $56&#160;million. As of each of June 30, 2025 and December 31, 2024, $56&#160;million was restricted cash in relation to the DDTL 1.0 Facility. Prior to the IPO, the Company was required to maintain restricted cash equal to 2.00% of the drawn balance on the DDTL 2.0 Facility, which was $77&#160;million as of December 31, 2024. In connection with the IPO, the restricted cash requirement was reduced to 1.00% of the drawn balance on the DDTL 2.0 Facility, which was $50&#160;million as of June 30, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, at the closing of the IPO, the Company became subject to a requirement to fund $500&#160;million into designated escrow accounts in connection with the DDTL 2.0 Facility, which was classified as restricted cash and cash equivalents, current, on the condensed consolidated balance sheets as of March&#160;31, 2025. In April&#160;2025, the conditions requiring restriction of this amount were lifted and the $500&#160;million previously classified as restricted cash in connection with the DDTL 2.0 Facility was no longer restricted. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-24<br></div></div></div>
<!--End Page 443-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 444-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Revolving Credit Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2024, and as amended in October and December&#160;2024, the Company entered into a senior secured revolving credit facility (as amended, the &#8220;Revolving Credit Facility&#8221;) with a capacity of $650&#160;million. The Revolving Credit Facility matures on June&#160;21, 2027. The Revolving Credit Facility included a $175&#160;million letter of credit sub-facility. The letter of credit sub-facility entered into by the Company reduces the available borrowing capacity under the Revolving Credit Facility. In May&#160;2025, the Company upsized the Revolving Credit Facility with a capacity of $1.5&#160;billion. With the upsize of the Revolving Credit Facility, the letter of credit sub-facility increased to $350&#160;million. As of June 30, 2025 and December 31, 2024, the amounts associated with outstanding letters of credit were $11&#160;million and $0&#160;million, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company had not drawn on the Revolving Credit Facility. As of June 30, 2025, the Company had drawn $450&#160;million and had $1.0&#160;billion of remaining capacity under the Revolving Credit Facility (after giving effect to the outstanding letters of credit). Obligations outstanding under the Revolving Credit Facility are secured by pledges of certain assets as collateral. The Company is required to pay a fee of 0.25% per annum on the average undrawn commitment. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">2030 Senior Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2025, the Company issued $2.0&#160;billion in aggregate principal amount of senior notes due 2030 (the &#8220;2030 Senior Notes&#8221;) in a private placement offering to qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act of 1933, as amended. The 2030 Senior Notes were issued pursuant to an indenture, dated as of May&#160;27, 2025 (the &#8220;Indenture&#8221;). The proceeds from the issuance of the 2030 Senior Notes were retained for general corporate purposes. In conjunction with the issuance of the 2030 Senior Notes, the Company capitalized $37&#160;million in debt issuance costs. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2030 Senior Notes are unsecured obligations. The 2030 Senior Notes will mature on June&#160;1, 2030 and bear interest at a rate of 9.25% per annum, payable semi-annually in cash in arrears on June&#160;1 and December&#160;1 of each year, beginning on December&#160;1, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may redeem all or a portion of the 2030 Senior Notes at any time prior to June&#160;1, 2027 at a redemption price equal to 100% of the aggregate principal amount, plus accrued and unpaid interest and a &#8220;make-whole&#8221; premium as provided in the Indenture. The Company may redeem all or a portion of the 2030 Senior Notes at any time on or after June&#160;1, 2027 at the redemption prices set forth in the Indenture. At any time prior to June&#160;1, 2027, up to 40% of the aggregate principal amount of the 2030 Senior Notes may be redeemed with the net cash proceeds from certain equity offerings, at the redemption price specified in the Indenture. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2030 Senior Notes includes customary terms and covenants, including certain events of default, after which the 2030 Senior Notes may be due and payable immediately. In addition, if the Company experiences certain change of control events, as described in the Indenture, the Company will be required to make an offer to repurchase some or all of the 2030 Senior Notes at a price equal to 101% of the principal amount of the 2030 Senior Notes to be repurchased plus accrued and unpaid interest. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">2024 Term Loan Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2024, the Company entered into a credit agreement providing for a $1.0&#160;billion term loan facility (the &#8220;2024 Term Loan Facility&#8221;) consisting of (i) a $229&#160;million secured facility and (ii) a $771&#160;million unsecured facility. In connection with the IPO, the maturity date of the 2024 Term Loan Facility was accelerated, and it was repaid on April&#160;11, 2025. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">Magnetar Loan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August&#160;2024, the Company entered into an AI Computing Service Reserved Capacity and Prepayment Agreement with MagAI Ventures (the &#8220;MagAI Capacity Agreement&#8221;). Under this arrangement, the Company will provide portfolio companies of MagAI Ventures with a pre-determined amount of cloud computing services at a pre-negotiated hourly rate. The specific amount of cloud computing services, inclusive of the capacity and term, to be used by each portfolio company, if any, will be negotiated individually with each portfolio company, and will be subject to final approval by MagAI Ventures. The Company received a refundable deposit of $230&#160;million in connection with the MagAI Capacity Agreement. Any consumption of cloud services by MagAI Ventures, including by their portfolio companies, under this arrangement is deducted from this deposit amount, with the unused portion </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-25<br></div></div></div>
<!--End Page 444-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 445-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">refunded back to MagAI Ventures at the end of the contractual term. Throughout the term of the arrangement, if MagAI Ventures portfolio companies do not contract for the full amount of the pre-determined cloud computing services, the Company may agree with MagAI Ventures to instead use this available capacity for other customers, and share profits with MagAI Ventures for any revenue realized above the revenue that would have been generated by charging these customers the MagAI Ventures pre-negotiated rate. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The initial MagAI Capacity Agreement provided for certain termination options for MagAI Ventures, including if a specified amount of capacity is not available by a target commencement date. The MagAI Capacity Agreement runs for an initial period of four years, with an option for MagAI Ventures to extend for two additional years. As of December 31, 2024, the refundable deposit was included within other current liabilities on the condensed consolidated balance sheets, as no services had yet been provided under this arrangement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, the MagAI Capacity Agreement was amended to provide certain termination for convenience rights to both MagAI Ventures and the Company. As a result of the amendment, the Company now considers the refundable deposit received from Magnetar to be in-substance debt (the &#8220;Magnetar Loan&#8221;) under ASC 470, <font style="font-style: italic;">Sale of Future Revenue</font>, and has reclassified the balance to debt, current on the condensed consolidated balance sheets. No services had been provided under the MagAI Capacity Agreement as of June 30, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the $230&#160;million refundable deposit remains available for cloud computing services for MagAI Ventures' portfolio companies. Upon such termination by either party, the unused portion of the $230&#160;million deposit will be refunded along with a specified multiplier that increases over the term of the arrangement that equates to a 12% annual rate of return. As of June 30, 2025, the Company had $257&#160;million classified as debt, current, including $27&#160;million of redemption premiums, on the condensed consolidated balance sheets. The accretion of the redemption premiums was recognized in interest expense, net in the condensed consolidated statements of operations during the six months ended June 30, 2025. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">2021 Convertible Senior Secured Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2021, the Company executed a note issuance agreement and a note purchase agreement with a related party for the issuance of an aggregate principal amount of up to $50&#160;million of convertible senior secured notes (the &#8220;2021 Convertible Senior Secured Notes&#8221;). The Company determined that the conversion features, the accelerated redemption features, the variability in interest payments, and the Company&#8217;s redemption option were required to be bifurcated and accounted for as an embedded derivative. The investors elected to convert all of the outstanding 2021 Convertible Senior Secured Notes on September&#160;17, 2024, pursuant to the original terms of the conversion feature. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the three and six months ended June&#160;30, 2024, the Company recorded losses related to the fair value adjustment of these derivative liabilities of $262&#160;million and $344&#160;million, respectively. During the three and six&#160;months ended June&#160;30, 2024, total interest costs for the 2021 Convertible Senior Secured Notes were $3&#160;million and $6&#160;million, respectively, comprised of coupon interest of $1&#160;million and $3&#160;million, respectively, and amortization of debt discounts and issuance costs of $2&#160;million and $3&#160;million, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">OEM Financing Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company entered into various agreements with original equipment manufacturers (the &#8220;OEM Financing Arrangements&#8221;), whereby the Company obtained financing for certain equipment with an aggregate notional balance of $2.2&#160;billion and $1.3&#160;billion as of June 30, 2025 and December 31, 2024, respectively. The Company granted a security interest for the financed equipment related to these financing agreements. These agreements generally have terms between two to three years. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 20pt; text-align: left;">DCSP Financing Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2023, the Company entered into a service agreement (the &#8220;DCSP Service Agreement&#8221;) with a data center service provider (the &#8220;DCSP&#8221;). Under the DCSP Service Agreement, the DCSP will design, purchase, build, and manage a data center providing access to up to 78 MW of electrical power to be delivered in phases. Separately, during the year ended December 31, 2024, the Company purchased $116&#160;million of critical infrastructure assets to support the data center site (the &#8220;Existing Critical Infrastructure Assets&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2024, the Company, as a lender, entered into a Senior Secured Delayed Draw Term Loan Credit Agreement (the &#8220;DCSP Note&#160;Receivable,&#8221; and collectively, with the DCSP Service Agreement, the &#8220;DCSP </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-26<br></div></div></div>
<!--End Page 445-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 446-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Financing Arrangements&#8221;) with the DCSP to facilitate the purchase of critical infrastructure assets. The DCSP Note&#160;Receivable provides for a total commitment of up to $305&#160;million in delayed draw term loan funding for a term of seven years with a stated interest rate of 13.00% per annum. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DCSP Note&#160;Receivable is secured by the new and existing critical infrastructure assets that support current and future phases of the build out at the data center and is prepayable at any time by the DCSP with no penalty. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DCSP has borrowed under the DCSP Note&#160;Receivable to settle amounts previously advanced to the DCSP by the Company, finance purchases of additional critical infrastructure assets, and purchase the Existing Critical Infrastructure Assets. Under the terms of the DCSP Service Agreement, the Company continues to control the Existing Critical Infrastructure Assets and the Company recorded a financing obligation related to the consideration received for the Existing Critical Infrastructure Assets. The financing obligation is payable over a term of 14 years and has an imputed interest rate of 15%. The Existing Critical Infrastructure Assets are included in property and equipment, net, on the condensed consolidated balance sheets and are depreciated over their estimated useful life. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the Company entered into a lease for data center infrastructure assets with the DCSP. The arrangement commenced in April&#160;2025 and is accounted for as a finance lease, with an initial term of 14 years and an imputed interest rate of 13%. The Company recorded finance lease right-of-use assets acquired through lease liability of $123&#160;million for the six months ended June 30, 2025 associated with this arrangement. For the three and six months ended June 30, 2025, amortization expense recognized related to this finance lease right-of-use asset was not material. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, the future payments under the financing obligation and finance lease due to the DCSP were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 46.2pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 5.24pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Financing <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">obligation</div></td><td style="width: 5.24pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Finance lease </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Remaining portion of 2025<font style="padding-left: 1.41pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 13.33pt;">9,835</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;">$<font style="padding-left: 13.33pt;">9,360 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">19,658</font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 13.33pt;">18,720 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">19,645</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 13.33pt;">18,720 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">19,630</font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 13.33pt;">18,720 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">19,616</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 13.33pt;">18,720 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">175,800</font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">168,480 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total future payments<font style="padding-left: 3.23pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">264,184</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 8.33pt;">252,720 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: amount representing interest<font style="padding-left: 2.56pt;"></font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(149,548</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(130,350</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 0.64pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.7pt;">114,636</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 8.33pt;">122,370 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Less: current portion<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,910</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(3,682</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Long-term portion<font style="padding-left: 2.52pt;"></font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.07pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">111,726</font></div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.2pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 2.69pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.7pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">118,688</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 46.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DCSP Financing Arrangements allow for the net settlement of amounts due between the parties and meet the criteria for right of setoff in accordance with ASC 210, <font style="font-style: italic;">Balance Sheet</font>. As of June 30, 2025, the gross amount of the DCSP Note&#160;Receivable was $288&#160;million, which is presented net of the financing obligation and finance lease of $237&#160;million. As of December 31, 2024, the gross amount of the DCSP Note&#160;Receivable was $224&#160;million, which is presented net of the financing obligation of $116&#160;million. The Company did not recognize any interest income during the year ended December 31, 2024, as the Company did not expect to be entitled to the accrued interest. The Company began recognizing interest income associated with this arrangement in March&#160;2025. For the three and six&#160;months ended June 30, 2025, the Company recognized $6&#160;million and $9&#160;million of interest income in other income (expense), net in the condensed consolidated statements of operations, respectively. The total interest expense related to the financing obligation and finance lease associated with this arrangement for the three and six months ended June&#160;30, 2025 was $8&#160;million and $12&#160;million, respectively. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-27<br></div></div></div>
<!--End Page 446-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 447-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">11. Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit) </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Redeemable Convertible Preferred Stock and Redeemable Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company had five classes of redeemable convertible preferred stock, which consisted of the following (in thousands, except per share amounts): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 216pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Authorized</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issued and<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issuance<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Per Share</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Carrying<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liquidation<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preference </div></td></tr><tr><td style="width: 216pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;Seed<font style="padding-left: 1.3pt;"></font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">60,000</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">45,567</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;">$<font style="padding-left: 5pt;">0.05</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 17.5pt;">2,039</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 17.5pt;">2,039 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;A<font style="padding-left: 4.07pt;"></font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">24,182</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">19,361</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">0.12</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">2,256</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">2,256 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B<font style="padding-left: 4.07pt;"></font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">79,979</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">79,979</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">5.58</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">550,595</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">446,002 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B-1<font style="padding-left: 0.74pt;"></font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">12,485</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">10,205</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">0.40</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">4,091</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">4,091 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;C<font style="padding-left: 4.07pt;"></font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,523</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,523</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 5pt;">38.95</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,130</font></div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,671 </font></div></td></tr><tr><td style="width: 216pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 1.64pt;"></font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">206,169</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">184,635</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.74pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,722,111</font></div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,618,059</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 216pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 38.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 34.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.63pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">As of June 30, 2025, there were no shares of redeemable convertible preferred stock issued and outstanding. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in <font style="font-style: italic;">Note&#160;1&#8212;Overview and Summary of Significant Accounting Policies</font>, in connection with the IPO, all shares of the Company's Series&#160;Seed, Series&#160;A, Series&#160;B, and Series&#160;B-1 redeemable convertible preferred stock then outstanding, totaling 155,111,700 shares, were automatically converted into an equivalent number of shares of Class&#160;A common stock. The carrying value of $559&#160;million was reclassified into stockholders' equity (deficit). All shares of Series&#160;C redeemable convertible preferred stock then outstanding, totaling 29,523,120 shares, were automatically converted into 29,874,066 shares of redeemable Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the year ended December 31, 2024, the Company paid a dividend in kind to the holders of the Series&#160;C redeemable convertible preferred stock, which resulted in additional shares being issued upon conversion. These additional shares issued upon conversion were not legally outstanding prior to the IPO and upon conversion were included in the redeemable Class&#160;A common stock shares outstanding. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The redeemable Class&#160;A common stock is subject to a right to be &#8220;put&#8221; to the Company on the first trading day immediately after the second anniversary of the closing of the IPO (the &#8220;Put Right&#8221;). Upon exercise of the Put Right, holders of these shares would be entitled to receive from the Company an amount in cash equal to the original issue price per share of the Series&#160;C redeemable convertible preferred stock of $38.95 per share, representing an aggregate price of $1.2&#160;billion. The carrying value of $1.2&#160;billion was reclassified from redeemable convertible preferred stock to redeemable Class&#160;A common stock and continues to be classified as mezzanine equity due to the shares being redeemable outside of the Company&#8217;s control, as the related Put Right remains outstanding and unexercised. Ongoing accretion is recorded to bring the carrying value of the redeemable Class&#160;A common stock to its redemption value over time, consistent with the original terms of the Series&#160;C redeemable convertible preferred stock. Redeemable Class&#160;A common stock approximates its redemption value. The Company did not record accretion during the three&#160;months ended June 30, 2025 as it was no longer considered probable that the Put Right would become redeemable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The rights of the holders of the Company&#8217;s redeemable Class&#160;A common stock are identical to the Company&#8217;s Class&#160;A common stock, except with respect to the Put Right. The Put Right with respect to each share is subject to a lock-up period after the IPO and will automatically terminate upon the expiration of such period if either (i) the share is assigned, sold, or transferred publicly, or (ii) the Company&#8217;s Class&#160;A common stock has a 20-day volume-weighted average price in any consecutive 30 trading day period of at least 175% of the Series&#160;C redeemable convertible preferred stock original issue price of $38.95 per share after the IPO and on or before the second&#160;anniversary of the closing of the IPO, which is in March&#160;2027. Upon termination of the Put Right, the redeemable Class&#160;A common stock will be reclassified into Class&#160;A common stock within stockholders&#8217; equity (deficit). As of June 30, 2025, the shares were still subject to a lock-up period and the Put Right. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, there were 29,874,066 and no shares of redeemable Class&#160;A common stock issued and outstanding, respectively. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-28<br></div></div></div>
<!--End Page 447-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 448-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Dividends </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of the redeemable convertible preferred stock were entitled to participate in any dividends distributed to holders of common stock, as if converted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of the Series&#160;C redeemable convertible preferred stock were entitled to a cumulative dividend that accrued from day-to-day at a rate of 10% per annum of the accumulated stated value, equal to $38.95 per share (the accumulated stated value is the defined &#8220;original issue price&#8221; at the time of conversion). Cumulative dividends were payable quarterly from the time the shares were issued until the completion of an IPO. These dividends could be paid in cash or in kind by being added to the accumulated stated value. After the IPO and conversion to redeemable Class&#160;A common stock, these dividend rights ceased, and there were no accrued and unpaid dividends as of June 30, 2025. For the three months ended June 30, 2025 and 2024, no cash dividends were paid by the Company. For the six months ended June 30, 2025 and 2024, the Company paid total cash dividends of $29 million and $0 million, respectively. In addition, for the three and six months ended June&#160;30, 2024, the Company issued a paid-in-kind dividend, which was recognized at fair value of $16 million. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the IPO, the Company's amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of preferred stock with a par value of $0.000005 per share with rights and preferences, including voting rights, designated from time to time by the Company's board of directors (the &#8220;Board&#8221;). As of June 30, 2025, there were no shares of preferred stock issued and outstanding. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, the Company was authorized to issue 3,400,000,000 and 690,680,000 shares of common stock, respectively, with a par value of $0.000005 per share. During the year ended December 31, 2024, the Company&#8217;s certificate of incorporation was amended such that the Company&#8217;s common stock consisted of Class&#160;A common stock and Class&#160;B common stock. In March&#160;2025, the Company&#8217;s certificate of incorporation was amended such that the Company&#8217;s common stock consisted of Class&#160;A common stock, Class&#160;B common stock, and Class&#160;C common stock. As of June 30, 2025, there were no shares of Class&#160;C common stock issued and outstanding. Common stockholders are entitled to receive any dividends if and when declared by the Board, and upon liquidation or dissolution, are also entitled to receive all assets legally available for distribution to stockholders, ratably in proportion to the number of shares held, subject to the rights of preferred stockholders (if then outstanding). As of June 30, 2025 and December 31, 2024, no dividends on the Company&#8217;s common stock had been declared by the Board. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Voting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of Class&#160;A common stock are entitled to one vote per share. Prior to the completion of the Company&#8217;s IPO, holders of Class&#160;B common stock were entitled to one vote per share. Upon the completion of the IPO, holders of Class&#160;B common stock are entitled to ten votes per share. Holders of Class&#160;A common stock and Class&#160;B common stock vote together as a single class, except where otherwise required by law. Holders of Class&#160;C common stock are entitled to no votes per share. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Warrants to Purchase Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company had outstanding warrants to purchase shares of the Company&#8217;s Class&#160;A common stock that were classified as liabilities. These warrants were issued in connection with the 2022 Senior Secured Notes, as disclosed in the Company&#8217;s Prospectus. As of December 31, 2024, the fair value of the warrant liabilities was $200&#160;million and was included within derivative and warrant liabilities on the condensed consolidated balance sheets. The Company recorded a loss related to the fair value adjustment of these warrant liabilities of $49&#160;million and $64&#160;million within gain (loss) on fair value adjustments in the condensed consolidated statements of operations during the three and six months ended June 30, 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On March&#160;21, 2025, the Company executed an amendment with the warrant holders to fix the exercise price to $1.5495 per share, subject to adjustments for standard anti-dilution adjustments. As a result of the amendment, the Company concluded that the warrants met the requirements for equity classification for contracts that are indexed to the Company&#8217;s own stock. The Company recognized a gain of $29&#160;million for the final fair value adjustment </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-29<br></div></div></div>
<!--End Page 448-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 449-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">pre-modification, and a loss of $2&#160;million in connection with the modification and fixing of the exercise price, which were recorded in gain (loss) on fair value adjustments in the condensed consolidated statements of operations for the six months ended June 30, 2025, and reclassified the final value of the warrants to additional paid-in capital. Refer to <font style="font-style: italic;">Note&#160;3&#8212;Fair Value Measurements</font> for further details. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">2019 Stock Option Plan and 2025 Equity Incentive Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2019, the Company adopted a stock option plan (the &#8220;2019 Plan&#8221;). The purpose of the 2019 Plan is to provide incentives to attract, retain, and motivate eligible persons whose potential contributions are important to the success of the Company by offering those eligible persons an opportunity to participate in the Company&#8217;s future performance through the grant of awards of common stock. The total number of shares authorized by the Board to be issued under the 2019 Plan was 73,637,600 shares as of December 31, 2024. Prior to the Company&#8217;s IPO, in the event that shares previously issued under the 2019 Plan were reacquired by the Company pursuant to a forfeiture provision, right of first refusal, or repurchase by the Company, such shares were added back to the number of shares then available for issuance under the 2019 Plan. As of December 31, 2024, 3,750,480 shares were available for issuance under the 2019 Plan. In March&#160;2025, in connection with the IPO and the adoption of the 2025 Plan (as defined below), the Company ceased granting awards under the 2019 Plan. Following the effective date of the 2025&#160;Plan, any outstanding awards granted under the 2019 Plan remain subject to the terms of the 2019 Plan, and any shares that are forfeited or repurchased by the Company under the 2019 Plan will be automatically transferred to be available for issuance under the 2025 Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company adopted the 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;) as a successor to the 2019 Plan, which became effective in connection with the IPO. The 2025 Plan authorizes the award of incentive stock options (&#8220;ISOs&#8221;), nonqualified stock options (&#8220;NQSOs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), stock appreciation rights, and RSUs, as well as performance and stock bonus awards. Pursuant to the 2025 Plan, the ISOs may be granted only to employees of the Company, while all other award types may be granted to employees, directors, and consultants. A total of 50,000,000 shares of the Company&#8217;s Class&#160;A common stock were initially reserved, plus any reserved shares of Class&#160;A common stock not issued or subject to outstanding grants under the 2019 Plan on the effective date of the 2025 Plan. The number of shares reserved for issuance under the 2025 Plan will increase automatically on January&#160;1 of each of 2026 through 2035 by the number of shares equal to the lesser of (a)&#160;five&#160;percent of the aggregate number of outstanding shares of all classes of common stock plus the total number of shares of Class&#160;A common stock issuable upon conversion of preferred stock (if any), in each case as of the immediately preceding December&#160;31, or (b) such number of shares of Class&#160;A common stock as may be determined by the Board or the compensation committee of the Board (the &#8220;Compensation Committee&#8221;). In the event that shares previously issued under the 2025 Plan are reacquired by the Company pursuant to a forfeiture provision, right of first refusal, or repurchase by the Company, such shares shall be added back to the number of shares then available for issuance under the 2025 Plan. As of June 30, 2025, 47,536,236 shares were available for issuance under the 2025&#160;Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may grant stock options to employees, contractors, or other entities in order to incentivize them to increase their efforts on behalf of the Company and to promote the success of the Company&#8217;s business. Stock options may be treated as ISO or NQSO depending on the specific circumstances of an optionee&#8217;s relationship with the Company and the number of stock options vesting or exercised in a calendar year. Stock options granted under the 2019 and 2025 Plans generally vest either over a three-year or four-year period. The Company may award stock options that are immediately exercisable, subject to a repurchase right. The Company may also grant stock options that allow for acceleration of vesting. The stock options granted under the 2019 and 2025 Plans will expire after ten years from the time of their grant. The Company issues Class&#160;A common stock upon the exercise of stock options. Pursuant to the equity exchange agreement between the Company and each of its co-founders, each co-founder has the right to exchange any shares of Class&#160;A common stock received upon the exercise of certain option awards granted prior to September&#160;2024 and held by such co-founder into an equal number of shares of Class&#160;B common stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-30<br></div></div></div>
<!--End Page 449-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 450-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Stock Options </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes stock option activity under the 2019 Plan (share data and aggregate intrinsic value in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 41.32pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 51.11pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise Price</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">(Years)</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic Value </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2025<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;">47,219</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;">$1.74</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.16pt; text-align: left;">7</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$2,163,455 </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 0.29pt;"></font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 1.67pt;">(2,950)</font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;"><font style="padding-left: 5pt;">1.53</font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited, expired, or canceled<font style="padding-left: 2.56pt;"></font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(164</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;"><font style="padding-left: 5pt;">6.62</font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at June&#160;30, 2025<font style="font-weight: normal; padding-left: 4.47pt;"></font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">44,105</font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;">$1.74</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.16pt; text-align: left;">7</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 0.37pt;">7,114,827 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested and expected to vest at June&#160;30, 2025<font style="font-weight: normal; padding-left: 3.22pt;"></font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">44,105</font></div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;">$1.74</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.16pt; text-align: left;">7</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 0.37pt;">7,114,827 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at June&#160;30, 2025<font style="font-weight: normal; padding-left: 3.55pt;"></font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">31,596</font></div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.16pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 13.33pt; text-align: left;">$1.14</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 18.16pt; text-align: left;">6</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 0.37pt;">5,116,131</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.67pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 41.32pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 51.11pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table above does not include 375,000 options outstanding as of June 30, 2025 that were issued in connection with the 2021 Convertible Senior Secured Notes. Refer to <font style="font-style: italic;">Note&#160;14&#8212;Related-Party Transactions</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company did not grant any stock options during the six months ended June 30, 2025 and 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The aggregate grant date fair value of stock options vested during the six months ended June 30, 2025 and 2024 was and $18&#160;million and $18&#160;million, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The aggregate intrinsic value of stock options exercised during the six months ended June 30, 2025 and 2024, was $170&#160;million and $14&#160;million, respectively. The intrinsic value for options exercised is the difference between the estimated fair value of the stock and the exercise price of the stock option at the date of exercise. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">Employee Stock Purchase Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company adopted the 2025 Employee Stock Purchase Plan (the &#8220;2025 ESPP&#8221;), which became effective in connection with the IPO. The 2025 ESPP enables eligible employees to purchase shares of the Company&#8217;s Class&#160;A common stock with accumulated payroll deductions. A total of 10,000,000 shares of the Company&#8217;s Class&#160;A common stock are reserved for issuance under the 2025 ESPP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of shares reserved for issuance and sale under the 2025 ESPP will increase automatically on January&#160;1st of each of 2026 through 2035 by the number of shares equal to the lesser of (a) the number of shares equal to 1% of the sum of the total number of outstanding shares of all classes of the Company&#8217;s common stock plus the total number of shares of the Company&#8217;s Class&#160;A common stock issuable upon conversion of preferred stock (if any), in each case outstanding as of the immediately preceding December&#160;31 and (b) such number of shares of the Company&#8217;s Class&#160;A common stock determined by the Board or Compensation Committee; provided, that the Board or Compensation Committee may in its sole discretion reduce the amount of the increase in any particular calendar year. Subject to stock splits, recapitalizations, or similar events, no more than 100,000,000 shares of the Company&#8217;s Class&#160;A common stock may be issued over the term of the 2025 ESPP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The purchase price for shares purchased under the 2025 ESPP during any given purchase period is 85% of the lesser of the fair market value of the Company&#8217;s Class&#160;A common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable purchase period. Each offering period may itself consist of one or more purchase periods. The 2025 ESPP has an initial offering period beginning on March&#160;28, 2025 and ending on November&#160;15, 2025, with a purchase date of November&#160;15, 2025. The initial enrollment period began on the date of the IPO and ended on April&#160;18, 2025. As of June 30, 2025, $2&#160;million has been withheld on behalf of employees for a future purchase under the ESPP due to the timing of payroll deductions and the open enrollment period. As of June 30, 2025, no shares of Class&#160;A common stock have been purchased under the 2025 ESPP. Stock-based compensation expense during the three months ended June 30, 2025 and unrecognized stock-based compensation expense as of June 30, 2025 related to the 2025 ESPP were not material. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-31<br></div></div></div>
<!--End Page 450-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 451-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Restricted Stock Units </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">RSUs granted typically vest over four years. The following table summarizes restricted stock unit activity under the 2019 and 2025 Plans (share data in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 56.28pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 6.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average Fair<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value Per Share </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2025<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">15,455</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;">$38.80 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 0.29pt;"></font></div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">13,188</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">62.39 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested<font style="padding-left: 0.84pt;"></font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 1.67pt;">(2,599)</font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">33.36 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited, expired, or canceled<font style="padding-left: 2.56pt;"></font></div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(367</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">36.57 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unvested balance at June&#160;30, 2025<font style="font-weight: normal;"> </font><font style="font-weight: normal; padding-left: 3.94pt;"></font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">25,677</font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;">$51.50 </div></td></tr><tr><td style="width: 360pt; padding-top: 3.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested and not yet settled<font style="padding-left: 1.99pt;"></font></div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 3.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">9</font></div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 3.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">45.96 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at June&#160;30, 2025<font style="font-weight: normal; padding-left: 4.47pt;"></font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">25,686</font></div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;">$51.50</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.05pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 56.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Restricted Stock Awards </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the three and six months ended June 30, 2025, 1,602,257 RSAs were granted in connection with the acquisition of Weights &amp; Biases. These awards typically vest over a four-year service period. The grant date fair value of the RSAs was based on the Company&#8217;s closing stock price on the grant date and is recognized as stock-based compensation expense over the vesting period. As of June 30, 2025, 1,460,477 of these RSAs remained unvested. Refer to <font style="font-style: italic;">Note&#160;4&#8212;Business Combination</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Stock-Based Compensation Expense </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, unrecognized stock-based compensation expense related to unvested stock options was $73&#160;million, which is expected to be recognized over a weighted-average period of two years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025, unrecognized stock-based compensation expense related to unvested RSUs and RSAs was $1.1&#160;billion, which is expected to be recognized over a weighted-average period of three years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Total stock-based compensation expense recognized in the Company&#8217;s condensed consolidated statements of operations was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;">$<font style="padding-left: 10pt;">2,701</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;">$<font style="padding-left: 7.5pt;">350</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">$<font style="padding-left: 10pt;">5,394</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;">$<font style="padding-left: 12.5pt;">738 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 0.47pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 10pt;">47,683</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 5pt;">2,080</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 5pt;">102,282</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt;">4,437 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 4.75pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 15pt;">8,494</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 12.5pt;">848</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10.37pt;">11,314</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt;">1,715 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 2.55pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">86,127</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,382</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">209,988</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8,959 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total stock-based compensation expense<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)(2)</sup><font style="font-weight: normal; padding-left: 0.99pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.71pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$145,005</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.91pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.72pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$7,660</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.6pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$328,978</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.6pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.06pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$15,849</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 54.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 44.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">Stock-based compensation expense was net of capitalized costs primarily related to the development of internal-use software of $12&#160;million and $2&#160;million during the three months ended June 30, 2025 and 2024, respectively, and $31&#160;million and $4&#160;million during the six months ended June 30, 2025 and 2024, respectively. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The Company recognized no and $177&#160;million of stock-based compensation expense, net of no and $17&#160;million of capitalized costs primarily related to the development of internal-use software, during the three and six months ended June 30, 2025, respectively, associated with vested RSUs as a result of the satisfaction of the liquidity-event performance-based vesting condition which was satisfied in connection with the IPO. </div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 16pt; margin-left: 0pt; text-align: left;">12. Income Taxes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company's effective tax rate was (20)% and (14)% for the three months ended June 30, 2025 and 2024, respectively, and (18)% and (14)% for the six months ended June 30, 2025 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company computed its provision for income taxes for interim periods by applying a forecasted annual effective tax rate to year-to-date earnings and adjusting for discrete items. However, the Company computed its </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-32<br></div></div></div>
<!--End Page 451-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 452-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">provision for income taxes based on the year-to-date actual effective tax rate for the three and six months ended June&#160;30, 2024, because the forecasted annual effective tax rate was highly sensitive to fluctuations in pre-tax income and a reliable estimate of the annual effective tax rate could not be made. The Company recorded income tax expense in all periods presented despite experiencing pre-tax losses primarily due to nondeductible losses on fair value adjustments and projected limitations on the Company's ability to realize certain tax benefits, which has resulted in the Company maintaining a full valuation allowance on its U.S. deferred tax assets. The increase in year-over-year income tax expense primarily resulted from an increase in pre-tax income excluding these nondeductible losses and the inability to record a net benefit from deferred tax assets generated. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">13. Net Loss Per Share Attributable to Common Stockholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company computes net loss per share utilizing the two-class method required for participating securities. The two-class method determines net loss per share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed income. The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A common stock, redeemable Class&#160;A common stock, and Class B common stock are identical, except with respect to voting, and in the case of redeemable Class&#160;A common stock, redemption. As a result, the basic and diluted net loss per share for all shares of Class A common stock, redeemable Class&#160;A common stock, and Class B common stock are the same and therefore presented on a combined basis. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company considers its redeemable convertible preferred stock and common stock warrants to be participating securities as the holders of these securities are contractually entitled to participate in income but not contractually required to participate in losses. As such, net loss for the periods presented was not allocated to the Company&#8217;s participating securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except per share data): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 107.58pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 97.95pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 107.58pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 97.95pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Numerator:<br></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss<font style="padding-left: 4.18pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;">$(290,509)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;">$(323,021)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;">$(605,150)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;">$(452,269) </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Dividends and accretion on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 3.11pt;"></font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(15,596</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(28,722</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(15,596</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net loss attributable to common stockholders, basic<font style="padding-left: 0.63pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;">$(290,509)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;">$(338,617)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;">$(633,872)</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;">$(467,865) </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Change in fair value of common stock warrants<font style="padding-left: 1.47pt;"></font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(26,845</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Net loss attributable to common stockholders, diluted<font style="padding-left: 4.72pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(290,509</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(338,617</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(660,717</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(467,865</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Denominator:<br></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss attributable to common stockholders, basic<font style="padding-left: 2.28pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 8.33pt;">486,591</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 8.33pt;">209,626</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="padding-left: 8.33pt;">366,765</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="padding-left: 8.33pt;">209,560 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Effect of dilutive securities:<br></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-align: left;">Common stock warrants<font style="padding-left: 3.09pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="padding-left: 18.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,842</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 30pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss attributable to common stockholders, diluted<font style="padding-left: 0.05pt;"></font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">486,591</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,626</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">368,607</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">209,560 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, basic<font style="padding-left: 1.95pt;"></font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.60</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.62</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.73</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.23</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 240pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, diluted<font style="padding-left: 4.72pt;"></font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.60</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.17pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.62</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.36pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.27pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(1.79</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 43.35pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.26pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(2.23</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 43.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.62pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 43.35pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-33<br></div></div></div>
<!--End Page 452-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 453-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of securities that were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive are as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">As of June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 384pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redeemable convertible preferred stock<font style="padding-left: 4.36pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">188,684 </div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding convertible notes<font style="padding-left: 4.87pt;"></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">24,544 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding stock options<font style="padding-left: 0.41pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">44,480</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">49,949 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding RSUs and RSAs<font style="padding-left: 1.53pt;"></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">27,146</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding warrants to purchase common stock<font style="padding-left: 2.13pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">4,337</font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">4,337 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">ESPP<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">147</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 384pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 4.64pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">76,110</font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">267,514</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 384pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table above does not include 5,248,300 RSUs outstanding as of June 30, 2024 because these awards were subject to a performance-based vesting condition that was not considered probable as of that date. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">14. Related-Party Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has entered into certain transactions, as further described below, with Magnetar Financial LLC (&#8220;Magnetar&#8221;) and certain funds or accounts managed or advised by Magnetar, and such funds or accounts collectively held a significant equity interest in the Company. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Senior Secured Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the issuance of the 2021 Convertible Senior Secured Notes in October&#160;2021, the Company granted Magnetar an option to purchase up to $15&#160;million of the Company&#8217;s Class&#160;A common stock at the IPO price, which is equal to 375,000 shares at the IPO price of $40.00 per share, which is exercisable until the one-year anniversary of the IPO. As of June 30, 2025, this option is still outstanding and has not been exercised. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2022, the Company executed a note issuance agreement and a note purchase agreement (the &#8220;2022 Senior Secured Notes&#8221;) and between October&#160;2022 and April&#160;2023, the Company issued $125&#160;million of 2022 Senior Secured Notes with maturity dates between October&#160;2025 and April&#160;2026 to funds or accounts managed or advised by Magnetar, along with warrants to purchase 12,144,668 shares of the Company&#8217;s Class&#160;A common stock. In March&#160;2025, the warrants were amended to fix the exercise price per share, and the Company concluded that these warrants met the requirements for equity classification. Refer to <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit)</font> for additional information. In July&#160;2024, the Company redeemed these notes in full, paying $137&#160;million. In connection with the issuance of the 2022 Senior Secured Notes, the Company granted Magnetar the right to purchase up to 5% of the Company&#8217;s Class&#160;A common stock issued at a price equal to the price per share in the Company&#8217;s IPO. This option expired unexercised in connection with the IPO. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Redeemable Convertible Preferred Stock Financing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Between April&#160;2023 and May&#160;2024, the Company issued a number of shares of different classes of redeemable convertible preferred stock, some of which were acquired by certain of the Company&#8217;s directors, holders of more than 5% of the Company&#8217;s outstanding capital stock, and their affiliates or funds or accounts managed thereby. As described in <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock, Redeemable Common Stock, and Stockholders&#8217; Equity (Deficit),</font> the shares of redeemable convertible preferred stock were converted in connection with the IPO. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facilities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, $388&#160;million and $438&#160;million in aggregate principal amount, respectively, of the DDTL 1.0 Facility was outstanding and held by funds or accounts managed or advised by Magnetar. The Company has paid to funds or accounts managed or advised by Magnetar $30&#160;million and $5&#160;million in principal and incurred $14&#160;million and $18&#160;million in interest expense for the three months ended June 30, 2025 and 2024, respectively. The Company has paid to funds or accounts managed or advised by Magnetar $55&#160;million and $5&#160;million in principal and incurred $29&#160;million and $31&#160;million in interest expense for the six months ended June 30, 2025 and 2024, respectively. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-34<br></div></div></div>
<!--End Page 453-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 454-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, $137&#160;million and $106&#160;million of the DDTL 2.0 Facility was outstanding and held by funds or accounts managed or advised by Magnetar, respectively. The Company has not made principal payments on the DDTL 2.0 Facility as of June 30, 2025. The Company incurred $3&#160;million and $6&#160;million, respectively, in interest expense for the three and six months ended June 30, 2025, respectively, and none for the three and six months ended June 30, 2024, associated with amounts held by funds or accounts managed or advised by Magnetar. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 20pt; text-align: left;">Magnetar Loan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In connection with the MagAI Capacity Agreement with MagAI Ventures, the Company had $257&#160;million outstanding under the Magnetar Loan as of June 30, 2025. The deposit of $230&#160;million was previously classified within other current liabilities on the condensed consolidated balance sheets as of December 31, 2024. The Company incurred $8&#160;million and $27 million, respectively, in interest expense in connection with the Magnetar Loan for the three and six months ended June 30, 2025. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 20pt; text-align: left;">Strategic Investment </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2024, the Company contributed $50&#160;million to a fund managed by Magnetar in connection with the fund&#8217;s purchase of a third-party&#8217;s preferred stock. The Company consolidated the fund and accounted for the purchased preferred stock as privately held equity securities that do not have a readily determinable fair value measured at cost, with subsequent adjustments for observable price changes or impairments. The investment is included in other non-current assets on the condensed consolidated balance sheets. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 20pt; text-align: left;">Unconsolidated Joint Venture </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2025, the Company entered into a forward-starting lease and a development management agreement in connection with the JV, which is an unconsolidated subsidiary of the Company and a related party. These agreements are deemed to be priced at market terms as they were negotiated as part of an arms-length negotiations with the other investor in the JV. During the three and six months ended June 30, 2025, the Company did not recognize any income or expenses in the condensed consolidated statements of operations pursuant to these agreements. Refer to <font style="font-style: italic;">Note&#160;8</font>&#8212;<font style="font-style: italic;">Leases </font>for additional information. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">15. Geographic Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue by geography is based on the address of the customer as specified in the Company's customer contracts. The following table sets forth revenue by geographic area (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 109.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 99.7pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 109.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Three Months Ended June&#160;30,</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 99.7pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Six Months Ended June&#160;30, </div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.66pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.16pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.85pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2025</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.35pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">United States<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.66pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.33pt; text-align: left;">$1,147,655</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.34pt; text-align: left;">$370,107</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.85pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;">$2,077,079</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.35pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;">$547,071 </div></td></tr><tr><td style="width: 240pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">All other countries<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.66pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.33pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">65,133</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.34pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">25,264</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.85pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;"><font style="padding-left: 12.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">117,341</font></div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.35pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">36,984 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total revenue<font style="padding-left: 2.11pt;"></font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 53.66pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,212,788</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 46.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.34pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$395,371</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.85pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,194,420</font></div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.35pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.93pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$584,055</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 53.66pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 46.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.85pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 41.35pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company's long-lived assets are attributed to a country based on the physical location of the assets. It defines long-lived assets as property and equipment and operating lease right-of-use assets because many of these assets cannot be readily moved and are relatively illiquid, subjecting them to geographic risk. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of June 30, 2025 and December 31, 2024, 87% and 90%, respectively, of the Company's long-lived assets were located in the United States, and no other single country accounted for more than 10% of these assets. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 15.5pt; margin-left: 0pt; text-align: left;">16. Subsequent Events </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2025, the Company entered into a definitive agreement to acquire Core Scientific, Inc., a leading data center infrastructure provider, in an all-stock transaction (the &#8220;Transaction&#8221;). The Transaction is expected to help the Company verticalize its data center footprint to support revenue growth and improve operational profitability. The Transaction is expected to close in the fourth quarter of 2025, subject to shareholder and regulatory approval. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2025, President Trump signed into law the One Big Beautiful Bill Act (&#8220;OBBBA&#8221;). The OBBBA amends key provisions of the tax code, including modifications to bonus depreciation, domestic research cost </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-35<br></div></div></div>
<!--End Page 454-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 455-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_303-annexd_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">expensing, and the business interest expense limitation. ASC 740, <font style="font-style: italic;">Income Taxes</font>, requires the effects of changes in tax rates and laws on deferred tax balances to be recognized in the period in which the legislation is enacted. Consequently, the Company is still evaluating all deferred tax balances under the newly enacted tax law and any other changes required to its financial statements as a result of the OBBBA, which will be reflected on the Company's Quarterly Report on Form&#160;10-Q for the three and nine months ending September&#160;30, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2025, the Company entered into an additional Delayed Draw Term Loan 3.0 Facility (as amended, the &#8220;DDTL 3.0 Facility&#8221;), which provided for a delayed draw term loan facility of up to $2.6 billion. The Company intends to use borrowings under the DDTL 3.0 Facility to fund the purchase and maintenance of certain equipment, hardware, infrastructure and other systems to be utilized by the Company in order to provide a strategic customer with certain services ordered by such strategic customer. The Company will pay interest at a rate per annum equal to daily compounded SOFR plus an applicable margin of 4.00%. The Company is required to pay an undrawn fee of 0.50% per annum on the average daily undrawn portion of the DDTL 3.0 Facility. The Company will commence repayments of the DDTL 3.0 Facility on the first monthly payment date on or after April&#160;1, 2026. Any remaining unpaid principal is due on the term maturity date of August&#160;21, 2030. The Company's DDTL 3.0 Facility requires the Company to maintain certain restricted cash balances based on a yearly schedule. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2025, the Company closed a private placement of $1.8 billion aggregate principal amount of 9.00% senior notes due 2031 (the &#8220;2031 Senior Notes&#8221;). The Company intends to use the proceeds for general corporate purposes. The 2031 Senior Notes and related guarantees were offered only to persons reasonably believed to be qualified institutional buyers pursuant to Rule&#160;144A under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and to non-U.S. persons pursuant to Regulation S under the Securities Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2025, the Company entered into additional financing agreements with an OEM. The financing agreements have an aggregate notional balance of $172&#160;million. The financing arrangements have terms of three years. The Company granted a security interest for the financed equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August&#160;2025, the Company entered into additional lease agreements, primarily for data centers and storage facilities, that have not yet commenced. The aggregate amount of estimated future undiscounted lease payments associated with such leases is $11.9&#160;billion. These leases are expected to commence between 2025 and 2027 with estimated lease terms of ten years to 16 years. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">D-36<br></div></div></div>
<!--End Page 455-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 456-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304a-annexefintoc_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: right;"><a name="tANNEXE"><!--Anchor--></a>Annex E</div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 19.5pt; text-align: center;">CoreWeave Consolidated Financial Statements</div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-1<br></div></div></div>
<!--End Page 456-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 457-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304a-annexefintoc_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">&#8195;<br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 432pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 19.44pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 432pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Page </div></td></tr><tr><td style="width: 432pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRIR">Reports of Independent Registered Public Accounting Firm<font style="padding-left: 1.8pt;"></font></a></div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tRIR"><font style="padding-left: 5pt;">E-3 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCBS">Consolidated Balance Sheets<font style="padding-left: 1.76pt;"></font></a></div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCBS"><font style="padding-left: 5pt;">E-5 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSO">Consolidated Statements of Operations<font style="padding-left: 0.66pt;"></font></a></div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSO"><font style="padding-left: 5pt;">E-6 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSC">Consolidated Statements of Comprehensive Loss<font style="padding-left: 4.56pt;"></font></a></div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSC"><font style="padding-left: 5pt;">E-7 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSR">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit<font style="padding-left: 0.94pt;"></font></a></div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSR"><font style="padding-left: 5pt;">E-8 </font></a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSF">Consolidated Statements of Cash Flows<font style="padding-left: 1.77pt;"></font></a></div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tCSF">E-10 </a></div></td></tr><tr><td style="width: 432pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tNCF">Notes to Consolidated Financial Statements<font style="padding-left: 1.22pt;"></font></a></div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 19.44pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tNCF">E-12</a></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 432pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 19.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-2<br></div></div></div>
<!--End Page 457-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 458-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tRIR"><!--Anchor--></a>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">To the stockholders and the Board of Directors of CoreWeave, Inc. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Opinion on the Financial Statements </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have audited the accompanying consolidated balance sheets of CoreWeave, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December&#160;31, 2024 and 2023, the related consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; deficit, and cash flows, for each of the two years in the period ended December&#160;31, 2024, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the two years in the period ended December&#160;31, 2024, in conformity with accounting principles generally accepted in the United States of America. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Basis for Opinion </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">/s/ Deloitte &amp; Touche LLP <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">San Jose, California <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">March 3, 2025 (March 19, 2025 as to the effects of the stock split described in Note 1) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">We have served as the Company&#8217;s auditor since 2024. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-3<br></div></div></div>
<!--End Page 458-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 459-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;">Report of Independent Registered Public Accounting Firm </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-align: left;">To the Stockholders and the Board of Directors of CoreWeave, Inc. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Opinion on the Financial Statements </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We have audited the accompanying consolidated statements of operations, comprehensive loss, redeemable convertible preferred stock and stockholders&#8217; deficit, and cash flows for the year ended December&#160;31, 2022, and the related notes to the consolidated financial statements (collectively, the financial statements) of CoreWeave, Inc. (the Company). In our opinion, the financial statements referred to above present fairly, in all material respects, the results of operations of the Company and its cash flows for the year ended December&#160;31, 2022, in conformity with accounting principles generally accepted in the United States of America. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">Basis for Opinion </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-align: justify;">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-align: left;">/s/ RSM US LLP <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">We served as the Company&#8217;s auditor from 2022 through 2025. <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">&#8195;<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Minneapolis, Minnesota <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">January 22, 2025, except for the effects of the stock split described in Note&#160;1, as to which the date is March&#160;19, 2025 </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-4<br></div></div></div>
<!--End Page 459-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 460-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCBS"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED BALANCE SHEETS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data)</div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.03pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets<br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.03pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.03pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current assets<br></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 1.4pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;">$<font style="padding-left: 7.05pt;">217,147</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 4.7pt;">1,361,083 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, current<font style="padding-left: 0.18pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">42,940</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt;">37,394 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable, net<font style="padding-left: 3.46pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">165,379</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">416,526 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.97pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">76,526</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">101,246 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current assets<font style="font-weight: normal; padding-left: 2.8pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">501,992</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">1,916,249 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<font style="padding-left: 2.96pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">219,988</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">637,356 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<font style="padding-left: 1.75pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">171,734</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt;">29,308 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment, net<font style="padding-left: 3.83pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 4.7pt;">3,483,990</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 5.05pt;">11,914,774 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease right-of-use assets<font style="padding-left: 0.63pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">461,966</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">2,589,547 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Intangible assets, net<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 21.14pt;">7,003</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 25.84pt;">4,909 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Goodwill<font style="padding-left: 2.15pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">19,544</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt;">19,544 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 1.48pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 12.09pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">110,758</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">720,912 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 2.68pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total assets<font style="font-weight: normal; padding-left: 1.02pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 2.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,976,975</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 2.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$17,832,599 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.33pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Liabilities, Redeemable Convertible Preferred Stock, and Stockholders&#8217; Deficit<br></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current liabilities<br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable<font style="padding-left: 4.8pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;">$<font style="padding-left: 7.05pt;">455,563</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;">$<font style="padding-left: 11.75pt;">868,259 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities<font style="padding-left: 2.72pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">77,782</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">355,821 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt, current<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 4.53pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">171,865</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">2,468,425 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue, current<font style="padding-left: 4.3pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">249,831</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">768,927 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 2.97pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">39,789</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">213,104 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 0.8pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 21.14pt;">3,534</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt;">57,801 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other current liabilities<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 0.65pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 32.89pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">97</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">230,244 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total current liabilities<font style="font-weight: normal; padding-left: 4.22pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">998,461</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">4,962,581 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Debt, non-current<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 2.3pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 4.7pt;">1,351,389</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">5,457,915 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative and warrant liabilities<font style="padding-left: 1.36pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">527,047</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">200,089 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred revenue, non-current<font style="padding-left: 2.08pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 4.7pt;">1,754,873</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">3,294,977 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 0.75pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt;">432,653</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">2,388,912 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance lease liabilities, non-current<font style="padding-left: 3.57pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 28.19pt;">510</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt;">34,120 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities, non-current<font style="padding-left: 2.24pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">36,447</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 16.45pt;">149,232 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current liabilities<font style="padding-left: 1.19pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 21.14pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">7,496</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 21.14pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">36,260 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities<font style="font-weight: normal; padding-left: 2.44pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 4.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,108,876</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 4.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,524,086 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Commitments and contingencies (<font style="font-style: italic;">Note&#160;9</font>)<br></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redeemable convertible preferred stock<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Redeemable convertible preferred stock, $0.000005 par value per share, 176,646 and 206,169 shares authorized as of December&#160;31, 2023 and 2024, respectively; 154,678 and 184,635 shares issued and outstanding as of December&#160;31, 2023 and 2024, respectively<font style="padding-left: 2.25pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 11.75pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">464,690</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 10.09pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,722,111 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stockholders&#8217; deficit<br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Class&#160;A common stock, $0.000005 par value per share, 469,031 and 540,680 shares authorized as of December&#160;31, 2023 and 2024, respectively; 208,003 and 121,277 shares issued as of December&#160;31, 2023 and 2024, respectively; and 203,520 and 114,689 shares outstanding as of December&#160;31, 2023 and 2024, respectively<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 37.59pt;">1</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 42.29pt;">1 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Class&#160;B common stock, $0.000005 par value per share, no and 150,000 shares authorized as of December&#160;31, 2023 and 2024, respectively; no and 118,198 shares issued and outstanding as of December&#160;31, 2023 and 2024, respectively<font style="padding-left: 3.85pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 32.89pt;">&#8212;</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 42.29pt;">0 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Treasury stock, at cost, 4,483 and 6,588 shares as of December&#160;31, 2023 and 2024, respectively<font style="padding-left: 2.25pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 13.32pt;">(32,054)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 18.02pt;">(33,524) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additional paid-in capital<font style="padding-left: 4.53pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 16.45pt;">48,397</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 9.4pt;">1,096,160 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated other comprehensive loss<font style="padding-left: 2.35pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 25.07pt;">(148)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 0.43pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 37.59pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accumulated deficit<font style="padding-left: 0.41pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 8.62pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(612,787</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.08pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 6.27pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,476,235</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total stockholders&#8217; deficit<font style="font-weight: normal; padding-left: 2.75pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="padding-left: 8.62pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(596,591</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; padding-bottom: 1.68pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="padding-left: 13.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(413,598</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.33pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; deficit<font style="font-weight: normal; padding-left: 2.29pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 2.44pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,976,975</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.33pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 9.4pt; margin-top: 0pt; margin-left: 0.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$17,832,599</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.85pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.85pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 12.75pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refer to <font style="font-style: italic;">Note&#160;14&#8212;Related-Party Transactions</font> for further information on related party arrangements. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-5<br></div></div></div>
<!--End Page 460-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 461-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCSO"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF OPERATIONS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands, except per share data) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 145.09pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 145.09pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revenue<font style="font-weight: normal; padding-left: 2.85pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">15,830</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">228,943</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$1,915,426 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses:<br></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 4.53pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">12,122</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">68,780</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">493,350 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Technology and infrastructure<font style="padding-left: 2.47pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">18,106</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt;">131,855</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">960,685 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sales and marketing<font style="padding-left: 1.75pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt;">2,481</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt;">12,917</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">18,389 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">General and administrative<font style="padding-left: 4.55pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">6,001</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,842</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">118,644 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total operating expenses<font style="padding-left: 3.57pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">38,710</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">243,394</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,591,068 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating income (loss)<font style="font-weight: normal; padding-left: 1.2pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 6.67pt;">(22,880)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(14,451)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">324,358 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss on fair value adjustments<font style="padding-left: 3.99pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 11.67pt;">(2,884)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(533,952)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(755,929) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Interest expense, net<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup><font style="padding-left: 2.61pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 11.67pt;">(9,444)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt;">(28,404)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(360,824) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other income, net<font style="padding-left: 0.92pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">192</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">18,760</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">48,194 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Loss before provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 3.1pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 6.67pt;">(35,016)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(558,047)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.17pt;">(744,201) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Provision for (benefit from) income taxes<font style="padding-left: 4.02pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 11.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(4,150</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">35,701</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">119,247 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from continuing operations<font style="font-weight: normal; padding-left: 4.18pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(30,866</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,748</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(863,448</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss from discontinued operations, net of tax<font style="font-weight: normal; padding-left: 2.82pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 14.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(189</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 25.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 30pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 0.63pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(31,055</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,748</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(863,448</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 2.1pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 1.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(31,055</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,748</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 4.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(937,765</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss from continuing operations per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 0.37pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 11.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.17</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(3.09</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(4.30</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss from discontinued operations per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 0.38pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">0.00</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 25.83pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 30pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 4.5pt;"></font></div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 11.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.17</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(3.09</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 19.17pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(4.30</font><font style="padding-bottom: 0.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted<font style="font-weight: normal; padding-left: 4.3pt;"></font></div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">180,632</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">192,164</font></div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">217,854</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Refer to <font style="font-style: italic;">Note&#160;14&#8212;Related-Party Transactions</font> for further information on related party arrangements. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-6<br></div></div></div>
<!--End Page 461-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 462-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCSC"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 143.17pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 143.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31,</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="font-weight: normal; padding-left: 0.63pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(31,055)</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(593,748)</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(863,448) </div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other comprehensive income (loss):<br></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Unrealized (loss) gain on available-for-sale marketable securities, net<font style="padding-left: 1.23pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(156</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 35.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">148 </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total comprehensive loss<font style="font-weight: normal; padding-left: 1.74pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(31,211</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(593,740</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(863,300</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-7<br></div></div></div>
<!--End Page 462-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 463-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCSR"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; DEFICIT <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 79.75pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 57.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 28.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.15pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 91pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold;">&#160;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 79.75pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable Convertible <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 57.32pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 28.88pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 34.17pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">paid-in <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">capital</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 47.77pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">other <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">comprehensive <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">loss</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 42.48pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 44.15pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders&#8217; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit </div></td></tr><tr class="BRDSX_header"><td style="width: 91pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold;">&#160;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 91pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; font-weight: bold; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Balance at January&#160;1, 2022<font style="font-weight: normal; padding-left: 0.98pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 3.85pt;">83,775</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;">$<font style="padding-left: 7.7pt;">5,290</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">180,000</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;">$<font style="padding-left: 3.85pt;">1</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;">$<font style="padding-left: 16.03pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;">$<font style="padding-left: 3.85pt;">1,001</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;">$<font style="padding-left: 6.41pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;">$<font style="padding-left: 6.41pt;">12,016</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;">$<font style="padding-left: 6.41pt;">13,018 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of common stock warrants in connection with debt financing<font style="padding-left: 0.24pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 7.7pt;">6,027</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 14.11pt;">6,027 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 1.59pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 7.7pt;">1,560</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 14.11pt;">1,560 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Unrealized loss on available-for-sale marketable securities<font style="padding-left: 0.55pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 3.85pt;">(156)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 17.32pt;">(156) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 3.43pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 7.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(31,055</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 7.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(31,055</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; font-weight: bold; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Balance, December&#160;31, 2022<font style="font-weight: normal; padding-left: 0.98pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 3.85pt;">83,775</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;">$<font style="padding-left: 7.7pt;">5,290</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">180,000</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;">$<font style="padding-left: 3.85pt;">1</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;">$<font style="padding-left: 16.03pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;">$<font style="padding-left: 3.85pt;">8,588</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;">$(156)</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;">$<font style="padding-left: 3.85pt;">(19,039)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 2.74pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;">$<font style="padding-left: 3.85pt;">(10,606) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Conversion of convertible promissory notes to Series&#160;B-1 redeemable convertible preferred stock<font style="padding-left: 0.13pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 3.85pt;">12,485</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 11.55pt;">5,006</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of Series&#160;B redeemable convertible preferred stock, net of issuance costs of $0&#160;million and Series&#160;B Tranche Liability of $10&#160;million<font style="padding-left: 0.02pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 3.85pt;">75,496</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 3.85pt;">410,465</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Partial settlement of Series&#160;B tranche option<font style="padding-left: 2.42pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 7.7pt;">45,531</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Conversion of redeemable convertible preferred stock to common stock for secondary offering<font style="padding-left: 1.42pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 1.29pt;">(17,078)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 8.99pt;">(1,842)</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.85pt;">17,078</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 7.7pt;">1,842</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 14.11pt;">1,842 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of common stock for private placement<font style="padding-left: 4.27pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.7pt;">4,483</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 3.85pt;">14,837</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 10.26pt;">14,837 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of common stock for business <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-align: left;">combination<font style="padding-left: 2.89pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.7pt;">2,105</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.56pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.7pt;">4,337</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 7.7pt;">1,669</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 14.11pt;">1,669 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Repurchase of common stock<font style="padding-left: 0.13pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.14pt;">(4,483)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 3.85pt;">(32,054)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 7.7pt;">(32,054) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of common stock warrants in connection with debt financing<font style="padding-left: 0.24pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 7.7pt;">3,959</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 14.11pt;">3,959 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Settlement of notes due from employees<font style="padding-left: 0.93pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 17.32pt;">240</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 13.47pt;">132</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 19.88pt;">132 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 1.59pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 3.85pt;">17,370</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 10.26pt;">17,370 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Other comprehensive income<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 14.11pt;">8</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 23.73pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 27.58pt;">8 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 3.43pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="padding-left: 21.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="padding-left: 10.26pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="padding-left: 3.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(593,748</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 3.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(593,748</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 2.74pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; font-weight: bold; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Balance, December&#160;31, 2023<font style="font-weight: normal; padding-left: 0.98pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">154,678</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.95pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$464,690</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">203,520</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.85pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(32,054</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$48,397</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 14.9pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(148</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 5.53pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(612,787</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(596,591</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.55pt; width: 91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 34.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 38.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 25.02pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 26.24pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 28.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 34.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 47.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 42.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 44.15pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-8<br></div></div></div>
<!--End Page 463-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 464-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 79.75pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 57.32pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 28.88pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.77pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.48pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 44.15pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 91pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold;">&#160;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 79.75pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Redeemable Convertible <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preferred Stock</div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 57.32pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Common Stock</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 28.88pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Treasury <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 34.17pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Additional <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">paid-in <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">capital</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 47.77pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">other <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">comprehensive <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">loss</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 42.48pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 44.15pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Total <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stockholders&#8217; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Deficit </div></td></tr><tr class="BRDSX_header"><td style="width: 91pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold;">&#160;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount</div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.22pt; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.5pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td><td style="width: 3.03pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 91pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of Series&#160;B redeemable convertible preferred stock<font style="padding-left: 4.37pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 7.7pt;">4,483</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 13.47pt;">25,000</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 2.22pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Closing settlement of Series&#160;B tranche option<font style="padding-left: 2.42pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 13.47pt;">69,598</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Issuance of Series&#160;C redeemable convertible preferred stock, net of issuance costs of $3&#160;million<font style="padding-left: 3.87pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 3.85pt;">29,523</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 3.85pt;">1,147,476</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Series&#160;C redeemable convertible preferred stock accretion to redemption value<font style="padding-left: 2.08pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">73</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 24.38pt;">(73)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 24.38pt;">(73) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Cash dividend on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 4.37pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 10.91pt;">(58,662)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 10.91pt;">(58,662) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Paid-in-kind dividend on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 0.13pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 13.47pt;">15,582</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 10.91pt;">(15,582)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 10.91pt;">(15,582) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Conversion of convertible notes to common stock<font style="padding-left: 3.26pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 3.85pt;">24,544</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 3.85pt;">1,080,295</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 3.85pt;">1,080,295 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercise of stock options<font style="padding-left: 4.56pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.7pt;">2,879</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 17.32pt;">2,890</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 17.32pt;">2,890 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Repurchase of common stock for business combination<font style="padding-left: 2.89pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.14pt;">(2,105)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212; </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Repurchases of common stock from an employee<font style="padding-left: 0.28pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 7.7pt;">(1,470)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 14.76pt;">(1,470) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Conversion of redeemable convertible preferred stock to common stock for secondary offering<font style="padding-left: 1.42pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 5.14pt;">(4,049)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 20.53pt;">(308)</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 7.7pt;">4,049</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 23.09pt;">308</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 23.09pt;">308 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Stock-based compensation expense<font style="padding-left: 1.59pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 13.47pt;">38,587</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 13.47pt;">38,587 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Other comprehensive income<font style="padding-left: 3.72pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 3.85pt;">148</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 29.51pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 1.78pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 23.09pt;">148 </font></div></td></tr><tr><td style="width: 91pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 3.43pt;"></font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="padding-left: 26.94pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.32pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="padding-left: 3.85pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: left;"><font style="padding-left: 19.88pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: left;"><font style="padding-left: 26.94pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 7.7pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="padding-left: 9.62pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(863,448</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 1.49pt; padding-bottom: 3.03pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="padding-left: 7.06pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(863,448</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 91pt; padding-top: 2.74pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; font-weight: bold; margin-top: 0pt; margin-left: 7.7pt; text-indent: -7.7pt; text-align: left;">Balance, December&#160;31, 2024<font style="font-weight: normal; padding-left: 0.98pt;"></font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.92pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.96pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">184,635</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.77pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.07pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.57pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,722,111</font></div></td><td style="width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 25.02pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.01pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">232,887</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.24pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 7.35pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.85pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 28.88pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 0.66pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(33,524</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.17pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: -0.48pt; text-align: justify;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,096,160</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.77pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.85pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.48pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 2.64pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(1,476,235</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 44.15pt; padding-top: 2.74pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 7.7pt; margin-top: 0pt; margin-left: 4.75pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.21pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(413,598</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 3.55pt; width: 91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 34.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 38.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 2.78pt; border-right: 1pt solid #000000; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 2.78pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 25.02pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 26.24pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 28.88pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 34.17pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 47.77pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 42.48pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 3.03pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 3.55pt; width: 44.15pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-9<br></div></div></div>
<!--End Page 464-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 465-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tCSF"><!--Anchor--></a>COREWEAVE, INC. <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">CONSOLIDATED STATEMENTS OF CASH FLOWS <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">(in thousands) </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 156.17pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 156.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 300pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from operating activities:<br></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 4.18pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(31,055)</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">(593,748)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">(863,448) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss from discontinued operations, net of tax<font style="padding-left: 1.74pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(189)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss from continuing operations<font style="padding-left: 0.33pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(30,866)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(593,748)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(863,448) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Adjustments to reconcile net loss to net cash provided by operating activities<br></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Depreciation and amortization<font style="padding-left: 4.21pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.7pt;">11,695</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">103,210</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">863,413 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-cash lease expense<font style="padding-left: 0.33pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">16</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">20,404</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">122,748 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Amortization of debt discounts and issuance costs<font style="padding-left: 2.58pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">3,803</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">16,533</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">33,376 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Loss on fair value adjustments<font style="padding-left: 1.99pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">2,884</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">533,952</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">755,929 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Stock-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">1,490</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">15,154</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">31,487 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Debt extinguishment loss<font style="padding-left: 4.19pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 21.2pt;">11,708 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred income taxes<font style="padding-left: 0.33pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(1,284)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">35,816</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 16.2pt;">112,785 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-cash reconciling items<font style="padding-left: 2pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 33.33pt;">632</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">3,286 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Changes in operating assets and liabilities, net of effect of business acquisition:<br></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts receivable<font style="padding-left: 0.32pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(1,893)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(162,413)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(279,720) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid expenses and other current assets<font style="padding-left: 2.59pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(1,047)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(71,964)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(29,200) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accounts payable and accrued expenses<font style="padding-left: 3.69pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">1,404</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">26,807</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">510,568 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue<font style="padding-left: 1.99pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">9,354</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,986,304</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">2,049,068 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Lease liabilities<font style="padding-left: 3.64pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">(9,302)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.87pt;">(87,611) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other non-current assets<font style="padding-left: 3.11pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">87</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(67,317)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(485,332) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other liabilities<font style="padding-left: 4.19pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,418</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 34.07pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">111 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash (used in) provided by continuing operations<font style="padding-left: 4.25pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(4,357)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,832,650</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">2,749,168 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash provided by operating activities&#8212;discontinued operations<font style="padding-left: 3.15pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,267</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by operating activities<font style="font-weight: normal; padding-left: 4.41pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">910</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,832,650</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,749,168 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from investing activities:<br></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Purchase of property and equipment, including capitalized internal-use software<font style="padding-left: 3.08pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(72,404)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(2,943,130)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(8,702,078) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Sale of available-for-sale marketable securities<font style="padding-left: 1.69pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">7,000</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">5,689</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">2,470 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Maturities of marketable securities<font style="padding-left: 0.9pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">185,218 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of restricted marketable securities<font style="padding-left: 0.37pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(171,734)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(34,053) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Purchase of strategic investments<font style="padding-left: 1.45pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(33,000)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(50,000) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Issuance of notes receivable<font style="padding-left: 2.57pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(59,615) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other investing activities<font style="padding-left: 0.31pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(14,852</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(5,535</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash used in investing activities by continuing operations<font style="padding-left: 0.36pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(80,256)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(3,147,710)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(8,658,058) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash provided by investing activities&#8212;discontinued operations<font style="padding-left: 4.25pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,073</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash used in investing activities<font style="font-weight: normal; padding-left: 3.12pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(79,183</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(3,147,710</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(8,658,058</font><font style="padding-bottom: 1.5pt;">)</font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash flows from financing activities:<br></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of debt<font style="padding-left: 4.23pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">60,000</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,415,862</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">7,022,291 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of convertible debt<font style="padding-left: 0.91pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">30,000</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Repayments of debt<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(3,055)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">(2,180)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">(588,555) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Payment of debt issuance costs<font style="padding-left: 4.78pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">(1,651)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">(12,053)</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">(3,786) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of redeemable convertible preferred stock, net of issuance costs<font style="padding-left: 2.51pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">420,765</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,172,476 </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-10<br></div></div></div>
<!--End Page 465-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 466-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304b-annexefintab_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 156.17pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 156.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 300pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Redeemable convertible preferred stock cash dividends paid<font style="padding-left: 1.5pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 14.17pt;">(57,745) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from exercise of stock options<font style="padding-left: 3.69pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">1,669</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 22.5pt;">2,890 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Common stock repurchased<font style="padding-left: 4.2pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 14.17pt;">(32,054)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 19.17pt;">(1,470) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from issuance of common stock<font style="padding-left: 2.02pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 17.5pt;">14,837</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other financing activities<font style="padding-left: 4.21pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(3,840</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(19,095</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(81,453</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net cash provided by financing activities<font style="font-weight: normal; padding-left: 0.51pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$81,454</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$1,787,751</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$7,464,648 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net increase in cash, cash equivalents, and restricted cash<font style="padding-left: 0.41pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 5pt;">3,181</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 7.5pt;">472,691</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$1,555,758 </div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents, and restricted cash&#8212;beginning of period<font style="padding-left: 2.61pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,203</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">7,384</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">480,075 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash, cash equivalents, and restricted cash&#8212;end of period<font style="padding-left: 3.16pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">7,384</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">480,075</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,035,833 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Supplemental disclosures of cash flow information:<br></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash paid for interest, net of capitalized amounts<font style="padding-left: 0.64pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 5pt;">5,124</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 25pt;">105</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 7.5pt;">183,657 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash paid for income taxes<font style="padding-left: 0.33pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 12.5pt;">255</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 25pt;">214</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 12.5pt;">14,332 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Non-cash investing and financing activities:<br></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Capitalized interest<font style="padding-left: 4.2pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 12.5pt;">41,376</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$<font style="padding-left: 12.5pt;">31,714 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating lease right-of-use assets acquired through lease liability<font style="padding-left: 2.07pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 10pt;">1,210</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 12.5pt;">481,145</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 5pt;">2,222,257 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Right-of-use assets for lease modification and renewals<font style="padding-left: 0.94pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">18,987 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance lease right-of-use assets acquired through lease liability<font style="padding-left: 0.4pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 5pt;">14,622</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">141,916 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Derivative liabilities from issuance of convertible notes<font style="padding-left: 0.37pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 5pt;">10,841</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 35pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Accounts payable and accrued expenses related to property and equipment additions<font style="padding-left: 0.29pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 12.5pt;">482,330</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt;">892,632 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Issuance of common stock in connection with conversion of convertible notes<font style="padding-left: 3.08pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 5pt;">1,080,295 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Settlement of Series&#160;B tranche liability<font style="padding-left: 3.11pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 17.5pt;">45,531</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">69,598 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Non-cash investments<font style="padding-left: 3.09pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">10,133 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Stock-based compensation capitalized as internal-use software<font style="padding-left: 3.17pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">2,216</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 22.5pt;">7,100 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred offering costs not yet paid<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 22.5pt;">7,951 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Reconciliation of cash, cash equivalents, and restricted cash to consolidated balance sheets:<br></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash and cash equivalents<font style="padding-left: 4.77pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 5pt;">7,384</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;">$<font style="padding-left: 7.5pt;">217,147</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;">$1,361,083 </div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, current<font style="padding-left: 3.98pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 17.5pt;">42,940</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 17.5pt;">37,394 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Restricted cash and cash equivalents, non-current<font style="padding-left: 0.65pt;"></font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">219,988</font></div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">637,356 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total cash, cash equivalents, and restricted cash<font style="font-weight: normal; padding-left: 3.67pt;"></font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">7,384</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.66pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">480,075</font></div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.67pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,035,833</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 9.47pt; text-align: center;">The accompanying notes are an integral part of these consolidated financial statements.<font style="font-style: normal;"> </font><br></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-11<br></div></div></div>
<!--End Page 466-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 467-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tNCF"><!--Anchor--></a>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">1. Overview and Summary of Significant Accounting Policies </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Organization and Description of Business </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave, Inc., together with its subsidiaries (the &#8220;Company&#8221; or &#8220;CoreWeave&#8221;), was originally formed as a Delaware limited liability company in 2017 and then converted to a Delaware corporation in 2018. The Company is headquartered in Livingston, New Jersey. The Company is a modern cloud infrastructure technology company which offers the CoreWeave Cloud Platform that consists of proprietary software and cloud services that deliver the automation and efficiency needed to manage complex AI infrastructure at scale. Previously, the Company had Blockchain Mining and Management Services business which ceased operations in September 2022 and the Company is reporting this as discontinued operations in these consolidated financial statements. Refer to <font style="font-style: italic;">Note&#160;16&#8212;Discontinued Operations </font>for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Basis of Presentation and Consolidation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;) and include the accounts of the Company and its wholly and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company determines at inception of each arrangement whether an entity in which the Company has made an investment or in which the Company has other variable interests is considered a variable interest entity (&#8220;VIE&#8221;). Investments that are considered VIEs are evaluated to determine whether the Company is the primary beneficiary of the VIE, in which case it would be required to consolidate the entity. The Company evaluates whether it has (1) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance, and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. If the Company is not the primary beneficiary of the VIE, the investment or other variable interest is accounted for in accordance with applicable U.S. GAAP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In circumstances where an entity does not have the characteristics of a VIE, it would be considered a voting interest entity (&#8220;VOE&#8221;). The Company would consolidate a VOE when the Company has a majority equity interest and has control over significant operating, financial, and investing decisions of the entity. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Stock Split </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On March&#160;14, 2025, the Company effected a twenty-for-one stock split of its common stock and redeemable convertible preferred stock. All share and per share information has been retroactively adjusted to reflect the stock split for all periods presented. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Use of Estimates </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates. Significant estimates include the fair value of financial assets and liabilities; useful lives assigned to property and equipment; the discount rates used for operating and finance leases; valuation of derivative and warrant liabilities; stock-based compensation, including the determination of the fair value of the Company&#8217;s common stock; and accounting for income taxes, including the valuation allowance on deferred tax assets and the measurement of uncertain tax positions. Assumptions are reviewed regularly to ensure they remain relevant and reasonable, particularly in areas of high subjectivity. The Company bases its estimates on historical experience and assumptions that management considers reasonable. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Foreign Currency </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The reporting currency of the Company is the U.S. dollar. The functional currency of the Company&#8217;s foreign subsidiaries is the U.S. dollar. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Monetary assets and liabilities denominated in currencies other than the functional currency are remeasured to the functional currency at period-end exchange rates. Foreign currency transaction gains and losses resulting from remeasurement are recognized in other income, net in the consolidated statements of operations, and have not been material for any of the periods presented. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-12<br></div></div></div>
<!--End Page 467-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 468-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Concentration of Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is subject to certain risks and uncertainties that could have a material adverse effect on its business, financial condition, results of operations, or cash flows primarily due to concentration of credit risk, significant customers, and supplier concentration. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13pt; margin-left: 20pt; text-align: left;">Concentration of Credit Risk </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Financial instruments that potentially expose the Company to significant concentration of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, and marketable securities. The Company maintains its cash, cash equivalents, restricted cash, and marketable securities with high-quality financial institutions mainly in the United States, where the composition and maturities of which are regularly monitored by the Company. The Company grants credit to its customers in the normal course of business, exposing it to credit risk in the event of nonrepayment by customers. The Company has not experienced any material losses in such accounts. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13pt; margin-left: 20pt; text-align: left;">Significant Customers </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following customers accounted for 10% or more of the Company&#8217;s revenue for the years ended December 31, 2022, 2023, and 2024: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 106.18pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 106.18pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer A<font style="padding-left: 1.62pt;"></font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">35%</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">62% </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer B<font style="padding-left: 1.62pt;"></font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">21%</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">* </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer C<font style="padding-left: 1.62pt;"></font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">17%</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">15% </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer D<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">16%</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">* </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer E<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">13%</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">* </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer F<font style="padding-left: 2.73pt;"></font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;">12%</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">* </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer G<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 26.18pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.09pt; text-align: left;"><font style="padding-left: 10pt;">*</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 26.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 26.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 26.18pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 8.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Customer did not represent 10% or more of revenue </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Customer A, C, and G accounted for 15%, 13%, and 56% of accounts receivable, net, respectively, as of December 31, 2023. Customer A accounted for 66% of accounts receivable, net as of December&#160;31, 2024. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13pt; margin-left: 20pt; text-align: left;">Supplier Concentration </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain materials and products used by the Company in its operations are available from a limited number of suppliers. Three suppliers accounted for 23%, 16%, and 10% of total purchases for the year ended December 31, 2022. Three suppliers accounted for 57%, 22%, and 11% of total purchases for the year ended December 31, 2023. Three suppliers accounted for 46%, 16%, and 14% of total purchases for the year ended December 31, 2024. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 20pt; text-align: left;">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cash primarily consists of cash in banks and bank deposits. The Company considers all highly liquid investments with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents consist of money market funds in the Company&#8217;s investment accounts maintained in financial institutions. The Company maintains cash balances in bank deposit accounts that, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has restricted cash and cash equivalents that consist of bank deposits related to a collateralized loan facility and letters of credit. Restricted cash is classified as current and non-current assets based on the term of the remaining restriction. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information on restricted cash. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 20pt; text-align: left;">Accounts Receivable and Allowance for Credit Losses </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Accounts receivable primarily consist of amounts billed that are currently due from customers. Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company&#8217;s accounts receivable balances are subject to collection risk and the Company regularly assesses the collectability of outstanding </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-13<br></div></div></div>
<!--End Page 468-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 469-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">accounts receivable on an ongoing basis and maintains an allowance for credit losses for accounts receivable deemed uncollectible. The allowance for credit losses reflects the best estimate of probable losses in the accounts receivable balance. The Company determines the allowance based on known troubled accounts; historical experience; current and anticipated macroeconomic conditions that could impact the Company&#8217;s customers, such as unemployment, inflation, and regulation matters; and other currently available information. The Company&#8217;s allowance for expected credit losses was not material as of December 31, 2023 and 2024. Additions to and write-offs against the allowance for expected credit losses were not material for the years ended December 31, 2022, 2023, and 2024. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Notes Receivable </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Notes receivable are related to the DCSP Financing Arrangements (as defined in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>) and reported at the outstanding principal value plus accrued and unpaid interest. An allowance for credit losses on notes receivable is established when, based on current information and events, it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the agreement. The Company considers certain factors, including the credit risk and financial condition of the borrower, the borrower&#8217;s ability to pay current obligations, historical trends, and macroeconomic conditions. The Company evaluates the extent and impact of any credit deterioration that could affect the performance and the value of the assets, as well as the financial and operating capability of the borrower. As of December&#160;31, 2024, the Company determined the carrying amount of the notes receivable to be fully collectible. The Company did not have any outstanding notes receivable as of December&#160;31, 2023. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s note receivable meets the criteria for right of setoff under the DCSP Financing Arrangements. The Company will recognize interest income under certain conditions due to the setoff nature of the DCSP Financing Arrangements. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">Fair Value Measurements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company measures certain financial assets and liabilities at fair value on a recurring basis. Fair value is determined based on assumptions that market participants would use in pricing an asset or liability at the measurement date. The Company maximizes the use of observable inputs when available and minimizes the use of unobservable inputs when determining fair value. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s financial instruments include cash, cash equivalents, restricted cash, accounts receivable, marketable securities, accounts payable, accrued liabilities, derivatives, warrant liabilities, and Series&#160;B tranche liabilities. Cash, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Cash equivalents, restricted marketable securities, derivatives, and warrant liabilities are stated at fair value on a recurring basis. Adjustments to the fair value of certain financial liabilities, such as derivative, warrant, and Series&#160;B tranche liabilities, are recorded as fair value adjustments within the consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 20pt; text-align: left;">Marketable Securities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Marketable securities consist of certificates of deposit and marketable debt securities that the Company has classified and accounted for as available for sale. The Company determines the appropriate classification of its investments in these securities at the time of purchase and reevaluates such designation at each consolidated balance sheet date. After consideration of its risk versus reward objectives, as well as its liquidity requirements, the Company may sell these debt securities prior to their effective maturities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company classifies its investments with maturities within 12 months as current within other current assets on the consolidated balance sheets. The Company classifies its investments with maturities beyond 12 months as non-current within restricted marketable securities, non-current on the consolidated balance sheets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company carries these securities at fair value and reports the unrealized gains and losses, net of taxes, as a component of stockholders&#8217; deficit, except for changes in allowance for expected credit losses, which are recorded in other income, net, within the consolidated statements of operations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company periodically evaluates its available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, the Company considers its intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized basis. If either of these criteria are met, the Company writes down the security to its fair value and records the impairment </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-14<br></div></div></div>
<!--End Page 469-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 470-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">charge in other income, net, within the consolidated statements of operations. If neither of these criteria are met, the Company determines whether a credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15pt; margin-left: 20pt; text-align: left;">Strategic Investments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company holds strategic investments in the form of privately held equity securities to support its business and strategic objectives in which the Company does not have a controlling interest. Privately held equity securities that do not have a readily determinable fair value and for which the Company does not have a controlling financial interest or exercise significant influence are measured at cost, with subsequent adjustments for observable price changes or impairments. These adjustments are recognized through other income, net, in the Company&#8217;s statements of operations. The Company periodically reviews these investments for impairment. If indicators of impairment exist, the Company evaluates the investment for write-down to fair value. There were no subsequent adjustments for observable price changes or impairments for the periods presented. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company reports the strategic investments in other non-current assets on the consolidated balance sheets. As of December 31, 2023 and 2024, the carrying value of the Company&#8217;s strategic investments was $42 million and $102 million, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 15.5pt; margin-left: 20pt; text-align: left;">Property and Equipment, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Property and equipment, net is stated at historical cost less accumulated depreciation and amortization. Construction in progress is related to the construction or development of property and equipment that has not yet been placed into service for its intended use. Depreciation and amortization are calculated utilizing the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs that do not extend the lives of the respective assets are expensed as incurred. The carrying value of property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Effective January 1, 2023, the Company changed its estimate of the useful life for its computing equipment utilized in data centers from five to six years, reflecting continuous advancements in hardware performance, software optimization, and data center design improvements. The effects of this change in estimate for the year ended December 31, 2023 on computing equipment that was included in property and equipment, net on the consolidated balance sheets as of December 31, 2023 was a reduction in total expenses of $20 million. The per share impact of the change in estimate was a $0.10 increase for the year ended December 31, 2023. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The estimated useful lives of the Company&#8217;s property and equipment are as follows: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 461.67pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 227.67pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 228pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology equipment<font style="padding-left: 2.88pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 227.67pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">6 years </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 227.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3-6 years </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Data center equipment<font style="padding-left: 3.32pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 227.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">8-12 years </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture, fixtures, and other assets<font style="padding-left: 1.12pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 227.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">3-5 years </div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Leasehold improvements<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 227.67pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Shorter of remaining lease term or estimated useful life</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 227.67pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 13.5pt; margin-left: 20pt; text-align: left;">Capitalized Interest Costs </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalizes certain interest costs associated with the construction of data centers and purchases of related technology equipment during the period in which expenditures have been made and activities are in progress to prepare the assets for their intended use. The interest cost incurred in the construction of the data centers is considered a part of the assets&#8217; historical cost and are depreciated over the estimated useful lives of the underlying assets. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15.5pt; margin-left: 20pt; text-align: left;">Capitalized Internal-Use Software </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalizes costs incurred to develop or modify software solely for the Company&#8217;s internal use, including hosted applications used to deliver the Company&#8217;s support services, and certain implementation costs incurred in a hosting arrangement that is a service contract. This capitalization occurs when the preliminary project stage is complete, management, with the relevant authority, authorizes and commits to the funding of the software project, and it is probable the project will be completed and used to perform the intended function. Capitalized costs primarily consist of salaries and payroll-related costs for employees directly involved in development efforts. Costs incurred during the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-15<br></div></div></div>
<!--End Page 470-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 471-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">preliminary project stage and during the post-implementation operational stage, including maintenance costs, are expensed as incurred. Costs incurred for software upgrades are capitalized if they result in additional functionalities or substantial enhancements. Capitalized software development costs are included in property and equipment, net on the consolidated balance sheets, are amortized on a straight-line basis over the software&#8217;s estimated useful life, which is between three and six years, and amortization is recorded in technology and infrastructure within the consolidated statements of operations. The Company capitalized $1&#160;million, $12 million, and $27 million of qualifying software development costs during the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Asset Retirement Obligations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">An asset retirement obligation represents a legal obligation associated with the retirement of a tangible long-lived asset that is incurred upon the acquisition, construction, development or normal operation of that long-lived asset. The Company recognizes asset retirement obligations in the period in which they are placed in service, if a reasonable estimate of fair value can be made. The asset retirement obligation is subsequently adjusted for changes in fair value. The associated estimated asset retirement costs are capitalized in equipment and depreciated over their useful lives. The Company&#8217;s asset retirement obligations relate to the future removal of certain equipment related to its data center fit outs. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Deferred Offering Costs </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred offering costs consist primarily of accounting, legal, and other fees directly related to the Company&#8217;s proposed initial public offering (&#8220;IPO&#8221;). These costs are capitalized as other non-current assets on the consolidated balance sheets until the offering is completed. The deferred offering costs will be reclassified to stockholders&#8217; deficit and recorded against the proceeds from the offering upon the consummation of an IPO. In the event the offering is aborted, deferred offering costs will be expensed. The Company did not capitalize any deferred offering costs as of December 31, 2023, and capitalized $10&#160;million of deferred offering costs as of December 31, 2024. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Business Combinations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">When the Company acquires a business, the purchase price is allocated to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated respective fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired users and acquired technology from a market participant perspective, useful lives and discount rates, and the cost savings expected to be derived from acquiring an asset. These estimates are inherently uncertain and unpredictable. During the measurement period, which may be up to one year from the acquisition date, adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed may be recorded, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded in the Company&#8217;s consolidated statements of operations. The Company includes the results of operations of the business that it acquires as of the acquisition date. Acquisition-related expenses are expensed as incurred and are typically included in general and administrative expenses in the consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Goodwill and Intangible Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Goodwill represents the excess of the purchase price consideration over the estimated fair value of the tangible and intangible assets acquired and liabilities assumed in a business combination. Goodwill is evaluated for impairment annually on December 1 for the Company&#8217;s single reporting unit, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Goodwill impairment is recognized when the quantitative assessment results in the carrying value exceeding the fair value; in which case, an impairment charge is recorded to the extent the carrying value exceeds the fair value. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-16<br></div></div></div>
<!--End Page 471-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 472-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s definite-lived intangible assets are carried at cost, net of accumulated amortization. Intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company estimates the useful life by estimating the expected period of economic benefit. The estimated useful lives for each class of intangible assets are as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 448.43pt; margin-left: 20pt;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 408pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Acquired technologies<font style="padding-left: 4.42pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.43pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">3 years </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Customer relationships<font style="padding-left: 2.19pt;"></font></div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.43pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">13 years </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Trade names<font style="padding-left: 3.65pt;"></font></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.43pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">5 years</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 34.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amortization of intangible assets is recognized in the consolidated statements of operations based on the function of the related asset. Specifically, amortization is allocated to cost of revenue, technology and infrastructure, or sales and marketing, depending on the use of the underlying intangible asset. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 20pt; text-align: left;">Impairment of Long-Lived Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company reviews long-lived assets, including property and equipment and intangible assets subject to amortization, for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The recoverability of the long-lived assets is assessed by comparing the undiscounted future cash flows expected to be generated by the asset to its carrying value. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If the carrying amount of a long-lived asset exceeds the expected undiscounted cash flows, an impairment loss is recognized in an amount equal to the excess of the asset&#8217;s carrying value over its fair value. Fair value is determined using valuation techniques such as discounted cash flow models, market comparisons, and, where applicable, independent third-party appraisals. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">For the years ended December 31, 2022, 2023, and 2024, no material impairment charges were recorded. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19.5pt; margin-left: 20pt; text-align: left;">Leases </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has lease agreements primarily for data centers, office buildings, storage spaces and equipment. The Company accounts for leases in accordance with <font style="font-style: italic;">Accounting Standards Codification (</font>&#8220;ASC&#8221;<font style="font-style: italic;">) 842, Leases</font> (Topic 842). The Company determines if an arrangement meets the definition of a lease at the inception and leases are classified at commencement as either operating or finance leases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Right-of-use (&#8220;ROU&#8221;) assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease agreement. ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred, and prepaid lease payments, excluding lease incentives received prior to lease commencement. Lease liabilities are measured based on the discounted present value of the remaining lease payments at commencement date. As most of the leases do not provide an implicit rate, the Company uses the incremental borrowing rate based on the estimated interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Many of the Company&#8217;s leases include renewal options, and termination options that are factored into the determination of lease payments when it is reasonably certain that the Company would exercise that option. When assessing the reasonableness of exercising lease renewal options, the Company takes into account all relevant facts and circumstances that contribute to the economic benefits associated with exercising the lease renewal options, which includes the expected changes in facts and circumstances between the commencement of the lease term and the exercise date of the options. Payments under the Company&#8217;s lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which generally relate to costs associated with common area maintenance, utilities reimbursed to the landlord, and physical security expenses within certain lease agreements. These are not included in operating or finance lease cost and are expensed as incurred. The interest component of a finance lease is included in interest expense and recognized using the effective interest method over the lease term. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company made an accounting policy election for lease agreements with a term of 12 months or less and does not recognize ROU assets and lease liabilities in respect of those agreements. Any payments related to short-term leases are expensed as incurred. The Company has currently elected the practical expedient to not separate lease and nonlease components across all asset classes. Operating lease expense is recognized on a straight-line basis within total operating expenses in the consolidated statements of operations over the lease term. Amortization </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-17<br></div></div></div>
<!--End Page 472-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 473-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">expense of finance lease ROU assets is recognized on a straight-line basis over the lease term and the interest component of a finance lease is recognized utilizing the effective interest method over the lease term and included in interest expense, net in the consolidated statements of operations. The Company currently does not have any lease arrangements with residual value guarantees. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Derivative Financial Instruments </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company does not enter into derivatives for trading or speculative purposes. However, certain debt and equity financing transactions are derivatives in their entirety or include embedded features that are bifurcated and accounted for as embedded derivatives. Refer to <font style="font-style: italic;">Note 10&#8212;Debt</font> for additional information about derivatives associated with financing transactions. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, in 2023 and 2024, the Company entered into power purchase agreements (&#8220;PPAs&#8221;) to secure power capacity for existing, under construction, and planned data center builds. These agreements are specifically designed to support the Company in managing its energy needs as it encounters rapidly increasing energy demands. Agreements that do not meet a scope exception, contain a notional amount and are for delivery of electricity in markets where notional amounts are readily convertible to cash are classified as derivative instruments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The PPAs which meet the definition of a derivative are measured at fair value using a discounted cash flow model. Significant assumptions in the model include forward energy prices and discount rates. The Company reassesses the fair value of the PPAs at each reporting period, and any changes in value are recorded within the consolidated statements of operations. While the Company considered the normal purchases and normal sales scope exception to derivative accounting, the PPAs do not qualify for this exception, as the contracts allow for, and the Company has a practice of net settlement in the event of consumption shortfalls relative to the contracted quantities. As such, the Company recognizes these PPAs as derivatives and applies mark-to-market accounting for them and did not elect hedge accounting. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Derivative assets and liabilities, including those related to the PPAs, are classified as either current or non-current based on the timing of expected cash flows. The non-current position is included in other non-current assets and derivative and warrant liabilities on the consolidated balance sheets. Cash flows from the PPAs are classified as operating activities reflecting their use to secure and hedge energy needs in operations. The Company applies Level 3 valuation techniques, including discounted cash flow models, to determine fair value due to the significant unobservable inputs. Refer to <font style="font-style: italic;">Note&#160;3 &#8211; Fair Value Measurements </font>below for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14.5pt; margin-left: 20pt; text-align: left;">Revenue Recognition </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company accounts for revenue in accordance with ASC 606,<font style="font-style: italic;"> Revenue From Contracts with Customers</font>. Revenue is recognized when services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for services. The Company determines revenue recognition by applying the following five steps: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Identification of the contract, or contracts, with the customer </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Identification of the performance obligations in the contract </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">3.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Determination of the transaction price </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">4.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Allocation of the transaction price to the performance obligations in the contract </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">5.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Recognition of the revenue when, or as, a performance obligation is satisfied </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company generates revenue by providing cloud computing services for customers in several verticals, such as artificial intelligence, machine learning, visual effects rendering, platforms, pixel streaming, and batch processing. These services are offered both on a committed contract and on-demand basis. Customers do not take possession of software or hardware used to provide the services. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Committed Contracts<font style="font-style: normal;">&#8212;These service arrangements provide customers with access to cloud computing capacity across the Company&#8217;s various data centers over a specified duration. Revenue is recognized ratably over the contract period. The initial contract period generally ranges from two to five years. The terms of these contracts are typically structured as &#8220;take-or-pay&#8221; agreements, requiring payment regardless of the level of utilization. Additionally, customers under committed contracts typically make a prepayment that is recorded as deferred revenue and consumed based on the terms of the contract. </font></div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-18<br></div></div></div>
<!--End Page 473-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 474-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg8"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On-Demand<font style="font-style: normal;">&#8212;These service arrangements provide customers with access to the Company&#8217;s cloud computing capacity on a consumption basis, with billing occurring monthly in arrears based on actual hourly usage of compute, storage, and other services. Revenue is recognized as the services are consumed. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Customers may also prepay for on-demand services. The prepayments are initially recorded as deferred revenue and recognized as the cloud computing services are transferred to the customer. Prepayments are typically consumed within a few months. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s contracts with customers may contain multiple promised services. To the extent a customer contract includes multiple promised services, the Company determines whether promised services should be accounted for as a separate performance obligation. The Company allocates revenue to each performance obligation based on its relative stand-alone selling price (&#8220;SSP&#8221;). The SSP reflects the price the Company would charge for a specific service if it were sold separately in similar circumstances and to similar customers. When determining the SSP, the Company maximizes the use of observable inputs. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. The Company generally does not offer a right of refund in its contracts other than for cases of the Company&#8217;s uncured material breach of the agreement, bankruptcy or insolvency. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 20pt; text-align: left;">Contract Balances </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Contract assets represent the Company&#8217;s rights to consideration in exchange for cloud computing services that the Company has transferred to a customer but where the right to consideration is conditional on something other than the passage of time. In some arrangements, a right to consideration for the Company&#8217;s performance under the customer contract may occur before invoicing the customer, resulting in an unbilled accounts receivable. These unbilled accounts receivable represent amounts earned but not yet invoiced and are recognized in accordance with the performance obligations satisfied. Such amounts have been immaterial for the periods presented. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance will be recognized as revenue during the 12-month period after the consolidated balance sheet date. The non-current portion of the deferred revenue balance will be recognized as revenue following the 12-month period after the consolidated balance sheet date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Remaining performance obligations (&#8220;RPO&#8221;) represent the aggregate amount of the transaction price, net of estimated variable consideration, allocated to performance obligations not delivered, or partially undelivered, as of the end of the reporting period. Variable consideration consists of potential reductions to the transaction price in the future related to estimates of future potential credits to customers under availability of service agreements and amounts that may not be recognized to revenue due to delivery delays. The Company&#8217;s estimate of such variable consideration is based on both historical experience and the specific facts and circumstances of the committed contracts included in the Company&#8217;s RPO. RPO includes both billed and unbilled consideration from the Company&#8217;s committed contracts. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 20pt; text-align: left;">Costs to Obtain a Contract </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company capitalizes sales commissions and associated payroll taxes paid to sales personnel that are incremental to the acquisition of customer contracts. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract. Total capitalized costs to obtain a contract are immaterial during the periods presented and are included in other non-current assets on the consolidated balance sheets. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 20pt; text-align: left;">Cost of Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Cost of revenue primarily consists of direct costs for data centers, including costs associated with the Company&#8217;s facilities, such as rent, utilities including power, personnel costs for employees involved in data center operations and customer success, including salaries, bonuses, benefits, stock-based compensation expense and other related expenses, and depreciation and amortization, including depreciation of power installation and distribution systems. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company operates data centers across the country and has co-location service agreements with several well-established data center vendors. These agreements generally commit the Company to pay monthly fees plus </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-19<br></div></div></div>
<!--End Page 474-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 475-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg9"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">additional fees for bandwidth usage above the committed level. Certain co-location agreements do not meet the definition of a lease and are expensed under cost of revenue. However, those that do meet the definition of a lease are recognized as operating lease ROU assets and operating lease liabilities and are amortized over the lease term. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Technology and Infrastructure </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Technology and infrastructure expense consists of costs associated with the Company&#8217;s infrastructure, such as depreciation and amortization related to the Company&#8217;s servers, switches, networking equipment and internally developed software, personnel costs for employees associated with research and development of new and existing products and services or with maintaining the Company&#8217;s computing infrastructure, such as salaries, bonuses, benefits, stock-based compensation expense, travel expenses, and other related expenses; and costs related to software subscriptions. The Company&#8217;s technology and infrastructure efforts are dedicated towards developing new services, improving the Company&#8217;s existing infrastructure, adding new features, bringing the latest compute technology to market and improving the accessibility of the Company&#8217;s services. Research and development costs were $5 million, $21 million, and $56&#160;million for the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Sales and Marketing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Sales and marketing expense consists of personnel costs associated with selling and marketing the Company&#8217;s CoreWeave Cloud Platform, such as salaries, stock-based compensation expense, commissions, bonuses, and other related expenses, third-party professional services costs, and advertising costs associated with marketing programs. Advertising costs, which are expensed as incurred are also included in sales and marketing expenses in the consolidated statements of operations. Advertising expense was immaterial for all periods presented. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">General and Administrative </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">General and administrative expense consists of costs associated with corporate functions including the Company&#8217;s finance, legal, human resources, and facilities. These costs include personnel costs, such as salaries, bonuses, benefits, stock-based compensation expense and other related expenses, third-party professional services costs, such as legal, accounting, and audit services, corporate facilities, depreciation for equipment, furniture, and fixtures, and other costs necessary to operate the Company&#8217;s corporate functions, including expenses for non-income taxes, insurance, and office rental. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Stock-Based Compensation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Stock-based compensation expense related to stock-based awards is recognized based on the fair value of the awards granted. The fair value of each stock option award is estimated on the grant date utilizing the Black-Scholes option-pricing model. The related stock-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including the awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying common stock, the expected term of the stock option, the expected volatility of the price of the Company&#8217;s common stock, risk-free interest rates, and the expected dividend yield of common stock. The assumptions used to determine the fair value of the option awards represent management&#8217;s best estimates. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has also granted to employees restricted stock units (&#8220;RSU&#8221;), that vest upon the satisfaction of service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying common stock as of the grant date. The service-based vesting condition has varying terms, but is generally satisfied over four years. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) an acquisition of the Company or (ii) the effective date of a registration statement of the Company filed for the IPO of the Company&#8217;s common stock. As of December 31, 2024, all RSU awards outstanding were subject to a performance-based vesting condition, and such performance-based vesting condition was not probable of being satisfied as a liquidation event such as a change in control or an IPO is not considered probable until it occurs. As a result, no stock-based compensation expense related to these RSU awards has been recorded to date. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Employee Benefit Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has a defined contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the &#8220;401(k) Plan&#8221;). Participants may contribute a portion of their annual compensation limited to a maximum </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-20<br></div></div></div>
<!--End Page 475-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 476-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg10"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">annual amount set by the Internal Revenue Service. The Company sponsors a 401(k) defined contribution plan covering all eligible U.S. employees. Contributions to the 401(k) Plan are discretionary. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Income Taxes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company evaluates the likelihood of realizing deferred tax assets based on projections of future taxable income and considers a valuation allowance if it is more likely than not that some or all deferred tax assets may not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A valuation allowance is recorded for deferred tax assets if it is more likely than not that some portion, or all, of the deferred tax assets will not be realized. In assessing the need for a valuation allowance, the Company considers all available evidence for each jurisdiction, including past operating results, estimates of future taxable income, and the feasibility of ongoing tax-planning strategies. This evaluation is updated quarterly to reflect new information and trends that may affect the realization of tax benefits. In the event the Company determines that all, or part, of the net deferred tax assets are not realizable in the future, it will make an adjustment in the valuation allowance that will be charged to earnings in the period in which such a determination is made. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company recognizes interest and penalties related to uncertain income tax benefits as a component of the provision (benefit) for income taxes in the consolidated statements of operations. The Company&#8217;s effective tax rates will vary depending on the amount of nondeductible items such as fair value adjustments, changes in the valuation of deferred tax assets and liabilities, use of tax credits, the relative proportion of foreign to domestic income, and changes in tax laws. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Net Loss per Share Attributable to Common Stockholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company computes net loss per share utilizing the two-class method required for participating securities. The two-class method determines net loss per share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in undistributed income. The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A common stock and Class B common stock are identical, except with respect to voting. As a result, the basic and diluted net loss per share of Class&#160;A common stock and Class B common stock are the same and therefore presented on a combined basis. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The Company considers its redeemable convertible preferred stock, non-recourse notes to purchase common and preferred stock, and regular warrants to be participating securities as the holders of these securities are contractually entitled to participate in income but not contractually required to participate in losses. As such, net loss for the periods presented was not allocated to the Company&#8217;s participating securities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s basic net loss per share attributable to common stockholders is calculated by dividing net loss attributable to common stockholders by the weighted-average number of common stock outstanding for the period, without consideration of potentially dilutive securities. The diluted net loss per share attributable to common stockholders is calculated by giving effect to all potentially dilutive securities outstanding for the period utilizing the treasury stock method or the if-converted method based on the nature of such securities. Potential shares of common stock that are issuable for little or no consideration are included in the calculation of basic and diluted net loss per&#160;share attributable to common stockholders once they become exercisable. Diluted net loss per share is the same as basic net loss per share in periods when the effects of potentially dilutive shares of common stock are antidilutive. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-21<br></div></div></div>
<!--End Page 476-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 477-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg11"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Segment Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s chief operating decision maker, the chief executive officer, reviews discrete financial information presented on a consolidated basis for purposes of regularly making operating decisions, allocation of resources, and assessing financial performance. The Company operates its business in one operating segment and, therefore, has one reportable segment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The CODM uses consolidated net loss to measure segment profit or loss in order to identify underlying trends in the performance of the business for purposes of allocating resources and evaluating financial performance. The Company&#8217;s objective in making resource allocation decisions is to optimize the consolidated financial results. Significant segment expenses that the CODM reviews and utilizes to manage the Company&#8217;s operations are cost of revenue, technology and infrastructure, sales and marketing, and general and administrative expenses at the consolidated level, which are presented in the Company&#8217;s consolidated statements of operations. Other segment items included in consolidated net loss include loss on fair value adjustments, interest expense, net, other income, net, provision for (benefit from) income taxes, and loss from discontinued operations, net of tax, which are presented in the Company&#8217;s consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Recent Accounting Pronouncements Adopted </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As an emerging growth company (&#8220;EGC&#8221;), the Jumpstart Our Business Startups Act (the &#8220;JOBS Act&#8221;) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards codification. The Company has elected to use extended transition periods permissible under the JOBS Act, while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, <font style="font-style: italic;">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</font>, which requires organizations to measure all expected credit losses for financial instruments held at the reporting date. Also, in April&#160;2019, the FASB issued ASU No. 2019-04, <font style="font-style: italic;">Codification Improvements to Topic 326, Financial Instruments&#8212;Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</font>, to clarify the inclusion of recoveries of trade receivables previously written off when estimating an allowance for credit losses. In November&#160;2019, the FASB issued ASU No. 2019-10, <font style="font-style: italic;">Financial Instruments&#8212;Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates</font>, which amended the effective date for certain companies. This guidance is effective for annual periods beginning after December 15, 2022, and for interim periods within the fiscal years, with early adoption permitted. Upon adoption, the guidance should be applied prospectively. The Company adopted this guidance effective on January 1, 2023, without a material impact on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August&#160;2020, the FASB issued ASU No. 2020-06, <font style="font-style: italic;">Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</font>, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. ASU No. 2020-06 reduces the number of accounting models for convertible debt instruments and convertible preferred stock and enhances information transparency by making targeted improvements to the disclosures for convertible instruments and earnings per share guidance. This guidance is effective for the annual periods beginning after December 15, 2023, and for interim periods within the fiscal years, with early adoption permitted. Upon adoption, the guidance should be applied retrospectively. The Company adopted this guidance effective on January 1, 2023, without a material impact on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In November&#160;2023, the FASB issued ASU No. 2023-07, <font style="font-style: italic;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</font>, which requires additional segment-related disclosures on an annual and interim basis, to enable investors in developing more informed and actionable analyses. This guidance is effective for the annual periods beginning after December 15, 2023, and for interim periods beginning after December&#160;15, 2024 with early adoption permitted. Upon adoption, the guidance should be applied retrospectively to all prior periods presented in the consolidated financial statements. The Company adopted this guidance effective on January 1, 2024, without a material impact on its consolidated financial statements. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-22<br></div></div></div>
<!--End Page 477-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 478-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg12"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Recent Accounting Pronouncements Not Yet Adopted </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2023, the FASB issued ASU No. 2023-09, <font style="font-style: italic;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</font>, which improves the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the effective tax rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. It also includes certain other amendments to improve the effectiveness of income tax disclosures. This guidance will be effective for annual periods beginning after December 15, 2024. Early adoption is permitted. Upon adoption, the guidance can be applied prospectively or retrospectively. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In November&#160;2024, the FASB issued ASU No. 2024-03,<font style="font-style: italic;"> Income Statement&#8212;Reporting Comprehensive Income&#8212;Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses</font>, which requires more detailed disclosures, on an annual and interim basis, about specified categories of expenses (including employee compensation, depreciation, and amortization) included in certain expense captions presented on the consolidated statements of operations. This guidance as further clarified through ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) will be effective for annual periods beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. Upon adoption, the guidance can be applied either prospectively or retrospectively. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 14pt; margin-left: 0pt; text-align: left;">2. Revenue </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Disaggregation of Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company primarily generates its revenue through providing cloud computing services, which include both committed contracts and on-demand services. Revenue recognized related to customer commitments, including revenue from delivering capacity prior to commitment start dates, represented 20%, 88%, and 96% of total revenue for the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Deferred Revenue </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred revenue, including current and non-current balances as of December 31, 2023 and 2024, was $2.0&#160;billion and $4.1 billion, respectively. For the years ended December 31, 2022, 2023, and 2024, revenue recognized from deferred revenue at the beginning of the period was $0&#160;million, $4 million, and $225 million, respectively. The increase in deferred revenue balances as of December 31, 2024 as compared to December 31, 2023 is attributed to the growth in revenue from committed contracts, which typically provide for certain prepayments at contract inception. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 14pt; margin-left: 20pt; text-align: left;">Remaining Performance Obligations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023, the Company had $9.9 billion of unsatisfied RPO, of which 41% is expected to be recognized over the initial 24 months ending December 31, 2025, 40% between months 25 and 48, and the remaining balance recognized between months 49 and 72. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company had $15.1 billion of unsatisfied RPO, of which 54% is expected to be recognized over the initial 24 months ending December 31, 2026, 42% between months 25 and 48, and the remaining balance recognized between months 49 and 72. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13.5pt; margin-left: 0pt; text-align: left;">3. Fair Value Measurements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company measures certain financial assets and liabilities at fair value on a recurring basis in accordance with ASC 820, <font style="font-style: italic;">Fair Value Measurement</font>, which establishes a framework for measuring fair value and a fair value hierarchy based on the observability of inputs. This hierarchy prioritizes the use of observable inputs and minimizes the use of unobservable inputs when determining fair value as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Level 1&#8212;Observable inputs such as quoted prices in active markets for identical assets or liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Level 2&#8212;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity, which require management judgment or estimation. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-23<br></div></div></div>
<!--End Page 478-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 479-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg13"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following tables presents the hierarchy fair value as of the end of each reporting period (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 300pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 36.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 300pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Hierarchy</div></td><td style="width: 6.23pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.23pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 300pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial assets:<br></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;1</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 5pt;">87,258</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 10.37pt;">2,411 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, current<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;1</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">42,940</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">24,185 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Available-for-sale marketable securities<font style="padding-left: 1.86pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;2</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt;">2,368</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 2.53pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;1</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">206,846</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">56,250 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Certificates of deposit<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;2</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">171,734</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">29,308 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Power purchase agreements<font style="padding-left: 4.22pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;3</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,459</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,562 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total financial assets<font style="font-weight: normal; padding-left: 2.34pt;"></font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$512,605</font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">114,716 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial liabilities:<br></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative and warrant liabilities<br></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Bifurcated embedded derivative liabilities<font style="padding-left: 2.01pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;3</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$386,469</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Warrant liabilities<font style="padding-left: 4.99pt;"></font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;3</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">70,930</font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">199,645 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Series&#160;B tranche liability<font style="padding-left: 0.87pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;3</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">69,648</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 300pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Power purchase agreements<font style="padding-left: 4.22pt;"></font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Level&#160;3</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">444 </font></div></td></tr><tr><td style="width: 300pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total financial liabilities<font style="font-weight: normal; padding-left: 2.88pt;"></font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 36.3pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$527,047</font></div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$200,089</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 300pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 36.3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.23pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following tables present information about the Company&#8217;s financial assets that are measured at fair value on a recurring basis as of the end of each reporting period (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172.34pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 172.34pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2023 </div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjusted <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial assets:<br></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<br></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">87,258</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">87,258 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, current<br></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">42,940</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">42,940 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses and other current assets<br></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Available-for-sale marketable securities<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt;">2,354</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">14</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt;">2,368 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<br></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">206,846</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">206,846 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<br></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Certificates of deposit<font style="padding-left: 0.54pt;"></font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">171,734</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">171,734 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">511,132</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$14</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$&#8212;</font></div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">511,146</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-24<br></div></div></div>
<!--End Page 479-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 480-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg14"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 172.14pt;" colspan="10"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="10" style="width: 172.14pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr class="BRDSX_header"><td style="width: 288pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Adjusted <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Cost</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gains</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Unrealized <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Losses</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Fair Value </div></td></tr><tr><td style="width: 288pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Financial assets:<br></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash and cash equivalents<br></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10pt;">2,411</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;">$&#8212;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 10pt;">2,411 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, current<br></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">24,185</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">24,185 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted cash and cash equivalents, non-current<br></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Money market funds<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">56,250</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.63pt;">56,250 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Restricted marketable securities, non-current<br></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 288pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Certificates of deposit<font style="padding-left: 0.54pt;"></font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,308</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,308 </font></div></td></tr><tr><td style="width: 288pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$112,154</font></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$&#8212;</font></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.18pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 11.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$&#8212;</font></div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.13pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$112,154</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 288pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.18pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.13pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of the valuation techniques and key inputs used in the valuation of instruments of Level 3 fair value measurements as of the end of each reporting period. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s valuation of the warrant liabilities utilized the Black-Scholes option-pricing model that relied on the following significant inputs: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock price<font style="padding-left: 1.41pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$18</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$48 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 0.46pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 5pt;">55%</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 5pt;">60% </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free rate<font style="padding-left: 1.98pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">4%</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">4% </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Dividend yield<font style="padding-left: 1.96pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">0%</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">0%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s valuation of the embedded derivative liabilities utilized the binomial lattice model that relied on the following significant inputs: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023 </div></td></tr><tr><td style="width: 396pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock price<font style="padding-left: 2.41pt;"></font></div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$18 </div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 1.46pt;"></font></div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 5pt;">40% </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free rate<font style="padding-left: 2.98pt;"></font></div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">4% </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Lattice or Monte Carlo model projection period (years)<font style="padding-left: 1.93pt;"></font></div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">2</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>, the 2021 Convertible Notes were converted into common stock on September&#160;17, 2024. The following table is a summary of the significant unobservable inputs to value the embedded derivative liability immediately before conversion: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.39pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.31pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.39pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">September&#160;17, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 396pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock price<font style="padding-left: 2.41pt;"></font></div></td><td style="width: 11.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.31pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.39pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.2pt; text-align: left;">$44 </div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Discount rate<font style="padding-left: 4.08pt;"></font></div></td><td style="width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.39pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 17.2pt; text-align: left;"><font style="padding-left: 5pt;">12%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 11.31pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.39pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s valuation of the Series&#160;B tranche liability utilized the Black-Scholes option-pricing model that relied on the following significant inputs: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 396pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 396pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023 </div></td></tr><tr><td style="width: 396pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B stock price<font style="padding-left: 1.32pt;"></font></div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;">$21 </div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Volatility<font style="padding-left: 1.46pt;"></font></div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 5pt;">21% </font></div></td></tr><tr><td style="width: 396pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free rate<font style="padding-left: 2.98pt;"></font></div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.08pt; text-align: left;"><font style="padding-left: 10pt;">5%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 396pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-25<br></div></div></div>
<!--End Page 480-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 481-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg15"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 180pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 55.68pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 180pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power Purchase <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Asset</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Warrant <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liabilities</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Bifurcated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Embedded <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Derivative <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liabilities</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Power Purchase <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Agreements &#8211; <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liability</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Series&#160;B <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Tranche <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liability </div></td></tr><tr><td style="width: 180pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2023<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 10pt;">3,887</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 20.83pt;">4,901</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;">$<font style="padding-left: 8.33pt;">&#8212;</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additions<font style="padding-left: 3.06pt;"></font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 5pt;">1,040</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt;">1,716</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20.83pt;">20,829</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 13.33pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">10,300 </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adjustment to fair value<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 12.5pt;">419</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">68,334</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">360,739</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 13.33pt;">&#8212;</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">104,879 </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Settlements<font style="padding-left: 0.84pt;"></font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 11.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(3,007</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(45,531</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 180pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at December&#160;31, 2023<font style="font-weight: normal; padding-left: 1.34pt;"></font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 5pt;">1,459</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">70,930</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">386,469</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 13.33pt;">&#8212;</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">69,648 </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additions<font style="padding-left: 3.06pt;"></font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 8.33pt;">770</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Adjustment to fair value<font style="padding-left: 2.54pt;"></font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 5pt;">1,103</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">128,715</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15.83pt;">627,263</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 5pt;">(326)</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 24.17pt;">(49) </font></div></td></tr><tr><td style="width: 180pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Settlements<font style="padding-left: 0.84pt;"></font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,013,732</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="padding-left: 13.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(69,599</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 180pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at December&#160;31, 2024<font style="font-weight: normal; padding-left: 1.34pt;"></font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.09pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,562</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$199,645</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 33.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 55.68pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.18pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">444</font></div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 22.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">&#8212;</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 180pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 55.68pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">DCSP Financing Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in the <font style="font-style: italic;">Note&#160;10&#8212;Debt</font>, the Company has a Note&#160;Receivable outstanding as of December&#160;31, 2024, related to the DCSP Financing Arrangements. The Company determined that the fair value of the Note&#160;Receivable approximates the carrying value. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Available-For-Sale Marketable Securities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023 </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Due in one year or less<font style="padding-left: 4.44pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Due over one year<font style="padding-left: 4.43pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,368 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total available-for-sale marketable securities<font style="font-weight: normal; padding-left: 1.31pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,368</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For short-term investments with an unrealized loss as of December 31, 2023, the unrealized losses were not due to credit-related factors. As of December 31, 2023, the Company did not intend to sell these short-term investments, and it was more likely than not that the Company would hold these short-term investments until maturity or a recovery of the cost basis. Therefore, no allowance for expected credit losses was recorded as of December 31, 2023. In November&#160;2024, the Company sold all of its available-for-sale marketable debt securities. As a result, the Company reclassified an immaterial amount to other income, net in the consolidated statements of operations that was previously recorded in accumulated other comprehensive income (loss). </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">4. Business Combination </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On January 1, 2023, the Company acquired 100% of the equity of Conductor Technologies, Inc. (&#8220;Conductor&#8221;), a company that develops cloud-based task management services designed to simplify access to cloud resources at scale. This acquisition aligns with the Company&#8217;s strategy to expand its cloud capabilities and strengthen its presence in the media and entertainment sector. The Company expects growth opportunities through further investment in product capabilities, among other factors. The purchase consideration for the Conductor acquisition was $27 million, which consisted of cash consideration of $17 million and equity consideration of $10 million in the form of a liability to issue shares. In May&#160;2024, the Company exercised its call option to settle the liability in cash. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-26<br></div></div></div>
<!--End Page 481-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 482-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg16"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The allocation of purchase consideration to the assets acquired and liabilities assumed based upon their estimated fair values as of the acquisition date is as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Identifiable assets<font style="padding-left: 2.76pt;"></font></div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">8,802 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total liabilities assumed<font style="padding-left: 1.78pt;"></font></div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,023</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net assets acquired<font style="font-weight: normal; padding-left: 1.83pt;"></font></div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">7,779 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Goodwill recognized<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">19,447 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total purchase price<font style="font-weight: normal; padding-left: 1.63pt;"></font></div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$27,226</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the year ended December 31, 2023, the results of operations for Conductor and acquisition-related costs were not material to the Company&#8217;s consolidated statement of operations. Additionally, the pro forma results of operations reflecting the acquisition of Conductor are not presented as the impact on the consolidated financial results would not have been material. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">5. Property and Equipment, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Property and equipment, net, consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.71pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology equipment<font style="padding-left: 2.88pt;"></font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$1,298,127</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">9,146,575 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Software<font style="padding-left: 4.41pt;"></font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 17.5pt;">14,937</font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">139,508 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Data center equipment and leasehold improvements<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 17.5pt;">29,332</font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">384,372 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Furniture, fixtures, and other assets<font style="padding-left: 1.12pt;"></font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 22.5pt;">1,717</font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt;">8,684 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Construction in progress<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,256,673</font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,200,866 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total property and equipment<font style="font-weight: normal; padding-left: 4.41pt;"></font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt;">3,600,786</font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">12,880,005 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: accumulated depreciation and amortization<font style="font-style: normal; padding-left: 3.71pt;"></font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 9.54pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(116,796</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(965,231</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total property and equipment, net<font style="font-weight: normal; padding-left: 0.25pt;"></font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$3,483,990</font></div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 50pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">11,914,774</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.71pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 50pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Depreciation and amortization on property and equipment was $12 million, $101 million, and $861 million for the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As discussed in <font style="font-style: italic;">Note&#160;1&#8212;Overview and Summary of Significant Accounting Policies</font>, the Company capitalizes interest associated with the construction of data centers and purchases of related technology equipment. There was $0 million, $41 million, and $159 million of interest capitalized during the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Asset Retirement Obligations </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following is a summary of activity relating to the liability for asset retirement obligations, included in other non-current liabilities on the consolidated balance sheets, which the Company expects to incur primarily in connection with the expected removal of certain equipment related to its data center fit outs (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Beginning balance<font style="font-weight: normal; padding-left: 1.06pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212;</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$<font style="padding-left: 5pt;">7,496 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Additions<font style="padding-left: 1.06pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 5pt;">7,254</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 5pt;">26,293 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accretion expense<font style="padding-left: 0.54pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">242</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,364 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Ending balance<font style="font-weight: normal; padding-left: 3.28pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$7,496</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$36,153</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-27<br></div></div></div>
<!--End Page 482-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 483-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg17"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">6. Goodwill and Intangible Assets </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Goodwill </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the changes to goodwill (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2023<font style="font-weight: normal; padding-left: 1.91pt;"></font></div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 17.5pt;">97 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Addition from the acquisition of Conductor<font style="padding-left: 2.22pt;"></font></div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">19,447 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at December&#160;31, 2023 and 2024<font style="font-weight: normal; padding-left: 1.57pt;"></font></div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$19,544</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 13.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">There were no impairment charges recorded to goodwill for any of the periods presented. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Intangible Assets, Net </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Intangible assets, net consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 142.08pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 142.08pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 142.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2023</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 142.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, 2024 </div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortization</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Gross</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Accumulated <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amortization</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Acquired <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intangibles, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Net </div></td></tr><tr><td style="width: 168pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Acquired technologies<font style="padding-left: 4.42pt;"></font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;">$5,453</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">$(1,600)</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;">$3,853</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;">$5,453</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;">$<font style="padding-left: 0.37pt;">(3,611)</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;">$1,842 </div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup><font style="padding-left: 3.99pt;"></font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,897</font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(747</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,150</font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,897</font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(830</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,067 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$9,350</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(2,347</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.36pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$7,003</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$9,350</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45.76pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.46pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(4,441</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.22pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 6.37pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,909</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 168pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.97pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.22pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Included in Other are customer relationships and trade names. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amortization expenses for intangible assets were $0&#160;million, $2&#160;million, and $2&#160;million for the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the expected future amortization expense related to intangible assets was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 420pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 27.99pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 420pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 10.01pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 420pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;">$2,058 </div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 12.5pt;">441 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 12.5pt;">427 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 12.5pt;">261 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 12.5pt;">246 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,476 </font></div></td></tr><tr><td style="width: 420pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total expected future amortization expense<font style="font-weight: normal; padding-left: 0.34pt;"></font></div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.99pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,909</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 420pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 10.01pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.99pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; margin-left: 0pt; text-align: left;">7. Consolidated Balance Sheets Components </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Prepaid Expenses and Other Current Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Prepaid expenses and other current assets consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$54,338</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 5pt;">67,393 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax receivables<font style="padding-left: 2.34pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 5pt;">17,647</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt;">9,145 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Available-for-sale marketable securities<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 10pt;">2,368</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 27.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other current assets<font style="padding-left: 4.44pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,173</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">24,708 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total prepaid expenses and other current assets<font style="font-weight: normal; padding-left: 3.15pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$76,526</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$101,246</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-28<br></div></div></div>
<!--End Page 483-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 484-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg18"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Other Non-current Assets </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Other non-current assets consisted of the following (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Escrow funds<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;">$<font style="padding-left: 22.13pt;">&#8212;</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$336,055 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Prepaid expenses<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;"><font style="padding-left: 9.63pt;">51,193</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">145,424 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Notes receivable<font style="padding-left: 2.76pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;"><font style="padding-left: 27.13pt;">&#8212;</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">107,597 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Strategic investments<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;"><font style="padding-left: 9.63pt;">42,087</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">102,220 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other non-current assets<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;"><font style="padding-left: 9.63pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">17,478</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,616 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total other non-current assets<font style="font-weight: normal; padding-left: 0.17pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.02pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$110,758</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$720,912</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 13pt; margin-left: 0pt; text-align: left;">8. Leases </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company enters into leases as a lessee for data centers, office buildings, and equipment. The Company determines if an arrangement is a lease or contains a lease at inception and whether that lease meets the classification criteria for a finance or operating lease in accordance with U.S. GAAP. The Company applied judgment in performing the lease classification tests related to transfer of ownership, bargain purchase option, lease term assessment, estimated fair value, and the specialized nature of the underlying asset. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Leases for offices generally have an initial term of four to ten years, often with multi-year renewal periods. Data center leases generally have an initial term from three to fifteen years, some of which include options to extend the leases for up to ten years. Additionally, the Company&#8217;s equipment leases generally have an initial term of two years and include the option to purchase the asset. Variable costs generally relate to costs associated with Common Area Maintenance (CAM), utilities reimbursed to the landlord, and physical security expenses within certain lease agreements. These are not included in operating or finance lease cost and are expensed as incurred. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The components of total lease cost related to leases for the years ended December&#160;31, 2022, 2023, and 2024 were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 120.5pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 120.5pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.58pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease cost:<br></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease cost<font style="padding-left: 0.76pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">236</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$41,515</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$288,628 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance lease cost:<br></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Amortization of ROU assets<font style="padding-left: 2.44pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,904</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">3,050</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">18,565 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest on lease liabilities<font style="padding-left: 1.33pt;"></font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">903</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">868</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8,709 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total finance lease cost<font style="padding-left: 2.58pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$2,807</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">3,918</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">27,274 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Variable lease cost<font style="font-weight: normal; padding-left: 3.34pt;"></font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">370</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$16,028</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">54,633 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total lease cost<font style="font-weight: normal; padding-left: 2.78pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$3,413</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$61,461</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$370,535</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">Supplemental consolidated balance sheet information related to leases were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating leases:<br></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 348pt; padding-top: 0.51pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease ROU assets<font style="font-weight: normal; padding-left: 4.44pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$461,966</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,589,547 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, current<font style="padding-left: 2.51pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 5pt;">39,789</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$<font style="padding-left: 7.5pt;">213,104 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating lease liabilities, non-current<font style="padding-left: 4.18pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">432,653</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,388,912 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total operating lease liabilities<font style="font-weight: normal; padding-left: 3.12pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$472,442</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; padding-bottom: 3.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$2,602,016 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance leases:<br></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.76pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 348pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Property and equipment<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$<font style="padding-left: 5pt;">15,250</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$<font style="padding-left: 7.5pt;">157,146 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: amortization<font style="font-style: normal; padding-left: 4.97pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 11.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(4,954</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(23,544</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment, net<font style="font-weight: normal; padding-left: 4.89pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">10,296</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">133,602 </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-29<br></div></div></div>
<!--End Page 484-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 485-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg19"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 348pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 348pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 1.88pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31,<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 348pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance lease liabilities, current<font style="padding-left: 0.84pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;">$3,534</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.51pt; padding-bottom: 0.88pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;">$57,801 </div></td></tr><tr><td style="width: 348pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Finance lease liabilities, non-current<font style="padding-left: 2.51pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">510</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 0.51pt; padding-bottom: 2.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">34,120 </font></div></td></tr><tr><td style="width: 348pt; padding-top: 1.76pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total finance lease liabilities<font style="font-weight: normal; padding-left: 3.12pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 9.83pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$4,044</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.76pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.33pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$91,921</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 348pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Supplemental consolidated cash flow and other information related to leases for the years ended December 31, 2022, 2023, and 2024 were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 120.5pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 120.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cash paid for amounts included in the measurement of lease liabilities:<br></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating cash flows from operating leases<font style="padding-left: 0.81pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 7.5pt;">456</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$30,381</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$253,285 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating cash flows from finance leases<font style="padding-left: 4.15pt;"></font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">903</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">868</font></div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 15pt;">8,709 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Financing cash flows from finance leases<font style="padding-left: 4.14pt;"></font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">3,840</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">7,606</font></div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">54,052</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Information relating to the lease term and discount rate for the years ended December&#160;31, 2022, 2023, and 2024 were as follows: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 72pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 384pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 384pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted-average remaining lease term (in years):<br></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating leases<font style="padding-left: 4.31pt;"></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">6</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">8</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">9 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance leases<font style="padding-left: 2.64pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">2</font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">1</font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 5pt;">2 </font></div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Weighted-average discount rate:<br></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating leases<font style="padding-left: 4.31pt;"></font></div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;">12%</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;">12%</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;">12% </div></td></tr><tr><td style="width: 384pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Finance leases<font style="padding-left: 2.64pt;"></font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 0.37pt;">11%</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 0.37pt;">11%</font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3pt; text-align: left;"><font style="padding-left: 0.37pt;">11%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 384pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The future lease payments included in the measurement of the Company&#8217;s operating lease liabilities and finance lease liabilities as of December 31, 2024, were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 94.41pt;" colspan="4"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 94.41pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Future Payments </div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 6.79pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Operating<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases</div></td><td style="width: 6.79pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Finance<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Leases </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 10.83pt;">507,855</font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$64,267 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">525,805</font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">35,000 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">538,988</font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">544,028</font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 2.5pt;"></font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 15.83pt;">475,670</font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 0.86pt;"></font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,775,509</font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total undiscounted lease payments<font style="padding-left: 0.47pt;"></font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,367,855</font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">99,267 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: imputed interest<font style="font-style: normal; padding-left: 2.91pt;"></font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,765,839</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 6.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(7,346</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Present value of lease liabilities<font style="font-weight: normal; padding-left: 1.62pt;"></font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">2,602,016</font></div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$91,921</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company incurred interest expense on its finance leases of $1 million, $1 million, and $9 million for the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company executed additional lease agreements, primarily for data centers and office buildings, that had not yet commenced. The aggregate amount of estimated future undiscounted lease payments associated with such leases is $15.0 billion. These leases will commence between 2025 and 2026 with estimated lease terms of five to sixteen years. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-30<br></div></div></div>
<!--End Page 485-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 486-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg20"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the Company had additional lease agreements for various data center locations with commencement dates subject to regulatory approvals and completion of landlord improvements. The Company may be required to make fixed lease payments up to $1.1 billion over the next seventeen years. The Company will assess the lease classification upon lease commencement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, in August&#160;2024, the Company entered into a lease agreement for various buildings located at a single site intended to be used as data centers. The agreement provides access to 50 MW of electrical power, which is expected to be delivered in phases between the fourth quarter of 2025 and the fourth quarter of 2026. The Company will pay a portion of the construction costs incurred by the lessor during the construction period and during the lease term, which are considered variable lease payments. The Company will assess the lease classification upon lease commencement, estimated to be in 2027. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">9. Commitments and Contingencies </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Letters of Credit </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023 and 2024, the Company had outstanding Letters of Credit (&#8220;LOC&#8221;) in the aggregate amount of $174 million and $533 million, respectively. These LOC guarantee the Company&#8217;s ability to fulfill its lease obligations, per the lease agreements. As of December 31, 2023 and 2024, the Company has not drawn on any of its LOC and is in compliance with the terms and conditions set forth by the financial institution. These LOC renew annually and expire on various dates through 2041. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Employee Benefit Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December 31, 2022, 2023, and 2024, the Company contributed $0 million, $1 million, and $3 million, respectively, to the 401(k) Plan, which are allocated to cost of revenue, technology and infrastructure, sales and marketing, and general and administrative expenses in the consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Indemnifications </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company enters into indemnification provisions under certain agreements with other parties in the ordinary course of business. In its customer agreements, the Company has agreed to indemnify, defend, and hold harmless the indemnified party for third party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic customers, the Company has agreed to indemnify, defend, and hold harmless the indemnified party for noncompliance with certain additional representations and warranties made by the Company. In addition, the Company indemnifies its officers, directors, and certain key employees while they are serving in good faith in their respective capacities. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">While the Company has entered into various indemnification agreements, it has not incurred any material costs or claims under these agreements to date, and management does not expect any future claims to have a material adverse effect on the Company&#8217;s financial position or results of operations. It is not possible to determine the maximum potential amount under these indemnification provisions due to the Company&#8217;s limited history of prior indemnification claims and the unique facts and circumstances involved in each particular provision. To date, there have been no claims under any indemnification provisions. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Litigation </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">From time to time, the Company may be subject to various proceedings, lawsuits, disputes, or claims in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that would, individually or taken together, have a material adverse effect on its business, financial position, results of operations, or cash flows. As of December 31, 2023 and 2024, the Company has not accrued any material potential loss. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-31<br></div></div></div>
<!--End Page 486-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 487-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg21"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">10. Debt </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The total debt obligations are as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 168pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 125.79pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.95pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 48.33pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 168pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Maturities</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Effective <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Interest <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Rates</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 168pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2021 Convertible Senior Secured Notes</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">October&#160;2025</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.47pt; text-align: left;">17%</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;">$<font style="padding-left: 12.5pt;">55,125</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 33.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2022 Senior Secured Notes<font style="padding-left: 3.88pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">October&#160;2025 &#8211; April 2026</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.47pt; text-align: left;">10%</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 12.5pt;">125,000</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 38.33pt;">&#8212; </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Delayed Draw Term Loan Facility 1.0<font style="padding-left: 3.94pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">March&#160;2028</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.47pt; text-align: left;">15%</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt;">1,374,924</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">2,012,500 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Delayed Draw Term Loan Facility 2.0<font style="padding-left: 3.94pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">May&#160;2029</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.47pt; text-align: left;"><font style="padding-left: 0.37pt;">11%</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">3,843,819 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2024 Term Loan Facility<font style="padding-left: 3.63pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">December&#160;2025</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 16.47pt; text-align: left;">12%</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 35pt;">&#8212;</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">1,000,000 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Original Equipment Manufacturer financing arrangements<font style="padding-left: 0.54pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">February&#160;2026 &#8211;&#8201;October 2027</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">9% &#8211; 11%</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 35pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,177,158 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total principal of debt<font style="padding-left: 4.01pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt;">1,555,049</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">8,033,477 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Less: Unamortized discount and issuance costs<font style="font-style: normal; padding-left: 2.75pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(31,795</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(107,137</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Total debt, net of unamortized discount and issuance costs<font style="font-weight: normal; padding-left: 2.2pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 5pt;">1,523,254</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">7,926,340 </font></div></td></tr><tr><td style="width: 168pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: Debt, current<font style="font-style: normal; padding-left: 1.74pt;"></font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(171,865</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,468,425</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 168pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total debt, non-current<font style="font-weight: normal; padding-left: 4.13pt;"></font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 125.79pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.95pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,351,389</font></div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 48.33pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">5,457,915</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 168pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 125.79pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.95pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.47pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 48.33pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the future principal payments for the Company&#8217;s total debt were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Amount </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$2,483,202 </div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">3,102,384 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">1,771,071 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">548,093 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">128,727 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$8,033,477</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December 31, 2022, 2023, and 2024, total interest expense for the Company&#8217;s debt obligations was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 122.72pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 122.72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Contractual interest expense<font style="padding-left: 3.55pt;"></font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$4,914</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">30,189</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 3.33pt;">474,844 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Amortization of debt discounts and issuance costs and accretion of redemption premiums<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">3,803</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">16,533</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 13.33pt;">33,376 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">PIK interest<font style="padding-left: 4.63pt;"></font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt;">21,621</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: capitalized interest<font style="font-style: normal; padding-left: 2.24pt;"></font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(343</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(41,376</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(159,017</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 1.64pt;"></font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$8,374</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">26,967</font></div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">349,203</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.64pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 18.5pt; margin-left: 20pt; text-align: left;">2021 Unsecured Senior Subordinated Convertible Promissory Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In 2020 and 2021, the Company entered into unsecured bridge loan agreements with various investors, for a total principal amount of $4 million, carrying an annual interest rate of 7.00%. In April&#160;2021, the loans were exchanged, pursuant to the original terms of the agreements, into convertible promissory notes with a principal balance of $4&#160;million, an interest rate of 7.00% per annum, compounded annually, and convertible into shares of stock similar </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-32<br></div></div></div>
<!--End Page 487-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 488-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg22"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">to shares of stock issued in the next round of financing. In April&#160;2023, concurrent with the Series&#160;B round of financing, the convertible promissory notes were automatically converted pursuant to the original terms of the conversion feature into 12,484,540 shares of the Company&#8217;s Series B-1 redeemable convertible preferred stock, with no gain or loss recognized upon conversion. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">2021 Convertible Senior Secured Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2021, the Company executed a note issuance agreement and a note purchase agreement with a related party for the issuance of an aggregate principal amount of up to $50 million of convertible senior secured notes (the &#8220;2021 Convertible Senior Secured Notes&#8221;). The Company drew $20 million at execution and the remaining $30&#160;million in April&#160;2022. The 2021 Convertible Senior Secured Notes are collateralized by the Company&#8217;s property, equipment and other assets, excluding the financed property, equipment and other assets collateralized by the delayed draw term loans and Original Equipment Manufacturer (&#8220;OEM&#8221;) financing arrangements discussed below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2021 Convertible Senior Secured Notes bear a stated annual interest rate of 10.00% for the first three years, payable semiannually on April 30 and October&#160;30. Interest may be paid in cash or paid-in-kind (&#8220;PIK&#8221;), in which case additional 2021 Convertible Senior Secured Notes will be issued with a principal amount equal to the accrued interest, and otherwise which carry the same terms of the original notes (the &#8220;PIK Notes&#8221;). In April and October of 2023, an aggregate of $5 million principal amount of PIK Notes were issued in lieu of cash settlement of accrued interest. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">If a qualified public company event (&#8220;QPCE&#8221;), defined as an IPO, direct listing, or special purpose acquisition company (&#8220;SPAC&#8221;) transaction, is not consummated on or prior to the date that is three (3) years from the issuance date, the interest rate shall automatically increase to 16.00% per year, prospectively, payable in cash. The 2021&#160;Convertible Senior Secured Notes have a contractual maturity date of October 18, 2025. In the event the 2021&#160;Convertible Senior Secured Notes are not otherwise converted or redeemed prior to the maturity date, and in the event that there is no QPCE, the investors will be entitled to redeem the 2021 Convertible Senior Secured Notes for cash in the amount equal to the principal, accrued and unpaid interest, plus a premium amount to ensure the holders realize an aggregate internal rate of return (&#8220;IRR&#8221;) of 16.00%. Prior to the maturity date, the 2021 Convertible Senior Secured Notes may be redeemed or converted as follows: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Redemption</font>&#8212;From the third anniversary until a QPCE, the Company has the right, at its option, to redeem up to a principal amount of $15 million at a redemption price equal to principal amount plus accrued and unpaid interest plus a premium amount such that the holders of such principal amount of debt realize an IRR of 20.00% with respect to such redeemed amounts. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;"><font style="font-style: italic;">Conversion&#8212;</font>Holders of the 2021 Convertible Senior Secured Notes have the right, at their option, to convert all or any portion of their notes into a number of shares of common stock at any time based on the outstanding principal and accrued interest divided by the conversion price in effect. The conversion price in effect shall be calculated as follows: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Initially, the conversion price is equal to $675 million (the &#8220;Maximum Conversion Valuation&#8221;) divided by the fully diluted shares of common stock outstanding, which was $2.20 per share. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">If a qualified financing occurs prior to a QPCE, the Maximum Conversion Valuation will be reduced, but not increased, to the enterprise value derived from the qualified financing on a fully diluted basis. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Upon the occurrence of a QPCE, the conversion price will be reduced, but not increased, to 75% of either the price per share offered to the public in an IPO, 75% of the stock price after the closing of a direct listing, or 75% of the stock valuation derived from a SPAC transaction. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company determined that the conversion features, the accelerated redemption features, the variability in interest payments, and the Company&#8217;s redemption option are required to be bifurcated and accounted for as an embedded derivative. Accordingly, upon issuances in October&#160;2021 and April&#160;2022, the Company recognized embedded derivative liabilities of $0&#160;million and $2 million, respectively. The Company used Level 3 inputs to determine the fair value of the embedded derivatives. Significant management assumptions and estimates were involved in this determination. As of December 31, 2023, the estimated fair value of 2021 Convertible Senior Secured Notes was $451 million. This amount includes the $55 million face value of the notes, $6 million in accreted redemption premiums, $2 million in unamortized debt discounts and issuance costs, which is a reduction to the net carrying value, and a $386 million embedded derivative requiring bifurcation. The embedded derivative is separated and included within derivative and warrant liabilities on the consolidated balance sheets. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-33<br></div></div></div>
<!--End Page 488-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 489-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg23"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">For the years ended December 31, 2022, 2023, and 2024, the Company recorded losses related to the fair value adjustment of these derivative liabilities of $3 million, $361 million, and $627 million, respectively. During the years ended December 31, 2022, 2023, and 2024, total interest costs were $7 million, $31 million, and $8 million, respectively. These amounts are comprised of coupon interest of $4 million, $5 million, and $4 million, respectively; PIK interest cost was $0 million, $22 million, and $0&#160;million, respectively; and amortization of debt discounts and issuance costs of $3 million, $4 million, and $4 million, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The debt host liability was initially recognized based on the proceeds received from issuance, net of issuance costs and net of the initial fair value of the bifurcated derivative. The debt host was subsequently accounted for using the effective interest method to amortize the discount and issuance costs and accrue for the premiums due at maturity in the event the debt was not early converted or redeemed earlier and no QPCE occurred. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The investors elected to convert all of the outstanding 2021 Convertible Senior Secured Notes on September 17, 2024, pursuant to the original terms of the conversion feature, resulting in the issuance of 24,543,980 shares of common stock and a cash payment of $2 million for accrued interest and cash in lieu of fractional shares. The conversion was accounted for as an extinguishment. Equity increased by the settlement-date fair value of the common shares issued of $1.1 billion. Additionally, a $6 million extinguishment loss is included in other income, net, which represents the difference between the fair value of the shares and the combined carrying amounts of the debt host and the bifurcated embedded derivative liability. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20pt; margin-left: 20pt; text-align: left;">2022 Senior Secured Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2022, the Company executed a note issuance agreement and a note purchase agreement (the &#8220;2022 Senior Secured Notes&#8221;) with a related party for an aggregate principal amount of up to $125 million. The Company drew down $30 million upon execution (the &#8220;First Closing&#8221;), an additional $30 million in November&#160;2022 (the &#8220;Second Closing&#8221;), an additional $40 million in January&#160;2023 (the &#8220;Third Closing&#8221;), and the remaining $25 million in April&#160;2023 (the &#8220;Fourth Closing&#8221;). The 2022 Senior Secured Notes are collateralized by the Company&#8217;s property, equipment and other assets, excluding the financed property, equipment and other assets collateralized by the delayed draw term loans and OEM financing arrangements discussed below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The first three tranches of 2022 Senior Secured Notes bear 0.0% interest from the issuance date through April&#160;16, 2024, and 12.00% interest per annum from and after April&#160;17, 2024. Interest payments are due, in cash, semiannually on April&#160;14 and October&#160;14 of each year, beginning on April&#160;14, 2024. All principal and accrued and unpaid interest are due on October&#160;17, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The fourth tranche of 2022 Senior Secured Notes bear 0.0% interest from the issuance date through October 19, 2024, and 12.00% interest per annum from and after October&#160;20, 2024. Interest payments are due, in cash, semiannually on April 14 and October 14 of each year, beginning on October 14, 2024. All principal and accrued and unpaid interest are due on April 20, 2026. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may redeem the debt at any time, or the debt may be required to be redeemed early upon the occurrence of customary events of default or change of control. In the event the debt is redeemed prior to the maturity date, the redemption price is equal to the principal amount plus accrued and unpaid interest, plus a potential early redemption premium based on the following schedule: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">No premium if redeemed prior to April 17, 2024, or on or after October 2, 2025 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) or prior to October 20, 2024, or on or after April 7, 2026 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">10.00% premium if redeemed on or after April 17, 2024, but before July 17, 2024 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) or on or after October 20, 2024, but before January 20, 2025 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">8.50% premium if redeemed on or after July 17, 2024, but before October 17, 2024 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) on or after January 20, 2025, but before April 20, 2025 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">7.00% premium if redeemed on or after October 17, 2024, but before January 17, 2025 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) or on or after April 20, 2025, but before July 20, 2025 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-34<br></div></div></div>
<!--End Page 489-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 490-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg24"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">5.50% premium if redeemed on or after January 17, 2025, but before April 17, 2025 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) or on or after July 20, 2025, but before October 20, 2025 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">4.00% premium if redeemed on or after April 17, 2025, but before July 17, 2025 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) or on or after October 20, 2025, but before January 20, 2026 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">2.50% premium if redeemed on or after April 17, 2025, but before October 2, 2025 (with respect to the notes issued in the First Closing, Second Closing and Third Closing) on or after to January 20, 2026, but before April 7, 2026 (with respect to the notes issued in the Fourth Closing). </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In conjunction with the borrowing under the 2022 Senior Secured Notes, the Company granted the 2022 Senior Secured Note&#160;holders fully vested penny warrants and regular warrants to purchase shares of the Company&#8217;s common stock upon each closing: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">First Closing: Penny warrants for 1,873,735 shares and regular warrants for 1,040,956 shares. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Second Closing: Penny warrants for 1,873,735 shares and regular warrants for 1,040,956 shares. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Third Closing: Penny warrants for 2,498,356 shares and regular warrants for 1,388,000 shares. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">Fourth Closing: Penny warrants for 1,561,456 shares and regular warrants for 867,474 shares. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All warrants issued in the First Closing, Second Closing and Third Closing expire on October 17, 2029 and all warrants issued in the Fourth Closing expire on April 20, 2030. The penny warrants have an exercise price of $0.0005&#160;per share. The regular warrants are exercisable at a price per share equal to the lower of (subject to adjustment as provided in the 2022 Senior Secured Notes): </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">if, prior to an IPO or SPAC Transaction, the Company completes a qualified equity financing, the purchase price or deemed purchase price per share of common stock in the qualified equity financing; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">b)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the purchase price determined based on a valuation of the Company of: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">$1,500,000,000, if the principal amount of the 2022 Senior Secured Notes is repaid in full within one&#160;hundred twenty (120) days after the original issue date; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">$1,300,000,000, if the principal amount of the 2022 Senior Secured Notes is repaid in full within one&#160;hundred twenty-one (121) to two hundred forty (240) days after the original issue date; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">$1,100,000,000, if the principal amount of the 2022 Senior Secured Notes is repaid in full within two&#160;hundred forty-one (241) to three hundred sixty (360) days after the original issue date; or </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">$1,000,000,000, if the principal amount of the 2022 Senior Secured Notes is repaid in full three&#160;hundred sixty-one (361) or more days after the original issue date. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The penny warrants are classified within stockholders&#8217; deficit on the consolidated balance sheets, as their settlement is indexed to the Company&#8217;s own stock in accordance with ASC 815, <font style="font-style: italic;">Derivatives and Hedging</font>. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The regular warrants are classified as derivative liabilities as their settlement amounts are not solely indexed to the Company&#8217;s own stock and settled in equity. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company recorded a loss related to the fair value adjustment of these warrant liabilities of $0 million, $67&#160;million, and $129 million within loss on fair value adjustments in the consolidated statements of operations during the years ended December 31, 2022, 2023, and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The fair values of the regular warrants were remeasured to $71 million and $200 million as of December 31, 2023 and 2024, respectively. These amounts are included within derivative and warrant liabilities on the consolidated balance sheets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Second Closing and the Third Closing were loan commitments that were required to be issued and funded. The fees associated with the loan commitment were initially capitalized and accounted for as deferred financing costs. As these closings were completed, the associated portions of the deferred financing costs were reclassified as the debt discount for the portion of the drawn loans and amortized to interest expense. As of December 31, 2023, the </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-35<br></div></div></div>
<!--End Page 490-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 491-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg25"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">carrying value of the notes was $124 million, which approximates fair value. The penny warrants and regular warrants issued in connection with the first three closings were recorded as part of the deferred financing costs equal to their issuance date fair values of $6 million and $3 million, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Fourth Closing provided the lenders the option, but not the obligation to purchase up to $25 million principal amount of notes and the associated portion of penny warrants and regular warrants. The option was accounted for as a derivative liability issued on the initial closing date, representing part of the deferred financing costs of $1 million for the loan commitments. The written option was remeasured to fair value through the settlement date completed in April&#160;2023, and the Company recognized a loss for the change in fair value of $2 million during the year ended December 31, 2023. The notes, penny warrants, and regular warrants issued upon settlement of the Fourth Closing were initially recorded at their respective fair values of $22 million, $4 million, and $2 million, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2024, the Company issued notice to the lenders to exercise its option to redeem the 2022 Senior Secured Notes. In July&#160;2024, the Company settled the entire principal amount of the notes for a redemption price of $137&#160;million, inclusive of prepayment premium and accrued and unpaid interest, resulting in an extinguishment loss of $6 million, which is included in other income, net. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loans </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facility 1.0 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2023, one of the Company&#8217;s subsidiaries, CoreWeave Compute Acquisition Co. II, LLC (&#8220;CCAC II&#8221;), entered into a delayed draw term loan with various lenders and U.S. Bank, N.A., as the administrative and collateral agent. The agreement provides for a delayed draw term loan facility of up to $2.3 billion (as amended, the &#8220;DDTL 1.0 Facility&#8221;). Borrowings under the DDTL 1.0 Facility were used to finance a portion of the purchase consideration, fees, and expenses relating to the acquisition of computing equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DDTL 1.0 Facility contains covenants that restrict the ability of the Company and/or CCAC II to incur or guarantee additional indebtedness; pay dividends and make other distributions or repurchase stock; make certain investments; create or incur liens; sell assets; enter into certain transactions with affiliates; and merge, consolidate or transfer or sell all or substantially all of its assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All obligations under the DDTL 1.0 Facility are unconditionally guaranteed by the Company. Obligations outstanding under the DDTL 1.0 Facility are secured by perfected first priority pledges of and security interests in (i) the equity interests of CCAC II held by its direct parent and (ii) substantially all of the assets of CCAC II. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest on outstanding borrowings on the DDTL 1.0 Facility accrues at a rate per annum equal to either, at the Company&#8217;s election, Term SOFR plus 8.75% or the alternative base rate plus 7.75%. On May 15, 2024, the interest rate was modified to Term SOFR plus 9.62% or the alternative base rate plus 8.62%. As of December 31, 2023, and 2024, the actual average interest rate being charged on the amounts borrowed against the DDTL 1.0 Facility was 14.12% and 14.11%, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Throughout 2023 and 2024, the Company borrowed against the $2.3 billion facility commitment. The principal amount of the loans is required to be repaid in quarterly installments, with the final balloon payment due on March&#160;28, 2028. The loans are prepayable at any time, from time to time, at the Company&#8217;s option, and are required to be prepaid upon the occurrence of an event of default or change of control of the Company, or with the proceeds of certain asset dispositions or incurrence of indebtedness. If the loans are prepaid prior to the fourth anniversary of the loan commitment termination date, in addition to principal and accrued interest, the Company is required to pay an applicable premium equal to (a) with respect to prepayments made prior to the third anniversary of the loan commitment termination date, the present value of future interest payments that would have accrued on the principal amount of the loans being prepaid through the third anniversary of the loan commitment termination date based on the interest rate in effect plus 1.00% of the principal amount of the loans being prepaid or (b) with respect to prepayments made between the third and fourth anniversary of the loan commitment termination date, an amount equal to 1.00% of the principal amount of the loans being prepaid. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023 and 2024, the amounts outstanding were $1.4 billion and $2.0&#160;billion, respectively, under the DDTL 1.0 Facility. The Company incurred deferred financing costs of $12 million and recorded debt discounts of $24 million and $22&#160;million for the years ended December 31, 2023 and 2024, respectively. These costs </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-36<br></div></div></div>
<!--End Page 491-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 492-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg26"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">are capitalized as a reduction to the outstanding debt balance on the consolidated balance sheets and are being amortized to interest expense over the term of the DDTL 1.0 Facility. Amortization of debt issuance costs and debt discounts was $2 million and $20 million for the years ended December 31, 2023 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company was required to maintain restricted cash equal to 16.00% of the drawn balance, totaling $220&#160;million as of December 31, 2023. In May&#160;2024, in conjunction with the amendment to the interest rate, the restricted cash requirement was reduced to 4.00% of the drawn balance, but in no event can the liquidity requirement be greater than $56&#160;million. As of December 31, 2024, $56&#160;million was restricted cash in relation to this agreement. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 12pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facility 2.0 </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, one of the Company&#8217;s subsidiaries, CoreWeave Compute Acquisition Co. IV, LLC (&#8220;CCAC IV&#8221;) entered into a second agreement with various lenders and U.S. Bank, N.A., as the administrative and collateral agent. The agreement provides for another delayed draw term loan facility of up to $7.6 billion (as amended, the &#8220;DDTL 2.0 Facility&#8221;). Borrowings under this agreement were established to primarily finance capital expenditures necessary to fulfill customer contracts, including the acquisition of GPU servers and related infrastructure. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Under the DDTL 2.0 Facility, additional loans may be drawn until June&#160;2025, with an option to extend the commitment period by three months subject to lender consent. The total loans available are constrained by the purchase price of assets for which the loans are being used to finance with such percentage based upon the depreciable cost of GPU servers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">All obligations under the DDTL 2.0 Facility are unconditionally guaranteed by the Company. Obligations outstanding under the DDTL 2.0 Facility are secured by perfected first priority pledges of and security interests in (i) the equity interests of CCAC IV held by its direct parent and (ii) substantially all of the assets of CCAC IV. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DDTL 2.0 Facility contains covenants that restrict the ability of the Company and/or CCAC IV to incur or guarantee additional indebtedness; pay dividends and make other distributions or repurchase stock; make certain investments; create or incur liens; sell assets; enter into certain transactions with affiliates; and merge, consolidate or transfer or sell all or substantially all of its assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Interest on outstanding borrowings on the DDTL 2.0 Facility accrues at a rate per annum equal to either, at the Company&#8217;s election, Term SOFR or the alternative base rate plus a spread based on the credit quality of the associated customer contracts. For specified investment-grade customers, the spread is equal to 6.00% for Term SOFR denominated loans and 5.00% for base rate denominated loans. For investment-grade customers, the spread is equal to 6.50% for Term SOFR loans and 5.50% for base rate loans. For non-investment-grade customer contracts, the spread is equal to 13.00% for Term SOFR loans and 12.00% for base rate loans. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The principal amount of the loans is required to be repaid in quarterly installments, beginning in October&#160;2025, with the final balloon payment due on five years after the applicable loan was funded. The loans are prepayable at any time, from time to time, at the Company&#8217;s option and are required to be prepaid upon the occurrence of an event of default or change of control of the Company, or incurrence of certain indebtedness. If the loans are prepaid prior to the 30-month anniversary of the loan commitment termination date, in addition to principal and accrued interest, the Company is required to pay an applicable premium equal to the present value of future interest payments that would have accrued through the 30-month anniversary of the loan commitment termination date based on the interest rate in effect. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, the actual average interest rate being charged on the amounts borrowed against the DDTL 2.0 Facility was 10.53% and the total amount borrowed was $3.8 billion. The Company incurred deferred financing costs of $3 million and recorded debt discounts of $58&#160;million related to the issuance of the DDTL 2.0&#160;Facility. These costs are capitalized as a reduction to the outstanding debt balance on the consolidated balance sheets and are being amortized to interest expense over the term of the DDTL 2.0 Facility. Amortization of debt issuance costs and debt discounts was $5 million for the year ended December 31, 2024. The Company is required to maintain restricted cash equal to 2.00% of the drawn balance, totaling $77 million as of December 31, 2024. Additionally, the Company incurred undrawn fees totaling $4 million for the year ended December 31, 2024, which is recognized in interest expense, net in the consolidated statements of operations. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12pt; margin-left: 20pt; text-align: left;">Revolving Credit Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On June 21, 2024, the Company entered into a credit agreement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent. The credit agreement matures on June&#160;21, 2027. The credit agreement </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-37<br></div></div></div>
<!--End Page 492-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 493-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg27"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">originally provided for a $100 million senior revolving credit facility. On October&#160;7, 2024, the credit agreement was amended to have a capacity of $650&#160;million consisting of (i) a $500&#160;million secured facility and (ii) a $150&#160;million unsecured facility to support the expansion of the Company&#8217;s data center infrastructure and AI-driven cloud computing operations. On December&#160;2, 2024, the credit agreement was further amended to provide for the $650&#160;million senior revolving credit facility to be fully secured (the &#8220;Revolving Credit Facility&#8221;). The Revolving Credit Facility includes a $175&#160;million letter of credit sub-facility. As of December&#160;31, 2024, the Company had not drawn on the Revolving Credit Facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Amounts borrowed under the Company&#8217;s Revolving Credit Facility are subject to an interest rate per annum equal to, at the Company&#8217;s option, either (a) for base rate loans, an applicable margin of 0.75% plus a base rate (subject to a 1.00% floor) determined by reference to the highest of (i) the prime rate, (ii) the greater of (a) the federal funds effective rate and (b) the overnight bank funding rate, in each case, plus 0.50%, and (iii) the one month term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) plus 1.00% or (b) for term benchmark loans, an applicable margin of 1.75% plus the term SOFR (subject to a 0.00% floor) for a one, three or six month interest period. Additionally, the Company is required to pay a fee of 0.25% per annum on the average undrawn commitment. The Company may voluntarily prepay outstanding loans under its Revolving Credit Facility at any time without premium or penalty. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 20pt; text-align: left;">2024 Term Loan Facility </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2024, the Company entered into a credit agreement providing for a $1.0&#160;billion term loan facility (the &#8220;2024 Term Loan Facility&#8221;) consisting of (i) a $229&#160;million secured facility and (ii) a $771&#160;million unsecured facility. On December&#160;16, 2024, the Company borrowed the full $1.0 billion of loans available under the agreement. The proceeds from the term loan facility may be used for working capital and general corporate purposes (including the financing of acquisitions and investments). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company incurred deferred financing costs related to the issuance of the 2024 Term Loan Facility of $16&#160;million. These costs are capitalized as a reduction to the outstanding debt balance within Debt, current on the consolidated balance sheets and are being amortized to interest expense over the term of the 2024 Term Loan Facility. As of December&#160;31, 2024, the unamortized deferred financing costs were $15&#160;million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The 2024 Term Loan Facility matures December&#160;16, 2025. The Company may prepay at any time, from time to time, at its option, upon the occurrence of an event of default, or with the proceeds of certain asset dispositions, incurrences of indebtedness or equity issuances, including a requirement to be prepaid with some or all of the proceeds of an initial public offering. Amounts borrowed under the term loan facility are subject to an interest rate per annum equal to, at the Company&#8217;s option, either (a) Term SOFR plus 5.25% for the first 180 days, 5.75% for the next 90 days, and 6.25% for the remainder of the term of the 2024 Term Loan Facility or (b) the alternative base rate (as described previously) plus 4.25% for the first 180 days, 4.75% for the next 90 days, and 5.25% for the remainder of the term of the 2024 Term Loan Facility. As of December&#160;31, 2024, the actual interest rate being charged on the amounts borrowed against the 2024 Term Loan Facility was 9.65%. The 2024 Term Loan Facility contains customary affirmative and negative covenants. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 13pt; margin-left: 20pt; text-align: left;">OEM Financing Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company entered into various agreements with an OEM between February and December 2024 whereby the Company obtained financing for certain equipment with an aggregate notional balance of $1.3 billion as of December 31, 2024. Related to the financing agreements, the Company granted a security interest for the financed equipment. The agreements are accounted for as financing arrangements, with terms between two to three years. The financing arrangements have a stated repayment schedule over the term with effective interest rates between 9% to 11%. The Company did not incur any debt issuance costs associated with the financing arrangements. Interest expense for the year ended December 31, 2024 was $60 million. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 12.5pt; margin-left: 20pt; text-align: left;">DCSP Financing Arrangements </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2023, the Company entered into a service agreement with a data center service provider (the &#8220;DCSP&#8221;) (the &#8220;DCSP Service Agreement&#8221;). Under the DCSP Service Agreement, the DCSP will design, purchase, build, and manage a data center providing access to up to 78 MW of electrical power to be delivered in phases. Separately, during the year ended December&#160;31, 2024, the Company purchased $116&#160;million of critical infrastructure assets to support the data center site (the &#8220;Existing Critical Infrastructure Assets&#8221;). </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2024, the Company, as a lender, entered into a Senior Secured Delayed Draw Term Loan Credit Agreement (the &#8220;Note&#160;Receivable&#8221;, and collectively, with the DCSP Service Agreement, the &#8220;DCSP Financing </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-38<br></div></div></div>
<!--End Page 493-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 494-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg28"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Arrangements&#8221;) with the DCSP to facilitate the purchase of critical infrastructure assets. The Note&#160;Receivable agreement provides for a total commitment of up to $305&#160;million in delayed draw term loan funding for a term of seven years with a stated interest rate of 13.00% per annum. The Company incurred an immaterial amount of fees in conjunction with the issuance of the Note&#160;Receivable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Note&#160;Receivable is secured by the new and existing critical infrastructure assets that support current and future phases of the build out at the data center and is prepayable at any time by the DCSP with no penalty. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the year ended December&#160;31, 2024, the DCSP borrowed under the Note&#160;Receivable to settle amounts previously advanced to the DCSP by the Company, finance purchases of additional critical infrastructure assets, and purchase the Existing Critical Infrastructure Assets. Under the terms of the DCSP Service Agreement, the Company continues to control the Existing Critical Infrastructure Assets and the Company recorded a financing obligation related to the consideration received for the Existing Critical Infrastructure Assets. The financing obligation is payable over a term of 14 years and has an imputed interest rate of 15%. The Existing Critical Infrastructure Assets are included in property and equipment, net, on the consolidated balance sheets and are depreciated over their estimated useful life. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2024, the future contractual principal payments under the financing obligation due to the DCSP were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 41.32pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Years Ending December&#160;31,</div></td><td style="width: 9.34pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Principal <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Payments </div></td></tr><tr><td style="width: 408pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2025<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;">$<font style="padding-left: 8.33pt;">19,672 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2026<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 13.33pt;">19,658 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2027<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 13.33pt;">19,645 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2028<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 13.33pt;">19,630 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">2029<font style="padding-left: 0.5pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 13.33pt;">19,616 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Thereafter<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">175,800 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total future payments<font style="padding-left: 1.23pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.01pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 8.33pt;">274,021 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Less: amount representing interest <font style="padding-left: 2.23pt;"></font></div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(158,081</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total financing obligation<font style="font-weight: normal; padding-left: 4.21pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.01pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;">$<font style="padding-left: 3.7pt;">115,940 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Less: current portion<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,087</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Long-term portion<font style="padding-left: 0.52pt;"></font></div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 41.32pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.25pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 3.7pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">113,853</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 9.34pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 41.32pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The DCSP Financing Arrangements allow for the net settlement of amounts due between the parties and meet the criteria for right of setoff in accordance with ASC 210, <font style="font-style: italic;">Balance Sheet</font>. As of December&#160;31, 2024, the gross amount of the Note&#160;Receivable is $224&#160;million, which is presented net of the financing obligation of $116&#160;million. The accrued interest on the Note&#160;Receivable is forgiven if the DCSP achieves certain construction milestones in the first quarter of 2025. For the year ended December&#160;31, 2024, the Company did not recognize any interest income as the Company does not expect to be entitled to the accrued interest. The total interest expense related to the financing obligation for the year ended December&#160;31, 2024 was $3 million. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">11. Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7pt; margin-left: 20pt; text-align: left;">Redeemable Convertible Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2023 and 2024, the Company had four and five classes of redeemable convertible preferred stock, respectively. As of December 31, 2023, redeemable convertible preferred stock consisted of the following (in thousands, except per share amounts): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 240pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 37.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 40.45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 240pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Authorized</div></td><td style="width: 3.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issued and <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issuance <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Per Share</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Carrying <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-bottom: 2.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liquidation <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preference </div></td></tr><tr><td style="width: 240pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;Seed<font style="padding-left: 0.3pt;"></font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.07pt; text-align: left;"><font style="padding-left: 5pt;">60,000</font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">48,896</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.93pt; text-align: left;">$0.05</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 10pt;">2,205</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-top: 1.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.48pt; text-align: left;">$<font style="padding-left: 10pt;">2,205 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;A<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.07pt; text-align: left;"><font style="padding-left: 5pt;">24,182</font></div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">19,879</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.93pt; text-align: left;"><font style="padding-left: 5pt;">0.12</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt;">2,316</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.48pt; text-align: left;"><font style="padding-left: 15pt;">2,316 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B<font style="padding-left: 3.07pt;"></font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.07pt; text-align: left;"><font style="padding-left: 5pt;">79,979</font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">75,496</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.93pt; text-align: left;"><font style="padding-left: 5pt;">5.58</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">455,996</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-top: 0.76pt; padding-bottom: 1.13pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.48pt; text-align: left;"><font style="padding-left: 5pt;">421,001 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B-1<font style="padding-left: 4.74pt;"></font></div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.07pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">12,485</font></div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">10,407</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.93pt; text-align: left;"><font style="padding-left: 5pt;">0.40</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,173</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-top: 0.76pt; padding-bottom: 2.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.48pt; text-align: left;"><font style="padding-left: 15pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,173 </font></div></td></tr><tr><td style="width: 240pt; padding-top: 2.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 0.64pt;"></font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.07pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">176,646</font></div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">154,678</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$464,690</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.45pt; padding-top: 2.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 1.48pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$429,695</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 240pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 38.65pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.44pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.67pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 34.36pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-39<br></div></div></div>
<!--End Page 494-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 495-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg29"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, redeemable convertible preferred stock consisted of the following (in thousands, except per share amounts): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 38.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 34.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 228pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Authorized</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issued and <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Issuance <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Price <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Per Share</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Carrying <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Liquidation <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Preference </div></td></tr><tr><td style="width: 228pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;Seed<font style="padding-left: 3.3pt;"></font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">60,000</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">45,567</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;">$<font style="padding-left: 5pt;">0.05</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 17.5pt;">2,039</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 17.5pt;">2,039 </font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;A<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">24,182</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">19,361</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">0.12</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">2,256</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">2,256 </font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">79,979</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">79,979</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">5.58</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">550,595</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.5pt;">446,002 </font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;B-1<font style="padding-left: 2.74pt;"></font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt;">12,484</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt;">10,205</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 10pt;">0.40</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">4,091</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">4,091 </font></div></td></tr><tr><td style="width: 228pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Series&#160;C<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,523</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">29,523</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.43pt; text-align: left;"><font style="padding-left: 5pt;">38.95</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,130</font></div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,163,671 </font></div></td></tr><tr><td style="width: 228pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 3.64pt;"></font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 38.65pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">206,169</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 5.08pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">184,635</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 34.36pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.74pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">1,722,111</font></div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,618,059</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 228pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 38.65pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 34.36pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.43pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In April&#160;2023, the Company authorized a total of 79,978,760 shares of Series&#160;B redeemable convertible preferred stock, with a par value of $0.000005 per share and an original issue price of $5.58 per share, pursuant to an amendment of the certificate of incorporation. Additionally, the Company issued a total of 12,484,540 shares of Series B-1 redeemable convertible preferred stock, with a par value of $0.000005 per share to settle the outstanding principal and interest balance of the 2021 Unsecured Senior Subordinated Convertible Promissory Notes based on a conversion price, equal to the original issue price of $0.40 per share. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">During the year ended December 31, 2023, the Company issued 75,495,640 shares of Series&#160;B redeemable convertible preferred stock for total gross proceeds of $421 million. At the time of the initial issuance, the Company granted an option to the lead investor, a related party, to purchase up to 40,348,040 shares of Series B redeemable convertible preferred stock over a period of up to nine months, at the original issuance price of $5.58 per share. The Series&#160;B tranche liability was required to be recognized as a liability as it represented a contract to purchase redeemable equity. A portion of the proceeds of the original issuance was allocated to the initial recognition of the liability. The liability was subsequently remeasured to fair value with changes in fair value recognized in earnings through the settlement date. In May&#160;2023, 35,864,920 shares of Series&#160;B redeemable convertible preferred stock were issued upon exercise of the portion of the Series&#160;B tranche liability. In January&#160;2024, 4,483,120 shares of Series&#160;B redeemable convertible preferred stock were issued upon exercise of the remaining portion of the Series&#160;B tranche liability. For the years ended December 31, 2023 and 2024, the Company recognized a fair value adjustment loss of $105 million and no material gain or loss, respectively, on the remeasurement of the Series&#160;B tranche liability. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, the Company issued 29,523,120 shares of Series&#160;C redeemable convertible preferred stock with a par value of $0.000005 per share and an original issue price of $38.95 per share for total gross proceeds of $1.1&#160;billion and incurred related issuance costs of $3 million. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders of the redeemable convertible preferred stock have the following rights, preferences, and privileges: </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 20pt; text-align: left;">Voting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Except as provided by law or by the Company&#8217;s certificate of incorporation, the holders of redeemable convertible preferred stock have full voting rights, equivalent to the voting rights of holders of common stock, as if converted. The preferred stockholders vote together as a single class, except as provided by law or by the Company&#8217;s certificate of incorporation. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 15pt; margin-left: 20pt; text-align: left;">Dividends </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of the redeemable convertible preferred stock are entitled to participate in any dividends distributed to holders of common stock, as if converted. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of the Series&#160;C redeemable convertible preferred stock are entitled to a cumulative dividend that accrues from day-to-day at a rate of 10% per annum of the accumulated stated value, which is initially equal to $38.95 per share. Cumulative dividends are payable quarterly and can be paid in cash, or paid in kind by being added to the accumulated stated value preference. The holders of Series&#160;C redeemable convertible preferred stock are entitled to receive the cumulative dividends prior and in preference to the payment of any other dividend. For the year ending December 31, 2024, the Company paid a total cash dividend of $59 million and a total PIK dividend, recognized at fair value, of $16 million. The PIK dividend payment increased the accumulated stated value of the Series&#160;C </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-40<br></div></div></div>
<!--End Page 495-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 496-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg30"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">Redeemable Preferred Stock by $14 million, which is equivalent to the amount that would have been paid in cash. This increased value will be used to calculate future quarterly dividends payable. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 20pt; text-align: left;">Conversion </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Each share of redeemable convertible preferred stock is convertible at any time at the election of the holder into Class A common stock. The conversion rate is determined by dividing the original issue price, or in the case of the Series&#160;C, the accumulated stated value plus accrued and unpaid dividends (without double counting), by the conversion price at the time of conversion, with the conversion price initially equal to the original issue price, subject to customary anti-dilutive adjustments for stock splits, dividends, and other applicable corporate events. As of December 31, 2023, each share of redeemable convertible preferred stock was convertible into one share of Class A common stock. As of December 31, 2024, each share of Series&#160;Seed, Series&#160;A, Series&#160;B and Series B-1 redeemable convertible preferred stock was convertible into one share of Class A common stock and each share of Series&#160;C redeemable convertible preferred stock was convertible into 1.0119 shares of Class A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Conversion is mandatory upon the occurrence of either: (i) an IPO at a price per share of at least $6.97 resulting in at least $125 million in proceeds to the Company, net of underwriting discount and commissions, or (ii) the election by the holders of a majority of the redeemable convertible preferred stock, voting together as a single class, provided that the consent of holders of at least 20% of the then-outstanding Series&#160;B redeemable convertible preferred stock is required with respect to the Series&#160;B redeemable convertible preferred stock, and the consent of holders of at least 90% of the then-outstanding Series&#160;C redeemable convertible preferred stock is required with respect to the Series&#160;C redeemable convertible preferred stock if in connection with a Deemed Liquidation Event (as defined in the Company&#8217;s certificate of incorporation) in which the holders of Series&#160;C redeemable convertible preferred stock will receive consideration per share that is less than the accumulated stated value. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 20pt; text-align: left;">Liquidation Preference </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In the event of any voluntary or involuntary liquidation, dissolution, or winding up of the Company, or any Deemed Liquidation Event (including mergers or consolidations), (i) first, holders of Series&#160;C redeemable convertible preferred stock are entitled to be paid out of any funds available for distribution, (ii) then, holders of Combined Series&#160;B Preferred Stock (Series&#160;B, Series B-1) are entitled to be paid out of any funds available for distribution, (iii)&#160;then, holders of Junior Preferred Stock (Series&#160;Seed, Series&#160;A) are entitled to be paid out of any funds available for distribution, and the holders of redeemable convertible preferred stock may elect to redeem their shares in the event the shares are not redeemed by the Company within 90 days of the consummation of such transactions, before any payments are made to holders of Junior Preferred Stock or common stock. Holders are entitled to the greater of: (x) the original issue price of such shares and in the case of the Series&#160;C redeemable convertible preferred stock, the accumulated stated value plus accrued and unpaid dividends, or (y) the amount per share that would have been payable had all redeemable convertible preferred stock been converted immediately prior to the liquidation. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Optional Redemption </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders have the option, but not the obligation, to force the Company to redeem their shares for a redemption price equal to the accumulated stated value per share plus accrued and unpaid dividends, with such option being accelerated upon the occurrence of a change of control. In the event the Series&#160;C redeemable convertible preferred stock is converted upon an IPO, the holders will be entitled to redeem the common stock issued upon conversion of the Series&#160;C for $38.95 cash per share at the second anniversary of the first trading day after the IPO. The Company concluded that the redemption features were embedded within the respective shares of stock and were not required to be bifurcated because the redemption features would not meet the definition of a derivative if they were freestanding. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Protective Provisions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In addition to the rights and privileges listed for all redeemable convertible preferred stock, the Series&#160;B redeemable convertible preferred stock includes certain special rights, such as the ability to elect one member of the Company&#8217;s Board of Directors (&#8220;Board&#8221;), and protective rights, such as the ability to veto an increase in the authorized number of shares of Combined Series&#160;B Preferred Stock (Series&#160;B, Series B-1). Series&#160;C convertible preferred stock also includes protective rights, such as the ability to veto an increase in the authorized number of shares of Series&#160;C redeemable convertible preferred stock. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-41<br></div></div></div>
<!--End Page 496-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 497-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg31"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Classification of Redeemable Convertible Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Although the Company&#8217;s redeemable convertible preferred stock is not mandatorily redeemable, it is classified outside of stockholders&#8217; deficit because it is contingently redeemable upon certain Deemed Liquidation Events outside the Company&#8217;s control. Accordingly, redeemable convertible preferred stock is presented outside of permanent equity in the mezzanine section of the consolidated balance sheets. With the exception of the Series&#160;C, the redeemable convertible common stock is not being remeasured to redemption value because the redemption rights are contingently exercisable upon the occurrence of events that are not within the control of the holders, the contingent events were not deemed probable of occurring at any time during the periods presented, and therefore, the instruments were not deemed probable of becoming redeemable. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The holders of the Series&#160;C redeemable convertible preferred stock are entitled to redeem their shares for cash on the date the put option becomes exercisable, without contingency. As a result, the carrying value of the Series&#160;C redeemable convertible preferred stock is being accreted to its redemption value over the period from issuance to when the redemption option first becomes exercisable. The cumulative dividends on the Series&#160;C redeemable convertible preferred stock are accrued as dividend liabilities in the event the Company elects to settle in cash, or included in the calculation of the accretion to redemption value in the event the Company elects to settle the cumulative dividend in kind. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16pt; margin-left: 20pt; text-align: left;">Common Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023 and 2024, the Company was authorized to issue 469,030,700 and 690,680,000 shares of common stock, respectively, with a par value of $0.000005 per share. As of December 31, 2023, the Company had one class of common stock. During the year ended December 31, 2024, the Company&#8217;s certificate of incorporation was amended such that the Company&#8217;s common stock consists of Class A common stock and Class B common stock. Common stockholders are entitled to receive any dividends if and when declared by the Board, and upon liquidation or dissolution, are also entitled to receive all assets legally available for distribution to stockholders, ratably in proportion to the number of shares held, subject to the rights of preferred stockholders. As of December 31, 2023 and 2024, no dividends on the Company&#8217;s common stock had been declared by the Board. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 20pt; text-align: left;">Voting </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Holders of Class A common stock are entitled to one vote per share. Holders of Class B common stock are entitled to one vote per share prior to the completion of the Company&#8217;s IPO. Upon the completion of the IPO, each share of Class B common stock will entitle the holder to ten votes per share. Holders of Class A common stock and Class B common stock vote together as a single class, except where otherwise required by law. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16pt; margin-left: 20pt; text-align: left;">Conversion </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Shares of Class B common stock are convertible at any time at the option of the holder into shares of Class A common stock on a one-to-one basis. In addition, each share of Class B common stock will automatically convert into a share of Class A common stock, as a result of certain events, including upon a non-permitted sale or transfer. Further, upon certain events specified in the certificate of incorporation, all outstanding shares of Class B common stock will convert automatically into shares of Class A common stock. Class A common stock is not convertible into any other class of shares. </div><div class="BRDSX_h4" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Dividend and Liquidation Rights </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Both Class A common stock and Class B common stock participate equally in any dividends declared by the Company, subject to the rights of preferred stockholders. In the event of liquidation, dissolution, or winding up of the Company, holders of Class A common stock and Class B common stock are entitled to share in any distribution of assets remaining after payment of liabilities, subject to the rights of preferred stockholders. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Treasury Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2023, the Company agreed to repurchase 4,483,100 shares of callable Class A common stock at $7.15&#160;per share in connection with shares issued pursuant to a stock purchase agreement with a customer. The aggregate purchase price of $32 million represented the approximate fair value of the shares, net of the fair value of the embedded call option, which was recorded as treasury stock on the consolidated balance sheets. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-42<br></div></div></div>
<!--End Page 497-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 498-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg32"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, the Company repurchased 2,104,900 shares of callable Class A common stock that were legally issued to Conductor. This action settled the Company&#8217;s liability to issue shares in connection with the business combination. Refer to <font style="font-style: italic;">Note&#160;4&#8212;Business Combination </font>for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Stock Option Plan </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2019, the Company adopted a stock option plan (the &#8220;2019 Stock Option Plan&#8221; or the &#8220;Plan&#8221;). The purpose of the Plan is to provide incentives to attract, retain, and motivate eligible persons whose potential contributions are important to the success of the Company by offering those eligible persons an opportunity to participate in the Company&#8217;s future performance through the grant of awards of common stock. The total number of shares authorized by the Board to be issued under the Plan are 66,637,600 and 73,637,600 shares as of December 31, 2023 and 2024, respectively. In the event that shares previously issued under the Plan are reacquired by the Company pursuant to a forfeiture provision, right of first refusal, or repurchase by the Company, such shares shall be added back to the number of shares then available for issuance under the Plan. As of December 31, 2023 and 2024, 11,061,240 and 3,750,480 shares, respectively, were available for issuance under the Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company may grant stock options to employees, contractors, or other entities in order to incentivize them to increase their efforts on behalf of the Company and to promote the success of the Company&#8217;s business. Stock options may be treated as incentive stock options or nonqualified stock options depending on the specific circumstances of an optionee&#8217;s relationship with the Company and the number of stock options vesting or exercised in a calendar year. Stock options granted under the Plan generally vest either over a three-year or four-year period. The Company may award stock options that are immediately exercisable, subject to a repurchase right. The Company may also grant stock options that allow for acceleration of vesting. The stock options granted under the Plan will expire after ten years from the time of their grant. The Company issues common stock upon the exercise of stock options. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table summarizes stock option activity under the Plan (share data and aggregate intrinsic value in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 233pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 62.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 62.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 51.11pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 233pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Stock <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Options <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Outstanding</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-Average <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exercise Price</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted-Average <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Remaining <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Contractual <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Term (Years)</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Aggregate <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Intrinsic Value </div></td></tr><tr><td style="width: 233pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2023<font style="font-weight: normal; padding-left: 1.91pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;">32,655</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$0.33</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">8</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 12.5pt;">20,770 </font></div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 3.29pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;">23,300</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 5pt;">3.48</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 1.67pt;">(4,337)</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 5pt;">0.38</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited, expired, or canceled<font style="padding-left: 0.56pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 9.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(379</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 5pt;">1.70</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at December&#160;31, 2023<font style="font-weight: normal; padding-left: 4.89pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;">51,239</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$1.75</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">8</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 7.5pt;">795,013 </font></div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 3.29pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 12.5pt;">&#8212;</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercised<font style="padding-left: 1.07pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 1.67pt;">(2,872)</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 5pt;">1.01</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited, expired, or canceled<font style="padding-left: 0.56pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,148</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;"><font style="padding-left: 5pt;">4.05</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 233pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding at December&#160;31, 2024<font style="font-weight: normal; padding-left: 4.89pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">47,219</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$1.74</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">7</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 2.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$2,163,455 </div></td></tr><tr><td style="width: 233pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested and expected to vest at December&#160;31, 2023<font style="font-weight: normal; padding-left: 3.65pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">51,239</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$1.75</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">8</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 7.5pt;">795,013 </font></div></td></tr><tr><td style="width: 233pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested and expected to vest at December&#160;31, 2024<font style="font-weight: normal; padding-left: 3.65pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">47,219</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$1.74</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">7</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$2,163,455 </div></td></tr><tr><td style="width: 233pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at December&#160;31, 2023<font style="font-weight: normal; padding-left: 3.97pt;"></font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">24,356</font></div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$0.37</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">6</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$<font style="padding-left: 7.87pt;">411,567 </font></div></td></tr><tr><td style="width: 233pt; padding-top: 3.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Exercisable at December&#160;31, 2024<font style="font-weight: normal; padding-left: 3.97pt;"></font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 42.67pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 7.58pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">31,019</font></div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20.21pt; text-align: left;">$0.98</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 62.94pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 28.97pt; text-align: left;">6</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 51.11pt; padding-top: 3.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.05pt; text-align: left;">$1,444,794</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 233pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 42.67pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 62.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 62.94pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 1.92pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 51.11pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company did not grant any stock options during the year ended December 31, 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The weighted-average grant date fair value of stock options granted during the years ended December 31, 2022 and 2023 were $0.47 and $6.50 per share, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The aggregate grant date fair value of stock options vested during the years ended December 31, 2022, 2023, and 2024 were $2 million, $10 million, and $45 million, respectively. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-43<br></div></div></div>
<!--End Page 498-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 499-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg33"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The aggregate intrinsic value of stock options exercised during the years ended December 31, 2022, 2023, and 2024, was $0 million, $38 million, and $117 million, respectively. The intrinsic value for options exercised is the difference between the estimated fair value of the stock and the exercise price of the stock option at the date of exercise. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Black-Scholes option-pricing model assumptions used to value the employee stock options at the grant dates were as follows, presented on a weighted-average basis except for the fair value of common stock which is presented on a range basis: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 49.99pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 54.99pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.76pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value of common stock<font style="padding-left: 2.99pt;"></font></div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">$0.55 - 0.99</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: right;">$1.86 - 17.27 </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected volatility<font style="padding-left: 1.85pt;"></font></div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">97%</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.5pt; text-align: left;">58% </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected term (in years)<font style="padding-left: 2.44pt;"></font></div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;"><font style="padding-left: 5pt;">6</font></div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.5pt; text-align: left;"><font style="padding-left: 5pt;">6 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Risk-free interest rate<font style="padding-left: 0.22pt;"></font></div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;"><font style="padding-left: 5pt;">4%</font></div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.5pt; text-align: left;"><font style="padding-left: 5pt;">4% </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Expected dividend yield<font style="padding-left: 4.64pt;"></font></div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 49.99pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;"><font style="padding-left: 5pt;">0%</font></div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 54.99pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 22.5pt; text-align: left;"><font style="padding-left: 5pt;">0%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 49.99pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.76pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 54.99pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">These assumptions and estimates were determined as follows: </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Expected Volatility<font style="font-style: normal;">&#8212;As there is no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of publicly listed peer companies over a period equivalent to the expected term of the awards. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Expected Term<font style="font-style: normal;">&#8212;The expected term represents the period that the stock-based awards are expected to be outstanding. For option grants that are considered to be &#8220;plain vanilla,&#8221; the Company determines the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the stock options. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Risk-Free Interest Rate<font style="font-style: normal;">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the stock options at the time of grant. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Expected Dividend Yield<font style="font-style: normal;">&#8212;The expected dividend is assumed to be zero, as the Company has never paid dividends on its common stock and has no current plans to do so. </font></div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 6pt; margin-left: 20pt; text-indent: 20pt; text-align: justify;">Fair Value Per Share of the Company&#8217;s Common Stock<font style="font-style: normal;">&#8212;Because the Company&#8217;s common stock is not yet publicly traded, the Company must estimate the fair value of its common stock. The Board considers numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting in which awards are approved. The factors considered include, but are not limited to: (i) the results of contemporaneous independent third-party valuations of the Company&#8217;s common stock, (ii) the prices, rights, preferences, and privileges of the Company&#8217;s redeemable convertible preferred stock relative to those of its common stock, (iii) the lack of marketability of the Company&#8217;s common stock, (iv) the Company&#8217;s actual operating and financial performance and estimated trends and prospects for its future performance current business conditions and financial projections, (v) the likelihood of achieving a liquidity event, such as an IPO, direct listing, or sale of the Company, given prevailing market conditions; and (vi) precedent transactions involving the Company&#8217;s shares. </font></div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 19pt; margin-left: 20pt; text-align: left;">Restricted Stock Units </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">RSUs granted typically vest over four years. The following table summarizes restricted stock unit activity under the Plan for the year ended December 31, 2024 (share data in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 32.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 56.28pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Shares</div></td><td style="width: 4.8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Weighted- <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Average Fair <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Value Per Share </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Balance at January&#160;1, 2024<font style="font-weight: normal; padding-left: 3.91pt;"></font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;">$<font style="padding-left: 12.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Granted<font style="padding-left: 0.29pt;"></font></div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">&#8199;15,733</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">38.56 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Vested<font style="padding-left: 0.84pt;"></font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 17.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Forfeited, expired, or canceled<font style="padding-left: 2.56pt;"></font></div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 14.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(278</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;"><font style="padding-left: 5pt;">25.18 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Unvested balance at December&#160;31, 2024<font style="font-weight: normal; padding-left: 4.69pt;"></font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">15,455</font></div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 56.28pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 14.4pt; text-align: left;">$38.80</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.8pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 56.28pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-44<br></div></div></div>
<!--End Page 499-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 500-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg34"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 6.75pt; margin-left: 20pt; text-align: left;">Secondary Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2023, certain employee and non-employee stockholders of the Company (the &#8220;2023 Selling Stockholders&#8221;) offered 41,476,000 shares of common stock (the &#8220;2023 Secondary Offering&#8221;). The Company did not offer any shares of common stock in the 2023 Secondary Offering and did not receive any proceeds from the sale of the shares of common stock by the 2023 Selling Stockholders. The 2023 Secondary Offering was conducted and led by a new investor and was determined to be an arms-length transaction at fair value. Accordingly, the Company did not record any compensation cost associated with the 2023 Secondary Offering. The Company incurred no costs in relation to the 2023 Secondary Offering for the year ended December 31, 2023. The Company received less than $1 million in cash (excluding withholding taxes) in connection with the exercise of 1,125,500 options by certain stockholders participating in the 2023 Secondary Offering. In conjunction with the 2023 Secondary Offering, 11,103,380 shares of Series&#160;Seed redeemable convertible preferred stock, 3,896,180 shares of Series&#160;A redeemable convertible preferred stock, and 2,077,980 shares of Series B-1 redeemable convertible preferred stock were converted to the equivalent number of shares of common stock to be included in the offering. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2024, certain employees and non-employee stockholders of the Company (the &#8220;2024 Selling Stockholders&#8221;) offered 13,851,240 shares of Class&#160;A common stock to new and existing investors at a purchase price of $46.99 per share, equal to the estimated fair value of the stock at the time of the transaction (the &#8220;2024 Secondary Offering&#8221;). The Company did not offer any shares of common stock in the 2024 Secondary Offering and did not receive any proceeds from the sale of the shares of common stock by the 2024 Selling Stockholders. The 2024 Secondary Offering was determined to be an arms-length transaction at fair value. Accordingly, the Company did not record any compensation cost associated with the 2024 Secondary Offering. The Company incurred no costs in relation to the 2024 Secondary Offering for the year ended December&#160;31, 2024. The Company received $1&#160;million in cash (excluding withholding taxes) in connection with the exercise of 1,368,680 options by certain stockholders participating in the 2024 Secondary Offering. In conjunction with the 2024 Secondary Offering, 3,329,540 shares of Series&#160;Seed redeemable convertible preferred stock, 518,060 shares of Series&#160;A redeemable convertible preferred stock, 201,420 shares of Series&#160;B-1 redeemable convertible preferred stock, and 1,067,020 shares of Class&#160;B common stock were converted to the equivalent number of shares of Class&#160;A common stock to be included in the offering. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Stock-Based Compensation Expense </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, unrecognized stock-based compensation expense related to unvested stock options was $91 million, which is expected to be recognized over a weighted-average period of three years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2024, unrecognized stock-based compensation expense related to unvested RSUs was $600&#160;million, which is expected to be recognized over a weighted-average period of two years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company will record cumulative stock-based compensation expense related to the RSUs with performance-based vesting conditions in the period when its liquidity event is completed for the portion of the awards for which the relevant service condition has been satisfied with the remaining expense recognized over the remaining service period. If the effectiveness of a registration statement had occurred on December 31, 2024, the Company would have recorded $78 million of stock-based compensation expense related to these RSUs. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Total stock-based compensation expense recognized in the Company&#8217;s consolidated statements of operations was as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 118.82pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 118.82pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cost of revenue<font style="padding-left: 3.53pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 7.5pt;">133</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$<font style="padding-left: 12.5pt;">694</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 5pt;">1,307 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Technology and infrastructure<font style="padding-left: 1.47pt;"></font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">624</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt;">7,100</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">10,137 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Sales and marketing<font style="padding-left: 0.75pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 17.5pt;">74</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt;">1,740</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt;">3,408 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General and administrative<font style="padding-left: 3.55pt;"></font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">659</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,620</font></div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">16,635 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total stock-based compensation expense<font style="font-weight: normal; padding-left: 4.47pt;"></font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,490</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$15,154</font></div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$31,487</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.58pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-45<br></div></div></div>
<!--End Page 500-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 501-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg35"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">12. Income Taxes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The components of the net loss before the provision for (benefit from) income taxes were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 312pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 143.17pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 143.17pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 312pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 312pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Domestic<font style="padding-left: 1.18pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(35,016)</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(558,047)</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(743,667) </div></td></tr><tr><td style="width: 312pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign<font style="padding-left: 3.39pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(534</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 312pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss before the provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 2.02pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 35.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(35,016</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(558,047</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(744,201</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 312pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 35.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The provision (benefit) for income taxes consists of the following <font style="font-style: italic;">(</font>in thousands<font style="font-style: italic;">)</font>: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 121.59pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 121.59pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 5.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 5.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Current:<br></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Federal<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$(1,664)</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 17.5pt;">&#8212;</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$<font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">State<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(226)</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt;">6,306 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign<font style="padding-left: 2.39pt;"></font></div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">155 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total current income tax expense (benefit)<font style="font-weight: normal; padding-left: 4.68pt;"></font></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,890)</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212;</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt;">6,461 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred:<br></div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Federal<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">(1,697)</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">35,765</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt;">109,010 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">State<font style="padding-left: 3.51pt;"></font></div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 12.5pt;">(563)</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 19.17pt;">(64)</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 15pt;">3,196 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign<font style="padding-left: 2.39pt;"></font></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 20.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 22.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">580 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total deferred income tax expense (benefit)<font style="font-weight: normal; padding-left: 0.24pt;"></font></div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(2,260</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">35,701</font></div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 5.37pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">112,786 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total provision for (benefit from) income taxes<font style="font-weight: normal; padding-left: 0.04pt;"></font></div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 30.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$(4,150</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$35,701</font></div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">119,247</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.2pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 30.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 5.19pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table presents the reconciliation of the statutory federal income tax rate to the Company&#8217;s effective tax rate: </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 114.19pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 114.19pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 336pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 336pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">U.S. federal tax benefit at statutory rate<font style="padding-left: 0.8pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;">21.0%</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 3.33pt;">21.0%</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 3.33pt;">21.0% </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">State income taxes, net of federal benefit<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">4.1</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">0.1</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">0.1 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock-based compensation<font style="padding-left: 0.76pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 1.67pt;">(0.4)</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">0.5</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">1.9 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Foreign tax rate differential<font style="padding-left: 0.95pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 7.5pt;">&#8212;</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 10.83pt;">&#8212;</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">(0.1) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Convertible interest<font style="padding-left: 3.53pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 1.67pt;">(0.7)</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">(0.2)</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">(0.2) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Change in valuation allowance, net<font style="padding-left: 4.38pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 1.67pt;">(9.5)</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">(7.7)</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;">(17.5) </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Derivative liabilities<font style="padding-left: 0.75pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 1.67pt;">(3.0)</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;">(20.2)</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;">(21.4) </div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">General business credit - federal<font style="padding-left: 0.8pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt;">0.1</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">0.2</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 8.33pt;">0.3 </font></div></td></tr><tr><td style="width: 336pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other<font style="padding-left: 0.73pt;"></font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">0.3</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(0.1</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(0.2</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 336pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Effective tax rate<font style="font-weight: normal; padding-left: 3.55pt;"></font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 23.96pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 0.37pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">11.9</font><font style="padding-bottom: 0.5pt;">%</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.3pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(6.4</font><font style="padding-bottom: 0.5pt;">)%</font></div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 27.29pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.23pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(16.1</font><font style="padding-bottom: 0.5pt;">)%</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 336pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 23.96pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 8.91pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 27.29pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company&#8217;s deferred tax assets and liabilities as of December 31, 2023 and 2024, were as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax assets:<br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net operating losses<font style="padding-left: 4.76pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$200,057</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;">$766,434 </div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Lease liabilities<font style="padding-left: 3.64pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5.37pt;">112,634</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">540,405 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Capitalized research and development expenditures<font style="padding-left: 3.14pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">13,637</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 10pt;">24,498 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred revenue<font style="padding-left: 1.99pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 15pt;">1,054</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 4.83pt; text-align: left;"><font style="padding-left: 5pt;">309,264 </font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-46<br></div></div></div>
<!--End Page 501-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 502-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg36"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 360pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 360pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Accrued liabilities and reserves<font style="padding-left: 4.23pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 26.2pt;">2,811 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Interest expense carryforward<font style="padding-left: 1.46pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 30.83pt;">&#8212;</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 20.83pt;">61,443 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Research and development credits, net of reserve<font style="padding-left: 1.21pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 18.33pt;">1,252</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 25.83pt;">3,244 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Stock-based compensation<font style="padding-left: 4.76pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 18.33pt;">2,135</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 25.83pt;">7,593 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Other<font style="padding-left: 4.73pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">650</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 25.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,907 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total deferred tax assets<font style="font-weight: normal; padding-left: 1.43pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 8.33pt;">331,419</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 8.33pt;">1,718,599 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Valuation allowance<font style="font-weight: normal; padding-left: 0.66pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(47,717</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(180,529</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Deferred tax assets, net of valuation allowance<font style="padding-left: 0.66pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">283,702</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,538,070 </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Deferred tax liabilities:<br></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Property and equipment<font style="padding-left: 4.75pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 5pt;">(207,054)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 5pt;">(1,147,258) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Intangible assets<font style="padding-left: 0.31pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 15pt;">(1,446)</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 30pt;">(969) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Operating and financing ROU assets<font style="padding-left: 2.57pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 5.74pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(111,649</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(539,075</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Total deferred tax liabilities<font style="font-weight: normal; padding-left: 1.97pt;"></font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(320,149</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(1,687,302</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 360pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net deferred tax liabilities, net of valuation allowance<font style="font-weight: normal; padding-left: 4.16pt;"></font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 3.17pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(36,447</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -1.17pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 7.5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(149,232</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 360pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 3.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 13.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">ASC 740, <font style="font-style: italic;">Income Taxes</font> requires that the tax benefit of net operating losses (&#8220;NOL&#8221;), temporary differences, and credit carryforwards be recorded as an asset to the extent that management assesses that realization is &#8220;more likely than not.&#8221; Realization of the future tax benefits is dependent on the Company&#8217;s ability to generate sufficient taxable income within the carryforward period. Because of the Company&#8217;s recent history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, a valuation allowance has been provided by the Company against federal and state deferred tax assets. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The valuation allowance increased year over year by $44 million and $133 million during the years ended December 31, 2023 and 2024, respectively. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023 and 2024, the Company had $933 million and $3.6&#160;billion, respectively, in federal NOL carryforwards to offset future taxable income, almost all of which can be carried forward indefinitely. As of December 31, 2023 and 2024, the Company had state NOL carryforwards of $57 million and $61 million, respectively, of which $19 million and $30&#160;million, respectively, can be carried forward indefinitely. If the NOL carryforwards are not utilized, $38 million and $31&#160;million, respectively, will expire in varying amounts between the years 2032 and 2044. As of December&#160;31, 2024, the Company had foreign NOL carryforwards to offset future taxable income of $5&#160;million that can be carried forward indefinitely. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December 31, 2023 and 2024, the Company had insignificant amounts of federal and state tax credit carryforwards available to offset future taxable income. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">A limitation may apply to the use of the net operating loss and credit carryforwards, under provisions of the Internal Revenue Code of 1986, as amended, and similar state tax provisions that are applicable if the Company experiences an &#8220;ownership change under Section 382.&#8221; For example, an ownership change may occur as a result of the issuance of new equity or certain shareholder transactions. Should these limitations apply, the carryforwards would be subject to an annual limitation, resulting in a potential reduction in the gross deferred tax assets before considering the valuation allowance. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company experienced a Section 382 ownership change during the years ended December 31, 2023 and 2024, and determined that these changes did not materially impact the availability of its NOL carryforwards for use in the future. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company is subject to income taxes in the United States, California, and other various domestic and international jurisdictions. The U.S., state, and foreign jurisdictions have statutes of limitations that generally range from three to five years. Fiscal years outside of the normal statute of limitation remain open to audit by tax authorities due to tax attributes generated in those early years, which have been carried forward and may be audited in subsequent years when utilized. We are not aware of any ongoing examinations. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-47<br></div></div></div>
<!--End Page 502-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 503-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg37"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Due to differing interpretations of tax laws and regulations, tax authorities may dispute the Company&#8217;s tax filing positions. The Company periodically evaluates the exposures associated with tax filing positions and will reserve amounts, if needed, for adjustments that may result from tax examinations. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s total amount of unrecognized tax benefits is insignificant, and did not change materially during the years ended December&#160;31, 2022, 2023, and 2024. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Recognition of the unrecognized tax benefits would not have an impact on the effective tax as they are recorded as deferred tax assets which are subject to a full valuation allowance. The Company does not anticipate any significant change in its uncertain tax positions within the next 12 months. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">13. Net Loss Per Share Attributable to Common Stockholders </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except per share data): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 324pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 135.72pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 135.72pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 324pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Numerator:<br></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss from continuing operations<font style="padding-left: 4.33pt;"></font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 1.67pt;">(30,866)</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(593,748)</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$(863,448) </div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss from discontinued operations<font style="padding-left: 1pt;"></font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 19.17pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(189</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss<font style="padding-left: 3.18pt;"></font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 6.67pt;">(31,055)</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(593,748)</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">(863,448) </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Dividends and accretion on Series&#160;C redeemable convertible preferred stock<font style="padding-left: 0.39pt;"></font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 27.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(74,317</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net loss attributable to common stockholders, basic and diluted<font style="padding-left: 0.76pt;"></font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 1.67pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(31,055</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(593,748</font><font style="padding-bottom: 1.5pt;">)</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$(937,765</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Denominator:<br></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 3.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-indent: -10pt; text-align: left;">Weighted-average shares used in computing net loss attributable to common stockholders, basic and diluted<font style="padding-left: 0.71pt;"></font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">180,632</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">192,164</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 3.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">217,854 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss from continuing operations per share attributable to common stockholders, basic and diluted<font style="padding-left: 0.71pt;"></font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 11.67pt;">(0.17)</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 15pt;">(3.09)</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 3.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$<font style="padding-left: 15pt;">(4.30) </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-indent: -10pt; text-align: left;">Net loss from discontinued operations per share attributable to common stockholders, basic and diluted<font style="padding-left: 0.71pt;"></font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 20pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">0.00</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212;</font></div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 30.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss per share attributable to common stockholders, basic and diluted<font style="padding-left: 0.23pt;"></font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 11.67pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(0.17</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(3.09</font><font style="padding-bottom: 0.5pt;">)</font></div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 40.83pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$</font><font style="padding-left: 15pt; border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">(4.30</font><font style="padding-bottom: 0.5pt;">)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 324pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.14pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 40.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The number of securities that were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive are as follows (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 324pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 128.5pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 128.5pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year Ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 324pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Redeemable convertible preferred stock<font style="padding-left: 4.36pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">83,775</font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">154,678</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">184,986 </div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding convertible notes<font style="padding-left: 4.87pt;"></font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">22,773</font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">24,544</font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 22.5pt;">&#8212; </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding stock options<font style="padding-left: 0.41pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">32,655</font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">51,239</font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 5pt;">47,219 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Outstanding warrants to purchase common stock<font style="padding-left: 2.13pt;"></font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">2,082</font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,337</font></div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">4,337 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 10pt; text-align: left;">Total<font style="font-weight: normal; padding-left: 4.64pt;"></font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">141,285</font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">234,798</font></div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">236,542</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 324pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 7.75pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The table above does not include 15,454,720 RSUs outstanding as of December 31, 2024 as these awards are subject to a performance condition that was not considered probable as of that date. There were no RSUs outstanding as of December 31, 2022 or 2023. The table also does not include 2,104,900 and 0 contingently issuable shares related to the Conductor acquisition as of December 31, 2023 and 2024, respectively, as the contingency had not been met as of those dates. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-48<br></div></div></div>
<!--End Page 503-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 504-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg38"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">14. Related-Party Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 7pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The Company has entered into a series of related party arrangements as described below. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has entered into certain transactions, as further described below, with Magnetar Financial LLC (&#8220;Magnetar&#8221;) and certain funds or accounts managed or advised by Magnetar, and such funds or accounts collectively held a significant equity interest in the Company. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Senior Secured Notes </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2021, the Company issued $20 million of 2021 Convertible Senior Secured Notes to funds or accounts managed or advised by Magnetar, with a maturity date in 2025. The principal amount increased to $50&#160;million in April&#160;2022. In September&#160;2024, these notes were converted into shares of the Company&#8217;s Class A common stock. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt </font>for additional information. In connection with the issuance of the 2021&#160;Convertible Senior Secured Notes, the Company granted Magnetar an option to purchase up to $15 million in the Company&#8217;s Class A common stock, at a price equal to the price per share in the Company&#8217;s IPO, which is exercisable until the one-year anniversary of such offering of the Company&#8217;s Class A common stock. In September&#160;2024, the investors elected to convert all 2021 Convertible Senior Secured Notes, resulting in the issuance of 24,543,980 shares of Class&#160;A common stock. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Between October&#160;2022 and April&#160;2023, the Company issued $125 million of 2022 Senior Secured Notes with maturity dates between October&#160;2025 and April&#160;2026 to funds or accounts managed or advised by Magnetar, along with warrants to purchase 12,144,668 shares of the Company&#8217;s Class A common stock. In July&#160;2024, the Company redeemed these notes in full, paying $137 million. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt </font>for additional information. In connection with the issuance of the 2022 Senior Secured Notes, the Company granted Magnetar the right to purchase up to 5%&#160;of the Company&#8217;s Class A common stock issued at a price equal to the price per share in the Company&#8217;s IPO. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Redeemable Convertible Preferred Stock Financing </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Between April&#160;2023 and May&#160;2024, the Company issued a number of shares of different classes of redeemable convertible preferred stock, some of which were acquired by certain of the Company&#8217;s directors, holders of more than 5% of the Company&#8217;s outstanding capital stock, and their affiliates or funds or accounts managed thereby. Refer to <font style="font-style: italic;">Note&#160;11&#8212;Redeemable Convertible Preferred Stock and Stockholders&#8217; Deficit</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Tender Offer </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In December&#160;2023, employees and certain stockholders of the Company offered 41,476,000 shares of common stock, which were purchased by certain existing stockholders and new stockholders. Entities managed or advised by a single stockholder participated in the tender offer as purchasers. Upon completion of the tender offer, these entities were deemed to beneficially own more than 5% of the Company&#8217;s outstanding shares of capital stock, on an aggregated basis. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In October&#160;2024, employees and certain stockholders of the Company offered 13,851,240 shares of Class A common stock, which were purchased by certain existing stockholders and new stockholders. Entities managed or advised by a single stockholder participated in the tender offer as purchasers. Upon completion of the tender offer, these entities were deemed to beneficially own more than 5% of the Company&#8217;s outstanding shares of capital stock, on an aggregated basis. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 16.5pt; margin-left: 20pt; text-align: left;">Delayed Draw Term Loan Facilities </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In July&#160;2023, a subsidiary of the Company entered into the DDTL 1.0 Facility of $2.3 billion, including $520&#160;million from funds or accounts managed or advised by Magnetar. As of December 31, 2023 and 2024, $311&#160;million and $438 million in aggregate principal amount, respectively, of the DDTL 1.0 Facility was outstanding and held by funds or accounts managed or advised by Magnetar. The Company has paid to funds or accounts managed or advised by Magnetar $0 million and $63 million in principal and incurred $6 million and $66 million in interest expense for the years ended December 31, 2023 and 2024, respectively. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In May&#160;2024, a different subsidiary of the Company entered into the DDTL 2.0 Facility of up to $7.6 billion, including $210 million from funds or accounts managed or advised by Magnetar. As of December&#160;31, 2024, </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-49<br></div></div></div>
<!--End Page 504-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 505-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg39"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: justify;">$106&#160;million of the DDTL 2.0 Facility was outstanding and held by funds or accounts managed or advised by Magnetar. The Company paid to funds or accounts managed or advised by Magnetar $0 million in principal and incurred $3 million in interest expense for the year ended December&#160;31, 2024. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt</font> for additional information. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Strategic Investment Related to a Purchase of Series&#160;D Preferred Stock </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In June&#160;2024, the Company contributed $50 million to a fund managed by Magnetar in connection with the fund&#8217;s purchase of a third-party&#8217;s preferred stock. The Company has the right to request a distribution in kind of up to 99% of its interest in the fund, which will be satisfied by distributing shares of the third-party company&#8217;s preferred stock. The fund did not meet the definition of a VIE, and under the VOE model, the Company has a majority equity interest and has control over significant operating, financial, and investing decisions of the fund. The Company consolidated the fund and accounted for the purchased preferred stock as privately held equity securities that do not have a readily determinable fair value measured at cost, with subsequent adjustments for observable price changes or impairments. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">To the extent there is an in-kind distribution of the third-party&#8217;s preferred stock to the Company and following such distribution the Company sells any shares of such preferred stock (or any securities into which such stock is converted or exchanged), the Company will allocate the net proceeds from such sale as follows: (i) 100% of the net proceeds to the Company until it receives an amount equal to its aggregate capital contribution and (ii) thereafter, 75% of the net proceeds to the Company and 25% to an affiliate of Magnetar. </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 20.5pt; margin-left: 20pt; text-align: left;">Other Transactions </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In August&#160;2024, the Company entered into an AI Computing Service Reserved Capacity and Prepayment Agreement with MagAI Ventures (the &#8220;MagAI Capacity Agreement&#8221;). Under this agreement, the Company will provide portfolio companies of MagAI Ventures with a pre-determined amount of cloud computing services at a pre-negotiated hourly rate. The specific amount of cloud computing services, inclusive of the capacity and term, to be used by each portfolio company, if any, will be negotiated individually with each portfolio company, and will be subject to final approval by MagAI Ventures. The Company received a refundable deposit of $230 million in connection with the MagAI Capacity Agreement. Any consumption of cloud services by MagAI Ventures, including by their portfolio companies, under this arrangement is deducted from this deposit amount, with the unused portion refunded back to MagAI Ventures at the end of the term of the arrangement. Throughout the term of the arrangement, if MagAI Ventures portfolio companies do not contract for the full amount of the pre-determined cloud computing services, the Company may agree with MagAI Ventures to instead use this available capacity for other customers, and share profits with MagAI Ventures for any revenues realized above the revenues that would have been generated by charging these customers the MagAI Ventures pre-negotiated rate. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Additionally, the MagAI Capacity Agreement provides for certain termination options for MagAI Ventures, including if a specified amount of capacity is not available by a target commencement date. The MagAI Capacity Agreement runs for an initial period of four years, with an option for MagAI Ventures to extend for two additional years. As of December 31, 2024, the refundable deposit is included within other current liabilities on the consolidated balance sheet, as no services had yet been provided under this arrangement. In February&#160;2025, the MagAI Capacity Agreement was amended to provide certain termination for convenience rights to MagAI Ventures. Upon such termination, the unused portion of deposit will be refunded with a specified multiplier. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In September&#160;2024, the Company entered into an equity exchange right agreement with each of its co-founders. This agreement grants each co-founder the right, but not the obligation, to exchange shares of Class A common stock received upon the exercise or settlement of equity awards for shares of Class B common stock. This right applies to equity awards previously granted to the Company&#8217;s co-founders and to equity awards that may be granted to the Company&#8217;s co-founders in the future. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-50<br></div></div></div>
<!--End Page 505-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 506-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg40"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">15. Geographic Information </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Revenue by geography is based on the address of the customer as specified in the Company&#8217;s customer contracts. The following table sets forth revenue by geographic area (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 324pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 134.32pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 134.32pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended December&#160;31, </div></td></tr><tr class="BRDSX_header"><td style="width: 324pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2023</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.08pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2024 </div></td></tr><tr><td style="width: 324pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">United States<font style="padding-left: 2.07pt;"></font></div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;">$10,367</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;">$200,469</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">$1,797,268 </div></td></tr><tr><td style="width: 324pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">All other countries*<font style="padding-left: 4.86pt;"></font></div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">5,463</font></div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="padding-left: 10pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">28,474</font></div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="padding-left: 12.87pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">118,158 </font></div></td></tr><tr><td style="width: 324pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Total revenue<font style="padding-left: 1.11pt;"></font></div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 32.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: -0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$15,830</font></div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 37.5pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0.01pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$228,943</font></div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 45pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><font style="border-bottom: 3pt double #000000; padding-bottom: 0.5pt;">$1,915,426</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 324pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 32.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 37.5pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 4.83pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 45pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 13.25pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The United Kingdom accounted for 18% of total revenue for the year ended December 31, 2022 and less than 10% of revenue for the years ended December 31, 2023 and 2024. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company&#8217;s long-lived assets are attributed to a country based on the physical location of the assets. It defines long-lived assets as property and equipment and operating lease right-of-use assets because many of these assets cannot be readily moved and are relatively illiquid, subjecting them to geographic risk. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As of December&#160;31, 2023 substantially all of the Company&#8217;s long-lived assets were located in the United States. As of December&#160;31, 2024, 90% of the Company&#8217;s long-lived assets were located in the United States and no other single country accounted for more than 10% of these assets. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 20.5pt; margin-left: 0pt; text-align: left;">16. Discontinued Operations </div><div class="BRDSX_h3" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold; margin-top: 7.5pt; margin-left: 20pt; text-align: left;">Blockchain Mining and Management Services </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">On September&#160;30, 2022, the Company ceased its Blockchain Mining and Management Services due to changes in Ethereum&#8217;s reward policy, which materially impacted potential future mining revenues, and concentrated its focus to its cloud computing business. This strategic shift resulted in the classification of the Blockchain Mining and Management business as discontinued operations in the Company&#8217;s financial statements for the year ended December&#160;31, 2022. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Blockchain mining utilized the Company&#8217;s computing capacity to mine cryptocurrencies, primarily Ethereum, under arrangements where rewards were received as digital assets and immediately converted to U.S. dollars. All digital assets mined were liquidated in 2022, and the Company held no digital assets as of December&#160;31, 2022. Management Services involved hosting and operational support for customers engaged in blockchain mining, with revenues derived through reimbursement agreements and revenue sharing. These activities are not present in subsequent periods, and there are no discontinued operations for any subsequent periods. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the net loss from discontinued operations (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Blockchain and management services revenue<font style="padding-left: 2.25pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;">$<font style="padding-left: 3.33pt;">9,692 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating expenses<br></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cost of revenue<font style="padding-left: 0.53pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt;">3,138 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Equipment disposal gain<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(99</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Operating income<font style="padding-left: 2.75pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt;">6,653 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fair value adjustments of trading securities<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 5pt;">(2,088) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Assets impairment loss<font style="padding-left: 1.09pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 5pt;">(4,510) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Other (income) expense, net<font style="padding-left: 4.72pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 12.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(300</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Loss from discontinued operations before income tax<font style="padding-left: 2.25pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 12.5pt;">(245) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Income tax benefit<font style="padding-left: 3.87pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 17.5pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">(56</font><font style="padding-bottom: 1.5pt;">) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 20pt; text-align: left;">Net loss from discontinued operations, net of tax<font style="padding-left: 4.74pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;">$<font style="padding-left: 7.5pt;">(189)</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-51<br></div></div></div>
<!--End Page 506-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 507-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg41"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">The following table summarizes the statements of cash flows of the discontinued operations (in thousands): </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 408pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold;">&#160;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-bottom: 2.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Year ended <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">December&#160;31, <br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">2022 </div></td></tr><tr><td style="width: 408pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Operating activities<br></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Net loss<font style="padding-left: 2.18pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;">$<font style="padding-left: 7.5pt;">(189) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Adjustments to reconcile net (loss) income to net cash from operating activities<br></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Depreciation<font style="padding-left: 3.86pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt;">1,428 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Noncash lease expense<font style="padding-left: 1.66pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 25.83pt;">6 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Assets impairment<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt;">4,510 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Equipment disposal gain<font style="padding-left: 4.97pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 17.5pt;">(99) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Fair value adjustments of trading securities<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt;">2,088 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Realized loss on trading securities<font style="padding-left: 0.56pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 15.83pt;">300 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Increase in digital currency from mining and management services<font style="padding-left: 1.73pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 5pt;">(9,692) </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: left;">Changes in operating assets and liabilities:<br></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Prepaid and other current assets<font style="padding-left: 0.01pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 16.2pt;">115 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Proceeds from sale of digital currency<font style="padding-left: 3.91pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 8.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">9,692 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Net cash provided by discontinued operating activities<font style="padding-left: 2.8pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">8,159 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">Investing activities<br></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds from sales of trading securities<font style="padding-left: 4.47pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 1.38pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 15.83pt;">866 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: left; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Proceeds from sale of property and equipment<font style="padding-left: 0.58pt;"></font></div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 1.01pt; padding-bottom: 2.63pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="padding-left: 15.83pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">207 </font></div></td></tr><tr><td style="width: 408pt; padding-top: 2.26pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 10pt; text-align: left;">Cash flows provided by investing activities of discontinued operations<font style="padding-left: 2.26pt;"></font></div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 47.16pt; padding-top: 2.26pt; text-align: center; vertical-align: bottom; white-space: nowrap;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 8.17pt; text-align: left;"><font style="border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">$</font><font style="padding-left: 3.33pt; border-bottom: 1pt solid #000000; padding-bottom: 1.5pt;">1,073</font></div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 408pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6.42pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 47.16pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">17. Subsequent Events </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has evaluated subsequent events through March 3, 2025, the date the consolidated financial statements were issued, and with respect to the stock split, described in Note&#160;1, through March 19, 2025. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">In January&#160;2025, the Company drew $50&#160;million on the Revolving Credit Facility. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In January&#160;2025, the Company entered into various additional financing agreements with an OEM. The financing agreements have an aggregate notional balance of $160 million. Related to the financing agreements, the Company granted a security interest for the financed equipment. The financing arrangements have a term of two&#160;years. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, the Company borrowed an additional $473 million under the DDTL 2.0 Facility, bringing the total borrowings on the DDTL 2.0 Facility to $4.3 billion. Refer to <font style="font-style: italic;">Note&#160;10&#8212;Debt </font>for additional information. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February and March&#160;2025, the Company entered into new agreements to lease additional space. The Company expects to make approximately $3.4 billion of additional rent payments over the next 15 years related to the leases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, the Company modified multiple lease agreements with a single landlord. The modifications changed the contracted power capacity, term, and contractual payments, and terminated the related escrow agreements. As a result of the modification, the Company will receive an additional 70 MW of contracted power capacity. The Company received a refund of $304&#160;million of unused escrow funds previously included within other non-current assets, and expects to make approximately $1.7 billion of additional rent payments over the 13 year term of these leases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In February&#160;2025, the Company entered into a definitive agreement to acquire Weights and Biases, Inc., an AI&#160;developer platform. The purchase price is anticipated to be payable primarily in approximately 20,400,000 shares of the Company&#8217;s Class&#160;A common stock. Given the timing of the acquisition, it is not practicable to disclose information regarding the final purchase price, purchase price allocation, or other related disclosure at this time. </div><div class="BRDSX_h2" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 12pt; margin-left: 0pt; text-align: left;">Note&#160;18. Subsequent Events (Unaudited) </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">The Company has evaluated subsequent events from the date the consolidated financial statements were originally issued on March&#160;3, 2025 through March&#160;19, 2025, the date the consolidated financial statements were reissued. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-52<br></div></div></div>
<!--End Page 507-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 508-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_304c-annexefinnotes_pg42"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into a Master Services Agreement (the &#8220;OpenAI Master Services Agreement&#8221;) with OpenAI, pursuant to which the Company provides OpenAI access to cloud computing capacity through fulfillment of reserved capacity orders submitted to the Company by OpenAI. As of March&#160;11, 2025, subject to the satisfaction of delivery and availability of service requirements, OpenAI has committed to pay the Company up to approximately $11.9&#160;billion through October&#160;2030. Under the outstanding order under the OpenAI Master Services Agreement, the Company has established a special purpose vehicle that will hold the infrastructure, and the Company intends for the special purpose vehicle to incur indebtedness to finance its obligations under the OpenAI Master Services Agreement. Additionally, the Company has agreed to issue to OpenAI, in accordance with the terms of the OpenAI Master Services Agreement and pursuant to a stock issuance agreement (the &#8220;OpenAI Stock Issuance Agreement&#8221;) with OpenAI, a number of shares of the Company&#8217;s Class&#160;A common stock equal to $350.0&#160;million valued at a price per share equal to the initial public offering price. The issuance of the shares in a private placement is contingent upon the completion of this offering. Any revenue recognized under the OpenAI Master Service Agreement will be offset by the value of the shares issued under the OpenAI Stock Issuance Agreement. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into a credit agreement (the &#8220;2025 Term Loan Credit Agreement&#8221;) with Morgan Stanley Senior Funding, Inc., as administrative agent, the guarantors party thereto, and the lenders party thereto, providing for a $300&#160;million unsecured term loan facility (the &#8220;2025 Term Loan Facility&#8221;). The obligations under the 2025 Term Loan Facility are unconditionally guaranteed by the subsidiary guarantors as described in the 2025 Term Loan Credit Agreement. Amounts borrowed under the 2025 Term Loan Facility may only be borrowed in a single funding. There have been no borrowings under the 2025 Term Loan Facility as of March 19, 2025. The proceeds of the 2025 Term Loan Facility may be used for working capital and general corporate purposes (including the financing of acquisitions and other investments). The 2025 Term Loan Facility will mature on December&#160;16, 2025. Amounts borrowed under the 2025 Term Loan Facility are subject to an interest rate per annum equal to, at the Company&#8217;s option, either (a) for base rate loans, an applicable margin of 0.75% plus a base rate (subject to a 1.00% floor) determined by reference to the highest of (i) the prime rate, (ii) the greater of (A) the federal funds effective rate and (B) the overnight bank funding rate, in each case, plus 0.50%, and (iii) the one month term SOFR plus 1.00% or (b) for term benchmark loans, an applicable margin of 1.75% plus the term SOFR (subject to a 0.00%&#160;floor) for a one, three, or six month interest period plus, in the case of either of clauses (a) or (b), a fee of 2.25% payable to the lenders thereof. Once drawn, the loans are prepayable at any time, from time to time, at the Company&#8217;s option, and are required to be prepaid with the proceeds of certain asset dispositions, incurrences of indebtedness or equity issuances, including a requirement to be prepaid with some or all of the proceeds of this offering. All unfunded commitments of the lenders under the 2025 Term Loan Facility shall terminate upon the earlier to occur of (i) April&#160;7, 2025 and (ii) the closing of this offering. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into agreements to lease additional space. The Company expects to make approximately $497 million of additional rent payments over the next 12 years related to the leases. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into a lease agreement for various buildings located at a single site intended to be used as data centers. The agreement provides access to 133 MW of electrical power, which is expected to be delivered in phases in 2026. The Company will make contractual rent payments based on construction costs incurred by the lessor. The total contractual rent payments range from $3.8 billion to $4.8 billion over the next 15&#160;years term related to this lease. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company entered into various additional financing agreements with an OEM. The financing agreements have an aggregate notional balance of $41&#160;million. The financing arrangements have a term of 2 years. The Company granted a security interest for the financed equipment. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company&#8217;s Board of Directors approved the 2025 Equity Incentive Plan (the &#8220;2025 Plan&#8221;), which will become effective in connection with the IPO. A total of 50,000,000 shares of the Company&#8217;s Class&#160;A common stock has been reserved for issuance in connection with the 2025 Plan. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">In March&#160;2025, the Company&#8217;s Board of Directors approved the 2025 Employee Stock Purchased Plan (the &#8220;2025 ESPP&#8221;), which will both become effective in connection with the IPO. A total of 10,000,000 shares of the Company&#8217;s Class&#160;A common stock has been reserved for issuance in connection with the 2025 ESPP. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Subsequent to December 31, 2024, the Company&#8217;s board of directors approved grants of 8,753,320 RSUs. Based on the midpoint of the price range set forth on the cover page of this prospectus, the Company currently estimates that the unrecognized stock-based compensation expense related to these RSUs will be approximately $450 million. This estimate is preliminary, subject to change, and may differ materially from the final amount recognized depending on factors such as the actual offering price and other valuation inputs. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">E-53<br></div></div></div>
<!--End Page 508-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 509-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tPART2"><!--Anchor--></a>PART II <br></div><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; text-align: center;">INFORMATION NOT REQUIRED IN THE PROSPECTUS </div> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 12pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 20.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">INDEMNIFICATION OF DIRECTORS AND OFFICERS </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Section&#160;145 of the DGCL authorizes a court to award, or a corporation&#8217;s board of directors to grant, indemnity to directors and officers under certain circumstances and subject to certain limitations. The terms of Section&#160;145 of the DGCL are sufficiently broad to permit indemnification under certain circumstances for liabilities, including reimbursement of expenses incurred, arising under the Securities Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">As permitted by the DGCL, CoreWeave&#8217;s certificate of incorporation contains provisions that eliminate the personal liability of its directors and officers for monetary damages for any breach of fiduciary duties as a director or officer, except liability for the following: </div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any breach of the directors&#8217; or officers&#8217; duty of loyalty to CoreWeave or its stockholders; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">under Section&#160;174 of the DGCL (regarding unlawful dividends and stock purchases); </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">any transaction from which the director or officer derived an improper personal benefit; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">with respect to officers, any action by or in the right of the corporation. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">As permitted by the DGCL, CoreWeave&#8217;s bylaws provide that: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave is required to indemnify its directors and executive officers to the fullest extent permitted by the DGCL, subject to very limited exceptions; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">CoreWeave may indemnify its other employees and agents as set forth in the DGCL; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">CoreWeave is required to advance expenses, as incurred, to its directors and executive officers in connection with a legal proceeding to the fullest extent permitted by the DGCL, subject to very limited exceptions; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">the rights conferred in the amended and restated bylaws are not exclusive. </div></td></tr></table><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">CoreWeave has entered into indemnification agreements with each of its directors and executive officers to provide these directors and executive officers additional contractual assurances regarding the scope of the indemnification set forth in its certificate of incorporation and bylaws and to provide additional procedural protections. There is no pending litigation or proceeding involving a director or executive officer of CoreWeave for which indemnification is sought. The indemnification provisions in its certificate of incorporation, bylaws and the indemnification agreements entered into or to be entered into between CoreWeave and each of its directors and executive officers may be sufficiently broad to permit indemnification of the directors and executive officers for liabilities arising under the Securities Act. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8.5pt; margin-left: 0pt; text-indent: 20pt; text-align: left;">CoreWeave currently carries liability insurance for its directors and officers. </div><div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Certain of CoreWeave&#8217;s directors are also indemnified by their employers with regard to service on the CoreWeave board of directors. </div></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-1<br></div></div></div>
<!--End Page 509-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 510-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg2"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 21.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The following exhibits are filed herewith or incorporated herein by reference: </div></td></tr></table><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 8pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 421pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 41pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 41pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="#tANNEXA">2.1^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Agreement and Plan of Merger, dated as of July&#160;7, 2025, among CoreWeave, Inc., Miami Merger Sub&#160;I, Inc. and Core Scientific, Inc. (included as Annex&#160;A to the proxy statement/prospectus that forms a part of this Registration Statement). </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525085800/d935353dex31.htm">3.1</a> </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amended and Restated Certificate of Incorporation of CoreWeave, Inc. (incorporated by reference to Exhibit&#160;3.1 to the Company&#8217;s Form&#160;S-8 filed with the SEC on April&#160;18, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525085800/d935353dex32.htm">3.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amended and Restated Bylaws of CoreWeave, Inc. (incorporated by reference to Exhibit&#160;3.2 to the Company&#8217;s Form&#160;S-8 filed with the SEC on April&#160;18, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex41.htm">4.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Class&#160;A Common Stock certificate of CoreWeave, Inc. (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;20, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex42.htm">4.2</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Third Amended and Restated Investors&#8217; Rights Agreement between CoreWeave, Inc. and certain holders of its capital stock, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;4.2 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex43.htm">4.3</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Regular Warrant between CoreWeave, Inc. and funds or accounts managed or advised by Magnetar (incorporated by reference to Exhibit&#160;4.3 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex44.htm">4.4</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Penny Warrant between CoreWeave, Inc. and funds or accounts managed or advised by Magnetar (incorporated by reference to Exhibit&#160;4.4 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex45.htm">4.5</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Put Option Agreement between CoreWeave, Inc. and certain holders of its capital stock, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;4.5 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex46.htm">4.6</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amended and Restated Registration Rights Agreement between CoreWeave, Inc. and funds or accounts managed or advised by Magnetar, as amended (incorporated by reference to Exhibit&#160;4.6 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;20, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000025/indenturepdf.htm">4.7</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Indenture, dated as of May&#160;27, 2025, by and among CoreWeave, Inc., the guarantor party thereto and Wilmington Trust, National Association, as trustee (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Form&#160;8-K filed with the SEC on May&#160;28, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000025/indenturepdf.htm">4.8</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of 9.250% Senior Notes due 2030 of CoreWeave, Inc. (included as Exhibit&#160;A to Exhibit&#160;4.7) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525165924/d73657dex41.htm">4.9</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Indenture, dated as of July&#160;25, 2025, by and among CoreWeave, Inc., the guarantors party thereto and Wilmington Trust, National Association, as trustee (incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Form&#160;8-K filed with the SEC on July&#160;28, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525165924/d73657dex41.htm">4.10</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of 9.000% Senior Notes due 2031 of CoreWeave, Inc. (included as Exhibit&#160;A to Exhibit&#160;4.9) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex4-11.htm">4.11**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Warrant Agreement between CoreWeave, Inc. and Computershare Trust Company, N.A. and Computershare, Inc., as Warrant Agent </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex5-1.htm">5.1**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Opinion of Davis Polk &amp; Wardwell LLP </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex8-1.htm">8.1**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax Opinion of Davis Polk &amp; Wardwell LLP </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex8-2.htm">8.2**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Tax Opinion of Wachtell, Lipton, Rosen &amp; Katz </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-2<br></div></div></div>
<!--End Page 510-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 511-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg3"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 421pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 41pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 41pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex101.htm">10.1#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Indemnification Agreement between CoreWeave, Inc. and each of its directors and executive officers (incorporated by reference to Exhibit&#160;10.1 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex102.htm">10.2#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. 2019 Stock Option Plan, as amended, and related form agreements (incorporated by reference to Exhibit&#160;10.2 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex103.htm">10.3#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. 2025 Equity Incentive Plan and related form agreements (incorporated by reference to Exhibit&#160;10.3 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;20, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex104.htm">10.4#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. 2025 Employee Stock Purchase Plan and related form agreements (incorporated by reference to Exhibit&#160;10.4 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;20, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex105.htm">10.5#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. Non-Employee Director Compensation Policy (incorporated by reference to Exhibit&#160;10.5 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525058309/d899798dex106.htm">10.6#</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">CoreWeave, Inc. Senior Executive Change in Control and Severance Plan (incorporated by reference to Exhibit&#160;10.6 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;20, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex107.htm">10.7^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Office Lease, between CoreWeave, Inc. and Livingston Circle Associates, dated March&#160;29, 2024 (incorporated by reference to Exhibit&#160;10.7 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex108.htm">10.8&#8224;^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Credit Agreement between CoreWeave Compute Acquisition Co. II, LLC and the agents and lenders party thereto, dated July&#160;30, 2023 (incorporated by reference to Exhibit&#160;10.8 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex109.htm">10.9&#8224;</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">First Amendment to Credit Agreement between CoreWeave Compute Acquisition Co. II, LLC and the agents and lenders party thereto, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;10.9 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1010.htm">10.10&#8224;^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Guarantee and Pledge Agreement between CoreWeave, Inc. and U.S. Bank Trust Company, National Association, dated July&#160;30, 2023 (incorporated by reference to Exhibit&#160;10.10 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1011.htm">10.11</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">First Amendment to Parent Guarantee and Pledge Agreement between CoreWeave, Inc., U.S. Bank Trust Company, National Association, and the lenders party thereto, dated November&#160;8, 2023 (incorporated by reference to Exhibit&#160;10.11 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1012.htm">10.12&#8224;</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Second Amendment to Parent Guarantee and Pledge Agreement between CoreWeave, Inc., U.S. Bank Trust Company, National Association, and the lenders party thereto, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;10.12 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1013.htm">10.13&#8224;^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Credit Agreement between CoreWeave Compute Acquisition Co. IV, LLC and the agents and lenders party thereto, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;10.13 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1014.htm">10.14&#8224;</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">First Amendment to Credit Agreement between CoreWeave, Inc., the guarantors party thereto, and the agents and lenders party thereto, dated August&#160;29, 2024 (incorporated by reference to Exhibit&#160;10.14 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1015.htm">10.15&#8224;</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Limited Waiver and Second Amendment to Credit Agreement between CoreWeave Compute Acquisition Co. IV, LLC, the Borrower party thereto, and the agents and lenders party thereto, dated December&#160;31, 2024 (incorporated by reference to Exhibit&#160;10.15 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-3<br></div></div></div>
<!--End Page 511-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 512-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg4"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 421pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 41pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 41pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1016.htm">10.16^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Guarantee and Pledge Agreement between CoreWeave, Inc. and U.S. Bank Trust Company, National Association, dated May&#160;16, 2024 (incorporated by reference to Exhibit&#160;10.16 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1017.htm">10.17^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Revolving Credit and Guaranty Agreement between CoreWeave, Inc., the guarantors party thereto, and the agents and lenders party thereto, dated June&#160;21, 2024 (incorporated by reference to Exhibit&#160;10.17 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1018.htm">10.18^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 1 to Credit Agreement between CoreWeave, Inc., the guarantors party thereto, and the agents and lenders party thereto, dated October&#160;7, 2024 (incorporated by reference to Exhibit&#160;10.18 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1019.htm">10.19^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 2 to Credit Agreement between CoreWeave, Inc., the guarantors party thereto, and the agents and lenders party thereto, dated December&#160;2, 2024 (incorporated by reference to Exhibit&#160;10.19 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1020.htm">10.20^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Term Loan Credit and Guaranty Agreement between CoreWeave, Inc., the guarantors party thereto, and the agents and lenders party thereto, dated December&#160;16, 2024 (incorporated by reference to Exhibit&#160;10.20 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1021.htm">10.21</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form&#160;of Equity Exchange Right Agreement between CoreWeave, Inc. and each of Michael Intrator, Brian Venturo, and Brannin McBee (incorporated by reference to Exhibit&#160;10.21 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1022.htm">10.22</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Director Nomination Rights Agreement between CoreWeave, Inc. and funds or accounts managed or advised by Magnetar, dated May&#160;20, 2024 (incorporated by reference to Exhibit&#160;10.22 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex1023.htm">10.23&#8224;^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Master Services Agreement between CoreWeave, Inc. and Microsoft Corporation, dated February&#160;22, 2023 (incorporated by reference to Exhibit&#160;10.23 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525052207/d899798dex1024.htm">10.24&#8224;^</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Master Services Agreement between CoreWeave, Inc. and OpenAI OpCo, LLC, dated March&#160;7, 2025 (incorporated by reference to Exhibit&#160;10.24 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;12, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525052207/d899798dex1025.htm">10.25</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Stock Issuance Agreement between CoreWeave, Inc. and OpenAI OpCo, LLC, dated March&#160;7, 2025 (incorporated by reference to Exhibit&#160;10.25 to the Company&#8217;s Form&#160;S-1/A filed with the SEC on March&#160;12, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000003/coreweavercf-amendmentno.htm">10.26</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Amendment No. 3 to the Revolving Credit and Guaranty Agreement, dated May&#160;2, 2025, by and among CoreWeave, Inc., as the borrower, CoreWeave Cash Management LLC, as the guarantor, JPMorgan Chase Bank, N.A., as Administrative Agent and as a lender and the other lenders party thereto (incorporated by reference to Exhibit&#160;10.1 to the Company&#8217;s Form&#160;8-K filed with the SEC on May&#160;6, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000041/amendment4tocwcreditagre.htm">10.27</a> </div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Fourth Amendment to Credit Agreement between CoreWeave Compute Acquisition Co. IV, LLC and the lenders party thereto, dated June&#160;6, 2025 (incorporated by reference to Exhibit&#160;10.8 to the Company&#8217;s Form 10-Q filed with the SEC on August&#160;12, 2025)</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000033/coreweave30-ex101xtermlo.htm">10.28</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Credit Agreement between CoreWeave Compute Acquisition Co. V, LLC, CoreWeave Compute Acquisition Co. VII, LLC, U.S. Bank National Association, as depository bank, MUFG Bank, Ltd., as administrative agent, U.S. Bank Trust Company, National Association as collateral agent, Morgan Stanley Asset Funding, Inc., MUFG Bank, Ltd. and Goldman Sachs Bank USA, as joint lead arrangers, and other lenders party thereto, dated July&#160;28, 2025. (incorporated by reference to Exhibit&#160;10.1 to the Company&#8217;s Form&#160;8-K filed with the SEC on July&#160;31, 2025) </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-4<br></div></div></div>
<!--End Page 512-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 513-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg5"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"> <table cellspacing="0" cellpadding="0" class="BRDSX_fintab" style="margin-top: 4pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 41pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 421pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 41pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Exhibit<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Number</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Description<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 41pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000176962825000033/coreweave30-ex102xparent.htm">10.29</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Parent Guarantee and Pledge Agreement between CoreWeave, Inc., CCAC VII Holdco LLC and U.S.&#160;Bank Trust Company, National Association, and the lenders party thereto, dated July&#160;28, 2025. (incorporated by reference to Exhibit&#160;10.2 to the Company&#8217;s Form&#160;8-K filed with the SEC on July&#160;31, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex10-30.htm">10.30**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Assignment, Assumption and Amendment Agreement to the Contingent Value Rights Agreement between CoreWeave, Inc. and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. as CVR agent </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000119312525044231/d899798dex211.htm">21.1</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">List of Subsidiaries of CoreWeave, Inc. (incorporated by reference to Exhibit&#160;21.1 to the Company&#8217;s Form&#160;S-1 filed with the SEC on March&#160;3, 2025) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex23-1.htm">23.1**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm of CoreWeave, Inc. </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex23-2.htm">23.2**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of RSM US LLP, Independent Registered Public Accounting Firm of CoreWeave, Inc. </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex23-3.htm">23.3**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Marcum LLP, Independent Registered Public Accounting Firm of Core Scientific, Inc. </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">23.4**</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Davis Polk &amp; Wardwell LLP (included in Exhibits <a href="ny20053122x2_ex5-1.htm">5.1</a> and <a href="ny20053122x2_ex8-1.htm">8.1</a>) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">23.5**</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Wachtell, Lipton, Rosen &amp; Katz (included in <a href="ny20053122x2_ex8-2.htm">Exhibit&#160;8.2</a>) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1769628/000114036125032095/ny20053122x1_s4.htm#tSIG">24.1*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Power of Attorney (included in the signature page to this Registration Statement) </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="https://www.sec.gov/Archives/edgar/data/1769628/000114036125032095/ny20053122x1_ex99-1.htm">99.1*</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Form of Proxy Card of Core Scientific, Inc. </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex99-2.htm">99.2**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of Moelis &amp; Company LLC </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_ex99-3.htm">99.3**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Consent of PJT Partners LP </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.INS*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.SCH*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Taxonomy Extension Schema Document.</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.CAL*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.DEF*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Taxonomy Extension Definition Linkbase Document.</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.LAB*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Taxonomy Extension Label Linkbase Document.</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">101.PRE*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">104*</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). </div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: center; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 41pt; padding-top: 0.01pt; text-align: left; vertical-align: top; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"><a href="ny20053122x2_exfee.htm">107**</a></div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 3pt; background-color: #CCEEFF;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 421pt; padding-top: 0.01pt; text-align: center; vertical-align: bottom; background-color: #CCEEFF;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Filing Fee Table</div></td></tr></table> <div><div class="BRDSX_rule-partial" style="height: 0pt; width: 72pt; border-bottom: 1pt solid #000000; margin-bottom: 1pt; margin-right: auto; margin-left: 0pt; margin-top: 7pt;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">#<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Indicates management contract or compensatory plan. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">^<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: justify;">The annexes, schedules and exhibits have been omitted pursuant to Item&#160;601(b)(2) of Regulation S-K. CoreWeave agrees to furnish supplementally a copy of such schedules and exhibits, or any section thereof, to the SEC upon request. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">&#8224;<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">CoreWeave has omitted portions of the exhibit (indicated by &#8220;[*]&#8221;) as permitted under Item&#160;601(b)(10) of Regulation S-K. </div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">*<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Previously filed.</div></td></tr></table> <table border="0" cellpadding="0" cellspacing="0" style="margin-top: 3pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt;">**<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; text-align: left;">Filed herewith. </div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-5<br></div></div></div>
<!--End Page 513-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 514-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg6"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6.75pt; margin-left: 0pt;"><tr><td style="width: 50pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">ITEM 22.<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">UNDERTAKINGS </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(a)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">The undersigned registrant hereby undertakes: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">To include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(3)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(4)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, if the registrant is subject to Rule&#160;430C, each prospectus filed pursuant to Rule&#160;424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule&#160;430B or other than prospectuses filed in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(5)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule&#160;424; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 40pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. </div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-6<br></div></div></div>
<!--End Page 514-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 515-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_400-part2_pg7"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6.75pt; margin-left: 0pt; text-align: left;">(b)<br></div><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(1)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes as follows: that prior to any public reoffering of the securities registered hereunder through use of a prospectus which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of Rule&#160;145(c), the issuer undertakes that such reoffering prospectus will contain the information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 20pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(2)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The registrant undertakes that every prospectus: (i) that is filed pursuant to paragraph (1) immediately preceding, or (ii) that purports to meet the requirements of Section&#160;10(a)(3) of the Securities Act of 1933 and is used in connection with an offering of securities subject to Rule&#160;415, will be filed as a part of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(c)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes to respond to requests for information that is incorporated by reference into the proxy statement/prospectus pursuant to Item&#160;4, 10(b), 11 or 13 of this form, within one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt means. This includes information contained in documents filed subsequent to the effective date of the registration statement through the date of responding to the request. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">The undersigned registrant hereby undertakes to supply by means of a post-effective amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of and included in the registration statement when it became effective. </div></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="margin-top: 6pt; margin-left: 0pt;"><tr><td style="width: 20pt; text-align: left; vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(e)<br></div></td><td style="vertical-align: top;"><div style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: justify;">Insofar as indemnification for liabilities under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable. In the event a claim of indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in a successful defense of any action, suit or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.</div></td></tr></table></div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-7<br></div></div></div>
<!--End Page 515-->
<div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;"><div class="BRPFPageBreak" style="page-break-after: always;"><hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px auto; width: 612pt; height: 2px; color: #000000; background-color: #000000;"></div></div>
<!--Begin Page 516-->
<div class="BRDSX_page" style="text-align: left; margin: auto; line-height: initial; width: 468pt;"><a name="ny20053122x2_s4a_401-sig_pg1"><!--Anchor--></a><p style="text-align: left; font-family: 'Times New Roman', Times, Serif; font-size: 8pt; font-variant: normal; font-weight: bold"><a href="#TOC">TABLE OF CONTENTS</a></p><div class="BRDSX_page-content"><div class="BRDSX_block-main" style="width: 468pt; margin-left: 0pt;"><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 6.75pt; text-align: center;"><a name="tSIG"><!--Anchor--></a>SIGNATURES </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, CoreWeave has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Livingston, New Jersey, on September 17, 2025. </div> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 2pt; margin-left: 0pt; text-align: left;"> </div><table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 204pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 252pt;" colspan="7"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 204pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="7" style="width: 252pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 0pt; margin-left: 0pt; text-align: left;">COREWEAVE, INC.<font style="font-weight: normal;"> </font></div></td></tr><tr><td style="width: 204pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 187pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 204pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td colspan="4" style="width: 228pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Michael Intrator </div></td></tr><tr><td style="width: 204pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Name:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 187pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Michael Intrator </div></td></tr><tr><td style="width: 204pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 12pt; padding-top: 0.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 29pt; padding-top: 0.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Title : </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 187pt; padding-top: 0.01pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">Chairman and Chief Executive Officer</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 204pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 12pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 29pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 187pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table><div class="BRDSX_h1" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; margin-top: 18.5pt; text-align: center;">POWER OF ATTORNEY </div> <div class="BRDSX_para" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-left: 0pt; text-indent: 20pt; text-align: justify; line-height: 12pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities indicated below, on September 17, 2025. </div> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 1.5pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 0pt; width: 480pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_header"><td style="width: 148pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Signature</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Title</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-bottom: 1.38pt; text-align: left; vertical-align: bottom; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: bold; margin-top: 0pt; text-align: center;">Date</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 1.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: bottom;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">/s/ Michael Intrator</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; margin-left: 0pt; text-align: justify;">Director, Chief Executive Officer </div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">and President<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">(Principal Executive Officer)</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Michael Intrator</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Chief Financial Officer<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">(Principal Financial Officer)</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Nitin Agrawal</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">* </div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Chief Accounting Officer<br></div><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">(Principal Accounting Officer)</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Jeffrey R. Baker </div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 0pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 0pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Director and Chief Strategy Officer</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Brian Venturo</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Karen Boone</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Jack Cogen</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025 </div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Glenn H. Hutchins</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 1.13pt; text-align: left; vertical-align: top; border-bottom: 1pt solid #000000;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">*</div></td><td style="width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Director</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td><td rowspan="2" style="width: 148pt; height: 12pt; padding-top: 0.01pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025</div></td><td style="width: 6pt;" rowspan="2"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.76pt; padding-bottom: 0.38pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">Margaret C. Whitman</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 148pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 148pt; padding-top: 0.01pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 148pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> <div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;"> </div> <table cellspacing="0" cellpadding="0" class="BRDSX_txttab" style="margin-top: 0pt; width: 468pt; margin-left: auto; margin-right: auto;"><tr class="BRDSX_boxspacer"><td style="height: 6pt; width: 17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 120pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 147.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 6pt; width: 147.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr><tr><td style="width: 17pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">*By:</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 120pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-left: 0pt; text-align: left;">/s/ Michael Intrator</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 147.5pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; margin-top: 0pt; text-align: center;">Attorney-In-Fact<font style="font-style: normal;"> </font></div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="width: 147.5pt; text-align: left; vertical-align: top;"><div class="BRDSX_fpara" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; text-align: center;">September 17, 2025</div></td></tr><tr class="BRDSX_boxspacer"><td style="height: 2.75pt; width: 17pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 120pt; border-bottom: 1pt solid #000000;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt; border-bottom: none;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 147.5pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 6pt;"><div style="font-size: 1pt;">&#8194;</div></td><td style="height: 2.75pt; width: 147.5pt;"><div style="font-size: 1pt;">&#8194;</div></td></tr></table> </div></div><div class="BRDSX_block-frill" style="width: 468pt; margin-top: 12pt; margin-left: 0pt;"><div class="BRDSX_unknown" style="color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 9.47pt; text-align: center;">II-8<br></div></div></div>
<!--End Page 516-->
</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.11
<SEQUENCE>2
<FILENAME>ny20053122x2_ex4-11.htm
<DESCRIPTION>EXHIBIT 4.11
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0);" bgcolor="#ffffff">
  <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
  <div>
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 4.11</font><br>
    </div>
    <div> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">WARRANT AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">BETWEEN</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">COREWEAVE, INC.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">AND</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">COMPUTERSHARE TRUST COMPANY, N.A. AND COMPUTERSHARE INC.,</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">AS WARRANT AGENT</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">[____], 2025</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%LCR%1%%%-->
    <div style="text-align: center; font-weight: bold;">TABLE OF CONTENTS</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div>
      <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 2px; width: 18%; color: rgb(0, 0, 0); text-align: center;" align="center" noshade="noshade"></div>
    <div>
      <div style="text-align: right; font-size: 12pt; font-variant: small-caps;"><a name="z_Hlk208979092"></a></div>
      <div>&#160;</div>
    </div>
    <table id="z84cd2dbbc0684d158edaf7987ec6068e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 13%; vertical-align: top;" rowspan="1"><br>
          </td>
          <td style="width: 79%; vertical-align: top;" rowspan="1"><br>
          </td>
          <td style="width: 8%; vertical-align: top; text-align: right; font-variant: small-caps;" rowspan="1"><u>Page</u></td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;" rowspan="1"><br>
          </td>
          <td style="width: 79%; vertical-align: top;" rowspan="1"><br>
          </td>
          <td style="width: 8%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 1.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Appointment of Warrant Agent</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 2.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Issuances; Exercise Price</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">2</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 3.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Warrants</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 4.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Execution of Global Warrant Certificates</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">3</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 5.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Registration and Countersignature</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">4</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 6.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Registration of Transfers and Exchanges</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">5</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 7.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Duration and Exercise of Warrants</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">9</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 8.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Cancellation of Warrants</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">13</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 9.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Mutilated or Missing Global Warrant Certificates</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">13</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 10.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Reservation of Warrant Shares</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 11.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Listing</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 12.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Adjustments and Other Rights of Warrants</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">14</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 13.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>No Fractional Shares</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 14.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Redemption</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 15.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Notices to Warrantholders</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">28</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 16.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Merger, Consolidation or Change of Name of Warrant Agent</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 17.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Warrant Agent</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">29</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 18.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Change of Warrant Agent</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 19.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Warrantholder Not Deemed a Stockholder</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 20.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Notices to Company and Warrant Agent</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">35</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 21.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Withholding and Reporting Requirements</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">36</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 22.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Supplements and Amendments</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">37</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 23.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Successors</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">37</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 24.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Termination</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">38</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 25.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Governing Law Venue and Jurisdiction; Trial By Jury</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">38</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 26.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Benefits of this Agreement</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">38</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 27.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Counterparts</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 28.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Headings</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 29.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Severability</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Section 30.</div>
          </td>
          <td style="width: 79%; vertical-align: top;">
            <div>Entire Agreement</div>
          </td>
          <td style="width: 8%; vertical-align: top;">
            <div style="text-align: right;">39</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Section 31.</div>
          </td>
          <td style="width: 79%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Meaning of Terms Used in Agreement</div>
          </td>
          <td style="width: 8%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: right;">39</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table id="z47aa8e7a61aa4fb397056e60abbc679f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit A</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>-</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Tranche 1 Global Warrant Certificate</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Exhibit B</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div>-</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Form of Tranche 2 Global Warrant Certificate</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit C-1</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>-</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Election to Exercise Book-Entry</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top;">
            <div>Exhibit C-2</div>
          </td>
          <td style="width: 2%; vertical-align: top;">
            <div>-</div>
          </td>
          <td style="width: 85%; vertical-align: top;">
            <div>Form of Election to Exercise Direct Registration Warrants to be Completed by Direct Participant in the Depository Trust Company</div>
          </td>
        </tr>
        <tr>
          <td style="width: 13%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Exhibit D</div>
          </td>
          <td style="width: 2%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>-</div>
          </td>
          <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div>Form of Assignment</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">i</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">WARRANT AGREEMENT</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">This WARRANT AGREEMENT (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), dated as of [___], 2025 by and between COREWEAVE, INC., a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;),
      and Computershare Inc., a Delaware corporation (&#8220;<font style="font-weight: bold;">Computershare</font>&#8221;) and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as warrant agent (the &#8220;<font style="font-weight: bold;">Warrant Agent</font>&#8221;) (each a &#8220;<font style="font-weight: bold;">Party</font>&#8221; and collectively, the &#8220;<font style="font-weight: bold;">Parties</font>&#8221;).</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">PRELIMINARY STATEMENTS</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, on July 7, 2025, the Company entered into an Agreement and Plan of Merger (the &#8220;<font style="font-weight: bold;">Merger Agreement</font>&#8221;) among the Company, Miami Merger Sub I, Inc., a Delaware corporation and
      a wholly owned subsidiary of the Company (&#8220;<font style="font-weight: bold;">Merger Sub</font>&#8221;) and Core Scientific, Inc. (&#8220;<font style="font-weight: bold;">Core Scientific</font>&#8221;), pursuant to which on [___], 2025, Merger Sub merged with and into
      Core Scientific, with Merger Sub surviving as a wholly owned subsidiary of the Company (the &#8220;<font style="font-weight: bold;">Merger</font>&#8221;);</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, pursuant to that certain Warrant Agreement, dated as of January 23, 2024, by and among Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A., collectively, as warrant agent
      (the &#8220;<font style="font-weight: bold;">Original Warrant Agreement</font>&#8221;), in reliance on the exemption afforded by section 1145 of the Bankruptcy Code from the registration requirements of the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Securities Act</font>&#8221;), and of any applicable state securities or &#8220;blue sky&#8221; laws, Core Scientific issued (i) Tranche 1 warrants entitling holders thereof to purchase shares of common stock of Core Scientific, par value
      $0.00001 per share (the &#8220;<font style="font-weight: bold;">Core Scientific</font>&#160;<font style="font-weight: bold;">Common Stock</font>&#8221;) at an initial exercise price equal to $6.81 per share, on the terms and subject to the conditions set forth in the
      Original Warrant Agreement (the &#8220;<font style="font-weight: bold;">Original</font>&#160;<font style="font-weight: bold;">Tranche 1 Warrants</font>&#8221;); and (ii) Tranche 2 warrants entitling holders thereof to purchase shares of Core Scientific Common Stock
      at an initial exercise price equal to $0.01 per share, which warrants were, in accordance with the terms of the Original Warrant Agreement, automatically converted upon consummation of the Merger into non-penny warrants having an initial exercise
      price equal to $7.50 per share, on the terms and subject to the conditions set forth in the Original Warrant Agreement (the &#8220;<font style="font-weight: bold;">Original</font>&#160;<font style="font-weight: bold;">Tranche 2 Warrants</font>&#8221; and together
      with the Original Tranche 1 Warrants, the &#8220;<font style="font-weight: bold;">Original</font>&#160;<font style="font-weight: bold;">Warrants</font>&#8221;);</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, upon consummation of the Merger, each share of Core Scientific Common Stock (other than shares held in treasury or held or owned by Core Scientific, the Company or Merger Sub) was cancelled and converted into
      the right to receive 0.1235 fully paid and non-assessable shares of Class A common stock of CoreWeave, $0.000005 par value per share (the &#8220;<font style="font-weight: bold;">Common Stock</font>&#8221;) (such number of shares, the &#8220;<font style="font-weight: bold;">Original Exchange Ratio</font>&#8221;);</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-indent: 36pt;">WHEREAS, pursuant to the terms of the Original Warrant Agreement, effective upon the consummation of the Merger, the Original Warrants were automatically redeemed, and each holder of such Original Warrants became
      entitled to receive a replacement warrant (a &#8220;<font style="font-weight: bold;">Tranche 1 Warrant</font>&#8221; or &#8220;<font style="font-weight: bold;">Tranche 2 Warrant</font>&#8221;, as the case may be, and together, the &#8220;<font style="font-weight: bold;">Warrants</font>&#8221;)




      exercisable for a number of shares of Common Stock equal to (i) the number of shares of Core Scientific Common Stock that such holder was entitled to receive under the applicable Original Warrant, <font style="font-style: italic;">multiplied by</font>
      (ii) the Original Exchange Ratio, with such Warrant having an exercise price equal to the exercise price of the applicable Original Warrant <font style="font-style: italic;">divided by</font> the Original Exchange Ratio, and in each case, otherwise
      having terms substantially the same as the terms of the Original Tranche 1 Warrants, <font style="font-style: italic;">mutatis mutandis</font>;</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, in satisfaction of the requirements under the Original Warrant Agreement and the Merger Agreement to issue the Warrants hereunder to holders of the Original Warrants, the Company wishes to provide for the
      issuance of (i) [____] New Tranche 1 Warrants each entitling the Warrantholder (as hereinafter defined) thereof to purchase up to [0.1235] shares of Common Stock at an exercise price of $[__] per share, and (ii) [____] New Tranche 2 Warrants each
      entitling the Warrantholder (as hereinafter defined) thereof to purchase up to [0.1235] shares of Common Stock at an exercise price of $[__] per share, in each case, exercisable from the first date on which such Warrants are originally issued
      hereunder (the &#8220;<font style="font-weight: bold;">Issue Date</font>&#8221;) until the respective expiration date therefor set forth herein, on the terms and subject to the conditions set forth in this Agreement;</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, the Company has registered the offering of the Warrants and the shares of Common Stock issuable upon exercise thereof to holders of the Original Warrants in connection with the Merger on a registration statement
      on Form S-4, which was declared effective by the Securities and Exchange Commission on [___], 2025; and</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">WHEREAS, the Warrant Agent, at the request of the Company, has agreed to act as the agent of the Company in connection with the issuance, registration, transfer, exchange and exercise of the Warrants.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">NOW, THEREFORE, in consideration of the premises and mutual agreements herein set forth, the parties hereto agree as follows:</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466015"></a><a name="z_Toc204470501"></a><font style="color: rgb(0, 0, 0);">Section 1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Appointment of Warrant Agent</font>.&#160; The Company hereby appoints
      the Warrant Agent to act as agent for the Company in accordance with the express terms and conditions hereinafter set forth in this Agreement (and no implied terms or conditions); and the Warrant Agent hereby accepts such appointment, on the express
      terms and conditions hereinafter set forth.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466016"></a><a name="z_Toc204470502"></a><font style="color: rgb(0, 0, 0);">Section 2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Issuances; Exercise Price</font>.&#160; On the terms and subject to the
      conditions of this Agreement, the Company may deliver, or cause to be delivered, to the Depository (as defined below), one or more global certificates (&#8220;<font style="font-weight: bold;">Global Warrant Certificates</font>&#8221;) evidencing all or a portion
      of each of the Tranche 1 Warrants and Tranche 2 Warrants. The remainder (if any) of the Original Warrants shall be issued by book-entry registration on the books of the Warrant Agent (&#8220;<font style="font-weight: bold;">Book-Entry Warrants</font>&#8221;) and
      evidenced by statements issued by the Warrant Agent from time to time to the registered holder of Book-Entry Warrants reflecting such book-entry position (the &#8220;<font style="font-weight: bold;">Warrant Statement</font>&#8221;). Each Warrant evidenced
      thereby entitles the holder, upon proper exercise, and payment of the applicable Exercise Price, to receive from the Company, as adjusted as provided herein, [0.1235] fully-paid, non-assessable share of Common Stock, subject to the Cashless Exercise
      provisions set forth in Section 7(e), if applicable. The shares of Common Stock or (as provided pursuant to <font style="color: rgb(0, 0, 0);">Section 12</font> hereof) securities, Cash or other property deliverable upon proper exercise of the
      Warrants are referred to herein as the &#8220;<font style="font-weight: bold;">Warrant Shares</font>.&#8221;</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466017"></a><a name="z_Toc204470503"></a><font style="color: rgb(0, 0, 0);">Section 3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Form of Warrants</font>.&#160; Subject to <font style="color: rgb(0, 0, 0);">Section 6</font> of this Agreement, the Warrants shall be issued (1) via book-entry registration on the books and records of the Warrant Agent and evidenced by Warrant Statements, in customary form and substance or (2) in the form of one or
      more global certificates (the &#8220;<font style="font-weight: bold;">Global Warrant Certificates</font>&#8221;), the forms of election to exercise and of assignment to be printed on the reverse thereof, in substantially the form set forth in Exhibit A attached
      hereto, with respect to the Tranche 1 Warrants, and Exhibit B attached hereto, with respect to the Tranche 2 Warrants. The Global Warrant Certificates of each of the Tranche 1 Warrants and the Tranche 2 Warrants may bear such appropriate insertions,
      omissions, legends, substitutions and other variations as are required or permitted by this Agreement and may have such letters, numbers or other marks of identification and such legends or endorsements placed thereon as may be required to comply
      with any law or with any rules made pursuant thereto or with any rules of any securities exchange or as may, consistently herewith, be determined by, in the case of Global Warrant Certificates, the Appropriate Officers (as defined herein) executing
      such Global Warrant Certificates, as evidenced by their execution of the Global Warrant Certificates.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">Any Global Warrant Certificates issued shall be deposited with the Warrant Agent as custodian for The Depository Trust Company (the &#8220;<font style="font-weight: bold;">Depository</font>&#8221;) and registered in the name of Cede
      &amp; Co., or such other entity designated by the Depository, as the Depository&#8217;s nominee. Each Global Warrant Certificate shall represent such number of the outstanding Warrants as specified therein, and each shall provide that it shall represent
      the aggregate amount of outstanding Warrants from time to time endorsed thereon and that the aggregate amount of outstanding Warrants represented thereby may from time to time be reduced or increased, as appropriate, in accordance with the terms of
      this Agreement.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466018"></a><a name="z_Toc204470504"></a><font style="color: rgb(0, 0, 0);">Section 4.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Execution of Global Warrant Certificates</font>.&#160; Global Warrant
      Certificates shall be signed on behalf of the Company by its Chief Executive Officer, its Chief Financial Officer, its President, its General Counsel, a Vice President, its Secretary, an Assistant Secretary or any other authorized person appointed by
      the board of directors (the &#8220;<font style="font-weight: bold;">Board of Directors</font>&#8221;) of the Company from time to time (each, an &#8220;<font style="font-weight: bold;">Appropriate Officer</font>&#8221;). Each such signature upon the Global Warrant
      Certificates may be in the form of a facsimile or electronic signature of any such Appropriate Officer and may be imprinted or otherwise reproduced on the Global Warrant Certificates and for that purpose the Company may adopt and use the facsimile or
      electronic signature of any Appropriate Officer.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;">If any Appropriate Officer who shall have signed any of the Global Warrant Certificates shall cease to be an Appropriate Officer before the Global Warrant Certificates so signed shall have been countersigned by the
      Warrant Agent or disposed of by the Company, such Global Warrant Certificates nevertheless may be countersigned and delivered or disposed of as though such Appropriate Officer had not ceased to be an Appropriate Officer of the Company, and any Global
      Warrant Certificate may be signed on behalf of the Company by any Person who, at the actual date of the execution of such Global Warrant Certificate, shall be an Appropriate Officer, although at the date of the execution of this Agreement such Person
      was not an Appropriate Officer. Global Warrant Certificates shall be dated the date of countersignature by the Warrant Agent and shall represent one or more whole Warrants.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466019"></a><a name="z_Toc204470505"></a><font style="color: rgb(0, 0, 0);">Section 5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Registration and Countersignature</font>.&#160; Upon written order of
      the Company, the Warrant Agent shall (i) register in the Warrant Register (as defined below) the Global Warrant Certificates as well as any Book-Entry Warrants and exchanges and transfers of outstanding Warrants in accordance with the procedures set
      forth in this Agreement and (ii) upon receipt of the Global Warrant Certificates duly executed on behalf of the Company, countersign by either manual, facsimile or other electronic signature one or more Global Warrant Certificates evidencing Warrants
      and shall deliver such Global Warrant Certificates to or upon the written order of the Company. Such written order of the Company shall specifically state the number of Warrants that are to be issued as Book-Entry Warrants and the number of Warrants
      that are to be issued as a Global Warrant Certificate. A Global Warrant Certificate shall be, and shall remain, subject to the provisions of this Agreement until such time as all of the Warrants evidenced thereby shall have been duly exercised or
      shall have expired or been canceled in accordance with the terms hereof. Each Person in whose name any Warrant is registered (each such registered holder, a &#8220;<font style="font-weight: bold;">Warrantholder</font>&#8221;) shall be bound by all of the terms
      and provisions of this Agreement (a copy of which is available on request to the Secretary of the Company) as fully and effectively as if such Warrantholder had signed the same.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">No Global Warrant Certificate shall be valid for any purpose, and no Warrant evidenced thereby shall be exercisable, until such Global Warrant Certificate has been countersigned by the manual, facsimile or electronic
      signature of the Warrant Agent. Such signature by the Warrant Agent upon any Global Warrant Certificate executed by the Company shall be conclusive evidence that such Global Warrant Certificate so countersigned has been duly issued hereunder.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The Warrant Agent shall keep, at an office designated for such purpose, books (the &#8220;<font style="font-weight: bold;">Warrant Register</font>&#8221;) in which, subject to such reasonable regulations as it may prescribe, it
      shall register the Book-Entry Warrants as well as any Global Warrant Certificates and exchanges and transfers of outstanding Warrants in accordance with the procedures set forth in <font style="color: rgb(0, 0, 0);">Section 6</font> of this
      Agreement, all in form reasonably satisfactory to the Company and the Warrant Agent. No service charge shall be made for any exchange or registration of transfer of the Warrants, but the Company may require payment of a sum sufficient to cover any
      stamp or other tax or other governmental charge that may be imposed on the Warrantholder in connection with any such exchange or registration of transfer. The Warrant Agent shall have no obligation to effect an exchange or register a transfer unless
      and until any payments required by the immediately preceding sentence have been made.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;">Prior to due presentment for registration of transfer or exchange of any Warrant in accordance with the procedures set forth in this Agreement, the Warrant Agent and the Company may deem and treat the Warrantholder as
      the absolute owner of such Warrant (notwithstanding any notation of ownership or other writing made in a Global Warrant Certificate by anyone), for the purpose of any exercise thereof, any distribution to the Warrantholder thereof and for all other
      purposes, and neither the Warrant Agent nor the Company shall be affected by notice to the contrary.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466022"></a><a name="z_Toc204470506"></a><font style="color: rgb(0, 0, 0);">Section 6.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Registration of Transfers and Exchanges</font>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466023"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Transfer and Exchange of Global Warrant Certificates or Beneficial Interests Therein</font>. The
      transfer and exchange of Global Warrant Certificates or beneficial interests therein shall be effected through the Depository, in accordance with this Agreement and the procedures of the Depository therefor.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466024"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Exchange of a Beneficial Interest in a Global Warrant Certificate for a Book-Entry Warrant</font>.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466025"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any Warrantholder of a beneficial interest in a Global Warrant Certificate may, upon request, exchange such
      beneficial interest for a Book-Entry Warrant. Upon receipt by the Warrant Agent from the Depository or its nominee of written instructions or such other form of instructions as is customary for the Depository on behalf of any Person having a
      beneficial interest in a Global Warrant Certificate, the Warrant Agent shall cause, in accordance with the standing instructions and procedures existing between the Depository and Warrant Agent, the number of Warrants represented by the Global
      Warrant Certificate to be reduced by the number of Warrants to be represented by the Book-Entry Warrants to be issued in exchange for the beneficial interest of such Person in the Global Warrant Certificate and, following such reduction, the Warrant
      Agent shall register in the name of the Warrantholder a Book-Entry Warrant and deliver to said Warrantholder a Warrant Statement.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466026"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Book-Entry Warrants issued in exchange for a beneficial interest in a Global Warrant Certificate pursuant to this <font style="color: rgb(0, 0, 0);">Section 6(b)</font> shall be registered in such names as the Depository, pursuant to instructions from its direct or indirect participants or otherwise, shall instruct the Warrant Agent. The Warrant Agent shall deliver
      such Warrant Statements to the Persons in whose names such Warrants are so registered.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466027"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Transfer and Exchange of Book-Entry Warrants</font>. Book-Entry Warrants surrendered for exchange or
      for registration of transfer pursuant to this <font style="color: rgb(0, 0, 0);">Section 6(c)</font> or <font style="color: rgb(0, 0, 0);">Section 6(i)(v)</font>, shall be cancelled by the Warrant Agent. Such cancelled Book-Entry Warrants shall
      then be disposed of by or at the direction of the Company in accordance with applicable law. When Book-Entry Warrants are presented to or deposited with the Warrant Agent with a written request:</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466028"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to register the transfer of the Book-Entry Warrants; or</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466029"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to exchange such Book-Entry Warrants for an equal number of Book-Entry Warrants of other authorized denominations;</div>
    <div>&#160;</div>
    <div>then in each case the Warrant Agent shall register the transfer or make the exchange as requested if its requirements for such transactions are met; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>,
      that the Warrant Agent has received a written instruction of transfer in a form satisfactory to the Warrant Agent, duly executed by the Warrantholder thereof or by his attorney, duly authorized in writing.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466030"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Restrictions on Exchange or Transfer of a Book-Entry Warrant for a Beneficial Interest in a Global
        Warrant Certificate</font>. A Book-Entry Warrant may not be exchanged for a beneficial interest in a Global Warrant Certificate except upon satisfaction of the requirements set forth below. Upon receipt by the Warrant Agent of appropriate
      instruments of transfer with respect to a Book-Entry Warrant, in a form satisfactory to the Warrant Agent, together with written instructions directing the Warrant Agent to make, or to direct the Depository to make, an endorsement on the Global
      Warrant Certificate to reflect an increase in the number of Warrants represented by the Global Warrant Certificate equal to the number of Warrants represented by such Book-Entry Warrant (such instruments of transfer and instructions to be duly
      executed by the holder thereof or the duly appointed legal representative thereof or by his attorney, duly authorized in writing, such signatures to be guaranteed by an eligible guarantor institution participating in a signature guarantee program
      approved by a participant in the Securities Transfer Agent Medallion Program, the Stock Exchanges Medallion Program or the New York Stock Exchange, Inc. Medallion Signature Program (a &#8220;<font style="font-weight: bold;">Signature Guarantee</font>&#8221;)),
      then the Warrant Agent shall cancel such Book-Entry Warrant on the Warrant Register and cause, or direct the Depository to cause, in accordance with the standing instructions and procedures existing between the Depository and the Warrant Agent, the
      number of Warrants represented by the Global Warrant Certificate to be increased accordingly. If no Global Warrant Certificates are then outstanding, the Company shall issue and the Warrant Agent shall countersign a new Global Warrant Certificate
      representing the appropriate number of Warrants.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466031"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Restrictions on Exchange or Transfer of Global Warrant Certificates</font>. Notwithstanding any other
      provisions of this Agreement (other than the provisions set forth in <font style="color: rgb(0, 0, 0);">Section 6(f)</font>), unless and until it is exchanged in whole for a Book-Entry Warrant, a Global Warrant Certificate may not be transferred as
      a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of such successor
      Depository.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466032"></a><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Book-Entry Warrants</font>. If at any time, the Depository for the Global Warrant Certificates
      notifies the Company that the Depository is unwilling or unable to continue as Depository for the Global Warrant Certificates and a successor Depository for the Global Warrant Certificates is not appointed by the Company within ninety (90) days after
      delivery of such notice, then the Warrant Agent, upon written instructions signed by an Appropriate Officer of the Company and all other necessary information, shall register Book-Entry Warrants, in an aggregate number equal to the number of Warrants
      represented by the Global Warrant Certificates, in exchange for such Global Warrant Certificates, in such names and in such amounts as directed by the Depository or, in the absence of instructions from the Depository, the Company.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466033"></a><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Restrictions on Transfers of Warrant Shares</font>. No Warrants, nor any Warrant Shares issued upon
      exercise thereof, shall be sold, exchanged or otherwise transferred in violation of the Securities Act or applicable state securities laws. Each Warrantholder, by its acceptance of any Warrant under this Agreement, acknowledges and agrees that the
      Warrant Shares issuable upon exercise of these Warrants will be issued pursuant to an exemption from the registration requirement of Section 5 of the Securities Act and, as such, a Warrantholder may not be able to sell or transfer any Warrant Shares
      issued upon exercise of these Warrants in the absence of an effective registration statement relating thereto under the Securities Act and in accordance with applicable state securities laws or pursuant to an exemption from registration thereunder,
      including the exemption provided by Rule 144 promulgated under the Securities Act, if available.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466034"></a><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Cancellation of Global Warrant Certificate</font>. At such time as all beneficial interests in Global
      Warrant Certificates have either been exchanged for Book-Entry Warrants, redeemed, repurchased or cancelled, all Global Warrant Certificates shall be returned to, or retained and cancelled by, the Warrant Agent, upon written instructions from the
      Company satisfactory to the Warrant Agent.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466035"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Obligations with Respect to Transfers and Exchanges of Warrants</font>.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466036"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To permit registrations of transfers and exchanges, the Company shall execute Global Warrant Certificates, if
      applicable, and the Warrant Agent is hereby authorized, in accordance with the provisions of <font style="color: rgb(0, 0, 0);">Section 5</font> and this <font style="color: rgb(0, 0, 0);">Section 6</font>, to countersign such Global Warrant
      Certificates, if applicable, or register Book-Entry Warrants, if applicable, as required pursuant to the provisions of this <font style="color: rgb(0, 0, 0);">Section 6</font> and for the purpose of any distribution of new Global Warrant
      Certificates contemplated by <font style="color: rgb(0, 0, 0);">Section 9</font> or additional Global Warrant Certificates contemplated by <font style="color: rgb(0, 0, 0);">Section 12</font>.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466037"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All Book-Entry Warrants and Global Warrant Certificates issued upon any registration of transfer or exchange of
      Book-Entry Warrants or Global Warrant Certificates shall be the valid obligations of the Company, entitled to the same benefits under this Agreement as the Book-Entry Warrants or Global Warrant Certificates surrendered upon such registration of
      transfer or exchange.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466038"></a><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; No service charge shall be made to a Warrantholder for any registration, transfer or exchange but the Company may
      require payment of a sum sufficient to cover any stamp or other tax or other governmental charge that may be imposed on the Warrantholder in connection with any such exchange or registration of transfer. Neither the Company nor the Warrant Agent
      shall be required to pay any tax or taxes which may be payable in respect of any transfer involved in the issuance of Warrants or any certificates for Warrant Shares in a name other than that of the Warrantholder of the surrendered Warrants, and the
      Company shall not be required to issue or deliver such Warrants or the certificates representing the Warrant Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Company the amount of such tax or shall
      have established to the satisfaction of the Company that such tax has been paid. The Warrant Agent shall have no duty or obligation to deliver such Warrants or the certificates representing such Warrant Shares unless and until it is satisfied that
      all such taxes and charges have been paid.</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466039"></a><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; So long as the Depository, or its nominee, is the registered owner of a Global Warrant Certificate, the Depository or
      such nominee, as the case may be, will be considered the sole owner or Warrantholder of the Warrants represented by such Global Warrant Certificate for all purposes under this Agreement. Except as provided in <a name="DocXTextRef21"></a>Sections
      6(b) and 6(f) upon the exchange of a beneficial interest in a Global Warrant Certificate for Book-Entry Warrants, owners of beneficial interests in a Global Warrant Certificate will not be entitled to have any Warrants registered in their names, and
      will under no circumstances be entitled to receive physical delivery of any such Warrants and will not be considered the owners or Warrantholders thereof under the Warrants or this Agreement. Neither the Company nor the Warrant Agent, in its capacity
      as registrar for such Warrants, will have any responsibility or liability for any aspect of the records relating to beneficial interests in a Global Warrant Certificate or for maintaining, supervising or reviewing any records relating to such
      beneficial interests. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Warrant Agent or any agent of the Company or the Warrant Agent from giving effect to any written certification, proxy or other authorization furnished
      by the Depository or impair the operations of customary practices of the Depository governing the exercise of the rights of a holder of a beneficial interest in a Global Warrant Certificate.</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466040"></a><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to <a name="DocXTextRef24"></a>Sections 6(b), 6(c) and 6(d) hereof, and this <font style="color: rgb(0, 0, 0);">Section 6(i)</font>, the Warrant Agent shall, upon receipt of all information required to be delivered hereunder and any evidence of authority that may be reasonably required by the Warrant Agent, from time to time register the transfer of any
      outstanding Warrants in the Warrant Register, upon surrender of Global Warrant Certificates, if applicable, representing such Warrants at the Warrant Agent Office (as defined below), duly endorsed, and accompanied by a completed form of assignment
      substantially in the form of Exhibit D hereto (or with respect to a Book-Entry Warrant, only such completed form of assignment substantially in the form of Exhibit D hereto), duly signed by the Warrantholder thereof or by the duly appointed legal
      representative thereof or by a duly authorized attorney and accompanied by a Signature Guarantee. Upon any such registration of transfer, a new Global Warrant Certificate or a Warrant Statement, as the case may be, shall be issued to the transferee.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466041"></a><a name="z_Toc204470507"></a><font style="color: rgb(0, 0, 0);">Section 7.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Duration and Exercise of Warrants</font>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466042"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms of this Agreement, (i) each Tranche 1 Warrant shall be exercisable, in whole or in part, at any time and from time
      to time beginning after the Issue Date and ending at 5:00 p.m., New York City time, on January 23, 2027 or, if such date is not a Business Day, the next subsequent Business Day (such date, the &#8220;<font style="font-weight: bold;">Tranche 1 Expiration
        Date</font>&#8221;), and (ii) each Tranche 2 Warrant shall be exercisable, in whole or in part, at any time and from time to time beginning after the Issue Date and ending at 5:00 p.m., New York City time on January 23, 2029, or, if such date is not a
      Business Day, the next subsequent Business Day (such date, the &#8220;<font style="font-weight: bold;">Tranche 2 Expiration Date</font>&#8221;, and together with the Tranche 1 Expiration Date, each an &#8220;<font style="font-weight: bold;">Expiration Date</font>&#8221;).
      The Company shall promptly provide the Warrant Agent written notice of the Tranche 1 Expiration Date and the Tranche 2 Expiration Date, as applicable. After 5:00 p.m., New York City time, on the Tranche 1 Expiration Date or the Tranche 2 Expiration
      Date, as applicable, the Warrants will become void and of no value, and may not be exercised.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref208000591"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, no Warrantholder may elect to settle an exercise of Warrants other than by Cashless
      Exercise unless a registration statement covering the Warrant Shares is in effect and available.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466046"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of this Agreement, the Warrantholder may exercise the warrants as follows:</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204465343"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;registered holders of Book-Entry Warrants must provide written notice of such election (&#8220;<font style="font-weight: bold;">Warrant Exercise Notice</font>&#8221;) to exercise the Warrant to the Company and the Warrant Agent at the addresses set forth in <font style="color: rgb(0, 0, 0);">Section 20</font> no later than 5:00 p.m., New York City time, on the applicable
      Expiration Date, which Warrant Exercise Notice shall be substantially in the form set forth in Exhibit C-1 hereto, properly completed and executed by the registered holder of the Book-Entry Warrant, and pay (x) the applicable Exercise Price <font style="font-style: italic;">multiplied by</font> the number of Warrant Shares in respect of which any Warrants are being exercised on the date the notice is provided to the Warrant Agent or (y) in the case of a Cashless Exercise, paying the
      required consideration in the manner set forth in Section 7(e), in each case, together with any applicable taxes and governmental charges;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204465358"></a><a name="z_Ref208000485"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;or, with respect to Warrants held through the book-entry facilities of the Depository,
      <a name="DocXTextRef33"></a>(x) a Warrant Exercise Notice to exercise the Warrant must be sent to the Company and the Warrant Agent at the addresses set forth in <font style="color: rgb(0, 0, 0);">Section 20</font> no later than 5:00 p.m., New York
      City time, on the applicable Expiration Date, which Warrant Exercise Notice shall be substantially in the form set forth in Exhibit C-2 hereto, properly completed and executed by the Warrantholder; <font style="font-style: italic;">provided</font>
      that such written notice may only be submitted with respect to Warrants held through the book-entry facilities of the Depository, by or through Persons that are direct participants in the Depository; <a name="DocXTextRef34"></a>(y) such Warrants
      shall be delivered no later than 5:00 p.m., New York City time, on the Settlement Date, to the Warrant Agent by book-entry transfer through the facilities of the Depository, if such Warrants are represented by a Global Warrant Certificate; and (z)
      payment must be made of (A) the applicable Exercise Price <font style="font-style: italic;">multiplied by</font> the number of Warrant Shares in respect of which any Warrants are being exercised or (B) in the case of a Cashless Exercise, the
      required consideration in the manner set forth in Section 7(e), in each case, together with any applicable taxes and governmental charges.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 9pt;"><a name="z_Ref204466047"></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The date that is two (2) Business Days after a Warrant Exercise Notice is timely and properly delivered is referred to for all purposes under this Agreement as the &#8220;<font style="font-weight: bold;">Settlement Date</font>.&#8221;</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">To the extent a Warrant Exercise Notice (as defined below) is delivered in respect of a Warrant no later than 5:00 p.m., New York City time, on the applicable Expiration Date, but the other deliveries and payments
      specified in clauses (i) and (ii) above are effected thereafter but no later than 5:00 p.m., New York City time, on the Business Day immediately preceding the Settlement Date, the Warrants shall nonetheless be deemed exercised prior to the applicable
      Expiration Date for the purposes of this Agreement.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref208000685"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event that a Warrantholder elects to pay the exercise price in cash, subject to Section 7(b), the aggregate Exercise Price shall
      be payable in lawful money of the United States of America either by certified or official bank check payable to the order of the Company or by wire transfer of immediately available funds or otherwise as agreed with the Company.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466049"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In lieu of paying the aggregate Exercise Price as set forth in Section 7(d), the aggregate exercise price for any Warrant being
      exercised hereunder may instead be payable by withholding from issuance a number of Warrant Shares issuable upon exercise of all Warrants being exercised by such Warrantholder at such time which, when multiplied by the Current Market Price of the
      Warrant Shares, is equal to the aggregate Exercise Price, and such withheld Warrant Shares shall no longer be issuable under such Warrants (a &#8220;<font style="font-weight: bold;">Cashless Exercise</font>&#8221;). The formula for determining the number of
      Warrant Shares to be issued in a Cashless Exercise of either Tranche 1 Warrants or Tranche 2 Warrants is as follows:</div>
    <div>&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img01.jpg" width="122" height="36"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z41fb31f3da3747d28a122164edac429d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">X&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: auto; vertical-align: top;">the number of Warrant Shares issuable upon such exercise pursuant to this <font style="color: rgb(0, 0, 0);">Section 7(e)</font>.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z1b4ccbc4351042c6afcdb2562a43008b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: auto; vertical-align: top;">the Current Market Price of a Warrant Share on the Trading Day immediately preceding the date on which the Warrantholder delivers the Warrant Exercise Notice.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div>
        <table id="z3a67dcd348114810aa5075c456561bd4" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">B&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: auto; vertical-align: top;">the Exercise Price for the Tranche 1 Warrants or Tranche 2 Warrants, as the case may be.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z9329b50586e6476da917e840e13770bc" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">C&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: auto; vertical-align: top;">the number of Warrant Shares as to which the Tranche 1 Warrant or Tranche 2 Warrant, as the case may be, is then being exercised including the withheld Warrant Shares.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">If the foregoing calculation results in a negative number, then no Warrant Shares shall be issuable via a Cashless Exercise. The number of Warrant Shares to be issued on such exercise will be determined by the Company
      (with written notice thereof to the Warrant Agent) using the formula set forth in this <font style="color: rgb(0, 0, 0);">Section 7(e)</font>. The Warrant Agent shall have no duty or obligation to investigate or confirm whether the Company&#8217;s
      determination of the number of Warrant Shares to be issued on such exercise, pursuant to this <font style="color: rgb(0, 0, 0);">Section 7(e)</font>, is accurate or correct.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466051"></a><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any exercise of a Warrant pursuant to the terms of this Agreement shall be irrevocable and shall constitute a binding agreement between
      the Warrantholder and the Company, enforceable in accordance with its terms.</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Warrant Agent shall:</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; examine all Warrant Exercise Notices and all other documents delivered to it by or on behalf of the Warrantholders as contemplated hereunder to ascertain whether or
      not, on their face, such Warrant Exercise Notices and any such other documents have been executed and completed in accordance with their terms and the terms hereof;</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466053"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;where a Warrant Exercise Notice or other document appears on its face to have been improperly completed or executed or some other
      irregularity in connection with the exercise of the Warrants exists, the Warrant Agent shall endeavor to inform the appropriate parties (including the Person submitting such instrument) of the need for fulfillment of all requirements, specifying
      those requirements which appear to be unfulfilled;</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466054"></a><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; inform the Company of and cooperate with and assist the Company in resolving any discrepancies between Warrant Exercise Notices
      received and delivery of Warrants to the Warrant Agent&#8217;s account;</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466055"></a><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; advise the Company no later than one (1) Business Day after receipt of a Warrant Exercise Notice of <a name="DocXTextRef45"></a>(A) the
      receipt of such Warrant Exercise Notice and the number of Warrants exercised in accordance with the terms and conditions of this Agreement, (B) the instructions with respect to delivery of the shares of Common Stock of the Company deliverable upon
      such exercise, subject to timely receipt from the Depository of the necessary information, and (C) such other information as the Company shall reasonably require; and</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466056"></a><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;subject to Common Stock being made available to the Warrant Agent by or on behalf of the Company for delivery to the Depository, liaise
      with the Depository and endeavor to effect such delivery to the relevant accounts at the Depository in accordance with its requirements.</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466057"></a><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All questions as to the validity, form and sufficiency (including time of receipt) of a Warrant Exercise Notice will be determined by
      the Company (acting in good faith). The Warrant Agent shall incur no liability for or in respect of such determination by the Company. The Company reserves the right to reject any and all Warrant Exercise Notices not in proper form or for which any
      corresponding agreement by the Company to exchange would, in the opinion of the Company, be unlawful. Such determination by the Company (acting in good faith) shall be final and binding on the Warrantholders, absent manifest error. The Company
      reserves the absolute right to waive any of the conditions to the exercise of Warrants or defects in Warrant Exercise Notices with regard to any particular exercise of Warrants. Neither the Company nor the Warrant Agent shall be under any duty to
      give notice to the Warrantholders of the Warrants of any irregularities in any exercise of Warrants, nor shall it incur any liability for the failure to give such notice.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466058"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;As soon as practicable after the exercise of any Warrant as set forth in <font style="color: rgb(0, 0, 0);">Section 7(f)</font>, the
      Company shall issue, or otherwise deliver, or cause to be issued or delivered, in authorized denominations to or upon the order of the Warrantholder of the Warrants, either:</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466059"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; if such Warrantholder holds the Warrants being exercised through the Depository&#8217;s book-entry transfer facilities, by
      same-day or next-day credit to the Depository for the account of such Warrantholder or for the account of a participant in the Depository the number of Warrant Shares to which such Warrantholder is entitled, in each case registered in such name and
      delivered to such account as directed in the Warrant Exercise Notice by such Warrantholder or by the direct participant in the Depository through which such Warrantholder is acting, or</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466060"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if such Warrantholder holds the Warrants being exercised in the form of Book-Entry Warrants, a book-entry interest
      in the Warrant Shares registered on the books of the Company&#8217;s transfer agent or, at the Company&#8217;s option, by delivery to the address designated by such Warrantholder in its Warrant Exercise Notice of a physical certificate representing the number of
      Warrant Shares to which such Warrantholder is entitled, in fully registered form, registered in such name or names as may be directed by such Warrantholder. Such Warrant Shares shall be deemed to have been issued and any Person so designated to be
      named therein shall be deemed to have become a Warrantholder as of the Close of Business on the date of the delivery thereof.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">If less than all of the Warrants evidenced by a Global Warrant Certificate surrendered upon the exercise of Warrants are exercised at any time prior to the date of expiration for the Warrants, a new Global Warrant
      Certificate or Certificates shall be issued for the remaining number of Warrants evidenced by the Global Warrant Certificate so surrendered, and the Warrant Agent is hereby authorized to countersign the required new Global Warrant Certificate or
      Certificates pursuant to the provisions of <font style="color: rgb(0, 0, 0);">Section 5</font>, <font style="color: rgb(0, 0, 0);">Section 6</font> and this <font style="color: rgb(0, 0, 0);">Section 7</font>. The Person in whose name any
      certificate or certificates for the Warrant Shares are to be issued (or such Warrant Shares are to be registered, in the case of a book-entry transfer) upon exercise of a Warrant shall be deemed to have become the Warrantholder of such Warrant Shares
      on the date such Warrant Exercise Notice is delivered.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466061"></a><a name="z_Toc204470508"></a><font style="color: rgb(0, 0, 0);">Section 8.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Cancellation of Warrants</font>.&#160; Upon the Tranche 1 Expiration
      Date or Tranche 2 Expiration Date, as applicable (if not already properly exercised), or if the Company shall purchase or otherwise acquire such Warrants, the Global Warrant Certificates and the Book-Entry Warrants representing such Warrants shall
      thereupon be delivered to the Warrant Agent, if applicable, and be cancelled by it and retired. The Warrant Agent shall cancel all Global Warrant Certificates surrendered for exchange, substitution, transfer or exercise in whole or in part. Such
      cancelled Global Warrant Certificates shall thereafter be disposed of in a manner satisfactory to the Company provided in writing to the Warrant Agent, subject to any applicable law, rule or regulation requiring the Warrant Agent to retain such
      cancelled certificates. The Warrant Agent shall <a name="DocXTextRef50"></a>(x) advise an authorized representative of the Company as directed by the Company by the end of each day or on the next Business Day following each day on which Warrants
      were exercised, of (i) the number of shares of Common Stock issued upon exercise of a Warrant, (ii) the delivery of Global Warrant Certificates evidencing the balance, if any, of the Warrants remaining after such exercise and (iii) such other
      information as the Company shall reasonably require and <a name="DocXTextRef51"></a>(y) forward funds received for Warrant exercises in a given month by the fifth (5th) Business Day of the following month by wire transfer to an account designated by
      the Company. The Warrant Agent promptly shall confirm such information to the Company in writing. The Warrant Agent shall keep copies of this Agreement and any notices given or received hereunder.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466065"></a><a name="z_Toc204470509"></a><font style="color: rgb(0, 0, 0);">Section 9.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Mutilated or Missing Global Warrant Certificates</font>.&#160; If any
      of the Global Warrant Certificates shall be mutilated, lost, stolen or destroyed, the Company shall issue, and the Warrant Agent shall countersign by either manual, electronic or facsimile signature and deliver, in exchange and substitution for and
      upon cancellation of the mutilated Global Warrant Certificate, or in lieu of and substitution for the Global Warrant Certificate lost, stolen or destroyed, a new Global Warrant Certificate of like tenor and representing an equivalent number of
      Warrants, but only (i) upon receipt of evidence reasonably satisfactory to the Company and the Warrant Agent of the loss, theft or destruction of such Global Warrant Certificate; (ii) upon receipt of an open penalty surety bond and holding the
      Warrant Agent and Company harmless, if requested by either the Company or the Warrant Agent, also satisfactory to them; and (iii) absent notice to the Warrant Agent that such certificates have been acquired by a bona fide purchaser. Applicants for
      such substitute Global Warrant Certificates shall also comply with such other reasonable regulations and pay such other reasonable charges as the Company or the Warrant Agent may prescribe and as required by <font style="color: rgb(0, 0, 0);">Section




        8</font>-<a name="DocXTextRef52"></a>405 of the Uniform Commercial Code as in effect in the State of New York.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466069"></a><a name="z_Toc204470510"></a><font style="color: rgb(0, 0, 0);">Section 10.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Reservation of Warrant Shares</font>.&#160; For the purpose of enabling
      it to satisfy any obligation to issue Warrant Shares upon exercise of Warrants, the Company will, at all times through the Tranche 1 Expiration Date and the Tranche 2 Expiration Date, as applicable (or, through 5:00 p.m., New York City time, on the
      Settlement Date with respect to any Warrant Exercise Notice delivered prior to <a name="DocXTextRef54"></a>5:00 p.m., New York City time, on the Tranche 1 Expiration Date and the Tranche 2 Expiration Date, as applicable), reserve and keep available,
      free from preemptive rights and out of its aggregate authorized but unissued or treasury shares of Common Stock, shares of Common Stock equal to the number of Warrant Shares deliverable upon the exercise of all outstanding Warrants (as if no Warrants
      were exercised pursuant to a Cashless Exercise), and the transfer agent for the Company&#8217;s Common Stock (such agent, in such capacity, as may from time to time be appointed by the Company, the &#8220;<font style="font-weight: bold;">Transfer Agent</font>&#8221;)
      is hereby irrevocably authorized and directed at all times to reserve such number of authorized and unissued or treasury shares of Common Stock as shall be required for such purpose. The Company will keep a copy of this Agreement on file with such
      Transfer Agent and with every transfer agent for any Warrant Shares issuable upon the exercise of Warrants pursuant to <font style="color: rgb(0, 0, 0);">Section 7</font>. The Warrant Agent is hereby irrevocably authorized to requisition from time
      to time from such Transfer Agent stock certificates issuable upon exercise of outstanding Warrants, and the Company will supply such Transfer Agent with duly executed stock certificates for such purpose.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">The Company covenants that all Warrant Shares issued upon exercise of the Warrants will, upon issuance in accordance with the terms of this Agreement, be duly and validly issued, fully paid and nonassessable and free
      from all taxes, liens, charges and security interests created by or imposed upon the Company with respect to the issuance and holding thereof.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466070"></a><a name="z_Toc204470511"></a><font style="color: rgb(0, 0, 0);">Section 11.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Listing</font>.&#160; The Company will use reasonable best efforts to
      list the Warrants on each securities exchange or market, if any, on which the Common Stock issued by the Company has been listed.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466071"></a><a name="z_Toc204470512"></a><font style="color: rgb(0, 0, 0);">Section 12.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Adjustments and Other Rights of Warrants</font>.</div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;"><a name="z_Ref204466072"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For each of the Tranche 1 Warrants and the Tranche 2 Warrants, the applicable Exercise Price, the number of Warrant Shares issuable upon
      the exercise of each such Tranche 1 Warrant and Tranche 2 Warrant and the number of Tranche 1 Warrants and the Tranche 2 Warrants outstanding are, in each case, subject to adjustment from time to time upon the occurrence of the following:</div>
    <div style="text-indent: 36pt;">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466073"></a><font style="color: rgb(0, 0, 0);">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The issuance of Common Stock as a dividend or distribution to all holders of Common Stock, or a subdivision or
      combination of Common Stock, in which event the <a name="z_Hlk207915207"></a>applicable Exercise Price shall be adjusted based on the following formula:</div>
    <div style="margin-left: 36pt; text-indent: 36pt;">&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img02.jpg" width="114" height="39"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z37b088ba86754bc3afc2ff0791c7669c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">EP</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">
                <div>=<br>
                </div>
              </td>
              <td style="width: auto; vertical-align: top;">
                <div>the Exercise Price in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution, or immediately prior to the Open of Business on the effective date for such subdivision or combination, as
                  the case may be;</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="ze1750018957641bab623f8a7e455f5c2" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately after the Close of Business on the Record Date for such dividend or distribution, or immediately after the Open of Business on the effective date for such
                subdivision or combination, as the case may be;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z4526f7f4a874413caf2f5798d4d21050" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">OS</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such dividend, distribution, subdivision or combination, or immediately prior to
                the Open of Business on the effective date for such subdivision or combination, as the case may be; and</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z542e600b0f0943d48c11878982b5b48a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">OS<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the number of shares of Common Stock that would be outstanding immediately after, and solely as a result of, such dividend, distribution, subdivision or combination.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>Such adjustment shall become effective immediately after the Close of Business on the Record Date for such dividend or distribution, or immediately after the Open of Business on the effective date for such subdivision or combination, as the case
      may be. If any dividend or distribution or subdivision or combination of the type described in this <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font> is declared or announced but not so paid or made, the applicable Exercise Price shall
      again be adjusted to be the Exercise Price that would then be in effect if the distribution or subdivision or combination had not been declared or announced, as the case may be.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204465719"></a><font style="color: rgb(0, 0, 0);">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The issuance to all holders of Common Stock of rights or warrants entitling them for a period expiring 60 days or
      less from the date of issuance of such rights or warrants to purchase shares of Common Stock (or securities convertible into Common Stock) at less than (or having a conversion price per share less than) the Current Market Price of Common Stock, in
      which event the applicable Exercise Price will be adjusted based on the following formula:</div>
    <div>&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img03.jpg" width="143" height="39"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z08f79663496b40619091c4b3d3c41a49" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">EP</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately prior to the Close of Business on the Record Date for such issuance;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="zf28912d3716f414cb7cbf81377f8e470" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately after the Close of Business on the Record Date for such issuance;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z1d5c83a4c51248a092e4c554de514678" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">OS</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the number of shares of Common Stock outstanding immediately prior to the Close of Business on the Record Date for such issuance;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z67e143b80f8146f7b07174ee461f2393" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">X&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the total number of shares of Common Stock issuable pursuant to such rights, warrants or convertible securities; and</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="zd3f77d8d4f604655a0b3d3a7a3d3aaa6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">Y&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">= <br>
              </td>
              <td style="width: auto; vertical-align: top;">the aggregate price payable to exercise such rights, warrants or convertible securities divided by the Current Market Price.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">Such adjustment shall become effective immediately after the Close of Business on the Record Date for such issuance. In the event that the issuance of such rights, warrants or convertible securities is announced but such
      rights, warrants or convertible securities are not so issued, the applicable Exercise Price shall again be adjusted to be the Exercise Price that would then be in effect if the Record Date for such issuance had not occurred. To the extent that such
      rights or warrants are not exercised prior to their expiration or shares of Common Stock are otherwise not delivered pursuant to such rights, warrants or convertible securities, upon the expiration, termination or maturity of such rights, warrants or
      convertible securities, the applicable Exercise Price shall be readjusted to the Exercise Price that would then be in effect had the adjustments made upon the issuance of such rights, warrants or convertible securities been made on the basis of the
      delivery of only the number of shares of Common Stock actually delivered. In determining the aggregate price payable for such shares of Common Stock, there shall be taken into account any consideration received for such rights or warrants, as well as
      any consideration received in connection with the conversion of any convertible securities issued upon exercise of such rights or warrants, and the value of such consideration, if other than Cash, shall be determined in good faith by the Board of
      Directors.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204465702"></a><font style="color: rgb(0, 0, 0);">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The dividend or distribution to all holders of Common Stock of <a name="DocXTextRef57"></a>(i) shares of the
      Company&#8217;s Capital Stock (other than Common Stock), (ii) evidences of the Company&#8217;s indebtedness, (iii) rights or warrants to purchase the Company&#8217;s securities (other than Common Stock) or the Company&#8217;s assets or (iv) property or Cash, in which event
      the applicable Exercise Price will be adjusted based on the following formula:</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img04.jpg" width="163" height="39"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="zff7ef085659a4ff882376be7e1f2248d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">EP</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">= <br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="zde565bc62e2049b6a75bccffafca71d6" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately after the Close of Business on the Record Date for such dividend or distribution;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z8039dc685e194bfc981ee87feb1819ba" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">SP</font><sub style="font-variant: small-caps; vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Current Market Price; and</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z41df64a7ca114464be5a51709fe57c06" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">FMV&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">= <br>
              </td>
              <td style="width: auto; vertical-align: top;">the Market Price, on the Record Date for such dividend or distribution, of the shares of Capital Stock, evidences of indebtedness or property, rights or warrants so distributed or the amount of
                Cash expressed as an amount per share of outstanding Common Stock.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div style="text-indent: 36pt;">However, if the transaction that gives rise to an adjustment pursuant to this sub<a name="DocXTextRef58"></a>clause (c) is one pursuant to which the payment of a dividend or other distribution on Common Stock consists of
      shares of capital stock of, or similar equity interests in, a Subsidiary of the Company or other business unit of the Company (i.e., a spin-off) that are, or, when issued, will be, traded or quoted on any national or regional securities exchange or
      market, then the applicable Exercise Price will instead be adjusted based on the following formula:</div>
    <div>&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img05.jpg" width="175" height="39"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z08d998743f9142f6b8d32adb36d8e798" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=&#160; <br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately prior to the Close of Business on the Record Date for such dividend or distribution;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z7c11486bfa704d458e5c727375233244" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately after the Close of Business on the Record Date for such dividend or distribution;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z45f5b528b2fb49d589b06004eebae808" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">FMV<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the average of the Closing Sale Prices of the Capital Stock or similar equity interests distributed to holders of Common Stock applicable to one share of Common Stock over the 10 consecutive
                Trading Days commencing on, and including, the third Trading Day after the Ex-Date for such dividend or distribution; and</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z073f67629f404e3aa13fe8e976f1a4b7" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">MP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">= <br>
              </td>
              <td style="width: auto; vertical-align: top;">the average of the Closing Sale Prices of the Common Stock over the 10 consecutive Trading Days commencing on, and including, the third Trading Day after the Ex-Date for such dividend or
                distribution.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 36pt;">Such decrease shall become effective immediately after the Ex-Date for such dividend or distribution. In the event that such dividend or distribution is declared or announced but not so paid or made, the applicable
      Exercise Price shall again be adjusted to be the Exercise Price which would then be in effect if such distribution had not been declared or announced.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466074"></a><font style="color: rgb(0, 0, 0);">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; For the purposes of <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font>, (ii) and (iii), any dividend or
      distribution to which <font style="color: rgb(0, 0, 0);">Section 12(a)(iii)</font> is applicable that also includes shares of Common Stock, or rights or warrants to subscribe for or purchase shares of Common Stock (or both) to which <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font> or (ii) is applicable, shall be deemed instead to be <a name="DocXTextRef59"></a>(x) a dividend or distribution of the indebtedness, assets or shares or other property to which <font style="color: rgb(0, 0, 0);">Section 12(a)(iii)</font> applies (and any Exercise Price adjustment required by <font style="color: rgb(0, 0, 0);">Section 12(a)(iii)</font> with respect to such dividend or distribution shall be made in respect of
      such dividend or distribution) immediately followed <a name="DocXTextRef60"></a>(y) by a dividend or distribution of the shares of Common Stock or such rights or warrants to which <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font> or (ii),
      as applicable, applies (and any further Exercise Price adjustment required by <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font> or (ii) with respect to such dividend or distribution shall then be made), except, for purposes of such
      adjustment, any shares of Common Stock included in such dividend or distribution shall not be deemed &#8220;outstanding immediately prior to the Close of Business on the Record Date.&#8221;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466075"></a><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Company or any of its Subsidiaries makes a payment in respect of a tender or exchange offer for the Common
      Stock (other than an odd-lot tender offer), to the extent that the Cash and value of any other consideration included in the payment per share of the Common Stock exceeds the average of the Closing Sale Prices of the Common Stock over the 10
      consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the last date on which tenders or exchanges may be made pursuant to such tender or exchange offer, the applicable Exercise Price shall be reduced based on
      the following formula:</div>
    <div>&#160;</div>
    <div style="text-align: center;"><img src="ny20053122x2_ex4-11img06.jpg" width="208" height="40"></div>
    <div>&#160;</div>
    <div>Where:</div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="zc436ab50f3d442749beb18cae404e87b" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">= <br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately prior to the Close of Business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or
                exchange offer expires;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z396a1af751ef478ebb6ee30ea0af5865" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">EP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the Exercise Price in effect immediately after the Close of Business on the 10th Trading Day immediately following, and including, the Trading Day next succeeding the date such tender or exchange
                offer expires;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div>
      <div>
        <table id="zac2f7999aef94652add1175857718f11" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">AC&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the aggregate value of all Cash and any other consideration (as determined by the Board of Directors in good faith) paid or payable for shares of Common Stock purchased in such tender or exchange
                offer;</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z0a9688a661df4d36bc302c3aa53a9837" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;"><font style="font-variant: small-caps;">OS</font><sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">0</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the number of shares of Common Stock outstanding immediately prior to the date such tender or exchange offer expires (prior to giving effect to the purchase of all shares of Common Stock accepted
                for purchase or exchange in such tender or exchange offer);</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z1ae63ddb7d3c41599b292f14b9a41f20" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">OS<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the number of shares of Common Stock outstanding immediately after the date such tender or exchange offer expires (after giving effect to the purchase of all shares of Common Stock accepted for
                purchase or exchange in such tender or exchange offer); and</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <div>
        <table id="z0e8f96ef06714082b8ad78e47d445a31" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 45pt; vertical-align: top;">SP<sub style="vertical-align: bottom; line-height: 1; font-size: smaller;">1</sub></td>
              <td style="width: 18pt; vertical-align: top;">=<br>
              </td>
              <td style="width: auto; vertical-align: top;">the average of the Closing Sale Prices of the Common Stock over the 10 consecutive Trading Day period commencing on, and including, the Trading Day next succeeding the date such tender or exchange
                offer expires.</td>
            </tr>

        </table>
      </div>
    </div>
    <div>&#160;</div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466076"></a><font style="color: rgb(0, 0, 0);">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Recapitalizations, Reclassifications and Other Changes other than a Change of Control Transaction</font>.</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466077"></a><font style="color: rgb(0, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If any of the following events occur:</div>
    <div>&#160;</div>
    <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466078"></a><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any recapitalization;</div>
    <div style="margin-left: 81pt;">&#160;</div>
    <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466079"></a><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any reclassification or change of the outstanding shares of Common Stock (other than changes resulting from a
      subdivision or combination to which <font style="color: rgb(0, 0, 0);">Section 12(a)(i)</font> applies);</div>
    <div style="margin-left: 81pt;">&#160;</div>
    <div style="margin-left: 117pt;"><a name="z_Ref204466080"></a><font style="color: rgb(0, 0, 0);">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any consolidation, merger or combination involving the Company;</div>
    <div style="margin-left: 117pt;">&#160;</div>
    <div style="margin-left: 117pt;"><a name="z_Ref204466081"></a><font style="color: rgb(0, 0, 0);">(D)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any sale or conveyance to a third party of all or substantially all of the Company's assets; or</div>
    <div style="margin-left: 117pt;">&#160;</div>
    <div style="margin-left: 117pt;"><a name="z_Ref204466082"></a><font style="color: rgb(0, 0, 0);">(E)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any statutory share exchange,</div>
    <div>&#160;</div>
    <div>in each case, other than an event that constitutes a "Change of Control Transaction" as defined in <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font> below,</div>
    <div>&#160;</div>
    <div>(each such event a "Reorganization Event"), in each case as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including Cash or any combination thereof) (the "Reference
      Property"), then following the effective time of the transaction, the right to receive shares of Common Stock upon exercise of a Warrant shall be changed to a right to receive, upon exercise of such Warrant, the kind and amount of shares of stock,
      other securities or other property or assets (including Cash or any combination thereof) that a holder of one share of Common Stock would have owned or been entitled to receive in connection with such Reorganization Event (such kind and amount of
      Reference Property per share of Common Stock, a "Unit of Reference Property"). In the event holders of Common Stock have the opportunity to elect the form of consideration to be received in a Reorganization Event, the type and amount of consideration
      into which the Warrants shall be exercisable from and after the effective time of such Reorganization Event shall be deemed to be the weighted average of the types and amounts of consideration received by the holders of Common Stock in such
      Reorganization Event.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466083"></a><font style="color: rgb(0, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;At any time from, and including, the effective time of a Reorganization Event:</div>
    <div>&#160;</div>
    <div style="text-indent: 117pt;"><a name="z_Ref204466084"></a><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each share of Common Stock per Warrant shall be equal to a single Unit of Reference Property; and</div>
    <div style="text-indent: 117pt;">&#160;</div>
    <div style="text-indent: 117pt;"><a name="z_Ref204466085"></a><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Closing Sale Price and the Current Market Price shall be calculated with respect to a Unit of Reference Property.</div>
    <div>&#160;</div>
    <div style="text-indent: 81pt;"><a name="z_Ref204466086"></a><font style="color: rgb(0, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The value of a Unit of Reference Property (the "Unit Value") shall be determined as follows:</div>
    <div style="text-indent: 81pt;">&#160;</div>
    <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466087"></a><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any shares of common stock of the successor or purchasing Person or any other Person that are traded on a national or
      regional stock exchange included in such Unit of Reference Property shall be valued as if such shares were "Common Stock" using procedures set forth in the definition of "Closing Sale Price";</div>
    <div style="margin-left: 81pt; text-indent: 36pt;">&#160;</div>
    <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466088"></a><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any other property (other than Cash) included in such Unit of Reference Property shall be valued in good faith by the
      Board of Directors (in a manner not materially inconsistent with the manner the Board of Directors valued such property for purposes of the Reorganization Event, if applicable) or by a firm selected by the Board of Directors; and</div>
    <div>&#160;</div>
    <div style="text-indent: 117pt;"><a name="z_Ref204466089"></a><font style="color: rgb(0, 0, 0);">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any Cash included in such Unit of Reference Property shall be valued at the amount thereof.</div>
    <div>&#160;</div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466090"></a><font style="color: rgb(0, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On or prior to the effective time of any Reorganization Event, the Company or the successor or purchasing Person, as
      the case may be, shall execute an amendment to this Warrant Agreement providing that the Warrants shall be exercisable for Units of Reference Property in accordance with the terms of this <font style="color: rgb(0, 0, 0);">Section 12(a)(vi)</font>.
      If the Reference Property in connection with any Reorganization Event includes shares of stock or other securities and assets of a Person other than the successor or purchasing Person, as the case may be, in such Reorganization Event, then the
      Company shall cause such amendment to this Warrant Agreement to be executed by such other Person and such amendment shall contain such additional provisions to protect the interests of the Warrantholders as the Board of Directors shall reasonably
      consider necessary by reason of the foregoing. Any such amendment to this Warrant Agreement shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this <font style="color: rgb(0, 0, 0);">Section 12</font>. In the event the Company shall execute an amendment to this Warrant Agreement pursuant to this <font style="color: rgb(0, 0, 0);">Section 12(a)(vi)</font>, the Company shall promptly file with the Warrant Agent a
      certificate executed by a duly authorized officer of the Company briefly stating the reasons therefor, the kind or amount of Cash, securities or property or asset that will comprise a Unit of Reference Property after the relevant Reorganization
      Event, any adjustment to be made with respect thereto and that all conditions precedent have been complied with. The Company shall cause notice of the execution of amendment to be mailed to each Warrantholder, at its address appearing on the Warrant
      Register, within 20 Business Days after execution thereof. Failure to deliver such notice shall not affect the legality or validity of such amendment.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-size: 8pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
    </div>
    <div style="margin-left: 36pt; text-indent: 45pt;"><font style="color: rgb(0, 0, 0);">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160; [<font style="font-style: italic;">Reserved</font>.]</div>
    <div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466092"></a><font style="color: rgb(0, 0, 0);">(viii)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Other Action Affecting Common Stock Equivalents</font>. If the Company shall at
        any time and from time to time issue or sell <a name="DocXTextRef73"></a>(i) any shares of any class constituting Common Stock Equivalents other than shares of Common Stock, (ii) any evidences of its indebtedness, shares of stock or other
        securities which are convertible into or exchangeable for Common Stock Equivalents, with or without the payment of additional consideration in Cash or property or (iii) any warrants or other rights to subscribe for or purchase any such Common Stock
        Equivalents or any such evidences, shares of stock or other securities, then in each such case such issuance shall be deemed to be of, or in respect of, the underlying shares of Common Stock for purposes of this <font style="color: rgb(0, 0, 0);">Section
          12(a)</font>.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466093"></a><font style="color: rgb(0, 0, 0);">(ix)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Adjustments to Number of Warrants</font>. Concurrently with any adjustment to the
        Exercise Price for the Tranche 1 Warrants or Tranche 2 Warrants under this <font style="color: rgb(0, 0, 0);">Section 12(a)</font> (including any deemed adjustment pursuant to <font style="color: rgb(0, 0, 0);">Section 12(a)(xii)</font>), the
        number of Warrant Shares for which each Tranche 1 Warrant or Tranche 2 Warrant, as the case may be, is exercisable will be adjusted such that the number of Warrant Shares for each Tranche 1 Warrant or Tranche 2 Warrant, as the case may be, in
        effect immediately following the effectiveness of such adjustment will be equal to the number of Warrant Shares for each such Tranche 1 Warrant or Tranche 2 Warrant, as the case may be, in effect immediately prior to such adjustment, <font style="font-style: italic;">multiplied by</font> a fraction, <a name="DocXTextRef75"></a>(i) the numerator of which is the applicable Exercise Price in effect immediately prior to such adjustment and (ii) the denominator of which is the
        applicable Exercise Price in effect immediately following such adjustment.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466094"></a><font style="color: rgb(0, 0, 0);">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Deferral or Exclusion of Certain Adjustments</font>. No adjustment to the
        Exercise Price for the Tranche 1 Warrants or Tranche 2 Warrants, or number of Warrant Shares for each Tranche 1 Warrant or Tranche 2 Warrant, shall be required hereunder unless such adjustment, together with other adjustments carried forward as
        provided below, would result in an increase or decrease of at least one percent (1%) of the applicable Exercise Price or Warrant Shares; <font style="font-style: italic;">provided</font> that any adjustments which by reason of this <font style="color: rgb(0, 0, 0);">Section 12(a)(x)</font> are not required to be made shall be carried forward and taken into account in any subsequent adjustment. No adjustment need be made for a change in the par value of the shares of Common Stock
        or any other Common Stock Equivalents. All calculations under this <font style="color: rgb(0, 0, 0);">Section 12(a)(x)</font> shall be made to the nearest one-one thousandth (1/1,000th) of one cent ($0.01) or to the nearest one-one thousandth
        (1/1,000th) of a share, as the case may be.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466095"></a><font style="color: rgb(0, 0, 0);">(xi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Restrictions on Adjustments</font>. In no event will the Company adjust the
        Exercise Price for the Tranche 1 Warrants or Tranche 2 Warrants, or make a corresponding adjustment to the number of Warrant Shares for any such Warrant, to the extent that the adjustment would reduce the applicable Exercise Price below the par
        value per share of Common Stock. No adjustment shall be made to the applicable Exercise Price or Warrant Shares for any Warrant for any of the transactions described in this <font style="color: rgb(0, 0, 0);">Section 12(a)</font> if the Company
        makes provisions for holders of the Warrants to participate in any such transaction without exercising their Warrants on the same basis as holders of Common Stock and with notice that the Board of Directors determines in good faith to be fair and
        appropriate. If the Company takes a record of the holders of Common Stock for the purpose of entitling them to receive a dividend or other distribution, and thereafter (and before the dividend or distribution has been paid or delivered to
        stockholders) legally abandons its plan to pay or deliver such dividend or distribution, then thereafter no adjustment to any Exercise Price or the number of Warrant Shares for any Warrant then in effect shall be required by reason of the taking of
        such record.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466096"></a><font style="color: rgb(0, 0, 0);">(xii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Certain Calculations</font>. For the purposes of any adjustment of the Exercise
        Prices and the number of Warrant Shares issuable upon exercise of a Warrant pursuant to this <font style="color: rgb(0, 0, 0);">Section 12(a)</font>, the following provisions shall be applicable:</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466097"></a><font style="color: rgb(0, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the case of the issuance or sale of shares of Common Stock for cash, the amount of the consideration received by
        the Company shall be deemed to be the amount of the gross cash proceeds received by the Company for such securities before deducting therefrom any discounts or commissions allowed, paid or incurred by the Company for any underwriting or otherwise
        in connection with the issuance and sale thereof.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466098"></a><font style="color: rgb(0, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the case of the issuance or sale of shares of Common Stock (other than upon the conversion of shares of capital
        stock or other securities of the Company) for consideration in whole or in part other than cash, including securities acquired in exchange therefor (other than securities by their terms so exchangeable), the consideration other than cash shall be
        deemed to be the Market Price, before deducting therefrom any discounts or commissions allowed, paid or incurred by the Company for any underwriting or otherwise in connection with the issuance and sale thereof.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466099"></a><font style="color: rgb(0, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the case of the issuance of options, warrants or other rights to purchase or acquire shares of Common Stock
        (whether or not at the time exercisable):</div>
      <div>&#160;</div>
      <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466100"></a><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the aggregate maximum number of shares of Common Stock deliverable upon exercise of such options, warrants or other
        rights to purchase or acquire shares of Common Stock shall be deemed to have been issued at the time such options, warrants or rights are issued and for a consideration equal to the consideration (determined in the manner provided in this <font style="color: rgb(0, 0, 0);">Section 12(a)(xii)</font>), if any, received by the Company upon the issuance or sale of such options, warrants or rights <font style="font-style: italic;">plus</font> the minimum purchase price required to be paid
        to the Company pursuant to the terms of such options, warrants or rights in exchange for the shares of Common Stock covered thereby;</div>
      <div style="text-indent: 54pt; margin-left: 72pt;"> <br>
      </div>
      <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466101"></a><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Exercise Price and the number of shares of Common Stock issuable upon exercise of a Warrant shall have been
        duly adjusted in accordance with the terms of this Warrant Agreement upon the issuance or sale of any such options, warrants or rights, no further adjustment of the applicable Exercise Price or the number of shares of Common Stock issuable upon
        exercise of such Warrant shall be made for the actual issuance of shares of Common Stock upon the exercise, conversion or exchange thereof.</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466102"></a><font style="color: rgb(0, 0, 0);">(xiii)</font>&#160;&#160;&#160;&#160;&#160; In the event of a cash exercise, the Company hereby instructs the Warrant Agent to record the cost basis for newly
        issued shares of Common Stock in a manner to be subsequently communicated by the Company in writing to the Warrant Agent.&#160; In the event of a Cashless Exercise, the Company shall provide the cost basis for newly issued shares of Common Stock to the
        Warrant Agent at the same time that the Company provides the Warrant Agent the number of shares of Common Stock to be issued pursuant to such Cashless Exercise.</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466103"></a><font style="color: rgb(0, 0, 0);">(xiv)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Change of Control Transactions.</font></div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466104"></a><font style="color: rgb(0, 0, 0);">(1)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event the Company shall, at any time or from time to time after the Issue Date while the Tranche 1 Warrants
        or Tranche 2 Warrants remain outstanding and unexpired in whole or in part, consummate a Change of Control Transaction, Tranche 1 Warrant and Tranche 2 Warrant shall be automatically redeemed, effective upon the date of consummation of such Change
        of Control Transaction (after which such Warrant shall be void and may no longer be exercised), and each Warrantholder of a Warrant so redeemed shall be entitled, following consummation of the Change of Control Transaction and compliance by such
        Warrantholder with the Change of Control Transaction Notice Procedures, for each Tranche 1 Warrant or Tranche 2 Warrant, as the case may be, held by such Warrantholder upon the redemption thereof, to receive:</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466105"></a><font style="color: rgb(0, 0, 0);">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Change of Control Consideration shall consist in whole or in part of Cash Consideration, in respect of the
        Cash Consideration on the earlier of <a name="DocXTextRef83"></a>(x) the date on which holders of Common Stock receive such Cash Consideration or <a name="DocXTextRef84"></a>(y) within twenty-five (25) days of the consummation of such Change of
        Control Transaction, an amount of cash equal to the Black-Scholes Value for the Tranche 1 Warrants or Tranche 2 Warrants, as the case may be, <font style="font-style: italic;">multiplied by</font> the Cash Consideration Percentage;</div>
      <div style="margin-left: 81pt; text-indent: 36pt;">&#160;</div>
      <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466106"></a><font style="color: rgb(0, 0, 0);">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Change of Control Consideration shall consist in whole or in part of Other Consideration on the earlier of <a name="DocXTextRef85"></a>(x) the date on which holders of shares of Common Stock receive Other Consideration or <a name="DocXTextRef86"></a>(y) within twenty-five (25) days of the consummation of such Change of Control Transaction, an amount of
        cash equal to the product of the Black-Scholes Value for the Tranche 1 Warrants or Tranche 2 Warrants, as the case may be, <font style="font-style: italic;">multiplied by</font> the Other Consideration Percentage; and/or</div>
      <div style="margin-left: 81pt; text-indent: 36pt;">&#160;</div>
      <div style="margin-left: 81pt; text-indent: 36pt;"><a name="z_Ref204466107"></a><font style="color: rgb(0, 0, 0);">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Change of Control Consideration shall consist in whole or in part of Stock Consideration, upon consummation
        of such Change of Control Transaction, in respect of the Stock Consideration, a New Tranche 1 Warrant or New Tranche 2 Warrant, as the case may be, exercisable for a number of shares of the Stock Consideration equal to <a name="DocXTextRef87"></a>(i)
        the applicable Warrant Shares, <font style="font-style: italic;">multiplied by</font> (ii) the Stock Consideration Percentage, <font style="font-style: italic;">multiplied by</font> (iii) the Exchange Ratio, with such New Tranche 1 Warrant or New
        Tranche 2 Warrant, as the case may be, having an exercise price equal to the applicable Exercise Price in effect immediately prior to the consummation of the Change of Control Transaction <font style="font-style: italic;">divided by</font> the
        Exchange Ratio, and otherwise having terms substantially the same as the terms of the for the Tranche 1 Warrants or Tranche 2 Warrants, as the case may be, <font style="font-style: italic;">mutatis mutandis</font>.</div>
      <div>&#160;</div>
      <div>In this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font>, the following terms shall have the meanings set forth below:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Black-Scholes Value</font>&#8221; means, in respect of any Tranche 1 Warrant or Tranche 2 Warrant, the value of such Warrant immediately prior to the date of the public announcement of the
        applicable Change of Control Transaction, as determined by the Board of Directors, in good faith, based upon the advice of a Calculation Agent, and shall be determined by customary investment banking practices using the Black-Scholes Option Pricing
        Model obtained from the &#8220;OVME&#8221; function on Bloomberg. For purposes of calculating such amount, <a name="DocXTextRef104"></a>(i) the term of the applicable Warrant will be the time from the date of consummation of the applicable Change of Control
        Transaction to the Expiration Date for such Warrant and the exercise price shall be the then applicable Exercise Price for such Warrant, (ii) the assumed volatility will be the lower of <a name="DocXTextRef105"></a>(a) sixty percent (60%) and <a name="DocXTextRef106"></a>(b) the six-month historical volatility of the Common Stock as of the date immediately prior to the date of the public announcement of the applicable Change of Control Transaction (or such shorter period that is
        available if the Common Stock has not been trading for such entire time period) as shown at the time of determination using the &#8220;HVT&#8221; function on Bloomberg or, if such information is not available, as determined in a commercially reasonable manner
        by the Board of Directors upon the advice of such Calculation Agent, (iii) the assumed risk-free rate will equal the interpolated rate on U.S. Treasury securities having a maturity nearest to but not later than the applicable Expiration Date, (iv)
        a zero cost of borrow, <a name="DocXTextRef107"></a>(v) the dividend yield will equal the dividend yield as generated from Bloomberg, and (vi) the price of each share of Common Stock will be the sum of <a name="DocXTextRef108"></a>(a) the amount
        of the Cash Consideration (if any) <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef109"></a>(b) the Market Price of the Stock Consideration (if any) <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef110"></a>(c)
        the Market Price of the Other Consideration (if any) being offered in respect of each outstanding share of Common Stock pursuant to the Change of Control Transaction, in each case measured at the time of the public announcement of such Change of
        Control Transaction.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Calculation Agent</font>&#8221; means any nationally recognized investment banking firm as selected reasonably, in good faith, by the Board of Directors.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Cash Consideration</font>&#8221; means the cash, if any, that a holder of Common Stock receives or is entitled to receive in a Change of Control Transaction with respect to or in exchange
        for each share of Common Stock held by such holder immediately prior to the consummation of the Change of Control Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Cash Consideration Percentage</font>&#8221; means, with respect to any Change of Control Consideration, a fraction expressed as a percentage equal to the <a name="DocXTextRef90"></a>(i) the
        amount of the Cash Consideration <font style="font-style: italic;">divided by</font> (ii) the sum of <a name="DocXTextRef91"></a>(x) the amount of the Cash Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef92"></a>(y)
        the Market Price of the Stock Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef93"></a>(z) the Market Price of the Other Consideration, in each case measured at the time of announcement of such Change of Control
        Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Change of Control Transaction</font>&#8221; means the occurrence of any of the following: <a name="DocXTextRef94"></a>(i) the sale, lease, transfer, conveyance or other disposition (other
        than by way of merger, amalgamation or consolidation), in one or a series of related transactions, of all or substantially all of the assets of the Company and its Subsidiaries taken as a whole to any Person or (ii) the consummation of any purchase
        offer, tender offer or exchange offer, or the Company consummates a stock or share purchase agreement or other business combination (including any merger or consolidation) the result of which is that any Person becomes the beneficial owner,
        directly or indirectly, of more than 50% of the voting stock of the Company, measured by voting power rather than number of shares.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Change of Control Consideration</font>&#8221; means the cash, stock, securities or other assets or property (or any combination thereof) that a holder of shares of Common Stock receives or
        is entitled to receive with respect to or in exchange for each share of Common Stock held by such holder upon consummation of a Change of Control Transaction; <font style="font-style: italic;">provided</font> that if in the applicable Change of
        Control Transaction the holders of shares of Common Stock may make an election with respect to the consideration to be received, the type and amount of consideration into which the Warrants shall be exercisable from and after the effective time of
        such Change of Control Transaction shall be deemed to be the weighted average of the types and amounts of consideration received by the holders of shares of Common Stock in such Change of Control Transaction.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Change of Control Notice Procedures</font>&#8221; means the Company&#8217;s delivery of written notice to holders of Warrants, including owners of beneficial interests in Global Warrant
        Certificates, setting forth any action to be taken by the Company that may constitute a Change of Control Transaction, the resulting effect of such action on the Tranche 1 Warrants or Tranche 2 Warrants, as the case may be, and the amount of cash
        and/or the number and kind of securities or other property to be received by the holders of such Warrants pursuant to such Change of Control Transaction (if any). Such notice shall be delivered by the Company (including by directing the Warrant
        Agent to so deliver such notice) to holders of Warrants at such holders&#8217; addresses appearing on the Warrant Register (and with respect to owners of beneficial interests in Global Warrant Certificates, to the Depository), and shall be delivered on a
        date calculated and by a method chosen by the Company to reasonably ensure that such notice shall be actually received by the Holders of Warrants as promptly as practicable and in any event the Company shall use commercially reasonable efforts to
        deliver such notice to the Holders of Warrants at least twenty (20) days prior to the consummation of the Change of Control Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Exchange Ratio</font>&#8221; means <a name="DocXTextRef95"></a>(i) the number of shares of common stock, ordinary shares or other units of common equity, if any, in each case listed on a
        U.S. national securities exchange, of the issuer or payor of the Stock Consideration in the Change of Control Transaction as set forth in the definitive agreement for such Change of Control Transaction offered for each one share of Common Stock, <font style="font-style: italic;">divided by</font> (ii) the Stock Consideration Percentage.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">New Tranche 1 Warrant</font>&#8221; and &#8220;<font style="font-weight: bold;">New Tranche 2 Warrant</font>&#8221; mean a warrant issued by the Person that is the issuer or payor of the Stock
        Consideration in the Change of Control Transaction, as the case may be, in place of a Tranche 1 Warrant or Tranche 2 Warrant, as the case may be.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Other Consideration</font>&#8221; means the Change of Control Consideration other than Cash Consideration or Stock Consideration that a holder of shares of Common Stock receives or is
        entitled to receive in a Change of Control Transaction with respect to or in exchange for each share of Common Stock held by such holder immediately prior to the consummation of the Change of Control Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Other Consideration Percentage</font>&#8221; means, with respect to any Change of Control Consideration, a fraction expressed as a percentage equal to <a name="DocXTextRef96"></a>(i) the
        Market Price of the Other Consideration <font style="font-style: italic;">divided by</font> (ii) the sum of <a name="DocXTextRef97"></a>(x) the amount of the Cash Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef98"></a>(y) the Market Price of the Stock Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef99"></a>(z) the Market Price of the Other Consideration, if any, in each case measured at the time of
        announcement of such Change of Control Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company,
        government (or an agency or subdivision thereof) or other entity of any kind.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Stock Consideration</font>&#8221; means the number of shares of common stock, ordinary shares or other units of common equity, if any, in each case listed on a U.S. national securities
        exchange, that a holder of Common Stock receives or is entitled to receive in a Change of Control Transaction with respect to or in exchange for each share of Common Stock held by such holder immediately prior to the consummation of the Change of
        Control Transaction.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Stock Consideration Percentage</font>&#8221; means, with respect to any Change of Control Consideration, a fraction expressed as a percentage equal to <a name="DocXTextRef100"></a>(i) the
        Market Price of the Stock Consideration <font style="font-style: italic;">divided by</font> (ii) the sum of <a name="DocXTextRef101"></a>(x) the amount of the Cash Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef102"></a>(y) the Market Price of the Stock Consideration <font style="font-style: italic;">plus</font>&#160;<a name="DocXTextRef103"></a>(z) the Market Price of the Other Consideration, in each case measured at the time of
        announcement of such Change of Control Transaction.</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466108"></a><font style="color: rgb(0, 0, 0);">(2)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If in any Change of Control Transaction a holder of shares of Common Stock shall be entitled to make an election to
        receive Cash Consideration, Stock Consideration or Other Consideration, or a combination thereof, with respect to each share of Common Stock Share held by such holder, for purposes of this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font>,
        the holder shall be deemed to receive or be entitled to receive for each such share of Common Stock the aggregate amount of Cash Consideration, Stock Consideration or Other Consideration, or combination thereof, received or receivable by all
        holders of shares of Common Stock<font style="font-style: italic;"> divided by</font> the total number of shares of Common Stock outstanding immediately prior to consummation of the Change of Control Transaction.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466109"></a><font style="color: rgb(0, 0, 0);">(3)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall take such steps in connection with any Change of Control Transaction as may be necessary to
        assure that the provisions hereof shall be complied with (including the adjustment provisions of this <font style="color: rgb(0, 0, 0);">Section 12</font>), and shall not effect or otherwise participate in any Change of Control Transaction unless,
        prior to the consummation thereof, the surviving Person (if other than the Company) resulting from such Change of Control Transaction, shall assume, by written instrument substantially similar in form and substance to this Agreement in all material
        respects (including with respect to the provisions of this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font>) and the obligation to distribute any New Tranche 1 Warrants or New Tranche 2 Warrants, or make any cash payments to the
        Holders of the Warrants, in accordance with this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font>.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466110"></a><font style="color: rgb(0, 0, 0);">(4)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font> shall similarly apply to
        successive Change of Control Transactions.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div style="margin-left: 36pt; text-indent: 45pt;"><a name="z_Ref204466111"></a><font style="color: rgb(0, 0, 0);">(5)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of this <font style="color: rgb(0, 0, 0);">Section 12(a)(xiv)</font> are subject, in all cases, to
        any applicable requirements under the Securities Act and the rules and regulations promulgated thereunder, in each case to the extent applicable to holders of shares of Common Stock in connection with the Change of Control Transaction.</div>
      <div style="margin-left: 36pt; text-indent: 45pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466149"></a><a name="z_Toc204470513"></a><font style="color: rgb(0, 0, 0);">Section 13.</font>&#160;&#160;&#160; <font style="font-style: italic;">No Fractional Shares</font>.&#160; The Company shall not be required to
        issue Warrants to purchase fractions of Warrant Shares, or to issue fractions of Warrant Shares upon exercise of the Warrants, or to distribute certificates which evidence fractional Warrant Shares and no Cash shall be distributed in lieu of such
        fractional shares or rights. If more than one Warrant shall be presented for exercise in full at the same time by the same Warrantholder, the number of full Warrant Shares which shall be issuable upon the exercise thereof shall be computed on the
        basis of the aggregate number of Warrant Shares purchasable on exercise of the Warrants so presented. If any fraction of a share would, except for the provisions of this <font style="color: rgb(0, 0, 0);">Section 13</font>, be issuable on the
        exercise of any Warrants (or specified portion thereof), as applicable, such share shall be rounded to the next higher whole number.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466150"></a><a name="z_Toc204470514"></a><font style="color: rgb(0, 0, 0);">Section 14.</font>&#160;&#160;&#160; <font style="font-style: italic;">Redemption</font>.&#160; The Warrants shall not be redeemable by the
        Company or any other Person, other than as specified herein.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466151"></a><a name="z_Toc204470515"></a><font style="color: rgb(0, 0, 0);">Section 15.</font>&#160;&#160;&#160; <font style="font-style: italic;">Notices to Warrantholders</font>.&#160; Upon any adjustment of an
        Exercise Price or the number of Warrant Shares purchasable upon exercise of each Warrant, the Company, within ten (10) Business Days thereafter, shall <a name="DocXTextRef168"></a>(x) cause to be filed with the Warrant Agent a certificate signed
        by an Appropriate Officer of the Company setting forth the event giving rise to such adjustment and any new or amended exercise terms, including the applicable Exercise Price and either the number of Warrant Shares purchasable upon exercise of each
        Warrant or the additional number of Warrants to be issued for each previously outstanding Warrant, as the case may be, after such adjustment and setting forth the method of calculation, which certificate shall be conclusive evidence of the
        correctness of the matters set forth therein, and <a name="DocXTextRef169"></a>(y) direct the Warrant Agent to give written notice thereof to each of the Warrantholders at such Warrantholder&#8217;s address appearing on the Warrant Register. Where
        appropriate, such notice may be given in advance and included as a part of the notice required to be mailed under the other provisions of this <font style="color: rgb(0, 0, 0);">Section 15</font>. The Warrant Agent shall have no obligation under
        any <a name="DocXTextRef171"></a>Section of this Agreement to determine whether such an adjustment event has occurred or to calculate any of the adjustments set forth herein. The Warrant Agent shall be fully protected in relying on any such
        certificate and in making any adjustment described therein and shall have no duty with respect to, and shall not be deemed to have knowledge of, any adjustment unless and until it shall have received such a certificate, in each case, absent gross
        negligence, bad faith or willful misconduct (each as determined by a final non-appealable order, judgment, ruling or decree of a court of competent jurisdiction).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">If:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466152"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; the Company proposes to take any action that would require an adjustment pursuant to <font style="color: rgb(0, 0, 0);">Section 12</font>;
        or</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466153"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; there shall be a dissolution, liquidation or winding up of the Company (other than in connection with a consolidation, merger or sale of
        all or substantially all of its property, assets and business as an entirety), then the Company shall (i) cause written notice of such event to be filed with the Warrant Agent and (ii) use commercially reasonable efforts to the extent permissible
        and practicable to cause written notice of such event to be given to each of the Warrantholders at such Warrantholder&#8217;s address appearing on the Warrant Register at least twenty (20) days prior to the effective date of such action (or at least ten
        (10) days prior to the applicable Record Date for such action if earlier). Notwithstanding the foregoing, it shall be sufficient for the Company to notify Warrantholders if it files or furnishes a Form 8-K to the SEC (if applicable) or publishes a
        press release. Such notice shall specify the proposed effective date of such action and, if applicable, the Record Date and the material terms of such action. The failure to give the notice required by this <font style="color: rgb(0, 0, 0);">Section
          15</font> or any defect therein shall not affect the legality or validity of any action, distribution, right, warrant, dissolution, liquidation or winding up or the vote upon or any other action taken in connection therewith.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466154"></a><a name="z_Toc204470516"></a><font style="color: rgb(0, 0, 0);">Section 16.</font>&#160;&#160;&#160; <font style="font-style: italic;">Merger, Consolidation or Change of Name of Warrant Agent</font>.&#160;
        Any Person into which the Warrant Agent may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, conversion or consolidation to which the Warrant Agent is a party, or any Person succeeding to the
        shareholder services business of the Warrant Agent or any successor Warrant Agent, shall be the successor to the Warrant Agent hereunder without the execution or filing of any document or any further act on the part of any of the parties hereto, if
        such Person would be eligible for appointment as a successor Warrant Agent under the provisions of <font style="color: rgb(0, 0, 0);">Section 18</font>. If any of the Global Warrant Certificates have been countersigned but not delivered at the
        time such successor to the Warrant Agent succeeds under this Agreement, any such successor to the Warrant Agent may adopt the countersignature of the original Warrant Agent; and if at that time any of the Global Warrant Certificates shall not have
        been countersigned, any successor to the Warrant Agent may countersign such Global Warrant Certificates either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all such cases such Global Warrant
        Certificates shall have the full force provided in the Global Warrant Certificates and in this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">If at any time the name of the Warrant Agent is changed and at such time any of the Global Warrant Certificates have been countersigned but not delivered, the Warrant Agent whose name has changed may adopt the
        countersignature under its prior name; and if at that time any of the Global Warrant Certificates have not been countersigned, the Warrant Agent may countersign such Global Warrant Certificates either in its prior name or in its changed name; and
        in all such cases such Global Warrant Certificates shall have the full force provided in the Global Warrant Certificates and in this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466155"></a><a name="z_Toc204470517"></a><font style="color: rgb(0, 0, 0);">Section 17.</font>&#160;&#160;&#160; <font style="font-style: italic;">Warrant Agent</font>.&#160; The Warrant Agent undertakes only the duties
        and obligations expressly imposed by this Agreement and the Global Warrant Certificates, in each case upon the following terms and conditions, by all of which the Company and the Warrantholders, by their acceptance thereof, shall be bound:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466156"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160; The statements and recitals contained herein and in the Global Warrant Certificates shall be taken as statements of the Company, and the
        Warrant Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Global Warrant Certificates or be required to verify the same (except as to its countersignature on such Global
        Warrant Certificates). Except as expressly provided herein, the Warrant Agent assumes no responsibility with respect to the execution, delivery or distribution of the Global Warrant Certificates.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466157"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall not be responsible for any failure of the Company to comply with any of the covenants contained in this Agreement
        or in the Global Warrant Certificates to be complied with by the Company, nor shall it at any time be under any duty or responsibility to any Warrantholder to make or cause to be made any adjustment in the Exercise Price or in the number of
        Warrants Shares any Warrant is exercisable for (except as instructed in writing by the Company), or to determine whether any facts exist that may require any such adjustments, or with respect to the nature or extent of or method employed in making
        any such adjustments when made.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466158"></a><font style="color: rgb(0, 0, 0);">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent may consult at any time with counsel satisfactory to it (who may be counsel for the Company or an employee of the
        Warrant Agent), and the advice or opinion of such counsel will be full and complete authorization and protection to the Warrant Agent as to any action taken, suffered or omitted by it in accordance with such advice or opinion, absent gross
        negligence, bad faith or willful misconduct in the selection and continued retention of such counsel and the reliance on such counsel&#8217;s advice or opinion (each as determined by a final non-appealable order, judgment, ruling or decree of a court of
        competent jurisdiction).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466159"></a><font style="color: rgb(0, 0, 0);">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall be authorized and protected and shall incur no liability or responsibility to the Company or to any Warrantholder
        for any action taken, suffered or omitted to be taken by it in reliance on any written notice, resolution, waiver, consent, order, certificate or other paper, document or instrument believed by it to be genuine and to have been signed, sent or
        presented by the proper party or parties<font style="font-weight: bold;">. </font>The Warrant Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Warrant Agent shall be
        fully protected and shall incur no liability for failing to take action in connection therewith unless and until it has received such notice in writing. The Warrant Agent shall not take any instructions or directions except those given in
        accordance with this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466160"></a><font style="color: rgb(0, 0, 0);">(e)</font>&#160;&#160;&#160; &#160;&#160; The Company agrees to pay to the Warrant Agent reasonable compensation for all services rendered by the Warrant Agent under this
        Agreement in accordance with a fee schedule to be mutually agreed upon, to reimburse the Warrant Agent upon demand for all reasonable and documented out-of-pocket expenses, including counsel fees and other disbursements, incurred by the Warrant
        Agent in the preparation, negotiation, administration, delivery, execution and amendment of this Agreement and the exercise and performance of its duties under this Agreement and to indemnify the Warrant Agent and save it harmless against any and
        all losses, liabilities and expenses, including judgments, damages, fines, penalties, claims, demands and costs (including reasonable out-of-pocket counsel fees and expenses), for anything done or omitted by the Warrant Agent arising out of or in
        connection with this Agreement except as a result of its gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable order, judgment, ruling or decree of a court of competent jurisdiction). The costs and expenses
        incurred by the Warrant Agent in enforcing the right to indemnification shall be paid by the Company except to the extent that the Warrant Agent is not entitled to indemnification due to its gross negligence, bad faith or willful misconduct (each
        as determined by a final non-appealable order, judgment, ruling or decree of a court of competent jurisdiction). Notwithstanding the foregoing, the Company shall not be responsible for any settlement made without its written consent; <font style="font-style: italic;">provided</font> that nothing in this sentence shall limit the Company&#8217;s obligations contained in this paragraph other than pursuant to such a settlement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466161"></a><font style="color: rgb(0, 0, 0);">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall be under no obligation to institute any action, suit or legal proceeding or to take any other action likely to
        involve expense or liability, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Company. All rights of
        action under this Agreement or under any of the Warrants may be enforced by the Warrant Agent without the possession of any of the Warrants or the production thereof at any trial or other proceeding relative thereto, and any such action, suit or
        proceeding instituted by the Warrant Agent shall be brought in its name as Warrant Agent, and any recovery or judgment shall be for the ratable benefit of the Warrantholders, as their respective rights or interests may appear.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466162"></a><font style="color: rgb(0, 0, 0);">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent, and any member, stockholder, affiliate, director, officer or employee thereof, may buy, sell or deal in any of the
        Warrants or other securities of the Company or become pecuniarily interested in any transaction in which the Company is interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it was not the Warrant
        Agent under this Agreement, or a member, stockholder director, officer or employee of the Warrant Agent, as the case may be. Nothing herein shall preclude the Warrant Agent from acting in any other capacity for the Company or for any other legal
        entity.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466163"></a><font style="color: rgb(0, 0, 0);">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall act hereunder solely as agent for the Company, and its duties shall be determined solely by the provisions
        hereof. The Warrant Agent shall not be liable for anything that it may do or refrain from doing in connection with this Agreement except in connection with its own gross negligence, bad faith or willful misconduct (each as determined by a final
        non-appealable order, judgment, ruling or decree of a court of competent jurisdiction). Notwithstanding anything in this Agreement to the contrary, in no event will the Warrant Agent be liable for special, indirect, incidental, punitive or
        consequential loss or damage of any kind whatsoever (including, but not limited to, lost profits), even if the Warrant Agent has been advised of the possibility of such loss or damage and regardless of the form of the action.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466164"></a><font style="color: rgb(0, 0, 0);">(i)</font> &#160; &#160;&#160; &#160; The Company agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered
        all such further and other acts, instruments and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466165"></a><font style="color: rgb(0, 0, 0);">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall not be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof
        (except the due and validly authorized execution hereof by the Warrant Agent) or in respect of the validity or execution of any Global Warrant Certificate (except its due and validly authorized countersignature thereof), nor shall the Warrant Agent
        by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of the Warrant Shares to be issued pursuant to this Agreement or any Warrant or as to whether the Warrant Shares will when issued be
        validly issued, fully paid and nonassessable or as to the Exercise Price or the number of Warrant Shares a Warrant is exercisable for. The Warrant Agent shall not at any time be under any duty or responsibility to any Holder to determine whether
        any facts exist that may require an adjustment, or the calculation of any adjustments or any amounts due in connection with any exercise of the Warrants. Provided the Warrant Agent has performed its duties as soon as commercially practicable, the
        Warrant Agent shall not be liable for the Company&#8217;s failure to timely deliver shares of Common Stock pursuant to the terms of the Warrants, nor shall the Warrant Agent be liable for any damages associated therewith.</div>
      <div style="text-indent: 36pt;">&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466166"></a><font style="color: rgb(0, 0, 0);">(k)</font>&#160;&#160;&#160;&#160;&#160; Whenever in the performance of its duties under this Agreement the Warrant Agent deems it necessary or desirable that any fact or matter
        be proved or established by the Company prior to taking, suffering or omitting to take any action hereunder, the Warrant Agent is hereby authorized and directed to accept instructions with respect to the performance of its duties hereunder from an
        Appropriate Officer of the Company and to apply to such Appropriate Officer for advice or instructions in connection with its duties, and such instructions shall be full authorization and protection to the Warrant Agent and, absent gross
        negligence, bad faith or willful misconduct (each as determined by a final non-appealable order, judgment, ruling or decree of a court of competent jurisdiction), the Warrant Agent shall not be liable for any action taken, suffered to be taken, or
        omitted to be taken by it in accordance with instructions of any such Appropriate Officer or in reliance upon any statement signed by any one of such Appropriate Officers of the Company with respect to any fact or matter (unless other evidence in
        respect thereof is herein specifically prescribed) which may be deemed to be conclusively proved and established by such signed statement. The Warrant Agent shall not be held to have notice of any change of authority of any person, until receipt of
        written notice thereof from Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466168"></a><font style="color: rgb(0, 0, 0);">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding anything contained herein to the contrary, the Warrant Agent&#8217;s aggregate liability during any term of this Agreement
        with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under this Agreement, whether in contract, or in tort, or otherwise, is limited to, and shall not exceed, the
        amounts paid hereunder by the Company to the Warrant Agent as fees and charges, but not including reimbursable expenses, during the twelve (12) months immediately preceding the event for which recovery from Warrant Agent is being sought.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><font style="color: rgb(0, 0, 0);">(m)</font>&#160;&#160;&#160;&#160;&#160; No provision of this Agreement shall require the Warrant Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of
        its duties hereunder or in the exercise of its rights if it believes that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466169"></a><font style="color: rgb(0, 0, 0);">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160; If the Warrant Agent shall receive any notice or demand (other than notice of or demand for exercise of Warrants) addressed to the
        Company by any Warrantholder pursuant to the provisions of the Warrants, the Warrant Agent shall promptly forward such notice or demand to the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466170"></a><font style="color: rgb(0, 0, 0);">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or
        by or through its attorneys, accountants, agents or other experts, and the Warrant Agent will not be answerable or accountable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to the Company or the
        Warrantholders resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct in the selection and continued employment thereof (each as determined by a final non-appealable order, judgment,
        ruling or decree of a court of competent jurisdiction).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466171"></a><font style="color: rgb(0, 0, 0);">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent will not be under any duty or responsibility to ensure compliance with any applicable federal or state securities laws
        in connection with the issuance, transfer or exchange of the Warrants.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466172"></a><font style="color: rgb(0, 0, 0);">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall have no duties, responsibilities or obligations as the Warrant Agent except those which are expressly set forth
        herein, and in any modification or amendment hereof to which the Warrant Agent has consented in writing, and no duties, responsibilities or obligations shall be implied or inferred. Without limiting the foregoing, unless otherwise expressly
        provided in this Agreement, the Warrant Agent shall not be subject to, nor be required to comply with, or determine if any Person has complied with, the Warrants or any other agreement between or among the parties hereto, even though reference
        thereto may be made in this Agreement, or to comply with any notice, instruction, direction, request or other communication, paper or document other than as expressly set forth in this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466173"></a><font style="color: rgb(0, 0, 0);">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent shall not incur any liability for not performing any act, duty, obligation or responsibility by reason of any
        occurrence beyond the control of the Warrant Agent (including without limitation any act or provision of any present or future law or regulation or governmental authority, any act of God, war, civil disorder or failure of any means of
        communication, terrorist acts, pandemics, epidemics, shortage of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or
        retrieval systems, labor difficulties).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466174"></a><font style="color: rgb(0, 0, 0);">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; In the event the Warrant Agent believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request
        or other communication, paper or document received by the Warrant Agent hereunder, or is for any reason unsure as to what action to take hereunder, the Warrant Agent shall notify the Company in writing as soon as practicable, and upon delivery of
        such notice may, in its sole discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to the Company or any Warrantholder or other Person for refraining from taking such action, unless the Warrant
        Agent receives written instructions signed by the Company which eliminates such ambiguity or uncertainty to the satisfaction of Warrant Agent.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466175"></a><font style="color: rgb(0, 0, 0);">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Warrant Agent and the Company agree that all books, records, information and data pertaining to the business of the other party,
        including <font style="font-style: italic;">inter alia</font>, personal, non-public Warrantholder information, which are exchanged or received pursuant to the negotiation or the carrying out of this Agreement including the fees for services set
        forth in any fee schedule shall remain confidential, and shall not be voluntarily disclosed to any other person, except as may be required by law, including, without limitation, pursuant to subpoenas from state or federal government authorities
        (e.g., in divorce and criminal actions).</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466176"></a><font style="color: rgb(0, 0, 0);">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160; All funds received by Computershare under this Agreement that are to be distributed or applied by Computershare in the performance of
        Services (the &#8220;Funds&#8221;) shall be held by Computershare as agent for the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company. Until paid pursuant to this Agreement, Computershare
        may hold or invest the Funds through such accounts in: <a name="DocXTextRef176"></a>(a) funds backed by obligations of, or guaranteed by, the United States of America; <a name="DocXTextRef177"></a>(b) debt or commercial paper obligations rated
        A-1 or P-1 or better by S&amp;P Global Inc. (&#8220;S&amp;P&#8221;) or Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;), respectively; <a name="DocXTextRef178"></a>(c) Government and Treasury backed AAA-rated Fixed NAV money market funds that comply with Rule 2a-7
        of the Investment Company Act of 1940, as amended; or <a name="DocXTextRef179"></a>(d) short term certificates of deposit, bank repurchase agreements, and bank accounts with commercial banks with Tier 1 capital exceeding $1 billion, or with an
        investment grade rating by S&amp;P (LT Local Issuer Credit Rating), Moody&#8217;s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.). The Warrant Agent shall have no responsibility or
        liability for any diminution of the Funds that may result from any deposit or investment made by Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party.
        Computershare may from time to time receive interest, dividends or other earnings in connection with such deposits or investments. Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any
        other party.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466177"></a><font style="color: rgb(0, 0, 0);">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160; The provisions of this <font style="color: rgb(0, 0, 0);">Section 17</font> shall survive the termination of this Agreement, the
        termination, exercise or expiration of the Warrants and the resignation or removal of the Warrant Agent.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466178"></a><font style="color: rgb(0, 0, 0);">(w)</font>&#160;&#160;&#160;&#160;&#160; No provision of this Agreement shall be construed to relieve the Warrant Agent from liability for fraud, or its own gross negligence, bad
        faith or its willful misconduct (each as determined by a final non-appealable order, judgment, ruling or decree of a court of competent jurisdiction).</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466179"></a><a name="z_Toc204470518"></a><font style="color: rgb(0, 0, 0);">Section 18.</font>&#160;&#160;&#160; <font style="font-style: italic;">Change of Warrant Agent</font>.&#160; If the Warrant Agent resigns (such
        resignation to become effective not earlier than thirty (30) calendar days after the giving of written notice thereof to the Company) or shall be adjudged bankrupt or insolvent, or shall file a voluntary petition in bankruptcy or make an assignment
        for the benefit of its creditors or consent to the appointment of a receiver of all or any substantial part of its property or affairs or shall generally not pay its debts as such debts become due, or shall admit in writing its inability to pay or
        meet its debts generally as they become due, or if an order of any court shall be entered approving any petition filed by or against the Warrant Agent under the provisions of bankruptcy laws or any similar legislation, or if a receiver, trustee or
        other similar official of it or of all or any substantial part of its property shall be appointed, or if any public officer shall take charge or control of it or of its property or affairs, for the purpose of rehabilitation, conservation,
        protection, relief, winding up or liquidation, or becomes incapable of acting as Warrant Agent or if the Board of Directors of the Company by resolution removes the Warrant Agent (such removal to become effective not earlier than thirty (30)
        calendar days after the filing of a certified copy of such resolution with the Warrant Agent and the giving of written notice of such removal to the Warrantholders), the Company shall appoint a successor to the Warrant Agent. If the Company fails
        to make such appointment within a period of thirty (30) calendar days after such removal or after it has been so notified in writing of such resignation or incapacity by the Warrant Agent, then any Warrantholder may apply to any court of competent
        jurisdiction for the appointment of a successor to the Warrant Agent. Pending appointment of a successor to the Warrant Agent, either by the Company or by such a court, the duties of the Warrant Agent shall be carried out by the Company. Any
        successor Warrant Agent, whether appointed by the Company or by such a court, shall be an entity, in good standing, incorporated under the laws of any state or of the United States of America. As soon as practicable after appointment of the
        successor Warrant Agent, the Company shall cause written notice of the change in the Warrant Agent to be given to each of the Warrantholders at such Warrantholder&#8217;s address appearing on the Warrant Register. After appointment, the successor Warrant
        Agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant Agent without further act or deed. The former Warrant Agent shall deliver and transfer to the successor Warrant Agent any
        property at the time held by it hereunder and execute and deliver, at the expense of the Company, any further assurance, conveyance, act or deed necessary for the purpose; <font style="font-style: italic;">provided</font> that, the predecessor
        Warrant Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. Failure to give any notice provided for in this <font style="color: rgb(0, 0, 0);">Section 18</font> or any
        defect therein, shall not affect the legality or validity of the removal of the Warrant Agent or the appointment of a successor Warrant Agent, as the case may be.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466180"></a><a name="z_Toc204470519"></a><font style="color: rgb(0, 0, 0);">Section 19.</font>&#160;&#160;&#160; <font style="font-style: italic;">Warrantholder Not Deemed a Stockholder</font>.&#160; Nothing contained in
        this Agreement or in any of the Warrants shall be construed as conferring upon the Warrantholders thereof the right to vote or to receive dividends or to participate in any transaction that would give rise to an adjustment under <font style="color: rgb(0, 0, 0);">Section 12</font> or to consent or to receive notice as stockholders in respect of the meetings of stockholders or for the election of directors of the Company or any other matter, or any rights whatsoever as
        stockholders of the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466181"></a><a name="z_Toc204470520"></a><font style="color: rgb(0, 0, 0);">Section 20.</font>&#160;&#160;&#160; <font style="font-style: italic;">Notices to Company and Warrant Agent</font>.&#160; Any notice or demand
        authorized or permitted by this Agreement to be given or made by the Warrant Agent or by any Warrantholder to or on the Company to be effective shall be in writing (including by facsimile or email, as applicable), and shall be deemed to have been
        duly given or made when delivered by hand, or when sent if delivered to a recognized courier or deposited in the mail, first class and postage prepaid or, in the case email or facsimile notice, when received, addressed as follows (until another
        address, facsimile number or email address is filed in writing by the Company with the Warrant Agent):</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">35</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="margin-left: 36pt;">CoreWeave, Inc.</div>
      <div style="margin-left: 36pt;">290 W Mt. Pleasant Ave., Suite 4100</div>
      <div style="margin-left: 36pt;">Livingston, NJ 07039</div>
      <div style="margin-left: 36pt;">Attention: Kristen McVeety; Andrew Vinci</div>
      <div style="margin-left: 36pt;">Email: [&#160;&#160;&#160;&#160; ]</div>
      <div><br>
      </div>
      <div style="margin-left: 36pt;">with a copy to:</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt;">Davis Polk &amp; Wardwell LLP</div>
      <div style="margin-left: 36pt;">450 Lexington Avenue</div>
      <div style="margin-left: 36pt;">New York, NY 10017</div>
      <div style="margin-left: 36pt;">Attention: Michael Kaplan; Caitlin L. Wood</div>
      <div style="margin-left: 36pt;">Email: [&#160;&#160;&#160;&#160; ]</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">Any notice or demand pursuant to this Agreement to be given by the Company or by any Warrantholder to the Warrant Agent shall be sufficiently given if sent in the same manner as notices or demands are to be given or
        made to or on the Company (as set forth above), except email and facsimile, to the Warrant Agent at the office maintained by the Warrant Agent (the &#8220;<font style="font-weight: bold;">Warrant Agent Office</font>&#8221;) as follows (until another address is
        filed in writing by the Warrant Agent with the Company, which other address shall become the address of the Warrant Agent Office for the purposes of this Agreement):</div>
      <div>&#160;</div>
      <div style="margin-left: 36pt;">Computershare Trust Company, N.A.,</div>
      <div style="margin-left: 36pt;">Computershare Inc.</div>
      <div style="margin-left: 36pt;">150 Royall Street, 2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Floor</div>
      <div style="margin-left: 36pt;">Canton, MA 02021</div>
      <div style="margin-left: 36pt;">Attention: Client Services</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466182"></a><a name="z_Toc204470521"></a><font style="color: rgb(0, 0, 0);">Section 21.</font>&#160;&#160; <font style="font-style: italic;">Withholding and Reporting Requirements.</font>&#160; The Company shall
        comply with all applicable tax withholding and reporting requirements imposed by any governmental and regulatory authority, and all distributions or other situations requiring withholding under applicable law (including deemed distributions)
        pursuant to the Warrants will be subject to applicable withholding and reporting requirements. Notwithstanding any provision to the contrary, the Company shall be authorized to: (a) take any actions that may be necessary or appropriate to comply
        with such withholding and reporting requirements, (b) apply a portion of any cash distribution to be made under the Warrants to pay applicable withholding taxes, (c) holdback and liquidate a portion of any non-cash distribution to be made under the
        Warrants to generate sufficient funds to pay applicable withholding taxes, (d) require reimbursement from any Warrantholder to the extent any withholding is required in the absence of any distribution, or (e) establish any other mechanisms the
        Company believes are reasonable and appropriate, including requiring Warrantholders to submit appropriate tax and withholding certifications (such as IRS Forms W-9 and the appropriate IRS Form W-8, as applicable) that are necessary to comply with
        this <font style="color: rgb(0, 0, 0);">Section 21</font>.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">36</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466183"></a><a name="z_Toc204470522"></a><font style="color: rgb(0, 0, 0);">Section 22.</font>&#160;&#160;&#160; <font style="font-style: italic;">Supplements and Amendments.</font>&#160; The Company and the Warrant
        Agent may from time to time amend, modify or supplement (i) this Agreement (with respect to the Tranche 1 Warrants) or the Tranche 1 Warrants with the prior written consent of Warrantholders holding at least a majority of the Warrant Shares then
        issuable upon exercise of the Tranche 1 Warrants then outstanding, pursuant to a written amendment or supplement executed by the Company and the Warrant Agent or (ii) this Agreement (with respect to the Tranche 2 Warrants) or the Tranche 2 Warrants
        with the prior written consent of Warrantholders holding at least a majority of the Warrant Shares then issuable upon exercise of the Tranche 2 Warrants then outstanding, pursuant to a written amendment or supplement executed by the Company and the
        Warrant Agent; <font style="font-style: italic;">provided however</font>, that any amendment or supplement to this Agreement that would reasonably be expected to materially and adversely affect any right of a Warrantholder of a series relative to
        the other Warrantholders of such series shall require the written consent of such holder. In addition, the consent of each Warrantholder affected shall be required for any amendment pursuant to which the applicable Exercise Price would be
        increased, the number of Warrant Shares issuable upon exercise of Warrants would be decreased (other than pursuant to adjustments provided in this Agreement) or the applicable Expiration Date would be revised to an earlier date, <font style="font-style: italic;">provided however</font>, that the Company and the Warrant Agent may amend this Agreement without the consent of Warrantholders to <a name="DocXTextRef190"></a>(i) to cure any ambiguity; (ii) to correct or supplement
        any provision herein which may be defective or inconsistent with any other provision herein; or (iii) to make any other provisions with respect to matters or questions arising under this Agreement as long as the new provisions do not adversely
        affect (other than a de minimis adverse effect) the interest of the Warrantholders. Notwithstanding anything to the contrary herein, upon the delivery of a certificate from an Appropriate Officer of the Company which states that the proposed
        supplement or amendment is in compliance with the terms of this <font style="color: rgb(0, 0, 0);">Section 22</font> and provided that such supplement or amendment does not adversely affect the Warrant Agent&#8217;s rights, duties, liabilities,
        immunities or obligations hereunder, the Warrant Agent shall execute such supplement or amendment. Any amendment, modification or waiver effected pursuant to and in accordance with the provisions of this <font style="color: rgb(0, 0, 0);">Section
          22</font> will be binding upon all Warrantholders and upon each future Warrantholder, the Company and the Warrant Agent. In the event of any amendment, modification, supplement or waiver, the Company will give prompt notice thereof to all
        Warrantholders and, if appropriate, notation thereof will be made on all Global Warrant Certificates thereafter surrendered for registration of transfer or exchange. Notwithstanding anything in this Agreement to the contrary, the Warrant Agent may,
        but shall not be obligated to, enter into any supplement or amendment that adversely affects the Warrant Agent&#8217;s own rights, duties, immunities or obligations under this Agreement.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466184"></a><a name="z_Toc204470523"></a><font style="color: rgb(0, 0, 0);">Section 23.</font>&#160;&#160;&#160; <font style="font-style: italic;">Successors</font>.<font style="font-style: italic;">&#160;</font> All the
        covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns hereunder.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">37</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466185"></a><a name="z_Toc204470524"></a><font style="color: rgb(0, 0, 0);">Section 24.</font>&#160;&#160;&#160; <font style="font-style: italic;">Termination</font>.&#160; This Agreement shall terminate at 5:00 p.m.,
        New York City time, on the applicable Expiration Date (or, at 5:00 p.m., New York City time, on the Settlement Date with respect to any Warrant Exercise Notice delivered prior to <a name="DocXTextRef193"></a>5:00 p.m., New York City time, on the
        applicable Expiration Date) with respect to the applicable tranche of Warrants. Notwithstanding the foregoing, this Agreement will terminate on such earlier date on which all outstanding Warrants have been exercised. Termination of this Agreement
        shall not relieve the Company or the Warrant Agent of any of their obligations arising prior to the date of such termination or in connection with the settlement of any Warrant exercised prior to <a name="DocXTextRef194"></a>5:00 p.m., New York
        City time, on the applicable Expiration Date. The provisions of <font style="color: rgb(0, 0, 0);">Section 17</font>, this <font style="color: rgb(0, 0, 0);">Section 24</font>, <font style="color: rgb(0, 0, 0);">Section 25</font> and <font style="color: rgb(0, 0, 0);">Section 26</font> shall survive such termination and the resignation or removal of the Warrant Agent.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466186"></a><a name="z_Toc204470525"></a><font style="color: rgb(0, 0, 0);">Section 25.</font>&#160;&#160;&#160; <font style="font-style: italic;">Governing Law Venue and Jurisdiction; Trial By Jury.</font>&#160; This
        Agreement and each Warrant issued hereunder shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be governed by and construed in accordance with the laws of such state. Each party hereto consents
        and submits to the jurisdiction of the courts of the State of New York and any federal courts located in such state in connection with any action or proceeding brought against it that arises out of or in connection with, that is based upon, or that
        relates to this Agreement or the transactions contemplated hereby. In connection with any such action or proceeding in any such court, each party hereto hereby waives personal service of any summons, complaint or other process and hereby agrees
        that service thereof may be made in accordance with the procedures for giving notice set forth in <font style="color: rgb(0, 0, 0);">Section 20</font> hereof, <font style="font-style: italic;">provided</font> that, nothing contained herein shall
        be deemed to limit in any way any right to serve process in any other manner permitted by law. Each party hereto hereby waives any objection to jurisdiction or venue in any such court in any such action or proceeding and agrees not to assert any
        defense based on lack of jurisdiction or venue in any such court in any such action or proceeding. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN
        RESPECT OF ANY ACTION, PROCEEDING OR COUNTERCLAIM AS BETWEEN THE PARTIES DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR DISPUTES RELATING HERETO. Each of the parties
        hereto (i) certifies that no representative, agent or attorney of any other party hereto has represented, expressly or otherwise that such other party hereto would not, in the event of litigation, seek to enforce the foregoing waiver and (ii)
        acknowledges that it and the other parties hereto have been induced to enter into this Agreement by, among other things, the mutual waivers and certifications in this <font style="color: rgb(0, 0, 0);">Section 25</font>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466187"></a><a name="z_Toc204470526"></a><font style="color: rgb(0, 0, 0);">Section 26.</font>&#160;&#160;&#160;&#160; <font style="font-style: italic;">Benefits of this Agreement.</font>&#160; Nothing in this Agreement shall
        be construed to give to any Person other than the Company, the Warrant Agent and the Warrantholders any legal or equitable right, remedy or claim under this Agreement, and this Agreement shall be for the sole and exclusive benefit of the Company,
        the Warrant Agent and the Warrantholders.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">38</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466188"></a><a name="z_Toc204470527"></a><font style="color: rgb(0, 0, 0);">Section 27.</font>&#160;&#160;&#160; <font style="font-style: italic;">Counterparts</font>.&#160; This Agreement may be executed (including by
        means of facsimile or electronically transmitted portable document format (.pdf) signature pages) in any number of counterparts and each such counterpart shall for all purposes be deemed to be an original, and all such counterparts shall together
        constitute but one and the same instrument.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466189"></a><a name="z_Toc204470528"></a><font style="color: rgb(0, 0, 0);">Section 28.</font>&#160;&#160;&#160; <font style="font-style: italic;">Headings</font>.&#160; The headings of <a name="DocXTextRef202"></a>sections
        of this Agreement have been inserted for convenience of reference only, are not to be considered a part hereof and in no way modify or restrict any of the terms or provisions hereof.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466190"></a><a name="z_Toc204470529"></a><font style="color: rgb(0, 0, 0);">Section 29.</font>&#160;&#160;&#160; <font style="font-style: italic;">Severability</font>.&#160; Whenever possible, each provision of this
        Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law in any jurisdiction,
        such invalidity, illegality or unenforceability shall not affect the validity, legality or enforceability of any other provision of this Agreement in such jurisdiction or affect the validity, legality or enforceability of any provision in any other
        jurisdiction, and the invalid, illegal or unenforceable provision shall be interpreted and applied so as to produce as near as may be the economic result intended by the parties hereto. Upon determination that any term or other provision is
        invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that the
        transactions contemplated hereby are fulfilled to the extent possible; provided, however, that if such excluded provision shall materially and adversely affect the rights, immunities, liabilities, duties or obligations of the Warrant Agent, the
        Warrant Agent shall be entitled to resign immediately upon written notice to the Company.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466191"></a><a name="z_Ref204466682"></a><a name="z_Toc204470530"></a><font style="color: rgb(0, 0, 0);">Section 30.</font>&#160;&#160;&#160; <font style="font-style: italic;">Entire Agreement</font>. This Agreement
        constitutes the entire agreement and supersedes all other prior agreements and understandings, both written and oral, among the parties, or any of them, with respect to the subject matter hereof and may not be amended, except in a writing signed by
        both of them. Notwithstanding anything to the contrary contained in this Agreement, in the event of inconsistency between any provision in this Agreement and any provision in a Warrant Certificate, as it may from time to time be amended, this
        Agreement shall prevail. The Company shall not amend any provisions of the Warrant Certificates without the prior consent of the Warrant Agent, not to be unreasonably withheld or delayed. </div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466192"></a><a name="z_Toc204470531"></a><font style="color: rgb(0, 0, 0);">Section 31.</font>&#160;&#160;&#160; <font style="font-style: italic;">Meaning of Terms Used in Agreement</font>.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466193"></a><font style="color: rgb(0, 0, 0);">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The language used in this Agreement shall be deemed to be the language chosen by the parties to express their mutual intent, and no
        rule of strict construction shall be applied against any party. Any references to any federal, state, local or foreign statute or law shall also refer to all rules and regulations promulgated thereunder, unless the context otherwise requires.
        Unless the context otherwise requires: <a name="DocXTextRef203"></a>(a) a term has the meaning assigned to it by this Agreement; <a name="DocXTextRef204"></a>(b) forms of the word &#8220;include&#8221; mean that the inclusion is not limited to the items
        listed; <a name="DocXTextRef205"></a>(c) &#8220;or&#8221; is disjunctive but not exclusive; <a name="DocXTextRef206"></a>(d) words in the singular include the plural, and in the plural include the singular; and <a name="DocXTextRef207"></a>(e) provisions
        apply to successive events and transactions; <a name="DocXTextRef208"></a>(f) &#8220;hereof&#8221;, &#8220;hereunder&#8221;, &#8220;herein&#8221; and &#8220;hereto&#8221; refer to the entire Agreement and not any <a name="DocXTextRef209"></a>section or sub<a name="DocXTextRef210"></a>section.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">39</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
      </div>
      <div style="text-indent: 36pt;"><a name="z_Ref204466194"></a><font style="color: rgb(0, 0, 0);">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; The following terms used in this Agreement shall have the meanings set forth below:</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">$</font>&#8221; shall mean the currency of the United States.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law or other governmental action to be closed in New York,
        New York.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Cash</font>&#8221; means such coin or currency of the United States as at any time of payment is legal tender for the payment of public and private debts.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Close of Business</font>&#8221; means 5:00 p.m., New York City time.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Closing Sale Price</font>&#8221; means, as of any date, the last reported per share sales price of a share of Common Stock or any other security on such date (or, if no last reported sale
        price is reported, the average of the bid and ask prices or, if more than one in either case, the average of the average bid and the average ask prices on such date) as reported by the principal U.S. national or regional securities exchange or
        quotation system on which the Common Stock or such other security is then listed or quoted; <font style="font-style: italic;">provided, however</font>, that in the absence of such quotations, the Board of Directors will make a good faith
        determination of the Closing Sale Price.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Common Stock Equivalent</font>&#8221; means any warrant, right or option to acquire any shares of Common Stock or any security convertible into or exchangeable for shares of Common Stock.</div>
      <div>&#160;</div>
      <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Control</font>&#8221; means, with respect to any Person, <a name="DocXTextRef211"></a>(i) the possession, directly or indirectly, of the power to direct or cause the direction of the
        management and policies of such Person, whether through the ownership of voting securities, by contract or agency or otherwise, or (ii) the ownership of at least 50% of the equity securities in such Person. &#8220;<font style="font-weight: bold;">Controlled</font>&#8221;
        shall have a correlative meaning.</div>
      <div>&#160;</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">40</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0);" noshade="noshade"></div>
    </div>
    <div>
      <hr style="background-color: rgb(0, 0, 0); border-width: medium; border-style: none; border-color: -moz-use-text-color; margin: 0px auto; height: 4px; width: 0%; color: rgb(0, 0, 0); text-align: center;" align="center" noshade="noshade">
      <div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Current Market Price</font>&#8221; means, in connection with a dividend, issuance or distribution or the Cashless Exercise of any Warrant, the volume weighted average price per share of
          Common Stock for the twenty (20) Trading Days ending on, but excluding, the earlier of the date in question and the Trading Day immediately preceding the Ex-Date for such dividend, issuance or distribution for the regular trading session
          (including any extensions thereof, without regard to pre-open or after hours trading outside of such regular trading session) as reported by the principal U.S. national or regional securities exchange or quotation system on which the Common Stock
          or such other security is then listed or quoted, whichever is applicable, as published by Bloomberg at 4:15 P.M., New York City time (or 15 minutes following the end of any extension of the regular trading session), on such Trading Day, or if
          such volume weighted average price is unavailable or in manifest error as reasonably determined in good faith by the Board of Directors, the market value of one share of Common Stock during such twenty (20) Trading Day period determined using a
          volume weighted average price method by an independent nationally recognized investment bank or other qualified financial institution selected by the Board of Directors and reasonably acceptable to the Warrant Agent. If the Common Stock is not
          traded on any U.S. national or regional securities exchange or quotation system, the Current Market Price shall be the price per share of Common Stock that the Company could obtain from a willing buyer for shares of Common Stock sold by the
          Company from authorized but unissued shares of Common Stock, as such price shall be reasonably determined in good faith by the Board of Directors.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Ex-Date</font>&#8221; means, when used with respect to any issuance of or distribution in respect of the Common Stock or any other securities, the first date on which the Common Stock or
          such other securities trade without the right to receive such issuance or distribution.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Market Price</font>&#8221; means (w) if in reference to cash, the current cash value on the date of measurement in U.S. dollars, (x) if in reference to equity securities or securities
          included within Other Property, which are listed or admitted for trading on a national securities exchange or quotation system, the average closing price of a share (or similar relevant unit) of such securities as reported on the principal
          national securities exchange or quotation system on which the shares (or similar relevant units) of such securities are listed or admitted for trading, or (y) in all other cases, the value as determined in good faith by the Board of Directors of
          the Company. In each such case, the average price shall be averaged over a period of twenty-one (21) consecutive trading days consisting of the trading day immediately preceding the day on which the &#8220;Market Price&#8221; is being determined and the
          twenty (20) consecutive trading days prior to such day.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Open of Business</font>&#8221; means 9:00 a.m., New York City time.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Record Date</font>&#8221; means, with respect to any dividend, distribution or other transaction or event in which the holders of Common Stock have the right to receive any Cash,
          securities or other property or in which Common Stock (or other applicable security) is exchanged for or converted into any combination of Cash, securities or other property, the date fixed for determination of holders of Common Stock entitled to
          receive such Cash, securities or other property (whether such date is fixed by the Board of Directors or by statute, contract or otherwise).</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Subsidiary</font>&#8221; means, with respect to any Person, any corporation, partnership, joint venture or other legal entity as to which such Person (either alone or through or together
          with any other Subsidiary), (a) owns, directly or indirectly, more than fifty percent (50%) of the stock or other equity interests, (b) has the power to elect a majority of the board of directors or similar governing body, or (c) has the power to
          direct the business and policies.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">41</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 36pt;">&#8220;<font style="font-weight: bold;">Trading Day</font>&#8221; means (i) if the applicable security is listed on the New York Stock Exchange, a day on which trades may be made thereon or (ii) if the applicable security is
          listed or admitted for trading on the American Stock Exchange, the NASDAQ Global Select Market, the NASDAQ Global Market or other national securities exchange or market, a day on which the American Stock Exchange, the NASDAQ Global Select Market,
          the NASDAQ Global Market or such other national securities exchange or market is open for business or (iii) if the applicable security is not so listed, admitted for trading or quoted, any Business Day.</div>
        <div>&#160;</div>
        <div style="text-align: center;">[<font style="font-style: italic;">The next page is the signature page</font>]</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">42</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered as of the day and year first above written.</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z86a2c18039d74082988c97ca7c87fa4a" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COREWEAVE, INC.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div style="text-indent: -35.8pt; margin-left: 35.8pt;">Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z9c51310ddb1040edb9528024a5e29be0" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COMPUTERSHARE INC. and</div>
                <div>COMPUTERSHARE TRUST COMPANY, N.A. as Warrant Agent</div>
                <div>On behalf of both entities</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div>
          <div style="text-align: center;">[Signature Page to Warrant Agreement]</div>
          <div style="text-align: center;"> <br>
          </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%EXHIBIT A-%%-->
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT A</u></div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF TRANCHE 1 GLOBAL WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">VOID AFTER JANUARY 23, 2027</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">This Global Warrant Certificate is held by The Depository Trust Company (the &#8220;<u>Depository</u>&#8221;) or its nominee in custody for the benefit of the beneficial owners hereof, and is not transferable to any Person under
          any circumstances except that (i) this Global Warrant Certificate may be exchanged in whole but not in part pursuant to <font style="color: rgb(0, 0, 0);">Section 6(a)</font> of the Warrant Agreement, (ii) this Global Warrant Certificate may be
          delivered to the Warrant Agent for cancellation pursuant to <font style="color: rgb(0, 0, 0);">Section 6(h)</font> of the Warrant Agreement and (iii) this Global Warrant Certificate may be transferred to a successor Depository with the prior
          written consent of the Company.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">Unless this Global Warrant Certificate is presented by an authorized representative of the Depository to the Company or the Warrant Agent for registration of transfer, exchange or payment and any certificate issued
          is registered in the name of Cede &amp; Co. or such other entity as is requested by an authorized representative of the Depository (and any payment hereon is made to Cede &amp; Co. or to such other entity as is requested by an authorized
          representative of the Depository), any transfer, pledge or other use hereof for value or otherwise by or to any Person is wrongful because the registered owner hereof, Cede &amp; Co., has an interest herein.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">Transfers of this Global Warrant Certificate shall be limited to transfers in whole, but not in part, to nominees of the Depository or to a successor thereof or such successor&#8217;s nominee, and transfers of portions of
          this Global Warrant Certificate shall be limited to transfers made in accordance with the restrictions set forth in <font style="color: rgb(0, 0, 0);">Section 6</font> of the Warrant Agreement.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">No registration or transfer of the securities issuable pursuant to the Warrant will be recorded on the books of the Company until such provisions have been complied with.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT A-1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: right;">CUSIP No. [_____]</div>
        <div>&#160;</div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z2ade251e109746a1b439fb5f4fe01742" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 75%; vertical-align: top; padding-bottom: 2px;">
                <div>No.</div>
              </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: right;">WARRANT TO PURCHASE</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 75%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div style="text-align: right;">SHARES OF COMMON STOCK</div>
              </td>
            </tr>

        </table>
        <div style="text-align: center;"> <br>
        </div>
        <div style="text-align: center;">COREWEAVE, INC.</div>
        <div>&#160;</div>
        <div style="text-align: center;">GLOBAL WARRANT TO PURCHASE COMMON STOCK</div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF FACE OF TRANCHE 1 WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">VOID AFTER JANUARY 23, 2027</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">This Warrant Certificate (&#8220;<u>Warrant Certificate</u>&#8221;) certifies that [&#8226;] or its registered assigns is the registered holder (the &#8220;<u>Warrantholder</u>&#8221;) of a Warrant (the &#8220;<u>Warrant</u>&#8221;) of COREWEAVE, INC., a
          Delaware corporation (the &#8220;<u>Company</u>&#8221;), to purchase the number of shares (the &#8220;<u>Warrant Shares</u>&#8221;) of Class A Common Stock, par value $0.000005 per share (the &#8220;<u>Common Stock</u>&#8221;) of the Company set forth above. This warrant expires on
          January 23, 2027 (such date, the &#8220;<u>Tranche 1 Expiration Date</u>&#8221;), and entitles the holder to purchase from the Company the number of fully paid and non-assessable Warrant Shares set forth above at the exercise price (the &#8220;<u>Tranche 1
            Exercise Price</u>&#8221;) <font style="font-style: italic;">multiplied by</font> the number of Warrant Shares set forth above (the &#8220;<u>Exercise Amount</u>&#8221;), payable to the Company as provided in Section 7 of the Warrant Agreement. The initial
          Tranche 1 Exercise Price shall be $[__]. The Tranche 1 Exercise Price and the number of Warrant Shares purchasable upon exercise of this Warrant are subject to adjustment upon the occurrence of certain events as set forth in the Warrant
          Agreement.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">No Warrant may be exercised after the Tranche 1 Expiration Date. After the Tranche 1 Expiration Date, the Warrants will become wholly void and of no value.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">REFERENCE IS HEREBY MADE TO THE FURTHER PROVISIONS OF THIS WARRANT CERTIFICATE SET FORTH ON THE REVERSE HEREOF. SUCH FURTHER PROVISIONS SHALL FOR ALL PURPOSES HAVE THE SAME EFFECT AS THOUGH FULLY SET FORTH AT THIS
          PLACE.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT A-2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 81pt;">IN WITNESS WHEREOF, the Company has caused this Warrant Certificate to be executed by its duly authorized officer.</div>
        <div>&#160;</div>
        <div>Dated:</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zcd3ab6d3e94c4fbbacdf1db309af76e4" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COREWEAVE, INC.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div style="text-indent: -35.8pt; margin-left: 35.8pt;">Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zb0840d951e844507819ea3ecb9d9e771" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COMPUTERSHARE INC. and</div>
                <div>COMPUTERSHARE TRUST COMPANY, N.A. as Warrant Agent</div>
                <div>On behalf of both entities</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT A-3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: center;">FORM OF REVERSE OF GLOBAL TRANCHE 1 WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">COREWEAVE, INC.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Warrant evidenced by this Warrant Certificate is a part of a duly authorized issue of Warrants to purchase a maximum of [___] shares of Common Stock issued pursuant to that certain Warrant Agreement, dated as of
          the Issue Date (the &#8220;<u>Warrant Agreement</u>&#8221;), duly executed and delivered by the COMPANY and COMPUTERSHARE INC., a Delaware corporation and its affiliate, COMPUTERSHARE TRUST COMPANY, N.A., a federally chartered trust company, collectively, as
          Warrant Agent (the &#8220;<u>Warrant Agent</u>&#8221;). The Warrant Agreement hereby is incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and
          immunities thereunder of the Warrant Agent, the Company and the Warrantholders. A copy of the Warrant Agreement may be inspected at the Warrant Agent office and is available upon written request addressed to the Company. All capitalized terms
          used in this Warrant Certificate but not defined that are defined in the Warrant Agreement shall have the meanings assigned to them therein.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Warrants may be exercised to purchase Warrant Shares from the Company from the Issue Date through 5:00 p.m. New York City time on the Tranche 1 Expiration Date, at the Tranche 1 Exercise Price set forth on the face
          hereof, subject to adjustment as described in the Warrant Agreement. Subject to the terms and conditions set forth herein and in the Warrant Agreement, the Warrantholder evidenced by this Warrant Certificate may exercise such Warrant by:</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; providing written notice of such election (&#8220;<u>Warrant Exercise Notice</u>&#8221;) to exercise the Warrant to the Warrant Agent at the address set forth in the Warrant Agreement, &#8220;Re: Warrant Exercise&#8221;, by
          hand or by facsimile, no later than 5:00 p.m., New York City time, on the Tranche 1 Expiration Date, which Warrant Exercise Notice shall substantially be in the form of an election to purchase Warrant Shares set forth herein, properly completed
          and executed by the Warrantholder;</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;delivering no later than 5:00 p.m., New York City time, on the business day immediately prior to the Settlement Date, the Warrant Certificates evidencing such Tranche 1 Warrants to the Warrant Agent;</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; unless Cashless Exercise applies, paying in cash the applicable Exercise Amount; and</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; paying any applicable taxes and governmental charges.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">In the event that upon any exercise of the Tranche 1 Warrant evidenced hereby the number of Warrant Shares actually purchased shall be less than the total number of Warrant Shares purchasable upon exercise of the
          Tranche 1 Warrant evidenced hereby, there shall be issued to the Warrantholder hereof, or such Warrantholder&#8217;s assignee, a new Warrant Certificate evidencing a Warrant to purchase the Warrant Shares not so purchased. No adjustment shall be made
          for any cash dividends on any Warrant Shares issuable upon exercise of this Tranche 1 Warrant. After the Tranche 1 Expiration Date, unexercised Tranche 1 Warrants shall become wholly void and of no value.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT A-4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 36pt;">The Company shall not be required to issue fractions of Warrant Shares or any certificates that evidence fractional Warrant Shares.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Warrant Certificates, when surrendered by book-entry delivery through the facilities of the Depository may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
          payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing a Warrant to purchase in the aggregate a like number of Warrant Shares.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">No Tranche 1 Warrants may be sold, exchanged or otherwise transferred in violation of the Warrant Agreement. The issuance of securities upon exercise of this instrument following the Issue Date has not been
          registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or the securities laws of any state and such securities may be issued pursuant to an exemption from the registration requirement of Section 5 of the Securities Act
          and, as such, a holder may not be able to sell or transfer any securities issued upon exercise of this instrument in the absence of an effective registration statement relating thereto under the Securities Act and in accordance with applicable
          state securities laws or pursuant to an exemption from registration under such act or such laws, including the exemption provided by Rule 144 promulgated under the Securities Act, if available.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">The Company and Warrant Agent may deem and treat the registered holder hereof as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone) for
          the purpose of any exercise hereof and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.</div>
        <div>&#160;</div>
        <div style="text-align: center;">[Balance of page intentionally remains blank]</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT A-5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%EXHIBIT B-%%-->
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT B</u></div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF TRANCHE 2 GLOBAL WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">VOID AFTER JANUARY 23, 2029</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">This Global Warrant Certificate is held by The Depository Trust Company (the &#8220;<u>Depository</u>&#8221;) or its nominee in custody for the benefit of the beneficial owners hereof, and is not transferable to any Person under
          any circumstances except that (i) this Global Warrant Certificate may be exchanged in whole but not in part pursuant to <font style="color: rgb(0, 0, 0);"><u>Section 6(a)</u></font> of the Warrant Agreement, (ii) this Global Warrant Certificate
          may be delivered to the Warrant Agent for cancellation pursuant to <font style="color: rgb(0, 0, 0);"><u>Section 6(h)</u></font> of the Warrant Agreement and (iii) this Global Warrant Certificate may be transferred to a successor Depository with
          the prior written consent of the Company.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Unless this Global Warrant Certificate is presented by an authorized representative of the Depository to the Company or the Warrant Agent for registration of transfer, exchange or payment and any certificate issued
          is registered in the name of Cede &amp; Co. or such other entity as is requested by an authorized representative of the Depository (and any payment hereon is made to Cede &amp; Co. or to such other entity as is requested by an authorized
          representative of the Depository), any transfer, pledge or other use hereof for value or otherwise by or to any Person is wrongful because the registered owner hereof, Cede &amp; Co., has an interest herein.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">Transfers of this Global Warrant Certificate shall be limited to transfers in whole, but not in part, to nominees of the Depository or to a successor thereof or such successor&#8217;s nominee, and transfers of portions of
          this Global Warrant Certificate shall be limited to transfers made in accordance with the restrictions set forth in <font style="color: rgb(0, 0, 0);"><u>Section 6</u></font> of the Warrant Agreement.</div>
        <div>&#160;</div>
        <div style="text-indent: 36pt;">No registration or transfer of the securities issuable pursuant to the Warrant will be recorded on the books of the Company until such provisions have been complied with.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: right;">CUSIP No. [_____]</div>
        <div>&#160;</div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zc978e595e3cf4e65a607f50642cb6154" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 75%; vertical-align: top; padding-bottom: 2px;">
                <div>No.</div>
              </td>
              <td style="width: 20%; vertical-align: top; padding-bottom: 2px;">
                <div style="text-align: right;">WARRANT TO PURCHASE</div>
              </td>
              <td style="width: 5%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 75%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div style="text-align: right;">SHARES OF COMMON STOCK</div>
              </td>
            </tr>

        </table>
        <div style="text-align: center;"> <br>
        </div>
        <div style="text-align: center;">COREWEAVE, INC.</div>
        <div>&#160;</div>
        <div style="text-align: center;">GLOBAL WARRANT TO PURCHASE COMMON STOCK</div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF FACE OF TRANCHE 2 WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">VOID AFTER JANUARY 23, 2029</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">This Warrant Certificate (&#8220;<u>Warrant Certificate</u>&#8221;) certifies that [&#8226;] or its registered assigns is the registered holder (the &#8220;<u>Warrantholder</u>&#8221;) of a Warrant (the &#8220;<u>Warrant</u>&#8221;) of COREWEAVE, INC., a
          Delaware corporation (the &#8220;<u>Company</u>&#8221;), to purchase the number of shares (the &#8220;<u>Warrant Shares</u>&#8221;) of Class A Common Stock, par value $0.000005 per share (the &#8220;<u>Common Stock</u>&#8221;) of the Company set forth above. This warrant expires on
          January 23, 2029 (such date, the &#8220;<u>Tranche 2 Expiration Date</u>&#8221;), and entitles the holder, at any time after the Issue Date, to purchase from the Company the number of fully paid and non-assessable Warrant Shares set forth above at the
          exercise price (the &#8220;<u>Tranche 2 Exercise Price</u>&#8221;) <font style="font-style: italic;">multiplied by</font> the number of Warrant Shares set forth above (the &#8220;<u>Exercise Amount</u>&#8221;), payable to the Company as provided in Section 7 of the
          Warrant Agreement. The initial Tranche 2 Exercise Price shall be $[__] per warrant. The Tranche 2 Exercise Price and the number of Warrant Shares purchasable upon exercise of this Warrant are subject to adjustment upon the occurrence of certain
          events as set forth in the Warrant Agreement.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">No Warrant may be exercised after the Tranche 2 Expiration Date. After the Tranche 2 Expiration Date, the Warrants will become wholly void and of no value.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">REFERENCE IS HEREBY MADE TO THE FURTHER PROVISIONS OF THIS WARRANT CERTIFICATE SET FORTH ON THE REVERSE HEREOF. SUCH FURTHER PROVISIONS SHALL FOR ALL PURPOSES HAVE THE SAME EFFECT AS THOUGH FULLY SET FORTH AT THIS
          PLACE.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">IN WITNESS WHEREOF, the Company has caused this Warrant Certificate to be executed by its duly authorized officer.</div>
        <div style="text-indent: 72pt;"> <br>
        </div>
        <div>Dated:</div>
        <div> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z711ad628d3e44825853c49fd6c07c54e" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COREWEAVE, INC.</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div style="text-indent: -35.8pt; margin-left: 35.8pt;">Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z0b742d933faa415cacbdb7074ed0598a" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td colspan="2" style="vertical-align: top;">
                <div>COMPUTERSHARE INC. and</div>
                <div>COMPUTERSHARE TRUST COMPANY, N.A. as Warrant Agent</div>
                <div>On behalf of both entities</div>
              </td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">
                <div>By:</div>
              </td>
              <td style="width: 46%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Name:</div>
              </td>
            </tr>
            <tr>
              <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 4%; vertical-align: top;">&#160;</td>
              <td style="width: 46%; vertical-align: top;">
                <div>Title:</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: center;">FORM OF REVERSE OF GLOBAL TRANCHE 2 WARRANT CERTIFICATE</div>
        <div>&#160;</div>
        <div style="text-align: center;">COREWEAVE, INC.</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">The Warrant evidenced by this Warrant Certificate is a part of a duly authorized issue of Warrants to purchase a maximum of [____] shares of Common Stock issued pursuant to that certain Warrant Agreement, dated as of
          the Issue Date (the &#8220;<u>Warrant Agreement</u>&#8221;), duly executed and delivered by the COMPANY and COMPUTERSHARE INC., a Delaware corporation and its affiliate COMPUTERSHARE TRUST COMPANY, N.A., a federally chartered trust company, collectively, as
          Warrant Agent (the &#8220;<u>Warrant Agent</u>&#8221;). The Warrant Agreement hereby is incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and
          immunities thereunder of the Warrant Agent, the Company and the Warrantholders. A copy of the Warrant Agreement may be inspected at the Warrant Agent office and is available upon written request addressed to the Company. All capitalized terms
          used in this Warrant Certificate but not defined that are defined in the Warrant Agreement shall have the meanings assigned to them therein.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">Warrants may be exercised to purchase Warrant Shares from the Company from the Issue Date through 5:00 p.m. New York City time on the Tranche 2 Expiration Date, at the Tranche 2 Exercise Price set forth on the face
          hereof, subject to adjustment as described in the Warrant Agreement. Subject to the terms and conditions set forth herein and in the Warrant Agreement, the Warrantholder evidenced by this Warrant Certificate may exercise such Warrant by:</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;providing written notice of such election (&#8220;<u>Warrant Exercise Notice</u>&#8221;) to exercise the Warrant to the Warrant Agent at the address set forth in the Warrant Agreement, &#8220;Re: Warrant Exercise&#8221;, by
          hand or by facsimile, no later than 5:00 p.m., New York City time, on the Tranche 2 Expiration Date, which Warrant Exercise Notice shall substantially be in the form of an election to purchase Warrant Shares set forth herein, properly completed
          and executed by the Warrantholder;</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; delivering no later than 5:00 p.m., New York City time, on the business day immediately prior to the Settlement Date, the Warrant Certificates evidencing such Tranche 2 Warrants to the Warrant Agent;</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160; unless Cashless Exercise applies, paying in cash the applicable Exercise Amount; and</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160; paying any applicable taxes and governmental charges.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">In the event that upon any exercise of the Tranche 2 Warrant evidenced hereby the number of Warrant Shares actually purchased shall be less than the total number of Warrant Shares purchasable upon exercise of the
          Tranche 2 Warrant evidenced hereby, there shall be issued to the Warrantholder hereof, or such Warrantholder&#8217;s assignee, a new Warrant Certificate evidencing a Warrant to purchase the Warrant Shares not so purchased. No adjustment shall be made
          for any cash dividends on any Warrant Shares issuable upon exercise of this Tranche 2 Warrant. After the Tranche 2 Expiration Date, unexercised Tranche 2 Warrants shall become wholly void and of no value.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-indent: 81pt;">The Company shall not be required to issue fractions of Warrant Shares or any certificates that evidence fractional Warrant Shares.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">Warrant Certificates, when surrendered by book-entry delivery through the facilities of the Depository may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
          payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing a Warrant to purchase in the aggregate a like number of Warrant Shares.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">No Tranche 2 Warrants may be sold, exchanged or otherwise transferred in violation of the Warrant Agreement. The issuance of securities upon exercise of this instrument following the Issue Date has not been
          registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or the securities laws of any state and such securities may be issued pursuant to an exemption from the registration requirement of Section 5 of the Securities Act
          and, as such, a holder may not be able to sell or transfer any securities issued upon exercise of this instrument in the absence of an effective registration statement relating thereto under the Securities Act and in accordance with applicable
          state securities laws or pursuant to an exemption from registration under such act or such laws, including the exemption provided by Rule 144 promulgated under the Securities Act, if available.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">The Company and Warrant Agent may deem and treat the registered holder hereof as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone) for
          the purpose of any exercise hereof and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-align: center;">[Balance of page intentionally remains blank]</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%EXHIBIT C-1-%%-->
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT C-1</u></div>
        <div><br>
        </div>
        <div style="text-align: center;">FORM OF ELECTION TO EXERCISE BOOK-ENTRY</div>
        <div>&#160;</div>
        <div style="text-align: center;">WARRANTS (TO BE EXECUTED UPON EXERCISE OF THE WARRANT)</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Statement, to purchase up to ________ newly issued shares of Common Stock of COREWEAVE, INC. (the &#8220;<u>Company</u>&#8221;) at the
          [Tranche 1][Tranche 2] Exercise Price of [Tranche 1: $[__]][Tranche 2: $[__]] per share, as adjusted pursuant to the Warrant Agreement.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">The undersigned represents, warrants and promises that it has the full power and authority to exercise and deliver the Warrants exercised hereby.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">In lieu of paying the Exercise Price in cash, Cashless Exercise will apply to the exercise of Warrants hereby unless (x) a registration statement covering the Warrant Shares is in effect and available and (y) the
          undersigned shall have checked the following box:</div>
        <div>&#160;</div>
        <div>
          <table class="DSPFListTable" id="zac6502d5d91e45b8bee0a6635494aced" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

              <tr style="vertical-align: top;">
                <td style="width: 81pt;">&#160;</td>
                <td style="text-align: left; vertical-align: top; width: 18pt;">&#9744;</td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Cash exercise election</div>
                </td>
              </tr>

          </table>
        </div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">The undersigned represents, warrants and promises that it has delivered or will deliver in payment for such shares $_______ by certified or official bank or bank cashier&#8217;s check payable to the order of the Company,
          or by wire transfer in immediately available funds, of the aggregate [Tranche 1][Tranche 2] Exercise Price to an account of the Warrant Agent specified in writing by the Warrant Agent for such purpose <u>or</u> through a Cashless Exercise, no
          later than 5:00 p.m., New York City time, on the business day immediately prior to the Settlement Date.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">The undersigned requests that a certificate representing the shares of Common Stock be delivered as follows:</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="zc3aa51417beb4165adb9c8b5a60fdb12" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Name</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Address:</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Delivery Address (if different):</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT C-1-1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%EXHIBIT B-2-%%-->
        <div style="text-indent: 36pt;">If such number of shares of Common Stock is less than the aggregate number of shares of Common Stock purchasable hereunder, the undersigned requests that a new Book-Entry Warrant representing the balance of such
          Warrants shall be registered, with the appropriate Warrant Statement delivered as follows:</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z54ebaa996d534ab6b6163a21d110c12d" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Name</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Address:</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Delivery Address (if different):</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 40%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td colspan="2" rowspan="1" style="width: 40%; vertical-align: top;">
                <div>Social Security or Other Taxpayer Identification Number of Warrantholder:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
              <td style="width: 60%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 40%; vertical-align: top;">
                <div>Signature</div>
              </td>
              <td style="width: 60%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>Note: The above signature must correspond with the name as written upon the Warrant Statement in every particular, without alteration or enlargement or any change whatsoever. If the certificate representing the shares of Common Stock or any
          Warrant Statement representing Warrants not exercised is to be registered in a name other than that in which this Warrant Statement is registered, the signature of the holder hereof must be guaranteed.</div>
        <div>&#160;</div>
        <div>SIGNATURE GUARANTEED</div>
        <div>&#160;</div>
        <div>By:</div>
        <div>&#160;</div>
        <div>Signatures must be guaranteed by a participant in the Securities Transfer Agent Medallion Program, the Stock Exchanges Medallion Program or the New York Stock Exchange, Inc. Medallion Signature Program.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT B-2-2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%EXHIBIT C-2-%%-->
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT C-2</u></div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF ELECTION TO EXERCISE DIRECT REGISTRATION WARRANTS</div>
        <div style="text-align: center;">&#160;TO BE COMPLETED BY DIRECT PARTICIPANT</div>
        <div style="text-align: center;">&#160;IN THE DEPOSITORY TRUST COMPANY</div>
        <div>&#160;</div>
        <div style="text-align: center;">COREWEAVE, INC.</div>
        <div>&#160;</div>
        <div style="text-align: center;">Warrants to Purchase ________ Shares of Common Stock</div>
        <div>&#160;</div>
        <div style="text-align: center;">(TO BE EXECUTED UPON EXERCISE OF THE WARRANT)</div>
        <div>&#160;</div>
        <div style="text-indent: 81pt;">The undersigned hereby irrevocably elects to exercise the right, represented by _______ Warrants held for its benefit through the book-entry facilities of The Depository Trust Company (the &#8220;<u>Depository</u>&#8221;), to
          purchase newly issued shares of Common Stock of COREWEAVE, INC. (the &#8220;<u>Company</u>&#8221;) at the [Tranche 1][Tranche 2] Exercise Price of [Tranche 1: $[__]][Tranche 2: $[__]] per share, as adjusted pursuant to the Warrant Agreement.</div>
        <div><br>
        </div>
        <div style="text-indent: 81pt;">The undersigned represents, warrants and promises that it has the full power and authority to exercise and deliver the Warrants exercised hereby.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">In lieu of paying the Exercise Price in cash, Cashless Exercise will apply to the exercise of Warrants hereby unless (x) a registration statement covering the Warrant Shares is in effect and available and (y) the
          undersigned shall have checked the following box:</div>
        <div>&#160;</div>
        <div>
          <table class="DSPFListTable" id="z9412dedc9b1f416eb86139055f1cb4d5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" cellpadding="0" cellspacing="0">

              <tr style="vertical-align: top;">
                <td style="width: 81pt;">&#160;</td>
                <td style="text-align: left; vertical-align: top; width: 18pt;">&#9744;</td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div>Cash exercise election</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">The undersigned represents, warrants and promises that it has delivered or will deliver in payment for such shares $_______ by certified or official bank or bank cashier&#8217;s check payable to the order of the Company,
          or by wire transfer in immediately available funds, of the aggregate [Tranche 1][Tranche 2] Exercise Price to an account of the Warrant Agent specified in writing by the Warrant Agent for such purpose <u>or</u> through a Cashless Exercise, no
          later than 5:00 p.m., New York City time, on the business day immediately prior to the Settlement Date.</div>
        <div style="text-indent: 9pt;">&#160;</div>
        <div style="text-indent: 81pt;">The undersigned requests that the shares of Common Stock purchased hereby be in registered form in the authorized denominations, registered in such names and delivered, all as specified in accordance with the
          instructions set forth below, provided that if the shares of Common Stock are evidenced by global securities, the shares of Common Stock shall be registered in the name of the Depository or its nominee.</div>
        <div>&#160;</div>
        <div>Dated:</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT C-2-1</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div>NOTE: THIS EXERCISE NOTICE MUST BE DELIVERED TO THE WARRANT AGENT, PRIOR TO 5:00 P.M., NEW YORK CITY TIME, ON THE [TRANCHE 1 EXPIRATION DATE][TRANCHE 2 EXPIRATION DATE]. THE WARRANT AGENT SHALL NOTIFY YOU (THROUGH THE CLEARING SYSTEM) OF (1)
          THE WARRANT AGENT&#8217;S ACCOUNT AT THE DEPOSITORY TO WHICH YOU MUST DELIVER YOUR WARRANTS ON THE EXERCISE DATE AND (2) THE ADDRESS, PHONE NUMBER AND FACSIMILE NUMBER WHERE YOU CAN CONTACT THE WARRANT AGENT AND TO WHICH WARRANT EXERCISE NOTICES ARE TO
          BE SUBMITTED.</div>
        <div>&#160;</div>
        <div>NAME OF DIRECT PARTICIPANT IN THE DEPOSITORY:</div>
        <div>&#160;</div>
        <div>(PLEASE PRINT)</div>
        <div>&#160;</div>
        <div>ADDRESS</div>
        <div>&#160;</div>
        <div>CONTACT NAME:</div>
        <div>&#160;</div>
        <div>ADDRESS:</div>
        <div>&#160;</div>
        <div>TELEPHONE (INCLUDING INTERNATIONAL CODE):</div>
        <div>&#160;</div>
        <div>FAX (INCLUDING INTERNATIONAL CODE):</div>
        <div>&#160;</div>
        <div>SOCIAL SECURITY OR OTHER TAXPAYER IDENTIFICATION NUMBER (IF APPLICABLE):</div>
        <div>&#160;</div>
        <div>ACCOUNT FROM WHICH WARRANTS ARE BEING DELIVERED:</div>
        <div>&#160;</div>
        <div>DEPOSITORY ACCOUNT NO.:</div>
        <div>&#160;</div>
        <div>WARRANT EXERCISE NOTICES WILL ONLY BE VALID IF DELIVERED IN ACCORDANCE WITH THE INSTRUCTIONS SET FORTH IN THIS NOTIFICATION (OR AS OTHERWISE DIRECTED), MARKED TO THE ATTENTION OF &#8220;WARRANT EXERCISE&#8221;. WARRANTHOLDER DELIVERING WARRANTS, IF OTHER
          THAN THE DIRECT DTC PARTICIPANT DELIVERING THIS WARRANT EXERCISE NOTICE:</div>
        <div>&#160;</div>
        <div>NAME:</div>
        <div>(PLEASE PRINT)</div>
        <div>&#160;</div>
        <div>CONTACT NAME:</div>
        <div>&#160;</div>
        <div>TELEPHONE (INCLUDING INTERNATIONAL CODE):</div>
        <div>&#160;</div>
        <div>FAX (INCLUDING INTERNATIONAL CODE):</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT C-2-2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div>SOCIAL SECURITY OR OTHER TAXPAYER IDENTIFICATION NUMBER (IF APPLICABLE):</div>
        <div>&#160;</div>
        <div>ACCOUNT TO WHICH THE SHARES OF COMMON STOCK ARE TO BE CREDITED:</div>
        <div>&#160;</div>
        <div>DEPOSITORY ACCOUNT NO.:</div>
        <div>&#160;</div>
        <div>FILL IN FOR DELIVERY OF THE COMMON STOCK, IF OTHER THAN TO THE PERSON DELIVERING THIS WARRANT EXERCISE NOTICE:</div>
        <div>&#160;</div>
        <div>NAME: (PLEASE PRINT) ADDRESS:</div>
        <div>&#160;</div>
        <div>CONTACT NAME:</div>
        <div>&#160;</div>
        <div>TELEPHONE (INCLUDING INTERNATIONAL CODE):</div>
        <div><br>
        </div>
        <div>FAX (INCLUDING INTERNATIONAL CODE):</div>
        <div>&#160;</div>
        <div>SOCIAL SECURITY OR OTHER TAXPAYER IDENTIFICATION NUMBER (IF APPLICABLE):</div>
        <div><br>
        </div>
        <div>NUMBER OF WARRANTS BEING EXERCISED</div>
        <div><br>
        </div>
        <div>(ONLY ONE EXERCISE PER WARRANT EXERCISE NOTICE)</div>
        <div>&#160;</div>
        <div>Signature:</div>
        <div>&#160;</div>
        <div>Name:</div>
        <div>&#160;</div>
        <div>Capacity in which Signing:</div>
        <div>&#160;</div>
        <div>Signature Guaranteed BY:</div>
        <div>&#160;</div>
        <div style="text-align: center;">Signatures must be guaranteed by a participant in the Securities Transfer</div>
        <div style="text-align: center;">Agent Medallion Program, the Stock Exchanges Medallion Program</div>
        <div style="text-align: center;">or the New York Stock Exchange, Inc. Medallion Signature Program.</div>
        <div>&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT C-2-3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr style="margin: 4px 0px; width: 100%; border-width: 0px; height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); clear: both;" noshade="noshade"></div>
        </div>
        <div style="text-align: center; font-weight: bold;"><u>EXHIBIT D</u></div>
        <div>&#160;</div>
        <div style="text-align: center;">FORM OF ASSIGNMENT</div>
        <div>&#160;</div>
        <div style="text-align: center;">(TO BE EXECUTED BY THE REGISTERED WARRANTHOLDER IF</div>
        <div style="text-align: center;">SUCH WARRANTHOLDER DESIRES TO TRANSFER A WARRANT)</div>
        <div>&#160;</div>
        <div>FOR VALUE RECEIVED, the undersigned registered holder hereby sells, assigns and transfers unto</div>
        <div><br>
        </div>
        <div>
          <div>
            <hr style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;" align="center" noshade="noshade"></div>
          <div style="text-align: center;">&#160;</div>
          <div style="text-align: center;">Name of Assignee</div>
        </div>
        <div><br>
        </div>
        <div>
          <div>
            <hr style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;" align="center" noshade="noshade"></div>
          <div><br>
          </div>
        </div>
        <div style="text-align: center;">Address of Assignee</div>
        <div>&#160;</div>
        <div>_______ Warrants to purchase shares of Common Stock held by the undersigned, together with all right, title and interest therein, and does irrevocably constitute and appoint _______ attorney, to transfer such Warrants on the books of the
          Warrant Agent, with full power of substitution.</div>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z0f47e2f6fd894d33862252a184c54d33" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 85%; vertical-align: top; padding-bottom: 2px;">
                <div>Dated</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 85%; vertical-align: top;"><br>
              </td>
              <td rowspan="1" style="width: 15%; vertical-align: top;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; padding-bottom: 2px;">
                <div>Signature</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 85%; vertical-align: top;"><br>
              </td>
              <td rowspan="1" style="width: 15%; vertical-align: top;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 85%; vertical-align: top; padding-bottom: 2px;">
                <div>Social Security or Other Taxpayer Identification Number of Assignee</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);" id="z2f8c9f12071349c1aa27f4ffc175fe6c" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 85%; vertical-align: top; padding-bottom: 2px;">
                <div>SIGNATURE GUARANTEED BY:</div>
              </td>
              <td style="width: 15%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
              </td>
            </tr>

        </table>
        <div style="text-align: center;"> <br>
        </div>
        <div style="text-align: center;">Signatures must be guaranteed by a participant in the Securities Transfer</div>
        <div style="text-align: center;">Agent Medallion Program, the Stock Exchanges Medallion Program</div>
        <div style="text-align: center;">or the New York Stock Exchange, Inc. Medallion Signature Program.</div>
        <div>&#160;</div>
        <div style="text-align: center;"> <font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;">EXHIBIT D</font> </div>
        <div style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;"> <br>
          </font></div>
        <div style="text-align: center;"><font class="BRPFPageNumber" style="font-size: 8pt; font-weight: normal; font-style: normal;"> <br>
          </font></div>
        <div>
          <hr style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; margin-left: auto; margin-right: auto; border: medium none;" align="center" noshade="noshade"> </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ny20053122x2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">EXHIBIT 5.1 and 23.4</div>
    <div>
      <div> <br>
      </div>
      <table id="zaa62c1a594c34c5fa0935ed2dcaff000" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" border="0" cellpadding="0" cellspacing="0">

          <tr>
            <td style="width: 12%; text-align: left; vertical-align: top;">
              <div><img src="ny20053122x2_ex5-1logo.jpg" border="0" width="150" height="24"></div>
            </td>
            <td style="width: 88%;">
              <div>
                <div style="text-indent: -0.05pt; margin-left: 1pt; font-size: 9pt;">Davis Polk &amp; Wardwell LLP </div>
                <font style="font-size: 9pt;"> </font>
                <div style="text-indent: -0.05pt; margin-left: 1pt; font-size: 9pt;">900 Middlefield Road </div>
                <font style="font-size: 9pt;"> </font>
                <div style="text-indent: -0.05pt; margin-left: 1pt; font-size: 9pt;">Redwood City, CA 94063 </div>
                <font style="font-size: 9pt;"> </font>
                <div style="text-indent: -0.05pt; margin-left: 1pt; font-size: 9pt;">davispolk.com</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; margin-left: 0.15pt; font-weight: bold;">OPINION OF DAVIS POLK &amp; WARDWELL LLP</div>
    <div><br>
    </div>
    <div>September 17, 2025</div>
    <div>CoreWeave, Inc.</div>
    <div>290 W Mt. Pleasant Ave., Suite 4100</div>
    <div>Livingston, New Jersey 07039</div>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We have acted as counsel to CoreWeave, Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), in connection with the merger contemplated by Agreement and Plan of Merger, dated as of July
      7, 2025 (the &#8220;<font style="font-weight: bold;">Merger Agreement</font>&#8221;), by and among the Company, Miami Merger Sub I, Inc. (&#8220;<font style="font-weight: bold;">Merger Sub</font>&#8221;), a Delaware corporation and a wholly owned subsidiary of the Company,
      and Core Scientific, Inc., a Delaware corporation (&#8220;<font style="font-weight: bold;">Core Scientific</font>&#8221;), pursuant to which Merger Sub will merge with and into Core Scientific, with Core Scientific surviving as a wholly owned subsidiary of the
      Company (the &#8220;<font style="font-weight: bold;">Merger</font>&#8221;) and the preparation and filing of the Company&#8217;s Registration Statement on Form S-4 (File No.333-289742), including the proxy statement/prospectus forming a part thereof (the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;) filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Securities Act</font>&#8221;), relating to the registration
      by the Company of (a) shares of the Class A common stock, par value $0.000005 per share of the Company (the &#8220;<font style="font-weight: bold;">Company Common Stock</font>&#8221;) and (b) warrants exercisable for a number of shares of Company Common Stock
      (the &#8220;<font style="font-weight: bold;">New Tranche 1 Warrants</font>&#8221; and &#8220;<font style="font-weight: bold;">New Tranche 2 Warrants</font>&#8221; (each as defined in the Registration Statement)), in each case, to be issued in connection with the Merger. We
      refer to the maximum number of shares of Company Common Stock that are issuable upon exercise by holders of the New Tranche 1 Warrants and New Tranche 2 Warrants as the &#8220;<font style="font-weight: bold;">Underlying Securities</font>.&#8221;</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: -0.05pt;">We, as your counsel, have examined originals or copies of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary or advisable for the
      purpose of rendering the opinions expressed herein.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">In rendering the opinions expressed herein, we have, without independent inquiry or investigation, assumed that (i) all documents submitted to us as originals are authentic and complete, (ii) all documents submitted to
      us as copies conform to authentic, complete originals, (iii) all signatures on all documents that we reviewed are genuine, (iv) all natural persons executing documents had and have the legal capacity to do so, (v) all statements in certificates of
      public officials and officers of the Company that we reviewed were and are accurate, (vi) all representations made by the Company as to matters of fact in the documents that we reviewed were and are accurate, (vii) the Registration Statement, as then
      amended, will have become effective under the Securities Act and such effectiveness will not have been terminated or rescinded or be subject to any stop order, (viii) the stockholders of Core Scientific will approve, among other things, the adoption
      of the Merger Agreement and any ancillary documents thereto, and all transactions (including the Merger) contemplated therein in accordance with the General Corporation Law of the State of Delaware (&#8220;<font style="font-weight: bold;">DGCL</font>&#8221;) and
      (ix) all other necessary action will have been taken under the DGCL to authorize and permit the Merger, and the Merger shall have been consummated, or will be consummated concurrently with, the issuance of the Company Common Stock, New Tranche 1
      Warrants and New Tranche 2 Warrants. As to any facts material to the opinions expressed herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Company
      and others and of public officials.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="text-align: justify;">Based upon the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, we advise you that, in our opinion:</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z5c663cec833d4506972efbba5d2eeda8" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 30pt;"><br>
          </td>
          <td style="width: 19pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top;">
            <div>The Company Common Stock, when issued and delivered as contemplated in the Registration Statement and in accordance with the terms and conditions of the Merger Agreement, will be validly issued, fully paid and non-assessable.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zdfa805d7968f4ebfb25f682b5026a1cc" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 30pt;"><br>
          </td>
          <td style="width: 19pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Assuming that the warrant agreement governing the New Tranche 1 Warrants and New Tranche 2 Warrants (the &#8220;Warrant Agreement&#8221;) and the New Tranche 1 Warrants and New Tranche 2 Warrants have been duly authorized by the warrant agent, when
              the Warrant Agreement has been duly executed and delivered by the warrant agent and the Company, and such New Tranche 1 Warrants and New Tranche 2 Warrants have been duly executed and delivered in accordance with the Warrant Agreement and
              applicable agreement against payment thereto, the New Tranche 1 Warrants and New Tranche 2 Warrants when issued as contemplated in the Registration Statement and in accordance with the terms and conditions of the Merger Agreement and the
              Warrant Agreement, will constitute valid and binding obligations of the Company, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors&#8217; rights generally, concepts of
              reasonableness and equitable principles of general applicability; provided that we express no opinion as to the validity, legally binding effect or enforceability of any provision in the New Tranche 1 Warrants and New Tranche 2 Warrants that
              require or relate to adjustments to the exercise price at a price or in an amount that a court would determine in the circumstances under applicable law to be commercially unreasonable or a penalty or forfeiture.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7f061a9892994e3b81c04addb6b88b9c" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 30pt;"><br>
          </td>
          <td style="width: 19pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>The Underlying Securities, when issued upon exercise by holders of the New Tranche 1 and New Tranche 2 Warrants and delivered against payment therefor in accordance with the terms and conditions of the Warrant Agreement, will be validly
              issued, fully paid and non-assessable.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify;">We are members of the Bar of the States of New York and California and the foregoing opinion is limited to the laws of the State of New York and the DGCL.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and further consent to the reference to our name under the caption &#8220;Legal Matters&#8221; in the proxy statement/prospectus which
      forms a part of the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Very truly yours,</div>
    <div><br>
    </div>
    <div>/s/ Davis Polk &amp; Wardwell LLP<br>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>4
<FILENAME>ny20053122x2_ex8-1.htm
<DESCRIPTION>EXHIBIT 8.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div style="text-align: right;">
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-weight: bold;">Exhibit 8.1</font><br>
  </div>
  <div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z064e04f8988446aca92e0b4d3903237a" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 108pt; vertical-align: middle;">
            <div><img src="ny20053122x2_ex8-1img01.jpg" width="104" height="17"></div>
          </td>
          <td style="vertical-align: middle;">
            <div style="color: rgb(19, 10, 226); font-family: 'Times New Roman',Times,serif; font-size: 8pt;">Davis Polk &amp; Wardwell <font style="font-variant: normal;">LLP</font></div>
            <div style="color: rgb(19, 10, 226); font-family: 'Times New Roman',Times,serif; font-size: 8pt;">450 Lexington Avenue</div>
            <div style="color: rgb(19, 10, 226); font-family: 'Times New Roman',Times,serif; font-size: 8pt;">New York, NY 10017</div>
            <div style="color: rgb(19, 10, 226); font-family: 'Times New Roman',Times,serif; font-size: 8pt;">davispolk.com</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;">September 17, 2025</div>
    <div><br>
    </div>
    <div>Re: Qualification of the Merger as a Tax-Free Reorganization</div>
    <div><br>
    </div>
    <div>CoreWeave, Inc.</div>
    <div>290 W Mt. Pleasant Ave., Suite 4100</div>
    <div>Livingston, NJ 07039</div>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div>We have acted as counsel for CoreWeave, Inc. (&#8220;<font style="font-weight: bold;">CoreWeave</font>&#8221;), a Delaware corporation, in connection with (i) the Merger, as defined and described in the Agreement and Plan of Merger dated July 7, 2025 (the &#8220;<font style="font-weight: bold;">Merger Agreement</font>&#8221;) between CoreWeave, Miami Merger Sub I, Inc. (&#8220;<font style="font-weight: bold;">Merger Sub</font>&#8221;), a Delaware corporation and a wholly owned, direct subsidiary of CoreWeave, and Core Scientific,
      Inc., a Delaware corporation (&#8220;<font style="font-weight: bold;">Core Scientific</font>&#8221;), and (ii) the preparation and filing of the related Registration Statement on Form S-4 (together with any exhibit, appendix, schedule or similar attachment
      thereto, in each case as amended or supplemented through the date hereof, the &#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221;), which includes the Proxy Statement/Prospectus (the &#8220;<font style="font-weight: bold;">Proxy
        Statement/Prospectus</font>&#8221;), filed with the Securities and Exchange Commission. In connection with the effectiveness of the Registration Statement you have requested our opinion as to certain U.S. federal income tax matters. Unless otherwise
      indicated, each capitalized term used herein has the meaning ascribed to it in the Merger Agreement.</div>
    <div><br>
    </div>
    <div>In connection with this opinion, we have examined the Merger Agreement, the Registration Statement, the Proxy Statement/Prospectus, the representation letter of CoreWeave (on behalf of itself and Merger Sub), dated as of today, and the
      representation letter of Core Scientific, dated as of today, each delivered to us for purposes of this opinion (the &#8220;<font style="font-weight: bold;">Officer&#8217;s Certificates</font>&#8221;), and such other documents as we have deemed necessary or appropriate
      in order to enable us to render our opinion set forth herein. In such examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the
      conformity to original documents of all documents submitted to us as duplicates or certified or conformed copies, and the authenticity of the originals of such latter documents. While we do not have any knowledge that any statement contained in the
      Officer&#8217;s Certificates is untrue, incorrect or incomplete in any respect, we have not undertaken any independent investigation of any factual matter set forth in the Officer&#8217;s Certificates or any of the other foregoing documents. For purposes of this
      opinion, we have assumed, with your permission, that (i) the Merger will be consummated in the manner described in the Merger Agreement (and no covenants or conditions described therein and affecting this opinion will be waived or modified), (ii) the
      statements and representations concerning the Merger set forth in the Merger Agreement and the Proxy Statement/Prospectus are true, complete and correct and will remain true, complete and correct at all times up to and including the Effective Time,
      (iii) the representations made by CoreWeave and Core Scientific in their respective Officer&#8217;s Certificates are accurate and complete and will remain accurate and complete at all times up to and including the Effective Time, (iv) any representations
      made in the Merger Agreement or the Officer&#8217;s Certificates &#8220;to the knowledge of&#8221;, based on the belief of CoreWeave or Core Scientific or similarly qualified are true, complete and correct and will remain true, complete and correct at all times up to
      and including the Effective Time, in each case without such qualification and (v) all applicable reporting requirements have been or will be satisfied, and CoreWeave, Merger Sub and Core Scientific will treat the Merger for U.S. federal income tax
      purposes in a manner consistent with the opinion set forth below. We have also assumed that the parties have complied with and, if applicable, will continue to comply with, the obligations, covenants, and agreements contained in the Merger Agreement.
      In addition, our opinion is based solely on the documents that we have examined, the additional <font style="color: #1B1B1B;">information that we have obtained, and the representations made by CoreWeave and Core Scientific referred to above, which
        we have assumed will be true as of the Effective Time.</font></div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div><br>
    </div>
    <div style="color: #1D1D1D;">Based upon the foregoing, and subject to the assumptions, limitations and qualifications set forth herein, it is our opinion that the Merger should be treated for U.S. federal income tax purposes as a reorganization within
      the meaning of Section 368(a) of the Code.</div>
    <div><br>
    </div>
    <div><font style="color: #1C1C1C;">Our opinion is based on current provisions of the Code, Treasury Regulations promulgated thereunder, published pronouncements of the Internal Revenue Service and case law, any of which may be changed at any time with
        retroactive effect. Any change in applicable laws or the facts and circumstances surrounding the Merger and related transactions, or any inaccuracy in the statements, facts, </font><font style="color: #1B1B1B;">assumptions or representations upon
        which we have relied, may affect the continuing validity of our opinion as set forth herein. We assume no responsibility to inform CoreWeave, Merger Sub or Core Scientific of any such change or inaccuracy that may occur or come to our attention: In
        addition, because our opinion is required to be delivered in connection with the effectiveness of the Registration Statement, there can be no assurance that it will continue to be valid at the effective time of the Merger.</font></div>
    <div><br>
    </div>
    <div style="color: #1D1D1D;">We express our opinion herein only as to those matters specifically set forth above and no opinion should be inferred as to the tax consequences of the Merger under any state, local or foreign law, or with respect to other
      areas of U.S. federal taxation. We are members of the Bar of the State of New York, and we do not express any opinion herein concerning any law other than the federal law of the United States.</div>
    <div><br>
    </div>
    <div style="color: #1C1C1C;">This opinion is furnished to you solely for use in connection with the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the references to our firm
      name in the Proxy Statement/Prospectus in connection with the references to this opinion and the material U.S. federal income tax consequences of the Merger. In giving such consent, we do not thereby admit that we are in the category of persons whose
      consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Commission thereunder.</div>
    <div><br>
    </div>
    <div style="color: #1D1D1D;">Very truly yours,</div>
    <div><br>
    </div>
    <div>/s/ Davis Polk &amp; Wardwell LLP</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
    <div><br>
    </div>
    <font style="font-weight: bold;"> </font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.2
<SEQUENCE>5
<FILENAME>ny20053122x2_ex8-2.htm
<DESCRIPTION>EXHIBIT 8.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 8.2</div>
    <div><br>
    </div>
    <div style="text-align: center;">[Letterhead of Wachtell, Lipton, Rosen &amp; Katz]</div>
    <div><br>
    </div>
    <div style="text-align: center;">September 17, 2025</div>
    <div><br>
    </div>
    <div>Core Scientific, Inc.</div>
    <div>83 Walker Road, Suite 21-2105</div>
    <div>Dover, Delaware&#160; 19904</div>
    <div><br>
    </div>
    <div>Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">We have acted as special counsel to Core Scientific, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), in connection with the proposed merger (the &#8220;<u>Merger</u>&#8221;) of Miami Merger Sub I, Inc. (&#8220;<u>Merger Sub</u>&#8221;), a
      Delaware corporation and a wholly owned, direct subsidiary of CoreWeave, Inc. (&#8220;<u>Parent</u>&#8221;), a Delaware corporation, with and into the Company, with the Company as the surviving corporation, as contemplated by the Agreement and Plan of Merger,
      dated as of July 7, 2025, among Parent, Merger Sub and the Company (together with all exhibits, appendices, schedules and similar attachments thereto, in each case as amended or supplemented through the date hereof, the &#8220;<u>Merger Agreement</u>&#8221;).&#160;
      In connection with the effectiveness of the Registration Statement on Form S-4 (together with any exhibit, appendix, schedule or similar attachment thereto, in each case as amended or supplemented through the date hereof, the &#8220;<u>Registration
        Statement</u>&#8221;) of Parent, including the proxy statement/prospectus forming a part thereof, relating to the Merger, you have requested our opinion as to certain U.S. federal income tax matters. Except as otherwise provided herein, capitalized terms
      used but not defined herein have the meanings ascribed to them in the Merger Agreement.</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">In providing our opinion, we have examined the Merger Agreement, the Registration Statement, the officer&#8217;s certificates, dated as of the date hereof, of Parent (on behalf of itself and Merger Sub) and the Company
      delivered to us for purposes of rendering this opinion (the &#8220;<u>Officer&#8217;s Certificates</u>&#8221;) and such other documents, records and papers as we have deemed necessary or appropriate in order to give the opinion set forth herein.&#160; In addition, we have
      assumed that:&#160; (i) the Merger and related transactions will be consummated in accordance with the provisions of the Merger Agreement and as described in the Registration Statement (and no covenants or conditions described therein and affecting this
      opinion will be waived or modified), (ii) the statements and representations concerning the Merger and the parties thereto set forth in the Merger Agreement are true, complete and correct as of the date hereof and will remain true, complete and
      correct at all times up to and including the effective time of the Merger, (iii) the Registration Statement is true, complete and correct and will remain true, complete and correct at all times up to and including the effective time of the Merger,
      (iv) the statements and representations (which statements and representations we have neither investigated nor verified) made by Parent, Merger Sub and the Company in their respective Officer&#8217;s Certificates are true, complete and correct as of the
      date hereof and will remain true, complete and correct at all times up to and including the effective time of the Merger, (v) all such statements and representations described in clause (ii) or (iv) qualified by knowledge, expectation, belief or
      materiality or comparable qualification are and will be true, complete and correct as if made without such qualification, (vi) all documents submitted to us as originals are authentic, all documents submitted to us as copies conform to the originals,
      all relevant documents have been or will be duly executed in the form presented to us and all natural persons who have executed such documents are of legal capacity, (vii) the Merger will qualify as a statutory merger under the DGCL, and (viii) all
      applicable reporting requirements have been or will be satisfied, and Parent, Merger Sub and the Company will treat the Merger for U.S. federal income tax purposes in a manner consistent with the opinion set forth below.&#160; If any of the above
      described assumptions is untrue for any reason, or if the Merger is consummated in a manner that is different from the manner described in the Merger Agreement or the Registration Statement, our opinion as expressed below may be adversely affected.</div>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
    <div>Core Scientific, Inc.</div>
    <div>Page 2</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">Based upon and subject to the foregoing and the exceptions, limitations and qualifications described herein or in the Registration Statement, it is our opinion that, under currently applicable U.S. federal income tax
      law, the Merger should qualify as a &#8220;reorganization&#8221; within the meaning of Section 368(a) of the Code.</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">We express no opinion on any issue or matter relating to the tax consequences of the transactions contemplated by the Merger Agreement or the Registration Statement other than the opinion set forth above.&#160; Our opinion is
      based on current provisions of the Internal Revenue Code of 1986, as amended, Treasury Regulations promulgated thereunder, published pronouncements of the Internal Revenue Service and case law, any of which may be changed at any time with retroactive
      effect.&#160; Any change in applicable laws or the facts and circumstances surrounding the Merger and related transactions, or any inaccuracy in the statements, facts, assumptions or representations upon which we have relied, may affect the continuing
      validity of our opinion as set forth herein.&#160; We assume no responsibility to inform Parent, Merger Sub or the Company of any such change or inaccuracy that may occur or come to our attention.&#160; In addition, because our opinion is required to be
      delivered in connection with the effectiveness of the Registration Statement, there can be no assurance that it will continue to be valid at the effective time of the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 72pt;">We are furnishing this opinion to you solely in connection with the filing of the Registration Statement, and this opinion is not to be relied upon for any other purpose without our prior written consent.&#160; We hereby
      consent to the filing of this opinion with the Securities and Exchange Commission as an exhibit to the Registration Statement, and to the references therein to us. In giving such consent, we do not thereby admit that we are in the category of persons
      whose consent is required under Section 7 of the Securities Act of 1933, as amended.</div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z00401d465cbd4884b5db57550aa23586" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50.96%; vertical-align: top;">&#160;</td>
          <td style="width: 49.04%; vertical-align: top;">
            <div>Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50.96%; vertical-align: top;">&#160;</td>
          <td style="width: 49.04%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50.96%; vertical-align: top;">&#160;</td>
          <td style="width: 49.04%; vertical-align: top;">
            <div>/s/ Wachtell, Lipton, Rosen &amp; Katz</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: right;">2<br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.30
<SEQUENCE>6
<FILENAME>ny20053122x2_ex10-30.htm
<DESCRIPTION>EXHIBIT 10.30
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div style="text-align: right;">
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-weight: bold;">Exhibit 10.30</font><br>
  </div>
  <div style="text-align: right;"><font style="font-weight: bold;"> <br>
    </font></div>
  <br>
  <div style="text-align: center; font-weight: bold;">ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">THIS ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), dated as of [&#9679;], 2025 (this &#8220;<font style="font-weight: bold;">Agreement</font>&#8221;), is made
    and entered into by and among CoreWeave, Inc., a Delaware corporation (&#8220;<font style="font-weight: bold;">Parent</font>&#8221;), Core Scientific, Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) and Computershare Inc., a
    Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent (the &#8220;<font style="font-weight: bold;">Agent</font>&#8221;) and amends the Contingent Value Rights Agreement (the &#8220;<font style="font-weight: bold;">Existing CVR Agreement</font>&#8221;), dated as of January 23, 2024, by and between the Company and the Agent, a copy of which is attached hereto as <u>Annex A</u>. Capitalized terms used but not defined herein shall have the
    meaning ascribed to such terms in the Existing CVR Agreement.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, on December 21, 2022, the Company and each of its debtor affiliates, as debtors and debtors in possession (such affiliates, the &#8220;<font style="font-weight: bold;">Debtor Affiliates</font>&#8221;)
    commenced voluntary cases, captioned In re Core Scientific Inc., et al., Case No. 22 90341 (CML), under Chapter 11 of Title 11 of the United States Code, 11 U.S.C. &#167;&#167; 101&#8211;1532, as amended, in the United States Bankruptcy Court for the Southern District
    of Texas (the &#8220;<font style="font-weight: bold;">Bankruptcy Court</font>&#8221;)&#894;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, on January 16, 2024, the Bankruptcy Court confirmed the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (With Technical Modifications) Docket No. 1722
    (the &#8220;<font style="font-weight: bold;">Plan</font>&#8221;)&#894;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, pursuant to the terms and conditions of the Plan and the Existing CVR Agreement, on January 23, 2024, the Company issued and delivered to holders of April Convertible Notes Secured Claims and
    August Convertible Notes Secured Claims (each as defined in the Plan) contingent payment obligations, in the form of 51,783,625 Contingent Value Rights (the &#8220;<font style="font-weight: bold;">CVRs</font>&#8221;)&#894;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, all of the CVRs are governed by the Existing CVR Agreement;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Parent, the Company and Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (&#8220;<font style="font-weight: bold;">Merger Sub</font>&#8221;), entered into an
    Agreement and Plan of Merger (the &#8220;<font style="font-weight: bold;">Merger Agreement</font>&#8221;), dated as of July 7, 2025, pursuant to which, among other things, at the Merger Effective Time (as defined hereinafter), Merger Sub will merge with and into
    the Company, with the Company surviving as a wholly owned subsidiary of Parent (the &#8220;<font style="font-weight: bold;">Merger</font>&#8221;);</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, the consummation of the transactions contemplated by the Merger Agreement, including the Merger, will constitute a Change of Control as defined in the Existing CVR Agreement;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, upon a Change of Control, as provided in Section 4.4 of the Existing CVR Agreement, the Company will cause the surviving entity to assume the Company&#8217;s obligations, duties and covenants under
    the Existing CVR Agreement and the surviving entity may elect to pay the CVRs (if and as payable) in common equity securities of the surviving entity in lieu of common stock of the Company only if such common equity securities of the surviving entity
    are listed on a principal U.S. national securities exchange, on the terms and subject to the conditions set forth in the Existing CVR Agreement;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, Section 3.1(a)(vi) of the Existing CVR Agreement provides that the Company, at any time or from time to time, may unilaterally enter into one or more amendments to the Existing CVR Agreement,
    without the consent of any of the Holders, so long as such amendment does not adversely affect the legal rights under the existing CVR Agreement of any such Holder or the Agent; and</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">WHEREAS, in connection with the transactions contemplated by the Merger Agreement and pursuant to Section 7.16 of the Merger Agreement and Section 3.1(a)(vi) of the Existing CVR Agreement, Parent and
    the Company desire to amend the Existing CVR Agreement to provide for the assignment to and assumption by Parent, in lieu of the surviving entity, of all of the Company&#8217;s obligations, duties and covenants under the Existing CVR Agreement and the
    ability of Parent, in lieu of the surviving entity, to elect to pay the CVRs (if and as payable) in Parent Common Stock (as defined hereinafter) (after giving effect to the Exchange Ratio (as defined in the Merger Agreement)), pursuant to the terms and
    conditions of the Existing CVR Agreement (as amended by this Agreement).</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">1</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">NOW, THEREFORE, in consideration of the foregoing, of the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby
    acknowledged, the parties hereby agree as follows:</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Assignment and Assumption</u>. Subject to the consummation of the Merger, as of and with effect on and from the Merger Effective Time, the Company hereby assigns all of its right, title
    and interest in and to the Existing CVR Agreement (as amended hereby) and Parent hereby assumes, and agrees to pay, perform, satisfy and discharge in full, as the same become due, all of the Company&#8217;s liabilities and obligations under the Existing CVR
    Agreement (as amended hereby) arising on, from and after the Merger Effective Time. As a result of the preceding sentence, each CVR outstanding immediately prior to the Merger Effective Time may be paid (if and as payable) in shares of Parent Common
    Stock (after giving effect to the Exchange Ratio (as defined in the Merger Agreement)), pursuant to the terms and conditions of the Existing CVR Agreement (as amended by this Agreement).</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Consent</u>. The Agent hereby consents to (a) the assignment of the Existing CVR Agreement by the Company to Parent pursuant to <u>Section </u>1, as of and with effect on and from the
    Merger Effective Time, (b) the assumption of the Existing CVR Agreement by Parent pursuant to <u>Section </u>1, as of and with effect on and from the Merger Effective Time, and (c) the continuation of the Existing CVR Agreement (as amended hereby) in
    full force and effect as of and with effect on and from the Merger Effective Time.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment of Existing CVR Agreement</u>. Subject to the consummation of the Merger, as of and with effect on and from the effective time of the Merger (the &#8220;<font style="font-weight: bold;">Merger Effective Time</font>&#8221;),&#160; Parent and the Agent hereby amend the Existing CVR Agreement as provided in this <u>Section 3</u>, and Parent acknowledges and agrees that the amendments to the Existing CVR Agreement pursuant to Section
    3.1(a)(vi) of the Existing CVR Agreement set forth in this <u>Section 3</u> (a) are necessary and desirable and do not adversely affect the legal rights of the Holders or the Agent under the Existing CVR Agreement and (b) are to provide for (i) the
    assignment to and the assumption by Parent, the sole stockholder of the surviving entity as of and following the Merger Effective Time, in lieu of the surviving entity in the Merger, of the Company&#8217;s rights, interest and obligations under the Existing
    CVR Agreement (in connection with the transactions contemplated by the Merger Agreement, including the Merger) and (ii) the ability of Parent, in lieu of the surviving entity, to make the Second Anniversary Payment Amount and/or the Third Anniversary
    Payment Amount, as applicable, in shares of Parent Common Stock.</div>
  <div><br>
  </div>
  <div style="text-indent: 72pt;">3.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>References Change</u>.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.1.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#8220;Agreement,&#8221; &#8220;Contingent Value Right Agreement&#8221; or &#8220;CVR Agreement&#8221;</u>. Each reference to &#8220;this Agreement,&#8221; &#8220;Contingent Value Rights Agreement,&#8221; &#8220;CVR Agreement,&#8221; &#8220;hereof,&#8221; &#8220;herein,&#8221;
    &#8220;hereunder,&#8221; &#8220;hereby,&#8221; &#8220;hereto&#8221; and each other similar reference contained in the Existing CVR Agreement (including all exhibits and annexes thereto) shall, subject to the consummation of the Merger, from and after the Merger Effective Time, refer to
    the Existing CVR Agreement as amended by this Agreement. Notwithstanding the foregoing, references to the date of the Existing CVR Agreement and references in the Existing CVR Agreement to &#8220;the date hereof,&#8221; &#8220;the date of this Agreement&#8221; and other
    similar references shall in all instances continue to refer to January 23, 2024.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.1.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#8220;Company&#8221;</u>. All references to the &#8220;Company&#8221; in the Existing CVR Agreement (including all exhibits and annexes thereto) shall be references to (a) prior to the Merger Effective
    Time, the Company, and (b) from and after the Merger Effective Time, Parent.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.1.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#8220;CORZ&#8221;</u>. All references to &#8220;CORZ&#8221; in the Existing CVR Agreement (including all exhibits and annexes thereto) shall be references to (a) prior to the Merger Effective Time, CORZ,
    and (b) from and after the Merger Effective Time, CRWV.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.1.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#8220;New Common Interests&#8221;</u>. All references to &#8220;New Common Interests&#8221; in the Existing CVR Agreement (including all exhibits and annexes thereto) shall be references to (a) prior to
    the Merger Effective Time, common stock, par value $0.0001, of the Company issued (x) on the Effective Date of the Existing CVR Agreement or thereafter under the Plan or (y) as otherwise permitted pursuant to the Plan, and (b) from and after the Merger
    Effective Time, Parent Class A common stock, par value $0.000005 per share (&#8220;<font style="font-weight: bold;">Parent Common Stock</font>&#8221;), which shares of Parent Common Stock are listed on the Nasdaq Global Select Market (for the avoidance of doubt,
    the number of shares of New Common Interests payable in respect of the CVRs shall be calculated after giving effect to the Exchange Ratio (as defined in the Merger Agreement)).</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">3.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Amendments</u>.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.2.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>&#8220;Corresponding New Common Interests&#8221;</u>. The definition of &#8220;Corresponding New Common Interests&#8221; is hereby deleted and replaced with the following:</div>
  <div><br>
  </div>
  <div style="text-align: justify; margin-left: 36pt;">&#8220;<font style="font-weight: bold;">Corresponding New Common Interests</font>&#8221; means 6,395,278 New Common Interests (subject to adjustments in connection with any stock split, reverse stock split,
    recapitalization, reclassification, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, exchange, non-cash dividend or similar event in connection with the New Common Interests).</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 108pt;">3.2.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. Section 4.1 of the Existing CVR Agreement is hereby deleted and replaced with the following:</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">&#8220;All notices and other communications under this Agreement shall be in writing (including by electronic transmission) and shall be deemed to have been duly delivered and received when delivered by
    hand, or when sent if delivered to a recognized courier or deposited in the mail, first class and postage prepaid and, in the case of notice or demand made by the Agent or by any Holder to or on the Company, immediately upon confirmation of
    transmission of electronic mail, where such notice is given by electronic mail, in each case to the intended recipient as set forth below:</div>
  <div><br>
  </div>
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z80caa711febc4dd9a678a2386d486aca" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top;">(i)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>if to the Company, to:</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zed0f07cafdcc4135b37a682e53a7b69f" border="0" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">CoreWeave, Inc.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">290 W Mt. Pleasant Ave., Suite 4100</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">Livingston, NJ 07039</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">Attention: Kristen McVeety</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">
          <div style="text-align: justify;">Email: <br>
          </div>
        </td>
        <td style="vertical-align: top;">[ ]</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">with copies (which shall not constitute notice) to:</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">Davis Polk &amp; Wardwell LLP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">450 Lexington Avenue</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" rowspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">New York, New York 10017</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">and</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">Davis Polk &amp; Wardwell LLP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">900 Middlefield Road, Suite 200</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify;">Redwood City, California 94063</div>
        </td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 72pt; vertical-align: top;">&#160;</td>
        <td rowspan="1" colspan="2" style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: justify;">Attention:</div>
        </td>
        <td style="vertical-align: top;">
          <div style="text-align: justify;">Michael Gilson</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">
          <div style="text-align: justify;">Michael Kaplan</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">&#160;</td>
        <td style="vertical-align: top;">
          <div style="text-align: justify;">Tierney O&#8217;Rourke</div>
        </td>
      </tr>
      <tr>
        <td style="width: 72pt; vertical-align: top;">&#160;</td>
        <td style="width: 5%; vertical-align: top;">
          <div style="text-align: justify;">Email:</div>
        </td>
        <td style="vertical-align: top;">
          <div style="text-align: justify;">[ ]<br>
          </div>
        </td>
      </tr>

  </table>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
  </div>
  <!--PROfilePageNumberReset%Num%4%%%-->
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zc0a824f50f474f4687aa1c3f2a02316b" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 36pt; vertical-align: top;">(ii)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div>if to the Agent, to:</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Computershare Trust Company, N.A.,</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Computershare Inc.</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">150 Royall Street</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Canton, MA 02021</div>
  <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;">Attention: Client Services&#8221;</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous Provisions</u>.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effectiveness of the Agreement</u>. Each of the parties hereto acknowledges and agrees that the effectiveness of this Agreement shall be expressly subject to the occurrence of the
    Merger and shall automatically be terminated and shall be null and void if the Merger Agreement shall be terminated for any reason.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Full Force and Effect</u>. Each of the parties hereto acknowledges and agrees that, except as expressly amended by this Agreement, the Existing CVR Agreement shall remain in full force
    and effect in accordance with its terms.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties to this Agreement and the Holders and
    their respective permitted successors and permitted assigns.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, regardless of any provision of law or rule that might
    otherwise govern under applicable principles of conflicts of law thereof.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Consent to Jurisdiction; Service of Process; Venue</u>. Subject to Section 1.5(g) of the Existing CVR Agreement, each of the parties to this Agreement and the Holders (a) irrevocably
    consents to the service of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the transactions contemplated by this Agreement, for and on
    behalf of itself or any of its properties or assets, in accordance with Section 4.1 of the Existing CVR Agreement or in such other manner as may be permitted by applicable Law, but nothing in this <u>Section 4.5</u> shall affect the right of any
    parties to this Agreement and the Holders to serve legal process in any other manner permitted by applicable Law&#894; (b) irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive
    jurisdiction of the Chosen Courts in the event any dispute or controversy arises out of this Agreement or the transactions contemplated in this Agreement, or for recognition and enforcement of any judgment in respect thereof&#894; (c) agrees that it will
    not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any Chosen Court&#894; (d) agrees that any Legal Proceedings arising in connection with this Agreement or the transactions contemplated in this Agreement
    shall be brought, tried and determined only in the Chosen Courts&#894; (e) waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient
    court and agrees not to plead or claim the same&#894; and (f) agrees that it will not bring any Legal Proceeding relating to this Agreement or the transactions contemplated hereby or thereby in any court other than the Chosen Courts. Each of parties to this
    Agreement and the Holders agrees that a final judgment in any Legal Proceeding in the Chosen Courts shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable Law.</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">4</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>. This Agreement and any amendments to this Agreement may be executed in one or more textually identical counterparts, all of which will be considered one and the same
    agreement and will become effective when one or more counterparts have been signed by each of the parties to this Agreement and delivered to the other parties to this Agreement and the Holders, it being understood that all parties to this Agreement
    need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or.pdf .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#8220;<font style="font-weight: bold;">Electronic Delivery</font>&#8221;), will be
    treated in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party to this Agreement or Holder may raise
    the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a contract, and each party
    to this Agreement and Holder forever waives any such defense, except to the extent such defense relates to lack of authenticity. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in or relating to this Agreement or any
    document to be signed in connection with this Agreement shall be deemed to include electronic signatures, including without limitation, digital signature provided by DocuSign, each of which shall be of the same legal effect, validity or enforceability
    as a manually executed signature. Parent agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Agent, including without limitation the risk of Agent acting on unauthorized
    instructions, and the risk of interception and misuse by third parties.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Headings</u>. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void or
    unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties to this Agreement and
    the Holders. The parties to this Agreement and the Holders further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and
    other purposes of such void or unenforceable provision&#894; provided, however, that if such excluded provision shall materially and adversely affect the rights, immunities, liabilities, duties or obligations of the Agent, the Agent shall be entitled to
    resign immediately upon written notice to the Company.</div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 72pt;">4.9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Entire Agreement</u>. This Agreement, the Existing CVR Agreement, as modified by this Agreement, and the Plan represent the entire understanding of Parent and the Holders with
    reference to the CVRs, and this Agreement supersedes any and all other oral or written agreements hereto made with respect to the CVRs. As between the Agent and Parent, this Agreement (including any schedules, annexes and exhibits hereto and the
    documents and instruments referred to herein) contain the entire understanding of the parties hereto with reference to the CVRs and matters contemplated hereby and supersedes all prior agreements, written or oral, among the parties with respect
    thereto.</div>
  <div><br>
  </div>
  <div style="text-align: center;">[Signature Page Follows]</div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">5</font></div>
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
  </div>
  <div><br>
  </div>
  <div style="text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.</div>
  <div><br>
  </div>
  <div style="text-align: justify;"><br>
  </div>
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z2ede7bb9f02a40328ec41feebf4c19ba" border="0" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">COREWEAVE, INC.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="2" style="vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 4.05%; vertical-align: top;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td style="width: 45.95%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 4.05%; vertical-align: top;">&#160;</td>
        <td style="width: 45.95%; vertical-align: top;">
          <div style="text-align: justify;">Name:</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 4.05%; vertical-align: top;">&#160;</td>
        <td style="width: 45.95%; vertical-align: top;">
          <div style="text-align: justify;">Title:</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zff8f4a91cab14f65b979b4b077f3b508" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 49.86%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">CORE SCIENTIFIC, INC.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 49.86%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 49.86%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 49.86%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 9.68%; vertical-align: top;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td colspan="2" style="width: 40.32%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 9.68%; vertical-align: top;">&#160;</td>
        <td style="width: 7.8%; vertical-align: top;">
          <div style="text-align: justify;">Name:</div>
        </td>
        <td style="width: 32.51%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 9.68%; vertical-align: top;">&#160;</td>
        <td style="width: 7.8%; vertical-align: top;">
          <div style="text-align: justify;">Title:</div>
        </td>
        <td style="width: 32.51%; vertical-align: top;">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z695cdd5a76174394a0aa1dba83da3731" cellpadding="0" cellspacing="0">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 50%; vertical-align: top;">
          <div style="text-align: justify; font-weight: bold;">COMPUTERSHARE INC. and</div>
          <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; font-weight: bold;">COMPUTERSHARE TRUST COMPANY, N.A.</div>
          <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; font-weight: bold;">as Agent</div>
          <div>&#160;</div>
          <div style="text-align: justify; text-indent: -18pt; margin-left: 18pt; font-weight: bold;">On behalf of both entities:</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td colspan="3" style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        <td rowspan="1" colspan="3" style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        <td rowspan="1" colspan="3" style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 10.37%; vertical-align: top;">
          <div style="text-align: justify;">By:</div>
        </td>
        <td colspan="2" style="width: 39.63%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 10.37%; vertical-align: top;">&#160;</td>
        <td style="width: 8.42%; vertical-align: top;">
          <div style="text-align: justify;">Name:</div>
        </td>
        <td style="width: 31.21%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 10.37%; vertical-align: top;">&#160;</td>
        <td style="width: 8.42%; vertical-align: top;">
          <div style="text-align: justify;">Title:</div>
        </td>
        <td style="width: 31.21%; vertical-align: top;">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <div style="text-align: center;">[<font style="font-style: italic;">Signature Page to Assignment, Assumption and Amendment Agreement</font>]<br>
  </div>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" noshade="noshade"></div>
  </div>
  <div style="text-align: center;"><u>ANNEX A</u></div>
  <div><br>
  </div>
  <div style="text-align: center;">EXISTING CVR AGREEMENT</div>
  <div>
    <center>
      <div style="width:100%" align="left">
        <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="right"><b>Execution Version </b></p>
        <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>CONTINGENT VALUE RIGHTS AGREEMENT </b></p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">This CONTINGENT VALUE RIGHTS AGREEMENT (including the definitions set forth on <u>Annex</u><u>&#160;A</u> and the provisions set forth on <u>Annex B</u>
          hereto, this &#8220;<b>Agreement</b>&#8221;), dated as of January&#160;23, 2024, is by and between Core Scientific, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;) and Computershare Inc., a Delaware corporation (&#8220;<b>Computershare</b>&#8221;) and its affiliate,
          Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent (the &#8220;<b>Agent</b>&#8221;). </p>
        <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>RECITALS </b></p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, on December&#160;21, 2022, the Company and each of its debtor affiliates, as debtors and debtors in possession (such affiliates, the &#8220;<b>Debtor
            Affiliates</b>&#8221;) commenced voluntary cases, captioned <i>In re Core Scientific Inc., et al.</i>, Case No.&#160;22 90341 (CML), under Chapter&#160;11 of Title&#160;11 of the United States Code, 11 U.S.C. &#167;&#167; 101&#8211;1532, as amended (the &#8220;<b>Bankruptcy Code</b>&#8221;)
          in the United States Bankruptcy Court for the Southern District of Texas (the &#8220;<b>Bankruptcy Court</b>&#8221;); </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, on January&#160;16, 2024, the Bankruptcy Court confirmed the Fourth Amended Joint Chapter&#160;11 Plan of Core Scientific, Inc. and its Affiliated
          Debtors (With Technical Modifications) Docket No.&#160;1722 (the &#8220;<b>Plan</b>&#8221;); </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, pursuant to the terms and conditions of the Plan, on the Effective Date, the Company will issue and deliver to holders of April Convertible
          Notes Secured Claims and August Convertible Notes Secured Claims (each as defined in the Plan) contingent payment obligations, in the form of the CVRs (as defined herein) contemplated by this Agreement; </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, the number of CVRs to be issued pursuant to this Agreement is 51,783,625 CVRs; </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, the Company desires that the Agent act on behalf of the Company, and the Agent is willing to act in connection with the contingent payments
          obligations in respect of the CVRs; and </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">WHEREAS, contemporaneously with the Company&#8217;s entry into this Agreement, the Company has executed that certain calculation agent agreement (the &#8220;<b>Calculation








            Agent Agreement</b>&#8221;), dated as of January&#160;23, 2024, by and between the Company and Delaware Trust Company (&#8220;<b>Delaware Trust</b>&#8221;) pursuant to which Delaware Trust has agreed to act as Calculation Agent, and references to such role in this
          Agreement shall be undertaken by Delaware Trust (the &#8220;<b>Calculation Agent</b>&#8221;). </p>
        <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows: </p>
        <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ARTICLE I </b></p>
        <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>CONTINGENT VALUE RIGHTS </b></p>
        <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z36c44afdd1034bba93fe5d73920072a1" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td align="left" valign="top" width="4%">1.1</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Contractual Rights; Initial Holders of CVRs; Appointment of CVR Agent</u>. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z7e24c59036e14dba9bf458a5a390b4e8" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(a)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The CVRs represent the contractual rights of the Holders to receive the Payment Amounts (as defined herein), if any, pursuant to and in accordance with the terms and conditions of
                  this Agreement. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z382b811ecc1e4827911b19e1cc320f8e" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(b)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Pursuant to the terms of the Plan, each holder of a Convertible Notes Secured Claim (as defined in the Plan) that receives a distribution of New Common Interests pursuant to the
                  Convertible Noteholders Equity Distribution (as defined in the Plan) shall be an initial Holder. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z044309e4242a401c9c9ec431781e6af8" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(c)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company hereby appoints the Agent to act as CVR agent in accordance with the express terms and conditions set forth in this Agreement (and no implied terms or conditions), and
                  the Agent hereby accepts such appointment. </p>
              </td>
            </tr>

        </table>
        <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
        <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">1 </p>
      </div>
    </center>
  </div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
  </div>
  <div>
    <center>
      <div style="width:100%" align="left">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1d491cc334c34e458c0cf5cce5911656" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td align="left" valign="top" width="4%">1.2</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Transferability</u>. Subject to Section&#160;1 of <u>Annex B</u> hereof, the CVRs shall be freely transferable and publicly tradeable by each Holder without the prior consent of
                  the Company, the Agent or any other Person; provided, subject to Section&#160;1.5(i), that the Company and the Agent may require (i)&#160;payment of a sum sufficient to cover any documentary, stamp, transfer or other similar Tax or charge that is
                  imposed in connection with any such transfer or (ii)&#160;that the transferor establish to the reasonable satisfaction of the Company and the Agent that any such Taxes have been paid. The Agent shall have no obligation or duty to monitor,
                  determine or inquire as to compliance with any restrictions on transfer or exchange imposed under this Agreement or under applicable law with respect to any transfer or exchange of any interest in any CVR other than to require delivery of
                  such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by the terms of, this Agreement, and to examine the same to determine substantial compliance as to form with
                  the express requirements hereof. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z902690ce1ce64c67afef55d9975a6452" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td align="left" valign="top" width="4%">1.3</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Exemption from Securities Registration at Issuance</u>. The issuance of the CVRs is exempt from registration under the Securities Act of 1933, as amended (the &#8220;<b>Securities
                    Act</b>&#8221;), pursuant to the exemption provided by Section&#160;1145 of the Bankruptcy Code. The CVRs shall not be considered a &#8220;debt security.&#8221; </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zac3911b7bbb743759f8d0d3fad6b49f4" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td align="left" valign="top" width="4%">1.4</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>No Certificate; Registration; Change of Address; CUSIP Number</u>. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze5d5855a214e49b89ad4002d334896a1" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(a)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The CVRs shall be issued (1)&#160;to Holders in book-entry form on the CVR Register (as defined below), in customary form and substance (a &#8220;<b>Book-Entry CVR</b>&#8221;) or (2)&#160;in the form
                  of one or more global certificates (the &#8220;<b>Global CVRs</b>&#8221;), substantially in the form appended hereto as <u>Annex C</u>. The CVRs shall not be evidenced by a physical certificate. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z189fe93e8bd7467ca745c4a8406712f6" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(b)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Subject to the Company furnishing to the Agent the list of Holders, the Agent shall keep a register (the &#8220;<b>CVR Register</b>&#8221;) for the purpose of (i)&#160;identifying the Holders of
                  the CVRs and (ii)&#160;documenting the CVRs, which CVR Register may be amended from time to time by the Agent to reflect any changes to Holders or the applicable number of CVRs as permitted hereunder. Until such list of Holders is furnished to
                  the Agent, the Agent shall have no duties, responsibilities or obligations with respect to keeping the CVR Register, providing notices or making payments to such Holders. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z05c088ef34e34584bc07ceac3fbf1d2b" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(c)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Global CVRs issued shall be deposited with the Agent as custodian for the Depositary and registered in the name of Cede&#160;&amp; Co., or such other entity designated by the
                  Depositary as the Depositary&#8217;s nominee, in accordance with the Global CVR provisions set out in <u>Annex B</u> hereto. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zab70cf3b957c4efcb9e91707a02457da" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(d)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">On the terms and subject to the conditions of this Agreement, in accordance with the terms of the Plan, the Company will issue the CVRs in the amounts and to the recipients
                  specified in the Plan. Upon written order of the Company, the Agent shall (i)&#160;register in the CVR Register the Book-Entry CVRs and (ii)&#160;deliver or cause to be delivered to the Depositary one or more Global CVRs evidencing the CVRs. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zaaa9c51cc54e47059ee6c595388ebb70" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(e)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">A Holder may make a written request to the Agent to change such Holder&#8217;s address of record in the CVR Register. Such written request must be duly executed by such Holder. Upon
                  receipt of such written request, the Agent shall promptly record the change of address in the CVR Register. </p>
              </td>
            </tr>

        </table>
        <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za578f4b97bf24f59a484a4b42659026f" border="0" cellpadding="0" cellspacing="0" width="100%">

            <tr style="page-break-inside:avoid">
              <td width="4%">&#160;</td>
              <td align="left" valign="top" width="5%">(f)</td>
              <td align="left" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The CUSIP number of the CVRs is 21874A 122. Each of the Company and the Agent shall use such CUSIP number (or any equivalent number, to the extent CUSIP numbers are no longer
                  generally in use) for all applicable bookkeeping purposes in connection with the CVRs. The Company and the Agent shall use such CUSIP number in notices in connection with the CVRs as a convenience to Holders; <i>provided</i>,<i> however</i>,
                  that any such notice from the Company or the Agent may state that no representation is made as to the correctness of such number and any such notice shall not be affected by any defect in or omission of such number. The Company shall
                  promptly notify, or shall cause the Agent to promptly notify, the Calculation Agent and the Holders in writing of any change in the CUSIP number of the CVRs. </p>
              </td>
            </tr>

        </table>
        <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
        <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">2 </p>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
        </div>
      </div>
    </center>
  </div>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zf73d118b93b44c9c86b8f0855d39f3aa" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(g)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The initial Holder of the Global CVR shall be Cede&#160;&amp; Co. as nominee for the Depositary. The Agent will have no responsibility whatsoever directly to the street name holders with
                respect to transfers of Global CVRs. With respect to any payments or issuances to be made under Section&#160;1.5 below, the Agent will accomplish the payment to any former street name holders of Global CVRs by sending one lump sum payment or
                issuance to the Depositary. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z9543fb6fa60b48f0826e51eb0edabf93" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.5</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Testing Periods; Payment Amounts; Payment Procedures; Dispute Resolution; Record Date; Deduction or Withholding; Undelivered Payment Amounts; Liquidated Damages; Availability of
                  Agreement to Holders</u>. Contingent payments pursuant to the CVRs shall be made, to the extent payable, to the Holders after each of the First Testing Date, the Second Testing Date and the Third Testing Date, in each case as defined
                below and pursuant to the procedures set forth herein. The calculations called for herein shall be made by the Calculation Agent. All distributions made hereunder shall be made to Holders as of the close of business on the date of the
                applicable Testing Date (each such date, the record date for purposes of determining the Holders entitled to receive the corresponding Payment Amount)&#160;(1) with respect to cash payments, (i)&#160;in the case of Book-Entry CVRs held on the CVR
                Register, (a)&#160;with respect to any such Holder that has not provided the Agent wiring instructions in writing as of the close of business on the date of the applicable Testing Date, by check mailed to the address of such Holder reflected in
                the CVR Register as of 5:00 p.m. New York City time on the date of the applicable Testing Date, or (b)&#160;with respect to any such Holder that has provided the Agent wiring instructions in writing as of the close of business on the date of the
                applicable Testing Date, by wire transfer of immediately available funds to the account specified on such instruction, or (ii)&#160;in the case of Global CVRs, to beneficial holders in accordance with applicable rules and procedures of DTC or
                (2)&#160;with respect to distributions of New Common Interests, (i)&#160;in the case of Holders who hold their CVRs on the CVR Register, issue in the name of the Holder on the books and records of the Transfer Agent; or (ii)&#160;in the case of Global
                CVRs, issue to beneficial holders in accordance with applicable rules and procedures of DTC. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4fd075e51f024d9aa14654ceb2ed8502" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The first testing period shall begin on the Effective Date and end on the first anniversary of the Effective Date (the first anniversary of the Effective Date, the &#8220;<b>First Testing
                  Date</b>&#8221;). On or before 10:00 a.m. (New York City time) on a Business Day within thirty-five (35)&#160;calendar days following the First Testing Date, subject to the Dispute Resolution Procedures, the Company shall, if required pursuant to
                this Section&#160;1.5(a), make a payment to the Agent, and the Agent shall transfer such funds promptly, and in no event later than five (5)&#160;Business Days following the receipt of each such payment, to Holders or DTC for the benefit of the
                corresponding beneficial owners of CVRs, as applicable, in each case in accordance with this Section&#160;1.5 and pursuant to the terms set forth herein (the &#8220;<b>Year</b><b>&#160;1 Contingent Payment Obligation</b>&#8221;), in cash (in United States
                Dollars) in immediately available funds equal to the lesser of (i) $43,333,333.33 and (ii)&#160;the difference between (a) $260,000,000 and (b)&#160;the Fair Market Value of the Corresponding New Common Interests (the &#8220;<b>First Anniversary Payment
                  Amount</b>&#8221;); <i>provided</i>, <i>however</i>, that to the extent that the Fair Market Value of the Corresponding New Common Interests is equal to or in excess of $260,000,000, the Company shall not owe any amounts to any Holder with
                respect to the First Testing Date, and for purposes of this Agreement, the Year&#160;1 Contingent Payment Obligation shall be extinguished and be deemed to equal zero, and the Company shall provide an Officer&#8217;s Certificate to the Agent stating
                as such, substantially in the form of <u>Exhibit D</u> hereof. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd83078cc4e8048709cf84de5fff1de50" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The second testing period shall begin on day after the first anniversary of the Effective Date and end on the second anniversary of the Effective Date (the second anniversary of the
                Effective Date, the &#8220;<b>Second Testing Date</b>&#8221;). Within thirty-five (35)&#160;calendar days following the Second Testing Date, subject to the Dispute Resolution Procedures, the Company shall, as applicable pursuant to this Section&#160;1.5(b),
                (i)&#160;make a payment to the Agent, and the Agent shall transfer such funds promptly, and in no event later than five (5)&#160;Business Days following the receipt of each such payment, to Holders or DTC for the benefit of the corresponding
                beneficial owners of CVRs, as applicable, in each case in accordance with this Section&#160;1.5 and pursuant to the terms set forth herein, or (ii)&#160;furnish to the Agent the Requisite New Common Interests Payment Documentation, in each case
                pursuant to the terms set forth herein (the &#8220;<b>Year</b><b>&#160;2 Contingent Payment Obligation</b>&#8221;), relating, as applicable, to a payment in cash (in United States Dollars) in immediately available funds or a number of New Common Interests
                (rounded up to the nearest whole New Common Interest), or a combination of the foregoing, in the Company&#8217;s sole discretion, equal to the lesser of (i) </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">3 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z37b39f3ef3394db9af18208fe8fbf5e1" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> $43,333,333.33 and (ii)&#160;the difference between (a) $260,000,000 minus the First Anniversary Payment Amount and (b)&#160;the Fair Market Value of the Corresponding New Common Interests (the &#8220;<b>Second Anniversary
                Payment Amount</b>&#8221;); <i>provided</i>, <i>however</i>, that to the extent that the Fair Market Value of the Corresponding New Common Interests is equal to or in excess of the difference of (x) $260,000,000 minus (y)&#160;the First Anniversary
              Payment Amount, the Company shall not owe any amounts to any Holder with respect to the Second Testing Date, and the Year&#160;2 Contingent Payment Obligation shall be extinguished and be deemed to equal zero, and the Company shall provide an
              Officer&#8217;s Certificate to the Agent stating as such, substantially in the form of <u>Exhibit D</u> hereof. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zabaa767598e04096a976a083e022cc11" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(c)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The third testing period shall begin on the day after the second anniversary of the Effective Date and end on the third anniversary of the Effective Date (the third anniversary of
                the Effective Date, the &#8220;<b>Third Testing Date</b>&#8221; and, together with the First Testing Date and the Second Testing Date, each, a &#8220;<b>Testing Date</b>&#8221;). Within thirty-five (35)&#160;calendar days following the Third Testing Date, subject to
                the Dispute Resolution Procedures, the Company shall, as applicable pursuant to this Section&#160;1.5(c), (i)&#160;make a payment to the Agent, and the Agent shall transfer such funds promptly, and in any event no later than five (5)&#160;Business Days
                following the receipt of each such payment, to Holders or DTC for the benefit of the corresponding beneficial owners of CVRs, as applicable, in each case in accordance with this Section&#160;1.5 and pursuant to the terms set forth herein, or
                (ii)&#160;furnish to the Agent the Requisite New Common Interests Payment Documentation, in each case pursuant to the terms set forth herein (the &#8220;<b>Year</b><b>&#160;3 Contingent Payment Obligation</b>&#8221; and together with the Year&#160;1 Contingent
                Payment Obligation and the Year&#160;2 Contingent Payment Obligation, the &#8220;<b>Contingent Payment Obligations</b>&#8221;), relating, as applicable, to a payment in cash (in United States Dollars) in immediately available funds or a number of New Common
                Interests (rounded up to the nearest whole New Common Interest), or a combination of the foregoing, in the Company&#8217;s sole discretion, equal to the lesser of (i) $43,333,333.33 and (ii)&#160;the difference between (a) $260,000,000 minus the sum
                of the First Anniversary Payment Amount and the Second Anniversary Payment Amount and (b)&#160;the Fair Market Value of the Corresponding New Common Interests (the &#8220;<b>Third Anniversary Payment Amount</b>&#8221; and, together with the First
                Anniversary Payment Amount and the Second Anniversary Payment Amount, the &#8220;<b>Payment Amounts</b>&#8221; and each a &#8220;<b>Payment Amount</b>&#8221;); <i>provided</i>, <i>however</i>, that to the extent that the Fair Market Value of the Corresponding
                New Common Interests is equal to or in excess of the difference of (x) $260,000,000 minus (y)&#160;the sum of the First Anniversary Payment Amount and the Second Anniversary Payment Amount, the Company shall not owe any amounts to any Holder
                with respect to the Third Testing Date, and the Year&#160;3 Contingent Payment Obligation shall be extinguished and be deemed to equal zero, and the Company shall provide an Officer&#8217;s Certificate to the Agent stating as such, substantially in
                the form of <u>Exhibit D</u> hereof. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z06ecec24562b4342b1337219b46142d7" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(d)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Calculation Agent, in consultation with the Company and in accordance with the Calculation Agent Agreement, shall determine each Payment Amount pursuant to the terms hereof and
                the terms of the Calculation Agent Agreement. Within three (3)&#160;Business Days after each Testing Date, the Calculation Agent, in consultation with the Company, shall deliver to the Company and the Agent a written notice stating (1)&#160;the date
                of such Testing Date and (2)&#160;the aggregate Payment Amount (if any) with respect to such Testing Date (including, in reasonable detail, the calculation thereof); <i>provided</i>, <i>that</i>, in the event of any dispute between the
                Calculation Agent and the Company with regard to the amount of such aggregate Payment Amount, the Company&#8217;s determination as to such aggregate Payment Amount shall be conclusive, subject to the terms and conditions of this Agreement. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z727263d768b6414b87f759cf46c3100d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(e)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Within five (5)&#160;Business Days after each Testing Date, the Company shall cause the Agent to deliver to each Holder a written notice stating (1)&#160;the date of such Testing Date,
                (2)&#160;the aggregate Payment Amount (if any) with respect to such Testing Date (including, in reasonable detail, the calculation thereof), (3) the corresponding <font style="white-space:nowrap">per-CVR</font> Payment Amount (if any)
                (including, in reasonable detail, the calculation thereof), (4) with respect to the Second Anniversary Payment Amount and Third Anniversary Payment Amount (if any), the Company&#8217;s determination as to whether such Payment Amount will be made
                in cash (in United States Dollars) or New Common Interests (or both) and if </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">4 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zdf0dff08846d4609a0e6a2beab783ec1" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> to be paid in whole or in part in New Common Interests, the number of New Common Interests that such Holder will receive, and (5)&#160;the corresponding Objection Deadline (as defined below) by which such Holder must
              object in connection with the contents of such written notice (such written notice, a &#8220;<b>Payment Triggering Event Notice</b>&#8221;, the form of which is attached hereto as <u>Exhibit</u><u>&#160;A</u>). </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4d88b1250ca24f06bdb2b602d80b9bf1" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(f)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Holders of not less than fifteen percent (15%) of the aggregate outstanding CVRs (collectively, the &#8220;<b>Objecting Holders</b>&#8221;) shall have ten (10)&#160;Business Days following the
                date on which a Payment Triggering Event Notice is sent pursuant to Section&#160;1.5(e) hereof (the &#8220;<b>Objection Deadline</b>&#8221;) to object in writing to the aggregate Payment Amount (including the calculation thereof), the corresponding <font style="white-space:nowrap">per-CVR</font> Payment Amount (if any) and the number of New Common Interests to be paid in connection with such Payment Amount (if applicable) in such Payment Triggering Event Notice (such written objection, a
                &#8220;<b>Payment Amount Objection Notice</b>&#8221;, the form of which is attached hereto as <u>Exhibit</u><u>&#160;B</u>) and deliver such Payment Amount Objection Notice to the Company, <i>provided that</i>, for the avoidance of doubt, such Payment
                Amount Objection Notice is only properly delivered to the Company if the aggregate number of CVRs represented by all Payment Objection Notices delivered is not less than fifteen percent (15%) of the outstanding CVRs. To the extent the
                Objecting Holders timely deliver a Payment Amount Objection Notice to the Company, the Calculation Agent (solely with respect to such Payment Amount), the Company, and such Objecting Holders shall have five (5)&#160;Business Days following the
                receipt of such Payment Amount Objection Notice (the &#8220;<b>Resolution Date</b>&#8221;) to amicably resolve in good faith any disagreement, dispute, difference or question in connection with such Payment Amount (including the calculation thereof),
                the corresponding <font style="white-space:nowrap">per-CVR</font> Payment Amount (if any) and the number of New Common Interests to be paid in connection with such Payment Amount (if applicable) (an &#8220;<b>Amicable Resolution</b>&#8221;). To the
                extent the Calculation Agent, in consultation with the Company, must amend the Payment Triggering Event Notice to make a correction, the Company shall promptly, and in any event no later than four (4)&#160;calendar days after the Resolution
                Date, deliver or cause the Agent to deliver to each Objecting Holder, such amended Payment Triggering Event Notice. The Company and each Objecting Holder shall have three (3)&#160;Business Days following the date on which such amended Payment
                Triggering Event Notice is sent by the Company or the Agent pursuant to this Section&#160;1.5(f) (the &#8220;<b>Second Objection Deadline</b>&#8221;) to object in writing thereto by delivering a Payment Amount Objection Notice in relation thereto to the
                Company (which the Company shall promptly then provide to the Calculation Agent). In the event (i)&#160;no Payment Amount Objection Notice is delivered by the Objection Deadline, (ii)&#160;an Amicable Resolution is achieved by the Resolution Date,
                (iii)&#160;no Payment Amount Objection Notice is delivered by the Second Objection Deadline or (iv)&#160;a Payment Amount Objection Notice is delivered by the Second Objection Deadline, in each case, as applicable, the Company shall promptly pay to
                the Agent, and the Agent shall, promptly, and in no event later than five (5)&#160;Business Days after its receipt of such funds, pay to all Holders (including any Objecting Holders) any corresponding Payment Amount pursuant to Sections 1.5(a),
                1.5(b), or 1.5(c), or in accordance with such Amicable Resolution, as applicable. In the event the procedures set forth in Section&#160;1.5(g) are conducted, the Company shall promptly pay any corresponding Payment Amount to the Holders
                (including any Objecting Holders) in accordance with the immediately preceding sentence without delaying such payment until the conclusion of the procedures set forth in Section&#160;1.5(g). For the avoidance of doubt, the Objecting Holders will
                (i)&#160;be paid the corresponding Payment Amount due to the Holders, concurrently with the other Holders, pursuant to this Section&#160;1.5(f) in accordance with the immediately preceding sentence, and (ii)&#160;be paid any corresponding amount equal to
                the difference between the Disputed Payment Amount (as defined below) due to the Objecting Holders pursuant to Section&#160;1.5(g) and the Payment Amount paid to the Objecting Holders pursuant to Section&#160;1.5(f) upon the conclusion of the
                procedures set forth in Section&#160;1.5(g). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zf09ce459ef69492f886d8fc74947d50a" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(g)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">In the event of any continuing disagreement, dispute or difference among any of the Calculation Agent, the Company and the Objecting Holders in connection with the aggregate Payment
                Amount, the corresponding <font style="white-space:nowrap">per-CVR</font> Payment Amount or the number of New Common Interests to be paid in connection with such Payment Amount (if applicable) to the Objecting Holders (such disputed
                Payment Amount with respect to the Objecting Holders, the &#8220;<b>Disputed Payment Amount</b>&#8221;), after the procedures set forth in Section&#160;1.5(f) have been conducted, which dispute cannot be amicably </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">5 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z2f12520b8d084d48a5e0214529be66f4" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> resolved by the good faith efforts of the Calculation Agent (solely with respect to the Disputed Payment Amount), the Company and the Objecting Holders on or prior to the later of the (x)&#160;Resolution Date and
              (y)&#160;Second Objection Deadline, then such dispute shall be resolved by binding arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association. The arbitration panel shall be composed of three
              arbitrators, one of whom shall be chosen by the Company, one by the Majority of Objecting Holders, and the third by the two arbitrators so chosen; <i>provided</i>, <i>however</i>, that if the Calculation Agent is involved with a dispute
              regarding the Disputed Payment Amount, the third arbitrator on the arbitration panel shall be chosen by the Calculation Agent. If all or either of the Company, the Majority of Objecting Holders or the Calculation Agent, if applicable, fails
              to choose an arbitrator or arbitrators within fourteen (14)&#160;calendar days after receiving notice of commencement of arbitration, or if the two arbitrators fail to choose a third arbitrator within fourteen (14)&#160;calendar days after their
              respective appointments, the President of the American Arbitration Association shall, upon the request of all or any of the Company, the Majority of Objecting Holders or the Calculation Agent, if applicable, appoint or cause to be appointed
              the arbitrator or arbitrators required to complete the board or, if he or she shall decline or fail to do so, such arbitrator or arbitrators shall be appointed by the New York office of the American Arbitration Association. The decision of
              the arbitrators shall be by majority vote and, at the request of any of the Company, the Majority of Objecting Holders or the Calculation Agent, if applicable, the arbitrators shall issue a written opinion of findings of fact and conclusions
              of law, a copy of which shall be promptly provided to the Agent and the Calculation Agent by the Company. Costs shall be borne between the Company and the Objecting Holders, as determined by the arbitrators. Unless the Company, the Majority
              of Objecting Holders and the Calculation Agent, if applicable, shall otherwise agree to a place of arbitration, the place of arbitration shall be at New York, New York, U.S.A. The arbitration award shall be final and binding upon the Company,
              the Agent, the Calculation Agent and Objecting Holders and may be entered in any court having competent jurisdiction pursuant to this Agreement. Promptly, and no later than 10:00 a.m. (New York City time) on a Business Day within five
              (5)&#160;calendar days thereafter, upon a final arbitration award being awarded, (i)&#160;the Agent shall deliver to each Objecting Holder a notice of the arbitration award and (ii)&#160;the Company shall make a cash (in United States Dollars) payment to
              the Agent, or issue New Common Interests to the Objecting Holders as set forth in this Agreement, in each case to the extent applicable, and the Agent shall, promptly, and in no event later than five (5)&#160;Business Days following receipt of
              such funds, transfer such funds to the Objecting Holders, in each case in accordance with this Section&#160;1.5 and pursuant to the terms set forth herein, of the corresponding amount equal to the difference between the Disputed Payment Amount and
              the Payment Amount paid to the Objecting Holders pursuant to Section&#160;1.5(f) (consistent with such final arbitration award), if applicable. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd3f3dd7807c841e789175188559b383e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(h)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company shall set a record date for purposes of determining the Holders entitled to vote or consent to any action authorized or permitted under this Agreement. The record date
                in connection with any vote or consent to take any action by the Holders under this Agreement shall be the date that is ten (10)&#160;Business Days prior to the first solicitation of such vote or consent or such other date as the Company may
                select. No vote or consent to any action authorized or permitted under this Agreement, except with respect to Sections&#160;1.5(f) and&#160;1.5(g) hereof, shall be valid or effective if taken or made more than one hundred twenty (120)&#160;calendar days
                after the corresponding record date. If a record date is set, only the Holders as of such date shall be entitled to vote or consent to any action permitted under this Agreement, as applicable. The Company shall provide the Holders at least
                ten (10)&#160;Business Days&#8217; notice of any record date set pursuant to this Section&#160;1.5(h). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zab70c6cc2bf0453fb75be9c5ec6a5bc8" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(i)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">All Payment Amounts shall be paid free and clear of and without any withholding or deduction, except to the extent required by applicable Law. To the extent required by applicable
                Laws, the Company, the Agent and any other applicable withholding agent shall be entitled to deduct or withhold, or cause to be deducted or withheld, from any amount payable hereunder, such Taxes as are required to be deducted or withheld
                as reasonably determined by such applicable withholding agent. To the extent that any amounts are so deducted or withheld, such deducted or withheld amounts shall be properly remitted to the appropriate taxing authority and will be treated
                for all purposes of this Agreement as having been paid or distributed to the Holder in respect of which such </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">6 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z437f82e1dfb44864832104f6cbc7db5e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> deduction or withholding was made. No later than seventy-five (75)&#160;calendar days prior to the first Testing Date to occur after it becomes a Holder under this Agreement, or if less than seventy-five (75)&#160;calendar
              days remain to the next Testing Date, on the date that it becomes a Holder under this Agreement, a Holder shall deliver to the Company, the Agent and any applicable withholding agent an Internal Revenue Service <font style="white-space:nowrap">Form&#160;W-8</font> or Internal Revenue Service <font style="white-space:nowrap">Form&#160;W-9</font> or equivalent applicable form that is reasonably acceptable to the Company or the Agent, as applicable, to permit any
              payment of any Payment Amount to be made without deduction or withholding of any United States backup withholding Taxes. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z6b84204641554e9ba57a020b6abaaccf" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(j)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">If any Payment Amount (or portion thereof, as applicable) is not able to be delivered to a Holder, or the corresponding Participants or beneficial owners of the CVRs (including as a
                result of uncashed checks, invalid DTC account address information or invalid information on the CVR Register) or otherwise remains unclaimed by a Holder on the date that is two (2)&#160;years after the date on which such Payment Amount became
                due and payable in accordance with this Agreement (or immediately prior to such earlier date on which such Payment Amount (or portion thereof, as applicable) would otherwise escheat to or become the property of any Governmental Authority),
                then: (i)&#160;such Payment Amount (or portion thereof, as applicable) will, to the extent permitted by applicable Law, become the property of the Company, free and clear of all claims or interest of any Person previously entitled thereto, and
                (ii)&#160;no consideration or compensation shall be payable therefor. Neither the Company nor the Agent will be liable to any Person in respect of such Payment Amount (or portion thereof, as applicable) delivered to a Governmental Authority
                pursuant to any applicable abandoned property, escheat or similar legal requirement under applicable Law, pursuant to this Section&#160;1.5(j). In addition to and not in limitation of any other indemnity obligation herein, the Company agrees to
                indemnify and hold harmless the Agent with respect to any liability, penalty, cost or expense that the Agent may incur or be subject to in connection with transferring such property to the Company. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z9a0042eb7c4945098381ae95593d147c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(k)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Upon the occurrence of a Company Bankruptcy Event or the Company&#8217;s failure, for any reason, to timely pay in full any owed Payment Amount (subject to the Dispute Resolution
                Procedures) in accordance with the terms of this Agreement (each, a &#8220;<b>Liquidated Damages Trigger Event</b>&#8221;), the Company shall pay, as liquidated damages and not as a penalty, to the Agent, and the Agent shall transfer such funds either
                (i)&#160;to Holders directly for those Holders who hold Book-Entry CVRs, or (ii)&#160;to DTC in accordance with applicable rules and procedures of DTC for the benefit of the corresponding beneficial owners of the CVRs (for the avoidance of doubt, in
                the aggregate among clauses (i)&#160;and (ii)) (x) to the extent the Year 1 Contingent Payment Obligation was not previously paid in full or extinguished pursuant to the terms of this Agreement, $43,333,333.33 in cash (in United States Dollars),
                <u>except that</u> if the First Anniversary Payment Amount was conclusively calculated prior to the occurrence of the Liquidated Damages Trigger Event, the First Anniversary Payment Amount, in each case, less any amount actually paid in
                cash (in United States Dollars) by the Company with respect to any Year&#160;1 Contingent Payment Obligation, <i>plus </i>(y)&#160;to the extent the Year&#160;2 Contingent Payment Obligation was not previously paid in full or extinguished pursuant to
                the terms of this Agreement, $43,333,333.33 in cash (in United States Dollars), <u>except that</u> if the Second Anniversary Payment Amount was conclusively calculated prior to the occurrence of the Liquidated Damages Trigger Event, the
                Second Anniversary Payment Amount, in each case, less any amount actually paid in cash (in United States Dollars) or New Common Interests by the Company with respect to any Year&#160;2 Contingent Payment Obligation<i> plus</i> (z)&#160;to the extent
                the Year&#160;3 Contingent Payment Obligation was not previously paid in full or extinguished pursuant to the terms of this Agreement, $43,333,333.33 in cash (in United States Dollars), <u>except that</u> if the Third Anniversary Payment Amount
                was conclusively calculated prior to the occurrence of the Liquidated Damages Trigger Event, the Third Anniversary Payment Amount, in each case, less any amount actually paid in cash (in United States Dollars) or New Common Interests by the
                Company with respect to any Year&#160;3 Contingent Payment Obligation. Upon the satisfaction in full of the obligations set forth in this Section&#160;1.5(k) (the &#8220;<b>Liquidated Damages Obligations</b>&#8221;), the Contingent Payment Obligations shall be
                extinguished.&#160;The Company acknowledges the impossibility of ascertaining the amount of damages that would be suffered by the Holders by reason of the failure by the Company to perform its obligations hereunder and that the Liquidated
                Damages Obligations are reasonable estimates of the damages, which the Holders will suffer or incur as a result of the event </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">7 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1949ffe7ea224f1cba97c1ab525b6d28" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> giving rise to the payment of the Liquidated Damages Obligations, and are not penalties.&#160;The Company irrevocably waives any right it may have to raise as a defense that any such liquidated damages are excessive,
              punitive or otherwise unenforceable. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8b94e0c7c96b4211a63d421bc0db0464" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(l)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Upon written request, at its sole expense the Company shall make this Agreement available to the Holders until the expiration of this Agreement and the CVRs pursuant to
                Section&#160;5.13. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z9143930414e84a1f9f84a7e090a0e846" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.6</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>No Voting, Dividends or Interest; No Equity or Ownership Interest</u>. Nothing contained in this Agreement shall be construed as conferring upon the Holder (solely in its
                capacity as the holder of CVRs) the right to vote or to receive distributions or to consent or to receive notice as a stockholder of the Company in respect of any meeting of stockholders of the Company for the election of directors of the
                Company or of any other matter, or any rights whatsoever as a stockholder of the Company. CVRs shall not represent any equity or ownership interest in the Company or any of its affiliates. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zbbd73fb315c34866936821033aae61e9" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.7</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Ability to Abandon CVRs</u>. A Holder may at any time, at such Holder&#8217;s sole option, abandon any or all of such Holder&#8217;s remaining rights in a CVR by transferring such CVR to the
                Company or its Affiliates without consideration therefor. Nothing in this Agreement shall prohibit the Company or any of its Affiliates from offering to acquire or acquiring any CVRs for consideration from the Holders, in private
                transactions or otherwise, in its sole discretion. Any CVRs acquired by the Company or any of its Affiliates shall be automatically deemed extinguished and no longer outstanding, with prompt written notification by the Company to the Agent
                of such transfer and cancellation. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za015074f66214321a837e5738546228b" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.8</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Trust Indenture Act</u>. The CVRs issued hereunder shall not constitute (i)&#160;a note, bond, debenture, evidence of indebtedness; (ii)&#160;a certificate of interest or participation in
                any such note, bond, debenture, or evidence of indebtedness; or (iii)&#160;a temporary certificate for, or guarantee of, any such note, bond, debenture, evidence of indebtedness, or certificate, in each of clauses (i), (ii)&#160;and (iii)&#160;hereof, as
                such terms are referenced in the TIA, and shall be exempt from the qualification provisions of the TIA. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zc0790a08cbe448259120711eaa2e722d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.9</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>No Fractional Shares</u>. The Company shall not be required to issue fractions of New Common Interests under this Agreement. If any fraction of a share of a New Common Interest
                would be issuable hereunder, such share shall be rounded to the next higher whole number. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ARTICLE II </b></p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>THE AGENT </b></p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z94191f0ae9fe4dacb97cc2ad0381e42d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.1</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Certain Duties and Responsibilities of the Agent</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4c5d45c7e2a54f198227ed06a6c68b0c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall not have any liability for any actions taken, suffered or omitted to be taken in connection with this Agreement, except to the extent such liability arises as a
                result of its gross negligence, bad faith, willful misconduct or fraud (each as determined by a court of competent jurisdiction in a final and <font style="white-space:nowrap">non-appealable</font> judgment). Notwithstanding anything
                contained herein to the contrary, the Agent&#8217;s aggregate liability during any term of this Agreement with respect to, arising from, or arising in connection with this Agreement, or from all services provided or omitted to be provided under
                this Agreement, whether in contract, or in tort, or otherwise, is limited to, and shall not exceed, the amounts paid hereunder by the Company to the Agent as fees and charges, but not including reimbursable expenses, during the twelve
                (12)&#160;months immediately preceding the event for which recovery from Agent is being sought. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z103df57776a641129eef7e42922e716c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall be under no obligation to institute any action, suit or legal proceeding or to take any other action likely to involve expense or liability, including, without
                limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Company. All rights of action of any or all Holders under this
                Agreement may be enforced by the Agent, including, to the extent permitted by this Agreement, pursuant to a direction by the Majority Holders, and any action, suit or proceeding instituted by the Agent shall be brought in its name as the
                Agent and any recovery in connection </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">8 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zb596f5db5352471280f58cb6fbf1a8e1" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> therewith shall be for the proportionate benefit of all the Holders, as their respective rights or interests may appear. The Holders, acting by the written consent of the Majority Holders, may direct in writing
              the Agent to act on behalf of the Holders in enforcing any of their rights hereunder. Notwithstanding anything to the contrary herein, the Agent shall be under no duty or obligation to institute any action, suit or proceeding, or to take any
              other action likely to result in the incurrence of expenses by the Agent; provided that, in the event that the Agent elects to institute any action, suit or proceeding, or to take any other action directed by the Holders, the Majority Holders
              (on behalf of all Holders) shall furnish the Agent with reasonable security and indemnity for any costs and expenses that may be incurred pursuant to an agreement in form and substance reasonably satisfactory to the Agent and shall reimburse
              the Agent for any such costs and expenses upon demand by the Agent. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zbca1ff2cb85343bea271296559de8a25" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.2</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Certain Rights of the Agent</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z6acca86e4abb4919a08580911a6c6610" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent undertakes to perform such duties and only such duties as are specifically set forth in this Agreement, and no implied covenants or obligations shall be read into this
                Agreement against the Agent. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za7dfc0b0ff32412080f4f4fe65b40947" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall be authorized and protected and shall incur no liability or responsibility to the Company or to any Holder for any action taken, suffered or omitted to be taken by
                it in reliance on any written notice, resolution, waiver, consent, order, certificate or other paper, document or instrument believed by it in the absence of bad faith to be genuine and to have been signed, sent or presented by the proper
                party or parties. The Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Agent shall be fully protected and shall incur no liability for failing to take action in
                connection therewith unless and until it has received such notice in writing. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z2208c1c5c71e43bab7b5ff9e9befdea8" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(c)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent may engage and consult with counsel, investment banking advisors, accountants or other professionals of its reasonable selection, and the advice or opinion of such outside
                counsel, investment banking advisors, accountants or other professionals shall be full and complete authorization and protection to the Agent, and the Agent shall be held harmless by the Company in respect of any action taken, suffered or
                omitted by it hereunder in the absence of bad faith and in reliance thereon. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1f6201abacbc45f28fc0bc5e1b81e087" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(d)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Any permissive rights of the Agent hereunder shall not be construed as a duty. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zdd8c0d947295488d849e223c74a4c645" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(e)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall not be required to give any note or surety in respect of the execution of such powers or otherwise in respect of such powers. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z040132e5fd1c4ca88fa6a7ef7fe9c234" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(f)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company agrees to indemnify the Agent for, and to hold the Agent harmless from and against, any loss, liability, damage, claim, judgment, fine, cost, penalty, demands, suits or
                expense (&#8220;Loss&#8221;) (whether asserted by the Company, any Holder or any third party) suffered or incurred by the Agent arising out of or in connection with the Agent&#8217;s performance of its obligations under this Agreement, including, without
                limitation, the reasonable costs and expenses of defending the Agent against any claim, charge, demand, action, suit or loss arising out of or in connection with the execution, acceptance, administration, exercise and performance of its
                duties under this Agreement, including the costs and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or enforcing its rights hereunder, except to the extent such Loss has been determined by a
                final <font style="white-space:nowrap">non-appealable</font> decision of a court of competent jurisdiction to have resulted from the Agent&#8217;s gross negligence, bad faith, willful misconduct or fraud. The Company&#8217;s obligations under this
                Section&#160;2.2(f) to indemnify the Agent shall survive the expiration of the CVRs and the termination of this Agreement and the resignation, replacement or removal of the Agent. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z847ff9ed69914fa6bc3b7d906a2642bc" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(g)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">In addition to the indemnification provided under Section&#160;2.2(f), but without duplication, the Company agrees to (i)&#160;pay the fees of the Agent in connection with the Agent&#8217;s
                performance of its obligations hereunder, as agreed upon in writing by the Agent and the Company on or prior to the </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">9 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z3817e553f6ea42eca3204e0fd47daa22" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> date of this Agreement (the &#8220;Fee Schedule&#8221;), and (ii)&#160;without limiting the foregoing (i), reimburse the Agent for all reasonable and documented <font style="white-space:nowrap"><font style="white-space:nowrap">out-of-pocket</font></font>
              expenses, including all Taxes thereon (other than income, receipt, franchise or similar Taxes) and charges of any Governmental Authority, incurred by the Agent in the preparation, delivery, negotiation, amendment, administration and execution
              of this Agreement and the exercise and performance of its duties hereunder, including any stamp and transfer Taxes. The Company&#8217;s obligations under this Section&#160;2.2(g) to compensate the Agent shall survive the expiration of the CVRs and the
              termination of this Agreement and the resignation, replacement or removal of the Agent. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z53e0599674284499b99eafd65f57ab3f" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(h)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">None of the provisions of this Agreement shall require the Agent to expend or risk its own funds or otherwise to incur any liability, financial or otherwise, in the performance of
                any of its duties hereunder, or in the exercise of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or indemnity satisfactory to it against such risk or liability is not assured to
                it. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z42f8b7bc66714e579eaea516671d31fa" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(i)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Anything in this Agreement to the contrary notwithstanding, in no event shall the Agent be liable for special, indirect, punitive, incidental or consequential loss or damage of any
                kind whatsoever (including but not limited to lost profits), even if the Agent has been advised of the likelihood of such loss or damage and regardless of the form of action. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z9d104b46abab46cbb14c7a97725ccefa" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(j)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Whenever the Agent shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Agent may rely upon an Officer&#8217;s
                Certificate, which certificate shall be full authorization and protection to the Agent, and the Agent shall, in the absence of bad faith on its part, incur no liability and be held harmless by the Company for or in respect of any action
                taken, suffered or omitted to be taken by it under the provisions of this Agreement in reliance upon such certificate. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zc185ae3969974420a5fa8fb66b6837c9" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(k)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall have no liability and shall be held harmless by the Company in respect of the validity of this Agreement or the execution and delivery hereof (except the due
                execution and delivery hereof by the Agent and the enforceability of this Agreement against the Agent assuming the due execution and delivery hereof by the Company), nor shall it be responsible for any breach by the Company of any covenant
                or condition contained in this Agreement. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z72a1dae6cab34494b528abef938cd7b4" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(l)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or through its attorneys, accountants, agents or
                other experts, and the Agent will not be liable for any act, default, neglect or misconduct of any such attorneys or agents or for any loss to the Company or the Holders resulting from any such act, default, neglect or misconduct, absent
                gross negligence, bad faith or willful misconduct in the selection and continued employment thereof (each as determined by a final <font style="white-space:nowrap">non-appealable</font> order, judgment, ruling or decree of a court of
                competent jurisdiction). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z390259aa1fad475dbc7051a4357aca18" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(m)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall not be liable for or by reason of, and shall be held harmless by the Company with respect to any of the statements of fact or recitals contained in this Agreement or
                be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z54896fb0eb1e47acb9998405179f616e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(n)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall not incur any liability for not performing any act, duty, obligation or responsibility by reason of any occurrence beyond the control of the Agent (including without
                limitation any act or provision of any present or future law or regulation or governmental authority, any act of God, war, civil disorder or failure of any means of communication, terrorist acts, pandemics, epidemics, shortage of supply,
                breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z2f6417bf4d9a4393a9994f9465bb98d9" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(o)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">In no event shall the Agent be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly,
                forces beyond its control, </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">10 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z24ea38d53da84026a82023de75011957" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top"> including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, epidemic, pandemic, disease, and
              interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, or other causes, in each case, reasonably beyond its control; it being understood that the Agent shall use reasonable efforts that
              are consistent with accepted practices in the banking industry to resume performance as soon as practicable under the circumstances. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z188b8880ed554122989199693c0683bb" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(p)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">In the event the Agent reasonably believes any ambiguity or uncertainty exists hereunder or in any notice, instruction, direction, request or other communication, paper or document
                received by the Agent hereunder, or is for any reasonably justifiable reason unsure as to what action to take hereunder, the Agent shall notify the Company in writing as soon as practicable, and upon delivery of such notice may, in its sole
                discretion, refrain from taking any action, and shall be fully protected and shall not be liable in any way to the Company or any Holder or other Person for refraining from taking such action, unless the Agent receives written instructions
                signed by the Company which eliminates such ambiguity or uncertainty to the reasonable satisfaction of the Agent. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z0768eadc11c44a34a46b283e9380b8e7" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(q)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent and the Company agree that all books, records, information and data pertaining to the business of the other party, including inter alia, personal, <font style="white-space:nowrap">non-public</font> Holder information, which are exchanged or received pursuant to the negotiation or the carrying out of this Agreement including the fees for services set forth in the Fee Schedule shall remain
                confidential, and shall not be voluntarily disclosed to any other person, except as may be required by law, including, without limitation, pursuant to subpoenas from state or federal government authorities (e.g., in divorce and criminal
                actions). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zcdf649c3820742edba229fba25654142" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(r)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent shall act hereunder solely as agent for the Company and shall not assume any obligations or relationship of agency or trust with any of the owners or holders of the CVRs.
                For the avoidance of doubt, the Agent shall not have any duty or responsibility in the case of the receipt of any written demand from any Holders with respect to any action or default by the Company, including, without limiting the
                generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at law or otherwise or to make any demand upon the Company. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z34e2ca535f524325b7d1f489cfab5a78" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(s)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Subject to applicable Law, (i)&#160;the Agent and any shareholder, Affiliate, director, officer or employee of the Agent may buy, sell or deal in any securities of the Company or become
                peculiarly interested in any transaction in which such parties may be interested, or contract with or lend money to such parties or otherwise act as fully and freely as though it were not the Agent under this Agreement, and (ii)&#160;nothing
                herein will preclude the Agent from acting in any other capacity for the Company or for any other Person. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za759916ce54242ff9cc8e2f9fb06acfe" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(t)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Computershare shall hold all funds received under this Agreement as Agent in accordance with the terms of this Agreement in a bank account at a U.S. chartered commercial bank with
                consolidated assets of $100&#160;billion or more selected by Computershare and as approved by the Company and listed in Annex D attached hereto. The Company shall have no responsibility or liability for any diminution of such funds that may
                result from any deposit made by Computershare in accordance with this paragraph, except for any loss of such funds as a result of a default by the bank where such funds are held. Computershare may from time to time receive interest and
                other earnings in connection with such deposits. The Agent shall not be obligated to pay such interest or earnings to the Company, any Holder or any other party. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z94a84080ecbe4179a7b69f8e97bee690" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.3</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Compliance Certificates and Opinions</u>. Upon any application or request by the Company to the Agent to take or refrain from taking any action under any provision of this
                Agreement, the Company shall furnish to the Agent an Officer&#8217;s Certificate stating that, in the opinion of the signer, all conditions precedent, if any, provided for in this Agreement (including any covenant compliance that constitutes a
                condition precedent, if any) relating to the proposed action have been complied with and, if requested by the Agent, an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent, if any, have been complied
                with, except that in the case of any such application or request as to which the furnishing of such documents is specifically required by any provision of this Agreement relating to such particular application or request, no additional
                certificate or opinion need be furnished. Notwithstanding the foregoing, and in accordance with </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">11 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1fe1ed25ddd74103ad37ff812974558d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top"> the Plan as confirmed by the Bankruptcy Court, in the event the Company elects to issue New Common Interests pursuant to the terms of this Agreement, no opinion shall be required from the Company in connection
              with such issuance of New Common Interests with respect to whether the New Common Interests are exempt from registration, are eligible for DTC book-entry delivery, settlement and depositary services, or validly issued, fully paid, and <font style="white-space:nowrap">non-assessable.</font> </td>
          </tr>

      </table>
      <p style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%; font-family: Times New Roman;">Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Agreement shall include: </p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zfc4d88c89b7147c68196f00af594dbc1" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">a statement that each individual signing such certificate or opinion has read such covenant or condition; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zc70e9172c81c4374be83c7a555b7fbfd" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z172024a872b745bd8c15a36cbb34ca98" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(c)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">a statement that, in the opinion of each such individual or such firm, such individual or firm has made such examination or investigation as is necessary to enable such individual
                or firm to express an informed opinion as to whether or not such covenant or condition has been complied with; and </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4d5274a628be46b5a9f759c242ff82d3" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(d)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">a statement as to whether, in the opinion of such individual, such condition or covenant has been complied with. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zffaaf11cf4e74dd4a74f1f90c3c378e6" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.4</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Resignation and Removal; Appointment of Successor</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8de1dcbe83c3406a8fe8bfc07863fced" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent may resign at any time by giving written notice thereof to the Company and the Holders specifying a date when such resignation shall take effect, which notice shall be
                sent at least thirty (30)&#160;calendar days prior to the date so specified. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z64c984d2ab5e45418e43d76bd14f9e3d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company and the Majority Holders shall each have the right to remove the Agent at any time by specifying a date when such removal shall take effect. Written notice of such
                removal shall be given by the Company or the Majority Holders to the Agent, as applicable, which notice shall be sent at least thirty (30)&#160;calendar days prior to the date so specified. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z67674c13d1b441f39d183672968d5d4a" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(c)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">If the Agent shall resign, become incapable of acting or is removed by the Company or the Majority Holders, the Company shall promptly appoint a qualified successor Agent, <i>provided,








                  that</i>, the Majority Holders may notify the Company of their preference of qualified successor Agent hereunder and the Company shall reasonably take such preference into account in its selection. The successor Agent so appointed shall,
                forthwith upon its acceptance of such appointment in accordance with this Section&#160;2.4(c) and Section&#160;2.5, become the Agent for all purposes hereunder. Notwithstanding the foregoing, if the Company and the Majority Holders fail to make such
                appointment within a period of thirty (30)&#160;days after giving notice to the Agent of such removal or after they have been notified in writing of such resignation or incapacity by the resigning or incapacitated Agent, then any Holder may
                apply to any court of competent jurisdiction for the appointment of a successor Agent. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z54a18490f64d4207b8a9518327f09cb7" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(d)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company shall give notice of each resignation or removal of the Agent and each appointment of a successor Agent through the facilities of DTC in accordance with DTC&#8217;s procedures
                and/or by mailing written notice of such event by first-class mail, postage prepaid, to the Holders as their names and addresses appear in the CVR Register. Each notice shall include the name and address of the successor Agent. If the
                Company fails to send such notice within ten (10)&#160;Business Days after acceptance of appointment by a successor Agent, the successor Agent shall cause the notice to be mailed at the expense of the Company. Failure to give any notice provided
                for in this Section&#160;2.4 shall not affect the legality or validity of the resignation or removal of the Agent or the appointment of the successor Agent, as the case may be. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">12 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z45a2195b837249d18b76747617f0a920" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(e)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Agent will cooperate with the Company and any successor Agent in connection with the transition of the duties and responsibilities of the Agent to the successor Agent, including
                transferring the CVR Register to the successor Agent; provided that, the predecessor Agent shall not be required to make any additional expenditure or assume any additional liability in connection with the foregoing. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z425a70b3c0ca447fa27e6607a47cf329" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(f)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Any Person into which the Agent may be merged or converted or with which it may be consolidated, or any Person resulting from any merger, conversion or consolidation to which the
                Agent shall be a party, or any Person succeeding to the corporate trust business of the Agent shall be the successor of the Agent hereunder without the execution or filing of any paper with any party hereto or any further act on the part of
                any of the parties hereto except where an instrument of transfer or assignment is required by law to effect such succession, anything herein to the contrary notwithstanding. The Agent shall give notice to the Company promptly upon the
                occurrence of such transaction as described in this Section&#160;2.4(f). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zc694d1c9667e48eaae37608a6b393871" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.5</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Acceptance of Appointment by Successor</u>. Every successor Agent appointed hereunder shall, at or prior to such appointment, execute, acknowledge and deliver to the Company and
                to the retiring Agent an instrument accepting such appointment and a counterpart of this Agreement, and thereupon such successor Agent, without any further act, deed or conveyance, shall become vested with all the rights, powers, trusts and
                duties of the Agent; <i>provided</i> that upon the request of the Company or the successor Agent, such resigning or removed Agent shall execute and deliver an instrument transferring to such successor Agent all the rights, powers and
                trusts of such resigning or removed Agent. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ARTICLE III </b></p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>AMENDMENTS </b></p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z075a5b27145549f89d192933d7f68094" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">3.1</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Amendments Without Consent of Holders</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4620a6357c17434eacb43ef0dc72162a" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">The Company, at any time or from time to time, may unilaterally enter into one or more amendments hereto for any of the following purposes, without the consent of any of the
                Holders, so long as, in the cases of clauses (ii)&#160;through (iv) hereof, such amendments do not, individually or in the aggregate, adversely affect the interests of the Holders: </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z3dd5f2e0b02e408d857f772bb47f0c8e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(i)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to evidence the appointment of another Person as a successor Agent and the assumption by any successor Agent of the covenants and obligations of the Agent hereof in accordance with
                the provisions of this Agreement; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zfe74578cc2f74a35a08fc14142ff1734" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(ii)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to add to any covenants of the Company such further covenants, restrictions, conditions or provisions as the Company shall determine to be for the protection of the Holders; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4e7036d55b354377943d7553987f2a12" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(iii)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to cure any ambiguity, to correct or supplement any provision herein that may be defective or inconsistent with any other provision herein, or to make any other provisions with
                respect to matters or questions arising under this Agreement; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z5a513477efd34005a70b4657dab5f59c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(iv)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">as may be necessary or appropriate to ensure that CVRs are not subject to registration under the Securities Act or the Exchange Act; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd1e41fcc988f4d468329332a4cba2bf3" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(v)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to evidence the assignment of this Agreement by the Company as provided in Section&#160;4.4; or </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z22234c87d5b34a89972a7946b60337ea" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(vi)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">any other amendment hereto which would provide any additional rights or benefits to the Holders or that does not adversely affect the legal rights under this Agreement of any such
                Holder or the Agent. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">13 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zfe7eeac3081d49e59f7915c3fa0f311a" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Promptly after the execution by the Company and the Agent of any amendment pursuant to the provisions of this Section&#160;3.1, the Company shall send (or cause the Agent to send) a
                notice thereof through the facilities of DTC in accordance with DTC&#8217;s procedures and/or by first class mail to the Holders at their addresses as set forth on the CVR Register, setting forth in general terms the substance of such amendment.
              </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z797a443058864371a243fc9f6b750017" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">3.2</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Amendments with Consent of Holders</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1789fb6f5a9f400ca824c4e11fa84d4c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(a)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">In addition to any amendments to this Agreement that may be made by the Company without the consent of any Holder pursuant to Section&#160;3.1, with the consent of the Majority Holders
                and the Agent, which consent shall not be unreasonably withheld, conditioned or delayed, whether evidenced in writing or taken at a meeting of the Holders, the Company and the Agent may enter into one or more amendments hereto for the
                purpose of adding, eliminating or changing any provisions of this Agreement; <i>provided</i> that no amendment shall decrease the aggregate Payment Amount with respect to any Testing Date or amend Sections&#160;1.5(a)-(c) or this Section&#160;3.2(a)
                without the consent of each Holder. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zdd44b96427dd4dd39e1dea8150a9fc3e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top" width="5%">(b)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Promptly after the execution by the Company and the Agent of any amendment pursuant to the provisions of this Section&#160;3.2 (but prior to the effectiveness of such amendment), the
                Company shall send (or cause the Agent to send) (at the Company&#8217;s sole expense) a notice thereof (i)&#160;in the case of Global CVRs, through the facilities of DTC in accordance with DTC&#8217;s procedures and (ii)&#160;in the case of Book-Entry CVRs held
                on the CVR Register, to each Holder on their address as set out in the CVR Register, in each case, setting forth in general terms the substance of such amendment. Any amendment to this Agreement made pursuant to this Section&#160;3.2 shall
                become effective ten (10)&#160;Business Days following the mailing of such notice. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z7ead7ea0f53a4266bbf41dfc1cc728ff" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">3.3</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Execution of Amendments</u>. Each amendment to this Agreement shall be evidenced by a writing signed by the Agent and the Company. Upon the delivery of an Officer&#8217;s Certificate
                which states that the proposed supplement or amendment is in compliance with the terms of this Section&#160;3 and provided that such supplement or amendment does not adversely affect the Agent&#8217;s rights, duties, liabilities, immunities or
                obligations hereunder, the Agent shall execute such supplement or amendment. Subject to compliance with this Section&#160;3, the Agent may, but is not obligated to, enter into any such amendment that adversely affects the Agent&#8217;s own rights,
                protections, powers, trusts, privileges, covenants, indemnities or duties under this Agreement or otherwise. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z860d8c70b6a54be8b1dc38976efe6003" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">3.4</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Effect of Amendments</u>. Upon the execution of any amendment under this ARTICLE III, this Agreement shall be modified in accordance therewith, such amendment shall form a part
                of this Agreement for all purposes and every Holder shall be bound thereby. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 24pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ARTICLE IV </b></p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>MISCELLANEOUS </b></p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z37c708769b0e45138e1e5547306ea6df" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.1</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Notices to Agent and the Company</u>. All notices and other communications under this Agreement shall be in writing (including by electronic transmission) and shall be deemed to
                have been duly delivered and received when delivered by hand, or when sent if delivered to a recognized courier or deposited in the mail, first class and postage prepaid and, in the case of notice or demand made by the Agent or by any
                Holder to or on the Company, immediately upon confirmation of transmission of electronic mail, where such notice is given by electronic mail, in each case to the intended recipient as set forth below: </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z55239b4ff3ff4b8198b03786635f8465" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(i)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">if to the Company, to: </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 6pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Core Scientific, Inc. </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">838 Walker Road Suite <font style="white-space:nowrap">21-2105</font> </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Dover, DE 19904 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Attention: Legal </p>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">14 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;"> <font style="white-space:nowrap">E-mail:</font> legal@corescientific.com </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">with a copy (which shall not constitute notice) to: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Weil, Gotshal&#160;&amp; Manges LLP </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">767 Fifth Avenue </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">New York, NY 10153 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Attention: Merritt S. Johnson </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Telephone: (212) <font style="white-space:nowrap">310-8280</font> </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;"><font style="white-space:nowrap">E-mail:</font> merritt.johnson@weil.com </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z3e644671bc024d3bb0490955962c5d9f" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">(ii)</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">if to the Agent, to: </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Computershare Trust Company, N.A., </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Computershare Inc. </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">150 Royall Street </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Canton, MA 02021 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">Attention: Client Services </p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4f7ebb36c87248ac846f5910e1ba6547" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.2</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Notice to Holders</u>. All notices, requests and communications required to be given to the Holders shall be sufficiently given (unless otherwise herein expressly provided) if in
                writing and transmitted through the facilities of DTC in accordance with DTC&#8217;s procedures and/or mailed, first-class postage prepaid, to each Holder affected by such event, at his, her or its address set forth in the CVR Register, not later
                than the latest date, and not earlier than the earliest date, prescribed for the giving of such notice. In any case where notice to the Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so
                mailed, to any particular Holder shall affect the sufficiency of such notice with respect to other Holders. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za817576cc5384c4285123ef8dee31389" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.3</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Entire Agreement</u>. This Agreement and the Plan represent the entire understanding of the Company and the Holders with reference to the CVRs, and this Agreement supersedes any
                and all other oral or written agreements hereto made with respect to the CVRs. As between the Agent and the Company, this Agreement (including any schedules, annexes and exhibits hereto and the documents and instruments referred to herein)
                contain the entire understanding of the parties hereto with reference to the CVRs and matters contemplated hereby and supersedes all prior agreements, written or oral, among the parties with respect thereto. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zbda01b32c4e448668e794090ff5d4e72" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.4</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Successors and Assigns</u>. The Company may assign, in its sole discretion and without the consent of any other party or Holder, any or all of its rights, interests and
                obligations hereunder to one or more its Affiliates (that are wholly owned direct or indirect subsidiaries of the Company) (each, an &#8220;<b>Assignee</b>&#8221;) and any such Assignee may thereafter assign, in its sole discretion and without the
                consent of any other party or Holder, any or all of its rights, interests and obligations set forth hereunder to one or more additional Assignees; <i>provided</i>, <i>however</i>, that in connection with any assignment to an Assignee, the
                Company shall agree to remain liable for the performance such Assignee of its obligations hereunder. This Agreement shall be binding upon, and shall be enforceable by and inure solely to the benefit of, the parties to this Agreement and the
                Holders and their respective permitted successors and permitted assigns. The Agent may not assign this Agreement without the Company&#8217;s consent. This Agreement shall not restrict the Company&#8217;s or any successor&#8217;s ability to merge or
                consolidate or enter into or consummate any Change of Control; <i>provided</i> that in the event of a Change of Control, (i)&#160;the Company shall cause the surviving entity to assume the Company&#8217;s obligations, duties and covenants under this
                Agreement, (ii)&#160;the surviving entity shall be entitled to elect to make the Second Anniversary Payment Amount and/or Third Anniversary Payment Amount, as applicable, in common equity securities of the surviving entity (subject to
                adjustments in connection with any stock split, reverse stock split, recapitalization, reclassification, reorganization, merger, consolidation, <font style="white-space:nowrap">split-up,</font> <font style="white-space:nowrap">spin-off,</font>
                combination, repurchase, exchange, <font style="white-space:nowrap">non-cash</font> dividend or similar event in connection therewith or with the New Common Interests) (the &#8220;<b>Surviving Entity Equity Securities</b>&#8221;), in lieu of New
                Common Interests, only if such Surviving Entity Equity Securities are listed on a principal U.S.&#160;national securities exchange, and (iii)&#160;the provisions of this Agreement in connection with New Common Interests shall apply in the same manner
                and to the same extent to such Surviving Equity Securities. Any attempted assignment of this Agreement or any of such rights in violation of this Section&#160;4.4 shall be void <i>ab initio</i> and of no effect. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">15 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1ec9c95c45964ad1baf0875360b6d95c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.5</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Benefits of Agreement</u>. Nothing in this Agreement, express or implied, shall give to any Person (other than the parties to this Agreement, the Holders and their permitted
                successors and permitted assigns hereunder) any benefit or any legal or equitable right, remedy or claim under this Agreement or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit
                of the parties to this Agreement, the Holders and their permitted successors and permitted assigns. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z844d8e8556624fbc95b7a360d9624730" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.6</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Governing Law</u>. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York, regardless of any provision of law or rule that might
                otherwise govern under applicable principles of conflicts of law thereof. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8dfc573279a347c8b4920159dfdd616e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.7</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Consent to Jurisdiction; Service of Process; Venue</u>. Subject to Section&#160;1.5(g), each of the parties to this Agreement and the Holders (a)&#160;irrevocably consents to the service
                of the summons and complaint and any other process (whether inside or outside the territorial jurisdiction of the Chosen Courts) in any Legal Proceeding relating to the transactions contemplated by this Agreement, for and on behalf of
                itself or any of its properties or assets, in accordance with Section&#160;4.1 or in such other manner as may be permitted by applicable Law, but nothing in this Section&#160;4.7 shall affect the right of any parties to this Agreement and the Holders
                to serve legal process in any other manner permitted by applicable Law; (b)&#160;irrevocably and unconditionally consents and submits itself and its properties and assets in any Legal Proceeding to the exclusive jurisdiction of the Chosen Courts
                in the event any dispute or controversy arises out of this Agreement or the transactions contemplated in this Agreement, or for recognition and enforcement of any judgment in respect thereof; (c)&#160;agrees that it will not attempt to deny or
                defeat such personal jurisdiction by motion or other request for leave from any Chosen Court; (d)&#160;agrees that any Legal Proceedings arising in connection with this Agreement or the transactions contemplated in this Agreement shall be
                brought, tried and determined only in the Chosen Courts; (e)&#160;waives any objection that it may now or hereafter have to the venue of any such Legal Proceeding in the Chosen Courts or that such Legal Proceeding was brought in an inconvenient
                court and agrees not to plead or claim the same; and (f)&#160;agrees that it will not bring any Legal Proceeding relating to this Agreement or the transactions contemplated hereby or thereby in any court other than the Chosen Courts. Each of
                parties to this Agreement and the Holders agrees that a final judgment in any Legal Proceeding in the Chosen Courts shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by
                applicable Law. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8c7eefaa03e449c9a7a3c92be5b1d7b2" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.8</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>WAIVER OF JURY TRIAL</u>. EACH OF THE PARTIES TO THIS AGREEMENT AND THE HOLDERS ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY THAT MAY ARISE PURSUANT TO THIS AGREEMENT IS LIKELY
                TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH PARTY TO THIS AGREEMENT AND HOLDER IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT THAT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL PROCEEDING (WHETHER FOR
                BREACH OF CONTRACT, TORTIOUS CONDUCT OR OTHERWISE) DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT AND HOLDER ACKNOWLEDGES AND AGREES THAT (A)&#160;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY
                OTHER PARTY TO THIS AGREEMENT OR ANY HOLDER HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (B)&#160;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS
                OF THIS WAIVER; (C)&#160;IT MAKES THIS WAIVER VOLUNTARILY; AND (D)&#160;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 4.8. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zc333501c798f44fba4edbe7c1b4dd3c2" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.9</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Further Assurances</u>. Subject to the provisions of this Agreement, the parties to this Agreement and the Holders will, from time to time, do all acts and things and execute and
                deliver all such further documents and instruments, as the other parties to this Agreement and the Holders may reasonably require to effectively carry out or better evidence or perfect the full intent and meaning of this Agreement. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8086a1b556af494b8721208f58b37e0e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.10</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Severability</u>. In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction to be illegal, void
                or unenforceable, the remainder of this Agreement will continue in full force and effect and the application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties to
                this Agreement and the </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">16 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze43bd05e6aab4c818e00c5613539e1a4" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top"> Holders. The parties to this Agreement and the Holders further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent
              possible, the economic, business and other purposes of such void or unenforceable provision; provided, however, that if such excluded provision shall materially and adversely affect the rights, immunities, liabilities, duties or obligations
              of the Agent, the Agent shall be entitled to resign immediately upon written notice to the Company. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za8278b5d51fa436bb1323984fc1138dc" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.11</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Headings</u>. The headings and table of contents contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this
                Agreement. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8889d3b533ea4f6ab6813ea7a4adedcf" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.12</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Counterparts</u>. This Agreement and any amendments to this Agreement may be executed in one or more textually identical counterparts, all of which will be considered one and the
                same agreement and will become effective when one or more counterparts have been signed by each of the parties to this Agreement and delivered to the other parties to this Agreement and the Holders, it being understood that all parties to
                this Agreement need not sign the same counterpart. Any such counterpart, to the extent delivered by fax or.pdf .tif, .gif, .jpg or similar attachment to electronic mail (any such delivery, an &#8220;<b>Electronic Delivery</b>&#8221;), will be treated
                in all manner and respects as an original executed counterpart and will be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. No party to this Agreement or Holder may
                raise the use of an Electronic Delivery to deliver a signature, or the fact that any signature or agreement or instrument was transmitted or communicated through the use of an Electronic Delivery, as a defense to the formation of a
                contract, and each party to this Agreement and Holder forever waives any such defense, except to the extent such defense relates to lack of authenticity. The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; &#8220;delivery,&#8221; and words of like import in
                or relating to this Agreement or any document to be signed in connection with this Agreement shall be deemed to include electronic signatures, including without limitation, digital signature provided by DocuSign, each of which shall be of
                the same legal effect, validity or enforceability as a manually executed signature. The Company agrees to assume all risks arising out of the use of using digital signatures and electronic methods to submit communications to the Agent,
                including without limitation the risk of Agent acting on unauthorized instructions, and the risk of interception and misuse by third parties. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z79d20023cba742259d952a51230ac6e4" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.13</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Expiration</u>. This Agreement and the CVRs shall expire and be of no force or effect, and the parties to this Agreement and the Holders shall have no liability hereunder (other
                than to the extent of any obligations which expressly survive or provide for performance following expiration), ten (10)&#160;calendar days after payment of any Payment Amount with respect to the Third Testing Date, or, if the Dispute Resolution
                Procedures are conducted, ten (10)&#160;calendar days following the conclusion of all procedures thereunder. Notwithstanding the foregoing, no such expiration shall affect any rights or obligations accrued prior to the effective date of such
                expiration. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z583e9d72bf6242be8524dad5873d120e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.14</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Legal Holidays</u>. In the event that the day on which any Payment Amount is due shall not be a Business Day, then, notwithstanding any provision of this Agreement to the
                contrary, any payment required to be made in respect of the CVRs shall be made on the next succeeding Business Day with the same force and effect as if made on the last day on which such Payment Amount is due. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z94f2331cc43d4f7680ca719cedd2bef6" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.15</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Interpretation</u>. When a reference is made in this Agreement to an Article, Annex or Section, such reference shall be to an Article, Annex or Section of this Agreement unless
                otherwise indicated. Whenever the words &#8220;include,&#8221; &#8220;includes&#8221; or &#8220;including&#8221; are used in this Agreement, they shall be deemed to be followed by the words &#8220;without limitation.&#8221; The words &#8220;hereof,&#8221; &#8220;herein&#8221; and &#8220;hereunder&#8221; and words of
                similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. All terms defined in this Agreement shall have the defined meanings when used in any certificate or
                other document made or delivered pursuant of this Agreement unless otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well
                as to the feminine and neuter genders of such term. Any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to
                time amended, modified or supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and
                instruments incorporated therein. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">17 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z49d7e1f661804c91a945b144540bc585" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="4%">&#160;</td>
            <td align="left" valign="top"> References to a Person are also to its permitted successors and permitted assigns. References to clauses without a cross-reference to a Section or subsection are references to clauses within the same Section or,
              if more specific, subsection. References from or through any date means, unless otherwise specified, from and including or through and including, respectively. The symbol &#8220;$&#8221; refers to United States Dollars. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z7c3811f2febf4166b85bcfc0df5b84c0" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">4.16</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>No Fiduciary Obligations</u>. Each of the Company and the Agent acknowledges and agrees that the other party, its Affiliates and their respective officers, directors and
                controlling Persons do not owe any fiduciary duties to the first party or any of its respective Affiliates, officers, directors or controlling Persons. The only obligations of the Company and the Agent to each other and their Affiliates and
                their respective officers, directors and controlling Persons arising out of this Agreement are the contractual obligations expressly set forth in this Agreement. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><i>[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK.] </i></p>
      <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">18 </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed by their respective duly authorized officers to be effective as of the date
        first above written. </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div align="right">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze9c72fbd734d469496622d04d9b77178" border="0" cellpadding="0" cellspacing="0" width="40%">

            <tr>
              <td width="12%"><br>
              </td>
              <td valign="bottom" width="1%"><br>
              </td>
              <td width="87%"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td colspan="3" valign="top"><b>CORE SCIENTIFIC, INC.</b></td>
            </tr>
            <tr style="font-size:1pt">
              <td height="16"><br>
              </td>
              <td colspan="2" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">By:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">/s/ Todd M. DuChene</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">Name:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">Todd M. DuChene</td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">Title:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">Chief Legal Officer, Chief Administrative Officer and Secretary</td>
            </tr>
            <tr style="font-size:1pt">
              <td colspan="3" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td colspan="3" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt;"><b>COMPUTERSHARE INC. and</b></p>
                <p style="margin-top: 0pt; margin-bottom: 0pt;"><b>COMPUTERSHARE TRUST</b></p>
                <p style="margin-top: 0pt; margin-bottom: 0pt;"><b>COMPANY, N.A.</b></p>
                <p style="margin-top: 0pt; margin-bottom: 1pt;"><b>as Agent</b></p>
              </td>
            </tr>
            <tr style="font-size:1pt">
              <td colspan="3" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td colspan="3" valign="top"><b>On behalf of both entities:</b></td>
            </tr>
            <tr style="font-size:1pt">
              <td height="16"><br>
              </td>
              <td colspan="2" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">By:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">/s/ Collin Ekeogu</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">Name:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">Collin Ekeogu</td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">Title:</td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">Manager, Corporate Actions</td>
            </tr>

        </table>
      </div>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><i>[Signature Page to Contingent Value Rights Agreement] </i></p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ANNEX&#160;A </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>CERTAIN DEFINED TERMS </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Affiliate</b>&#8221; of any Person means any other Person that directly or indirectly, through one or more intermediates, controls, is controlled by, or is under common
        control with, such first Person. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Bankruptcy Law</b>&#8221; means Title&#160;11 of the United States Code or any similar federal, state or foreign law for the relief of debtors, and all other liquidation,
        conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, <font style="white-space:nowrap">winding-up,</font> restructuring, examinership or similar debtor relief
        laws. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Business Day</b>&#8221; means any day that is not a Saturday, a Sunday or other day on which banks are required or authorized by law or other governmental action to be
        closed, or are in fact closed, in New York, New York. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Change of Control</b>&#8221; means (i)&#160;a sale or other disposition of all or substantially all of the assets of the Company on a consolidated basis (other than to any direct
        or indirect wholly owned subsidiary of the Company), (ii)&#160;a merger or consolidation involving the Company in which it is not the surviving entity, and (iii)&#160;any other transaction involving the Company in which it is the surviving entity but in
        which the stockholders of the Company immediately prior to such transaction own less than fifty percent (50%)&#160;of the surviving entity&#8217;s voting power immediately after the transaction, other than (x)&#160;the issuance of New Common Interests pursuant to
        (1)&#160;the exercise of the Company&#8217;s Warrants, (2)&#160;the conversion of the Convertible Notes into New Common Interests, or (3)&#160;the CVRs, and (y)&#160;any bona fide equity financing transaction solely related to the continued financing of the operations of
        the Company and its subsidiaries. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Chosen Courts</b>&#8221; means the courts of the State of New York and any federal courts located in such state (and appellate courts thereof). </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Company Bankruptcy Event</b>&#8221; means an Insolvency Proceeding is commenced by the Company or any Guarantor; the Company or any Guarantor makes an offer of settlement,
        extension or composition to its unsecured creditors generally; a trustee is appointed to take possession of any substantial real or personal property of or to operate any of the business of the Company or any Guarantor; or an Insolvency Proceeding
        is commenced against the Company or any Guarantor, and the Company or such Guarantor consents to institution of the proceeding, the petition commencing the proceeding is not timely contested by the Company or such Guarantor, the petition is not
        dismissed within 60 days after filing, or an order for relief approving such Insolvency Proceeding is entered in the proceeding </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Convertible Notes</b>&#8221; means the 10.00%/12.00% <font style="white-space:nowrap"><font style="white-space:nowrap">Cash/Cash-and-Payment</font></font> in Stock
        Convertible Secured Notes due 2029, in the aggregate principal amount of $260,000,000, issued pursuant to the Convertible Notes Indenture. For the avoidance of doubt, no Additional Notes (as defined in the Convertible Notes Indenture) shall be
        included in the definition of Convertible Notes for purposes of this Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Convertible Notes Indenture</b>&#8221; means that certain convertible notes indenture, dated as of the Effective Date, among the Company as issuer, the guarantors from time
        to time party thereto and Wilmington Trust, National Association, as trustee and collateral agent, as may be amended or modified from time to time. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Corresponding New Common Interests</b>&#8221; means 51,783,625 New Common Interests (subject to adjustments in connection with any stock split, reverse stock split,
        recapitalization, reclassification, reorganization, merger, consolidation, <font style="white-space:nowrap">split-up,</font> <font style="white-space:nowrap">spin-off,</font> combination, repurchase, exchange, <font style="white-space:nowrap">non-cash</font>
        dividend or similar event in connection with the New Common Interests). </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>CVR(s)</b>&#8221; means the rights of a Holder to receive contingent payments in the form of cash and/or New Common Interests, as applicable, pursuant to this Agreement and
        the Plan. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Depositary</b>&#8221; means, with respect to the Global CVRs, DTC and any and all successors thereto appointed as Depositary hereunder and having become such pursuant to
        this Agreement. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Dispute Resolution Procedures</b>&#8221; means, collectively, the procedures set forth in Sections&#160;1.5(f) and&#160;1.5(g) hereof. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>DTC</b>&#8221; means The Depository Trust Company or any successor entity thereto. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Effective Date</b>&#8221; means January&#160;23, 2024. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Fair Market Value</b>&#8221; of the Corresponding New Common Interests means the following: </p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z6cddefd329f74140a3826ed67228622b" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">i.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">As it relates to the First Testing Date, the product of (i)&#160;the VWAP of a single New Common Interest in the consecutive sixty (60)&#160;calendar day period immediately prior to the First
                Testing Date multiplied by (ii)&#160;the Corresponding New Common Interests as of the First Testing Date; </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z6290d792a5714684b564d85dbe02bb7b" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">ii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">As it relates to the Second Testing Date, the product of (i)&#160;the VWAP of a single New Common Interest in the consecutive sixty (60)&#160;calendar day period immediately prior to the
                Second Testing Date multiplied by (ii)&#160;the Corresponding New Common Interests as of the Second Testing Date; and </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z1aee3708d59c451097d09a2acd2aefc0" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">iii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">As it relates to the Third Testing Date, the product of (i)&#160;the VWAP of a single New Common Interest in the consecutive sixty (60)&#160;calendar day period immediately prior to the Third
                Testing Date multiplied by (ii)&#160;the Corresponding New Common Interests as of the Third Testing Date. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Governmental Authority</b>&#8221; means any government, any governmental or regulatory entity or body, department, commission, board, agency, instrumentality, legislature,
        taxing authority, political subdivision, bureau, official and any self-regulatory organization and any court, tribunal, judicial body, arbitrator or arbitration panel, in each case whether federal, state, county, provincial, and whether local,
        foreign or multinational. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Guarantor</b>&#8221; has the meaning ascribed thereto under the Convertible Notes Indenture. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Holder</b>&#8221; means a Person in whose name a CVR is registered in the CVR Register at the applicable time. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Insolvency Proceeding</b>&#8221; means any case or proceeding commenced by or against a Person under any state, federal or foreign law, rule or regulation for, or any
        agreement of such Person to any or a combination of the following: (a)&#160;the entry of an order for relief under the Bankruptcy Code, or any other insolvency, debtor relief or debt adjustment or reorganization law (including any moratorium or any
        other marshalling of the assets and liabilities of any Person and any similar laws, rules or regulations relating to or affecting the enforcement of creditors&#8217; rights generally); (b) the appointment of a receiver, trustee, liquidator,
        administrator, conservator or other custodian for such Person or all or substantially all of its property; or (c)&#160;an assignment or trust mortgage for the benefit of creditors. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Law</b>&#8221; means any and all applicable federal, state, local, municipal, foreign, multinational or other law, statute, constitution, principle of common law, ordinance,
        code, rule, regulation, ruling, order or other legal requirement issued, enacted, adopted, promulgated, implemented or otherwise put into effect by law under the authority of any Governmental Authority. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Legal Proceeding</b>&#8221; means any civil, criminal or administrative actions, demands, countersuits, proceedings suits, claims, charges, arbitrations, oppositions,
        investigations, reexaminations, lawsuits, litigations or other proceedings brought by or pending before any Governmental Authority. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Majority Holders</b>&#8221; means, as of any time of determination, Holders of not less than a majority of the outstanding CVRs. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Majority of Objecting Holders</b>&#8221; means, as of any time of determination, the Holders of the majority of the CVRs held by the Objecting Holders. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>New Common Interests</b>&#8221; means common stock, par value $0.0001, of the Company to be issued (a)&#160;on the Effective Date or thereafter under the Plan or (b)&#160;as otherwise
        permitted pursuant to the Plan. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Officer&#8217;s Certificate</b>&#8221; means an officer&#8217;s certificate of the Company, signed by the Company&#8217;s Chief Executive Officer, Chief Financial Officer or other authorized
        officer, acceptable to the Agent. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Opinion of Counsel</b>&#8221; means written opinion from legal counsel acceptable to the Agent. The counsel may be external counsel or <font style="white-space:nowrap">in-house</font>
        counsel to the Company. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Participant</b>&#8221; means, with respect to DTC, a Person who has an account with DTC. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Person</b>&#8221; means any individual, corporation, partnership, limited liability company, trust, joint venture, governmental entity or other unincorporated entity,
        association or group. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Relevant Stock Exchange</b>&#8221; means the principal U.S.&#160;national securities exchange on which the New Common Interests (or such other security) are then listed; <i>provided</i>
        <i>that</i>, prior to the First Testing Date, the Company shall inform the Calculation Agent of the Relevant Stock Exchange on which the New Common Interests are then listed, and thereafter until the termination of this Agreement, the Company shall
        promptly inform the Calculation Agent of any change to the Relevant Stock Exchange. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Requisite New Common Interests Payment Documentation</b>&#8221; means the following: (i)&#160;a copy of an irrevocable instruction by the Company to the Transfer Agent (or other
        agent performing similar services for the Company) to issue to the applicable Holders the requisite number of New Common Interests in connection with the corresponding Payment Amount in the form appended hereto as <u>Exhibit C</u>; (ii)&#160;a copy of
        written confirmation from the Transfer Agent (or other agent performing similar services for the Company) that the issuance of the aforementioned New Common Interests to the applicable Holders has been completed; and (iii)&#160;an Officer&#8217;s Certificate
        addressed to the Agent, certifying that the aforementioned New Common Interests have been issued to the applicable Holders in connection with the corresponding Payment Amount (with respect to a Second Anniversary Payment Amount and Third
        Anniversary Payment Amount, also setting forth what portion, if any, of such Payment Amount was in cash). </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Tax</b>&#8221; means all taxes, customs, tariffs, imposts, levies, duties, fees or other like assessments or charges of a similar nature, however denominated, imposed by a
        Governmental Authority, together with all interest, penalties and additions imposed with respect to such amounts. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>TIA</b>&#8221; means the Trust Indenture Act of&#160;1939, as amended. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Trading Day</b>&#8221; means a day on which: (1)&#160;trading in the New Common Interests (or other security for which a VWAP must be determined) generally occurs on the Relevant
        Stock Exchange or, if the New Common Interests (or such other security) is not then listed on a Relevant Stock Exchange, on the principal other market on which the New Common Interests (or such other security) is then traded; and (2)&#160;a VWAP for the
        New Common Interests (or other security for which a VWAP must be determined) is available on such securities exchange or market; <i>provided</i> that if the New common Interests (or other security for which a VWAP must be determined) is not so
        listed or traded, &#8220;Trading Day&#8221; means a Business Day. In the case of (1), if the New Common Interests (or other security for which a VWAP must be determined) are not then listed on a Relevant Stock Exchange, the Company shall promptly inform the
        Calculation Agent of any such change. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Transfer Agent</b>&#8221; means a transfer agent for the Company&#8217;s New Common Interests, as may be from time to time appointed by the Company. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>VWAP</b>&#8221; means for any Trading Day, the per share volume-weighted average price as displayed under the heading &#8220;Bloomberg VWAP&#8221; on Bloomberg page
        &#8220;[CORZ]&lt;equity&gt;AQR&#8221; (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on such Trading Day (or if such
        volume-weighted average price is unavailable, the market value of one New Common Interest on such Trading Day, determined, using a volume-weighted average method, by a nationally recognized independent investment banking firm retained for this
        purpose by the Company). The &#8220;VWAP&#8221; shall be determined without regard to after-hours trading or any other trading outside of the primary trading session trading hours. As of the date hereof, the ticker symbol of the Company is &#8220;CORZ&#8221;, and
        following the date hereof, the Company shall promptly inform the Calculation Agent of any change to the ticker symbol of the Company. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8220;<b>Warrants</b>&#8221; means the warrants issued pursuant to the warrant agreement, dated as of the Effective Date, among the Company, Computershare Inc., a Delaware corporation
        and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, as warrant agent. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ANNEX&#160;B </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>CERTAIN TERMS </b></p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze0d35d68de44441e9ff297f164a2d21d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">1.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Registration of Transfers and Exchanges</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z5f66a8b8197d47c6abcfc5aff25e8f9c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">a.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Transfer and Exchange of Global CVRs or Beneficial Interests Therein</i>. The transfer and exchange of Global CVRs or beneficial interests therein shall be effected through the
                Depositary, in accordance with this Agreement and the procedures of the Depositary therefor. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze86932b0299b4d77bb5de74e227dfbba" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">b.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Exchange of a Beneficial Interest in a Global CVR for a Book-Entry CVR</i>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd8f0a2faa9fb49628dba1a7244b71266" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">i.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Any Holder of a beneficial interest in a Global CVR may, upon request, exchange such beneficial interest for a Book-Entry CVR. Upon receipt by the Agent from the Depositary or its
                nominee of written instructions or such other form of instructions as is customary for the Depositary on behalf of any Person having a beneficial interest in a Global CVR, the Agent shall cause, in accordance with the standing instructions
                and procedures existing between the Depositary and Agent, the number of CVRs represented by the Global CVR to be reduced by the number of CVRs to be represented by the Book-Entry CVRs to be issued in exchange for the beneficial interest of
                such Person in the Global CVR and, following such reduction, the Agent shall register in the name of the Holder a Book-Entry CVR and deliver to said Holder a statement, as issued by the Agent from time to time to the registered holder of
                Book-Entry CVRs reflecting such book-entry position (a &#8220;<b>CVR Statement</b>&#8221;). </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zb6e051f777b848d5b07bd556fede058f" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">ii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Book-Entry CVRs issued in exchange for a beneficial interest in a Global CVR pursuant to this <u>Section</u><u>&#160;1</u> shall be registered in such names as the Depositary, pursuant
                to instructions from its direct or indirect participants or otherwise, shall instruct the Agent. The Agent shall deliver such CVR Statements to the Persons in whose names such Book-Entry CVRs are so registered. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4fb6e426857741bcbfb4416a386b2f73" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">c.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Transfer and Exchange of Book-Entry CVRs</i>. Book-Entry CVRs surrendered for exchange or for registration of transfer pursuant to this <u>Section</u><u>&#160;1(c)</u> or <u>Section</u><u>&#160;1(i)(iv)</u>,
                shall be cancelled by the Agent. Such cancelled Book-Entry CVRs shall then be disposed of by or at the direction of the Company in accordance with applicable law. When Book-Entry CVRs are presented to or deposited with the Agent with a
                written request: </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze271ccdcc5744be7949c6ff80407e261" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">i.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to register the transfer of the Book-Entry CVRs; or </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z2fe8e00ce93442e78770b1d907451369" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">ii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">to exchange such Book-Entry CVRs for an equal number of Book-Entry CVRs of other authorized denominations; </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 13%; font-family: Times New Roman;">then in each case the Agent shall register the transfer or make the exchange as requested if its requirements for such transactions are met; <u>provided</u>,
        <u>however</u>, that the Agent has received a written instruction of transfer in a form satisfactory to the Agent, duly executed by the Holder thereof or by their attorney, duly authorized in writing. </p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z7770f54686fa4061b6eb5e42853b24d4" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">d.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Restrictions on Exchange or Transfer of a Book-Entry CVR for a Beneficial Interest in a Global CVR</i>. A Book-Entry CVR may not be exchanged for a beneficial interest in a
                Global CVR except upon satisfaction of the requirements set forth below. Upon receipt by the Agent of appropriate instruments of transfer with respect to a Book-Entry CVR, in a form satisfactory to the Agent, together with written
                instructions directing the Agent to make, or to direct the Depositary to make, an endorsement on the Global CVR to reflect an increase in the number of CVRs represented by the Global CVR equal to the number of CVRs represented by such
                Book-Entry CVR (such instruments of transfer and instructions to be duly executed by the holder thereof or the duly appointed legal </p>
            </td>
          </tr>

      </table>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zb08c308ca5a24cc5bce42a04c7d428c8" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="13%">&#160;</td>
            <td align="left" valign="top"> representative thereof or by his attorney, duly authorized in writing, such signatures to be guaranteed by an eligible guarantor institution participating in a signature guarantee program approved by a participant
              in the Securities Transfer Agent Medallion Program, the Stock Exchanges Medallion Program or the New York Stock Exchange, Inc. Medallion Signature Program (in each case, a &#8220;<b>Signature Guarantee</b>&#8221;), then the Agent shall cancel such
              Book-Entry CVR on the CVR Register and cause, or direct the Depositary to cause, in accordance with the standing instructions and procedures existing between the Depositary and the Agent, the number of CVRs represented by the Global CVR to be
              increased accordingly. If no Global CVRs are then outstanding, the Company shall issue and the Agent shall countersign by either manual, facsimile or other electronic signature a new Global CVR representing the appropriate number of CVRs. </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd99badfe7b3c4f2ebd4341b48d5b0b52" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">e.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Restrictions on Exchange or Transfer of Global CVRs</i>. Notwithstanding any other provisions of this Agreement (other than the provisions set forth in <u>Section</u><u>&#160;1(f)</u>),








                unless and until it is exchanged in whole for a Book-Entry CVR, a Global CVR may not be transferred as a whole except by the Depositary to a nominee of the Depositary or by a nominee of the Depositary to the Depositary or another nominee of
                the Depositary or by the Depositary or any such nominee to a successor Depositary or a nominee of such successor Depositary. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze26956d550a3465fbd19551a1d32ee86" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">f.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Book-Entry CVRs</i>. If at any time, the Depositary for the Global CVR notifies the Company that the Depositary is unwilling or unable to continue as Depositary for the Global
                CVR and a successor Depositary for the Global CVR is not appointed by the Company within ninety (90)&#160;days after delivery of such notice, then the Agent, upon written instructions signed by an Appropriate Officer of the Company and all other
                necessary information, shall register Book-Entry CVRs, in an aggregate number equal to the number of CVRs represented by the Global CVRs, in exchange for such Global CVRs, in such names and in such amounts as directed by the Depositary or,
                in the absence of instructions from the Depositary, the Company. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z243c09a34b5e4e8ea7d51b525be5b463" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">g.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Restrictions on Transfers of CVRs</i>. No CVRs shall be sold, exchanged or otherwise transferred in violation of the Securities Act or applicable state securities laws. Each
                Holder, by its acceptance of any CVR under this Agreement, acknowledges and agrees that the CVRs (including any New Common Interests issued at the Company&#8217;s discretion pursuant to this Agreement) were issued pursuant to an exemption from
                the registration requirement of Section&#160;5 of the Securities Act provided by Section&#160;1145 of the Bankruptcy Code, and to the extent that a Holder is an &#8220;underwriter&#8221; as defined in Section&#160;1145(b)(1) of the Bankruptcy Code, such Holder may
                not be able to sell or transfer any New Common Interests in the absence of an effective registration statement under the Securities Act or an exemption from registration thereunder. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="ze572cd0e02da40319b3f23737b0f65e6" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">h.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Cancellation of Global CVR Certificate</i>. At such time as all beneficial interests in Global CVRs have either been exchanged for Book-Entry CVRs, redeemed, repurchased or
                cancelled, all Global CVRs shall be returned to, or retained and cancelled by, the Agent, upon written instructions from the Company satisfactory to the Agent. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z35ba1a3833334eea917a455c99206ae7" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">i.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><i>Obligations with Respect to Transfers and Exchanges of CVRs.</i> </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zefe23f84260c4ca6967913beeb58f9a6" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">i.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">To permit registrations of transfers and exchanges, the Company shall execute Global CVRs, if applicable, and the Agent is hereby authorized, in accordance with the provisions of
                this <u>Section</u><u>&#160;1</u>, to countersign by either manual, facsimile or other electronic signature such Global CVRs, if applicable, or register Book-Entry CVRs, if applicable, as required pursuant to the provisions of this <u>Section</u><u>&#160;1.</u>
              </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zac2d58e50c49456eba2210eb761b517e" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">ii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">All Book-Entry CVRs and Global CVRs issued upon any registration of transfer or exchange of Book-Entry CVR or Global CVRs shall be the valid obligations of the Company, entitled to
                the same benefits under this Agreement as the Book-Entry CVRs or Global CVRs surrendered upon such registration of transfer or exchange. </p>
            </td>
          </tr>

      </table>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zb4a4e1462be5430d8c6d29ef3a5bb12c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">iii.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">So long as the Depositary, or its nominee, is the registered owner of a Global CVR, the Depositary or such nominee, as the case may be, will be considered the sole owner or Holder
                of the CVRs represented by such Global CVRs for all purposes under this Agreement. Except as provided in <u>Sections 1(b)</u> and <u>1(f)</u> upon the exchange of a beneficial interest in a Global CVRs for Book-Entry CVRs, owners of
                beneficial interests in a Global CVRs will not be entitled to have any CVRs registered in their names, and will under no circumstances be entitled to receive physical delivery of any such CVRs and will not be considered the owners or
                Holders thereof under the CVRs or this Agreement. Neither the Company nor the Agent, in its capacity as registrar for such CVRs, will have any responsibility or liability for any aspect of the records relating to beneficial interests in a
                Global CVRs or for maintaining, supervising or reviewing any records relating to such beneficial interests. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Agent or any agent of the Company or the Agent from
                giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair the operations of customary practices of the Depositary governing the exercise of the rights of a holder of a beneficial interest
                in a Global CVRs. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z5e94b68aa70e46ba9859abd3e6f61822" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="18%">&#160;</td>
            <td align="left" valign="top" width="4%">iv.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Subject to <u>Sections 1(b)</u>, <u>1(c)</u> and <u>1(d)</u> hereof, and this <u>Section</u><u>&#160;1(i)</u>, the Agent shall, upon receipt of all information required to be
                delivered hereunder and any evidence of authority that may be reasonably required by the Agent, from time to time register the transfer of any outstanding CVRs in the CVR Register, upon surrender of Global CVRs, if applicable, representing
                such CVRs at the office of the Agent, duly endorsed, and accompanied by a completed form of assignment, duly signed by the Holder thereof or by the duly appointed legal representative thereof or by a duly authorized attorney and accompanied
                by a Signature Guarantee. Upon any such registration of transfer, a new Global CVR or a CVR Statement, as the case may be, shall be issued to the transferee. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z4d0150d32aa14d5db4d4a97618da2eb3" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td align="left" valign="top" width="4%">2.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left"><u>Execution of Global CVRs</u>. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z0bbe843087d346cdad0752a39f89417c" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">a.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">Global CVRs shall be signed on behalf of the Company by its Chief Executive Officer, its Chief Financial Officer, its President, its General Counsel, a Vice President, its
                Secretary, an Assistant Secretary or any other authorized person appointed by the board of directors (the &#8220;<b>Board of Directors</b>&#8221;) of the Company from time to time (each, an &#8220;<b>Appropriate Officer</b>&#8221;). Each such signature upon the
                Global CVRs may be in the form of a facsimile or electronic signature of any such Appropriate Officer and may be imprinted or otherwise reproduced on the Global CVRs and for that purpose the Company may adopt and use the facsimile or
                electronic signature of any Appropriate Officer. </p>
            </td>
          </tr>

      </table>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z8f6001aabd2d4223bfd38687b8003f2b" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="9%">&#160;</td>
            <td align="left" valign="top" width="4%">b.</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">If any Appropriate Officer who shall have signed any of the Global CVRs shall cease to be an Appropriate Officer before the Global CVRs so signed shall have been countersigned by
                the Agent or disposed of by the Company, such Global CVRs nevertheless may be countersigned and delivered or disposed of as though such Appropriate Officer had not ceased to be an Appropriate Officer of the Company, and any Global CVRs may
                be signed on behalf of the Company by any Person who, at the actual date of the execution of such Global CVRs, shall be an Appropriate Officer, although at the date of the execution of this Agreement such Person was not an Appropriate
                Officer. Global CVRs shall be dated the date of countersignature by the Agent and shall represent one or more whole CVRs. </p>
            </td>
          </tr>

      </table>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>ANNEX&#160;C </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>FORM OF GLOBAL CVR </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE CONTINGENT VALUE RIGHTS AGREEMENT (THE &#8220;<u>CVR AGREEMENT</u>&#8221;) HEREINAFTER REFERRED TO AND IS
        REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE OF A DEPOSITARY OR A SUCCESSOR DEPOSITARY FOR THE BENEFIT OF THE BENEFICIAL OWNERS HEREOF. THIS SECURITY IS NOT EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE
        DEPOSITARY OR ITS NOMINEE EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE CVR AGREEMENT, AND NO TRANSFER OF THIS SECURITY (OTHER THAN A TRANSFER OF THIS SECURITY AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF
        THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY) MAY&#160;BE REGISTERED EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE CVR AGREEMENT. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART&#160;FOR SECURITIES IN DIRECT REGISTRATION FORM, THIS SECURITY MAY&#160;NOT BE TRANSFERRED EXCEPT AS A WHOLE BY
        THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.
        UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (&#8220;<u>DTC</u>&#8221;) TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR PAYMENT, AND ANY CERTIFICATE ISSUED IS
        REGISTERED IN THE NAME OF CEDE&#160;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&#160;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
        TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&#160;&amp; CO., HAS AN INTEREST HEREIN. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">CORE SCIENTIFIC, INC. </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z65066a51bdde493aa8eb2d545ec22484" align="center" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td width="35%"><br>
            </td>
            <td valign="bottom" width="1%"><br>
            </td>
            <td width="32%"><br>
            </td>
            <td valign="bottom" width="1%"><br>
            </td>
            <td width="31%"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid; font-size: 11pt;">
            <td valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em; font-size: 10pt;">No.</p>
            </td>
            <td valign="bottom">&#160;&#160;</td>
            <td align="center" valign="bottom"><font style="font-size:10pt">Certificate for</font></td>
            <td valign="bottom">&#160;&#160;</td>
            <td align="right" valign="bottom">Contingent Value Rights</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">CUSIP 21874A 122</p>
            </td>
            <td valign="bottom">&#160;&#160;</td>
            <td align="center" valign="bottom">[________]</td>
            <td valign="bottom">&#160;&#160;</td>
            <td valign="bottom"><br>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">This certifies that __________, or registered assigns (the &#8220;<u>Holder</u>&#8221;), is the registered holder of the number of Contingent Value Rights (&#8220;<u>CVRs</u>&#8221;)








        set forth above. Each CVR entitles the Holder, subject to the provisions contained herein and in the CVR Agreement referred to on the reverse hereof, to payments from Core Scientific, Inc. a Delaware corporation (the &#8220;<u>Company</u>&#8221;), in an amount
        and in the form determined pursuant to the provisions set forth on the reverse hereof and as more fully described in the CVR Agreement referred to on the reverse hereof. Such payments shall be made by the Company in accordance with the terms of the
        CVR Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">Payment of any amounts pursuant to this CVR certificate shall be made only to the Holder (as defined in the CVR Agreement) of this CVR certificate. Such
        payment shall be made at the office or agency maintained by the Company for such purpose;<u>&#160;provided</u>,<u>&#160;however</u>, that the Company may pay such amounts by wire transfer or check payable in such money or in New Common Interests, as defined
        in and in accordance with the terms of the CVR Agreement. Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company have been initially appointed as the Agent. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">Reference is hereby made to the further provisions of this CVR certificate set forth on the reverse hereof, which further provisions shall for all
        purposes have the same effect as if set forth at this place. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">Unless the certificate of authentication hereon has been duly executed by the Agent referred to on the reverse hereof by manual signature, this CVR
        certificate shall not be entitled to any benefit under the CVR Agreement, or be valid or obligatory for any purpose. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Dated: [&#8195;&#8195;&#8195;&#8195; ] </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div align="right">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z448ae38bf791473b9abb6be44af7d7db" border="0" cellpadding="0" cellspacing="0" width="40%">

            <tr>
              <td width="7%"><br>
              </td>
              <td valign="bottom" width="1%"><br>
              </td>
              <td width="92%"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">By:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;" align="right">&#160;</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="bottom"><br>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Name:</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="bottom"><br>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Title:</p>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">[Form&#160;of Reverse of CVR certificate] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">1. This CVR certificate is issued under and in accordance with the Contingent Value Rights Agreement, dated as of January&#160;23, 2024 (the &#8220;<u>CVR Agreement</u>&#8221;),







        between the Company and Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, as agent (the &#8220;<u>Agent</u>,&#8221; which term includes any successor Agent under the CVR
        Agreement), and is subject to the terms and provisions contained in the CVR Agreement, to all of which terms and provisions the Holder of this CVR certificate consents by acceptance hereof. The CVR Agreement is hereby incorporated herein by
        reference and made a part hereof. Reference is hereby made to the CVR Agreement for a full statement of the respective rights, limitations of rights, duties, obligations and immunities thereunder of the Company, the Agent and the Holders of the
        CVRs. All capitalized terms used in this CVR certificate without definition shall have the respective meanings ascribed to them in the CVR Agreement. Copies of the CVR Agreement can be obtained by contacting the Agent. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">2. Contingent payments pursuant to CVRs shall be made, to the extent payable, to the Holders after each of the First Testing Date, the Second Testing Date
        and the Third Testing Date, in accordance with and pursuant to<u>&#160;Section</u><u>&#160;1.5</u> of the CVR Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">3. In the event of any conflict between this CVR certificate and the CVR Agreement, the CVR Agreement shall govern and prevail. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">4. The First Anniversary Payment Amount, if any, subject to the Dispute Resolution Procedures, shall be payable by the Company in cash. Each of the Second
        Anniversary Payment Amount and Third Anniversary Payment Amount, if any, subject to the Dispute Resolution Procedures, shall be payable by the Company in cash and/or New Common Interests, or a combination of the foregoing, in the Company&#8217;s sole
        discretion, as set forth in the CVR Agreement. Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company have been initially appointed as Agent. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">5. Holders may dispute the Payment Amount as set forth in <u>Section</u><u>&#160;1.5</u> of the CVR Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">6. The CVR Agreement permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the
        Company and the rights of the Holders of CVRs under the CVR Agreement by the Company with the consent of the Majority Holders. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">7. No reference herein to the CVR Agreement and no provision of this CVR certificate or of the CVR Agreement shall alter or impair the obligation of the
        Company, which is absolute and unconditional, to pay any Payment Amounts determined pursuant to the terms hereof and of the CVR Agreement at the times, place and amount, and in the manner, prescribed herein and in the CVR Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">9. As provided in the CVR Agreement and subject to certain limitations therein set forth, the transfer of the CVRs represented by this CVR certificate is
        registrable on the CVR Register, upon surrender of this CVR certificate for registration of transfer at the office or agency of the Company maintained for such purpose duly endorsed by, or accompanied by a written instrument of transfer in form
        satisfactory to the Company and the Agent, duly executed by the Holder hereof or his or her attorney duly authorized in writing, and thereupon one or more new CVR certificates or Book-Entry CVRs, for the same amount of CVRs, will be issued to the
        designated transferee or transferees. The Company hereby initially designates the office of Computershare Inc., a Delaware corporation and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company at 150 Royall Street,
        Canton, MA 02021 as the office for registration of transfer of this CVR certificate. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">10. As provided in the CVR Agreement and subject to certain limitations therein set forth, this CVR certificate is exchangeable for one or more CVR
        certificates or Book-Entry CVRs representing the same number of CVRs as represented by this CVR certificate as requested by the Holder surrendering the same. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">11. No service charge will be made for any registration of transfer or exchange of CVRs, but the Company and the Agent may require payment of a sum
        sufficient to cover any documentary, stamp or similar issue or transfer taxes or other governmental charges imposed in connection with any registration of transfer or exchange. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">12. Prior to the time of due presentment of this CVR certificate for registration of transfer, the Company, the Agent and any agent of the Company or the
        Agent may treat the Person in whose name this CVR certificate is registered as the owner hereof for all purposes, and neither the Company, the Agent nor any agent shall be affected by notice to the contrary. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">13. Neither the Company nor the Agent has any duty or obligation to the holder of this CVR certificate, except as expressly set forth herein or in the CVR
        Agreement. </p>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b>AGENT&#8217;S CERTIFICATE OF AUTHENTICATION </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">This is one of the Global CVRs referred to in the within-mentioned CVR Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 60%; font-family: Times New Roman;">Computershare Inc., a Delaware corporation and its </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 60%; font-family: Times New Roman;">affiliate, Computershare Trust Company, N.A., a federally </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 60%; font-family: Times New Roman;">chartered trust company, as the Agent </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; margin-left: 60%; font-family: Times New Roman;">On behalf of both entities: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Dated: [&#8195;&#8195;&#8195;&#8195;] </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div align="right">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z744a1fc243a540caa1328d46f33077c6" border="0" cellpadding="0" cellspacing="0" width="40%">

            <tr>
              <td width="7%"><br>
              </td>
              <td valign="bottom" width="1%"><br>
              </td>
              <td width="92%"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">By:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td nowrap="nowrap" valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;" align="right">&#160;</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="bottom"><br>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="bottom">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Authorized Signatory</p>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="right"><b>EXHIBIT&#160;A </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">[COMPANY LETTERHEAD] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><u>Payment Triggering Event Notice </u></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[DATE] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">This Payment Triggering Event Notice is being delivered to you pursuant to Section&#160;1.5(e) of the Contingent Value Rights Agreement, dated as of [__], by and between Core
        Scientific, Inc. and Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent (the &#8220;<b>Agreement</b>&#8221;), in connection with the following
        Testing Date: [DATE]. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Capitalized terms used herein but not otherwise defined shall have the meanings given to such terms in the Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Aggregate Payment Amount:___________________ </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;"><font style="white-space:nowrap">Per-CVR</font> Payment Amount: ____________________________ </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Calculation, in reasonable detail, of such aggregate Payment Amount and <font style="white-space:nowrap">per-CVR</font> Payment Amount: [__] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[(For Second Anniversary Payment and Third Anniversary Payment only): </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Type of Payment Amount:&#8195;&#8195;&#8195;&#8195;Cash (United States Dollars) &#9744; </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194;&#8199;&#8201;&#8201;New Common Interests &#9744;] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The number of New Common Interests subject to Payment Amount: __________________] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Objection deadline in connection with the information herein: _____________________________________ </p>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="right"><b>EXHIBIT&#160;B </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><u>Payment Amount Objection Notice </u></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[DATE] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[Core Scientific, Inc. </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">838 Walker Road Suite <font style="white-space:nowrap">21-2105</font> </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Dover, DE 19904 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Attention: Legal </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Email: legal@corescientific.com] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">This Payment Amount Objection Notice is being delivered to you pursuant to Section&#160;1.5(f) of the Contingent Value Rights Agreement, dated as of [__], by and between Core
        Scientific, Inc. and Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The undersigned, as beneficial owner(s) of CVRs in the amount specified below, hereby objects to the following terms of the Payment Triggering Event Notice delivered on
        [DATE] in connection with [__] Testing Date: </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z847c910285734a86aea58c4c76c60901" align="center" border="0" cellpadding="0" cellspacing="0" width="92%">

          <tr>
            <td width="50%"><br>
            </td>
            <td valign="bottom" width="1%"><br>
            </td>
            <td width="49%"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td colspan="3" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.00em; text-indent: -2.00em;">&#9744;&#8194;&#8201;&#8201;Aggregate Payment Amount (including the calculation thereof)</p>
              <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.00em; text-indent: -2.00em;"><font style="white-space:nowrap">&#9744;&#8194;&#8201;&#8201;Per-CVR</font> Payment Amount</p>
              <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.00em; text-indent: -2.00em;">&#9744;&#8194;&#8201;&#8201;Number of New Common Interests to be paid in connection with Payment Amount</p>
              <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
              <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 2.00em; text-indent: -2.00em;">&#9744;&#8194;&#8201;&#8201;Other: [__]</p>
              <p style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
              <p style="margin-top: 0pt; margin-bottom: 1pt;">Description of Objection: [__]</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Number of CVRs beneficially owned:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">&#160;</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Name:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">&#160;</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Signature:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">&#160;</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top"><i>Signature must be guaranteed by a participant in the Securities Transfer Agent Medallion Program, the Stock Exchanges Medallion Program or the New York Stock Exchange, Inc. Medallion Signature Program</i></td>
            <td valign="bottom">&#160;</td>
            <td valign="bottom"><br>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Title:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Street Address:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p>
            </td>
          </tr>
          <tr style="font-size:1pt">
            <td height="16"><br>
            </td>
            <td colspan="2" height="16"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">City, State and Zip Code:</td>
            <td valign="bottom">&#160;</td>
            <td nowrap="nowrap" valign="bottom">
              <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000;">&#160;</p>
            </td>
          </tr>

      </table>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="right"><b>EXHIBIT&#160;C </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">[COMPANY LETTERHEAD] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><u>Instruction Letter to Transfer Agent </u></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[DATE] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[Computershare Trust Company, N.A., </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Computershare Inc. as Agent </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">150 Royall Street </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Canton, MA 02021 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Attention: Client Services] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Re: Authorization Letter for Issuance of Common Shares </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; text-indent: 4%; font-family: Times New Roman;">Reference is made to (i)&#160;that certain CVR Agreement, dated as of January [24], 2024, by and between Core Scientific, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;),








        and Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent; and (ii)&#160;that certain <i>Fourth Amended Joint Chapter 11 Plan of Core
          Scientific, Inc. and its Debtor Affiliates </i>(as may be amended, modified or supplemented from time to time, the &#8220;<b>Plan</b>&#8221;), which was confirmed pursuant to an order of the United States Bankruptcy Court for the Southern District of Texas,
        Houston Division entered on January [16], 2024. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the CVR Agreement or the Plan, as applicable. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The Company hereby authorizes and instructs Computershare, as transfer agent and registrar to issue and allocate New Common Interests (CUSIP 21874A 106) as follows: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[IF ISSUING IN DTC] </p>
      <p style="margin-top: 18pt; margin-bottom: 0pt; font-family: Times New Roman;"><b>Via SCL <font style="white-space:nowrap"><font style="white-space:nowrap">Add-to-Balance</font></font> </b></p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z065b7a91094549049072973dffd49652" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="5%">&#160;</td>
            <td align="left" valign="top" width="3%">&#8226;</td>
            <td valign="top" width="1%">&#160;</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">To accept an SCL <font style="white-space:nowrap"><font style="white-space:nowrap">Add-to-Balance</font></font> from Cede&#160;&amp; Co. for [&#9679;] shares of New Common Interests (CUSIP
                21874A 106). </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[IF ISSUING ON BOOKS AND RECORDS OF TRANSFER AGENT] </p>
      <p style="margin-top: 18pt; margin-bottom: 0pt; font-family: Times New Roman;"><b>Via books and records of Transfer Agent </b></p>
      <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="z6a96dc3220234796aaaeaad44a972b5d" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr style="page-break-inside:avoid">
            <td width="5%">&#160;</td>
            <td align="left" valign="top" width="3%">&#8226;</td>
            <td valign="top" width="1%">&#160;</td>
            <td align="left" valign="top">
              <p style="margin-top: 0pt; margin-bottom: 0pt;" align="left">To issue [&#9679;] shares of New Common Interests (CUSIP 21874A 106) to those Holders who hold CVRs on the CVR Register, and to hold those shares for the same Holders on the books and
                records of the transfer agent. </p>
            </td>
          </tr>

      </table>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The foregoing issuance is in connection with the [Second Anniversary Payment Amount/Third Anniversary Payment Amount]. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The &#8220;Effective Date&#8221; of the foregoing issuance shall be [&#9679;], 20[&#9679;]. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The New Common Interests will be duly authorized, validly issued, fully paid and nonassessable. </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div align="right">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zecad4016267a4996bf9ce75ccbf2a443" border="0" cellpadding="0" cellspacing="0" width="40%">

            <tr>
              <td width="12%"><br>
              </td>
              <td valign="bottom" width="1%"><br>
              </td>
              <td width="87%"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td colspan="3" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">CORE SCIENTIFIC, INC.</p>
              </td>
            </tr>
            <tr style="font-size:1pt">
              <td height="16"><br>
              </td>
              <td colspan="2" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">By:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000; margin-left: 1.00em; text-indent: -1.00em;">&#160;</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Name:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Title:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top"><br>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="right"><b>EXHIBIT&#160;D </b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">[COMPANY LETTERHEAD] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center">OFFICER&#8217;S CERTIFICATE </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[DATE] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[Computershare Trust Company, N.A., </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Computershare Inc. as Agent </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">150 Royall Street </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Canton, MA 02021 </p>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;">Attention: Client Services] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">This Notice is being delivered to you pursuant to Section&#160;1.5[(a), (b) or (c)] of the Contingent Value Rights Agreement, dated as of January [_], 2024, by and between Core
        Scientific, Inc. (the &#8220;<b>Company</b>&#8221;) and Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, collectively, as CVR agent (the &#8220;<b>Agreement</b>&#8221;), in connection
        with the following Testing Date: [DATE]. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">Capitalized terms used herein but not otherwise defined shall have the meanings given to such terms in the Agreement. </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The undersigned hereby certifies, solely in [his/her] capacity as [TITLE] of the Company and not in [his/her] individual capacity, and on behalf of the Company, as of the
        date hereof, that: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[First Testing Date: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The Fair Market Value of the Corresponding New Common Interests is equal to or in excess of $260,000,000, and the Company does not owe any Holder, with respect to the
        First Testing Date, the Year 1 Contingent Payment Obligation and such Year 1 Contingent Payment Obligation is extinguished and deemed to be equal to zero.] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[Second Testing Date: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The Fair Market Value of the Corresponding New Common Interests is equal to or in excess of the difference of (x) $260,000,000 minus (y)&#160;the First Anniversary Payment
        Amount, and therefore the Company shall not owe any amounts to any Holder with respect to the Second Testing Date, and the Year 2 Contingent Payment Obligation shall be extinguished and deemed to be equal to zero.] </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">[Third Testing Date: </p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;">The Fair Market Value of the Corresponding New Common Interests is equal to or in excess of the difference of (x) $260,000,000 minus (y)&#160;the sum of the First Anniversary
        Payment Amount and the Second Anniversary Payment Amount, and therefore the Company shall not owe any amounts to any Holder with respect to the Third Testing Date, and the Year 3 Contingent Payment Obligation shall be extinguished and be deemed to
        be equal to zero.] </p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <div align="right">
        <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="zd6dc5b29ef3c4886a1bbb2547ab721f3" border="0" cellpadding="0" cellspacing="0" width="40%">

            <tr>
              <td width="12%"><br>
              </td>
              <td valign="bottom" width="1%"><br>
              </td>
              <td width="87%"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td colspan="3" valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">CORE SCIENTIFIC, INC.</p>
              </td>
            </tr>
            <tr style="font-size:1pt">
              <td height="16"><br>
              </td>
              <td colspan="2" height="16"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">By:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 1pt; border-bottom: 1px solid #000000; margin-left: 1.00em; text-indent: -1.00em;">&#160;</p>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Name:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top"><br>
              </td>
            </tr>
            <tr style="page-break-inside: avoid;">
              <td valign="top">
                <p style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.00em; text-indent: -1.00em;">Title:</p>
              </td>
              <td valign="bottom">&#160;</td>
              <td valign="top"><br>
              </td>
            </tr>

        </table>
      </div>
    </div>
  </center>
  <center>
    <div style="width:100%" align="left">
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
      </div>
      <p style="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b><u>ANNEX D </u></b></p>
      <p style="margin-top: 12pt; margin-bottom: 0pt; font-family: Times New Roman;" align="center"><b><u>APPROVED BANKS </u></b></p>
      <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
      <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" id="za8dcf4a1061b477d94058b3b94bfb486" align="center" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td width="100%"><br>
            </td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Banks</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">JP Morgan</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Bank of America</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Citibank</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Wells Fargo</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">BMO</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Truist</td>
          </tr>
          <tr style="page-break-inside: avoid;">
            <td valign="top">Bank of New York Mellon</td>
          </tr>

      </table>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
    </div>
  </center>
  <font style="font-weight: bold;"></font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ny20053122x2_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">
    <div>
      <div style="text-align: right; font-weight: bold;">Exhibit 23.1</div>
      <div><br>
      </div>
      <div>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div><br>
      </div>
      <div>We consent to the use in this Registration Statement No. 333- 289742 on Form S-4 of our report dated March 3, 2025 (March 19, 2025 as to the effects of the
        stock split described in Note 1), relating to the financial statements of CoreWeave, Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.</div>
      <div><br>
      </div>
      <div>/s/ Deloitte &amp; Touche LLP</div>
      <div><br>
      </div>
      <div>San Jose, California</div>
      <div><br>
      </div>
      <div>September 16, 2025</div>
      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>8
<FILENAME>ny20053122x2_ex23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.2</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Consent of Independent Auditor</div>
    <div><br>
    </div>
    <div style="color: #000000;">We consent to the use in this Amendment No. 1 to the Registration Statement (333-289742) on Form S-4 of CoreWeave, Inc. of our report dated January 22, 2025, except for the effects of the stock split described in Note 1 as
      to which the date is March 19, 2025, relating to the consolidated financial statements of CoreWeave, Inc., appearing in the Prospectus, which is part of this Amendment No. 1 to the Registration Statement.</div>
    <div><br>
    </div>
    <div style="color: #000000;">We also consent to the reference to our firm under the heading &#8220;Experts&#8221;.</div>
    <div><br>
    </div>
    <div style="color: #000000;">/s/ RSM US LLP</div>
    <div><br>
    </div>
    <div style="color: #000000;">Minneapolis, Minnesota</div>
    <div style="color: #000000;">September 16, 2025</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.3
<SEQUENCE>9
<FILENAME>ny20053122x2_ex23-3.htm
<DESCRIPTION>EXHIBIT 23.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: right; font-weight: bold;">
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade">Exhibit 23.3</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;"><u>Independent Registered Public Accounting Firm&#8217;s Consent</u></div>
    <div><br>
    </div>
    <div style="text-align: justify;">We consent to the incorporation by reference in this Registration Statement on Amendment No. 1 to Form S-4 (File No. 333-289742) of our reports dated February 26, 2025 relating to the financial statements of Core
      Scientific, Inc. and the effectiveness of internal control over financial reporting of Core Scientific, Inc. appearing in the Annual Report on Form 10-K of Core Scientific, Inc. for the year ended December 31, 2024. We also consent to the reference
      to us under the heading &#8220;Experts&#8221; in such Registration Statement.</div>
    <div><br>
    </div>
    <div>/s/ Marcum LLP</div>
    <div><br>
    </div>
    <div>Costa Mesa, CA</div>
    <div>September 17, 2025</div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>10
<FILENAME>ny20053122x2_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div>
      <div style="text-align: right;">
        <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-weight: bold;">Exhibit 99.2</font><br>
      </div>
      <div><br>
      </div>
      <img src="ny20053122x2_ex99-2img01.jpg" width="107" height="27"></div>
    <div><br>
    </div>
    <div style="text-align: right;">September 17, 2025</div>
    <div><br>
    </div>
    <div>Board of Directors</div>
    <div>Core Scientific, Inc.</div>
    <div>838 Walker Road</div>
    <div>Suite 21-2105</div>
    <div>Dover, DE 19904</div>
    <div><br>
    </div>
    <div>Members of the Board of Directors:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20.8pt;">We hereby consent to the inclusion of our opinion letter, dated July 7, 2025, to the Board of Directors of Core Scientific, Inc. (&#8220;Core Scientific&#8221;) as Annex B to, and to the references thereto
      under the headings &#8220;Summary&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8221;, &#8220;Summary&#8212;Risk Factors&#8221;, &#8220;Risk Factors&#8212;Risks Relating to the Merger&#8221;, &#8220;The Merger&#8212;Background of the Merger&#8221;, &#8220;The Merger&#8212;Recommendation of the Core Scientific Board of
      Directors and Reasons for the Merger&#8221;, &#8220;The Merger&#8212;Certain Unaudited Prospective Financial Information&#8221; and &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of Moelis &amp; Company LLC&#8221; in, the proxy statement/prospectus relating
      to the proposed merger involving Core Scientific, CoreWeave, Inc. and Miami Merger Sub I, Inc., which proxy statement/prospectus forms a part of Amendment No. 1 to the Registration Statement on Form S-4 of CoreWeave, Inc. ( &#8220;Amendment No. 1 to the
      Registration Statement&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20.8pt;">The foregoing consent applies only to Amendment No. 1 to the Registration Statement being filed with the Securities and Exchange Commission as of the date hereof and not to any amendments or
      supplements thereto, and our opinion is not to be used, circulated, quoted, or otherwise referred to for any other purpose, nor is it to be filed with, included in or referred to in whole or in part in any other registration statement (including any
      other amendments to the above-mentioned Amendment No. 1 to the Registration Statement), proxy statement or any other document, except in accordance with our prior written consent.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 20.8pt;">By giving such consent, we do not thereby admit that we are experts with respect to any part of such Amendment No. 1 to the Registration Statement within the meaning of the term &#8220;expert&#8221; as used
      in, or that we come within the category of persons whose consent is required under Section 7 of, the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission promulgated thereunder.</div>
    <div><br>
      <div>
        <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zbbcd6ad063db497fbf5d098664a2a681" border="0" cellpadding="0" cellspacing="0">

            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">
                <div>Very truly yours,</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">/s/ Moelis &amp; Company LLC<br>
              </td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
              <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;">
                <div>MOELIS &amp; COMPANY LLC</div>
              </td>
            </tr>

        </table>
      </div>
      <br>
    </div>
    <br>
    <div style="color: rgb(0, 0, 0); font-family: Arial,Helvetica,'sans-serif'; font-size: 9pt;">399 Park Avenue | 4<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor | New York, NY 10022</div>
    <div style="color: #000000;"> <font style="font-family: Arial,Helvetica,'sans-serif'; font-size: 8pt;"><br>
      </font></div>
    <div style="color: rgb(118, 146, 60); font-family: Arial,Helvetica,'sans-serif'; font-size: 8pt;">Moelis &amp; Company LLC doing business as Moelis</div>
    <div><br>
    </div>
    <div style="text-align: right;">1<br>
    </div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>11
<FILENAME>ny20053122x2_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div style="text-align: right;">
    <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"><font style="font-weight: bold;">Exhibit 99.3</font><br>
  </div>
  <div style="text-align: right;"> <br>
  </div>
  <div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z93a76e8252e24181aebee938925de48b" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div><img src="ny20053122x2_ex99-3img01.jpg" width="120" height="16"></div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="text-align: right;"><img src="ny20053122x2_ex99-3img02.jpg" width="70" height="51"></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>September 17, 2025</div>
    <div><br>
    </div>
    <div>Board of Directors</div>
    <div>Core Scientific, Inc.</div>
    <div>838 Walker Road</div>
    <div>Suite 21-2105</div>
    <div>Dover, Delaware 19904</div>
    <div><br>
    </div>
    <div style="text-align: justify;">RE: Proxy Statement/Prospectus of CoreWeave, Inc. and Core Scientific, Inc. which forms a part of Amendment No. 1 to the registration statement on Form S-4 of CoreWeave, Inc. ( &#8220;Amendment No. 1 to the Registration
      Statement&#8221;)</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Members of the Board of Directors:</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Reference is made to our opinion letter, dated July 7, 2025 (the &#8220;Opinion Letter&#8221;), with respect to the fairness, as of the date thereof, of the Exchange Ratio in the Transaction to the holders of the Shares <font style="color: #000000;">(excluding any Cancelled Shares (as defined in the Agreement))</font> from a financial point of view. Capitalized terms used but not defined herein shall have the meanings set forth in the Opinion Letter.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">The Opinion Letter was provided for the information and assistance of the Board of Directors of the Company, in its capacity as such, in connection with and for the purposes of its evaluation of the Transaction. We
      understand that the Company has determined to include and reference the Opinion Letter in Amendment No. 1 to the Registration Statement. In that regard, we hereby consent to the reference to the Opinion Letter under the captions &#8220;Summary&#8212;Opinions of
      Core Scientific&#8217;s Financial Advisors,&#8221; &#8220;Summary&#8212;Risk Factors,&#8221; &#8220;Risk Factors&#8212;Risks Relating to the Merger,&#8221; &#8220;The Merger&#8212;Background of the Merger,&#8221; &#8220;The Merger&#8212;Recommendation of the Core Scientific Board of Directors and Reasons for the Merger,&#8221; &#8220;The
      Merger&#8212;Certain Unaudited Prospective Financial Information&#8221; and &#8220;The Merger&#8212;Opinions of Core Scientific&#8217;s Financial Advisors&#8212;Opinion of PJT Partners,&#8221; and to the inclusion of the Opinion Letter in the proxy statement/prospectus which forms a part of
      Amendment No. 1 to the Registration Statement.</div>
    <div><br>
    </div>
    <div style="text-align: justify;">Notwithstanding the foregoing, it is understood that our consent is being delivered solely in connection with the filing of Amendment No. 1 to the Registration Statement and that the Opinion Letter is not to be quoted,
      summarized, paraphrased or excerpted, in whole or in part, in any other registration statement (including any subsequent amendments to Amendment No. 1 to the Registration Statement), prospectus or proxy or information statement, or in any other
      report, document, release or other written or oral communication prepared, issued or transmitted by the Board of Directors of the Company, including any committee thereof, or the Company without our prior consent. In giving such consent, we do not
      thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission thereunder, nor do we admit that we
      are experts with respect to any part of Amendment No. 1 to the Registration Statement within the meaning of the term &#8220;experts&#8221; as used in the Securities Act of 1933, as amended, or the rules and regulations of the Securities and Exchange Commission
      thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: center;">[Signature page follows]</div>
    <div><br>
    </div>
    <div style="font-family: 'Times New Roman',Times,serif; font-size: 8pt;">280 Park Avenue&#160;&#160; |&#160;&#160; New York, NY 10017&#160;&#160; |&#160;&#160; t. +1.212.364.7800&#160;&#160; |&#160;&#160; pjtpartners.com</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfd6dcb6be88d423bbf1a73348a49caba" border="0" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">/s/ PJT Partners LP<br>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div>PJT Partners LP</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <div style="font-family: 'Times New Roman',Times,serif; font-size: 8pt;">280 Park Avenue&#160;&#160; |&#160;&#160; New York, NY 10017&#160;&#160; |&#160;&#160; t. +1.212.364.7800&#160;&#160; |&#160;&#160; pjtpartners.com</div>
      <div style="font-family: 'Times New Roman',Times,serif; font-size: 8pt;"> <br>
      </div>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>12
<FILENAME>ny20053122x2_exfee.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Sep 16 22:30:37 UTC 2025 -->
<!-- Created by CompSci Resources, LLC on Tue Sep 16 21:51:12 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
 <body><div style="font-family: Times New Roman; font-size: 10pt;"><div>
  </div><div style="text-align: right; font-weight: bold;">
   <span>Exhibit 107</span>
  </div><div>
  </div><div style="text-align: right; font-weight: bold;">&#160;
  </div><div>
  </div><div style="text-align: center; font-weight: bold;">
   <span>Calculation Of Filing Fee Tables</span>
  </div><div>
  </div><div style="text-align: center; font-weight: bold;">&#160;
  </div><div>
  </div><div style="text-align: center; font-weight: bold;"> <span>Form <ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-20"><span style="-sec-ix-hidden: hidden-fact-0">S-4</span></ix:nonNumeric></span> </div><div>
  </div><div style="text-align: center; font-weight: bold;">
   <span style="font-weight: normal;">(Form Type)</span>
  </div><div>
  </div><div style="text-align: center; font-weight: bold;">&#160;
  </div><div>
  </div><div style="text-align: center; font-weight: bold;"> <ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-29"><span>CoreWeave, Inc.</span></ix:nonNumeric> </div><div>
  </div><div style="text-align: center;">
   <span>(Exact Name of Registrant as Specified in its Charter)</span>
  </div><div>
  </div><div style="text-align: center;">&#160;
  </div><div>
  </div><div style="text-align: center; font-weight: bold;">
   <span>Table 1: Newly Registered Securities</span>
  </div><div>
  </div><div>&#160;
  </div><div>
  </div><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;">&#160; </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Security</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Type</span> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Security</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Class</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Title</span> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Fee</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Calculation</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">or Carry</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Forward</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Rule</span> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Amount</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Registered</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Proposed</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Maximum</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Offering</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Price Per</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Unit</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Maximum</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Aggregate</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Offering</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Price</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Fee</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Rate</span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: bottom;"> <div style="text-align: center;"> <span style="font-weight: bold;">Amount of</span> </div> <div style="text-align: center;"> <span style="font-weight: bold;">Registration Fee</span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c1" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-106"><span>Fees to Be Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTp" id="ixv-110"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c1" name="ffd:OfferingSctyTitl" id="ixv-114"><span>Class A common stock, par value $0.000005 per share</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-403">457(c)</ix:nonNumeric>, <ix:nonNumeric contextRef="c1" format="ixt:fixed-true" name="ffd:Rule457fFlg" id="ixv-404">457(f)(1)</ix:nonNumeric></span> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-405">5,195,397</ix:nonFraction>(1)</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>N/A</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-406">653,670,341.42</ix:nonFraction>(2)</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c1" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-407">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-408">100,076.93</ix:nonFraction></span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c2" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-137"><span>Fees to Be Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTp" id="ixv-141"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c2" name="ffd:OfferingSctyTitl" id="ixv-409">New Tranche 1 Warrants to purchase CoreWeave common stock</ix:nonNumeric>(3)</span> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c2" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-148"><span>Rule 457(g)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c2" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-410">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c2" decimals="0" format="ixt:fixed-zero" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-411">&#8212;</ix:nonFraction>(3)</span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c3" format="ixt:fixed-false" name="ffd:PrevslyPdFlg" id="ixv-168"><span>Fees to Be Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTp" id="ixv-172"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c3" name="ffd:OfferingSctyTitl" id="ixv-412">New Tranche 2 Warrants to purchase CoreWeave common stock</ix:nonNumeric>(4)</span> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c3" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-179"><span>Rule 457(g)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c3" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-413">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c3" decimals="0" format="ixt:fixed-zero" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-414">&#8212;</ix:nonFraction>(4)</span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c4" format="ixt:fixed-true" name="ffd:PrevslyPdFlg" id="ixv-199"><span>Fees Previously Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTp" id="ixv-203"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c4" name="ffd:OfferingSctyTitl" id="ixv-207"><span>Class A common stock, par value $0.000005 per share</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c4" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-415">457(c)</ix:nonNumeric>, <ix:nonNumeric contextRef="c4" format="ixt:fixed-true" name="ffd:Rule457fFlg" id="ixv-416">457(f)(1)</ix:nonNumeric></span> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-417">53,100,853</ix:nonFraction>(1)</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>N/A</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:MaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-418">5,877,640,852.04</ix:nonFraction>(5)</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c4" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-419">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c4" decimals="2" format="ixt:num-dot-decimal" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-420">899,866.81</ix:nonFraction></span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c5" format="ixt:fixed-true" name="ffd:PrevslyPdFlg" id="ixv-230"><span>Fees Previously Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTp" id="ixv-234"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c5" name="ffd:OfferingSctyTitl" id="ixv-421">New Tranche 1 Warrants to purchase CoreWeave common stock</ix:nonNumeric>(3)</span> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c5" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-241"><span>Rule 457(g)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c5" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-422">97,434,281</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c5" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-423">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c5" decimals="0" format="ixt:fixed-zero" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-424">&#8212;</ix:nonFraction>(3)</span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <ix:nonNumeric contextRef="c6" format="ixt:fixed-true" name="ffd:PrevslyPdFlg" id="ixv-261"><span>Fees Previously Paid</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 8.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c6" name="ffd:OfferingSctyTp" id="ixv-265"><span>Equity</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 10.38%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonNumeric contextRef="c6" name="ffd:OfferingSctyTitl" id="ixv-425">New Tranche 2 Warrants to purchase CoreWeave common stock</ix:nonNumeric>(4)</span> </div> </td> <td style="padding: 0; width: 10.78%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <ix:nonNumeric contextRef="c6" format="ixt:fixed-true" name="ffd:FeesOthrRuleFlg" id="ixv-272"><span>Rule 457(g)</span></ix:nonNumeric> </div> </td> <td style="padding: 0; width: 12.02%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c6" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRegd" scale="0" unitRef="shares" id="ixv-426">12,406,445</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>&#8212;</span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c6" decimals="8" format="ixt:num-dot-decimal" name="ffd:FeeRate" scale="0" unitRef="pure" id="ixv-427">0.00015310</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c6" decimals="0" format="ixt:fixed-zero" name="ffd:FeeAmt" scale="0" unitRef="usd" id="ixv-428">&#8212;</ix:nonFraction>(4)</span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt;">&#160; </td> <td colspan="4" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <span>Total Offering Amounts</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c0" decimals="INF" format="ixt:num-dot-decimal" name="ffd:TtlOfferingAmt" scale="0" unitRef="usd" id="ixv-429">6,531,311,193.46</ix:nonFraction></span> </div> </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlFeeAmt" scale="0" unitRef="usd" id="ixv-430">999,943.74</ix:nonFraction></span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt;">&#160; </td> <td colspan="4" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <span>Total Fees Previously Paid</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:TtlPrevslyPdAmt" scale="0" unitRef="usd" id="ixv-431">899,866.81</ix:nonFraction></span> </div> </td> </tr> <tr style="vertical-align: top; height: 0.75pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt;">&#160; </td> <td colspan="4" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <span>Total Fee Offsets</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span><ix:nonFraction contextRef="c0" decimals="0" format="ixt:fixed-zero" name="ffd:TtlOffsetAmt" scale="0" unitRef="usd" id="ixv-432">&#8212;</ix:nonFraction></span> </div> </td> </tr> <tr style="vertical-align: top; height: 3.7pt;"> <td style="padding: 0; width: 9.62%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; font-size: 0;">&#160; </td> <td colspan="4" style="padding: 0; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div> <span>Net Fee Due</span> </div> </td> <td style="padding: 0; width: 9.92%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;">&#160; </td> <td style="padding: 0; width: 17.14%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 10.44%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle; font-size: 0;">&#160; </td> <td style="padding: 0; width: 11.34%; border-top: 1pt solid black; border-bottom: 1pt solid black; border-left: 1pt solid black; border-right: 1pt solid black; padding-left: 5.4pt; padding-right: 5.4pt; vertical-align: middle;"> <div style="text-align: center;"> <span>$<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NetFeeAmt" scale="0" unitRef="usd" id="ixv-433">100,076.93</ix:nonFraction></span> </div> </td> </tr> </table><div>
  </div><div class="footer" style="page-break-after: always;">
    <hr/>

  </div><div>
  </div><ix:nonNumeric contextRef="c4" continuedAt="_OfferingNote-c4_alt_0_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-339"><ix:nonNumeric contextRef="c1" continuedAt="_OfferingNote-c1_cont_1" escape="true" name="ffd:OfferingNote" id="ixv-340"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Represents the estimated maximum number of shares of Class A common stock, par value $0.000005 per share, of CoreWeave, Inc., a Delaware corporation (&#8220;CoreWeave&#8221; and such shares, the &#8220;CoreWeave common stock&#8221;), issuable in connection with the proposed merger of Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave, with and into Core Scientific, Inc., a Delaware corporation (&#8220;Core Scientific&#8221;), with Core Scientific continuing as the surviving company and as a wholly owned subsidiary of CoreWeave (the &#8220;Merger&#8221;). Consists of, based on the exchange ratio of 0.1235 shares of CoreWeave common stock per common stock, par value $0.00001 per share, of Core Scientific (the &#8220;Core Scientific common stock&#8221;), in each case with respect to outstanding Core Scientific shares or securities convertible into Core Scientific shares, and Tranche 1 Warrants and Tranche 2 Warrants, outstanding as of September 11, 2025: (i) 58,296,250 shares of CoreWeave common stock to be issued, in exchange for (a) 306,833,449 shares of Core Scientific common stock, (b) 288,460 shares of Core Scientific common stock reserved for disputed claims in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) filed with the United States Bankruptcy Court for the Southern District of Texas by Core Scientific and certain of its affiliates, (c) an estimated maximum of 6,553,528 shares of Core Scientific common stock underlying certain Core Scientific restricted stock unit awards (whether vested or unvested), (d) an estimated maximum of 7,088,694 shares of Core Scientific common stock underlying certain Core Scientific performance stock unit awards (whether vested or unvested), (e) an estimated maximum of 48,004 shares of Core Scientific common stock underlying in-the-money Core Scientific options that may be exercised prior to the closing of the Merger pursuant to the formula set forth in the Merger Agreement, assuming that the Per Company Share Price (as defined in the Merger Agreement) is $13.24, which is based on the average of the volume weighted averages of the trading prices of CoreWeave common stock (as reported by Bloomberg L.P.) on each of the five consecutive trading days ending on (and including) September 11, 2025 and (f) 41,825,776 shares of Core Scientific common stock reserved for issuance upon the conversion of Core Scientific&#8217;s 3.00% Convertible Senior Notes due 2029, (ii) 12,032,877 shares of CoreWeave common stock issuable upon exercise of New Tranche 1 Warrants (as defined in the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. (the &#8220;Warrant Agreement&#8221;)) to purchase shares of CoreWeave common stock issued in exchange for Tranche 1 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock and (iii) 1,480,409 shares of CoreWeave common stock issuable upon exercise of New Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of CoreWeave common stock issued in exchange for Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock. 53,100,853 shares of CoreWeave common stock were previously registered on Form S-4 filed by CoreWeave on August 20, 2025 and 5,195,397 shares are being registered herein.</span> </div> </td> </tr> </table></ix:nonNumeric></ix:nonNumeric><div>
  </div><div style="margin-left: 10.8pt;">&#160;
  </div><div>
  </div><ix:continuation id="_OfferingNote-c1_cont_1"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(2)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:FeeNoteMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-434"><ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:ValSctiesRcvd" scale="0" unitRef="usd" id="ixv-435">653,670,341.42</ix:nonFraction></ix:nonFraction> is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on September 12, 2025 ($<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:ValSctiesRcvdPerShr" scale="0" unitRef="usdPershares" id="ixv-436">15.53</ix:nonFraction>) multiplied by (y) the maximum number of shares of Core Scientific common stock (<ix:nonFraction contextRef="c1" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRcvd" scale="0" unitRef="shares" id="ixv-437">42,090,814</ix:nonFraction>) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.</span> </div> </td> </tr> </table></ix:continuation><div>
  </div><div style="margin-left: 10.8pt;">&#160;
  </div><div>
  </div><ix:nonNumeric contextRef="c2" escape="true" name="ffd:OfferingNote" id="ixv-364"><ix:nonNumeric contextRef="c5" escape="true" name="ffd:OfferingNote" id="ixv-365"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(3)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 1 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 1 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 1 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 1 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table></ix:nonNumeric></ix:nonNumeric><div>
  </div><div style="margin-left: 10.8pt;">&#160;
  </div><div>
  </div><ix:nonNumeric contextRef="c3" escape="true" name="ffd:OfferingNote" id="ixv-377"><ix:nonNumeric contextRef="c6" escape="true" name="ffd:OfferingNote" id="ixv-378"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(4)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 2 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 2 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 2 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 2 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table></ix:nonNumeric></ix:nonNumeric><div>
  </div><div style="margin-left: 10.8pt;">&#160;
  </div><div>
  </div><ix:continuation id="_OfferingNote-c4_alt_0_cont_1"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(5)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:FeeNoteMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-438"><ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:ValSctiesRcvd" scale="0" unitRef="usd" id="ixv-439">5,877,640,852.04</ix:nonFraction></ix:nonFraction> is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on August 14, 2025 ($<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:ValSctiesRcvdPerShr" scale="0" unitRef="usdPershares" id="ixv-440">13.67</ix:nonFraction>) multiplied by (y) the maximum number of shares of Core Scientific common stock (<ix:nonFraction contextRef="c4" decimals="INF" format="ixt:num-dot-decimal" name="ffd:AmtSctiesRcvd" scale="0" unitRef="shares" id="ixv-441">429,966,412</ix:nonFraction>) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.</span> </div> </td> </tr> </table></ix:continuation><div>
  </div><div>&#160;
  </div><div>
 </div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="ffd:SubmissnTp">S-4/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-445">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-446">0001769628</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-447">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-448">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-449">333-289742</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>1</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>2</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>3</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV6][qacypAQOdgGMzF3NXPt1MO7PNaXnzfDLmfTGuKUoxkchte9z/NaIk+nygZRoCmOCMTRN3kcMbluGzJWao8L5E4kJ6lncUdvj3Wjx263rmbC3vFUyLx1jtJC77mjC9ViSL/scFEeBqyqJA9Z/9z9A7EVt0xqt84V/XbjusMnUPsxglxSTW9DqR8ql3gpt3LzQOu04OrpfxwLS012zT/VkBu89q2nYmswIRGZ94mQqS3OvFD4JnvJSyHaaOGVzxu5CPCKlkqNfOLOSiiGqoLLE5CJ4RRfO9gDFZ7k9GxYGf7PkhpmwheUVOnjH2kotpr7dPXmPujPac21Q9SAbkE0uq/Flt921G7jgilhX] CSR-->
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>4</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>5</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001769628</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ffd:OfferingAxis">
        <dei:lineNo>6</dei:lineNo>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-09-17</xbrli:startDate>
    <xbrli:endDate>2025-09-17</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="shares">
  <xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="pure">
  <xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit></ix:resources></ix:header>

</div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>logo_corescientific.jpg
<TEXT>
begin 644 logo_corescientific.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M"DM_!>6>BZL-)E&K>(M96VDU6T34=+L]*GTVYAO9I?WJ_P""C'[:/A/]@O\
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M&_\ E0?VEF/_ $'XW_PJK_\ RP^X_P#AYK_P45_Z/E_:O_\ #]?$O_YHZ/\
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MFFFKIIIG[0FI)2BTXR2::=TTU=-/JFM4PHHHJ1A1110 4444 %%%% !1110
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MZ=*<^3"QI2C"4U#2I5DY0G>'-[D$DKN,V].6_P#FX?\ $.]_P5@_Z-^\,?\
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M][=W,5@MS=322JAGF=88HHE1%\5_XB0?^"I/_11_AA_X9SP9_P#(M?DC^TZ
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M-KVF>'-:NK9+H>%O"_AN*[LK6\U6PMYH)-4U;6I+JR@N'-C!I-QL:\/ZP?\
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MV5G9V%M Q:*XN;FXG,\4=M^MW_!-W]OCXP?M*?\ !+[Q'^US\6-/\,:E\4_
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MO/AG\1/$D^C6'B/Q!X6N'U?0++3YM+N!JOAG4M*U-4@>>4M;K=B";<!-&X4
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MD_\ ]$!\4?\ A[OC-_\ -Q4_ZY^%G_1)O_PQY3Y?]1?]6??6/[#XS_Z'=/\
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M>XL[D+Y5S!-"SQM^??\ P=6*J?LH?LWHBA57X[Z@JJH"JJKX$U<!5 P
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MC7Q-"C*6*BXQJUJ=-R7LHJZ4Y1;5]+K2^A^I%%?EO_P^L_X):?\ 1Y/PU_\
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MXIE&'$G#TYR480J8:4IR:C&,5CX-RE)V44DFVVTDDV]$?ZH=%?EO_P /K/\
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MW_TVZ57^B?7^=A_P;5?\I/?#/_9%OB[_ .FW2J_T3Z^L\7O^2LC_ -BK!_\
MIW%'A\$?\B1?]A>(_*F%?Y#W[2'_ "<5\??^RT_%/_U.]?K_ %X:_P A[]I#
M_DXKX^_]EI^*?_J=Z_7O^"G^]\0?]@^7_P#IS%GF>('^[Y;_ -?L1_Z12/\
M0L_X*9_\H,/BK_V;!\%__2_X:5_F]:5JVJ:%?6NK:+J6H:/JEFWF6>I:7>7.
MGZA:R%&0O;7EI)%<P.49E+12*Q1F4G!(K_2%_P""F?\ R@P^*O\ V;!\%_\
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MV8_]D_#_ --X$^.J_P#)"8?_ +#I?^I-<_IJ_P"#;?\ Y1=^ _\ LJ_QA_\
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MMK#%;6UM%';V]O;QI#!!!"BQPPPPQJL<444:JD<:*J(BJJJ% %8/C'PEX?\
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M7B#_ *%N3?\ @&._^;O+\^[/!_U!RK_H+S+_ ,&87_YD]?Z6O^8I_P ..?\
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MI3DIPG%])1DDT^C1]9*,9QE&24HR3C*+5U*+5FFNJ:;378_SC_VA_P#@W?\
M^"C?PD^(.M:#\+_AA9?'_P  K?7#>%_'?@GQ7X/TJ34-(:5S9?VWX<\6^(=!
MU;1=8C@*+J%I'%?Z>EP'%CJE[!LF/@G_  XY_P""K/\ T9YXS_\ "P^%7_S?
MU_IUT5^K4?&+B2G2ITZN"RC$3A%1E6G1Q<)U6DO?G&EBX4U.5KRY(0A=OEA%
M:'QE7@7**E24XU\?1C*3?LZ=6@X1N[VBZF'J3LM;<TY/NW8_S%/^''/_  59
M_P"C//&?_A8?"K_YOZ[_ .&G_! +_@J/X_\ %VD^'-9_9[7X9:3?7=O#J/C3
MQYX[\ 0>']#LY)%6XO[N#P]XF\0Z]>+;1%Y/LFEZ-?7<Y41Q1%FR/]*RBJJ>
M,G$<H2C# 9/3FXM1J*EC)N#:MS*,\:XMK=*2:ONFKIS#@/*8RC*6)S"HDTW"
M57#J,DK73<,-&23U3Y9)V>C35SX[_8,_8[\'?L)_LQ?#[]G3P?J4NOCPQ!=:
MGXI\4SVXLY?%?C36W2Z\1:]]B5Y%LK:XN5CMM/L_,E>VTVTLXIYKBY6:XE_F
MS_X+._\ !!WXY?&?XZ^*/VJ_V-]*TGQU<?$JXBU3XF?"2ZUO2?#?B*S\5K#'
M;W7B7PI>Z_=Z=H6J:9K$<,4NH:7/J=CJ%C?[Y+*&^MKA_L?]B%%?$91Q9G.3
M9Q7SS#UXU<;BY5GC5B8<]+%JO456I&K"#IM7J)3BZ4J<H.*46HWB_H\=E&!S
M# PR^O3<</25-453?+.BZ4>2FZ<FI).,+QU33BVFG<_S%/\ AQS_ ,%6?^C/
M/&8_[G#X4G]1X_YH_P"''/\ P59_Z,\\9_\ A8?"K_YOZ_TZZ*^Z_P"(R\0_
M]"W)O_!>._\ F[R_J[/FO]0<J_Z"\R_\&87_ .9/7^EK_F)G_@AQ_P %6<'_
M (P\\9_^%A\*A_[O]?V\_P#!$/\ 9;^,W[(7[ G@GX3?'OPU'X,^(T_CGXA>
M,-0\*#5--UB[T'3O$6M*=*M-3O=&N[_2O[0GM+)=0E@L;^\2VBO(89I4NTN+
M>']<Z*^=XF\0LVXHR^&6XS"9?AZ$,33Q7-A88E593I0JTXQ<JV)K14+59-I0
M4FTO>M=/U,HX8P.38F>*P]?%U:DZ,J#5>=%P4)3IS;2IT*3YKTU9N325U:^I
M_GA_MQ?\$5?^"E?C?]M']J#QM\/_ -FW5?&_@;XC_M ?%7Q_X/\ %^B^,OAS
M!I.J>&O'GCK6O$^B7,D>L^,-+U.PN(M/U:WBU.UO;"&2SO(KF(>;'&DTG]L_
MASX"^.;#_@G3H/[+]V=*B^)5E^Q5I?P%N3]M,FAQ>.;;X&0?#V8_VC'$Q?2D
MU]&_TV.%BUF//6(Y"5]JT5Q9YQKFF?X7*,+BJ&"I1R9QE0GAZ=93JSA3I4XR
MK>TK5([4DW&G&FFY2TMRJ/3EV0X/+*V.K4)XB<L>VZJJSA*,$Y3ERT^2G!I7
MJ-7FYNRBKWNW_F-W/_!#+_@JS;7-Q;?\,@^+)_(FDA\^V\:?"F:WF\MV3S()
M1X^420OM#QR8&]&!P.E0?\..?^"K/_1GGC/_ ,+#X5?_ #?U_IUT5]=_Q&7B
M'KEN3-]?W>.6NG3Z]Y;?YL\)\!92VVL7F*795,+IY:X1OON_RU_S%/\ AQS_
M ,%6?^C//&?_ (6'PJ_^;^MCP]_P0M_X*J:AKVBV,W[)GB328;K5+"&75-5\
M;?"VWTS3HY+J)9+V_FA\<W$\=I:J3-<-#;SS")&\J&63:C?Z:=%*7C+Q"TTL
MMR9-II/V>.=O.SQUG;L]'UO=W<> \JC)/ZUF+LT[.IA;.S3L[85.SU3LT[/1
MZ'YS?\%(/V<OB9\?_P#@FY\=?V<_A=8V7B+XG^(OA=X5T;PYIDVH6^EVVNZO
MX0\0^$M?N-/M]0U)X+2VN-4M_#MW;:;)J$]K:F\GMDO+FUA:2>/^6G_@CK_P
M2._X*!_ G_@H-\#OC1\;/@!J?PQ^&OPY?QGJWB'Q+X@\5^!;N,B_\#>(] T[
M3]/L/#WB?6]3O;^]U/5K.-%6R2WB@$]Q<3Q1Q#=_=?17Q^4<99GDV2YKD>&H
M8.IALW^LNO5K4ZLL12>*PT<+6=%PK0IK]U!.*G3GRSN]5[I[V-R/"8['X+,*
MTZ\:V!<'2C3G!4I^SJ>UBJBE3E-VFW?DG"ZT"OGK]J;]F'X2?MA_!#QI\ _C
M5H*:YX+\96:IY\(ACUGPYK=HQFT;Q5X9OY89CI?B#0[O;<V-XB,KH9[&\BN=
M.O+RUG^A:*^7H5ZV&K4L1AZDZ->A4A5HU:<G&I3JTY*4)PDM8RC))IK9H]:I
M"%6$Z=2,9TZD7"<))2C*,E:49)Z---II[H_S9_C7_P &_P#_ ,%*OAO\3_%_
M@[P!\"M0^,G@C1]6N(O"OQ*\+>)? .G:5XKT)W+Z;J)TK7O&&FZOI%^UJT::
MEIEW:_Z%?+/#!<7ENL5U+_95_P $2/V7?C+^R'^P-X'^$WQY\-1>#OB-+XT\
M=^+]1\++JFFZQ=:'8^(M3A;3;/4[S1KJ^TK^T7MK,74T%E?7D=O'<0Q23"X6
M:&+];J*^TXAX_P YXERNAE6/H8&-.E6HXB=>A3K0KUJM&E.DI3YJ\Z45+VDI
MSC3I07-;EY8KE?@Y7PU@,HQE;&86>)<JM.=)4JLZ<J5.$YPFXPY:4:FC@DG.
MI-\N]WJ%?D=_P6Y_9:^,O[7W[!'C+X3_  %\-P^,?B-;>.? 7C'3O"K:IIND
M76NV'A[4KA=3L],O=9NK#2AJ$=M?F\BAOK^SBGBM9XHYC<M!#+^N-%?*99CZ
MV59A@LRP\:<Z^!Q-+%4HU5*5*4Z,U.,:BC*$G%M6ERRC*VTD]3VL5AX8O#5\
M+4<E3Q%&I1FX-*2C4@X2<6TTI).Z;35]TUH?Q<?\$'_^"67[<W[,/[<2?&W]
MH7X(W_PI^'_A_P"%/CO0QJ>N^)O!FHW.K:YXG&E6.G:9IFG^&?$>NWKR+''=
M7MS<W,-M9P6]L4,[7$T$,G]H]%%>CQ)Q%C.)\R_M/'4L/1K?5Z6&5/"QJ1I*
M%)S:=JM2K-R<JDFVYVV22L<F597A\HPBP>&G5G352=3FK2A*HY3M>[A"G&VB
MLE%!7^<3^T#_ ,$-O^"G6N?M(_%^?PS^S7J/B/PQXG^+WC35-!\:Z?XV^',7
MAS4-#\1^+-2U/3M9+ZAXOL]3M+,65_#/=1W6FQ7=L5EB>W:6,JW^CM179PMQ
M?F/"57&U<OH82N\=2I4ZJQ<*LU'V,IRIRA[*M1::=22:DY1:MHFKF&<9)A,Z
MA0ABJE>FL/4E.#H2IQ<N=)2C/VE.HG%\J^%1DK:25V?F=^W'^S)\4OC'_P $
MN/B;^R]\/]/T_6?BUJ'P%\$>#]'TEM2MK&QU?Q)X-/A*]O--M=4OFMK.(Z@W
MA^[M=.N;V2UM7GFMS<S6T+/)'_+#_P $E_\ @D!_P4+^#'[?_P"S]\7OC'^S
MYJGPT^&_PS\0:MXF\2>)_$'BSP'=6ZV\?A[5M.M[&RL_#_BC6M3O-0O;N_MT
MMXHK+R0GFRSS0Q1EZ_O/HK7*>-<TR?*<WRC#T<%4H9Q+$SQ%6M3K.M3GBZ$<
M/5=%PKTZ:_=Q3@ITYJ,]7S+W18W(L)C\=@<?6J8B-;+W3=*%.=-4YNE556'M
M5*E*;M-?8G"Z=G?0****^//:"OP/_P"#@O\ 8N_:(_;._9B^%7A_]F_P,?B/
MXM\ ?%Q?$NL>%+76=$T75KC0M0\,:MI#W^FR>(=0TK3+K[#>RVHNK4ZA'=F&
MX$UO#.L,P3]\**]/)\UQ&29G@\UPL:4\1@JOM:<*\92I2;A*G*,U"<)-.,Y+
MW9Q:=FGH<N-PE+'X2O@ZSG&EB*;IS=-I32=G>+E&2332:O%KNF?R;_\ !N]_
MP3@_;#_8]^-?Q^^)O[2WPEN?A1H/B;X6Z1X%\-6NL>(?"VK:KK>KR^+--U^Y
MGM;3PQK>NK!I^GV>D-'<W%_-:-)<7EK':1W 6Y:W^@O^"YW_  1L\=_MVZEX
M6_:+_9NN=$/QU\&^%H_!OB;P+KU_!HEC\2/"UA?7FHZ+/I>MW6W3]/\ %FAR
M:CJ%I&FKRVNG:OI<MK;2:C8S:9;"Z_I&HKW:W&^<U.)?]:*2PV&Q_)3HNC2I
MU'A9T(48T71J4ZE6=2<*D8IS;JJ2G:=.4)1@X^=3R# 0RE9-/VM;"IRES5)Q
M]LIRJNLIJ<(0C&49OW;02Y?=DI)R3_S%Y?\ @AK_ ,%68I)(C^Q_XP<QLR;X
MO&7PHDC?:2-T;K\0,.IQE6'!!!%,_P"''/\ P59_Z,\\9_\ A8?"K_YOZ_TZ
MZ*^O_P"(R\0_]"W)O_!>._\ F[R_J[/"_P!0LJ_Z"\R_\&87_P"9#_,4_P"'
M'/\ P59_Z,\\9_\ A8?"G_YOZ^[/V:_^#?S_ (*(Z[\/[W4?&'A?PI\(-4E\
M3Z@D/A7QGXPTJ?6IK&+3](2+5V_X12\\0:;%:W<XN;:"*6^6\S922RV\<,MN
M\O\ ?_17-BO%[B/$4O9PP>4T'S1E[2%'%3E:/2U7%SAKI=\K>FC5V=.#X+RO
M!UE6C7QM9J,HJ%6I0Y/>M[W[O#TY75G;WK:ZIV"J]W:6M_:W-C?6T%Y97MO-
M:7EG=0QW%K=VMS&T-Q;7,$JO%/!/"[Q30RHT<L;LCJRL0;%%?E.VQ]>?YDW_
M  6:_P""?MW^P/\ M=^(=#\-:9-%\#?BQ]M^(/P;OTCF-GI^E7U])_;?@1YY
M-R_;O!>IRFQBC\QY)=!N-#OI&$EW)%#^2%?ZA7_!6_\ 8)TC_@H#^R'XO^'5
MC9V:_%SP*MW\0_@CK4T2+<6_CC2--NU/AF2\XDAT?QQ8/+X>U*-G:UCNY=)U
MB>":?1;0Q_Y@^LZ/JOA[5]4T#7=/NM)UO0]1O-)UC2KZ%[>]TW4].N)+2^L;
MRWD"R0W-K<PRP3Q.H9)(V4C(K^LO#OBC_6/(X0Q%12S/+5#"XU-WG6BHVP^+
M=]7[>$6JC_Y_TZKT3C?\8XKR9Y9F$JM&'+@\8Y5:/*K1I5-/:T=%:*C)\U-;
M>SDHJ_*RC%-+;RQ3P2/#/!(DT$L;%)(IHF#Q2(ZD,KHZJRLI!5@"""*_I(^'
M/_!T!^W)X#\!>#_!6H_"W]GWQ]>^%/#FD>'[CQKXNTWXD/XI\4-I-E#9#6O$
M,NE?$/3=.GUF_6%9]1N;6PM8[FZ:2<PJ\C9_FSHKZC-<BRC/(T89M@*&.CAY
M3E0]LI7I.HDI\DH2C)*:C'FC>S<8MJZ37BX'-,?EKJ/!8F>'=5153E49*?(V
MXW4XR5U=V:5[-J^I_4!_Q%6?MK?]&_?LM_\ @K^+/_ST*/\ B*L_;6_Z-^_9
M;_\ !7\6?_GH5_+_ $5XO^H'!W_0AP?WU_\ Y<>A_K3GW_0QJ_\ @NA_\J_J
M[\K?U ?\15G[:W_1OW[+?_@K^+/_ ,]"OE#]M/\ X+^_M??MK? 3Q)^SSXH\
M%?"'X8>$/&5[IC>+=3^&-IXYL]?U[1-.F:[?PO=W7B+QIK]HFB:C>I9W&I10
M6<=Q=+8Q6K3BUFN89?PNHK;#<$<*83$4<5A\DP=.OAZD*U&HO:R=.K3DI0FE
M.K*+<9)25XNS2?0SJ\29W7I3HU,PJRIU(2A.*C2BY1DK27-&FI*ZO=Q:>KU
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M?]#2I_X21_\ F@_QT?\ A&_$7_0 UK_P5WW_ ,8H_P"$;\1?] #6O_!7??\
MQBO]BZBC_B-D_P#HFH_^'=__ #L#_B']+_H:5/\ PDC_ /+S_'1_X1OQ%_T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
24444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>logo_moelis.jpg
<TEXT>
begin 644 logo_moelis.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M97Y\.1ZJEI/XDEL[RSN+;0HM1N8KJW>(3)_)5_P:&?\ (W?MX_\ 8N?LZ_\
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MJ?V:U2-?[/U>ZO?AQKFLZE=S75U_;GPPT2SC2UTUMO\ 0S_P7S_Y1&_MD?\
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MQU7[!_\ !JQ_RDG\;?\ 9I_Q._\ 5B_!NOQ\_P""DO\ RD4_;X_[/3_:F_\
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MJ1J?5Z+Y9:*<]+IRLU&/1:/5[ZZ6LV_[NOV!?V1O^"C?[>WP.\&_M2?MY?\
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MFUC7K'\7?^"RG[:6J?MP?M\_&KX@6FN2ZI\+? 7B"^^$7P2LX;\7VBVWP[\
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MQ^/O_!?/_E$;^V1_V+?PR_\ 5Y_#"OT8_9L_Y-T^ 7_9%?A9_P"H-H5?G/\
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M]G+X/74>G1V]A+%?W9EN+71D6TLI(;F1KHK:RK/,&7^#8 D@ $DD  #))/
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M.@H)**<N51LHVM&UK:6]#^GG_@T,_P"1N_;Q_P"Q<_9U_P#3G\:*_M,\8_\
M(H^*?^Q<US_TV75?Q9_\&AG_ "-W[>/_ &+G[.O_ *<_C17]IGC'_D4?%/\
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MC)!X;T[X@>%;/3-*@FNM"7QCX<L[9/$GQ!7BO^"N7_!MUX$\#?#;QW^TW^P
M-7T:/P)I.I>,/'_[-6N:O=:_I]QX1T:PEO\ Q%KOPB\4Z]>W'B"+5=!LK2XU
MFZ\ >)M1UZ3Q':-J,7@_6]/U73]"\$^)/XO:^QY<IXFP<IJ*E*-X*;BH8K"U
M&KI-INZUYK<TZ-2S6KB^7S+XG 54F[)ZM)MTZBZVNM^E[*4?*^O^TQ17RI^P
MEJ7BW6?V'_V-M8\?7^JZIX[U7]E3]GG4O&NIZ[<R7FMZCXMOOA%X0NO$=_K%
MY*\DMWJMWK$MY<:A<RR223W<DTKNS.6)7Y34A[.I4IMI\DY0NMGRR<;KR=KG
MT47S14K6ND[=KJ]C^4[_ (.!OC%_P46_:_\ '^H?LB_LY?L:_MGW7[+/PO\
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MX8^*/#?[7_[,^AZY\2/@OXV\$^&_C;\/]2TCXA_ CX\^!M;\)>+]#@U>&_\
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M24HMI\]&BJ-2,X2FI)VU<6FGHTUR[-?\#4]T_P"#E#]@#]OC]K3XO_!KXH_
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A[>WA18X8((8U6.*&&-5CBBC54C151%"@ %%%?$GJG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ny20053122x2-architecture.jpg
<TEXT>
begin 644 ny20053122x2-architecture.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MO+[OZ_IORL>T?:/X_P"?]7?E;_2^_P"(P/\ X)=?]$T_;0_\-5\)?_G^4?\
M$8'_ ,$NO^B:?MH?^&J^$O\ \_RO\T&BCGEY?=_7]-^5CVC[1_'_ #_J[\K?
MZ7W_ !&!_P#!+K_HFG[:'_AJOA+_ //\H_XC _\ @EU_T33]M#_PU7PE_P#G
M^5_F@T4<\O+[OZ_IORL>T?:/X_Y_U=^5O]+[_B,#_P""77_1-/VT/_#5?"7_
M .?Y1_Q&!_\ !+K_ *)I^VA_X:KX2_\ S_*_S0:*.>7E]W]?TWY6/:/M'\?\
M_P"KORM_I??\1@?_  2Z_P"B:?MH?^&J^$O_ ,_RC_B,#_X)=?\ 1-/VT/\
MPU7PE_\ G^5_F@T4<\O+[OZ_IORL>T?:/X_Y_P!7?E;_ $OO^(P/_@EU_P!$
MT_;0_P##5?"7_P"?Y1_Q&!_\$NO^B:?MH?\ AJOA+_\ /\K_ #0:*.>7E]W]
M?TWY6/:/M'\?\_ZN_*W^E]_Q&!_\$NO^B:?MH?\ AJOA+_\ /\H_XC _^"77
M_1-/VT/_  U7PE_^?Y7^:#11SR\ON_K^F_*Q[1]H_C_G_5WY6_TOO^(P/_@E
MU_T33]M#_P -5\)?_G^4?\1@?_!+K_HFG[:'_AJOA+_\_P K_-!HHYY>7W?U
M_3?E8]H^T?Q_S_J[\K?Z7W_$8'_P2Z_Z)I^VA_X:KX2__/\ */\ B,#_ ."7
M7_1-/VT/_#5?"7_Y_E?YH-%'/+R^[^OZ;\K'M'VC^/\ G_5WY6_TOO\ B,#_
M ."77_1-/VT/_#5?"7_Y_E'_ !&!_P#!+K_HFG[:'_AJOA+_ //\K_-!HHYY
M>7W?U_3?E8]H^T?Q_P _ZN_*W^E]_P 1@?\ P2Z_Z)I^VA_X:KX2_P#S_*/^
M(P/_ ()=?]$T_;0_\-5\)?\ Y_E?YH-%'/+R^[^OZ;\K'M'VC^/^?]7?E;_2
M^_XC _\ @EU_T33]M#_PU7PE_P#G^4?\1@?_  2Z_P"B:?MH?^&J^$O_ ,_R
MO\T&BCGEY?=_7]-^5CVC[1_'_/\ J[\K?Z7W_$8'_P $NO\ HFG[:'_AJOA+
M_P#/\H_XC _^"77_ $33]M#_ ,-5\)?_ )_E?YH-%'/+R^[^OZ;\K'M'VC^/
M^?\ 5WY6_P!+[_B,#_X)=?\ 1-/VT/\ PU7PE_\ G^4?\1@?_!+K_HFG[:'_
M (:KX2__ #_*_P T&BCGEY?=_7]-^5CVC[1_'_/^KORM_I??\1@?_!+K_HFG
M[:'_ (:KX2__ #_*/^(P/_@EU_T33]M#_P -5\)?_G^5_F@T4<\O+[OZ_IOR
ML>T?:/X_Y_U=^5O]+[_B,#_X)=?]$T_;0_\ #5?"7_Y_E'_$8'_P2Z_Z)I^V
MA_X:KX2__/\ *_S0:*.>7E]W]?TWY6/:/M'\?\_ZN_*W^E]_Q&!_\$NO^B:?
MMH?^&J^$O_S_ "C_ (C _P#@EU_T33]M#_PU7PE_^?Y7^:#11SR\ON_K^F_*
MQ[1]H_C_ )_U=^5O]+[_ (C _P#@EU_T33]M#_PU7PE_^?Y1_P 1@?\ P2Z_
MZ)I^VA_X:KX2_P#S_*_S0:*.>7E]W]?TWY6/:/M'\?\ /^KORM_I??\ $8'_
M ,$NO^B:?MH?^&J^$O\ \_RC_B,#_P""77_1-/VT/_#5?"7_ .?Y7^:#11SR
M\ON_K^F_*Q[1]H_C_G_5WY6_TOO^(P/_ ()=?]$T_;0_\-5\)?\ Y_E'_$8'
M_P $NO\ HFG[:'_AJOA+_P#/\K_-!HHYY>7W?U_3?E8]H^T?Q_S_ *N_*W^E
M]_Q&!_\ !+K_ *)I^VA_X:KX2_\ S_*/^(P/_@EU_P!$T_;0_P##5?"7_P"?
MY7^:#11SR\ON_K^F_*Q[1]H_C_G_ %=^5O\ 2^_XC _^"77_ $33]M#_ ,-5
M\)?_ )_E'_$8'_P2Z_Z)I^VA_P"&J^$O_P _RO\ -!HHYY>7W?U_3?E8]H^T
M?Q_S_J[\K?Z7W_$8'_P2Z_Z)I^VA_P"&J^$O_P _RC_B,#_X)=?]$T_;0_\
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M $OO^(P/_@EU_P!$T_;0_P##5?"7_P"?Y1_Q&!_\$NO^B:?MH?\ AJOA+_\
M/\K_ #0:*.>7E]W]?TWY6/:/M'\?\_ZN_*W^E]_Q&!_\$NO^B:?MH?\ AJOA
M+_\ /\H_XC _^"77_1-/VT/_  U7PE_^?Y7^:#11SR\ON_K^F_*Q[1]H_C_G
M_5WY6_TOO^(P/_@EU_T33]M#_P -5\)?_G^4?\1@?_!+K_HFG[:'_AJOA+_\
M_P K_-!HHYY>7W?U_3?E8]H^T?Q_S_J[\K?Z7W_$8'_P2Z_Z)I^VA_X:KX2_
M_/\ */\ B,#_ ."77_1-/VT/_#5?"7_Y_E?YH-%'/+R^[^OZ;\K'M'VC^/\
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MY)=\-O\ L0?!W_J.Z=7?5[BP=!I-J>R^VO+^[_5_2PYM-[:/^OZ\WY6^R/\
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MO+:&9 RED (R#L[7L[=[:&!1110(**** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?Z^7PI_Y)
M=\-O^Q!\'?\ J.Z=7?5P/PI_Y)=\-O\ L0?!W_J.Z=7?5]/'9>B_(<MWZO\
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MS_-G^2T?V-_AX23_ &_XNY)/%SI..3G_ *!1I/\ AC;X=_\ 0P>+O_ G2?\
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M+"_\^8_?+_Y(.2/\J^[T_P D?(O_  QM\._^A@\7?^!.D_\ RJH_X8V^'?\
MT,'B[_P)TG_Y55]=44?4L+_SYC]\O_D@Y(_RK[O3_)'R+_PQM\._^A@\7?\
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M&#Q=_P"!.D__ "JH_P"&-OAW_P!#!XN_\"=)_P#E57UU11]2PO\ SYC]\O\
MY(.2/\J^[T_R1\B_\,;?#O\ Z&#Q=_X$Z3_\JJ/^&-OAW_T,'B[_ ,"=)_\
ME57UU11]2PO_ #YC]\O_ )(.2/\ *ON]/\D?(O\ PQM\._\ H8/%W_@3I/\
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M55]=44?4L+_SYC]\O_D@Y(_RK[O3_)'R+_PQM\._^A@\7?\ @3I/_P JJ/\
MAC;X=_\ 0P>+O_ G2?\ Y55]=44?4L+_ ,^8_?+_ .2#DC_*ON]/\D?(O_#&
MWP[_ .A@\7?^!.D__*JC_AC;X=_]#!XN_P# G2?_ )55]=44?4L+_P ^8_?+
M_P"2#DC_ "K[O3_)'R+_ ,,;?#O_ *&#Q=_X$Z3_ /*JC_AC;X=_]#!XN_\
M G2?_E57UU11]2PO_/F/WR_^2#DC_*ON]/\ )'R+_P ,;?#O_H8/%W_@3I/_
M ,JJ/^&-OAW_ -#!XN_\"=)_^55?75%'U+"_\^8_?+_Y(.2/\J^[T_R1\B_\
M,;?#O_H8/%W_ ($Z3_\ *JC_ (8V^'?_ $,'B[_P)TG_ .55?75%'U+"_P#/
MF/WR_P#D@Y(_RK[O3_)'R+_PQM\._P#H8/%W_@3I/_RJH_X8V^'G_0P>+O\
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M[-3TE*-]"KKJNC73?G<N;2VKBU%Q^%:VT44OLC]CSX#? ;XO?"O4(-:\,O\
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M1ZDE[97FMWDUE9ZG<ZQJ-_%'<3:LK-U(I*SE=*UE.HY-MQ_Y]>R6ZM+VCO\
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ML\D.A>%?"FFSV&E^+?#'C_P+$=5\/>*+Z62\TG5[-+"74--GO1:0: GQ'_;
M\*_\%:+3XC>&?VC]=U7X0_%_P=X>M[K]C#P'\/M.UCQ#\//$7C+4;ZWMM=\$
M:YI-O9:KXL\2?$;XBW"Z#HFB:LUQ::1IEG \UGIUB]K>PZWR_OU7=5RE]7VY
M?+2/P;[^_P S7PZ^1.O-=?#HK:I]MGYZW[>6A^$5%?J;\:/^"-O[=GP(^#E_
M\;?&?P^\/7WAG0=);7?&&C>$_%VG^(_%O@S1X8O.O=2U[1[2)8)[33(MTVJS
M>'M0UU--MHY[R\,-G;7%Q%^<OP]^'?CCXL>,=$^'WPW\,:OXS\;>));J#0?#
M&@VQO-7U:>RL+O5+J&QM5(:>6*PL;NZ,:9=HX'"*S84]4:D)IRA.,DM&TTTM
M+ZOIIJ5=/9W.,HKO]/\ A7\1M5\(>-_']AX+\0W'@OX;:AHND^//$PTV=-)\
M*ZKXBO9M.T33-8NI%1+74-1O;>>WM[-LW!>&0O&B*6' 52:>S3M:]G>UTFOO
M337DT]F&VX45U?B+P-XL\)Z5X-UOQ'H=WI.E?$'P]-XK\&7MR83%X@\/6^O:
MSX8FU6R$4LCBWCU_P_K.F,)TAE^T:?,1&8S'(YJ?@;Q9HWA+PMX[U/0[NS\(
M^-;SQ#I_A77)3#]CUJ]\*2Z?!XBM[0)*TP?29=5T]+GSHHE)NXO*,@W%1-/9
MIZM:/JFTUZIIIKHTP_X?Y/5/YK4Y2BBBF 5^E?['W_!.FZ_:*^%GC#]HKXO_
M !Q\"?LN?LW>#M>A\(/\4OB#;R:A)XE\83Q03'0/"NA)?Z2=3>UCN;?[7<G4
M8W::7[/IUIJ,EKJ?]G\[_P $QOV5I_VJ_P!K#P'H.N:'8:G\'OAS?6?Q0^/.
MH:[J$6D>&M*^%WA:^M[O6(-;U*9HTCAUZ58=%6VCDCGF@NKRY:6TL;*^U"S]
ML_X*??\ !0SXA_M'^+O'?[-^BZM\*[S]EGX7?&635O@C:_#'PU;:7I46A^$-
M*\1>#_#%SI^K6ZVIO]/O-!U^\FN8#9BPCO3'_8HM=.ACCFPJ3G*:I4FE))2J
M3=GR1;5DDTTY25[7T23>KL)WV5O/RUZ*SUWM?33Y'CO[5/\ P3K\<?LW^.O@
MAIV@_$CP'\8_A)^TI=65O\$_CCX0N_)\&^))+G5-+TJZM=64SWXT6_TF;6-/
MN+Z*.]U&U>SN"]K>37-KJ-G8Z/\ P4._X)P^,?\ @GWJ'PIM_$OQ$\._$&S^
M*FAZMJ5E/I&G76CW>EWV@G2AJ5K<6-U=7C7%DZZS:-9:A%,K2,D\5S:VK+";
MC]3O#?PF_9@^+O\ P1\_85LOVH_VG;O]F71-!^)WQMO/"'B.#P#KOQ!E\0:M
M+XS\8Q7.BI::&KW&F):6B+?K<R%879!$OS[<?"W_  65^-WPK_:'^-_PD\6_
M /XA:C\8/A?\//V>/ 'PNO\ QZF@^+M)TL>,]$U[QG-J-K=+XFTG3&AUC4--
MNM(U.Z\M95N!<QJ+FX>!_+SA5J2J0A>ZC*M&I+V;2DXRY86E\/,];J+WOIT2
M5W;7:]]-[.RUM;[G\CY"_9-_9\\-_'[P_P#'JRU.6:S\3^&O#GPAC\ ZJ;FX
M33M'\0_$/]H;X5_"RYU'5K&WPVJ64&B>,]2;[(64K+Y<\9\V) ?K[X3?\$\?
M@OIWQ:\-O\4/CSI7C_X1Q6?[6%CKQ\*^$_'GAJ]N?B5^R;X(A\8^,_!-PUQ8
M-JL7AM]*U/3_ !)#XITM5N=;TG3M7T+3[?2]=N=,F?X!_9LU;]H\^+-2\$_L
MTVGB35O%WC6WT&?5=$\,>'-+\17E]8?#[Q;H/Q*TB_NQJFF:C#I>F>'/%'A3
M1/$%[J4DEC8QQZ<(-7N)-*GNK:?T+XE?$#]LWX!:];>%/B?+XG\ :S?7'QE\
M=Z9::WX4\*+!JX_:5\,KX$^+WB31-131;G3=;TOQWX=T_P#L1KS2KR]TK1Y;
M29_#9T?4XIIAK44[M0J1BY0FHQ;5W)QM&6L9.T7S-\O5+>S1:L]'>R;<FK72
M<=-?\:C>^G*Y6U:/<+O_ ()J>+;CX>^&?B/%\2?!.B7/CG3?A[X\T7P1>PZA
M!Y'PY^+7C32O#7A";3->O[P/KGBVUTW7](\4ZGX.CL1>6WAAY[@:S=ZM8ZAI
MMMN>&/\ @EKK/B[4/B#'HOQ\\!R>'_!?Q=USX :?XPO?#VOZ3X>UKXM^%-)M
M-6\76&HS:Q+IUSX8\$^'1JNAV5UXXO;>\CN;K5X9;+1I]/M;^]M?D?2OVF?V
MEKKX<:5X.TO79M3\'?"M/"ES::XGP[\&ZOXB\(:)X?\ %EKK'@O1-3^)<WA.
M[\96W@C2_&4EG-H7A36/$S>%$U26VLK?3&5H+4:\_P"T;^U1\#_$_P 5O!^M
M:^NC>)O%OC;4_&/Q!T#Q=X'^'OBE].^(^LV]P-1\9:!9>(_#6MV/@;QG<V6J
MS6Y\1>"$T'58[*6WM8KJ.&SLH[:7&LKQ56-_?<$TF^7FIJ%[IM\L>=2;YO>E
M%MM/0NG9VUNN:VVJ=TET]ZS2T]VZW]X]NT[_ ()O^)O$7A3P\WA+XN^#->^+
MGB#X;?"OXM)\(CHGB+3Y;7P5\5OBIH_P:TNY;QU/"_A:XU/3O&_B#1UN].@D
M99=#NGU:&[W0/9G+\-_L%:-\0/BK=_#'X7?M'>!O'TO@[1OB3K/Q;U&Q\&>.
MM%N_ =M\+9=,M-;N-,TGQ#8:;'XTL?$&JZM;:1X+N;#5=-GU2]2X?7++PU80
M_;F\*TKXU_M//X.UOQKHOBO78/"7ACP-\.?V=]8\2Z;IGAVR.A^$++Q9)\3O
MAMX.34[;3(-3LKZ+Q7\/YO$>E:]92IXC>;P]+#<:TUH7MIMS5OVZ_P!J+6_%
M7A_QC?\ Q%L?[8\/0^+(D@LOA]\--,\/^(6\?VEI8^/;KQYX3TWP?:>%OB+?
M^.+2PL;?Q;J'CO1_$-[X@CLK0:E/<&V@,=6K<T_?A92J<J_E4M:*E[K>D'&4
ME=-MW4I1LF:65KW]W?;11Y^UVYJ:3T25KQ;T7G7[1OP,U#]G?XGWWPXOO%/A
M_P :1)HGAOQ)I7B/PY,#:WND>*=%M-:LH=1L&EGN-"\0Z:+I]+\1:!=2S3Z3
MK-E>6BW-Y D-Y<>%5[9XSM?C5\9?$7B+XC^*/#FHZAJ<W@F'XAZE>V7A+2/!
MFAV_PYT*:R\&V>O:#H.B:7X?\.6?@_2Y[6T\/6"^&M,BTN&:U>SMHO,M[A4\
M3K2-[)2:<E\5N]VO+LT]%JGHMD/NE967WV3?WW37DUTL%%%%4(*_87X;?\$.
MOVYOB=\"].^.VDZ/\/M(TS7O!S^.O#/@37_%5Y9_$/Q!H$FF'6-):TTBUT*]
MTJSO_$&GF*?1]/U;7-/N7^TVRWZZ>TI"?CU7^D#^R_\ M=? [QO^R'\./BYX
M*\2:AXRT?PA\(O#=OXE\->"_#?B'Q=X[TG7/"7A"PL]<\,W'@[P[IFHZY_:]
MOJ%G-86ZK9_8KZ3R[BSNYK&5+H\F+K5*,8.FDW*33;3?:RT:M?75]M+$R;25
MM[I?U^1_*UX6_P"#>/\ ;N\1^&M$U^^UCX'>%+O6-+L]3E\,^(O&OB%->T5K
MVW2X73M832O!FJ:=#J5NLBQWD-KJ-Y%!.'B$[E":Y[P!_P &_P#^WUXUC\22
M:M9?"OX=-X>\3:GX:@B\;>,M0CE\1KIC(K>(O#W_  C_ (<U^.Y\-7QD4Z9?
MWDEA<7B!W%E&JY/]</[)G[7R?M:_ _PQ\9?#/P/^+GAN/6H;BSFTSQ'9^%]#
MTZ75M(EDTW4Y-!UK7?$VEG7/#R:E;36L&KVFG[S)'/ ]FMU:7,$>-^R_\5_V
MROB-\2OVC=)_:%^"7@_X1^!/!?CVQT[X22R>)I->\0:GX?U#0=-NX8S+H5K-
MH7B32_(":M/XCM]3T^6WUC5+[PQ_9\C:///;<3QF)7.G[-..Z:5UJHM)<SOJ
M_/370GFEKMIO]Z\WW_IG\$W[7O[&OQO_ &(_B=!\+?CAI&E6FK:GHL'B/PYK
MOAS4_P"V?"_BC09[FXLO[1T74FM[.X86]]:7-G>V=_8V.H6D\0,]HL,]M-/\
MJU_0_P#\'&FD?%.R_:<^$.I>-?%/AO7? VJ_"Z^7X9:3H'A^[T"Z\-V]CXBE
M3Q1:ZZ+S6-<DU;4K[4+BQNDU>*\M;::S%O:1:38O932WGXA^%_V>_C7XUO/
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M6LU9I:6WNDVDTC]_+#]J7]BNW\8^ -7\0>)?AGXA^$L'QN_9K\2_"3X5:9\
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M=J,59.,;I:)II0C"VVJY4F[6YI/F=WJ?6W[5GQ:\*?&B'X >,+"?0[SXDP_
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M]5\9V7C7Q!)#H.AQZ-'/>KJT\5KJMIIF\/74>!O^"B?P"\;:O\/_  [=:/\
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M<+#/%]HLY@/,CW#<$D#H/QA\7HD/BWQ-'&BI'%XAUE(T485434;A550.@
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MF:-=^-]8U75+/3Y]<UVXTY=0U"Z=+[R4AC-Q-%93W4L$"5]+Z?\ M)_MZ_\
M!*N"?]E[4M#\&^$XKS79OBI)IWB71=)\>6GB*S\3:?IFA,=/UFWU2XTYO#LK
M>%IH)(=):ROX=4&K+=7*RLB18+GA.*A7]K623JT9U()--7;C%1;IM-IQ2TY7
M9W33*T:UMIU77ULKKRNO75IGY)$$=:*_7_\ ;$\-?"G]I?\ 9)\!?\% /AE\
M//#_ ,)/'7_"S+GX+?M#>!O!]JFG^#=0\9C2/[;TWQGH&FH$CL&U*SEL9M0"
M)YES)K445]/>ZCIMUJFI?G#\!OA)-\=?BCX=^%5CX@L_#FM>+H]9L_#5W?VK
MW5IJ/B>UT34=1\/^''\NXMVMYO%&JV=MX?L[LF5+:]U&VD>"9 R'HA44X.33
MBXN2G%ZN+A\2T^+3566J:LKNQ-M;>F^F_KT\_F>/45]@:'^R%XDUCX5:'\0F
MUZ2'7O$_@_XA>.=#\!6WARZO=4?PWX%\>^%OAK;ZGJFHG4+2#2;3Q)XOUS6=
M*L+B>UDBMY?#5SYK2?;8Q;W[G]@+]IW3O!_C+Q;J_@>QTB;P1XP\+>"-7\*7
MWBKPPOBXZYXL:_BL(H=(@U6<((;BS@MYX;RXM+V5]1LY+"TO;=+Z>S'5IK><
M5K;5VN^90TOO:;46U=)[V'RRM>W6WG>R>JW5TU:^]]+GQA17NFC?LT?'/Q!J
M%MIFD_#S5+BZNO%7COP4K27NBV=G;>)/AA9:?J/Q LM1U*^U.VT[2;?PG8ZK
MI]WK&JZG=VFD6\%TCB_<!]O7Z]^RKXW\'>#+'Q!XX>?PEXDG^.\'P.U#P9J6
MG![S3;N[\(Z%XOL_$O\ :=O?26=_IE[I^O6DEB+)9;:_M&AU"SU&:UN8F-<\
M&TE*+<N6UFG?FDHQ>^SE)*^VNK%9]GK?=6^&]_NY7?S36Y\N45^B'Q)_X)Z>
M,]$O=0TGX.>+9/C?KV@_%_Q#\$=?\.67@K6O VM1>-?#?A?Q3XQOW\/KXAO)
M]+\4:''X?\%^)+R?4M,U42VILK:.:R!U.P,_AGC/]DWXL^$_#GAGQ#;^'M4U
MU-5T[39?$,&GVME-%X:UG7?B5XU^&'A_2(+RRU;4(_$EOK/B#P5>VMIKND(V
MEG4IQI)D^T)%)=3&K3ERVFO><5%.\9-R7-'W9)2M)?"[6;T3;T&XR7397Z;)
MM/[FG=;Z-[(^8J*^CI/V2/VB8=(UW7IOACJL>E>&==U#P[KMR=4\.&2PU#2/
M$D'@_6+@V8UDWMQH6C^*;B'0=8\46EM<>&M)U-S:ZAJUM(CA>W\7_L'?M*^%
M/B9XB^%47@FT\2^(?"^F>'-6U._\/^)/#LGAQ;?Q8A7P];1Z[J>I:78_VQK-
M[%>Z9H_A^62+7=:O;"Z&C:=?VXBGE?M*>G[R&J;7O+6UKVUM]I?>*SUT>F^G
MFE;UNUIYGQU17TG\+?V>3XKTWXE>+/B?XRA^#/@'X1ZIHOAOQKKFM>'-8U_Q
M GC3Q'=ZO::)X(T3P=IYM+_4O$D__"/>(+R_AN[S2[/1]/T6^N-0NXI1;6]S
MVFI?LBWFI^&=8\1_!_Q_IGQQ"?%;X7?"_P (V'@7P]K27WBFZ^*'@?QKXVM)
MI;+5!:WVA:QX>C\&SZ5XAT&ZM;E+&\N)ICJS6EC)-*.I!?:_E5TFXIS<5%.2
M3BG+FBTF[VDI?"[AROM;??397=KVO:SO;LUNF?'%%>[>-/V9?CK\/1KTGB_X
M=:KI-KX:\-Z7XPU;4EO=%U+1T\,:UXEMO!VG:U8:UI.IWVDZS8S>*;R#09)-
M&O=0-IJ;26MXL#P3B/U_X-?L#_M%?%KXDZ=X#F\#ZMX3TZ/XC:5\./%OBK4_
M['DM/"^JW@T^ZU7[-8S:W83^*[KPYHNHV^O:UIGAF;4+K3]+>.[OC9V\JS4>
MTIVYN>'*DW?F5K)I-WO:R;2]6ENT%FM;.WH^U_RU]-3XJHKZH^$W[,K?$2VD
MUGQ#X^TKX?>%9_C;X(^ VD:_J>E7&J1ZGXR\93:G++<-;6]]9FTT7PQHVF?V
MOXAO9)Y'MUU'2+6"WF:]>:V].^&O["/B+Q?/!9^-/'-I\-]0N/BS\7OA7%IE
MYX;O]>U*67X%_#[4?'?Q)\0P65K?V$MQ8:-)!I/AN"W@#RWNKZP$CE3[!<1N
MI5:<5)RE;E2;T>B:@]K7>DX-I:I23=E<?+).UM;VMI>_O:?^22]6K+6Q\$T5
M]]7W[#D>GK8>-KSXR:'8_ 6X^%B?%F\^*^K>"_%6E:OI^C3>/;_X8V?A^3X:
M7*'Q!/XLUCQGIMQ9:#8PWQTC5-,!UM=<AL(;AXO+]4_9P\/:A;_$:^^%7QD\
M-?%2Q\"_"ZP^+]NNG:#K6@:KJ/A5/$-OX=\6Z=JVD:O^_P##WB[P9)>V>LZA
MHIDU2RO_  [)-JMAK+B&."X%5@]4VTFTWRRM%IM-2=K1:L[J5FDFWIJ+E>UN
MW56=^6R3V;?-'17>I\JT445H(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* .MTKP#XZUVRBU/1/!?BS6--G:18=0TOP[J^H64S0NT4JQ75I9S02-%(K1R
M!)"4D5D8!E(&C_PJGXH?]$W\>?\ A(>(/_E?7[]_#_\ :E^,'[)7_!&[]G?X
MA_!;6-+T7Q/J_P =_'/A2]NM6T+3?$%N^C7OB3XG:E/"EGJD,]O'*UWI5FPN
M%3S51'12%D;/B/AC_@J?_P %+_$GPX\;?%7_ (3?P7IW@WP9;6V=1NOA=X1
MUK4KG5+#3/[-TH?V<OGM:_;A<7UR"8+81K 2UQ*L8Y56K2<^2G2Y8U)4TYU9
M1;<9<NRIR2N]E<I)/U]?_M7^9^.7_"J?BA_T3?QY_P"$AX@_^5]<1<VUS97-
MQ9WEO-:7=I-+;75K<Q/!<6UQ [1303PRJLD,T,BM'+%(JO&ZLCJ&!%?T?_\
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M^NW?CCPJ_C/P=>^$9+/1M0E\16'B+P^J7MA]DA74(U=Q>Z?:BUOVM.O^'/[
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MR]Q-,WR?6E/G<(^T5IZWM;N[/1R2NK.R;M>UR96OIM9=]/+5*_K9>05^O_\
MP0Y_Y/V\,?\ 9./B1_Z9HZ_("OL#]AO]JL?L:_'O3/C:?!9\??V=X;\2>'QX
M>&M_\(_YI\06:6GVK^TO[,U;9]E"E_*^QMYN=N^/K48B$IT*L(J\I0DDM%=M
M>8+?Y-?>FB]^S'\2?AY\*OC9XS\5?$'4M4TVV%CXBTS3)+"Q>_AFN=0UJVCN
M(;J.WCDO(RMLC7$$UN4"B"99&9GBBD^C_ 'PN^"O[,?B71OCYK?QA?6_"6OP
M:G%\-[*RT2\>^U&WU:-;.YN+Q[>2XDOUTG3[]OM.+*R7S66XD6*X2.QE[Z?_
M (*(_L,W,TUQ/_P2V^$LL]Q+)/-*_C6,O)+*YDDD8_\ "$<L[LS,>Y)J27_@
MHO\ L/SPP6TW_!+SX5S6]L"+>"7QT)(;<-C<(8V\%%(@V!N\L+NP,YQ6$G6D
MV_858\R49I3H6:[)\UU\3N]=.;0I-:7OIMMUMK9NUTW_ )[:-_X(^7.B7G_!
M2-KOPY->7.@W7A3XS7&D7&H1Q0WMQI\^FW$MK/=10JD44LL3+(T:(H3<%V@@
M@?D1XRY\8^*1_P!3)K7_ *<[FOVO^&G_  5?_9;^#?BB/QM\*O\ @G+\/_ 7
MB^"PO],M_$7AWQ]'9ZG!9:G#]GOK>.<>!F*Q7,/[N90/G3Y<@$U^'NM:C_:V
MLZKJPB\C^TM2O=0$);?Y/VRYDN/*WX7?Y?F;-VU=V,[1G THJHZM2I.G*FI0
MIQ2E*#;<>9OX9/\ F6]M;D^NMVG^#OU\_P#AF?HEH_[/OP=\6_LQV/B#X=^%
MKSQ_\5+?X<7GB[QS?6/Q5L?#_C_P'XF@\73Z>LL_P8\0:1:1^*?@Y!X<.GS7
MOC#PG?ZMJ=M>7DM]?WVFVEG<V*=)KG_!+SQEX>\4^&?"FJ_&#P)8WE[KWC#P
MKXRGO-/UB)/"&M^#OA?XO^*.H75E9PBXU;Q=X4.G>"-=T63Q'I>GVK6VLP0Q
M/I;PWFGR7OQW:?M4_':R^&A^$MOXV1?!X\/7'@^&1O#7A27Q=:>"KN_&J7?@
MBP^(<FAOX^L/!EW?J)[GPM9^)8-#E!>!K(VTTT,FUJW[9'[1&MZGH.N7_C?3
MCKWA^V\2P0^(+;P)\/;'7M8E\7^$+[P%XBU/Q?K%EX5@U'QMKNI>#]2O=$?7
M_%UQK6LV\,[W=I?0:D?MM5*%>\W"<4FZDH\SE)WE\"VM&,=N6*VMK)I\U7BU
M%/HDFUO:T5=WW=U+LK=-CV'PO^Q'_;.F:!\3=+^(^B>)_@KJ&GV%Y%XN;1]=
M\/KK/BB?XSZ5\);?X5&RF$^I:3XKUC^T[?Q7%,Z2BR\(S2:LUN\MNUNU7XR_
ML?\ AWX:3>*+KQ#\6O"'@/7=8UOXI7OPD^%MWIWC/Q#=^)O"7@'XA^)? ,$<
MWC6ST5],TS5=9UCPSJ^G>&8-8A1M4_LXW6LW6@BZ@W_,FB?';XL^'/ 6G?"_
M1?&>H67@'2OB5IGQ?L/#*VVFSV$'Q&T>P&F:;XDWW-E-=2R6]FJQ_P!F37$F
MC32(ES<:=+=(LP[V\_;!_:'U'PQXI\):AX^COM*\87GC"\U6XN_"?@J;7[1?
MB%J<VL^.M.\->*7\.GQ)X.T+Q;JEQ/>Z[X>\):KHNAWTT]SOT\)=W23-QKW5
MJB<4ZET]'*+=-PV@XJ46IQ<N3X+<MI2DTDU9IK=Q?5VLFG;75/1M75WHW:"O
MZG^T=^PKXO\ V</!L'B?7O''AC7=4L/%FD^"/%_A:TAN=.U#1?$.L:/=ZO!)
MHDM])_Q5N@63V%YH^K:W:VVG"QUA+>+['-8WMI?R^J^+OV>/@3\%6^.WBKQ=
MX6\3_$O2_P!G[4?@9\))O!]AXMNO#,/BWXI_$;PCKWB+Q?XV\3Z]9Z=?:CH?
M@S2;_P -ZUI'AO1M&@M9M4EET=;C5(WAU!K_ .+OB7^T7\7/B_H>C^'_ (A>
M(=.URST>YMK_ .W1>$/!NC>(M;U*RTQ=%L]6\7^*]#T#3?$WC;5K325&GV^I
M^+=6UF]C@WXG\V6:23T'4?VQ?BROQ!U7XF>&+G3?#WB'QEX+\(^$OB?IU_I&
MA>-/!WQ*N?".D:;I$6O^)_!/C/1];\,WM[J0T>PU>XCO=/OS9>(3J&JZ5<6)
MOO(@7+6Y4I33=W=Q]RZO2=KI72:C5BFKN+G&2O**<7>*2LM;*^^]U^*=FK63
M491=E*\OLS]G;]D#X ?M1:/\2/&?A6P\:_#G0?"GQ#^$!M?"7BCQ=I-YXSUG
M1O$GP[\>>(/$OPQ^'5Q=6^CZ=XM\2^-?%N@Z-I7PWU/4[6UOTT>X.H7]M=21
M7$=QP/PI^"?[/_Q2^&GB;4?#_P .M0UGXJ:GXK^+.SX7-\8AX*^('@;PAX<T
M:QO? TGPNT;Q?HW]D?&K4+:Z_MEO']E)JC>(DCTL6NE^']/>XBNG^0O$7[4_
MQ]\5W.JWFN?$?5+FYU?QCX'\>SS6]AHFF267BCX::;J6C^ ;S06TO3+,^&;+
MPEIFK7]EHNA>'3I>@VD,L>W3"UK:M!U%G^VM^TI8P^)XK?Q_9*_BK7?%/B>Y
MO&\"?#Q]1T#Q#XXMS:^,M9\ ZBWA0WOPVO\ Q1"S_P!MS?#^?PU]OGDEO)@;
MV1[@ITZWOM37O*/)'VE3W.54[WFDI2YI1ES7U5KIWJ3&I)6OK9IO16:]Z\;=
MMFG9-[-6A%&%\<OAEX;\)>#OV>OB+X12\L]&^,WPFD\0W^DWUR]W+I7C3P7X
MV\5?#/QHMK-*!.=*U?5O"7_"2:=%.TCV2:U+I:22PV$,C_.=>M?%+XLZC\2[
M+X:Z(=,MM"\-_"KX=:3\/?"VC6EQ+=*L,.HZKXC\1ZY>7$L</G:KXJ\8>(-?
M\0W[)!'';+?6VF0[[;3H';R6MHII._\ /-J[NU!SDX)O750Y4]7KU(=KJW:/
MWJ*3_&]^X44450@HHHH **** "BBB@ HHHH **** "BBB@ K]@?BWXN^!_[:
M7[&/PP\6W_Q0T+X:_M/_ +'WPG7X>ZS\/_%4BVD'QE^'GAQX5\/7?@>[D>-+
MSQ%;P&2YETVU$UW]MN=8BN;&#3UTS47_ !^I<GIDX],UG.GSN$E)QE3ES1:M
MZ2BT]&I1;3ZIV:=T-/O>W:]K^I_0+^S!\.M"T/\ 9(\1_#;3;C5K;P_^TKX:
M^'/B/XC3I?[-7BU#0!#K5@/#=_'"G]D6YO)76XBDAO6F@8Q;USNKB_\ @H1X
M*TSXF^!_A]XS\0:@]CX@^&OAKX;?!#PQJ4MTMMH]KX/MM=:Q@O\ Q$LJ227=
M];IJES<7NI"YMD94WF!=ASX#\+_V^?A[X$^'/@CP9?\ @KQE>7OA?PQHVA7=
MW9OH@M;FXTVQAM99K<3:C',(9'C+1B2-'"D;E!S7"?M'?MG>"?C1\+=4\!Z'
MX4\5:3J%]J6C7L=[JK:2;-$TV^CNI4?['?SS[Y$0K'MC(W$;B!S7*J=55E/E
M=O:7<KK9VBWO?X(I>B1;E&SLNW;;3SNM$NGY,](_;'^*_P "OA+^S7\/?V"O
MV;O'$/Q8TKP[X[N_BS\</C#IT'V?P]XR^),VFOH]KIGA;$LT5UH^DV+1P/=V
MT]U9-#I>C)!?W]X-2G'Y@>$/%.L^!_%7AKQGX=NWL-?\)Z]H_B71+V,D/9ZO
MH>H6^IZ=<KM(),%W:Q28!&=N,C-<[1772@J2LFY/F<Y2E9N4F[MO1+R22LDD
MDK(AN_IV>I^B'C']OW4/%7QB^(/Q/M?A7HGAW0_%OPFTKX2>&_A[I7B&X71_
M NC67C3PSX_OKO3[TZ(C7[ZOXIT?6]3N;9K"Q5)_$L[":3[$@N>(B_;&F;Q'
M^T)XBOOA[:W4_P :?CKH'[0_A^-?$UW!_P (#\0/"GB_Q;XI\/Q7$@TIQXM\
M/0P^,]6TK4M-DAT*XO@EI>07U@T;P-\344HTJ<5%*"7*DEK+93C46M[W4XQE
MS?%=;CYY;>:D[]6HJ*OWM%*-NJW/T[G_ &_OAT-6M9M._9HM++13XL^.GC^_
M@O\ XAV?BG6[+QY\=['P;;ZSXI\'7WBOX<:QH?AV_P##,OA!8O#']H^&?$@M
MM.U2ZCDSJD<>KUYO\>?VX+WXX-;F?X=VWAT6WQ=\&_%9-OBFXUB1Y?"'PM\'
M?#&/1))9="T\NM_#X0CUF74BOF137\EH+.58%N9?@RBE&C2BXM0UBDH^]-VY
M6I1T<M;-)J]UHE:R21SR\NO1;2NVOFVVWO?J?=&K_MY?%?Q-^T1JGQT\8ZGX
MO\8:2TOQI_X1'X9^(_B)XAU;P[X"L?C#X*\9>"7TWPS-J$-U;:=;>&[+Q9%-
M;KI^BV"ZC%H]K9.EE$Z/;ZOPA_;T\1_""\^%<^F^ -#UZR^&GP2U?X12:/KF
MIRW&E^(]1_X6SXB^-G@CQW<6ITMX[#5O /Q"U+P_K&EV2K>?:3X;*#4;(:M,
M;7X"HI^RI\JCR)))15FUHHU(+5-.ZC5J>]\5Y<U^91:.9]D];[:;I[*RW2>Q
M]_\ AG]N"T\-_ +Q1\((_A1:2>)O&OP\\>^ /%GCZU\1:=IP\33^.?%;^*Y?
M'/B338_!,_B37O&=@Y@T**2_\=/H']AV4$=IHEE?/+>GO?#_ /P4;.E>(?'6
MKW'PJOX+/XEVWPIUKQC:^&OB1)H6I2?$GX3:%?>&=.\2Z#K%WX,UMM&\->(-
M$O/LNM>$IK/4KVVN$74-&\4Z=<JF/S#HI.C2=[P7O;ZRUM+G6E[)*232227+
M&R5D',_75O7N[7;MN].O=]W?ZQ\(?M.P)=_&?2OBWX%;XJ?#_P".OBFP\<^+
M_#[^+=3\/>)M,\;:)J.O7V@>+?#7C4V6MW%MK%C;^)_$&DW[:OI.LVVN:9JM
MS'J$!NDMKR#U'P7^W%I?PQEO['X:? GPKX3\)W7Q#\(^+5\+KXK\1ZE'/X?T
M+X2?$KX.^(=!U;5KR,ZI>>(/&?A_XFZOJ6H^,;"?2#INM0176FZ#&KA(OS]H
MINE3::<=&HIQO+E:CRI7BGRNRC&-VG[JY=M YG>_K\KJSLMEWTMK=[GZ&0?M
ML>![7PTWPAA^ \A_9\C^'&K>!K;P'-\3]2?QH-3U;XG:#\6[CQ5<_$8>%D66
M8^*?#>EV@T>#PI:Z:FAI+;QA-0FFU&7OX?\ @H]H.I?$CP]\3/&W[/MKXCU;
MX;?&GQ#\:/A!9:;\3]:\.6OA/4O%D7A0:YH'B-X/#5\?&6F)>>#]*U32+IH=
M%O[2[66UU"35M*E>P/Y:44O8T_Y7M)7YYW]Z7-)WYK\TI;ROS-73=FT',W=.
MVKO_ .2\K6^SCH^^[N]3Z<@^,.@ZI^SIXU^%NJ/?:/XHM/CMI'QN\!W5G#)<
M6E[)JOAZ]\)>,]$OKR/RY;&ZM;>#PKK6AWC1>3)_9FKV\C07%S:"7Z#\3_\
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MR6X233WN%U&WMO-C<&_N+2'3PN)&NA&RNQSP>TX_^!1Z[=>O3O9]F/EEV?\
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MS]17N3_LU?'6/2-0UU_AGXF&FZ9JSZ'>2"V@:X348YH8&CBT]+AM1N[82SQ
M:A9VEQI[*6D6Z:..1DU&_91_:%76;C03\+]>_M.UTH:U/&)M)-LNGF0Q"2/4
M1J1TV>X\P$?8(;N2_ ^?[+L.ZAS@MYP7K*/EOKINK]KZ@HM]&?/-%>ZQ?LS_
M !WFT[0=5C^&7B4V7B;45TK1W:"V2:6]>>>V5+RSDNEO-)A,MO*/M>K6]C9A
M0LIN!%)%(\\O[+WQ\A?Q(DGPQ\1!O"44,VN;18.(8Y[=KJ,V+)>LNM,8%+-'
MHC:C)&^(9$28K&3GA_/'_P "CZ=^^EN^FX6?9_<SP.BO?T_9:^/\ESX=M%^&
M/B#S_%5D^H:*I.G*DUK':)?.U[,]^L&CRBWD1A:ZS)I]TTA:!83<(T0I3?LU
M?'6#2M7UF3X9^)AI^AZK)HNHNMM!)<1ZA%/%;O';V$=P]_J%N)ID O\ 3K6[
ML'0M*ETT22.IS0_GA_X%'T[]]+=[K=,+/L_N/#:*^B3^R=^T,-<?P[_PJ_7O
M[5CTO^V7B\_1_L@L!.+?>-4_M/\ LM[CS2!]@2]:_P!N9?LWE N,J']FCX[7
M&FZ'JT7PS\3&Q\1:I%H^DNUO;Q3RW\TTMO''=64MRE[ID!EAD!OM4M[*Q10L
MCW*Q/&['/#^>'_@4?\^NMN]G;9CY9=OZ5O\ ,\+HKWZ3]EOX_1R^)('^&/B(
M2>$K6.]UP :>RPV\MK+>(UC(E\T>M2&WAD8P:(^HW"2!8'B6>2.-B/\ 9<^/
MLL_ARV3X8^(3+XKMI[O1 PT]$F@M[5;R4WLKWRQ:/(+=U9(-9?3YY9"8(HWG
M5H@<\/YX?^!1[7[]M?378.66UG?_ (;_ #1X#17N<O[-'QW@TS7-8D^&7B86
M'AW5&T?5'6WMWGCOUFMK=DM;)+EK[4[<2W< %]I=O>V+*9)5N3'#,\>F/V4?
MVA3K4?A\?"[7O[4DTC^W%B\[21:_V=YPM_,.I'4O[,%SYQV_V>UX-1V_O?LG
ME?/1SP_FC\Y)=GU?1--]D[[!RR[/^G;^O+78^>:*]RC_ &:?CM+I6E:TGPR\
M3?V?K6K+H>G.UO;I<2:B\]Q;*EQ8/<K?V%OYMK.#J%_;6VGJBI*UT(IH7DNO
M^RU\?X[KQ#9M\,/$(G\+6<%]K0!TYDBMKFU>\B:RF6_:#6)#;QLSV^CRW]Q%
M(!!+"D[+&3GC_-'YR2ZI=^[2^:#EEVWL_OU7]?YG@%%>^1_LO?'V5O#2)\,/
M$1;Q=#+/H886""6*&VCNY#?,]ZHT5A!*C+'K9TZ21RT,:M,CHM>;]F?X[P:=
MK^JR_#+Q*++PSJ,FDZNZP6TD\5]%+%"Z6EG'=/>:K ))XPM[I,%]9.I:1;@Q
MQR,KYH_S1_\  EWMW[Z>NFXN5]G_ $D_R:/"Z*^AE_91_:%;6K;P^/A?KW]J
M7>E'6H(S-I(M3IXE,&]]2.I#3(;CS 1]AGO(K_;^\^S>60U9,?[-GQUET?3]
M=3X9>)CINJ:JFBV3M;0)<OJ$D\ENJ3Z>UP-1L[<RQ2 W]Y:0:>J!96NA$Z.R
MYH_S1UMM)/?;KU_1]F/EEV_I6_S/#Z*^@'_98_: CO=>L'^&'B$7/AG3X]3U
M=0VFM'%9RVS7:-9W"7[6VK3&!&9K329KZ\23$#P+.RQF&/\ 9?\ CY*OAID^
M&'B/'BT2-H>Y+)#,(H!<O]N#WBG1B(6# :T-.+L3&FZ0%0<T?YH_^!+M?OVU
M]+O9,.67;^MOZ^_8\%HKW6;]F;X\06/B'49/ACXE%IX6OCIVLLL-K)+%=B6*
M$K9VT=T]SJ\7F31C[5H\-_;%29/.V([+H#]E+]H4ZO8Z$/A=KW]I:EI;:Q:1
MF;2A;-8*VQGFU$ZB-.M;@-Q]ANKN&^(Y%L002<\?YHZ?WEVOW[:^FHN679_U
MI_7W['SU17N"?LU_'9](M=<7X9>)O[.O-770K=S;P+<MJ3320"-]/:<:A#;>
M9&X.HS6L>G!0)#="-D9M%_V5OV@X]0UK2V^%_B#[;X?TY-6U1 ^FO#'920M.
MCVMXE\UGJ4YB4DV>F3WEZK#RVMQ)\E'/#7WHZ;^\M+6O?7I=?>NX<K[/_ASY
M^HKWB+]F+X^31^&Y8_AAXC*>+7DCT,LEG&TS11B1Q?))=J^B@(05;6ET]7/"
M%B" V7]F7X]06WB.[D^&/B00>$[D6FME8K622&=F50ME!'=-/K$>YU!GT:._
M@ R3(%!(.>'\T?\ P)=[=^^GKIN'*^S/":*^@T_94_:$?5-,T9?A?KW]H:QI
MC:O8(9=+6W>P0 L]Q?MJ L+&?!&+&^N;:^/06Q/%9H_9K^.QT@:X/AEXF_LT
MZO\ V$)/LT/VG^TO.-OY?]G^?_:(MO-!']H&U_L[;\_VK9\U'/#^:/\ X$NK
M:77NFO5-!RR[/^O^'_JS/#J5>H^H_G7T$W[*G[0BZGJNCM\+]?\ M^BZ:FK:
M@@ETMH$L9$+H]O?+J!L;^<JI)L["YNKU3\K6X;BL/4/V>/C;I6C:/XAO?AIX
MI32M<9QITL-A]LNI#%DO]ITVS>?4M/Q@X_M"TM=_&S=D9%*+M:47?:S6MU=6
MUZK7T#EEV?W']C/A+_D5?#/_ &+^C?\ INMJZ"L+PM&\7AGPY%(C1R1Z%I$<
MB."KHZ:?;JZ,IP0RL"&!&000:W:X3F"BBB@ HHKQO]HO7-7\,?L^_'7Q)H&H
M7.DZ[X>^#GQ-US1=5LY/*O-,U;2?!6MW^FZA:RCF.YLKRWAN8'P=DL:-@XQ4
MRDHQE)ZJ,7)I;V2N.*YI1BMY-+[W8]DR/7_)Z?G17\G?AKXM_'FR_80C^/D7
MQ._X*>:)\2=2^&G[*VL7_CGX\>+?"T'P#\3:G\2/C#\$;/Q9J'P;G\/#_A*)
M8=;L=7U<>'I-5GA:3P-JFH0:B))[DQU]\^%/^"P/B#Q3^T/?^#]/^ .M:M\"
M++XX^//@7>>+?#OA_P",VL>/]!D\ W6KZ/?_ !8\0M'\)X_@]#X!N_$&C3V$
MVAVGQ/F\::'93P:IJNG*RSV$62Q%.Z4GR-VLG=WV3>BT2<E>]FKWM9-J_9R:
MYDKIV7;5JZ7FW9Z+MW:1^Y=%?ST_#_\ X*]_M!?'KPMXQNOAG^SIINACQK\#
MOB[\3O@IXPO;3XT-H7P_O/ &CWFNZ59_&OQ'XE^#>A?#J_N_$OAFRO\ 7/#D
M_P -?$_C#0YO$%G9^$]2N%&H_P!IP^M^)_VP_P!K#1?^"4'P5_:!\6ZAX \#
M_''XWQ?LV^%U^+6DI'K_ (4\ ^&/CUK'@?0A\=?%FB:AH6C:)I6L:9I'B6YU
M[5O#26=SX3T+Q!<6EI#<ZGI<!@FJ->$E)QYG:,9?"U=RFX1C>5DI-_S-))IM
MI7:3IM-7:5W)7O?2,8RE+3=)26VK::2VO^W=%?B-\0/^%P_\$^?CE^R_#H?[
M4GQU_:<\*_M#:_\ $'P-\1/A5^T'XHT#QKJXN?"WPO\ $?C^W^*GPXU32?#&
MAZIX,TCPWJ&A0VWB[1K=;[P[_8VMVZB*&ZALIEC^!W_!3_\ :+\5Z/\ LR^.
MOB[^S#X'T?P%^V-X*\>:E\";7X6?%>]\7^/9/'/@/X=:Y\0[?PQXNT'5O"ND
M:?96?CZR\-ZC:>'[_2=3U%O#MW<:=;>)A')-.UN>V@I.$N:,HR49+EE)*4N7
MD7-%-/GYHJ-M7)\MKH?LY-1:LU)7CT;2W>NR6K;;M97O;4_;VBOS9_X)X_MO
M^-/VQ-.^(\7Q"\%> OA[XL\ CP=<ZGX.\.>)/&TGC+PI-XOLM4NYO"?Q%\#?
M$?P'X"\4^'M?\-S:8UA)K]A9ZKX,\5SF[D\,ZK/%IUS7Z35I&49Q4HM2C)73
M7K9_BGKLUJM&0TTVGNO\K_UVV>J:"BBBF(**** /IS]G+_F<O^Y>_P#<Y11^
MSE_S.7_<O?\ N<HKQ\5_O%3_ +<_](B;0^%?/\V?SMT445] =04444 %%%%
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M@HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,W4R:=';3Z=;:?&_B*Y2.TBN)-, "SIOWUW?Q*^#OPYT3Q3XCUGQ<GCO5?\
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M@#]>]-_Y!UA_UY6O_HB.KM4M-_Y!UA_UY6O_ *(CJ[7.>>%%%% !117Y9_\
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M;X 7P_M3;XNT9OLJH=-_T#55_M5FC9G4Y@/V'9(%CS/OW!MX  (I\\>[_P#
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M1[_F?/\ 17T(W[/]Z&U,+XOT9EM45M-;[!JH_M1S$69"#!FQV2@1;I]X8'S
M,#%*O[/]X9--5O&&CK'<P,^HR?V?JS?V9,(5=8 @@W7NZ4M#YL.Q1M$A&UL
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M#+ S07$44\126-'7L**&D]&DUU35T_5/1@FUJG9]T?-W@G]CO]E;X;^$M/\
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M,IMJ/:-.UW\3C\,;7C:_V_.Z6]M6K+6K+3W5K;[3ZV\O/^M+_0/_  OW2_\
MHF/QV_\ #0^+?_D2C_A?NE_]$Q^.W_AH?%O_ ,B5Q/[,GB_QQXID\9)XI\2_
M$'Q7I=CI/PZN--U3XA^ +7P#J%OXAU;0]1N?&ND:?;6GP^^'::CIVF:E%91Q
MS/IFH/;F3RCJEP'&/JZKBY3BI*5D[[Q71VZ2:MH[6;T:^:?*G;E73:3ZJ_\
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MEJK_  1VYN3^?OUVLT[]W9?RK_P*79/:U]GZ[]F>_P#_  OW2_\ HF/QV_\
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M% \I2E*'+>5^:2BK16[MWDOU_!W:Y7?W=E?XF>N_\+]TO_HF/QV_\-#XM_\
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M  ;K.G^+-9OY/#=OID&EQW/F:G:_8U+6XAE]CUW_ (*(?%K1OC/\+O"*>#_
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M2DT[VCM;^3KHO^7?E_5V=3_PN36?^CEM-_\ $6O'O_RWH_X7)K/_ $<MIO\
MXBUX]_\ EO4#_M&>+D\'^(-1B^*WP3U"TTSX]>%?AE!\7K7P_,/AQ!X8UOP5
MH'B34-5N[*/XJ7%G+>:=JVJ7.C-=+XZM[%7B1);=+E7C/TW\"?&^K_$;X5>%
M?&6NW6B7^IZN-:6;4?#EM+9Z%J<6F^(M6TBSU32K6?5-:DALM2LK"WOH5_M;
M4$(GW17<L3(Q44I/E4Y7LWK*IT:3U59]]UH[NS[#:2ORZ:6^#M?_ )]^77S[
MN_R5XH\=VGC71W\+>+_VF-/7PYK&H:);ZDJ?LY^,?#KS)'K>G7-O:KKFH:G+
M9:4;N[@M[47ES&\4/G;F4U]2_M!PZ*_PRN9]=\91^ K;2O%_PRUZR\42Z#<^
M)X[/7_#WQ+\(ZWX9LW\/VDD5UJPUKQ'I^E:)]CMI$GD.HCRF# 53_::_Y(?X
MX_W?#O\ ZEF@U/\ M!?\B3X:_P"RV_LX_P#K07PRJFN554_>]R+NW-WNYJSO
M-NRLVK-:M^5INFXM)KWMO=Z6UTBE]Z9X!_PN36?^CEM-_P#$6O'O_P MZ/\
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M*UU6PTN/2GTQ[&P,J6<BRWRR2%7DRI(086A?'3Q!=ZQXA_M7P3\/!H,/A?\
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M@FFDU&:;NU4@F[O5VIV>][I6\G8FZO%VTMM9>:^>NMSQK_AH37?^C@/V)O\
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M)XUN74,.A ;QH0",G!QGFOL>TTG2C:VQ.F:?G[/#_P N=M_SS7_IG7DWQ?\
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MDO\ PFQ7_P I_JS\K_M[17XA?\/J[7_HUJV_\/3??_.VH_X?5VO_ $:U;?\
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MX@MXA^]?)J;<DDV\UR=62O:R6,MO)O5/MJK7/]:\BT_VQJSO_NV+WTWO1?\
M2=NA^HW_  E_[0?_ $13P-_X>RZ_^=17&^)M)^(?C6ZT^^\8_LN?!?Q7>Z2'
M72KSQ)\2+'7+K3%DEBFD&GSZG\'+J6S$DT$,KBW>,-)%&[99%(_.O_A]7:_]
M&M6W_AZ;[_YVU'_#ZNU_Z-:MO_#TWW_SMJ/^(+>(K5GE%-K2Z>:9-;I_U%^O
M])7%Q9D7_07_ .6V,\O^G7K^/D?HI-I/Q#N?%,?CFX_9<^"\_C6(QF+Q?-\2
M+"3Q/$8;3^SXFCUY_@XVJ(T5@391LMT"EI_HZD0_)2Z-I7Q$\.Z]J7BGP_\
MLN_!C0_$VL+=IJ_B+1_B18Z;KFJ+?W<5_?+J.K6?P<AO[U;V^@@O;M;F>47-
MW#%<S!YHT<?G5_P^KM?^C6K;_P /3??_ #MJ/^'U=K_T:U;?^'IOO_G;4?\
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M97EI<?"62"ZM+JWDD@N+>>-X9H9'CD1D9E/YB?\ #ZNU_P"C6K;_ ,/3??\
MSMJ/^'U=K_T:U;?^'IOO_G;4O^(+>(B22RBFDK*W]J9,]--/][]?Q\KBXKR+
M_H+^_#8SR[4O7\?(_0.'PEXMMO#UYX1M_P!DGX#P>%-1OHM4U#PS#X[TB+0+
M[4X! (-1O-'3X+KI]S?0BUM1%=S6[SQBV@"2 0Q[4U'PAXLU?1]'\/:M^R1\
M!M3T#PZ+I= T/4/'>D7FD:&+YQ)>C2--N/@O)9Z:+R15>Z%E# +AU5I0[ &O
MS]_X?5VO_1K5M_X>F^_^=M1_P^KM?^C6K;_P]-]_\[:E_P 05\1/^A/2Z+_D
M9Y+LN5V_WKNF_P ME=_ZV9%_T%O_ ,)\;Y?]._7\?(_4./Q7\?X8XXHO@CX#
MBBB18XHX_C3<)''&BA41$7X3A51% 554 *H   %8.H6'QJ\<^,/A1<>(_AYX
M/\)Z!X(\?S>,M5U*R^)EUXFOI;=? 7CGPM#96>E'P#H*22RWWBFTE>6348UB
M@@F.R1BJU^;7_#ZNU_Z-:MO_  ]-]_\ .VH_X?5VO_1K5M_X>F^_^=M3_P"(
M+>(CLGD]-K33^U,G2TY7TQ:>Z>S[^5U_K9D7_079]_JV,TVU_A-?AW\C]2/B
MEX>\?R^./ACXY\":!H/B>7P=%XWLM4T?6_%$_A3S(?%.G:1:VUS::A#X=\2+
M*UM+IK^=!):1;EE1DFRI%-_X2_\ :#_Z(IX&_P##V77_ ,ZBORY_X?5VO_1K
M5M_X>F^_^=M1_P /J[7_ *-:MO\ P]-]_P#.VI_\07\1+MK)Z<>9IM?VKD[5
M[177%M[*V_=]KG^MF1:7Q=[::X;%][]*2[OY7\C]%;K2?B'>^*+?QO>?LN?!
M>[\9VAA:U\6W/Q(L9_$ULUO"UM;F#79?@X^J0F"W9H(3'=+Y4+-%'M0E3!I^
M@^.](U76==TK]E7X):9K?B*&_M_$&L:?\1-.LM4URWU6=;K5(-7O[;X-1W6I
M0ZE<HEQ?Q7DLR7DZK-<+)(H8?GC_ ,/J[7_HUJV_\/3??_.VH_X?5VO_ $:U
M;?\ AZ;[_P"=M27@MXB?]">GO?\ Y&>3;^[=_P"];O6[_P E<_ULR+_H+?3_
M )A\;Y?].OZUMT/T:\*6/Q+\"07=MX(_9C^#O@ZVU"6*>_M_"_Q,M- @O9X(
MS%#-=Q:5\';2.XEBB9HXY)E=D0E5(4XKK/\ A+_V@_\ HBG@;_P]EU_\ZBOR
MY_X?5VO_ $:U;?\ AZ;[_P"=M1_P^KM?^C6K;_P]-]_\[:A>"_B*K+^R*:6F
MG]J9,NW;%^OX]E<_ULR+KB_OPV,\O^G7]:VZ'ZM?"/P5XA\)?!S1/!OB&/3X
M/$<&F:\E_#IU[+?Z=;7FM:IJ^HK;P7\MG8RW45N-0CA:X:RMS(T;NL*@@5YU
M\.Y?VA? OP_\"^")/A#X#U*3P=X.\,>%9-1B^,MY;1Z@_A[1+'2'ODMG^%L[
M6Z7;69N%MVFF: 2"(RR%"Y_.K_A]7:_]&M6W_AZ;[_YVU'_#ZNU_Z-:MO_#T
MWW_SMJ?_ !!;Q#]VV34X\L>56S7*'I[MT[XQ_P O2W7?0/\ 6O(KMO%MW=]<
M-B^]WM27Z[/R/TJ\17'Q>\7Z7-H?BS]G3X5^)]%N)()I](\0_%>/6=,FFMI5
MGMI9;#4?A#<VLDEO,B302-$7BE59(RK $<QJ'A'Q9J^CZ-X=U7]DCX#ZGH'A
MT72^']#U#QWI%YI&AK?.)+U='TVX^"\EGIJWDBJ]T+.&$7#@-*'89K\_/^'U
M=K_T:U;?^'IOO_G;4?\ #ZNU_P"C6K;_ ,/3??\ SMJG_B"WB(]\GI.]D[YG
MDNJ]W1_[5Y/^DKBXLR+_ *"__+;&^5_^77W_ #\C]$M4T7Q_K>MZ5XFUK]EG
MX*ZOXCT**Q@T37]3^(VGW^LZ/!I=U->Z;#I>IW7P;EO;"+3[VXGN[*.UGB2U
MNIYKB 1RR.[=I_PE_P"T'_T13P-_X>RZ_P#G45^7/_#ZNU_Z-:MO_#TWW_SM
MJ/\ A]7:_P#1K5M_X>F^_P#G;4UX+>(J_P"9136W_,TR9=O^HOU^]]E<_P!;
M,B_Z"O\ RVQGE_TZ]?Q\C].O#&D?%/7OB]H_CSQOX.\,^#M(\/?#?QIX1MX=
M'\<W'B^\U+4?%?B?X?:S%(T<GA#PS'96ME;>#KI9',MT\TMW JQQJCL4\3:1
M\4]!^+VL>._!/@WPSXQTCQ!\.O!_A.>+5_'5SX0O=.U'PQXD\=:O+(L4?@_Q
M-%>VUW;>*K58W$UJ\4MM,K1N&1A^8W_#ZNU_Z-:MO_#TWW_SMJ/^'U=K_P!&
MM6W_ (>F^_\ G;4?\06\0[)?V-3OS*7-_:N47O9)Z?7+:K3;N][72XKR*_\
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M/Q!^(?C.?3-'U>77;+3K?Q?XNU77[*R75IM,T=[V6WM;V*.>7^SK53*&")M
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MJR-<VLB22#>H_+G_ (?5VO\ T:U;?^'IOO\ YVU'_#ZNU_Z-:MO_  ]-]_\
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M-\1PZ7X]TJPBU_3I_-,UAK4=K\&(DU2SE\^;S;6^$\$GG2[D/F/G<\+I\5/
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MJ>68JK'#348J.+Q$\-3<I-<M2FTI2J:/DA\=I:W]E5LO<U_*RBOIOX6_L?\
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M_).URVD:7KNHV5DL[N))9(H;>=%@,[JK7 @\M;EE4SB3 QS?_"2^(1)K\O\
M;FJ^;XJ26/Q-)]ONM^OQSZA#JTR:PWFYU%)=3M[?4)%NS*'O(8KE@945Q?\
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M->#JSG2C>3Y*<K-0O)MZ2YGO9<UD83ESM.UGRQ3T2NTK-Z=PHHHKH("BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@ D@ $DG  Y))Z #N
M37UC^RK^Q-^T5^V3XK'AKX)>!+W5M/M+F&'Q%XYU82Z3X#\*1R%2TNN>(Y87
MMQ<)$WG1Z1IR:AKMW&"UGIEP 2/[ OV%_P#@B]^SI^R?_8_CKXAP6?QW^-UG
MY%Y%XF\2Z:G_  AGA'44VR!O!/A"Z-Q;+=VLP4V_B37_ .T=:26%+O2UT$R2
MVQ_.N-O$_AC@BG.EC,1]>S;DYJ638&<)XIN2O"6*G=T\#2E=/GK_ +R4&Y4*
M%>SB>WE608_-7&=.'L<-?WL3534&KZ^RC\566_P^ZFK2G$_GL_86_P""*_[0
M_P"U2VC^.?B=%?? ?X*W7V>]36_$.F2?\)UXMTYR)!_PA_A*[\B6WMKN+ @\
M0^(OL6G".6.]TZSUV-6@;^O[]EG]BW]G7]CGPB/"OP.\ V.AW-U;P1>(?&>I
M[-7\>>+IH0#]H\1^)YXEN[A#+NFBTJR6PT&PDDD_LS2;)'9#]4@      8
MP /0 < 4M?QSQKXG\3\;U)TL;B'@,IYE*EDV!G.&$2B[PEBIW53'5HV3YZ[]
ME&:<J%"@I.)^F97D6 RJ*E1A[7$6M+$U4G5=UJH+:E%_RPU:TE*6X4445^='
MLA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ny20053122x2-dashboard.jpg
<TEXT>
begin 644 ny20053122x2-dashboard.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /Y* "3@#/?J!P.IY(X
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MTN<@*""%Z#CC/_ZN])J[6VG^<7^GXH35VMM/\XO]/Q044F1ZC\Z6F,***/\
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MT(P*D@]1Z4E!;).2-Q//0'/TI0">@)^@S3O_ %ZC$HI2".H(^HQ3<@=2!^-
M"T4I! W$$+ZD''/3GIS3<CU'YBBZ[A==Q:*7!]#^1HP?0_D:+KNOZ_X=?> E
M%!!'4$?6EP?0_E0 E.0A8V0]21C'3@Y^OZ4PD#J0/K2]L]O7MSTYI-)M7Z;:
M]=/^!]XK)_+_ (#_ $044F1ZC\Q1D>H_,4[KNOZ_X=?>.Z[K^O\ AU]XM%+'
MM+,&(V@<<X&<>OUI""OW@5^O'\Z2:=_)V_KUZ"33OY.W]>O0**3(SC(SZ=^>
ME."LW"@D^@!/\J8Q**4@CJ",=<C&*;D'H0: %HI,CU'YTM !10.>G/TY_E3@
MK'HK'Z G^E%UW_K^F@&T4'CKQ]>/YT8.,XXZY[8]<T77=?U_PZ^\+KO_ %_3
M044F1ZC\Q0""< @GT')HNNZ_K_AU]X77=?U_PZ^\6O\ 1"_X-)?^4<7QJ_[/
M:^(__JB?V;J_SO<$=1BO]$+_ (-)?^4<7QJ_[/:^(_\ ZHG]FZIE\+^7YHF?
MPOY?FC_/1M[-9H'EDGD14<J$1$(&%#$[C\QX.,8P3R:G_LZWXS=RC*@DG8 N
M>0'.#M)'(+ *>@-6](B6=8K=[F&T2>]2)[F<,8($D6-&FFV!I!%'G>QCCD;@
M#RW4L*_4BP^!W['R>$?".D^,?BOX-?QIH/@"Z/C;6O!'Q$TR+1!=WWB?XEZE
MI_BDIJ>@7D_C+45T>S^'VCIX&T,Z=JMK:ZVTVIQ6]Y87L:Z4Z<:BU<4[7O)[
M[?UZ-]K&";>K\OR7ZW7R/RM_LZ $@7#2, /E9(I!DX( +%$!(R<[LX' -*-+
MMV;/GL/F.,6Z@8'1MP+*H;'R9P"<CC&:_4WXD_#K]C/0_P!H;X?-X5\5>&S\
M,_$L/Q)?Q;II\;V/C#P[HL&G>#V_X0/78-0TRRMFTA]9UZYFC3PM?S:EJ6GR
MZ9 ]S/,E]'&/(_VL?!'[-_@KP+\'+'X&:OH_B#6Y-4\>R>,=7L_&&E^*]8U?
M2UGT!/!VMZO;:;I^E#PJNIV9U*YM_"MY#=:GHKK+9W\[2Q*R.5!13?-!J/:5
M_P"79=]5?O;KJ--]-+[W6NZ_R_I;_"+:7!QFZE'T6.F_V7;_ //W-_WRE:R#
MKD>G4?7UI /GZ<9/;COCVK!6LKQW_P TM?7^MV3S;IO9)WMNK+SW?^7SR#IM
MN& ^US<C.=J?R _S^%._LJ \"[F)^B#^E:Y5,@D+D=.@I2%QR!C\OUJN5=EY
MZ^G]?\.Q*>VC^75Z;?C^!DC2X!PUU+GM\B']>#^A_I5."Q5VN5DE91%,%S&
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M1QR._<?3UIVU3V'\OY52BK+1=]WY:KL_\K7)Y[76ZZM):[/\[WMY&.=)B/\
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MG^9BZ;;XYN2?>2!)#^!8I@>P!I1IEL#S=2GVV@ ?38Z,/H&''7-?LO/\!_\
M@G_I\%_XHNOB1X?GN]3\>>.],T+P/8_&;2+^QM?"]UI7Q&B\'SW]TGANWO+&
M73=1T?P7=M?23W%A<1^(K:&>X26"X!^,/VJ/AQ^SM\/+GX;P? /XAWGCU=7\
M+RW7C*:XUG1M:A@U93:/;W%O_9EK9SZ/]H$MW#+H6HPRWUH;59)+ATE4!SPL
MJ<7-NDTK:1J*3Z:I?GWZ[BO;6^WW]/-:_P":^?QP=*@;E;F7'3L?_1C2'O\
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MXQBA>5&>>O7ZFD8'C:,>N./\*6R32T>K2U;;M^6X]_=>ZT3Z*UO3MU'T4F<
M9[ 9[T @]#5?U;J19[VT[D>-F#G/.,=.Q^M+C?STQQZ^_MZTYP2./7_&FJ0H
M(;@YS_+TJ+)-K:-KOM>_?_@FB;:;WELN]KKI_P  <QVC.,\XIF-^3G'.,=>P
M^E/RK<=>_3_&EX ]!UIVO?5.+Z=GIU1*=M+/F_33IYF:1F]L&] XQZ\2?X58
M6-6QD DE3G:N>W4XW'Z[L_IB#_E[LAWPY_#]Y_C5U2NP=,[1VYSCUQZ]Z2[M
MI.ZO?T5UY?\  -6[-=;W_-:_+48+=5QM8KM4KD9+D'KN9B=V>_ .  ",<J(
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MN-V!ZYQZ_K2@@]#27FT^J]-/U_0;DVDU?3=]W^1$GWA^/'X&IJ8R\?*,'/;
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M\!EOI6M7NJ+HEEI5_>ZP]R;1-*L["^N=0:Z#LC6JV<<!N'N8W CDB$88.'R
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M'8?+;P*.<O)U]PS?_6K1K.T__CWM\?PF8'Z[B*NNI)X';V]Z-DK:[+3KTO\
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M:1HMV\=AX8L[R_M8+[4+/3(HX9Y46,J(5*'H]*_;C-A<^'?&T_P:\&WWQO\
M"?@NV\#Z#\5YM5U6$P:?8:0=#T[5;CPQ"RZ/=:Q9:<S0I(91#D+-+;R-Q7PI
M4:H00>/\CZ5Q_P"KN3JG3I+!N,8M.K*GB<1"=9^RC2DZLO:2;A)13E05L/)1
M49T9:N7$LDROV4*?L&G!*\N=MS]V$97E;VB4G"_(JGL[.TH2LVY)[J6]N;B\
MG.9[RZFNIW"",/-<2F69P BJ5>1V*^7E NU5P%VC-L23-?>]S(/^^)) /T)S
M6E698?ZZ]_Z^9O\ T;)7M1C&$5&*M&+?*F^9Q5DDKO5V2WZGK7O!K2R=HKJH
M^ZDK];));+8TZCD[?C_2I**;5TUW)3LT^Q"K'(';/\ZD*AL9SQ3688(YS_@:
M8%+9QCCUJ+V]WXGV[6MIU7^74NU_>^'SWO>UGT[Z_B,< ] 7VG[JY9B 02 %
M!); X Y)P,&OJ&Z^.7A^Y_9 T?\ 9Y72-77Q)IGQGG^)$VMG[.-$DTFX\/3Z
M0;*,&1;Q+T32)(S21>6@0KSN./F14((/'^1]*DK#$8.AC%AO;P;>$Q-+%4+2
M:Y:M)IP>VJTM;UN85J-*N\,ZJE-X:M"O!J7+>5-J4$]'HFKV^5M#Z>@_:!TV
MS_9.TKX%:7;Z]8>,-+^,,OQ#/B"UNEATS^RY=+FLUMHQ'-]L%TETOG%606[A
M51<L<U])0?MG?!S7?B]\#?V@O'7@;Q3>_%7X?>"I=+\=2Z?%HYTSQ?XTT:T:
MU\$^)PUW<HZO;1Q6+:L9[0RDPEXE+9-?F<2 ,FDSN!Q[CGZ5Y=;AO*:[K.=.
MK&>(>.E7E3K.$JGU^A[#$)N,;QC/2;2>K36EVUP5,GP-7GE*%2,JLL2ZU2%1
MQE/ZW).K&Z5U%Q2BXW=U>S5[+]"OA%_P41^,.B_%%=;^,?C'QA\0/A3K/]OV
M/B[P$M];26UWHGB"PO8([73H;A8;2-[*:Z00,S1@+:JG(.*Y6V_::^'.D_"K
MX3_#/2/#OBF./X;_ +2%Y\7O.N&TUDG\+C4;6YL=(@5KXN^KQ6D,BRDC[,9&
M5$(5<GX>52#DXZ?X4%ADKSD\>W-1/AC)ISA4CA(X91=&U+"OV-)RHT*N&I2]
MFKKF5*O5CK?XV].DRR++)22AAU22]DU&@W3IWIT9T%+D][7V5:K#5Z*I);'W
MQ8?MIP^'/VR/%_[0OAO1]5E^'OCW5IK?QAX&U7[*]QX@\&7\5M#J&EWB?:9K
M(7L3PQWMA,FV*&YMXF,BD@#K_&G[:_@'Q)\6?VM?'EMX7\4PZ;^T#\*;+P'X
M<MI3IPNM)U&UL-)LI+K56%R;<V;?V?*8UMI7;!&6! !_-A5*YSCG']:?2GPM
MD]6K3Q$J%2-:G@8Y=!PJN,5A:=7#5J,902M*=.6&@O:.TI0?)HHZQ/(LME)2
M]E+F6$C@E*,DO]GA.C5IJW+I.G.FTIWOR2Y;+EO+ZU^)_P"TK;^(_"G[*5GX
M$M=?\.^+?V>/!-MX:NM:EDMECGU>SU>?5TU+2!:3//\ 9U\V.-A/AO+9R5;/
MR^U_M&?M[P?%?5/V;/''@3PS>^#?B%\%[O5O$OB%YHK#^P=6\7ZM=Z/J6JWV
MEQP$2)#J%_8WLUW%/"N#J#X0@;J_-TL <'-,V$\\<\]^_P"%-\-93[3"5/J[
ME4P?UOV3Y[:8QU'6516]]/ZSB>52TC*M*2UO?99+EO-A9RP[7U5XB,/?MST<
M3[?GI3]V[2>(E*,MDU>WO,_42W_:?_8I'CJ#X^3? [XFV_QACN(?$EQX3T[Q
M5;6WPRU#QM /M9U6:(!+R#3Y-3"7CV(#AB62/<"5'S\/!OA']HC4O$?QD^)7
M[3'PK^&_C+QSXHUK6=9\*^(-%\;7>HV+SW/[N42:1H][8BUGCVR6\:S"4Q"(
MR*"O/QYL/J/U_P *-A]1^O\ A4X7AZC@9RJX'%8ZCB'3P]"GB:]=XNIAL'AG
M!PP>&59<E'#<L>7DA%2UOS-Q5LZ&38?!<U3 XC$T*[I4*"K2J>V<:5%4TJ:C
M45E%\KLE;E3LGH[_ '/X,^(WP_\ V8]+_:*^'6E^-+7XN#XN_">'PMX<\9>
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M(U($@K:?0H@/XC%-VZC_ '++_OB/_"FO/RWNNWD^G]7T#EO=W2UVT?;L_/\
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M^B=NMOP_$;U=[NUTM+Z/2_3U?JAH6(= !] 1_*G!5/('ZFF,NW'.<T]>$SZ
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MNU9B^P[38PME<DJ5!^85[/XU\7ZQX:\)>#8-/F9$\<_"AM*U+>T\I2PGUK3
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MB#P1CE4 ..>!VKV#QY--#X7\-W*SR^;KS6&L.06&Y8?"F@Z=D@Y!VRP3 \$
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MG7(-]Q8F_P#M8FLW4Z= #&WV2:Z(2..^SY=J[&3<CLIKEB"9)< G#D#'88!
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M_C/\*4EO=3\.OKNAP1O-+KWAUVU.UB@5G(GNXU:2[M?E4!DE4A"1NV@DM_1
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M?#;Q_;W=JLY"AQ%9F\8SQP%Q(1-9:EJ%M@!V@C3#5_3F%7# @,K')5QYBY
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M>!_6O5_!P#6'AR7./(UWQW-@\'!\$EC[<8 /N1R.M>7&)<86:+MC_6= >/\
MEF?YGZFO6/!\ 70[:3SX,07?CN0-^^PH'@8%P3Y1')96YR0 <'!-<N):5..^
MM6"^]V7ZW,*]E3N]?>5[:NSMHO/7_AS&^'%O)J%WK5DBEGNM/T90,CE8O&?A
M=]V,$D((V<X&0O/0$CNOA3=1ZE\:IKJ!V\J]'B>6.3!W&)K>9UPC8VD^7@G.
M<D=J\T\'>)IO!M]J6H01V%Y+>Z!JNBQK=&Y"6TFI1A([Y/+C\PSV$RK>6X&
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M<6UPBS0W$+*2C0S1L'B*G#*1M]*G+A 7W8W$1#.<!V.00,'YU(&TD8&37PF
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M\,K+&M-<LL5-Q\_?2;3ZVMT;&M]^+_?%32_?D'3+. ?0DG!_ \U'C++]W/\
M#DJ.<C&-Q'Y]N_6EFXN)LLH4328'F)C&XXXW?E75L;6=E;=-NW_@/0Z2?Q"T
MWA33_#/V=]EAKNH:R)\[T;[?8Z9:/'MVC8R?V<6SN;>)0NU=N6YHJ,;0>!@
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M<%'#-*F0HMHW9@,%FE));ID^9GJ?4'WKAO#G_'X_O;RL?=C+%EC[GN>IKM6
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M7?Y>7:WZ$WFIW@C/U:4X^G[RCS4[01C_ ('<C]!.!^0%0T4Q%Q94\EOW$?\
MKH/X[GL6/><__6J%)UP&,2\8P-\I&00 /F=AT'IUH7_4M_UVA_FU0=A]$_\
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M ;H\$#;('#$D@D]0/08&*S=\C$#S&'/8(/\ V6K[J +O"2@>4J\RD[2V""V
M1C_=^G.<G,'  ] *^23GJYSK.;E%SO4GRO\ <8=^[[VSW]+'U'$4I+$4'&4H
MQ:Q32C*HDO\ ;:ZMJTWRQ48WZVN7K1G%Q*OG2D?8YB41@S$8.6=0NT(.I&T_
M+R<YYJAW&2KM@D]0AZ>@V#'4_P#Z@,6+$?OIL#?FSF!5>JY!P3NVYQU^4GCI
MSG-8\<8Q@MQQD<]\9[@]3FB\NDZG3_EY/I_V]_76YPUU-91ELU=)XG,[U%*K
M>3YL#'E4[\KE%QO))W3;32L)ND/61R#VR%_50K#\"*4.XZ.P^I+_ *ON(_#
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M.0:=+I+!]#3^PO&<R:Q.^B^(-636!>^&["&*1]1TVV,[30Q*\5?"RB5]S!V
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MZ3[Q7GW?X?/Z,J1"/WO(_P!2G_HQJ^=&_:N_9Y;'_%T?#_!SS'?>A':T]_\
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MY-4U-S*[:GJ$C7"O'<%[VXD:>*7'GQSLTA::.X(S<+*7$[,QFWEB:I^;;_\
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M'3[B]M1&P\MOSE2_@1<$S.<YW-&-QX'7! .#PH 4!=JXXR6&\MR%!,IVYZQ
M@Y8L58;L,HW2!=P+#?DNQ'.<:D8MZ1:=MVM+.Z_X?RMUL)7N][.UM_GWMO\
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M^X98QD;0D;)@ EA@I*C*RM@HR,FT9!4@\*;V$@@--CD -&S +D[%.9/FV D
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MC;))=>,DM=0L5\.R3Z;#ILDEY!-?1V9MY48_"_VVW[></4^6 6.S8"VTJ"0
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MEY>O>6&BE]6\/KX=LVTZYC6UU.POI;^/4@\EY#J-F9;.7\U?[1C]7_[\+_\
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M2-0M(Y)KK2KNVAAG-K-+/I\L44-TJ[FMI9'A5([A5P6A<K*N5W*-RY_3*/\
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MX\N,G)_@3KWYQ5FHA]_\6_K2;:<5W?\ D"DW?797^ZW^6OJ^XSR5_P">4?\
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MVI#Y*_\ /*/_ +XC_P */)7_ )Y1_P#?$?\ A5BBF+F?]7\O/R_%]ROY*_\
M/*/_ +XC_P */)7_ )Y1_P#?$?\ A5BF,Q!P,=/\:&TM6-.3=E_6WGY?B^Y!
ML3_GG'_W[3_XFE$2GD11_P#?$?\ A4OE^_Z?_7IX& !Z5*YNJ5O+Y>?]6&Y)
M+1MOSOY>G;\7W(/)7_GE'_WQ'_A1Y2C_ )91_P#?$?\ A4K,5QC'.>OX4N<H
M2?0_UIW5[=4).6C>S:6_I_E^?<@$:'I''_W[3_"CRTSCRX\_]<T[?A4L??\
M#^M!&TE@>^<8]?Q]Z2;:3TZWWVOT^0[VDU?M;?5^[:_W:^K[D7E+G'EQY/\
ML)_A7^@[_P &F2[?^"=OQQ& !_PV[\1BH&,8_P"%#_LV= .G.:_SY@26!/\
MG@U_H._\&FW'_!.[XX#T_;<^(W_JB/V;:F3NM.C_  LOU92OL^R?SV?Y??<_
MST-, :(Y 93+)P1D?ZN,'@^QQ],UI%T5MFTY R<)G"@ !S@?=/W PR-RE>-M
M4-+4"!C_ '9GQ^*1YS7Z5_LPZO\ L;S?"RQ\._'>/2M(\=VGBGXL>)K+Q6VD
M:EJUQ/8VWP]\/6/A;P=KME:KY4NE:OJUSJ^IZ'J2+/+INO:3]FO(_LFHI);;
M4H.I:*:7NIZNVFB^_4A)-I:_"MO-I]/7KZON?F\TT6% R#\HV;&##>J$#:0,
MX$B[E&2-W .::SH@);"^6=C!AM:-@<>65;#*0001@ %6!(VFOUY\&^#?^"=.
MD>-=$U2Z\2^']5M++3WN[W2->\7>-KCPO+HT<S1V^O3WR^&(;JZ^(+P^4[_#
MI[*/P_'M:1]5S!Y4GFGC'0OV&/"OQ%_9PO\ X<^(I]=\/7]C/=?&0^)7U6_T
M])#H$$MK-?:*8&N-)OY-=OM1M;C2K.2:WAAM[%H8296SH\+)ZMQMU]YZZQ^6
MGR[Z.QHE9)+\3\U!(BMM(.YL%?E/S;EZH?XP<;-R;E+#9NR,4BR1[F)!4 X?
M<A7"D<;@P'RX..>G(QG(K]"/VM];_9]N-&T-OAM/\,-6U)-=\+W/A2#X>:-J
M>E2V?@JW\':8/$5C\1'FT_1K2]U>[\7J[V*J=1OT\K5I)[DP3V0D\P^)?CCP
ME>_#B"ZL/"'@JRN/B%;PG2]/TZ.V;5_"-OI\RC5KJYDCE:Y5KN_CFL]*%S#;
MR2:<SS3(TD8W1*CRJW,O=L]]_7;6_3LU9[A9:O75:_=V/DGA^4'4 -P ?8'\
M,?ACVJ90 !P < '\.@_#G%-557<5YW').<\@ ?R I]9I;OJ[7^1E)WLELMN_
M3<*B3J?I_44K,02 >E."@'(S2>K5G;E>OH[/] M:+O\ :2:^3_X(I( )/  )
M)] .35=I4897<0O+$*Q"@H9 6V@E5V@?,P"Y=!GYJGWX< \+E<D E@.,D 9R
M<=  >>QK]A-0;_@G-XYTE)(KWPYX5\0CQ%X"TN7PZ'\4:)H>M2>&O@YXO^UZ
MX/&&F:;J.H:!X4\9^--4T:V\56MG8S7%IK&BVLEL@L]3,]GK3INMS).*Y;7Y
MFUU6UM]?0<%K>^W3\/U_-]&?CDLBL=HSG(&-I(Y#L,L 5&1&Q&XC/&,DT\2*
MO4.2<?*$8$'#'!R  QP/ESGYE)&"#7[$^&/!/_!,^W\/WVDZEXYM9K35O'&D
MVW]MW.L>,&\8BQL?%/BK[1I5KIDNA6&G:)X-N=.M/#P_X2^*^&L:GIEY//-I
MMM*6BA\N^%DO["F@_%/XX>$_&4T%_P#"O5_B;\.-*^%_BZ_^WZWK'@_PW#JU
M_?\ B'Q!%):)'_;FCVKVD>DZM9W&V]O-!ODO;=9)[1#)?U9Q<?>6J_FOT2V]
M5;;Y:(T:3T?]6/S(,\*@LS!< $DC&,[NI.!GY3D DC(!P3BE\^/C[V"5 .Q^
M2W*X! 8[@1MX^;/RYK]?->\%_P#!-6PTG0_%$GBN#Q+KNI^)/&3:WX;\.^)/
M&.A6$>DZMXJT!/#UP(6T8R:,V@Z+J&O/#910):WD>EV\"K,A,TWG7BKP3_P3
MPN?A7\5_$7A7Q'KVG_$*/PIIDW@/P>FO:_J%OINNPQZ] L,-]JNFV2^(!J%W
MIVER:M#?!6TVTU*2:W=%A'EMX>:5[P].;6VFOX_@3R+SV77_ (']=D?F0)XC
M@!CDD+@JRD,6"[6W!<$$\YZ<YJ16#KE<C('4$$94,,CW!!'L0:^L_A7XU\):
M?\-[G4=4\+^";F7X?N\>I6NK16"ZKXW%\TDFGQV$5S,)T9;V,VNI3PK<"/3T
MENHB701M\HS3"YN+FX$,5O\ :+F:;[/ B);P"5S(D, 3CR8D940-\Z!?+?YD
M-92CRVNTVU?3M_GOIY$RBHZJ_P"#[;^7R[?.N 5.2.#QV_SVI6!W;L<#![=L
M9I7Z#Z_XT9RA)]#_ %K)6ORZZ6:^5OZM:PTW=2LM7RO?RU7W/_(C=UXR0H&2
M68@*HXRS'/RJ.['@9 SDJ"GFJ4Q\^><91P#M/(5BH4D#!V@DXQQR*]G_ &>[
MKP!9_%_PG<?$QM%7PJ@UL22^);2]O?#-MKC^']47PI=^);;30]_+H%KXI.C3
MZQ'!#,)-.2Y66&X0_9I_M0>&?V/?$*^*=2^*GC#X<-XPAU#PW9:GJ'PDNO&/
MAGPZ&CT?PR?,\&>%!X9CT[63J=]-J5EXUOX5TG3]%EMFO]%M+J&2*"MJ=)SB
MI72<FU9OM9;7[?\ #HOE5DNSN?F )4/0Y'KT''4<XZ'@G& 2 3S4JSQX'/&,
M[@5(P&9">&) W(_4 X4MC:-U?K3\/=,_X)YC43XPD_L32Q<:-J0O/!_C/QAX
MTUJ#PM<1V_BNQTB[\,2-X8E?Q;JVLWMAHM[>Z;K365GH]K=!XI+E2\<'4ZQ;
M?\$\?%9NH(=1\(:);WNHPSZ?;V>M^,-*/B36-(O?C#"D_BG51H5_>^"M(U3R
MO -P5\,V\MH]MJ%O_H5HJS20ZK"27VHZ^;::M&VEEK\O+31 TGO]_P#7^1^-
MYF4<$/S@C"DDJ?X@!DD=R,;@"#C!!*>;'@D@J <$LN!DC(P3P<]O<BON7X_>
M'_V,])^&\D/P0U+4=5\?V&J:)J']MZCKOB&ZCUC3[WQ#\0;?7=&;0;S2[*T@
M32-#TOP9J5EJ45S'=7T&I3+/$T[M';<OXT\?>#[CX51ZU:>#O ]M>>,+"31+
M#1+2*V75_#5Y9M]GU?6I%AN)KT64P57T?[3:P-)),7>9Q %?.5/E<DVKQ5][
MZ;;Z==-NJ)Y$N_W^G^7]:'R*&#*=H/=<$%>>XP0.AX/OFD52#R.WM[4P':.#
MG)9CR3RS%B/F^8=>0<8)/ J>LE9Z]M--G>Q+O%6Z/7SZ>GY"-T/T/\J9'W_#
M^M2'D$>M1-\F,'KUSC\.WO2>Z?17]== CJG'JW==NG^1'YBAVR<%6((_B/4C
M"CYCN .WC#8('/%/,J9(97^7&28V( 9BH;(!&TD  C.=R^O'U]\ _&OP6\+?
M"SQS8^/[*QN?&GB'Q[X3T[0[N7PWH.O3Z=X3ET_44\0WTTNOZ=?1V&E0W,UH
MUU=:3LUB*6-A"43#'Z*U'0_^"?\ JOB'XG1Q7]E8P:3X+?Q%X7\33^)_%\%A
MXF\8WWB'Q-=S:3%X;TC2H1:166@VGAZTLH;,I"&NYYC'*LDCV6L:3:T:UUU>
MJV\NW];%\MTKWNDEI_P>Q^6S2(<*HRW!( !(!!P2 22",$%=V<@#)XJ,R(#M
M+;6& 58,&5CT4J0&W'L "6.0N2"!^GGPKG_98'QS^.MMJMQ\)O"OPOUC1-"7
MP+J.N2>(O%]MX;L+FPMKO53X?TSQ%I%TVJW[W;20:QI]Y?:-K]H68^'M6C-J
M\<GJGAOX8?\ !*N<>%9-;^(_BJ>6?P#<WFIK'K.M:5;ZEX@GO-"CNI+E9H+F
M3PUJNG17?B";2=&D8Z?J":=9VUPI<O<7%+#N;7O)/;>UK-?EKMKJM.J:5E;7
MY_UMZ:?B?CKYR9V_-N'50-S+CKD*3C RQ/0 $D]J!-&2!DC<0HRI'S';\I]#
M\XX/OZ5]:_&R+]F+2_#'P\U'X*VUQ-XGT76]-M_%]KK&OZIK%MXIL#X6\-ZW
M+JMQIU]IUE!HXC\17.O:!<6.DSS1/%:* P9A<21_%SQIX2N? =D^E^&/!=O<
M_$%K75=+MM+CTX:MX1TRU>WN)XKXPNTKSW>H2W5C8M*('>QL!</$S3#"E2<;
MJ35TD]-4T]K?._=D\D?,^4Z86'*\YZ?CTH<D8QWS463G/?.?QK&4DG;SU]/\
MR8QV;VZ=[ICQ\F<@\].G;\?>G\ ;L>AR%)(SWP 3@9R3V&2>*8/GSDGCIT[_
M (>U,D)*LI*A>A+@;57NS?(^5499@%)(! ()!"3M;L]%O>^BUZ:?\,-J[M?7
M[6^VEK?\'J.\^+"')PX!4[' ;Y=V Q4 L!U7.Y>I '--::,@C.,'G/ )VJQ
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M/;FHC(@Y8E0-N2R. N[.,G;V(*GT8$=CC0M/(2YM_M!'D>?"9MV2/*\Q?,R
M"2-@;( )(R ">*_7WQ-%_P $Z/'-T]_I5QX=\-W5UXQ;3KCP5+<>+?#7ATIX
M6\#6EA8^([7QQ9Z9J]]IGASQ]J#OJ]QI$=@UUI_BW3[S3V6+2=4LKJMZ6']K
MS-2C&22=G*W-KK9)-NUK]'K?5K2HNZTV5DN_S/QS5U)XW''S'".2 "H)("Y
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MH['3]91X(XP9+B'>G0=6DIW2>K2O9>Z^NCT[_ITV22VO^/E\OZ['Y'>=&Q
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MOM*ENM1U#Q'X3BLHX;I=0*O8Z8KV<]U'_HEA]EN+U7F=H]0N[BT"J+/<WSL
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ME@(D+(,E08BV,D?*-^6^ZWW<YVL!R,%3<1@GY$VYVAMIPS$*0%&W<<JQ;.W
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M!D<#J/PI2$49;"CIDM@9].33?W1'WE.>.&'^-2HRTVZ=^EO_ )%$\Z[/[O\
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M:PTSP[!J%E%-]MO7N(Y=L2'&E%.>NEFUY62TW>NWZ] VUUOI^>_;U/BC[0@
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MWJ;NK_%>S5M-M]4*S?5_EV]//[_(_/DFU/7)^NUOYXQ1BT]!_P!\)7WMX1^
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M+E08B2#YLI&2" 0'>0*5W'RV7#("P#$' ^[-3_8\\(B\^+&BZ'X\U^ZU_P
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MK?\ KOZ]$]AJSUW]'UY>W?SO]R:/A7;+N#"8<$X!D.T DMQA@P8,=^_<3O\
MF  ^6DV2C.)DP05V^8Y4IU7<-Z!F5\OG 4MRRDY)^_\ 2/V%KFST']G_ %OQ
MMXB\0Z=)\<;SQ>HTOPYX3CUMO#MAI&D>'=;\.WTNIW>IV&EFUU33=>GUO6+F
M]EMK;P[HEFTM[-YW[I>(^'W[*.B^.-&\3ZC#\0Q)<6VNZKX>\&SZ;H3W&B7=
MYIFA^(O$)O/&6HW=WIB^&;"ZL=%V0S>7=PI-=!S*8[.8)3H3WO=+?RV6M^U]
M+/MW#YJVW7>Z7?O?7TW/C@*^5+2*Q1%C3?(S!8U!VH-S.0JEFV '"J=N#]Z@
M@^8A)4[>?D.0?;)Q@\>GI7T)\?O@=H_P<U#0(-%\0ZMXBM=0N_%^A:B^M: F
M@SP>(/ OB&Y\.ZQ-80+>7@O= O;B,3:/J)D#W,?F++''/#+''\^!55P%4*,=
M@!Z^E93BX-)O7W;[=6O7I^>UR6[-]U%N_P!WF[ZWW_SOEZ<-JW8SUNB<GH,*
M5Y]N,UT]IK>N:=8ZAIFFZW>6FFZI&(]3LK.]O8+2_09 2]@A=(KA0K%3'(C*
M5+*VY&9:YO3B +K/3[0W49]:]Y^&_P #=:^)VCZOKEAK6D:3;::UW''%J$6H
MRS7[:;I5SK&HI%-96TUM8&WLH1)"^ISV45U*3'!)*RR*O9E>"QV8XFGA<OA.
MIBZBE[-0ER.R?O-O3W4OB\M7HC&O7P]"FYXN<84M%S2CS1<FDU%*V[M)W6R7
MW>)K'&<J&1P269<;,@C!7*QY5,D?=P_',G44>7A\EQN).=S.P.XYP<QG(&6
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MN(]16W;2(OMEK#-?)>_N:(T9RT49JVMV[[.*W;76WIZ6L:]U_P -9[7TO?\
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M[=;IW7_!^:Q&'KX/$3P^+HSHXB$OWL*EE.,IVF[VNM>9-6>SNMQ@$P& D?\
MW\'^%+^^_N1_]_!_A49!!P:F# G S6D9='96LK/_ (/]:KYXRLM>6_6_W6_K
MU\QI\X@C9'S_ --!_A0D<AW JH!5@2&W'E2#V Y!/7K[8I&4DD@?J/2A3L;Y
MN 5?GM\J%CD]OE4GZ T7=]8WMYV[>MK_ -;,::LK6UMI?TO]R.R/Q&^)+:-H
MOAX^.O%W]A>'&9] T;_A)]5&DZ-(RW$;2Z7IAN396$CQW,R,UM!&6$DF23-,
M9*>C^-/'/AW1]9\/:!XL\2:)H'B*(0Z_HNE>(M2L-*UJ$1M"(M5T^UGBM-0B
M,3R1-%=0RQO%)+$ZLDL@;WSP3^R+X_\ 'FE>#;_2_$'A*WU/QM-X9:P\,W5Q
MKK:Q8:%XSU^\\/>'_$6J/;:#>Z,EC?ZK8W"1V<%_+K:PJKQ6,C2QH6>+/V1?
MB/X4USPOHLVJ^%[_ /X2]+Z7P_J%GJ&HVL-Q:67A.'Q@\MQIVHZ79:OH\\ND
MW$2"SU6QL]1ANG(GMP%W+U*G6:CRQFDU%][7Y?/OIMZ:711XOIGQ,^)VB70O
M=%\?>,=)NUO+W44N=.\5ZS:S1ZAJ5N+34;Y)(KM6^UW]JB6]Y,Q9KB"..&3=
M$BH(D^(OQ(C6S2/QUXOC33HX8;%8_%>LHMG%;7=W?6T=LJW8$"6U[J&H74"Q
M;5CN+Z[G4"6XE=OI36/V#/V@M&D\7PQZ+I6KW/A+4?ACHZ6VDZREV_B:_P#B
MMI;:OH$/AIYDABO5T^S21_$+3W$<>BR1M%<21NC1KR"?L<?M)-#JLS?#&_A&
MC7FH6%_#<:YX6M[Q;K3(89KF.VT^;7$O[Y6%U9Q6TUE;7$-Y<7MG;VLDTMS$
MK9RIUTU:-66G5MI;7LEML[>5M /%)_'OQ"NM&L/#MUXU\5W.@:5;7-GIFB3^
M)]6ETK3[6\N8;RYM[+3VN3:6T,UW;6]TT442Q_:((I0H=%(AU/QIXYUJUCLM
M7\6>)=3LX+T:E;6E_P"(]4O+:VU /<S"^@AN;F6..[6XN[BX6<+YBS2RL& F
ME5_7+/\ 94^/M_##<6_P]NQ!-I]IJ7G76L^&["&"._O=$T^RM+N6^UFVCM-6
MNKOQ+X?C@T:X:/594UG3ITLS;W*2ULZ'^R=X_P!5T#5=6U/5M%\+^(+%M M]
M,^'NL)KLOB_Q+>^,-2N=#\)6VCV6CZ5J5F)O$&M6LVE62:E?:?LF*74I6UD2
M<B^L-V<9+U3UV[[WMY]-[:AXW_PLSXG_ -E3:%_PL#QI_8L^IW>M2:2?%NM'
M3FU:_DGEO=1:U-V8GO;N2YF:XNG5II3)(SNS33&1+#XE?$S2Y+Z73?'GC"QE
MU.SNM/U&:U\5:Q!-?V-\(EO;.\EBNDDN+:[$$*W$,K/',L,2R*RQ(%]L@_8I
M_:?N;G5;./X3ZFMSHMS;6M_'<:YX3L]KWECINHVLEO)>:_!%>VT]IK&EO%<V
M;SP.VH6<:R%[B%7I:?\ L@_M(ZE)I,&G?"G6[Z;6+(ZC;16E]H$\MO9M:6VH
M02ZK#'JYFT4WEC>07=A#J\=E/?V[&2TBF7!+2Q+T<:BV>TO+_A_Q[MIMK97/
M)M4^*GQ5UJ/3H-8^(GC;5(M*@LK;3(K_ ,5ZU?1V-OIDUO<:?#:1SWCI:QV4
M]M!-:K"J"&:))(MLB*PQ['Q5XPT?5='\2:3XHU_3O$&D--)I>N6>N7MKJ^GR
MFYG9Y++489DO;661YYI&>&9&#R.RE6)KW*W_ &1/VB;F\^PCX:W\-['H4'BB
MYL[C5O#D6H6/AVYGNX(]9O=,.L'4[:S T_4;B0/9^?'::?=W30"",.W :_\
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M=UQ(8+FZE1',DZVEE;0:?9R3B1XX(V",K2SR2^7I\JA2<8X )Z+V SV'0>@
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M0X;>+39;"UTBR\JTCMYT7R+NTT'28IH+JWN(@;&%H1$"^[R9/VBOB?%X&@\
M6>J6ECH,<]A<7!T^PCM;_4XM)U_Q/XFTVSU![9D-]8V6J>,?$#I:2*8S;7SV
M]PACC4+R'A7X=_$?QO>IIOA7PQK6M7\CVB)9VFGS">0WZ7LEFT*3S0F:*XCT
MZ^=)8M\96TG;=MC)K*\0^%?&OA35[[0/$&@ZSI>LZ;<Q6=[I]UI=U%<6]W<0
M1W5O;NKNJL]Q:S075NT321W-K<07-N\L,T3N<^)M_P O+66O,_S5M_ZWL'7_
M ('IO^/WO0^K-=_;^^/OB9[.36I?"%Z-+T*VT;187\+631Z)]FLO%.GQZCI!
M>5OLNHC3/&'B>R$[;8((-5F@A@C\N,CY^^)WQD\:?&*\T6_\;S:?>7NA0:U:
MV%Y:6L5O/]DUG7K[Q!-:7#1/M>&&^U*ZDM"Z-($F=-P5!GG/#?@GX@>+[^]T
MSPSX7U_6[_3A ;VUT_2+J>6U^TWMKIT N%63]RTM_?V5HB/AVENH@JL-Q7,;
M1?$JZ?;:K_9]Z]A=2ZA!#<16DDJ--I/D?VBF(YVD'V3[3%YS,BH-QPS8-)RK
M26JFUUN[KIY=+(&DUVNDM%K;MZ>5M-;F.6&#@CIZU&#N/S'H..@]*]/TCX0_
M%O7I_$%MI/@S7;R;PK96FI>(@+%H(]'T^_CCFLKJ]N;JY@M8Q=Q30M;PI/)<
MS&:!8H7:>,'SYK;64>..6UO86E$+)YEA= %9WE2)LAB"DA@G:*1"\4RQ2>4[
ME6 AQJ.W[MVUT[_AT8E%+U[VV]+W7?[RKD!< C@''(J!BS%>I^:/&!ZS1>GT
MKI/$'ASQAX4EM8?$FB:OH<E\':T&J:;<6:7*1,T<TEO)-*L=PD,B-%*T#R!)
M<1G#'%8?VBYC>-C.>)(F.Q ,@2Q]=YDYY&,;>^<\4FI)I.+BENKKY?E;[UW$
MDEHWK>]VM=+7U\_UZV9ZGX$^,?B?X;:%XZ\.:#IOAZ6U\<Q6-OJU_J6C&YU>
M"/2IFNK%=,U-;BWGM-MX(KH)&6@DD@A,Z.L8 ]&N?VP/BC=C6DO=-\%3VWB#
MPWJN@:A:OX4BA55\0:O_ &_XIU:WDM9X+BWUGQ)JI2YUB\BF"7,<<=FL*V<:
MPCQOP[X!^(GC33O%&N>$_#.M>(-)\(VLNI>)+[3=.GNH=)LDCEG>XNGB8#:D
M$,L\BQ(SQP133M$L,,CKUDWP#^.T-W<V+?#;Q<UU:^'AXLF@31;EY%\/,+@I
MJ6%E(VL+6<&WS]KCDAFBD@26"9$UC/$1^!3MNK/3R:T+-#QS^U#\<_B'H/AK
MP_XH\<WL]EX2T76/#^FR:;!:Z)>S:'KD6FQ7>D:I>:9:V4NHZ<T&C:= EM>R
M3H(K6%,<5</[4GQ:_P"$.N?!)U#1AITFEKH]EJB:/91Z]H.E"PT"QU"ST/5]
MD4VG1ZS9^&]$MM5>-@9X[%-C@RSAO(-4\-^+M$TKPOKFKZ1J>GZ/XU@N[KPE
MJ-UI]Q';>(;6PO'TZ]N=)D\PB\AMM2CDT^1HLC[5')&NXHV.RU?X,?&;0-(\
M0Z[K/@#Q5IFD^%%T^3Q'?7FBW4$&CQZI!9W5A)?2/($BCFM=1T^X>3<4MXKZ
MT-RT1GC#1[2KVGI_>:MVO\M_F^XKK\;;/2]M/*^GEL2Z+\=OB7HUK<VL&O/?
MRZAJ^L:W>WNL>=J.H7NI:]X1U/P+J$]S?W/G/*TFA:G=6J*[-M(B=?F0,-;X
M7?M%^/\ X3:1;:!X>M_#FH:7:S^+[NSMM>T4W\MC=^,]%T?P_KEQ:3M<6TMI
M<7.F:+;6D4L%PKVJ&8PLAF8GG-!^$?Q>\4^'8_%GASP)XIUGPY+'XBFBUBQT
M:YEL)(O"6ESZSXFE6X$HC\O1=-MIKN^D8A(H8W<,P4XM>&?@M\:/&6GZ%J_A
M?X?^*=;TKQ,=9&@ZC9:/<-9ZK_PCPMSK/V*YEFCAN#8?:K82B-VS)<6\2;II
MXXRU.MHTIZ:IN6O3[^GE^(;Z_FGW^7Y'4^"_VH_B]\/= \0>%/!&MZ5X7\+>
M*H;5=9\.V.BZ7/IES=VITQH]36&]@O)5U!X]&L83,EY&TD44D<I;SI&.]XC_
M &OOBOXK\8V7C?6H?"M[K%GI-]H2HVBI+:W6BZXOB"3Q+IUU9FZ<7$'B.7Q-
MJ3ZK;Q,#%YL*6)MUM8(X_#-%\(^./$<>O2Z'X?UC5(_"UE'J7B-[33;B5=#L
M)=2L](CN]3VR$V<3ZGJ%I8Q^<$:2[D:"-6DC=1T]Y\'?C#I_C'2OA_>^!?$M
MOXRURQCU+2?#SZ5.=0O=/ECN)5O(TCF>(6RK:7/G2/*HMC!,+D0F*38U5Q&E
MG4?;WF]=-K_U]P??]UNWE_6O;3KO%W[3WQ1\;>%]?\)ZY+H1L/$4TL-[>6GA
M[3[74;30Y-6LM>7PQIMWNQ;>'H]5TVQNH;.*%G0VZQJ50$-\])O*S_*!^ZZ
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MB3Q#H>HZW%X=L=0TN+[5%=:Q//!:Q6D,<<QN&W7=U:6;3F$6T5Y=06\LR22
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M:0GB;1(M$U>6S=H;BYTPW&FZB]LMRA6:%9+FR@,AB=6>,/$3M<BNP;XW^/\
M[#8VEO=:7:3Z;X<7PK;:M;Z;;0ZP^BHD2I:RWR)YDC1F")TF/[T/&&WD\5QF
MCZ!XF\57%Q;Z);W.HR:=IR7UX$FA@2VM,64)GDDGGA0+YL\,>,EBS# K5@^'
M7Q!N;)M0@T'5);59(HBRL"Q::.RE3; 91/*FS4+,M)'&T2K/$S2*DJ,WD8S+
MLAQ-:K4QV$RVKB)Z598B&'E5DJE.%*T_:1<GSTHQIZM\T$HZK1?1Y=1XK>'I
M5,JAG3PR3G2G@J>+E1M0J>TE*G*C>"5&HW.;BVH3DY2<78[_ %G]IWXO:]<W
M>H:GJ6BSZQ>75[=R:X/#^EQZM$VHBQ74HK6]@M(Y;6'4$T^WCO(X\>?&KH6"
MR296U_:>^,UI_:!M_$\4:ZJ^B2WL)TRQ>"230-7N=;T\K ]HRH5O;RX$^T#[
M1;LMO/YD4:*OFK>!?'L<EO%-X>UB*6\M-/O[1#$R?:++5+MM/L;E#YS*T=Q?
MJ]HA!^22.5I=D2-(,;7='\0^&=0;2]=M+C3KY$BE:"5T9S!.K/!<1S07$UO<
M02A&"SV\LL;$8!PP-<L.&>%*BC1ADV3S:YN2,<+A9-*4E4?+'V;Y4Y>]:-ES
M:KWFS6MCN,<)2=?$XK/<-2YU!UL0\;1BYM\J7/5<4VVN71]'KN;?C?QYXA^(
M=YI]UXB>R6/1M-71](T_3+&'3M.TS3Q<W%\]O:VD"+'&)+V[NKJ0J/FFN)3T
M( X_(]12B2X/_+>3_OZ_^-,\^X[S''^R&5O^^O,.??Y1GVZ5[>'H4,%0IX;#
M4:=##TDXTZ5**A"";YGRP22LY-MV6N[W/FZ]6MBJTZV)K5*]:;3G4JRE.<G9
M).4I-MW27]*PI4$YYII&T9!.>G;_  ]J7SY_^>TO_?Q_\:?YESVF;_@9=Q^6
M]<'WSZC'/&U[WY4KZ:V].K2\_N^[*UK)RT[-:/;_ ('I]XU22 3_ )YH(#$
MC(VOQ[$;3^:LP/L33O,N.\SY_P!EG0?@NYL>_)R>>^*<L]Q&6/VF1=T<B_?9
MNJYZ%AT /O5)V2OV7=ZZ>7=]_P!;))<UU+KLEWZ?CV[[6=O??"?[57QJ\%:!
MHGACP[XALK"ST'^PH;#44T/3CKITWPSKDOB30-%N=4^S"XN]'TG79I-3M()I
M&,=RV[S"BA*QO#W[0?Q.\+Z5K>DVFLV.HG7[G6+R;5?$>FV&NZ[IM[K^AW/A
MW6KW1]6U5)KZPN-1T>[N+*YD@F!(D1@5>*!HX-*^ OQOUOPQ)XRTOP'XDO\
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M<N?#4>M:7974:VG]IW)FGC9;>W1?E9!<RH9$LY)(\R@201>8I,*EI "C,7V
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MO7KW^?W5X _;VUWP)\.K'X?K\.O#NJQZ5X-7PC9ZC-J]Y"9;1]&\:Z!>R7\
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MY?#OB?XM^,_BGK-CXCDCAL--AO=4U"/P;X7T'2[:^U"RL+33+*_U+6M2>U:
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MJL\@U&VG@/Y.A".=LA8]26+ CMP[,01[, >ZDX(E#, !Y;<?2AXB3TY(*/\
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M?_"$7GAWQ%J>H:1>:+'HME:P>(8H-,N[>*XF\06BW4]XLL[$O\[?%.7 'RY
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M_P",V_B-_P"J(_9M_P _6L)ZJ^N_72VENHH==MDM+>>]GN?U!4445D6%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
C!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ny20053122x2-efficiency.jpg
<TEXT>
begin 644 ny20053122x2-efficiency.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( CH"^ ,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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MG6E)6OI%24+>ZFT^6Z/Z"?VT/VU_A/\ L4?#*W^('Q*CU;6M3\0ZK%X=\!^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ#N(/_"W!_\ SL]?Z6I_K1F?_/G"?=4\O[_K_6_]X?\ P_=_X)R_]%0\:_\
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MQW_\IZ/^'[O_  3E_P"BH>-?_#3^._\ Y3U_!Y11_P 2^\$_]!W$'_A;@_\
MYV>O]+4_UHS/_GSA/NJ>7]_U_K?^\/\ X?N_\$Y?^BH>-?\ PT_CO_Y3T?\
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MWNZ_G]^E]#^PP_\ !RA\"AC/[./Q7&1D9\1^$N1@-D?/R,$'/H0>E+_Q$G_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^B%V)567(][(]9XA)\LK4FF[<CLYWC)[KFT2:\]2)O1>M_/0X6:.36V'PO\
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M3Q1OHTP:+Q_\.YP+F'3$<C[1!): -)<Z%>R3S26ER(G?3E"LL@B7[-;+&_\
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M;PI*2YN6SMHYQE'XDW:*YMKT]+M2U3NTE?5RM=<O;SWNQ0(/AY#]JM5D\;_
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M ?\ LGOQ1_\ 4::OQOK]D/\ @@[_ ,I%? /_ &3WXH_^HTU?'^(/_)#<6_\
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MIQ=I6OKRV?S6J:T:M;<V5EMMTZ_Y_P!7/BBBBBO])3\@"BBB@ HHHH ****
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M">;K4M*MU:P_X2@V(\IK^PM90NS6XU@=[^S$3&Z:5K?][E2L=O++XVN6\=^
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M];_5]'M9"LL\=P0PU/2I&DD7>L3J)9;>2X=;RSZX\WQ8^%,*:)XNT3?<^./
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M(6VQZGIYEP%W2)!M#HYL@^'-M'8W[OXV^!?CDO+:7R,);K1[]E5A=Q>6TO\
M9_B73"J^?$VQ;N#S%0K-YL*DJP^ (8?#'BF>7QC\%_&(:X\.>(;8M-<Z)-)N
MC>_TTJSFPU:W\P#4M)=H_-59)%7&%E$WH[Q4DW%.6D91=DJ325I1ELI:23>]
M[@?<?_!-*ZN_!O[?/[(/P\\;VJ>)?#DGQL\':G\,O%MI+YC6\TU^9-.FL[M5
M=SIUS<2>3J5G/,_V?=)$D941QJ4O_!-6>_\  O[?'[('@GQ#''XP\":Y\;_!
M^H_#KQ,CB;^SKU]3?[#<Z?=K,PMPT[^3JVE&1P2\TL*20,KS%?-9NE]9BN62
MM!)J7O6=U=7W:O?E[0-H?"OG^9\34445_I,?D(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !7[(?\$'?^4BO@'_ +)[\4?_ %&FK\;Z_9#_
M ((._P#*17P#_P!D]^*/_J--7Q_B#_R0W%O_ &3^:?\ J)5/0RK_ )&6"_["
M*?YG]WD??\/ZU)4<??\ #^M25_G9#9^OZ(_4 HHHJP"BBB@"&;H!@'KP?7C!
M'N#@CTQ7^7%\3ROPY^(GQ"OH&;QM\"_'/C[Q9'J-J,O/ID[^(;YY8)TC,<6E
MZ_I\Q#6WFO'%>B(+]]N/]1Z8#86/\*L?R )';GC/X>]?Y<'Q1$?@'XB?$CQ3
MX7_XK;X+^+O'7B^W\3>'I_FETF=O$5^)-,U/8;E;35;5GC&G:E'Y,<A%NH=T
MDB=_>R/X\1_AI?G/?R_KS436B];'$8MOAW;BQOI#X[^!?CAS+:W,8::ZTRZ*
MDI+$'*QZ?KNG-N6:W.U9X@N<F4*6LD/P_A3PQXID;QE\$_&31W/A_P 0V6)9
M])GD\T+?V#%HY+#4[!E4:CIC,%G57DCBFWO'*A:W^'5NU_IQD\?? SQLZQ7=
MG+EIM(O)L*+>9G+)8^(-,8/Y5PFP7L*JBJ C/$YEMOA[!]AOC+XZ^!7C9T:V
MO(2#=:7*SRHTD3NP%AX@TI_,26W22""]$?F%X7+QQ?0JT;)WY%M)KFE33W5[
MKW'*U[[.VZVR_73;TV_K\QLD%OX*C7P)X\D_X2;X3^)R;_PEXOT]5NI](>5F
M>TU/3IY=GV4J5C&K:7G"12G"YW$NEB7PM%'\,/BE+_:O@?5(S=>!O'5@7NX]
M'FO8T%IJUE<;%C.F-O4ZA91QF6S#!O)1 );=91;^ 85\.>*6D\:_!'QB!=:'
MK]HRM<:4\F&BOK!Y(XUMM5L# (K[3Y'BBN1YDPBA9OL\2/#%X,CC\ >/I5\5
M?"SQ&YG\)>,=."M+HTMVA6#6M,E8%4\D-%)J^D_:)%%N)G3.%5VKZ*:A=-1D
MI:J,7:UFDDX3Z5;/DT;B]0'3VXTWR?A)\694;1Y(S-\/?'\#/=0:2;O$MK.E
MX<_:M#N8Y(([N)%\W3IF1F3!4A)85E*?"+XN2K97UK&B^ ?'\<K26UM#<0[[
M2"6[4@7_ (?O%2**"XP[V4DJAVCQNHDBC\.);_##XH3C5/ FK[KKP+X^M$WG
M1C,I>+4=/GD9C+IK*\4&J:?YA-J^V0,%/[Y)8X=-\CX3?%B5)-"DS<> /B)!
MG&DP7 62WN()9(S+?Z!=?NUN+9I9GM-S,CJ@,JI)W7,W%I\BES7:[4JTOM)O
M6$]I1Y4US(!)8'UIU^$WQ5*Z-XRT?]SX#\=.8Q;W,(!^P:5JFHR;FN]'O_\
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M^I2C>+E=:=.]K=>G_ \P)M?AU;L7#>.O@1XV!VJ"3<Z3.!C:8_,5=*\1:85
M6+>!<QB-E9W H80_#V$:/KI_X33X'>.,R:3JL AEO-+><%H[RS+A1IVO:;*Q
M%S:$Q"ZBCDEVLS_O&,]O\.X)-<T%3XZ^"/C.06^JZ/.6^TZ1<MD/8W,C1O\
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M?ZC<QPI&"0P*D#N#@$=L<'J2 .<D"O\ +B^)4A\+_$KXC_%'X8K_ &GX,O\
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MWW;3Y9E(CI9$D^(<\?A+QB[>&?C)X4S;:'XBNYELH_$4.GY^RZ7J%PT:D:F
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MC_9+V$F232+@;Y%EM?,;_B6:WIKE#=Q*L O41TCVNAV.Q!X AC\+^*3)XO\
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M)3L)DBW!*SY))VUYHO6Z>S;2LUMK%VNM;6=P;;W=_P"MN@L3QZ#&_P 6?A;
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M-!$2F7E3(HBN%M8Y_C#\)DBACB+KX_\  -UNECLH;AF^TJUI&T3WGAJ\8R(
M3(;!DD96"12Q1+!-'H*R?%GX5Q&X\+7CBS\=^ ;XM<G2ENV(N;6\M5C476B2
MNZR:?>)$TMH^WSXV5&CB>MV]4XRO*G'6+=E>I%K>/\Z1IRP[K[_Z_IORLT31
M>!K:7QEX.C/BWX,^+62R\3>'-2_TE]'N)RK/9ZC;L0MI?6Q>.73=3*1+(ZK"
M\SY7+@MMX @?7-%#^-?@5XSE^RZMI5S(T]QHMPGEHUK<JN?[,URQ=HC9WJI
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MX])T^_)B+=5#&KDJO$J-*<)>RBH2DY.5E-0J1<4VGK*,DY):.UT)PNV[V?\
MP%Z=?P['REX!^%GQ&^._B[3/V<7\&^(O$WQ?MK>\D^&NJ^&=*O=<U#4;.PL&
MU*:UU)+&&>YN] 2RM_MJ:L"#801F28I)O23F==T+5]2UF_\ @[\9+"]\%_&3
MP3>3^'M$UK6(&T^XEN=/N)(CX?\ $:W2K,IAD'E6>H.BNKQ+&2A\QKK]W_V1
M_P!D#]JS]D__ (*$VG[,&D?&?X<^'OCSI?P>U[QQ\!OBMJ7A#6?%W@?QW\--
M9MKR#7/#VOVTJ+J6F+ -*:9M/O%-S;WFF(UCK,D7V&34OD63]BK]HK]LC]I/
M]LKP-\=O$FC6OB7]F_6?&_COXI_M1W&CS:;X5L;&VUS7+F0Q:)8V]F^HP>(V
MTG7]1\)Z):K:S6UIIMTES/:&R9T?UJE*<Y2DE1CAZ5:ZYE.7/4]G**>R:6J<
M4W?1J^HU%*-D[W6OSV^5O/>Y^9,D,_Q$E'@[QH?^$6^,?AT):Z'XAOB+"#Q%
M%:D-;:;J,GEQ+'J /[[2]34.LRNGIM=&^T?$JZ&F:JK>$_COX7?=8Z@\C6/_
M  E<VGDFWM)786Z6_B&%(HTLY=OEW;*TCS(DK.GW;\7/V'=0LO@K\$?C3XD^
M),6I?#'XC^+=0^'GA7XW7_@^[\/>*O"/B/PYJVIV%QX4^)O@JQUOQ% 3<PZ1
MJ>L^#M;T?Q;K,6KZ;$BM-9:A+'8CZ_\ C+_P1PNO OQ.^!'P?_: _:]^"_@;
MXH?%R>WTCX4^/]/T+QCJ&K>,=<CU73]+TGPY=^&XK?3;PWS7-[81V_BC4-3T
M72(+FYL+".]O]0NVLXKGC\-#EE*JY2<&Y6@VJG*[.$XK15*>CYFULE:UK3R>
M?X+R^_T/Q5 G^)EUY\(;PG\>/";EGBVKIZ>+Q9;BKI& C6OB")$1 JLRW2*^
M#*'12L;7'Q(F_P"$F\/HWA?XV>%&,^K:3$5LU\4QV3LK:A80R+%)!KBLYBO+
M)A(;B&-5*GSD<_H#\5/^"</Q]E_;&MOV*!/H>I?M/Z7IVF>(O!GQ T*2_L/!
MOQ \"RV3:E;^,=:NI+:2X\.RZ)96-_%J+2V\LD-YITUE"NHRO;"ZZGQ)_P $
MY]7^*'PY_:0^*7P:^,FA^+_C5^Q!XC'AWXY06GA&]\#:1XEGTQ=274=>\ :I
M>ZQ=R^)I--GT;6X!?:KHW@^778M+_P!!TN9I[..YKZY0Y8_O(_OG#DY7:?*V
MK2<K7@[M+9J2NM.5M'L]-^VMOEWZMH_-))IO&DP\>^!T;PW\7O#1-[XF\,Q1
M?9XM?,"C[5J6D6;\FYD*2#5=+VME7D"AFS=7*PR2>)9I/BE\,E30?B%X?,LW
MB_P7"#MOA*?)OM4T>T509K*X#M)J>G"+<I:X^5C$AD_4KXS_ /!,;Q5HW[(7
MP\_X* >!_C#X5\0W^NC2)UT[P7X6\0Z;JFI:W>W%QITMAK=IJ<BV?AWQ'I>I
MZ7JF@^)(&FGM?[;MSI49OC);W+_''Q[^#&E^!]7\ >)/AC\1[75OC=JGPT\(
M_%?QCX,L/"VH^$;S3M,\<:'9>(-(CN=+U6[GAF\3W?A_4(-4UW1+%KZRBM[J
MS>*[NC="2"H8FC5D_9RYI\[A+E4HTYM)2E-)JT91C]EO6SM+5![.]_>O9+L[
M=.^VEO)Z'S[:O/K$S?%+X.6S6'B.P=(?&_P]M@UT[Q7)$5Q>6-BO[V_T6]:1
MH[BS2V>:TD"SQQ[X@#]"7W[*/[3GA^SM?C;\.O@+\5M'MM2TYM3\7?#+4?!&
MO)J)TB<%KO4++PXUC#K.H^#;M#YZZA'I+PVB-]I!>(R"+]O_ /@@/^SE\'O'
M;_'']O3Q#X-23Q?\*X;CP;X<\-31QR>&])\66F@2>*_%_BRQLUVQMJDFG3:'
MI>D>:F-*,^J7*Q/>R6D]G^"GCOXY_$GXJ?%_Q+^V+\/O%OB2S^,<_B2[\7>.
M=*;6=0;6M.EEO=T-[H-RER+L^'K.V6.TM--LI(DT.WBAMM/M[>WMK;=E];E4
MQ%6AAE#EI<K=62YN:<HIW49-)<NJU;ZJR*4>5WOT[>AQFM>$_%'PXMM*^+?A
M/POJ^E>$_&6D/?Z[X$\16-Q9F70[C4M3T:^GM[6\MQ+?^&'U32]5LK'5XHI$
MM+RQN82[/#)&O+PO'X11_B-\-8FUOX<:ZITSQIX-OQ'/)I)D$ANM-U&,12A;
M<JS/I>J()#!))L')$TGW)^T?^TS\4_V__B5^S_\ %KP'IK:M\8-.^&?@3X!_
M$;P:Z:?''XO\13>,M>M;#65LT:.UETOQ8OB?38-1<06]O8ZT^HRJEE9)&P^L
M/#G_  2#\3V/[2_B;]GKP!\;/#/AWX]VGP_LO%GB3X/^)_!.N3?"O6[+4-+M
M=<OM!TKXC1ZT^I7=D\%Y)%I>LM\/XM/^U6>IVD6H$6\RBEB8TJ<'5:IU)J[B
MESQII22E73VA#7]ZDGRQ;=GLRWO<VS?3Y)?AW/QJ0P>![=O&G@F ^+?A#XK;
M[+XH\+7G[Z;1GD"EM.U15(>UF@F,_P#9^IQ[0X,4<CJAAEE=^Z^'MJ=:T!+C
MQM\$/&A5=5TBYV?:M(N96,;VE_Y;R#2];T]P9+&]$B)>JRK+)O02U^H/[&/_
M  3!\:_M&_&#XU_#_P"'WQ+\%?#W6_AG>:IHWQ8^#OQ&TK6=7MXY-%UJZ\.:
MYI4&K:*MU:SFPUI)TTJZE\HW%L8[J*\> M&NOX#_ ."76I>)OA=\=OB7^RM\
M?_AO^T-'\(I[^'XT?LW6>C>)+.^@BTV*^N=6TWP;XNOHX=+\9:MIATS4DT:^
ML+"RT_5IK.XMM'UG4B]@][4\90A)P<X0E&44I).5/WTN2;DK>TIS3NG:RO9N
MZ$X2;;2T>[OZ;J_=:72N?E,S6OPZMRB!_'/P+\;ODJ0CW6D2LW0;8RFG^(M*
M$OF*S) MV8AQ"#\HRP?#VW.@:RTGC/X'>.)&N--U2WPUUI$C;/*O;9HT/V'7
M+!I )[7<K74:O*C*ZD4[=!\/[636O#ROXU^!WCAQ::KI-UODN-(GDX:TN@T3
M/I^N:>"387W'VDP1QS/DQR3+^Z^'UH[EI?'/P)\=R@! X>XTN[QO)<.Q.F:_
MIOF*0T7D+=.F/F+DMNME)*2C:\H?%*FGI%Q6B]G*5[/2S<MVM8DN5VWZ]O\
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M+/8V-OJEM-/;&&\?\@_!O[./[37[26B>$O%GQI\+^/'_ &.OV</V9_&R>/\
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M90#?VDEE,PO-0TR*Y_.?X<_L[?&?X'?M_P#A;PC:_"*SA\>6/QG\+>$/B?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7\_5-)A5;-_%XM JS:E9K*L)MM7@59C>V,GFK>0A 2D:AU63S_B=,=(U(_\
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M^&+DAAH=T^!<:/J"!&\BYM%>*2PUA8E2=/*$T818J>I@^'B-KFAJ_C?X&^.
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M=JZ9$]EKUV[_ -7.$\B'P9#%\//B2R:]\-=?(O/!GC+30DZZ-)<%EMM0TN\
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M> ;=HGB2.0J+V[TW3E+K=Z)=$2"]@V1O8,=XB29D#.CF*-+\6_A IB6WB/\
MPL'P!DW"V4<V3=^781B5;SPS=[Y\SR;?LP".4CVDEL4TOBB1OB?\+XET'Q]H
M.ZZ\9^"[8,8KRV/%[JFF6Y'ES6%P@!U339I%E597C53*8A.MO,-1$OQ:^$J#
M3O$6E(9/B%X$5%EB$+\7E_8VF=E]H=YYD@NK0L9;>0(Z+'L?<)I\K3M]J+6\
M;Z-M*S3ZN+2=NFJNK2EKOTZ?UU")QHPG^*_PGMX[OPS=1"V\?^ IU-P=,>YW
MM>V]_:+%.Y\.S!F;3M0=9!:,\B,4"MD22W\)B?XC?#6$ZQ\-=?1+7QQX+O%C
MEETE)B5O+'6+8F81V;AI6TC4F)%M+MQ)$"FYL4JQ+)\7/A''&B0(T7Q$\ RD
M7*V(G#R7DPL]NZ]\/7D22O'(09+.1B86!22*T6*6+1DE^*?PHMFG\+7T)@^(
M?P_F:.X31$E)BN;.\BWNTVB7+-<'3;P*'LMT.\*%>WC$O=3:?5N,'9V5E[6D
MMY7>LZ4KM[J-TA*+>R_(2)H/ D;>-?!4<7BCX.^*B+3Q7X7N_)EET5KLL&T[
M6(5,@L9X))F72-2$A65A$PD50"J!H?A_;MKNAJWC#X%^-62WU729)([J?2II
M60/;:@L;2-INMV#.&T^],O\ I@0*[-E&95D@\(Q-\1_AM%_;GPWUS;:^.O ]
MW^_716N2B-I6J0R$%H%>20:5J2%HX L>99HBC,J&#P-!)XU\$I)XL^#7BIEL
M?$_AJ\=S+HUU<+^\TS4HC^]AO+99#_96K0H^$VQ2R[)+>6Y=K6E9Z1NG'WER
MO1[7322U5KQ6MEN#;>[O;^M_UU$4VOP]MRREO''P$\<2J2Z())])N)%)8&-(
M@FG^)=,5F6,-)"UXJ+(7!DWT%8?AW;+HOB!O^$T^!/C&22YTV_M)8KA]*E83
M-%<V4RR"'3/$5@8Q]OL%>)KPQ/)\ZMN+B;7X?6QUS0%D\:? SQIY<.KZ5.Y:
M;1YY=Y>RO$)1M.UNP4R+I^H*6AFV(LD[.0[JPMOAU Q8R^/?@1XXD1BREC=Z
M7,K^8(M[NHTWQ+I;B,_+((+MX\NT<A22!723:ORJSDFN:4=N5Q<;Q<))WTO;
M1.VJ%_7]?<,,47@2%/!7C:4>+/@YXN#WGAKQ-8$31Z/=R/B'4=.FEBB%OJ%J
M0T>L::TH1HO/=%,C/2O#'X3BA^''Q(D&M_#77 ]UX(\:6"QW$>C2R$>1J&G7
M2Y5H4DE4:WI1<BW<,C(-N(D=(/A] -#UV1O&OP,\:L+C3=8M YET:[8*HO;4
ML5EL-<TT1[;NT$0AO(0S)%YR.D2M%#X%CA\&>,[@^+/@[XKWW'A;Q9:@RMH\
MKKAM2TPC>]I>6DDR'4=,DCC2X\N9PCL98U;NG=<K?+RZVE&4='RRM>ZEM?6V
M[:'=M6O=::6_X%S[B_X)IW,_A/\ ;Z_9!^'7C^UC\0:0OQL\&:I\,?%M@5N%
M@=]06ZLO[/OQ\[Z+=7#QIJ%H9'CMI=T911LP4?\ !-.2^\#_ +?/[(7@+Q5!
M_P )7X,U3XX>#-4^&WBFW<21VERVH^=97>GSB9 EJ]S(+?5]-EPT8:18X9H"
MHG*^:S?E^L0T?\-.TK2<;V]VZ3NE>T=;VLO,UA\*^?YGQ51117^DI^0A1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?LA_P0=_Y2*^ ?^R>
M_%'_ -1IJ_&^OV0_X(._\I%? /\ V3WXH_\ J--7Q_B#_P D-Q;_ -D_FG_J
M)5/0RK_D98+_ +"*?YG]WD??\/ZU)4<??\/ZU)7^=D-GZ_HC]0"BBBK ****
M (9AD?@?;T/ZD#CO]:_RXOB<$^''Q$^()D>3QQ\#?''C[Q8ER I:YT^?^W[Y
MG0-M$>D^(=.D#JCLHCNDB!"-+(&'^H], 48D9"JS$9QD#GCWXX/!'4<U_EO_
M !,,7P]^(_Q#UO1?,\;?!/QIX]\66^NZ-, L^GRR>(;S=87I,;MIFJZ>[G[!
M>"6#[0(XXF;<8VE][(OBQ/E"FWZ)SN_EU(GLOZ_K_@LX=_LOPZMDT?5YCXY^
M"'C=UEL-2B4_:=)NY-OEW-FRONT[6[#&;BV\M8[A3YBA^89'ND7@6$>#?&4Q
M\7?!WQ>!=>&/$UC('FTEW!\C4-+D5;C[#>6CR#^T],:(K)EYK=(P\RW<8-O\
M.H!,BGQW\"O'$V&4,3<:;<2X.P2(8Y-.U[3)#((@LJQ7>X@@N<TK"V^',2Z1
MK3MXV^!GC9WN--U&!#]ITR96*B>TF4;]/UO3V\U;JU61;:X:)B K^9&/H5:2
MBG)WLU&HUS-7:D^>3UY;1M=[:)=$9_UK\O\ @W\ALJP^#HX_AU\0Y'\0?##Q
M#MU'P;XTT]5FN]*%R$EMM1TY]YCBMP&5-5T<DK$6,J-( _VA\\2^'O+^%'Q6
MG6^\+:@HN? OCVQ#SOIDMTP6RO[:ZD#B;0YFC5;K2V"26ZREB6C6&2)'CB\"
MQ+X-\9O_ ,);\&O%P2]\.>)+0&672Y9T!MM0T^>,!8+V !3J>F&14G1Y9D V
M@4CPIX0C3X:_$9_^$@^&NO[[WP=XPTY1<'1;B\B*6FK6%PA$OV>(,7U72WG>
M.&(SD1NNP ^/>*3C%)Q6JC%VTUWOT>Z\A"W$)M?)^$/Q9DBCM8QYOP_^($;>
M?%IHN%)A=[O>?MF@W@\N)X)"LUA(JJTA_=M L\(O#%\)/BPR:;K.GX3P%XY)
M::."VF+&UBN[K;)_:&AZAF-(9"2]N9-Z['0)(/$=#6/X5?%2=+WPEJ$?VOP!
MX\@)DCT5[@@QWUK<@C[7IEP&MUU"SF\Q;#@D[/+8,EACMS%\(_BQ)&+90TGP
M_P#B%&3-%I\-TX:S'V@O_IGAZ\+16\HF\R2S>1EWC8#19R=KI-12YK_%%6_=
MU6]KV]R2U6BV+LN7^]OOY_=LR2:W;Q'*GPL^)^-"\?:#(EOX(\8RF9DO4R@T
MS2=5O'W/>V%[B./2]55GE GAW N)OMC)H9?&\Z_#[XALOAOXK^& MOX7\32R
M>2->^S(/LVDZQ=ER\\\I>!],U*%XR1M*.LOVE[N2> 7S+\)?BVZZ=KNEY7P!
MXX#"2.))$5M.L;R[BDC%]H-]+Y2QW<A>>!YB7DA:,$LD@D\0G_A57Q/DCT3Q
MYH/E6_@?QO)(RQW08!+#3=3ND*I>:==D12:=J$JR/"C$221R(C$;NKIR2?*M
MN5TY2M%137O/7X9ZO5:[$ T<OQ$N/^$4\2D>%OC5X2#6VCZPY%@GBJ*QVF&Q
MU*=1D:P/(>2QOTDV7B%N98Y%$+F$WQ,N%L;N.7PO\=?"J&."X#"PA\5#28P4
MM[CY1)#XCABC8PW,<D27K)O=64CR&2P2>.95\ >/I/\ A'?BOX:5++PSXJN=
MUI'J\-KN>UTO5'C\H223(BR:7J8B,CNI;<0TD1D\N?XC77_"+^)E/AKXU^&"
M+/2=:G)M5\31V 46^EW[[D1=911'+8WL2J+Q75GW"7;3=FVTO>5G)-64DDE9
M2WYUOY_,%^7^:^\$\_XEW#:IIBOX4^./A/S6OK&%$L4\5-IS?O9X(S(HAUVW
M4![JV6-8+V,RXCV2A$9$\OQ"F/B[PD&\-_&CPNQN-;T"W0VD7B5+-'BNM3TZ
MVE8/_:!,974M-D=TO5D/[AY3_I2QBX^)5Q';SJWA?XZ^$VS;W+9L!XQ_LW++
M;R!2D5OXC@2+,4H++?;V61'#2!V(TOQ*G&I:<6\*_'3PK(6O;.-!:)XKCT[_
M (^+FWC8&.'78O*_TBT"!+Y2V5$8D83NTU[RE+FC+X:C:M[ME90E"^JLF[N]
M]"X13O?I_5O1V5^HL$[>-99/B+X V>'_ (I>'?\ 2O%GA2 ?9[75[>T'^E:Q
MI5JYQ-%+% !JFDL)&+1S[5=W9W=%-+KQD^+'PMA.B^,]"(O/'/@M&+VMR'R;
MW4M+LBOGWFE7312KJ&G&8NCE6@FCD3?"JRR?$&0^,/"I/ACXU>%I&N/$&BQ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8F-K)<ETM;*\D[)MZJ]_3;96-8JR7]?>?%5%%%?Z3'Y"%%%% !1110 4444
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MA?JI1L_>C)*]HZ:RB^JZQU7FQ2=W?\.WX?D$4R^'HY_BC\*(Q?>#K]19>-?
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M];+WM7K>S:L;)W5SXHHHHK_24_( HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1^"/'-PSL+Q-C&PTG5M0!476FWY,3:;J)R(W:-)Y"Q9F;<)/XQF_X5]\0?\
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M3=JL5[R<GHXSC)67+=..[U#^OQ\KZ>GJ*#/\2IO[2TPCPK\>/"S22WEE'&+
M^+OL"()+F$-@0^(HHT?[7;LPCO(AN$!28LJAY?B).WBOPKGPK\:_##.^N:':
M(NGCQ0UH7-SJ]A!,@8:R_P \>KV$N1<Q@F3YB2R'[1\2+DVUTS>$OCOX1F"P
M3DC3/^$M;30KQP3L"GE>(+=8HS%=.Q2[BW2%6C+BA!<?$FX>_P!-9O"7QV\*
M2$W5JH.F-XN.GB03W,<1\KRM?LXU(O(Y)5-S"N]U:$LL"3OR^\W=)MI<KA)6
M]QM:*:>VK3[A_7IM_7](6*2;QM+)\0/AXI\+_%30!YOBKPC9@6D.L11LQO=:
MTRV"HSQW(0+JVFNBCEBR%MV%@N&UN:;XL?"E/[#\::)%]L\=>!K%76UGM0_^
MFZEIMFCQFZTV[9$DU'2U52OFNT060*58CS_$69O%7A ?\(O\:/"IDGUW0K/.
MGQ^(ET]RES?6%HQ0'4@(_P#B:V#EENAE'1U5&CDAFF\93CXA_#Q'T#XK>&D^
MW>+_  K9P"V@U6&V=DN-2TG31EKB.XC0+JND'>TYG:.2,R F5-]TI.?\2G%<
MJY5KSP>]V_C5[NU[N[0#8)I;OS?BY\(8DTW5+")9/B#\/T5VAAAEEQ<36E@K
MXU#PY?2@>=;D.(9C&[2"2,*66\XT]I?BS\)(1_9TD;VWC_X>,_VB#3HYM[WD
M+611?MGANY1U,+*F+%IG4N88V!6"237W;XK?"Q4TCQGHB+/XY\#VT92&[3:X
MOM3TW3D8"]TR[",+_2F#JC2,^,QR22)#<>>DOQ9^$$<>GZC8PO\ \+"\!;4>
M&*.4,+VZM[!&1;WPW=1R!9(O+D-JLLK?(T4K579K6$HZ5([N^KC%[III*HFE
MTM?H._6_S!)(- BE^*?PQMQJG@S42MMX_P# %Z1+!I4,HB\_3=2M@NZ72FS(
MNGZ@ZCR8Y"[.BK(0Z*6/P;%/\0? ,7_"2_"KQ"PM/&?@K4&,EOID]R"HTO4X
M%Y6.WV[M+U(G*.T:@[>C8YH;!9/BY\)8(SIBKY?Q#^'USLGM=+B<A[V.?3E5
M/M/ARX<SO#,R-_9C++)F...18$AD7P]%/\4OA5%]O\%WX-CX^\$7CK=0Z0;I
ML76G:E9(D4+Z<SR2R:=?.A2Q5@PR$/E+:/54[QE*,%=4Y75G!O7DT?-%12LV
M^6^HTKNR[7U_I@)+?X?V\_BOPJ&\:?!7Q@39>(_#E\?,_LJ[)5C9ZA;REULM
M2L':&;2=4>/8SA(<!]CAR"#X=Q?VIIB'QS\"_&TS1WVFRL)9M'NF"@I<($#:
M=XCL%6!X;IMOVT1P @,87+A-%X*MY_'_ ,/(W\0_"SQ&8].\9^#]15K@:2\V
M&;3M1LV)C5T\P?V1J>S$<D20GS QC+"8? =I)XM\*HGC#X)>+GCL_$'AZ^4S
MG1IV"";3M2B>21;+5;%]DEAJ& &,D0:5TDC>0;VO:\DFE&[3B[/FB[? ]+7L
M]KH%%MM::"_Z-\/K86UTS>./@1XU9C;3$++<:/<3,%@FC1U+:=XCTLL2\3!1
M=.A?#DM1B#X?VT7AKQ/_ ,5K\%/&9:?P_KD:+)/HM[*KN-1TQH^+36+(*ZW]
MD6VW,:.R)$R2;T5X/A[ =2TY9/&WP(\;MY=[8NXN9M'G9)"T5QRQTOQ+I66D
M2[94%ZL67#8;*L+?X?PK:W9/C?X%^.'86UR2)9-'NI$):6$_,FE^(M*7>]SF
M.%KJ%)I"J8?:-):2:<$TTW?W).R?PW4H6_F^'>UU=#5G8'2+P7##X#\>SGQ-
M\)?$X%YX1\6VH%S)HKR(95U/2)/*=K:0F7R]6TT?,Q$\@<^9+A"T/A>"/X8_
M$R8ZSX#U4&]\#^.[.+[5-HL4\2?9;_3+D)E=+>18CJ>FDE[=@6(,9BV.=8/
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M"01Q*NGCQ@-+\1ZE$BJKF!;7Q%;1P!00TBW4<02.,1%%C_U'9\[<#N#^.,9
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MKFC6ZBW_ .$F^Q(%N-0TRVE93'J02-%U#3<,E\CRQ%"SJL[V6Y^)LYL+L_\
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M)&MY(B_+=7BWRWDXZQ496C[NKO>]I+=.Z)=[Z[Z?DOZ\Q-L'P[A^Q7+GQO\
M KQTPDBDC ENM*N"QD#P[0K:;X@T^6.+SCMA%_' =H,D2HB,\'P[MT\+^(6;
MQG\$/&LJZCHNL6+N;C3)9I,+>V$@1C8ZM9%BM]8M&RR"2:>*&5IYX;IL;0_#
MNW35M-1_''P)\;S^5>:?([//I=UD.;>[1A,=*UW364"WO1!"-16",I(1+%EX
M,?P[MTM;GS/'7P(\;L9K=U=R^E7,NY6EVF5IM-U_30PCEC9+9;P(),EAYC%E
M'23]S1IIV<&K63>O-![M?+80DB1>!H5\ ^-YO^$J^$_B>0W?A;Q;998://<D
MM#J^FRAW6%[8RXU/2_/*L&EEC67SIA.2QIX75/AE\3G_ +7\ :PHO/!'CBSQ
M*=)$^[[/J%A<;WSISOQJ&FO(H@9RZ;BRM1BU^']LOAGQ+,_C?X*^-29M"UVV
MP6T6XD4&34;&,)))8ZO9"8RWVFXC^U"$@;7\UI"2*W\$PIX%\=./%/PF\5JU
MSX1\6VF;B31O.\LQ:KIFU)9()HV<#5=(=X78,-L8=20-6YTXWNE&23LIQ7O)
M*6S7O-*2V=^S0?\  _K?^O(=-$FF)#\)?BO(DN@3(+GX?^/H ;E=)AN66.TG
MANU>47'AV[*1K/9JQDM"'C=1&L C)K=G%O\ ![XM2BVN;*-E^'?CQ'>:WMH[
M@ 6<<]P-B7F@WVRW$/S(UF L5QY12- R18?"L,?PQ^*$PUCP!K$<FI^!O'-J
MBWAT:.YCVP7VFSH)I#I\C",:GHH=&M&#R& )(HI9H1I")\)?BNZ2Z',!+\/O
MB#;LMU!I*W7EM:S6EU'Q<:'?EK<W%G)*WV!) 3&5;=1JN77X7'DE)>XG]FC4
M=O>5W92?NZ--ZH/Z_K86:)M;EC^%'Q8==*\4:,B0>!/'4P,D+0 *]M8:A<B4
MK?Z5J<7D"PO_ )F@\Q5WB5FBNDE@D\5R)\-/B2#X<^)7A[-GX0\8W+F./5(;
M=FFM-(U2579;J&X+L^DZDKL%9G)</)(;A9HF=5^$?Q<?[+<P*@\ _$ R"[M[
M2"215L89+Q%9[O0+Z+:!(9\::I+2':'EE;<1OJYC^$_Q6(T?Q;H_EKX(\>S.
MKQR0C#V>E7MZL8^TZ-?$E[*_:[D%FQS(R3&>64T?-!KX9)-2TG=6>JM>R>S6
MC=U>]P_J_P#7Z_YCI5N?'TJ^#/&Q?PU\8_#9,'ASQ'<$6R^(5A=&M-+U.=9X
MA]O,J1G3=6\XK)&$W%^I=()_B=<-HVK_ /%+?&_PH1%IVH3LUE_PE4NE[]EK
M=3*%6#Q#;"W46UXTS6\Z!RCB,!(HYHI?%4X^&7Q*=O#_ ,3/#[1V_A/Q=<%4
M;5T4%M.T;4[T -+;3B2)M-UB6ZDC53'"75XFP^6.Y^($_P#PA7C-O^$7^,GA
M;9:^'?$-SOL_^$D^QHR6NEZG>1E<WVU VDZNOGFX;RB"5DQ1KS+6+E=<K>D:
MEU\$EI^\C9\LWI96Z@FUMH!>;XGS>9&A\*_';PD P")_9[>,$TY\@JFQ4MO$
M,*K&S98+>QY$992@022;XD3?\)'H!_X1?XW^% UUJ6F1!K/_ (2I;#S%%QIE
MLP$<&K0+&R7EFV(;A2T:;WEQ(K+/\2ISHNL,?"_QQ\*833]2E>.S;Q8;$*8K
M&ZFQ916VM0JV^UNS(RZC&I822#BF[KCXEW(<!_"?QX\*!Y<,QTN3QD]B@97A
MV- EOXAA1#&0[F34%W[)'BW*!)62Y9Q49<ZBW:3DVG>3>JDK7[6+;BX[6EIW
M\K_?TN_S/N3_ ()F0V'Q'_;_ /V3/&&DB/PM\1=!^-G@_P#X3O0$D%C#K]C#
M??9]6UC3(5EC:)UMDVZIIIW&8B4D,L@CE*B_X)HM8?$?_@H#^R7KI,?A;XJ^
M%?C;X.;Q5ILL;Z?#XMTZRU%8]4U!(5\M[?58-/22*]L]K"\1<R1F!W9"OFLX
M<GB8WDK\B;:C:[DU=V:T>NO2_P [7#X5\_Z\_P >I\64445_I,?D(4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !7[(?\$'?^4BO@'_LGOQ1
M_P#4::OQOK]D/^"#O_*17P#_ -D]^*/_ *C35\?X@_\ )#<6_P#9/YI_ZB53
MT,J_Y&6"_P"PBG^9_=Y'W_#^M25''W_#^M25_G9#9^OZ(_4 HHHJP"BBB@"&
M;)7 ZD'O@8R-PSV)'0]NO/2O\N+XK"3Q_P#%+XA^"O&&_P ,?&+P[X]\50^%
M_$<["P7Q!'::_J BTS5[G<5:Z(B5M/U>(!Y5>(BX9 L<O^H[/]Q@ 2Q1P!]5
MQ^A(-?Y<?Q7C/C'XG?$/X;_$G/A[XAZ'XV\56W@OQA>[XH;ZVB\0:FUEINK7
MB^6MS$Z1+_9VI*WSSM&@+2!8F]W(VE+$MNRM1C\VYV7S,YNZ5FK7_K[NO78X
M4B;XDR-H&OL?"WQP\+NL>F:E-MTT>*(K'<R6=V<*(=90@-9W4$8DNXR=IC&]
M8U'VKXD7*A$E\)?'[PM+DGY-,'C!M-90$=!'%]F\0VX=%(166\52WF#(*)*E
MQX^N!X+\=,WA;XP>&A''X>\0WX^P+KT5B[_9=)U.5?(Q>[?FTG459#*<A"P5
MBKF%Q\2;A]!U_?X4^.7A9X8K"_N3_9\OBPV/,%E>2(8?*UZ-1%_9]W(6^T1H
MCJ[LS[?HI-)2;Y7&ZYXW:YN73W>5JTEHT]+I/5F8U6G^(D[:WH0?PM\=/"I\
MS4]-B":6OBL6@8W%Y:PEHO)UR(>9#=6;*8[Q8@I15!\H@DF\=R_\)MX'C;PS
M\8O# -UXC\-VB_9(O$$=FJ&;4],L@C;KN8QLNHZ2%6*1#+#Y2G9N,77Q,NC&
M3)X5^._A,D ;CI=QXQETX-'LE2/R1!XCC1 4$BAKR%8@I<. 7H9OB5</XCT'
M_BEOCAX5D:]U'2XD.G/XM^PN9)[C3[5TC*ZWY:,U]IZ*1/"0K1_/YLDJ44K<
M[:DVXSBOXFGPS27N2@M7:R=NMP_K[[;^6FGGZC8+B3Q7+_PLOX:QMH'Q+\/!
M[CQIX0@A"1:E&J-'=ZGI6FM$&NHYEC<:QI.UXX(W.Y49 URV"635F/Q5^$ZC
M2?%.CJ[>._ T<:W$+[@J7VI:;IK^>;S1[O<[7=L8Q]C8%XW1E4JZ.:7QY<?\
M)QX*0^&OC)X48W'B'P_:J87\2?9PT<VHZ19N6\V]4I*-9T\(_FPRMYL6%7<E
MO-/XMF/Q+^'!&A?$[0)&F\5>#885\W5I@?(O-5T;3/\ EXAEE6X35[!(2?,1
MR8TDB!2]%&[5XM\ST3<6DHITE]FUVYQLD[2=FV[@L4KYD^+7PBB:V>#>OQ"^
M'K%[J*TC<)_:$B:>9#+?>';P/)N<XFT[#3I):F(-&R&<:2DOQ9^$L:3>'KC9
M#\0?A[<;;^'2HI>;NVEM%64W.A76Z86MZ65K JP4A&D@@?#--JC2?%CX2)_9
MGB?24D?Q[X$MW$B/%(Y2]OK#3=IBN]$O7E/VJT\IS9,K2JL4D<;*D<P)G^+O
MPB06TEN"OQ!^'RB.:.V@N4=KUX[!%3[7X8O1 V0D?DV!(C41910D](ZQ>EXR
M6JFHKF<FGI?HXI):)<NNI_3&+(OAB&7XF?#2/^U_ &K1I9>.?!-^%N(M)>=W
M:YTV^MA%DV*L1_9&JL=T!=$!6&3;(]6@\&0R>._ JMXE^$?B0K8^*O"EYNE?
M199_,6YTO4;8@-:R6RHSZ/JK.5)6$-O! D2*7^QDE^+/PE1;C0;J)(/'_@*;
M=>#3%N&(OHI[,EUN]!NF?=9WHA)L=BLKK&<U(A7PU%)\4/AG&NL> M9C^P>.
M? MV/M1T=+I7^UV&I6S[S_9;.TCZ9J('E6WG+$9 C$TG9*"ORJ[Y)1?OTG+[
M25W[CZP:LM=.P1@V_P /XG\0^'HCXO\ @=XU<6VM:->)YDNC/,V)+*\8LITW
M5]/WEM,U'S8OMC0".=B>74"#X>1":(/XY^ OCB1E,;HLD^CW#D,$>2-6.C^(
M=):1PAWQ&]6$H")?GB=$T/@F*7QQX$C_ .$F^$?BD?9?%OA6X5;MM$291YFF
M:M&Z2+:S1>;)+I6I[4!9=GFK\N&@V_P_@/B#PZK^,O@EXT81:WI$Q21]'N6"
MEK2_#19T[7-/BE<Z?>DQ/=^6P9AA:.:-^5W4N6]X)2BE&S4TW_R[J7?/K>%H
M\N]P_K^OZ_0218/A] FEZFTOC7X$^-I6?3M255FGT2\E55>>WD5<Z=K^FAHV
MNK%)(UO$1'\I-SHKG2W\#0IX5\8.?%WP8\82/=^&/$MNRS3Z1)*P$-_IMU@K
M::C"9BNH:<Y9)DVS1Q']XLCL1?#NW,UN[^./@5XXF*RH59YM%O+@J-CL78Z3
MXETH.'BDS;_:!''(ZL0A*,+?X>P?V7J9/C;X&>-W2XT^_@82S:/+)N,,UO.!
M+_9NO:?YA6ZM,J;C9)*J%F<4N:#Y8N=FDDIJTDDVG:<I)MQEHDVVTWI;6Q_7
MY?TR%H8O",2_#SXCR-XA^&'B-&N_!7C2QV3S:*TQ)M-4TZ4,(H4#211ZOH\F
M1&//>)6 'VES)'H")\+OBC-#J7A"]1;GP!X_L42X726G<_9;S3[XIY=QI%R7
M!U"P>1TM3M<_N@I#Y((? \4?A'Q=++XO^#'C!A=>'/$=FQF?2+B56:VOM/NC
MN6TO['S5;5=-1XUF47+*LBO.0UUB\'Q1?#KX@2CQ#\+_ ! 7O?!?C2QWSIH\
MMUEEU/2KAF/R1M+MUG2P0!MDF:,+&S57-=N+44^5<\4VTN:VFM]'T;=V']=O
MZ_$)8ELO*^$_Q<F0:>B";X>_$./,T-A;W(+VC17Y0-J&@79F'G)-(5L9,H'!
M"LCKBW>\,?PF^+K?V;J]@AB\ ^/-CRFWCD(%A;SW;1J-1\/WOFI(MR<26N2A
M=)8X5B;(D6@+!\+?BA<1:AX-O$:Z\">/K,0S+I"7&YDOM.O561KC19IW7^TK
M+S7%M)&RNL4408$L LQ#\(_BXZC3PC-\/OB! Y>&P29F%C+'?;G-YX=N9&6.
M1=Q6R)Q(56+)+W:C>*ERI1=W%22<?W56W7K":][FTYK7N?U_6OX"R1'Q'L^%
M_P 4&70O'6B*(O!/C:67:E[N1&T_2M6OLK]JT^Z41C2]17]\KS>2[;PHF;-
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MXWT-96\;>!K/8ZW<4O%WJ6G:856&YTFZP?[4L4MI%@)28"-U2GPSM.TGQ?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ K]D/^"#O_*17P#_ -D]^*/_ *C35^-]?LA_P0=_Y2*^ ?\ LGOQ1_\
M4::OC_$'_DAN+?\ LG\T_P#42J>AE7_(RP7_ &$4_P S^[R/O^']:DJ./O\
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M **** "BBB@ HHHH *_9#_@@[_RD5\ _]D]^*/\ ZC35^-]?LA_P0=_Y2*^
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M+Q3_ +[A_P#L%C_Z>JGIX'^'/_'_ .VH].HHHK_1H_- HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "OV0_X(._\I%? /_9/?BC_ .HTU?C?
M7[(?\$'?^4BO@'_LGOQ1_P#4::OC_$'_ )(;BW_LG\T_]1*IZ&5?\C+!?]A%
M/\S^[R/O^']:DJ./O^']:DK_ #LAL_7]$?J 44458!1110 5_CZ_\%"?^3^?
MVV?^SLOVBO\ U;WB^O\ 8*K_ !]?^"A/_)_/[;/_ &=E^T5_ZM[Q?7U7"O\
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MV:2DET4U>26EK[)61YU16FTKI6LT]TT^KZOH[:73U>XE%%%:DA1110 4444
M%%%% !1110 4444 %%%% 'Z9?\$:O^4I/[#G_9?/"7_MU11_P1J_Y2D_L.?]
ME\\)?^W5%?"\4_[[A_\ L%C_ .GJIZ>!_AS_ ,?_ +:CTZBBBO\ 1H_- HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OV0_X(._\I%? /\
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M_P#PVXYFW$G).2#R<DG&,GKDXXSUQ3:**$DDDE9+1)"_'S>[]0HHHI@%%%%
M!1110 4444 %%%% !1110 4444 ?IE_P1J_Y2D_L.?\ 9?/"7_MU11_P1J_Y
M2D_L.?\ 9?/"7_MU17PO%/\ ON'_ .P6/_IZJ>G@?X<_\?\ [:CTZBBBO]&C
M\T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_9#_@@[_RD
M5\ _]D]^*/\ ZC35^-]?LA_P0=_Y2*^ ?^R>_%'_ -1IJ^/\0?\ DAN+?^R?
MS3_U$JGH95_R,L%_V$4_S/[O(^_X?UJ2HX^_X?UJ2O\ .R&S]?T1^H!1115@
M%%%% !7^/K_P4)_Y/Y_;9_[.R_:*_P#5O>+Z_P!@JO\ 'U_X*$_\G\_ML_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "OV0_X(._\ *17P#_V3WXH_^HTU?C?7[(?\$'?^4BO@'_LGOQ1_]1IJ^/\
M$'_DAN+?^R?S3_U$JGH95_R,L%_V$4_S/[O(^_X?UJ2HX^_X?UJ2O\[(;/U_
M1'Z@%%%%6 4444 %?X^O_!0G_D_G]MG_ +.R_:*_]6]XOK_8*K_'U_X*$_\
M)_/[;/\ V=E^T5_ZM[Q?7U7"O^\XK_KS'\Y'F9EM1]9_E$^.FZGZG^=)2MU/
MU/\ .DK[6.R]%^1Y,=EZ+\@HHHIC"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#],O^"-7_*4G]AS_LOGA+_VZHH_X(U?\I2?V'/^R^>$O_;JBOA>
M*?\ ?:'_ &"K_P!.U3T\#_#G_C_]M1Z7D^J?F:,GU3\S7^BA_P .J_\ @GI_
MT:G\,/\ P$U7_P"6E'_#JO\ X)Z?]&I_##_P$U7_ .6E?TU_Q,5PM_T(L^^[
M+O+_ *C/+\7W/FUPKB]/]KP_3_EU+^[?KY/\>Y_G7Y/JGYFC)]4_,U_HH?\
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MD_Q[G^=?D^J?F:,GU3\S7^BA_P .J_\ @GI_T:G\,/\ P$U7_P"6E'_#JO\
MX)Z?]&I_##_P$U7_ .6E'_$Q7"W_ $(L^^[+O+_J,\OQ?<%PKB]/]KP_3_EU
M+^[?KY/\>Y_G7Y/JGYFC)]4_,U_HH?\ #JO_ ()Z?]&I_##_ ,!-5_\ EI2'
M_@E;_P $\U!)_94^%X Y)-IJH _\JE'_ !,5PM_T(L^^[+O+_J,\OQ?<%PKB
M]/\ :\/T_P"74O[M^OD_Q[G^=AD^J?F:,GU3\S7^BA_PZL_X)YGI^RI\,#_V
MZ:K_ /+2C_AU7_P3T_Z-3^&'_@)JO_RTH_XF*X6_Z$6??=EWE_U&>7XON"X5
MQ>G^UX?I_P NI?W;]?)_CW/\Z_)]4_,T9/JGYFO]%#_AU7_P3T_Z-3^&'_@)
MJO\ \M*/^'5?_!/3_HU/X8?^ FJ__+2C_B8KA;_H19]]V7>7_49Y?B^X+A7%
MZ?[7A^G_ "ZE_=OU\G^/<_SK\GU3\S1D^J?F:_T4/^'5?_!/3_HU/X8?^ FJ
M_P#RTH_X=5_\$]/^C4_AA_X":K_\M*/^)BN%O^A%GWW9=Y?]1GE^+[@N%<7I
M_M>'Z?\ +J7]V_7R?X]S_.OR?5/S-&3ZI^9K_10_X=5_\$]/^C4_AA_X":K_
M /+2C_AU7_P3T_Z-3^&'_@)JO_RTH_XF*X6_Z$6??=EWE_U&>7XON"X5Q>G^
MUX?I_P NI?W;]?)_CW/\Z_)]4_,T9/JGYFO]%#_AU7_P3T_Z-3^&'_@)JO\
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M>^<=1VJ2C&/7\23_ #HK^7(JRM^EK^OF?8?AY;V^?4****8!1110 5_CZ_\
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M7^K?_P ..O\ @D__ -&3?"C_ +_^+_\ YIJ/^''7_!)__HR;X4?]_P#Q?_\
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M (Z?\*_U;_\ AQU_P2?_ .C)OA1_W_\ %_\ \TU'_#CK_@D__P!&3?"C_O\
M^+__ )IJ/]:L+_T"XC_P92\O[OK_ %L?V=5_Y_0_\%KR\O7\/,_RD/E_N_\
MCI_PH^7^[_XZ?\*_U;_^''7_  2?_P"C)OA1_P!__%__ ,TU'_#CK_@D_P#]
M&3?"C_O_ .+_ /YIJ/\ 6K"_] N(_P#!E+R_N^O];']G5?\ G]#_ ,%KR\O7
M\/,_RD/E_N_^.G_"CY?[O_CI_P *_P!6_P#X<=?\$G_^C)OA1_W_ /%__P T
MU'_#CK_@D_\ ]&3?"C_O_P"+_P#YIJ/]:L+_ - N(_\ !E+R_N^O];']G5?^
M?T/_  6O+R]?P\S_ "D/E_N_^.G_  H^7^[_ ..G_"O]6_\ X<=?\$G_ /HR
M;X4?]_\ Q?\ _--1_P ..O\ @D__ -&3?"C_ +_^+_\ YIJ/]:L+_P! N(_\
M&4O+^[Z_UL?V=5_Y_0_\%KR\O7\/,_RD/E_N_P#CI_PH^7^[_P".G_"O]6__
M (<=?\$G_P#HR;X4?]__ !?_ /--1_PXZ_X)/_\ 1DWPH_[_ /B__P"::C_6
MK"_] N(_\&4O+^[Z_P!;']G5?^?T/_!:\O+U_#S/\[__ ((VX_X>E?L-8&/^
M+^^$\\%>!]K9O3("AC_]<BBO]'WX7?\ !(K_ ()O?!7X@^%/BK\+/V3?AQX+
M^(?@;5HM=\)>*M*E\3-J6A:Q!')'!J%D+S7[JV%Q$DT@C:6WE"EMP7< 05X.
M:YE2S&O3JQI2IQA25.T^64F^9MN\;*UI::+;8ZJ&'G1BXMQDV[MKW>BZ)?TD
M?H]1117C':%%%% 'FGQH\;WWPS^#OQ8^)&F6MG?:E\/OAIX[\;Z?9:AYWV"\
MOO"GA;5=>M+6^^SRP7'V.XGL(X;GR)H9O)=_*EC?:X_G._:]_P""I_\ P5"_
M8J_85^#W[9GQA^%?[&L&J_&+QOX(\+V/P;TSPY\;)=<\)6'COP/XP\=:7>>)
M_$-S\4[:Q&LVVF>%H8-1T*PL;@6EWJ1@;4&DLKA1_3M<VT%Y;7%I=0Q7%M=0
M2VUQ;SQI-!/!/&T4T,T,@:.6*6-F22-U*.C,K J2*_E^_P"#L*%8/^"<?PFB
M0*J1_M<?#U$1$$:(D?PA^."(B(ORHBJH"HH"J.  , *6S:=K+_)_I^++@US1
M32=Y):]CZA\$?MR?\%']3^'W[ /[0VL^ ?V3O$O[/_[77C7]GWPU\2HO"'AW
MXN:)\1O@_9?';4]%TO3K^U_M;XE^(- U^SM[_5XM,751$OV:_GLFN='FM9GE
M2E^Q-_P5,_:)^/7_  5)_:C_ ."?7Q8\%_!2U\-_L]Z!X^U'3_'OP\TCQUHV
MO>(KSPIXQ\%:#IS7ECXD\;>*-.M+:ZTWQ5-+?6]NLDJ7]K&;>[^RDB3[E_X)
M;6%MJ'_!-3]AE+J"WN$@_9L^#=Y"ES;Q7,<=W9^%](NK.Z1)056XM+F&*XMI
M5Q)#/&DL;*Z*1_,;^RO\"](_:)_X.&_^"F_PQ\2^-?B/X-\(ZKX<^,<GBJ/X
M8>+K[P)K_BG1E\;?"FU;PQ>>+-%$7B32M$NKNZM+_4D\/:EI-[J:Z;%I5[>2
MZ+>ZGI][%VN6SWM>_P OZ[FED_:Z)<MU=+;WM-.]D]C^W[<N<;ESZ9&>2 .,
MYY) ^I [T!E.,,IR,C!!R/4<]*_A]_X)(?MN_'']GG]F#_@M$-2\>^,?BCHG
M[&<$6N_ S3_B#KFH>+Y_#GB#4-2^+GA&TS<ZQ<3W#Z+<ZIX:\)ZQK&EK<16;
M-8:A-:I:SW]S+)S_ .SQJ?[;W[2/_!.SX6?M*?LM> /VHOBE_P %!V_:9U?X
MC>)/VE)O'O@NT\$^*?#6C>)_$.BZS\+;A?$WQ?TI[KP3#H$.@Q'P'?> +3P_
M%=F]%B!;W#375<VUE?2[77>VG?\ #8CV>]W;9+3=M)]]-&C^Z+>@)!=01P1N
M&02,@$9R,CGZ<T;EQG<N..<C'/3G/?(QZU_)?JW[3/Q8_;9_X+J_#[]AWXP/
MXC\(?L\?!#X.V?C#QY\!M.\0:AI&A^./BO=_ C0_B3JH^(9\/:C OBVS\*>+
MO&D&C:9IMQ>WGAZ:T\*&Y@MIDUB\N;A?^"?_ .T+X[3_ (*2_P#!2_\ X)7^
M-O$_C/QS^S;H-K\7O$GP;T_7/%GB;4?$/PJL-$UO1ED\#^'?&+:NOBRP\*'1
M/%9MK!3K3SZ-J6A:5)IT]M-J.H27!S:V[OE7KIY=W;?\!*%UOJES/LEWO?6V
MKM;TN?UG>8G]X=OUZ?GD8^M*70=64?5@.I('?U!'U!':OX'?^"1O[+'[0'_!
M4W]E?]K#P9XH_;L_:2^&5Y\-OC1X!N_A[<V/C'Q)XIT5=9NM-U*XU2[\8V%U
MXATKQ!XCL(M*TNVMO#&E:;XL\.V>@ZQ<:AKUY:ZQ<RVBVOV!XA_:)^(_Q!_X
M+,>'_P!@;XO)\;_VFO@7^Q_^SKH/@N'X9>"=1TS2==^/'Q:TCX.^!=8UWXU?
M$[2]:\?^!=*\1ZH\_B;4M42WO_$]U'ISZ3876DV%Q/<:C=7IS:)VWLEKUO:W
MZWL5*FHOE4KM*[5K65DU;6SO?NK?E_7IX_\ 'W@_X7>"_%'Q$\?^(](\)>"O
M!>B:EXC\4^)==O(K#2-#T/2+26]U'4;^ZE95BAM[>%W(&Z20[8XDDE=(V^$O
M#_[;_BC]HS_@GMXP_;'_ &.OA3J/Q"\7:KX1^)NI_!'X9>*0+;4/&NK>"_%?
MB#PEI#7ME87L,[#63H3:Y%X=MKZWU6YBFAT&.[@U.82I_.Q\9_A=^V-8_P#!
M&'_@HO\ #O\ ;F^'_P 5-#\._!'XBZ-XV_8_UOXF?$+3==\7WWPPU?QU8Z=H
M7AWQ5<^$O&_B*775\#:=<".'3O&D^HV<$FN64-C'<CP[I\EAV7[)?P:\(>%/
M^#;+XA?'/PSJ'Q \/?$W4_@;\4?%W_"0Z+\4_B5IXTGQ%\./B;XZ_P"$4U+P
MSI<'BH:/X5DM @6^B\.:?ID&LJSC6([XR2,XFV[6^S?6Z:=[=N_=>?8<:<5&
M+<G)NHH[*VR=M&KK75WW5K6U/Z+?^"=GQC_:C^.?[*W@/XB?MC?!F'X#_'36
M+[Q+;Z]X#BL-4T0II.FZS<6NA:U<>&]=U'4];\,7&JZ:L4DVBZM>2W22H;Q$
MM[.\MK>+[DW+TW+GTR/8_P B#^(K^#JU_P""DG[1O[.'_!OC\$?%?A'XF^,K
MCXZ?'S]HOXH_"J+XNZ_K>I:_XL\'^#=-U'Q'K.NZAHWB#6+J\O;771!8Z=HN
MB7'FM-I5EJ&IZAI\MG>6-I/'^[OPV_X)W_&3PK^T#^P;^TQ^S;^T'=^"/A%X
M:^"OARP_:N\(^(O%/C_Q7KG[1^H:IH\FM+XKU>"_O=7\.^(_$?B*]UN2YO\
MQ!K5UI^H:&MK87FDO>+;V^G()[+R3;NKZVZ7U\[V_%$SIVNV^5.34;+>S5^K
M:[:I^EC]Z-R\_,.,YY'&.N?3'>OS _X*Y_MD_&C]@C]C[Q%^T]\&-#^%WBN^
M\#>)O">G^)/#'Q/TSQ7?6FK:/XMUVQ\,V[Z'=>%/%/ANYL-3L-3U*VNYC>)J
M-K<6"7*A+::)'E_ ;XVS:]X4\&?\%;-*_:M^.&F_M*?M4:-8?$;XJ?LXS?LP
M^(_C1XM\6_LI^$_"FD>*+_09?'>OZ!;:'\._V?/"_AN]M?"K7'A&]URV\17D
MEIXLMKR+Q-<W&GPR^>?$O]H'XL_M+?\ !K+XF^(WQK\7ZGX]\>V/Q,\.>!KK
MQ?KD\EYK^MZ1X0_: \/66ASZ[J,S/-J>J6]A-'93:C<%KJ\BMH);N2>Z,UQ*
M-W3Z.S>^JMW73T];V!0<;._,DTFVM'=)WUW6O;4_K _8*_:'\3_M8?L>?L\_
MM&>,]%T#P[XI^+_PWTGQGKFB>%Q?CP_INH7\D\<UKI(U._U._%FAAS&+J_NY
MN3NG;M^.O_!:W_@KE^UU_P $M_'GPH7P!X"_9U^)/PY^,]CXHE\-P>,M!^)=
MIXR\.WW@I?#D.M6^LZCHGQ#L=$UFVOYO$,-WIMQ8:5I<]M#'+9W5G.T(OY_T
M+_X(R?\ *+C]A[_L@WAK_P!'WE?SG_\ !W\"+C]AC:3GROCT!@/D'=\,.0(_
MG)&<@*">,8;H4W:%[Z^[KYMH=/E=7E:3T=D]NR\M]D?II^W!_P %<_VLO^"8
M'BG]GC6/VKOA1\ _C#\$_CO%J2W/B3X!?\+ \">-_!=WH47A^YUZ$Z%X_P#$
MOC;1_$9M++Q)8WFF+'JVC#6#'<V<LNDRK!+<?T"^ ?'&@_$CP5X1^('A6_AU
M3PMXY\-:#XP\,ZE"CQI?^'O$VDV>MZ->B.1BZ?:=.OK>?:X5@'&Y5.0/Y\OV
MT/\ @E)^U!_P5.\7_LW']J/XE?!/X+?L\?!6TN=2C\$_ V\\>?$;XA^+I/$M
MKX?76EO?%7C;PI\/M$T:;4-)T&TTVVN;;1-3BT03WEY]FUI_+5?C#Q]^T=J?
MQ'_X+9C]@W5_ ?Q9^(?[)?[(?P03P;\/?V7OA%JNFZ=;^,?%FB_##PK<VWBS
MQ98:[\0/A]IGB>/PMHWB*Y&BKJFOR#1[?0-+NM)TPWLVJW4[NT_)M)>MNOEY
M[^0^6,DDK<RC)RY==%MI=*_S77R/[#=R@9++CUR,4SS8_P"^OY^^/Y\?7BOY
M!_$6@_MX_#7_ ()"?\%(?#/[6'A_XQ?#G_A1OC&?Q[^Q=X^\2_%**Y^*-E\-
M=0\4VUOH'A^_\4> _'6N:S.?!5G))9Q6_B76+YWM?$[Z0DEW8Z/IYM8/^"8O
M[!/QY_;@_9,_X)Y_MF:[_P % ?VD?"?B[X8?$;QAK>I>$9-:U'Q-X5USP%X'
M^-'B.V_X1>VCF\0:5>)XD\1SZ#J4>O>*_%%QXPBOM'UV+P^-#&C:%964PFWI
M9[)OR5[/^NOD3R*S;FDKV6C:=TI+9]G\C[ ^._\ P5N_:=\0_MU_M7?L<_L>
M_##PEXAO/V0_V??&?Q7U:'5O OBSXD^//C/\2/#47@2.#X;^#?#7A_QGX(AT
MG3Y-4\?Z?97U]&VNZY>1Z9JUQHUM<7KZ5IEU^W'[)GQ4^)?QJ_9R^#OQ2^,G
MPGU;X&?%#QMX*T[6O''PHUZ*^M=5\%Z]*TT-SIUS9ZM'!J]BMP($U&VT[5X(
MM7L+2^M[/4XUO[>Z"_R$?L!?LY?"[5/^#C/]N/X<7=MXS;PS\+/#'C;QCX0$
M/Q,^)%MK<.M^'/'?P+GTM]>\46OBJ'Q-XLTY9+^Y^W:/XIU;6=)U16B35+*\
M2VM5@^MOV3?C3X@_X*>_\%C?VX?AC\?M3\1ZM^SM^R_X+\>>"?A+\$K;Q-X@
M\/>#]/U?1/B)HOP]F^(FL:3H.IZ2VL^.;V"+7K^VUK5!>S:#_:=E!I4EL=+T
MV2%)NU^[LETWTZ7Z>?RZ-I;)6Y5=M+6UNU[-NS=]KZ']9>Y?[R]<=1U)P!]2
M>/K2%T7AF SZG\?Y GZ<U_%/^PE^UU\9_C5^Q9_P6'_9*^,7Q!\=^.KO]B_P
M1\4/%/P0^*UUXM\1V/Q%T>P\-#XD6WA_3;KQKIVKP^([N3PKXA\"Z3J>@R:C
MJ-U<"SO[S1KJ;4-(LXK2# _X)9_L.?M _P#!3+]@SX7?%W6O^"A'[2OPQ\;?
M"']J7Q5%X9^R>(=:\4Z%_P ([H7_  BVMZK+=6D_B+0=<O/'%WJ6JEM(\2ZI
MXAU#3=$TZQ32+;0)(;Z]N&?->UEO^CU_X'?R%[/?FERI6ULWH[6V]?D?V[>8
MG]X?Y_\ UC\Z!(A&=ZXQG.0!CDYR>V 3GV/I7\6>A^&O%_C?_@XO^.'['X^.
M?[0/A+X#>(/ GB&]U[PCX.^,/CC2/M-O=_"+PEXZUS3=(U"75KN[\+VOB'Q(
M\T^HS^&I-,OK>PN[_3-'N]+MKE1#QG_!+KX=>,?C)^V9_P %//\ @GMXR_:(
M_:0/[+OPCU?XB^(/#G@_2?B[XFTS7Y[[PG\2;_P!H4%WXYBN'\6V^E#2=3CN
M]<TG2-5TVP\5:KHN@W7B2'4TTXPW!S:VMNW%>NGX:E.BFM)N_*I-<MFHW\W:
M_EKYG]P(92,AE(QG(((QZY]/>DWIQ\Z\D ?,.2>@'/)/8=Z_C&_X(:?&?]KK
MXR_\$Z/^"C_PG\*?M!/IGQ#^$&H2Z7^S]\4/C'XJO[BP^%]SXJ\)>(9M1N=1
M\6ZHNK3:'H&F2>&WUK3[N2VN+#PQJU]J&M?9G@,D ^+?VV?C]?\ [/?["/[%
M_P 8O@!\8/%NM_MB_#/XVIX'^./[77P2UWXR:E\%/BGK2>'O'FJZOX2U'XG_
M !!?3] ^.?B*>?0_#EYXF;2--\2^%1-8>(;$SV6E7EKI]X<VB=M+7^YVT[[^
M1*I2O:[EK%7LOM)-7U5M^[9_H&%E R2,#W_"F^8F0-P!(R 3C(XY^G(YZ<U_
M&W_P7]^)'Q.\)?%G_@DWXZ^&WQ.^(GPM\5?'EY[7XB7G@+QMXGT'2M9-AK7P
M#N]"DNO#-OJP\.W?]B3^.O$PMUNM-E^VVVI266J->VB1Q*GQHM/''["'_!PK
M^Q?\*O@Y\;/CGKO@C]I3P'\/]8^,NB?%#XI^)_B!:>-=3\;^,?B]X)UZ?4+3
M7+R338HWB\%:-KNF6UI96T&@ZZLDNB+IU@L-A"V[.W;EOZ2M:WW[:>HXTU)7
MYK.S:7+>Z6CUOIKIW\K']DX92,A@1Z@C'YT!E.,,IR,C!'(]1[5_)[^SQ\7/
M$/\ P5(_X*S_ /!1+X&?&OQ9X@C^"/[+7@SXF?"CX)_"'3M?US1/"VG>)= \
M?CX4:I\8=7T32=3TS_A(_&-O=6NJ:KIFHZR]R^AR:[IL-D+-]+L77YT_X*(?
M$O\ ;X_X)6?\$S_@'^RU\1?VH=6^(OQC^-_QW\::'>_'/P5K'BA_$WA#X!>'
M].T.]'P^T+QMXHBL/%QUN^O=7MG'B"633[C3/#QOO"^GW1MA9WB+FW?177G=
M=+>?KZV)]DY2C%2:D];6Z:.][VT2>]ONW_M,WI_>7KC[PZ\\=>O!XZ\'T-.K
M^;CX$>!_VMOAI_P48^ 'BS]FW]FS]H+X:?L&^-_@?:>!/VC=$^+GC7P1>:-_
MPGNG6'BG4/#OQBL?#\'QA^(%])XEND_X1"SU?Q%I<46IZVMQJBZK:W,MS-=5
M_2)&28XR3DE%))&"25')';Z=J:=^EOZZ;$R5GO?\UY-7?_!'T444Q!1110 4
M444 %%%% !1110 4444 %%%% !1110 5^2__  5'_P""KOPY_P"";GA/P7I;
M>$KKXN_M _&&]?3/@]\&M%OFL[K6&%U;Z:WB'Q+?PVU]<Z1X=BU:\M-*M?)L
M)]0U[593I^DQ.MKJE[IOZT5_!]_P6/BUYO\ @XE_8K;XDC/P]EU[]CL>$?[3
M42:6O@A?C#<)XAV@XB,"^,?^$M2\0LS"1M\@"M#YBD[+YI7[7ZLTIQ4II/;5
M_<?TC_&'XC_\%2_@1^S+KO[3&J+^RC\3/&G@#P9=_$SXG?LT>'?A_P#$CPU!
M!X8T337\0>+_  YX ^+]S\5?$$FK^+_#^C0:@]G>ZKX#.F>(+VREAL;&-KBT
M23!^&7_!5_0?VL/^";_QO_;4_94@\*:9\1/@9\/O&WBOQM\*?BU;:GKJ>%?$
MWP[\+77C76O"&N#PIXA\-7UU:>)-"L)_^$.\66-[#97@N8;NXTXW%AJNC6OZ
MP?$-=(;X>^-T\1?9SH#>$O$B:[]KV_93H[:)>KJ9N<C:+?[$9S/N!7RMX(P:
M_P ]W_@A,GC/_AE#_@MS+9K<#X:G]B'QJFJ,H;["?&;> _C%)X>VEOE-S_87
M_"2#$).R$#S]B2609-M./6]UYZ6U_'7T"-FKM*ZEVLFG;31Z_GJM7>Q_7[_P
M1R_;Z^)'_!1S]D27]H7XI^$? O@GQ1%\6/&W@ Z+\/HM>BT#^S/#5CX;N[*[
M*>(];U[4!?SG6YUNC]O-L1#%Y$*?,S_JWO3^\O?^(=NO?M@Y]*_S_OV'_P!E
M_1O'/_!OY^T;^TAIGQ!^+_A#XR? ?XC?%[X@?"O6O!_Q5\;^%="\)S>"M/\
MA[K.J6EIX2T'7=,\-75SXJMHKFWU76=3TV]USS5T?[/J$-KI-G:CU_QW^WI^
MW-\:?^"3/[!?[1MUX7^(WQH^''PM_:!\8^&OVY[?P=K>O>&=;^,/@;X6Z[X>
MN/ L/C7Q'X0<>([#PAXJ\.7FJ:5XZ\0QQW%A<>)[&VU/Q$/,GCM)TI66O\J?
M_#_T]!RI\S3B[:V:2\HN^CUWLMM7VNS^Z+<O]Y>H'4=3C Z]3D8]<CUI=R\?
M,O/3D<\$\?@"?H":_D,\(?\ !2/]FC0?V-/^"@?[<'[ OC_XC^'_ !7X>^"G
MP?\ "Z?LJ?%>[UG6$_9[^(>O^/=0\#V7Q&\$:=J_B;Q/X:D\'ZMJ'Q M-5>P
M\-23Z(FO>%WDUFTL1K4>BKX'\"T_;@^)/[#_ .P?^T]^Q?\ "']J#XC_ +7L
M?QIU?X@?'_XZ^)_B/X/7P+\>_AC>^)?B%IWC7P5XC?Q)\9CJ'B;1K+4]*\(:
M!H^CZKX,TB+1X]*UR\T-;*>:.>Z?-Y7TOIKI>VFFK^ZPN3?7JDMKW=MUS:+7
MHWJ?VV^8G]X<''X],?G2>;&<8=3D9'/4#&2/4#(_,5_&9^W;+\59_P#@X2_9
MD^ 7PZ^.?QJ^"G@OX^?#/PCKOCZP\%_$3Q HL=4\5Z1\7M)\7ZCX=TC4=1U;
MPOHGB2\T'0+6QTS4[/2)+30];C@\2V5D]_;EYON;QC_P1N^-/P?_ &!_VROA
M-X&_;-_:"^,/Q2UCQ/J?QR_9JU>^\1^*_#7B?P'K?A/3[R[M_ ":OIWC*^G\
M17OQ+TV.3PSXGU*1-.T6?4KC3M9M?#EC>6\TL[N];*]O/R37WW&X07+>I9S2
M:7*V];7V=K*^]]D]-D_Z3PRD9##'3KW]*-R@@%ER2 !D9)() '/)(!(QU )'
M0U_&]_P2A^-6A_M[_L8?LT?LD:WKOCN?X\>%_P!J'Q#K?QY\5P_$;XD6WCR+
MX,?"\V_Q+UKQKJNNVOB>WU<6/Q)CU+P+^SI=Z?<78M([CQ5J^HV6F17.G-=P
M[=W^U-XD_:G_ ."VO[1W[,OQ)\!?&KXS_LZ?LN_"7QGX*^&/[.?PEUO3=,A;
MQGH-W\//#NM_%KQ/8Z_\0OAU8Z]?VLGB#Q#%I>JZAKFJZGI33>';S2;&.2SE
MOD7-MMK:VO7JOE^;L+V=GN[:ZVW71I7Z^;6VI_8/N7CYEYQCD<Y.!CUR>!CO
MQ7X'?\%LO^"GO[3?_!,+0?A!\0_A5X1^!/Q$\%_%#Q-JO@R?0/B!H'CV/Q/H
MVL:-H\>M3:A!KOAWXB:1I6HZ?>P&:WCL3H-I=6,Z1%KN^25_)_%C]IK]L+_@
MJ)^PC_P2.O?A-\?[7XE_"GXU>-OVG-8^$7PC^*WB?Q9X?\1_$8?LVR>$W\7B
M*/Q?X:\2>(]1A\4Z?J=M<>%+/6=4OQJUKX;NTLK2</IMK>P>'?\ !;[]DOPI
M^S7_ ,$[?^"=.K^&O&OQ5\0:U\0K[3=<^)4?CGXD^*O'.D>)/B#K?PDTO7M7
M\<V6E^*=2U:T\,ZQ+?WNH6CP>&4TO3+O3)K6WU*SOKBPM;Q4Y:-*Z=DWTMJM
M/Q*A"TE>S3;2T33LF[W^72_W,_OUTF_EU#1M*U*1(TFO["QO)4C#&)'NK>.:
M14)8ML4N50EG; 'WB>?YF_\ @HK_ ,%A/VWOV)OV^_A)^QQX<\"_LL^,]"^/
M,7P_U;P'XRUSPM\6[75O#ND?$3XCZY\/;*S\56.F_%%;74]1T2ZT2:\O+W2%
ML;34H)H7@M+!VDMX?Z6O"G/A?PV0, Z%I&!Z?Z!;\5_#E_P<'-JZ?\%M/V '
M\/VNF7NN)X#_ &<WT>TUF]O-.TBXU-?VF?B,;"'4]0T_3M7O['3Y+H1)>7EE
MI>H75O;F26&RNG402.3LFUY?FB:23E9I--/?R\^A^OO[0_\ P65^./\ P3Y_
M;/\ A'^S+^W!\,?@]XD^&GQJTCPYK7ASXZ? 2;QOX<?PUI^N>)K[PC?7'B;X
M?>.-4\7W%TOAW5["2;5(])\3-(^C7-GJ-IYUW*VDI_15%()$W93(.#M.0#@=
M_0YR,X)!!(!.*_G2^/G_  1X^-7[?_[;/PJ_:C_;C^(WPD\.?##X+:-X=T7P
MC\!/@)_PG'B9O$%IH?B34/%LMGXN^(7C?1O!<P@UK7+X'6KW2/"$,UUH]I::
M-9V^ESQ+K=?FK\'_ -IOXF?\%"_VY?\ @J%H/COX?_'[XVVOPR\*?$'X3_LI
M?#;X6>(-'\.Z1\"9K+Q)XK\':#\3[FTUGXE?#NRTKQS/J&@Z%?7?C"Q.NZY8
M:G=7T4"P644%L"[6^NJ2[^;=K_E<'%2VLK+6U[7TV_$_M:#*1D,I!S@@@@XZ
M]#V[TTRQ@$EU 7.23@# R<GH,#DY[<]*_BZ_;Q\0_MW> /\ @@W\/O%O[7$G
MQ/\ A'^V%\'OC]X>\ 0^-+3XCR67C;Q'X$U6XU"'3M:U_6OAYXMN]/UJ?5]"
MGM=(U)]8N+J_N;_P^=6G1=0N'U"Z^W?V*?\ @F1\3?CGHW[!7[<7CC]NG]HO
M6H]9_9;\*Z=\7OA#J'B#78]!\::!XF^'DNC:9X9\,ZYH'BK0+KP5I=MHNL6?
M_"0:@UEKWB;7O$VF3^,X];LO$>K7%S;G-=V2>R?:U[?DG]^GF"A&UY3MZ+FO
MOLT_+K8X4_\ !:G]M3XY^+_VX/$/[&G[.WAKXM>!_P!C[XK?#WX;^%/A1H?@
M'QW\1OBG\;M-\2>/?$?A/Q'XUN]4\+^+]+D\*:+;:7X4U'6M'&B>"O%%QIW]
MIZ2FLVEQ:P:I>VW]0?A+6-0UWPKX9UO6=$N?"^LZSX>T;5=5\,7]Q;7-_P"'
M=2U#3K:[O]"O;BTDDM9[O2+J:73[F:VDD@DFMW>)VC96/\4?_!M+\+? -U\?
M/^"@?Q&UJ+Q.=1^!WCO0KWPC]@\:>-K.SBM;R_\ B[8ZBFN:!INO6^D>-[A]
M.M%CMCXNT_7&MKMGO;3[-=RR3GO/^"=?Q"\;_P#!4_X+?\%7_P!K#]H[QCXS
MO?&GA'0]9T[]G+3]&\9^*/#^D?LW6^G> ?'?C?1+GX8Z=H6LZ?9Z1K%A?VOA
M59]<:.;4M5?0[I-4NKV'6=7BNE&3:3ZRO9=/R;6FFEU\W<JI!<SBO=Y.6[23
M>ME;=)]VV^^_7^T+<O\ >'3/4=!C)^G(_,4A=!P6 Z_IP?R/7TK^%^U_;E^.
M7[6O_!N]\=OB]\1_'_CJ/]H/]E7XT>"_AYX=^,?A[Q=XC\*^+?$.E:EXG^&L
M-CK&N:OX<U/2WUO5Y_#7C?5_#.LG4UNHKZ.PT_6;J.76;F:\/WM_P3B_X)Y?
M&?\ ::^$_P#P31_;S\1_M[?M%Q:WX4\,0ZQ\0?AAK6L:EXB\&>-O!>E^*-5T
M_3?!&B[?$.DOX?M]=T>PN;#Q]JVMP^,=0\43ZK=ZM$^E2PV=O"^:[22W2?WO
M]-R53LO>E9+1.S=]$]KWV>^J\S^JGS$_O#U_#&<_D0?I1YD?]]>H') Y(R!S
MW(Y ZXK^);_@G)\+->_:G_X*<?\ !63]DSXC_'O]I*R_9^^&'C+XU:'X8\!>
M%OCC\0=*%MHOA;X^Z]X.\):,GB"XUN_\16FD:#I1A=K&PU.T36KBQT^/77U'
M3;=]/G^?/^"95I\4/VN/^"8G_!273_C/^T=^T1JGAW]C[PCXW\<_!7P]HOQ6
M\2:!;Z?XJC^&GC?Q;;WGB35K&Y7Q%XJT:PU'P1I_]E^#]9UBX\(V#:IK]['H
MC:EJ$-Y9I2OT[VUWMKV*=)6TG=IQNG&UN:UM;O77T\S^^[(]1Z=1U]*,@9R0
M,=>>GUK^.[]ASXN_MH?M,_\ !OEX^O?"'[4^A_"_XO>"/BSXD\ V7QY^-/Q"
MOO"*Z#\(?#=]X0UC5-*OOBI);ZCJ>BZJNF>([[0]$UV;=?PZ<MMHME>6LGV*
M6'Y7_:E_:E3]GSXZ?\$F_B=^QEXO\<^'KGQX/"7P_P#C[XX\,1?%W0OV=/VG
M-9T[Q!\.-!\<7WA32_BE-IM_\3/#<FL:QXJA/CJ7PZ(=2M[_ $JYT_Q#?:K8
M/+I[YK).VC2;UVO;YNUQ*DY-Q3L[VVNOFV[)V]?P/[N"Z#JRCC/+ <>O)Z<C
MGIS1O0G:'7<.HW#(_#.:_CA_X*>ZC\0]%_X+X?L2_!_X>?&;XR?"GPA\=M&^
M%,GC^T^'WQ'\3:1;W&H^(?%OCOPGJFMZ7H]S?WWAW2]9?P_I5G:VUU;Z-Y-O
M>P6^J?99+R(O([]D+Q%XU_9(_P"#ASXZ?LA^!?BK\6M>_9VU_P"&6O>(=7\$
M?$7X@^*OB.$U&V^$.@?%2+6;>[\4ZEJ5\^O66NKJ$%IJK3-J#:5JM]ILTTL$
MQ%#E9[:74;^;M;\]2%2O%-3;;CSVY=TN6^M[^2TNWY7;_L=W+Q\PYZ<CG@'C
M\"#]"/6C<O\ >7OW';K^7?TK^-K]@+6?BI_P6PTC_@J7X]^)'Q'UK0?B-83Z
M3\./V2-/D\7>+M*\#_LS+K=MXXO_  YXB\-Z!X5U*Q2WUV+4]"\/_P#"0>,T
MTV_\1:B-/O"LTBW5U829'[>'QY_:Z_9Q^(G_  21_P""8_QP^,7CCXOZGXPO
M/ASK?[4_BOX1:W?Z/XR_:,TG6_C?<^"O"?PEL/%NMZOX,UG4(KG0=%N/#NI:
MAK6L>%Y?%6I:AIVL^(;N&42"(YM+VTZ??;7337;=VZ="O9OF44]=WZ6O=.]F
MONUZ=3^SS(]1W[CMU_+O2U^"/[ ?A3]LOX8_\%!?VG-(NO@;\8_A3_P3J^(W
M@?1_%7P8\/?%/Q1X(U@?#7XL:5:>"+;7M&\-Z!HOQ)\>WWA70?%5S=>.;H:5
MIUTVAR26&C7306$B+$G[VCH._ Y]>/J?YGZTUZ6_K\ON(:MUO_7SL+1113$%
M%%% !1110 4444 %%%% "$9!'J"/\]?Y5^*/_!8__@G'^T3_ ,%-OAAX+^!'
M@7XC?!GX6_#3PIX_TCXHW.M^++#QMKOC/5O%.D>&O%GA>UTV.STBWM]'TW0H
M++Q;?W#R?:[Z\OKE;;<EG';NMU^U]%)JZLQQ;BTUNNY\0_L"_ CXW_LS_LQ?
M"_\ 9[^,NO\ PS\67OP;\%^'?A]X6\6?#K_A)K:#Q#H'AVREL+*[U_2/$>G0
M'2M5BLX[&WD&GWFHVMZT<]U(MN\@A/YJ_LO?\$J?VH_V?O\ @I?^T5_P4'U/
MXH_ 3Q)#^T+IGQ*TW4_AM8V'Q L9?#D/BS4]!\0Z MCK\]A-'>M9:MX4T2SU
MF:?3H!<Z9<ZG-:01W*VL(_H(HHLM/+;^O/J5SOWMO?W_ ,U][/YR_P#@G]_P
M1/\ B3^S3>_MW^%_V@OB1\)_BO\ ";]O+PYJ6E>/=(\$Z=XPT+Q)X9N[R]\;
M7$2:)<:W;W&GSVBQ?$'6F2\G*7]E?Z5HMY;K)NN8DJ?L*?\ !+7_ (*2?L%V
MOC;]F[X6?MD_ UOV0O%OC75?%&G^*=8^%OB;6OVA/!46MVMI:ZT?A_IL^KV/
MP_T/Q+K%CIUE%+J'B.\\;^&M*U:,^);#PI///?Z3??T?TFU<EMHW'JV!DXZ9
M/7BA)*V^FWZ_?_PUM =23>MONOJK:ZWUT7EY'XN?%W_@EYXAT#]O[X6_\%)/
MV9/%'A^;XP^&?!8^'/Q>^&OQ;U77[+PU\:/#:>!;CX?V?B*3XC:)H_BW7_"_
MCVTT%=)CN]0NO!WBO3=<GT+3;RZM+:=+]-6I?LC?\$N/&G[/?Q7_ &S/VS?%
M'C#X?>,_VS/VMI?' L8;>W\26GP9^%'A_P 3ZS'KMGX(TN^DMSXP\3Z>-0L/
M#_\ ;GB6?3M'O;^S\/V-EI^CZ>9+^]O_ -L"JGJH.1@Y .1Z<]N3^=+@#H *
M+*]^JN_F[:_@+G:5NZ2=^J6J7I^-M+VT/PC_ ."-7_!+3X]_\$PXOC;X5\<?
M%'X1_%+P1\8]<T?Q<][X5TWQAHGBC0/$.AVEYIUO:I:ZO;2Z3J.D7EE?.9I'
MN;:]M+BV1HQ=QW#);\;^VM_P2%^.?BC]O+P/_P %*OV$/C=X ^$O[16F6^G:
M=\0/"WQ;T/6]7^'WCF/3O#C>"_[0DNM CO-4B&K>#%M?#>OZ$;...Z@L;74=
M+UK1]0$SS_T'4A /4 XZ9&<465DNVJ]1N<G)R>[5GV:LE;[DC\L/C!^P_P#'
MS]J#]B3]HOX"?M)_M!^']8^+W[17A+3=-?6/A[X,O_#OP4^$^I>'9[/6O#>C
M^!O!VLZWK7BG4=!EUZQ2;QCK_B7Q'=^)?$L%Q(+5-$M+'1])T_X:^!?_  2K
M_;D^'_\ P35^(_[!/B[]HKX#:I:Z]X%\6_";X=6FA>%/&%MX/\,^%/'GBZ?Q
M?XL\:^+]:NH7\4>,?'D,EU=Z'X.T[1[#PCX<T/2KS4)]:D\27\MH=._HUP,8
MQQTQVQZ48'H*+)N_E9Z[KS_K] 4Y)):64E-*RW5O\E^)_-=X3_X()ZIXB_X)
M;2?\$[OCQ\6/!5SX@\#_ !5UKXM?!7XS_#O0==E/A[Q#JPOI6'BCPOK\M@^H
M64RZSKFB:E8:?JT*7>EWEE?0W%IJ>F0,WV/^P9^S)_P4P^"7@'X:?!3]I+]I
MOX#^(_A+\%+?1=$\.:M\+/A_XIO/C-\0?"/A>(6WA[P?XR\9>,KZQ\):!H%G
M80:?I>HW>B^ ]1\6ZOHMM'8)XETG4C=:]=?L52;5_NK^0H22^Y+[MK_UY; Y
MREH[;M[=7O\ EUO;H?RB_L\?\$*/VU?@1HG[?OP9TG]KCX,'X*_MH^&?%&@:
MUXLU+X;>*/%?QIU.6XLO&UIX:?4)]3U;2_#_ (6.K#QE>V_Q"O(Y/'5Y>V4M
MXWAG^R=8DT_Q!8=5X1_X(G?M@VO_  29UG_@FOJ_QQ_9U@D\0?%E?&LOC"R\
M._$BZM]'\,V_BBW\<36*7CRV<FNZWJ_B6ULXPXT+0;'0-#AGM&?Q#J%[]LL/
MZD-J_P!T?D*  ,X &>N!C/UHY5^#6_1[_P!;C=23WMJ[[=4K?HCXP_X)\_L[
M?$']DS]D3X*_LX_$GQ#X0\5^(/@]X67P5#XD\$QZS!H^MZ-I]W/+I-_+::[;
MP7MIJ;V]QY6H0(9;7S8A+;R[93''^4G_  65_P""/W[2G_!4SQ]\,+KP]\8O
M@C\*?AU\'++Q+!X3M=9T3QUKOC#6KWQG'X=DUZ^\036*6^D6D4%SH44.EV.G
M"9EMT\^XO6FNFBM?Z*Z*+:6Z:+[K?Y$*5I<Z2O\ .V]^_<\G^#>D_%/2/AOX
M8TGXQW'@.Y^(&EZ;#IVMWGPW&O)X3OFM(DMX;W38/$L2ZM8F[2-9[BRG:Z2V
ME)BBNKB-0[?B5^VK_P $A_CAXG_;R\#_ /!2?]A'XV?#_P"$G[1&D0:?8^._
M"/Q9\/ZWJGP\\;PV?AZ?PA/J$EYX<2[U*!=9\)&W\.>(]".FA;Z.VMM<TW7M
M#U6V4S_T&TA /4 _4#MT_*BR:2>MO/7U&IM-R5KN]]--=;6/R%_:'_8L_;&_
M:8_8@^./P&^(WQ]^$^M_&S]HNST'0?%&KVGA'Q3X7^!?PF\):9<V]]<Z-\*_
M!T5_XD\8ZKJD]W:E]3\1>-?$L^H:[=7TER\>C:=I6BZ!:^F_\$K?V.?C!^P;
M^R9X0_9:^*/B_P"'/C^U^&U]XGD\'^,? L/B;3KK4K#Q=XN\0^,M0A\1:5X@
MM/*M;O3M0UZ2TL;C3+R6"YLT3S[6WEC9KG]+0 .@ ^@Q2T6L[Z[6WZ7O^8W-
MN+CI9N^UK622M;LE;[[ZZG\^/[-W_!*O]JWX%?\ !4#XU_\ !1&_^)_[/NOV
M/Q_B\4^'_&7PPL['XAV=SX<\*>*M<\'ZJTWAOQ'/ILL6H>(='7P7I@A.HZ99
M6&I-)=0R?V>DD4T'K>G?\$T?B%^S-^WU\9_V[?V.=6^&FJ2_M)^#-=T#XO\
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M6C#5=;.D>&;*W^'FBV5B9=6OM3U.6YU'4;E=.2>+38.Z_:F_X)6_M0?M$?\
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@  ] !QTH  Z #Z "EID/7_@!1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ny20053122x2-flywheel.jpg
<TEXT>
begin 644 ny20053122x2-flywheel.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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M'</$J2DL'MFF$,A&5+H2#UJ]I>O^(_#$-GJ&A>);O3)+B20F'2K^YMIXA$0
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M&S2WE%W5]-;V7GUZ/1O%HT6_M+M=$\.7]O:R^8UGJ<%Q>6URN#E)(7F";6&
MK*BRIG<K@@9RG&GZUJ,I5;;1I;V]>0"$NVEVXN':39%'M,D,,;2+&B[Y3MC
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MU(5J-6*E"I!IQ:[76S5]4]4]&D+1117,;!1110 4444 %%%% !1110 4444
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M4^+'P[TG0M>\<_#ZRU."7Q3X6T?Q-"EQH&HZUI:N9K*TU:"2.>QFD&)X989
MH65"WXR_L\?&#]LO]G#_ (*8:=^P5^TO^T5#^U)X&^-O[.&N_'#X7?$?5/AS
MX2\ ^-/!OB7PIKU]IFM^'[^S\)6=GI=]H]Y!9:I>0+<_:WB==+CM7L4^V0W/
MY\? W]FC]LW7?^"S'[?'@_PO^W_XJ\'>/?#7PN^!GB'QG\4H/@=\*-6OO'?A
M'6].T6^\-^![CPWJ%HV@Z,OA/39H-,MM<TV!+[4DM#<W8WRR*R6#:C5E4JQA
M;#QQ%+1M3C*7(M;:>\FG?9^5Q/1I/JM-_+7;HK_I<_KUW+C.X8]<C'KU^G-
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M\)!:Q^&]7MX],T5?'^AR/H]_?Z1#83:7=L^I:/#9!XK1>&_X(J:3\9OV?/\
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MES)',A!-NR31QVQ&0O[N*#8@P0[.DFQU !8 C H%+EP5VKL PVQXPF.>JJ0
M!WW-D@X+5C4KT<'S8?#47.4HISK32O-RL[\S^':]KN[=U>QT1I3Q$55Q$XJ,
ME:%*%UR17+[LDGKKY;=[W+#7;*^=R0'@;I";B<\'A0%"1 9R(XEB5.-IQDU7
M))Q'Y;3S.$DD:3!/R/N5&&3\J@*[!I-@R %P#DBMT3+N!(5!*K%(GE;SPH+I
M+M..2ZKT]>M,=9WR-K*FXNR(J ,2#\S="W  )).0,]LUP>TJR2G)ZRWA;F:U
M2LDM-5K=]/6YT4XT[QA:/)!-WDTE;3H]NFFE]-4]"W=N!/-N=E(\L"&%@%X0
M##LP7ICC ;DGH,8HARHVHIC#$C:@9W;GG<S.&P..AVKW'>M@Z1?7<UW,D&VW
M@02S7$K>4B1J%!*DJ3+C/"0K([=AFJ3/:VQ\N!#<O\V99E>.(E\9VPA3)(A.
M,"78#_%&0,B\3AZOMYSK-TJ4G\4FXSE%-*T'NM7J]MNX4ZD'3I1C#VC4>5\J
M;2=[IOM?7M=[7:L1I#+M+0J&Y/FW#$)#%QC E;=&6!X9RRL>0N[.:0+;PD$D
MWLN5) WI;(X .=QVSRY()8A$4D<,>E12S22D&9LD#Y8RJA$ ^]L15 4#G(5<
M\Y.6YJ58%AVS7._:?FCMEXDE# X+<[H;?!(,C$/( 1%P5>L8R5XQIP?)%R3K
M5K.,=%:2B_SUYGHNA:6JO+ED]H15[VMOY/R]29C)=0J\SQP6J2R A4 C):.)
MO+C@55::4D?+D,,C+L%#,*\DX9/)C4Q0!@[(&W/*RJ</.P4!G'W556:.,$A,
M*22DDS3)N<8\N7]VB#;'$@3[B#G:N,'DY8X=B6Q3[5%8O<2\0P RG.1YCJ1Y
M<2$$[FDDVC;A1LW-DA2*IR4Y1I4G*49<OM*UK65XJ7:U.W731WZZ#@TI3=HO
M>,4UKHGVO>W2V_>Z'21LD:6\@VJI$USGC,KA?+C7N)(X\*RC'EL2),$$B"0!
MQ@91%)"(<%1SU8# 9L\@Y(!X7C@DC-(S.7ZL^$& /F<DG&2223NSDYSQ@8%-
M#D<8'''.>WXC]*QQ-9.I/D:A3@W3C9Z249)1<7O=VOW=VWV*IP_=IM/FFTVK
M:+F2?W)WUV7IM=B5;V6(F18IXR@GD<,^ZWRJM.2/F:2,?ZP<LT8+$EQ\P]MY
M=S+:P3I=*)@EK<1'87<_)'+&&P^'Y1E! _A89SB;3=+U34[F%=.LY9YRW[GR
MD8D2(#("A^9B0 6.T'(!'I77ZMI_A6PL]'.EZCJ$^MS6UQ)X@@FM/LL&F:A#
M.J&VTJ:7;YD9+@O(ZEHR,1$90CV\%E]?&X-XRI1=*A2J./UFH_9K%RC*$94L
M/LJU6GS1<XI7BK-LXJ^,6&K.C[2,Y.,7[&"<Y4DTO>JVNJ<6EI)VZZ[6Y"[L
M'L+AK?4XC%>H%_T,_*&9AD&X*-MC+#D(IW$G]X4X)S99)9'#RMA@!A-JJL63
MM"(FT*% 4!0%R23DDDFK5QY!F=KJ*\EN"=TC2RQ9R3PS;X6;:> #D\8.3TIH
MGM=H62V9E&461IRSH#PP(&T,I P O*_PD$8KSL1&-Y474I0@I6LW^\ER-/W[
M1NI)I]4O+<WI.2?M)1<G*SW344[646M&FM=&UJT]="HIZX ;UXSC_"I&P8HF
M'."R$\\X;<G/?Y2.A_G4S21Q''V* J0"C/)=2 C!)*D3H.!R1M&.,D]E6Y81
MR8@M%SM<#[.DK?*RJ0'G\Y^A)R6Y(R>*YH4:2?)*JTY.-HI2M=2B[7MUWZ=+
MWV-G4=N?DUW]Z=XZV7P:+\^^MB!G9)7<9!$C/VZB27CWX/ R?QI/NLDL2@*^
MXJ#']T[@'C.X'=R1U^]G /!!MM>3[V $$0W,<);VZ\^9(<$>7G."#STXXYI%
MO;DX7[0\>X[@R$1[9%/R'Y N QP#C'0'(Q5Q6'YY)5JB?,TM)+71ZOFZ_F[L
M.:M[MH4[^:3[6\K;:/;9BQ/=NI6W$[$ YMV!E0XP"(HV1E4*2 T>T$8PN1DU
M/&DC$F;3\JJ-ET6>V?YE*8'E812=QZQE >V#5"2YNY0%GN+EV5CGS)G;# D=
M&)YS^/7U-/4B2.9V)67,:!N2)"2Q(;/W6!4#(P/7MC:E6I-M2E6FXKX;0<7;
MET7-%RN]KWVV29E4A-W<HP4K;QT<5H]$M/NT[[$ZV2G&Y9[8@X+3B*2$Y)'S
M2!X2G0Y/ER,1R%)-=/:>$M3N_#6I^)([S26M=!GM[.>V_M*);^XBN'VP?9;;
M&Z=K<B7S A,@C9!G*2HO(^2(=T]RAQGY(0S+-,!N&0P)$<../-*C)(5&.>+4
M]SLDBBD PJXN(D4*G[\8DB15'[MH(2$7!)$HD.6)S7;AW@E&L\1AJM-5J/LJ
M:A5Y'"JYQY*NB?NIOFM;5W5^AA7^L2M&C5@HQ<9OG@Y-PBXWBK6M=*5G=)-W
MMLB,2R0O*ARL;866*0%XSD#Y9HV"A6'.)QB3C<I P &V27+V@\MQPUD[M)(%
M(/[RV?:!-&>NTMYZ[U8I(,M3&N)XF,#NMS&B_NQ* 0T3J61D<#S8TD0APJN%
M!. .*>BV\H!A#PX :1)2TRQ,N,,DRJ98D.,!W$C9^7<.HPBZ-?FI7]I%-WC.
M/+*$HVMRU'=2V3:5N9633-)\]*T[<BERV<?>BW:-WR7NM7IVZ/=K2UUO"S0Z
M$/#:ZJMR-)A3Q"-32%4_M@@&9M/:%]WV3:FP&4JVXA,;@2_M7P2_:'\1_"J]
MATV_,^N>#;B1!=:5(X>YT]=V7NM'DDR(I0.6M),6UR,K^[<[Z\8:*UN+:X,P
M9[\M&UOJ,<FVR;!P\=Z%#(DK#@3?(./W@W9:N>DCDB?8RLLB!=RLN" I #$G
M*D$L!N!93E0#D@5O1QF:9#CL/F67U)4)>[;V3E&C))13I8NG%\M2$OB<9J4;
MZI)JZQGA\'F6%J8'&1]K%.4I7M[22DT_W#E?DE%VM)=VK[G](/[-_P"T-XC^
M'?B'PS\;/@-XVFTO5+-E>SU#39-Z7%NQC^UZ#KNERJ(KJT=RUM?:9?QNA<;H
M\,L$R_VG?L#_ /!0SP+^V)X/_L^Z%GX3^,7AK3K>3QAX+N)@L=]$@$4WB3PL
MS2&>]T.:?BXA:,W>C3210WBM!/9W=S_EJ?!?XU>)?@WK\=_I[F^T&[8)KF@2
ML?LU_;XCB,UOA&%KJ,,8!@O(BDJ!3&=T3.C?T6_L+0:A^T?\6OAGI_P<\::G
MX?F\83WVG:OKNC74ECJ_AGPTNDW,GC!+A8D,R:A;Z*-0M?LDRQVT]Q/:D231
M/&Q_0<XPO"_BMD-;%8JM1R;B/*,)/$5,9:,IPH8:'M*[K4HM3Q. :BY*'-ST
M)-.#M)JK\.GFW!N.A&'M,;E>+KPIPP]FN:M7E"-&A2E)\M/$7E9R:4)1NVM'
M;^Q#QY_P4)\,0^+=;^'/P#^&OC3]H_QSX=GDLO$$O@<6&G> /#-_$R)+8Z_\
M0-7N(=$COH'?$MGI?]IS(RR0S>1.C1CDD_;*_:UT/&I>+_V+)K[08V#7D/@#
MXK^&_$'BBVMADRR0Z+?6^F0ZA/&H9Q:6]\))5&(G)P3SGCOQ;\$/V"/V9]9\
M9:E97'A[X6_"C0H9Y[31[!M5UW6-2O+VWT^QMK:&/;<ZIXC\2:WJ%K9I-+(D
M<MW>9N9H+<LZ>*_"W]NOQ3K?Q>^%WP:^/O[+7Q-_9KUOXZZ=XEU+X*ZOXN\3
M^ _&FC>,)?"FDCQ!J_AW5)O!FMZC=^$O%5KH7_$U&D:]:QR31+)"CQ3HHD_&
M(X3AW#Q=##</TL=AX7C/&YEC<?''XCE2YJL88+%X7"X:Z;FJ%.C7=.ZC.M7L
MV_IE5SBO%U:F8RPM25W"CA\-AY4:*=K0G[9NI6E'K)M*6MDEHOTN_9]_:S^%
M/[2%GJ@\#7]YIWB?PW,EKXP^'_BRS;P_X[\)7;DJ(-:T"ZE,T<9D#0QWMI)=
MV$TD<B1W32*R#Z;1]_H01D$ X(.,$'.",'M^G2OQN_:H\"ZIX+DT[]K3X40?
MV=\6/@F&U[7(K,QPQ?$/X:6)BN?&7@W7$CC\N\$FBQ74VD7.S[19748,#KN7
M9^KGPW\8Z3\0_ WA#QUH4R3Z/XO\-Z-XCTV5'#J]EK.G6VH09()'F*DX5^!@
M@C:I! ^6XCR3#8.E@\URJ=5Y;C9U*%3#5YJI7R['4(TY5<-5JQ48UJ56G4A6
MPM5QC*</:4YQYZ4I2]7)\SK8F5; XWD>-PT*=1UJ<?9T\51J*RK0IMR=-J:<
M9PYGRMI[227<T445\N>Z%%%% ",=JLQZ*"> 2>!G@ $GZ $^@)K\T#_P5@_9
M,B_;NO/^">%]K7B[2_CY:7ECI$=SJ/A9[?P#?^(]0\&6OCZV\,67BHZ@SG6I
MO#%W#>01W&EV]E=7#'3[6^FO (C^E[<JP]C_ "K^)#]KCX(>)_B%^V1_P6I^
M-7PQMW;XT_L:?%7]A_\ :H^&-U;(IN_M'PX^$FGS^+]+5P?.-I?^#9]7OIK5
M"R7MUHMC$P,@BQU8*C2KSK^UE/EIP3CRVO[2=2%**=_L\T]>V^NX.]M%>UM]
M-+I/\S^V2^U"QTVRO-0OKNVM+*PM;B]O+JYFCAM[6UM8FFN+BXFD98XH8(D:
M261V5(T4LQ &:_.W]B/_ (*D?LO_ /!0'QG\8/!/[/=YXVO[_P""\FE/X@O_
M !1X3?P]I6MZ9K5U?V>FZWX6G;4KV?4=+O)M/E>"2]MM,N'MI(+A;8I*-OQO
M^WQ^VXWQ6_X)G?"*;]GR[2?XL_\ !2BP^'GP$^#&FP/')>:=JOQNMK31?B!<
MRL)%^S?\(+HM[X@L=0OBPBTO4A:2.Z,$KPW_ ()4_!WPA^S;_P %3/\ @IK\
M$?!D(LO!_P )/@E^Q/X-TUG"AYK7P]\!/ MM<:E=NJ*)+W49X;C4K^;:OG75
MS-+L3=L72&%A]5Q=6HYJM!/V4$[6]G4A"<I;W3<N5+36_702;YE=::M]=K;:
M6ZM:G]*P<$D97 Z<C\>_8]?3O1O3^\O?^(=LY[]L'/I@YZ&OYT?V?_&__!0C
M_@J9:?%[]H'X0?M@-^QI^SMH/Q5\:?##X >"_!GP@\!>._$?C&S^'VH+I]U\
M0OB%KOC"VO;R*UUK53-8_P#"/Z/>V]LBV5P/LT4*6UU>=[^S/^WA^T?XT_9"
M_P""C_@_XU:EX?M?VOO^">EE\7?!>O\ Q"\)Z196GA_QEJ.@^"O%>L_#WXD6
M?AZZADTZWFU2;PW=7MU8?V;!I%RL$$\6FVT-S)908/"5;RBI1E.$J<:B37[O
MVDHQA?36\FD[:)E6OMY+9Z7MOIY[JZ/WQ#H20'4D=0&!(^HSD?C1O3GYEXZ_
M,./KS[&OYV?^"?WCG_@H=\3_ ($?##_@HS^U=^U5I^A?!C3_ (0:OXYU/]F_
MPG\,?!DT7C[P!X;\#ZL(_'GBOQO!!I][IOC7QAK%BWC==,T18M)T>QFL=&\N
MS\VYMK+Y:^'/[;?Q\_:=^">M?M57'_!7?]G;]E7X@>)(O%/BKX/_ +(OV?\
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M]F3_ (*-_%S]K;XZ^+=&^$'[)>L7O[)G@;XN^./@GXA_:=UOXF^%-)NV\7>
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ML$DSW,T:V]DT5Q"EQ+9P\!X)^)?_  4!_P""C7[27[7'_#/?[5%G^R!^S?\
MLH_&'7OV?O!L6@_"?P/\2O$OQ5^)G@=YH_$OB/Q+>>,[2^%MX5BO&MS%IEA+
M#;W>EWMC&MH+Q);PIX::NG4@H1A"HZS;<.2<E&+T5_>DU&S6F\@TNDWIWU_#
M3UW1^FG[+/[:]G^TQ\?/VT_@9;> ;OPK/^QW\2_"7PYOO$D^LQZE;^.9O%&D
MZ]J)U*TT];"TDT5+"709K=[::YOVF$\<@ECVE6^ZJ_G"_P""&D7Q@M_VJ_\
M@L+:_'VZ\*:A\8;+]H/X/6'C_5O!$4UMX6UK7['P]\2K2?6]'LIRTNGVNL0P
MV^J#3G;.GR7;V85$A1%_H]IXJE&C6=.+C)*G0E>#<HMSH4YR:;W]Z3\KWMH1
M';YR6]]I-!1117.4%%%% !1110 5^.)^!7Q=3_@N7#^T8? FN?\ "DC_ ,$]
M]9^& ^(PMT;PW_PGLOQA\-:W'X7-VLOFC5WTBUO-12U, \RUMWE5R@+5^QU%
M7"I*GSVM[].5-IKI*VJ\U;0-.JOMY;-,_'/]@OX$?%SX;_\ !0?_ (*K?%'Q
MQX#U[PUX ^,WQ(^#^J?"_P 4:G D6E^-=.T3P3<6VJWFARJ[-=06%U=):W4A
M5!%<[X,,\;D1_P#!-;X$_%[X1_M2_P#!5WQC\1_ >N>$?"_QF_:VL_&OPNUK
M5H(H[+QKX7CT'45DUW17CFD:>P5[^V@,^T W#26[!9K>=(_V0HJW7FXU(NW[
MV-*,GKJJ*M#KT5K^@.W:W]*_WV_K1G\R7A7X%_%SX*_L%_\ !?F7XJ^!-<\$
MV_Q3^)?[;OQ(^'T^M010Q>+/ ^N_"V]31_$^DLLTD=QI-_)&1;3%PLCQRJ<F
M-A7F7[,G[5O_  4;TG_@F[\'?V:? _\ P3W\:?$'QSXT_9P\/>$O@G\?_!7B
MS0)?@4W@;Q3X4CT_P[XM\?7&J20:GX3\4>%],ORFN>%K^3R=3U+3FN[/4+:T
MOTC3^E_X^?![0OV@_@G\6?@9XGU'4](\.?%[X=>,?AMKNIZ-]F&KZ?I/C30+
M[P_?WFF&\AN;1;ZVM;^6:U-Q;S0B9$,D;+D4SX _!OP_^SS\$_A9\#/"FH:I
MJOAOX3^!_#W@31-3UM[>35[_ $[P[I\.GVUWJ+6D-O:F[G2$23"W@AA5F*QQ
MH@ &\L8Y4IJ4(RG+$TJZ3NHQ<*3I\RUW:459]&W8>EM%KMZ+3;UU/P"_:@_X
M)U?&?X<_\$?OV/\ ]C?X8>%]2^+GQ*^$'QS_ &=_$WCB#P7;>>CO;>.-9\3?
M$+6K);K[-+/H.@ZGXAN(Q?S)%*VDV\6I744)6XBC_2/_ (*J_L;>,?VW_P!B
MOQ;\&OAYJ>FZ+\5M"UGP3\3/AA<:S((=)E\=_#S45U33-,U.X(?[);ZM;?;-
M-6\\N6.QNKN&\FCDAMY%/Z<45C]:KN5.=US0K5*Z;6U2JXRF^S7-%66RUM:^
MB5DDK;?=TZ>B[_\ !_G _: ^/_\ P4;_ &W/V>/$_P"Q7I7_  3E^*GP%^*O
MQI\-VWPW^+?QM^(_B7PPWP#\ >']0DL[?QWXB\,:YITM]J'B\:EIL6KV>@:=
M:V\=Y M]:3K)J#Q!7^N?VWO^"?ES\0?^"5<G[(?PN2;6OB'\"?A1\-]0^!6J
MF*&TU>[^*'P&T_2-0\-7.G2G9;Z=JWC!M%O]!\\-'# OB2[BDE2)GF7]AJ*F
M.)K4Y4W3BHJG6]M&*^%SM:[3;>UUOL]AMIVT6FO5ZW3_ $6A^&__  2$_9U_
M: 7PW^TS^UA^V?X%O_ G[3'[77C:VMO$?A+6[<1:QX4^&'@#P[;>#_"&@.DA
MDEMXKQ8]1U.*U=]KVKZ:QA"QQJOPG^S-\$_'W_!.?PUXQ_9?^,?_  2>OOVT
M/#/AKXC^--4^"7[1GPB^&GP>^(-[XS^'GB;5+C5]!TCX@VOBR/\ MOPQKFBS
M2W-M++?ZI=0Q6UQ!8PVD=EI]IJ>K?U:45I+%5)NKS**C5]DW"-XQBZ45&/+9
MWLHIJVVK?1!==E^/^9_/_P#MN_LC?&O]L;_@G9\-F^#_ .S1X5_91_:"^#7Q
MK\.?M-?#;]G$:OX0ETX:]\.M5\0)8:+J.J>"M+T?PII_B;QEX?OSJB1QQB"Q
MUF:WT;4]4W"6]B^4O^"@'Q!_X*0?\%'?V1)_A#X/_P""<_Q0^!MIHWBCX:>*
MOB]-\4-9TJZ\1^)=3\,^--$G'A3X*>&])2/4/$5A!J 3Q3J?C#5X=+LHO#VC
MW=C;V?VZ>&9OZK:*JGC)TXT[4Z;G2J.I1E+F;IN5N973]Z]D_>NTUYLE+6[U
M2Z?\&^OSZF?I,4D&EZ=#*I26&QM8I$;[RND"*RM[@@@^^:_!;]E+]F;X[>#/
M"7_!;;3?$_PT\2Z)=_M$_'O]HW7_ (,1:A:PP-\0=%\6>"?$MAX=U3PZ/M+"
MZLM5O=4L[:TGF>W2660H2ACE*?OS17/3J2@JB22]JX\R>M^2:J+KI[R*3M_7
MFG^A^0O[!/P1^+'PY_X(\?#+X#^.O VM^%?BY8?LT_$;PGJ/@35H%BU[3_$&
MNP>,GTS2;NU#%(=0N5U.Q'V9YE>*6<0R$2(X'C/['$'[27[&/_!)7]EGP9K7
M[&GCCXY^-O#^GW/AGXR? C3M4\/:7X_\/>#M:UOQ;?7^JVGAGQ#:7VE>-+^V
M2XTJ*?P8UWI\UW:ZE(_VL_9)8I/W@HJWB*C52#C%PJUHUI='S132M;HDWIUT
M$[/RW^Y]/PWW/YTO^">?[./Q!7_@H;\4OVM/AM^R/XT_8&_9<\3?!+_A"=>^
M#GC Z+X7NOBW\6[G7].U1?'-K\)?#MU/I'@NST338IK5+Y(K==1G1I;4;]3U
M)5^--3^%/Q9_9=_X(;_\%!_ GQBM=;^!GCSXH_M=_$NY\!:1KFFS7&K_ !"T
MGX@?$GX6VVA^&-%M--N4N'M?BOIVB:]X5MM0$B_9M(OKW6I0MA;-*O\ 7Q7S
MI^U1^RU\)/VQ?@QXF^!7QITO4-2\%^)9M*U#[1HNI3Z+X@T'7M U"WU7P_XE
M\.:Q;9FTS7-%U&UBN+.Z"2Q.AFM+NWN;.YN+>36.*E[2G*22C!X=-124N2A/
MF2NK7=M.9^]HM=K"T7=W33?2W32U]=^_XG\O7@SP!>_\$\?#_@W]LGXV_P#!
M&?2] \%_"&T\.:WJOC3PS^W%JOQBN?@FNJWNF:=<>+?!7P-^(>EZGI>BZE8W
M^I0FWL- U^*^T>=@/[;CD@-XOZN>,?AQ\1/BU_P5T_84_:T\">"O$.L_L^V_
M[&'Q'M=2^)0L6AT/2M0\<7-_KGAC2-3,KB>PU74].UNQGM[&1'8H\B[@UM,J
M];?_ /!'KPCX[LM)\'_'[]L7]L[]HKX.:/?:9>?\*3^)OQ.T-? GB*'1I()]
M,TSQRWA?PGX?U_Q=IEM<6UO.UI?ZQ%'=20J;L3!G#_KQIFFV6CZ?9Z5IMM!9
M:=IUM!96%E;1+!;6=E:Q);VMI;PH D4%O!''%%&H"HB!5 4 "Z^)3J.K&U2I
M4A5IS:YU"-.K%1<4IOFYDVY-[-Z)62;/ZW]%HNFW?L?C]\7O@)\7=:_X+9?L
MH?M#Z3X#UN_^#7@W]D/XM^!?%7Q @AC;0-"\5:MX@UNYTG0[^X\T21W^I0:E
M!):1>4?-7S&0L(I?+^=_B3HO[47['/\ P5A^/G[5?@C]DKXK_M1_!_\ :M^!
MWPJ\#6US\&Y]!;5/ WCGX?QZ'HK1^+;;7+ZS73M&N;?3IKMM4=UMT@O8I8VE
M-E>1)_0Q17.\14LHM*<51]ARMV7LE+G4='T;=FK-%75TVD[+S6VSNM;VT/P>
M_P""A/C#Q#\6;CXF_L\_%_\ X)$?%+]J/P_+I<5K\#/BOX/N/ 'BCP_?ZGKO
MA;3KC^T[KQ1?RZ3XG^".J^'/%-[?:5J,UI<:B;BUT6?4H+B\L;\6LGW-_P $
MP?@E\:_V=?V'/@'\'?VA-;FUSXJ^#/"DMGX@:XUN3Q)-HEO=:OJ6HZ)X2DUZ
M0M_:K>$=#N]/\."[A>2U9=-5;262W5#7WW142JR=#V/*E'F4K7;:Y;JT6VTD
MT[M:W:7:PFTTDE;YMW_ROU/QJ_9^^ _Q@\,?\%F?V]_C[KW@+7-,^#_Q+^ 7
M[/?AKP)X^N88%T#Q/KOAKPYX5L]>TK3)Q<&:6\T>[TR^@OXS ! T*,Q GBW.
M_P""*'P(^+O[/?[,WQM\'?&7P'KOP^\1^(/VQ_V@?&^B:3X@@6WN]0\(Z_<^
M'(=$U^"-&<-I^JC3;N2PG!*W$$:W"'RY4K]DZ*N5><J;INW+)4$]-?\ 9XRC
M"SZ:2?-W?9: W?IJDDO)==K;O74_"K_@ES^RK\9/ 7[(?[;_ ,'OBUX,UCX;
M:_\ &;]I?]K*^\+1^)(%MWOO"?Q&@;1_#GBJW2&69WTK4"[W5G-]^6"(R*N&
M0GR;_@F]\/\ ]HNX_8GUS_@E9^TG^R5\7?A!:>$O@C\:_A3J_P"T1J-WX9U#
MX5>*[;Q=XDU^P\/_ /"&26=Z]_JU[>Z%XODU1_*CDM(1HURKW)FN8HX_Z+J*
M<\76J.K*4()SJPK)+[,X144XW;TLM4V[V]&%_)>7EM?[['\UO[,OQY_X*1?L
M2?LU>%_V*=>_X)P_%?XT_%GX2:->?#/X3?&CX;^*O"K_  '\9:'!=7<7@OQ1
MXM\1W\L5_P"#+73+2YM1K-G<V5U<S6UBS.FF2S%(?TA_X)1?L7>+/V'?V4],
M^&WQ)UK2]=^+7C?QMXP^+_Q5O-#+OH=MXV^(%Y'J&H:)I$\H$UW9Z'!!::>M
M[(J?;)K>XN(88K=XD7],:*=7$RJJHG"$/;352KR<UY2MMK)VC>\K+J][)$I6
M?WZ=%?5A1117/L,**** "BBB@ HHHH *_./_ (*;JUG\$?AYXDN68>'O"'[1
M/P/\2>+%QB'_ (1ZR\;V,5S+<D8=;6WNKJSN)W0KM2(ERT>]3^CAX!/I7S3^
MU_>_!JP_9O\ B[>_'V_M--^$\'@O6/\ A+;VYD9)K>V:V=+5])5")KC7SJ#6
MJZ!:VP:[NM8-E!:(]Q)&I]OAG&?4>(<FQ/LJV(]EF6$O0P\7*O5C.K"$J="*
MUE7E&;5**WJ.*V/.S:A'$Y;C:$IQIQGAZEYS=H045S\TGHE%<MY7=K7OI<Y2
M!DGC$@821R(CQLC<.C+E'RO52"KK@X^ZV3@&ORB_:$M;:S_X*L_\$Y[>SMK:
MU@7X5?M=N8K2W6&-"WA3P\[[4C(53)(YDD9@6=R6+98D^2_\$_O^"H?PN\:^
M%=.^%?Q@\4OX;\0>'3'HWA?QCXID@LH_$6A6TC6FC6WB6XMWFM=,\1V]HEM!
M<W4T@L-2D#2B\:[\Q9?UJOM!^#WB?Q#X4^+]_9^!M8\2>"M+UNV\&?$"X?3+
MO4/#ND^)H8+;7ET;7!(19VFKVT,,6HB.?RIXT03'8N:_2<YX=S;AO'U<%F.%
MKQ:YJ5#$*C/V&*A90A6HS:L_:0LY0O[2G)RISC&<7$^1RO.,'F%)U:-:,7*E
MS8C#R<55H5*D>>I"I&^G+)R490]R=-*=-N$DWZB0, J>F7SN/''0E64@$XR=
MW SG(K_-J_X+1^(]#\5?MZ_%>7P[)%/ FO:W TMIAXI'7Q!JZD[E&&C+0M-'
M)DJ8Y1(ORLHK^O+_ (*-_P#!6WX(_LT_#7Q1X=^'?C#2O%_Q4UFPO-(TZ3P_
M=1WUAH5U-') \\=W&Y6_U5%9A:VU@9X+.8QW-Y<10I&D_P#G]?$7QQJ_CWQE
MXA\;:Y.;C7?$FH2WMQ)*[SB"%P!:VY.?,D\F(1QABI,KQF:4G>H;WLNRBME^
M2YA6S.+PKS582E1P]5^SQ$,'AZRQ57%2HNTXJK5C2H8;F2E4;J32]EK)8;$+
M%9EAIX=J=/!QK.K4BTX^WJ)4U#36T/=E67PJ,HJ+YKHXE(UT]EB38^H3;5#G
M!6T64,'D(8?>0(&  R4Q)G'7.O'-Q/(REC;I^[B>4@9C'S&1F.W<TK'S6"$M
ME@%48 .I)975E9#4)8&W:BIBMI9G!RJY,\NQF1HPT;B--Y#-O^5  %K&*&0C
M,D;M\H"J=Y'8*JJ/O<8 [G^+T\S&S<L/1PJA*FF^;V--Q7N:*$IR6LY22YKI
MMV:3M8^DI4H2JRJRG&<UI.IRO5I1;2BW=);+2W7J.CN!; JH-S&RD21296"0
MG)R%RLFX8&UT:,\8&""Q>T7GC=:OY@)VM:,R"6,JO0!$7ST!S^\0/(H&9E/W
MRK6L<(9KFX$9&W;#&F^X;/7*,1'&0.<2N&/'[L@C-VTO;*WANS%:S"Y\M6M+
MLN#-!)N"%B591&,.S;4&1VYYJ:<;)4\37ITX17NP>M3E23M>-VM5:S[W-)M?
M%AX.4^LK-1W2=T];NZM;;JBDUJ J"4_9H5#'?('W2R,,%HH8U=Y5R,(2L:G#
M%I ,"H_.BC %M%EP<^?.(I&W%@,1VPC,49P20K-*0!EMO>1GBNB3,3%<$<7
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M_+R=UM>_2^Y^8_[+OPS_ &H?VLO^"C<G_!0S]H'X ^(OV7/AA\(_@3J'P1^
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MVW=E^+/Z#**_!?\ 9D^-W[7G[,O_  4=C_X)]?M2_'2/]J'P1\8O@;J_QI^
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ML8PC7A&U/F]]-Z74K;+?F?1*ZLD4;E'>:5WADMR6V,IC)C14;:JJZ LNW #
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M_?T_1=[?T=T9 ZG%?A9^U#^W=\3)O$O_  1I\7?!#Q+<^#OA]^VO\=O -O\
M$/09K'2=5FUWP#XR\(:1K_\ PC=W>W=C/)9M;-J122\TJ6QNVGC5E?RPR'UG
M_@HM^TG\9_@?^U'_ ,$N/AY\,_%K^'_"7[0W[3VI^ _BYIBZ;I5Z/%'A*WL_
M# 32FN+^RN+G3D5]6NY/M&F36=SN,>96V 5G]5K)THR<8RJ1K3Z-)4')33?=
M.$NWW:BT[];:WT;VTUW\K^=C]>J^%3^VG9K_ ,%#8_V"_P#A [HWLG[.;?M
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M ."AW_!5'PGX_P#VH_AW^V9<?L5_ V?XB>+_  A^SQ\-/ _P<\&>/]6US0O
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M_M ?\$R?C)\*O^")WPC_ &(OA/H<_P 7?C#X.^)7PD\9^,(?#$ENL6I:[/\
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M+FELKM-].BV$[;)+5/KNO5_UT/PR_9;_ &:/CEX)_P""#]O^RYXJ^'>LZ/\
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ML8K1XF;FZBBH2:FI7E*:;G'EG+WF[-K9+X=+6$[/I;375Z_CI_5[GX]?MN?
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M^=NUY.DN6#;WNDVF^MM>MCI:W1+KT^?]=#\7O^"H_P"SG^T9JOQB_8N_;?\
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MFGB30+IK2*Y,SP6TFJV[7C11),8^F^.WQS_X*5?MM?LY:_\ L56/_!/+XE?
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M[XIUOP5_P3\^!?@'2= UZWU+PSH(U3X]?M!>-]"CUS4] EU'5=$OM:TGP_\
M"'2=2TZ+5(]!U32'N?$GV-GN-4TK52EKF_LJ?M<_M"?$+0?^"S=[XP^(4VLW
M7[*_QR^//A3X%W#^'?"EH? GASP=X-\4:EX=TZ"&PT2UAUM=+OM,L[A9?$HU
MB>[\J1;N66.>6-J^J5(NM&;BITHT92C?6#JU%!0=M.973EKIJNP^ETT]NNU]
M^FKMTOH?NYN&<'@\=01UZ8/0GMP3S02 <=ST_P _YSVR:_DU^'/Q"_X*_?&O
M_@F99?\ !163]N#1?AUK7@+X1:E\1?!WPB\.?!WX:ZMHOQ1T#X=-<MXD\0?%
MG7M3\._:(?$_C<:/KDEKHOA:RT[P[HUL-+2.VBNKB\>W[_Q-\7_^"L'Q9_8$
MO?\ @J-HW[5?@KX%1^&OA*GQQ\%_LM^"_A=X0\5> ?$_P]\.6,>J^(4^(GC3
MQAI6I^*W\3>+]+L]3OK6TT=X++P_&++3K&>"]NI]2MD\)43256F_WSH.UVU5
M5E%)+=3?PM:ZM6NM!:NUOGT_S_"Q^]'[27[5'A7]F?5/@EIOB7P-\5/&LWQR
M^*VB_"/06^&GA&3Q5!X;U?6XIIH=?\9NEU:_V+X9M4@<7>HJMU+'DE+60(S)
M]1;AWR/P/].#^%?@A^U7^W?\<1\$/^"0WQH^%7B,_#C_ (;"_:#_ &=M'^*F
MB6VD:!K,6I^#_B7X+EU[Q!X3677],U:6RM#?.%BOM,DL]258$V7J*[[NH_X*
MQW7[3'P \"_$C]JOP=_P45\>?L]?#S0/#&CZ-X/^ OAKX&?!7Q_<>,/B;>+_
M &3H.@>&M>\9:-=>([K4O&>NW%HUQ:237B:5:QWE_ D5E:S1$AA9R=&,Y*FZ
MLJD$VI2O.G/D:M&+MJG?M?7R'ITZ[].G9;Z^:MV/W(R/Z\\<>O-(K!AD CV.
M/P/!(Y^M?C3\./"W_!2#5?\ @GK\"O\ A;/[87@[X#?M&ZI*_C']H#XW>,_A
MI\.M9U#PA\/];3Q!J>G^$]&\/W6DZ!\.+/Q?HMM?>$M.U75M;TPV=HUKK(4W
M=R+5Y/D'X%?M>_%CX,_\%(_V<OV6+;_@H;X<_P""@OP9_:1\*_$NWUP7=I\(
MV\>?!KQ[X&T*;Q#IMU<:Q\)K"P632?$:PBQM=.UN,)Y2ZA+!F33Q).+"R:K<
MM:G*5+G?+&-1W4&DVY<G)%22DU=]+73:32>EVFO7;HM_-M)=V?T$1_&?X4R_
M%2?X'1_$#PH_QAM?!T/Q"N?AHNM6!\:V_@:XU271+?Q9-X>$YU./09]6@GT^
M+4FM_LTEU#)$KDHV/)+G]JGPU;?M9:=^R)_P@OQ2E\6ZG\*;SXMQ?$&+PE+)
M\)H-&M-6;1_[#N?&2W6+?Q--<()(M/:R>%HY8$%R)IXH7_G1\1?LU?M=^(O^
M"[WQ2\)>$OV^O&O@3QKJ7[&-K\0]+^)%M\&/A/K6HZ-\*M4^-&K0:)\$$\/Z
MEI;>'+O2O#]RKW:>,)[/_A)KXPI#=SR+*SK^I8_:$^/&C?\ !8CX??LDWOQ)
MN]7^#5Q^P9>?$S6O#<WA[PI:+K?Q,T[QXWAR7QG/J-IHR:Y9W-[9VQWZ18ZK
M%H4+W$ABTY<(!I/"17+[.K"I?!_6I)WBXVBFXK1IO739O:W4$][INR5[7TO:
MW2[M=/;_ "/V)#*JKR3D#'4L>,]#\Q) ]"Q/7FG9XSSTSC!SZ].N?;&>U?SR
M?"OQ_P#MU?\ !3_XL_M+^,?@I^U[J/['G[*_P'^-?BCX!?#73/ 7PS^'?C;Q
M]\2?%_P[M;*/Q/XT\5:YXRTS4OLGA^YOM4A;3M%TZ>&UNK1HK:>VAN;&74K[
MV;]A;]K+]IZ_\4?MW_L<_M3^*]$\=_'[]C"STK5_#_QH\/>&]'\)Q?%#X?\
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M_P"K5<\H\DG%RYFG9NSCK975GY]=F)VZ._\ 7H@HHHI %%%% !1110 4444
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M.K^2ELO3M;\.GH?J(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTZ/2KJWN-.UA?#/B2T6.WU?[)X4NYY;C4?[:B>33KJ&VD)XGPA\!/C5\5_\
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M*WB61HXHQ#$I*1\?@+XCUNY\2ZYK.O7K%[O6-4O-2G<@YW7L[7!3=GE4615
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M<LI-M=-[;LEX;VM6;C4=.A".D(Q^*HFFY)V>J6BL[VWV1H0[-T\+QR2//;R
MC$<9(0Q7$>,(^<K"3M&"25084L##%<&)CY4?#YW1NQE1@<G:R;E7CC&1QP1P
M,A]K,PDA;<HGB=&B=B.0H"LLGJ-I&P\EB&7GH>W\.^"YKRX2XU/-O:1.XV#)
M>X,9PO92L)VX+$LY49S\QKTLAR7-^),50PF386=6O.K*-2:=H8:#=U6Q-2?,
MJ=".MII2FW:*@[IG-F688#*\/4Q.,K*E0A3CR7LW.48I.-.,=?:-Z7C?M9.[
M*_AGPK=^))%DM]FGV<8)G>1855UC)!6WDD927R2,2?*F?E9LXKW/3K6STNTC
ML[*W6..,@^860M+(C-^\(XW\.H))<,0#G*J13B%O:Q);VJI' BI''$BA%"+P
M %4<#.3QR223U.+0N25V3$2*$*Q\L3'R/NGL/4=#W!K^N^#>!<MX5PT9Q4,5
MFU:G'ZYCYW<G+=TZ"=U2I1DVDHKG:MSRDK)?A/$'%&*SBLH3C.A@:4I2PN&N
MVHWY4IU''XJEK2OJHO5*Z9HK(67:R@J&W*-^P L<G& W!(SMX4<X')H##.X@
M@ \$LQY]."#_ $/Y5G8=N58%1WP>/<E2,?CQ^=1^;SC=@?B0#T/J>V:^ZY(]
M&EY*W9?U?J?-*M!))MM/9O5NUGT2\M5:Z^9N1W3+&X(&9)'')',<:*P3:,@;
MFPO0,-V2>#B);AFC56^Z-N%(Z =,$#.0.!DX[^U9)D("$9/+$<GJQP>,'CC&
M!^'>DS(S;55\L3M"Y)/7'&,X]P*7)VLFK7?R5K:=-?0)8BZ2;E)*]KI)K;=V
M3^3W^3-?S(R3M.!TPYY!] 1P?Z]JCWL&(\LD#![@[3_$>G'>H418PIF8L3@A
M8OF)]MV0 /7J1V-6A<X!C4%(V(#JBD2$8XWR.26'?!P,]-N 06:VN]/.WV=K
M?\#;R'SW26D;]DN9WV7EMWOM;96E7RT<F1R-O1(\,<],,Q4A!GG(\P@$<$\4
M27CC)0 * ,#<"W&!][:I)]PJY[**JLA<EU)96+,WRE,Y)(R,]0?S.2 .E,6%
MW;:JX![G' [DD\\=L_A2M%_$]K:-=K77K:]DO^ 5&I4A&T6E=JSM=W:3ZZ=%
M?[MK&E')N7S6;:%!W$N01T5 !D;R['  #'L>.:JO<-(Y)+ ;?E0L3M /"@Y.
M 3DXSC))J.20KF$.WDX"[3D+("V?,89X(;E0#U'H3FBY8$[2<8ZX_#_/UIJ*
MN]--+.W1V:2;^ZUOF$JLDN9\U[J]M+NZU>VK2MI]Q?\ /8*> &SQP,'ICI[_
M ..:LM<M<1KO4?*0),$!BH&,J%RI)R.N3GD^M8C,P '4D ]@<'IVQ[]NO'O)
M%(P.3D,#\H."I'<'C@'O^'2FXI[6TV?JH[;NW=]+WU(A77PWD[[I.VUGJK6T
M\DUKT>I=;S"H>/!7G) ''U!R1W].A]*C61P2"1GWV?UP/ZTQOW>)8W;RWS@,
M0=O?:RC@CGY<X+?-G))Q7;$F ,LW)VD<^^,]3].>>]-*ZMKZVUZ:;OT_"VC(
ME42;:U2Y;13N[62U3LWW6BT5]=RZ)F.3Z=?E3_/Y591D51+,3M7("JT:N[,"
M5X)SM!P"2 ,#MG-9P:*( R#=D'"98'V+8Y'/0# (SGK5;SF8GYMO'4D] 1@#
M !^G; Z4N2W732]W;33_ (/X:[FD:MK-:;--1T6RNVTX^5OEI8V?M<C?>$0P
M>-DB?)Z?>8Y([D=?4]WM<,1YJE?/>1Q/*9%<S)T5&B9F157G# <G'RJ0*Q-[
M9)\T<DD\OU/XT"4@$%]V&! +':<KR>_?]?K2]FGMRV^_M?37KKN/ZQ;5S;DM
MFTM7HMDM]=O57W(O$.A67B*T,5U;K%.JD6=S"Z!HMJG>9692 A; Y90V0,X7
M*_.>LZ'?:'=/!=IB-F(AN(P6BF0<[HVY 8]"I.0 1@X&?I'S,#_6GYS^\0 [
M0H' !S@\YSD?_6I7UI;:I;2V-XJM;/N*@J"RML"B1""I#*%"ABPVCG!Z'\OX
M]\-L!Q;1EBL,J>!SRE&7L,6J:=/%-1LJ.+BG%M27*HU(\LX-W;FERK[/ACB_
M$Y15C1KPGB<NE:+I1E9T7)ISG!N3U5TW"UFM$[GS(<'(9CC'! )QG!'!(PW7
MJ01VXQ5P@WFY]Q^UPKE@N%>XC0<LIW;VF15W%0#F-6?*["*W?$?AN\T:=W7,
M]@[-Y4X4DICA4FV_*KG[J$DB0@!>3BN6#,K;E.&!5@>A5E.5//0@Y[=V&.37
M\DX_+\PR+&8K+<UPT\)6HRY*L)IRB[R]RK3GRQ4HR5G&2NMU=V/V_#8K"9AA
M*6-P5>%>E47-"<=.6RYG":=VG%Z3NU>U]$TRS;N9+J#?\^)8E5LE9CF1#CS"
M"23P<L"I&,,1P'2>5/*[(ZB5RSYD7RPY<\C"L1N;(P1M!XR <BK5K']LNK>>
MW3]ZLT,EU$@W*I#[GN8P/NQ2L#O3 \N8Y!*2!:@8)8+DKNOMA*%P&6TW*#N,
M?4W!. BG C4NSJ6" )8=K#PE5BHX6=6SK-7<HI)-4XMI\VMK6EUZ782KTY5N
M2F^>LJ::A?K*SE*32:5/JFVM.K98N;:;2F6*[M7AOVC\_P B0$BV,NYH9&#*
MN^;RMC1)R(2=[$MBLQ 99$ 9C)*44G)W,[.H9B#U(R68G&<')S5J>XEE>1I)
M&FE5%SYS/(LD84 Y+$R%T))4AE^7(YX%+:",RO.O[LPP2R!792F]Q]G0JY'R
MX>7.U@QX4D\9&=90E7ITJ&F'C%I1G;2,4M9-)+FTN[Z=%[J2-(.5.'-)2=5N
MT6FVDFU:$6VKJU]+M]BO-(K3ET+!59A'GKLC_=("0,9" +D9^5B">HK5C_?V
MD;H0&4E0VT'RVA^5HV..,V[6[(O0?9Y-PVXSBE64@.""%.#_ 'LY;((X;+="
M,YZ"M#37;=<0@G#1^?$N3M\^!]Y#8QCS(FEB<D$%2 1@8&F Q$EB:D:FL<1[
M2-W>UU&'+_=NVVE?K:UV3B8*5&%1JTJ+LN322BVDVUOLKW326E^J&P3F!R4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*)_!WP?\17%I*;?4-:-IX=L)$V;@NH70&H@;_F.=+COX\C<59U& ":_'+(!
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MNQZ+*%W$KEMHSL..2!GKU_(=1T!KN-+T/S" 4)(;:F5 V\9"C"\\ D]3@9'
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MIKTV-9=GD7NPX\KY8'96RT=SEVD0$9 1$!<9SB1PF&W$T% .HM%*?]</(8,
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M>,_APFKPAFV 7_A;6+/RT1"N3)+9:Q<RMEOE6W<@ DY_K &,<=!7YSXOY?\
MV?X@YW:*A#&_5LPBDK*;Q.&HNK/S<L1"MS?WKJR9V<(XEXG(<&Y.\J#JX>7E
M[*;4(^5J;@OZNUHHHK\T/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'[>.0LWV5O"W@GPQX;N4CW<*DVH:5>WFT9&ZZ=\;W85^R^!6&]MQM5Q#BG'
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MGT)J MGJH Z'# #W_'%:>ERZ;#=*VI6LUU:>5,##;SBWD:1D(B/FL&&T-RP
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MPIX;T?PAX=T3PQX?L;?3-#\/Z58:-I%A:HD=O9Z=IUNMM:6\,<:JBQQ1*%7
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M/:263]X&!(W<@@D' .#C&,9K"U.(A]IQGT*\=21QGTP?3//2J-B'$VU?-SD
M(K9^8G SP-H)/4YP">"!7^A:IQC",%M%*,59644DDON5MO,_G"][VD]4I26_
M-.Z;G)O5M]4FD^KT/['_ /@B3^V;%\3OAJ_[-OC;5?-\;_#"U6Y\&2W4H-QK
MG@,&&,6D18+YMQX;N9!;&-22--N+)E7$$NW]._VV/VD-._9F^!7BGQV;B$>)
MKVTF\/\ @;39F57U'Q5J<,L5@X3#.]MIJB34KTH"5MK9URC2(U?PS?LQ_'#Q
M5^SS\7O!'Q7\&3R+JGA#5X;NYMD;Y-8TR7;!K&C3_(5DMM0L'N;-MRMM>02H
M%EBB9?W^\._$;5/^"M/[7O@2.UT/6O#W[._P6TBS\0Z]HNKF(/=75S<6]Q?0
MW_V%I[1K[Q-?6%OI-G$+AI(M TV_N('M[B6?S/Y.X\\,,'E_&U3B:M&-'@]4
M:V>YS9QBJ>)PLH2J8"E#37,\1*C"A".ZEB(Z."3_ %O(.*\1B<B65TY1>>2K
M++\OC)W<Z=17AB:K2?+&A2C5<FTW^[3MNU]U_P#!++]FJ]\!?#K6/C_\0[2:
M3XK_ !ONI=?N[O4HB=2LO#=U<F]M@\DH^T)<:[=-+K-X&8!EFM$9,1E:_6&[
MN8;&WFN9Y4BMX8I)YYI"$CBBAC>2221S\J(B(S.S$ !<$TRSM;;3;*VL[-(H
M+2UMX;:"&)%CCAA@C6*&-$7A45%5%  "@<<8%?E]_P %0?VF9_A9\*;3X3>"
MKB9_B9\9(IM#LH=.D#:EIGAV=EL]1NHXD82I=ZI+<1Z1II0!FDDNI(G#6ZD_
MB,O[1\0N+4E:-?-<5&$(W_<Y=EU%:17\F'P."IMNW*FJ;=N:6OWZ^J<-Y/*3
M_A86G.I*3OS5\34:NV[-N=:O)**=[<R7PK3X8\3&\_X*8_MVZ9X9A6:Y_9Z^
M!<MS<:A(C&73]5L;*_B;47+)NMWG\9:M96NF0ASYBZ#;RO%N(GQ_1/IEE:Z;
M96UG910VUE9V\-K;6T"+'#;V]N@BACB11A8XT"HJCY5 P .<_$_[ G[+]E^S
M3\$--TO48(C\0?&:6GB;QY>X4S#4)X UGHJ2@!S:Z%;RFTC#%E>Z:ZN65GF9
MF^MO'OCCPY\._"'B/QSXKO[?2?#?A31M1UW6]1O&$4%GING6[7-U,SO@?+%&
MV%&6=BJ*"S+6_&N;X?-<SP60Y'"4LDR&G#)\FHTTW]:JNHHXC&\D4N>MC\6W
M*,E:52'LEUL8</X*MA,)7S#,I)9CF4WC,=)W_P!GI**]AA5)[0PU%6DK)>T<
MVHKK^-/_  7%_;AB_9O_ &;Y_A'X/U8V?Q5^.UGJ>@6LUE<A+_PWX$18[3Q5
MK[K&?.MWOHKAM$TR;=&3-->3Q2!K-A7^?9XIO8Y)G4$LS2!F)/3:&[Y8'DDD
MY/7KWK]'O^"A?[6VN_M?_M$>._B[J4]PFBZA?2Z)X&T:4DC0/!FD7$\.B6$:
MK$L0DEB<ZAJ+))A]2O+YB718G/Y?:O,KS.\C!G,Q.U6!P%5#RZ[E/IP00>_%
M?V[X4\&T^!N$L/0JP@LTQZCC\VJV_P"8BM"'+AT[N]/"PM2C9N,I*<TDYL_%
M.+,YGGN;UG3;>%HN%#!I*_-"$N:51:K^+*5W=:)6O>S,.0<D@#G)/X'DY_'M
MUJ$R",@D9((( &1UXSVYXX[\C(ZTQY<GY> I/ SC(! !ZY[X;O@=ZSYYC%'-
M*O+QQR2 -G!*(S<GC@XQD>O%?68S,84%.KS7E!2;G\7+""<I2C"*U>FFJ=]$
MD1A<&Y1ITF[-\ONQ5Y.[48J3OT;5XVUNU=6=MW4]6FU*5)Y(K>%H[>" );P+
M FV%-@9D3Y=[XR['EFYZ<5F"9OXL8[\?YX]?:O+X/&NHRMY!@M TH_=EFF4>
M:%S$I^9Q\Y C)"\[L]L5!_PG.H 8:VM!Z,?//?N%*D>G X/!)ZG\]J^*G#4D
MJCQ6*?.W%KZI6M>#Y9.[TLVK[6U5E;4^PI<(X^E%THX:C)1BW"U2%[6BXJ\F
MFFO.]KZMWLO6C)@8 ..N[J"?KVR>,8^O6CS 5).-PP!UZ$GTXSUXQTYYZ5Y)
M_P )SJ':VLR/4?:/_9I/YBG+XXOV.UK6V!8J%91,2.2,,%?.,GJ 3UPI/7!>
M*?"C>N(Q%]%;ZK5DNG\J?5^E]+E1X5S-.\J,(KLZ]*ZVU;]IMY6VOYGK!R0<
M=QQCO^'U[4YI%4;<YQU(/!)SQG!Z9P:\OF\9ZE:8C,%HTK(6D,;2LD>=I2(.
M2 TA4EGP0J$["0RN5BC\;ZBQRT%FL9(5I2'!49ZYWDO@Y7$9)XZ"M%XG<+J2
M@J^+C-ZMO!U6HI\K6NFLEWU7;O'^JV:2:<J$)4[/WHUZ5KW5M.9OT5O6VAZH
MTB\*,$  \'/7/7I_GTK&U32;+5D"3HJ.(Y(UF"@. X.$9\.2@.UMK<Y0$,.:
MX^_\7W*7+QV?V.]C"H3(4N(9-[(I93%)/E@A)7*$G@_*,UG-XWU,$+]EM-V<
M; )E<$]MK2 L?0+N/H*Y,=X@\(XVC5P>*=;%T:L'"<98*<XZJ+4HM.T9QUY9
M1OL^YTT.',VPSIU:$/9U$G::K4G9MK5)SZ)::M;7T;1S>JZ9=:3=-;7",/F8
MQ28/ER1Y^1U;&-S ?,GWD/# ' JBL?F(4)7S(V?8&8*SJV&9<G&?+ZKZ+D5Z
MI''=>)?#>O:AJ5QH6G'P]%:3+;WMU<V^H7GVN9H573;>-&E>:)\-(KHHPY#8
M568>9J;.%HY$^T7$BG>,F.U3(R <AIF9?7YQWV[2,C\-SK+<#A,;&ME&*E/*
M<;'ZSA)8JE*EB*5*4DO93C+FYU!J7+)6:L_=U5_MLOQE>M2E'&46L30DJ5?V
M5Y4JC233B^CLU=*Z6B3O=#K":9)XHXY716DA5E!5HVVR;@3$P:-F/(Z<C<>2
M<B<8O-\<EG(-\KL);;>JB3H@="KP@/\ =)0P')!9^Q+>Y\JZM&@MH(D>[A8O
MAKB7!D021EKEIE#)\S;HQ&VTC)PQS"2TLDEQ=2S&"%V4@,2974G$4*%U*%BN
M]R"D21C..5%<].?+AZ<>>5;EK-+EIV2C:.^M[;MMJ^K39K.TJC7)"G>+=Y3U
MLDG;RO;5=%YGJ,7AFVO/A3K7B&37-)CNM/UBUMUTZ95?5+J,>5'$8'6X>57(
MNIQA(G1X;23?(GEH&\FMY#%<P2C[T<\4@QCAED5AZ@8(Y';! K=N96;2W1L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>W4/C'VB=A-*.IW*KYBC.".-CD#C=P ))V>5!<2O,XF0K"[[MHVX,P3.$!#
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MCV,<@;7+@]ZR)8)8LB2,L S)N0JZ$J?F(90RXY/7;@Y&.XLGSY%NI&24/))
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M1C;_  T^:]]+_'TCIM<?1117X:??A1110 4444 %%%% !1110 4444 %%%%
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M#3[^+%Q9"_3Q=?Q%[9HW>6VB=75X%8?SB;MNU2<M@_B<< _KC'4]SQ7[<_\
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M>N7.D6DVOR^$=-9;&]M-/74V6*SC6T@N68[X(Q"DDG=?%O\ ::_9N^#FN?\
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MYE;STVZ%5Y':"X>7F1KV'>W)&!%=*.#D@$#&&)QCJ!2V1VM*C#:]Q:S(BL,
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MS>*O&'V6VE^8;].T#3;:W4+D;2HU"ZU$[D(!?(X9'!_4<  8' _R:^=_V5?
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M?FI&OR5,<:B-.IP<,QQ@[B "1@<CA3Z=<ZK-&HKVL^6ZNHN5V[KM;1-[WO\
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M^=[Y9$PS \9((^7UY&2.">.A-2ZC/:S3>9:22&,@;UDP"&QA@,$Y4'@<#C'
MSBG_ &@U0JSC*-Y\D8PDUI&"C&\8KHK6TLDK6LK#67QA5Y.63^&\TVXM:.,=
M+*RU>ME<MM<_:(?*8G>F3&0?O(1E@3WV]0<GDX[BL2YE813\_P#+-P.<= 0#
M^'7KP:C\XQOD9!R2""Q YSC/0\<#@$]:9?L##+(G"R1MP,_*PR&7/L3GMG/X
MUX^,QOM:,YR3YHPFG:WO+DMI?LK)]$K=3TZ.'5.2M%24FK744T[QO:S:_P W
M>]FCB=X#D8 C<!7.<X;8"K =MK9!]03TY%*%9$O%.1B.'/\ M9F7!'J&558'
M)X '-5F?: ,9 X^;J<#/3D \>^/PJ]$?,T^60_ZP7-O$,\;T19GQNQR5W* I
MSPN>N!7XG2D^>5M73AB&[VNXR4^57OT:U5_3=M?<R3BTFOB=**\K1A=)*^\7
MMMKWVSSCC@#'/'<XP2?\_K0>01G@\=B.>V#D'/3!!!IS_>/X?R_S_GBG(%#@
ML&VJOF-)MRJ@#('&226PH&<Y.<$=>&SDU&.MVWRZOF=T^5=;OIWV.GF487;T
MVT6VFUO(OOJ-VT=M;7<T][;V<92&&6>5_L:EBP%GO9UM@N5PD2"-B26C).:Z
M35]#73-"\/ZM%JVG7EYK<-ZATZ"7.IZ5'',%!OK=1N@FF1B8L*-ZH[@C(SRK
M*MN3/,,S2 R11$AMBDG$SJ<#*G:$5B>1DK@@4R+$0^URY:1P_P!E'.'D(&Z=
M^3\L7.T8RSG"#Y37M4<3&G2JPQ$'5E7H1I1ES-O#Q3@^64W=N44K1CI:[L<#
MI.<X.C-4%2DY22C;VK?516G*[N_=V;5]4C'R8A "HD;YK@8 * <I &Y.Y3EI
M&'RL3CG::>^\R6DZ,4:2-</DC$EJIB+-C&<(@<YRI$BY!X-0D&<C:"TSG&,<
MRL3C '4R'(.WOS\P/%6VMYH+26"8>3-;R^<ZS QO$CKY<L11@'W,WD, %&#E
M?>N>E>HY^R3A1Y;T+N\7.-KOJ[VUE)K5]&TD:2Y8*GSZRNH2C>\DGR\JE?=7
M5TK]+WU9-+B:R,\("K%=Q&>+W=)%DG5!@>4Y;=G&(BV/NX-4K-%>8,J?+"#<
MLH 8%8@,+DX4%WV)SP=V#Q6IIEW;Z<//DMA>*TDUNRSY$>7B\LL8^3LY( 8
M OD LM4YP8[/S4)$=S.RF(D PBW($L.[&2&8KY3 D.N1P1BNRI&%7V&*=O:4
M:"E4IPUNX<KA)I)*3D^9-IW:1A3E*DZE*RM.K[.,TG=*HHW:;UOK9::::[CY
M8T,ES,\@=YK<3%8^23=&(D[A@=9';: <CJ<BK45W):7,]Y"1%):PQQ6Y7&5F
M2%(#*">R>5(1QR2.@Z16<0E$$F1L\J-9&'0^5?(&!SCG:P(&>V<GJ*MRY6!!
M@!IY)+EAUVE_ECCSP !'\P&<[G.<=])25*BZ[5KJ=6#TYKSDFHJ[WYY.6O5;
M-(B,.><*$6Y*/+&>[BI0:E:5KVO'?NM7?6W?_!_X?:I\8?BQX"^'>GF22]\<
M>+-+T6:95+F&TN[M3JMZZ@',-CIZ7EY<%EVK;V\CD#'']X7[.7PBM_%/Q(^%
MWPQTJSV:+:ZCH6BF".,>7;>&]!6W,R/&N/*B33--:$ X5>  JD"OYA/^".GP
M+E\4?%7Q5\<=3L\Z)\-M-F\/Z!<RH_ES>+/%-D]M=21D@I_Q*?#DE_%<9*L7
MUJSD7<C$'^XK_@FK\-GO_%?C#XFWT(\C1[%/#>BR-'D"_OF,^H21,0OSPV4$
M,;L&9O\ 3^50'!]G#8K_ %>X+SC.:DG'&8M5UAY-M.53$..%P_+JG)Q<I5>9
M-KEO)W=SY'.'_;/$V799"-Z&%K1=:RBXJ-+DK55?;E]U02LG>2BVM+_LA:11
M06T,$*A(H8UBC0  *D8V*H X 4  >P[=*L4BC: ,YQGGVR2.YZ#C/?K2U_-M
MV]6[MZMO=OJW\S]/T6B5DMDMDNB^04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!&01ZC%%%3)73
M2\OS0'Y^?\%!?ADGBCX4V?C2P@8ZOX'U**XGFC!,SZ'JK+I]ZCE5):*WNIK2
M[=B"(8HYI2"$(K^+3_@LE\$4\8?!GPQ\9]*L!_:WPJUA],UF2.$[I?"'BFXC
MA>6;:';R=,UF.R=0"$BCO[MY"?-^3_0K\5^'-.\6Z!K'AO5XA/IFNZ5?Z3?1
M'^*WOK=K=R/1E5RRGLP4CI7\O/[0WP-L]1MOBM\"_&]H9[#4[77O!NHQ, _G
MZ;J5O<6=MJ<,4@2%7DLGM[^TD4[;2X\G9\HR/W+PTQ\,UR'-.&<5-.5"-2I0
M3=VL-B^7F:UVH8B$96L[.JFD]+?G?%%*669QE^>TDTFXPJJ*MS5:,H\B?1NI
M2J5%K9ODLGK(_P __3+YM,O['4%A@N6L+RWO%@N8VEMYS!(K^3.BE&:*3;AP
M&7/M@"NM\2D>(I[KQ/#:VNGQ:G?M/+:6W[JQ@N+A<R6T2EG-N&=L1[V96)!+
M)CFW\7/AMKWP@^)OC;X8^)[>6WUKP7XBU'1+DRC;]J@AN7;3=1@! :6UU/37
MM-0M9$#+);7$31X#$"+1/#;ZK8ZS!9:SIDMII>F+K%Y'<7GV&9LD+)!9V]P0
M;F\MI@K*D:CSD=T+8<"MLNC4_P!KRG%4TE4G4J>RC*,72Q<(QI\UI6;3C3MH
MU;1<O?Z'%N*=',<-).-Z:4XW3E2J*+<I6;6\K2]+W.0B;]TUK>;TS(=I<,I@
MERP6:/<!F.10HE(+ JJL"2@4YTB-%*T<F5=#DL.A&>'1NX/4'T//?&F)9(9#
M:S@W$;_*BO@M&0#M:*0EFA(VYVAC&3T7  J4PB]A"QJ)9H2 @RR3H#\QB=6;
MYT93)*DJ(0#^[X&"#$86->DJ=-N-:A^ZM-*,O=MI9WYM]._EH;4ZLJ%23F[T
MZMIJ2?-%.5EIY];-Z+>^ZR<B9L.@\SGYFZ/@94D_WL<9[\8]*NON,-K(N8Y-
MEQ!(8V(&]9!+#DC!#8=EW _=D3J"!4/V2=B4EMKF @J'%P!$(\]&<R%0N.J[
MF7=C (KK8;#PVWAE+E]=EG\2'78[1='2R9;-M/FM07O)-2D0<I+;01%(E==[
M;E<JA=LL#A:\OK-*52$*DJ*:<Y>R:C&SY==7*U]%%MON@KUZ?[N<>:<7);13
M3NU>Z3T6MV_+:SN^56\G,81S]H9V!VSQ"7<L>],!G#/@N2!@@\8R.VEIT5B;
MR!-01]/M+F:&&[:W9GF^SO(JR/'9R,X\V+.^/:Z*K!=QP<B/5[2YTF[-H1'"
MB1*4>V=FWB4!CF=LR$C.3NQDYP!Q67:\3B9@S>0CSL22WS11R&/)/)_?>4.>
MY[<85.M[#$*G*,L1*$5=5(_NW9[^\[232>UDTVEHU=U*;K49--4W)<L7%VDG
MINK:M>FEE;N=!XC3PY9:[J,/ARYO=7T:WE2#3[N^5;.2XM%B3+20Q+C>LF_<
M0R849!9C6(]P5 >"""%,;01'YDT9Z[?,DWME1_$, C!V@Y-4UP0."<YR2 2=
MP 7/8G)P/IZ]9H$E<LX*1Q(&,TDS8@ !.0S $NY!&U$#,Q[@ XY9XRK7Q->4
M(PIJ=:?L^2/+&G337+%6;=DE=*3;MIT-X484HP4I.3A"*Y?YVTG>VFO-Y7M?
M<027%RR1M+),['"J/F!/'1#\@^N!VJW#Y5C-#DI<3B09.[?# QSP  8Y'0\$
MC=&#G +KE8I'2./R[3*QLN))V51<N2.4/=8 00@X) R2#5>(%I(@. K@\Y[=
M?T"C]?K5":HXFA[\JM2I6A!SDVTN:TN:"3M&S2OHEV2E9BJTW5HUM%&G[.3<
M=7S6Y%[SO9V;[)ZWUL=I'/*4GN#(V\J OI\QP3C'4(" >.6S@\U+%=>="8L9
ME!9TR,9S\SC)'3 R >I]L5F,Q2V1?^>C,<_[*J%)_$Y'Y]^E>.=HG#*V2"3T
MX^A)/?\ +/)K]1^MS@X03ER\EJK>NLW=RU>[5KOR2NK(^5]FI1@E%63OM\+5
MDM>VEFEW?8Z?3)(;B5XY)_LVU';+#()7YE4CD')& ",9 -5VO(G9C(RG+'YE
M4JY)SDMA=@.><[<CI6;,QVI<1':LAVN%'"OP9 >IY 5AV.2!T)JI(^UW D.W
M=QC'<!N,8/&0"<_X5H\;-4X4U%2G2;_>/>I%ZQ<KMV??3\58SC2C/F^*^FC4
M5M:^N_;1Z:>=EN8@DP8KE<G^"1BO/9=VWGZX7/J*CECN(R'."F1G:P(&2,#(
MW#GIG/6L3SB.0P.>.1DX_#D'CKVJ6*YEC8-&[;@0<$DAN1R1D'&.,<9([@G.
M*QE*;M*+A.\;R@W&.G+=<FO,[KI:_9EJFXVM;6R]Y63T7NNWPZ]6C<FCG>99
M #RL9))&,%5RQ/3#-U] ".2,&1@5CDGAC\U8G57D*$JC,. !SU;(!) [].*N
M:_XJ?5_[/B33=,L1ING6^GG[%;B!KMH5.ZZNBA42W+LQW.V25&3ELFL+^TW1
M#$D8"D#>H=U#LN2"P#8(4GY05XZ\XKOJU\'"M5=.M4DFKJHZ?*N=K6T;MIWU
ML]K:6NF<\(U)4X<]-4Y+E7+&4)6BK7O*.G,^EM4]_-'N6<Y9F![YR3UZ_EV_
M+'9AFR<[CC'H??U)%-^U6K@F6W_>$'[LN #C@@%#W.>2,_F2T-8MSLFR,GY9
MX@!C_9:/)_#.>G7->?*=WS1K0FY-M\SDI;QW7+H^KM=+3?<WC%*]H2=K+:+3
MVTW:_#?;R4S,#P01WR,5(TY=!\_(X;WSR.@'0<=?TJ!GLSQF=/7+(Y(^FV,?
MY//3#E6S/25^?E&Y4ZGG&%+ CUZ'GTY"C.:DK2A9_P![;1:V:OII\NQ2<4[N
MFTXN]U"_;HD[]-K)/7<NPW F7RW)+;@8B, [\D;2>@4\9/.,#.:BRY<1Y.XM
MM .#SW_IVY_*JJQPEL13/OXP!$ZGKW.25Q[=?P./2(/"E@_A"]\4R^(=,CUB
MUN4MX= 8E=0N(F>-6O$&8UVK&S855)PK$D5WT*-?%QFTX-T(^UG/G@HR@N63
MCS.\G-))0BM9;+X;&%>=*CRWDESSY81<;Q<G9[I:+>^RNOD<5<77E*+96&4S
MYO&06/4#MA<X.,C/0^M!;AE(&.-Q) X!&/QY'8?4YZXBDCN#\TG)."=O/U/!
M./Q//<YZUB"OM^(S^AKBKXJK.7.U*$;)15E%J'NV7=Z)7>[ZZ;=$;)*R3YD[
MNR;=[/3:2UZ-Z+1;6-!IF1=P&8\C'(/7H,8! QVSCZYJ2.>*2"6%_P!V958J
M0,HK[-JGCISPV!SZ"LY9#C:W*^_4<CD>N.N*BE5E1\'!VL V?4'G\OP^HK.>
M*DDYKWHQIR4E*VW+:7WKJNOGJ792E&+NKN*NM':Z>N^J=GL[F)+'(,D;6( !
MV9(!& 200",D'J/?H03,C-';+CEC=-(01MR$A$;=>S)*5_\ K4K S1)=(<3P
M;8Y]IP61/ECF]R<;).HR$Z;Z=+(Q@@$JAFD::8NJ[2%8A-Q[':L1/)QR, G-
M?F:BE/$\K;3P\W3LK-.5>*MI:UTY1:MWZ71],W)^Q4M&I0<W?1Q5+E3>Z;O9
MVZ6O>Z16G(X*D!)%W*H/"C^(<<84YR>.AX %6DQ;0;Y<F>4*T438*(HR!)(I
M&?F/,2X(SM8M@8-K3[)II((D,<MQ-S:6DC*A#!68S3M)E1&57Y$&P2O@=>34
MN$<W$JSB1[@.T6Q "6=3M/[PG&WJ<*?E497)'#C0=",*L8QG4J-*E=W]G4E:
M[O9N+44K:O31]QRJQG+D;]R%I-I;V:25U)[^2_X,,"&:9W<NRJ-\\A.YBI.
M@))_>2D84852<OV(I\SM,QDD8Q# 2.--HV*O&P $[0N,\Y)/MQ2S3!$-K Y$
M*D&1HR3YLHX)WL-[)&,Q+G&_YW/+55/;DGCDG&<_A6-64*3=*/OS3;JREK%S
MDT_=5W=*VCZ[[6-(TG)WDWR_9L];.VFM[?<2).\+JUN/*9""LH/[P,/X@V.#
M]1C'UXM^=)=W[23MYTEXKQ2R2MR9)5*1,3C Q<&)\^BE?XLC/J3):.)U^\C.
MO?@@^;&3[[E/0_P_E%#$V=K\D()SY8)N_+:VE[:-[W]4ARHQY=%S2O%QYWLX
MO=.W;>]QX5S:1PYVN+R9<<GYA"HQ@>IP>Y!_&K<\S)=QHBH\1C,$B,<HP W2
MMCHCK=-*X<G*D #DYJ<%%C^TE%\I))+L#J&,EO JQ#US<28YY 4L> :KP64]
MPNWE7\UFEF/"!78 KAL,^TGY@BL=QP,]1ZL:-=<E.@G*I4A'DM%R<^2UHN5[
M<E1RM+1Z1U5UKPNO"TI5I1C",M7*UE*7+>:T6JWC;9O=7-2Q@WV][Y(+6T,;
M&.7HI6X:%&,I!*I(?*6(KG'S<'D"K-]X9U)-#T;Q-YMA<6FOW]SIMGI]M=)+
MJ4<]E((2MS9*1)$DK,%A8EU=3QARE='#K5MX:\'>(?#ULUK)=^(DM6NYKNU6
M>Y,5M,9$2R!&VTPQS+*RF24;!M7:&'V=_P $Q/V;S\?OVB]&UC6K'[5X$^%!
MM?&OB,3KFRU#5+>Z">%O#\HF#))]OU2-+R]4++G3-.O#MD8HC>MB<+3J5LNR
MCD53&5*:EBE2DG'!8A33?/**;Y84N9MZI.459[KSX8GZO0QF9NRH4JCE!M-2
MQ$>32,$WK*4DN57:W?,GH_Z)_P!AOX 'X!_LV_#SP#/9O#XGU;3X/%7B[,0\
M^X\6>)HK:_O;9T50[/ID TO1K<.26%E&YP&VC^NW]F?X7I\+/@YX1\/2P+'J
MUQIZZUKNT*N[6-547=W%P!\MN72UCX&(X5X'(K\B/V.OA%-\3_B]IEW>PM/X
M7\%O!K^K^9&6M99K9LZ19EGSNEN+Y(I98R0WEVLWRIC:/WXA39&B<#:,8' '
M)X [!>@';&*^5\5<WA&.7<-X27[K"0CBL5"+LHR<(PPM*:5K2C3YJLH;+GA)
M=SS^#,)4K3QF>5[RJ8J<J=&4KN[YW+$3BVMG.,(1:T:C+1.Z'*"%&>#C)'H3
MSC\.E.HHK\>6ROO97/O@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK#Y9,*2068!^G7U[;I?16MY/;1WEKMNHH9'BCN%@GAF"3(C%944#Y49< 9!
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M>B6ROIMI^&JO8KE&#!2K$DX 52V?8%003[ U=AM)65X93';D[7C$KJ)&<#:
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MH3UY>647S.6_+%+:R?/.<J;]I33NX.G7IRNHJ7+=2CK=]&K-J\>FQRZ%ED4
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M )QDD9PV23]?TI\$$EP[!F;8, R;7."<X5%"DNYZ!$!8G';)$MO:K-B2;*1
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M1XJ\16BC3+:X11+H>BS?.  P4Q7FH@K+.%4>3;^5;JV&F#?>Z*%4 #& ,^Y
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MVM\^GW:>'=4\365G*^L67A>761;07^HQVI'V99Q;NTZHI^#=6_;&^(/[*O\
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M1KT)TE-7]R3E":>FNO)ROI:3OIJA;]-FM;VN^K2U?7;6]K=3X2_X*8?M5?\
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MSVTL/AYRHQKXC$RI-4YS7MI1C3E&<90]K+FC-)3BN1QO_F;_ !F_X)I?MA_
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MY?3XXI+-+5H%6UDN8D=))FE8R/(690 RB$IM).X2,"2"2,9+A54QB99(B?\
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MC8!LQW$F-HR^V6.+ VX+'.&&,?P\XJ[%;CRS<3A4VD?NFPHD8_=R2R#=MR1
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M8F$IUI3YI+V]&=&#BG",8-\R2=[1MRW2TE;7:X-ZJR3T6]_*_P#E;;\SQ_\
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M27?PTT;2-/%QI.G^&G:[,=M#83@S6QF2XDCFR0^Y!M_J21'$;(Q]0I!^;;M
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MEL;AY8BL<UYI5V=JSI,'^&(_@]\,_B3_ ,&MG@GQ=XZ\%Z)XG\3?"?X.^/\
MQ5\-M;U2W:6_\'^(+SXXZWI%WJNAS))&;>ZN-+DDL96PZM;N8BIRM?T5?LG_
M +%6G?LL?L3^&_V1-)\4KX@N=+\">,-!U[X@/I36,GB;Q?X[;6[SQ+XPN])-
M]<SI)=ZMKLUPEK)JEQ,MI:V]N]ZS@./(_@]_P37T?P3_ ,$PK?\ X)N>/O'I
M\9:1/\+?&OPXU?XAZ1H;:%)+)XM\1>(/$MMKEAH%YJ>L&UGT._UFVDM[:?4[
MM+F335,DL:S%(T\124[TKJ$,72G3NDI2I4XQ7-*UDN:S<DM=6D[WLXJ*2NO>
MNKWOM;YK^G;<^&O$W[+'[/7[/O\ P0N^.7C/X,_"?PI\/?%?Q?\ ^"=WA3Q#
M\3]9T"TN(;_QEK8^"]KJ9U#6)KBXN!-.-0\0:O> 0B*,3ZC<.$#%=OQUX\_X
M)@?LK>&/^"(0_:2C\,ZUJO[2^E_LK?#O]H'1OV@-;\1ZQ=_$K0O%NG^%O#7B
M;1]'T+5(KR&WTCPIH=B(_"^BZ%96<5O8Z-%"X)U"-;X?JW\./^">7[6<'[$W
MQV_8N^.W[8GAKXM>%O&'P+L_@'\$-:L/@CIGA&?X8^&;#P_J?ANVU'Q.=/\
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M<W*^5OLG:S?H(Z@D#KW./QI 0>A__7Z?7U'6O-_$/Q>^%GACQ)IW@SQ)\1O
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MW-%0>FRYH*>GRDDWU:?H'FFFNZV"BBBH **** "BBB@ HHHH **** "BBB@
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MO:0IRJR5].6,.=OOMMIK^(>FJWNOZ\S]6****P3;2;Z@%%%%, HHHH ****
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MM)<ZYXE,,Z/,+5J^X?!Y+?\ !Q=\5&(_YQI^$N@/\?Q>M'!Y).".!ZU]L_\
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MD-XNB^$_Q$U:>&]\%I?&W\G2)+?3)7T6$Q3#[=J$/VV3U+]GK_@E[XX_9/\
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M=DC&^MGMY)(VPP6&*11+*TBY\LA0#UW8S6G?#2X)%70[21;,+A[S598((VE
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M/VCDM7)Q2OOM9_-_[,/[#'A_P%8Q^*OBGINE^*_&=]:/#_9%]!'?Z%HEI<J
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M]0;P;X!\0:YI%GJ7AS6]$TR2\FOX[:]DF6S=C/)!YA^B?@C\!/A%_P %$?\
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M=2.C_P!LMM5OLO\ :#$>>?Q1_P""F?PDT+X#?#3_ ((Y?L@>+OBOJ/P@\+>
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M8#F6RBGAF_;7_@H#^R?XA_;<_9C\8?LWZ/\ $N7X1V/Q U7PU%XN\26^@?\
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MZM\/]"^+\LQUFS\'W\EO]AL+.]@O#I>BR_V/)%J-FKI+^@WQD_90^.D'P[^
MO@C]B7]I*3]E6V^ ?AQ?!&E:!J?PXT#XJ> _&?@JQT;P_H>B:/XKT'7;BRO5
MO- M?#L8TO6=.O[>^5M2U1Y1,]T)(HEB8P]FE7C5DL0Z\92=6$80<(JUX.$X
M-N[:IM)-:-ZH2UC%;:RT;>E_5=7K\SPW_@EG\5_V'OB)=?''3OV8_P!G:[_9
M'^,OAW4/"]G^T;^SYK_@1OAEXH\+:O!:WD/AO4;OPI8LGAJXTZZA;4(+/Q!H
M-I:OJ*Q*VJ00S&W5M7_@J+XF_8ETK3O@1H?[6_PD\9?M&>*?$/Q!U6V_9_\
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MA)E7I2QE:NTY0YG*"2Y;R48J-U;35=KIZ]!6LDDT[);W5]K]_,_ 3Q3_ ,%
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M=R;=VVVWJ?:QC&$5"$8QC%)1C%*,4DDDDE9+1(****104444 %%%% !1110
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MMX>^(>H0Z#XLU.]O-?G\,VES]CO)K 6EM&41[>S,?[>_MS_L02?MD>(?V/\
M7H_B$O@3_AE?]JGX;_M)R6S>&CXA_P"$SB\ 7\=^WA%)5UG2#H<FJ/%'&-8*
M:FMLF_=IMP2N/(_VL?\ @G1XV^*/[06A?MA?LI?M&:I^R=^TU9^"_P#A7'B_
MQ5#X&T?XC>"?BCX%A;S],T7QSX(U74-*M[V\TJXCM%T[5S=RS6MI9VL$<*O:
M6TJ12K4IPHQJN\W0JT^:I>2A-5H3HMR7O6]FG%._NZ6=E8$K.3[I?*UCXM_8
M"^ ?[0_P>_:;_;*\70?LDZ[^QM^R#\8?@58:]IOP<U/XA_#_ ,9:'I'QY\.2
M7-IJ>N>#](\$ZO>0>&['Q'X9O=1;4K.TL+6RDN;2U7S(8H+&VB^6O^"0?_!-
M']D;]HS_ ()@O\2OCE\-[?XJ>/OB3;_&CPY;^*/&EY=ZSJ/PWT#P_P"+_%>F
M:'I/PM:298_!,%C?6\WB8W&D+%>W?B*_N[R\NKB$P6L'[F_LQ?LW_M;> 5^)
M^H?M2_MEW?[2NJ^/O#5CX=T'1-)^$OAWX5^ _AY%$FLF^OM'T72=1U/4-7U3
M5/[4MH+V^U#4HR]KI5HJHKNQ31_8)_8QG_8G_9#\+_LM3>/A\0G\/W'Q N'\
M9Q>'7\.)=GQOXDUW7U2/0SK&M-;C3H]76U+'5)A=- T@6'S%1%+$KEJ)RBI.
MKA4Y04O>ITE+FU:<KM25W?6W=W3TMY^5U]_>S6JMKW/PX^!VB:'^TG_P;-/X
MA^.6AZ9\4=>^%?[/_P"T'J?@+5O&-K'K>H^&-;^&=W\2/#G@K7M)N[T2RVFK
M>'/#ZQZ3IMZC>=#81+;EFC!!^OOV4_V%/ .O_P#!'[1M-_9B\)> _@A^T1^T
MW^PWX8\,ZQ\7?#&DV^@Z[X@\1^(_ MK=_P#%3>(=.MGU)[/6=7N9[?4[Z)7N
MK2/4KO4+=)+N&(5]E_LF?\$[-#_9Z_X)WI^P%XS\<R_$OPU?^$/BKX+\0>,;
M+07\*2ZGI/Q3U;Q-?7K6NC2ZOK[6<NG6GB'R("^IW*S3VPF9$1P@\-_9H_X)
MT?ME_ 3]G_QS^SG>?\%%?$.K^#]+\#Z%X(_9LU[PY\$_#/ACQ7\%H] \06VO
M66KZGJ4^N:S<^.LZ?91>%9](O[JVL)=$N+V)9(G:U6W=3$0E&K3IU(PIK&K$
M4^>,FFG%1=TDWLE=-_>]Q))MWZZK=-=_PU5[-6ZGQQ_P3U\0?LP_ ;XQ?LR_
MLN?M.?L!:=^QY^W!X1\-WOA?X3?%ZW\+:#J7@GXX:UI?A2?0_%6K>$/B_P"&
M)GGUW7/$^D75YJ5_H_BMKXK<WYMQ?MJ;VEO7]-,>=BYSG'.0 <GKPO QZ#@5
M^,'PP_X)L_M)^*?VC?@7\?\ ]N3]LRV_:9;]F>[US7/@QX)\*?!+1/@YHVG^
M,]:L$TQO&_BJ[TW7M9FUS4X;.*.2'3X8+*T2\$4H<11/#/\ M"HV@ =OP[YK
M'%2IRJ)TY1FW&]24')TG-NZ]GS^_&/*TN675.UE85[WZ:O\ I7_KS8M%%%<P
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444FKM/M?\0&N@<8->?\ C3X7^!_B%9M8^,/#>EZ[ 5=5:ZM8
MS=0EUV[[:[ %S;., AH94Q@8Q@5Z%154*E?#5(U</7JT*L&G&I1G.G.+5G>,
MH.+6JWOT7RB=.G4BXU(0J1?V9Q4E]S35S\R_B/\ \$]-%G>?4_AIXHNM)N'W
M&/1?$(:_L0<EMD6I0(;Y%QA%:Z6[9?E)DR#GX;\??LQ?&#P*9EU[P3>:II67
M\W4='BBUS37B4$%Y(8!/*J$%@PNH(^",J :_H8J.1 Z[<#TYZ8(P>*^^RKQ*
MXBRWV=/%3I9I27N_[5%K$):64<3!J;L]G.,_0^7QW!^58MRG0]K@:DKW>'FU
M2N]VZ+O&[U;Y7&[/XM?B_P#L _LI_&66[D\9?!C0M-UR8LTGB#PK#-X)\0I/
M(X9IIYM"-A#=W&0Q(U&SO(F<>8\9<9/YO?$W_@AMX'OS-=?"/XO^)/#CG+II
M?CO2;+Q#8$G 1%U71H]&OHHDR23-:7S%02>1FO\ 05\6_!'X8^.-S>)_!6@:
ME<-G-Z;""WO\DGYA?VJP7F1N.-TS8.",$#'RMXQ_X)^_#G5FEN?"NO:[X7G=
MB4@DD&L6*';A-J7+)<H%P,E[B9R/^6@))/V>'\0>%LS]W-\KJX6K-)3K*G"N
MNB_CTN6M;K94]-7K8\?_ %>XCRYVRW,X5:$?AISYDUM[RA-N%^F^W;8_SIO'
MW_!&W]K[PG)<3^&K3P)\2;%6(67PWXIM-+O-H&0K:?XE32!O) "I;W%R2> :
M^9;S]CG]I?X6ZA>7?Q#_ &9?B-J^FQ65[;M'9:3?ZE803RQF.UO_ .T?#9U&
M >0X\P"258W(52.2#_HS^(_^"?OQ1LF<^'?$?A?Q!$I8JMVUWHURW<$K,MW:
MAW'3%RQ#9)=5.ZO%=<_9-_:!T$R-<^ ;_4(E8*DFCWFDZJ)1UW*;.^GN0JGG
M$T$;G!^0C!;V,+5X(Q<XSPN=8:$M.6G6Q<8-)\J4?8XF%WRZV37?5;G//,.*
ML)!QQ65^V2YKU:6'G%RTLY>TIMQ5W9\RNEORH_S8-3\(>+-":5=:\,^(-'>-
ML21:EHVHV+1,2?D87=O$1@@@EL9(W#)/.59"T6[A.HB9;/>//\J-_,*, %P<
M8(+9!P<D<8)XK_17\1_!3QPF]?%/PQ\22PQ@ESJ?@V\O;4)@\EWL)(SM+8&]
M@ 3D9'!\4UO]GCX7Z@\B^(?@?X!U"0!?,CUKX:>&KJ4."7#9O]%=@[;\LP=6
M;)!Y.#K'A;!U*GML+F]&2OSQ7+"<=97M>%5)JS2<=$]=M#1<75HTHQQ.45DK
MQ@^6;OI&-G[T$T[IW;U['\&GB[Q%;>(;VT>UTW3M-MM+TVVTFV_L^U^RF[AM
M-Y2ZO2&+374AD/FRMU"H"#M^;#T;2K[7]5L-$TR);G4=2N8[:TM_,2-9)I#A
M099&5$'!+,V JKNR<$#^ZZY_9*_9JN8Y$G_9L^"3>8/W@'PC\#02,X8-N:XM
MM!CG5N"-PEW8YR3UMV'[*W[-^E7%G-8?LX_!:UN;9HY+2X@^$_@Q;J":%]Z3
MPW0T,W$4R;B1.L@E!"$,I0,;GPG4JU74J9E3:FXN2A1<&U'E>CYG;;:UO-[C
M7%]&--TZ> J1<9-Q52M3?+=*^E^9VLK-R3UV6Y_"W>Z5J/A+Q!>:3XATQ)=0
MTQY(+O3WDWI'(\:D-YMOOCE6-&1AM<J2<$CFJ^F^&/$>M2!-'\/:WJ)D9C''
MIVDWU]]XEMBBU@E8JFX*"!C'. ,U_>]8? 3X:QWC7NF?!;P,+VX;=)=Z?\-]
M 6YFD^5&=KBVT02N[!1GS)&S@=5 !]CT#X*^,6\M/#/PLUZ.)A^[72O!UW:P
MD>C/:Z>D"<< KM&,\4ZG#. A)^VS6A1AK*TXTJ<[65KU)U-==+M)):)+8A<7
MUW%_5\KE5JJRE-2YK[+:$==&]F]+;'\&WA']CC]J;QV(7\+? 7XG:E;W&WRK
MV7PO?:98."0-PO\ 55L;$(,\NUPJCC.-P-?7G@/_ ((\?MB^+?*EU_1_!OPZ
MLG",TOBKQ79W=TBMC<!8^&TUN82KS^YG:WD. , <C^V;1_V4_C]XC91:?#K4
M+9.#YFLSZ7IB@$\*RZC?VTFP8.56-B3C<5^7=[3X=_X)_P#Q8U3RW\0:SX9\
M.1@@LJ7%QK-VBE1DA+6".T+*004%X5Z'?TKAE3X)R]-XS/*%>4;\U/ZY&=]5
M;_9Z$92V:M9ZN\NEEK_:_%.,;6&RIT$[6E[&2D[I.\:M:22Y=&TXJ_PJS=S^
M1OX9?\$-/"UGY%U\7_C)K6L2 *9M*\!:-9Z+;[1U3^V=<35+FXC<GEH]+B=2
M<"3^&OT>^$O_  3Q_9)^$ M)/#7P;T#Q!K<( &O^.GD\;ZM+(FY_M"6^NM)I
M5I<$@$+IFCV<>X*0@89K^E3PA_P3^\!:44E\7>(]:\3R*P=[:U2/1+%F'\#&
M*6ZOV7'5EO8F;.#A<BOJKP?\!_A1X%2(>'/ ^@6<Z!,WL]DE_J#%23DWM_\
M:;A#DYPCJI/+ GFO,K<?\(Y6N7*<JJ8RJG_$5*-".RWK56ZC6B:7(]-%9%1R
M+B?,(_[?FBPT)?\ +N,G)I=G&G9/U<EU:O9(_#7X>?LY?%CQR+>U\*^ ;VST
MN)%AM[V[MHM T.TCCQ&J0-.86\I &8'3[:7Y< ,Z@;ON;X;_ /!/:T22"_\
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MK<ZDCP7":@FK^=_8.^=K8ZX.,],XXS_^H_0]*_&7XH?\$S?CIX3_ &AOBO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%
M,<1/CT_J*YR9<AB3P<G/3O\ K_7KBNCG_P!4_P!!_,5S5QRCXZC!'J/E/3V)
M.".A!.:VI)-I:7<K:KS7SM_74RFVMGU[VZ1LK_-Z=3GKL'! 8Y!*X')<G/'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:1%I\MK:ZMXMOHFBEU&[ETRPMT>"ZO+&W:">6>ZF%VEO;>H?M ?L ?%#XO\
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M/X=OK*&WMY9K*X)2&YM[B*W91M>4E9V\V&-X8VN/UKG_ &1_VIG;=_PSO\:
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M:8*[7^ GQ<49#'=\/O$ZDE<8Y_LW)(X( R,#'/!&U!^R_P#M'JN'^!'Q;PY
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MEU64(OE7):,HQBTG[S5].6UW^>/[:/P9\>?&[X3Z+X8^'5II=SXATCQUX?\
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M9=-&[/;U,'@G1JNM-RG*52M.,7HJ<:KB^6.FEE%75[-N^G7?L@0I].G7\O\
M]=7:JVL;QQX88SVQ@^OIGN1C)Z<<5:KYV6[UOK?[SUE?JK!1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ111_7W )M'JW_?;_P#Q5._$GZX_H!110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ny20053122x2-map.jpg
<TEXT>
begin 644 ny20053122x2-map.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
M+0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0":
M )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T!
M$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I
M ;$!N0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<"
M<0)Z H0"C@*8 J("K *V L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-:
M V8#<@-^ XH#E@.B ZX#N@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$
M?@2,!)H$J 2V!,0$TP3A!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%
M!=4%Y07V!@8&%@8G!C<&2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&0<K!ST'
M3P=A!W0'A@>9!ZP'OP?2!^4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC[
M"1 ))0DZ"4\)9 EY"8\)I FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*
M\PL+"R(+.0M1"VD+@ N8"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT-
M#28-0 U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/
M>@^6#[,/SP_L$ D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('
M$B8211)D$H02HQ+#$N,3 Q,C$T,38Q.#$Z03Q1/E% 84)Q1)%&H4BQ2M%,X4
M\!42%3055A5X%9L5O17@%@,6)A9)%FP6CQ:R%M86^A<=%T$791>)%ZX7TA?W
M&!L80!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;
M8QN*&[(;VAP"'"H<4AQ['*,<S!SU'1X=1QUP'9D=PQWL'A8>0!YJ'I0>OA[I
M'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B<B52*"(J\B
MW2,*(S@C9B.4(\(C\"0?)$TD?"2K)-HE"24X)6@EER7')?<F)R97)H<FMR;H
M)Q@G22=Z)ZLGW"@-*#\H<2BB*-0I!BDX*6LIG2G0*@(J-2IH*ILJSRL"*S8K
M:2N=*]$L!2PY+&XLHBS7+0PM02UV+:LMX2X6+DPN@BZW+NXO)"]:+Y$OQR_^
M,#4P;#"D,-LQ$C%*,8(QNC'R,BHR8S*;,M0S#3-&,W\SN#/Q-"LT932>--@U
M$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.% XC#C(.04Y0CE_.;PY^3HV
M.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_
MXD C0&1 ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:
M1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+
MXDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q
M4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9
M&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV %
M8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUG
MDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>
M;WAOT7 K<(9PX'$Z<95Q\')+<J9S 7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW
M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$
M?^6 1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B 2(
M:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI &D&Z0UI$_
MD:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:
MU9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16
MI,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVN
MH:\6KXNP +!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1
MN4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'# [,%GP>/"7\+;PUC#
MU,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZV
MSS?/N- YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':
M=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-
MYI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_R
MC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[<
M_VW__V1E<V,         +DE%0R V,3DV-BTR+3$@1&5F875L="!21T(@0V]L
M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>MQVFL:/X>U35/#MS<:6AO[5+5I8K8W2[/JC_@I1_P %'O@G_P $O_V?M/\
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M,@4_ []J@1[\&0>'?AP2$SC?Y?\ PL0$G'.W=[9[U^H'[!G_  7H_P""=/\
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M4>";)/#N@2ZB(+DZ?IMO;66J>(=?O4@FGM_#^AZH]G#<7WV6WF_'G2OVW_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$MXM2T]YDD2VUG1;PVVLZ'?!#)IVL6%C?0D36\;#^4']J_0?CY^P)<_M;_\
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M? #5O#LG@O2XO"/B+Q9I]SJ-I'/!=WUPNM3R7/\ :=BD4$44<<D_Y5_\&?\
M^T;\ OA)\+?VR/!7Q5^,_P ,/AIXK\4_%;X*7'A70/'WCGPUX0U3Q2NIZ-XG
M\.V<?AFS\0:EI\_B"YDUN6UTQ[72$O+B&[OM/BFCC:_M!-_8!^QG^PM^S?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M37!D@D6,.Y9]\L2CZ>:6)76-I(UD96=8V=0[(I4,RJ3N*J64,P! +*"02,_
MOASXF:_X.\$KJUS-=VN@7=K8W>FZ>VJSR:E<:O\ VE;1OX?T.?43J/V+1HM-
MAN-;NI!;3S1VFK6MF]RLOV9SYY'^T)XEO-:CU+Q/I.D^)K6VD+6%E>1?9I=/
M"W<]U"UM=VJH1,@FC@EE:$FY@M8$E!PY?GGAY3DVN2*2LE'2]K='I>[UU225
MKNS8DG*[2_K^M3]0**^&-0_;$N?W']E>"H?N,;DZCJKD^9YAV"$6UL,IY8!9
MG(.]B N%#-SUG^U[XPBO9I;WPWH5WI[REHK.*2\M;B"$GB/[:7G25U7@R-:*
M'8[MB#"C'ZM5MLEY<RO^#:_']0Y9=OR/T(HKPOX<_M >"?B!,FF[YO#^N-&6
M&G:L\*17)4$N+"^20PW)11N\N5;:X*Y*PLJDU[=!<VUTGF6UQ!<1_P#/2"6.
M9/\ OJ-F7]:RE"<':46GY[:[.^S7FF22.P16<AB%!)"JSM@=<*H+,?0*"3T
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\4:&_AKQ#K.@23I=/I.H7-B;A%*+-Y$A42;&+%"PP60LVULJ&8#<2W]?=?\
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MS\J4GHWIIJ]=7:^_7I=HTCMJK/;:S_JUON"BBBJ*"BBB@#]$/V0_^1"\0?\
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M_J-]^"/[;G[:'[1;?M)?$WP;X4^)'C+X:^$_A;XXU[P1X=\/^#=;U#PU'/\
M\(GJ<^D2^(M9DTN6UGU;5-=N;.752]_+=0V-M=0Z=IX6S@4R_P!+5?'_ ,</
MV$_V</V@O&,?C_QYX;U[3_%TL=G!K6L>#/$ \//XG@L(8K6T_P"$AM9].U2S
MN;R"SABLEU2R@T_4YK6***\N[GR+9H?ON .,LGRWB7,\[XSH5<VK9CAIJ..J
M8>CC:M#%RJ0E.HZ-9QBE6I1=%3I)2HP4:,(*A4GR>9FF78BM@Z&'R^4:$:,U
M^Z4Y4XRIVLDI03?NRM)J6DM7)N25Z_[!7QO\:?M ?LV^'_''Q"*W7B[2O$WB
M/P/JFN+;Q6A\5)X>@T>]LO$<UO;QPVT=[/::Y%I>I/;1+%=ZCI%UJ#!9[R:*
M+[(KE? _@?PC\-?".@> _ >@V7ACPCX8LC8:)HNG^<T-K"\\UW<RRSW,L]Y>
MWU]?7-S?ZCJ%[<7%[?WUS<7=U/+-*['JJ^#XAQN S'/,UQV5X3ZAE^+QV(KX
M/"<L8>PH5*CE"'LX-TZ6CYO94VZ=*_LZ;<(Q;]3"4ZM'"T*5:HZM6%*$:E1M
MMRDDDW=ZOM=ZO=ZLGM;:6\NK:T@4O-=3PVT*#JTL\BQ1J.O+.P X/6NP^(UQ
M%/XTUV&V8-::7<0Z#9D=#:>'[6#1;=EX'#QV*R=.K$]\U)\-88V\9Z1>SH'M
M=#^V>)+H,,H8?#EC<ZT5?@C;(]E'%@CDR =37$SS27$TUQ,Q>6>62:5V.6>2
M5R[L3W+,Q)/J:\A.SOU2^^[3_#EU]4;_ &O1?FU_D=U\2B7\2QS1Y-A/X>\*
MMI$N<K-I47AS3+:TD']UP('CGCR3%<QSPL2T9K@*]$\3I_:7A7P5JNGJ9['2
M-'D\/:HY(>ZL=7&K:KJ?E7NTDI;7<%\)=)D*A'@BF@#-/;3@>=TNB\DE]VE_
MG:_H$=EY:/Y:!1110,L6]W=6CK+:W-Q;2*05DMYI(74CH5>-E8$=B"#7=Z5\
M6?B3HH4:?XTU^-$^[%/?27D0]O*O?M$>#W^7GO7GE%#L]TI>4M4[=[BLGNE]
MQ]':3^U)\4]/VK=W.CZQ&",_;]+2.4@=O,L);/KT)96//':O0]/_ &QM30(N
MJ>![&Y.,/)8ZU/9\_P!Y8I]/O1_P$RC_ 'ACGXNHK.5*E+>G%?X5R]$ME9=.
MG5L7+'M^9^@EA^U_X2EVC4?"^OV9(^8VLUA?*#GG!>2S8C'?:#[5VEC^U%\)
M[S;YU_J^G$@$B]TB<[2>H+6;7:<?[+'..,U^8]%0\/2?V6O23\N]]?PUV%R+
MN_P_R/ULL?C=\*=1P(/&^BQEL86\EEL3DD  _;(H #D]SQWQ7:Z;XJ\,ZPRI
MI7B'1=2=\E8[+4[.YD; +'"0S.YPH)/' !/2OQ>KU7X,@)XW6^;[ND^'/%^J
M$_W3:>&=4*,/0B1TP>,'G(QFH>%A9VE)-)O6S6BOT2)<+)N^WE_7]?>?K.LL
M3_<DC;C/RNK<>O!/%25^)D&I:A:D&UO[VV(/RF"ZGB*_0QR+^8K=MO'7C6SQ
M]D\7>)K8#H(-=U.,#'LET/05+PG:I]\+?^W,.1]U_7WG[+45^1=K\9?BG9D&
M+QWXC; P/M-_)>#'N+L3Y_'/;/2MR/\ :$^+T2A1XPN7"C&9+#2I&/N7>Q+$
M^Y)J?JDNDX_.Z^>S#DEY'ZL45^5J_M%_%]01_P )8QS_ 'M+TAC^&;&I1^T?
M\7P,?\)0A]SI&D9_](@/TH^J3_GA_P"3^7]WU_IZ')+R^_\ K^D_*_ZFT5^>
MVE?'SXFW7P]\2:XVL6QU70?$&@0B[GTK3C#=:=K-OJ4+6,426Z1"Y@NK%+O?
MLWM 95W *%/#_P##3?Q>_P"@[8?^"/2O_D:E]5J=X;VWEV3_ )>S0E%N_EIO
M_7]>9^C>L>,/#V@:QX?T'5K];34_$\UQ;Z+ T4KK=SVQ@$D7F1HR0L6N84C,
MS(LCN%5B00.FK\G)_C%XI\0^,/!GB7QC?'4H_"6KVE]"EE96-G,+9;ZTNKQ(
MUMX[>.265;1%3SF !4+N168U^A_ACXU?#;Q=/:V>D>)+<:A>2/#;Z=>Q3V5X
M\D< N)%6.>-48+'N_>+(T;-'(J.Q4TJE"4(Q:3EH^=Q3:B[^B:5NK5M-Q.+6
M_P#7EZGJE%<;%\0_ \VM'P[%XIT636Q<-:?V:M[$;@W2D*;=1G:T^X[?*5BY
M?*A2P(KLJP::M=-75U=-77=7W0@HHHI %<MXJ\:>&O!5O97GB?4X]*M-0O!8
M6US-%.\!NC#+.$EDABD$(,<,C!Y=J?*?FX.+WB37]/\ "V@ZKXAU1V2PTBRF
MO;G8 TKI$N5BA4LH>:9RL,*%E#2NBEE!)'YK?&WXT7?Q,O!I-E$+;POI6J7%
MUIG$B7%^/L\=K!=WL;,561!]KDMU4*8XKTQR*70LVU&BZKN[J"OS2\[:);ZO
M3IM=C2;?Y^A^EUOKVB7=C9ZG;ZMITNG:@H:QO5O(!;78(8_Z/,SA)3A6)5"6
M 5LCY3C5!# ,I!4@$$$$$$9!!'!!'((X(K\:)_%VKW/A*R\&SS>;I&G:Q-K-
MBK%C);37%LUO/!&<X%O(6:?9CY9GD=>97S]]?LS_ !,7Q5X6_P"$5U6Y#:[X
M7BBAA::0>;?Z*?W=G*I8[I)+(@6<W4A!;2,2TK&KJX?D@YJ7-9ZJVT6]'?K;
M1/1:NZT&XM*_]>3^9]/45#'<03/+'%/#+) 56=(Y$=X6<%E6558F-F )4. 2
M.0,5-7,2%%%% !1110 4444 %%%% !1110 4444 %>!_M*>(/["^%6L0(^RX
MU^YLM#AYP2D\OVJ\ &02&LK2XC/^_P#@??*^0OVP+J)/"?A6R:VD>6XU^>YB
MN@<0P+:Z?+'+"XS\TEQ]K1HQ@X6"4Y' ;6@KU8+^]?\ \!3:^6FOET8X[KU7
MYGY_,S/C<S-M4*NXD[57HHST4=@.!7U?^R5XG_L[QEJWAF:3;;^(M,,]LI/!
MU'2"TR*HZ9DL9KUF(Y/D(.1T^3JZSP+XA?PIXQ\-^(4<QKI6KV=Q.PR<V9E$
M5ZA Y(DLY)XR!R0Q KT:BYX3C_,K:]U9K[FD;25TTOE\C]E**RM(US1O$%K]
MNT35+#5K3=L-QI]U#=1+)M#>6[PNX20*RL8WPX# E0"*U:\EIK1JS[,P"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P"-0T4"LNR_K_AE]Q-]HG_Y[2?]]G_&C[1/_P ]I/\ OL_XU#10%EV7]?\
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M)O\ KT3>J26A459*]K_IVOU"BBBF4%%%% !1110!^B'[(?\ R(7B#_L:IO\
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MUU'4+JTT51;VB6&C:;=ZK=VUEHL(33I[J[ALY(D2>WD6YN)?,N_.W2%N@O\
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M2=4O5@N$CBM[:-YTL8) [VTJ2S[9[D*IF1UA1R(I5K[7          P !P
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MHH **** "BBN0\8^//"O@*P74?%&K0Z=%-YBVL)#S7E[)$%+QVEI"KS3,NY
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M>1Y?15W4+"XTR[EL[D)YD8C=7B=9(9X9HUFM[BWE7*RV]Q"Z30R*</&ZG@Y
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M@HHHI#"BBB@ HHHH _1#]D/_ )$+Q!_V-4W_ *:M,KZPKY/_ &0_^1"\0?\
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M-0DNK_4&LRRO+:0WLWF0PSE&91,5'FN@)\HR>6WSHP'LU(2%!9B J@DDG
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MG18;ZP34-,M[CQ_XJB@?QK<1R*UM*-!@N%M8-.OXIK2YUEM%-U'=6,MW9O\
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M?0_D:,'T/Y&@!*W+#_CW7_>?^=8F#Z'\C6W8@BW7(Q\S]?K0!<HHHH ****
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M9SLE?2-UNVDKV6M]KL^PZ*_FR_8<_;1_:-G_ &D_AMX(\8_$GQK\3_"/Q/\
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M%NJ-YJ)RH2ZMY(+H+&2B-*T8QLP/5J\V:DIR4W>5W=]WW6VG;1:=$8A1114
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MW/PRCN9?B'X*CM(6N)SXET<K$D<4K,BWL33'9.#"0L*R.Q?A54OD%01^P_\
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M@>N?,U2Z?.>Y.<D]SS6&O,MK):W3>[7:4;:)][^6X._-II[O:_4[4? OXCL
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M#R*T-5U?4]<O9-1U:]GO[V58T>XN'+OY<*+'#$O18XH8U6.*) L<4:JD:JH
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MUO=*^O4]=Z?\ ****S **** "BBB@ HHHH YR?\ U\W_ %UD_P#0VJ*I9_\
M7S?]=9/_ $-JBH ^$?\ @I+\&?CI^T)^R-\1/@[^SW>:=9^.?'%YX8TV^_M+
M7CX;AO/"$&O65_XFTT:L(Y!$NI6=HME>6SF./4--FOK"5GBN7AE_('Q5_P $
M9OCW^S%IGP-^._[ 7Q#U*Q_:2\#^'](A^*7ACQ)XGTB+2?%?B"ZTRU_X2.?P
MQ?:M9:?X>FT"XU%[_3]0\(^*F.DZGHWV*XCO([^UDCO/Z;**^WX?\0,_X:R^
MGE67+ /+GC,5C,;@\5A(XBAFRQF&HX2MA<TA*:6)PBHT4J=./LIPE*4E5?NJ
M/GXG+</BJCK5>?VO)"%.I&3C*CR3<XSHM:PGS-\TM5)635EK^+__  3(_8S_
M &A_@=\0_P!HK]K?]L[7= @^-7QS1$U72=,U31;RTT#0[6_?7-=U77+_ $(C
MPQ9"YFM-*@T[3M&NKFPT?1]()ENE:X^SVOYD^(X+_P#X*P_M5?M-_M$:K'=7
MG[)G['?PD^(]A\+K.Z29-)\3^(]+\+>)+WPI<1VTP1)KCQ%KUC/\1->#Q/+%
MH6E^%/#>LQF"XM%K^A'_ (* ^!OC!\3?V-OCY\//@-:SWWQ3\9^$+;P]X>T^
MUU.QT:XU&RU/Q#HMMXKT^'4M2N[&QM7OO!K^(+0-<7<"R>=Y*2"62.OYMOAU
M\+O^"SO[*7[,?COX-^$O@+X)\+_!C_A&OB'J_CR[N5^$^IZ_>:7KNB7P\7ZU
MJ.L1^-)=3OK^#P_$;2SDBAEN+:QTZPM+2%OLT2-^I<%YC4SYY[Q;4S?A?*N*
M\;7P'#N5X/%X[#Y/0RC)*5#"0QE?*L+.5:M[2KA/9Y;@'#WJ4HXJ3KN3<7Y6
M-I+#O#8-4<55P=)5,56G"$J\J]=SDX1JR24;*HY5:E]WR:+<^M/^#;4D?"_]
MJ3'&/'OPX_7P]XE_P/Y^U?MQ\1O@;^Q]X'\)>-?B;\0/@#\ ;?P_X3T+Q!XU
M\7:YJ/P?^'ES+'IVCV5UK.LZC<2S>'7FNKIH8+B9BSO<75PP4%YI!G^93_@@
M#K7[5-E\5]<TGX:>'-#U#]F75?$L!_:!U_4%T;^U=#U*U\">+Y? HTB2YU6U
MUH27>LBTAFCTS3=1@>&23[68$'FI^@?_  <!_M5'X:_ 3PO^S/X9U+R?%GQV
MO_[6\716TH%W8_#'PI?V]PT,ZHPF@3Q9XIBL+*!QF.]T_0?$5C(&CD=6QXUX
M>S/-O&BKE.7YC[/^WZV68C$RRW&3]M@<#A\#1IXOZ]&DX>PQ5&AA*^)I4*C?
M-2K86:DOK"2>!Q5*AD:K5*=_J\:B@JL$HU*DIMP]FY7YHN4XQ<UM)27V;GP!
M_P $@_A);_M>?\%"OBG^UQ>^"="\'_#7X2ZQJWC;PUX4\.Z+IFB>&=#\6^+I
M[_2?AIX5TW2M*M+/38XO"GAJ#5-8DFLX$D75M%TJ^N5,^HF9N@^&UEI7[4'_
M  <!^/1\3+&V\4:!\.OB#\3[33] UN"/4-+*?!+PCJ7A/PG ;*Y62V-OI_B#
M2;'Q(D!C:&74H6GF1C/*6_<?_@E#^RX/V5OV,?AOX<U?3C8_$'XB0#XK?$83
M1&*\@U[Q?:6L^F:)=JX$L,WAKPO#H6AW5JQ*Q:I9ZG,H5KAQ7X/^$_$^@_LA
M_P#!?3X@ZS\6]3L_!G@SQK\1OB7>R>*/$$\6G:)9:=\;O"6I>)/"^K7.HW31
M6=OI,GB+6M-TF^U*>>.RTX_;)+N:%;*X,?T-#B!<2<2^)ZRB4Y/*. <RR+AF
M&'G*=>6$P#5*O4P<HN52=3$XMJK2G!^UE"="-W**9S2PWU7"Y2ZUE[;,:6(Q
M;DE&/M*JNE)+1**M%IZ:/9-G:_\ !Q+\.?#G@#XE_LL_&+P3I=CX7\7^(]+\
M?Z/K&K:%:P:5=7-S\/=2\$:OX2U*62RCA,NHZ<_BC4X8;Z0-<QP6]C LGE6T
M*1Y?_!?OQ#)XS@_8!\67*)YOBOX:>+_$-Q&%Q'YFNQ?"K4I4VL#\FZZ9=I!^
M7@BD_P""\'Q>\$_M+_&S]E/X _ CQ/H'Q1\6:,?%-O>+X(UC3_$]B/$OQ6UK
MP5HGA7PX+_1I[VT_M@CPW-=7=DLSSV]KJFG2S1Q+,F^__P '!?AR+P?=_L'>
M$H9#-#X6\!>./#D4I7:98]#?X7:8DA7G:76U#8!(&<9KU^"E6I+P4H9BJL,T
MCA..YJGB%*.)A@)4,3]5]I&:4XTY45A_8<UDZ<5RZ)VQQMF\_E3LZ/-ER3C;
MD]HI4_:)6TNI7YENFW=%W]AN[?\ 8!_X+!_%C]F+4)&TGX9?'F6YT7PE;R2-
M'IRQ^((!\1_@S,KMA;JXLK;4-0^'L,B\G5-8NX?ED5T'J?\ P67\4ZQ^U1^V
M-^R=_P $\O M],\4OB+1?$_C\63&5+#6?&LSVEK=7T )Q-X(^&UIKWBIRP(&
MF^)B^<[PN?\ \%\_A3KO@#Q#^RI^VS\/Q+IOB3PAJFF> ]9URW0[K#7?#EX?
MB#\+-18H!^\ANK3QA#++(WS+;Z; I  !QO\ @C1I'B;]L#]N;]IG_@H!\2M/
M"W&DM=Z?X8A+27%II'BKX@HVGVFF:5>2HIN(?!'PRT>3PP!M21;+7M.FD5"Z
MJWFPGA*V7X'QGJ3I2Q66<'8G+J]*?*YU.,<+4CD> Q-6$KN2KPQ,I[N4(4\/
M426C=OFC5J9'&+Y*N-A5C:]E@9I8FK"+Z.,H.%M$W*2U:.&_X(S>'])\)_\
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MS?ZA\)_@'XGUTZ>H>5%\3)X0\6_&+7[9%0D)/JOA+P]X0TZW<@!;R>!9%*@
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MMCY=W9+)&ZJVQ<IX9.4>1\L6VFGJXZ7T>\KVZO1O30EPLUV;MZ'U%XT_:/\
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M5_A/XT;6=/6S6VLO"MII.OVB7-KJOB2_L-0DL]/L;N8R&+5;33-+,\<JQ(#
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M3SU_&DHHIF@4444 %>O>*3'KGPP\#Z]:[[.#PW>7?@>[TL%7MGOC"=<.NPR
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M(]9NKA6(Z M#:Q8ZG:%YQBO'J2V_[>E_Z4TOGRI?ET)CLWW;84444R@HHHH
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M:_M*?LZW6N?#?P/:>#_L.I_#UKSXBV=[I,%O\0?ASI7A\Z)!XDLKB.]:3)^
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MB&+4]:\(W$^E>(YY[S49+6ZF:XTS49YW:=K558AM.RY*6\D1>&)2$>$J Z?
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M'#?$SQ7&O M;RVL0#U'V#3K.S(_ P$>V/2BVJ?E+\X?G?\!=5Z/\XGF-%%%
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MLMEHC>\.^)-5\+Z@-1TF9$D:*6VNK:>-;BQU"SG0QW%CJ%I(#%=6D\;%9(I
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M?UT_/NP+?VZY_OC_ +X3_"C[=<_WQ_WPG^%5**+^GW+^NGY]V!;^W7/]\?\
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M_"M2UD>6$.YRQ+ G '0\<#BL"MRP_P"/=?\ >?\ G2 N4444 %%%% !1110
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MPKX;OQ>21M%)J%]!I-KI^LW,\4@5XKH:O:7D=RKHA>1// 99E=SK\G]]XO\
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MU23QCJFJ>*=$T&;1M3\/LL'AY/[1M]4NIK<:%I.FW-I-;Q3M/+:074<O=?\
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ME=0V\\<L3:C+:3>3ILKQL([DA&PLS&O*))'ED>5SEY'9W. ,LY+,<  #))X
M '0 "ENVW?9*ZE*-]V](M7WM=OHU:R3<63E+3:W7\+=M/PT\O8/#OQ2BL9KK
M6M>TK^V/%VG0ZI-X2UUV\Q[/4=5EED<ZJD[M]KMM/ENKF_TIES+:73-$ T4J
MO;<I+\2O'-SHMWX>N_$FHWVC7L'V::ROG2]00"6.<1PR7*2SVZB6*-@()8P"
MB^@KAZ*=E=.RNFFO)K:R>BMJ]$MV-1BNGWZA117TU^S7X'\">-]7U^U\6VIU
M*^LK6SN=*TR2:ZAMY8/,E%_=2&V:+S&@?['&(Y9@A6X;$4N6:-2DH1<I7LE?
MW5=[]KKYZC;LKG*?"RX\4:II7CS0] O=:.MS^&8KO1$L]4OK=F.G:QI\FHVE
MM&C&%IY[!Y63#PS?N#!&Y2XE1O.=3\1>,-9MK?2]<UW7KZQBNRD-MJVH:A<6
MD%U&1%(?*N'D198=X$FU#)&&QM!.#^J7BO1V\.^ ];B\":)I=I?Z=IDL^F:?
M;6QM()3;,EQ- !8O:SM)/%%($VS*TMP8_-9@6!^8+/P]\5=8^&Y\?V5[HMA<
M?9[W5(?!DGA?1!HQT:!FNI=0LX+RUN1%K&IE;BYFDF0RZA:R1Q27"D1+64*T
M9WDU&*YE&/-+7FLEK:+M%I>6SO)Z&:DM^5;JWE^%_P -^Y\]>*]3E\$7<WA#
MP[_9UG<V.F6FF>(M;T^VE75+[57@CDUJWBU2[5+R&R6Z9[/99QV<=S#"0XEB
M<9Q/#GC"&VL?^$:\4VD^N^$IIUE6S%U)%>Z%<LSB34] E9C';W)260SVCK]C
MU#A;E X29)=-M[3Q.?&'BSQ7=7A99K66>32K>W64:KK]_)G4I;54C@_L^T6*
MZDN+>'R#+++:V\4D)E#B.XMOAY9[+!K_ %_4K@00"YUS2DMCIBW+*9IVLM+U
M*VTZ_N8HV*66+FZLRQ62[1BNR%]_-[Z7=GO9._-WMK^%K72K1:6;?5I7=]-;
M[]?^!KKKO\,[6Z(O=$\=^"[O0G+$:AJ>JG1;RT4-S'?Z/=PG45G1<'_0H+R*
M7_EC(V<#:OM&^&_@6TT74KDZG\1+O5[&?4M-,8_L+PJX@NI].:&Z5S+K5X+>
M^M+HS1@::942 8$<Q:N&&C>"W#.OC6XB#!3'%/X9O?.3< VVX,-Y+"#&"$D,
M,DP,JOY0DC\N23TWP]X<L]9\/7NB3W0\4>'=/@NM9\,7&BSV]GXG&NWEQIUC
MJ>FVVC:AJ$;-!'!;-J5S!=VK%[*W%U92PS7CH5MKS6VNMKIVZJUK2MLU[M]-
M+";:M=R>NNG+I_7]+=T/#?Q(T:>X;3KSP[H?@ZYOY(K73_%_A33K:WO_  _N
M!CA>:*]CO9+FT2=_.N[BUN[+5!'EDNI3%%$/)_$MKJUCK^KV.NSS76KV>H7-
MK?W,\TEQ)/<02M&\QGE)DF63:'CD8DO&RMT-8S !F S@,0-V-V 3C."1G'7!
M(ST)KU_3KY/B3I6I:/JL.B+XTLK#3G\-:W<31Z3J&N&RGAM;C2=2O9[B+3[Z
M[DTQ@UG->"*XD>R2+[0\DN&+6?Y]=K)/SMK?5Z*_=MV4=5MU_1_Y_(\>HKL=
M0^'_ (TTFSO]0U+PYJ=E9Z:D$EY<7$(CC2*YF6WBFC9F_P!)@,[QQO/:^=%$
MTD0E=/,3/'4?U_7WHNZ>SN%%%% !7?>&/B%J_ANQFT@VFFZQHLT>H@:;JEMO
M6VGU2T%E=W=G>6[0:A:3RVH,$GV>Z2.2%Y49#O+#EM*T+6]<D>+1=(U/5I(\
M>8FG6-S>M'N.%,@MXI-@)Z%\ ]JBO-)U73N=0TV_L?G\O-Y9W-L/,!.4S-&G
MS#!RH^;@\<4TKM+3=>=KVLVMUOH]+]&)V>CMZ7/M'X+^%?B1#\1M!UN]O!=>
M%4\,0W\S6,AMM#M+3Q!I,MUIVCV5@JP0)<VUP]O+/%!;[8T03/(3-&TGV_7&
M_#PV<G@;PE<6,:QV]UX<T290JA"W_$KM(U+ =&5(TCQ_"J!1P!795Y=:HZD[
MM)<J4;)6^'_@WV27D8!11160'):CX#\'ZMK]IXHU/P_IU]KUBD4=KJ-S"9)H
ME@<O 0K-Y3/ [,T$CQL\1),;*:ZVBBFVW:[;LK*[;LNROLO0 HHHI %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5@>)_#6D^+]#U#P]K=LMSI^HP-%*O DB?K%<V[D'RKBWD"RPR 9
M5U&05)!WZ*:;333LTTTUNFM4_D!^27Q0^$_B+X8:I]GU&,WFC74CC2M<@C;[
M+=H-S+#-P1;7R(,R6SME@&DA:2(;AY97ZK_M!:!;Z_\ "KQ*)YF@;1X$UZW=
M45PT^FDOY+AL$)/$\L)=65D+J_S*I1ORHKTJ-1U(<S233Y7;K9+7YWU\[]+&
MT'=:[K\@HHHK4H**** "BBB@ HILCQPPSW,\L5O;6L+W%U=7$L<%M:V\8S)<
M7-Q*R0V\$8YDFF=(T'+,!45G=6FHV=OJ.G7EGJ6G7:LUIJ.FW=MJ&GW2HVQV
MMKVSEFM9PC_(YBE?8WRM@\5?LZC@ZJIS=-2Y74Y9<BDU=1<[<JE;6U[VUL+F
MC?EYES;\MU>W>VY/1114#"BBB@#T[PP_]L>!/'>@7 \S^QK?3O&.DR/AOL<U
MI?P:5JL,))_=KJ-GJD3S!<"233[8L&*C'F->H:$JZ/\ #+QCK:_O+KQ'JFE>
M"X0!Q:V<13Q#J4[$$Y:X:RL+6-6"#:9G5G*E5\OH[^OX6CT\G?7J[[B7VK=_
MT5_Q"O4-8L/#.M-I5T/&^CZ?%;^'?#U@+";3?$,UQ:SV>DVL6HQM]FTF2V)?
M4Q>SDQ7#J[3,^[+&O+Z*/OZ;?CT>X-7:=[6OTOOZ['='0/!2'$GC\/ZFT\+:
MO*._3[3+9$].X7J..IK/U_0])TZPTO4M&UFXU>UU&?4K5C=:4VE2Q3::M@[E
M(S>7OG0R+?H$DWQL'CD5DX!,_@3P/K7Q"\16OAO0Q +J=)+B:>YD\NWM+.$H
M)[J4@%W6/>H$<2/)([*JKR6'T1>_LY>,_P"S9O"A?0[^?2KQM4T76[75! %@
MU*:PMM4L]7TVX03PQ^1 NHVEQ$'"/9W%L7G-U"(E*I!-*4HI\NS<5H]%+:]K
M^;V:[DMV:O)WZK^EIT^5[:O7Y2T^Y:RO[&\0D/:7EM<J0<$-!,DJD'L04'->
MN_$SPIJNK_$[XAG1[-[F.QCNO%]YM/\ JM+GM;+4;BYS_%@Z@A"@Y?<0,GBO
MIC0OV2O!,FG0S:AXIUC5YY?+?[9I1L;.Q=58B5($:/4&=&8%!*;DD;=P4$E:
M]VL?A5X5L[W5=2DBN;N_UWPS!X5UF:>=O+OM-@L;/3\F!0$AGDAL8C))$1EV
M=L9V[<)8FDG=7DTFMFMW!];6M9^;\B7/6Z6MK.__  Y^=AU?P=X>T70[J#X;
M:9X@^V:=:K-K^KZOKLEO/K44$1U:S:QL;VVMK::TN'.+9RLK6DEK=[?)N(F:
ME_PM6XB+?V5X&^'6E@<JT/A=+^5%4?>,FL76I991@[BN.,D<5]]^&?@+X+\-
M0Z-;*MSJUOH]_K6IK%JZP7<=U=ZS90:<S3PF(6WEVUG!&L2+ "TR1SN^]"&[
MNV^'?@:SMM1M+7PMHL$&KBX74UBLHD>]2Z9FN(YYE F:*3>RF(.(PAV*JH
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MLGI_7]?CJ=K11UHK  HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=ATGQG=Z5J=UIY^PV%_I_GE[_2[91#:W.H+."HNYHE5I!&2"#\^7+,>\  &
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ny20053122x2_annexb1.jpg
<TEXT>
begin 644 ny20053122x2_annexb1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M3XK?$3XB^'RNJO'$UV\.E^*%\.2:9&8IH[:ZUB34!"YC^;W_ ,%_"K6?A/\
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MCS/GE/VJJM**D[\KG[B4;V]FZ?+SNUOB;:DKKHO%?[=OPR\/>*/&&B:%\/\
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M[GQ)'X-M+;Q/JNE:7%#!/)J6JRZ;H]VNE:?:PW%S>ZNEC8PQ&:=!7?'B[BS
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MVU]97"H[J)K:>*0*S*&PQ!_./]GCQ]<V'Q<^!'AS]E?X[_'OXS^"O%-];/\
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M-HNEZ7)>Q&TC%SJXO7FFM#]C6&^LYIOS[^)7QP\.?&7]BK2OV5/ 7@3QE?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>ny20053122x2_annexc1.jpg
<TEXT>
begin 644 ny20053122x2_annexc1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M#2^(/C;J>H1^(S:2:G]F&A:WIFI_9VMA+&SQW"VYBPK@*6!P1FOU9_X+K?\
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MXD"UO;[PO>6ZKX>MKG63:[;];>97*PA<P[P0<$@?S4_LB?"W]NCQK^UUX_\
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M'Q4M[)-?@Z_<0SZC<6FBJZ:=';6QCMU55,X:8X7R<G\.<RS3)ZF=XC-,ER/
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M3X?>&=/\0:7/X.GTJ&>ZN;_7(M.EBO/[4TW44:)8I2Z>4L;!QR6!Q7[^:?\
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MO@V?VQ/$^F>*/CIXE\<?!WQ'XBN](NK>[M=/L;W4M)&C:0LME##8K_9VG+#
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M)/\ ?\E_[%^"_0B&TO\ '/\ -G,/\%?@W)X3C\!2?"7X9OX&AO\ ^U(?!;^
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K.DZ=;)G9;V.G6$-O9VD"Y.V*WACC7)PHS1117R5;^+5_Z^3_ /2F:'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>ny20053122x2_annexc2.jpg
<TEXT>
begin 644 ny20053122x2_annexc2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M,?\ B.?A+_T2N._\1_(__FX]K_5K.?\ H8P_\'XGR_N?U;T/XF/^'@_[>_\
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M]_\ H]W]KK_Q)'XQ_P#S94?\/!_V]_\ H]W]KK_Q)'XQ_P#S95_;/_Q#V?\
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M,G4=6#G%TJ]9I*+2:?-RN][;76FXK=3]3_.O]&3_ ((5_P#*-/X%?]=?%O\
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M\,NPTL34A.I&,H1<8-*3YY*-_>:6E[G][9\3^&P"3XAT, #))U:P  ]23<8
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M )?B^Y_D0-U/U/\ .O\ 1D_X(5_\HT_@5_UU\6_^I!=U_G-MU/U/\Z_T9/\
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M7_9;?AQ_Z;O%U?O+7X-?\'&O_*.:Z_[+;\./_3=XNK[3PW_Y+[@[_LH\I_\
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MEE>,G%Z7?5.WD%%%%?-'4%?@U_P<:_\ *.:Z_P"RV_#C_P!-WBZOWEK\!O\
M@Y"U>SL?^">=MITLT:WNJ_'+X>I:6Y8"66.VTOQ;)<RHG5DA#Q"0@84RIG&1
M7VWALG+C_@Y)7?\ K%E3T[1Q=.3^Y)LX<S:678YO1+"8B_\ X*F?PF_#;_DH
M?@7_ +&_PY_Z=[.O]9/P]_R -#_[ ^F?^D4%?Y/GPATZ?5_BM\-=+M4:2YU'
MQWX3LK=%&YGFN=<L88U4=22[@ #DYXK_ %A]#C:'1='A<$/%I>GQL#U#):0J
MP/N"#7[E])^47C^$(77-'!YO)KJHRK8%1?HW"2^1\YP>O]EQ;_ZB(K_RG$U*
M_BY_X.A?^2U_LX_]DWUS_P!2*ZK^T:OXN?\ @Z%_Y+7^SC_V3?7/_4BNJ_,_
M S_DYW#W^'-/_53C3V<__P"1/CO^O</_ $]3/S._X(>_\I+/V=_^PGX@_P#4
M:U6O]'>O\XC_ ((>_P#*2S]G?_L)^(/_ %&M5K_1WKZ;Z2/_ "7>"_[)W!?^
MIF8G%PI_R*O^YFM^5,****_GT^E/\B%@<G@]3V/K7^C)_P $+ 1_P34^!601
M^]\6]?\ L8+NOJK_ (=T?L)G_FTWX%_^&_T/_P"1J^GO /P\\"_"OPMIO@CX
M<>$]"\$^$-'$HTOPYX;TZWTO2+$3R---]FLK9$AC\V5VD<JN68DDDU^\>*GB
M]E_B%DF7Y5@\FQF73P>91QTJV)Q%"K"<(X:O0]G&-**:DW64N9NR4;6N[GSN
M39%+*JU:K+$1K>UI*FHJFX<MI1E=MRE?:VR.RK^('_@YJ^$E_P"'_P!I_P"$
MOQ@2V/\ 9'Q!^&@\.27,<;")-3\':E,?*GD"!?/GMM6$D:EV9HH"<*J\_P!O
MU?E9_P %@/V)9OVV?V1_$GAGPQ:QS?%'X>3GQY\.F*@RWFHZ9"YU/0HV+H =
M;TP3VD1;?B<Q;8V<KCXOPKXFH<)\<Y+FN+G[/ 3JU,!CZC=HTL+CZ<L/*O-[
M^SPU65+$SMKR47OL_0S?"2QV78G#P5ZDH*=)::U*<E4A&[T7,X\C?:3/XDO^
M"3G[2UE^RM^W-\&?B+K5REIX6U;5G\!^++F7)AM-!\9A-&N[YU\R-3]C,Z3*
M[MMBP9#]W!_TN+2[M;^UMKZRN(;NRO((;JTN[:5)K>YMKB-98+B":,M'+#-$
MZR12(S(Z,K*2"#7^1UJ^DZMX<U>_T76;&\TC6M&O9['4=.O89+6^T^_LY6BG
MM[B"54EAG@E0JZ,JLK+TK^I?_@E9_P %Z]-^$G@[PU^SW^V(^K7WA7P[;VNC
M>"/BY90R:G?Z-H\");V6B^*M/AB-U>65A&JQVNK0O-<QP@17$3)&LE?T/X\^
M&V9<22P7%_#>&EF6(P^#CA<QP6%7M<1B,)"4JN%QN$A&[Q+IJK.G5IT^:I*D
MZ4Z<9*$[?+<,YM1PT9Y=BYJB_:2E1G4]V*D[*=&3=E"7,G*/-:\G*-^;E3_L
MVHKYQ^&?[7O[,'QBTB+6_AQ\>/A=XFL)8XY-UKXQT6WGC$@)"36E[=VUS'(I
M#*Z-%E65E/(-=IXC^/?P/\(Z9<ZSXE^+WPUT73+.,RW-Y?>-?#L4<<8!);']
MH-(W /"(Q/85_'L\%C*59X>IA,33KQDX2HSH585HS3LXNG*"FI)Z.+C>^EC[
MI2BUS*2<7LTTT_FM#UJOXR/^#F7]I_1?%/Q ^$?[,'AG58KV;X>6NH>-/'\-
MM+N%GKNOQ6T.B:5=A7*>?;:5"+\+L#QF^9'(9=H_17]O7_@X"_9W^"7AK7/!
M_P"S#JEG\;/BW<V\UE8:[IZR'X?^&+A\(=1NM5>(IKD]L"[0V-BKQ-<(JW,J
M1Y#?P\_$;XB>-?B[XZ\2_$7X@:[?^*/&OC'5[G6-=UF_D:>\U#4+R3<[$G)"
MC*Q0Q(-J1JD:# %?TOX%^%^<K/,-QAGV!KY=@,MA4J970QE*5'$8W&5:4J4,
M0J%1*I3PV&ISG4C5J1A[2LZ3H\T83DOD^),XH0PU3 8>I&KB*]H5?9M25*G=
M.4925USS7N<B;:BY.5O=4OMW_@E#\#;WX_\ [>W[/G@^"%WL-$\8VGC_ %R<
M1-+%::5X&9?$#2W 56"Q37MG966Y@%\RZC#$ FO],L      #  X  Z #L!7
M\U/_  ;T_P#!/[5O@;\,-9_:I^*.AMIOC[XOZ?!8^ =-U"VE@U+0/AX?*N&O
M9XI=KP7'B6[5+CRVCW"PMK0DHSNI_I6KX7QTXLP_$_&U6E@*T:^7Y%AHY50J
MP:E3K8B%2=7'5:<DVI0]O/V$9I\LXX>,XMQDF_0X>P,\#ET%5CRU:\G7J1:M
M*/.HJ$)=;J$4VG\,FU9.X5_%U_P="@GXU_LXX!/_ !;?6^W_ %,-U7]HM>&_
M%G]F;]GWX\7NEZC\9O@[\/\ XF7^B6\EII%WXR\.:?K=QIUK+(99+>TEO(I&
MAB>5FD9$(4NQ;&2:^,\/^**'!O%>6<18G"5<;1P"Q:GAJ%2%*K4^LX.OA5RS
MJ)Q7*ZRF[K51:6KN>AF&$>.P=?"*:INM&,>=QYE&TXR;Y;J^D;;K<_S^_P#@
MA\"/^"EG[.^0?^0GX@[?]2WJE?Z.U?,?P_\ V+?V3?A3XJT[QQ\-_P!GGX3^
M"?%^D&8Z7XC\.>#M)TS5[ SPO!,;6]MX%EA,D,CQN48$HQ'>OIRO5\4>.<+X
M@<0T,ZPF KY?2HY9A\ Z&(JTZM24Z-?$U744J:45&2KJ*CJTXMMZHQRC+WEF
M$^K.JJS]I.HYJ+@O?4=+-RVY=[A1117YN>F%%%% !1UZT44 ?SN_\%3_ /@A
MOX3_ &L-1UGXX_LZ3Z1X ^.5RDEWXB\/W:I8^$?B#/&C,;B0VMJ3I?B.X*QQ
MF^=OL=T?FNO+<&1OXT_CU^R%^TC^S-X@OO#OQI^$7C+P7<64LJ#4;[1[N30[
MR*.1XUN['68(Y+"XM9]ADMY1,OFQ$.%VFO\ 5.K"U_POX9\66+Z9XI\.Z%XE
MTV0YDT_7](T_6;%SC&7M-1M[FW8XXRT9XK]OX!\;^)^$J&&R?$T:.?Y12<*6
M&P^,K5*&+P=.Z2I8;'0A5:H17P4:]"O&FDHT73@N4\#,N'L%F$W67-AL1+65
M6DDXS?>I3=E)_P!Z+A)Z7DTK'^2);W=W9R"6UN;BUE7@26\TD+CV#1LK#Z9J
M>[U75+_'V[4K^\V]/M5W<7&/IYLCX_"O]3'5_P!B']B[7YWNM>_9"_9?UNYD
M8M)<:O\  'X4:E.['DL\UYX3FD9B>268D]ZIV/["'[#VES+<:9^QK^RGITZ$
M,D]C^SQ\(K296!!#++;^#XW4@@$$,"" >U?T33\7X5<%',7PS!3Y')1>:J4D
MNRJ_V6G_ .2KT/FI<.3C66%683Y)6O\ N&HZJ^L/K%GLNI_F2_"GX$?&3XY:
M[:>&OA'\-/&/Q UF^F6&WM?#6AWVHJ9&) $MS%$;:$<')FF0<=S@5_5Y_P $
MR_\ @WVG\':[X>^-W[;$>G7^HZ5-;:OX;^"EC-'?6=O?P.)K:X\=71@>VNQ!
M(L<R:/92LC.I2\D 4QM_4UX3^'O@'P%;-9^!O _@_P %VCA5:U\)^&M%\.VS
M*G"*T&CV5G$0@ V@J0N.,5V%?@_'7CUQ/G]'%9/E6&H\.8&JI4<34PV(J8K,
M:].2M*DL;*EAU0ISBW&?U?#TZLDVO;<K<7]#EW#6"P,XUJDI8NM"SC*I&,:4
M)+:4:2<O>3U3G.?+HU9JY!:VMM96UO9V=O#:6EI#%;VMK;Q)#;V]O"@CA@@A
EC"QQ111JJ1QHJJBJ%4  "IZ**_G\^C"BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>ny20053122x2_annexc3.jpg
<TEXT>
begin 644 ny20053122x2_annexc3.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M-GX>?\$O/V@?@1\6?CE^UM\#_&WPDT+]J;QU^W/\:OB_:VE_KWB^S^&'QO\
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MINL?%#5/BQ?:=H^O>*] \9>/-+@^%%W/<Z'X5UWQ;IMJ9[_Y0_:B^'EW\&_
MEO9_M ?$7X,2?ML?\%#?^"I/["/Q9LOA3\.]=>:$^&?@Y\?OV6/ VA> _AK)
MXDTSPMXZ^)/A?X-_!KX8:5K7C[XGZKX)\)6,GB37==U>^T#PK;:SI.FR_HQX
M _9N^._PC_X*%_M)?M#>$+3X1^)?@+^UYX>_9Z/Q*N_$7Q!\9:!\7?AKXJ^
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=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>ny20053122x2_appsoftware.jpg
<TEXT>
begin 644 ny20053122x2_appsoftware.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MPO=K9O-4_;"_X)^_%CXM^%?V:?B9\%_B9X0\-?M;_LK?9;_PQXMNO"]GX0\
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MZPM[?:EY/A'7](T34] U^[@M+O46AU66YDCOF:>"X^0?'_\ P31_X*#?%?\
M9R^'7[/R_"3]B[X,Z!\)KKPF+K5? UY<VGCKXT:GX>M&TE?%7BSQ+::-J21E
M[<W&MZI]J^S:GK7B"\-S+;Q6^(+3MRW%<%5\YS/$YK4X#PV!Q6:4<(\NP-/(
MO88?(H8#DH5_KM7 5'5K8G$5']<I9+0P6*HXRE&M5QU#"*G&.-2&/C0I0I+'
MRJ4Z,IJK4>(YIXAU%S0<%62C&,?@>(G4C*#Y8TYS33K_ /!0SX7?M/Z[_P %
M._V1]5\*_M$VNB:K\6[O5+K]G*\O/"6G7]M\"-.L;73Y+ZWO=(N;6YTSQ+<:
MG=WLUW<7=W:W=Q,OD6]Q-+%9VBP_9/BSXE?&+X=?\%.?V+/@SX_\9>&/&LT?
M[+<=U\4_%P^&7P\M]:\7^-=#T3QA%XC\3Z5XA?PL?%OA:QUK4]*DU%- \/ZY
MI6D0),\"V*QRSI)[3^WG^QE^T)\5O%_[*?[0G[,OB#X?VOQN_9>N)39>&/B-
M)J$/A/Q)9W\>EM=H+[3X)9&DBN-/>WFM)WTQ;S3KN:2WU:PO((%FI:E^R-^T
ME\0_VZ?V4/VLOB/:?#&SLO O[/<'@WXUZ5X9US5$AM_B-JND^)1XDL_!6EWU
MOJ-Q>>%H=5UWR=.N=0UUKTV*AII)Y4,LGSU+B')<=D>1QQF-X?\ 99?P5Q5D
M\\++#8'#YE1S6/UY9<H+ZM"HZ6(PM3#3P\Z<Y4ZN/E6K./UJ=6;Z_JU>GB,0
MX0Q/-5QN$KJ7/5G2E2<:/M=Y.*<:D9J2M=4N6*]R,4OE+X2_%/\ X*1?\%+M
M1^+/QD_9U_:+\)_LJ_ ?P)XYUCP+\+?#O_"#Z1XKU/QGK.@VMG??:?%6HZEI
M.I7\,-Q8:II5QJ=V)+G3();[['I_A:Z-I<SMR^H_\%+OVG]6_8'_ &NI=?U3
M3?A_^UY^Q]\4/"7PM\:^,O#&C>'[W3-8?4_%]_X<.LQ:+JVFZKX;CU"\N?#'
MBC3=16STU=+D^R0:EI5M81WD=K;>I^&/V.O^"DG[#/BCXJ>$?V#M?^ _Q ^
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MEB)J>"IRI.=2I4G]9E3JQJJ$YR<E)M4VXQ:C%R32C<_*7XF?M)_MO:I\8/\
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M6<9P:2SIT<7&I&LWBN=8ZC#D=2HZ?U1X:FJK]DY.FX^TYKR<;J2T:OK\B_\
M!0ZTM;[_ (*G_P#!,.TOK:WO+2XU75XY[6ZACN+>>,Z^"8YH95>.1"0,JZE3
MCI70?\%M/@%\)M'_ &7IOVD_#/ASP_X!^-WP;\;>!=3\#^/O"NG6/AWQ)=2W
MGB6RLCH]SJ&F16EQJ26AE&MZ:MR\\FFW.F//8F#SKGS>]_X**?LB?M9_&+]I
M']E_]H?]EH?"J37O@#9ZO=)#\3]:U*QT^37;C5H[RQ$FG:;82S:A8&W\P3[-
M0L9!)M56QR?-M6_8*_;U_;1\8^!I?^"AOQE^$VD? [P'K]GXF'P.^ 5KK @\
M9ZK8$[$\1ZGJVG6C6EO/&QM7NY=8\27%O92WT&DV&C7EZ^II>2YCEN&H^'6=
MU.*LLR_"\-9;B89SEL<76JYKB?\ A7S'%2RZGEE"G/VZQ^'K4Z$G7G3HQIUI
M3J248ZK$TJLY9E06$JU)8JK!T*O+%4H?[-AJ:JNK*2Y72G"<O=3E>*4=6CPK
M]JG_ (*<_$]/%O[.7[/.B_'?PU^R1_PE?P-\ ?%+XZ?M"Z_X$N_B%JVDW_BS
MPM%JMMX6\,^%(=+U3-W>@K=3RK:V=Q+=7UJD>NZ+:6EX;KH/V'?^"C/Q*\0?
M&WXQ_LO>)OVB_#W[6.A6?PE\8?$+X-?M&:+X E^'NM?VAX:\.OJ=YX?\0^&+
MW2+".22V#23*;ZUU)XKRQE4ZYJUC>00V_P!2?MG?L$_&'5/C[\/?VP/V.1\(
MYOBEX,\&P?#GQ3\)?C'I NOAWXX\%V%O/:Z5#;F.)XX-0LK62*P^SS3:.P@M
M;"\LO$.GW&G);W73_L^?"']L_1],^/\ \4?VL/\ AG/P98:W\+_$NF^"?@W\
M#/ 6B01>$YXO#U^M_J]QXZ>QD\0)]NB39-HQ\3^)[2\DD^UF?3!"EB^\\?P)
M7X3I+!X').?$9="%7!U\1@*.<8?B&KF*DZU*E'(J^<XA4XRBJ36<4LFJ9<I8
M>I2I5%K,*>.6.]^>(2C6TE&-25"6%]DO=;^L1HQ=]_W+K1JVDFXM,_._]C'7
M?^"N_P"WG\#[KXK>'_VS?#/PIT;PIKVN^'_"DEY\,?!MWJWQ(\2Z:T=[=?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5BTK));)677;S>K^84445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCAJ-7$5I?#2H4YU:DME:-.FI2D]5HDQ-I*[:26[;LE\V>]T5^#7QC_X./?\
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M6J!^24325\3/J<L@ ),<-I(^ 3MQ7^4?KWB;Q)XIO7U+Q/X@UOQ'J,A9GO\
M7M5O]7O79CEF>ZU"XN)V+$DL3(22<G)K$KZ3#^!6$BD\7Q%B*KTYEA\OIT%Y
MI2JXK$7ZV;@N]NCQEFKUY:*\G*;?WI17YG^GCXF_X+:_\$K_  D\B:I^V/\
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MVO\ _P -U\'_ /Y_='_$4M_P3S_Z)9^U_P#^&Z^#_P#\_NOX#**/^(.<&?\
M/K,O_"^7_P K#^TL3WI_^ ?\'^KORM_?G_Q%+?\ !//_ *)9^U__ .&Z^#__
M ,_NC_B*6_X)Y_\ 1+/VO_\ PW7P?_\ G]U_ 911_P 0<X,_Y]9E_P"%\O\
MY6']I8GO3_\  /\ @_U=^5O[\_\ B*6_X)Y_]$L_:_\ _#=?!_\ ^?W1_P 1
M2W_!//\ Z)9^U_\ ^&Z^#_\ \_NOX#**/^(.<&?\^LR_\+Y?_*P_M+$]Z?\
MX!_P?ZN_*W]^?_$4M_P3S_Z)9^U__P"&Z^#_ /\ /[H_XBEO^">?_1+/VO\
M_P -U\'_ /Y_=?P&44?\0<X,_P"?69?^%\O_ )6']I8GO3_\ _X/]7?E;^_/
M_B*6_P"">?\ T2S]K_\ \-U\'_\ Y_='_$4M_P $\_\ HEG[7_\ X;KX/_\
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M4FVD5&,IM1C%RD]DE=_AVZOH?Z#7_!!O_E%C^S%_V#_'/_JP_%%?L!7Y!?\
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M:[^T5XG\'^+/%MLGBI;S1M4DU'PWI-IH^ER7]M93:;.T<UU;BZ%S<6>WXU^
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MOB'\.O!_QK\ ^*OBYX5^'.O6^G7&F_$;6/AMI>JR^);#P?,FJ6C&]O+2WO1
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MYIHK>*6>>6.&"&-Y9II76.***-2\DDDCD(D:("SNQ"JH)) !-?E?HFN_M3_
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MA3^T[XZ^/-AHO@'X+^(=?^(K_ GXH?"7PCX.O%;5YOBSX9^&;>+M#\3:A?\
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MB87DUO+&DD,DX=HG560A@"'S^&/#=S)J4MQH&CSRZQ9PZ?JTDNFVDCZE86X
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M,^K6/Q+;QG#XCB^,/QG^%G[/W@?X1ZI\.=?U/PAXQ\-^/?B3XNU+5K.7Q/\
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M%+EC_*MV]EO)--^K3:?=-I[L?/.Z?/*ZM9\SNK--6UTLXQ:[-)K9'QQ\3_\
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M=I>F6,4-I9VEO$H6.*&)%ZL<LQ)Z:BBF2%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5K)]Q?\ =7^0K)K63[B_[J_R%9U.
MGS_0N&[]/U1TL'^HA_ZY1_\ H"T40?ZB'_KE'_Z M%9FI@S_ .OF_P"NLG_H
M;5%4L_\ KYO^NLG_ *&U14 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKYC[CY=.(XXZ$C/>K67XU[8>I\TE^;1+Q>&7_+ZGKII*_;M?NC_1<_X(-_\
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MJ?\ #//_  ;V_P#0Z?\ !1+_ +[^&7_S&4?\,\_\&]O_ $.G_!1+_OOX9?\
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M[Y'_ ,31_HWK-_WR/_B:+^3^[T_S_!]@Y'WC]_\ P/-?>0T5-_HWK-_WR/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK-7YDU>SNEJG:Y'111789!1110 44^.-Y76.)'DD=@J1QJ7=V)P%55!9F)X
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M7:8\/@2XT?&HMX3&D?VO-JKS)++'I\\]NU8K//$&MDV,YLLHX/&5</F-.C/
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M%.Q6<,45FQ@,P1RH)RP1B 0IPVOV1\'>%O@3\7OA=X?_ &:OAIK5S%\(=/\
MVM/@GI>I_%C4M"F\/^-?B5K?B[P#\9KWQ%JDE@MGK^IZ5]HM]$T;P1X#T%;#
M6Y+&>!-2BTB_U+7+ZRNN:^'GP\_9<L/BO\#?$&F>&?A_\1HM8^)GB3X?^(/A
MSH=S^T/JWP^O+*+PV;S2=9U77?C%\*_A\\GC30[Z00ZUX7L;[5=,U+[5INI#
MP[H-M&]M<8_ZTTHO%0J9;F*JX>-6JJ4:-W[!8:6)PTL3*JZ,<'6Q<*<U&A6]
M[#S2AB94I72:P<FH.-6BU-I7YG9RYW"<:=E+VBI[N2LI[TU,_).I)(982@EB
MDB,D:3()$9"\4J[HY4# ;HY%(9'&5=3E21S7Z8?L\_L]_"7XLGP_9>,/"F@^
M#9_C=XD^(2?#L7'C[XHZOXQMO#7ARWN;6*[^'?A?P=\._$7AZ"/PKKMEJ8\0
MZY\;/$]GI6OZ?8RQ:6F@IIU]K4WR_P#M-?\ (9^#W_9M?P&_]0/3Z]'#YS1Q
M683R^G1K0J4H2G5G5]GR64ZE)>RE2J585>6M0Q%&K:472JT9TY)R34<G0E&G
M[24H-.+E%1YKZ2I+WE*,&E*-6-2#L^:#3LKW/FNBBBO8,0HHHH [;X:^,KCX
M=_$/P+X^M(_.N?!?B[P[XIAAP#YTF@ZM::F(AN(7,GV;8-QP"P)XS7V5_P %
M$?A7-H_QNU?]H3P>CZW\"?VJ-1U'XT_"KQK9(TVD3-XTN'U[Q5X(N[I T=EX
MG\">)+[4]!U;1+ITU.UAM+:>[@BDFDCC_/\ KZO^ G[9?QB^ &@:QX#TJ/P5
M\2?A#XCNTU#Q%\$_C/X1T_XC?"S5=2C&U-5C\/:HT5SH6L*H .L>&-3T34I=
MD7VBYF$$(C\3,L)CHXS"YKEL:%;$X>A7PF(P6(JRH4\9@\14HUFJ>(C3J^QQ
M>&JT(SP[J4IT:L:E>A5='VL,30VISI\DJ57FC&4HU(U(14Y4YQ4HZPNG*G.,
MG&:4DXM1G%2LXR^6;.RO-1N[73]/M;F^O[VXAM+*RLX);F[N[JXD6*"VMK:%
M7FGN)Y76.&&)'DDD94168@'^]3_@DM^R!JG[,_[)'@*Q^)^@167Q3\3ZIK7Q
M&U73KV+_ (F7@U?%D%C!8>'K@$YM]4@T2PL6UFWP&M-0N+BPDW26C.V;_P $
MOO@[^S3XX_9\^%'[4V@_LN_ WX8_%+QE:ZQ?S:CX+\+7%Q_8%U9:SJ>D%_"M
M_P"+-1\2:WH"7%M;#S4L-4C)$LL6\Q'97ZRU_*'B_P"*%7B*-7A/"9;7RVAE
MV95%F=3$UJ-3$8C%X&57#_5Z<</*I2AAJ=1SFZBK5)5Y*DU&E&$E5^PR;*5A
MFL74JQJRJ4DJ2A&2C&%11FY/FM)R=DK<JY5=>]?3E;?P/X1M8M)@MO#^FPPZ
M%J,^KZ/&D "Z=J=S(9;B^M1G]W<2R$N[CDL<TC>!O"#130-X>TPPW&M_\)'/
M&;<;9==\WSO[5<9YO/-/F>;UW<UU=%?@GM*G\\^_Q2WO>^_=M^KON?0V79?=
M_79?<<K=^!_"-]%K4%YX>TRXB\1W-K>:['+;AEU6YLI4GM)[P9_>R6\L:21D
M_=90:EN/!OA:[DU:6YT+3YI==L(-+UAY(06U'3K88M[.Z.?WD$0X1#P!72T4
M>TG_ #STV]YZ6Y;=?[L?_ 8]D%EV7W?UW9S:^#_"ZW*7BZ'IXNDT)O#*3B'$
MBZ YR^D@AN+-B!F,#MUZTRW\&>%+5M&>WT'3H7\/6ES8Z(R0X.F6=Y_Q]6]K
M\V(XI_\ EHN#G)Y%=/11[2>W/.VWQ/:S5M^S:]&^X679?<CEK;P1X1LX]'AM
M?#^FP1>'[^YU/18XX2$TW4+N0RW-W:C<?+FGD8O(V3N)Z4S_ (03P=Y+6W_"
M.:9Y#:X?$K1>2=AUXR"4ZKC?_P ?9E <R?WAG%=911[2I_S\G_X%+NWW[MOU
M;8679?<<K=^!_"%_#K4%YX=TRXA\17MOJ.N1R0DKJ=]:.CVUU= .-\L+QHR,
M,8**>U?E#_P5^\5W7[.O[/=_^T-X&L[.?QQ-XH\+^ _LVK++/HHBURWU5(M:
M:V@EM[A]1TU;&-8(OM2V<X">?"Q1O,_8BOQ-_P""_7_)@=Q_V6;X;_\ HGQ'
M7U_ %"ECN,^&L%C(+$83%9MA*&(P]5N5.K2G.*G3G&^L9*,5)=4DGIH<>83E
M2P.*J4WR3IT*DH26\91B[-7ZIZJ_74_B-U'4+O5M0OM4OY3/?:E>7-_>3E54
MS75W,]Q<2E4"HIDED=MJJ%&<*  !5.B@]#CKVK_15))*,4DDDDE9)):));))
M:+HD?FGX^NK^;ZGZ._"/]CCX)77[.O@7]HO]I#X]^+_A/X7^+7Q!\2_#GP$?
M OPBN?B=8:'>^%!9QZIXA^)&J+XET"'0M-^TWJ+9:-8I>:[J-G;W5]9130PW
M M_!O#7['_QK^*7Q)^(GP^_9[\,WG[1-K\.]4NK.]\<_"RUN-1\%ZCIZ3S1:
M9J]MK>HII]G;PZVD#OI=I=3I=7TJ2PZ>E[Y8D?[P_80^.7P]^&'PPT.TT#]N
M'6/V</$:^+-0N?CK\'?C-\--3^,?P'^*7@R:]MFMM1\!^'-"\(>(+?3_ !&=
M#@71M=TS6%M]9U>XVW6F>(-/LH8[=???AO\ M@?L7Z]X9_:8^#/A2R^"?P7\
M'>)OVI;GXZ?"D?M ?"KXF>+?AAJ_@Z;PYH>@?V4-%^$&M:;KWA'Q%X>O-$N_
M$'A.SO5NM'@L];;2+2#2[Z.20?F.)SSBC+\;G?LL)F.9PIXE1PSGEE>6!P.&
MGF%.C"4,+1RW XG&SI86HYQ>!SK-*>*I0GB\3+*Y0>'EZD*&$JT\/S5*=!R5
MI?O8^UJ35*<Y+FE5J0IQ<XQC)5,/2=*4E&#K)W/R"\%?L<_M3?$76_%WAOP3
M\!/B;XA\0> -?A\+^.-%LO"]^NI^$=?GBN9HM-\165PD%QH\IAL[F5I+Z.""
M..(O)*BLA;G1^S/\?#XUB^'0^%7BX^-9_ J?$Z'P^+!6NI?AZ^C_ -OIXS25
M93:-X=;1Q]N&J+<&U,?R"3S?W=?IS^T+^V_X)^)/PH_;ITBQ^*VCZAXZ^*OQ
M*_9[L_ U_P"!OAUX[^%MA\2? OPSTMM'UO61HNJZYXTN-$MH;:VL[=[7Q9XQ
MCU36K*VM+DZ7:2R2Z79THOVY?A&W_!/Y]/EOKU?VW;?X;S_L=6=Z;'5F8?LU
MR^*X/&Y\2)K8TUM(2X72[W6/A[!:'6TUN-KJ[U#[ ME%83#T(9[Q9*E1KRR.
MDUB<=E^6QP\,-CU4PD\9EF"Q=7-<35KRHRGE>%QF(KX2NEA:%:B\/RSFZWM*
M=.'AL$IJ'UF=E2JUG/GHM2]G7G#ZO%1BTJ\J4/:0?/*-3FCRJTE?XO\ %O[&
M/Q(OOBKX%^$GP(\)?%'XM^*?%WP>\!_%.YTI_A]>^'=4TY/%>F1WNHR);RW=
MU;/X/TZXF@M]/\9WEW8Z7JD<\,R^098T;CM4_9I_:TO?BOIG[..L_"CXNWOQ
M7L;)KK1_ACJ.EZU=ZI9Z+Y3R/K&FV=P\EA;>&_)MY)'UZVF30A% [M?!(V*_
MK%J?[77[,WQ&MOB5\&&^.,_PLL_C'^QI^RA\+[3XZ6WA'QM=Z5X3\>_!FRU5
MO%_PX\76%AI%OXL/ACQ#)JJV-_K6A66H:09;".21M0M)(Y(>/^ /[2?[/'P+
M^*WQ%^%_B/\ :7NOV@_"'C[]F'3/@QI'QO\ C!\._B7KGPG^'_B2PUNYUR;P
M)I_A"W\0V7Q0O/@KJ$9&G7$^D6_AVX74[Z::32;K21<:A+Q4^(N)Z>%KRJ9-
M6JXG"8&E5P^'KY1FE3$XJ<Z.%G6QWURA2I8!+#RKXFA+)XQHYCB?J4Y4:B^L
M4H%/#8-RARXB,83G&%1QKT5"$7:U-PFW4DYV4_;*3I4^:THKD;7YA7/['O[4
M-G\7K7X"W/P+^(L/Q>OK%M5LO [:!/\ VG=Z,B/(^NVUP"=,G\/1I'(TOB".
M^;18A')YE\NQL>7_ !0^$_Q*^"GC'4/A_P#%CP3XA\ >,M,CMY[SP_XET^73
M[];6\C\VSOH!(#%>:?>Q9DL]0LY;BRNXP7M[B5037[>WO[9WPZM/C5\+_!NG
M_'[]FJP\!?#_ /9Z^(?PL@U'PU^RY\8#^SIJS?$/5;:XU7X->-K+Q+X^UGXJ
M:G\-KBUM6N(?&WAK0=+FT+4KN6UM-#N=-EN+V#\X/V_?%'P%\5?&K0KC]GG7
M9-<\(Z5\+O!>A:^=.U7XBZM\/])\;Z>=5_MW0_A$WQ6;_A.;#X9:=!-IRZ'I
MFK16T%G?R:NNE6T6E-9Y];),^SW&YEA,+F.52PV'KY94Q4J]/+LSHPAB:>)J
M4X^VKXWV5/"NO05*K3P"ABZU.52<:F,Y:<'7SKX;#4Z52=.NY3C5C%1E5H2<
MHN$&U&---S<)2DG.]-6CI!OF4/A^BBBOMC@"BBB@ HHHH **** "BBB@ HHH
MH **** "OZH/^"&__!.U]-@TW]M/XQ:(5O+^UE'P%\.ZE 4:VL+E9+>]^)5U
M;RJ',NH0-)8^$"P6,6$MYK:+.+W2+BW_ "]_X)1_\$_-0_;/^,T7B3QGIUU'
M^S_\+]1M;_Q_?;'BB\5:ND:WFE?#[3KD@(TNHDV]UXB>)FEL= 9E!@NM3T^8
M?W6:9IFGZ+IUAH^DV5MIVEZ79VVG:;I]G"EO:6-A90I;VEG:P1*L<-O;01QP
MPQ(H6.-%50 *_G/QO\1/[/P]3@W)Z]L;C*2_MO$4I>]A,'52<<!&47I7QD'S
M8C5.GA)*%F\2W3^DR++N>2QM:/N0;6'C+[<XNSJV_E@](=YW?V%>]7PG\4OV
M_?A9\*/VNOA3^QYK?A7Q[J'CCXK6%I>:?XFTO3+&7PKI$NJM?II%O>O-?Q:G
M=I.VF7?]H7>GV$]OI2F!IVE!NOL?W96)=>&O#E]K6F^)+W0-%O/$6C07-KI&
MO76EV-QK.E6UYC[9;Z=JDL#WUC!=[5^TPVT\4<^U?-5\#'\N997RVA6KRS3
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MS1O%'ARSL==\1^)5MM2TKPIJ>GQ^+;B>Q@Z77_V_XO!OQT\(_"7Q]^SQ\6/
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MP]J6B?VI<Q:R^O+:P32<]XH_82_:1L='^-_P(^#_ .T3\-O!_P"RK^T9XO\
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MF247*<_^TG^PQXK^,'PR_95\):'XA^$7BF7]FB+3H]2^&O[0/PXU7XB_L_\
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MXB:'XPUKXV_!_P",7A3PU\>M)_:G^-G[0_PZU#QEX!U3Q-\.)_"GQS\"^$O
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MN+_NK_(5G4Z?/]"X;OT_5'2P?ZB'_KE'_P"@+11!_J(?^N4?_H"T5F:F#/\
MZ^;_ *ZR?^AM452S_P"OF_ZZR?\ H;5%0 4444 %%%% !1110 445\V?M/\
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M*70_$5K?-I<:^#-?\4:IH7AK]2_V._@1\#?V[/C)X*_X*,ZA^SU^T5_P3_\
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MXP3T6V]OB>E[NZOLD@HHHKL, HHHH **** W/:_$'[2O[1OBWPHW@/Q5\?\
MXV>)O [V=GI[^#/$/Q5\=ZUX4;3].6)-/L6\.ZEKUSHYL[%(($L[4V?D6JPQ
M+ B"- M*]_:"^/&I:%IGA?4/C5\6+SPUHT>D1:3X?N?B'XMFT73D\/WMAJ6@
M+9Z8^KFR@_L/4-*TN]T8QPJ=+NM,TZ:Q,$EC:M%Y#17)'+\!!14,%A(*-1UH
MJ.&HQ4:SLG5BE!)5&HQ3FK2=E=Z(ISF]YS>G+K.7P_RO76/D]/(]'\%_&+XM
M?#?4]9UKX>_$_P"('@;5_$:[?$&J>$O&'B#P[J&N?OY+H-J]YI.H6EQJ,B7<
MTMW'+>23217<CW,;).QD/*+XG\2I%XB@3Q#KB0>+DBC\60KJU^L7B>.#5+;7
M($\11BX":TD.M6=IK$2ZD+E8]4M;;4$"W<$4RX=%;+#T%.=14**J5/9\]14X
M*<_8M.ESRY>:7LFDZ=V^1I.-K$W=K<TFM79RDU>7Q.S=O>^UWZW-FR\1^(=-
MTZ32-/U[6K#29M7TW7Y=+LM4OK73I==T6*]@T?6I+*">.V?5M)AU+48=-U)X
MC>6,5_>QVLT274ZOW'BGXW_&?QQK/A[Q%XS^+7Q*\5Z_X1EBG\*ZWXB\<>)M
M9U;PU<0S1W,=SH.HZAJ=Q=Z1=+<PQ7/VFPFMYVN8TN&D,RJX\NHI2P^'G-5)
MT*,ZD5-1J2I0E.*J14*B4G%R2J0C&$[/WXI1E=)(:;2LI22[*3MH[I6O:R>J
M6R>JLSV>P_:/_:$TNUU>RTOXZ?%_3;37]:NO$FMV]A\2/&-G%JWB"^DAEOM;
MU!+;6(A=ZM?2VUM)>ZA-ONKN2VMGN)96MX2GE6IZSJ^M/9R:QJNI:M)I^FV&
MC6$FIWUU?O8Z1I<"VNF:59M=2RM;:;IUJB6UA8PE+6S@58;>*.-0HS:*5+#8
M:C*4J.'H493LYRI4J=.4FE9.3A%.5DDE=O338'*4K*4I22NDI2E)*[N[)M[O
M5]PHHHK<04444 %%%% ']_G_  1X_P"4=G[._P#V"?$W_J7ZY7Z:5^9?_!'C
M_E'9^SO_ -@GQ-_ZE^N5^FE?YP<<?\EGQ7_V4.<?^I]<_3L#_N>%_P"P>C_Z
M;B%%%%?+'4%%%% !1110 4444 %?B;_P7Z_Y,#N/^RS?#?\ ]$^(Z_;*OQ._
MX+\@G]@.YP"<?&;X;D^P\GQ&,GT&2*^W\-O^2]X3_P"QW@O_ $X<&:?\B[&_
M]@U7_P!(9_$!1117^B)^;!1110%EV_K^DON"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#^W_ /X(/QQQ_L >&VCC1&G^*'Q,EF9$
M56FD&J6D(DE90#(XAABB#N681QQH#L10/V9K\:_^"$2L/^"?OA1B" WQ,^)Q
M4D$!@-9B7*D]1N5ER. RD9R"*_92O\\O$7_DNN+/^Q[F'X5YGZ+@/]QP?_8-
M0_\ 3<0HHHKXPZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K63[B_P"ZO\A636LGW%_W
M5_D*SJ=/G^A<-WZ?JCI8/]1#_P!<H_\ T!:*(/\ 40_]<H__ $!:*S-3!G_U
M\W_763_T-JBJ6?\ U\W_ %UD_P#0VJ*@ HHHH **** "BBB@#Y-_;%_;9_9Y
M_83^%L7Q8_:&\67FAZ1JNM6OA?P?X:\.:+?^*O'OQ"\77ZLUAX4\"^$M*234
M-<UJZ5&8C-KIUG'MEU+4+*)T=OYR?^"V&G?M%_%O7?V1_P!M3]E7X6WOQ1F\
M?_LM_$3X4Z/\ /&/AC3[W]ISX.'XU-INJW7QV^&O[/\ J.L)KFN_%'PUX7EO
M/"]TGA]-2U3PE?+#<7%S81+;:YI/ZJ_\%2OV.?VLOC1\4/V-?VKOV,;GX)^(
M?C7^QIXR^(/B#1_A-^T*VOV_PU\;P?$?P[8^')=66_\ #S175EXI\)?8_M^B
M2R7ND",SS7-OJ\%U;16=_P#SC?MA?L8:IXA\=3?!WXGWWQ7_ &N_^"^?[0_C
MOX4_%"'XK?"VP^)NA? 7]B3X<1>)5N=*O?"OBA/^$?\ "EAX(\(>'-*D@N99
M],N95O&@V6.@M;0ZAK<RV:]+/;L[+JVW=+1][6U*CO>]ON[K\%OT3U1^W'_!
M%OX'?&[PW\0/BS\5KKX/?'G]D[]D'1_@U\'_ -G;]F+]F7]H2]N=.^(]^GP[
MBGU'QQ\<O&'PXAU"YT7X?>(O'/B6]U35=0M[*VAEUO5?$NN7H>>UA@OM1_9K
MQT3\5/%,GP@LF)\(:/'9:K\8[Y3NAU"RNT%QHOPMB"X5I?%,3+JOB\R,R6W@
M^%-'>VG;QA%=:;V/Q"\87O@OPS8V^E01:UXZ\17%KX7\$Z-*QC36?%%W;MBZ
MOFC!:UT+1K:&[\0^);Y5/V+0].OGMX[B]:SL[G3^'W@NW\!^&+71%NY=5U2:
MXN]8\3>(;I5%_P")_%&K3&[US7[\KD":^O'9;:V0_9M,TR&PT?3X[?3-.LK:
M'U,*E@Z/U^7\>4G3R^.S52%O:8VUK\N&NHX=VBI8J2G&4OJE:F\9OVC]G]E)
M.IZ65H7VO+>6K]U-6]Y-=JJJJJJJJJH"JJ@*JJ!@*J@ *H      & ,5^%'_
M  4#_;4\<?%#XJ_%/_@G5^S'_P $\]&_X*+>)_"GPVT7QC^U#X<^(_Q'\&?"
M[X1^ _"_C!#<>$?#3:MXQM+F'7OB)X@MXVU;0K/3[S1]5T3R(=9TA[^>POI-
M)^V/V_/V^= _8?\ "_PTLM)^%/C7]H7X^_'OQQ'\-_V?OV?/A[=6.E^(_B5X
MN6W%_J1N_$6IPW6G^%/#.A:;F]UOQ#<V&I_84DA?^SI;5;Z[L/YTOAMXE_;P
M^/W_  4\_:(\3_LQ6>G?\$OOV_?%/P<\&7W[2/[*G[6"VOQ_^"7QB^%OA*73
M_"_A/XT_"OXI> O#%O!JOB3PG+J6D:7<Z5:^&+>RVWMQ/IWB[4=.G\4Z-9^8
MWTUOIZV>NE]+O3?I=VV-4M--.WRMVVM?]#A/V#/V*M7_ &U/AWHGPX\&>"7^
M(W_!,W5OC%\0/AA\=OV3/VJ/&-]9_M._\$P/CWX)TJ#7M=D_9J^-UKHP\3ZQ
MI$$^I^%7T/2;;3=*76HO$1T?QMX=L([KQ/XNB_J1_:0_:(^"/_!-;]D5O'OC
MK5=7D\%?"3P;H7@7P%HFK^(+S7_&_C_7=)T1=)\'^$XM;URXO-5UWQ)K2Z:D
MFJ:YJ<UU/';0ZGK^IR/%;7#'@_V!OV0]&_X)S?LU^.]+^(_Q=7XC>-O&GQ#^
M(?[37[2WQOUW3K+PGI/B+XD^+]/TI_&?B.VTF&22U\/>%](T/PQI.GZ?:&8A
M+32WO7CMY;M[6'^&/_@KS_P4:\9?\%*_VG8M#^'<6OWOP*^'>MW_ (0^ G@?
M3;.^N-1\5WE[=1:?>>/+C0K5);JZ\3>.)[>W&E6"V\M[IVAKINDH@O&OS<?=
M\ <'5>+<V5.LITLIP/)7S/$KW?W=[PPE.>RK8AQDE9_NJ2JU=>2,9<F+Q*P]
M.^CJ2]VG'JY:*]NR37J^6*WT\=T7]I?XD_MP?\%#M%^.'QUN[?Q%KOC?6O$2
M1Z'<I]M\/>&?#-CX0\3-X>\':#I]X)8;;0?#\!1+.'RPT]V;C5;GS-1O;JXD
MRI?@)^S6WAO3/#%KI?QJ;XH_\,KZ#^TKJOBZ?XA>"8_ ]U?QZ#;>+O$O@'3O
M!$?PJDUO3K"_\/\ VRUT/Q9<^.-4N=+UMK5[[PWJNGI,K_*OBCX;_M%?LN^*
M_#VI^//AQ\6_@/XQEM[G4O"\WCWP-XI^'^L75I+#/IMW>Z/%XITG3)KRW\N>
MXLYY[:.:.-GDA=ED!4<4OQ.\?K="]'BS6!=KX'_X5J)_M ,@\!#3/[&'A4,4
MXT@:5_H M^OV?Y-W>OZR67Q<:+RO$4</@J6%P^'PM/"U)1HQ6%>(5)+V%X3H
MP56$73;E&7(U.+LD_#C6BE:M3E.;G*;YHIW4_97^)IIM0DE962:::>WZT?$S
MX6? WXU?$;Q.UEI?C#P#\'_V:/V=_@AJ-C\-?%?[1/PL\*V^L:O\3M*\!6UB
M-$^(.H? [PSX7\ :>MUXA?7?'6H77@;QQKOCOQ=%F";0Y?%D<_ASP'Q9^SI^
MS'X4\'_&[QO9:YXU\?P://\ L\:#\-]&\&_%OP#?Z3X(\7_''0/C)=:WIOQ&
M\>Z?\,]7TOXEV/@#5/AQILMG=>#-*^'X\5:7>R)=OX9O;ETTGY#\-_%GXX>'
M=9U#XLZ!XA\3"Z33=(\ >(/$MQID6M>'-0T=](BL=%\$>+;/5=/O_"NN:7=:
M/X9A%GX9\1V5]9WL.@1W2V,[Z6)H,;QA\:OBKX^'B1/%_CG7-<M_%MYX2OM=
MLKJ>./3;F3P#IVLZ/X&MK73+6*#3])TOP=I'B#6=*\,:+I%M8:1H>F7\NGZ;
M8VUHL4,>%#*L=0=.C3QS6&I0PL)0CB<1[2\*N&JXJFW*,IRE7MB:GUF56&(E
M]85*35*,;5.O1DY2=*2E)RE!RC%VBE:E]JUHV47#EG"T6WS2>GZ0_$+]B+]G
M;PKXJU+X70?$B.R\<^!OBQ\-/AUJ=_;?'OX7^/K_ .*Z>(?B/X>^'?CB/P[\
M+?#7@/3]?^$^KZ2FM7?C'1#XE\3^.K"'0]$O=)UAI=6EM)[CDM"_9:_9K^+,
MVN:W\-O^%V>"O"/P@^)'Q&\,?$^Q\7>+_!/CWQ;\0_!_@/X0_%/XRV>K_#I=
M&^'?@/3O!_C+Q'I/P9\5>'6\-:Q#XZTS2=0U[0-3CUK5K;2]3M-1^2O$O[1G
M[2YT7POH7B?QWXRL;& >#_%VAW%[IUMI&L^)(/"LP?X?Z]K/B-=+L_$/Q L/
M#,MD%\%WGB?5/$%CH:VGDZ"UK'!L3SCP[\8/BCX0N([SPKX\\3^';V'QWI/Q
M.AO=%U2XTV]@^(&A0:O;:/XM@O+1HKF'6=/M]?UJ"WNHI4*Q:G=H5996%%/+
M\V^KM2S+_:8J2I5HUJTZ/--485)SIR@E+FY*\Z=*:JPP]6JO8RC&,%34JM#F
MBU1]W3FBXJ+Y6IM)2YV]W3]_24HQ=[N33^O/@_\ !;]FW]H'Q?XCU7PAIGQ/
M^&?@7X9_"?Q;\2?'7A+XE?&?X:^?XEFT/Q5X-\):%I?A'XX7GPP\'^'?#_\
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M ,])?^^1_A1MM?\ GI+_ -\C_"JH(/<?Y_S_ /KJ"XO+2S$1N[JVM1<7$-I
M;B>* 375PXCM[:(RLHDN)W(2&%-TDKD*BL2!3^;?W:[>7]7]+*]NBTWT[6_R
M_%]S1VVO_/27_OD?X4;;7_GI+_WR/\*SKB\M+3R/M5U;6WVJXCM;;[1/%#]H
MNI=WE6T'F,OFW$FUO+ACW2/M;:IP<6*+>;_#R\OZOZ6+^2^[T_R_%EG;:_\
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ME1%4LSL0JJJC+,S$@!0 222  ,DXIV\W^'^7]7?E97\ETZ>GYV_%]RWMM?\
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M27_OD?X4;;7_ )Z2_P#?(_PJM11\W^'^7]7?E8OY+[O3_+\7W+.VU_YZ2_\
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MYUNM US2K;4+6XAT[6-#N42XT?4[-(;W3)T66RG@<!JS+WX9_#C4I/',NI>
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M +N=K.YN;ZZDCAM+'5?A[KOQ"T6^RZ+-<W.D7$K'^SH@/H;7?'OP8\>_#/\
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MP   *IU_H9'FY8\R2E9<R3;2E;5)NS:OLVKV/R1VN[7M?2^]NE]]?F?:UO\
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MOX#N/ NNZ9J]M\1/$^FW5NWA6SE5;N&]M)[2[MHWKZQ\1? WP]XD^/7PT_:
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MM.U&=M/\3\=?MO\ CO\ 9J_;.\4>&?C=!X0U7]H+XM?LX_L\>#O@W^S?\/\
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MXW72M"/BWP3KD#6NL>'=:GT31[V6QO5M]0TRSO;:>(?(_P"SE_P3D\6?#?\
M9M_9;TS3_BSXO_9Z_:=^"'P^\:^$9_'_ ,/I/"7Q+MG\*_%'QUJ'Q%\3?"GQ
MMIWQ+\/^)_#_ ,1]$TC6+K3);7Q&UMIVOQ>)=$.OZ-KMK:ZGJ=EJ7Z2?!OX:
MW_PG\"6'A#5OB7\1OB]K,5[JNK:S\0?BGJ^GZMXLU_5=:OYM2OI'BT32M!\.
M:%I%O/.UKH7AGPSH6C^'] TJ&VT[3;"*.)GDN-TY)VMKRZ))>_[JC9MM*%U+
MF>KU5]+15=)JT%JFM=6[)-.^D4[NUK;);)MI^I4444S$**** "BBB@ HHHH
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M9=&*P.%DHQBZE"C4GRQC%2G*G%RDU%)7;U=D%%%%?+':%%%% !1110 4444
M%?CY_P %P_\ DQZX_P"RM_#W_P! UZOV#K\?/^"X?_)CUQ_V5OX>_P#H&O5]
MIX<_\EUPK_V.L%_Z<1YV;_\ (LQW_8-5_P#26?QQ4445_H(?E 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z??\$Q?V%[W
M]K;XL1^)O&.GW*? SX;ZC;7?C.Z*/'%XJUE(UO-.\"V-Q@*S7>ZWO/$+QDR6
M>B.(LP7&J64Z?V?Z?866E6-EIFFVEO8Z=IUK;V-A96D206MG9VL206UM;P1A
M8X8((42**)%5(T554  "ORD_X(L1HG[#/A=D1%:7X@?$625E4*TCC6DB#R$
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M+Z_OS&8[+5AX0T.YF;3I%:YBNXH++=YC)B?XM_L?_&?QA\'_ /@J7X-T33=
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M;QCX=6]L9-.^&.O>'=(\<>.&NXU\'Z;JD*3W$7RYX _95_;.^'=W\/?VI/\
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MQ_;X9W?\*>^'6J2>'AXZ^%G@#X9_$2?PO\?]0O\ X<?#[Q[X@\0Z;<Z#X/\
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M\G/H._J*R>.PB_Y?+Y1F_P HL#^Q/_@E+_R85\!/^P3X@_\ 4IUFOT0KX/\
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MT%8#_P +</Y?W_/^KJ_XB45^W?\ PR7_ ,$H/^CD?VH__"5T+_YVU'_#)?\
MP2@_Z.1_:C_\)70O_G;4?Z\Y=_T*.*?_ !&\T\O^G'G_ %=7/J$O^@K ?^%N
M'\O[_G_5U?\ $2BOV[_X9+_X)0?]'(_M1_\ A*Z%_P#.VH_X9+_X)0?]'(_M
M1_\ A*Z%_P#.VH_UYR[_ *%'%/\ XC>:>7_3CS_JZN?4)?\ 05@/_"W#^7]_
MS_JZO^(E%?MW_P ,E_\ !*#_ *.1_:C_ /"5T+_YVU'_  R7_P $H/\ HY']
MJ/\ \)70O_G;4?Z\Y=_T*.*?_$;S3R_Z<>?]75SZA+_H*P'_ (6X?R_O^?\
M5U?\1**_;O\ X9+_ ."4'_1R/[4?_A*Z%_\ .VH_X9+_ ."4'_1R/[4?_A*Z
M%_\ .VH_UYR[_H4<4_\ B-YIY?\ 3CS_ *NKGU"7_05@/_"W#^7]_P _ZNK_
M (B45^W?_#)?_!*#_HY']J/_ ,)70O\ YVU'_#)?_!*#_HY']J/_ ,)70O\
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MC_XW1?R?W>G^?X/L'(^\?O\ ^!YK[R&BIL6W_/2;_OD?_&Z,6W_/2;_OD?\
MQNB_D_N]/\_P?8.1]X_?_P #S7WD-%38MO\ GI-_WR/_ (W1BV_YZ3?]\C_X
MW1?R?W>G^?X/L'(^\?O_ .!YK[R&BIL6W_/2;_OD?_&Z,6W_ #TF_P"^1_\
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MG=1-J6ISI#IVGQRR#[1?W=O&S@R;J_.3_@FE\+?V?_%L_C?]KC1?^"9FL?\
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MC&,K-21^(U%?O/\ %SX%_"+X4^&-(UCXP_""RT/3/"7[0OA;X+7FI2?L_1?
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M9[VT[EJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ K63[B_[J_P A636LGW%_W5_D*SJ=/G^A<-WZ?JCI8/\
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M1 CEF *J%8D@*<04?U_7W,=[_P!>G^:^]!1110 444=>E &AI>FW&K7L-C;
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M2>)YM1L;;4M2OM7\$74>MZJ@UC7+?4M7"7R_4/BOX4^ ?&WC+X9_$#Q/H/\
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M9X'\?CP]X=UG1CJ%Q_PE/B(V<VD^,?',ZR:SXZB>R_MVW86,2'][-/\ @?\
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M^#O[0_[9FG/XVM_VF?AS_P %,9=)\!?$G_A._',FH>'?!5W^V/\ #OX<:MX
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M.GS_ $+AN_3]4=+!_J(?^N4?_H"T40?ZB'_KE'_Z M%9FI@S_P"OF_ZZR?\
MH;5%4L_^OF_ZZR?^AM45 !110.H_KT_&@#QBV!\1_'O4KG :Q^%_PXLM*@<
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MLG[*'^&-I3?FFW%>L6>3F-2\H4NB7/+;=Z1_#F?W>04445[QYH4444 %%%%
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M "BBB@#^F[_@EU'&G[)GAYD1%:7QAXUDD95"F20:L8@\A &]Q%''&&;+!$1
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M7^0K)K63[B_[J_R%9U.GS_0N&[]/U1TL'^HA_P"N4?\ Z M%$'^HA_ZY1_\
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ME?Q67B#]HCQ6^BQ2(D__  @'@J>WN-53)5EAUSQ3+%<Z?:N &2XL]$M-1RK
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MTZ<8PA%-M1C%)15VV]$DM6V%%%%8%A1110 4444 %%%% !7FWQ;^$_@OXW>
M=>^&_CZPFOO#NO0QK,;2?[+J%C=VTBSV.IZ9=[)/LU_8W"+-!(T4T38:&Y@N
M+:6:"3TFOG[]ISQ?JW@SX1:[?:)<26>H:G<V.A1WL+%+BTAU*1Q=2V\BE6BF
M:WAEA252'B,OF1LDBHZ^CE%+%5LTR^E@:\L-C)XS#QPV(C)PE0K>TCR5HRBU
M).D_?7*[^[9:G/BZE*EA<14K052E"C4E4IM)J<5%WA9Z>]\.NFNNA^:.L?\
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M\*/)@_Y^!_WW%_A5:BBS_F?W+_+U_I:G,OY%^'^19\F#_GX'_?<7^%'DP?\
M/P/^^XO\*K446?\ ,_N7^7K_ $M3F7\B_#_(L^3!_P _ _[[B_PH\F#_ )^!
M_P!]Q?X56HHL_P"9_<O\O7^EJ<R_D7X?Y%GR8/\ GX'_ 'W%_A1Y,'_/P/\
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M@_Y^!_WW%_A1Y,'_ #\#_ON+_"JU%%G_ #/[E_EZ_P!+4YE_(OP_R+/DP?\
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M@MX9#R7?B>ZCR(BUCIH8<>81F[N!GNB%((R.[S<9"D?1-96AZ3!H>D:?I-L
M([&UBA+  &24+F:9L<;YIB\K]MSG&!@5JU\MB:SKUIU.C=HKM%:1]+K5^;8!
M7JO@7X6_\)GX=\0^+-1\>^"/ /A[PYJFB:+=ZCXQ3QO.+K4]?M]5N=/M;*V\
M$>"O&=XQ,&C7SRS7=O9VT7EHOG%Y%4^55]!_#E_"NM_"7X@>!-9\?^%O FL:
MKXT\!^(M,G\6VWB^73KZQT+3/&-GJ213>$?"OBJXBN8I=:LF1+JU@CEC,A24
MLFT^5F-2M2PW-1E5A)U\+"4Z%!XBK"E/$TH5IPI*E6YG&E*;;=*:BDYM6B;4
M(PE4M+ELH5&E.2A&4HTY.$7+FA92DDK*46[V3NS@_%GPL\5^%-;T?15AMO%
M\3:=#K/A+5O!TD^OZ7XKTB>2>".^T1H;:._D*7%K=6MY87EA9:KIUY;7%GJ-
MA:W4,L2\G;>&_$=[>7VFV>@:W=ZAI<<\VI6%MI=]/>:=#;-MN9;ZUB@>>TCM
MV^6=YXXUB;B0J:^Z?!7Q>^%GA;2D^%EAKVC:S_9'PZO?#FF_$K73\1/"WAK4
M?$>L^-(?%/B32[&]\)_V7\0-%\+WMC%#I.G:E>65B]Y<VLKZSI6FZ;JDXM]?
M3OC/X6U'QOKL%[X]^'^D:2VG_#*TU35-)U#XW^'+K5)O!EMJ$?\ PD?A;XC@
M:]XQU7Q-X:AOQIBP^.-$N=&\3V]C:W$&FR75A9/+XJSC-(*K"658BK[*#E3K
M.C5I_6:?MZ<*=545"4J=2I0J.<\/-4Y4ZM.:ER0YO9=/U;#/D?UF$>=Q4H<T
M7R3Y+SAS7M)1J7BIQYTXV:4I63^"7\*ZH_\ PCL>F :Y?^)+.6\L])T6VU.]
MU2W:*_O+(V=S:_8(C)>.;-[I$TY[^'[-+$7G2<30111>%/%,]\-,@\->()M2
MWLHT^+1]1DOMZ7$EHRBT2V,^]+N&:U8>7E;B&2$XEC91]R:#XT\.^(;+6_"W
M@CQKXAT[57^&/B;3(_B:/#WBR\O?#%C'\7M<\2SR>+Y/"6C:IX@TG3?%?AJ^
ML4UW6?#FE:FEI/>)9W4!M)KV.+<^+OQ&O/!'PZTS0G^*?B#5O'6L_ #P=HUG
MXE\GQ3H>N:[!!\<?$NL2Q))J=K8^(+72G\-PPMI5WXBATB^U[PXEE=S6:'45
MM"WG6.6(I86. ;JUL5[",:RQ,)1I2E)_6Y..#]DJ-.G\5*4X5U&'M9+V4O:(
M>%H\DYNLG&%*-1N'LVG-*FI4DG5YN>4I/EDE*%[0^).*_/>W\.^(+LZH;30M
M8N3H4<DNM?9],O9CH\4+.DLFJ>7 W]GQQ/'(DCW?DJC1NK$%6 QZ_2#0?C-X
M*U6]EDU;XGZ;I6GW\7PNUSQ;JHNOB/X7^(,'B71_AEH^@>)O%7A;Q!X:TO5M
M,\9:\NHKJ]CJ7AOQSHUUI^J7JP7NGZ@]OK&KZC:_G-=&)KFX:&226$SS&*69
M DTD1D8I)+&C.J2.F&=%9@K$JK, "?3R['8G%SK1Q&#J87V5/#3BY1J\DY5J
M?-4A&52E2YG1FG&5HIJ\;JS3?/6I4X1IRA453G<T_ANE"2Y&U&4K<R=UKO==
M-8*^Y?V2?V%OB1^T[>PZ[,9O!7PJMKAH]1\;W]HTDFJ/;RB.XTWPE8R&/^UK
MY6#Q3WKLFE:<Z2"XGFNHTL)O9OV#/V!;SXY75C\5?BO:76F_"73[Q)=)T>02
MVM]\0[FU?,D44@"S6OAB&5!#?7\9CGU%M]IITJ!;B[@_H[T?1])\/:5I^AZ%
MIMEH^C:5:0V&F:7IMM%9V%A96R"."UM+6!4BAAB10J(B@ #U)-?EGB#XH4\D
ME6R;()4Z^;1O3Q6-:C4H9=)JSITXN\*^,C?WE+FHX=^[4C4J<U.'T.2\/RQ:
MCBL8I0PSUITE>,ZR_FD]X4GT:M*>ZY8VE+R;X(_L]?"C]GKPTOAKX8^&+72E
ME2,:OKMP$O/$OB&>-0/M6M:R\:W%T=VYXK2/R-.M"[K96=LC,I]KH_IR?0#U
M)[#U)KA[SXG?#73KJ:RU#XA^!K&\MW,=Q:7GB[P_:W,$@ZI-!/J$<L3C()5U
M5L$'&#7\UUJN89KB:V*KSQ>88NM+GK5INKB*TY/3FG-\TK;)7=DK15DDC[NG
M"C0A&E3C3I0BDHPBHPBEMHM/\V]VV=Q17GW_  MKX4_]%.^'G_A:^&O_ )9T
M?\+:^%/_ $4[X>?^%KX:_P#EG4_4,=_T!XK_ ,)ZOE_<\T5[2'\\/_ E_GYK
M[ST&BO/O^%M_"G_HIWP\_P#"U\-?_+.NVL-0T_5;.WU'2K^RU/3[N,36E_I]
MU!>V5U$V0);>ZMGD@FC)!P\;LIQP36=7#8BBE*MAZU*+=E*I2G"+;5[)RBDW
M;6U[C4HR=E*+=KV33=N]D]M46Z*ABN+>:2>*&>&:6U=8KJ.*6.22VD=%D6.=
M$8M#(T;*ZI(%8HP8#!!J:L"@HHHH **3<NXIN7>%#E,C>$)P&*YW!2<@-C!(
M(!R#2T %%%!( ))P "23T '))/8 <D]J-P"BD5E90RL&5AE64AE8'H58$@@]
MB"0:6@ KY2_;*_Y(Q-_V,^@_^WE?5M?*7[97_)&)O^QGT'_V\KWN%_\ DHLF
M_P"QAA__ $M'GYK_ ,BW&_\ 8/4_(_)2BBBOZ:/R\**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]8_V1O\ DC6E_P#89U__
M -+S7T[7S%^R-_R1K2_^PSK_ /Z7FOIVOYJXE_Y*#.?^QCBO_3LC]+RW_D7X
M+_L&H_\ I$0HHHKQ#M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M9/N+_NK_ "%9-:R?
M<7_=7^0K.IT^?Z%PW?I^J.E@_P!1#_URC_\ 0%HH@_U$/_7*/_T!:*S-3!G_
M -?-_P!=9/\ T-JBJ6?_ %\W_763_P!#:HJ "O&=/'VWX_\ BB=0,:!\*O">
MGN5).6\0^)_$U^F]>S;=$8(<#< V,X./9J\:\%*;OXO?&[4PN%LE^&GA L#E
M6?2?#-[XL.1T#JGCV+=W*&/(P 3Z&"THYG-;PR_W?^XN.P-"77^2K-==]B)Z
MNFN\]?E"<EU[I?Y'LM%%%>>6?R]_\'./@KXS_%;X1?LR?#?X2?#GQA\0(/\
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M&=?_ /2\U].U\Q?LC?\ )&M+_P"PSK__ *7FOIVOYJXE_P"2@SG_ +&.*_\
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MJ_G9Z_?J<W];W_'KZA1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXKXNMM)>+4(X[[PPFG:VCRO));+;);3W%U;Q/:2R+<$S>8UL51RN3QN;8F.
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MVA_#WXLZKX*TWX:_%#5?!4VBZNWB?0_AUXO\0ZQ:6^B:Z\5LXT;5&L^(M?\
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M '5_D*SJ=/G^A<-WZ?JCI8/]1#_URC_] 6BB#_40_P#7*/\ ] 6BLS4P9_\
M7S?]=9/_ $-JBJ6?_7S?]=9/_0VJ*@ KQCX$X_X1'Q1C_HM/[0&?K_PNSQY^
M@Z"O9Z\7^!&/^$1\48_Z+5^T!^?_  NOQWG]:[Z7_(MQO_87E_\ Z;S SE_%
MI_X:G_MA[12CJ,=<C%)0.HQU[5P&A^&GQHECF^+/Q%DB1(T_X2_7$VQJJ+OB
MOI8I&VH -SR([N<;F=F9B6)->95V'Q#N#=^/_'%T3N^T>,/$L^?7S=:O7!_)
MJX^OZNP,/9X+!T_Y,+AX?^ T81_0_)*\N:O6E_-5J2^^<G^H4445U&04444
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M].^%NIVWB.S778XM&M==.C^(6MK?68#.+1=16\BTD6Z7B&=)?LRQ;6?YMO\
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ME"][IM-VU8U7DN9\L;R4HO?6,Y.4H[Z)MNUK.*V>B/S%^+'@O]KG]L#]DO\
M:]^&OQ"^"'@#]GKQ#\2OAE=>#O@KX1OOBEI_Q \5:EK:Z3J=Q?7GQ.\4^$-,
ME\&Z#H^IZU_8^F>&H?#MSXDO-,T]M4U;6B)Y+;2H</Q+H?[9?A?X_:!^U7X!
M_9C\.>,M:^*O[.&@?!GQ_P#"#5OCKX3\,:I\&O&OA;QMX@\4Z'KVH^,3I&H>
M'?'/@2\B\1W5MKD_A-)_%-@;2WETSP[JYN)H8/U6HH<;]7JK=.THM[:.2FT[
M6MIR\K2%&LTK6BUKIKLW3=MWHG2B^[UNVFT?C-^QM^P_\:_AD?AK8_%6TT30
M+;3_ /@F=X1_94\4ZEX?U^RUBZTKXGV_Q-\=>(]=ATI8"DMWI=CHGB&QNK35
M5D2UN;I?LZL)(V9?%OV:/^"?7Q?\!^(_V;OAA\2O@Y\1];\.?LV>,?#?B27X
MS^+/^"B7[0GC?X(:R/AQ:WT'@GQ1\(_V8[CQQ=QZ+XXO9KBQEE\*^,?"'AWP
M'X+MV\06.E:QXFM6TV&\_H"HI\JOS=>;FV6_M)5%TTY92=K6=G9M[CE6E+FN
ME[R2>^GN1@[>4HQ5T[ZZW/AK6/@/X]O_ -JK]I7XKQZ=I;^$/B9^QE\)_@GX
M5O9-1M1>W/CCPMXV_:-UO7K"\L3FZL]-2P^(OA*5+^8"VNI)[F.,,]E,!^7F
MF?\ !/7]HCX1W'PI\>V?P_\ BY\6;^]_90^!OP1\<>!/@'^W5\2/V1M?\ _$
M'X.Z;K%I#>W^I^#_ !MX+\(?$;X?:U'K<T=U?2ZC>>)O"^HV<MQH7AS7K35;
M@0_T44F1[_D>_P"%3[->ZDVN7FML_BG5F]&FG9UYI:7MRZW5VE5EJK)IJ*:=
M[-15-+9IZNG!Z/>_>R_"3Q1^R#^U=\/?#/[/?PN^'GP_\4:Y\"_"GP&UOPWJ
MWP8^!G[;GQ5^">D>$?VA_$OC;4_$FJ>+_B)\9]2U;PQ\>?BK\)AI>L+8PV^G
M>(KG7H]3MM9OI? =]'JMDNGR_LY?\$^_V@?"?PQ\-_#[QW!X4\.WTO\ P2L\
M9_L>ZUJEMXG;Q)8:/\6O%7Q#\3ZS$!*!-K&K^'K/1];M[V77662>Z:.2&0/>
MLP/[KT9'3//I3Y%[VKM)23792A4IVOO91JR4;MM6BD[1LZ5>:M91NG%WMUC*
M$DWYN4$Y;)MMVN[GY9_ KX%_'Z7XD?L+_$3XF?#;2/AX_P"S]^S+\4O@G\0]
M(A\=Z!XQD@\0W-O\+] \,ZKH.HZ1#;C4]'\4V7@O4=8C_P!'M;S2;:>WLM6M
MX+PF.OI;]C+X/^,?@G\-?B'X6\;65AI^H>(/VF_VJ?B;H]OIU];W]O\ \(=\
M5?V@/B#\0?!<S/;'RK:YN?#'B'2[B[T\@2Z?<2R6<ZK/#(H^MJ*K[3EU<)0;
M[J<Z=23]7*E%]MU;:V;G>/(DE%.+76W*I)6\K2=^K>M][E%%%! 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5K)]Q?]U?Y"LFM9/N+_NK
M_(5G4Z?/]"X;OT_5'2P?ZB'_ *Y1_P#H"T40?ZB'_KE'_P"@+169J8,_^OF_
MZZR?^AM452S_ .OF_P"NLG_H;5%0 5XQ\"?^11\4\8/_  NGX_''0_\ ):_'
MG/\ P($'/< &O9Z\:^##;+/XD6& O]G?&;XE)M[@:KK?_"29(' +G7#+ZD2!
MB/FKT*&N78^/6-; U7_AB\53?_DU:._YF<OXE/TFOG[K_),]EI1U'U_3OTI*
M4<$=/QZ5Y_\ 7<T/P \22^?XBUZ?.?.UG5)L]<^9>SOU_P"!5BU<U%_,U"^D
MY_>7ERYSUR\SL?U-4Z_K6G'EIPC_ "PC'[HI?H?D$G>4GW;?WL\:_:+\9^)/
MAU\ ?C5X^\'26,7BWP7\+?'/BCPS+JEN;O38]>T/PYJ&HZ3)J%J"IN;)+ZWA
M:Y@# RPAT!!:OA?Q#^W/\0M1TWX9^$?"7@VUT7XMZ/\ $#X<^'_VHK/7+2YF
MT3X7Z=X@\7:-X633M#GD$<.MZG\3VUBT\2_#NZ@FFM3\/_MWB"[>.]CM+27]
M#OBOX"M_BI\,?B#\,[K4IM'M?'_@WQ'X.N-6M[=+N?38?$6DW6E27T-K))#'
M<26JW1F2%Y8EE9 C2(&+#F/B-\%]$^(/A;2O#;7B:'-I_BKX;>*;O6K'2[62
M_P!8E^&NN:9K.F6=^Q:%Y8[D:=]B66665K&&XD,",!Y;>;C:&859U987$RHP
M]A1C&FE']Y4C4KSJ<DW).C/3#PG-J49T9U812J*%6EV8>IA8P@JU)3G[6HW)
MN248.%.,>9)/GCK5DHIJ4:D8._(Y1GXM;?M::/I#:)H*^'?B)\5?%GB7Q!\8
M1IVE^$_#O@/P]JT&@_"WQA_8&N"WTKQ#\2-.3Q)/I)O;*VTZP\,W>L>+O$EK
M!+J:>&+.0R6D?HNG?M(:#K/Q4U7X6:+X!^)6K3>';WPUI7BOQ59:7X;;1?">
MJ>+?#=KXIT6#Q#X?E\51?$BQTY]-O;2&^\1CP)+X9TO4YO[/U#5[>:"[-OY-
MX[_8Q_X2_P &MX'M_B)I::%>^(?B+KFIZ?XO^%7A7QY:07/Q#\37GB7^WO";
MZC>:=JW@_P ?>$Y+V6T\,^+K'5[JVMN+NZ\.7=RD+P]!J?[)\VJ_%/P-X_OO
MB2U_I_@'4?#&JZ(VH> ?#,WQ4M3X:T.+17\-VOQFM)-/UY/ GB9XFU?Q;X9U
M'1]6N=7U*[O1'K=E8W"V4.499NI4TZ3<54P7.U/#<KINERXN*<ISJJ-.JE-U
M)<]6K?DIPIJ]4N2P#YN6:3Y:]O=K7YO:)T6TH*-Y0;BHKEA%KGE*?\,I>&/V
ML;:]\,^";?P[X$^+'QV\7ZG\.K/XD^)T\!>%O 7AR]T#PGJ&L:WHVEZSX@TS
MQ1\2](T2RU#7+WP_K<&B>$_#GB+Q-XAU-=&O[BVT\Q",R2ZQ^VSX"M[236/"
M?P[^+?Q(\+Z;\+]#^,OBCQ7X.T;PA'I'A'X>ZX=7_P")IJ]MXJ\;^&=>O-4T
MI=!U:75_"_A[1=;\36L>GW?E:5<2P21"MHO[)GB;X?6OAR7X/?&[4OA_K]K\
M.-'^%WC'5+SP)HGBRQ\7:!X<UCQ+K7AK68='O-4T]="\9^';CQ?XAATK6A>Z
MKIK6E^+;5M!U6*VMEAZ;P_\ LF>$O"?@_P >>"/#_B+6+?1O&WP*TSX'F2]M
M[>]U"PM+"Q\96EQXJN+D/;)J>M:K<^,KW4[^$P6=LUY$3&4CN&2+-?VXX0CR
MQIU%"7M&WAYTU.-&HZ"P\G4G5DIU%3CBWB%S*<I?5Y*FW4BW_9_-)W<HN4>2
MWM8R2=2FJOM5RQ@N6+J.A[)M.*7M5SVB]/XI?$;QGK'C/X7_  E^$'B#1/#>
MJ?$SP[XC\=W_ ,1]5T,>*$\/>!?#4>BCS/#7AR>]TZPU3Q'XAU#Q!I5I8W&L
MW$FE:/I_V[4;K2]7G2WL&KR^.OB)\!- U>X^-/B*V^,%OJ?B;P[X:^$C^!/"
M=MHGQ3\;Z]XB$\8\(ZOX8%[IW@4:G#=0O/9>([/6?#NB'2([RZUZTT./39+V
M\Z+QE\"I=;TWX:7O@_QSJ?@+XD?"321HW@_QW:Z/IVN6MSI=UI5EI&NZ%XL\
M*:C)'9>(/#FNP6%I=7&GQ:AI6I6&IV6GZCI&MZ?<VS-/QVI_LV^,/%>@W=QX
MY^/'BS7/B;!XP\-^._!OC'2_#VDZ'X3^'FO>$H+RVTF#PI\-)KO6=/&BZA;:
MCJ%KXJMM9UW5M7\1V][(LFO6;VVG/8]-:&,C6Q,Z4*TYN5\/-8B*PT:'LJ<7
M3^K3K1C+$^T56<)SH\KG*'/B(TKTHYPEAW"G&4J:C;]Y%TY>V=3GD^;VL:;:
MI.'+&48U&TN;EI.=I.O?_M@>&]&LKVSUSX4?&'2?B38>.O!?P^G^#LVG> ;K
MQU)JWQ%L]5O/!.JV.I:?\0[OX=:CX5UX:%K-M'XCL?'=Q8Z=>:5J=MK!TY].
MO?L_.:S^V'J@U/X6Z;X9^!/Q+U'4/%7QCUKX._$;0-5O/AKI>O\ PS\0:-X?
MGUUK.\$OQ'70]=N=0LWL];TK4/#6M:[X=O?#D=[=)JXU-],TO4.ET_\ 9<O;
M[7['Q]\0OB=>^-?B8OQ&^'GC?4_$=KX5L?#.AG1?AA:>*+;PKX"\.>%X=4U1
MM T"&X\8^(-7O+R[US7M8OM7U2]N;F]D@-E:6>MKG[-?VW6;_P 3Z#X[N="\
M22_':S^.>F7=SX=M=9TZRU!/!6G> ]1\.7FF/J5B^H:??Z)9W,D5[%?Z==65
M]=Q3*LT=JT5QBXYQ*"DYN#]O%*G%815'AH5:4^><GSTO;U*2J4:L8-4E*4G3
MY5[.HKO@4VK)_NVU)NLX>U<7%Q25IJE&3]I!M<[44IMMRB9[_M<^&C8ZSJ-I
M\+_B[?P0_$G4?A!X*BMM,\#_ &[XK_$;1]4UK3=8T#P#I\WCZ*\%II,/A[6]
M9U'Q+XRA\(>%[71=*U&]DUC=8W,,61/^TO>>(O$OP]\,Z1X>\3?#KQ5'\:]'
M^'GQ3\ >/]/\-2^(])TS6O _B7Q1I4L%]X9U[Q9X9OM.UJ/3K2]TO7O#?B+4
MK:=+>ZM&GBN(;NVCZG4OV:+>3P5I6A^'_'FK^&O&7A+XN^+OC1X"\>VNCZ??
M7'AOQ1XOU?Q;=ZCI][H5Y*;+7O#UYH/C77_"FL:;-<V<FIZ3>R3V]WI>I1VE
MY:9_A[]E^6V\26'Q!\:?$?4/&?Q)D^).@_$3Q)XBB\-V'AS1]17PMX3UOPAX
M;\):%X;MK^_/A[P[I&GZY=W$1N=7U_5KF]ENI[W4KIKE?(&LW;HQ=_CP\JLH
MNA&FJ2E1J5XIQE&LJZJ^TIJ*4L//!K6<\1)MN+P"YY=.6K&$6JKDY^]&G)IQ
M=/V3A:;?,JJKO2,::/K"BBBO;/."OSW_ &A?COKW@[]H:S^&D_Q\TOX%^$3\
M&-&\=6U[<_#>P\>7FN^(]0\<>*= N[8R7<4SV5M;:9I%G+&B*BM*TK,S%E"_
MH17F,'PSM(?C/J'QD&JW#7U_\,-&^&1T/[,@M8K32/%>O>*5U87@E\U[B>;7
M'LVMC"J)';I*)6:1D7CQE&M7C2A1J.E^^O4FI58VIJE5T?L*^&JR3J.GI"M'
M6TI*4%*+Z,/4I4Y3E5CSKV;48V@[SYX?\_*=6"]U2UE!KLU*S7G7P4^(GBCQ
M5\1/C'X.UK7[/Q/HW@&Q^#S>'-=@T:WT6XU=?&7P^B\1:MJ=W;6Y")_:-^_V
MJVM0B"QAD%M&"JC'FOA+6_VD_CCH.K_%OX=_$_P5X T!_$7BS3_AC\.M8^'T
M7B+1?$FC^#O$FJ^&X;WXF^)WU2/Q39S>+;[1KN91X,716\+Z7=63M:^(;^"=
M+GO+[X&_$RP^,GC;XH^ /C59>$M)^(ESX%N/%G@W4OA?IWBEKD>"='BT)8M/
M\13^*=*N-.&IZ>DJR.--N&M9IA,GF^6J'+E_9Q\?:%+XD\/?"WX_Z]\-OA?X
MPUS6=?U3PG:^"M"UOQ-X7O/%&HW.J^*X_A;X[N[ZU;P;;:SJ-[?:C!'K'AKQ
MF^A:E?7-UH,FG(+:WM^)QQLK1J4<9*G3JXY6HXFC2J5?:8CGP56%2.+A/V-+
M#\].5.M*,E*=.]&HH<T>ERPR?-3G04I4\+_$I2G&')1C'$PE!T''VDZUI1G3
MBTXQG:<7*SIR^(/CI\7/B1\1/!/@[Q[H/P:T;X.CP=H/B/5-,\(Z?\0M9\4_
M$/Q1X(T7QU?6EG/XJ>QTW3_!&@Z3XCT6")AH$7B'7KVXN9/[0T.&T,$WTCX!
MC\?P^$])@^)\OA2Z\;6Z7%OK.H>"8]6M_#>IF&ZFCL]3L+#6O,U#27U"Q6VN
M[S2);W58]+O9;BRM]8U2WABO9O%=>^ OB_3O%VJ^.?@U\7[[X;Z[XKT?P_HW
MCRV\4>$[7XHZ'XJD\+:8FBZ'XJ>TU'6_#NKV/CBTTB*#3+C7!K]WIVK6EK9C
M6-!OY[2&X7VGP#X4N_!/A/2O#FH>+?%'CO4;)+B34?%OC&]@O=?UN_O;J:]O
M+NY^QVUGI]E;_:+B2+3]*TNRL]+TG3X[;3K"UAMK:-:ZL-"M&M6=6&(NY5OW
ML\0IX><'6<L/&C055^SE"@XPG)4*-Y1ES.M)\YSUI4W3@J;I64:=X1I<M525
M-1JRG4Y4Y*55.48NI4M%JW(DT=C1117><P5\^_M5?$+QA\*?V>?BK\0OA^VE
MIXT\,>'$OO#3:W;->:0-5EU33[*W&I6Z$/)9M]J99_+/F*A+H"Z@'Z"KS#XS
M_#.U^,?PP\7_  RO=5N-#M/%VGP6$^JVMM'>7%DL&HV6H"2*VEE@CE9FLUB*
MO*@"N6!R #SXN-6>%Q,*$G&O.A6C1E&2A*-65.2IRC)Z1DI--2>B:39K0=.-
M>C*JDZ4:M-U$US)TU.+FG%:M.-[I;['R'JW[6GBS4K7P%'I%E8^%?%J>$OVC
MK/XO^!M5M(K_ %+P;\3_ (/?#VRUZTTD3-)F31GU6X76-(U&$R6GB?PKJ&E:
MC;RF&[^3V3Q)\:/%NA_LX_"[QYI=GHVJ?$[XIZ?\%O#7AN#5([BW\,CQ[\7)
M?#>EIJ>KPV,L5S'H&BSZS>Z]>V-K<V]Q=V6FMI=I=V]S=0SI7^(W[)'@KQ[\
M8$^-%KK>J^%_$UW\-O'GPW\1V>G0PW&D>)H/&'AJ7PQIGB/4;.66%5\0^%]/
MN;JVM+V,L^HZ>]OIMZP@L+-XL[P_^S-XUG^&4GPC^*'QK?QMX2TOP_X,TOP)
M>>&?AWI?P]\5^!M=^'M_H^I>#O&&FZ_%X@\2I>ZUH=[H.EWENMWIXM)KFV87
MD5S:7%Q:2^5&&;1GBX3YZBJ1E##UH5**IQ]G2I151PE4C.C4KN-1^Y2JQI5I
MMM2IQBY=KE@7"C)<L7&<95:<HS<FG*5Z<6HN,X4KQ7O3@ZE..C4VU'1NKGX[
M? [2/%OQ'^(WQ1\-?%_X:^%/AUXV\:>,K"3P+:^ O%^A7_A'0KCQ!;?\((_A
MZ?4-+UC0]3BL[[3[O1O%;#6--VV.H0>*M4876GSQ^"=%_:QOK?P7\0M8^*'P
M[OF\02Z'JWBWX.S^!/[)\)Z'X8UE;:;4=,\*>/\ 3[W4_&$OBSPY8SM+;:QK
MEOJV@^)]0M)+.30O#5GJ,>H:7T6@?!7XA:CJ%R_QI^-^H?%/PX?#&O>$H? ^
MD>"M,^''A36=/\367]EZQJ/Q L=,UC7)?&>MR:9YEK9".XT#PUIK75]>67AB
M&^EMKBSQ/"GP!^*/AQO"?A>X_:2\7ZC\)O!%]I-QHOA>W\*Z/HWC_5-+\/20
MR:%X3\7_ !6LM0:ZUOPQ:?9;.VU"/3/"_AWQ!X@TZW.FZ]XAU&UO-22]VC2K
M\]-^PQZHIITZ;QT74HU%43G/$R>*G[:C-<KIT_:XI0C&HG2_>0A'/GIJ,K5,
M-[3[<_JSY)QY?=C17L%[.I%WYI*%'F;C:?NRD_JRBBBO7.$**** '*-S #J2
M /<]A^)XK]X_AUIB:-X!\&Z7& J67AG1H0H& I^P0,RX[89B/K7X16F#=6P/
M0SQ _C(M?OWH0 T/1@OW1I6G!?I]DAQ^E?E7BC4DL/E%)-\LJV+FUT;A"A&-
M_15)6]3ZWA2*]IC)]5"C%=[2E-O[^6/W>1JT445^.'V9^77_  5M_8XC_:Z_
M97\0KX=TV.Z^+'PC@U'Q_P##ATC#7FIO8V9D\1^$H9 I?/B32;9H[.$LL4FM
M6>DF5DC5I$_@7EBD@EDAFC>*:&1XI8I%*21R1L4DCD1@&1T8%65@"K @@$5_
MJ6$ @@@$$$$$9!!X((/!!'!!ZU_"[_P6D_8S_P"&8_VGM0\?>$-+:S^$OQXF
MO?%_AU(("ECH'BW,3^-/#,;(!%'$-1G_ +=TV!1&(-/U9;.)&CL/,;^H_H_<
M9V>*X+QU71^US#)7.75>]C\#"^NJOC:4%HN7%R>K2/D^(\#\&.IQ?2GB$EW:
M5.H_1ODD_.&EEI^.5?TK?\&_G[9?_"+>-?$?['WCG5A#H'CDWGC#X3S7DV(K
M/QG:QQ'Q!X7@+MB,>(]*B.K6: HAO]'N80'N-1B%?S4UU'@GQGXE^'7B_P ,
M^//!VJ7&B^*O"&MZ;XBT#5;9MLUCJNE745Y9SCJKHLT2B6)PT<T1>&56C=E/
M[_QAPUA>+>'<RR+$\L?K=%O#5VKO"XVD_:87$+1NU.LHJHHV<Z,JE.]IL^<P
M>*G@\32Q$-7"5IQ_GIRTJ0?K&[7:2B^A_J$45^&'PM_X+\?L7Z_X"\-:C\4)
M?'_@/Q_)I=I'XL\.VO@G4?$&F6VMQP(NH3:-JVE37,5UI%S<B2:P:Y6VO8X&
M2.ZMDE4L_H'_  _>_P"">7_0[_$/_P -?XE_^-U_"M7PUX]HU:E&7"F=SE2J
M3IN=+ UJU*3A+E<J=6G&5.I3>\9PDXRC[R;1]_'-<ME&,OKN&7,DTI581DKV
MT:;NFKI-/9Z=&?L?17XXC_@N[_P3Q) /CGXA 'N?A?XFP/<XB)_($^@)K],/
M@7\=_A9^TE\-M#^+7P;\4P>+O WB W<5EJ<=I?:=<PWEA.UK?Z=J.F:G;6FH
MZ=J%G.A2>UN[:)]K1S1^9;S0RR>/FO"G$V1X>&*SC(<URW#3J*C'$8S!5Z%%
MU91E*-+VLX*"J2C&4HP<E*2C)I/EE;>CC<)B).%#$T:TTN9QIU(SDHZ:V3;M
MJM?,^,/^"LW[<ND?L"_L8?$GXMP:A;1_$[Q!:'P#\%]'=E-SJ?Q!\1QO;6VH
MQQ')-EX2TTWWBK4)67RO+TN&R+"XO[5)/\K_ %K6=4\1ZSJWB#7+ZYU36M=U
M.^UC5]2O97GO-0U/4[J6]OKVZGD+237-U=32SSRNQ>21V=B237[Z_P#!QE^V
MIK_[2?[<WB#X+V#W=A\,/V6#=_#G1=*DD81ZOXZDE6Z\=^+YX00@DN;HV>@:
M<IW>7I>A0SJ4EO[E:_GWJ,'1]E23?QSM*6VB:TCIT2U]6SGQ%3GG9?#&Z7KU
M_+KMJ%?U.?\ !LG_ ,$_5^-'QUU_]L[XBZ/YWP]_9^NX-*^&<%[;[[;Q%\7M
M1MWE;4H1(ACDM_ 6CNE^9%^9==U;1GA;=97*K_-=\&OA+XU^/'Q5^'_P;^'.
MDS:WXX^)/BK1_"/AK38$9VGU+6+N.UCDDV@^7:VB/)>7L[8CM[.">>1ECC9A
M_I/_ !:O_!?_  11_P""1^IVWPVTF#4-;^#WPSL/#.AW:P(H\6?''QLL>F7'
MC?7,\RP7'C#4;GQ+>V[/QI5C%HUK)%'';>68JJXQ5*'\2J^1>2=KO[FDO5]@
MH0NW4E\-/WOFM?P6OW:H_FB_X.:/V_\ _A=O[06C_L<?#O73=_#3]GFY&H_$
M&2QN=]AK_P 9M0M)(KJSD\IS%<IX"T>Z_L8%P6M]<U'Q#;@#R \G\N5;7B/Q
M%K?B[Q!K?BKQ+J5WK/B'Q)JVH:YKFK7\K3WNI:MJMU+>ZA?74SDM)/<W4TLT
MC$\LYQ@8%8M=%*FJ5.,([15O5[M_-W9G.;G)R?7;R71%S3M.O]7U"QTK2[.X
MU#4]3O+;3].L+2)Y[N]OKR9+>UM+:&,%YKBXGDCAAB0%GD=54$D5_J3?\$>O
MV#[#]@7]B_P%\/=4L;>+XM>/K:R^)7QIOD1#/_PFVOZ=;2+X;:=<M-;>"M--
MOX=A(9H9+NVU"]@"I>XK^1+_ (-N_P#@G^/VE_VJ)OVE/B%H9OO@[^S+/:ZM
MIT5[;%].\3?&"[C\WPCIC&1##=6_A:#S?%>H0 L1=P:##<*;>\D23_0[KS<P
MK:JC%[>]/\XKY;OY'5AH63F]WHO)+K\W^"\PHHHKS#K"OE+]LK_DC$W_ &,^
M@_\ MY7U;7RE^V5_R1B;_L9]!_\ ;RO>X7_Y*+)O^QAA_P#TM'GYK_R+<;_V
M#U/R/R4HHHK^FC\O"BBB@ S_ )_3^5%%% "@D="1].W(.1Z'('(]*]-U3XS?
M$_6O#A\)ZIXQU2\T%[>&TEM)%M%FNK2 J8K6\U&.W34KRV3:H%O=7<T+  ,A
M %>8T5C5PV'KRI2KX>C6E0FJE&56E3J2HU$TU.DYQDZ<TTFI0:E=+71&D*M6
MFI*G4G!33C-0E**G%[QE9KF3[.Z^\*7)]3245L9BY/K_ )_S_(>@I*** "BB
MB@ HHHH **** "BBB@ HHHH **** /U>_9"@@B^#ME+%#'')=:[KLMS(B*KS
MR1W20(\S  R.D,4<2LY)6-%0850*^HJ^8OV1O^2-:7_V&=?_ /2\U].U_-?$
MK;X@SB[O_P *&)6O959)+Y))+R1^EY;_ ,B_!_\ 8-2_&"N%?GQ^UW^VYXJ_
M9B^,?[-WPNT+]G[QE\6+#X[>*%T#4_%>@WEU:6GA5&UC2=*:.QMK?0-8BUK6
M+:#4I-;O-/OK_0+>'2K,2"^9;B>XT_\ 0>D(!QGMTKDRO%8'!XR%?,<MCFV%
M5+$0E@IXNO@E.I5H5*=&K]8PUZL7AZTH8A02Y:KI^RFU&;DNJI&<H2C3J.E-
M\O+44(S<;3C)KEE[KYHIQN_AYN9*Z0HZ"ODS]NKXX>*/V<?V2_C;\8O ]MI]
MQXU\+>&+2R\'OJZF31]-\4^+_$&C^"?#VO:S"!_I.C>&]7\1V?B#5[0M$+S3
M=,NK9I[<2F>/ZS_S_G-<1\2OASX,^+_P^\:?"SXB:';>)? OQ"\,ZSX0\6:%
M=F1(=3T'7K"?3M1M?.A>.XM9FMKAVMKVTEAO+&Y6*[LYX+J&*5/-DFXR2W::
M6K6MM-5=K7JE==#6#2G!RU2E%M6O=)IO3KITZGP_HO[ NN^$HO!?C#PE^V'^
MUDGQUT#7=#USQA\2_'7QH^(GQ*\!_$^*.]AD\8>&O$W[-WB/Q@OP(T/POXDT
MY]1T[1;3X?\ @_P=JG@:273-0T'6&N=+D&H<5XM_;L_: N!\?_B5\%OV7?"O
MQ&_9Q_9=\8^.O!7Q+\4^(OC=>>"/C!X]O_A.'_X6[>?!/X9Q_"SQ+X7UJV\
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MA^'/#_CE- ^&7PQU:35+[QKX]\/^&_%%B=#T:;5=)M;RPNX+I<71O^"=^O\
MPNL? %U^S?\ M.>-_@=XS\._!7P#\!?'GB-?A[\._B+I7Q/\'?#2#4(?!VOZ
MGX4\7Z?)8Z%\0_#JZQK$6B^)M-O9=/2QU%]-UOP_K]G;6<5O]3>*_@-XFU;X
M&^&?A-X6_:!^,?@[QCX,M_"TVB?'!=3T+Q'X_P!9U[PH8I$U/XB66M:*_A;Q
M[I/BJ:.4>./"U]HUCH^M65W<VFG)H4D>G7-@/FM.S:?.W'2/P\\FDKO^3EB^
M:VJ;6MVT_8J2LTX[:\U[\J3<DEK>5VG&ZMHULC\YOCC^VQ^V;-^SQ\$OBO\
M!+P%^R]+J'BO]J_X6?";7O%?AK]IV#XH?!_XF>!?%OC7PMX<TK4OA!X]\+_!
M/Q;=2>'_ !OJNM:EX6\7ZKXN\'>%/&7PP?0-7N- \->.'N=(U.O3/VT/^"C/
MB;]C_69(?$/A3]F*UTOPQ\-M,^(GB;1OB/\ M@Z!X ^*_P 1YGCU23Q+X/\
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MWI%]&8KJQOK60;9(I%(*L"LD4BI+$Z2HCKS_ ,'?@Q\*_P!GWX=>'?A+\%O
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M .&'/AU_T-GC?_O_ *%_\I:/^&'/AU_T-GC?_O\ Z%_\I:/^(A<-?]!.(_\
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M$_OR?FG_ ,11]D3^_)^:?_$4<\?/[OZ_I/RN<C[K\?\ (HT5>^R)_?D_-/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .C@_P!1#_URC_\ 0%HH@_U$/_7*/_T!:* ,&?\ U\W_ %UD
M_P#0VJ*I9_\ 7S?]=9/_ $-JBH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .C@_
;U$/_ %RC_P#0%HH@_P!1#_URC_\ 0%HH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>ny20053122x2_ex4-11img01.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  D 'H# 2(  A$! Q$!_\0
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M /\ AQO^"67_ -,LH_X;(_:*_P"D3O[?_P#X<;_@EE_],LK[_K\@/VM_V_\
MXC?L^?MH?LT^%].T#2KC]CI?B=X=_9O_ &NOB1>3VUM<^"/CK^T[H']I?LP6
M^G2WVFK$FD>%-1T+1+?XHW":]8I96/[0_P +[D6FIR17$=B1]_$83#*WM<;B
MJ."PZ;48SQ6*J1H82BY-J,98O%U*&"P_,TJF,Q6&H74JT0E[M#%XF6E' X3$
MX_$RU<H87!TI5\55C3BG4J^PH0J5ZD:4)SC1I5:KC[.G.4?H#_ALC]HK_I$[
M^W__ .'&_P""67_TRRC_ (;(_:*_Z1._M_\ _AQO^"67_P!,LK[_ ** /S2^
M%7Q,\8:?\9M5\80_\$I?VW?A_P"+_C/KGA#PU\1OCA\0OBG_ ,$]_&,?AWPG
M9ZQ=)IG]LW>E?\%&?B5\0M*^$OP[E\1^(_%4'PX^%GA/5[329-4\4ZAX)^'F
MI>*/$%W::O\ I;110M(TX+2%*G&E2@OAITH*T*=..T*<%I&$4HQ6B2!N\YU'
MK.K-SJ3>LZDVDG.<GK.;48IRDV[)*]DC^?;]H;]JOX__ +.O[0OBG]C#P+\=
M;;5?AE\8/B5X$35?VR/'VE>(O%^L?\$UI/V@];UF:R^#/Q"\0MX.\0?#?QGX
MO^)5\L=I^Q?)\5_$&EK\-+[QGX0TSX[Z?XE^'H^#UE\5/WK\*Z!'X4\,>'?"
M\.JZ_KL7AS0]*T./6_%6L7?B'Q/K":58P6*ZIXBUZ_9[W6=<OQ!]KU75+IC/
M?WTL]S+AY2!YKI7[.OP/TCX<>/\ X10_#+PMJ'PV^*^J?$36OBCX1\16+>+-
M,^)&J?%G4=2U/XC7GCP^*)=8N?%TGBR?5KRWU,:_<:A'_9/V30K9(-$TW3M/
MM?2?"GAC1O!/ACP[X.\.6]S:>'O"FAZ5X;T*UO-3U36KJVT?1+&#3=-M[C5]
M;O=1UG4YH+.VABDO]5U"]U"[9#/>75Q.\DK9X*,\/@5AJS53$+ZI*>*3G*>(
MA2HUH0PE;VC;ME/.Z&%QT6\1G5+$U,9FU*GFE&OC,SK$-5,2JM.ZHKZVE2DN
M7DJ5:].I+%1<7*[S!)3J8*3]AD[PT,-EU6OA<3*&%_';]H3P1\._VLO^"M7@
M7]D[]IKPYI7Q._9\^&/[!>I?M*^"?@#X_M'USX._%;XP^)OC]%\-/$'CCQY\
M/=527P5\5-0^"GA/0?#UIX3TKQ=IGB.P\&7GQ<U#Q%9Z;8:O>Z=J2_G;\2O^
M",/_  0Q7XB^/EU/]O7QM\&]27QKXJ74/A!X1_;_ /AI\.O"GPJOAKM^+OX;
M^&/A]+$LO@3P]X&G\SPQHO@V15D\,:;I=MHCJ&L2*_HE^/\ ^R)\ _VF[_P+
MKOQ9\*^(V\9_#"YUJX^'/Q,^&?Q2^+/P&^,'@:/Q-91:?XHTWPI\9/@1XX^&
MWQ3T+0?%5E;VEOXJ\-Z;XOM] \2QV.G?VYIM^=.LC;_!>H_\$ ?^"/>M:A?:
MQKW[#_P_\1:YJUY=:GK/B#Q+XP^+?B/Q'KNJW\[W6HZSK_B'6_B%?ZUKVMZG
M>2S7NJZSJ]]>ZIJE]//?:A=W-W/+,_K9#7^IT:-"MGF<Y!+#K-N?'9!0JXK$
MYD\PX@S#-\/]<A#/N&Y4_JF#QN'RV+J8K,'[/+<,J7L:#AA\-L\31AB\5B*F
M4X3-J&(IY7"A@<?++U1R]X'*,!E^)>'_ +1R'B*E;&XW"XO-9^PPV"?UG-,7
M[1U9^TJXG]B:***\TYPHHHH **** &NQ5'8=55F&>F0"1FOYFKO]@GX!_MC?
M\$J?CA^TI\:=7_:-NOBA^TM\(OC-^U)\1K?PM^V)^UEX4^%!^+]K::SXN\%:
MSI?[/6E?&A/V?I;'X8S^"?A_I'@33_$?PP\1);:-\/\ P@OB"7Q%JFF/JER4
M5XF?U*F&R;B''8><\/C<)P_CYX3&492I8K"SC"6+C+#XB#C6HRCB\#@L4I4Y
MQ:Q&#PM9/VF'I2A[.11C6S7(\/5C&K0J\290ZE"I%3HU'?$T;SIR3A-^QQ%>
ME[T7^[KUH?#4FI?L9_P37^,GCC]H7_@GW^Q?\<?B7>6FH_$+XJ?LT?!WQMXU
MU*RM?L5MJ?B;7? ^CWFLZFEH))4MGU&^>:]FAB80)//(+>.&#RX8_MNBBOMN
M)80I<1Y_2I0C3IT\[S6%.G"*A"$(8ZO&$(0BE&,8Q2C&,4E%))))'QO#LI3X
K?R*4FY2EDV62E*3<I2D\%0;E)N[;;=VWJWJPHHHKQ#V0HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>ny20053122x2_ex4-11img02.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G '(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBOS=A_
MX*O_ +'EYXI^)/@G2+?]K_Q)XH^#OB$>%/BEI/A+_@FQ_P %(/&$G@+Q!)I-
MIX@M=-\3W'A?]E#5[/2I-1\.ZAIOB72);FX6VUGPUJ>F>(M*FO-%U&ROI]GX
MC?\ !4?]CCX6^+? ?@?Q+X@^/.J^)/BC\+X_C3\.;;X;_L6?MJ_&.P\<?"W^
MQM!\0:AXR\+Z]\(OV>_'&@:SI?AS2?%'ANY\9I8ZI->>!I-=TFT\8VNAWM_;
M6\F:K4G1AB%5INA4C1G3KJ<71J0Q&$Q684)PJ)\DXU\!@L;C:,HR:JX3"8K$
MP<J.'JSA?LZGM94/9S]O%U%*CR2]K%TJ]#"U5*G;G3I8G%8;#U+KW*^(H496
MJ5:<9?H317FGP;^,GPM_:$^%O@;XV?!/QSX?^)7PJ^)7A^S\4>"/&_A>\^VZ
M-KVC7H94FA=ECN+2\M+B.XT_5M)U"WM-7T/5[2^T;6;&PU6PO+.#TNNBK2JT
M*M2C6IU*-:C4G2JTJL)4ZM*K3DX5*=2G-*4*D))QG"24HR332::,*56E7I4Z
M]"I3K4:U.%6C6I3C4I5:52*G3J4ZD&X3IS@U*$XMQE%J46TTPHHKY!_:4_;I
M_9V_9)\3_#7P=\;;WXR6/B'XQ:G)H/PRL_AM^RS^U+\?(/&/B:.SU;4SX/TK
M5/@'\&?B;I/_  FTFCZ#K>NVW@JYOK?Q7=^']'U/7[71YM'L;F^CQ<X1E2A*
M48SKU84*$')*5:O4;5.C2BW>I5J--0IP3G)I\J9LHRE&I*,9.-&G.M5DHMQI
M4::O4JU&M(4X+6=25HQ6LFD?7U%? FK?\%,_V2_#OPL^*_QE\4W_ .T/X/\
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MNJ4L1AH99BJ].*C#FQ<Y0Y?:.$/Q+^#G_#=G_"UOAW_PFW_#[7_A$/\ A,=
M_P"$E_X7'_Q#B_\ "J?[%_M&#^T?^%B?\,^_\7Q_X0_[-YG]O_\ "IO^*_\
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,-2;;;U;;U;>K9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>ny20053122x2_ex4-11img03.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G (\# 2(  A$! Q$!_\0
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M4::O4JU&M(4X+6=25HQ6LFD?7U%? FK?\%,_V2_#OPL^*_QE\4W_ .T/X/\
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MS]G[6_V=_C)\4"E_\3[#P]JOPM_9U_:%L?C%\*_&?BY%\<:1X9O[/X.:_P"
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MQ7_:C_:C\ ?M&?M%:9XC^+'P?F^!_P"T%\5_A-\'?V;/#Z>+];G^#GP^T?\
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6..P^%KQS"GR8^+P6!@L2J>!PD*/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>ny20053122x2_ex4-11img04.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G *,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBOS=A_
MX*O_ +'EYXI^)/@G2+?]K_Q)XH^#OB$>%/BEI/A+_@FQ_P %(/&$G@+Q!)I-
MIX@M=-\3W'A?]E#5[/2I-1\.ZAIOB72);FX6VUGPUJ>F>(M*FO-%U&ROI]GX
MC?\ !4?]CCX6^+? ?@?Q+X@^/.J^)/BC\+X_C3\.;;X;_L6?MJ_&.P\<?"W^
MQM!\0:AXR\+Z]\(OV>_'&@:SI?AS2?%'ANY\9I8ZI->>!I-=TFT\8VNAWM_;
M6\F:K4G1AB%5INA4C1G3KJ<71J0Q&$Q684)PJ)\DXU\!@L;C:,HR:JX3"8K$
MP<J.'JSA?LZGM94/9S]O%U%*CR2]K%TJ]#"U5*G;G3I8G%8;#U+KW*^(H496
MJ5:<9?H317FGP;^,GPM_:$^%O@;XV?!/QSX?^)7PJ^)7A^S\4>"/&_A>\^VZ
M-KVC7H94FA=ECN+2\M+B.XT_5M)U"WM-7T/5[2^T;6;&PU6PO+.#TNNBK2JT
M*M2C6IU*-:C4G2JTJL)4ZM*K3DX5*=2G-*4*D))QG"24HR332::,*56E7I4Z
M]"I3K4:U.%6C6I3C4I5:52*G3J4ZD&X3IS@U*$XMQE%J46TTPHHKY!_:4_;I
M_9V_9)\3_#7P=\;;WXR6/B'XQ:G)H/PRL_AM^RS^U+\?(/&/B:.SU;4SX/TK
M5/@'\&?B;I/_  FTFCZ#K>NVW@JYOK?Q7=^']'U/7[71YM'L;F^CQ<X1E2A*
M48SKU84*$')*5:O4;5.C2BW>I5J--0IP3G)I\J9LHRE&I*,9.-&G.M5DHMQI
M4::O4JU&M(4X+6=25HQ6LFD?7U%? FK?\%,_V2_#OPL^*_QE\4W_ .T/X/\
M!'P,@T'4?BU'XU_8A_;=\&>.? _ASQ)9>(=0TKQSJ_PH\4_L[Z1\5&^&K6GA
M/Q-)J'Q/L_!EU\/=%;0=6AUKQ-I\UC<1IWO[.W[=W[,/[4WB[Q-\//A%XT\6
MI\1_"/A#PS\1-9^&OQ9^"OQR_9V^)+_#KQC<7=GX9^(VB?#[]H;X;_"WQEXI
M^'FKWUC<:=;^._"^B:QX334_(TVXUB&^N[2WFTA&52=6G",IU*$:<J]."<IT
M8UJ$L51E5BKRIQJX:$L13<TE.A&56+=-.1G.<*<*52I.,(5YU*="<Y*,*TZ5
M:.'JPI2;2J3I8B<*%2,&W"M.-*24Y*+^OJ***DH*_!/]I+]L/XE^$/\ @H'\
M0OV</B+^VXW[ 4^M^!?A_)_P3YTGXB_!OX7ZY^RQ^USXDU/PU<#XDW7Q3^+/
MQ#\%MXCUSQUX1^*&MZ'X&M_@1\*OC]^SQXR31E\%:YI<_CV\\?2V6F_O97Y2
M_MB?LS?M7_'70?VF/@_+\.OV+?VK?V<?VBY=/A\-?#?]JGQ;\4/ DO[/<^F_
M#+P9X9_X2K3?^$7^#WQST[XMB3X@Z5J'Q(\,>#M(B_9Y\0?#GQ+I,GB#1OC/
MK6M?$&&7X3<6+C6G94J=6LU1Q7+AJ6*^H3Q%6=-4:5*CCY7PV"Q5ZKJ4,1F,
M*^6P4*GUBG1K/"YC@.O".E>HJU2G1C:C+VU6@\5&BJ.*H5ZDY86'+6Q4%2I5
M%6PV%JT<9B*+J4<*\17G# XNO\<_C%^W9X=_:P_99_9;^%7Q<_93\%6_Q3_9
M5^+WQ4^(GCCXP_LT_%'XUZC;?$+X!Z]\'= \3SZ-)X$_:P_9AT5/"OC4?%^V
MN[.VN/#EE=>&)O"M[<O-JEKXFM]+\*>W_P#!.#]J[QG^V1^S4/BQX_T#P7I7
MBG0?BY\</@UJ?B'X7:A?:I\(_B;/\$?BEXG^&,WQ4^$MYJE[J>JCX?\ C>X\
M-3:EH]EJ6JZS=:7.+[2_[<UV&RAUF_\ B3QC_P $L/$/B_XU?\$V_#WQ8^&'
M[*O[9O[*O[&?[(GBK]G3XDZO^UM=7WB_XI^-/''B33/A-I5O\6_#7P:\2_ ?
MXJ_#B^UW1XO@QI\XO->^+FD:O?Q_$CQ1I\=]IB^&8+WQK9NOCO\ %OP-^U*_
MA3X4_$+0O /P4^!O[<W[/_[!<'[%WACP)\(M+^'VK_"3XH?LN^$/BRWQ.TZ3
M_A7^B_%?PU\1?#&N?$!M=\.67@KXEP_".#X1_"K5=.D^&FL>(YM7UJW]B]&K
MC5AZ56GB:F/Q^;8.C*&'^I495<=XBT\GR/-70J\N(P&'J8//.'<JP>68:%7!
MQPN:/&XAJKE6)GA.!0<<MC7G3JX:IE>58+,\=SUWC)K"8#A/$XO-LLY\/&>'
MQV,5?!ULQQ.9U94\2L3ED\'!7S9+$_N+17E/QC^ _P #OVBO"*?#_P#:"^#/
MPI^.O@./5K/7D\$_&/X=^$/B=X137-.CN8=/UI/#?C;1];T9=6L(;V\BL]1%
MD+RUCN[E()D6>4/\]^#?^":'_!.+X=>*_#OCSX??\$_OV)? OCCPAK%AXB\)
M>,_!O[*?P)\,>*_"_B#2KB.\TO7?#OB+1/ =CJ^B:QIMW%%=6&IZ;>6U[9W$
M<<]O/'(BL.2GK4:J^Y2]I%*=/][4]DXPYYNG+V,54C)U%&E[5QE&,).K!SE&
MGI4TA>E[]3DD^6I^[A[2\N6'M(^UER.*@Y5/9\T7*25*2@I3\]_;Q^-W[4?P
MK^(?[$OP^_9J\7_ +P=+^TU^T!XD^!WC#6?CE\#OB)\:X]"C@^"?Q+^,&A^)
MO#6F> ?VD/V>&B>S;X4:KX>U;2-4U+4EU8>*M/U6SU/1#X8N=.\3_*'QT_::
M_P""I'P=_9C^,WQ$\,:U^PG\:?B;X3_:I^%?P@^!'B+PC\'OB;I_PM^/_@WQ
MWJO@/X5>(_#%_P"$M'_;.^('BKX0?%3P5^T'XE\6> M7U35_''C"RM5\"7-G
M/\._M6KC4=+^BO\ @H_^QWX\_;#\3_L5:98_!S]EWXY?!GX*_M'W7QC^.WP[
M_:@\5ZS8:!XL\,K\+?'?PPTS0_#_ ('A_9[^.GA7QSJ5G-\2]0\=1P^,9?">
MGVFL>!?#^D6]PS^)I_$O@W<^//['VN>#?V:_A)^SY^P9\'O@'X2\*_#O]I?X
M0_&>+X>>-OB5XU^#/P[\,>&O 7Q_T[]HOQ5I?@A_!?P:^.D]M/XB\6:7-H>A
M^$;?P[X<\)>%=,\0S7&CW%GI?AK2_"6H30@Y481=>>&J8GB?+<)[>5.&)^K9
M-+,>&*N/Q\Z.)C>E'"JGFT*<>6KA\7@:^/IU8^QAAE'JK3HQJ864*,,1"CP[
M6KUJ3G*A3JYBJO%\70=2C*-6KBJ^'>1*,>:G+#<F&JX:7UJ=X_&'[4__  5P
M^)<OP _8G^(G[#GA?X:ZEXK_ &I=2^ OBKXC:K\<_#7C#QCX5_9\^$?Q=^,G
MP\_9VU*'Q%X3\!^._AGJFL_&#3OC5\3;7PII/@B[\=^&(+@?#/XOM>W4-SX3
M:W/UCX/_ &E_VE_#7[</[7W[/_[0/C#]G?P_\&?AS^S-X4_::_9W\6^'?A!\
M0=!\27O@;7?$'C7PUXWU3XIZ_KG[0WB+1?$/_"D]:\&P6?B_2/"/@_P>/$6E
M^,_"/B0:_P""VOE\/3?.7[2W_!)N]T3X4?$71/V&O#_@*X^(?QP_;W^!/[9_
MQ.B_:*^-?CCPAX-\.6/PE^.>D_M%:U\-OA3J'@KX'?&#4O#W@[Q!\1[+Q=JN
MC>"V\.VND>'/$_QC^(_CQ=5OG-MX0U#WS]OS_@G[XP_:Z^+_ .RW\1_!?B_P
MIX)TSPF?'OP6_:RTG6AJ-Q<?%_\ 8R^+7_"+>)OB=\']"%MH>H6E_JWB#QK\
M,_ VG0?\) NCZ9:>%];\:WT=XNI?9-,U"VHUJ$)PC'!XC'9]G^%Q%.3KXBCE
M> SSA7)(9$Z$98BE4J9?PWQ'BGA<?F"Q#Q>)PV5\09O@7A,1F&"P6%Y?=HVI
M3E7Q=#"Y;EF(PN*IQP]#&8ZIE'$6(J9N\72Y?8QS//<CP4ZN"P-:*PM"6<Y7
ME=6GBUEN.QN+T?V8]4_X*A?&CX ?"GXN?$+XU?L5?#CQ1\2O"-CXVF\$P?L,
M?M!W<OA_1O$CS:KX3M-4_MO_ (*#:'JMCX@E\)W.B7?B71;S38I- \07&IZ&
M)[Z/3TO[DK]0(XTBC2*)$CBC18XXXU"1QQH J(B* J(B@*JJ J@   "BO:>>
M8BFW3PV&RN.&@^3#QQ.1</XO$QH1]VE'$8NIE,9XJNJ:BJN(G%3KU.:I))S:
M/+AED)PA+%5L9+$RC&6(EALSS?#X>5=I.JZ%!8]JA1=1R=*BFU3ARP3:B?S\
M_L]^&_VM]6_X*#?\%8M4^ GQM^ OPU^'&C_MJ?LFW_Q5\,_$KX$^+_&WCSQ3
MX8TO]F/]F;5/B#;^"OB[I_QT\->#_AP^K?#>WUG0K >(?@+\3)(=7G^W1ZUH
M?VFWU#0M+]JGXK?$;Q]_P4D_X)C?%+]BW0O@O\<-0\;?L?\ [?&K^!KOXL_%
MGQS\&?A?KW@[5-7_ &6)+;QKIOC7P9\#OCGK^N:?<A=.U+PY;V'@FWT7QEH5
MZNK:;XQL=/GTZ]O_ -!M4_X)8_\ !,76]3U'6M:_X)R?L':OK&KWUWJFK:MJ
MG[(7[/NH:GJFIZA<27=_J.HW]W\/9;J]OKVZEEN;N[N99;BYN)9)II'D=F/I
M][^P]^Q7J7Q"\&?%S4?V0/V7;_XK?#FS\'Z?\/?B=>_ #X3W7Q"\!V'P]MK:
MR\ V/@SQI/X2D\2>%[/P/9V=G:>#[;1-2L8?#5M:6T&BI9101(GS^&IN-'(*
M5:<Z?]D8+"Y?5>'?-5G2_P!3\?PQCZU/$U(QKSYZE?"XG!X6^'CAZ*Q5*CB<
M/5J4ZT/:K5FZV95:5.%3ZW.M6I*M[E-5(YOA<QPD*F'IJ5**4*=>.(K_ +Z5
M2JJ#K4,33]I$^+_V+/AMJG_!+/\ 9L_95_9G^+,.O?&'Q]\?/C[\1[?Q[\3/
MA'I?A;2/@_X ^-WQX\0_$#XYZKID'A_QS\0-!\=V'PJM]3EUSP?X)O/"7A;Q
M9K%P-)MM:\4>&O",>LRQVGZ'_M!?\)M_PIGX@_\ "N?^%Q_\)O\ V&?^$<_X
M9]_X9^_X7-]O^V6N/^%??\-5?\8\_P!N^3YN/^%J_P#%-?8_M6[_ $_[%7C'
M[7OPO^.7Q+U#]E^\^"OA_P"%&O+\*?VF_!'Q=^(*?%'XG>+_ (;&/P5X<\/>
M+M U"+P:?"?P;^+H\1^*)!XL:[L](UO_ (0[293IXMY_$=M]L,]I]E4_>Q6#
MQ\*R^IRCFF(R[+Z>$_<+#9!A^'.&89=]42Y_9QPV/JYQA,--WE"&#ITVG&C&
M4L5_L^,P\J?^TPG@*68XVKB?WKQ.>8K/N(:N9/$OW5*6(PT,LQ5>G%1AS8N<
MH<OM'"'XE_!S_ANS_A:WP[_X3;_A]K_PB'_"8Z!_PDO_  N/_B'%_P"%4_V+
M_:,']H_\+$_X9]_XOC_PA_V;S/[?_P"%3?\ %?\ ]G>?_P (O_Q-OLU:W_!7
M*Q^(NI_$C_@E#8?"7Q3X*\$_$6Y_X*-:2GA;Q5\1? .N_%'P5HU^/V6?VFWE
MN?$'@'PU\2?A!KOB6T>R6ZMX[+3OB3X3FCNIK>\:_EBMI+&Z_9ZOF[XW_L;?
MLA?M-:OHGB#]I']E3]F[]H+7O#6FS:/X<UOXW_ WX8_%?5] TBYNC>W&E:)J
M7CSPOK]YI6FW%XS7<UC8S06LMTQG>)I27JYRE*>4M4Z?+EV?93G-6<93HXBM
M#*\SR_-/JT:U-.2]M/+88>E-<KPGUJOBH^VE".'J.%HPS1<\^;'Y'FV44XRC
M"K0I3S3+,PRSZRZ,_=E[*.8RKU:;YEBEAJ.&DZ49RKT_SC_;L\5_$#2_^"67
M_!1WX*?M"_&/X6_%K]ISPY^Q;^U9\1?&4OPB\"ZU\._#.G_"WQM;?%^R^#=\
M_@/5?$OC_4/ ,%YX:T.3PWIFE^)OB'XOUC7M4\%^+[RP\3^+8]&UC5XN%^ G
MP3^/.B?&KP!_P4]_;+;X%_"3X;_LU?\ !.Q/@K\+OA?^S]X\^)/QR\3>)]%\
M5S>&OB'X\\?_ !+\9>+/@S\!I3J@LO!WAG0OA_\ "#PKX'\81G7=7U:Z3QE<
MZC]@M]1_2#3O^"=G_!/O1_ 'B7X4:3^PK^QQI?PM\9ZYH/B;QA\-=._9C^"=
MCX \5^)/"T=[#X8\0^)?!UMX(B\.Z[KGAR+4]2BT'5M4TZZO](CU"]33[BW6
M[G$FS\2_V5_!4W[*7B_]F+]GGPQ\.?V?O#Y\,W=M\+O#_@7P+H7A3X9^!_$]
MKKB^,]#F3P+X2T_2M(M?#]QXS@BU#Q+8Z-96ES?P7NJSPNNHW7VBBG)8:KFF
M/YI/%UZ&70PM2C0@EAWA,LXPRS&XFGA80JP>)K9;QAC<LHT72Q=%\E;,H4:6
M+Q.#P^4NM?%QP&$Y(1PM/'9KBJ]*IB)_O%F.9<)YI1PGUF2@Z>#H9GPK0QL>
M18>>'PU;#Y4JE;#X#$XO-O0O@5\;;+XX>&-:U:3P'X\^$WC#P?XGN?!?Q%^$
MOQ0/@9_B#\.?%<6CZ+XGM-%\2W/PQ\<?$SX=WTFK^#O%'A7QAI5_X-\?^*]'
MN="\2Z9OU&'5$U+3-/\ QP_;H\:_'KX-_'SXMM_P3PU7XFZ_X@\8>#-'\5?\
M%!O#G@3P)IGQGTC]G3P\T'AC1="_:*^"O@WQ%XLT*PG_ &W-3^%L.HW>@_L^
M:%8^,;'XP^"/"&B?$7QI\/9M?T#P!I?QK_4[]E;X3?$GP'!\:OB-\:-.^'^@
M?&']HSXNI\6?'WA'X4^+O%'C_P"'?@V;0_A;\,_@GX5\/^&_'7C'P5\-/$/B
M\CP/\(_#6L:YKE]\.? Z2^(]7U>SLO#\5A96M[>_26C^&O#GAV?7;GP_X?T3
M0KGQ3K<OB;Q-<:/I5AID_B+Q'/I^G:3/X@UV6R@@DU?6YM*T?2=,EU74&N+^
M33]+TZS><VUE;1Q1BL/[2K@JJ]C2J0RVA+'8=.K7PE3,,5EF%_M+)ZWL<7!X
MG)*>:3KNI&&-K5*L<OP4\#CH8U83/<$8:JH1O>K52Q2G2E5I4Z56-.E6J^SQ
M<(SA4IQQD*%H8:5;"^QFJ]2>.P,L-+$Y1B?&OV5],^"FE?L\_":/]G7Q8/'_
M ,&;_P )66O>!OB _C/4_B+?^/[#Q')-KU[XYUWQ[K=_J>M^,/$WB[5M1U#Q
M!XG\0ZU?W&KZGX@U#4KC4F2\::*/R#Q9X^_X*26?BKQ+:>!?V4/V(/$?@FU\
M0:S;>#O$/BS_ (*#?'GP7XJUWPK!J-S%X>UGQ+X.T?\ X)E>/=(\)^(-4TA;
M2^UGPUI?CKQIIVA:C/<Z78^+/$=M:Q:Q>?8^A>'M \+V#:5X9T+1_#NF/J&K
M:L^G:%IEEI%@VJ:]JEYKFNZDUGI\%O;MJ&M:UJ%_K&K7AC-QJ.J7UYJ%Y)-=
MW,TS[%=-:K[:M5K6DO:U)U.64HSE'GDY<KG"E1A-QO;FA1HQE:\:5)-0CC2@
MZ=.%-M2<(J+FE-<[6CFU4J59IS^.2G6K33;4JM5WJ2^ /^%C_P#!4W_HS?\
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M7+Q3_@H7\5/'MA^T3\<[?0?C-\5OAOXO_9B_9\_8=^-?[.7AKP)\0OB'X*\
M^*/&WQL_:[^)7PM^(%C\8?"GA/7SX ^,'A_X@1^!_ /PJ.A?&CP3XKT;X?Z)
MKNN^+?!5KI.M:AJ^OVG[Y445C@INIE6#K64/;8SB+GIPO[/GPG$F;98JJ4G*
M7M*V'R_#RKMS<754G3C3I\M.&F.CR9OF--2;A1P_#,:47RVA'$<%<-9C5C!1
@248RQ>/Q-5QBDI5*DZTU+$5J]:J4445J8A1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>ny20053122x2_ex4-11img05.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G *\# 2(  A$! Q$!_\0
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M4::O4JU&M(4X+6=25HQ6LFD?7U%? FK?\%,_V2_#OPL^*_QE\4W_ .T/X/\
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MSHSG3I91G&6YCC'A83Q%/#_HS_PL?_@J;_T9O^P!_P"++/VBO_I3M'_"Q_\
M@J;_ -&;_L ?^++/VBO_ *4[7Y_V'Q__ &FO@IX7_P""M_P9^*O[77Q1^)7Q
MS^#'C#X5V7[&OB";P=^REH?C:S\+_M3>#=*TK]E'2/#NA:9\!O#G@?Q+XQ\3
M?M!7WBCX.>(-5^*.C>-=/UR[\%0:O9:3X9AO+PW_ .TWP*\'?$;X?_"'X?\
MA#XN_%OQ!\=OB?HOARR@\>?%GQ-X=\ >$M3\9^*9E-UK&HIX9^%_A#P+X)T/
M28;V>6PT#3-*\.03VFA6FG1:QJ.O:TNH:[J4T_WE+VR?+%X7*,3&,])^TS3!
M3QM; 2C!S5/,,DBJ&'SO#U)1CAL5B\/2PU3&1]M4HJ;E3J1I2CS3>(S.A*5)
MJ=*$<NK8>E2Q;E+V<_JF;PQ'UK)ZCIQK8C"T:U3$X?!U(*E+UFBBBD4%%%%
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>ny20053122x2_ex4-11img06.jpg
<TEXT>
begin 644 ny20053122x2_ex4-11img06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  H - # 2(  A$! Q$!_\0
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M:@N:;2;48N48*4FOA7/*,;NRYI1CNTCZ1HKX^T__ (*&?L!ZM\.?$'QATO\
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MM?T;X!_$[XR>&]%^$GP3\->%M4U;0=6^('C/1?&[:IXVN8++PA9:?%K!M_T
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M_$GPOX-U9UBTZ;X3? :/3?B5\=[^]EET?6H(YM=\&6<'PA\(-):QL?B=\6O
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I^%<SO5C"G"?M\;6SW"U<9RTZ<*7UF"K>UI25/V4*E&A#V3PU*.'/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>ny20053122x2_ex5-1logo.jpg
<TEXT>
begin 644 ny20053122x2_ex5-1logo.jpg
M_]C_X0;817AI9@  34T *@    @ " $2  ,    !  $   $:  4    !
M;@$;  4    !    =@$H  ,    !  (   $Q  (    ?    ?@$R  (    4
M    G0$[  (    )    L8=I  0    !    O    .@ +<;    G$  MQL
M "<0061O8F4@4&AO=&]S:&]P(#(T+C @*%=I;F1O=W,I #(P,C4Z,#DZ,3 @
M,3DZ,#@Z,3@ <V=L96YD;VX      Z !  ,    !  $  * "  0    !   !
M2Z #  0    !    -P         & 0,  P    $ !@   1H !0    $   $V
M 1L !0    $   $^ 2@  P    $  @   @$ !     $   %& @( !     $
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MV?_M#\!0:&]T;W-H;W @,RXP #A"24T$!       81P!6@ #&R5'' (   (
M !P"4  (<V=L96YD;VX< @4 0$UI8W)O<V]F="!7;W)D("T@36EA;6D@+2!%
M>&AI8FET(#4N,2!A;F0@,C,N-" M($105R!/<&EN:6]N+F1O8W@ .$))300E
M       0:%IQVC; WXZQ8Z8@W"G)[#A"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 2P    !  $!
M+     $  3A"24T$)@      #@             _@   .$))300-       $
M    6CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-!         (  #A"24T$ @       @  .$))300P       ! 0 X
M0DE-!"T       8  0    (X0DE-! @      !     !   "0    D
M.$))301$       0     @   D    )      #A"24T$'@      !      X
M0DE-!!H      \4    &               W   !2P   $@ 30!I &$ ;0!I
M "  +0 @ $4 > !H &D 8@!I '0 (  U "X ,0 @ &$ ;@!D "  ,@ S "X
M-  @ "T ( !$ %  5P @ $\ < !I &X :0!O &X (  H $4 > !E &, =0!T
M &4 9  I "  * !3 "T - !! "D 7P!# %< 3P M #4 .0 S #@ -P M #$
M   !                          $              4L    W
M              $                         $     $       !N=6QL
M     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<    W     %)G
M:'1L;VYG   !2P    9S;&EC97-6;$QS     4]B:F,    !       %<VQI
M8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M   &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E
M9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    -P    !29VAT;&]N9P   4L    #
M=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M  $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O
M; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /
M15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M  ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N
M=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L
M;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T
M;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P
M   "/_         X0DE-!!0       0    ".$))300,      6F     0
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MZ'U/Y[]$N*IIS6_\US]8\K,NZ4,BC]F,.-15-_\ WGGJ5E>;DV,VU?\ !O\
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M &@ ;P!P    % !! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ #(
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M0R!S4D="               !  #VU@ !     -,M2% @(
M                                                $6-P<G0   %0
M    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H
M  (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M
M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X
M%&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\
M   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE
M=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q
M.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                                      !865H@
M        \U$  0    $6S%A96B                      6%E:(
M &^B   X]0   Y!865H@        8ID  +>%   8VEA96B         DH
M#X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M       6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                     &1E<V,         +DE%0R V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@                            !D97-C         "Q2969E
M<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M       L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V
M+3(N,0                                  =FEE=P      $Z3^ !1?
M+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
M          $                        "CP    )S:6<@     $-25"!C
M=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/
M %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P
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M P,# P,# P,# P,# P,# P,# P,# P/_P@ 1"  W 4L# 1$  A$! Q$!_\0
MLP   @,  P$!            "0L " H%!@<$ @$!
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M+=VC6W@G#/-T' KAJ+[!-6?.##2)5RKVEY2$HI04G+F&N]6WM2L3\JD%#DT
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MX^$!VXYY_C#*/E[R/KGS^Y_%_P#&ESZYY_C#*/E[R/KF/^E^"_->L]7STZ>
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A?DE,S\G3K!4U7+:242;B9FBI\2F=)9%)4G_C_'_W=?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>ny20053122x2_ex8-1img01.jpg
<TEXT>
begin 644 ny20053122x2_ex8-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B - # 2(  A$! Q$!_\0
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M[IVCZ<=3UK4K*R%]JVH6&F6AG^T7][:VL<L\?[A3?\&O?_!=.")YG_87N&1
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M">$?&/A+PS!K_AJ^A\0:78:?XENKC3;:\T[2=5TS1+PW]KI.%_P3U_X+I?\
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MI>HVNE>#K3Q'<C[;X.OO$.BWND:MJ?(?$3_@H%_P=7_MH?#;Q9H?P6_X)E^
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M%(-"^'WCZ."P\H0V5D_@:\^#NL/+%*S:AKNM:_=3PQS%YKKX"_X-E;ZWT_\
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M/X LO$%K)X9U743.FGV_CF'P7K5A<>=9W5C/86]OKNH?PT?M9W-Y_P %K/\
M@K]\5=:_X)_?L^Z]X9MOVJOB5X3_ .%>?#2XT/2-'NM!MM.\%^#?"'C'XH?$
MF+P5_;/AWPC8:UKFBZ[\6/B7KD=[JMAHDWB#6+W4-9UF\$M]? '^S,DT5Q;I
M<02QSP3PK-#-$ZR1312H'CEBD0E)(Y$971U)5E(9200:_P %_P"!WPC\3_M
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M+M%;7=Y;Z[JN@^*-5T?3+W2XEUNQN[^*]T*YL]8@L;R#^WC_ (,B_P#D#_\
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M06 ((/P_P01U%%% 'Z8_ /\ 9O\ V=_V<_"_]A?L]_ 7X+_ C1-4VWNIZ/\
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M)9?'4WC.3P:WB.7QC+XC9M?D\3OJ3:V^ML=5:^-^3/7Z9^-/!?@[XC>%-?\
M OQ"\)^&?'?@GQ5I=UHOB?P=XRT'2_$_A7Q'H][&8KS2=>\/:W:WVD:QIEW$
M3'<V&H6=Q:SQDI+$ZDBBB@#_ #1/^"P7[,7[-?PS_;R\#^#_ (;_ +/7P.^'
MWA*[\?7%G=^%O!'PF\!>%/#EU9K9^(&%K<:)H.@6&F36P:&%A!):M$&BB(3,
M:D?W7?\ !++]G#]GCX(?LY>'M>^"WP&^#'PAUWQK8VA\9:U\+_A=X'\ :MXM
M-A&AL3XFU'PIH6DWFO&S,TQM#JLUV;<RR&'89&R44 ?IIUZU^/7P]_X)R_\
M!/7P=X^\#^+O"/["'[&GA7Q9X5\8>&O$GACQ/X;_ &7_ ((Z'XB\-^(M#UJR
MU/1=>T'6M,\#VNI:/K6CZE:VVH:7JFGW-O?:??6\%W:3PW$,<BE% '["T444
M 1RQ17$4L$\4<T$T;Q30RHLD4L4BE)(I8W#))'(C%'1P59258$$BOX&/^#A;
M]DC]E/X:_'3X;S_#G]F3]GOP!-XI^*'A:?Q--X)^"_PX\*R^(YM:U2SN-8FU
MV30O#=@^KRZM<7-Q/J<FH&X>_FGFENC*\KLQ10!_5Y_P2X_9O_9W^"'[.'A?
M7_@O\!/@O\(==\9Z;;MXPUKX7_"WP/X U?Q6UJD)MF\2ZEX4T+2;S73;DDP'
M5)KHPDDQ[37UA^TU\)?A7\;OA'K/P[^,_P ,_A]\7?A_JVHZ'=:IX%^)_@SP
MYX^\':E=:5J<&HZ7<ZAX9\5Z;JVB7D^FZA;V]_837%C))9WD$-U;M'/$CJ44
M >-_LA_LM_LR?LZP_$Q/V??V=/@3\"D\;6WAB+QFGP;^$7P_^&*^+HM"3Q.-
M$B\3KX)\/:&-?CT8:YK0TI-5%VNG#6-4%H(1J%WYWB'[/_[!?[#/P@^,'@OX
MC?"7]C#]D_X7?$+PU=:G-X<\>?#K]G7X0>"?&?A^74-"U32+^71/%'AKP=IF
MN:5)?:3J%_I=X]A?0-<Z=?7EE,7MKF:)RB@#]0-8TS3=:TC5=&UG3['5M(U;
M3;[3-5TK4[2"_P!-U/3;^UEM;[3]0L;J.6UO;&]M99;:[M+F*2"X@EDAFC>-
MV4_CYX3_ ."<W_!/;P9XI\->,/!_["/[&GA3Q;X4\0:-XE\+>*?#7[,'P1T+
MQ'X:\1Z%J-MJFB:_H&MZ7X'M=3T;6]&U.UM=1TK5=.NK:^T^^MH+NTGAN(8Y
&%** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>ny20053122x2_ex99-2img01.jpg
<TEXT>
begin 644 ny20053122x2_ex99-2img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $Z!-\# 2(  A$! Q$!_\0
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MZE.<$W:]DY)7=M=.A49PE\,HR_PR3_)FW1116104444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/WP3^!G_  E_]K_\(E_PN'XJ^!?AE_PE'_"/_P!F?V]_PCO_  FNO:)_;?\
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M[&4(Q;:C.:2F>%B<VDY..&245HJLE>4O.,9*T5?;F3;ZI;']7?Q%_P"#M_\
M;3U/QEK%]\)?V;/V7O!/P^G_ +/_ .$?\,?$6#XK_%'QEIGE:58PZK_;'CKP
MU\1?@_HFN_;=;CU+4-/^Q?#KP[_9FE7=CH]S_:UWI\^NZGQ/_$6A_P %&?\
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M #]H_P"/'[*WQ&TSXM?LZ_%?QM\'_B#IGV.'_A(/!6M7.F?VQI5EKNC>)?\
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M@/Q<\4VGB7^U_%OC/6/%/BK_ (7;_8V@Z9:>&?AM)]G_ (-Z^O/V!?VG[_\
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M]IIM---.S3T::W371H^OWV"BBBD 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OY#_\ @XK_ ."I'_!0W]A3]HWX#?#K]E[QI_PI
MOX1^+O@G=^-;CQU_PJ#P5XR_X6%\1G\=>(="\4>$O^$G^*?A/QKX9?\ X5MX
M9T?P#K']@^#K'1==TK_A9_\ :'C2[UC3]>\$0Z/_ %X5\O?MB?L=_ ?]NOX#
M^*_V>/VA_"G_  D?@GQ'Y>H:5JNGR6UAXR^'OC*PMKR#P_\ $7X=>()[._\
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M::Y91:4HR3C)*2:7R555%.4:O-[2+M+G;<DUYMNZZIWLUJM&%%%%=! 4444
M%%%% !7]0O\ P:7_ /*1GXT_]F4?$;_U>G[.%?R]5_4+_P &E_\ RD9^-/\
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MO_",?8_[=\9ZUXFU[_A3?B9[[X=ZG_8_ACPYX%^'GPYU;X >$=/\_4+^;/\
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M^IMT445\H>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^*/\
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M[24)1\[,,+3K4IU?AJ4H2FI)?%&"<G"7=.SY7O%^3:?^8A1117Z^?,!1110
M4444 %?U"_\ !I?_ ,I&?C3_ -F4?$;_ -7I^SA7\O5?U"_\&E__ "D9^-/_
M &91\1O_ %>G[.%>+Q%_R),R_P"P=_\ I<#JP7^]X?\ Z^+]3_0SHHHK\1/K
M@HHHH **** /BC_@I5_RCF_;]_[,H_:I_P#5%^.Z_P AZO\ :XK_ !F/CA\)
M?$?P"^-/Q?\ @3XQO=$U+Q=\%?BCX_\ A+XIU'PU<W]YX<O_ !'\./%FK>#M
M<O?#]WJFFZ-J=UHEUJ>C74^E7.HZ1I5_/8202W>FV-PTEK%^C\!UHNGF.'T4
MHSH5EKK*,HU(2M&VB@X1N[N_M$K*UWX6<Q=Z$^C52+\FG%K[[OII;S/+J***
M_03Q HHHH **** "OZA?^#2__E(S\:?^S*/B-_ZO3]G"OY>J_M!_X-&?V8+^
M;Q'^U1^VAJ]IK=KIFG:)HW[,'P\OX-9\.-X<UV_UF_T#XK?&2TU7P\L=SXNA
MUOPG;Z%\"9O#^LRS:-X<N;#QIXEL8(_$NIVMPWA/PN)JD*61Y@YM+GI1IQ76
M4ZE6$8I+J];NVT5*6R9V8",I8NC97M+F?E&*;;?;LN[:74_MWHHHK\4/K HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *_(?_ (+=_L=_ ?\ :J_X)]_M#^)?BUX4^V>-OV:?@G\:/CU\%?'V
MCR6VG>,O!'C+P#\/-6\83:58ZQ+9WGVCP3X^_P"$6TWP_P#$7PC>P7&E>(=*
MBT_5;9-+\;>%O _BWPM^O%?%'_!2K_E'-^W[_P!F4?M4_P#JB_'==F75*E+'
MX.I2G*G..)HVE!N,DI5(QDKKI*+<9+:46XM--HSK1C*E4C)*2<)735ULVON>
MJ?1ZK4_R'J***_?#XL**** "BBB@ HHHH *_TA/^#93]LRP_:+_8!M?@)KFK
M:WJ/Q4_8WUL?#W79/$&N>(_$U_JGPJ\<:EXE\4_!36X-4U?1;73-&T31M,M?
M%/P<\-> ]+\0>))O"OASX.:5=R+X?T'Q#X7T.U_S>Z_4+_@CO^W7_P .]_V\
M/A5\:M>OOL?PC\4_:/@]\?\ _1?M'E_!SQ]J.D?VSXB_T/PAXU\3/_PK;Q-H
M_A+XL_V1X*TJW\4^,?\ A ?^$#M-3L]/\4ZGYOA<1Y8\TRNM2IQYL11:Q.&2
MWE5IQE>FDMW5IRG3BFU'VDH2?PG9@<1]7Q$9-VA/]W4OLHR:][RY9)2;_E32
MW/\ 5VHHHK\4/K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R'
M_P""YO[8FJ_L5_\ !-WXW>//!GBO_A#_ (N?$W^Q_@+\&M5AC\90ZK!XR^)L
MEU!XCU7PQX@\$WFE:AX-\;>#?A'I7Q,^(7@7Q=J&MZ1I6C^,O"&A,[ZOJ$VG
M>&M<_P K^OZ&?^#DO]NO_AK']O#4?@KX2OOM'PC_ &+_ /A)O@]HW^B^3_:W
MQCO-1T__ (7_ .(O^)GX0\.>)K#[!XF\.:#\)O[(N]5\4^%KK_A47_">>"M3
M33_'UYY_\\U?L?"N6O+\KISJ*U?&M8JHFK2A"44J%)O1^[3M-QDDX5*M2/0^
M6S&NJ^(DHN\*2]G&VS:?OR^<M$UHXQBPHHHKZ4X HHHH **** "OH;]D7X2^
M'/C[^UA^S#\"?&-[K>F^$?C5^T-\%?A+XIU'PU<V%GXCL/#GQ'^)/AKP=KE[
MX?N]4TW6=,M=;M=,UFZGTJYU'2-5L(+^."6[TV^MUDM9?GFOM?\ X)J_\I&?
MV O^SU_V5O\ U>G@2L<3*4,-B)Q;4HT*LHM;J4:<FFO--)ETDG4IIJZ<X)KN
MG))K[C_6K^&GPZ\&_!_X<^ /A+\.M'_X1WX??"[P3X5^'7@7P_\ VAJNK?V%
MX-\$Z%8>&O#&C_VKKM]J>MZG_9FB:98V7]H:QJ6H:K>^1]IU"^N[N6:>3MJ*
M*_GYMR;E)N4I-N4FVVVW=MMZMMZMO5L^T2222222LDM$DMDET2"BBBD,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5^*/\ P<3_ /*'+]L+_NW[
M_P!:E^"-?M=7XH_\'$__ "AR_;"_[M^_]:E^"->CD_\ R-LK_P"QC@O_ %)I
M&&*_W;$?]>*W_IN1_EZT445^[GQP4444 %%%% !7]0O_  :7_P#*1GXT_P#9
ME'Q&_P#5Z?LX5_+U7]0O_!I?_P I&?C3_P!F4?$;_P!7I^SA7B\1?\B3,O\
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ME^V%_P!V_?\ K4OP1K]KJ_%'_@XG_P"4.7[87_=OW_K4OP1KT<G_ .1ME?\
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M81TLXQJK='C950=2LZ\M8TMF^M26WKRJ[?FXGM=?Q1_\'A?_ #CM_P"[M_\
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MWIGG_P#"/V.NW5GIG@WPA]MTKP]H^J_\(+\.O#5EHGP^\!_V_:>%/#TWB?\
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M4;)=6WYM[A\1?^"M/_!3;XH^,M8\=>)?V[OVH=,UO7?[/^VV/PZ^+WB[X/\
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M=^''AR]T/QC\+?BC\?=3NM;N=5@\8_%KXU^.]&\1Z;83V&FVD7AJRM?@3?\
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MN_XE.[BO6#O*RW;4I.VT7;7_ $[Z*_+W]A3_ (+$?L'_ /!0C[#H/P6^*O\
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M110 5_4+_P &E_\ RD9^-/\ V91\1O\ U>G[.%?R]5_4+_P:7_\ *1GXT_\
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MBBB@ HHHH *^U_\ @FK_ ,I&?V O^SU_V5O_ %>G@2OBBOM?_@FK_P I&?V
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MI5*;;E3DUK*,H3E]1AL33Q--3@[-:3@_BA+L^Z?V9;-=FFD4445YAT!1110
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M</\ ]C&C_P"HV+/G\G_WFI_UXE_Z<I'[74445^5'T9Q/Q+^'7@WXP?#GQ_\
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M?@;X,6XCM=3T;X7:-J=KJ'A[XF>(C';7_P 6[^VO_"&CF'X-PZO?_&G]#?\
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M/#&B>&/B3X2\=Z=\/?#'AZUU6PT7X51^ [2]UR^UY=9CMOQLK_0S_P"#J?\
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MNQ_RAR_8]_[N!_\ 6I?C=7^7K7^H5_P;L?\ *'+]CW_NX'_UJ7XW5^F<<_\
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M_P 2GQ?9ZA;_ /" _"/Q3:>&O[(\6^#-8\+>*O\ A=O]LZ#J=IXF^&TGV?\
MO'KY>_8K_99\&_L3_LJ_ _\ 9:\"W7]IZ)\'_!-KH5]X@\C5;+_A+_&6IWE[
MXE^(OCK^RM8\0^*[O0/^$]^(.M^)_&7_  C$/B'4]*\+_P!N?\([H4T>B:9I
M\$7U#7P6=YD\US*OBDW[*_LL-%W]W#TVU3T>L74;E6G'7EG4DD[)'LX2@L-0
MA3M[UN:H^]227-JM&HV44^JB@HHHKR3I"OXH_P#@\+_YQV_]W;_^^R5_:Y7\
M4?\ P>%_\X[?^[M__?9*^BX3_P"2@P'_ '-?^H6).',O]RK?]P__ $[3/XHZ
M***_9CY4**** "BBB@ K[7_X)J_\I&?V O\ L]?]E;_U>G@2OBBOM?\ X)J_
M\I&?V O^SU_V5O\ U>G@2N?%_P"Z8K_L'K?^FY&E'^+2_P"OD/\ TI'^O#11
M17\_GV@4444 %?%'_!0G]N'X<_\ !/']E7XA_M.?$73_ /A)O^$9_LO0? OP
MZM/$>A>&==^*'Q&\37BZ?X8\%:#?:[-_U_>*/%MWH^E^)M=\-_#GPSXU\9Z?
MX2\3?\(S-H]W]KU_G8_\','_  4>L/VIOVF]+_9-^%.O:W-\&_V1M;\7>'_'
MT<UEXC\.V'B_]INVU?4/"WCN>72[W7CIGBC1/A+IFE+X$\#^);_P;H6KV'B/
M7/C4_A[5?$G@'Q9X>US4?:R#*WFN8TJ$HR>'IOVV*DKI*C!WY.9-.,JLK4XM
M-27,YKX7;DQN(6&H2FFO:2]VFG;XGUL]U%>\^FB3W/YR_B7\1?&7Q@^(WC_X
MM?$76/\ A(OB#\4?&WBKXB^.O$']GZ5I/]N^,O&VNW_B7Q/K']E:%8Z9HFF?
MVGK>IWU[_9^CZ;I^E67G_9M/L;2TBA@CXFBBOVV,8QBHQ2C&*48QBDHQBE9)
M):)):)+1+1'R3;;;;NWJV]V^["BBBF 4444 ?H;_ ,$F_@!_PT]_P4B_8X^#
MT^F>"==T34_C9X;\:^,_#OQ%L_[3\&^*?AS\'X[SXP_$SPEK&D/HVOVFM_\
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MJB5]KN#2;WV=GL?Y*E%%%?O)\:%%%% !1110!_7C_P &I7[=?_" _&/XD?L
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M]/\ G(E_W:1_[\W7\4=?VN?\&>G_ #D2_P"[2/\ WYNOG>+/^2?Q_P#W*_\
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MX\(^'KCQ-X2TK0;WQ+HGA+Q'HOC[PXD'P\\&-\*?"EU_9-_P1V^$OASX*_\
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MO4/!/C;1)=-\8>!=>O=$TS_A)/!NN:%X@MK2.TU.#/\ LFU_%'_P=:_L ?\
M)-_^"BGPT\-?] GX*_M,_P!B:-_UV_X4S\6?$']@>#/^O_X/>,?'GC_QO_T;
MK\/O"NE?ZZOL^#,S^JXZ6 JRM1QUO9W>D,5!/DMT7MH7IOK*:I(\K-</[2BJ
MT5[]'XO.F]__  %^]Y)R/XHZ***_53YP**** "BBB@ KMOAI\1?&7P?^(W@#
MXM?#K6/^$=^(/PN\;>%?B+X%\0?V?I6K?V%XR\$Z[8>)?#&L?V5KMCJ>B:G_
M &9K>F6-[_9^L:;J&E7OD?9M0L;NTEF@DXFBDTI)QDE*,DU*+2:::LTT]&FM
M&GHT";333::=TUHTULT^C1_L+_L5_M3>#?VV/V5?@?\ M2^!;7^S-$^,'@FU
MUV^\/^?JM[_PB'C+3+R]\-?$7P+_ &KK'A[PI=Z__P (%\0=$\3^#?\ A)X?
M#VF:5XH_L/\ X2+0H9-$U/3YY?J&OXH_^#4K]O\ _P"2D?\ !.OXE^)?^@M\
M:OV9O[<UG_KC_P +F^$WA_\ M_QG_P!>'QA\'^ _ '@C_HXKX@^*M5_U-?VN
M5^&9SE\LLS+$X2S5.,W/#MMOFP]1N5)\SMS.,?W<W_S\A-=#[#"5UB*%.I>\
MFK3Z6G'26G2[U2[-!1117EG0%<3\2_B+X-^#_P .?'_Q:^(NL?\ "._#[X7>
M"?%7Q%\=>(/[/U75O["\&^"="O\ Q+XGUC^RM"L=3UO4_P"S-$TR^O?[/T?3
M=0U6]\C[-I]C=W<L,$G;5_(?_P '6O[=?_" _!SX;_L >"K[9XF^.W]D_&'X
MV?Z+N^Q_!SP5XIF_X5OX=_XFWA"\T^X_X3[XN>%KOQ+_ &OX2\9Z/XI\*_\
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MJFA^(/#^N:7/=:9K.B:SIEU:ZCI6JZ==7-AJ-A<P7=I/-;S1R-_BQ5_I<_\
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M?^W(_P \RBBBOV\^2"BBB@ HHHH *_M<_P"#/3_G(E_W:1_[\W7\4=?VN?\
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M\;:)+J7@_P =:#9:WIG_  DG@W7-=\/W-W'::G/G_7B_9P^/_P .?VJ?@/\
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M\->(_&GB/P_X.\'>'];\6>+O%FMZ5X:\+>%O#6E7^N^(_$OB/7;^#2]#\/\
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MU9\M>6MGI=6UNO,S:;CA+?\ /RK"#UZ)2G\]8+33OTL?BC1117ZV?-!1110
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M;JEWI4&F:SI%W??YO?\ P[5_X*,_]&!?MK_^(K?'3_YA*/\ AVK_ ,%&?^C
MOVU__$5OCI_\PE=,.$,E4KU,WG.-MH5<)3E?2SYI*JK:[<NMUJNL/,\6U[N&
M2?=QJ273HN7OWZKY_P"AG_Q$3_\ !'+_ */"_P#-?OVI?_G(UXI\8?\ @Y\_
MX)6?#+_A'?\ A"O%GQL_:'_MO^U_[3_X4]\&]8T3_A$/[-_LS['_ ,)%_P +
M_P!1^!GVG_A(/M]W_9'_  B7_"4>3_8FI_V]_8GFZ-_:_P#!O_P[5_X*,_\
M1@7[:_\ XBM\=/\ YA*/^':O_!1G_HP+]M?_ ,16^.G_ ,PE=$.$^'(R4GCZ
MU1+>$\;A%&5U97=.A">ETURR6MKW3LX>98YJRHP6VJI5;[KO-K7;;KIK9GQ1
M17VO_P .U?\ @HS_ -&!?MK_ /B*WQT_^82C_AVK_P %&?\ HP+]M?\ \16^
M.G_S"5]C]<PG_05AO_!]+_Y+S7WGE>RJ_P#/NI_X!+_+S7WGQ117VO\ \.U?
M^"C/_1@7[:__ (BM\=/_ )A*/^':O_!1G_HP+]M?_P 16^.G_P PE'US"?\
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M]EG]M3]E7]MCP;=>.OV6OCAX)^,&B:9Y'_"06.A75YIGC+PA]MU7Q#H^E?\
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M]JZ%?:GHFI_V9K>F7UE_:&CZEJ&E7OD?:=/OKNTEAGD_V@J_@X_X.M?V%/\
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M.:!1110 4444 %%%% !7XH_\'$__ "AR_;"_[M^_]:E^"-?M=7XH_P#!Q/\
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MM:%14:]&JTY*E5IU&EHVH34FD^[M8F:YHRBOM1:^]-'^+%1117]!GQ(4444
M%%%% !1110!_KP_\$U?^4<W[ 7_9E'[*W_JB_ E?:]?%'_!-7_E'-^P%_P!F
M4?LK?^J+\"5]KU_/^+_WO%?]A%;_ -.2/M*/\*E_U[A_Z2@HHHKG- HHHH *
M*** "BBB@ K\4?\ @XG_ .4.7[87_=OW_K4OP1K]KJ_GF_X.?/C#_P *R_X)
M6>+/!7_"._VW_P -#_&SX-_![^T_[7_LW_A#_P"Q-8U'X_\ _"1?8_[,O_\
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M/C7Q!X6\;01>(X/#G@7XJ^/_ !!X4^'.AP:KJ>ES6V@S:WXL^%>N_&NP\/\
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MS_A-?#7]B?M!?M#_ &#XU?&S^T]&_LWQ3X=_MO3H_P#A6_PFU?\ M;P9X/\
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MYL^OC%0C&,5:,4HQ2V22LE\DK!1114#"BBB@#^#C_@ZU_84_X0'XQ_#?]O\
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MRCXC?^KT_9PKQ>(O^1)F7_8._P#TN!U8+_>\/_U\7ZG^AG1117XB?7!1110
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M3DKI0@^52E/YG,,;]8G[.F_W,'=:6YY*ZYGUY5=\JT[M7M8HHHKZL\T****
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M-W:SP75G-:ZGHVMZ-J=K8ZYX:\2Z'?:;XC\*^(]-TKQ)X;U72M>TK3M1M?\
M+U_X+ ?\$Q/$?_!+_P#:;B^&UIKNM^//@A\2]$NO'GP)^(VL:)?V-_>^'(]7
MNM,U?X>^,-6BT?3?".J_%'X<7"Z<GBUO!T\EAJ'ASQ)X!\<W6B>"'\>0>"=
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M8BK3H48.I5K3C3IP5KRG-J,8IMI*[:U;26[:2;)E*,(RG)J,8IRDWLDE=O\
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M3I0;3J5)6TBM$KRDXPC*2UHT:E>:ITHN3>[^S%?S2?V8KN_17;2>W_P;P_\
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M$O'7D:S:7>K>?\0?BC\)?&'AC0;G1-8T*75?!$WB"]N](UOPUX:_M#^KNO\
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MA1110 4444 %%%% &)JOAKPYKM_X:U37/#^B:SJ?@O6Y_$O@[4=5TJPU&_\
M"?B.Z\.>(/!UUX@\-7=W!-<:%K=SX1\6>*?"T^JZ7):W\WASQ+X@T.2=M,UG
M4;6YVZ**=V[7;=E9>2NW9=E=M^K;ZA^NX4444@"BBB@ HHHH **** "BBB@
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M"NL:G<V'@WXO^#;"YN)8;&^FBM[_ /X1SQMX<^WZE>_#KXBV6FW^J^#-5O\
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MA_V?=$_MG4_^%V?!:PU'6_\ A'?"VF_\)GJW]K_%GX;^7-XV^&7]D>"?!_\
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MD_G<3E]?#MR2=6GNIP3NE_?CO%^:O'SO=+\4:***^D. **** "BBB@ HHHH
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MIW33V:85_D/?\%'_ -HK_AK']O#]J_X_VGC#_A/O#/C[XV>-/^%;^+?^$?\
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MQ!X@US5)[73-&T31M,M;K4=5U74;JVL-.L+:>[NYX;>&21?P!_;K_P"#DO\
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M ,U(_P#RFZ/^(/3_ *R)?^:D?_E-U_:Y177_ *V9_P#]!_\ Y:X+_P"9C/\
MLW!?\^?_ "I5_P#EA_%'_P 0>G_61+_S4C_\INC_ (@]/^LB7_FI'_Y3=?VN
M44?ZV9__ -!__EK@O_F8/[-P7_/G_P J5?\ Y8?Q1_\ $'I_UD2_\U(__*;H
M_P"(/3_K(E_YJ1_^4W7]KE%'^MF?_P#0?_Y:X+_YF#^S<%_SY_\ *E7_ .6'
M\4?_ !!Z?]9$O_-2/_RFZ/\ B#T_ZR)?^:D?_E-U_:Y11_K9G_\ T'_^6N"_
M^9@_LW!?\^?_ "I5_P#EA_%'_P 0>G_61+_S4C_\INC_ (@]/^LB7_FI'_Y3
M=?VN44?ZV9__ -!__EK@O_F8/[-P7_/G_P J5?\ Y8?Q1_\ $'I_UD2_\U(_
M_*;H_P"(/3_K(E_YJ1_^4W7]KE%'^MF?_P#0?_Y:X+_YF#^S<%_SY_\ *E7_
M .6'\RO_  36_P"#=SQ'_P $Z/VN/ ?[4&A_MVZWX_TSPWHGCGPUXQ^%^E?
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MX_Y_U=^5C^RL)_+4_P# W_E_5WY6_P \S_B$O_X*,_\ 1:?V*/\ PXWQT_\
MH<*/^(2__@HS_P!%I_8H_P##C?'3_P"APK_0SHH_URSO_GYAO_">/^?]7?E8
M_LK"?RU/_ W_ )?U=^5O\\S_ (A+_P#@HS_T6G]BC_PXWQT_^APH_P"(2_\
MX*,_]%I_8H_\.-\=/_H<*_T,Z*/]<L[_ .?F&_\ ">/^?]7?E8_LK"?RU/\
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607:$5%/ULE=^;U"BBBN<L**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>ny20053122x2_ex99-3img01.jpg
<TEXT>
begin 644 ny20053122x2_ex99-3img01.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "8!'<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#\Y/VV?VV?
MVS?#7[9O[7'ASPY^UQ^T[X?\/>'_ -IWX]Z)H.@Z)\>_BKI6C:)HVE?%7Q78
M:7I&D:78>*X+'3=,TVQ@@L["PLX(;2SM(8K>WBCAC1%^8O\ AO3]N;_H\_\
M:P_\2*^+_P#\V-'[>G_)\W[9_P#V=A^T5_ZM_P 8U\GU_P!%G"/"/"E3A3AB
MI4X8X>G.?#V2SG.>2Y;*<YRRW#2E*4I89N4I-MRDVVVVV[L_@#-LVS6.:YG&
M.9YA&,<PQJC%8W$I)+$U4DDJEDDM$EHEH?6'_#>G[<W_ $>?^UA_XD5\7_\
MYL:/^&]/VYO^CS_VL/\ Q(KXO_\ S8U\GT5]#_J=PC_T2W#G_ACRS_YE//\
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MMPY_X8\L_P#F4_#/[8S;_H:9C_X6XG_Y:?6'_#>G[<W_ $>?^UA_XD5\7_\
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M=4<PPM+VE903:M#%8.E4=7XOWF%H\L5SU)/^K.BBBO\ (T_J@**** "BBB@
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MD'@*69>!WBMAZTJ<84^!>(L>G4MRNKE675LTH15]/:2K8.G&EU]JX6UL?A'
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MBGC#_P!3HU_)U7^\OT2_^4>/#3_L79O_ .M-G9_$?BQ_R<#B+_KYE_\ ZJ<
M?6'[!?\ R?-^QA_V=A^SK_ZM_P '5_K85_DG_L%_\GS?L8?]G8?LZ_\ JW_!
MU?ZV%?Q?^T1_Y*[PW_[)S.?_ %9X<_7? '_D4\0_]C'"?^HT@HHHK_.H_?PH
MHHH **** "O\\W_@YK_9WT_X1_\ !0'3?BOH&F)8:)^TE\+- \;:K+"Y$%Q\
M0_"%S=>!/%9BM=JQVS3:#I/@C5KUHOEO=4U>_OYLW=S<._\ H95_%=_P=M00
MKXK_ &%KE8D%Q-X>_:&@EF"@220V^I?!J2")WZLD+W5R\:DX5IY2,%SG^MOH
M1YSC,L^D%PY@<-4E##\19/Q/E.804I*-7"X?(\9GU.,DI)2Y<=DN#FN922<;
MI*5I+\M\9,)1Q' 69UJL%*I@,3EF*PTFDW"M/'T,%*2;3:OA\97@VFG:5KV;
M3_CPKUW]GWXB1_"'X]?!'XLRO-%%\+_B]\-?B)));Q&>XCC\%>,]%\2N\$"O
M&TTR+IA:*)9$,CA4#J3D>145_MACL'0S#!8S 8F+EA\=A<1@\1%-)RH8FE.C
M5BFTTFZ<Y)-II/H]C^-L/6GAJ]#$4[>TP]:G6I\R;CSTIQG'F2:;7-%72:=M
MFMS_ &8**P_#'_(M>'O^P'I/_I!;UN5_S-SCR3E&]^64HWVORMJ]M;7MW/\
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M*&)E.I5J3E&%.G",I3G)1BFVD?IE117.^*_&'A+P'H.H>*O'/BCP[X,\+Z1
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M>'?!/@_P[JS-;"97TX:_XW/BB.W2=ULYWU7PKI=PLD=S+!:W%NEM+=^0VO\
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MS_\ L[#]HK_U;_C&OD^O^DW@[_DD>%O^R<R/_P!5F%/\\,X_Y&V:?]C'&_\
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M9MFN R/+L7FN9UXX?!8.G[2M5:;>LE"%.$5K.K5J2A2I4X^]4J3C".K1U_\
MP4X_X+'_ +.O_!.+19/"U\8_BQ^T;K&DG4/"_P %/#VII;2Z=;W",MAK_P 2
M-?BM[^#P9H$TA62TM9K>Y\1Z]"KOHNDRV27>J67\%'[;/_!43]LG]O77-3D^
M-GQ4U:U^'ES>>?I'P4\$W%UX8^$^B6T5Q9W=E!+X:L[DGQ5>6-W86U[;:YXV
MN_$>MVUZ))+&^LX&CM8OB'Q[X\\9_%'QGXF^(GQ$\3:SXR\<^,M9O?$'BGQ3
MX@O9M1UC6]8U&9IKN^OKN9F>221VVHB[88(5CM[>.*"*.-.2K_;#P.^B_P
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M<\"_LZ:IX@_9A^ ,GVFPM[7PYJ$=E\8O&M@\A47OC+QSI4\MQX:2Y@5,^&/
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M-1A/.\HQ."I5)*$,1>CB<*YM75-XK"5:^&C4DKN-.553DHRM%\DK?='[ O\
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M;7=-=5N?XCJ*_5."?H(^$?#6-HYCQ%C<_P".*U"49PP.:5L/EV22G'EE&=?
M9;2IXO$6G%OV-?-*F$J0DZ6(PU:-^;YC./'#BG,*,J&78? 9-&:DG7H1GBL8
MD[JT*N(;HP]U_''"^T4DI0G#8]/^,GQH^*G[0GQ(\3_%[XT^.-<^(OQ(\8WB
MWWB+Q7XAGCEOKV6.)+>V@AAMXK>PTW3K"UBAL],TC2[2RTK2[&&&RTZSM;2&
M*%/,**]1^#/P3^*_[0_Q&\.?"3X)^!-?^(_Q&\671M=#\+>'+59[VY*+ON+J
MZN)Y+>PTK2[&+-QJ6LZM=V.DZ9:J]UJ%[;6Z/*O]E-Y5D&5ZO+\ER7)\$EK]
M6RW*\KR[!4;)?\N<)@L%A,/3LOX5"A1A]B$=/R'_ &S,<7_S$X_'8RM_T]Q6
M+Q6(K2_[?K5ZU6;_ +U2<GU;.V_93_9F^)G[8/Q^^&_[/7PFTJ?4?%GQ"\06
MFFR7P@,VG>%?#R2I+XD\::\_FP)!H/A31UN]9U)C/'-<QVRZ=IZW&J7MC:7'
M^KG^SO\  OP1^S+\#?A7\ ?AQ;RP>"_A/X+T7P;HCW*PB^U!-+ME6]UO5&MX
MXH)=9\0:D][KFM7$<4:W.JZC>7 1?-Q7YA_\$=O^"2/A#_@FU\+[[Q#XRGT7
MQM^U)\2["V3XE>.=,^U7&C>%M$1HKJT^&?@.2]2"3^P=/O$-[KNOFPT_4O%^
ML^7/>Q1Z3I'A[3M,_:*O\7?I<>/^&\8.*<)D'"]>=3@3A&KB%E^)Y9TUG^<5
MHJCC,Z=.?+)8.E3@\)E$:D(U?J\L5BY*F\>\/0_L+PKX%GPEE57&9C!1SO-H
MTY8FG>,OJ.%@Y2H8)25TZK<G5Q<H/D=7DI+G6'C5J%%%%?R"?JH4444 %%%%
M !1110!_GB_\'/?_ "DLLO\ LW'X5_\ I^\?U_.S7]$W_!SW_P I+++_ +-Q
M^%?_ *?O']?SLU_T"?1O_P"3$^%?_9'Y7_Z1(_A/Q%_Y+CB;_L:5O_28'ZM?
M\$/?^4J_[&W_ &/WB7_U6GC>O]0:O\OG_@A[_P I5_V-O^Q^\2_^JT\;U_J#
M5_G=^T(_Y.UPE_V;K ?^M+Q0?OW@-_R269_]E%B?_59E04445_!A^W!1110
M4444 ?RN_P#!UY_R:+^S7_V<=/\ ^JR\95_"#7]WW_!UY_R:+^S7_P!G'3_^
MJR\95_"#7^VWT'_^4?\ (O\ L?<3_P#JUJG\;^-/_)=8K_L7Y=_Z885_L1?"
MG_DEWPV_[$'P=_ZCNG5_CNU_L1?"G_DEWPV_[$'P=_ZCNG5^%?M&/]S\(_\
ML)XX_P#37"9]M]'WX^+/\.1_GFYWU%%%?Y?'])!1110 4444 %%%% !1110
M4444 ?PR?\'8W_)QG[)__9%/&'_J=&OY.J_K%_X.QO\ DXS]D_\ [(IXP_\
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MXW2E&^(C+6ZA*,:B7-")_I94445_@"?W4%?Q9_\ !VY_R,O["/\ V _VC?\
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M^)?_  <0_P#*)7]I'_L.? S_ -7Q\.*_S4Z_TK/^#B'_ )1*_M(_]ASX&?\
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MN.-JT8RO*,K4</1G5A9QA6E2<E&LU+V.BBBO\G3^H0K\J/\ @KM_P3F\%_\
M!0O]ESQ/X>AT338OC[\-M(UOQ;\ O&IME35K+Q1;6375QX%N]1ABDO&\(_$,
M6=OHNM:>5N;6VU$:+XECL;G4_#^G@?JO17T'"O$^=<%\19/Q3P[C:N7YSD>.
MHX_ XFE*4;5*4O?HU5%KVN%Q-)U,-B\/.]+$X6M6P]6,J52<7PYEEV#S? 8K
M+<?0AB,'C*,Z%>E-)IQDM)1NGRU*<E&I2J*TJ=2,*D&I137^-)/!/:SS6US#
M+;W-O+)!<6\\;PSP3PN8Y89HI LD4L4BLDD;JKHZE6 8$5%7^G9XR_X(1?\
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MU_X)@Z9=)=VW[%/P1DE1754U#0;W5K4B12C%[+5=2O+.1@"2C26[-&V'C*N
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M2 X!_P"RPQ7_ *I<4>CX!?\ (ZS[_L5T/_4N)^A5%%%?Y+G]2!1110!^%/\
MP<>?\HJ/C%_V/WP5_P#5EZ!7^;K7^D5_P<>?\HJ/C%_V/WP5_P#5EZ!7^;K7
M^Q_T ?\ DRF=?]G%SS_U0<*G\D^._P#R6& _[)W!_P#JQS8*_P!2W_@C9X T
MKX;?\$O_ -B[0='LC8V^K?!K2?']TC-,[SZK\4M2U3XDZQ>N]Q<74K"\U/Q7
M=7$*^:(8;>2&WM+>SLX;>SM_\M*O]7C_ ()A_P#*.7]A?_LT_P" O_JM?#M?
M-?M#<36AX?<!X2-2:P]?C'$8BK24FH3K87),93H5)1ORRE2AB\1&$FFXJK-)
MI2=_0\ J<'GF>U7&+J0RFE3C-I<T85,93E.*E:ZC.5*FY).S<(MI\JM]T444
M5_DJ?U,%%%% !7\&_P#P=;^#]/T_]L/]G7QU!+*-0\4_LX#PW?VNR);98O!G
MQ*\:7]C>HRH)GN[H>,[FUN3([1K;Z=8K$J$2E_[R*_AD_P"#L;_DXS]D_P#[
M(IXP_P#4Z-?UE]":M5I?2$X7ITYN$,3E/%-&O%6M4I1R#'8A0E=;*OAZ-32S
MYJ<=;73_ ##QBIPGP!F\I13E2KY74IM_8F\SPE)R7FZ=2<=>DGU/Y.J^MOV
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M_P!'X?L9_P#B4'P1_P#FXK_)KHH_XIW\&?\ 1Q>)_P#PU95_\D'_ !'[./\
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M &9G\0O_ %=_[.]?W^5_ '_P:J?\I"_C'_V9G\0O_5W_ +.]?W^5_CK].?\
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M &<=\#__ %9OABOG&OH[]CK_ ).Z_98_[..^!_\ ZLWPQ7^V7%7_ "3'$?\
MV(<X_P#5?B#^.,I_Y&N6?]C#!?\ J32/]=*BBBO^:T_T0"BBB@ HHHH ****
M /Q+_P"#B'_E$K^TC_V'/@9_ZOCX<5_FIU_I6?\ !Q#_ ,HE?VD?^PY\#/\
MU?'PXK_-3K_8K]G[_P F7XA_[.5G?_K-<('\E>/'_)89?_V3F#_]66;A7^JM
M_P $F_\ E&G^Q!_V;C\-?_3#;U_E4U_JK?\ !)O_ )1I_L0?]FX_#7_TPV]?
M._M#O^2 X!_[+#%?^J7%'H^ 7_(ZS[_L5T/_ %+B?H51117^2Y_4@4444 ?A
M3_P<>?\ **CXQ?\ 8_?!7_U9>@5_FZU_I%?\''G_ "BH^,7_ &/WP5_]67H%
M?YNM?['_ $ ?^3*9U_V<7//_ %0<*G\D^.__ "6& _[)W!_^K'-@K_5X_P""
M8?\ RCE_87_[-/\ @+_ZK7P[7^4/7^KQ_P $P_\ E'+^PO\ ]FG_  %_]5KX
M=KY/]H?_ ,D/X>_]E7F'_JHJ'I^ 7_(YS_\ [%F'_P#4I'W11117^3A_4844
M44 %?PR?\'8W_)QG[)__ &13QA_ZG1K^YNOX9/\ @[&_Y.,_9/\ ^R*>,/\
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M?V3_ /PY7Q*_^<Q1_P 0M7_!1K_H??V3_P#PY7Q*_P#G,5_H,44?\3U>//\
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M_P!9?-3\!X._Y*[A;_LH\C_]6>%/].6BBBO^=D_OT*_BS_X.W/\ D9?V$?\
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M."KS6,RZHL,Y45%X*K@L5AI3<*E?GQ<8PE'"SF?H'AUQZN-\'CY8C#4,#F&
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M7M*52&MG>#TM9O\ /G]O3_D^;]L__L[#]HK_ -6_XQKY/KZP_;T_Y/F_;/\
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M?6-.E,<\#26\L]G>6LJ[+K3M4TZYN]*U?3I[75-*O;W3KRUNIO\ 8CK\1_\
M@KO_ ,$;/AO_ ,%'?"C_ !!\$W6D?#;]K'PCH::=X/\ ']ZETGAOQSI&G?;;
MFQ\!?$N&PCN)_P"S)+F[D32?&-E8:AKWA9W799ZWHZ2Z%-_:_P!$GZ2M#PFQ
M]?@GC2M5? 6>XV.)P^8*-2M/A7-ZRA1JXQTH*52ID^.A&E_:5*E&=3"U:,,=
MAJ4G/&T\3^/>*?AW/BK#PS?*(Q6>X"C*G*BVH1S3"1;G'#N<FHPQ5&3F\+.3
MC"HJDZ%:27L9T?\ -7JU8WU[I=[9ZGIEY=:=J6G75O?:?J%C<36E[8WMI,EQ
M:7EG=V[QSVMU:SQQSV]Q!(DT,R))&ZNJL/;_ -HW]F/X[_LE_$O5?A'^T)\-
MO$7PU\<:7F5+'6K96T[6]-+M'!KOA;7K1[C1/%/A^Z='CM]:T"_U#3VGBGM'
MGCO;6ZMX?!J_V,P&/R[.<!ALQRS&8/-,LS##PQ&$QN"KT<9@<;A:T;PK8?$4
M95*&(H58.\9TYRA)/1M'\CXC#XG XBIA\31K87%8:HX5:-:$Z->C5@]8SA)1
MG"<7T:36C/Z _P!CS_@XY_;N_9ITO2O!OQ0F\/\ [57P_P!*AAL[2#XIW-_I
MWQ-L-/M;6"VMK.Q^*ND+-J.I$&$RSZAX]T+QUJT[32K_ &A&@A6+]M? ?_!U
M[^R;J&E6,OQ/_9H_:(\):V]O;MJ=AX#N_AK\1-*M;IHF-U%8ZMXA\6_"^[OK
M>*<*EO/<:+ITD\3-+);VSH(7_A'HK^?N+_HF^!'&>-JYGCN"J.4YA7FZE?$\
M-8W&Y#3K2DVYRJ9?@JT,J]I.3<ZE:. C7J3;E.K*[O\ >Y5XJ<;Y11CAJ6<2
MQ="$5&G#,J%'&S@E:UL15C]::27+&,Z\H1CI&*W/[^)O^#JS_@GTL4AM_@Q^
MV1+.$8Q1S> O@G!$[X^59)D_:"N'B0GAG6"4J.1&W2OD[XV_\'9&@QVMQ8_L
MX_LDZQ>7DUM=+:^)_C7X[L=*M]/N]FVRDF\#^!K+6GU:#>WFW,:?$#1W"Q""
M-V,YN+?^+BBOF\L^A/\ 1^R_%4\36X;S?-53?,L+F?$F;2PLI6]UU(8*O@9U
M%%^]R3J2IR?NU(3@W%^AB/&7CNM2E3AC\'AG*R]KA\NPOM8JZ;Y77A7@KI--
M\C:3;BU*S7WG^VA_P4N_;%_;WU6*;]H7XJWNI>$=/U!M2\/_  J\*6R^%/A=
MX=NC$L4=Q9^%=/D;^U]0MD\U+37?%M]XC\16L5U=V\&L);7,D)^#***_IK(>
M'LBX6RO#9)PWD^6Y%E&#BXX;+LJP=# X.E?6<XT,/"G!U:LO?K5I*56M4<JE
M6<YRE)_F^/S''YIBJF-S+&8G'8NJ_P!YB,56G6JR2^&/--MQA!>["G&T*<;1
MA&,4DBOZ??\ @W7_ ."6NI_M _%O1OVW?C-X?NK?X&?!7Q(;OX3Z9JU@$L_B
MO\7="F'V35K>.]MV_M#P9\,=2"ZE<:E9%+:^^(.G:;H<5Y=+X>\7Z5'Q?_!*
M'_@W]^+O[5FK^&?C9^UKHGB;X+_LU6UY'J=IX.U6UO?#GQ5^-%M:RMY6GZ;I
MUTMMJW@/P/J,L:M>>,-2M8-9UO1R5\$6@BU:S\9Z/_?5X#\!^#/A=X+\+_#K
MX=^&='\&^!O!6B:?X<\*>%O#]E%I^C:%HFEVZ6UCIUA:0@)%#!"B@D[I99"\
MT\DDTDDC?P1]+3Z5.491D^;>&'AQFM+,N(<TI5LMXGX@RZM&K@L@P%52HX[*
ML#BZ;E3Q&=8NFYX;%5</*5/*:,ZU-55FGNX']T\+/#'%U\9A>)>(L++#X+#2
MAB<KP&(BXU\97BU.ABZ])M2I86C)*I2IU4I8J:C-P^K)/$=;1117^3Q_4 44
M44 %%%% !1110!_*[_P=>?\ )HO[-?\ V<=/_P"JR\95_"#7]WW_  =>?\FB
M_LU_]G'3_P#JLO&5?P@U_MM]!_\ Y1_R+_L?<3_^K6J?QOXT_P#)=8K_ +%^
M7?\ IAA7^Q%\*?\ DEWPV_[$'P=_ZCNG5_CNU_L1?"G_ ))=\-O^Q!\'?^H[
MIU?A7[1C_<_"/_L)XX_]-<)GVWT??CXL_P .1_GFYWU%%%?Y?'])!1110 44
M44 %%%% !1110 4444 ?PR?\'8W_ "<9^R?_ -D4\8?^IT:_DZK^L7_@[&_Y
M.,_9/_[(IXP_]3HU_)U7^\OT2_\ E'CPT_[%V;_^M-G9_$?BQ_R<#B+_ *^9
M?_ZJ< ?6'[!?_)\W[&'_ &=A^SK_ .K?\'5_K85_DG_L%_\ )\W[&'_9V'[.
MO_JW_!U?ZV%?Q?\ M$?^2N\-_P#LG,Y_]6>'/UWP!_Y%/$/_ &,<)_ZC2"BB
MBO\ .H_?PHHHH **** "BBB@ HHHH *_R]/^"U?[-6H_LP?\%)/VD?#3V-];
M^%_B;XON_CWX!O+V2S=-3\,_&"\O/%.H_P!G+:!&BTOP[XZF\9>"+**]ABOA
M'X6+3O>*\>HWO^H77XC?\%NO^"6I_P""BGP(TCQ#\,H;&T_:;^"$>L:E\,)K
MV\&G6'CCP]JPM9_%'PQUB[D9;*&75Y-.L=2\(ZKJ($&C>(K0V;WFE:/XD\0W
MH_J3Z(_B[EWA/XI4ZG$&(CA>%N+,!+AW.<94=J.5UIXBCB<JS>MJDJ&%QE+Z
MKBZDI<F'P&/QF*<9RH0B_P U\4^$\1Q5PU*G@(>TS/+*ZQ^"I*REB5&$Z6)P
MD6]I5:,W4I+3GQ%"C3<HQG*2_P UBO5_@7\;?B3^SA\7OA_\<OA#XAN/"WQ'
M^&GB&U\2>%]9@'F)'=0I+;7>GZA;%ECU#1=;TRYO=$U_29R;75]$U'4-,NU>
MUNYD;B?%OA+Q/X"\3^(/!7C7P_J_A7Q=X4U>_P! \2^&M?L+G2]:T/6M+N9+
M34-+U33[N.*YL[VSN8I(9X)HU='4@C&">>K_ ' KT,!F^7UL-B*6%S+*\TP=
M2A7HU(TL5@L?@,;0E3JTJD7ST<3A<5AZLH2B^>E6I5&GS0EK_&%.>)P6)A4I
MRJX7%X2O&<)+FI5\/B</44HR6TZ=6C5@FMI0G'HT?Z$O["__  <C?L?_ !\\
M-^'O#?[4NH0?LN_&IU@T[5IM6M=8U+X,>(M1"3;]6\/^-[:WU!O!^GW20"ZN
M-.^(G]DVVBS74>DV_BKQ,T0U*X_<CP-^T_\ LU_$_1X?$/PX_:#^"?CW0[A"
M\6K>#_BGX'\1V!"S2V[JUSI.N7<4<D5S;W%M-%(R2P7-O/;3(D\,L:?Y"5%?
MPEQG^S_\/,[S#$8_A'BG/.#*>)K.L\KJX3#\1Y7A.:4G*C@(U\3EN8TJ"3BJ
M<<7F6.G3M)>TE"4(4_V[*/'?/<'0IT<WRG!9O.G!0^LTJ\\MQ%5I12J5^6CB
ML/*;M-S]CA\/"3E'EA#E?/\ Z]WCC]I[]FOX9:1+K_Q'_:#^"7@+0X%#2ZMX
MQ^*G@;PWIZAIH;9%%WK&NV<+O+<W%O;0QH[237-Q!;Q*\TT:-^0_[6/_  <5
M_P#!/7]G:PU+3?AMXOU3]J+XAPHT5CX>^#]J7\&PWDMI=7%K/KGQ1UM+'PK_
M &/YT$-K>7/@QO&^K6LMY;XT21$O)+3_ #B:*Y^%?V?/A_EF+I8GBSC'B'BF
ME2FYO 8+"87AO!XA)PY:6*E"OFV/=.RFJGU7'8.K+FAR5:?)+VFF9^/6=XBE
M*GE638#+9RBDJV(KU<QJ4W=\TJ:]E@Z-VN5152E5C&TKJ7,N7[X_X* _\%&?
MVAO^"C'Q4A^(7QIU2TTSPYX=%]9?#?X6>&7O(/!'P_T:\N/-DCL+:ZGFFU7Q
M%J$<=JOB'Q7J).I:S):V\:1Z=I-GIFD:?Y+\=_V0?C?^S;\._P!G?XE_%SP_
M;>&M%_:>\":M\1_AGIKW,[Z^OA33-4M[""\\16$EG#!I4^MV%_H_B31[2&\O
MII/#VMZ7=7ZZ?>32V$'[M?\ !#[_ ((B>(?VEO$OA#]K#]K'P9/I7[,VCR6?
MB7X=?#_Q):F&Z^/NH0RF;2K_ %+2;A?-7X1P30I>W4E]#'!\08?LUA81WOA>
M\U"\N/W+_P"#C/\ 86\0?M1_L<Z#\6/A;X;DUSXE_LI:IK'C"'0M(L%GU76/
MA'KVGV5G\2M,TBWCGM]\V@QZ'X;\:K:Q17=Q+I?A75K#2K*;4+^"*3[',/I%
M^&_ASXI>'?@;P52R3 \)X+'U\DXKS#!*G'*<BQ>*PF+PV39-A,3&K[%XJ.?U
ML+B.)<QKSJ+"RE.GB<1/&/,_JWET/#[B+B'AG/\ C3.YXW$9O7PU+&91AZKD
M\5BZ-&K2JXK%5:/)S*G/ 0J4LLPU/E<U:<**IO#<_P#G>5[G^S-\?O&?[+/Q
M_P#A'^T/\/Q;R>*_A)XWT;QAI]C><6&M6UC/Y>L^&]2<1RR1:9XGT.?4O#VI
M36RK>06&IW$UE+!=I!-'X917]B9A@,%FN QV5YCAJ6,R_,L'B<!C\)7CS4<5
M@L91GA\5AJT;KFI5Z%2I2J1NKPDU<_(,/B*V$Q%#%8:I*CB,-6I8C#UH.TZ5
M:C.-2E4@];2A4C&47T:1_HB?"[_@YI_X)N^,O"FGZM\0+WXN_"#Q2]M#_:_A
M/7/AQJ?BM+6^/F+=)I>O>!I-?L=2TY'C#VUY>1:/>3V\\#S:7:3_ &BVM_M;
M]E3_ (+&?L)_MH_%[3_@;\ /B#XL\2_$34]$USQ#;:;JWPV\9>&++^RO#MJ+
MS5+B35==TNRL4:*)D$<'FF:9W CC(#LO^7+7[\_\&U'_ "E%\'?]D>^,'_IA
MM:_SQ\7OH7^$7!_A]Q[QID>,XSH8_(>'\VSK+<!6SG+L1E=+$83#SK4*%2%7
M)'F%;"QDE%QJ9B\1**][$.5Y'] \(^,'%.<Y_DF38W#Y-*ACL90PF(KT\)BJ
M>*E">DJD6L>\/&K*UW;#^S3;M32LE_HSU_%G_P ';G_(R_L(_P#8#_:-_P#2
M_P""=?VF5_%G_P ';G_(R_L(_P#8#_:-_P#2_P""=?R3]#3_ )2.\/O^O?%W
M_K$<1GZAXN_\F]S_ -<J_P#5UEQ_'77T=^QU_P G=?LL?]G'? __ -6;X8KY
MQKZ._8Z_Y.Z_98_[..^!_P#ZLWPQ7^V7%7_),<1_]B'./_5?B#^.,I_Y&N6?
M]C#!?^I-(_UTJ***_P":T_T0"BBB@ HHHH **** /RV_X+6?"]_BY_P2V_;)
M\-1%TGT+X80_%"*6)4,L:?!KQ3X>^+-X%+PSA4N-.\&7EI<LJ*_V2XN%6:W+
M">/_ "Z*_P!D_6-(TWQ!I&J:#K5G#J.CZWIU]I&K:?<J6M[_ $W4K:6SOK.=
M05+0W5K-+!*H()1V (/-?Y9O_!47_@G[XZ_X)X_M1>+/A;J^FZI<?"KQ-?ZO
MXI^ _CFXM[I].\6_#R;4&:TTXZK(AMKGQ9X,BNK+0O&=@DQN[:]-CJ\EO#I?
MB'19KO\ T\_9\^(664<+QAX8XW%0P^98K,8\79%0JSC%9A&> P^79W1PZ:3E
MB,)1R[+<2Z,93G5PT\17A3C3P>(F_P"</'G(,14EE/$M"DZF'HT)97CYQB[T
M$Z\J^!G-IO\ =5*E?$TN9QBH5/9P<I.M!1_.*OTH_P""?O\ P59_:Q_X)PWO
MB"T^!^L^&?$'P[\7ZA'K'BOX2?$?2+S7/ VIZ\D-C8_\)/8C2=4T'Q#X?\3'
M2;"#2I-2T77;2VU&SBLH]=T[65TG2%L/S7HK_1?B3ACA[C#)\7P_Q1D^ SW)
M<<H+%9=F6'AB,-4=.:J4JBC-7IUJ-2,:E"O2E"M1J1C4I5(32DOY\RW,\PR?
M&4L?EF+KX'&46_9XC#S<)I25I1>\9TYKW9TYJ4)Q]V<6M#^NBR_X.T/B]':P
MIJ'[&GPWNKQ5(GN++XL^)["UD;<Q4PVD_@_498%"%5*O>W!+!G#*&"+:_P"(
MM+XH_P#1EG@'_P /+XB_^8*OY#:*_"G]$/Z.C;;\-L+=MMVXAXOBKMWTC'B!
M12[)))+1)(^X_P"(M>(/_10R_P##9DS_ #RX_P!0?_@D7_P4;\0_\%,O@)\0
MOC-XC^%NC?":Z\$_%[4?AC!H.B^)[[Q5;W]O8>#/!GBH:O+?WVD:+)!-+)XK
MDLC9I:R(B623?:&:=HXOU9K^7_\ X-3/^3&?CS_V=AXB_P#50?!ZOZ@*_P ?
MO'KAK).#_&#CWAGAS QRS(\GSMX3+<!&OB<3'#8=83"U%35?&5L1BJGOU)RY
MJU>I/WK<UDDOZPX(S'&YOPID>99A6^L8W&8*-7$5W3I4O:5'4J1<O9T84Z4=
M(I6A",=-KW/PI_X.//\ E%1\8O\ L?O@K_ZLO0*_S=:_TBO^#CS_ )14?&+_
M +'[X*_^K+T"O\W6O],OH _\F4SK_LXN>?\ J@X5/YS\=_\ DL,!_P!D[@__
M %8YL%?ZO'_!,/\ Y1R_L+_]FG_ 7_U6OAVO\H>O]7C_ ()A_P#*.7]A?_LT
M_P" O_JM?#M?)_M#_P#DA_#W_LJ\P_\ 514/3\ O^1SG_P#V+,/_ .I2/NBB
MBBO\G#^HPHHHH *_AD_X.QO^3C/V3_\ LBGC#_U.C7]S=?PR?\'8W_)QG[)_
M_9%/&'_J=&OZM^A5_P I#\(?]B[BK_UF<T/S/Q@_Y-_G?_7S*O\ U;8$_DZK
MZP_8+_Y/F_8P_P"SL/V=?_5O^#J^3Z^L/V"_^3YOV,/^SL/V=?\ U;_@ZO\
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M<:?;V7AW7/M-NEH 9II7M]LCJB))AROX5?\ $,+_ ,%+/^?W]G'_ ,.IKO\
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M\.IKO_S 4?\ $,+_ ,%+/^?W]G'_ ,.IKO\ \P%%%>[_ ,3W>.W_ #\X/_\
M$=G_ //$XO\ B"? _P#SZS3_ ,.#_P#E1_4C_P $-?V!_CM_P3S_ &9_BC\)
M?C_)X(E\5>+_ (Z:K\1=(?P'XAN_$>E?\(_?> / 'AJ%;J\O-'T66'4!J/AC
M43);+:R1K;-;2K<,TKQQ?M3117\M\:<79OQ[Q3G7&&?/#/.,^Q;QN/>#H/#8
M5UW2ITOW-!SJ.G#DI1]WGEK=WUL?I6495A,DRW!Y3@546$P-)4:"JS]I44%*
M4O?G9<SO)ZV1^8W_  5\_9)^*_[;W[#GC_\ 9Y^"K>%T\?\ B?Q5\.=7TZ3Q
MCK$^@Z EGX6\8:9KVIFZU&VT[59XI#964J6L<=C-YMPT<;&)"TJ?Q_?\0PO_
M  4L_P"?W]G'_P .IKO_ ,P%%%?K?A9])CQ,\'N',1PMP?+((Y7BLWQ.=55F
MF4RQV(^NXO"X'!U7&LL702I>QR_#\M/D?++GES/FLOE^)O#OASBW'TLRS>&-
MEB:6$IX*#P^*=""H4JM>M%."A*\N?$5&Y7U32MH'_$,+_P %+/\ G]_9Q_\
M#J:[_P#,!7]T'[%OPE\5_ 7]D3]F7X)>.SI;>-/A)\"_A?\ #KQ6VB7CZAH[
M>(/!_@_2="U9M+OY;>TEO-/:]L9FL[F6TMI)H#'));PNQC4HK@\6?I#^(?C/
MEF593QG+))83)L=5S#!?V5EDL!46(K8=X:?M9O%5_:0]FW:/+&TM;]#;A?@+
MA_A#$8K$Y/#%QJXRC"A6^LXEUXNG"?M(\J<(\KYMW=W6A]-4445^%GV@4444
M %?S-?\ !=;_ (),_M5_\%%/B_\  SQK^S[-\,(=$^'7PWU[PMX@;Q]XPO\
MPW=/JNJ>)WU:W&GV]EX=US[3;I: &::5[?;(ZHB28<J45]SX<^(7$/A=Q9@.
M,^%W@5G66T<=0PSS'#/&850S#!UL#B.>@JM%SE["O44'[1<LVI6=K'CY_D6
MXDRK$9/F:JRP6*="554*GLJC>'KT\13Y:G++E_>4H-Z:JZZGX5?\0PO_  4L
M_P"?W]G'_P .IKO_ ,P%>Z?LO?\ !N3_ ,%#/@_^TQ^SO\6O%EW\ 7\*_"[X
MZ?"3XB^)DTGXEZS>:J_A_P $^/\ P_XEUE=,LYO!%I%=:@VG:9<BRMI;JVCG
MN3'$]Q"K&12BOZ(S#Z<'CAF6 QN78F?"7U;,,)B<%B/9\/SA4]ABJ,Z%7DG_
M &@^6?LZDN65GRNSL[6/@*'@SP7AJ]'$4J>9JIAZM.M3<L>W'GI3C.%U[+5<
MT5==5H?WC4445_'Q^KA1110!0U72M+UW3;_1=;TVPUC1]5L[C3]4TG5;.WU#
M3=2L+N)H+NQO["[CFM;RSNH'>&XMKB*2&:)VCD1D8@_SH_MG?\&TW[&O[0-U
MJWB_]GK6=7_9,\?ZA,UV^F^&-+C\7_!R\N9;BVEN2WPWOM2TB]\."2WBN+:R
M@\%>*_#^@:7)="Z'AF^2W6RE**^WX&\2..O#;,GFW _$V9\/8N;IO$1P=6,\
M%CHTFW3IYCEF)A7RW,:4&VX4L=A<1"#;<8INYX^<\/Y+Q#AOJF=9=ALPHKFY
M/;0:JT7))2EA\13<,1AIR22<Z%6G-I6<K:'\ZWQU_P"#;/\ X*6?">YO9_ 7
MA7X<?M"Z!%J%U'9WWPP\?Z3H^MG2$:Z>SU'4_#/Q-_X06X@O);>&W%YI.@7O
MB>2UO;M;:TNM3MHI;\?G9XW_ ."8W_!1+X>ZG+I7B;]B3]IX31!"U[X?^#/C
MGQIH3-(\R)'#XE\&:-K_ (=GF)@D;R(-4DF$>R8QB*6)W**_OSP>^F)XK<6X
MMY3GN!X-QGU>C.3S".49EAL=7E'V5I5EA<[HX!-\[NJ&!HK:R1^(<5^$/"N6
MX66-P5;.*#E5A!8?ZWAZF'@I<U^7VV"J8AO1?'B)G'VW[ /[=][.EM9_L4?M
M;W=S)N\NWMOV;_C'//)L1I'V11>#'D?9&C.VU3M168X4$CZK^&?_  0Y_P""
MIWQ3_L6;2/V1O&WA?3M9.GN=2^)FM^"OAE_9%E?BWD:^UK1?&_B;1/%-D+"W
MN//U#3$T"?7H##<64>D3:G$;$E%?=^*GTJ_$3@G)Z.-RC*.#:M>M.=-_7\NS
MJM"'N2:E"-'B'#>\FDUSN<>\6M#P^%_"WA[.<55I8O%YQ&%*$9I4,1@X.3<K
M.,G/+ZCY6M/=Y9=I(_:S]EO_ (-3/%%U=Z5K_P"V/^T/I&CZ:DAFU#X;? 2P
MN=7U6\B$BM!;W'Q,\9:=IUAI,AC4K?06'@#75;S#'9:O&T:W3?U8?LL_L7_L
MR_L6^"3X"_9N^$WASX<Z5<K VMZI9QSZEXM\5W-NI$=[XM\8:M->^(_$-RA9
MS NI:C-;6*N8-.MK.V"0*45_G?XD>._BGXKOV/&7%6+Q>5QJ>UI9#@84LKR*
ME*,N>FY9;@84:6,J47?V.)S%XS%TTVHXBS=_WKA[@OAKA=7R?*Z-"NX\L\;5
M<\3C:BM:5\37E.I3C.UYTJ+I46]535E;ZBHHHK\A/J0HHHH _@$^*_\ P;5_
M\%&_&WQ2^)7C/1[O]GN/2?%WC_QEXGTN.^^)^M0WJ:=K_B+4=5LDO(8O MQ%
M%=+;7<2W$4<\T<<H=$ED4!VX#_B&%_X*6?\ /[^SC_X=37?_ )@***_L7"_3
ME\<L)AL/A*,^$%1PM"CAZ2EP_.4E3H4XTH<TO[07-+EBKNVKU/R>MX,<%5ZU
M6O4IYFZE:I4JS:Q[2YZDG.5E[+1<S=ET1_0[_P $%?\ @F%^TM_P3?\ ^&K/
M^&B)_AQ-_P +E_X49_PA_P#PK_Q5?^)MO_"N_P#A<7_"0?VO]M\/Z%]BS_PG
M.B?8/*^U?:<7N_R/LZ>=_0[117\V^(/'>?>)G%^;\;\3/!O.\[^H?77@,.\)
MA/\ A-RO!91AO98=U*KI_P"R8##^T_>2YZO//3FY5^@Y#DF!X<RK"Y-EJJQP
M6#]O[%5JGM:J^L8FMBJG-4:CS?O:]1QT5HVCTN%%%%?&'KA1110 4444 ?DE
M^W3_ ,$5OV'_ -N^YU7Q?XQ\$7/PK^,^IN)[CXS_  C-AX;\4ZO=@6B>=XTT
MB:RO/"WCEY;>RM[*34/$&CS^(X;%3;:9X@TT$,/Y=?V@/^#6[]MOX?3W][\!
M?B/\(_VB- M=-DN;.SN;RY^#WQ U/48OM+MID'AWQ1<:SX&MQ<1QVB65[>?%
M."%[JYEBO4T^UMA>W!17]!>''TH/&7PQPM#+,CXG>9Y%AE"-#(>)J"SO+L/3
MIJT*&#J5IT\SR["QC=+"9=F.$POO.7L>=1DOA>(?#?A'B6K/$X[+%0QM2[GC
MLOJ/!XBI*6\ZRIIX?$5'9?O<30K5$DHJ2C=/\O?B!_P1Y_X*>?#.!KCQ'^Q1
M\<=2C66*$K\/_#MO\69]\S.J%;;X5W_C.Y:(&-C+.L1@@4HT\D:R1EO"3^P5
M^W.I*M^Q?^UB&!((/[.GQ@!!!P00?!V00>"#R#117^@GA[])WCWBS(*>:YCE
M'"%'$3JS@X8+ 9S3HVC&$DU&OG^)G>\G?]XUMIW_  SB+PRR'*,>L+AL7F\Z
M;HQJ<U?$8*4^9SJ1:O3P%*-K07V;WOKV],\ ?\$J_P#@I#\2[I[7PQ^Q)^TA
M 4BCF%WXQ^%WB7X;Z5-'+YNPVNL_$6S\*Z1>$>2XD2TO9GB)B$JH9X1)^E7P
M#_X-E/\ @HA\4+G3+OXM/\*OV<?#T]RXU4>+_&5IX[\:6EBN]4NM,\,_#,^)
M- U"YF81O'8:KXY\.,D#NUS/;W$8M9"BOQOQ?^F5XN<-9I7R'(<+P=EL94X.
M&9PR;'XK,J+G0C)NFLPSG%Y;+EG4YHJMEM57A!24H\\9_6\*^$'">.P>'S#'
M5,VQ4INISX6>,HTL-+V==Q5_JV$H8E<T8<LN7$K24G'EERN/]+/[#7_!O?\
ML1?L@ZCH/CSQQ9:A^T_\8M%-C>VOBOXJ:;I\/@30M=M%B<ZKX/\ A1;/?:)8
MRQWL2WVF3^,=4\>:OHMTD-SI6KVEU"MQ7[O*JHJHBJB(H5$4!555 "JJ@ *J
M@       #%%%?P5QEQWQCX@YK+.^-.(LSXBS)J4*=;,,0YT\-2E+F=# X2FJ
M>#R_#.7O?5L#A\/AU)N2IJ3;?[;E.2Y5D6%C@LHP&&R_#*S=/#TU%U))6YZU
61WJUZEM'5K3J5&MY,=1117R1Z9__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>ny20053122x2_ex99-3img02.jpg
<TEXT>
begin 644 ny20053122x2_ex99-3img02.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" ,F!$T# 2(  A$! Q$!_\0
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MX;%_:Z_Z.G_:._\ #X?$W_YIZ^<:*/\ 57AC_HG,A_\ #/E__P SA_:V:_\
M0SS#_P +<3_\L/H[_AL7]KK_ *.G_:._\/A\3?\ YIZ/^&Q?VNO^CI_VCO\
MP^'Q-_\ FGKYQHH_U5X8_P"B<R'_ ,,^7_\ S.']K9K_ -#/,/\ PMQ/_P L
M/H[_ (;%_:Z_Z.G_ &CO_#X?$W_YIZ/^&Q?VNO\ HZ?]H[_P^'Q-_P#FGKYQ
MHH_U5X8_Z)S(?_#/E_\ \SA_:V:_]#/,/_"W$_\ RP^CO^&Q?VNO^CI_VCO_
M  ^'Q-_^:>C_ (;%_:Z_Z.G_ &CO_#X?$W_YIZ^<:*/]5>&/^B<R'_PSY?\
M_,X?VMFO_0SS#_PMQ/\ \L/H[_AL7]KK_HZ?]H[_ ,/A\3?_ )IZ/^&Q?VNO
M^CI_VCO_  ^'Q-_^:>OG&BC_ %5X8_Z)S(?_  SY?_\ ,X?VMFO_ $,\P_\
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M)S(?_#/E_P#\SA_:V:_]#/,/_"W$_P#RP^CO^&Q?VNO^CI_VCO\ P^'Q-_\
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M#/,/_"W$_P#RP^CO^&Q?VNO^CI_VCO\ P^'Q-_\ FGH_X;%_:Z_Z.G_:._\
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M_P"CI_VCO_#X?$W_ .:>C_AL7]KK_HZ?]H[_ ,/A\3?_ )IZ^<:*/]5>&/\
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MIP1[A:7MLS%Z_I^_8Z_X.I4>32O"?[<GP4$(DEMK.7XP_ >-FA@$UW';B_\
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MFO\ V,L=_P"I54****^G/-"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ6(I\M/,,!.2E6P6(:;Y):+GHU+2EAZZBHU8)IJ%6G6I4[%%%%?C1]8%%%%
M!1110 4444 %%%% !1110 4444 %%%% '^37_P %&_\ E(7^WA_V>9^U!_ZN
M_P <5\9U]F?\%&_^4A?[>'_9YG[4'_J[_'%?&=?])/!/_)&<(_\ 9,9!_P"J
MK"'^>.<_\CC-?^QECO\ U*JA1117TYYH4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110![#^T/_R7_P".7_98?B9_ZFNMUX]7L/[0_P#R7_XY?]EA^)G_
M *FNMUX]7DY!_P B+)?^Q3EW_J'1.[-/^1EF/_8=B_\ U(J!1117K'"%%%%
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M .:@_P"(!9U_T/LK_P#!&+_^1/\ *IHK_56_X=-_\$T_^C(/V<?_  VNA?\
MR/1_PZ;_ .":?_1D'[./_AM="_\ D>C_ (J'< ?]$#QA_P"%62__ #4'_$ L
MZ_Z'V5_^",7_ /(G^5317^JM_P .F_\ @FG_ -&0?LX_^&UT+_Y'H_X=-_\
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M<?\ PVNA?_(]'_%0[@#_ *('C#_PJR7_ .:@_P"(!9U_T/LK_P#!&+_^1/\
M*IHK_56_X=-_\$T_^C(/V<?_  VNA?\ R/1_PZ;_ .":?_1D'[./_AM="_\
MD>C_ (J'< ?]$#QA_P"%62__ #4'_$ LZ_Z'V5_^",7_ /(G^5317^JM_P .
MF_\ @FG_ -&0?LX_^&UT+_Y'H_X=-_\ !-/_ *,@_9Q_\-KH7_R/1_Q4.X _
MZ('C#_PJR7_YJ#_B 6=?]#[*_P#P1B__ )$_RJ:*_P!5;_ATW_P33_Z,@_9Q
M_P##:Z%_\CT?\.F_^":?_1D'[./_ (;70O\ Y'H_XJ'< ?\ 1 \8?^%62_\
MS4'_ ! +.O\ H?97_P"",7_\B?Y5-%?ZI]S_ ,$D_P#@F?=V\UK+^Q%^SPD<
M\;Q.UM\/M+LKA5<%6,-W9K!=VT@!^2:WFBFC.&C=6 (\B\7_ /!";_@D_P"-
M6MI-5_8_\*Z=+9P7$%N_A#QY\7_ J@7!5FEN;?P9\0M"L]2GC9%-O+JEO>M
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M-/\ Z,@_9Q_\-KH7_P CT?\ #IO_ ()I_P#1D'[./_AM="_^1Z/^*AW '_1
M\8?^%62__-0?\0"SK_H?97_X(Q?_ ,B?Y5-%?ZJW_#IO_@FG_P!&0?LX_P#A
MM="_^1Z/^'3?_!-/_HR#]G'_ ,-KH7_R/1_Q4.X _P"B!XP_\*LE_P#FH/\
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M_9Q_\-KH7_R/1_PZ;_X)I_\ 1D'[./\ X;70O_D>C_BH=P!_T0/&'_A5DO\
M\U!_Q +.O^A]E?\ X(Q?_P B?Y5-%?ZJW_#IO_@FG_T9!^SC_P"&UT+_ .1Z
M/^'3?_!-/_HR#]G'_P -KH7_ ,CT?\5#N /^B!XP_P#"K)?_ )J#_B 6=?\
M0^RO_P $8O\ ^1/\JFBO]5;_ (=-_P#!-/\ Z,@_9Q_\-KH7_P CT?\ #IO_
M ()I_P#1D'[./_AM="_^1Z/^*AW '_1 \8?^%62__-0?\0"SK_H?97_X(Q?_
M ,B?Y5-%?ZJW_#IO_@FG_P!&0?LX_P#AM="_^1Z/^'3?_!-/_HR#]G'_ ,-K
MH7_R/1_Q4.X _P"B!XP_\*LE_P#FH/\ B 6=?]#[*_\ P1B__D3_ "J:*_U5
MO^'3?_!-/_HR#]G'_P -KH7_ ,CT?\.F_P#@FG_T9!^SC_X;70O_ )'H_P"*
MAW '_1 \8?\ A5DO_P U!_Q +.O^A]E?_@C%_P#R)_E4T5_JK?\ #IO_ ()I
M_P#1D'[./_AM="_^1Z/^'3?_  33_P"C(/V<?_#:Z%_\CT?\5#N /^B!XP_\
M*LE_^:@_X@%G7_0^RO\ \$8O_P"1/\JFBO\ 56_X=-_\$T_^C(/V<?\ PVNA
M?_(]'_#IO_@FG_T9!^SC_P"&UT+_ .1Z/^*AW '_ $0/&'_A5DO_ ,U!_P 0
M"SK_ *'V5_\ @C%__(G^5317^JM_PZ;_ .":?_1D'[./_AM="_\ D>C_ (=-
M_P#!-/\ Z,@_9Q_\-KH7_P CT?\ %0[@#_H@>,/_  JR7_YJ#_B 6=?]#[*_
M_!&+_P#D3_*IHK_56_X=-_\ !-/_ *,@_9Q_\-KH7_R/1_PZ;_X)I_\ 1D'[
M./\ X;70O_D>C_BH=P!_T0/&'_A5DO\ \U!_Q +.O^A]E?\ X(Q?_P B?Y5-
M%?ZJW_#IO_@FG_T9!^SC_P"&UT+_ .1Z/^'3?_!-/_HR#]G'_P -KH7_ ,CT
M?\5#N /^B!XP_P#"K)?_ )J#_B 6=?\ 0^RO_P $8O\ ^1/\JFBO]5;_ (=-
M_P#!-/\ Z,@_9Q_\-KH7_P CT?\ #IO_ ()I_P#1D'[./_AM="_^1Z/^*AW
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MPZ;_ .":?_1D'[./_AM="_\ D>C_ (=-_P#!-/\ Z,@_9Q_\-KH7_P CT?\
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M4445[1PA1110 4444 %%%% 'L/[0_P#R7_XY?]EA^)G_ *FNMUX]7L/[0_\
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M]9%%%%?Y,G]1!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#DO_QR_P"RP_$S_P!376Z\>KR<@_Y$62_]BG+O_4.B=V:?\C+,?^P[%_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]_E%%%?X"']U!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\B+)?^Q3EW_J'1.[-/\ D99C_P!AV+_]2*@4445ZQPA1110 4444 %?TR?\
M!JI_RD+^,?\ V9G\0O\ U=_[.]?S-U_3)_P:J?\ *0OXQ_\ 9F?Q"_\ 5W_L
M[U^%?2:_Y,)XH_\ 9,5__4G#'VWAQ_R7/#7_ &,H?^FZA_?Y1117^ A_=044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %?QT_\'8/[/%E+X<_9<_:
MPTZUM(-0L=<U[]GKQ?>+9Q_;M3M-8T_5?B/\.[>6_5UD^S:)+H/Q/>&TECF0
MR:]++"]N5G6Y_L6K\EO^"Y7P9C^-G_!+K]JG24:.'4_ /A#3OC-I%W):B[^S
M2?"37],\;:XJ1>; T<FI>$-*\2:*MTLH-F-3-VT5U'"]I/\ MGT<^+I\$^-G
MAWG7M94L-5XAPF29C)-\G]F\1<V1XR=6*A4=2GAJ>/\ KG(H2G[3#PE3Y:L8
M3C\?Q_E2SG@[B#!<JG467U<7AT[7>)P%L;0C&3G!1=2I05+F<E%1G+G4H.49
M?YA%%%%?] A_!X4444 %%%% !1110 5^YW_!N?\ %-_AO_P5.^$.B-&#8_&'
MP3\5OA9J-PU[]D6S23P7?_$+3)#$89%U W?B'X>Z+I<=DTMMB74$O$FDELX[
M2Y_#&ON#_@FA\0K[X6_\%!_V+_&=B\,9L_VD_A'HVHO<&81CP_XO\9:5X/\
M$P!@GMW65O#NO:HMN[N\"3F)KJWNK82VLWYYXN9)'B/PL\1<C=.-2>9<%<38
M?#QE*44L8\HQ<\#4;BTTZ.,A0JJ]XMP2E&46XOZ'A+&?V?Q1P]C.9PC0SK+9
MU6HJ3]@\72CB(I-.[E1E4CIJN:\6I)-?ZP%%%%?\Z1_?X4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% '^69_P6-_Y2?_ +:O_9:]:_\
M3?I=?FE7Z6_\%C?^4G_[:O\ V6O6O_3?I=?FE7_1GX5?\FO\-_\ L@N#_P#U
MGLN/\_\ BW_DJN)O^R@SG_U8XD****^]/GPHHHH **** "BBB@#V']H?_DO_
M ,<O^RP_$S_U-=;KQZO8?VA_^2__ !R_[+#\3/\ U-=;KQZO)R#_ )$62_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_EF?\%C?^4G_[:O\
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MAE$I3RK+)SE*<YY?@I3G-N4I2EAJ3E*4FVY2DVVVVVVVV[A1117S9Z 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_,+_P""Z]^NI?\
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MO_GD?ZF=%?Y9G_#XW_@I_P#]'J_&O_P=:?\ _*NC_A\;_P %/_\ H]7XU_\
M@ZT__P"5='_%/7Q0_P"BSX"_\&\0_P#SC#_B/7"O_0JX@_\ !&7?_/(_U,Z*
M_P LS_A\;_P4_P#^CU?C7_X.M/\ _E71_P /C?\ @I__ -'J_&O_ ,'6G_\
MRKH_XIZ^*'_19\!?^#>(?_G&'_$>N%?^A5Q!_P"",N_^>1_J9T5_EF?\/C?^
M"G__ $>K\:__  =:?_\ *NC_ (?&_P#!3_\ Z/5^-?\ X.M/_P#E71_Q3U\4
M/^BSX"_\&\0__.,/^(]<*_\ 0JX@_P#!&7?_ #R/]3.BO\LS_A\;_P %/_\
MH]7XU_\ @ZT__P"5='_#XW_@I_\ ]'J_&O\ \'6G_P#RKH_XIZ^*'_19\!?^
M#>(?_G&'_$>N%?\ H5<0?^",N_\ GD?ZF=%?Y9G_  ^-_P""G_\ T>K\:_\
MP=:?_P#*NC_A\;_P4_\ ^CU?C7_X.M/_ /E71_Q3U\4/^BSX"_\ !O$/_P X
MP_XCUPK_ -"KB#_P1EW_ ,\C_4SHK_+,_P"'QO\ P4__ .CU?C7_ .#K3_\
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MGKXH?]%GP%_X-XA_^<8?\1ZX5_Z%7$'_ ((R[_YY'^IG17^69_P^-_X*?_\
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MJ\G(/^1%DO\ V*<N_P#4.B=V:?\ (RS'_L.Q?_J14"BBBO6.$**** "BBB@
MK^F3_@U4_P"4A?QC_P"S,_B%_P"KO_9WK^9NOZ9/^#53_E(7\8_^S,_B%_ZN
M_P#9WK\*^DU_R83Q1_[)BO\ ^I.&/MO#C_DN>&O^QE#_ --U#^_RBBBO\!#^
MZ@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9++%!%)--)'###&\
MLLLKK'%%%&I>2221R$2-$!9W8A54%F( )I]?)G[>?Q?;X!?L6?M3_&&WFMX=
M3\!_ CXEZQX?-VXCMY?%;^%M1L/"-K*Q#<7OB:\TFT"A6:1IPB LP%>AE&6X
MG.<URS)\''GQ>;9A@LMPL-N;$X[$TL+0C?\ O5:L5\S'$UZ>%P]?%5GRTL-1
MJUZLK-\M.C"52;LDV[1BW9)M]$S_ "K_ -H'XA6_Q<^/7QN^*UIYOV7XG?%W
MXD_$*V^T1>1/]G\:>,M:\20^=".(9?+U)?,B_P"6;[D[5Y%117_2M@<'0R_!
M8/ 89..&P.%P^#P\9.\HT,-2A1I)M))M4X13:2N];+8_SJQ%:>)KU\14M[3$
M5JE:IRIJ//5G*<N5-MI<TG9-MVW;W"BBBNHR"BBB@ HHHH *UM T+5?%&NZ+
MX9T&T;4-<\1:MINA:-8)+! ][JNKWD.GZ=:+-=2P6T+7-Y<0PK+<30P1EP\L
ML<89QDU]>?\ !/[P3>?$7]NG]COP79V#ZF=>_::^"-O>VJH'4:-;_$;P[>Z_
M=3JT<R_9-/T.UU&_O6,,P2SMIW,,NWRV\K/LSCDN1YSG$O9J.4Y3F.9R=9\M
M)1P&#K8I^UES0M3M2?.^>-HW?-'==F7X7Z[C\#@K3?UO&8;"VIJ]1_6*T*5J
M:Y97F^?W5RR]ZWNO8_UE=*L(]*TO3=+B(:+3;"SL(V6-8E:.SMX[="(E)6,%
M8P1&I*H/E!( J_117_-*VY-R;NY-MONV[M_-G^BFP4444@"BBB@ HHHH ***
M* "BBB@#_)K_ ."C?_*0O]O#_L\S]J#_ -7?XXKXSK[,_P""C?\ RD+_ &\/
M^SS/VH/_ %=_CBOC.O\ I)X)_P"2,X1_[)C(/_55A#_/'.?^1QFO_8RQW_J5
M5"BBBOISS0HHHH **** "OZ)O^#83_E)9>_]FX_%3_T_> *_G9K^B;_@V$_Y
M267O_9N/Q4_]/W@"OQ/Z2'_)B?%3_LC\T_\ 2(GVGAU_R7'#/_8TH_\ I,S_
M $.J***_Y^S^[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /A?_
M (*>?\HY?VZ/^S3_ (]?^JU\15_E#U_J\?\ !3S_ )1R_MT?]FG_ !Z_]5KX
MBK_*'K_6/]GA_P D/XA?]E7E_P#ZJ*9_+GC[_P CG(/^Q9B/_4IA1117^AI^
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110![#^T/_P E_P#CE_V6'XF?^IKK=>/5[#^T
M/_R7_P".7_98?B9_ZFNMUX]7DY!_R(LE_P"Q3EW_ *AT3NS3_D99C_V'8O\
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M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#YD_;*_:<\'_L<?LQ_&+]H_QM)"VF?#/P??:IIFER3)#+XE\77ICTKP
M7X3M&=E_TKQ-XJOM)T:-QD6Z7DEY+M@MYG7_ "9_'_CCQ+\3O'?C7XE>--0;
M5_&/Q"\6^)/''BS5718WU/Q+XLUF]U_7=0>-,(C7NJ:A=7+(H"J92J\ 5_45
M_P '-O\ P4&M?BI\5/#?["OPSUL77@WX(:K%XN^-=Y82SBUUCXO7FF20Z%X1
M>10EO>6_P\\.:I<W&I^3)=6P\4>)KG3+M;?5_",L<7\I%?[,_0B\):O OAS6
MXSSC"RH<0>(;PN84:=:#C6PG"^%C4>24^62O"69/$8C-YN+2K87$Y:JD54P^
MG\B^-'%,,YS^GDN$J1J8'(/:TJLH-.-7,ZKBL7JM']54(86SUA6AB5M(****
M_M<_&0HHHH **** "BBB@ K_ $0O^#9CX'?\*Q_X)R1?$F\BE75?VA?BYXZ\
M>H\]M]GEB\.>%)[7X7Z)9H6423VIO_!?B#6;:=OED76W,.8MCR?YZ.AZ)J_B
M76]'\.:!I]UJ^N^(-4T_1-$TJQB:>]U/5]5NX;#3=/LX5^::ZO;RXAMK>)?F
MDEE1!R:_UTOV6?@EIO[-O[-WP+^ >E2">U^$7PK\$> I;W]SOU/4?#V@6-AK
M&L3&WAMX7N-9U>*^U2YDC@A22XO)9!&F[:/X"_:!\81RSP[X5X,HU5'%<5<1
MSS+$TU).4LJX<PSE4A.%FXQJ9GF>65:<[QYI82I&/.E4Y?W?P&REXC/<USB<
M&Z66Y?'"TI-.RQ.854[Q?64,/A:\9)7Y8UHN5N:-_>J***_R,/ZI"BBB@ HH
MHH **** "BBB@ HHHH _R:_^"C?_ "D+_;P_[/,_:@_]7?XXKXSK[,_X*-_\
MI"_V\/\ L\S]J#_U=_CBOC.O^DG@G_DC.$?^R8R#_P!56$/\\<Y_Y'&:_P#8
MRQW_ *E50HHHKZ<\T**** "BBB@ K^B;_@V$_P"4EE[_ -FX_%3_ -/W@"OY
MV:_HF_X-A/\ E)9>_P#9N/Q4_P#3]X K\3^DA_R8GQ4_[(_-/_2(GVGAU_R7
M'#/_ &-*/_I,S_0ZHHHK_G[/[L"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ^%_^"GG_*.7]NC_ +-/^/7_ *K7Q%7^4/7^KQ_P4\_Y1R_MT?\
M9I_QZ_\ 5:^(J_RAZ_UC_9X?\D/XA?\ 95Y?_P"JBF?RYX^_\CG(/^Q9B/\
MU*84445_H:?@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 >P_M#_ /)?_CE_V6'XF?\
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M7TYYH4444 %%%% !7]$W_!L)_P I++W_ +-Q^*G_ *?O %?SLU_1-_P;"?\
M*2R]_P"S<?BI_P"G[P!7XG])#_DQ/BI_V1^:?^D1/M/#K_DN.&?^QI1_])F?
MZ'5%%%?\_9_=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'PO\
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MQPS_ -C2C_Z3,_T.J***_P"?L_NP**** "BBB@ HHHH **** "BBB@ HHHH
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M4>VJ_P#/VI_X'+_,++LON1A_\(QX:_Z%[0__  4V'_R/1_PC'AK_ *%[0_\
MP4V'_P CUN44>VJ_\_:G_@<O\PLNR^Y&'_PC'AK_ *%[0_\ P4V'_P CT?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC+ 9:ZE"%6+T:Q-=SEB,0I+XJ<JD</+=4$PHHHK^D3\Z"BBB@ HHHH ****
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M<F=9NJ>)QRDK3PM&,6\+@-VE*C&<JM>R4OK%6=.3E&C3:****_DT_4 HHHH
M**** "BBB@ HHHH **** "BBB@#_ ":_^"C?_*0O]O#_ +/,_:@_]7?XXKXS
MK[,_X*-_\I"_V\/^SS/VH/\ U=_CBOC.O^DG@G_DC.$?^R8R#_U580_SQSG_
M )'&:_\ 8RQW_J55"BBBOISS0HHHH **** "OZ)O^#83_E)9>_\ 9N/Q4_\
M3]X K^=FOZ)O^#83_E)9>_\ 9N/Q4_\ 3]X K\3^DA_R8GQ4_P"R/S3_ -(B
M?:>'7_)<<,_]C2C_ .DS/]#JBBBO^?L_NP**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#X7_ ."GG_*.7]NC_LT_X]?^JU\15_E#U_J\?\%//^4<
MO[='_9I_QZ_]5KXBK_*'K_6/]GA_R0_B%_V5>7_^JBF?RYX^_P#(YR#_ +%F
M(_\ 4IA1117^AI^!!1110 4444 %%%% ']\'_!J9_P F,_'G_L[#Q%_ZJ#X/
M5_4!7\O_ /P:F?\ )C/QY_[.P\1?^J@^#U?U 5_@1])__D_OBA_V4<O_ %!P
M9_=/AO\ \D-PU_V+H_\ IVJ%%%%?@Q]N%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!_D ?M#_\ )?\ XY?]EA^)G_J:ZW7C
MU>P_M#_\E_\ CE_V6'XF?^IKK=>/5_TM9!_R(LE_[%.7?^H=$_SMS3_D99C_
M -AV+_\ 4BH%%%%>L<(4444 %%%% !7],G_!JI_RD+^,?_9F?Q"_]7?^SO7\
MS=?TR?\ !JI_RD+^,?\ V9G\0O\ U=_[.]?A7TFO^3">*/\ V3%?_P!2<,?;
M>''_ "7/#7_8RA_Z;J']_E%%%?X"']U!1110 4444 %%%% !1110 4444 %%
M%% !7XR?\%O/^"@?QO\ ^"<_[-GPQ^+WP(TCX=:SXG\8_''2OAOJMM\2M"US
M7]&CT&^\!>/O$\T]E:Z!XH\)W<.IKJ'A?3HX[B6_GMA:27<;6;RR130?LW7\
MO_\ P=9_\F,_ ;_L[#P[_P"J@^,-?L?T?<BRCB;QG\/LAS_+\/FN3YGGJP^8
M9=BX.>&Q=!X/%3]E6@G%RCSPC*R:UBCY+CO&XO+>$,^QV!KU,+B\-@95*&(I
M-*I2FJE-<T6TTG9M;/<_&?\ XBE?^"C7_0A?LG_^&U^)7_SYZ/\ B*5_X*-?
M]"%^R?\ ^&U^)7_SYZ_FWHK_ &<_XEJ\!O\ HUO"G_A%4_\ EQ_(/_$1N./^
MBFS/_P &P_\ D#^DC_B*5_X*-?\ 0A?LG_\ AM?B5_\ /GH_XBE?^"C7_0A?
MLG_^&U^)7_SYZ_FWHH_XEJ\!O^C6\*?^$53_ .7!_P 1&XX_Z*;,_P#P;#_Y
M _I(_P"(I7_@HU_T(7[)_P#X;7XE?_/GH_XBE?\ @HU_T(7[)_\ X;7XE?\
MSYZ_FWHH_P"):O ;_HUO"G_A%4_^7!_Q$;CC_HILS_\ !L/_ ) _I(_XBE?^
M"C7_ $(7[)__ (;7XE?_ #YZ/^(I7_@HU_T(7[)__AM?B5_\^>OYMZ*/^):O
M ;_HUO"G_A%4_P#EP?\ $1N./^BFS/\ \&P_^0/Z2/\ B*5_X*-?]"%^R?\
M^&U^)7_SYZ/^(I7_ (*-?]"%^R?_ .&U^)7_ ,^>OYMZ*/\ B6KP&_Z-;PI_
MX15/_EP?\1&XX_Z*;,__  ;#_P"0/Z,[[_@Z%_X*2W<RR6^@?LR:6BQA#;V/
MPO\ %TD+L&=C,S:G\3M1G$C!E0A)UAVQH5B5S([^0>,?^#CK_@JQXGA2+1OC
M)X#^'C+>2W+S^#O@M\,[R:6"19%73G_X3WP_XWB2SA+J\4L$4.H[XH_-OY5,
MBR?A7179A/H\>!N"J0JT?"K@B<H:Q6*R'!X^F[)KWJ..IXBE/?[<):V>Z36=
M7Q!XVK0E"?$^;J,E9NEBYT)K_#4H^SJ1>F\9)^>K/U(\8?\ !:W_ (*G>.=.
MO-+UK]L[XH65M?6TUK/+X/M/!GP\U%(I[6XLW:SU?P!X6\,ZMIURL5S(\-YI
M][:W=O=+;WUO/%>VEK<0_&'C_P#:H_:>^+%A=Z5\4_VCOCS\2]+OU*WVF^/_
M (O_ !"\96%ZIDDF*W=GXB\0ZE;W"F:664B:-P9)))#\SL3X-17W&4\ \"9!
M*,LBX*X2R649QJQEE/#F3Y;*-2%N2I%X/!T6IQLN6:M*-E9JQXN*S_/L=IC<
M[S?&+E<+8K,L9B/<E\4/WM:?NRZQV?5!1117UIY 4444 %%%% !1110 4444
M %%%% !1110 4444 %?V&?\ !NA_P23FUS4-"_X*$?M'>$YX-%TFY%Y^RUX+
MUZ#8-<U&-)(IOC=JNE3(2VD:;([VGPP2^53?ZK%=^.K>T2ST_P %:UJ?P1_P
M0[_X(ZZ]^W'X_P!-_:$^//AW4-)_9"\ :P)K>.]1[.3X]^,=#U* 2>"-#21%
MFG^'^F3P7-M\0_%%LR12W,+>"- GFUJ3Q'J'@[_0^TW3M/T?3K#2-)L;33-*
MTNRM=.TS3;"WBM+'3]/L8([:SL;*T@2."VM+2VBC@MK>%$BAAC2.-%10!_G)
M],OZ2M/*,)F/@_P)CXSSC&TIX3C?.L'6O_9."J*U;AO"5:4K?VEC:;=+.9*5
ML#@Y5,OE&6,Q5?ZA_0WA#X=/$5,-Q=G=%K#TI*KDN"K4VG7JQ:=/,ZL9K^!2
M?OX)6?M:JCB4XTZ=)UKM%%%?Y5']-!1110 4444 %%%% !1110 4444 %%%%
M !1110!_DU_\%&_^4A?[>'_9YG[4'_J[_'%?&=?9G_!1O_E(7^WA_P!GF?M0
M?^KO\<5\9U_TD\$_\D9PC_V3&0?^JK"'^>.<_P#(XS7_ +&6._\ 4JJ%%%%?
M3GFA1110 4444 %?T3?\&PG_ "DLO?\ LW'XJ?\ I^\ 5_.S7]$W_!L)_P I
M++W_ +-Q^*G_ *?O %?B?TD/^3$^*G_9'YI_Z1$^T\.O^2XX9_[&E'_TF9_H
M=4445_S]G]V!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?"_P#P
M4\_Y1R_MT?\ 9I_QZ_\ 5:^(J_RAZ_U>/^"GG_*.7]NC_LT_X]?^JU\15_E#
MU_K'^SP_Y(?Q"_[*O+__ %44S^7/'W_D<Y!_V+,1_P"I3"BBBO\ 0T_ @HHH
MH **** "BBB@#^^#_@U,_P"3&?CS_P!G8>(O_50?!ZOZ@*_E_P#^#4S_ ),9
M^//_ &=AXB_]5!\'J_J K_ CZ3__ "?WQ0_[*.7_ *@X,_NGPW_Y(;AK_L71
M_P#3M4****_!C[<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#_( _:'_P"2_P#QR_[+#\3/_4UUNO'J]A_:'_Y+_P#'+_LL
M/Q,_]376Z\>K_I:R#_D19+_V*<N_]0Z)_G;FG_(RS'_L.Q?_ *D5 HHHKUCA
M"BBB@ HHHH *_ID_X-5/^4A?QC_[,S^(7_J[_P!G>OYFZ_ID_P"#53_E(7\8
M_P#LS/XA?^KO_9WK\*^DU_R83Q1_[)BO_P"I.&/MO#C_ )+GAK_L90_]-U#^
M_P HHHK_  $/[J"BBB@ HHHH **** "BBB@ HHHH **** "OY?\ _@ZS_P"3
M&?@-_P!G8>'?_50?&&OZ@*_E_P#^#K/_ ),9^ W_ &=AX=_]5!\8:_>?HP?\
MG]\+_P#LHX_^H.,/B/$C_DAN)?\ L72_].TC^!^BBBO]]S^%@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M?/\ X(X_\$5/'/[?OB:U^,GQLM?$'P\_9&\+:G#]IU,07&E^)/CAJMI+%+<>
M$?A]/.L4MGX7@3,/BWXAPI-!:R,?#GA;[;X@_MG4/!WUI_P2!_X-]/%GQPN_
M#7[1_P"W'X>U?P1\%4%AKO@;X(WPO-&\;_%7$PN+>_\ '5NR6VH^#?A]-"D;
MPZ:KV_BGQ9%<^8IT#1XX+O7?[G_#GASP_P"#_#^B^%/"FBZ7X;\,>&]+L=#\
M/^']#L;;2]&T31M+MH[/3M+TO3K..&TL;"QM(8K:UM;:*.&"&-(XT55 K_/+
MZ3?TPL'PW2S'@#PGS"CCN(YQJ8/.^,,'4A6P7#]_=K8/)*T>>EC<Y4>:G6QU
M-SPN52;C0G6S*$O[/_?_  X\)*N.>'SWBK#SHX*,HU<%D]:+A5QJ2YH5L?!V
ME2PC=G##24:N)2;JQAAVEB,_P+X&\'_#+P9X7^'GP_\ #FD^$/ _@K0M,\,^
M%/"^A6D=CI&@Z#HUI%8Z9IFGVL0"Q6UI:PQQ("6=R#)*[RN[MU5%%?Y05:M6
MO5J5Z]2I6K5JDZM:M5G*I5JU:DG.I4J5)MSG4G-N4YR;E*3<I-MMG]/QC&$8
MPA&,(1BHQC%*,8QBK1C&*LE%))))))*RT"BBBLR@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH _R:_P#@HW_RD+_;P_[/,_:@_P#5W^.*^,Z^S/\ @HW_
M ,I"_P!O#_L\S]J#_P!7?XXKXSK_ *2>"?\ DC.$?^R8R#_U580_SQSG_D<9
MK_V,L=_ZE50HHHKZ<\T**** "BBB@ K^B;_@V$_Y267O_9N/Q4_]/W@"OYV:
M_HF_X-A/^4EE[_V;C\5/_3]X K\3^DA_R8GQ4_[(_-/_ $B)]IX=?\EQPS_V
M-*/_ *3,_P!#JBBBO^?L_NP**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#X7_P""GG_*.7]NC_LT_P"/7_JM?$5?Y0]?ZO'_  4\_P"4<O[='_9I
M_P >O_5:^(J_RAZ_UC_9X?\ )#^(7_95Y?\ ^JBF?RYX^_\ (YR#_L68C_U*
M84445_H:?@04444 %%%% !1110!_?!_P:F?\F,_'G_L[#Q%_ZJ#X/5_4!7\O
M_P#P:F?\F,_'G_L[#Q%_ZJ#X/5_4!7^!'TG_ /D_OBA_V4<O_4'!G]T^&_\
MR0W#7_8NC_Z=JA1117X,?;A1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_D ?M#_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^%_\ @IY_RCE_;H_[-/\
MCU_ZK7Q%7^4/7^KQ_P %//\ E'+^W1_V:?\ 'K_U6OB*O\H>O]8_V>'_ "0_
MB%_V5>7_ /JHIG\N>/O_ ".<@_[%F(_]2F%%%%?Z&GX$%%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\ )K_X*-_\I"_V\/\
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M_I$3[3PZ_P"2XX9_[&E'_P!)F?Z'5%%%?\_9_=@4444 %%%% !1110 4444
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M -376Z\>KV']H?\ Y+_\<O\ LL/Q,_\ 4UUNO'J_Z6L@_P"1%DO_ &*<N_\
M4.B?YVYI_P C+,?^P[%_^I%0****]8X0HHHH **** "OZ9/^#53_ )2%_&/_
M +,S^(7_ *N_]G>OYFZ_ID_X-5/^4A?QC_[,S^(7_J[_ -G>OPKZ37_)A/%'
M_LF*_P#ZDX8^V\./^2YX:_[&4/\ TW4/[_****_P$/[J"BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?_DO_P <O^RP_$S_ -376Z\>K_I:R#_D19+_ -BG+O\ U#HG^=N:?\C+,?\
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M\ESPU_V,H?\ INH?W^4445_@(?W4%%%% !1110 4444 %%%% !1110 4444
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M9>_]FX_%3_T_> *_$_I(?\F)\5/^R/S3_P!(B?:>'7_)<<,_]C2C_P"DS/\
M0ZHHHK_G[/[L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^%_\
M@IY_RCE_;H_[-/\ CU_ZK7Q%7^4/7^KQ_P %//\ E'+^W1_V:?\ 'K_U6OB*
MO\H>O]8_V>'_ "0_B%_V5>7_ /JHIG\N>/O_ ".<@_[%F(_]2F%%%%?Z&GX$
M%%%% !1110 4444 ?WP?\&IG_)C/QY_[.P\1?^J@^#U?U 5_+_\ \&IG_)C/
MQY_[.P\1?^J@^#U?U 5_@1])_P#Y/[XH?]E'+_U!P9_=/AO_ ,D-PU_V+H_^
MG:H4445^#'VX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO\HHHK_ 0_NH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\
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M_2UD'_(BR7_L4Y=_ZAT3_.W-/^1EF/\ V'8O_P!2*@4445ZQPA1110 4444
M%?TR?\&JG_*0OXQ_]F9_$+_U=_[.]?S-U_3)_P &JG_*0OXQ_P#9F?Q"_P#5
MW_L[U^%?2:_Y,)XH_P#9,5__ %)PQ]MX<?\ )<\-?]C*'_INH?W^4445_@(?
MW4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^37_ ,%&_P#E
M(7^WA_V>9^U!_P"KO\<5\9U]F?\ !1O_ )2%_MX?]GF?M0?^KO\ '%?&=?\
M23P3_P D9PC_ -DQD'_JJPA_GCG/_(XS7_L98[_U*JA1117TYYH4444 %%%%
M !7]$W_!L)_RDLO?^S<?BI_Z?O %?SLU_1-_P;"?\I++W_LW'XJ?^G[P!7XG
M])#_ ),3XJ?]D?FG_I$3[3PZ_P"2XX9_[&E'_P!)F?Z'5%%%?\_9_=@4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'PO_P %//\ E'+^W1_V:?\
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MC/QY_P"SL/$7_JH/@]7]0%?X$?2?_P"3^^*'_91R_P#4'!G]T^&__)#<-?\
M8NC_ .G:H4445^#'VX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P &JG_*0OXQ_P#9F?Q"_P#5W_L[U^%?2:_Y,)XH_P#9,5__ %)PQ]MX<?\
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MK_PXLOAG:PPLR2RR_%KQ;X<^&DK K/;YBM++Q3=W]TK2%9+2TG0P76[[)/\
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M37-4B[<R37]*5%%%?XC']DA1110 4444 %%%% !1110 4444 %%%% !1110
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MY+GAK_L90_\ 3=0_O\HHHK_ 0_NH**** "BBB@ HHHH **** "BBB@ HHHH
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MO_(YR#_L68C_ -2F%%%%?Z&GX$%%%% !1110 4444 ?WP?\ !J9_R8S\>?\
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M_)\WC)2>.P&'K5;;1Q/(H8JGLE>EB85:;LDFX.VE@HHHK\]/<"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ K_*__ ."NWQ[/[2'_  4>_:P^(UM=75SH=E\3]1^&_A;S
M[EI[=?#7PDM;3X9Z;<Z9'YLL5IIVMGPM/XDCMX/*5[C6KF[FB2\NKDG_ $>O
M^"@G[2%O^R3^Q?\ M&?'\WUC8ZSX#^&>OOX+-_<&V@N_B)KT(\-_#VP#+^^E
M>\\9:OHD1A@_?/&9"K1!6EC_ ,F6O]+?V>7!<IX[C[Q#Q%)J&'PV"X.RNJXW
MC4J8JI2SG.XQDVE&="&%R+:,G*.*DN:"3C4_G;Q\SA1PV1Y!3DG*M6K9MBHI
MM.,*$)83!W5O>C5E6QC^)6E0B^5MIQ****_U#/YH"BBB@ HHHH **** /LO_
M ()W?"&Y^/'[=?[)?PJALXK^U\3_ !Z^'$FO6LX)B?PAX?\ $=EXG\;.R"*8
M2&#PAHNMSK$\?E2O$L<KQ1,\B?ZRM?YY?_!L=\"S\2_^"B%U\5+_ $B2[T7]
MGCX0>-/%UKJK2LMIIWC;QPMM\-/#]K+ DZ?:;F^\->)O'EY9I/;W-I VCRWG
M[C4+?3I1_H:5_CY]/[B>&:>*V0<-4:BG2X5X3P\L3"\6Z.9Y[C,1C:\&HSE9
M2RRCDU5*<:<_WC?*Z;ISE_6O@7ELL+PKC,PG%J6:9K6E2=I)2PV#I4L/!J\4
MFUB?KD6XN4=$N934XQ****_A(_:PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /A?_@IY_RCE_;H_P"S3_CU_P"JU\15_E#U_J\?\%//^4<O[='_
M &:?\>O_ %6OB*O\H>O]8_V>'_)#^(7_ &5>7_\ JHIG\N>/O_(YR#_L68C_
M -2F%%%%?Z&GX$%%%% !1110 4444 ?WP?\ !J9_R8S\>?\ L[#Q%_ZJ#X/5
M_4!7\O\ _P &IG_)C/QY_P"SL/$7_JH/@]7]0%?X$?2?_P"3^^*'_91R_P#4
M'!G]T^&__)#<-?\ 8NC_ .G:H4445^#'VX4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*.7_ *@X,_NGPW_Y(;AK_L71_P#3M4****_!C[<**** "BBB@ HHHH ****
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M=?B__P#,=1_PP7^W-_T9A^UA_P"(Z_%__P"8ZO\ 6PHKJ_XJ(\7?]&WX<_\
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M ,/.9_\ S.?$?\0!RG_HH<Q_\),-_P#)'^2?_P ,%_MS?]&8?M8?^(Z_%_\
M^8ZC_A@O]N;_ *,P_:P_\1U^+_\ \QU?ZV%%'_%1'B[_ *-OPY_X><S_ /F<
M/^( Y3_T4.8_^$F&_P#DC_)/_P"&"_VYO^C,/VL/_$=?B_\ _,=1_P ,%_MS
M?]&8?M8?^(Z_%_\ ^8ZO];"BC_BHCQ=_T;?AS_P\YG_\SA_Q '*?^BAS'_PD
MPW_R1_DG_P##!?[<W_1F'[6'_B.OQ?\ _F.H_P"&"_VYO^C,/VL/_$=?B_\
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M]*/PTZ%"G&E2@NMHPC%7>KM=NX4445Y9T!1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[BST_P *>.X]!U+7I8+6&:Y>;PVFLV1MX9YH[N2."9H_\K"BOY X]^@QX/\
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M46TFTV>Y0XGX:Q2;PW$.1XA1:4O8YM@*O*W=I2Y*\N5M)M)V;L?I/17YZ_\
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M?Y+G]1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_BAF3AE471P?"'%6-J+V>51;C2HY%G=>=G#+(MJ.79G6FX9;&V#Q<HY>J%7
M_P _>*?A?4S&=7B3AO#1>-:G5S7+:46IXQI.3QF$@M)8MI6KX>,5+%-^UIWQ
M'/&O_#=15J^L;W2[V\TS4[.ZT[4M.NKBQU#3[ZWFM+VQO;29[>[L[RTN$CGM
M;JUGCD@N+>>-)H9D>.1%=645:_U/C*,HQE&2E&24HRBTXRBU=2BU=-----.S
M6J/YA::;3333:::LTUHTT]4T]&GL%%%%,04444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME*K"5.I3G%VE&<)I2C)/1QDDT]T%%%%;$!1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
$% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>ny20053122x2_first-nvidia.jpg
<TEXT>
begin 644 ny20053122x2_first-nvidia.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M68]C>$MM1,$E@3-$/ER3SE@01QP02,G//-7)=:\X[A82<ECMV.Q7G:?X5(R
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MSV/Z5]+_ +0NH6&I67P[DTU;Q;>+PCHT8CNUC$L;-:K.(U=(HO-$>X122M&
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MH_&3XO6ES-9W'P>^$5K<QB,R11Z#X2NFB$J!U#/:64D>[DJ02,,K#L<<]/\
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M3H^SIPY8PC)\D4FU+W7TW25UK='4>)%5KRS8'KHFB_-ZYT^'@<]ON\\_GFL
MIM0G.=WMZ'_Z]=GXW^QMK:-IZ".Q?3;%K6(,9#';K"$@7><,P154!F 8@ N
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MX/\ AKQ5J^E%6>8+%;W6H6,OF2_:&66VNO.EM0H201%3LS(XW UVEA\>/@+
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M.&/??RLLLD,">9&$\R1H@(VE("*7"*XP 3DURRJQ(VAP>N N. .2 HZ8')X
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ME>*LY1:M*UU'9N_2Z;1\+>-_ U_X.N4+F6[TF0[;;4HY&56& WE74;J?LEP
M2%CD*"4\1N^UMO0Z'\,+*^T>RUG5M;_LR"^M_M4:^7"7=)0Q C\T1F8A07W?
M+N P"S8)^H=1TNSU"VEL;ZWANK2]C\JYMIUS%)"P)VQ[</%+D;HI8RK0R!9"
M?E7/C^K^$+C25M5L'N+_ $N&..U@5OWUY:8P8X98P  B* (I8XQ$R_>*RG8?
MSZAX>Y7@LRQN+KX+^U,NJTN7#X.O*5)X3$N2=62JTVJDJ7Q1BI-.-K7:2O\
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MP?)6J.-W&%*2BYWLK*26MK?(%G^Q)XLOB5B\:>'  2N^6RU18SZ$LT("YP2
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M25DY4ZSE..NL+.+=GNDSE_$7[+WPXT2VC@T_5]*US7KM(H])T.RU:[GO;O.
M9WCM=2E:&QME#/-=21)$J)D,[.%7O/#/[#&F:S86K,D,NJS(7N+2T77[E8P0
M-L8,%ZF68GC)7 &<D=?8O!/PKUGPK);SW_B/PU?^0GE*6M;TW,$9+,4MIYCP
MCL0TB$%250[<\U[MI?BI?#KJZW\=Q)'_ ,^[,I+* N%#*5 )((^3 Z8 -?6+
MA'AQKF619:IR2=I8:+L]-[*S5];];J_<\:MG>:4Z<H4LRQ%=QYFJSDTZB=Y)
M**<E%I-12WYE=N^AX%I__!+;QOJD$5SIW@;5KN&12Z/'9ZKM9,\/ON-<4+TS
M\Q0C'3!%<YXJ_P"";OC+PI;//<?#S5)FC+>8K^?;! %W=9==8GGCA3G/!P17
MZ!Z+^UO?>'K)K2[T[7;U8HO+@%IXAMM.56[&4'1;MY$.,[%=&P/O\FO*O%W[
M5VIWQNI)=-OG@DF8-#<>(-_\ *KDZ5#$$S@.Q!<IN*[GP#ST>&:2KN$\AR2.
M&@TTXX./,U[MVFJJ=TD[^ZM5H6\[S7V-)TJV+G6E%R476BXRE%)QIRTYE[26
MB;ES;ZI:'P)HG['NGS^(+.R\6Z+)X3T.WD2ZUB^>>>ZNFL;=A)-;V,/VMP;B
MX7]R9798H RR$O@K7(?&G3?V>9?%*:3\/?A58^#/#6@PBUFUB35=>U;4/$UT
M@\IY[A]1U>^CAV20R-));06:W$\DCQ0+!'&J9OQM_;8\:Z_J.J>'/ D=KH'A
M]9I+?4;V55U&^U>XMV*D1//!#;65FDP=(5CM/M$L85I) 3BO%/".O'QQ#?GQ
M#J%IHJZ;':BXO3&?WOV@S#<4DF4+M,2XV93+@<%N?CI\0\$8O.:N0Y1@L!+.
M:4YQE2JX*G3P4^1251.O4BXMQE&5KMZ+W6[N_P!AEV79W##+,<\Q$Z%-PA*G
M2H5%.K'F:Y6X1:;=FDH/F=_BLTK-BTOP!<WWV.UTRS:>5BL$1AN '*#<R*X<
MKN2,>8Y) V@]#Q7&^)].T;4+BS\/^%-(#^(&U/[-);VUK*7D*JRF,22R!,"1
M@Q89 17D;A?F[R#PWH<6JPS:/XE75+WS)/+@ M\.KI)&TKK'+(^Y%"$*%9\,
M"P R!JZ=>Z=X2O=2:S2";Q'XBNI8CJ\\\;MIEE-(B74-@-JR>=,R%9)LAE5M
MF,9)\W%Y30Q%&M1Q>'RO 4%4O7Q>%H4&Z<7[JIT7"-Y3G4:IQ2U5U*2LKGMR
MQ3IPC.@\17;5/E]I&49)))<[C)7Y5=.6STTT32^2?$=A-IFHZAI]VJBZL;EK
M.X"E67SK:5HI"K)E64LI*LI92/F!8$&I?"EY#INJVU_/8VVHQVC><;*\!-K<
M?*P$<ZC.] 2&*,"K$?,".GW/\+/V#/BG^T#?:IKS?$;]G;X2^';J^O;E-<^-
MGQ\^'7@&::&2[D"SKX<O-:O_ !DR$$&)V\/1),"K0!UYJ#XR?L3:5\$(F%K^
MU'^SK\8M;C>.*Y\-_![5_B!XE>,N""P\3WOP\TOP6_E!,O\ 9O$,\JEP#;L&
M++_-5/(<TJ\15H9?A:[]CCJDHRMS2A"-67)SMQ<.;ELFFE=OX=CZ>..PU3!*
ME4JVG4I0C-I?;<8*7*D]KWVMY=6OC.:Y-Q<W5Y/'&TEP[W'V>&.&*VC? 8+'
M!'&B)&BJ0D6"J';@_*,]9I%I?:E"'MDM$ D:)OM%Q:PME0/F*%/E3! !)(R#
MS6_:_#*\FW*89S@E2#J%F!DC(SBS<@XY (R"=O!/'?:+\*[W3[22YDAT];54
MDDEGO=0LICS") Q>73)&V[4.W:-GF956WOMK]@X?X1XCGBY/&8;GPMW4K2G"
MG-R<MY*7+9)))6Y;IJ5FG<\NOCL'AU!.O2A*T84XS]JKI):7A3G#5MVO)O=6
M2LVG@#09?[6U$:A%I4T,>@:Q(@66TU$&5;4F.1%,10.AY#!MR\X()S5/6;>$
M:9J+I'$C_P!FWVTK'!&_$$Y^7(RNU\LI"_Q%1ZUN>'1I>F:A-(ES:0Q2Z9JU
MENA:-GEDDA5(TA"Z;;@^;*ZQX4,QW '')'UQ\(_@!)J4EIKWC.U40E1-9Z#>
MIB.56!DCFOXWCVO"X.TVC(4D1OWJ@<G[ZK@L%2RJC1C'#TY\^+C)QH4^>/,E
M3B](<R3IOE225_B3;?,OF\9FBR[$8K$5IMITL-[&DYW=1N+G*,6WUDU+F>D5
MHWI9_+WP%_9GUSXA36'B+Q8EUIOA;>CV]J/-COM:1@Q5H_W:^18NVW-P[*TB
M;]B[>:_1#Q/X1\-^'](\&V]O:Z<UWH?C;0)=.TN"T65+/3K:RUAKN4NJI!CS
M8;:.621F9MV\L) 2?2+[4-/\-VK6EJD<+P8C-R@A,$<($)06RQ!P$=0R_-*6
M"QA60#;7SYXK\32ZM>2"W-Q) K* 24>1I-S*'2!$9E B;:!N 9&VDC) ]?@_
MA/"4:4*>&HQH4E#GK8B4G[6K-N,Y/VCY5"GS7Y8JR2=DM[_C7$_%.,Q>)C6G
M-N6L*6&BTZ5*,DHKW;7<VM92:2O:]E:T?COQ7;7=Y=Z>BPW<LK/!)*7W6]H&
MN#)*Z$F-)I_W4:!@NQ .!_>\8E@E9I;J\=W##*Q-D23HREO-D(1$M;1  7N'
M**R_- &0B0=#=R6NGQ'4=1G2WA@&!YTJR+;C=(S-(K[I;JXWL,1KNA+.26.T
M8^=?&/C2XUF2[MK'S+/3V;+C)%Q>.D;8>[D1V4QL579 -P((+R,PY]+.,XPN
M7QJ83+U&M.C=U)]ZL4FXN]^96O[R_%HVX=X:Q^=3A4J4O9X5V<JTDW*_-'G4
M=-[\RN]/Y6M+5/B#\6;32 VGZ5-'=7SQO;>?;K$8X5VC?%8))((P=H"/?S@M
M* =AD<\_*L]_/J^LP7-X4>34=2ADN6*@*SRS*)'90HR74[7 VJP& HW;3%>6
M^HW-VTK6]U,S.Q,@@G(VAV&W<R@;5Z  D8^F#-::9J!O]/?^S[H)'>6Y9C:R
MA%43QG+,4P% !YR.!^%?RQQ#G^=\0YG35;#XNEA*6*A&"HT9*+Y:L5SR:24D
M[:WC9QT:=FW_ $3D^1X#)\-&.'A!S=-*K6G*+EI%7::=_=NK:7]=CW2V?3/M
M<RV=LMJMN\\$@^Q"VWA,':I7RY)(R& #AP20>PJS<KI]RB_:;:.[\L[TCGA6
M1$[L$$F]U5@,%0^>X/!S$1YER!N3&USDX89+Q9PPSC@G/'.3W)JP5BB ;S 2
M-Q*GT*GK@8/0>Q/8]*_=*-%2HT8584W3Y:35)TX0I74(-M4X)6F[ISWO:^FI
MBU:<HIW7).SZ;==UIU_+0[^P2./3;5(E"1I:1JB*,*JB, *H[*!PH[# KYL\
M='=XHU5NF+EEQU[+SGCT_6OI:T=!IT(SEC:@K\K9 *[5 R.,' 'I].:^9O&O
M/B?4_1KEC]?N#)_7K7S_ (D13X<H))+_ &FE9)62M3T271*]DK:+T.'*';$5
M/.^VVLDOU.4K[4_X)J#;_P %%_V!QG/_ !FG^RP?_,Z>!:^+"RF3:,9! (Q[
M#VQ7VO\ \$UL?\/&?V!QC_F]/]EOMZ?'+P*?R'Z5^ T;N4=/LS:7K3E^A]1:
MUO/D?_D\3_70HHHKY,[C_$V;(+'/WF;VY0X Y/?//^&:W+:,1VQ)&UG].K\X
MX^F3GCV.*O7NF0 [E&TE\*?5E9=W0<9Y]\8]:9(GEG:!D(&!_+I[_A^E?<\&
M8%^TQ&/FK)06'HN2MS2D_P!ZXM]4DHRWMIJCSLPJQ48TE=RO[]GI=='O:][V
MZ?.Y#&,A6(&,[1UR.GX9]?Y<U(Y+$9Z],X]\?T%)P %4\MR >,ENW/3UQSU[
MGI'O4,002!D;?7@@@'/J>"?QK]#<.6GR1CRW^)*[NW97:UV5WIT/,3;=E=K1
M+7;9==4NGE=M;%JVMYKJ6.& !I)'VI&75/,8CA=[#:,^C,@.,!LG%4@6V[U5
M=I;8S!<'.[(SQDX49)SG(Y.,Y]%\&:-%?1WEQ>V[R60B6!]C ;&=D,C*W42Q
MK@1]1O.,\UPNI6UNMU>V]I<3+;QW,J0/,4??&K*H#.H!W;MZQR8 \O /+9KR
ML\P52.78.M&2:KQK-4G)J2E!KHFFW=]6UUMJV9X7&TYXROAJ?,YT'&-:32Y(
M-O2-[/WO*ZV;VU,J2X.YEB?Y4.'<$/@\$[5^\0 >OKGFKME?A>'+H[<;^A'<
M$9Z$G Z$_C6(\$MO(4=&4;OE(SM9>.C<9S^7:G@@G&,_7'YXSG/IQUX-?E%6
MMBX5)PK.=*3;7LYQM[K=EHULXVMNW=MMH^EA&G."LXN5E9JV]TKKE=NEE?9[
MO0^Q_@A^T7XN^%FLV5U8ZG<FUBECVHLFP(BL'VY+ =0.,9 P.M?II^VM_P %
M7_'/[1W[(W@;]FW57TSQ-I]MK]CXFU+7=5A\WQ#ID>@64NGZ-HEK?E$;[,L]
M]>7=PCF0L$MX49(/,C?\$[:\EMV4;RZ\ (1D GW[X&!W]<9KJI5=;6U5B$,B
MB5HP/F*RD/VX +JIP,\9Z"OH>#LBPF+S98^O3:_L]*LH*ZC6G5:2A))ZOW>9
M*^EF[,XL>I4J2CSOWWJE9<R5M_2_3J[=4=5K>TV?ASC[V@1') !&;F[^50"0
M%7&U0.BA1QC%<NWKW/\ @I_K73ZN"-.\*$]?[$96]25OKT$>XRX SZ$GWYW!
M"JIZAB?U'K]#7[OBD_;R<W>:H8*7/WE+#Q;:V^)V:>VFFZ/*H).D[ZVJ5''R
M49I+U]?D:_A,?\59I_M!/T[X28?R%>D_$9L^ M>C[F73V![96[A ^A_>'GGI
MQBO-O#9 \6Z:>GF0RA1[ON"YQQU# ^F?>O0OB&&'@S6DXPYLA[96]B!_'TZ?
M7TY^?EX8XE@Y7<L+C-.\Y8:#;MKK=MM+KV/(Q\K9GEBMO7PZ;OT]NK7T=]?Q
MW9\MH.<@8*XYY[Y!S_D<ULZ?*4N(6CD92KY!&,JX'#J<;@R]N?<@BL%#@*0>
MP_4?X5?L&/VI&;.!GT_E^=?S%AY.G6HU%+E<90<9+1QDK-6?7575GUV9]]I.
M\9I---:V:ULK6?Z'T]\(?B;/X0\1Z?JC:A>6=S:W,4\5R@,R;K=UE5"K$ ;F
M0-O!!&W"XR:_KS_8*_X+26=WIFG?#7X[?'6_^$W@SPCX86?1O%D7@X^+;B^N
M+&6VLK+1)+"QTW4+Z2![1IY1)/(X:2WV[-I)/\3,$K1%&7)"D]" <LK+DDY!
M !SQUR.F.=ZQ\1ZE9.J17EQ&J1J$,<SQR(ZMN1N/E."20>#@GGK7Z!BL3DF?
M8:E0SNEB9XF$.7#YC#$U(U:.S<9VG>2DTM)*S5_>V/FZF!S#!5UB,OG%P_Y>
MX><DXS?NM733?NI/5<MGH[G]4O\ P45\=?L!_'%O&OQ2\._\%";CQC\3K^%]
M=A\+:U\!O&NEV6OW$5F?(L[;5M#TIX+.XN7@CMQ(]@EI%)L%T;9-\H_$/0?$
MD,\*137<=S;39ABOE >*$JN!:W 0.5?I'*K>4\#!GD(4;1\':EK6H3S)<"1G
MD=2GG AGCWMMD>($9BG/:9.4SN4$U-X9\8ZMX6OGGMY3<VLKL;S3KF5F@N23
MG>7<AX[AOF+2J07<ELC)%??^'WB%F/!E;#Y7F%;Z]D?NPPU3V3@L/1NN6/-R
MIN.LG*,];^\I-61\GG_"&"SUO&T:/U3'3;=6"J\_M)NS<^5.5I<R2:B[+9J^
MA]Y7]FJ2H8 CE,;8D^<$88B>*12 \<@.?5-O)R0:YAVDB&X8221&+,J%L#;N
M.X*&:1-WSE,'(XZ'-8OA#QOI?B#3XI[.X9X-K(UL7 U#2I?X@RJ%18U8MYCJ
M/*D780^]6)ZF00NF[",%8E77D$-N"DC&<$GH1D=QGFOZ0G5RS.\-3S7*ZM-Q
MJP51QA*+C)M*,FDF]4T_1WTZ'Y#CLHQ66UW3?UB#BVVFI0F_925Y1;5XI)7N
MGRR3NXM,^;/BKX1\0EF\1V5_=:KI<";+FR*K)<Z2B)L'SQIBYL8VR!+*5N8$
M*QR1N KGP>\OKJ[2&*XN9KB/3XWMK-97+);0O++<O#"@(5$:>:60C!(9\*0H
M K[^*&-?F4%9%E5B"!#+YB^64E'\<95WS@!B2>>,U\V?$3X9/;&[U_P[$&M6
M=IK[2HD+R6^X[I+FU(ZVX;K",R1+D+NC.:_FWQ'\/<7&KBL_RM2J^VDZN88?
MWI34TDU6HI-RDK*3FE[JM&R25C]8X+XRA*E1RG-.6E*FE#"8F32O'1*G4DTH
MMIVM>\I-N[OJ>'P2(,H^%\Q#\Y((4."IRH^88 R">,^O0ZD-[<:=>V&H0>6[
MV5[;WL+ADEA,ELZ2QB8$A5RT2[E8YP3CG;6&,$]A@_-P1T)7;R!D@CZ<=NVB
ML1&ER3CH-0A0$<??MYW4]>IVD^QZ5^/X?-)T\#6P'LT[\DI5&I1J)*2<%*.T
M;.+M?ST>Q^ESPT)U(5I2E:;<'!-.-[0M)-):-6TTM;<_7O\ 9O\ VK_^"5/A
M3PG#HWQ__P""8M_\3?%T5K*+OQMIW[3/Q5LFUB[6-G<#0+'4-&L=)5\-LCM]
MZJH"L99=TC^.?%?X\?L2^,_B"TO[/'[,GBS]EKP[JUJ^DS7-U\9?$'Q-M+:6
M21I;*^:Q\3Z?/?6 6=8ENY/^$ANH!;!XDLT#R3#\[[6SM[C3KNZD5_M-M-"(
MV#(49&WEQ(IB+LV6(!\SH>,4S3[1;^\M[']Z?M,C1+''@%V,4KJH!R"S-&F!
MQWR1P:^LR+,\?D68Y5F^'HTIXNI#VE%IR;E335.4;0MR2DGRSY%%I^>IYV(P
M&'Q*K87VM6"A%Z2^!.Z=[2T:NO=YN9:);,^H_&'Q"\1_#?3KKPZNL)>^*+B6
M9(-1LI8)88M%O+6%K;4%\F)XV:\MKEOLJM'YL61*I*A,?*:Y)617D>25IA)&
MOG&16+#AI&VB5YBXRL<;?-SP>:JN;F3>TKW$LBM%"WG/YC8@_=QP@DY7R@-@
M5V&< *"!7LWPK\%IJE]'X@U*/.GV,F;& LR?:KM< 3MLW Q6S98 @;Y J\C.
M/I,5F^>>)G%6$RZ\Z5*DZ=*GAZE6I*&"P-.I!8C$S<[..)57E7--\TX.-[MI
MG+2PF&R/ U:L*<(SDIR=2G&$95IVC*-.R5OB?PI?"[;;_HO\!M+\2:?\+_"U
MGXB)6^CMYS%:SR#SK73IKF6?3HKD3,$:1()$PD@$L*/$G!4BOH33K34&=0KQ
M>81\OF3VYCV=ES)<-",'/50<=QTKY"\/:L&D*7&LZ_$I V&+6+N,9QSO E'9
M1]T*#C &.!ZUIU_;E5V>(/$3# (W:W?D<@=EFQT]\\GC %?V5@\#]3P.%PD:
MLZL,-AZ5"-2I)SE-4H1@I3GS7;E;7OV2T/Q7,YU:V-KUYT:=/V]3VBA&E"+5
MTHWG%K2;E&5]M+/S?UMHNC>)+EH_(%C*6; ,VI:3;Y'N\MUYAZ?=#X/4#@8]
M!@T[5K$_Z9!91.HVLUOJNDW(QVVJMX6+#O@Y)R!C-?&,.MK H:/6]<&<LI77
M-18Y7G)!G7OW//7CDFJ=]X]N[8,O]L:TV$+9.LWWS*25P0+@CJ><8XSQS5NA
M5E+24;/[/)*ZNXK7W[6LWO'I>]M_"JY=[5)<_*T[W6CMM;6^GETZ6UO]O76H
M642@W5U;I*I1-LCAI#D@<J)954@<Y#=<>]<=>^)=&@=O,OHD&YAM*OM 4GAB
MAQ@CD[5R<XP3FO@S5/BEJ<+%8Y]1<#/SMJ5XQS@D<232 8SD' .?;BN(O_B3
MK\Y(AOK^(\X_TZX8 GISNY[=/?KWF5.%"RJ5(Q3Z*232TOMJE;IUO;4UP7#4
MJMZO-=-QC>ZD])1^*3ULK6\E\F?H+>>,_#2%"=3M5 ?>[ RY54(<A08RQ;"E
MB5(*@-R"1C\M/B7J?B6Y^)5IIWB74[S7]*TOQU_;.@7CO--9)H=S?6[D6T@9
MG+^3#&MS&WE20F+:6+!B=V[\8^(I59GU*^D)Z9O9 0"""/F27J#@XQP<'=GC
ME;KQ+K,F=]]=97N98W*$GG:6M\]3U/)&2>QKP<V>!Q,*=*>)Q5.,*D:C]G?E
MJ.#4N2325T]'HU;>Q]ID635<!5=2,*595(2AS5$GR*3LY1U:3Z=+Z*^K9^B]
M[\1/"C$;-;TPH-[+MEC0!9%&!M:0N&"\N6)9GR6)S7(7OCWPW.KQKK.GG(QC
MSU(_+S". >!@CTZ5\ 2ZYK#JY_M.\ '/^N0=!@'_ %'U_P \5CR>(=65\_VA
M>-[;XCU[D&#''<D@_P!:EQ)EE*T7'$\\$D^6#:;C&.MUWZMWUW(P_!U?GE)U
M*3C*HZD4W&+BI3<K*\M+:VWZ6M<^\+OQ;X?D9V&L6*ACT69,$@ 9(W$8P!SQ
MQ^O/W'BOPY&'<:Q9,P)91YR'<1G*C 8$E"VTL0 P#;LBOB@ZWKS?,-1E(QQN
M:,-^2Q =>G J)]<UQ]H;5+EU#*Q4B! P!Y5MMN20PRI'H36+XLP*:2I5W?1I
MPU^S>RMKKIT>G>QZ4>%*JMSUH126G*X.Z5NO2VEGK?3565^>_:._LRZ\;0SZ
M596UJ%LV@FNK;R(H-4\MTF@O%$/R'*3RI]I^9I638[%]P/B.@Z8UWK6D0>>B
M">\MU=[>XVRQAF8':R'<I&, C'3 KU3Q]>S7FA1I=I#++:26EO;W!BA-Q';"
M>1XK<2^0',09W<@G<)!N!Q@#A/ UJ9_$-I.68/IP-XB#E92I\H(Y)RH+2@Y
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MWOH[-'T8?%7@X?\ ,8 ^MM>+^C6Y)^O3]:SYO%OA4[EM]2\SCJ\5RJ@'@_\
M+ ]N1GKP.:\ ^S:KD*='U%3C_GE)C'X1?7ZX]J?Y-T7$4-C-<79"E[(*#/"I
M4L7=!ER.F<J,9'&:YWXAQKJ34,)3]FKR_P!EQ%-M2M\*KRM)Z;0UWONBWEZI
M2A>KB)<TDO?Y9)-<O\L86ON[WOHK=_?[?Q5X7CC^;5!D*I"K;WLB#Y@2.+<+
MDE1D8R>YZ58'B_PEC:=590>F^SNU!.>Q:(@E3\Q7'(5N17SY]BUD':VAWR-C
M) 3:,>O*<_7V]J<+;5LK_P 234=P,A*MDA5()W?\>Z@  <G/?C'6B/B&H)\M
M&C=I<LOJ.+C>UG>-1MT=?YDW#;>^C677G%\TDN>#O;M.+_FO;IMMK;1H]Q^,
M%U!>>$/ UQ:R^;;26LKPR%64NAO[M,D.%89 _N@^IQ@GYXKVGQJS2?#3X=M*
MA1A:7B[,Y*%=7U 8)PI[<\$=!SUKQ:OG^/<3]<SV&*L_W^69=6;Y7%7GAXMJ
M*;;LFM%T32\WY^10E3RZ--[4\5F-.+Y5%M4<RQE!-VO>\:49_P#;UNEWKZ#-
M%;:UIMS*<107,,LV1N_=1N)),+C+90$;1R1TYZZVM:?X1>6\NM"U^XC\V*>:
M'3KC1KF1?.9GD6WBN$FW()#M13)&1&3E\ @'G]/#-?1*JEV92JHH)9F:*0*
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MM#96UUX4U6QOK+5=9T#2?$-HTUI(9H8X?#WB+3]2TF[L%F(E/]KV-RER0!+
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MZ[W9@ZT(8G#TI6YJK?*M&VU=]4]%9V;:[)K1/BHHQ(L<2* 713,0H !!)V@
M8)ZG@ @#@#)JS+9Q. I49  !Y4\8ZX((/'(/?K67-,\$;2(2"BEB <9P0,?K
M4]KJZ,"DV,G ).<Y&.<]<G';KR..!7XABI_O6W)WE9MZWE[JLV]W;6U]CZ*C
M&*A!624;J.BM'WGHELEIZ?F59[*1"22'7&<*/WBKD_<'W6)/9LGMSG(I^6<D
MQAI"IR-I.1R1@Q]3_P"@\@<\"NJ'ESJ2F#A202< \]LX.>>^,5#:Z:DVH6J
M["TH=W0J B1AI78ACM;A-NWOGH2,&L#"KBL5A\+15ZV(JQI4Y:NS;3D]59*,
M=6VEMU=KE62A"I4E%-0O>UM=+V3]/,YH3RH<$;U8,VTX  &0V&QP%P1D$ '/
M Y-6HP[1>9&K8 R$8L&SG_EF<X;CD%<MCI@9QWE[8:<FJ3/=644,T-P #;*8
M87E#>9%/) \;6L_RG#J0IY()R :JG3[+9YT<$LQ0 AH;N3>#D$$Q[.%X(..Y
M&:_2*/ ^+BYQQF-A6I4ZW[NFE459*/)[.LYR2TNY)QYF]+M+0\_ZY'7DI-)[
M\R@_-6N_ZT.B9WD\+>#PV24M]74;ASD:K=/L/&25)Z$D@8'2LA@W0J!@D\#N
M>N>M=5J;D^'_  HY38L5KJ-NJ'YI"D5V=KR/@;IGW N^!QQBN9<MAB%SG/0]
M,_A[_P#ZJ_4*M#ZNL-AW+F=/+<MIN?\ ,Z6"H0YM=7=IO5WW>EV>90NXU7U>
M)Q$GJG\=9RNWW:=]'\@T=V7Q5H04XRS9X!_Y:8[@]J];\?K_ ,4EK8& !:9/
M&>MW!R<_X]_>O)-&&?%?A\GO(01]9!W_ /K5[3\0HO\ BD=?(YSIX[]/])1N
M^>/D]O6N>$5+(N*E9?[IB/\ U&C^2M_PZ/&S&:AF^4-O_E]3T>S;JM1TVOS6
MMVW/CC]:$_UR>@_3(/7]* , #TX_*E0;9 WTX_+O7\MP?5ZVEU[JQ^B6O)=+
M).WSV_X)V,;OA%8DYYS]W+#I@@ 'CMQ[CI52XC>>Y4+L9MT:@R2B%0?E #2R
M$1@ D$\Y .35:&60-$)'!"'))&,GKQDD#.#D_P J_0OX/?LX_#WXU_L\3:O;
MZ@="^)VE>,/$5O;:DAC>WO=/2RT2YLK74;9_WC[));GR;F!DEBP% 8  [8C$
MQH4O:3ERPBXIR?,[*UM%%-Z/78JHU'1V5[;=[JR72[U\M--$?GS?V,]I>7%L
MZK(L-S<0M-#(L\;O!*82RR0YC9'8;D96(;<,9!%9Q.-X!^7<OT^[G_Z]>N:S
MX'UCP#XZ@T#QAI^H+='4H0SP72O;ZI#)= N8+AX D\#B1/-CE4.K(5V@_-7E
M%YY'GW'V99$@,C&))'C=T4#&TM$D<9 .0H5!M4!6+,"Q(S4XPJ4I\T9:IQEH
MXZ=GIWL]7>]B+*376S3Y;:):7[+?LM2-"=Z#/&[^A-2-R#G/0G@9.>Q ^N*B
M3_61_P"]_P"RM4H.<]L''KT_QK9-N*LW%:ZZZ7Y=;=;7(FD[NRVOLNWH58[4
M7%V8+=9I92C2*J': 8XP[9QR2IR1_=X( /->G^%/%.IZ9M2_2[>TA"*+N+=+
M):KNQMESA)H,G +EY@2=QQ@5YQ;M)97BW<3#<%D7:1QB1=IZ'T_3C'>KK:W=
M-!+:L5,,J[&0+P1N!).6.6^7 8C(SG/K])PUF>$RBJL8\5C:&*A*2=&E3@J-
M6.G(JLHR?NW3?NKFLW=:)G!C\)#'+DG"$H2IJ/,XQ;C=6=KZK1]-=.O3["TK
M6(KZV69'&9(PZ,O,4L>3AD8HI/.0V"6!R"W&!#>W<<0/D;@;AWDE17;/FRG>
MQ4$L0"R@@@X5@I7:<5\T>%O&=[H%RA*?:--9U>6Q4Y9=I8AK4G)MW4-C<N0Y
MSN4@ 5[YY]EX@TY-8\/S-=0")6EC "S6TQ3+1S1$EXF0DKM(*MM+(Q ./WSA
MSBK!\3X5J,XTLPH0;GAYSY9RBK*4X)V]IS6^!-MIN\;'YYB^&X8#%^_&4\-5
ME=54TX*;<96G%R34EOS.*3ULW9I\1XE\-6>M.]XB)'J(&-[[BEWP$5;E59,E
M2!MEWB17^:42(*\<GT]()S;7,0MY8Y-DD3#$B\L,L1A2K8!5E &.I)Y/T#9W
M G9XY&4RIN8C!QN!).1P2..5QR01FJ>M>&8-=AC1F\FZCCV6]VFV,A5)8PR+
MC]] =PW>8Q<<!7 R*\O-^%<)C7/'8?!8?Z^])TZU&FU4<4M;2CRW>J=WKL^Y
M]!AL54PRC1<ZB@E&TE.3Y8I122MJE;2T='JK6V\(%O:+&R"%3*&W"4,Y+9."
MN,@ 8R<CGT-3:Y96$,=K_9D44TK22"8JTK,D:!MBLCM&AYVA6#L6'!;D9[ZX
M^'%Q%]FW:BI%S=BT(^RI@%D+*^1(,J6&P #)///2L7Q-X77PS::;<K?+>IJ,
MC1A5M7MFB90=VX2,6;#AE^XH( 920<#XW'Y!CL-EF/KXW*L+A<-1IP=3%4Z.
M&4J,>>$7*"I7GJY+6";6B6NWHT<4I3@J=>4Y2DU%.52TFK73;M96[Z[GG!AN
ME8$0Y4XPI0 ],C[TI [9!)XXYSBKMG ZSJ]U8LT+'$AC4+*F<C>C))\Q&.AR
M!U(QBIH[^ JK&.4L><*5RN1DX)!SUP<CD=L5-_:41&&CG/8$C)QG..!C^OZ5
M\E@L!D%-PJU<VE>-_P!T\/5JQE)2Y6I2E34K\R<6F[-*^M[GI5)XR=H1HN,E
M%KFC.G%O_MY3OILK[ZHAOM/,;H]JS2V\G/S9RN,<,!D@=1D]P.1WS4@F82,(
MI#C<%VG  !.6 ,JD#URO0'!K2FO]P41C: ,%20<_7 [8S]:JI<OYF]CA?+*L
M%XXW9R!G' /3N0/F%<&-AD=?'M4'5I8><U><(-QA"R5XTGR-7=M%%M+IJ:TG
MB(4_WMI225E>[;5KW:;5K)NY"+>8#_4L2>H?&/PP[_J!GKV%6[.%'N +V*3R
M"I4F/'RNH^0OE';8IR6*J202#N'%2BYBQ\PE7_>VC]5<YZ=_PI?M47]V0CH2
M%R".G7.">V>O:NE8+)</.%2&85*RIRC)4JE"+C46GNOG@DE)-KIZKKG*IB)I
MWI<N_*[QTT5MGN]VM-GL0ZAIYAE 14FA;)B;._C@L,@* <%0?E7GL:I&WE X
MMV('0")MA].B@$=QZ\5?:Z0[1^](&<;E)V]/<]<5)]N0+M,<W  X1>WN9 >W
M<#Z5Q8C#9=5JRG2Q"IJ4^90CS<L$^6T8QBK1LNUD^G1E0G6A"*<(2:^)^ZNR
M:5VKNVZV^1F"&8<_9#GVB8<>_'3T^A]!5[3K>UEG*7ZR1HZ[DD0[-DA.-TIE
M23( !^6,+T! 7!J07R#_ )9S_@$'_LYIANHC_P LI@?4A>O_ 'V?Y4\+3P6'
MJ1E+%2KPC)2]E4IQE2=N6ZO);/371J_D$JE:47&--P<E:\9033=K-6E=6>JM
MKHOE7NX)8KAX8098P6(D49#IV?A>!CKD@YZ@C%06MNSW,"7$#+"\L:R-M)VH
MSJKMDA@I56+ D$<="#5];M0Q9EE/R%1\JY ]<ENU3V\\=Q<V]LOF*UQ/#"KN
M$"JTKJJDXD)QDC.!W)KIHX;+ZV.@XXMTJ4JL+4E*=JG-**4%:R2;=GS:6?EH
M3J5Z5.*C"4VU:4GK;9OSNK.S1O7VB:/;WEI;VTWFQ3">-Y!- 6C$<D)C?<($
M$6X-(V& 8G?@G:#4=WH>GQ .D\CC)5E\V!PWRMMW;47Y<C)8GK@'KSVY^'>H
M-YJI?V1,$@C<,EV6\QR&P)/)$;* V25=@3\IPP($B?#C5"W%Y8#"ALK'<# .
M1T,>#R/IW]<?K*X.7+*:R/#2YVI*U2,9-2LVWRRLFW\5K:W[GDRQ=HMNO+I[
MWO7=VM;;ZWZ7M?L<?;Z%H4[6<9O707$,DLB,]NIC"!^&+($C9W41I&6#%"K#
M(//.:SIT%EJ,UK8)++;QK"%EPL@D9H4:1M\'[H_.S A3\I4J<8P/3&^'NIQW
M,RO>V68H8+AY1'=%O+F:X1<83"X,!)&W'S@'HQKC]<@/A[4Y]+NY'DEA\MS)
M"IVE9HDD1B7^;!#G (&,=.>/(SSAO#87+E+&86CD\'B84Z>-HS<ZG/.-XT>2
M\HU&U3G)\U[:O1\K=X7$RJUER5)57&*]V=VE_P!NRNFW\[=M#C5@GY!@D(Y'
M*."1TZD'![Y!SD<>M:=AI\%TMP9_-@N8HR83@%)5*,-CEE#;MRK\PR<8Y!/+
MQJ-LS8Q/U/)3DXYY/ )/?'7Z4G]H1QN'C+!@,@NA^]GN 3D8 ^AZ"OCJ& R"
MA4A5EFL\7%)J5.5.48R3BDI.T$KQ;4HI+XDOEV.IB:EHK#RBDT[V232<7:ZL
M[/9K;S1FE)P2#')D=U\PD>V.<'!!Y'J/2D*3 @'S%)Z!BX)_# K1:]C;<6$G
MS8/R0DD'!ZX(P.>3G'3K5:X<EHRK;L\Y('&1G'&<;1T&>H' Q7F8NA@*-%2P
M^-KU:S;<J<+J"3=U:4U&[L[+6R273;:C4JN2C+#J*22O:"OLWJG=Z;=-.I#Y
M5P =L<ISP<F4C'U(X(/3'UZ@5I6]@DME<W$CSI=V^0ENI"J\80Y.#A@6W%6X
M)<CDGM$MW$B*K-,6'4A!L(]F+#GID8Z=\U*NJ(FX()-KJ%8E8\D9.['[P,,C
M_9Z]L<UVX3#Y135*K7S*I6C5IU(SP]2,TJ-24'R5).*FY<LDMI-)NZLD<]?Z
MPW3Y*;BHU:3<8N/PWBYIZMN+7-=/1Z+5M6RS%.?NP2CURSGZ?=Z=.<T"*Z'2
M&4^VZ3]"W _R/2M(W\!_YZCZ*!^?S4X:@F!@W&,<<#I^=/\ L[)7%.6?UXR:
M2:C"<TK**6LH7=TNNS;6VV_M\1?_ '9;]Z/==I>5WHNO?3+\NZ#H?(<##9W%
MCT7CD'CD\>IJVUJ4M3.I;SSG,6"-I+ DC//)^;'(_P!G'!F?4$.,K._U X]N
M_'^%*-3PIC_?A"Q;:(UQGMSR??CC/M4QPF1T.9K-IXESI5(04Z<X\DW&*C-<
ML%JM+.VEDUJ2ZF*J<BC1Y&JE-MJ4%S1NN9.TKVVNNK[[&<8[@,2('8<#>&&W
M&!QD]<9//X5U_@_1-)UBXO8M=U)](CMX8Y8)I)8E6X=LB6)1-EB40L?EYPN#
MUQ7/&]C(/R3$C."5 'J!@D8 Y[#UKI/"^BGQ1=7EM'<_8OL=K]I:2>(R*X>3
MR-BB*0N&#,&[K@$<$+GT,@P6 J9IA:%'%2S6K->[@ZJG3HUI\EG%U7R."3][
MFEK=+6QGBIUXT*SE!4U[.7[R*BIQ:BK.+B^9-.UFM4_O/3?'4%O;^ O!ME97
M*W=I927\%K=+@+/"-5U!]X(4!BS9.<'GOMKQBO:_'6FMIG@/PGIK3+.UA)<I
MYJ(R"7SK^\G!PV6&T2!<')." <<UXI7V7'$7#-\/!P5)PRO+Z<J,6Y1I2IT%
M&4(S;;DHO1/;S>IX65-?5)*.J6+QS3[^TQE:I?\ [>Y^9^<FWJV6;7<+E2HR
MWEMM_P![R9,8]3G&!ZXK#6*?"D6P)P"2/D)8K\V[(.XDDYSG!X/08W;0_P"D
M(W.$5V(')(2-CQ[G'X>]9*WL9"CRI^G?;GD;AUQG[V..,@U\#FRHO"X55*CI
M-SE>REK\+]YPBV[=//SU/8P?.JM3DIQF^6.LFNZ772^GSVVN53%+AE6V0$#A
M5W-@KT&,JHYX9@>!D\XQ71ZYH^FV,>GI8B2XN+BT$UZ)BFV-SY<BI&H1"P9@
MRX#DD*>O)K$^UPD''G'G&TLH'7D$X&".W)YQUJ234/.96E,TA7"J7E0E44 *
MB_*/E'7GN3TX->/0G@J5.K#V_,ZL4DW"HW!Z7<;P;OZ?+H=;IXB=>DW!PA&%
M3FBI04:C48\D)I2LUS<RU32=V[%4QSX_X\HQSGA=O7Z2YQ['/;/3(&B<GFU*
MG&,*./S:7.?4U9:ZAQ\PE(R, K"<$]#PH_SVIXO(<9 F _V3&!Q[;:JG1RQW
MC4QL._NT:Z:V_P"G2\[Z_(<GBDE?#PDKJZ_=NSTWYG;SZ]=+%:"SFGN((?(3
M][*D>9%C=5W,HW')R, G!PPSC<"*VO%>E6%I?6]OID5PX$"K<22LLFZ<R, $
MVQQA=FWY#O/RE=Q'!&>FHPHZLIN@RG<K)(B.K+T(.WIGKP?SP:>=;U>!1'!J
M=]#$^]RD=S<*#N9V)8";!;))/&PG)92,BM^;)*.$Q&'=6MB)U94VJD*<E.A:
MUU"=3EE[S?O*-KJZ;:N94Z>+GB:=62C1HTHN+I)QM5<TFW*,9.+<79KF6EM/
M//,4Z80V<>Y"P._RD?<#R&&_=D8Y#="3CJ:7R;D DVJ9)!4@QX )'<2#&/7J
M>2<9XLF]3):8W,LKLTDCF4'<SDDGYP[9P0&)/501@YIG]H6X/"S CC)=>WK\
MH%*.#R-P4EF-6+]V\*M&<6OA^U3I/F;=]+Z;VN:<^+A4DE1C*-DDX^SBNBZR
M3V6NET[Z]58TVPEO=0@MGA2.*1L22$QL$B5=[L,.[;B%*K\I12V7P",6=<M[
M%=0F@T>VD^R0JD9\QUF:6489I0Y:-1&%^4JHR7&X\8JE'J21N)$-TK@$!HY4
M7AAAA]P\D'KG\*0WT07.V8Y/.]T)/)R=VT8)/L:VY<F6%>%ABDYRJQG+%.G5
M=3D25Z5.I[/GA!ZZ*RYMT^N"AC'B?K$H2]FJ;A&A&<%#F=K3G#G5.4EM=JZ6
MG1V+?3KB8;Q]@AP=NVZE6.3IG.,MA2,[222=IXP#7HFG6'@H:5!'J,Z'6HUC
M:Z6!KUH7_P!-V/"DR-Y6^2SSEXXP@W2#<) HKB[*_P##_E-_:5IK,LWF?(UA
M=6D40BV'Y6$UG.S2>9M)8,%"!DV9;</5O#OP^L=<L;'6XI=2MM.O8FEA8W%C
M/=6US;R3H_VHM%;B.#9''Y&U7;+LQ#[N/L.$<JRS&XJO2RZ&&S6M]5E[:AC(
M5)JC3YZ?^TP=6,(*I#X>9.4[3]U?$<698BK2A&6(=7"4T[1JTG3OS)1T7+._
MO*]TU>T?(L6^@_#N14 \TL(5*JT6L*XWQKA5"QRJ5W(50J$1MAQ_$:Q]1L_
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M5Z:Z?ZY-%%%?'GKG^+S'F1I)B?F:5QN[#.V/@^H7GC& O:H9@&*+GY6SG_9
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MZA,)'8DNOFPA(RH8C[I7<3P !Q7/:;!9ZGXWL-0L85\J?5[&?<9'5PRHK7>
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M)HU>_M:+V<;V][;^MK7^-5*]"5))XY!]._./QJSII":EI[D8Q?6QW!0Y'[Y
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MH(?),IX/R@/N;@GYAD#M@XSCJ/F/P_N_M[1BI56&IV>UFSM5O/0HQP>BN%+
M@@J#Q7TIJ#&/2YCJTZ7#($>]E*[HI=BR*R[  2I9\8(&3&,?>)'[MX3N^59U
M#92KTFY/9<M*:75:+1O?1-::7^>SGW:^&E:[E&4+7LK-I_\ MJ6NFKNCSGQQ
M=BZ\/VLBR,ZR:S;2 E>2#:WA1L\[B01COZ9KQM59AM4,Q;Y<+EBS>@QG/X9Q
MS[U] :K#I5SI7V>5(YH)#%-!&HD0IY,,BJZ+'+$8W&X%9"6V<@+R:X&WTZ&Q
M4^0CR2,%#W+MON&R "H<C"H3T"@-_M>O/Q;PQB\WSNEBXXJA'#U,/1]JXN3E
M'D:]VG>323<F[-ONO.L)B:5*A4@X34XSNE>*3;M;HNJVZZM/4YRRT8#9)>JH
M&-WD0O(9&/4"9P=L2#J50>8_W00.:Z&&,%4CB0+&F[RT5"$/)R3$.7)Z;W)8
M=234Q58U>64A03SN(+CN20>6]PH)X/XQIY\_[NW1K>'/%Q,"A<''S11@[^,Y
M&[ Z$BNW+<DR_*H^RP].+G*W/7?O5*E[-N3^%*[>R5N^YA6Q-6HG?W8:VC;X
M4U&_G;1??YV-"3[+9H3-+F:50([.+YYW/5FDD?*HRDDB-4G\Q" RJ "6>3=W
M0(<BUMR 6C5U>>1-RY#2<)#QP=@W>A(+"K=M:6T3[]WGS$X>>8>9(< <(2 8
ME!&<1D'D_,>,6W0(LB@D[%VY/?E3G]:]Z%%5:EV[*/+I&UK<\(INZUNVD[:?
MF<?M$FM%=*I;5ZVI2DM4^\5:_GMT^D]%B6/0])C .U=.M N2S-L\I<99B6/&
M<G.#U'%?(?C9"?%FM=A]KEQW_B /?V%?8NDC=H^D#IG3;-?_ "7CY_6OCWQR
M"/%6LA<_\?LW?'<?2O5\4[+AC!Q5OXN'MWM[*#]-'MY,^2X,J.>:YNF](RD^
M]N:JW;5VM=/R.4*8!Y_3_P"O7W'_ ,$PP3_P4?\ V"P/^CP?V<&X.?N?&/P2
MW;T&X^PR:^&B'P<YQWY_^O7WQ_P2ML_MO_!2?]A2/>L?E?M6_ :[RPX/V+XG
M^%KLIGLTGD;$]688Y%?@>54G5QM*,=W&NDO-8>J]_P M-['Z/4FJ=&<Y6M%Q
MO\Y071]+^K]=#_6NHHHKX4]@_P 9"\^6%_ER%&1T!!SC!&,]^AZ^G%4;"VE:
M4OL9D48<C[H) /3H<''(X&.>F*T=5 ,A0$J S'GI)L( P<\\GGOC' Z5HZ':
MM-=1[E*HSJSCD!D50S!><9+#:,YXXQ7]22I_O.:2]WW5T=F[:OR7XO;J?-UJ
MBI4:E1NWLXN:OM?2*NNN[[>;LK'7WMXWAWP=-<NK+-*CHH4CYIYCM*<YWA1P
MF,C(X]!\\3W!E?>22VXDY # DC+,1@%MV22,DD^N37JGQ*UJV6#2M'DFE#1H
M;MTC^8))YCB(,,9*,#YD8ZXR"Q(KQY98';:DF2<#YAL+<#G!R2S$$G &6SBO
MR;C_ #"%?,:>&A5ISIX*E[.<8RO-5;P<KQUOK[M]UL^C7-PUA9PP^*QDZ<XS
MQM:4IMJZE"G4Y:;4M$X\D5HEMKZVI"-V.X!!'IZ^W<?Y%1SV<<RQBUG)8Q?O
MHIVCB*S%Y&D2#!8/%M5"GF%9-[LJC:JK3GR6+<9(!]LD#/'IP.YIZ-$007C6
M7CB4J@'^Y*%9<]1ABK ]>>#\2Z,*LY1F_A4=MUS1C)/;LT_,^EA-QCT=TK:-
MV6FOKW8W0=*:_P!6M+64M$XNHF,3(P8Q1L7F)?& $C!;)(^\H W$ ^O73N9Y
M695D5 Y.59F5MVU7&TJ0ZGH6RIZ\CFO,K:\NK&>&XMY2LR9C63A_W<FT2+E@
M0P8*H)8%L #.,5NQ>)IA!)#-!$\TA!,RRF-25[. )#SQE1CGIM&*_0N$,RRC
M)L%B*6(E.&(KUE/VB@Y7@HI*[BTVXN]DK6^:1Q8M5,3*-H^Y"-KII-;:V=];
MW?HEIH;=R[&,M(0=N=[NQ^4'N[,% .#V!'3#&L^37K2V"K:QK-<X50RM^X"H
MPP&R 6SMWG&2P&&R#@<W=7]U>R_O9V* Y6-"0BG'3#*-P&!C=NX/4U74;OFP
M 4;&  HVX/&  ...@'<]:Z\7Q=.K4=++:+LU+GK2;B^1.*3LY6U5VDDO6V^<
M:,(QA=OHMU;YJRT[O\]3U:T=I?!^B22G=++JNO2.QQDR-)I\DF,=!N9BO3(/
M/.:H,#_#[YQQG..OK5G22)?!.C.2?^0YKB =L"/3#WSSGWQCI4#;@?EP<$YS
M[=.F.:_0,-*5;"9;6<N9U,OP+<WHY.6&I*[NVU=N^KTON<5)\LJ\/^G]6S:U
M^-NW3I;HO\V6.!XE\,$CIJ$9/ S@/%_2OH?QTA_X0WQ(O?\ L6]& >"1:LI!
MY ZJ>O'?G-?.EJQ7Q!X:;C/]H <].&C[9S^M?2GCA W@_P 2$YS_ &'J+\8Z
MB"3VZ<GW]Z]C)*;>5\6II/EPU9-/5:X"OT>F]ON1\'Q=54<XX<AUJUX\C2?V
M<7A&[OHN63MI?7IJ? 0 P, =.N*5/]='_GLU X 'I0G^NC_SV:OY%A]GY?H?
MLF\O^WOU.B0_NN3Z@9Y[<#Z?I6?=$ALYZ1@]?1S^7U/:KL?*1#L^XGZCIC_)
MJG<VYF=\;MH&QL$9 SD8R,9(X[_3M77NNM^GR44^]_3M<VEVV;2V]%=_CKW,
MZ261"#\BYZ=&)XSG@'T//O6C9ZO<6^Z-F:6,!<1L%PK*W/EM@E!CMW/:JOV$
MN5P#QQP<\8/7(/U_"K":5,6+;@!R2"><<?U_0C&:P<;VY4WZ^B[VT[?@9-+2
MS;7GMI;OIW5_1>N_'<07>9+>54EP"8V#8/!+#&-HYYS@9SUXP*EQ!'*"/NR%
MF+$D%5/)(!R1@G('IG/M5=-*DB(=)0K9SE< \>H_R?>K WH'63#'=R3GGYLD
MXS]<=N<^U)1DG=[*S>O31O[OT!::=M7;5VT?5V[=]MN\'V5KB618!M"L3R"-
MP/0C*]L8QP<@\=*KW>EW* .H=OFV\1GJ.O !X /7D=\\5U^G6X"R7#?< 0*?
M0,2#GC_/<FMCR[)8X@0"Q<R%R^U0DO,?K@E 3TY/0 #!UY>:-^CL]_EY_P"1
MG4GM;5.[N_E:UK6^[6^JND>6'3[Q6VM&^01D>6_UZA36UH^GW+1ZF)$:,II]
MQ(A8!B=A0A4()*G/3IW]Z[MULR[,1%R<G$WH , =>WKS2/>0V44IM!&K7$;6
MLI1"?W,W#D[R0,8&"!D'KD9!2C%.+UT=W?;5+3N^OZ$>U<=596Z[_=U7Y^9Y
MF;:\+\0R  $%F' /()Y/.TY (R,#\]E0!'$""&5<%A_>51TZ<@EN?Y9..N<6
MI?<PA8'<^YPV 0<Y(5E&..0!R,UR3R+([21D&-WD=  0-C$A"/8I[GD=1TKZ
M?(.6G7E44[2Y$XW:V:5TUVLUK=6T.#'.56G%KI)-K:^L7Z/;_([7P6Z)KFEA
ME1RL\TB$A3MD2$,&YSA@>C<'/W3D#'7_ !)U 2Z0T:DB5;ZSDB(!^5U>4(<Y
M7;EE WX8C .WI7F>@7$D>JV3Q!OEF3>54E55W",692P4[\C+;>,9&>:Z+QU<
MNT"KQ@W-L3U./+DF9>_?<=V1D]01GC]?AF$JG!^8TU.K3M1E^\IRY9J:E32:
M:3>\='>VNJMOXU.E;%TZK4>92TBTW&UM;I-7;WLF[Z-]#0A\6^-XE(\S<ORX
MW:M<G&64@@;1R?91@] . +#_ !"\:VXVL&?(.6&J3MT&2IS"[<#!YX^;'4DG
M),0624X((88^8G^+ZX_3OQ44P^1SD\HQQQC+94XR#V45X=7&YO02=/.LRO[+
M#VYJSM=T*.C2;TO:[O?RZGSE..7U*\HRRO!R3G-RG[-PFY.I)RNXR3^*^^ZW
MU>FA%\7_ !>EPUM$;R6X7YG\K4+IU #;=S!4P #P7R>O'WN.D7XN>/[9H[B1
M96EV_NYQJSB=0%!VB0(LB[5P-O\ P'!KR#10/[9U!L8S8HW4A5)F))."#@]"
M,\DCK@"NJN_N6^1U25N>Y$:8(QSM/49YQCGN?$P6=9_CL/5K8K.L74<<0X*+
M5-I2@TF]:;Z[6>M];[KT<7E^482M2I8?*\(E.E&4G:K%RYU&:NXSO>SUOWZ6
M/2+?X[>/;<@R0W<W.?FUB5#N[,Q:W?<1^G)!]="+]H?QLFX-9W9#9S'_ ,)!
M( 22>0?LA"@Y'&.N21S7C0;<2  N,'(+$G(4_P ;,.YZ =J4@8)P"0.X'.!W
MKI6:YQ"[CFF)IROM!4MO=TO[/9VOTU[G.\%E#<8O+Z+;Y;/]YII'E:O.UUTT
M_$]OC_:)\61N';2)G8EF8MKP<EF.68F33)"2QY)."2226-)=_M$>+KH_-H]U
M''M4+LUD*JD8&XE=-4OD< X].U>&[O\ 97\J"Q^GT)X^@SC]*J.>9S2ESQS3
M%*?25Z3D[6W;I?E;30N>499.*C/ 4ZD;V:G.;23LG9<RZ7^[1*^OKLOQS\4S
M==-O&7&#MUEBV<Y #&QCP3Z '/7-9DGQ?\0R!A_9ET3R1_Q-P3QGK_HF>._Z
MUY@^,#<%?GC>,XSW&,<C'&<CVIOF-Z+^"*I_-0I_7!K9\2<2RCIGF,C&VD4Z
M5K::7=.^]WNMWKK<B/#V26TRW#KE:LE[1*^B7_+Q=GT]6=S/\3_$DI)>PD4D
M9&[4UW <D8S9Y!YXYQ6:?'?B:X>%&AN%#3Q*=VH)M8%QD%1:+D8)Z$9QC.!7
M,OQL_P!Q3SSZ^O;VZ5+;L6FL\A>;F \*HY\Q5[ =C^8![44,[S^IB,)'$9OC
M*D9XBA>/-32?[RFFK^S>CV?J=<,NRVA!>SP,(2BIQ@X3FN62IR:T<I=$_F]]
M=/L/4F9](NWE0A&LQ(\8<NHRD)< G;GEGZ ?>;;QR?)(XX3)R@*/+/E#M.1O
M!4$]".X'." .#C'J.L2,-%O3_>TQG/7 )B@S@9Z<>YKQM+M8=LCG $DW4D?>
M..Q]??IW]/Z'S_$257!2E:\J+ES6U]V/).[\VW>R7-=NW0\W((R^K8E623KT
MVHWVY8.*5VGTAZMMOK8Z.!X1/&&3*B>$Y/)4AQM4@_>PN<#G X&!@5T'CH?\
M4SK!7'.C:EG& 3\LH)/?EUR3W(!]#7#P7(E>)B<;[JW[\LHE093W(..0>0.E
M=IXZ96\.:T$)PND:BN,C_GG._H#R6Z]P![YXXN+R7.E'3_9IRMHD_P#9<3=V
M[I\MM.K^796A...P5];U$U9_XEOZM?-O;IXGI/Q0\0:9I=C96]O>M%:P)$C?
M:;8)Y<8(&T/:9"DL0%+' 5>3@$ZT?QI\3Q@*+>[*GDYNK-<C., ?9&(/'4D<
M'!%>3P9$" $_<*CD]"-W3IG/'3&.,4[) 49/3U]S7\W87BSB:C0ITJ>=8N,*
M<(QA"].R@E!12?):R2M:U[);GHU<FRBHY2E@*+G*3DY6GJV[MOW^K;VZZ]F>
MOQ_&SQ.H*K:73$9VGS[)R#VX-DI'J3G@X&!GC0'Q]\6HB)]CF78A50T>DN5#
M'<P4R:<[@,Y+$!L%CGK7B.]L8SQG/O\ Y_SZ4T\G.3D>Y_QQ6T^*>(:ZY<3F
MM6M#?DJPC*STU324=KW3B]=5YXK(<G4E)8*,':W-"<XOIW;U?4]N3X^>+8U"
MKIS8# Y^SZ&"?F#-D_V8>I )Z[B 3S5IOVB/',B2*8[H[F8E6?2,;6/.4.ED
M8()W*3R"<C'->%^8W^6D_P#BZ57;#\]C[]<YY.3^9K)<29W2C:&8SBGHTJ<;
M/1;KKU6M[(I9%E'-S2PW,UK=R;>C5K:I7OUZZWNK'LW_  OOQ@./L2D'L8-!
M/9@>NE+U#L#UR&8="<PGXZ>+W=F:VE4ONW%9--7ALY&Q; * <D%5^4 D 8KQ
MLLQ[G^7\J>)&Q@M@!6].RD]2">2.?R%$.*<_I:TLTJ1<[*?[M)VNNL;7=D_\
MS3^Q<FFWSX&,G*R<I3DY2V5I:I62T2U6U^I[ WQU\8G_ )=[I@.!A]*/ Z==
M-?MVR,?C5=OC9XJ<2AX+O:_(!FTU1N]<QZ:I!'KD?E7E8/"X8G*ACSW(]@./
MKD^_81"0;L*S9)QS^N,_UI/BGB*+4XYI53DT[\D;V25K_>R5D&3*R674$MUS
M2G;=/1*2U_X>YZ/-\6O$<NQE@N@RY)<W-HQ!)+'G[&,X)SSU[FNR^&GC;6M9
M\13170N&CCTZ>>,,]LX61#'&6 2-"#B1@22![<@CPARP8#<3ERO.,X !X..O
M)KU#X-Y/B6[()!&D78&/>:VZYS7TO!W$>=XKB;)J&(S3$SA6Q:56F^5TY^XW
M9IQYK<RBK<VU]>IQ9IDN4T<OQ=2GE]"+C1D[IU+K9*UZC5_DSN_C9=&ZT2R>
M0%&CNRJ@@ G<4(SLXP?+;!." HYY&?F  GH*^F_C*O\ Q(+1B23]L7J<@X,A
MQC'M]>V<5\R!BN<8Y]:]CQ2E5EQ15G4DI3EA<+:RLE%4TEU;VWU] X9IPI9-
MA84KJBG-4XO>.D>9;*^ME\M.QJZ'D:OIJ]S?6H YY)F7@E>0#D D<@<CD"OI
M5?#<[*S364 *R$%3JVM]&5#\KI>IM51]T%78YYVXP?FO0R3K6E-T/]HV0X]Y
MT&?KQQ7VR8GD7Y?FW!2Q8C(.T+\OU R<Y.<\XXKT_#S"0Q."S&<FU*.*I6LE
MUIN^][:'S_&F9SRZI@$E"U9RJ1E)/:$8WNTU;WY)+R>FNIYHWAF5EE_T*WQO
MPBC5-98,@&T%BVHASV).!EADC'2&7PIOGS]AMS#L!;.HZR7+9C4HH:_P!M,A
MW''W<9R5KTUK9T7)4$9'4KW('MZ]^GTI5M]V[(4;6V]5ST!]/?\ ^L,5^@?V
M30=O:1E.7>ZV[;=&WV_"Y\I'BA2BG^[TM?W7?:+[M[7ZO?[O)Y_":B"0C2;?
MS-QQLU#5F7877;E9+]\D]<!>,]N_EGC31[BRET^);**U:[NS&7C>YN"R-B-2
M$G$X 1@3PPY&<#%?52V$LJE&CW$C.U"0< CW..<9XQCBH+_0)7M;BX%IDA'^
M8J&96"J% 8J2H.3D*1G//?/A9UPQ2S' 5L)2D\-.I9^TT;LMX[==-;V]VS6J
M9ZF XQHT:E*4J,:R<[<L?=:T3NM>EK6=]'M=7/E'PQI0N8-=FO(!+/9>:;6<
M?:(FC>.UO&#$1K$"PDAC8'Y]H[ 9-2ZAICMX/M-6BM7;4Y_*,KDSS2*[32+(
MW D:16*[$'EJ%"@<K@GZ5O/"%RND7,@LY<)I5\Q+((P"EK,1T ) &3@^_.*9
MX \(SWOA'1+E(D8S6\Y.T,&)COKI!YA,;!@"G]_IQD=*^1I\)2ISAEGM7:64
MUD\1RJTYJNW!\K3?-%+EWO;TT]*KQ;"4WF%.C*"I8NC3=-M*+@X5.=MW6K46
MU;:25]CYG\*Z.UYK26VHP->6R:7'*@GAEB3[3)'&X1RD2;C%(3&L8?(*D2 ;
M:]@B\*^&&4.VD6SDKG'[Q7!.,Y/G,K$<[NH.3@YKT:/PU/:QW(:)5:"_N4.!
MDJP9R"N02/DE#@$X\P[@,84,_L38""A'< 8Q@GC@C&?KC\>:^DR+AJ.4X54'
M%8KGJ<_.XI--R6EFFVMUH]EJC+%<44,5734I4;\KY$^;LFW);*ZOMI?=G$+X
M4\,OPND6P(&2,$GZ_>QV^G0\5(/!WAQAG^R+4CKT((QR3@MU !XQ78QZ>(G.
M=J?)A.N<@GJ0<=3C'&3@^M5WLYURJMG/4Y^;![C&,#IZX'/->_+!4;6EA::O
MHU*,6K>[I9).[OM=/\;J&:1J-J.*=TTKN3>ONZ[Z[&)#X+\,NP_XDEDP(R<[
MMQZ]@W7@\X!P,<]!8U/PAX7LM.N[NVT*SAN[2WDN(+A%D#1R1(61HQYCC>&
M(W *,$E@< ])8V<B 9))!]^F!^1]_3G Q5J\L([P1VA:%892/M4<AE+7%LX*
M[(B)05SN#$\\C/3(/OX?+<(L/&4<%A%4UY)>QLXOEB[WO>6][R;::=K,SGCZ
ML:\5];<KPG)1LVFO<TM==-+^3UL1W$*+$&PN 0<@8/[R:+GGD,=K!@#V(Z8%
M4?$GDGP_?H40^8B(RL@*.KS1A@QRN&*E0I&6QN'3-23W%NEW?6WFQ#RD5X[;
MS=NQ1/P%!!.$7KN+,0,Y))%7G.GWD%[9226UV$M]\D8?<R.J9R!QEH]RL/\
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M^E,0V&U_1LL8]A7;J=LB@#&/F\PLP]<=,$'T1?"-Q*EPRQI@-)NP!EMQ)W9
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M4734HY3@9V>MI1PN'G9OK[\Y*W969S-\M;$\NWUFM_Z<;^[96];D$9SK?AS
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M!P<G/ /%?-/BJ74+K5KF_NHIX(;N>;[*TT3Q1RQ6Q"XB>4?O!'E-VUF"L1D
MU^]^)&-^IY,L%2E+FQ<U0DHV=Z<'&=12=^9IV22M\6]K7/EL%1IXG,J-:=G3
MP<92II[\_-"*O:Z:47+=[I:/IC*>"20,DG_/Y5(I5@1N8\$84]<YP!]?U[5G
M,\QP!C&< +SSC.#G/8_Y-(LK+(021SCTP1P>2!C_ .MBOP6E-7O9VO:UE=ZK
MI?KT/JI>\Y-?:N^^_72^GZ'L4)>\^%KC<Y71O'$!*^7A%/B+1&;+-]]?WF@
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MV>UG%1\]XR5G;3L>KE5+W9UY)I22C3OOHW=OR>GGZ'N7AH9\#69[+XBU0_\
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ME:T@U"S\R(N8Y?(98'>/S$C?9(49EW(" P[U\L3D>>F2,AK@GGL6ROX$=/\
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M]>,YKFD^9M^GX)+]#HG-).G:5[63Z7:5M;K1-J^GR+08_,#U4 CW# D?3O\
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M1Y+PD:=*I.I4<Y/X(Z6NMHWBE>_2]];6TWRM:N"\PB=]TCB6XDSG#22.6'S
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M[&B_7"$Y]NM<UL8KC9&.,8* MTY.X=^X/:NCMW46]MD\F->QY(!'.!UY _\
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M0-V4@'!Z=CR!CV/YYK['_8;T6+7_ (SSV,@R$\(ZU<$$E1F.YTM02<'(&\G
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MR<K)[M];)GPOX@TF6'3-28*XQ9,< X4J98=W !)SD\Y[@\XR<?Q=8Y\ ^(Y
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MT $_#CQ4^-QR0EWHA/!_V0>W4 ?Q5[O".*I_ZR95[-I7Q,;>]=K1W6SUM?\
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M.&6;=TY^[C'^Z",=1U'0$5\1?'/1]W@'QS,@()\+^(BZ$9"%-)O Y!(.<G'
MP6_"OT_)\0W1HW3E[T;.Z6Z79?U^7P^.IN,[^<NEM-'^%^RZ^1\?>,/#ZS>'
M+SS;="6T2)E#*/E9X8W!SQD MD Y!&,G&:\E^('@^>'X<^/)G $,7@OQ(\>U
M2P9XM%NIU^5,!1A6Y&,X [&OK?6-'^U^&PI!8/HEN3D9/S6EF4&,9(((! /R
M@D8SQ65XZ\)^?\*?B1,\01(OAQXRN8RJ%20GAJ]*GYLC(W$D#) !YP:^OAC?
M9X=QY_BBDM8^[>*BE;NF]>OS9\[/#QEB%423E&HY-*Z;:DI=UKI9_?9V._\
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M1F?;$9Y\LX*!F2.,Y#;@.1O]-\(2RSBWO+.(;,(\,\G4$'+JY82*,8^X&'0
MXW'@RS)ZLJ-7$U*U%RQ>(JU^6536G!N,8TUJ]$HJ26BO+;JHQ&:0A6BHPK:0
MC%M0W=U=W5TV]-=?SMY3]@MER?WF2JG*R.#U Q]QN/PZCK4PLK=HWC+2E&.[
M:6##=@8(W(#GT)[5UBG2(C+&\<=U&&(6>/S X&?X,HN6]0<# X.:D(\.L L<
M,@?&,R>;M!8$DMA<<9!.<#&<GBN[ZA3>K>'3TO>48)Z):<S2=U:ZZ[VL#S";
M5G3KR2U]R'-;97TV2ZW27I=-<2-,M=R_*2.<[A&W<?WHSCKVQVSG J865FH=
M?*!!^\%:-"VP$ YV$#CK@#/08KL)K73H6@,1ADCDCW@&0$C.,B09)7&,+U!!
M/?($IM=*>+<OD1,69F0N&#$Y8@$?,HSD@ 'I@XY(GZE03GS.D[1]UQM*/PIJ
MTDVFUUWL]+7)CF3TM&O9Z7<+6NU?7IJ^OYK3C8["Q"JX@N%;YB#'+"V,Y4_>
MB.#CVZU$MAIX&#'*V,\LWS GN615((//&!GMCBNE9M.#*"D6 2> Y^4''8=>
M/Q]NM4WDA2<LL<4D#'YEVJ,DY&"0Q/7'OGTKG>'H1M=0=^K5K:+S_K;H;PKU
M)J]ZB2LTYR3[;7UW_K0YZYMX8S&MLKHYXY=SD'Y4/)R#O(S_ +(XQS7Z>?\
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MO$=B6M;&.)+C5C#J&KZ1(MQ,($D\DRF,F-6'[SZMI8D@<8R^Q22<9^X<DXW
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MO17_ *]3Y'-L-R2DFNNW+TC9V].FG3Y'P1XUT\2"1E7(V%?4\@;\\8/ X/7
M[U\6?&K2S-X#\<PJI&?"GBHDHNX@+H]Z2",CMDY]>V2*_0'Q;:,DKAE[3+WX
M^5",\ 8Y''L>*^0/B]IBGP/XW0(=S>%/%*CKU;2KH9)P2,9SG^=?J^45I*A3
MLV_A5VU>.W:V_P"%OF?G6-I-UG%Q=KIZ=+VV\_3\K'S9_P (^9O#EEE#MD\,
MZ=+RI5B+C3K60[@2<8(&WI\N.*7XC:1';?!CXCKY2@K\,O&F2I.>/"6J<$[C
MQD>V2 >U>R:1I$;>"]+G,;$R>#]$=%8'Y=VD6I4\ \C.6Y.#TSWY;XD6+CX1
M?%'< "?AKXR(!R/N>%]1<G&W."!P?7D@5](\5%TXQ;2=HIOFUYO=UV[[K[K;
MGB.ERU)/EM?F[:;I?\/?TZGT!\)].5] \/LZ#_D#Z84)'7?909+'D$GKG'N/
M?[;\ Z0R20-M'"1E..AR!@XQZ\XQ]>E?+_PIT_?X;\-$CY6T319#UZ'3[;'\
M/;." <$GN.*^YO FGJ#"@C8;P"#CY2&96R2.1T8$8[]37Q.=8A1C92O=2=[V
MZVMMKWTOO:VA])E&'<JL6UZ75[IV=]T[7[>GI](>"[$!(4Q]P*W3C(./Q& >
M/QSW/TAX>M ,;@./F'X@'OUY[?\ ZSXQX6M=D:D8^90P]AG8 >, _0XXZU[S
MHZF..,'^X6X].![<G.:_)LZJM\RC+5O3_P EMV71W;7;R/T_)Z<$XOE5[QL[
M;ZJ]O*^NO5>AU]J H#-GEN.>/\]_<G'T_,G]KC]A#PY\5/VF?A;^V-JGB&WB
MU_X.:%H'A[PWH$GA^:[F2[BUOQ#,-4M]9CUZVCMIS_PE,L2P2:'=AUB.Z<QD
M(OZ?6RGRE''# _H*X3XOH&\!ZIN^Z;O1QQ][(U6P4>V-S+WY7/&>OSN7XFMA
M<QP\Z/*I2J*$G))Q<9./NM--:]7NK:-,^DQV%HXG!UX5N915/F]Q\LN:.J=T
MTW;JG==T[GA_[+'[-NE?LI_LWZ9\$]"U?^VM)\/W?C#6;&Z739=+0)XP\2ZK
MXF>U6TN-6UV51:3:G- LO]H[9MGF_9K<;(8U_:V_8[^%O[8O@_PCX8^)EDDW
M_"$^*]-\;>'+\VPO7L-3LH_+N52T>Z@M9TO;>4V\C7(9K?8DT 5U#GZ@N#N\
M.S$@?\>1''M%_P#7-;0CS8*0 2;1?K_J1Z ]*Y?KV)CB(XR%3DQ+QE2JIQBF
MN=NG=J/PZM-VU3N^ED;+!T'0>$E!SPWU6E#DE)I\BYE;FNVWHNM]$[[GY_?L
ML?L8^&O@A\7_ (R_M">%_$]]_:/[0<INO''A<Z5;6]A+J.G:G-)IFJQWJW3S
M33VJRZC$"]LBNNJ7CN_RQY^_9(\H0<YV]>A./7BN>\ O"?"VG>3G9_IB*>/X
M-0O%/0G^+=SU/4UTTS##'GC _P#'JK%XBMB<77K5Y*4W4DG-1C#2G:$4HQ2B
ME&$4M$MKMMW;,+0I8?#T:5%-4U335YRG?G_>2=YMR=Y2;U;WLK+0Y:^@4JPY
M/7C.!SD$]^XSWKQ_Q)IX*2J!P'=5![_*>I..V0./4GCBO;;X99AW)##Z'/!^
MF..M>=Z_;$I*S8VX/&3DD@-D<8QCCU]??T<MK2A.*UL_.U]GKOOL<&945.$F
MDD[+6RW5FK[?G?3<^,/'VC>8MXVQ?E63J!W"8^HZC QQG(.!7YW?&_P\J/X)
M;RPH'Q<^%R<$Y'F>/="CP,DXX<C., CZU^KWC#31(TQ 'SK)CEN"54#H#@\>
MO (&<9KX$^-^BJ!X3)3Y1\5?A<3@$D;OB'X>4$Y&/XP&/8=/0_I^48KE46KI
MJVTGKK%7=E9;O3?UV/S7,\/%-R:3ZWMZ:;_*_='YK_%_0\QVZL@!&O:,#C&-
MPO(MV1C/61L 'ICD<U^.'_!1#2F3PMX*8J%W>(KQ.@SA[.5F/XXR /\ :&#V
M_>[XRZ$(XFQ&7!UW0R4QD+NUJW0D @9SYR.0.H!]L_BC_P %*-/6U\%> 9\*
M"?%<\:Q^6$#LVDWTG.W(( C..3R1QC+5];F.,4\CS&.CE+ 57R\VKY8Q2=[+
M=/:WSW/$R>FXYO@ERM6KQ7*^C=2/+UTL]MNE]3\9;6W(DNHPH)%Y.F5X*XM;
M>0;NN?GD8<=AQZG9M;0 DR==IVX/3!&>>>OOZ4Z"#+7Y(^7[6"P_B#FPM1P#
M@$#&<@G(Q@>FA90E>& &%;  SP<#Z#UZ>]?R=S)TW*.DDXI6;NM876R5[:7\
MNCN?T/!.*DY:M2=GI=K1)K72_7\18[0JG &PD<'N"P"Y]\D'/'0\8-2K L<B
MAV 8-M.1G(P#P>,=2"#GV[UH0K&J(AW+MR2!C!XSDDD<Y&>!UY!]9IMJOM.3
ML P!@HP(W @YSC#8SCKG'J<54FW?FD]MK]+7=VUWMY+4OFTU=OG=_EK\K_Y9
MS1J%XSE <KUVDGY0>.=WIQC]*F5-P4GJ5!/&,<8_PQP?3ITL(-I)/1T;&/<C
MZ4YK>3 <;2&Y !)//J,<8[\UHYI+9)[<[=WT26W7]-3%SMO)K516KW?3YF;<
MP9C#@  ,@Y"L&(8 DA@>?IC)ZUY5J.V/78'D*QCR;QBQ"[-I2X5?E P/F&#D
M,,=0>_LMQ [0<@ ,-PRPZ(PR#@DY(! ZY/'!Z>1:G%"^OVGFH)$,%T2DH+#[
METZX'17CD1)$QU;)R#7[)X93O@\QBW[SQ5#=ZM>STW]+[]3X/BQ)8BA96OA*
MT;I;MSBVO)N%[7\_,YSQ"N)[8$*%,&55'RI!V8;"[0NX'''7!YXK / X'3MS
MZ_B?_P!5=!XK"I)9A=V[RG )Q@*)2<#GH"#C(Y[X%<PI ;<N=I&"#USZXZ=?
M>OTR?Q/Y?DCAP$H_4Z-Y*Z:OK=I-*W]??I8?)]X_0?A[>^/6DW'&,#&,=^WX
MTK'=C&0.F3T[>F::!D@#O4FLOC:B[WLDUUNEI]^A=M1NZ^N!]!@9_4U+<$@H
M1S^]4?J3G\U!].O:DM4W$ *20,$C&#CGZYY].F?:GW*%0<D?-(Q&/]LKC_Z_
MZ9JTKI:V7/#7YI6WZ=#.I93@F[..K[KF2C^%F_E;S/VO^'4);X2?#!P.6^'G
MAKMP6;3K8GMDX/(Y&/<<5^+_ .T*GD_&+QO%LW!-6F'))_N^GOGG ^@K]L/A
MG$Q^#OPL/&#\/?#6.^?] M^HQ_CW/U_%K]I2+R?C5X[0L05UJZR1D@Y?/L<C
MW_'FO3X\:_U6I)._+7PU]]'R)??8^0X)5N),>DN6]"O>VC:5:+V[7W_X)X82
M"#^[ ]^>*^X/^"9+$?\ !1S]@D#H?VQ_V:,^^[XQ^#,_SKX>.,'YR?;!YK[@
M_P""9//_  4=_8)_[/'_ &9^OM\9/!G^'%?AE!?OH-;*-7F>FSH3WMT_K:Q^
MOZ^[_CAW_FC?J_Z^;/\ 7%HHHKX0]D_QI#;?"S5'O)(-1\6^$@\\DEG:W>GV
M/BZUA22[C46T^IVMWX>N9%@M?-8W4.CR//(L8%M$I=@]? -GJ,\4?AWQKX0U
M431/+Y5[J$GABXM@MPZM%='Q-'IE@;@6T8N%CM-2ND=9DACFEN%*GRQKK:3Y
ML,J$,R$>6^W((_O*!GGIG/\ 26.XAD&%D1, _+( K=R<<G'MZ]:]]8; SM&'
MNO2\G)M6TOM=WNTUI96ON['!&5:'O:OI:ZTVL]-'M_P[/4?A;I>GZCXXTF/5
M;BQM;/3Y)+Z4WMY9PPSRVTJ):VR223B*1Y;PP[4BD>1H5>0*4#FOL#42DMQ<
M,DD<D46YMRE=I,9>.-R%XQ* 6!)*N64C=D$?G@7^ZRX?#!EV,K$,IX)&TD '
MD$$<]:N0:MJ-EYYM=1U"T^T*5E%M<S6X=<'Y7*&(%<DY#.PQW]?V[P_X]P?!
MN4U\J_L:>+GB*\\15QN'J1E4J2<(1I0J4Y+:DD[2_O7M;5_)YUDM7-<PAC)8
MOD=+#^P5&4).%./,I.I&2DX\W-[S]U/17>C9]K7^J:1IT2#4=2L;11^_F$UQ
M&C,6!+#"N'#_ "@*H1LGH!SN^8_B=XATCQ!K%E)H\OGV]E8M;R7.R1!-++<2
MS,H$JJS;%)^?&TJ,J &%>7R"1BKK(9&ZL[@2%VSDMN+.0V2<G>_/6IO(FN(9
M JDE7#LQ(!++$2P(&,$=3CWXKS>+_$S,^*,'4RFCED<!@Y5(N<95%4JU%2:D
MG91BH;:OHUIJCT,MR3#X*K2K2KRJS@_=6B@Y.TKJWE*S5DM'=#@6V[ 20ISC
MK@D CWZ8P#QC!]ZOQXR-I&.1P<^_\ZQW^T[_ )054HAXSGA0N2 >H(Y_2IT%
M^H'SN!V.U>/TS_GI7XK7:J<RUE9M+3LUM=.UG?[KKR^DA[NEE=VU=N]^B\].
MQK$+G)QGKU_^O4$D@'!;OP!CD]@3C@8YS5!GO<\SKD?WG5#^6W]:B992!F:$
MD'))EC_'&&/.>A_R>6,+*\K]+)V>FFN[2MYM=O,VM>U_5VV;\^Z/9O#+EO!5
MZ?XCXAA! YPOV/G/Y(2>Q/& :%7*KD'[K#OT*C^>./TJMX0)'@S4"Y5L:[ H
MVD,"9;1\'/3"F$Y^N!TJW*H;R\DC$:],?UK^F<@_Y)KAU;?\(]!=M/K.*^X^
M5=OK..C_ -1TY7=_^?="/+WLE333_O,P]0!2;2F[#6;+C&<'S9% .>Y'./<'
MFOW;\<LC_"S5]I4%O"B*6;>05;0+0<;3@ D$ <'(QZU^$>HX#:8<$A==LCC
M)(#R+P.YR,U^ZGC38_PIU=0'CW>%[-!O7!;_ (DUON*C/(0-N.,9Z<<5Z6"2
M6(S=-K6$)7[6P=6-EWOS_@M#X[C!WKY7_P!>\0_3_:<N_1G\X\D #,#P-QY&
M3G![ CD=*B,(7YE.,#N,8YZX/&/?!_*M1TP^<^O&/<]\U5GZ-_N#^;5_+=:A
M",Y)))\UKI*]N:W]=/(_8*<VU%:IJ*>_56U]?/<O(20">I]L=N@_6NN\.(C1
MW>[J"O0\\$'IWP1T]L5R4?&T_P!UP?K@5Z!X*LFO'NP.%5HV8XS@.S C Z'
MX)XS^%<R24VE_*ORB_U.K%^_AI]+I)VZ).S?SZ^O4ZW2=+^TRQ,P*PG@_*=S
M$'(^7&2O&#QCKVZ^IZ1I7FMN:-/+B/R_NP,XQAC@<=,'H.I&,5G:9IP8QVD,
M95003(!DC!YQW]1@D'TX)KT:WMEBC91A, 1C:"-QQW&>_)/_ .NN>M44WR?%
M:SOZKS7GTWTTZGB6:C>]F[KMMKZ]+:[[$D4#Y !Z@ 8  PO0  =@>0 #^E<?
MXG^(>A^";NVMM5M-0FEN;5KN%K1(Y$,4;2PN"6D4AF:)G VLV2JCJ /0;,#*
MLRYVN<>^01^&"??ITKY=^/R^7K^@]P-(GZ<8 U"?'Z./RK*A34ZG):UX<W,E
M=N2:M'T:Z]]NB!1O;73>U[[67?UU3?HMCZPL98+N"VN8498KB"&:(.RNQ2:/
MS4)** "R,&*Y;![\8'RU\1)9/&GQ2TSPS;/^YTV:WT\$ %/MDS_:-2<8QD0K
M+&-Q)&(2"0N\5]"VNJPZ)X+MM6G;$.G^';:^D0$ R)!IL#JA&#G,K1 !65G&
M] <L,>%_ 32Y_$'BGQ#XRO-V86N3YH(8-J>KO)(X42*V!;VYE$93&P",'K50
MBOWLW+X+I:;/HTT[J[71=+MEPDH:1][F=GY)?\._N/JZULX+:"*"W0>5%"B6
MZ@[,(F410AB<DB-5+98\GGDDUD>,-;7POX5UG7'(#:;8S26T>/FEO)2(K.%6
MY(,ET\:D\@+N[!JZ9D!>0!48H&16.<@L5(. <9 (!'&3STP*^;OVC]?:'3-#
M\(0R.9]4NUU"[C4;&-O922VEC;JB$J5GNGDG3()$D",<C(KSZ49UJO*E>TWS
M/=WBTTNBWLGKULMF:IIRN^U_1J-W]UO/R3/.?A3821Z+K?B"Z5GNM7O5TVW>
M7RY)7@MV6_OI]S!GS)=R6B.5P9%W D@LIX/Q$"-=U3<"/^)A-G.1CA#CGI@=
MN,>E?1-OI T+2=&T)<YTZQ#7&PH5-[<XNKYV*J"TAN99(V)X"Q(@ "#'SQXL
M7_BIM6?+@B\EP-WR8*QL#MQU&[KWK^DEE"RCA#(Z;@E7Q%:5>NVE%\]>E*6[
MLWRI-)O=6[:_,3KO%8NK.[<5!N+MO9*-K-WMJFF[=.I6T'']JIDXR!@GUZ]^
MOTK;\4PC[&Q/&);?DD@<S)^7^?45B>'%SJT"C)#,I.>N,,<#'UQ[8KK?&$(_
MLQY /NRVH(QS@SQ@\\'/K[=^YSP=&4^&\WYKPY*U9Z6>U*5O+5)/=/6SOH*#
MOBX:*SC%-I]H-_GH_+:Z>GTO\2;02:-I&Y%.=/T]2Q0$8-G #SC )QC(Z>M>
M :;;M'XGT0#=&/[:TM!G*@JM_:YP#@?WLD]-O)XKZD^(UH3H6D@$#_1-.P&!
M#$?9;<[@ <D;N#^)]J\#T^$-XJT>W"Q%Y=8T]8_-8(/-DU"-8D#D,%,CD+N/
M3@D=*\S,92]O3LY*U##;/3^#3WL]-_G]UOE,"VHU9;_O\3=?]QI7>V_SMUWN
M?N%J&D*UC<1^6Y1;GPZ3'DX4?VK$0P20E5W1K&S, "Z'))5V+>V>'-$L_M<%
MS]F:&=E@1YBZQA%,OV@LW\"JLLLCEMNU5^0#8H6O%;RP\2Z;XA:/4Y(SI4VF
MZ2\EN;E<6##7[>6&26W62..+S!<O"]W) 5>UAM2GDMYT=?1_AG6O#TFJ06(U
M&S\TVT-PDPN(Q:LS2I#';+>$^2;HL2?(3S)@GERF(K(,>I[>FX2;G&G+ETC4
MERMW2LK/75;/;H?/4Z=3FA44:DU&I&[HMNRMKJDM%M9-]-$?SM^'O%/PS\-^
M(]2=?"HT6YU+2AH>NKXG>1]#U^QFM+:YU.:":Z36M3\):R-:TR35M$\0Z7+<
MV=U.4MI[+2K63RFU]/\ B'\.O!7C77_B/I^I^#[G3=1\%:Y9:'X+TOPQ/K$E
MC=^*+)+NST[R[NWTNTTB[T'5FBTF_P!3MA>W$UG!-?1J/[1C6'T'XYZM\,8/
MA_8ZGX>L/A3XF\:Z7J.G:?J<EO;^(=2\0/8/<ZGH[VNLO*UGIUD=/72=.L-.
M@EN[FYN[20_9K81V9GEE\&^"O@U=_"S1+_5IO!J^.+S4=4U36;.PDM/MMF+^
M">VT?0WML27*6MG<Z?)<S10LRVT5U:W+7!2</7P=7"3KXRK0IUJ'-%2?.I<J
M7/;5/3WE=RVLFM6^OW3QD(82%:M2QKA54*;BI.<[023]V\FHM*S;VYK+2ULS
M4/C;\&? ZZ7\1]!^%>GZ]J7BS39=/TSPG<*;?PQX3@CT_25\0:;/J %Q=3:S
M=7RK<KJ6G6$.JG36LOLFMV\][?35\\:C\?VU+Q=8>*H? >DZ5!I6H:M=VNE:
M/*MI8E=4T0:.L<I?2'-[)9PB*0W%]'=75\8!%=22'<1^BVG_  ^^"<VI?"Z_
MNM"\+7FG7\GPQO/$'A6.YT:YT:Q-_8^']-\=WFJ68NQIVGZ@'M9;^^)N%GB$
MFH.FYX4C7U[PM\+_ ("VGBWQKHLGA_P1J.DW7@OQ/>:1JLL]G;:9I.MP:[I$
M.C#2;^%VN)K[^RI+^;3]-MQJ,$BPSO+<7<=K%]HSI</XRG.T<RYTW'^)5C46
M\=?LV=^MNG+V(AG> I\J_L_$3<7))R;NE;2*T>F_DW?J?E'<_M(W5WXATS7?
M^$,0?8=<O=:6TCU<9G>]\-S:1<0W5S<:._G!A,\[33)=>;$BP&(1*I-7XD_M
M"W7CZ.V?3_"\OA&^L/$5AXCTW5M*OX);NRGMM(GTQU2X.EVMQ.]Y#+;R--<A
MS MNEK"7B^9?UWTSX4_!R^\#>(H/^$>\,V.M^'/'&N6VC:M(NGQ:CX@\-7W@
MS3+[0_(TQH4O[RT@\1WEU;W5_?VVG>1=M>VLACM;1)&Z)_AM\&X)_A'XKE\"
M^%B+V+X6P^-?"]FVDS-:1ZIIUAI'CFYUR2.\M[#3+NSU&Z:]U".TNKAK&.&\
MFMTN)=/(DZYY'C6I0EF%)IIW2W>BV2>[TY=5=JZ$L]P4)*=/ 5$XN+C=MM7M
M)7]VVE[/M>VNQ^-'PUN_$GQ0\27;>(_%?B"_&DVUMK$JZ\J:Q:7]Q:7ERUI'
M=1[+>7=%<7]U/%*DP>.:>23 <YK^L;_@GQHECXA_9ZGG.BWUG:-\4?%UQ:66
MH6SV-W';*?#M_ 9+2XE-ZD4UP1>0+<$M<6QMYY?-CDA9OR?\(0>#/#G[0WQ1
M\'?$KP5^SY;^$O!VB:9-X6U_P-JGCA/!NO:IXX_L"\\+07^OZWK(U2^B\.SW
M,NE>+Y[/2+RVL)6\1ZDBWT&C6-TG]'WP.O/A9:^ ->U'P!J7PRU;PZGC[78G
M/P9W:CX;_M+;I5G<6MK%#96EW=W-HTD4<US':%7TR*TO"S0*):[\DP]/ .E-
MU%.I+$4X5)IR<W*-2*IQBG=**][J^:ZW1Y6>8NIF,WR472A:,H**]U1Y).4F
MXI:RTU>UFF[[?R2_'R$0_%'XS1%=BIXU\;+M.T;3_P )!J893LPH(^;/<'.>
M0:_/_4,"Y8=,7<@.>V%8 <^A##Z@CMQ^B7[1L83XQ_&^-.B?$'QYU4KR?$>J
M,?E(.,%N 1^8K\[-1M@+J=/-D8"[FCRY!(#/+(&4C&''GXS_ +(]<5_0/'*;
MHY$TF_\ 85.\MXI.D];^;2:WU/GN#I\RQ47)_N)1ANVINI%3E=/5<LM%??<V
MM.'_ !(KK(P3JUBV>>5W >N., =,Y_&O9?&D:?\ ",ZR,8QHVILHR?O>5/CO
MD^N.]>+Z1;"VT*:-7>0)?V)'F')),\9SGIG]YC)!X'OQ[;XT0OX;UEC\N-(U
M'CKG,,_TZ'\/>M,A7_"#G<^O]E56UY*AB[:^>WGOL>]BY<N9Y<N5-?6H_+W$
MU;M>^O3[SXP@,D%M!*[2I&Q*QR 2,I9 "P.TD KE<#J,J>A%6K75&L+F/4+>
M_DM[JW8O#<@2JT+E3'YJ,W"R!7*B088$KA@>1<U63Q&? &@1RW"OX7A\2:Y_
M9=H+JW,=MK4UAH?]N7!LDF-Y&US:II,3SS0B"86D7V=RZW&?/KMF58K8PQ^=
M*R2;TE8EE9!Y49#85%!>1G#,2Q$9XV@G^/\ %8B5)0CRJ:J0C=3UC[RLERM6
M:\]-/F?I=&A"K&-1*SYTW%V:2NM;R2=OP['6/?6D\CRO=K--,Q:24Y:61V;<
M7=WW%F+=6)+9)R2 ,R;Y00T9+(%!9@\9X[8#*Y. /FP3]:YBX\-ZA;:);:[*
M(?LEY=RV<$6X-<>;$75C(F1&@^4E2LKC!.2,5ERV%Q;SW4$B;);1G6<$I\OE
MOY9Q\K[OFQP">#[5S?6ZM-1C*E&"Y8N,8>Y%)ZQTMY>6WS-(T*,G-0=TIM.Z
MCTY;K=[:;=EU/0(KJ13LCE;#GY@-F"#QAL@ +S7U+X)^#7P1USP;HGB+Q/\
MM#Z/X/\ $.HM<MJOA2?PO)>OHZQ74T,&^^BU2-;G[1!''=DK!"$,PMRIR9%^
M%5A>4D##;%:0X2-,*@R3PG/'8]34T<+/A5CR?+\S>3&!MQG/ #9QS@8;\:WP
M^:.C-RJX:CB8N/*H5>91BVXOF7)ROF23756D]&<F(RSVT(PI8FMA9*2DZE#D
MYI1LUR/VB:LV^9];Q1],_&/PA\.?!&NZ)I_PZ^*%A\4=.U#0HM1U#5+;03HG
M]E:L][>02Z+)!)J-^)3#;V]M=1W0GVR)=;=BND@KR=U;R_,_<JJ@' :!6P<
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M/F(\-,.O<-D =^F.*_!'(]1^8K^@'_@LG;%;?PO(T8!&H:XI9BQSM_L->%Z
MC8<=LXSSFOY]P<$'T.:_9.-_]_P#WOE>&=_5S?ZGQ_ U5QR"G:*=\7C+W?\
MT_E_F;&B*/[8TUNZZE9,#Z$74)''3\Z_O3\&J&TS00!E3IEB>,D%FMU<\^I9
MLX'8C'45_!7HT@&JZ?P<?;K8]?\ IM$!V]N:_OC\ V[2:/X>R<XT?2'.1P6%
MC 6('3GY3[8ZG)KRLIGS8>JK?:2^[E?_  ##BSWYX6_7F;UULE)/S>F_D?0G
MA&VD9D&PX)1>A.>W?MP!U'/7I7VK\.M-+>20N%_<@?+U_P DG)'X=*^5_!-H
MSM; IN!"G'7(\X8QG\#[U]S?#RP CMB5QN"MR!_ P/8CKG\/7BN'-*MH.+DT
MTG%J[\NV[ZN[LM-[N_/E=%.25KWY7MKK9VU];[Z-]&?2/@ZR:(1L1D!8\\ '
M+$GGCCH/IFNU\<0>9X \71[#^\\,Z^K?*2,-I=T,<<\\ 8/?CM5#PS:E(P21
M\R1CD'CEB, GJ!].>YYKIO&2;O!?B>/H)/#NKH#SU;3[AL\ < *<^]?E6-K.
M>,IZM_O:;U;>BE%O3R6NN]DMFD?IF H^SP4G9)<DGT6MKQ6G=JS[;65B'X;K
ML\">&%P<#1[$ ?[(ACSUZ\;ASWK:T&/RH-20C[^O:O)P.@FNYY V#V.XX/(]
M*ROAZ-O@?PV.NW1;4>F?]'!_#K6]IHV_;QUQJ-R?S:0UY6(UJ8SSK-_?-?>D
MVFO2W5GJ896IX1?].8Z^L8/KZV^5R#05VWGB'@#=JJ-]<V%H<_CZ]\>@K7NT
M#+C&0P(;WZYY['_]59FB_P#'WKGMJ$*_B+"U_P :V9^(SWSGC_>(_D2/K[5G
M)_O^:[5X4V]^D(*S^[<N"_=>CG;Y5)7_  /+/$UDK1L57!4,.YRI4X.,G@C.
M/RYZ5\K>.=-#0W *C)W]SUV8YYZY..V<?B?LK680PE+ ']V/T^4C\LG/TXS7
MS7XWL08YB%ZM)VZX4@<_EV[>H(KZ_(Z\OA<FK+35J][.^G5:??9)'RF>44Y.
M2@K-*]DE=V7==T]==?5GYY^.]+*37#$@864 =#D*.>O)XP<9Z8QS7R/\3]-,
M_@OQL692%\*^),=,9_LB\) ('/SA !G@\=\'[Z\>Z:K/+E.5$S'(ZDJF1G]/
MQ]0:^-/BE9"/PAXPBC9XPWAKQ( Z$JR_\2^X((([\="?7BOUS**\E1A%2>KB
MMWIHD]=[N][+SN?F684;57=)74MK*]K;VW^6]WYH\;T&V$GP^\/2-+!F?P%X
M>=1YB---(-"L6D\B",[V"NP+$*53<I.%(KD/B5IJGX2_%9GFB9[?X9^,$GC6
M1?M$)N?">IM!');AMZ/(@9HPZ!W4%E!'-8\GPFL_%3_";XG76KZC'J_@SX;>
M';/1[8.SV2Z??^$[5=4AE@W*CS7*2A4E78A+.;F&Y\NV$.?XA^$=EH>C?'GX
MA1:C<2ZAXT^&_BRUO[$@I90VMGX/NH=/%O'EF6>V3,;2&5D=$C*1HYE9_HU.
MT5K_ "NVEV[I*-WIK%7OH[GS4TY5)QY-FUS<RVLW>W=/2U]5K=[+[?\ @]:[
M_"7A1]N=_AOP\RG'WLZ9:$D#H03R<<<D8 Y'W!X#@.Y&*DE0=O!&-K*!@="?
MF/OWY'-?'OP8A_XH?P*<9QX3\..,\DB31[#@^XYR>A)X%?<'@F *$;@C?W'?
M@GUQP.G_ .JOC<YJO565O>U]';^MCZS*H6=.2;NHQ=M=7[N[Z[OMUTU9]$>'
M(MJ*2,@!1GVZ_EDC\>#QBO9=.!VH<' A&>.G*]:\D\/ K$,]?E./Q''Z5Z_I
MIS&H_O)CZ<9_I7YAFK;J+3NOE:&I^B93'6.NB?Y6M^-UZ+T.PMR##E2"=R@X
M.?K^@KSWXQRF+X=ZO,3D17&D.1@<_P#$[TT#MQGD=.OO7=V3X4QXZDMG/3&1
MC'XUY?\ 'JY%M\*/$\V#F-M'(Y SC7M))&3ZA\?@>#7@8?3&X7K_ +51^:<U
MNNUMUV/H<1*^%Q/2V&J]=W96_'KK:YZ9/@^''88 ;3(Y,9SS)"K$\\C'(Q[5
MN0L&TZ,D@9LU!^IAQT]?:N;#F7PPC#@G1[9OSMACGO@N.W.*VK)M^BP/C&ZT
MC;&<]8U[UQRBN6.KTQ%2W_DC_K^D=*DE-+^;#T_E=-^?\VOF].QQ7PJD1_ ^
MD,KEAYNJC<W!XUG40.N.PX/?W.37=2X.02-IW9YQTY'/UQ]:\[^%!7_A!=**
M]!<:R.OIK6H<9Z?Y_"O0G&_"C@D9_K_2MZZM5K):_O:N_7WY$47>C1Z?NJ?_
M *1%&3??ZP8Z;5_/'_ZZXW6X\QR#!(*$KU.3C&!@=<#I78WAS)CV'Z9_QKF-
M64"+<>0/,; Z_>Q_-OT]Z[,))QJ0MKHOD[K77_@7.7&+FA)7LM-==U;2W6^J
M/#/$MKO63 _@DPO0] <]S@=CTZ]Z^)?C=IP:U\,L5P5^*/PI8YXR&^)GA5 !
MG@YW$#@'G .>*^\_$,0^?'.$<=OXBO0>F">OH*^/_C5:[M*\.2 #?%\3OA)R
M5W8"_%3P@&9<,N&&2V[/ '(.1C[S+*LG%:V6SU?]W6RWUZ_TOA,QHQ?M$[>[
M%O5+7_/K?^K?!_QLL]/B3[#-J&G1:Q/J&A:C::.]S%'JMWIEOXDT:UN]0M[,
MRB9[*UN+J"WN+KRWACGFAA>19)8U;\)O^"G;:=<^!/!T-C=VEU=:3\0CI^KP
MV]W:W,^EW+^']2G-G?PV\C26-RUO)%.(+I(I?)DCD"[)%8_MY^T5\ -,UGXK
M>'?C=IFN:IH7C#P_/I'A_P 00H9;K1O&OA:XUW2+&+1M9TZ2Y2W273IYC>V&
MI0IYZRPV<<R2Q6L0'XR_\%-OAMX.\'?#_2]9\,^'-+T/4/&OQ:;6_$]Y86WD
M7&M:I)X7U:W%[J#!BDUPMK9Q0^8JIQCY.I/U6)K*.5XR/,YN6 KKWF]+J-K/
M;56U^_8\#"0C3S;"RTC_ +33:5M&O:1U]U7NK/1ZI][7/Q%@B -X,,X^V=2"
M22+*UVXSTXZ8Z]>>*O1(% 8GEA\AZ #G/L1TP3Z'UI8("K7JD\"Z8D#@Y2TM
MP.F>W3KC&,5*Z\)N_NJGRX"Y7KCKZ\\^G%?S.U9I*3:EK:[MS*U[KKW?IITM
M^ZS?N.5[K3T:;5NC>GD+"BF4*_W/F#,,X^ZV.1TR<8^M7'CB8Y8 D * 6(!5
M> 2<@@]0<\^IQ@U%#$%WAFVX/IGCH.A^F?2KT,2,IY#8/7:1V'')I6;:M9:7
M=EI?2ZTWZ>NJN8J?E=[)-[QTU5]M+M%!@ OTX'/OS]:T8%S$"#V(Q@'H>!@@
MYX^I[\BFI&C%43(8GJ"5XP226'/Z5<B"A/E#$%.I8DYR>,L,GU_EDYJ9N_)V
M=2-_/Y/]7M8QF[N#V_>+K=7WOIUU_ H7$96W)PN FU=JJ.78%LX ))ZX/3C%
M>)ZL OB"R[JZW /))X6Z7;@'.W:!N8?=&23U->_3QD6@PHR<-S@C [<CGIP<
M_P!:\%UA7/B73U*_P73':.SQW6 !_>]LCGIU%?LGAE/W,?%*ZE6I3NF_LQ44
MOFGN^JT7;X[BR/-6PG1QI55>VK]UZWTU[^9Q_BEO](L03UC<'MP"#_Z$2/KQ
MVQ7+QN2C9X(*[0<9P1DG'?)SSR!T%=5XQ4B>S8+G,<P^4[A]Y#C=P-PW89>W
MJ<UR ?D#'0!?Q!/;ZG'^<5^G5I.,FU=[JS=K:)-K[E;[SR<OC&6#IN^NEU;L
MDK7TZ:]]2V"<MZ#&/RY^M/3&>?2HDZ'Z_P!!4B]1]1_.B,KQ4K:M7LM%T_)(
MZ&^25UKRV?K9)_B:-OE06!(.2,Y.,8';IZ\XJ6X;='DCD,#NZ#(4$<=.N".N
M?S%,MR H)&1D\?\ Z\BI)QF%/^NBG\MI_I6RT6]_>INVO62W^_OT5^QA.7-5
MIM_\O*L;ZO1*,I<OG';3;R/W,^%:'_A3'PD=QN$G@'005Y!(CMHU XP<A%[<
MD#/7)K\4_P!IL-_PNOQP64;GU:9R&&" YW XP.H(/X@]Z_;CX3#=\#_A')L8
MA? FD'(QPL<+1..1R#M+>V1G.,C\6OVK;=[;XY^-DD3RW-[$Q7(Z/:V[#ITX
M(.,<=/6O1XW7-PKS7LU7P<K>333L^VJ3V_(^6X+;7$6/=KVH5]7NOWZ_.]O^
M&=_F\AL'Y5''H/\ &OMW_@F7_P I'/V"/^SROV9_U^,O@W%?$K_=/X?S%?;/
M_!,W_E(U^P/[_MF_LQ_^KG\&FOQ"C\?_ &Y5_P#34S]<3<K/^_#_ -*C?]?R
M/]<FBBBO@CVC_&$G0.S$C(:63:K'(/(&>2?IG]:BAT@ZA<VUI!;H]Q=7$-M
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M>K7NOUOI?I9;'QM:6UQ=_8+6WMOM5S/>6T,%OD(TTTT9@2,/@D%CY*#J 0G
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MY^G^->!^+X%:.X4  JSXZ8R4[<#J3W_F:^@M34)'@9. 3^6#C]*\2\61@K<
M <LYZ=RI&,8],=3U':OH,HG:I:[V??35*_X6/$S:/-2??T7>/Y:NW<^,/'5B
M-\Y(!_=R\D=.%...W'(X_P ?B#XNVN/#7B@*F%;P_KPP <,6TN\&W'<LY QZ
MXXK] /'D&/- ZD3+VZ;4.1U]?7OSQT^,/B=H=_?^'/$2V]K/+&VCZN#+#$\H
M0R6%QN5F5/*#!<D,LK#*X(YR/UG)JB<(+FV:WO=Z.WXO1*^MS\RS&*4KM?@G
M_+;;I9/:ZO\ A\T^"8_/^%?@*0KN,OPQ\)/(< [F;PAIK%V/^T>>W7W.4\;V
MV_X6>/5(X?X=^+,D],OX6O4QCKER%7Z\=.:V?!%E<V7PG^'\=W;2VLI^%7@P
M/'+&5>)V\%Z43%(#AE>-FV/N P5/89J[XCTJXU'X:>,;:SADN;FX\">)8(X8
MD:21WD\.703;%&K2R<D@+&CN6*(J[G /U,IIPT;3]UK?9--W=KO;0^8<+U&^
M6RE?S>MK:>K_ "MH>\? Z%9/A]X!9@"S>#/"9W<G.="L2QS[DY/H,<=J^V/"
M$158,< [6)QQDYYSCK]<U\D?!/1=1L?AQX >\L;NVV>#?"R2B:VFB,;+HEE&
M ZS+'-'DK\R2QQLG0KGBOL#PNRJEO@_> ^O&.?YY&/7OP?C,UFI5)VDVDMKN
MW-I;2UG>V[?7?M]1ET'&,'RI75.VU[7@G^-[>5NFJ]ZT,J$49'49Y[8!/3MU
M/''IVKU?2W^1<?-C XYYP!C\O3U_/R+1=H5<'.1_[+Q_^OUXKU'2I,*I'J"0
M"1C@=3[&O@<RBVVVO>M>U]M([>EE\M]#[C+'RJS=N_75\MUHO6VG5OJ=G:,=
MZGD#/).<8/;TZX^H.<5Y-^T6VSX.^,'_ +D>EN/8KKNCX/Z_3FO4(I<+QCJ.
M_7 Z?CZ=L5Y)^T;(7^"?C8G@FRT\@^XUS2B!QCM&/Q->#ATUC<&VE;ZS036^
M]1=.N^FY[V(:>"Q2>C>'J:K>[BM.K[??]_K,4@'A2!@1A] MF'('(LHCUZ<'
M)]./I6UI,@;1K0'D&PB;/UA!4X[Y!S^'M7*0S%_ ]C+T)\-V;8SG)>RC)R2.
MV0!@#-;FBRC^Q+$\ _V5:GKG_ET7(_G_ "ZUSU*;5.:6G^U5%NKV3AU^?EZ=
MM855.I!VT>%I-O7=W7KIRO6R6FM[G,?"H1CP1IZ1[<)J'B!"!R 5U_4E*_@5
M((]0:]!D941FX!"\=,CL,5Y'\'KKR_ UI@*^=9\59PY.&'BC6%89QV((QVQC
MC%>DRW#.')&!@'&<YSS@\=!Q_P#6JZ\'[>KH[.M/LGK-Z;[ZV'0E^XHIZ2]E
M#9;6@M?DM=RM*Q?G:<YY)')'J/49_P ?IS.JDF%P3QL)'XL,_F16Y-*V<^@]
M^Y(Q_CC&?:N;U&7,4Q.,#*CD#@#=GIC)(YXKIPL6IQ>VL>MU:ZMK\^O;8Y\7
M./)9N[OO:U]GKZ).W]7\YUP$M+P2-C9_\<_^O^M?)OQH39H6G2#CROB%\,),
M^FWXG>$N<XXYVG/YU]9:S)D3$#@C;U]<<\^A/^>M?-7Q=T34K_PY;_9+.:[D
M_P"$O^'MWY,$4TD@AM?B#X7OII/DB="B06\TK.&(2*-I)-J88_9Y?4C"/O66
MBZ7NG;IK>Z5_)^I\=CDW.;2NI*RV=W%)/\^O^9\P_&BTW6%X2O)UOP^6)[9\
M7^'< ^GWBH]SSS@U^#W_  5IL1'\'/ <F "OQ/MT)(Z*?#GB7Y>G\6%!XYZ]
M2:_H ^.%MY&DWP<JSIXA\, M&RL"5\;^']P!!X7="5).&7)! ((K\*?^"O5J
M/^%%^"Y0-FWXL:<A(YQO\-^*VS@@<'R]OX^V*^CES2R_&VYI7P-;EZWY8)RM
M>^BBGTZ:7L>%3A;,,*VE;V].]K=)MW>EVG_F?SN1QL9+XG<&,^>!SQ:6^\CM
MG@Y/&,'FHBA^0%OE#9 YZ8.=QSD<XP#WQZ5IQ1L9KGD']X#N/'^NLX6Y'/0G
M_P#5SB-E D2,C).[)X'09  /7.#T_P#K#^=9R47'1^\KIV::T5[)K\]C]F;O
M&][)M6CJ^JLN7M_2(;<,R,2<,"NUSG()(!SCJI!(7WQ5U/W9 9^I).]@.B@G
M .,#H1]< GI1!$50%#RV) , ["2&8G)&X %N2,@#(!(P?'/C5XEUOPWIVBW.
MAZC+8RW>H30SS0I$3-%' 'C"B:)]@5U8_=R<X(  )NG%U&HQ6K:\KO1ZWM;5
MV>FIFM=K_@GIRIJ]WT]%Z]/9(E')+;QNRA/H..O?K_*KZ+A5<<C 4@=.,<8'
MN?U_+)T=YKG2K"XD?=)/I^G3R,5&9&DMD9I,\ %G8D@<9'X5N+&4RO) /<?0
MYXZ?0\BH<J=E[T>9/2*:?;5>=].F_2YC.2[MM-6[MJU^]GZ?/6XER?\ 16!Q
M@ @9W>C=-H)S[FO!M?A,GB+3HUD:W$L<L0EB)$J-Y=P24+#(R"3]5[\5[Y<1
MAK5LD],C&1SSW_'C\#GBO#]=6W_X2/P_L+>9NG,P+;\,K7:!4!X7,91P3NPQ
M(VG%?KWA@N:&-DK\L9T[MW3UY;73L_/9_B?(<525Z#?_ "\A/E?9P6RT;2:Y
MF_/2^YP7C+Y9]/P1CY\<@G85B.& [@G:>.2*XX0$@M@DGD8R.I^HZ#/3V/>N
M[\=QQ^?8O&Y9"DC*2$!.5@;G:H[L1U.<=C7&"4; <'.T'';..F?K[5^I5E[S
M[-?FDFOP7WL\3!>TCA*<DO=<WRN]]+Z)J^B?G;2W48!@ $8.!FGIC>N>F:0M
MN(XQ\JG\\F@$#! Y'OQT^G]:E-.*2WM9*W\S3_*QTR;M9_$UMZ^?IYFLNW:N
MS& H!Q_>[Y]_6BXR%&,X +8[?*K$D#IQ@?E[5%;?,N.F3GUZ@?X58N,85<X!
MS&Q_NF0%3^6XD>N,>];PW:3;MRW];Q>OXZ^IE'E]O1A?55+/??V,WVU/W=^#
M(>;X ?"9@<,W@JSC4GT2YGCP#Z8&,8_(\U^+G[7\BO\ 'SQJT9?#SV;/NZB1
M=.LE89^IS^/M7[8? R-)?V>/A!*I.3X4CA QD?)?W8SVR<C]?45^*7[84?E_
M'GQ@<8W2VA/'<Z=8M_-B/PS[#TN+FI<)M?$_:X+?7RW?R/EN#I*/$>.B[I_5
MZ]^W\=-;7OU/F')]3^=?;O\ P3/W?\/&_P!@4@#;_P -F?LR[B?7_A='@P#!
M]<9 'O\ 6OB G )]!FON#_@F>W_&QG]@5<=?VSOV8SGZ?&GP;7X>[QJ0MI[M
M:]M+KV4ETWLV?KL6U%-*[<HN*[IRC]V_4_UR:***^#/</\6%/&L)+_\ $NE&
M7=^+F(Y4D%<YM^,D $@ XX[D#]._V8?#<^C?#Z[\3:A9?8K[Q5>QSK 7)E6P
M@_T:R5RJI&05.H7 ../.3(W8S^8O@?PQJ>K^,?"NE06DXN=1URQMH8[B'$;N
MUU"H)$D:[H%W%II'C:)$!9U*@U^X0TB#0=!TG0K8JMOI6G6MK& VY?+@ABM(
MFW  LI6/S0QR7,AD)(; _IGZ/W"=\?F'$^,HU:53!QEEN$HU::@HSJ.,Z]5W
MCS.<5%0@TXI*;NG=6_-?$;-+8'#99!O_ &NKSUIQE?\ =T&FH);.\W!MM/2/
M1M,X1+%;F[FD*,R6T,ERX9@<[I \*C<PP&"L< >H(YKG=52UL;34-8U.]@L=
M-MBEW=W,S(D<%JLID+D2.@;YPL,<8.Z1B(D#9(KN)Y[;3M*O=4O9A:6LC(UQ
M<RLHA@L;(.)))#D;(, EY"656P,#<*_-/XW_ !DG\=ZA)H>B2O:>$=/N9! F
MU(I-5G4L7NYRC,Q@VH#;QEL1H=W,AW+_ $'QEQG@>#LL>+KN%7&54X8'!7_>
M8BJK*_*FG[.$I)S:LVM$[GYYDV2XC/,6Z,$J>'A98BO9N$(I1;BTU?VDXZ1U
M2YG=IK0H_&[XPW_Q-U1+;3&FM?!^BLR:58,X#S,8@)+^]!6-Y9)6=YTB9G6(
M2[ 5(-?/LNL0[I]L6Y0R#S#QD)\A?;SC<?X<G Q@D#-2WY>&V4*2'N'"#YB9
M"N,2.S'G!&P>@ Z"N;\L!63)(/!/T;/&1ZCODX]Z_@SB[/\ ,^(LVQ.89I6J
M3KUYN<*4M(T*+;E"C2BU[M*-[13;DK*\F[M_OV5X3"X'"4:.%H0IPIP4=KMR
M22<Y--)R;5[VMK:VQI2ZF)F7RX\8&,#Y02<YZXZC@^W%,:]!&/*/4  MD?ED
MU02-4.023[X_H!2*2_7L>,>Q([YKY;^OR_R_K0]"_P#7W??ML[HO"[!!^1@>
M1A=F,^^3GZT1W*JV6C<#_89 2>V<\$=??TK.9RC[0!@D'G.>>O0BI'8J 1CE
M@.?0YIIV=UOY[;6V_KJ"=M5_7]>7=]#Z$\"3++X#UED64*/$VG*=QC(W?V;>
MYXR6Y'< <9'7K?3EPW. N.A[Y]O\YK*^'@_XM]KOMXITT_GI6HYS[?(/S/MC
M;B(RJ[5P45B<<Y.?TK^G.'TJW"O#<FVN;*8TG;33ZYCM5>[O9K5Z7>Q\I-J6
M+QNZY<;67WT<+=ZMW\MO.YA:G_S#\_\ 0<TW.?0-/G],C]*_</5G#> I58D@
M^%;103DX+:-"5Q[$ ^F,<XXS^'FI'<MBQ !_MJP; Z<-/@?2OV[U%PW@7#<;
M_#-@#CC@:'&>"<XY/<'^=>SAXI5\Z:O=82B[=+RP[B^G2+;6N_?8^*XQ=JF7
M3U]VEB(Q71OZUEE[K?KNK=/,_GAN8EWN6X0LQSU."V01WYR..HS]<4]B*5V8
M//7'/;CGD?2K4\X+,N =KE<<C( SG.?;VQT/-5BVYEX P1ZGO[U_*&(<?:U5
MK>-245]ZW>V[]7UZG[+%*T6NJBKO?6RUTZO8Z%AE4 ZG"K^(Z#T''TKT;P#X
M_P!+\%1ZG'J-M=W!O3 \7V54;:T(G1U8O)$R\,I^1BK9YR0:\Z;@*1_"P(_
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M .G?%#X0:_XHLX#'XU\!:)-K>@7)GE@@GM[*[L]5U;3[Z,$075NMG8SSV:7
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ML*MM9Q76JW LKO4[^."T62P>21=6>?4WGA-Q8W]^9[2WL8)%D>YEUF*W\DR
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MI^%_B-\58[;3Q9^'K6PO="71=>\76UC$ME*EQIXEF@(:"2>.PNKFQ%LA\?\
MB!X-\*G6D6'1=2TD-X<FN)X=-OI-;:#4XEU]#,K7=PC3V\AMM.E #1KI\<A
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MX+.5\!6RRQLCIX@\91E'1D(*>+M;7< RCB08D! PRN'!(8$^HO*IR%/J".>
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M+TK*_E:_X7=OF8'C)P7TX$#&&XQQM*0'!'3'!X'?M7#(Q*J,<9"]#Z\\]/\
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M]F^QS8BI%YA0C=MJ<7?2SLF]&W=W6J_X<_2'Q78%O"FBNZ,%_L32@N[&%/\
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MAP./L>C8/<_\2C3^?IUP<\U^M_[)Q$W[,7PRZD >*4 S@H%\6:H!@]\#)QV
MZ<9K\F?VXD*_'#62>^G:*2,<<:59+^H4>A.,UZ_$7O<)U$E\7U.U^T7!.^^N
MOW'C<-R2XHQ#ZN&+CK?9U$G^-M]>_4^.5ZCZC^=?;G_!-<X_X*+_ + I[_\
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MZ22RF-8[*,P22%<XN44D%E:OP@UJZ,^H2@<HA$4;*,*0CY+ 8X#9YZ<Y ^7
M'F>.V<4,'EV!R/#1I4925Y*E&FG&C'E4()Q2<;P4GR?"XRC;H>AX:X2OBWB,
MWQ4ZM?VLXNE[>;DH\J@FH*[32FFXMI?#??W5D,FX*,XVD=NM/9@,MSC/X\G
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M;T_?5+1@^E];NR;NMMC[-O=%MK:RLM/M8]EO;6\-M;*JH@CM[=%@5 J!0BM
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M?I;5RDXJ:33]R6_,VW*E"^NNKU2OM;7J6?B5\9-!T']K#Q=X6^*GQ)U#Q)X
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MWZ65W?K;IE:I< JS8/ #9XR<D_XGCGZFOF?X[7._X9>.B 3MT&^?' R(=C,
M<G&0&P>/>O==4OMN]6Q]Q@>@.>"@XY!ST&>??-?-WQNN';X:>/1N./\ A&-9
M8>@;[%*XQCJ6*@ <Y)XYKUJ$5;;^7>_1Z;=/,\^M.3;;=TF[:6T=DUT_X'X$
M/QEG+6GB2, @C4H6R>A"ZY#R,>NW([9Z^WXL_P#!9_$W[%WB1CTB\8:&_/7
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M3/G;]FO2](U[XV?"K1]?TNUUC1M0\4Z5:ZCIE]']HM;NUD:X>5)HL?,B@!R
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M8?"_6[]? GC+Q[-%)H+P>&Y8O'4<&L*;G0&D3[3J:I;6\=S:RLD=PRO?2?\
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M\DK;:NW?I;;?7S/I,+B)<UM&GILUUCMZ:??8]!^!5RO_  IKX41D\CX;>!6
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MMO)A3D[(8XV5(@>NU5"+@Y^5%YSDGC_AE?;O 'A,ME7_ +&MAC)&-H8+U)(
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M<^Y/A-(O_#)WQ+3S#E/CE\,':((Q#*_@CXG '?\ =!!0\$@GC&1G'G&1D#U
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M,8!;GFO>4(J#7*K*$HKM:2W_ #2O>WFCP)-N=[O6<9;[<JBDO2UM&K==V,^
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M.O\ M'(QC(;K@9^O_P!A28M\"=2C!SY7CK6R,?[6F^'F()].I'0 \\\U\?\
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MH^".>X]Q_A3G7YWY4?,W&>G)XY&:="-LJ,<$9QQTSQU/!''7GWK^1:G\2?\
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MQDK[;U7H]=%9;V;=[W/ZMQ=3W'PQU#R\R7;>";*)57EFE1+I8P@R"Q>4(J@
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M7IM^OH-\?WY_X0+73G<7^'UXYW'@A_!^ 0>H.6)SCZ8KX!_X*"2O<?LC?%1
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MM?0]B4N;1;:627IT_K;YDM%%%20)D?-GLNY>>^2#^@&?8TB'*Y8$-G]/Z_\
MUNO:G4@(8;N.N/?CZ?AGMGOF@")RX< =.._Y]_Z4_P M/[HI]% 'O?PZ"CX?
MZYQ@#Q3IB^WSZ;>Y/3J/\^VW\I.21TQ@X]?>L/X>L/\ A =94@?-XHT\GW_X
MEE\ 3].,>XXK5'0 X)P.#S^/_P!>OZ>X>]WA;AF6EXY1!.^NCQ>-E=^5IK?9
MIGR\K/%8M77^^UK[:_N,-;OK=?<9&K<K9D=!K-A_.<=O\_7K7ZP:>1_PCUN
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M7VZ$ Y_#%?(OQO'^@Z"/^HH!G_KG;G^88#VQWS7UA?N%\':'GD_V%HZD'O\
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M5'7K_J\X_$GCG:LY2UI:KD_<B?'3.UW&W)]2W4@].E<C\+I2/ MF2,$^(?B
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M?-+OM97\E_PR5AY.1R3GGMVX]P/7_.*0$ $=B1SZ<^E(,E@H Y[DX]O\._\
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MS+R"PWX!X)(#<@YXY'WL8//;/I5I(T="ZR;]HP8W!W@\G[Q&QEQZ \<'G)J
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M)K5%4=>48RC0YJ$%*=!1<JJDXQC%QU;;MXCX<N(/[4LI!%Y@34-,+Y8X*B2
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M#X?NFX'98G<I^9[U^\E[?E(U0/D"1D.?8$#CJ>GJ#S]<_P ]G[&OB>S\0?\
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M#MQXNP^M_>E=;+6F]M[ZZOI^1^5"[L+\P'RC)].%R>/?GTQZ\5]J?\$VR?\
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MJNF!=Y6?S7DV)E&&]A&48-O6)=P8"N%\3ZG<:OK%U>W#9+R%45,+&H&<A4&
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M%^Q6F[J<D:M;%MI/7 &2!]T=<9%?>_QNB!^#?B##;O\ B@K_ !D!>FD2 X(
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M&*^^)"?Q/H_A\KG&?W5_J6, ]<&1N0?FW '@"M_]NZ%3X T!P"2NLR9/4[C
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MT1$,"%[I88VE")(ZPHYDD(<1QR,HK-U7QAX>ENEE,FHZM="99I?*5H[8OY8
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M,F# G)_UC;L]N>"<=>HSS6"Q(C<L!D*^0#D< XY]Q74:0H.GIQC]_,?S<_\
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MOMRO;1I7T\CB57^JQ@G*"=1KFI45JVM5*G4;Z]5:][Z[^,?&?2/A;_PCGBB
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M"1E]7P[5_P"!1ZZ?PX-:?<]C<&JD ;KF4CYSM*MW88[GMG!/^&$;4DDVYN)
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M+[>H)/WB(\$@#(3N:\67'!7D<$ D9([>A_3\Z]MN-K^%8LC)_L1&)/JIN4
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M6/\ 80TZ:QM-.-PNHQBZ?6XY+>YGFA.F/-]@AAEM574C')<7)@#(?T=_8_\
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MSQ%X+TBVTGX-+XQ3P9I44&D#XJ_$SQ-XQTO3YH[&"T2YGT'PQ9^!K%YKA;:
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M/[3=SP ESX!M"3SG*7UQNP!@ =%QC.UF]<CZ/CD"H5#$!6+ Y&3G(P3TP.W
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M8Y4MDY0BW?6\L70DFE=;>S:MUYKW7*?C,%W  #YL#G&/KSCFI(E*L%.,DY_
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M\HQ3:M!WN]6V^5.[?RU7IJQ5CE4<B1CUR<'CW/;^E/&\'IC\S_,4Z.Y(&,L
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M^MW7B70-(@NY-7OY[*;1+Z$W0N1I!L'O(DMRSJ4DN6,P6V3YP&=7][AC%X;
MYM3JUI.,%&E/F?>JU:+ZW5GMI;4\?/\ #U\?E[PU"/-5<=-;W5DY-W:M\*77
MIZG[RZF(+?0-<T]C-)=6^A7\S2&&582ET^H%'6:1$26658Y$>&$RO'"%G=1
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MX.!JU]C@_P">U?FV57=7%./:+U[<T8_?Z.]C[/B%?N*$E>ZJ-6>SNO3;7O\
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MVF^MM=?ZU/,K.UDMG=NROVVU\NEO75G->&_E\9?$L<%O[7\+SE0>BOX+TR
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MZO>_3OIV>JL><?"=U34_'G&TC5M'<@G[Q?0[)B?;'3IS^-;VG/'_ ,+>UP#
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MC@M)!:Z\5H,%H_$T#YXX23PIX38G&.ZVTB@9_B)'3!IB/=<7T9)7]_$NX#(
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MHOP%7&>>G^?\_P"<TX[-VW)SD#&01D_K_6D";NA''U'K["E6,A@2IP#]X<G
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MDVFT[^MM$MBY=:G/J4Q+[W9B2G7'7).#@?*HR!Z]ZS'4&1R6V@2%2=O&%!.
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MS# ) !ADSN'XIG2]04#;$6ZD+')&>W=0W YYXQZU(VD:GM#-&J \F,RQAO\
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M]-NQ^Q\7C/\ 8;5B3\//!\FY6 .SP_)@R%=X+>:"=P15"D$( 2I!)J.Y\?\
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MR3>'K]^<![?S+TD $YXWCCJ#G-?K[^TBI;]DSQ254(J_"6W4#JP_XE>FQ\Y
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MI25-KIM=_*_9?)^23Z]XJOF#3:A?$(ZS*MI,EA;_ &A8_+$X@LUMXS(%P ^
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M@^N,]1D'M],X^@UI>]&*:NTM]KMO32RZ;&4^:-MM=;Q:EVW:7HO/8:&VDN<
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M50#P2#,SAAM9P<D=B>Q]37S]L=>J!<]-P//T^G?I7U!^UE;M;_M#_%2 @_\
M(SR2/CG&^UA;(/7G))XY)R>:^<V5.A)X]F/IZ?Y/6OP[-J5\SQ]NE><O).57
M7[[O6UNEMD?M662_X3\))R3O0I6:ZVIP[6Z[VO\ <97!.TJ >F1[>G'M3'4
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MZ.=DK:;]M-EK^!YU%H=Z5!E\B+G)$TH#XYYVX/X _3J*T(=#M@P-Q-(R\?\
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M?J/K3DT:]"_+"SG/W<[>,'G/UP,>]>@23JF2T87IDG*LQ/5F4D')Z< ].O!
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M$>&4_?"D,0,@MM(.U1W9C@ >_P"%>MZ):W0T6TBD@ $2Y2*0;6(E<N=P'S9
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M=ZMO5O1GGJ;FY2V=[)7V45%))ZV225ETT5D9D&I:I?#.&CVG!!#2KG@*<;@
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MLBMY4\\D9QMFN))"S#.?+Y'3&0,?CZ0QZ!_9P4BPD4$XS<7,VWKG"J#@ <
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MZZ%%%%?G)]&?XJRVZ$@M)(#V0<Y/OD#CW_R9O+4>W'//IW_^O39+KLO&<CH
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M&6Q76VK-A<11?+T)CCY.!R-H QC YZXZXP*2U\/S@@B)9"3D*%5V)')8A5!
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M_5Y5:2VG$R;<@R,BK$V1@M')\N,$X;D@X]:>MC=K*<O*)%;:ZF%2LK]&*.G
M5C]TXR <]J]2TW3WM8?-VI<1L=D2*^TJ#G)<*#T(4 'C'3-7ULKQKR)XK6(H
M "45-Q..N_.,#'7!SUX'%+D7=_?_ , F]_-]&]>BNK6=]=O-W.#L8_$4@M?+
MTXIEGA\TAF5U#8 +%1\X]<DXZG!-;,FFW,3$7**Q8[&C$88 DX+!R2 1T)'
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MD [!3DL-HP2,9&6XK N(1(&58BNQB=PR,G &.X./3GC)] .^OR)Y6CB%FVQ
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M=M= MK;;;\3AG8^9LEG$:@ YC"%@W;=G 8#@X.1VZ596WAE4RQSR2DE1()4
M.<_P[04"YY&,8!_"NDET/2HVSYPF5_F5BNS@GH[D,H8>@4=N.]8D]D\)($4T
M<;-F(*IFC8 \$F/8>F"OS #N&Z5,6G>WO)>3Z->NZ6O3\@(WMHHUR]O%*IC?
MDY/S,!M!"Y /Y$?E61=PHP*6]G%',.<[G5@H!!QR"""0<]<9'3.=LA\#==*
MH^=7 ! YVX &1T(^8L>.YJ1+&*1#Y@7OL!GC \SH"23&V-N[C>1R,J< @E:T
MMT[65M]+6MYV3[?(:=VDV[;;_=^-CS^6UN(UECN+=RKH3#<*&9K.4ON9AR2\
M+KQ*KGC+$#C-8=W#+:O&0?,C*K)\D1)PG+RG R$QC!P,9_+TZ[@AC#+)-%$H
M!&X3B21O5=BLXS_".6SD$CJ#S5];V:JLD4LVS+,4B5XY(V YN(93G$L><B [
MXYL[1&"H(Y]?Z7HMU^NWJSHOHEV5EWLNYX+KDP6ZFE>)V67>&8MM#*IR?O<$
M8/ / _A(R0.3FM(IL2J\.R-7)C38&5&' ..6^;&,9QG/J:]!\5:!;+/C[7>2
M3.DK1NN]D8)EVD1I1(6E!;=<Q,7\KV& //CI#KY;_:FVO'MR&0.) P+*0$7"
M_=P"">N#WKBGNWLK\K?G=:)/MY/KN=N':=-Q?\UE;3I'J[W_  \KF*-.:02%
M(I)3')&64K&JJ HR.2"VT D$9)VY[U!)I#Q(PEMRB,&91M5RC.Q8/A06VE=O
M& N<\Y&*ZYK74%A=8XDDC+ RN"6/ V$;4VL<] "2%;DDJ&!NBP:6%I?M @(0
M9B6:(R8  VR1RD-@^D6YLG[E8W2>KEIIUULEVOWW>]^UD;)P[M??V7;T_I6/
M+Y+*P8LKI,)9!AVQ(%7'0\KCZ<Y&/RJ/I-N2P#R*1"58C:P8Y^3:&.0P!.3C
MVSV/:R: W,@NX".F6E+?.O+C: "  /P/7J*J/;/#"T:RPONW#S-N[)[!2<\C
MI@Y&:-%UEV_"/SN_31MZW8TX)+67GOTMHM&O7U['!_V3/O\ ,6Y<(N0FZ% <
MYP2V1P>>A&2/QJVMC=AMJRB<G#,SI\X( ^5-@))Z8SD9]NO4J((8@DL4+,Q4
M.$C"R# (WDCKN_B.!DGM6G;+I\T<FQS;RJ,#+*,G' )V9'0#((QUQ0G%;7\_
MBZ6[Z*VFO0+TWKS*ZTM)J^MK+:[T???7U\\DT/4)R"SI&Y\PX.PD(,$[U!."
M>V0#G. >M8-[X:5EDED+(Q)Q+&H##!SG(YQU SA3ZYKUYK=TPX??'@[GR)4'
M0 ,4"$;NBY)R0?3G"O;/SF8Q^2$?/_+1DV+P<&/)VGU!SM. 0*:2F[::6?Y:
M]VG=+;R[%74;7;6JMMOV>FV_^9Y(=+M.(VFN[AHVSAHT#)MZE0OS%1TQRWIT
MK,GMX8V8F9XXPY)B:.5=Y)P&R!M4Y(..#G@#)->AW%@T3OO6 %AA7(5P5SR=
MV 5ZX(! R.E8L\"IN4M$%Q@KL"+NZJ1'R&(/(8C@\]:4D]'>R6KWVT?S*;CR
MMKFORW2=O+M_P-MSD9758S'_ *R,X9V4C(0Y &0?E<$$DG!^89JC,K",.;90
M& VNC.Y(;) .2P ^7+ C((&1R,[-PCF7R0D7ER*XDD1<,BOQO.&VY&WY?E'N
M","F/8R)+)%91$Y8[6:=65D?YD*97J,8SD]2,@5<>DNBLW]^W]?>8+WFEM?1
MZ^G?;5=_RUY5+(S.\@$1/\<01$<# Y*MAF!'S< D#H:^ZO!A_P"*)\,,V&>/
M2;*/:2&_U,2QR=<_=;@>O!''-?%;P7T,N613M)4D21[U9LCDA 6&<=<G' QQ
M7V'X#N'?P-X=DD"[WT\,Q /WC(ZL!EB0H"+@<X]37VO"-3GQF*2M_!IMZ--:
MIZ;_ #\_O/ XAIIT*;?6JWI;:R6MUM^OE<_.C]H.+_BY6L'/)<,3R"Q/.20>
MN3G/7]:]G_X)L+C_ (*+?L"[B2?^&U?V6,<D_P#-<_ GKG']?PKR7]HE OQ$
MOY!UE$;#N.5 Z?GUZ^E>M_\ !-S/_#Q?]@/./^3U?V6.@Q_S7/P)7Y]QLG_;
MN9;?"I:=;TT]_5VUZ67K^C\-MK)\MB^E.*U6OQ)K7?\ RZVT/]<^BBBORH^N
M/\5]T)=]O4.#SP,8/?G)_P#U>]2JISN?&['U''3_ #V]S4L<H9Y"4V\CYOO9
MX_'&?IVZT%E9C^&<$#TYQC_ZU?J+P\;?'=;6:MVUMKIOTZ=SY58E15G!K:_O
M)]MDEV?X]]Y/.^55"X(ZD'^O\N.QZ<4]4\S_ %@!'7'<CT.?\]!CI35B!(RV
M >AX(S^ (_QJ9H749B^8#&<\ <'';'/;'O@5+PCD[K6]EH];Z*ZNE?\ )N^M
MMLGB87MRV;2Z[:+_ (.^]^HT(J$80%1T [>H]><<]OK5^U@*DS1Q$!L ;W.W
M<3S\NT\<G '(S[546*Y+)E67OPJMGW.X<#T^G/K6E!#>2AE#Y1 3\H50I/3>
M2, J>6"GU SG%:TL'4YDE%M-I:I7M)I-VOTOMV^9E5Q4%!\LXZ)MW?E??3R3
MZ:NQHI([2+$\<8XZ/AD/?/J?0X!Z#GJ*U(+>*-1<7(@MXF;*L4PTS=O('20#
MD$G*CHW'6G%8M;@R(AO+@[=TLK%H(LJ"?*CR'=@<Y5R$[XI&@NBS37"R3':?
MG8KLZ<*%&0H[?*%ZX->G3R^5GSW;2O'1::^3U;WLM;[L\F>,O?E:TVL[J5[7
M5_R=NNQNS70^S21VT4,4,N TBF W,@'=W8LR+TQ&@"==O)-5_M"FV.Y.$0H&
MC5B3\K 9W!>. ?7ZGFJT4%U.8VB@CA 7:6"J6.WN"00#R?P]\U*UMJLD.U6
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M%PRX^T2<]1N8<_BSXX Q_*K,%XR;5\R0\@85MN <Y!)!S^OIZ9_OY_XA2_\
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M']_8\P5'Q4_:?56\O*CQC\)2/W6-GWO@DQXP#USD?7+7%V4+[>(T_P"G#_\
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MO*KG/T&".U?UC#_@A;^R2!&H^(?[1($>2/\ BJOAAEBV26=S\("[$DYP6VY
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>ny20053122x2_head1.jpg
<TEXT>
begin 644 ny20053122x2_head1.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MZW!K5[XONM7TO^XZ@#\EO^"Q'[8W[7?[&'P"^#GBO]B'X+>&_P!H#X\?%?\
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MQ2\5Z'J/Q#N_"WA*^UR_\'>*?!=E=W_P[;Q+XC\!ZU<:GX;UB71?Z,Z_'/\
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>ny20053122x2_head2.jpg
<TEXT>
begin 644 ny20053122x2_head2.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
M+0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0":
M )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T!
M$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I
M ;$!N0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<"
M<0)Z H0"C@*8 J("K *V L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-:
M V8#<@-^ XH#E@.B ZX#N@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$
M?@2,!)H$J 2V!,0$TP3A!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%
M!=4%Y07V!@8&%@8G!C<&2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&0<K!ST'
M3P=A!W0'A@>9!ZP'OP?2!^4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC[
M"1 ))0DZ"4\)9 EY"8\)I FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*
M\PL+"R(+.0M1"VD+@ N8"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT-
M#28-0 U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/
M>@^6#[,/SP_L$ D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('
M$B8211)D$H02HQ+#$N,3 Q,C$T,38Q.#$Z03Q1/E% 84)Q1)%&H4BQ2M%,X4
M\!42%3055A5X%9L5O17@%@,6)A9)%FP6CQ:R%M86^A<=%T$791>)%ZX7TA?W
M&!L80!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;
M8QN*&[(;VAP"'"H<4AQ['*,<S!SU'1X=1QUP'9D=PQWL'A8>0!YJ'I0>OA[I
M'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B<B52*"(J\B
MW2,*(S@C9B.4(\(C\"0?)$TD?"2K)-HE"24X)6@EER7')?<F)R97)H<FMR;H
M)Q@G22=Z)ZLGW"@-*#\H<2BB*-0I!BDX*6LIG2G0*@(J-2IH*ILJSRL"*S8K
M:2N=*]$L!2PY+&XLHBS7+0PM02UV+:LMX2X6+DPN@BZW+NXO)"]:+Y$OQR_^
M,#4P;#"D,-LQ$C%*,8(QNC'R,BHR8S*;,M0S#3-&,W\SN#/Q-"LT932>--@U
M$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.% XC#C(.04Y0CE_.;PY^3HV
M.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_
MXD C0&1 ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:
M1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+
MXDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q
M4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9
M&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV %
M8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUG
MDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>
M;WAOT7 K<(9PX'$Z<95Q\')+<J9S 7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW
M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$
M?^6 1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B 2(
M:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI &D&Z0UI$_
MD:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:
MU9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16
MI,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVN
MH:\6KXNP +!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1
MN4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'# [,%GP>/"7\+;PUC#
MU,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZV
MSS?/N- YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':
M=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-
MYI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_R
MC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[<
M_VW__V1E<V,         +DE%0R V,3DV-BTR+3$@1&5F875L="!21T(@0V]L
M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /Z#_P#@LSXT_P""N4/Q
M&_9(^%7_  28U]='\8^,?!W[3?CWXRVUWH?[/MWIEUX8^&VL?LV:!X5O+G7O
MV@M U;1M+NK#5OBGJ=M9:3X=OK+5M<35;R\N++4;'P_)<Z3^#_P^^,/_  =O
M_%/XB?&#X8^ /B;I?B3Q#\!]?TCPA\4=2L_!_P#P3ZC\%^'_ !OJ^@:;XI'@
M6T\>77P^@\'^(_&>B^'M:T/4_%OAOPSK6L:GX,36])M/%4&CZA?V]F_]Y-?R
M@_ML_L;?\%I?V/OVB_CY\;/^"2OQG\&S_L]_M0_$K7/CO\1/@EXPO?@;I]WX
M&^-?BG0]'A^(?B".\_:*MO\ A&;JQ\=ZUHBZUI^I^&?%6@W=JU['X9UGPXNF
M>'++Q'JP!XC^QMXW_P"#@K0O^"J'[%/P\_X*4ZUKNL?":^M?C7XGATG3+_\
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MWBS4/#_B^\\$6=OI%[K%YJ.H:#KWB;5O%7B;Q+^LM !7\J?_  4N_P""EO\
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MJ?'CXDI\+?$MY&]UX+\6^/4^&GACX4RZY8>:PT;QWJ$4]EJ(\NSE_2K]G?\
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K@26FLZ/JGB#2]5T2[T.^\-0FW&M0ZR^JF32XK/\ ;B@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>ny20053122x2_jane-street.jpg
<TEXT>
begin 644 ny20053122x2_jane-street.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MC77E*0S'2[^]L;>\\4>(K^*99K'5K#X?:.^E:6ZEKCQLL \X9N3?PZ);M_\
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M'Q%\(?A/X4_X)^?M#_%_3M)\+^*M-\?V^E>$_ GB22'4+G4+?2?"GC:TUAO
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M_P""9GQM_P""R?QCT'3M6^-?Q4L-1^%'['_AC5X [W,-_*+'3M0M%ED1H_\
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MV966S,A* _7;S _I+HH'(SZ^O7\:* "BC^G6B@ HHR/6C(]: "BBC(Z9Y]*
M"BC('4CM^O3\^U% !117Y0_\%"?^"S7[$'_!-B:T\/?'3QSJOB+XH:E9#4-.
M^#OPRT^R\4?$$6$L)FL]3UJSN=2TG2/#.F7OR):77B#5]/DNT<3V-M=Q)*Z
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MMUL;BTUOXA6M_!(ES807!^-O^#;'_@ECH'[>'[1WB+X_?'709-=_9]_9PO\
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M,/#'A+5/"GB:\DT?Q*WAKQ#X7N/$<<^H6TFE7\4L=M'+8S7%C?VE]+_F&_\
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MQHFNWFDR0QZIH>NVWEWK::;BUOQ:,]A<*O\ J8?L$_L:>"_V!/V6_AU^RMX
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MG4K^;6O%OC378+1+)-:\5:[<+')?7D=L@AMX+:"STRRC:1-/L+5)9%;\^_\
M@JM_P0<_9H_X*B>)-'^*6N^*/$WP5^.NB:';^&1\2O!FFZ-JMKXFT*RN)9M/
ML?&WAK4$M?[>FTI;B>#2M4@UG3=0M;006,TES8VEG;0N46XI*UU\NCV_I"T?
M6VB_33J[=OD=-^R7_P %I/\ @FS\0/#_ .R-\#/"O[3'A/4?BM\5? _@+P=X
M?\'M9ZW:7FE>*K#P5:)-X>\67UWIL.D>&]6EU+3Y-!L+._U%9-5UR>RT_3/M
M;7MJ\I7YE?LM_P#!I!^RU\&_B/HGQ$^,O[1/Q?\ C2?"VK:=KGAWPQX;L=-^
M$.F+J6FS-<6\NL:QHVHZ]XIGBCG6WGA&@:UX:O8)K<.-0=6\H%4K]4OD_/T?
M2_7L&G=KT2?;O;S_ *U/K/\ X.2?^";]_P#MO_L42_$SX::%+K/QY_99?6OB
M'X4L[.&2XU/Q/\/)M/63XF>#K&VA!DN]0N+'2],\2Z3;)'/<7-_X<&F6<+3:
MJ0?Y-_\ @W[_ ."AWPV^"7C'XG_\$_OVN[FSG_8Y_;1L[[P3K:^([TV>@^!/
MB)XCTV+PK'JFI75U*MOI&@^,M)>#PYXAU-3:R:=?VGAW7+FYAATJX(_T[;F%
M;B"2%T21)$9'CD ,;JP(9'5E8,C*2K*1A@2,C.1_G7?\'%?_  0^U[]FSQWX
MK_;C_97\)37W[/?CK6;[Q'\8/!?AVT4O\$_&VM7]Q?:AX@T[3;81_9_AIX@O
M)HG@_L^V^S^$-5DDLYEM=&GTT6TR33YE\_-?U_F%_P"MKZ^F_F_T/RJ_X*)?
ML(_M)?\ !%W]M70]>\$ZQXDTSPI8^+8_B-^RW\>]#AN5LM9TS3;R*_L-/N]4
M6V?31XP\,)+#I/BK0GFGCN;62&_,<VCZK!+)^[6D?$G]@?\ X.3OA)X2\$?'
M/Q/X7_9&_P""JO@'PS:^&_#7CV9;/3?#'QI3388S;Z?81WEY;Q>*=(U;5=0N
M+P>!5N!XZ\)WDTUSX8FUG1(KR%ODS_@G7_P6"_9P_:*_9ZT__@F9_P %C-(/
MCGX(7%M:Z'\(OVE-36ZOO%7PIG@@-EX<M?$&K6UCJ'B#3)-"$PM?#OQ T]+E
M]'TMET3Q79W?A:.>YB^??V]?^#>']JO]F-3\=OV.]1G_ &P_V7M0C3Q5X0^(
MGPFN;74/B%X6\/7>;W2[C6_#>BWL]]KPL[,0,?%O@2/5--FB3[?>VGA\R+9P
M3TTNT]X]G^??5=M;AKTU_"[=KV6W;36VEKVN?*W[0'_!,K_@JS_P2N^),OC:
MT\"?&'PS!X:NY?[$_:)_9QN?%FN^"KBUB8/;7MSXM\'6L=YX<AN5:.4Z;XPM
M-%E,PF@,4SPRR#TKP;_P<=?\%@?AWHY\-3?M-#Q"]M']F-YX_P#AG\/O$'B"
M+:-FZ;4KSPU;WEQ.N 'FN_.EDD!>:61]TAN?LL?\'#O_  5$_9!L+?X?:K\2
M+3XX^!]#C;3)_ ?[2'A^?QAJ=A!;J8C8CQ9-=:5\0+06JJ+=+/4-=O=/MDC6
M%M/!0"OT3T[_ (.EOA[K-I#=?%#_ ()._LO^./%&S?<:W9ZMH&FP2SY^>5;3
M6OA'XKOT#R@R.KZO+N)&')^<FBVDUY-/R[/KZ+;<+[].MMU?3O\ /Y:>OXT?
M$K]M_P#X*X?\%.-1B^&NK_$;]I+]H:WUV41Q?"CX4^&-:;PU>*\D;L;GP7\,
MM$L],N[6-HQ)+=:S;W<-K"KR27$$4;,/U^_8<_X(#Z;^S/H^B_MO_P#!7_XM
M>'?V6?@Q\,;ZP\:Z'\(XO&L&D_$WQ5KGAZ>'7M(TC6-5TF>*XT:]O)=-/]G^
M$O!%WJGCO5Y$CM[1M#NV,J\=\3/^#KC]J?\ LO4-#_99_9A_9F_9@L[VV-M%
MJ>E>'7\9ZYIOR[4EM$^S>%?#+S1,6:-;_P ,WENI"[K>496ORETGPS_P52_X
M+3_&6&6-/C5^U3XN-ZMN^L:S?#3?AA\/K:^E\V9EN]0N=#^&OP]TB,(T[VMD
M=(%Q]VTM;FY:&-RZ\Y-_)7TWOJ]NNGH'HV]%KVV^[MU_%'US_P %J?\ @M'\
M0?\ @J7\1-'^#7P<T?Q'X6_95\#^(5B^'O@9899O%OQ3\4*\^E:5XT\7Z?9/
M>O+J$T$RVWA?PK!]L72TO'9GN]3NC<Q?K%^RI\+_  I_P;M_\$\O''[:'[0U
MAI2_\%%/VJO"EYX)^ WPDU62%O$/P[TG4+9+O3[/5]'F"7ENNES+I_BWXFR+
M#LMI;?P]X':ZM+RZG:D^%O[)?_!/G_@W>\&Z=^T5^V]XP\)_M2_\%#+C1WUC
MX/?L\^$BNH:-X(U:6-5M]0LX[RQO8M,GL+D2"Z^*'BFRTZ"Q2&>'P5HUWJML
M+F[_ )[/B!\0?VYO^"ZW[<^G[;&_^(7Q3^(&I)I?A+PAI#2VG@#X/?#ZUOP\
MD=L;N<V/A[P?X8@NY=0UG6+Q_M^IW?GZE<SZEK.J W)JMW=O;2]KV_'R6W;4
M?7IT27XK?IY]>[NV>W?\$7_V%?'W_!5'_@H=9:]\3X]5\5?##PCXPF^//[3?
MC+5!=3Q>(/MFOS:W_P (S>:HX9)=;^)/B>62UEM_M2WDFBCQ'JD0QI[-)_JX
M6UM!9P0VUM&L-O;Q1PP0QJJ1Q11(L<<:*H 541551T   P*_-[_@EQ_P3?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>ny20053122x2_mfu-gap.jpg
<TEXT>
begin 644 ny20053122x2_mfu-gap.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
M     0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&
M$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W
M.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KB
MX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH
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MZK5;I+6_6_1/8_MHWI_>7GI\PY_6@LH!)90!U)( '&[GGCY2#SV.>E?QB_\
M!2S08/\ @G)_P6A_9#_:^U:YU2;]E7]H7QA9W'C_ ,-:KJ>J7'@+P9X_M3!X
M0\>>([+0KB^?2+*\TVUU[P]\7[%Q:PL_B:/7;NV"&VD*_0G[=GQ8\3_LC?\
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M1'8QL([F_NI%=G'F$8 ^U=R]=RXSCJ.N<8Z]<\8]>.M?P:?MW";PY_P;>_\
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M&^(L,WAS2[.SN+5]7B\#2>!8D\07D6K6EM>ZGJ%UHEK-!+I4]Y+^?G_!)/\
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M4^I)YH3N_)IV^5M>_5E<J5.3LN:-KO?=K3Y*WEJU;J8?_!)__@JM_P % O\
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M5(HW\12:(==80HD&=1)A1(BBC[ZJEJD^YD]&UV"BBB@ HHHH **** "BBB@
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M+?:1X+UR]UGP_:>"/#.C:S8V6FL&UC6?[7N/%=UXEEU75;UM6<V]GY.@6O\
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M:.= DU2?PCJ'B*6]TUKG0Y[SP[=Z;J.J^);'4_#1T_3+\-=6#:G=^N_M)_\
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M?<ETMT7D?S__ /!13_@BW\3/^"@W[2GPS_:%UW]K/P]\-!\%%L+;X6>$]"^
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M1X;UOQGKFN>&[ZPU75!H6MW.MZ=HN@WMY+X<$&G6E[>Z-<W-Q="7UC_@DO\
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MF _X+Z-O^.'_  3^V$ #QEXG!RRX(;Q5\,SG)QQDY+ [5]<'(_I_KX/^//\
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M^I_P4:_Z*CX._P##5^!/_E/1_P /U/\ @HU_T5'P=_X:OP)_\IZ/^)?N./\
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MO^BH^#O_  U?@3_Y3T?\/U/^"C7_ $5'P=_X:OP)_P#*>C_B7[CC_H*X=_\
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M4_\ Y<?WF[T_O+_WT/\ &C>G]Y?^^A_C7\&7_#]3_@HU_P!%1\'?^&K\"?\
MRGH_X?J?\%&O^BH^#O\ PU?@3_Y3T?\ $OW''_05P[_X7XWR_P"I7YO[O,/]
M9\N_DQ7_ (*I_P#RX_O-WI_>7_OH?XT;T_O+_P!]#_&OX,O^'ZG_  4:_P"B
MH^#O_#5^!/\ Y3T?\/U/^"C7_14?!W_AJ_ G_P IZ/\ B7[CC_H*X=_\+\;Y
M?]2OS?W>8?ZSY=_)BO\ P53_ /EQ_>;O3^\O_?0_QHWI_>7_ +Z'^-?P9?\
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M_DQ7_@JG_P#+C^\MI%& &4DY.,@\#'/!]^:DK^3[_@EI_P %3?VR?VI/VR_
M/P<^,7CKPYKG@37M \=W^HZ=IW@/PMH5W+<Z%X3U35=.9-2TFPM;R)8[VVAD
MD1) )53RV^5C7]8"C: ,YQW]:_-.+N$\TX+S2GE&;SP=3%5<)2QD98&K5K45
M2JU*M.$7.K0P\^?FHSYDJ?*ER^\[Z>M@<=1S"BZ]!34%4E3:J)1ES1C&3T3D
MK6DM>;7MN+1117S)V!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '^5?1117^H!^/A1110 4444 %%%% !1110
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M9[>+;YLT,&[SI(H_,C\R14*()%W,"R@_%/QH_P""?O[.'Q0^#WB#X;:%\+_
MWPZU*Y\/7MAX4\8^!_#NG^%/$OAG5Q:3C3M1&NZ%;V>KW]H;QE?7-/O;JYMM
M?M)+RWU*.X^UR,?G.;PO9>$O^"L'P/CBLM.BU:X_83^(+^(]0L+:.W?6]4TO
MXA>#-&2^O'CCC>]F6WC>""YNA]HAM1'  J91.G!Y9@L?#$/#XW$1JX; YIC9
MT:^$IQ]S+\,L11Y:E/$S4OK-JL)1Y5*BX1_B*=U$ZM2DH>TC#WZM*FG&4FOW
MC47HTK.[LKZ:+4_78'(!]:6OB2^_;+T^Y\(?$GXG_#[X7>,?B;\)_A)K/B71
M?%WB[PUJ&@PW^JS>!FE3QQ=_#WPWJ5[;3^+].\*7%O>V=]=37^BR:K?:=?VW
MANVUI8H)KC0M_P!MOX8ZMX\_9:\*>%[#5?%GAW]KK1O%^L?"_P ?Z+/8'0K>
M/P5X3E\8:O;^(["]FM-9T^9K!$LX5@L[MX]3^T6=]'926S;^>&2YI/FY<'4;
MIK$NJKTTZ3PF#J8_$0JISO1J4\'1JXCV53EJSA2J<D)2A)*_K%'1^T7O*+6^
MJE*,(M::IRE%76EVM3[+JC?ZE9:9%'-?7-O:12S16\<ES/%;QM//(L4$*O*R
MJTLTKI%%&I,DDC*B*S,!7REX5_;$\":SXV_:@\$>*=&U3P#+^R?IWAC6_B1X
MAUV]TJZ\-3>'O%7AK6O%MIK6E7NG7,UU]FLM$T6>?48-0LK*[AFEC@AAG8JS
M?GE_P4 ^)MW\5? ?[%_CA_@_KWA[0/$W[9G[+^I^!?&&MRZ(==@T'5_&EE?1
M0^(-'MYI-9\)Q^)K)+/4;;3U?4A/':1V6O1Z5J8MK&7LRSAW&X[,L)E]>,L)
M'%2H+V\O9SC&.)PD<=0<$ZL8U74PTZ=7DA-SA3J*4HI^Z\ZF+HPISG&:DX<R
M:5[KDJ^RG?33EFFM;)M:.SN?N%YIW;0F>,D[NF<]L>V?I6-+XFT:&^.F-J%C
M_:83S3IOVZU&H"('!E^QF07!C ^<L(R"A!4L3BKMUY@C_=_?*L%)./GP"N>F
M0<'@9/\ =&:_F_\ V9_%W[/3W?Q'_8Q_X*#>!+3X>?M:>*O''CV:7XQ>.;!-
M,U/XPCQ;XBU.7PQXG^&OQ@DC^WZ-J5E:7MKI_AC3;/6K33[>.SL+;1'>>6YT
MJ#+*,EJYMAL?B:*KU5ESPLZ^'P=&.*QKPM>I*%;&T\)[2%2KAL':+Q,J//*F
MJL)3Y*:G4A5:M[*<(.R52,FIS?+34DTHPE*UDY7O&^]M[M'])5M<QW<,-Q"R
M20SQ)-%)&ZR1R1R*'1XW3*NCJP9'4E64A@2"*F9MJEL9QV'UKY%C^)>C_LY>
M#_V=?@1?27WQ'^*_B;PUIG@/P3H>AM:6=UXJ;X=>#K:7Q1XNU&ZU2=;?0?#&
ME:=IXU+5]1N6N+B)[NTL+&SU'4+J"UE=X6_:JT_Q/X^^(WP,U/P#K_AGX]?#
M[PM8>-U^'.IZKH,EGXZ\':I<_9++Q5X#\7?:H=(U?1$OPVF:DVI0:/J.CZDH
MMM1TR%9())N)Y9C91JU:-&5;#PIU*\*RM#GPL*ZPOUOV<OWBPWMVJ<J[@Z=.
MHW"<E*+2T56'NJ;49.UTM;2<>9Q3M9RM=I;M6TU1],/XK\/QZQ!X??6M(37+
ME&DM]&;5+-=6GB1=\DT6FF07DD,:89Y4A9%!RS!1NKH5.X9QCG%?S\?LY^-+
M[Q'^Q[XL_:^^(OP @^)/Q2^"OQ!_:A^./A'Q[JWB_1;"_D\5^'_B!XYT\Z2+
MVQU)=>BT;0/#%LVA#2[RWOM'DTK0+&STK3&\G2?)^SO"W[=/B+P-^RE^RY\;
M?C)\*_$UU+\:;;X'^'-3U_0=4\)+I%GXA^+'A?P]=:7XUUJ)=30>'/!^JZYJ
M=Q;R!XC>Z,S6L$FG,MQ!7M8WA3,,-B:F%P_+BZN'S&ID]7EKX.,:N8T_:SY,
M,O;JI.G*A"-3FJ4Z34Y2IVNE?FCC:;2<_=O25:ZC-Q5/FY'*3LTO>3:5[M:V
M2M?].J*^5[3]J/39OVHY_P!EB]\">(=*\3#X8K\7-,\6WFHZ+_PB_B#P@=97
MP]*=#6&ZDU>ZU>QUDFVU+3I]/M196Z_;6N9()8#+BZS^V'X;\.>![?QGK?@3
MQ?;MKWQ\N_V=? NC6+:;JEQXS\;0>+-2\%PZE;7MG<-8Z+X6EUO0]>,VKZY+
M9/:V&D3W+VKRW-A;77DO*,Q4J$?JSYL52PU>@E4HOVM+%\_U><6JEN6:IU&[
MM.G&G.550C"372JU-W:E?E<U*R;LZ:3FGIHTI1=NJ::O='V%17QOIG[8GAM9
M_P!I#1/$?@?Q98>./V7M)T'Q%\1/".AS:+XBFU'PQXF\+W?B[0==\(:F][HM
MKJEO>:7IVK136NK+H>H6=]I-Y#+:^0UI<W7GOP^_X*$^$_&_A#3/BM??!SXN
M>#?@?K'PAC^*FG?%_P 26/A\>&;N[GU[3- MOA];V>GZY>ZTWC&_O=6M;?1K
M:73XK/7;I+E-%O+^T2&^N-(Y%FTH3J+!5'"$L+3<N>E:=3'8:.,P=.C>HOK%
M3$X:4:U&%!5)U*;3C%[$?6:%XQ]HKR4I)6EM!N,F]-.62L[VL].J/T*HKXKT
M+]LW0A\>? _P!^(?@/7_ (=>*_BUX>\1>(?A/J%SX@\)^*-"\6IX1@M[[Q+X
M>N[KPWJU[)H'C#1]-O+?4;C2KB&YTZYLV=K#6[R6+RG^SVE"H)",*1D\]/Z_
MIG]:XL7@\3@716*I.E]8HQKT)*4*E.M1E*4%4IU*4ITYQ52%2G+EDW"I3J4Y
MJ,X2BM(5(5$W!W479Z-6=KVLTGMKIW7<@>]CCNDM&,8EE61XD,J"61(EC,KI
M$<.R1F6,2,NY4,D8<J9$4VP<C/2OPN_;>^+?Q-\%?&KP5^VKX6U>^D^!'[(7
MQ@T3X'_$?PO9QN]IXB\,_%&RBTCXX^/)I(6*ZA#X*U?5/AQX8T: !%L_$WA[
MQ)+++LM)HY?UR^(/QK^'OPI^$^L_&+QAK4=KX#T71+77I-5L5:^?4[?5&MHM
M%M]%@@;?J>H^(+Z_T_3M#L[>3S=1U#4+.VB8O.I/HXS(\3A<+E&+A+ZS#-E6
MHJ%*$W/#YA0G3<\OFN77$+#8G!8AQ3O_ +3&"7-":6<*\9SK0=HNDT]U:5-M
MQ4UJ]'.,D^UD]+H]0NM3M+*XM;>ZN+:W>]E$%H)[F&%KFX(9A!;QR,'FFVJ6
M$<89RO(! .+RMN&<8Y(]>E?BS^U7XFUGQ1^US_P3-UGQ'\(=3\!:KJ?QS\42
M6&M7U_X=UF]FT)?AAXCO5\,>(KK2KD2:5K5I=20Z@-&$NM:4LJW+V&L3W4$@
M/WQ\.OVIM+\<_M!?&#]G&Y\">(O"?C/X/^'_  YXIO+W7K_1SIGB[PYXJ>9-
M&U[P@EE<W%]?:3YL$EKJEW>6MD=,U!HK"6*2XDPM8C(<71P6$QD'[:-;+\1F
M6)C%T;8:A0S6OE;DIQK2]M#VM.FY3@KQ=1*4%%.;F.*INK4I.\>6I"G%M/WY
M3I>ULE;2R3Z:M;]%]845\<S?M@:)!X*^%OB>Z\ >*K;6/C9\4;CX5?"_PR+C
M3+LZ[JL4VN?9_$NHZW9RS:9HW@V\TWPWJOB&TU:9KBYN="^P7%MI\]]J-MIQ
MS[;]MGP?!X%_:8\4:SX&\90^(/V2KK4X?B]X)T6;0=9U..TL/"D?C>#6_#&I
M7NK:)IFLZ-J/A=VU*VDN9M+U"-[>[LKC3(KR$0R<_P#8V9OGMA)RY*BI3Y)T
MI\LI8J&"3?)4E^[>,J0PWME^Z]O)4^?FT*^L4=+S2NFU=25TH\[T:W4/>:WM
MT/M;/3W./T)_I17YVZ%_P4&\/ZKK'[-KZU\%_BKX/^'G[4C^'M'^&GQ-\0CP
MO'HTOC/Q3X;;Q/HGAC4M#MM?G\3Z=%J-I'-9V&MWNDVMI?W\6ZT2739(]0>;
MX)?M1_%/XC_M>_M3_!K6?AJVE>!?@;/\,]$T[4;;Q!H%U/ ?%7AW7_%;^)]7
MC,D%]<2>);-]&M[72-+6^CT2*RB6[D%W-?3/M/AS.*4,56K8>-&EA,'+'595
M*^&2=&GCZ>65%3:JM3K4\;4C0G1BW5A/24$W'F(XJA-J,9\TI35-)1E\3IJK
MNTM/9R4K[6ZW31^AE%?!.D?M[^!M4TKX1>/I/!?BK3_A%\<OC ?@=\/_ !U>
MS6<%_+XSN-=U[PSH5YKO@^=HM1T;PSXFUSPYJ%MH^J"YO-1%O+I]UJVCZ7'=
MLEOZ)XZ_:HL="\?_ !&^&'@+P!XC^*7C7X1>!M ^(7Q&T?0=2T72Y=&T;Q0N
MJ3>'M$TPZO=P+K7C+6++1=1U&ST-/LEHMF+-[K6+:?4+*";!Y/F49^SEA)QE
M:HY.4Z484U2Q$,+5]M5<U2HNEB:E.C456<'"I4IQDDZD+U[>E:_.K>ZNM_>B
MYQLK7=XIM671]4SZRHKXE\!_MT?#/XC?!KX>?&7P_P"%/'UEI/Q@\0P>%?A/
MX?\ $EOX3TGQ#X[U>>QOK^1M-6'Q5J.DZ;IFG6^D:Y)K%_X@U/2CI::'J1N;
M8,+..[Z/X)?M:^&?BS\6/B;\!M6\+ZSX#^+_ ,*]/T+Q%K?AO4M3T+Q!I>M>
M#_$Z(=%\5^%/$GA^\N;/6--,KK8:I!/!8:AI.J'['<VK)MG)4R?,Z,,74JX.
MI3C@'4CBU.4(U*/LJZPU64J+FJLJ='$25"M5A"5.E5:IU)1D[ JU.3BE*[G9
MQ5GK=7732ZU2=F?6]%%%>8:A1110 4444 %%%% !1110!_E7T445_J ?CX44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z_?\$+?^4CGPH_[
M%/XI_P#J ZW7]Z5?P6_\$+?^4CGPH_[%/XI_^H#K=?WI5_%OT@O^2YP?_8AP
M/_J7CS[[AC_D73_["JO_ *;HA1117XB?1!1110 4444 %%%% !7Y+_MM_ /X
MKZ#^TW^SK^WE\#_!][\3?$7P5T_7?A[\5?A=H\UK%XI\6_"/Q)_:TEU>>"5O
M9+>WOO$?AN;7->OH-&ENEFUB2ZLHK,>9;&*?]:*CDC5Q@J&Y[@=^O7_([5Z&
M69IB,HQ?UFA"G553#XK!XG#UHRE1Q.#QM">&Q-"JH.,U&=*I+EE!J4)J,XN\
M4GE6HQKP4)-QM.$XR7Q0G!IQDNEUY]&SY*T;]K7PKXTTN*T^'_PW^..N^,9X
MXHU\)Z[\(/B!\/5TN[D"*T?B3Q=XX\/:-X.TBSM'<?VA=6^M:I,($E.FV>JW
M'DVT_P S^+=/\4W?_!4#X2>,;KP5XU'A33?V1_'WP[U_QAIWA;Q+J/@W2O''
MB7QWH&OZ?H)\6C18=,DE;3M,O)EO6\BWB<01W!MIYUA7]2D@C7&(U'.20 #G
M!&<ANP.!QTX]*0P)@?(,Y))!QR3U/3.?\?6M<+FE+ U\34PF"<88G XW N-:
MO*I.$,;1=&4U4C3II^RA)RA%TDY25IR:T45*+JPIQJ3OR5*=6ZC:\J;4DM^Z
MU?7T/QZ_9 L_&_[*G[/WQ5_9=^)OPZ\=Z[XK\!^+?BN_PKO_  YX/USQ%X?^
M-'@SQ]K.K^)?"\^D:_I]G=:+IVK2W^L76D>)M-\3:CIK>'I_*OK^X_LN870\
M&TS]GKXD?L?^'?\ @E5K?B+P3XS^(6E?LVZW\;[?XSP?"OPY?^-M7\):C\<O
M"'B%;&2TT'2$N]1U'PYX>U_7#HU_>Z?'+L@@2^5#]HBMIOZ EC7'*#KG\<YR
M0..OUSWZFHW@5FW!%[$\ %B-QY/J<@9/0' .,UZT>+\=]:Q^)>&P_+FN(KXK
M,Z*E.,*]?$95F&55JE)W;HMT\UQ]:-G-*K63LX4XP>2P5-4J=)3DO8QC"E.W
M-*$(5(SC%W?O)<J3=UIOW/P#\5_!'XS_ ![\0_\ !6G2-%^&/Q#\"0_M+?##
MX$M\'M=\7Z1!X>T[Q#J'@CP7?B]\/7<\UYOTS5-5GN;+2I[6Y\U]'BU&:+6W
ML+ZTNM.M];XZ_$[XB?M ?L]?LH>&](_9M_:&LOBG\+/VD/V9_%7Q8\&W/PLU
M[2X?#4?PVUB.?Q9+I/B+5O[/\/>(-,F6QN9M(O\ 2=4N;1]/>*75I],24L?W
MG6", Y0?-DD=0,@J<=LD$Y..<^U1BUC&/W2\8P>,C'H<\=\XQD$@\$BM:?&5
M95<%4GE6%D\NK8.OA+5:\53J83)\'DLE4<;NK#$8; X:K-7@X5Z<I0DH5)P:
M^HQ7,E4ERU$U4]U7FI5WB'I>R?M)2LU]GW;/=<AX@NM;O/".L77AM'L/$5UH
M&HS^'TU&VCN#9ZS-I<K:7]MLTF:&86M]Y7VJV%SY4@5XUE975C^1/[3OB+P%
M^V)^QAJOASXP?LQ_%B+]H;7?AQ=W/@/X<W7P?\9W/B;PS\7[OP_)_P (WJ/A
M3QS:Z))X?TK0'\1M;7E]J]_XJT^RBT S6WBNVMIC<V _:EH$SE47)&#VR.P/
MJ!S@=LG'4T-!'@8C7(QTX]\]N_3ZGU->%E69?V7B*&,HT9+%X7&4,9AL12Q-
M7#U:;HWYJ#G3?OT*ZY5537,XQY8RBI2OT5J/MHRA*2=.=-PG"4%)-NWO+9QD
MG?E=]--&?B6/@E^T-\%O$G_!-KX]>,[/7_BKJ'P(^$>M?!']I2R\-V]YXM\5
M:3:^._"6G62>-M-L;2.?5/%L'AC7;"S@\47&G6U[K%]IUF-3@LK@R2FW^A;3
MP/?_ ! _;PMOVKK?1O$6B_"_X3_LTZK\+;35=2\,Z_I>M>/?%GB_Q;+X@U"#
M1O#E[I]OX@U#PYX1TF.(+>#2@E]KNKRVVD"^^PWCQ?I<L" G*#!Y]>?7KG/?
M/KSUYJ3R8A_RS7OU /4DGKT.23D<\FNVMQ/C<0W4GA\/"O+ YAECJ4J;ITU@
M<QQU?&UJ,:/O0BX/%XBE2FK<E.4-)3IPFLXX2$6[-RBYTZB4U=QJTZ4:2FFG
MU4(MQV;N^K/Q1_9*\!?$"]_X)B?&[X,WW@/QOX=^*&KZ5^U5:Z;X4\7>%-=\
M,:K?3_$?Q1\1-9\(?9/[>L;*&Z.L6>M6#(8)I3;RRO%=^3(C"O5?A/\ #&W_
M &G/^"9?A;]F[Q3X0\<^ ]<L/V:?A]\+;X_$'PCJ?A&_T/XF^!_ FC:;;ZEI
M-AK,=KJ5Y#X5\9Z#9W\.JP6JZ9J"1QMIU[>)]I6']5C;Q[2%11EMP&,#.,$_
MD3GVXQC(*?9XF4AHD)R2,J,YQQS_ "YX^E:8KB;$XFIBL1##4\/7K9]'B"A.
M%23>&Q234J<8R352F[Q<>:THN+3<DV*.$BHQ@Y\T%0EAY1<;WIRU:O=:ZM>=
MNB9^!=]\'_VOM>^'/[,O[:5QX7N8?VS_  YKOA#X9:UX,OI+J6VL/@_XIT*/
MX1ZVNKV\-L#Y5SXRNY?V@-91[6.;1QK5WI4EW-%X>AN)?LC]JJZ^*W[.'P6_
M9[\(_!CPOXY\4>"M+^(_P\\&?&OQ#\/O#L_BWXI:3\*;:UN'\5^*= TFPM+F
M\/B3Q!?PPIK'B*RM+K4K"75=1U"P2#5+FUU"T_2K[+&<9C0!6+ 8X#'JP X!
MZ\C!Y/."<N>!&ZJ&Z<-@_=((//N ?4$ CGFE6XFJXK$8*IBLNP56A@<1BJE+
M"J$X4GAL1[66'P3FI2FJ.73Q&(G@FW*5.56?/*<'R#CA5"-10JU(RJ1I^^[-
M^TA:]6222E*<5&,[))QA%65C\*/"5OK7AKX]_P#!1G5X_@G\<M"\+?';]FSX
M6_\ "L+S4?A]XMUV;Q%=>'/A]\2O#VHP:E>PG7M2B\3WVNZ]I-K%H>L7<OBJ
M1[R*;4M.LO)O/LVO_P *2^+7Q%_X(]_#7X3>$_!>M6GQI^'7@CX4ZN_PX\;:
M#?\ AV\UGQ/\)?%V@>+[WP=J.G>([2R%U%K":&UO:B5)=,U*YDM8)+A(9998
M?W $*_\ /-3VY_\ U_Y//4DTX6\(&!&F,D\#') !QZ X&0#@GDY/-=<^,,6Z
MF"KPP="%7 XW(,92<ZM6K&<N'LOI9;AX58R?-*-:A34J[YXRE4O*G*":MG'!
MI<Z=23YJ5:E=1Y6E6FJDFGJK\ZNNRT[GYG?LZ?$3P1\7-8\$7O@C]B#Q-\%_
M&NBE+GQWXH^)GP0T+X;V7P\D^PO::WI?A3Q0]I;:IXQUO4Y0-*TR3PQ$+&/2
M;EM6\0W6GQ10:'JGV)\?OB;JWPG^#OC/QEX<\'^*/'WBS2=#N_\ A%/!_A/0
M=3\1ZOX@\42V\R:'I_V/2;:[GAL9-16$ZI?S1I;V-@EQ/(^Y8UD]L6",$_NU
M YQ@#USVY_.E:WA8 &-3@Y!(!(.0<\YY) )]P#U KP<7C:&(QM'$+"3CA:4X
MM8.>+KXG]W&;FZ/UFMS5(TG=PC&*2C#?FJ)U)=,*;C3Y7+WFK.48J*VM?EO:
M_F?F;IO["'P;\9?LQW'A3QKKOQLU'_A./ FJ77CV2;XG?'#2['5/%GBQ+O6?
M&'B&;X3/XGBT>"XO?%FH:EKO_",R^&&@-W*(&L)B?G_/CPQX3_:D^,G_  3$
ME^!FI_#7XBVOQY_9@^(/@B^\*:)XS\,:[X7A^-WPZ^$'CW2?$/A/^Q]2U^QL
M;6[GU#PSI[6<.F2R-?O?^'M/%S:QC4HI4_HZ\I A0(,>AP0>>XZ<^G]149@&
M"-@P<],<9Z@9Z#M@<>G%>SA.+LPPL;5*4<>Z><X/.\)]<J2J1PF*PCJ1G"$8
M\BE3QE*HJ&)^%N%&C*').E%F,L'"5FI.$O92HS<4US1;@XR>KUBXWC:]KRT=
MS\5?C1\3_%'[1/Q<_P"">_C[P!^S_P#M#K8_#+XXZIXG^*%GXB^%FM^%+OP7
M!J?P^U;0[FVOSXH?1X+Z/2[[42EYJ>FS7FAB'Y(=1>[O+.SNO9_VS?@O\6;C
MX^_L]_'S]GVRFC\7ZW;^)_V9OBY=6>Z*6P^$?Q5TV\FT_P ?7DJ17$,C?"'Q
MCI]IXOL[25%&HW;0:8UW!'-N7]1$MHADF)<\?D/3K^/KQGI3OL\08$1(,<C"
M@8;.<\>O?U[UC'B2KAZF7O!X*C0H9=@<QRZ.&J5*F(AB,+F6(Q.(J4L1S<JJ
M1I3Q<U3:46G2I3=YQYA_5N:,U4FY2G.G-RBE%Q=-*,7'>SY;W?=MVMH?F_\
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M>9-J3YD1PBB[JK.,N:$KJ,7;DHQH:-O^2,;)V=U>[6A_-[XM\2_&WXP_ _\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM_Y2.?"C_L4_BG_Z@.MU_>E7\6_2"_Y+G!_]B' _^I>//ON&/^1=/_L*J_\
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M444 ?Y5]%%%?Z@'X^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]H/Q9_P3B^&?[",7Q"^$%IJ'@/X@7?B6Z\>O-XRDM+[0X]:\1^(M-M[;2O\
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M^@_*EHH 3:,YQS_GMTI:**++L PHA.2.>N<G_&EVJ.WZG_&G44K+L@"BBBF
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M[]*47$F#\QR,8^9AGGG@,!^5 &OD>H_,4N1ZBL;[1+_>/_?4G_Q=!GDXPQ/
M/5C@^F<Y'Y\4 ;&0>A!_&BL^VE=V;<2?N#DD]6]R3]><44 ?Y8%%%%?Z@'X^
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^OW_!"W_E(Y\*
M/^Q3^*?_ *@.MU_>E7\%O_!"W_E(Y\*/^Q3^*?\ Z@.MU_>E7\6_2"_Y+G!_
M]B' _P#J7CS[[AC_ )%T_P#L*J_^FZ(4445^(GT04444 %%%!. 3Z#- & 5
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M$D'A:^NM#UY+[3F2?3/[*N;*:UNK72K93MO;QG(U")_L<XN8)IK27YCB'AG
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M+TRQMD+SW=[>7DD,,,**"2S.-Q&Q,N54_P 27_!4/_@X0^(?Q\\0>*?V9_\
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MG^)VN0VZ>'-"O9#>IX=C?!TV]NU::5'ND^0:+IZ1KY2A2JX3:?WU_P"":/\
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M^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDK^8^=S%59AN-,UV,>//&L,5EX8T8+IG@[P99LD#W]O 6:UBMVF?+:?$Q?\
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MW^2K_@UN_;4^&7PE^*_Q1_8>\12"+5?C3<V?Q \!^,&4)9:KX]\,Z7<V>O\
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MG=::/5=GH_,. >N>.WN/?TS03D_@!^0 /YXS01@D'L2/RI*R*+=I]\CUP?\
MOEAG\]P_7\2BT^_GTX_[Z9<?^@G/X44 ?Y8E%%%?Z@'X^%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*4>5K"X%2=\5B>:7M,;CKNA1DI0E)KF<?]A\?,2>N06/X@\CUZBD.,\>@_/
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M8D&XDY%=(;WP_<2:1HTAUCX@ZW$5U2\CVSV^D6MSEFM=YD6(WSEH'O;G8R1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /U^_P""%O\ RD<^%'_8I_%/
M_P!0'6Z_O2K^"W_@A;_RD<^%'_8I_%/_ -0'6Z_O2K^+?I!?\ES@_P#L0X'_
M -2\>??<,?\ (NG_ -A57_TW1"BBBOQ$^B"BBB@ HHH)P"?09H PFZ#_ 'W_
M ))35ZCZC^=.SN(7IU;/7[Q(QVZ;?UIE  ."#Z4'DD^M%% !2Y_EC]<TE.(P
M2,] #^>/\: &T44X+E6;/W=O'KDX_#%  JDG.0 ,@<9YZY[]/8$U_F*_\%I(
M+?1/^"FW[77B[X@/-K0A^(GV?P#X4EG%U#=0_P#"-Z((;V_C7>MKHELQ:4VP
M'G7$J"-XD/S5_IV)GW(R3M SD@=3[8.,>IZU_F)_\%H[:R\(_P#!3O\ :W\9
M>+677M8O/B1%_P ()X9FN!<00V:>'=$^SZKJ!!E>*SLI<I:Z6 'EG1=Y2/;N
M_0?#R,?[1S"K4A1]E0R_VL\5BIOZG@8K%8:*Q5?"6?\ :-6$I)8#!*,G5Q\L
M,^2:BXOQ,[BIT*,%SRE4KJ"I4H\U:LW"SITY6<:47%MUJDW%1HJH^>*U/S N
M?M'A@1>)?&D+>(/B%K<,;>%] N?*O[71K20LUEJ.H1YD0D%PNDZ6B%-Y0S%>
M48O$O/",\>H^(Q)XE^*VO20)IFG76-2'A^-W1+.ZNE<3+)JI9ECTVT";;94C
M:4;6&Z25KCP-/%K>LY\0?%?Q R3Z18R2B\7PVER'6VU&<L)Q+J<SO$--M(F'
MV,@%RKKM2-HKOP%>)N,WB#XN^()$2,;Q>#PS]M*1INR3'=ZQ<+(XCVXBM(RK
M%B5 K]BFIQE6E+VF&>'KTN=5K8^KEM3%24J=?'0=UF?&N9*?^PX-*=/)E.FZ
MBA[.3A\U=.,9WHU'63:LW"E75&$7.EA922^HY3A^12JU(6CB6G[U1:N"YM[[
MPU<I!>>;K_Q8\1O#")9[F.<>&$N0B6LPN)&6)=8"/A'6X$-BD2LTB<,&.EWH
M%Z_ASP]NU?XG:M+*=:U]9U>3293&[7%GIEX0569T9S>ZB\_ #) 0PV"1[:X\
M)7(T"R8:[\5?$Q2TU"^,WG)X;74DBC-M:W9R)-7F6<_:;Q952RW_ 'MX.(TM
M[O1;F3P/X)9]4\9ZIE/$'B&.5U^R2(&FNM.L)W\OR+>%7!O+Z2;>2DAV@O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=[BTO+9?'?C6..&RM%^Q>"/!T>Z."\M(2WV=T7$<R:3:SRR&:<1%;J8,%?\
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ME)0 [;PV1T"G\#_B"/\ (H X8^F/U-&<D\X'3OR!]T?H.M)SSC@<9_R??\J
M%49W?[I/\J0@J2.XX./\]* <!O4D8_W<'(_/%!)))/)/)H MVOWL]_D_5R#^
M8 _(>@HI+3[Q^J?^AT4 ?Y8E%%%?Z@'X^%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!^OW_  0M_P"4CGPH_P"Q3^*?_J ZW7]Z5?P6_P#!
M"W_E(Y\*/^Q3^*?_ *@.MU_>E7\6_2"_Y+G!_P#8AP/_ *EX\^^X8_Y%T_\
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MLX_XB!OVA/\ HY'X3_\ @B^&O_RLI/\ B($_:#W;O^&D?A1G_L!?#3TQ_P!
MROXR**/]8.'O^C?<(.W? 1Z6\O+\7W#^Q\Q7_-3YY_X/I?\ RL_LX_XB!OVA
M/^CD?A/_ ."+X:__ "LH_P"(@7]H3_HY'X3_ /@A^&I_]QA_D:_C'HH_U@X>
M_P"C?<(?^$$?+R\OQ?</[&S'_HI\\_\ !]/R_P"G?E^?=G]FO_$0%^T$.?\
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MQ&DN]0ADNLB6XM9[B_<6UQMPL<\:K)$ #$5;FOTH_92_X*HZO^Q9\(K3X(_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% ']"/_!L3_RE=^'O_9)/C-_ZC$=%'_!L3_RE=^'O
M_9)/C-_ZC$=%? <2_P#(Q7_7BG^<CW,#_ 7^)_\ I,3YNHHHK_1\_*PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /U^_P""%O\ RD<^%'_8
MI_%/_P!0'6Z_O2K^"W_@A;_RD<^%'_8I_%/_ -0'6Z_O2K^+?I!?\ES@_P#L
M0X'_ -2\>??<,?\ (NG_ -A57_TW1"BBBOQ$^B"BBB@ KS3XT?\ )'?BQ_V3
M3QW_ .HMJM>EUYI\:/\ DCOQ8_[)IX[_ /46U6KI_P 2G_CC_P"E(4MGZ/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-[#/=_%+0[C_ (3'4-&\ S74FO\ BSQYXKT;P[I%C+J>FV26WQ1\6->_;/\
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M?WI5_%OT@O\ DN<'_P!B' _^I>//ON&/^1=/_L*J_P#INB%%%%?B)]$%%%%
M!7FGQH_Y([\6/^R:>.__ %%M5KTNO-/C1_R1WXL?]DT\=_\ J+:K5T_XE/\
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MCLO1?D%%%%6,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /Z$?^#8
MG_E*[\/?^R2?&;_U&(Z*/^#8G_E*[\/?^R2?&;_U&(Z*^ XE_P"1BO\ KQ3_
M #D>Y@?X"_Q/_P!)B?-U%%%?Z/GY6%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!^OW_  0M_P"4CGPH_P"Q3^*?_J ZW7]Z5?P6_P#!"W_E
M(Y\*/^Q3^*?_ *@.MU_>E7\6_2"_Y+G!_P#8AP/_ *EX\^^X8_Y%T_\ L*J_
M^FZ(4445^(GT04444 %>:?&C_DCOQ8_[)IX[_P#46U6O2Z\T^-'_ "1WXL?]
MDT\=_P#J+:K5T_XE/_''_P!*0I;/T?Y'^,"_;Z?^R&H*G?M]/_9#4%?K4/AA
M_P!>J7_I!\O'9>B_(****L84444 %%%% !1110 4444 %%%% !1110 4444
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MYMNWDC!(/RD@-@LH,^!Z#\A1_P 1C\1_^BBE_P"&W*/_ )@#^P\M_P"@=_\
M@VKY?W_+^K*W\L/_ !#1Z9_T=[?_ /AF8?\ YYE'_$-'IG_1WM__ .&9A_\
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MG_1WM_\ ^&9A_P#GF4?\0T>F?]'>W_\ X9F'_P">97]3V!Z#\A1@>@_(4?\
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M_P"?97]JPN8CC!/)(Q@D@@A2"!G^(@#&<Y!&5.:G!R,^O-']NYO_ -!CZ?\
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MAU>P\77>LW-S=R:HUK>V<%M#;SV[R2'Q7XF_\$W_ (L?$#X6?\%!OAE%\4_
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M_P -/A[9?\(WXA'BCXEZAX'6VU]=*U.?PSHR-KGAC3#K[7^LR#3_ !;XS_\
M!3O2_AG%\0KSPK\*M7^( ^"UWX T_P"+7@B'Q!/IWQHM]5\:Z+X4\3:MX<^&
M_P .-*\)>*+/Q[XG^'GAOQEI5_XOTN_\7>$4:^BO=&T2]U:_M+GR6:-^Q%^T
M[\+?CEX@^+WP!_:(\ >!],^-G@'X3>%OVB?!'C/X4ZEX\TR7Q;\)?"%KX$T?
MXH?"*XB\9>'#X>\2W/A>WBT^?2/$T>O>'KB6SM;[4['5&2.TAU[#]C']I?X5
M_M _&'XC_L[_ +1WA?PE\,/VD+[PEXE^+W@_XD?#&Y^('C+PY\0/#?@[1_!&
MJ_$'X3>([3Q=H.BV7B#QCHN@:3<:I:>,M \2Z!::Y;)J(T:^M@=.!K^/EMJU
M]^B?SM;<2Y.O9=UKI=72?6]M+6WUL?IWIEXFH:?97\6\Q7EM#=0M(C12-#/&
MLL321.%>)VC96:*15DC)*2*KA@+U9^E6;:?IMA8-/=W1LK2"T%S?SFZOKE;:
M-85N+RY)+7%U,J"6XG<EY9G>1SN8UH4R HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1ONMCK@].#T]>U?B+^
MSCJ+?MT?MK_M^W/QS6Y\4_"7]DCXJ^'?V;O@Y\%=6N[I_A[9ZI9>&7UCX@?%
M#Q-X4$J:1XJ\7>(]5NXK3P]J^O6^HMX;T.&2VTA+:>[GE?\ ;H]#]#[_ -#_
M "/TK\^%_9'\>_";]I'XO?M*?LS^*O!VB77[1=AX7/QT^$WQ)TC6;OP;XC\9
M^"--FT3PW\3?"^O^&+V#6/"GBMM"F.B^);)],UK2/$\ MM0EAL=5L1=S)WNO
M77]-^S_K0:VFKV;MROMJN;IIHG9^?0_#S]NOXD>,/@EIW_!6C]B/1O%7B_4O
MA3X1_9 ^&7[67P&6]\3^(+O7O@O<>(?B!HO@3Q=\.O#WB2;41K4?@VZU1TUO
MPKX=N-3DL_#]E+J&E6$<6E2+"GZS2_\ !1OQ+\*?'7C+X5_M%_LX^+?A;JVD
M?LU?$C]I;X0W7ASQQX=^*#?&+P/\&-)34?'GA2*#0=/L!X7^*.G:?-87B>&7
MNM<TJXBO2]OXEN%AAEO,GQU_P2YE^+_PW_;=E^*GQ6@U']H?]N'P?H7@?Q5\
M3M!\)R6OA7X8>#/ \=NWP]^'WP]\'WVO7>HGPEH=W;F_UZXU+Q%'K'BS5KNZ
MU6[EL)([*"U]QU7]E'XK^.?&MK\;_&_COP/I/QR^'OP!^)WP8^!%[X-\-:M<
M>"OA]XC^)UMHXUOXI:K9:_JC:SXBU1KKPUX?M;;P^+VQT^PT.'6+-KO5;O5X
M[VQ23O?5+331Z7>FG9;:^5[&CE!Q2W:OKJG=J"NK:6=G>Z;TO:[=Z*?M_P#A
MBQ^#%E\<=7MO!&L> _&FJ?"'PY\'/%GPV^*%CXV\&?$SQ5\8-8G\.V7AY/$4
MGAC0Y?#MSX'U:VGD\?O>:7>7&AZ%:WFL+8S75O)I \1\6?\ !52\\!?"K]H;
MQ[XE_9]\1ZOJG[._Q ^$7@[5?^$#\7QZM\.OB#HGQGU'1-,\+^,_AG\1?%?A
M#P2?$MOI6I:T-$\6^'SX8M]:T'6K8V=U"]O<17J<YXS_ ."2]MKL'QK\0_#7
MQEX<_9P^(/C_ .(7P ^.'P]@^#WA:Z'PN^'_ .T!\ /$&L>(K+XM7'@+5=6M
M],U/5OB!)K<OA[QG8:=::+:W7AVSB>Y?5-5N)KMO5/CQ^QU^UC^TY^S+XS^$
M/Q?^//PID^('C7Q#\+K\:EX-^&'B7P[\+_"^E?#+Q]H_Q $FF^&+[QYK_B?6
M/$_BS4-#L[/6=7U/Q/:Z?8V*V]OHVAV0M;E]6-=>^MO/MZ=-'?3N[VE<FG75
M7O=:75]-5M=;K75=$=HO[:/QE\)?&_\ 9[^#_P <_P!FF#X06/[1GC3XO^"?
M"/C63XT:#XRT^QUGX<Z1/XH\):;>VWA[P>;%-7^*?A>UO-0\-Z3>:]I]U;WF
MDZYI=P)KFUL5U \0_M[IHMIX$TMO"W@O3O'7Q4F^,6M?#?3O$_Q1O-&\$:U\
M*/A3XLA\+Z?\5M5\:67PVUK5-.T[XE)JGAG5_ VDZ5X-U\7VF^([.[DU2.RM
MM0OK;U7]L']E67]K;X(Z;\.[SQ;<?#?Q_P"&/&_PY^*/@+XE^%;=I]3^'_Q$
M^'WB&QUFVUWPXMW+%(DEQIXUG0%:21B+'5YS,LJ;[>;RW]H7]C3XDZS\0_V<
M?C7^R=\2/"/P7^)W[.7@OQ%\)]+T7QWX,U+QY\,?&WP=\6VWAV&^\!^)=(TO
MQ+X9U^Q_L&[\):!JWAO6-'UN.\M[ZV9;H21;)(7KW[:Z;:7_ %>W70/<=M+/
M6ZUMUMK=M7NEN]KM),ROA)_P4'_X7]IWP-\+> _@_KNC?&?XT>#OB;XXUSX8
M?$_6KOP3!\,O!_PH\70?#[Q7KOB7Q!;^%=:U/4M,U_Q?>V.F_#:\T/PI)'XQ
MTJ]7Q%(VAZ?;W&WFO^"/^H:YJ?[,OQ4/B&'4K._L?VS_ -L[13H^J^(+CQ5<
M^'K;1_V@O&^G6GAF/Q!=3W$NJ67AZU@ATBRN_-,4MO:(T"1V_E(NOXR_8T_:
M,E^-OP6_:K\#?'WP9+^T7X(\$^.?A;\43X[^&^KW'PC^(WPT\=>(=)\4CP[H
M/A+PYXVT_7? B^ M:T>QN/!DL?B/7;V_*7,OBB_U.]OM0OKCW/\ 8B_9G\9?
MLL?#;XB>"/&'Q"T3XC7WC?X]?&KXVP:KHW@RZ\%PZ;+\9?'>K^/M2T22TN/%
M7BE[Y+#5=9NDMKM9=/:*V*6;0736PU*\%?K^G97VUW3\OP!VL[=5MK>]T_N2
MV>C^9^ NDVO@>3Q9_P %DO".D^'?VC/$7QT\*?M%^)]'_91B^ NA_M!:SXD\
M!^(KOX.^%]6\(Z9X0\5?#BTN?"?@/0H_B'JS:MK&E>(=:T?0%T^YN;S5[)](
M$17]$=$_X**?%'X$_ O2/#GQ6\%6WQK^/W[.7PZ^">@_M9Z'X=\7)8_$?5/B
MAXE\!^#?%/C32OA3X,T+P;XDT_XD^+/"OASQ;H?BGQ3;MKO@[1-1O-2ETOPK
MJ.JWB7-K9?5W[(7[)WQ/_9W^,'[87Q(\7^-_!7BW2OVJ?C1'\:(=(\/>']<T
M74/!.I1^&M(\(IH+WVHZQJ,&NV7]C:%IT\EZ+33[C^U#=ND7V6>*&UY/4?V0
M_P!IKP+^TY\:?C%^SC^T)X(\"?#;]IJZ\&:_\9/A]\0OA=?^/M1\+^/O!G@O
M2?AX/B!\&]6T[QEX5T_2=8\0^#?#WAS3]5TOQ9I7B/11J>B0:E-:W\3K8Q*U
MDK*W1VMUZV6E]%]][="G*+>JNE;=OM%636RW;5MR:W_;D^+7C?\ :'^*G[/G
MP6_9<UGQS?\ P?LOV=O$?BOQ=XJ^*?A3X<:-%X'_ &@M,\8ZI8>)QIVHZ5K.
MOI-X:MO"Z3ZEX9&FS>)KBV.L;=,M;[3]%L/%/P5^RQ\<4T'X::M^VM^T#X L
MO$OQSN_VO_CY^S9\'M7\(?%/Q)=>*_B%XL^)W[1FM?##PW\(=;TO4_#/A3PO
M#X$\&6'AKP]#X8U?6[KQ+!X?\,>'-9\0Z3X9\/:I]HTO4_TS^$'[+WQ&^%G[
M5O[3O[0L_C;P[XCT7X^_#WX"^"--T*]TW5QXET2X^ >A>,M'TC6=<U\W\EGK
M<WBEO&=]>:[]FTNQ>UFM83:&4W$@3YJT'_@F1XKE_9*UG]GCQ?\ %C1[;QMH
MO[4VM_M=?!_XI>#?#-_"G@?XH7GQ@UCXR:&NJ^&=9UF9->TC3-4UF]\,ZC:)
MJMD=7\/7ETQ>QO6B*FOY]NZM^&J\]Q7@M/*-]]=%=-J[M>][).VBO9'>?&#_
M (*,:E\ ]4_:0\%?%'X+WB?$_P" G[-M]^UEHWASP3X]TW6O#7Q8^"VD:G)X
M?\3:OX;\6>(O#GA2?1M;\%>(8X].\3^']8\/&Z$6H:5?Z!-K\5\;>VK:]_P4
M ^,_@^S^ 6I^,/V0=>TK3?VFOCCX*^#OP@FMOC1\/M0N=5M?'OPCU_XIZ'XH
M\0626<<WAN2(>&-=T+4]#O#))92V1OUU&[22TLKNO\=_V!OB/^T9:_'_ ,:>
M//'/@/2_C+\8?V1=7_8X\-7F@^'-?E\"> ?A_P",M<N?$GC_ ,0_8KW6QKGB
M#Q)XAUE]*GMH)+O2].TFU\-:59*]^UUJ-Y+Z/\4_V1OBC\2/#O["6EIXX\%:
M5??LA_&/X>_%[Q%</H.NW5OXZN_ 'PR\9?#*/1M'C&K1RZ#!J]AXVU+5I;N^
MDU5[2\M;6U$,\+R2EZ]WOMIW_KY>>Y>G9>[VN[RZ)75K]=5?7TT/ =:_X*D>
M/O"7P]^//Q#\7?LO2Z;I7[)OQXT7X+?M)BP^,NA:HF@6_B+5_ =IIWBSX6R'
MP;9W'Q%2WT3XB:!XAU/2-?LOAV]O")M-M+^^O1*UO[S^T#^WA<?L_:IXPU#Q
M9\*]5L?AEX(^(OP'^'T_C77O$</AK5OB'_PN[Q+X/\,7GB3X->&9M U*'Q]H
M/POOO'6ACQQ(VNZ)>QM;:[:V,!N=,MGU'P?XC?\ !-[XL>/OA-^W_P##!/BG
MX"TS_AMCXY^%OC%9:L?"/B"?_A7\/A\_#2"?0[JV_P"$AC_X2)[NV^&&E>5>
M0RZ.L$FJ:DSV\R06D;8/QW_X)M?M(_%Z?]JRUMOVA_AU%H?[1'B?]G;X@>'O
M^$K^&/B/Q-XH^'>M_L_>)/A_XMTOX<Z=XAA\>Z+:+\'-0\0>!KC5UTFST./7
M8;_Q)JLZW<=S=7=]<FMO.WEJ]?/T_J]CW+ZV2^;TO%]V]N:V_FNIV?QH_P""
MGOBOX17_ .V3<P_LTZSXF\&_L,^)OAQ%\:?$\GQ1\,:/<WG@+Q_X:T;Q:_BK
MP1H,>C:K=:UKFCZ#K0U'_A%-1N]%M[JUL+A+GQ+9:D\-A+]#^//VOO&<>H_'
M+3/@'\%=1^/M_P#LX:/X4U#XFZ+IGBZ'PSXFUG7/%OAZR\;V?P^^%FD-X<UV
M#Q?X]@\!ZEIOB&;3]:U+PCHSW>L:#X?M-<NM3OKY=+^8_BU_P3C^,7Q4\(?\
M%'_#=W\6?A[IU[^W]8_"[3Y-3M?!/B!;7X>KX \"Z1X U&Z&FS>*KJ36#K>G
M:2-1M;;[?:MI5[<>1+<:C%'YQ[^R_8Q_:=^'7[0OQ#^+WP$_:(\$_#[PI^T3
MHWP_/[0/@7Q9\*KOQ['I_P 0? /@S3_ :?$OX,:B/%_A]-$U?6_#>DZ?9WFE
M^,M/\2:(;ZRL]3OM.U5%&GPKWOZM?>7_  -P?)Y;+O:]HM]WUDE\M!OQT_X*
M9Z3\*+[XE_\ "(?#*]^*,7P0USP5H7Q7\'Z3XDN;/XOMJ7BW3/"WB#4](^%O
MPYTWP?XI@^(6O^!O#OBO3-2\3Z5>^*O!ZR7/VS1M"O-7U*SO!!^I=E<QWMG:
M7D)+0W=M!<Q,RNC&.>))4+)(J2(2K@E9$1U/#*K @?F+9?L9_M+_  N_:%^-
M'Q$_9U_:.\(^#_A/^TGJWASQ7\5/!7Q&^%UY\0?%_A3Q_H7A#1_!.H^//A7X
MEA\9:!I=MKOBO1=!T>75K3QGH?B70K?6[--3_LO4+0'2!^FVFVGV#3K"Q\ZZ
MN/L=E:VGVB^N&N[V?[/ D/G7ETY+W-U+LWW%PY+33,\C$EC35];_ '=O1];Z
M$RM96MY[WZ;IZ+6^U_NL7:***9(4444 %%%% !1110 4444 %%%% !1110!_
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>ny20053122x2_mistral.jpg
<TEXT>
begin 644 ny20053122x2_mistral.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
M                                                          !8
M65H@        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($AE=VQE='0@
M4&%C:V%R9"P@,C P- !S9C,R       !#$0   7?___S)@  !Y0  /V/___[
MH?___:(   /;  # =?_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! ?_  !$( '(!5@,!(@ "$0$#$0'_Q  ?   !!0$!
M 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T!
M @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F
M)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M#Z<5S9+$C@?=]>F"/0<_7''KS6UX9+?\)'H7_89TKC)Z?;8>?3CGC ]>W/\
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M)U1&W+8PL&&UGR&#J1SV)YSD_<L8PH_S[?TK\XO^"<X ^'GC4#H?%D1QT/\
MR#K4#..X!(^O-?H\O0^@)Q]*_P"FOZ&.7T<K^C#X/X+#KEHT>&JZC'F<WKG.
M92;E)MMR<JDG+6RE=*R22_S.\9</#"^)W&&'IW]G2S*G"*D[M+ZA@Y:OK\7G
MZCJ_%/\ X* ?\%X_V-/^";_QPMO@!\>?"?Q[UKQK=>#-%\<QWGPU\&>#M?\
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M(P>1GD=CZCM7^+;X2);]K_PSN)._]I#1-^2<L9?B? )"3G.7 ^8]37^TF
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MQ=V.C^ OC9KOC;P'H\L%K/\ !_XUIJGC[P5#:64@6;1]/M]5U&V\1^$(F13
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M_@UH_9A@^/W[=?Q1^(7BVQDU#P3\*OV?_'=IK4EQ;":WU#6OC'"?AW'ICS,
ML5Q<^'M3\87R.K-+ML NPQN[#\X_V6?&GB/_ ()A_P#!7'P1<>(M3FT__AGK
M]J._^&OQ!O8\QM=> _\ A*[OP'XUFEB'FN\5UX1O[Z]\AC)]T1(Q9D==G_@F
M3_P6,_:!_P""5NC_ !5TSX$_"[X&^.)/B]J'AF]\2:K\6M&^(&JWUI'X4M]4
M@TRPT<^#OB!X,MX+1CJUY/<+>6][)),8V62,*5?XC_:Z_:6\3_MC?M(?%/\
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MV<CU^ 7P5SDG/_"J_ F>>W_(!Z?K[UJVOP-^#&G0+::;\(_AGIUFCM(EK8>
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MM+4W @*";[/!Y@;RDQQT?[.O[/UA<6]W8? [X.Z?=0LTD-U9?#+P3:W$;!<
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MJFN^(?#NIZM=C3];U>\TNQ2ZNW^RV%E;VL2I##&B_P ^_P#P=>?L*?!+X6?
MC]FG]H'X%?!?X9_"*#PY\1_$OPS\<0?"OX>>&/ 6GZW;^-]!@USPW=Z]#X3T
MO2;2[GTR\\'ZI;6-U?12RQIJ<\"2JKB-_P"X6.)(E5(U"(BA$10%55'10H
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>ny20053122x2_replicate.jpg
<TEXT>
begin 644 ny20053122x2_replicate.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
M+0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0":
M )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T!
M$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I
M ;$!N0'! <D!T0'9 >$!Z0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<"
M<0)Z H0"C@*8 J("K *V L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-:
M V8#<@-^ XH#E@.B ZX#N@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$
M?@2,!)H$J 2V!,0$TP3A!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%
M!=4%Y07V!@8&%@8G!C<&2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&0<K!ST'
M3P=A!W0'A@>9!ZP'OP?2!^4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC[
M"1 ))0DZ"4\)9 EY"8\)I FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*
M\PL+"R(+.0M1"VD+@ N8"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT-
M#28-0 U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/
M>@^6#[,/SP_L$ D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('
M$B8211)D$H02HQ+#$N,3 Q,C$T,38Q.#$Z03Q1/E% 84)Q1)%&H4BQ2M%,X4
M\!42%3055A5X%9L5O17@%@,6)A9)%FP6CQ:R%M86^A<=%T$791>)%ZX7TA?W
M&!L80!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;
M8QN*&[(;VAP"'"H<4AQ['*,<S!SU'1X=1QUP'9D=PQWL'A8>0!YJ'I0>OA[I
M'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B<B52*"(J\B
MW2,*(S@C9B.4(\(C\"0?)$TD?"2K)-HE"24X)6@EER7')?<F)R97)H<FMR;H
M)Q@G22=Z)ZLGW"@-*#\H<2BB*-0I!BDX*6LIG2G0*@(J-2IH*ILJSRL"*S8K
M:2N=*]$L!2PY+&XLHBS7+0PM02UV+:LMX2X6+DPN@BZW+NXO)"]:+Y$OQR_^
M,#4P;#"D,-LQ$C%*,8(QNC'R,BHR8S*;,M0S#3-&,W\SN#/Q-"LT932>--@U
M$S5--8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.% XC#C(.04Y0CE_.;PY^3HV
M.G0ZLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B ^8#Z@/N _(3]A/Z(_
MXD C0&1 ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:
M1=Y&(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+
MXDPJ3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q
M4GQ2QU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9
M&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV %
M8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUG
MDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>
M;WAOT7 K<(9PX'$Z<95Q\')+<J9S 7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW
M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$
M?^6 1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B 2(
M:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI &D&Z0UI$_
MD:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:
MU9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16
MI,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVN
MH:\6KXNP +!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1
MN4JYPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'# [,%GP>/"7\+;PUC#
MU,11Q,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZV
MSS?/N- YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':
M=MK[VX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-
MYI;G'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_R
MC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[<
M_VW__V1E<V,         +DE%0R V,3DV-BTR+3$@1&5F875L="!21T(@0V]L
M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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MU'R\O/\ 'R9_FZ?\,+?ML_\ 1G_[4/\ X8'XK_\ S)U_J&_\&\G@?QM\-?\
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M\,:1-J=S!!<S6^GQ:AJEL]Y/%;SR16XDD2&1E"'^EG_B$0_X*=X&?%_[,H)
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M"YAN8=#\0:?IZQ6KWHMX-ELLC+&6D)8X#;2W[V#3JTO7^O,_L;HK^23X8?\
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MRZB_'^OO+OQE_P"20?%7_LG'C?\ ]1G4Z_Q#$_Y'I?\ L;%_]/ K_;S^,O\
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M?XA>,8[?5/L.JA]K7'AG2-/U#5H(P\>H/I$IC=AM+<#^B"BO\T#Q=_P=V_\
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MWC:ZT?Q?XKT36;JY\:16V\&=O!&AZ;J>O6^Y6M1K2:+;W44D%R4?_+@_9O\
MV>OCY_P4$_:>\+?!KX96NI>._C+\9O%6H7=YK&MW=]>!)+I[O7/%?C;QAK?V
M>^NK;2]+M%U#7/$&LW*32$)(0L]Y=0PR_P!=/_!Z!XSUE?$_[#GP\6XE7PZ^
M@_%[QE):+)(()-:74?".B0SR0[_*>6&Q-Q''(4\R)9W16"2,#Y9_P9H_#+PG
MK7[0?[8/Q8U2QMKSQ9X#^%WP]\)>%KFX@AF?1K/Q[XCUVZ\0W=DTD336]Y?1
M>$M/T[[5:RQ,MC)?V<V^+4-IF7O2Y>B_RNQ/XE'I;F?3TU6O1=K-^I^L7[-O
M_!HU^P/X!\!Z7#^T5XQ^+/QO^)UQ90R>(M5T;Q1%X!\%66I21+]HMO#&BZ3I
M1U@Z?;3 BWNM<UB^N[G#3/#:K(+:'X!_X*B?\&HGA'X>?"GQ5\:O^">'BGQ]
MK?B'P7I5SKVM_ +Q_J%MXFO/$VC:?%')?CX;^(;#1;#4!XBM[2*\O8]!UO[8
MNKLD=CIE_;7\EK;W7]X(Z<<CMW_7O3'CCD!#HK@@@AE!R""".>Q!((Z$$@Y!
M(JN56M;^M/\ )?U<J^EM/N7YVN?X5%^)EGD6Y\[[2LA%P+@OYRS+E'682@2B
M0%!O$F70Y1]K J/]?W]@_P"$/A[X^_\ !&K]F/X)>+KW5;#PK\7?V%? OPW\
M1WFA3P6NM6FB>,OA;::!J5QI-Q=6UY:PZA#9WUQ):2W-G=0)<"-I;>:,/&_^
M8S_P6 ^%?A;X*_\ !3C]M?X:^";2'3_"?A[X\^+)=$T^W$26^GVNOM;>)GL(
M(H4CCA@LI]9FM88411%%"L39>-B?]3[_ ()/?\HS?V$,=/\ AECX,?\ J$:3
M40^)^C_-$I_$O[T7?Y/\?ZZ'\OO_  4*_P"#7_\ 8._9/_8B_:?_ &D?A]\2
M_P!I+5?&GP7^$'BSQ_X:TWQ-XM\"W7A^]U?0;(W-I!J]MI_P\TZ\GLG;*S1V
MU]:S,I(2>,\U_&'^Q-\&/"O[1G[8'[-OP(\;W.L6/@_XO?&;P%\/O$EWX>N+
M6SUNUT;Q/K]GI5_-I5U?6>I6D%]'!<.UO+<V-Y$L@!DAD&0?]8+_ (+5_P#*
M)W]O_P#[-F^)'_IJ-?Y;'_!*C_E)5^PU_P!G0?"#_P!3+3*))<R5M':_WB?Q
M06EN9=%W1_=1_P 0??\ P3?)_P"2M_M6C  X\:?#KGECDG_A6/7G&.@ &*_1
MG_@FQ_P0R_94_P""7'Q7\<?&'X">-_C1XF\2^// #_#G5K3XDZ_X6U72;?0Y
M/$6C>)))[*WT#P?X=N$OS?:'9H))KJ:#R&F4P;V$B_M-W/T'\VJ*YD$-O-,0
M2(HGD('4A%+%1[D# QSD\<UI9=E]R*_K;Y?H?YOW_!TU_P %0?%WQL_:8U+]
M@_X9^)+S3O@A^SW<Z?'\2K72+YH;7X@_&&:RBO[N/6&M9?+O=*\ VM[!I&FZ
M?,&CM_$ UB\F0W$5L+?2_P""&G_!N'HO[;_PPT?]KC]L;7?%7A?X&>)KN\/P
MK^&?A"Y.A>*/B/8Z;<W>F7OB;Q%K=]IUQ-H?A"34+>6#18](#:IKXLY[O[;I
M]@;9[[^8?]J?QCK7Q#_:8_: \<^(;JXOM<\6_&?XFZ[J=S<L7GFN]0\9ZU/*
MTA/.X,VW;Q@#  &*_13X9?\ !:'_ (*V_"'X>>#OAC\,OV@OB'X3^'W@3P_I
MGACP?X=T?P-X?AT[2?#^DVRVNFV=H?\ A%Y&DABMT4>;([R2MF1WD<L]973E
M=_=^0D_>EY6M9:;:NW6]NJ>[T1_?9XP_X-IO^"07BOP4_@^S_9OO/!UT+1[>
MU\9>$_B/XZM_&%M.RL%OFO=6UK6--O;D.WF%-0TF[M6("FWV "OX+/\ @L[_
M ,$C/&__  2A^.V@:)9>(;[XA? CXK6NK:K\'?B%>60M=5;^Q[B)-:\&^+DM
M[6'2X?%?AY;RPN))-/9+;5-+O+2_AM;60W]K:=!_P_I_X+3#_FZ3XK?^$;X?
M/_NIU\E_M9?\%!?V_OVX_#'A;P?^U'\1_&_Q8T#P5K=SXB\+V>L^#M/M'T?5
M[RR&GW=S:7>F:%8W2"[M$BAN8C,T4RPPEXV:&-D<G%K16?31+\@YD^K>R6G>
MUM[::^=K[:G]SO\ P:H?\%#/$_[4'[*WC7]E_P"*OB&\\0_$;]E>YT:V\'ZI
MJ5V+N_U+X(Z] MIX5L[F>XN)+^YN/!^LV&J:")Y8FCCT2;PY;?:9'B*(5^'W
M_!GC!XIT?_@HS\?=*OM/UG3=%U+]B?QS?W"7=G>VEC<ZII7QV_9\M]-D/GQ1
MPR7-O9ZSJJ0<F1(9KG8-C.:*N+NM>F@[WU_S_77_ #/Y._"PQXU\-CT\5:,/
MRUB$5_L,_P#!0K_E%;^U1_V9Q\0/_59WE?X]'A?GQKX<QS_Q5>D'\/[7@;/Y
M$?GCK7^PM_P4*(_X=6_M4'*@?\,;_$ Y) &/^%9W?.21Q\RCZLHZL 9I]?E^
MH0W\N96]+(_R=O\ @G__ ,GY_L4?]G;_ +.7_JXO!W^?YU_I[_\ !Q?_ ,H8
MOVX_^Q7^$_\ ZT!\(Z_S"/\ @G]S^WE^Q01T_P"&M_V<>3T&?C%X.QDG&/QZ
M<D\ U_IZ_P#!Q>Z_\.8OVXCN W>%_A.!D[<D_M ?"/ YQ\QZ!>I;Y0,\41^"
M7S_)$Q^U_B?Z'^>-_P $%QG_ (*\_L+>WQBB;Z[?#>OG'XU_KXU_D&_\$%SC
M_@KQ^PL>@_X7)"I)Z?-X<UX8R>YZ8ZFO]?($$ @@@C((Y!!Z$'N#3AL_7]$$
M/@_[>E^40K\E_P#@N3^S-KG[67_!+O\ :J^%?A/39=7\:6'@^Q^)7@_3K:%)
M[R^USX7ZYIWC?[!8HY!-YJ6EZ/J>F0+$3-*;PPQ)(TOE/^M%13('C*,BR*WR
MLC*'5E;Y2"I!4J<_,&!7;DD8JWJFNY2W74_QK?\ @EM^UYIW["O[>'P$_:)\
M4:=)JO@;PKXM31/B5IT5NEQ/+\.O%43^'/&4L-E-#.MW>:3I-[-K-A8R1%[J
M\TJWMD>W>5;F+_7F^$GB[X%?';X=>$?BU\)'\">._AUX[T.Q\1>%?%.@Z;I%
MUIVJZ7J$*3PNK?8E>VN(U<17EC=K!>V%TDUI>V\%S!+&O\&?_!=[_@W:^*7P
MP^(OCK]KG]AOP%J?Q$^#?C.YU3Q;\1?@WX1L);[Q?\*M<O/M&H:]JGAC0+:6
M>]\2>!;R;SKU+?2K:34?#+W$]F]E+I\-I?5_-'^SE^W7^VU^Q!?ZI8_L[_'W
MXK?!"26ZF_MGPQI6HS1Z-/>X\J>34O!WB"VO]!>]7;Y;3W.CM=(PP7X:LDW!
MV:T_K;N-V7IJT[>2T?1??H[[WT_V:I_#'@BUAGN+GPYX7MX;:&2XN99]'TB&
M&"")2\LTTTEJL<<4:@L\C,$1069@H)K\)?#W_!?G_@EOK/[;'BS]C:_UWPSH
M,&BW&G^'O#GQ]OM)TAO@WXO^(!FGMM?\%P:ZFEK_ &,-&NXXM/M?%>I./"FM
MZ@+RWMM5@CALKC4O\\3X_P#_  5O_P""DW[47A2Y\!_&W]KSXN^-/!FH)+;W
MWA6TU'3/"NBZK%<Q^5)::O8^"-*\.6^L031.8GM-06[BD1W#0D.RU]@_\$F?
M^"$_[4__  49\?\ ASQ+XH\)^*/@W^RO8WUO>>,/C+XFTB?2Y=>TRW=WFT+X
M7Z9J9L;CQ/K.I>2;'^U;99-$T-)%O;Z[++;65T^=MKE7K_73U_IG7Y7;VMMZ
M_+37M>Q_JUZ7;:9;V<!T>"QM].D0W%NNFQ6\=FZ7(\P2V_V94A,<A.\/& K@
M@E"6!'^6#_P="_\ *8?X[?\ 8B_!?_U7&B5_J(_";X6^"_@C\,/ ?PA^'6EO
MHO@7X;>$]%\&^$]*EN[K4)K'0M L(=/T^">^OI9[N[G6W@0SW-Q*\LTI>1FR
M<#_+N_X.A?\ E,/\=O\ L1?@O_ZKC1*<]EZ_HR);2_P_^WP/W_\ ^#3/_@I#
M\.+[X):W_P $]OB/XHT_P_\ $[P;XKUSQM\$[/5[^*UB\=^$/%<D&H>(?#>B
M23I' VO^&=?>[U,Z2MP]YJ-AK,]S:PR#3+SR?[4TDW+N(VXQG+ X&,]1GGV_
M/!XK_&U\-?\ !/3]JJY_8V\&_P#!0GX,^'O$OB_X767CKQ9X8\7:QX AOY?%
MGPC\2>!+C3KNV\0ZK;Z6[:E;Z#>VU]:W=EXGLO*BTN_MKBUOI+,&UFNO4_#O
M_!='_@K5X+\*6G@71/VX?C'#H6FV(TVVCU1O"^MZS;6\8,21#Q%KGAS4/$GF
M0@86275Y)T"A?,!&:49V5FGY>A;>U]'9>FRMKYZ:?\,O[XO^#BC_ (*5_#W]
MC/\ 89^*'P<TSQ)82_M$?M->"O$'PL\"^#[.^!U[0O"7C#3+W0_&7Q%U&WA2
M233M+TC1+J\L-*ENFM9;_7[^T33Q<+8Z@]M_GH_\$FOV8O$7[77_  4._98^
M#F@6,MU;7?Q4T#Q=XMNQ'(T.D>"?A_=CQGXIU6^=B$2*/2]#FM44N'NKRZM;
M*&-Y;E%;YNT+0/VFOVW/C5!8:59_%3]HWXY?$75+>V#E]>\=>,=:U&X:.*&:
M]O[AKZYCM(,A9+B]GAL;"&,R3300H6'^D_\ \$!_^"*D?_!-+X:ZI\7_ (UP
MZ5J_[6GQ>T6SLO$ILGAU"P^$_@MI8=03X>Z+J$4TUM?:M=7<<5QXOUNSQ;W<
M]K8Z;I[FRTUIM26LWMHO7YZ]_N$M=;:)Z76KV=G^%U=I>KL?O;\8DV?"#XJ#
M.0/AOXV4<<@#PSJ?^ XQQSCK7^(>G_(]+_V-B_\ IX%?[>7QF8#X0?%3)Q_Q
M;CQQ]./#.IGKT_#OSCI7^(>BM_PG2C:<_P#"6+Q@]]8&*=3I\_T)E]C_ !/_
M -L/]R/P_P#\@+1?^P5I_P#Z215_F$_\'77_ "EP\4_]D2^"O_ICNZ_T]O#Y
M']A:,/32M/S_ . D5?YA'_!UTP_X>X>*SD87X)?!7=STQH=V3QUX[XISV7K^
MC*Z/_MW_ -*B?TW?\&AW_*,/QE_V=!\1_P#U%? %?EG_ ,'C7[*NO6WQ"_9J
M_;'T33&G\+:SX7U/X&>.-0M[=R=+\0Z%J-[XI\&OJ4^[:8=9TO6->M-.VQ?N
MY-"N4D=GN8$'ZF?\&AW'_!,/QD.X_:@^(^?_  E/A^>O0]>W0Y!Y!%?T#_M@
M?LH?"3]MC]G?XE?LV?&K1?[7\#?$C1A8W$]OLCU?P_K%G,E]X?\ %6@73#=:
M:YX=U:&VU.QE!$<YADL;M9K&[NK>6FKQ2_NQ^]17Z[CDKZ/9J._HOZTU/X _
M^#6'_@IC\._V1_C;\1_V5OCMXMLO!WPS_:.OM U?P-XIUFY-OX?T'XS::8?#
M]CI.K7/D20Z99>.-&NHK(:U>W-MIMKJ.@:1!=NB7C3V_^D9!=17,4<]NR3P3
M1B:*:&2.2&6)P&BECE5BCQRQLLD;JQ5D(8$@C/\ D1?\%-/^",_[7O\ P34\
M?:Q'XV\%ZS\0/@9/J4R>!OC[X/T>[U#PAK.FW+3O8V_B7[$EP_@WQ/'!#(M]
MH^M_9U>>.2?3;C4; PW#^+_!'_@K5_P4B_9Q\'P> O@W^V+\:O"/@ZUBC@L/
M#G_"1P^(=,TNWMU>.*VTB#Q39ZZVC6Z*YV0:<;6+:!LB0JC+FI<NC3T_K^F*
MUK)WV5NMUI;MLOT6A_JF?\%'?^"A_P $O^"<?[-WC+XW_%C7-.&O1Z3J=A\+
M/A\US_Q/OB7\0'L)GT#PUI=G D]RMC->".76]9:'[!HVEQW%S=S+,;6WN/R%
M_P""77_!S5^S-^VQKOA'X)?'[PU-^SA^T9XIO=-\.^&K-;C5?%?PS^)?B2^<
MV]M:>&O$-IHYOO"NHZG<;5L]$\7Q1VXGFBT^S\1ZI<M&)/\ .F\4>-_VJ/VW
MOBYI]QXK\0?&+]I7XP>*KNWTG2HKV?Q+\1/%=\]W<*D&G:58)]ON+>U:>3]W
M:64-O:1YR$C4$C^\C_@WS_X-_?$_[)/B'1/VV/VR-'L[7X^1:7.?@_\ "222
M&^?X2P:[IEYIFI>)_&$T4DUE+X\OM&U&6RLM)B,\?A2&:ZDGDDUMQ#IC4G)Z
M;=?3S\^UOQ!-/9.W=Z-[;+;M;?=MK8H_\'@W[+VL?$/]ESX _M1^';">];X&
M?$:_\%>-1! SR:=X+^*&GH]GKUR=P*V5AXK\.Z3I<X2-F63Q#:3$K''+7\YW
M_!MS_P %#? _[!'[<]WIGQ@UZ'PU\%?VCO"L/PO\8>*+\RII7A'Q%9W_ /;/
M@#Q-JOE+.(=.&L?:O#FH7SIY6F6'B*ZU"X:.VM9Y(_\ 3U^-WP7^'?[1'P@^
M(GP/^*WA^W\2_#OXI>#];\%>+=&G4(USH^O6,ME<O:S8,EEJ-H)%N]-OX-MS
MI]_;VUY;,DT$9'^5+_P5J_X(H?M,?\$TOB;X@U&+PSXC^)7[+^IZA+<?#SXW
M:%I4U[IUCI=W/<OIWAKXABQ2<>%_%NFVT8L[J2\,.F:W)&+S2;B2.X-M;DDT
MU)?/^O/;_AQ65^:VOZ/3]>VBUZ:?ZT5AJ=EJEG::AIMS;WUA?6T-Y9WUI/#<
MV5W:7$:S6]S:W4+R17%O<0NDL,T3-$\;!@^",_._[6G[6GP6_8K^!7CG]H/X
M\>*K'PIX$\$:5)=N\\A?4=?UB8&'1O"_A[3H8YKS5-=UW47M["QM;6WDV&9K
MRZ:"QM;JXA_R2/V>O^"LW_!1G]E/PC%\/?@)^UM\5O O@BT#"R\*M=Z5XGT'
M3$QC9H^F^-=*\0VNBPGD^1ID5E"'(;8QXKM/#-M_P4V_X+3?'CPWX+O/$_Q?
M_:>\?27!BBU'Q->W3>!/A[IDODQ7^N:F]O;V?@[P1I,$:0M>7265D;EMD4,<
M\_DI1S]EK_7WC5F^_P"&UKZ].NOEZV^*OVH/COXD_:?_ &A?C+^T/XNC,'B+
MXR?$7Q1X^U.T$PN$L9-?U2XO+;38[@)&)H],L7MK"*01Q@I;@B.,$(/]>G_@
MD[_RC-_8/_[-7^"__J$:17^0/^T-\([KX"?''XL?!*_U:WU_4?A/\1/%?P]U
M#6;2&6"UU6\\(ZS>:)>:A:P3YGBM;NYM)9[>.8F98'3SEBD#QK_K[_\ !)T@
M_P#!,S]A#!!_XQ8^# X.>5\$Z2"/P((/N*4-WZ?JA)OWTU]I.]K+9Z>O]:'"
M_P#!:O\ Y1._M_\ _9LWQ(_]-1K_ "V/^"5) _X*5?L,D]!^U#\'^O _Y'+3
M.I[?7M7^I3_P6I /_!)_]OX>O[,WQ(Z^VDMWK_'\\(>,/%7P]\6:!XX\$>(-
M6\*>,/"FKV>N^&O$N@WLVG:UH6LZ=.MQ8:II>H6SI<6=]9SHDUM<P.DL,JK)
M&RL 0YZ-/^M'_P $3TE!]I)_BC_<_#9)...,8R<]>HQD=>XP1R":C=P5*E0<
MY&">,KDX; .,@9(QTX&3Q7^,U_P]1_X*1=OVY?VHQP!@?&3QJ!P !_S%^P '
MT K^I;_@U'_;(_:L_:._;,_:"\*_'O\ :(^,/Q@\-Z/^S9/X@TC0OB-X\U_Q
M5I>GZVGQ*\#Z>NKV5EJ][<0PWZV5[>VBW4,8E%O<SPF0H[@M33=K/4I--VUO
M9M72Z*[O9NS]5V[G\R'_  5K_9BU[]DG_@HK^U-\'M7LKBVL;;XIZ_XQ\(7,
MZN$U;P1X_NG\8^%M0MY'),RMINLQ6<S  "^L[N #=& ?]&K_ ((5_M[? ?\
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M"3P%H.NZ5=!'B^TZ=JVE:#9W]E/Y4LL7G6]Q')Y<DB;L,:^@ ,  =AC\J**
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MP'[%_P"Q^'$H_96_9R$P8.)_^%)_#83"0'<)1(/#0<2!OF#@A@WS YKZ7HH
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HX50,XXKT"B@+OO\ U_27W" 8 &2<<9))..V2223ZDGD\T4M% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>ny20053122x2_tooling.jpg
<TEXT>
begin 644 ny20053122x2_tooling.jpg
M_]C_X  02D9)1@ ! 0$ P #   #_[0 V4&AO=&]S:&]P(#,N,  X0DE- ^T*
M4F5S;VQU=&EO;@     0 ,     !  $ P     $  ?_B"^!)0T-?4%)/1DE,
M10 ! 0  "]!N;VYE @   &UN=')21T(@6%E:( ?4  < %0 3  L (6%C<W
M         $E%0R!S4D="     0            #VU@ !     -,M2% @(
M
M$&1E<V,   %$    =&)865H   &X    %&)44D,   ',   (#&1M9&0   G8
M    B&=865H   I@    %&=44D,   ',   (#&QU;6D   IT    %&UE87,
M  J(    )&)K<'0   JL    %')865H   K     %')44D,   ',   (#'1E
M8V@   K4    #'9U960   K@    AW=T<'0   MH    %&-P<G0   M\
M*&-H860   ND    +&1E<V,         &G-21T(@245#-C$Y-C8M,BTQ('=I
M=&A"4$,
M                                                    6%E:(
M     "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@
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M;W5R(%-P86-E("T@<U)'0@
M
M      !865H@        8ID  +>%   8VEA96B            !0
M;65A<P         !                               "6%E:(
M  ,6   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E
M<V,         +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@
M-C$Y-C8M,BTQ
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MU=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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ML;2!!EYKB9$W%4!+LJG^*K_@I!_P=U>'?"VH^)/A9_P3@\ :;XZN((;K3?\
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MI^&__P TM'_#7/[*/_1SG[/7_AZ?AO\ _-+7^(Y11[1]E_7]/^EJ>T7\K_\
M O\ @>O]+7_;C_X:Y_91_P"CG/V>O_#T_#?_ .:6C_AKG]E'_HYS]GK_ ,/3
M\-__ )I:_P 1RBCVC[+^OZ?]+4]HOY7_ .!?\#U_I:_[<?\ PUS^RC_T<Y^S
MU_X>GX;_ /S2T?\ #7/[*/\ T<Y^SU_X>GX;_P#S2U_B.44>T?9?U_3_ *6I
M[1?RO_P+_@>O]+7_ &X_^&N?V4?^CG/V>O\ P]/PW_\ FEH_X:Y_91_Z.<_9
MZ_\ #T_#?_YI:_Q'**/:/LOZ_I_TM3VB_E?_ (%_P/7^EK_MQ_\ #7/[*/\
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M.44>T?9?U_3_ *6I[1?RO_P+_@>O]+7_ &X_^&N?V4?^CG/V>O\ P]/PW_\
MFEH_X:Y_91_Z.<_9Z_\ #T_#?_YI:_Q'**/:/LOZ_I_TM3VB_E?_ (%_P/7^
MEK_MQ_\ #7/[*/\ T<Y^SU_X>GX;_P#S2T?\-<_LH_\ 1SG[/7_AZ?AO_P#-
M+7^(Y11[1]E_7]/^EJ>T7\K_ / O^!Z_TM?]N/\ X:Y_91_Z.<_9Z_\ #T_#
M?_YI:/\ AKG]E'_HYS]GK_P]/PW_ /FEK_$<HH]H^R_K^G_2U/:+^5_^!?\
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MM3VB_E?_ (%_P/7^EK_MQ_\ #7/[*/\ T<Y^SU_X>GX;_P#S2T?\-<_LH_\
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M%[?!#_HLGPJ_\.'X1_\ EQ1_PO;X(?\ 19/A5_X</PC_ /+BOQTHI^P_O_\
MDO\ ]L'M%_*__ O^!Z_TM?W#TSQ3X9UJQMM4T?Q%H6K:9>(9+34=,U?3[^QN
MHP[1F2VN[6XEMYT$B.A:*1E#JRD[E(%[^U=+_P"@E8?^!EO_ /'*_"ZBG[!?
MS/[O^#Z_TM3VGE^/_ /W1_M72_\ H)6'_@9;_P#QRK,-Q!<#=!/#.HZM#(D@
M_-&85^$M2PSSV\BRV\TL$JG*R0R/%(I'(*NA5@<\\&E[#^]^'_!#VG]W\?\
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M+INE?;-7DUOQ)KGX1T45@VV[LQ;<GK\EV"BBB@04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% '^I+^SM_P F_? K_LCGPQ_]0G1*]CKQ
MS]G;_DW[X%?]D<^&/_J$Z)7L=>M#X(_X8_D@"BBBJ **** "BBB@ HHHH ]O
M^$'QP\2?"R_CMPTNK>%+B;=J&@RRX$1D*B2]TN5PXM+Q  S( +>[ \N=0YCG
MA_5'POXHT3QEH5AXB\/WJ7VEZC%YD,R@HZ.I*36]Q$V'@N;>0-%/#( \<BD'
M(P3^']>^? /XP77PQ\2QVFH3N_@_7)XH=:MVRZ6$K$10ZU;J%9Q):@@7<<7-
MU:!E*O-%;%,:M-23DE[RU]>]_EL7&5M'MMZ?\ _62BHXI8IXHYX)$FAFC26*
M6-@\<L4BATDC=25='4AE920RD$$@U)7*:GEOQR^)^G?!+X*?&#XS:O$)])^$
M?PN^('Q.U.%G,:S:?X"\)ZMXJO8FD )19+;2I$+@$J"6 )&*_P 1SXC?$'Q=
M\6?B#XX^*/C_ %BY\0^.?B-XN\1>.?&.O7A!N=9\3^*]7O-=UW4Y\8427NIW
MUU<LB!40R;$5455'^LA_P<,?&;_A2?\ P2 _;)UBWU#[#J_COP7X?^#FCH&*
M27[?%GQKX<\$^(+&(@$DMX,U;Q-<RKQFVMIQN7[P_P CRLY[I?U_6A%1Z)=V
M[_*UO(****S,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#_4E_9V_Y-^^!7_9'/AC_P"H3HE>QUXY^SM_R;]\"O\ LCGPQ_\
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MCKM?YW=<D_B?R_(B>Z]/U84445) 4444 %%%% !1110 4444 %%%% !1110
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M:?L.^-/C'>_"/XO^ /A;K7Q7\,_%_P"$'QB\:0>,_$7@'4O#_AS3=7UKPO\
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M@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_PKO7?^>VF_^!%Q_P#(E'_"N]=_Y[:;_P"!%Q_\B5[910')'M^+_P SQ/\
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M1<?_ ")7ME% <D>WXO\ S/$_^%=Z[_SVTW_P(N/_ )$H_P"%=Z[_ ,]M-_\
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MP6_[)-\.?_4/T:O6:]:'P1_PQ_)&3T;]6%%%%4(**** "BBB@ HHHH ****
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M[LKZ.^MGI:S8U:3B]UO;5)ZW7JK:KI?O>Q1115""BBB@ K]=?V=/^2+^!?\
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MZ#XL\5>-- U?2= ET.^^'5U;6EW<Z5J<>HZ*UAK:&V\\UC_@H+^RC>?MZ_\
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M.I:G&*DHJT9M333?LXRY6FX<ZE-)ZJ-*-64)5.9I7C32O-:-I2DDH[?Q(?\
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M3WU+5-:\/QZ_<Z[<ZMIT5OIUH^7X;M+F:N[^ZD\34PJE=VO%U(73T]V46[;
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M2C!N\:M2A%-:-^TQ*H3CUY;6FU.SV3LVG!_Q-_6N]^%7PR\9?&KXG?#WX/\
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MIO9M<C5=0B.D,!JA%J?;OB=^P#\0OB9XT_8)^#W[+W[,/C+2/BG^T3^Q_P"
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M[::MH^FB$7NK7]AI\L5T_P!0?';_ ((Z?\%'/V:O@_XP^.OQG_9OU3PE\-O
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M5M;^SFE.:W7N1E#GWLW!O5H<5)I--+DC[C?VOWM-<D>C:E4C4Y7=+XDE:)^
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MB)N/E*5",==5'>4VD$:G+%16MDD^B:C3E3BGNW:,Y[O5NZ25T?U'?M8_MU?
M/Q;_ ,$E]!^*_@_QEX;O/VZ?VS/AA^S[^QY^TQX>M?$%C>^.M#\!_LE:QXYN
MM:^(NMZ9',VLZ0_QFL;7X=Z=JD]]!!I7B+1Y;.WTQI9M#U3R_H+Q[\>_V<_C
M3XW_ &P_V/M+_:4^#GPR\5?MC?\ !.G_ ()\>!OA)\?=5\;:;)\+=,^(WP%\
M-PZSXR^!_CCQ_P"'9=4L?!:^/8]1F\,>))=5N8+?3'TJ[TW4K.]U:73=%OOX
M[]H]/\C'^ HP/R]SW_S^?/6J<[^V35XUY.4XZV2=.K"4(/5I>TJSK+HIM\RD
MI2YA5&O9VNG344GIJX3A)2:TN^6G"G>]^6$==$E_4)^Q=K_P,_X)N_ME?!?X
M5?'7]MWX0?M$'Q=^R3\>?@3XB:TOO%7Q*_9:_8]\:_%W68_$7@_PQ;>.M(\1
M0V_BCP=XSO1>6_Q6_P"$*L_ \?AB\\5ZW-J>LPP2W.N67??M#_M 7OP'TG]B
MG]GN?XT?\$M/V7[&U_;@\.?M+W>H_L$^&/BA\<]/^!M[X/T8^$_#OQG\<WNH
M_$KQ'X+US1?%,-]<VOB+X="WTCQ')HFC:)JK7%[87FM6=A_)[M7T'K_G_#I1
M@?Y)Q^73Z>E)2:<'I>#CK_-&-;V\8OKI-M<S<KQM=<_OASJTE9V<6DF[V<J:
MI3=WI9Q7PI))V2:C[I_17_P6(T;]G2[^ O@'XAWL?[)W@W]M7QK^T?X]UCQ=
MX5_8;^-6J?%/X%_%;X0:MX6AO)OC]K_A0ZYKNA_"?QIK_C6.TT_3M&$UKXBU
MW2KB^OM9.H-;+:^&OYU:0* <@?Y_S_ATI:A*U[6M[J22LDHPC#9:)OEYI<JC
M'FE+EC&-HI3GSM/716NVVW[SEUOHK\J5VU%*[;NPHHHID!7[&?\ ! [QAX/\
M!_\ !4[]GKQ-X\\7^%? OA>RT'XY6]_XH\:^(-*\+>&].EU3X#?$O2]/74=<
MUN[LM-LOMFHWMI8VWVBYC\^[N8+:(/-+'&WXYTA )R1R*-TT]FFGZ-6?X#6Z
M?9I_--/;KZ:']#7[)G_!,_1OV>?VU_V:O$7[4G[67[-=E\-O$_C[Q79:5J7[
M-_[8NB6_BO\ X3?2/A_XM\5^"= \0>/O!<UCK/PK\,^,]>T>S\*W_C.VOK&[
M5]671--O['4]6M+VW_6.\^+W[/?[+?P8_P""?-CXUT/]D_\ 9ENOA;_P5U\*
M^._B%\&/@#^T&W[0<GPO\"ZS\(?%FB2^.OB+XLNO&OCS6=1U*9+S2]6\5:OH
MU]+H%EH\F@VLEO:>(TU/3H_X@B >M&T>G^>O^1]/04XR<>165H3IRL]G[.O2
MK:[-N3I*+NW%1:Y8J4;RM32YK)KF4T]7ISTJE+9W5HJHVDDFVGS2:E9?UM:W
M\"/#_P"QO^R]_P %#/#_ (Y_:0_9C\::Y\?/VXOV-?BA\,?#WPS^,WA'Q;X@
MU+X4Z%^TAJNMVWCS4M,L[X2Z?9:EIFOSW,M@&N[K1K?0M2O]5:#3;C3;V]SO
M&WQZ\!ZU_P % _\ @X8U2\^,OA#4_!7Q)_8)^/FA?#S4+GX@Z)=>&O'WB+3=
M"^%6G>!M%\&7<FK/I?BG6;.QCU2R\,:=HDM]?):I?P:9"8A< ?R:[5]/YTNT
M>G^?3Z>W3\A2VY;)6C1K44FKIQJX;#X92=]'*$*'-JK3E.7PK?1UTX<O)K[2
MG4O=O6%6K5<5>[493J[7T4(K5NZ_K+_:5^';_M>?&KX>?\%)_P!G[_@HQ\(?
MV5OV</#_ .R/X8\-'68_BI>Z'\:OV8M?\$?"&]\#^(_V??#_ ,']"U/1/'NH
MW7BCQ(VHVUJWA0P1ZM9^*M<UC1+?6@N@Q>)?%_#GQQ\*:;XH_P"#:BVM?B_X
M=M-(^%GB&"Y^)2Q^.=+M;+X?C6OVK=-.OW7CJ-=4$7A'^UO!D:2ZJ_B$V'VC
MPZ&DN2VG N?YF]H]/U/Z\\T;1Z=?<U7-^]C5_EK>WY;MIR<JLY)MW?*Y57RK
M[*BOBDW)PJB4'"UW*BJ-[)<JC[%)Q7?EI--[OFW4?=/K3]OC5-$US]NO]M/6
M?#.HZ7K'AS5OVL?VB=3T#5]#O+34=%U31+_XO>,+K2M1T>_L))K&^TN]L98+
MJPO+*66TN;26&:WD>%T8_)M(!C\?<G^=+6<(\D(03OR1C&_?E25_G8B3YI.6
MNK;U=WKY]0HHHJB0HHHH _TA_@'_ ,D+^"W_ &2;X<_^H?HU>LUY-\ _^2%_
M!;_LDWPY_P#4/T:O6:]:'P1_PQ_)&$MWZO\ ,****H05^4?[97P#_P""C_Q?
M^(^I+\"OBI^R?IWP'%GH%QHG@7XX_"^S\>:M:>([/3A%K.ISG5/AMXKLQ]HO
MVFET^5+Z26WMG*!(<^6/U<K\T/VG/^"??Q"_:%^+&I_$OP[^WA^UQ\!-+U'2
MM%TU/AU\(OB#JWA_P382Z38QV4M_9:9::O9P17FJNGVO4)!!NFNG=V=MV!G4
M3:BDI/WKM1FHZ6>]]&KVTUM+EE9\MBHNU]4M%:Z;^U':VSM?7M=75S+_ ."7
M_P 8?VA?B-X4_:$\!?M0>+O!/B+XM_ #XZ:I\(M1TSP#X7TKPYX<\/Z3H?A_
M19--727T73=*T_5=(U222\N]+G>QLM1LX4DT^_T^Q:WBB;]0Z^1OV,_V-OAM
M^Q3\,-2^'G@'5O%'BW4_%/BC4?''C_X@^.=075/&'CGQ?JD-M;W6L:O=QQQ0
MQHEM:00VME @CB_?W4\EWJ5]?WUW]<U<;J,$_B4(*3762A%2>N]Y)MO[3;EU
M(5M;:)RDXKM%R;BOE%I!1113&%%%% !7ZZ_LZ?\ )%_ O_7EJ7_I]U2OR*K]
M=?V=/^2+^!?^O+4O_3[JE85]H^K_ "+AN_3]4?SG?\';/_*/_P" W_9XGA#_
M -4K\=*_SVZ_T)/^#MG_ )1__ ;_ +/$\(?^J5^.E?Y[=<$_B?R_)&H4445(
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '^D/
M\ _^2%_!;_LDWPY_]0_1J]9KR;X!_P#)"_@M_P!DF^'/_J'Z-7K->M#X(_X8
M_DC"6[]7^844450@K\1?VE_#/Q+_ &_OVW_'7[%4'Q@\=?!;]FS]GGX7^ O&
M_P 9H/AK?P:5XN^+?C+XBSQZQX=\-3ZPR^;I_ANPT%8K@I+;ZK8#4+*\DN=.
MN;VYTJYT?]NJ_(7]IN#X-?LC_MQ_#W]MKQO^U-X2^ GAOXD_#^^^%7QI^&'B
M'2+[7M3^,=EX:M+N?P5K?ARUTNPUW5=/N/#VK3>'[?7=5M]+LK>RTG2K:VBU
M6-]8U&TO\JEKT^>WL^=J=W9:TYJ%]5>*J.+<5>3:5D[-.HMJ,^6_/RKDLKNZ
MG!R2[-P4DFVEK9M7NO"?"WP?\;?\$L?VKOV9/!?PX^-?Q.^)W[)_[6GC[5_A
M)KGPK^*NMP>(]2^'/Q(N-$CO?"OBWPKK*V]J/*U2\@\G5XK32]-#6-M<PZF^
MIRR:-<Z3^^ Z#/7O7YO:M\!+']KK]I[]FO\ ;%TWXY^'O'_[,7PA\'7WB[X/
M?#_PQ;07=GJWQ?UZ35-*O?'5[XDLF@:XT_2M*316M=*OI+F_TOQ)HUU8266F
M1/JD5]^D-533C%Q?2<N5/>-.T>57ZIS524;ZJG*";>EI=FU)6UA%RM:SF[MO
MOI'DC+9.<96044458!1110 5^NO[.G_)%_ O_7EJ7_I]U2OR*K]=?V=/^2+^
M!?\ KRU+_P!/NJ5A7VCZO\BX;OT_5'X ?\'4EIIM]^P=\%;?4M-M]2C?]J_P
MPL N)]1@-G<-\&_C6B7UN=/OK(O<P*[^4EW]JLB6/G6DV%V_P1OX;\+,DBKX
M;L8V>PBM$D2_\0EH;B,DMJD8DUJ1&OI\@2QS)+I@"CR=.A)<M_?#_P '3G_)
MBOP0_P"SL_"O_JGOC57\&E<,]_E_F=,$FG=)Z]O0RI?#GA60783PU86_VA+1
M(3%?^(F-@UNV9I+3S];G#O?CY;L7XO8T7_CQCLFRQ63P[X4=K@KX8TZ$37%K
M-$D>H>)2MI'!L\VTMS+KTKM;WH5_M+7;W5TAE<V5S9[8Q'J45!=EV7W(RSX>
M\*$L1X7TX!M02\"_VAXEVK;*BJVDKG7MW]GR,ID>5F.JAW81ZG'&(T07P[X4
M5D8^&-/<)?S791M0\2!9+>4.$TN0KKJO]AMRRM#+&\>ILR+Y^HSJ75M2B@++
MLON1EP^'?"D36I?PQI]P+>6ZDE6;4/$@%ZEQO\F"Y,&NPLD5CO'V5K,VL[^5
M']MFO!YHE2+PYX5C6U#^&K"<P07,4K2ZAXB#7LDY4Q7-SY.MQ*DUD!MMELUM
M;=PS?;(+ML,-6B@=EV7W+R\O+^KLR$\-^%E15/ARR<KI\ED9'O\ Q#O>Y?&W
M5W":TB?VA%C]W$B)I)!;S=,D.THK^'/"K*ZCPW8QEM/CLPZ:AX@+1W*%BVK(
M)-:=#J$P8+)%(DFD@(IATR([BVM10*R[+[D94OASPK(+D)X:L;<SQ6T<31:A
MXA9K%X"3+/:^?K4ZO->@[;H7RWD" #[%!9MDE9?#OA21[ED\,6$ GFM)8HXM
M1\2,EDEL$$UO:F?7)G>&_*,UVUZ]Y<H99!8W%FHC6/4HH"R[+[E_EY?U=F8W
MAWPH6=AX7T]0U_#>!%U'Q*52WC5%?2E+:ZSFPN"K-+([OJ@,C^1J4($8C0>'
M?"@96/A?3R%U![TH=1\2;7MG#!=);&NAAI\18-%(C)JA9$\[4IEWJ^I10%EV
M7W+^NAEQ>'?"D;VS-X8T^=8)[N:6.74/$@6\CN XAM;@PZ["Z06.\&U:T>UN
M',<?VVXNQY@D2+P[X5C%J'\,V$_V>*ZCE,NH>(U-\UP<PS77D:Y"%EL0-MJ+
M,6D+J3]MBNVPPU:*+_U9?U_7FPLNR^Y&2OAOPLJQJ?#=BY33Y;-G?4/$.Z6X
MD*E=5D":VB#4(<$11Q)'IA#MYVFRD(50^&_"Q5E_X1NQ4MIRV(=;_P 1;TN5
MSG6$#:VR?VC)D;XW1])&T>7ID?.=>B@++LON1DR^'/"TBW(3PW8P&>WMX8VB
MU#Q$39R0,3)=6XFUN96GO 0MRMTMS;*%!L[>T8L6=-X=\*R-=E/#.GVXN)+1
MX5AU#Q&RV*VY4S16OVC79V>._P!K"[-ZUY*@=OL,EF1&4U** LNR[;+I_P ,
M9;>'O"C,[#PQIZ![Z"["+J'B3;%!$$$FF1[M=9C97)1FFDE:745\QQ;ZA  @
M0'AWPH""?"^GD#4'O2O]H>)<-;,A1=()_MW<-/C)$BRAAJQ=5WZFT9>-]2B@
M++LON1EQ^'?"J- S^&=/F$-S<SR))?\ B-4NHIPXBLIS#KD3I;61=6M7M7MK
MUS&GVV[NP9!(D/ASPK&+0/X9L+@VRW8F,VH>(U.H&X.87N_L^N0",V ^6U&G
MBQ61?^/Y;UOFK5HHO_5E_7]>;"R[+[C)C\-^%D6)6\-V,ICLIK5WDO\ Q"&G
MGD*E-2E$6M1(M[;A2L,=ND&G,';[183L%*H?#?A8H5'ARR!_LT6(<:AXA+BZ
M!.=9YUHH=28<&(I_8XP"NE+\V[7HH'9=E_7_  R^XR9/#?A5UN%7PW90F:U@
MMXWBU'Q"6M)H2QDOK<3ZU,C75T&"SI=)<V2A%-K9VS;B73>'?"DINRGABPM_
MM#6C0B'4/$A%@+<J9DM/M&NS[UO\$7?V_P"VL@=OL+61"%-2B@-.R^Y>7EY(
MRG\.>%&:5E\,V$8DO;>Z1$U'Q(4@@A""73HO,UQW:RN]K&>29YM00R/]EO[<
M",([_A'O"F<_\(OIV/[1-[M_M#Q)M^S%"O\ 9!_XGNXZ<&/F"0,-5WX!U,Q_
M)6G10*R?1?<O3]#+3P[X41H6/AC3Y!%=W%RZ/J/B3;<0S>9Y6GSF/78W%I:%
MU-O);M;W[>4@N[VZ!D$A#X=\*1?9-_AFPN/LQN_.$^H>(P+\7))A%W]GUR I
M]@!"VAL39%PH-]]M8LS:E% 679=MD9,?ASPJBP*_ANQF,-I/;2/)J'B$-=32
ME3'J$_DZU$JWEL%*P+;+;V+!F^T65PVT@_X1SPML*_\ ".6.[^S#8>9]O\0;
MA=<_\3K']M;/[3':+9_8_KI)K6HH"R[+[D9,GASPLZSJOANQB,MG#:QNE_X@
M+6TT6[S-0A\W6I%:\N<@3)<K/8+M'V>Q@)8ETOAWPK)]KV>&-/@^T_8_)\G4
M/$9^P?9F#3?9//UR??\ V@ 4O/MWVT(K$V LGPPU** LNR^Y&7)X=\*N\[+X
M8T^(2W5M<1I'J'B,K;0P!!)8PF77)7:TO"K-<O<//?*9'%I>6JB,1K_PCWA3
M<3_PC&GX.HB]V_VAXDVBV"!3I _XGN[^SF/[PR,S:MO)VZH$P@TZ* LNR^Y&
M8GA[PHK1,WA?3I!'>7%TR/J'B0+-!,'$>G2^7KJ.+*UWJ;=X7AU!C%']JO[D
M&02)#X=\*Q&U+^&;"X%N]VTHFU#Q$!?"Y+&&.[^SZW 433PP%F;$V3N$7[>]
M\2Y;4HH"R[+[D947ASPK&MNK>&K&<PVUQ!(\NH>(0UW+,08[RX$&M0HMS:8V
MVZVB6MHP9OM5K=-M94'ASPL$"GPW8EAIK6!D-_XA#FZ.,:R0NM"/^TEQQ$$&
MD<G.E'C&M10%EV7W(R)/#?A9UE5?#EE$TEC#:(\=_P"("T$\1)?4XA)K,B&^
MN =LT<R3::%5?(T^ [BSY?#OA60703PS80?:$M4B,6H>(R;%K=B99+3S]<F#
M/?CY;L7HO$1>;%+)OF&I10%EV7W+_(RY?#WA21K@IX8T^ 37%K/&D6H>(RMI
M';B,2V=N9M<F=K:]*,UTUTUS=H97%G=6BB-8P^'?"A9B/#&G@'44O@@U#Q'M
M6V555M(!.N%SITC N\C,VK!F(CU1(PJ+J44!9=E]R,Q?#WA161CX7TYPE]-=
MLC:AXD"RP2JXCTQRNNJXL+8LK0O$\>I,T:?:-1G4R*Y%X>\*1M:%_"^GSBWD
MNY)EEU#Q(JWZW)?R8;LP:["Z16 =1:&Q:RF?RT^W37A+[].B@++LON1DP^&_
M"L:VH?PW8W!MX+B&5IM0\0AKV2=@8KJZ\C6H56>S *VRV:VELX8_;+>[8*0+
MX<\+*BJ?#=B[+ISV1D:_\0[GN7(*ZNX76E3^T8\8CC1$TDAF\S2Y/E*ZU% 6
M79?<C(?PWX699 OARRC+Z?'9(Z:AXA+0W*%M^K()-:=&OY@0)(Y5DTL!08M-
MC8L2LOASPK(+H)X:L8#<16L<)BU'Q$38M;DF6>U\[6I@\U]TNA?"\@0 ?8H+
M0\UK44!9=E]R,R7P]X3D:Y*>%]/@$\]I+$D6H^)&6SCM_+\ZVMO/UV9V@O\
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MJ_@TK^\O_@Z<_P"3%?@A_P!G9^%?_5/?&JOX-*X9[KT_5G5#9^OZ(***]/\
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M-^])S25J<WM!INZTM>RO=[(N%_?M=^ZM$HNZ=2FG=R6B2;=UO;EZGHO_  2
M^,O[$FEM\9?V:_V??B=XQ^(OQ/M/B)XE\>>,?B%\2;I-1\3?'X_9M'LM1^*^
M@7]JDD:>$TD>UL;;2]6N$U^UN)I]0U-+FZU6XO9_W'K\=?\ @D_IG[&?Q$L?
MCS^T;^R_\'?&O@?_ (3?XP^(M]]\4OAC\,_!VI^%TOM)T&75_ OPCO/ T5V^
MG?"W3[FVMDDT#^V)4M]=@NX[B(R0(U?L56D$U"FFTW[.G>VBUA%I+II%K9)/
M>/NM&>\IM/3GER][7LV[ZW<DW9NZ32=VKA1115#"BBB@ K]=?V=/^2+^!?\
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M^/O@MXFNO%7A;3K&U&KP:9<^&[S4;MX]9L]0M+J\NK5%CM;^S??(WT)\;_\
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MU#FHU%!RO+FO.CRWDY)*K*3DEHOWA_;;^%=K^SK\"/\ @I_X_P#!;VD6G?\
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M&_MB_M::IX?^/?Q1\(_!WXW_  (_X)A_\-!_MP^,O@%H/AOQ#X9TS]H'X?\
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M_@I-XK^,=TW[(G[5<?@WX]_L8?$'6ET[2)/CG<ZI+H?A'PS\5?@1?:6M[?\
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M&[]/U1^ O_!TY_R8K\$/^SL_"O\ ZI[XU5_!I7]Y?_!TY_R8K\$/^SL_"O\
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MT#JWBRQO-0GM=8U&2?7TTKPLWVJT\&V%[=3227ZQ@>977_!-']EC]GS]F_\
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MW+GA3:D[-I7CRQ4?LJ"3\YE\;V]Q>ST>D>64DX>;4KR;ZN3U"BBBM!!1110
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M&D!(I7T+6XU=WT;542.PCU61VTZ\54TN8LL6I.QA 6PD9'"7C$6[E&"R':<
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M1?&/QWI_@;XA:-IO[..J&\N_!OP\&LW=E8:WIWC"T?3;ZXM(6O1)K,<*:L=
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M4>7'_P \T_[Y7_"GT4%C/+C_ .>:?]\K_A1Y<?\ SS3_ +Y7_"GT4 ,\N/\
MYYI_WRO^%'EQ_P#/-/\ OE?\*?10 SRX_P#GFG_?*_X4>7'_ ,\T_P"^5_PI
M]% #/+C_ .>:?]\K_A1Y<?\ <3_OE?\ "GT4 ,\N/_GFG_?*_P"%'EQ_\\T_
M[Y7_  I]% #/+C_YYI_WRO\ A1Y<?_/-/^^5_P *?10 SRX_^>:?]\K_ (4>
M7'_SS3_OE?\ "GT467;^OZ2 9Y<?_/-/^^5_PH\N/^XG_?*_X4^B@!GEQ_\
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ME_7_  R^X!GEQ_\ /-/^^5_PH\N/_GFG_?*_X4^BF SRX_[B?]\K_A1Y<?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7))7_,^BBBK$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME\5V=M::[HVI6&JZMJ>GZSIVL[=5GUW[191RZU)XBUN*]9K.XAM+?F?VC?\
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M=_!_]J/X:V.A6,>C>!?B!=V>@ZQX;\07/AT1'3T\,>/O#FMZ1;WLL-@FC_\
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MCX9OM.D\&> =+^(OB?6](OFO9;&PFTA=0\0QS-+JWB:XU*SM8&TU/&_VE_\
M@H)\,?VN/"?Q6TGXP7'B^]\7_#K]IK5?BE^Q]XV3PQIGVJ'X->(_$2P:Q\(_
M&]M9W]FNBVMEX:TK0=6TR^B77KVZUZWM[2^NX[>RFNKQ_P"U]^WC\#?CAX-_
M;ET'P7%XU6^_:&^/GP*^)/P_.LZ!:V$*>'/AU\/](\,^(%U^2+5[LZ=J+:E9
M3&PM8$O8[FVVRO<0LWE5#YHPIVAS.*7+'WKJ,YY?"\K/^)&F\0YIM)NG*W+%
M1M6]2I=\J?->2LTW%XB247;X':FH65[R2=Y.5^;G_P""5]OHOQO^)6@>+OVA
M_#GA_P#9A^&7P8\%_M!ZM^TN/!^HZA%J/PR^(ZS1> _[,^'UGK$NIS^)O$NI
M6&LV%EI,6KSM+'I$]S:?;;J[TS2KWQ3]K#]BWX:? CX(_!W]H'X1?M'6O[0'
MP\^-OBOQIH'AB[MOASJ7@&YTVU\'0V:7;:S:ZSX@U'4K?6H]5DO],O=(N-*L
M5@2RAU""[N8-0BBB_2/X.?M*Z+^U#XUU/X0^!_@=X\^/_P %=3_X)X? OX3?
MM$^ ]"UGP[X*^*=GK/[/U_J5W'XS^%&G:CK37/CJ_P##VM>)=NB>']-VW^N7
M.HVTLUI&EH+.]\C_ ."EVB_#WX<_L2?L4_##P3\*OB+\#;2'Q]\</$NB?#GX
MT7UO+\9K[PY)-HEFWC_X@Z1;V]H?#FH^*M3N'FM='>TMH+6TCBM[%!!:O%;W
M+2*WC=Q46W[[4L5.G[UU%<OLHP:E&-W[S?,^=QF/O22UORN4E>\8M8>G-6W:
MDJDI\RDVD^5:>ZI?A71115C"BBB@ HHHH **** "OWZ_X)SZ9XOO/V/_ !-<
M?L7>%/@%XY_;.M_C3<O\4?"OQ=LO!U_XTUSX$1^&+2;2-'\"VWCB]T_2SX<U
M'6H[F+Q!]BOK"YFF-ZLM_!=0Z21^ M?H?^SKXQ_84\0_!^R^'/[1VF_$[X+_
M !4\%>-[WQCX3_:*^"5A#XAUWQ5HNIQ6RS^#?&6BZE>1M9SZ++:1S>%]7T98
MX[=I \@L94U5_$;Z2WU44K-)_P 2G)M733247S1=N:-XIW9,OBAV3>Z;6L))
M72:>[TE?W96;T/O'X&?L[_LE_M&?'7]O&\^/WPX/[(7BGP!\#?%GB&W_ &?_
M /A'?'>O:7\'-2T7P_HQ\;_M!:,?#I\+P7FG>%=:D@UK0/A)&+K3]9T_Q4/[
M#?4='MK*2+X_^&W["/P)O?A_JOQQ^.O[7]A\&/@-XE^*WC#X7?L^^-!\(/%?
MB[Q)\:8/"6IW6GW?C[_A!M/U.VU?P9X3ACB@EOAJCWES87QNM)OY+&X73Y]4
M]U7_ (*,? _QC^VY\<?B7XY\._$?3/@!\;/V8/$/[(UWKMF=)UCXN6/A*^\-
MZ%HEK\2]8MIY$TO5O%.I77A];C4+#[5,+"UU*/;<:Q+I7D:EYWX1^.7[#OQ/
M^!/AS]E;]HSQ#\</#7@G]G#XL?$[Q%^SK\6_ 'AK0M1\0>+/A?\ $+Q)<:UK
M/A3QQX4O)7MM!\2:K<Q6FKV^J6SZE:6=S,EFYM[;394UC.*M:T5K2C9/FC'3
M$.,WR_%&?L6IPC_>DH\WLXQ3=TWJVW-N]DVF\/%J-[<LH>V7)*?514G;GE-V
M]!_X)40:7XT_:IT'XW?M&^'/A/X+_9F\.?"KQ_\ \+0L? VH^._#/Q ^&GQ4
MO=5.D>+-&M-)\1:?JUO</I>F :=HEE;ZY/JOB6X'AV.Y@6,:I-R_[.'[ W[/
M?[0 TW1X?VT+#2_'?Q%^(/C;P3\&_!>@_!?Q?XSU"^L/#>J-I_ASQ3\6I--U
M:U'PFL_',+V5_I-GK*7*6UC?+<MJ5Y-8:I967HOQ:_X**?"GXK>%/V[?#MMX
M3\3>#='^+_PG_9I^"W[./AP0P:PVD^"O@'XLN]0#>-]6-_&;*_U'3IY]21+:
M/5Q!=7W]DF\NTLO[4NO;OV1?^"C/[.?P6^"W[*_AW4?B1\>/A'<_!#7M<N?B
MW\'OA)X&\,W7A[X_ZGK7BMM2LO&/BGQY<:MIFJ2:?IVERQ#6?#=['/-J=O:O
MX>T];6U6UU)G%7;NWRV25_=G:56:]H[;25*--N$8NTIMV2ORDDTDT_>O+2]T
MN6G2?*M[Q=2=1)RE%.,-&[*_QI\,_P#@GWX&L?AMXM^*_P"UY^TEI7[,/A'3
MOC#XI^ W@K[+\/==^+&L>,_B!X)N;NP\77D6E>&M1L;JQ\)>'K^TGM;C6?*N
M8[B:VN8I7TYCIIU/TS6O^"3C^'?V@/&/PTU/X]6<_P (?A7\"?!?QT^*'QNT
M3X<ZKKZV&F>./M4.@^'?!7@/0O$&JZMXTU/7+VTEC\/S0:C8?VC80W5^]I!-
M#!I]Y]*_"[6]"_:\^!GQ@M_B1^R?\?/V@_@+X6_;&^*WC_X,>*?V=-=\//\
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M%M(_JB_9@U+P_P#%O]E?]B*^^!'P6^&7QBU?]F75O%T/CB[\;?M+^*/@/?\
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MUT;C9:*R4(QTMHK\MVDHQ3=HQ2WJ[:5]TG=WO=N3?771.UY.4G:[;;"BBBJ
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MRU+_ -/NJ5^15?KK^SI_R1?P+_UY:E_Z?=4K"OM'U?Y%PW?I^J/QM_X.+?\
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MH8 D+X')$"3 #Q--EI&(!M1G2@//C!+.S%;8A3LN'.T,!S+NOO/A6BONI_\
M@G?^T,HE(7P._EI$R!/$TH,QDQOCBWZ4@#P9/FF8Q(<'R'FXRK_\$[OVAE,@
M \#2>6\:*4\33 3*X):2/?I*$)#C$@F$4A)'E1RC) ',NZ^\^%**^[#_ ,$[
M?VA06'_%"D"X6 ,/$T^&B/6\7.D!OLZ_Q*RK=G/RVK<X0?\ !.[]H4E01X&
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M+;;9L:409Y=H*,A:V =?,N(R&"A_X)W_ +0P!.WP.2+<3@#Q-+DRE@#9C.E
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M(7MP&7S9XB&"G_#N_P#:&QG;X'S]G\['_"32Y\S=C[)_R"L?:,?-NS]EV_\
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MW8O_  3M_:%)0'_A!5#3O$6;Q-.1'&H&VY?;I#,8),D(J![D$'S+=!@EJ?\
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M,OB:?#QMG-TN[2586\>!O5U6Z.1LMGYP!==U]Z/A2BONL?\ !.[]H4L!CP,
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M)#7?_D&C_A1?QH_Z)1\0_P#PD-=_^0: /*J*]5_X47\:/^B4?$/_ ,)#7?\
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M#'XDO+A]1U[4]>N+B2^CT70U5?/U.2*.'[*Q5$4F5B<  XS^W=;_ .@SJO\
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M7;"FOXU\(:IX3T2'7M.^*&G>,;)M?N/#5W_8%SXMMY-/U2VL_MLD5PNO:5I
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MJ_#>-I+::2"1D/A'XJ,4+Q,K%"RJQ4G!*J2,@8\T_MW6_P#H,ZK_ .#&[_\
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MT0:SI,08KX7T*UU<6::O+I)F:&XBC$GD"1B"%;Y*KUCX9?\ ($^,O_9)Y_\
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MB1XB?0;Q_$=OI$6JZ>8/$.F:)//;1Z9)<6C@I?O-$)9')>-0ZJ"5JAXZ\'^
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MOI+&1["6PFDO6\IXF=/M$-OE2-P)R [>FU_R_'77Y@>C?VK\8O\ HJ_[-_\
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MN^W2[,BBBB@D^@;KP%XX\8?"OX67'A+P=XH\3P63^.H;R;P_H.J:Q%:S2Z_
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M6VN+^ZU.<)I^FZ3%:K)->WEQ/+(L:M(\C,^6)8XWV;P=_P!%X\0?^$EXH_\
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M$EXH_P#ES0!@_P#"D?C-_P!$G^)'_A$^)/\ Y6UW?A/X<_$#PCX6^,.I^*O
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MGZ3#:3M)>0I+*60&7Y@Y.:XG[-X._P"B\>(/_"2\4?\ RYH^S>#O^B\>(/\
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MR(K]E_@]IK:3\+? -E(NR1?"^E7$B$$%9;ZV2^D4@@$,KW+!@1]X'KUK"O\
M#'U_0N&[]/U1\P_M^V;3?"/PW=J"?L7C_3MY R%CN=!\11DGTS*L0!/&3CJ1
M7Y#5^WG[96BMK'P!\62QJ7ET2\T#6D4#)VP:Q:6=RW0D".SOKF1B,85#DXR#
M^(=<QJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!ZKXM_Y)C\(O
MIX]_]2*WKRJOH6#P@/'/PS^'4.F^,/AUI5WH4OC&'4M/\4>//#7AK486O]:B
MN;1Q8ZM?V]RT,T*,Z2B,(P^Z3FL/_A2&K_\ 0_\ P6_\.]X'_P#EM0!'\)[+
M1VTSXDZ[J?@[3_'%SX;\+Z1?:3HNIOK8M3=W_C/PYHEQ<,F@:CIE_(T-AJ5T
MR*+GRU8!Y$95(KT-O#7A6S^+/C5%\!:9>Z7I'PMT_P 7V'@F6;Q"=-BUJZ\#
M^$]:EM@T&JQZ\\2:CJ=ZRPOJ;3 /Y;.0H PO#GP]^(/@ZZGOO"?QC^&7AJ]N
MK?[)<W>A?'+PII5S/:^8DWV>::QUR"22#S8XY/*=BF]$?;N4$7(?!WQ0M_$=
MQXO@^.'P\A\5W<?DW7B6+X]>&8]=N8O(AMO*GU5=>%]+']GMX(-CSLODPQ1X
MV(H ']?U^)HKX;\*WOQ8\"(W@+3+#2]9^&%_XLU'P5%-XA&FRZS:^$/%NK16
MY:XU677DBDOM+LF:)-268A-B.H8@^>_%>ST<:5\-]=TSP;I_@>Z\1^&]9O-6
MT;3'UPVHNM/\7Z]HUO<*FOZCJ=_&TMCI]LS*;GRV8ET158"NQF\'?%"Y\16W
MB^X^.'P\G\56<?DVGB27X]>&9-=MHO)FM_*@U5]>-[%'Y%Q<0[$F5?*FECQM
MD8&GXD^'WQ!\8W4%]XL^,?PR\2WEK!]EMKK7OCGX4U6XM[;S'E^SPS7VN3R1
MP^:[R>6C!-[LV-Q)IZ=OZT_X+^8?U_78^=*]5\(?\DS^+_\ UP\"?^I/6I_P
MI#5_^A_^"W_AWO __P MJW)?!X\#?#3XCQ:EXP^'6JW>N_\ "'V^FZ?X7\>^
M&O$NHSM8Z_\ :[M_L.DW]Q<K%! ?,>7RRBC)8@#-(#D_$'_)%OAA_P!CW\6_
M_35\*J\FKZ"TOPNGCCX2>"]-T_Q;\/\ 1]1\/^-/B)=:A8>+/''AWPO>BVUS
M3?A\FG7,%IJ]];3SV\SZ-J"":-#&'@9=VX$#&_X4AJ__ $/_ ,%O_#O>!_\
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M\!^(],2XCNET_6_C_P"'-4LUN85D2*X%M>^()H1/&DLBI*$WHLCA6 8Y2_\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M2?\ @=\)/_DRC_AZ)^Q1_P!$T_:D_P# [X2?_)E'_$(/$C_HE<;_ .%& _\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@'@C(]#T_*EHH
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M%LU4YPE3C%PRA9S/F;7+0:=J$KKW<2Y1G%4W9/DD^9),_F ZT4@Z#Z"ONO\
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M\"+VX-SXK\-VJPO-<2^ ]=U*],_B^PB*'RO#FI,WBF)-L=A?>);B9+:#^O\
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MTLO6$F\QP,\/@YT8T).>%P-*"Q6'JRM5H5N9QDW.I*OS2LS^@_QSX)T?0O\
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M,73SM!(MLEY.Q6$O96EYIM[/=6NH&!?RZ_X)??M1_#[P1=_M>?"#XR_%B_\
M@B/VM?AW'I&A_'*"/47C\"_$'3KKQ-)8:E>G2GM[JRBO#XPO[TZ@+VPMH)M-
MCMKB\M%O$N8>U^.?[,VL:#\'OB/KP_X*[_#;XQ0Z3X0UG6$^&,/Q'\63W7Q
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MA#=YL;U)+FRNMB3B6/K=<TS]ESPMH.O77A_Q/\0?BMXDU;2[RP\,:5J'AQ/
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M._,YKFBUS747%MIZ;)\_.Y1?/67PB^!-SX2\2_%&?XF>.[;X=:#X[TGP/IT
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M(WPPTOQEJ-AX"^+-WX6OOB%X9MHK*/3_ !)=^"[M[[PY/<@6WG6[V-TRS/\
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M_HT[XL_^"FR_^6%?JW^MG"O_ $4W#_\ X><N_P#FD^6_L?-O^A7F/_A%B?\
MY4? U%??/_#K;_@H1_T:=\6?_!39?_+"C_AUM_P4(_Z-.^+/_@ILO_EA1_K9
MPK_T4W#_ /X><N_^:0_L?-O^A7F/_A%B?_E1\#45]\_\.MO^"A'_ $:=\6?_
M  4V7_RPH_X=;?\ !0C_ *-.^+/_ (*;+_Y84?ZV<*_]%-P__P"'G+O_ )I#
M^Q\V_P"A7F/_ (18G_Y4? U%??/_  ZV_P""A'_1IWQ9_P#!39?_ "PH_P"'
M6W_!0C_HT[XL_P#@ILO_ )84?ZV<*_\ 13</_P#AYR[_ .:0_L?-O^A7F/\
MX18G_P"5'P-17WS_ ,.MO^"A'_1IWQ9_\%-E_P#+"C_AUM_P4(_Z-.^+/_@I
MLO\ Y84?ZV<*_P#13</_ /AYR[_YI#^Q\V_Z%>8_^$6)_P#E1\#45]\_\.MO
M^"A'_1IWQ9_\%-E_\L*/^'6W_!0C_HT[XL_^"FR_^6%'^MG"O_13</\ _AYR
M[_YI#^Q\V_Z%>8_^$6)_^5'P-17WS_PZV_X*$?\ 1IWQ9_\ !39?_+"C_AUM
M_P %"/\ HT[XL_\ @ILO_EA1_K9PK_T4W#__ (><N_\ FD/['S;_ *%>8_\
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M^6%'^MG"O_13</\ _AYR[_YI#^Q\V_Z%>8_^$6)_^5'P-17WS_PZV_X*$?\
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M!@>@_(4A13U4?E110/;;3^O^ ON'4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Sep. 17, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001769628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">CoreWeave, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-289742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">S-4/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Sep. 17, 2025 </div>
<div>USD ($) </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A common stock, par value $0.000005 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">5,195,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 653,670,341.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 100,076.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457fFlg', window );">Rule 457(f)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRcvd', window );">Amount of Securities Received | shares</a></td>
<td class="nump">42,090,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_ValSctiesRcvdPerShr', window );">Value of Securities Received, Per Share | $ / shares</a></td>
<td class="nump">15.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_ValSctiesRcvd', window );">Value of Securities Received</a></td>
<td class="nump">$ 653,670,341.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeNoteMaxAggtOfferingPric', window );">Fee Note MAOP</a></td>
<td class="nump">$ 653,670,341.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Represents the estimated maximum number of shares of Class A common stock, par value $0.000005 per share, of CoreWeave, Inc., a Delaware corporation (&#8220;CoreWeave&#8221; and such shares, the &#8220;CoreWeave common stock&#8221;), issuable in connection with the proposed merger of Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave, with and into Core Scientific, Inc., a Delaware corporation (&#8220;Core Scientific&#8221;), with Core Scientific continuing as the surviving company and as a wholly owned subsidiary of CoreWeave (the &#8220;Merger&#8221;). Consists of, based on the exchange ratio of 0.1235 shares of CoreWeave common stock per common stock, par value $0.00001 per share, of Core Scientific (the &#8220;Core Scientific common stock&#8221;), in each case with respect to outstanding Core Scientific shares or securities convertible into Core Scientific shares, and Tranche 1 Warrants and Tranche 2 Warrants, outstanding as of September 11, 2025: (i) 58,296,250 shares of CoreWeave common stock to be issued, in exchange for (a) 306,833,449 shares of Core Scientific common stock, (b) 288,460 shares of Core Scientific common stock reserved for disputed claims in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) filed with the United States Bankruptcy Court for the Southern District of Texas by Core Scientific and certain of its affiliates, (c) an estimated maximum of 6,553,528 shares of Core Scientific common stock underlying certain Core Scientific restricted stock unit awards (whether vested or unvested), (d) an estimated maximum of 7,088,694 shares of Core Scientific common stock underlying certain Core Scientific performance stock unit awards (whether vested or unvested), (e) an estimated maximum of 48,004 shares of Core Scientific common stock underlying in-the-money Core Scientific options that may be exercised prior to the closing of the Merger pursuant to the formula set forth in the Merger Agreement, assuming that the Per Company Share Price (as defined in the Merger Agreement) is $13.24, which is based on the average of the volume weighted averages of the trading prices of CoreWeave common stock (as reported by Bloomberg L.P.) on each of the five consecutive trading days ending on (and including) September 11, 2025 and (f) 41,825,776 shares of Core Scientific common stock reserved for issuance upon the conversion of Core Scientific&#8217;s 3.00% Convertible Senior Notes due 2029, (ii) 12,032,877 shares of CoreWeave common stock issuable upon exercise of New Tranche 1 Warrants (as defined in the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. (the &#8220;Warrant Agreement&#8221;)) to purchase shares of CoreWeave common stock issued in exchange for Tranche 1 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock and (iii) 1,480,409 shares of CoreWeave common stock issuable upon exercise of New Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of CoreWeave common stock issued in exchange for Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock. 53,100,853 shares of CoreWeave common stock were previously registered on Form S-4 filed by CoreWeave on August 20, 2025 and 5,195,397 shares are being registered herein.</span> </div> </td> </tr> </table><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(2)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $653,670,341.42 is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on September 12, 2025 ($15.53) multiplied by (y) the maximum number of shares of Core Scientific common stock (42,090,814) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">New Tranche 1 Warrants to purchase CoreWeave common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(3)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 1 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 1 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 1 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 1 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=3', window );">Offering: 3</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">New Tranche 2 Warrants to purchase CoreWeave common stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(4)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 2 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 2 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 2 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 2 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=4', window );">Offering: 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Class A common stock, par value $0.000005 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">53,100,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 5,877,640,852.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 899,866.81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457fFlg', window );">Rule 457(f)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRcvd', window );">Amount of Securities Received | shares</a></td>
<td class="nump">429,966,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_ValSctiesRcvdPerShr', window );">Value of Securities Received, Per Share | $ / shares</a></td>
<td class="nump">13.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_ValSctiesRcvd', window );">Value of Securities Received</a></td>
<td class="nump">$ 5,877,640,852.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeNoteMaxAggtOfferingPric', window );">Fee Note MAOP</a></td>
<td class="nump">$ 5,877,640,852.04<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(1)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Represents the estimated maximum number of shares of Class A common stock, par value $0.000005 per share, of CoreWeave, Inc., a Delaware corporation (&#8220;CoreWeave&#8221; and such shares, the &#8220;CoreWeave common stock&#8221;), issuable in connection with the proposed merger of Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave, with and into Core Scientific, Inc., a Delaware corporation (&#8220;Core Scientific&#8221;), with Core Scientific continuing as the surviving company and as a wholly owned subsidiary of CoreWeave (the &#8220;Merger&#8221;). Consists of, based on the exchange ratio of 0.1235 shares of CoreWeave common stock per common stock, par value $0.00001 per share, of Core Scientific (the &#8220;Core Scientific common stock&#8221;), in each case with respect to outstanding Core Scientific shares or securities convertible into Core Scientific shares, and Tranche 1 Warrants and Tranche 2 Warrants, outstanding as of September 11, 2025: (i) 58,296,250 shares of CoreWeave common stock to be issued, in exchange for (a) 306,833,449 shares of Core Scientific common stock, (b) 288,460 shares of Core Scientific common stock reserved for disputed claims in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) filed with the United States Bankruptcy Court for the Southern District of Texas by Core Scientific and certain of its affiliates, (c) an estimated maximum of 6,553,528 shares of Core Scientific common stock underlying certain Core Scientific restricted stock unit awards (whether vested or unvested), (d) an estimated maximum of 7,088,694 shares of Core Scientific common stock underlying certain Core Scientific performance stock unit awards (whether vested or unvested), (e) an estimated maximum of 48,004 shares of Core Scientific common stock underlying in-the-money Core Scientific options that may be exercised prior to the closing of the Merger pursuant to the formula set forth in the Merger Agreement, assuming that the Per Company Share Price (as defined in the Merger Agreement) is $13.24, which is based on the average of the volume weighted averages of the trading prices of CoreWeave common stock (as reported by Bloomberg L.P.) on each of the five consecutive trading days ending on (and including) September 11, 2025 and (f) 41,825,776 shares of Core Scientific common stock reserved for issuance upon the conversion of Core Scientific&#8217;s 3.00% Convertible Senior Notes due 2029, (ii) 12,032,877 shares of CoreWeave common stock issuable upon exercise of New Tranche 1 Warrants (as defined in the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. (the &#8220;Warrant Agreement&#8221;)) to purchase shares of CoreWeave common stock issued in exchange for Tranche 1 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock and (iii) 1,480,409 shares of CoreWeave common stock issuable upon exercise of New Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of CoreWeave common stock issued in exchange for Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock. 53,100,853 shares of CoreWeave common stock were previously registered on Form S-4 filed by CoreWeave on August 20, 2025 and 5,195,397 shares are being registered herein.</span> </div> </td> </tr> </table><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(5)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $5,877,640,852.04 is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on August 14, 2025 ($13.67) multiplied by (y) the maximum number of shares of Core Scientific common stock (429,966,412) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=5', window );">Offering: 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">New Tranche 1 Warrants to purchase CoreWeave common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">97,434,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(3)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 1 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 1 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 1 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 1 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=6', window );">Offering: 6</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">New Tranche 2 Warrants to purchase CoreWeave common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">12,406,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01531%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text"><table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"> <tr style="vertical-align: top;"> <td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">(4)</span> </div> </td> <td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"> <div style="font-size: 7pt;"> <span style="font-size: 10.0pt;">Consists of CoreWeave New Tranche 2 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 2 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 2 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 2 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.</span> </div> </td> </tr> </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRcvd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRcvd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeNoteMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeNoteMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457fFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457fFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_ValSctiesRcvd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_ValSctiesRcvd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_ValSctiesRcvdPerShr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_ValSctiesRcvdPerShr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=6">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=6</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Sep. 17, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 6,531,311,193.46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">899,866.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">999,943.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 100,076.93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>7</ContextCount>
  <ElementCount>27</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="ny20053122x2_exfee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20053122x2_exfee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20053122x2_exfee.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="ny20053122x2_exfee.htm">ny20053122x2_exfee.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="69">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>54
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20053122x2_exfee.htm": {
   "dts": {
    "inline": {
     "local": [
      "ny20053122x2_exfee.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 27,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 7,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 69,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20053122x2_exfee.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>55
<FILENAME>0001140361-25-035263-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-035263-xbrl.zip
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M9I]:K,T@AV N83P@C:[I X;'*62GVU]L<J+4T$TZPW@]U(<E-*D5^HRS55S
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M7#K@&V<)1WLOVIH@\,-VFSE,^,1WM,4]/R![@L0UM;HN1B-RYMDX4>S-8)\
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M\IY3_S]02P$"% ,4    " "HA3%; !9OZ' 5   <S   %@
M@ $     ;GDR,# U,S$R,G@R7V5X9F5E+FAT;5!+!08      0 ! $0   "D
%%0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>ny20053122x2_exfee_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>3</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>4</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>5</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769628</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>6</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-17</startDate>
            <endDate>2025-09-17</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-20">S-4</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-29">CoreWeave, Inc.</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c1" id="ixv-106">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c1" id="ixv-110">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c1" id="ixv-114">Class A common stock, par value $0.000005 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c1" id="ixv-403">true</ffd:FeesOthrRuleFlg>
    <ffd:Rule457fFlg contextRef="c1" id="ixv-404">true</ffd:Rule457fFlg>
    <ffd:AmtSctiesRegd
      contextRef="c1"
      decimals="INF"
      id="ixv-405"
      unitRef="shares">5195397</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric contextRef="c1" decimals="INF" id="ixv-406" unitRef="usd">653670341.42</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c1" decimals="8" id="ixv-407" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c1" decimals="2" id="ixv-408" unitRef="usd">100076.93</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c2" id="ixv-137">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c2" id="ixv-141">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c2" id="ixv-409">New Tranche 1 Warrants to purchase CoreWeave common stock</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c2" id="ixv-148">true</ffd:FeesOthrRuleFlg>
    <ffd:FeeRate contextRef="c2" decimals="8" id="ixv-410" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c2" decimals="0" id="ixv-411" unitRef="usd">0</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c3" id="ixv-168">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c3" id="ixv-172">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c3" id="ixv-412">New Tranche 2 Warrants to purchase CoreWeave common stock</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c3" id="ixv-179">true</ffd:FeesOthrRuleFlg>
    <ffd:FeeRate contextRef="c3" decimals="8" id="ixv-413" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c3" decimals="0" id="ixv-414" unitRef="usd">0</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c4" id="ixv-199">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c4" id="ixv-203">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c4" id="ixv-207">Class A common stock, par value $0.000005 per share</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c4" id="ixv-415">true</ffd:FeesOthrRuleFlg>
    <ffd:Rule457fFlg contextRef="c4" id="ixv-416">true</ffd:Rule457fFlg>
    <ffd:AmtSctiesRegd
      contextRef="c4"
      decimals="INF"
      id="ixv-417"
      unitRef="shares">53100853</ffd:AmtSctiesRegd>
    <ffd:MaxAggtOfferingPric contextRef="c4" decimals="INF" id="ixv-418" unitRef="usd">5877640852.04</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate contextRef="c4" decimals="8" id="ixv-419" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c4" decimals="2" id="ixv-420" unitRef="usd">899866.81</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c5" id="ixv-230">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c5" id="ixv-234">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c5" id="ixv-421">New Tranche 1 Warrants to purchase CoreWeave common stock</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c5" id="ixv-241">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c5"
      decimals="INF"
      id="ixv-422"
      unitRef="shares">97434281</ffd:AmtSctiesRegd>
    <ffd:FeeRate contextRef="c5" decimals="8" id="ixv-423" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c5" decimals="0" id="ixv-424" unitRef="usd">0</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c6" id="ixv-261">true</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c6" id="ixv-265">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c6" id="ixv-425">New Tranche 2 Warrants to purchase CoreWeave common stock</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c6" id="ixv-272">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c6"
      decimals="INF"
      id="ixv-426"
      unitRef="shares">12406445</ffd:AmtSctiesRegd>
    <ffd:FeeRate contextRef="c6" decimals="8" id="ixv-427" unitRef="pure">0.0001531</ffd:FeeRate>
    <ffd:FeeAmt contextRef="c6" decimals="0" id="ixv-428" unitRef="usd">0</ffd:FeeAmt>
    <ffd:TtlOfferingAmt contextRef="c0" decimals="INF" id="ixv-429" unitRef="usd">6531311193.46</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt contextRef="c0" decimals="2" id="ixv-430" unitRef="usd">999943.74</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt contextRef="c0" decimals="2" id="ixv-431" unitRef="usd">899866.81</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt contextRef="c0" decimals="0" id="ixv-432" unitRef="usd">0</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt contextRef="c0" decimals="2" id="ixv-433" unitRef="usd">100076.93</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c4" id="ixv-339">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Represents the estimated maximum number of shares of Class A common stock, par value $0.000005 per share, of CoreWeave, Inc., a Delaware corporation (&#x201c;CoreWeave&#x201d; and such shares, the &#x201c;CoreWeave common stock&#x201d;), issuable in connection with the proposed merger of Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave, with and into Core Scientific, Inc., a Delaware corporation (&#x201c;Core Scientific&#x201d;), with Core Scientific continuing as the surviving company and as a wholly owned subsidiary of CoreWeave (the &#x201c;Merger&#x201d;). Consists of, based on the exchange ratio of 0.1235 shares of CoreWeave common stock per common stock, par value $0.00001 per share, of Core Scientific (the &#x201c;Core Scientific common stock&#x201d;), in each case with respect to outstanding Core Scientific shares or securities convertible into Core Scientific shares, and Tranche 1 Warrants and Tranche 2 Warrants, outstanding as of September 11, 2025: (i) 58,296,250 shares of CoreWeave common stock to be issued, in exchange for (a) 306,833,449 shares of Core Scientific common stock, (b) 288,460 shares of Core Scientific common stock reserved for disputed claims in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) filed with the United States Bankruptcy Court for the Southern District of Texas by Core Scientific and certain of its affiliates, (c) an estimated maximum of 6,553,528 shares of Core Scientific common stock underlying certain Core Scientific restricted stock unit awards (whether vested or unvested), (d) an estimated maximum of 7,088,694 shares of Core Scientific common stock underlying certain Core Scientific performance stock unit awards (whether vested or unvested), (e) an estimated maximum of 48,004 shares of Core Scientific common stock underlying in-the-money Core Scientific options that may be exercised prior to the closing of the Merger pursuant to the formula set forth in the Merger Agreement, assuming that the Per Company Share Price (as defined in the Merger Agreement) is $13.24, which is based on the average of the volume weighted averages of the trading prices of CoreWeave common stock (as reported by Bloomberg L.P.) on each of the five consecutive trading days ending on (and including) September 11, 2025 and (f) 41,825,776 shares of Core Scientific common stock reserved for issuance upon the conversion of Core Scientific&#x2019;s 3.00% Convertible Senior Notes due 2029, (ii) 12,032,877 shares of CoreWeave common stock issuable upon exercise of New Tranche 1 Warrants (as defined in the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. (the &#x201c;Warrant Agreement&#x201d;)) to purchase shares of CoreWeave common stock issued in exchange for Tranche 1 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock and (iii) 1,480,409 shares of CoreWeave common stock issuable upon exercise of New Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of CoreWeave common stock issued in exchange for Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock. 53,100,853 shares of CoreWeave common stock were previously registered on Form S-4 filed by CoreWeave on August 20, 2025 and 5,195,397 shares are being registered herein.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(5)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $5,877,640,852.04 is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on August 14, 2025 ($13.67) multiplied by (y) the maximum number of shares of Core Scientific common stock (429,966,412) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c1" id="ixv-340">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(1)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Represents the estimated maximum number of shares of Class A common stock, par value $0.000005 per share, of CoreWeave, Inc., a Delaware corporation (&#x201c;CoreWeave&#x201d; and such shares, the &#x201c;CoreWeave common stock&#x201d;), issuable in connection with the proposed merger of Miami Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of CoreWeave, with and into Core Scientific, Inc., a Delaware corporation (&#x201c;Core Scientific&#x201d;), with Core Scientific continuing as the surviving company and as a wholly owned subsidiary of CoreWeave (the &#x201c;Merger&#x201d;). Consists of, based on the exchange ratio of 0.1235 shares of CoreWeave common stock per common stock, par value $0.00001 per share, of Core Scientific (the &#x201c;Core Scientific common stock&#x201d;), in each case with respect to outstanding Core Scientific shares or securities convertible into Core Scientific shares, and Tranche 1 Warrants and Tranche 2 Warrants, outstanding as of September 11, 2025: (i) 58,296,250 shares of CoreWeave common stock to be issued, in exchange for (a) 306,833,449 shares of Core Scientific common stock, (b) 288,460 shares of Core Scientific common stock reserved for disputed claims in connection with the Fourth Amended Joint Chapter 11 Plan of Core Scientific, Inc. and its Affiliated Debtors (with Technical Modifications) filed with the United States Bankruptcy Court for the Southern District of Texas by Core Scientific and certain of its affiliates, (c) an estimated maximum of 6,553,528 shares of Core Scientific common stock underlying certain Core Scientific restricted stock unit awards (whether vested or unvested), (d) an estimated maximum of 7,088,694 shares of Core Scientific common stock underlying certain Core Scientific performance stock unit awards (whether vested or unvested), (e) an estimated maximum of 48,004 shares of Core Scientific common stock underlying in-the-money Core Scientific options that may be exercised prior to the closing of the Merger pursuant to the formula set forth in the Merger Agreement, assuming that the Per Company Share Price (as defined in the Merger Agreement) is $13.24, which is based on the average of the volume weighted averages of the trading prices of CoreWeave common stock (as reported by Bloomberg L.P.) on each of the five consecutive trading days ending on (and including) September 11, 2025 and (f) 41,825,776 shares of Core Scientific common stock reserved for issuance upon the conversion of Core Scientific&#x2019;s 3.00% Convertible Senior Notes due 2029, (ii) 12,032,877 shares of CoreWeave common stock issuable upon exercise of New Tranche 1 Warrants (as defined in the Warrant Agreement, dated as of January 23, 2024, by and between Core Scientific and Computershare Inc. and its affiliate, Computershare Trust Company, N.A. (the &#x201c;Warrant Agreement&#x201d;)) to purchase shares of CoreWeave common stock issued in exchange for Tranche 1 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock and (iii) 1,480,409 shares of CoreWeave common stock issuable upon exercise of New Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of CoreWeave common stock issued in exchange for Tranche 2 Warrants (as defined in the Warrant Agreement) to purchase shares of Core Scientific common stock. 53,100,853 shares of CoreWeave common stock were previously registered on Form S-4 filed by CoreWeave on August 20, 2025 and 5,195,397 shares are being registered herein.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(2)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Estimated solely for the purpose of calculating the registration fee required by Section 6(b) of the Securities Act of 1933, as amended, and calculated in accordance with Rules 457(c) and 457(f)(1) promulgated thereunder. The aggregate offering price $653,670,341.42 is (x) the average of the high and low prices of Core Scientific common stock as reported on Nasdaq on September 12, 2025 ($15.53) multiplied by (y) the maximum number of shares of Core Scientific common stock (42,090,814) to be exchanged for shares of CoreWeave common stock upon completion of the Merger.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:FeeNoteMaxAggtOfferingPric contextRef="c1" decimals="INF" id="ixv-434" unitRef="usd">653670341.42</ffd:FeeNoteMaxAggtOfferingPric>
    <ffd:ValSctiesRcvd contextRef="c1" decimals="INF" id="ixv-435" unitRef="usd">653670341.42</ffd:ValSctiesRcvd>
    <ffd:ValSctiesRcvdPerShr
      contextRef="c1"
      decimals="INF"
      id="ixv-436"
      unitRef="usdPershares">15.53</ffd:ValSctiesRcvdPerShr>
    <ffd:AmtSctiesRcvd
      contextRef="c1"
      decimals="INF"
      id="ixv-437"
      unitRef="shares">42090814</ffd:AmtSctiesRcvd>
    <ffd:OfferingNote contextRef="c2" id="ixv-364">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(3)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Consists of CoreWeave New Tranche 1 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 1 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 1 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 1 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c5" id="ixv-365">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(3)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Consists of CoreWeave New Tranche 1 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 1 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 1 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 1 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c3" id="ixv-377">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(4)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Consists of CoreWeave New Tranche 2 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 2 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 2 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 2 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c6" id="ixv-378">&lt;table style="font-size: 10pt; border-spacing: 0px; border-collapse: collapse; width: 100%;"&gt; &lt;tr style="vertical-align: top;"&gt; &lt;td style="padding: 0; width: 4.82%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;(4)&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;td style="padding: 0; width: 95.18%; padding-left: 5.4pt; padding-right: 5.4pt;"&gt; &lt;div style="font-size: 7pt;"&gt; &lt;span style="font-size: 10.0pt;"&gt;Consists of CoreWeave New Tranche 2 Warrants to purchase shares of CoreWeave common stock issued in the Merger in exchange for Tranche 2 Warrants to purchase shares of Core Scientific common stock. The registration fee with respect to the CoreWeave New Tranche 2 Warrants has been allocated to the underlying shares of CoreWeave common stock issuable upon exercise of such New Tranche 2 Warrants, as described in footnote (1). Pursuant to Rule 416, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.&lt;/span&gt; &lt;/div&gt; &lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ffd:OfferingNote>
    <ffd:FeeNoteMaxAggtOfferingPric contextRef="c4" decimals="INF" id="ixv-438" unitRef="usd">5877640852.04</ffd:FeeNoteMaxAggtOfferingPric>
    <ffd:ValSctiesRcvd contextRef="c4" decimals="INF" id="ixv-439" unitRef="usd">5877640852.04</ffd:ValSctiesRcvd>
    <ffd:ValSctiesRcvdPerShr
      contextRef="c4"
      decimals="INF"
      id="ixv-440"
      unitRef="usdPershares">13.67</ffd:ValSctiesRcvdPerShr>
    <ffd:AmtSctiesRcvd
      contextRef="c4"
      decimals="INF"
      id="ixv-441"
      unitRef="shares">429966412</ffd:AmtSctiesRcvd>
    <ffd:SubmissnTp contextRef="c0" id="hidden-fact-0">S-4/A</ffd:SubmissnTp>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-445">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-446">0001769628</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-447">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-448">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-449">333-289742</ffd:RegnFileNb>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
